Citrus Sinensis ID: 038211
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 605 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.381 | 0.247 | 0.597 | 2e-81 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.386 | 0.285 | 0.605 | 2e-79 | |
| Q54TM7 | 1288 | Probable serine/threonine | yes | no | 0.370 | 0.173 | 0.468 | 2e-53 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.414 | 0.390 | 0.427 | 8e-51 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.434 | 0.158 | 0.346 | 1e-49 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.386 | 0.339 | 0.427 | 9e-49 | |
| Q54Y55 | 506 | Dual specificity protein | no | no | 0.340 | 0.407 | 0.456 | 3e-46 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.433 | 0.286 | 0.361 | 4e-46 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.373 | 0.301 | 0.436 | 4e-46 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.347 | 0.129 | 0.396 | 5e-44 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 304 bits (778), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 138/231 (59%), Positives = 173/231 (74%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH 434
I W DL + E IGLGSY VY W+G++VAVK + ++ L ++ E+ I+++LRH
Sbjct: 664 IPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLRH 723
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
PNV+ F+GAV L IVTEFLPRGSL++ LH+ +D +RR++MALDVA GMN LH
Sbjct: 724 PNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMGMNCLHT 783
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEP 554
P IVHRDLK+ NLLVD NW VKVGDFGLS LK+ T+L++KS GTP+WMAPEVLR+EP
Sbjct: 784 STPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 843
Query: 555 SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
SNEK DV+SFGVILWEL T +PW +N MQVVG VGF +RRLE+P+ LDP
Sbjct: 844 SNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDP 894
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 297 bits (760), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 143/236 (60%), Positives = 177/236 (75%), Gaps = 2/236 (0%)
Query: 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKK 431
D I W DL + E+IG GS+ V+R W+GSDVAVK+ ++ + + +E+ I+K+
Sbjct: 543 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKR 602
Query: 432 LRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN--YQALDIKRRLRMALDVARGM 489
LRHPN++LFMGAV L IVTE+L RGSL++ LHK+ + LD +RRL MA DVA+GM
Sbjct: 603 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 662
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEV 549
NYLH+RNPPIVHRDLKS NLLVDK +TVKV DFGLS LK +T+L++KS GTP+WMAPEV
Sbjct: 663 NYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 722
Query: 550 LRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
LR EPSNEKSDV+SFGVILWEL T PW NLN QVV VGF +RLE+P L+P
Sbjct: 723 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 778
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (536), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 110/235 (46%), Positives = 148/235 (62%), Gaps = 11/235 (4%)
Query: 377 WE----DLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL 432
WE ++ +G IG G Y V+RG W G++VAVK+ F + + +KE+D++ KL
Sbjct: 844 WEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLCKL 903
Query: 433 RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
RHPN++LFMGA IVTE+L RGSL L +D RL++ D ARGM YL
Sbjct: 904 RHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYL 963
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS 552
H RNP I+HRDLK+ NLLVD +W VKV DFGL+++K+ T+ AK+ GT W+APEVL
Sbjct: 964 HSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTF--AKTMCGTTGWVAPEVLAE 1021
Query: 553 EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDR--RLELPEGLDP 605
E EK+DV+S+ ++LWEL+T IP+ N MQVV + DR RL +P P
Sbjct: 1022 EGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSI---DRGERLPMPAWCPP 1073
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 202 bits (513), Expect = 8e-51, Method: Compositional matrix adjust.
Identities = 109/255 (42%), Positives = 150/255 (58%), Gaps = 4/255 (1%)
Query: 353 SRSRESSSSKGD-NETSCATDG-GIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYF 410
+R R S K D N+ + DG I +++G IG G+Y VY G W GS VAVK
Sbjct: 345 NRYRSSGYYKPDKNDYTQIKDGKDIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLP 404
Query: 411 GSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNY 470
E LK + +EI+++K LRHPNV+ F+G+ + I TE++PRGSL+ LH
Sbjct: 405 AHNINENILKEFHREINLMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQA 464
Query: 471 QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530
L ++M +D A+G+ YLH+ P I+HRDLKS NLLVD+NW VKV DFGLS+++
Sbjct: 465 LQLQWSLLIKMMIDAAKGVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQ 524
Query: 531 TYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590
+ GTP W +PEVLRS+ EK+DV+SFG+ILWE T P+ + QV+ V
Sbjct: 525 G--ATMTACGTPCWTSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAV 582
Query: 591 GFMDRRLELPEGLDP 605
G R +P+ P
Sbjct: 583 GREGMRPPVPQNGPP 597
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 198 bits (503), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 94/271 (34%), Positives = 167/271 (61%), Gaps = 8/271 (2%)
Query: 335 DVNELDPDGKQYPSLGESSRSRESSSSKGDNETSCATDGGIRW----EDLQLGEEIGLGS 390
D +++D D + S ++ + ++ +NE + G W +++++GE+IGLGS
Sbjct: 1351 DYDDMDTDNSTF-SARVPHQAYQYHAAIENNERYLTSAGLCSWVINYDEIKMGEQIGLGS 1409
Query: 391 YAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450
Y VVYRG W DVA+K + + E L ++EI +KKL HPN++ +GA + +
Sbjct: 1410 YGVVYRGKWKNVDVAIKKFIKQKIDENHLLGIREEIAFLKKLHHPNIITMVGASLKKPNI 1469
Query: 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLL 510
IVTE++ +G+L + L+ +++++ +++A+G++YLH +PPI+HRD+K SN+L
Sbjct: 1470 CIVTEYMAKGNLRDAMRTCTPKLEWHQKIKILVNIAKGISYLHSFDPPIIHRDIKPSNIL 1529
Query: 511 VDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWE 570
+D+NW VK+ DFG + +K + + GTP W APE++R++ +EK DVFSFG+++WE
Sbjct: 1530 IDENWNVKIADFGFARIKEENAIMTRC--GTPCWTAPEIIRNDIYDEKVDVFSFGIVMWE 1587
Query: 571 LVTASIPWNNLNLMQVVGVVGFMDRRLELPE 601
++T P+ N M++ + D R ++P+
Sbjct: 1588 VLTCKEPFIGANFMKITMDI-LEDVRPKIPQ 1617
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 195 bits (496), Expect = 9e-49, Method: Compositional matrix adjust.
Identities = 101/236 (42%), Positives = 139/236 (58%), Gaps = 2/236 (0%)
Query: 356 RESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYI 415
R+ +SK T I + +++G IG G++ VY G W GS VAVK
Sbjct: 367 RKRLNSKRSGYTQIKDGKDIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNIN 426
Query: 416 EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDI 475
E LK + +EI+++K LRHPNV+ F+G+ + I TE++PRGSL+ LH +
Sbjct: 427 ENILKEFHREINLMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISW 486
Query: 476 KRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535
RM +D A+G+ YLH P I+HRDLKS NLLVD+NW VKV DFGLS+++
Sbjct: 487 SLVKRMMIDAAKGIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--AT 544
Query: 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591
+ GTP W +PEVLRS+ EK+DV+SFG+ILWE T P+ + QV+ VG
Sbjct: 545 MTACGTPCWTSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVG 600
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54Y55|SHKC_DICDI Dual specificity protein kinase shkC OS=Dictyostelium discoideum GN=shkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 187 bits (474), Expect = 3e-46, Method: Compositional matrix adjust.
Identities = 95/208 (45%), Positives = 132/208 (63%), Gaps = 2/208 (0%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH 434
IR E++ E IG GS+ VY+G VAVK+ + TL ++KE+ ++ K+ H
Sbjct: 19 IRPEEINFEELIGTGSFGKVYKGRCRQKAVAVKLLHKQNFDAATLSAFRKEVHLMSKIYH 78
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
PN+ LFMGA R IVTE +P+G+L LH L + R+RMA D A G+N+LH
Sbjct: 79 PNICLFMGACTIPGRCVIVTELVPKGNLETLLHDQKIQLPLYLRMRMARDAALGINWLHE 138
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA--KSGRGTPQWMAPEVLRS 552
NP VHRD+KSSNLLVD+N VK+ DFGLS+LK + S +GTP +MAPEV+
Sbjct: 139 SNPVFVHRDIKSSNLLVDENMRVKICDFGLSALKQKHKMLKDQSSAKGTPLYMAPEVMMF 198
Query: 553 EPSNEKSDVFSFGVILWELVTASIPWNN 580
+ NE SDV+SFG++LWE++T P+++
Sbjct: 199 KEFNESSDVYSFGIVLWEILTRKEPFSH 226
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (473), Expect = 4e-46, Method: Compositional matrix adjust.
Identities = 97/268 (36%), Positives = 160/268 (59%), Gaps = 6/268 (2%)
Query: 336 VNELDPDGKQYPSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVY 395
+N P+ QY + G ++ S + +D I + +L++ ++G G++ VVY
Sbjct: 620 INNHSPN--QYNNQGNILKNSGSVVEPPSQQQQYFSDIEISFSELKISSKLGEGTFGVVY 677
Query: 396 RGIWNGSDVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454
+G+W GS VA+K + + L+ ++KE+ I+ +LRHPN++L M A + L +T
Sbjct: 678 KGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFIT 737
Query: 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN 514
E+LP GSL+ LH ++++ ++A+ +A+GMNYLH ++HRD+KS NLL+D++
Sbjct: 738 EYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYLHLSG--VIHRDIKSLNLLLDEH 795
Query: 515 WTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTA 574
VK+ DFGLS LK+ + KS G+P WM+PE+L E EK DV++FG+ILWEL T
Sbjct: 796 MNVKICDFGLSKLKSKSTEMTKS-IGSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTG 854
Query: 575 SIPWNNLNLMQVVGVVGFMDRRLELPEG 602
+P++ L+ +Q+ V R +P
Sbjct: 855 ELPYSGLDSVQLALAVTTKSLRPPIPNA 882
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (472), Expect = 4e-46, Method: Compositional matrix adjust.
Identities = 100/229 (43%), Positives = 140/229 (61%), Gaps = 3/229 (1%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLR 433
I ++ + IG GS A V+ G W G VA+K +E E L +E I+ +LR
Sbjct: 486 IDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNEDDEDFLNELAQEATIMSQLR 545
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
HPN+ F+G + + IV E++P GSL++ LH +LD R MALD+A+GMNYLH
Sbjct: 546 HPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMALDIAKGMNYLH 605
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTPQWMAPEVLR 551
+P ++HRDLKS NLLVD+++ VK+ DFGLS+ K+ TA + GTP W APEVLR
Sbjct: 606 CCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGTPCWTAPEVLR 665
Query: 552 SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELP 600
++P EK+DVFSF ++LWE+VT P+ + Q+V VG R +P
Sbjct: 666 NDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVP 714
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 179 bits (455), Expect = 5e-44, Method: Compositional matrix adjust.
Identities = 84/212 (39%), Positives = 133/212 (62%), Gaps = 2/212 (0%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH 434
I ++++ +G++IGLGSY +V+ G W G DVAVK + + E L ++ E+ + +L+H
Sbjct: 1359 INYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSETQLLEFRAEMAFLSELKH 1418
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
N++ F+GA + + IVTE++ G+L L + +L++ A G++YLH
Sbjct: 1419 SNIVTFIGACIKKPNICIVTEYMRMGNLRDVLKNPDIKITFANKLKLLYGAAMGIDYLHS 1478
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEP 554
NP IVHRD+K +N+LVD+++ VK+ DFG + +K T + GTP W APEV+R E
Sbjct: 1479 SNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDN--TTMTRCGTPCWTAPEVIRGEK 1536
Query: 555 SNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
EK+DVFSFGV++WE++T P+ N M+V
Sbjct: 1537 YCEKADVFSFGVVMWEVLTGKEPFAECNFMKV 1568
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 605 | ||||||
| 255537317 | 730 | map3k delta-1 protein kinase, putative [ | 0.993 | 0.823 | 0.541 | 0.0 | |
| 225426834 | 721 | PREDICTED: uncharacterized protein LOC10 | 0.983 | 0.825 | 0.540 | 0.0 | |
| 297742573 | 695 | unnamed protein product [Vitis vinifera] | 0.948 | 0.825 | 0.541 | 1e-179 | |
| 147794123 | 723 | hypothetical protein VITISV_001269 [Viti | 0.943 | 0.789 | 0.496 | 1e-157 | |
| 297803818 | 724 | predicted protein [Arabidopsis lyrata su | 0.995 | 0.831 | 0.456 | 1e-152 | |
| 30686028 | 736 | PAS domain-containing protein tyrosine k | 0.986 | 0.811 | 0.439 | 1e-150 | |
| 18416060 | 735 | PAS domain-containing protein tyrosine k | 0.988 | 0.813 | 0.434 | 1e-150 | |
| 356495657 | 770 | PREDICTED: uncharacterized protein LOC10 | 0.641 | 0.503 | 0.608 | 1e-125 | |
| 224108736 | 781 | predicted protein [Populus trichocarpa] | 0.890 | 0.690 | 0.425 | 1e-117 | |
| 449462150 | 774 | PREDICTED: LOW QUALITY PROTEIN: uncharac | 0.892 | 0.697 | 0.404 | 1e-114 |
| >gi|255537317|ref|XP_002509725.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223549624|gb|EEF51112.1| map3k delta-1 protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 645 bits (1663), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/689 (54%), Positives = 457/689 (66%), Gaps = 88/689 (12%)
Query: 1 MAGDE--SGPSLYRDLLDRFEGLEAGHAKLREELNDLLLQEK-----KKNDDV---DEVA 50
MAGDE SG SLYR + DR LEA HAKL+EEL++L+ + KKND+V D
Sbjct: 1 MAGDENESGASLYRVVADRCISLEASHAKLKEELSELVDENNRKRIIKKNDEVVMQDSDE 60
Query: 51 TTSDSV-----------GPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVF 99
TSDS PY+ VLES+GHAVHVC A+S +IIYWNRSAE LYGWK+ EV
Sbjct: 61 VTSDSGMGCVSGFFAAGSPYKRVLESIGHAVHVCNAASGEIIYWNRSAEHLYGWKESEVL 120
Query: 100 GQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLYEDGELA 159
GQ V +++EE+ P +I+ERL+ GQSWSG+FPFKK+SGEI MA+V+KSPLYEDG+L+
Sbjct: 121 GQSVAGLIVSEEYSQPLNRIVERLSFGQSWSGRFPFKKKSGEIFMAMVSKSPLYEDGKLS 180
Query: 160 GFITVSSDAAIFNSINPQHPRPYPNRGQMHGLNLKKIQWQPHQPQIAQVPNIASSVTN-- 217
G ITVSSDA + N + ++ R +R ++ +N K+IQW P +P IA VP IASS +
Sbjct: 181 GIITVSSDAQMSNGAHSENLRTQQDRARIPRINWKRIQWHP-RPPIAPVPQIASSSVSAF 239
Query: 218 ----------------------------------------------LTAKVLEKMHIGET 231
L +KVL K++IG
Sbjct: 240 FCLINQASKLILRKNGDDTCDENVNSKDKEHTLTKTNDVKSTLPGALASKVLAKLNIGGI 299
Query: 232 GTYVGGDDGSLRQNGLRYKSFCNEITNKPNSSRFPDQHTSSSEDKAKCVGKINSSFAAEN 291
DD S ++NGL S + + S + S +E K + K NSS A +
Sbjct: 300 SCKEKEDDISSQENGL---SVTETYSARGLESSSSHCYNSGTEYKGEVPLKRNSSLADKK 356
Query: 292 ANANICQHRLPNA-SEEIFCDLAFSRECN------DRGTSTGHRELL---PGHDVNELD- 340
++N+ R PNA + L +EC+ D G + + P + E++
Sbjct: 357 VSSNVNAGRSPNALHDRCQSSLMECKECHGLAKPGDPFPKLGCLDDMNDFPNVEALEIED 416
Query: 341 ----PDGKQYPSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYR 396
DGKQ+PS+GESS S SS+S+G+ +++ I WE+LQLGEEIG GSY VVYR
Sbjct: 417 EQRPSDGKQFPSVGESSSSNGSSTSRGEKDSNSVVKCEIHWEELQLGEEIGQGSYGVVYR 476
Query: 397 GIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456
GIWNGSDVAVK+YFG+++ E T+++Y+KEIDI+K LRHPNVLLFMGAV S ERL IVTEF
Sbjct: 477 GIWNGSDVAVKLYFGNQFKEETVQDYKKEIDIMKTLRHPNVLLFMGAVHSPERLAIVTEF 536
Query: 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT 516
+ RGSLFKTLHKN Q LDI+RRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD+NWT
Sbjct: 537 MLRGSLFKTLHKNNQVLDIRRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDRNWT 596
Query: 517 VKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASI 576
VKVGDFGLS KNAT++TAKSGRGTPQWMAPEVLR+EPSNEKSDVFSFGVILWEL+T SI
Sbjct: 597 VKVGDFGLSRWKNATFITAKSGRGTPQWMAPEVLRNEPSNEKSDVFSFGVILWELMTVSI 656
Query: 577 PWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
PW NLN +QVVGVVGFMDRRLELPE LDP
Sbjct: 657 PWINLNSVQVVGVVGFMDRRLELPEDLDP 685
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225426834|ref|XP_002276689.1| PREDICTED: uncharacterized protein LOC100244444 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 644 bits (1662), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/681 (54%), Positives = 443/681 (65%), Gaps = 86/681 (12%)
Query: 1 MAGDESGPSLYRDLLDRFEGLEAGHAKLREELNDLLLQEKKKNDDVDEVATTS------- 53
MA D+ +YR L+DRF LE A +R +L L+ + K+ D + S
Sbjct: 1 MAADD----VYRALMDRFRSLEQSQANMRAQLEVLMEERSKEEKDGGTLWPDSGWGHVPG 56
Query: 54 --DSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEE 111
GP RSVL+SMGH+V+ T S +I +WNRSAE LYGWKD EV GQRV + LI E
Sbjct: 57 YFSGGGPCRSVLDSMGHSVYAFTPWSGEIFFWNRSAEKLYGWKDCEVLGQRVVDVLIDEA 116
Query: 112 FHSPHKKIMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAAIF 171
+++ KKIME+L +GQSWSGQFP KKRSGEI MA+VTKSPLYEDG+ G ITVSSDAA+F
Sbjct: 117 YYTHVKKIMEKLTNGQSWSGQFPLKKRSGEIFMAIVTKSPLYEDGDFVGVITVSSDAALF 176
Query: 172 NSINPQHPRPYPNRG----QMHGLNLKKIQWQPHQPQIAQ-VPNIASSVTN--------- 217
N+I Q+ R Y + ++ LNLKKIQWQ QPQIA V N AS V +
Sbjct: 177 NNITSQYLRAYEDHANCQHRVRELNLKKIQWQS-QPQIASSVSNPASKVLSQNCGEDACN 235
Query: 218 -------------------------LTAKVLEKMHIGETGTYVGGDDGSLRQNGLRYKSF 252
L AKVL K+ I +G DD S +QN Y S
Sbjct: 236 PFASSQEKGKNMLDAKDKSSEKSETLAAKVLAKLRIRGSGKNAKEDDRSFQQNNSSYSSV 295
Query: 253 CNEITNKPNSSR-----FPDQHTSSSEDKAKCVGKINSSFAAENANANICQHRLPNASEE 307
CNE+ +PN R P+ + K + K SFAAE +N +HR+PN E
Sbjct: 296 CNEVIKEPNYHRDAKESCPNCRNFDTRYKGENPKKKIVSFAAEREYSNGNEHRIPNTPGE 355
Query: 308 IFCDLAFSRECNDRGTSTGHRELLP----GHDVNELDPD------------GKQYPSLGE 351
S+EC++ R P D E +P+ +Q+P + +
Sbjct: 356 -----GSSKECHNCFAVPRLRCSSPILTFQLDAKESEPELEDLKVLGIQSSVQQHPDVNQ 410
Query: 352 S-------SRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDV 404
S + + SSSSK D+E+S +D I+WEDL GEEIG GSYA VY GIWNGSDV
Sbjct: 411 SPGTGGSINSNNGSSSSKTDSESSSVSDCEIQWEDLHFGEEIGRGSYAAVYHGIWNGSDV 470
Query: 405 AVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFK 464
A+KVYFG+EY EGTL++Y+KEIDI+++LRHPNVLLFMGAV SQERL IVTE LPRGSLF+
Sbjct: 471 AIKVYFGNEYSEGTLQDYKKEIDIMRRLRHPNVLLFMGAVYSQERLAIVTELLPRGSLFR 530
Query: 465 TLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524
LHK+ Q LDI+RRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW VKVGDFGL
Sbjct: 531 VLHKSNQVLDIRRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWNVKVGDFGL 590
Query: 525 SSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLM 584
S LK+ T+LTAKSGRGTPQWMAPEVLR++PSNEKSDVFSFGVILWEL+T SIPW +LN +
Sbjct: 591 SKLKHTTFLTAKSGRGTPQWMAPEVLRNDPSNEKSDVFSFGVILWELMTQSIPWVHLNSL 650
Query: 585 QVVGVVGFMDRRLELPEGLDP 605
QVVG+VGFMDRRL+LPEGLDP
Sbjct: 651 QVVGIVGFMDRRLDLPEGLDP 671
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297742573|emb|CBI34722.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 634 bits (1634), Expect = e-179, Method: Compositional matrix adjust.
Identities = 366/676 (54%), Positives = 436/676 (64%), Gaps = 102/676 (15%)
Query: 1 MAGDESGPSLYRDLLDRFEGLEAGHAKLREELNDLLLQEKKKNDDVDEVATTS------- 53
MA D+ +YR L+DRF LE A +R +L L+ + K+ D + S
Sbjct: 1 MAADD----VYRALMDRFRSLEQSQANMRAQLEVLMEERSKEEKDGGTLWPDSGWGHVPG 56
Query: 54 --DSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEE 111
GP RSVL+SMGH+V+ T S +I +WNRSAE LYGWKD EV GQRV + LI E
Sbjct: 57 YFSGGGPCRSVLDSMGHSVYAFTPWSGEIFFWNRSAEKLYGWKDCEVLGQRVVDVLIDEA 116
Query: 112 FHSPHKKIMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAAIF 171
+++ KKIME+L +GQSWSGQFP KKRSGEI MA+VTKSPLYEDG+ G ITVSSDAA+F
Sbjct: 117 YYTHVKKIMEKLTNGQSWSGQFPLKKRSGEIFMAIVTKSPLYEDGDFVGVITVSSDAALF 176
Query: 172 NSINPQHPRPYPNRG----QMHGLNLKKIQWQPHQPQIAQ-VPNIASSVTN--------- 217
N+I Q+ R Y + ++ LNLKKIQWQ QPQIA V N AS V +
Sbjct: 177 NNITSQYLRAYEDHANCQHRVRELNLKKIQWQS-QPQIASSVSNPASKVLSQNCGEDACN 235
Query: 218 -------------------------LTAKVLEKMHIGETGTYVGGDDGSLRQNGLRYKSF 252
L AKVL K+ I +G DD S +QN Y S
Sbjct: 236 PFASSQEKGKNMLDAKDKSSEKSETLAAKVLAKLRIRGSGKNAKEDDRSFQQNNSSYSSV 295
Query: 253 CNEITNKPNSSRFPDQHTSSSEDKAKCVGKINSSFAAENANANICQHRLPNASEEIFCDL 312
CNE N K K V SFAAE +N +HR+PN E
Sbjct: 296 CNEGENP----------------KKKIV-----SFAAEREYSNGNEHRIPNTPGE----- 329
Query: 313 AFSRECNDRGTSTGHRELLP----GHDVNELDPD------------GKQYPSLGES---- 352
S+EC++ R P D E +P+ +Q+P + +S
Sbjct: 330 GSSKECHNCFAVPRLRCSSPILTFQLDAKESEPELEDLKVLGIQSSVQQHPDVNQSPGTG 389
Query: 353 ---SRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVY 409
+ + SSSSK D+E+S +D I+WEDL GEEIG GSYA VY GIWNGSDVA+KVY
Sbjct: 390 GSINSNNGSSSSKTDSESSSVSDCEIQWEDLHFGEEIGRGSYAAVYHGIWNGSDVAIKVY 449
Query: 410 FGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN 469
FG+EY EGTL++Y+KEIDI+++LRHPNVLLFMGAV SQERL IVTE LPRGSLF+ LHK+
Sbjct: 450 FGNEYSEGTLQDYKKEIDIMRRLRHPNVLLFMGAVYSQERLAIVTELLPRGSLFRVLHKS 509
Query: 470 YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529
Q LDI+RRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW VKVGDFGLS LK+
Sbjct: 510 NQVLDIRRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKLKH 569
Query: 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGV 589
T+LTAKSGRGTPQWMAPEVLR++PSNEKSDVFSFGVILWEL+T SIPW +LN +QVVG+
Sbjct: 570 TTFLTAKSGRGTPQWMAPEVLRNDPSNEKSDVFSFGVILWELMTQSIPWVHLNSLQVVGI 629
Query: 590 VGFMDRRLELPEGLDP 605
VGFMDRRL+LPEGLDP
Sbjct: 630 VGFMDRRLDLPEGLDP 645
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147794123|emb|CAN62358.1| hypothetical protein VITISV_001269 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 561 bits (1445), Expect = e-157, Method: Compositional matrix adjust.
Identities = 338/681 (49%), Positives = 412/681 (60%), Gaps = 110/681 (16%)
Query: 1 MAGDESGPSLYRDLLDRFEGLEAGHAKLREELNDLLLQEKKKNDDVDEVATTS------- 53
MA D+ +YR L+DRF LE A +R +L L+ + K+ D + S
Sbjct: 1 MAADD----VYRALMDRFRSLEQSQANMRAQLEVLMEERSKEEKDGGTLWPDSGWGHVPG 56
Query: 54 --DSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEE 111
GP RSVL+SMGH+V+ T S +I +WNRSAE LYGWKD EV GQRV + LI E
Sbjct: 57 YFSGGGPCRSVLDSMGHSVYAFTPWSGEIFFWNRSAEKLYGWKDCEVLGQRVXDVLIDEA 116
Query: 112 FHSPHKKIMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAAIF 171
+++ KKIME+L +GQSWSGQFP KKRSGEI MA+VTKSPLYE G+ G ITVSSDAA+F
Sbjct: 117 YYTHVKKIMEKLTNGQSWSGQFPLKKRSGEIFMAIVTKSPLYEXGDFVGVITVSSDAALF 176
Query: 172 NSINPQHPRPYPNRG----QMHGLNLKKIQWQPHQPQIAQ-VPNIASSVTN--------- 217
N+I Q+ R Y + ++ LNLKKIQWQ QPQIA V N AS V +
Sbjct: 177 NNITSQYLRAYEDHANCQHRVRELNLKKIQWQ-SQPQIASSVSNXASKVLSQNCGEDXCN 235
Query: 218 -------------------------LTAKVLEKMHIGETGTYVGGDDGSLRQNGLRYKSF 252
L AKVL K+ I +G DD +QN Y S
Sbjct: 236 PFASSQEKGKNMLDAKDKSSEKSETLAAKVLAKLRIRGSGKNAKEDDRXFQQNNSSYSSV 295
Query: 253 CNEITNKPNSSR-----FPDQHTSSSEDKAKCVGKINSSFAAENANANICQHRLPNASEE 307
CNE+ +PN R P+ + K + K SFAAE +N +HR+PN E
Sbjct: 296 CNEVIKEPNYHRDAKESCPNCXNFDTRYKGENPKKKIVSFAAEREYSNGNEHRIPNTPGE 355
Query: 308 IFCDLAFSRECNDRGTSTGHRELLP----GHDVNELDPD------------GKQYPSLGE 351
S+EC++ R P D E +P+ +Q+P + +
Sbjct: 356 -----GSSKECHNCFAVPRLRCSSPILTFQLDAKESEPELEDLKVLGIQSSVQQHPDVNQ 410
Query: 352 S-------SRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDV 404
S + + SSSSK D+E+S +D I+WEDL GEEIG + D
Sbjct: 411 SPGTGGSINSNNGSSSSKTDSESSSVSDCEIQWEDLHFGEEIG---------RVVRSPDP 461
Query: 405 AVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFK 464
++ +IDI+++LRHPNVLLFMGAV SQERL IVTE LPRGSLF+
Sbjct: 462 ETQIL---------------QIDIMRRLRHPNVLLFMGAVYSQERLAIVTELLPRGSLFR 506
Query: 465 TLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524
LHK+ Q LDI+RRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW VKVGDFGL
Sbjct: 507 VLHKSNQVLDIRRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWNVKVGDFGL 566
Query: 525 SSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLM 584
S LK+ T+LTAKSGRGTPQWMAPEVLR++PSNEKSDVFSFGVILWEL+T SIPW +LN +
Sbjct: 567 SKLKHTTFLTAKSGRGTPQWMAPEVLRNDPSNEKSDVFSFGVILWELMTQSIPWVHLNSL 626
Query: 585 QVVGVVGFMDRRLELPEGLDP 605
QVVG+VGFMDRRL+LPEGLDP
Sbjct: 627 QVVGIVGFMDRRLDLPEGLDP 647
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297803818|ref|XP_002869793.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297315629|gb|EFH46052.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 545 bits (1404), Expect = e-152, Method: Compositional matrix adjust.
Identities = 312/684 (45%), Positives = 414/684 (60%), Gaps = 82/684 (11%)
Query: 1 MAGDESGPSLYRDLLDRFEGLEAGHAKLREELNDLLLQEKKKN-------------DDVD 47
MAG+ S SLY+ L++ + +E A+LRE+++DLLLQ++ + D D
Sbjct: 1 MAGNNSESSLYQVLVEWCQRMETSQARLREDVDDLLLQDESRTGKESAAETEAEAADSWD 60
Query: 48 EVATTSDSV--------GPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVF 99
T + YR++++SMGHA+HV +A+S +I +W+RSAE+LY W EV
Sbjct: 61 NPTATWERAVSGFYFADSAYRTLMDSMGHAIHVTSAASGEITFWSRSAENLYHWYAEEVV 120
Query: 100 GQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLYEDGELA 159
G R + L+ EE+ + I R+ G++W+GQFPF+K++GE+ MA+VTKSP+YE+GEL
Sbjct: 121 GYRTIDVLVTEEYRNSLTGIRNRVCRGETWTGQFPFQKKTGELFMALVTKSPVYENGELV 180
Query: 160 GFITVSSDAAIFNSINP-----QHPRPYPNRGQMHGLNLKKIQWQPHQPQIA---QVPNI 211
G +TVSSDA +FN ++P Q NR H NL+K QW +PQIA QVP +
Sbjct: 181 GVVTVSSDATLFNRMHPLSNEHQQQARSNNR---HESNLRKHQWHLPRPQIAVASQVPVV 237
Query: 212 ----ASSVTNLTAKVLEKMHIGETGTYVGGDDGSLRQNGL--------RYKSFCNEITNK 259
++ ++NL A L G+ + S +N +Y S ++ K
Sbjct: 238 PQYSSTVISNLKASKLLPQRNGDDSFNANQNSRSRDENVPVVASSTFEKYGSLADKFLGK 297
Query: 260 PNSSRFPDQHTSSSED-KAKCVGK--INSSFAAENANANICQ------HRLPNASEEIFC 310
Q +E C+ K S +++ +NA C + P +E F
Sbjct: 298 LQRKISGSQGNEDNEPILGNCINKSACGSGASSKASNAVTCTAFRDNGNGKPKRAEIRFS 357
Query: 311 DL-------------AFSRECN------DRGTSTGHRELLPGHDVNELD----------P 341
D+ F N RG +G + G +++L P
Sbjct: 358 DVYGNGADGLIHNGDRFEYIGNLGQGKPPRGLESGLVSGMRGTKMSDLTGEIEDAWNTRP 417
Query: 342 DGKQYPSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNG 401
P LG + R+S +++G+N + IRWEDLQLGEE+G GS+A V+RG+WNG
Sbjct: 418 CDDPLPILGVNIGRRQSPANQGNNRLVTDSSCDIRWEDLQLGEEVGRGSFAAVHRGVWNG 477
Query: 402 SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGS 461
SDVA+KVYF +Y TL +KEI+I+KKLRHPNVLLFMGAV ++E+ I+ E++PRGS
Sbjct: 478 SDVAIKVYFEGDYNVMTLTECKKEINIMKKLRHPNVLLFMGAVCTEEKSAIIMEYMPRGS 537
Query: 462 LFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGD 521
LFK LH Q LD KRRLRMALDVARGMNYLH RNPPIVHRDLKSSNLLVD+NW VKVGD
Sbjct: 538 LFKILHNTNQPLDKKRRLRMALDVARGMNYLHRRNPPIVHRDLKSSNLLVDRNWNVKVGD 597
Query: 522 FGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581
FGLS KNAT+L+ KSG+GTPQWMAPEVLRSEPSNEK DVFSFGVILWEL+T IPW+ L
Sbjct: 598 FGLSKWKNATFLSTKSGKGTPQWMAPEVLRSEPSNEKCDVFSFGVILWELMTTLIPWDRL 657
Query: 582 NLMQVVGVVGFMDRRLELPEGLDP 605
N +QVVGVVGFMDRRL+LPEGL+P
Sbjct: 658 NSIQVVGVVGFMDRRLDLPEGLNP 681
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30686028|ref|NP_849424.1| PAS domain-containing protein tyrosine kinase family protein [Arabidopsis thaliana] gi|3292831|emb|CAA19821.1| putative serine/threonine kinase [Arabidopsis thaliana] gi|7269152|emb|CAB79260.1| putative serine/threonine kinase [Arabidopsis thaliana] gi|17065376|gb|AAL32842.1| putative serine/threonine kinase [Arabidopsis thaliana] gi|21389625|gb|AAM48011.1| putative serine/threonine kinase [Arabidopsis thaliana] gi|332659300|gb|AEE84700.1| PAS domain-containing protein tyrosine kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1386), Expect = e-150, Method: Compositional matrix adjust.
Identities = 308/701 (43%), Positives = 415/701 (59%), Gaps = 104/701 (14%)
Query: 1 MAGDESGPSLYRDLLDRFEGLEAGHAKLREELNDLLLQEKKKNDDVDEVATTSDSV---- 56
MAG+ S SLY+ L++ + +E A+LRE+++DLLLQE+ + +D+
Sbjct: 1 MAGNNSESSLYQVLVEWCQRMETSQARLREDVDDLLLQEESRTGKESATGLETDTEKEAE 60
Query: 57 -----------------------------GPYRSVLESMGHAVHVCTASSEDIIYWNRSA 87
YR++++SMGHA+HV +A+S +I +W+RSA
Sbjct: 61 VEVEAEAADSWDNPTATWERAVSGFYFADSAYRTLMDSMGHAIHVTSAASGEITFWSRSA 120
Query: 88 ESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRSGEILMAVV 147
E+LY W EV G R + L+ EE+ + I R+ G++W+GQFPF+K++GE+ MA+V
Sbjct: 121 ENLYHWYAEEVVGYRTIDVLVTEEYRNSLTGIRNRVCRGETWTGQFPFQKKTGELFMALV 180
Query: 148 TKSPLYEDGELAGFITVSSDAAIFNSINP-----QHPRPYPNRGQMHGLNLKKIQWQPHQ 202
TKSP+YE+GEL G +TVSSDA +FN ++P Q NR H NL+K QW +
Sbjct: 181 TKSPVYENGELVGVVTVSSDATLFNRMHPLSNEHQQQARSNNR---HESNLRKHQWHLPR 237
Query: 203 PQIAQ------VPNIASSV-TNLTAKVLEKMHIGETGTYVGGDDGSLRQNGL-------- 247
PQIA VP +S+V +NL A L G+ ++ G + R +
Sbjct: 238 PQIAAASQVPVVPQYSSAVASNLKASKLLPQRNGDD-SFNGNHNSRSRDENVPVVASTTF 296
Query: 248 -RYKSFCNEITNKPNSSRFPDQHTSSSE-------DKAKCVGKINSSFAAENANANICQ- 298
+Y S ++ K Q T +E +K+ C S +++ +NA C
Sbjct: 297 EKYGSLADKFLGKLQRKITGSQGTEDNEPILRNGINKSAC----GSGGSSKASNAVTCTA 352
Query: 299 -----HRLPNASEEIFCDLA-------------------FSRECNDRGTSTGHRELLPGH 334
+ P +E D+ + RG +G + G
Sbjct: 353 FRDNGNGKPKRAEVRISDVYGNGAEGLIHNGDRFQYIGNLGQSKPPRGLESGLVSGMRGT 412
Query: 335 DVNELDPDGKQ----------YPSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGE 384
+++L+ + + P LG +S ++S ++ +N + IRWEDLQLGE
Sbjct: 413 KMSDLNGEIEDAWNTRLSVDPLPILGVNSGRQQSPVNQRNNRLVTDSSCEIRWEDLQLGE 472
Query: 385 EIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAV 444
E+G GS+A V+RG+WNGSDVA+KVYF +Y TL +KEI+I+KKLRHPNVLLFMGAV
Sbjct: 473 EVGRGSFAAVHRGVWNGSDVAIKVYFDGDYNAMTLTECKKEINIMKKLRHPNVLLFMGAV 532
Query: 445 ASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDL 504
++E+ I+ E++PRGSLFK LH Q LD KRRLRMALDVARGMNYLH RNPPIVHRDL
Sbjct: 533 CTEEKSAIIMEYMPRGSLFKILHNTNQPLDKKRRLRMALDVARGMNYLHRRNPPIVHRDL 592
Query: 505 KSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSF 564
KSSNLLVDKNW VKVGDFGLS KNAT+L+ KSG+GTPQWMAPEVLRSEPSNEK DVFSF
Sbjct: 593 KSSNLLVDKNWNVKVGDFGLSKWKNATFLSTKSGKGTPQWMAPEVLRSEPSNEKCDVFSF 652
Query: 565 GVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
GVILWEL+T +PW+ LN +QVVGVVGFMDRRL+LPEGL+P
Sbjct: 653 GVILWELMTTLVPWDRLNSIQVVGVVGFMDRRLDLPEGLNP 693
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18416060|ref|NP_567676.1| PAS domain-containing protein tyrosine kinase family protein [Arabidopsis thaliana] gi|15810437|gb|AAL07106.1| putative serine/threonine kinase [Arabidopsis thaliana] gi|332659299|gb|AEE84699.1| PAS domain-containing protein tyrosine kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 537 bits (1384), Expect = e-150, Method: Compositional matrix adjust.
Identities = 304/699 (43%), Positives = 413/699 (59%), Gaps = 101/699 (14%)
Query: 1 MAGDESGPSLYRDLLDRFEGLEAGHAKLREELNDLLLQEKKKNDDVDEVATTSDSV---- 56
MAG+ S SLY+ L++ + +E A+LRE+++DLLLQE+ + +D+
Sbjct: 1 MAGNNSESSLYQVLVEWCQRMETSQARLREDVDDLLLQEESRTGKESATGLETDTEKEAE 60
Query: 57 -----------------------------GPYRSVLESMGHAVHVCTASSEDIIYWNRSA 87
YR++++SMGHA+HV +A+S +I +W+RSA
Sbjct: 61 VEVEAEAADSWDNPTATWERAVSGFYFADSAYRTLMDSMGHAIHVTSAASGEITFWSRSA 120
Query: 88 ESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRSGEILMAVV 147
E+LY W EV G R + L+ EE+ + I R+ G++W+GQFPF+K++GE+ MA+V
Sbjct: 121 ENLYHWYAEEVVGYRTIDVLVTEEYRNSLTGIRNRVCRGETWTGQFPFQKKTGELFMALV 180
Query: 148 TKSPLYEDGELAGFITVSSDAAIFNSINP-----QHPRPYPNRGQMHGLNLKKIQWQPHQ 202
TKSP+YE+GEL G +TVSSDA +FN ++P Q NR H NL+K QW +
Sbjct: 181 TKSPVYENGELVGVVTVSSDATLFNRMHPLSNEHQQQARSNNR---HESNLRKHQWHLPR 237
Query: 203 PQIA---QVPNIASSVTNLTAKVLEKMHIGETG--TYVGGDDGSLRQNGL---------R 248
PQIA QVP + + + + + K+ G ++ G + R + +
Sbjct: 238 PQIAAASQVPVVPQYSSAVASNLASKLLPQRNGDDSFNGNHNSRSRDENVPVVASTTFEK 297
Query: 249 YKSFCNEITNKPNSSRFPDQHTSSSE-------DKAKCVGKINSSFAAENANANICQ--- 298
Y S ++ K Q T +E +K+ C S +++ +NA C
Sbjct: 298 YGSLADKFLGKLQRKITGSQGTEDNEPILRNGINKSAC----GSGGSSKASNAVTCTAFR 353
Query: 299 ---HRLPNASEEIFCDLA-------------------FSRECNDRGTSTGHRELLPGHDV 336
+ P +E D+ + RG +G + G +
Sbjct: 354 DNGNGKPKRAEVRISDVYGNGAEGLIHNGDRFQYIGNLGQSKPPRGLESGLVSGMRGTKM 413
Query: 337 NELDPDGKQ----------YPSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEI 386
++L+ + + P LG +S ++S ++ +N + IRWEDLQLGEE+
Sbjct: 414 SDLNGEIEDAWNTRLSVDPLPILGVNSGRQQSPVNQRNNRLVTDSSCEIRWEDLQLGEEV 473
Query: 387 GLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS 446
G GS+A V+RG+WNGSDVA+KVYF +Y TL +KEI+I+KKLRHPNVLLFMGAV +
Sbjct: 474 GRGSFAAVHRGVWNGSDVAIKVYFDGDYNAMTLTECKKEINIMKKLRHPNVLLFMGAVCT 533
Query: 447 QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKS 506
+E+ I+ E++PRGSLFK LH Q LD KRRLRMALDVARGMNYLH RNPPIVHRDLKS
Sbjct: 534 EEKSAIIMEYMPRGSLFKILHNTNQPLDKKRRLRMALDVARGMNYLHRRNPPIVHRDLKS 593
Query: 507 SNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGV 566
SNLLVDKNW VKVGDFGLS KNAT+L+ KSG+GTPQWMAPEVLRSEPSNEK DVFSFGV
Sbjct: 594 SNLLVDKNWNVKVGDFGLSKWKNATFLSTKSGKGTPQWMAPEVLRSEPSNEKCDVFSFGV 653
Query: 567 ILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
ILWEL+T +PW+ LN +QVVGVVGFMDRRL+LPEGL+P
Sbjct: 654 ILWELMTTLVPWDRLNSIQVVGVVGFMDRRLDLPEGLNP 692
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495657|ref|XP_003516691.1| PREDICTED: uncharacterized protein LOC100813707 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 456 bits (1172), Expect = e-125, Method: Compositional matrix adjust.
Identities = 252/414 (60%), Positives = 293/414 (70%), Gaps = 26/414 (6%)
Query: 216 TNLTAKVLEKMHIGETGTYVGGDDGSLRQNGLRYKSFCNEITNKPNS-----SRFPDQHT 270
+N+ A+VL K+ IG G D+G+++ N S N + N+ + S Q
Sbjct: 314 SNIAARVLAKLQIGAHAK-CGKDNGNIKNNCTADNSGSNRVNNENDLLGDLLSLNRHQDV 372
Query: 271 SSSEDKAKCVGKINSSFAAENANANICQHRLPNASEEIFCDLAFSRE-CNDRGTSTGHRE 329
++ DK + + K NS FA + A+ +C R N ++ FS E C G+ H
Sbjct: 373 ANGADKEENLHKCNSLFAMKRADTKVCACRASNVVKD-SSGKPFSGEWCECFGSPIPHDP 431
Query: 330 LL---PGHDVNELDPD---------------GKQYPSLGESSRSRESSSSKGDNETSCAT 371
LL D +L+P+ G Q PS ES S ESSSSKGDNE++ +
Sbjct: 432 LLRLRCQFDQKKLEPEAMNMATGDEVQKQQEGLQLPSSRESIGSHESSSSKGDNESNSVS 491
Query: 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKK 431
I WE LQL EEIG GS AVVY GIWNGSDVAVKVYFG+EY E TL++Y+KEIDI+K+
Sbjct: 492 KCEIHWEHLQLREEIGQGSCAVVYHGIWNGSDVAVKVYFGNEYTEETLQDYRKEIDIMKR 551
Query: 432 LRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNY 491
LRHPNVLLFMGAV SQERL IVTE LPRGSLFK LH+N Q LDI+RRLRMALDVARGMNY
Sbjct: 552 LRHPNVLLFMGAVYSQERLAIVTELLPRGSLFKNLHRNNQTLDIRRRLRMALDVARGMNY 611
Query: 492 LHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLR 551
LHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS LK+AT LT KSGRGTPQWMAPEVLR
Sbjct: 612 LHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSRLKDATLLTTKSGRGTPQWMAPEVLR 671
Query: 552 SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
+EPSNEKSDV+SFGVILWEL+T SIPW NLN +QVVGVVGFMDRRL+LPEGLDP
Sbjct: 672 NEPSNEKSDVYSFGVILWELMTQSIPWKNLNSLQVVGVVGFMDRRLDLPEGLDP 725
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108736|ref|XP_002314950.1| predicted protein [Populus trichocarpa] gi|222863990|gb|EEF01121.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1099), Expect = e-117, Method: Compositional matrix adjust.
Identities = 259/608 (42%), Positives = 341/608 (56%), Gaps = 69/608 (11%)
Query: 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKK 118
Y ++L+S+G +VH+ S IIYWNR+AE+LYG+ E GQ E LI ++
Sbjct: 129 YLNILQSVGQSVHIFDHSGR-IIYWNRTAENLYGYSAAEALGQDAIELLIDSRDYAVANG 187
Query: 119 IMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLYED-GELAGFITVSSDAAIFNSI--- 174
I++R++ G+ W+G+FP K + E V T +PLY+D G L G I VSSD+ F +
Sbjct: 188 IVQRVSMGEKWTGKFPVKNKMAERFTVVATNTPLYDDDGALVGIICVSSDSRPFQEVGVA 247
Query: 175 -------NPQHPRPYPNRGQMHGLNLKKIQWQPHQPQIA-QVPNIASSVTNLTAKVLEKM 226
+ P M L L Q P Q +A ++ N+AS V+N KV K+
Sbjct: 248 LLDSRNLEAESSNSSPRNIVMSKLGLDSQQ--PLQAAVASKISNLASKVSN---KVKSKI 302
Query: 227 HIGETGTYVGGDDGSLRQNGLRYKSFC----NEITNKPNSS------------------- 263
GE G G + Y E N +S
Sbjct: 303 RPGENSMDREGGSGDSHYSDHGYSDAALSDHREDANSSGASTPRGDVHPSPFGVFSHLDD 362
Query: 264 RFPDQHTSSSEDKAKCVGKINSSFAAENANANICQHRLP--------NASEEIFCDLAFS 315
R P Q S D+++ I+ F ++ A A I + L SE +
Sbjct: 363 RSPAQSCRESGDESEGKPAIHKIFTSK-AEAWIGKKGLSWPWKGNEKEGSEARTTRFGWP 421
Query: 316 RECNDRGTSTGHRELLPGHDVNELDPDGKQYPSLGESSRSRESS---------------- 359
ND+ + T H+ +E P+ E+S S SS
Sbjct: 422 WLQNDQESETFHQRSPSSGAKSESHVSESNRPANNEASGSWSSSINVNSTSSASSCGSTS 481
Query: 360 --SSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEG 417
+K D +T C D I WEDL +GE+IG GS VY +W GSDVAVKV+ EY +
Sbjct: 482 STVNKVDPDTDC-LDYEILWEDLTIGEQIGQGSCGTVYHALWYGSDVAVKVFSKQEYSDD 540
Query: 418 TLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKR 477
+ +++E+ ++K+LRHPNVLLFMGAV S +RL IVTEFLPRGSLF+ L +N LD +R
Sbjct: 541 VILAFKQEVSLMKRLRHPNVLLFMGAVTSPQRLCIVTEFLPRGSLFRLLQRNTTKLDWRR 600
Query: 478 RLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKS 537
R MALD+ARGMNYLHH NPPI+HRDLKSSNLLVDKNWTVKVGDFGLS LK+ TYLT K+
Sbjct: 601 RAHMALDIARGMNYLHHYNPPIIHRDLKSSNLLVDKNWTVKVGDFGLSRLKHETYLTTKT 660
Query: 538 GRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRL 597
G+GTPQWMAPEVLR+EPS+EKSDV+S+GVILWEL T IPW+NLN MQV+G VGFM+++L
Sbjct: 661 GKGTPQWMAPEVLRNEPSDEKSDVYSYGVILWELATEKIPWDNLNSMQVIGAVGFMNQQL 720
Query: 598 ELPEGLDP 605
E+P+ +DP
Sbjct: 721 EIPKDVDP 728
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462150|ref|XP_004148804.1| PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein LOC101221874 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 417 bits (1073), Expect = e-114, Method: Compositional matrix adjust.
Identities = 245/606 (40%), Positives = 345/606 (56%), Gaps = 66/606 (10%)
Query: 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKK 118
Y ++L+S+G V++ + IIYWNR+AE +YG+ E GQ E L+ E +
Sbjct: 116 YLNILQSLGQPVYIFDLNYH-IIYWNRAAEIVYGYSAAEALGQDAIELLVDPEDFAITNH 174
Query: 119 IMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAAIFNSINPQH 178
++ R+ +G++W+G P K + G+ + V T +P Y+DG L G I +SSD+ F + +
Sbjct: 175 VILRVMAGENWTGHLPVKNKMGQKFVVVATNTPFYDDGALIGIICISSDSRPFQDL--KI 232
Query: 179 PRPYPNRGQMHGLNLK--------KIQWQPHQP-QIA---QVPNIASSVTNLTAKVLEKM 226
P ++ Q ++ K+ P QP Q+A ++ N+AS V+N KV K+
Sbjct: 233 PLSIGSKQQDADSSMVRSRVPVSVKLGLDPQQPLQVAIASKLSNLASKVSN---KVKSKI 289
Query: 227 HIGETGT--YVGGDDGSLRQNGLRYKSFCNEITNKPNSSRFPDQ-----HTSSSEDKAKC 279
GE G DG +G C+ + +S + H + S+ + K
Sbjct: 290 RTGENSLDREGGSGDGYHSDHGHPDAVLCDNRDDANSSGASTPRGDSTAHGAFSQVEEKL 349
Query: 280 VGKINSSFAAENANANICQHRLPNASEEIFCDLAFS-----RECNDRGTSTGHRELLPGH 334
G++ + E Q L + +EE S E + R + P
Sbjct: 350 SGRLVRDSSDEGKGKPTIQKILSSKAEEWIAKKGLSWPWKGTEQEGGSETRAARFVWPWV 409
Query: 335 DVN-ELDPDGKQYPSL----------GESSRSRESSSS---------------------- 361
++ E +P + S+ G + + E+S S
Sbjct: 410 QIDQEAEPANHKSSSISGKLEMQQNDGHRAVNNEASGSWSSININSTSSVSSCGSTSSSA 469
Query: 362 --KGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTL 419
K +++ C D I WEDL +GE+IG GS VY +W GSDVAVKV+ EY + +
Sbjct: 470 VNKVESDMDC-LDHEILWEDLTIGEQIGQGSCGTVYHALWYGSDVAVKVFSKQEYSDDVI 528
Query: 420 KNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRL 479
++++E+ ++KKLRHPN+LLFMG V S +RL IVTEFLPRGSLF+ L +N LD +RR+
Sbjct: 529 LSFKQEVSLMKKLRHPNILLFMGVVTSPQRLCIVTEFLPRGSLFRLLQRNTGKLDWRRRV 588
Query: 480 RMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539
MALD+ARGMNYLHH NPPI+HRDLKSSNLL+DKNWTVKVGDFGLS LK+ TYLT K+G+
Sbjct: 589 HMALDIARGMNYLHHCNPPIIHRDLKSSNLLIDKNWTVKVGDFGLSRLKHETYLTTKTGK 648
Query: 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLEL 599
GTPQWMAPEVLR+EPS+EKSD++SFGVILWEL T IPW NLN MQV+G VGFM++RLE+
Sbjct: 649 GTPQWMAPEVLRNEPSDEKSDIYSFGVILWELATEKIPWENLNSMQVIGAVGFMNQRLEI 708
Query: 600 PEGLDP 605
P+ +DP
Sbjct: 709 PKDVDP 714
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 605 | ||||||
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.428 | 0.351 | 0.698 | 1.9e-144 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.381 | 0.298 | 0.658 | 3.7e-111 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.4 | 0.316 | 0.655 | 2.7e-109 | |
| TAIR|locus:2084304 | 671 | AT3G06630 [Arabidopsis thalian | 0.381 | 0.344 | 0.662 | 4.4e-109 | |
| TAIR|locus:2158019 | 831 | AT5G49470 [Arabidopsis thalian | 0.236 | 0.172 | 0.682 | 3.1e-99 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.380 | 0.261 | 0.630 | 1.1e-78 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.479 | 0.281 | 0.518 | 2.4e-76 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.403 | 0.245 | 0.573 | 1.2e-75 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.469 | 0.304 | 0.513 | 1.9e-74 | |
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.386 | 0.285 | 0.605 | 1.4e-73 |
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 954 (340.9 bits), Expect = 1.9e-144, Sum P(3) = 1.9e-144
Identities = 181/259 (69%), Positives = 208/259 (80%)
Query: 347 PSLGXXXXXXXXXXXKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAV 406
P LG + +N + IRWEDLQLGEE+G GS+A V+RG+WNGSDVA+
Sbjct: 435 PILGVNSGRQQSPVNQRNNRLVTDSSCEIRWEDLQLGEEVGRGSFAAVHRGVWNGSDVAI 494
Query: 407 KVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTL 466
KVYF +Y TL +KEI+I+KKLRHPNVLLFMGAV ++E+ I+ E++PRGSLFK L
Sbjct: 495 KVYFDGDYNAMTLTECKKEINIMKKLRHPNVLLFMGAVCTEEKSAIIMEYMPRGSLFKIL 554
Query: 467 HKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526
H Q LD KRRLRMALDVARGMNYLH RNPPIVHRDLKSSNLLVDKNW VKVGDFGLS
Sbjct: 555 HNTNQPLDKKRRLRMALDVARGMNYLHRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSK 614
Query: 527 LKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
KNAT+L+ KSG+GTPQWMAPEVLRSEPSNEK DVFSFGVILWEL+T +PW+ LN +QV
Sbjct: 615 WKNATFLSTKSGKGTPQWMAPEVLRSEPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQV 674
Query: 587 VGVVGFMDRRLELPEGLDP 605
VGVVGFMDRRL+LPEGL+P
Sbjct: 675 VGVVGFMDRRLDLPEGLNP 693
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 846 (302.9 bits), Expect = 3.7e-111, Sum P(4) = 3.7e-111
Identities = 152/231 (65%), Positives = 192/231 (83%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH 434
I W+DL +GE++G GS VY G+W GSDVAVKV+ EY ++++++E+ ++K+LRH
Sbjct: 489 ILWDDLTIGEQVGQGSCGTVYHGLWFGSDVAVKVFSKQEYSAEVIESFKQEVLLMKRLRH 548
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
PNVLLFMGAV S +RL IV+EFLPRGSLF+ L K+ LD +RR+ MALD+ARGMNYLHH
Sbjct: 549 PNVLLFMGAVTSPQRLCIVSEFLPRGSLFRLLQKSTSKLDWRRRIHMALDIARGMNYLHH 608
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEP 554
+PPI+HRDLKSSNLLVDKNWTVKV DFGLS +K+ TYLT+KSG+GTPQWMAPEVLR+E
Sbjct: 609 CSPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETYLTSKSGKGTPQWMAPEVLRNES 668
Query: 555 SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
++EKSD++SFGV+LWEL T IPW LN MQV+G VGFMD+RLE+P+ +DP
Sbjct: 669 ADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVGFMDQRLEIPKDIDP 719
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 862 (308.5 bits), Expect = 2.7e-109, Sum P(2) = 2.7e-109
Identities = 160/244 (65%), Positives = 199/244 (81%)
Query: 362 KGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKN 421
K D ++ C D I WEDL +GE+IG GS VY G+W GSDVAVKV+ EY E + +
Sbjct: 470 KVDMDSDCL-DYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIITS 528
Query: 422 YQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRM 481
+++E+ ++K+LRHPNVLLFMGAVAS +RL IVTEFLPRGSLF+ L +N LD++RR+ M
Sbjct: 529 FKQEVSLMKRLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHM 588
Query: 482 ALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGT 541
A D+ARGMNYLHH +PPI+HRDLKSSNLLVD+NWTVKV DFGLS +K+ TYLT +GRGT
Sbjct: 589 ASDIARGMNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTT-NGRGT 647
Query: 542 PQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPE 601
PQWMAPEVLR+E ++EKSDV+SFGV+LWELVT IPW NLN MQV+G VGFM++RLE+P+
Sbjct: 648 PQWMAPEVLRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVPK 707
Query: 602 GLDP 605
+DP
Sbjct: 708 DVDP 711
|
|
| TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 849 (303.9 bits), Expect = 4.4e-109, Sum P(2) = 4.4e-109
Identities = 153/231 (66%), Positives = 192/231 (83%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH 434
I W+DL +GE+IG GS VY GIW GSDVAVKV+ EY E +K+++KE+ ++K+LRH
Sbjct: 429 ILWDDLTIGEQIGRGSCGTVYHGIWFGSDVAVKVFSKQEYSESVIKSFEKEVSLMKRLRH 488
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
PNVLLFMGAV S +RL IV+EF+PRGSLF+ L ++ LD +RR+ MALD+ARGMNYLH
Sbjct: 489 PNVLLFMGAVTSPQRLCIVSEFVPRGSLFRLLQRSMSKLDWRRRINMALDIARGMNYLHC 548
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEP 554
+PPI+HRDLKSSNLLVD+NWTVKV DFGLS +K+ TYLT+KSG+GTPQWMAPEVLR+E
Sbjct: 549 CSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHQTYLTSKSGKGTPQWMAPEVLRNES 608
Query: 555 SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
++EKSD++SFGV+LWEL T IPW NLN MQV+G VGFM++RLE+P+ DP
Sbjct: 609 ADEKSDIYSFGVVLWELATEKIPWENLNSMQVIGAVGFMNQRLEIPKDTDP 659
|
|
| TAIR|locus:2158019 AT5G49470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 518 (187.4 bits), Expect = 3.1e-99, Sum P(3) = 3.1e-99
Identities = 99/145 (68%), Positives = 116/145 (80%)
Query: 461 SLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVG 520
SL + L+ Y L I L ARGMNYLHH PPI+HRDLKSSNLLVDKNWTVKV
Sbjct: 635 SLIQLLYLVYNMLHIF--LTYFFAQARGMNYLHHCTPPIIHRDLKSSNLLVDKNWTVKVA 692
Query: 521 DFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580
DFGLS +K+ TYLT K+GRGTPQWMAPEVLR+E ++EKSDV+SFGVILWELVT IPW +
Sbjct: 693 DFGLSRIKHETYLTTKTGRGTPQWMAPEVLRNEAADEKSDVYSFGVILWELVTEKIPWES 752
Query: 581 LNLMQVVGVVGFMDRRLELPEGLDP 605
LN MQV+G VGFM++RLE+P+ +DP
Sbjct: 753 LNAMQVIGAVGFMNQRLEVPKNVDP 777
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 791 (283.5 bits), Expect = 1.1e-78, P = 1.1e-78
Identities = 145/230 (63%), Positives = 180/230 (78%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH 434
I WEDLQ+GE IG+GSY VYR WNG++VAVK + ++ L ++ EI+I+ +LRH
Sbjct: 604 IMWEDLQIGERIGIGSYGEVYRAEWNGTEVAVKKFLDQDFSGDALTQFKSEIEIMLRLRH 663
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
PNV+LFMGAV I+TEFLPRGSL++ LH+ LD KRR+RMALDVA+GMNYLH
Sbjct: 664 PNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPNHQLDEKRRMRMALDVAKGMNYLHT 723
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEP 554
+P +VHRDLKS NLLVDKNW VKV DFGLS +K+ TYL++KS GTP+WMAPEVLR+EP
Sbjct: 724 SHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTPEWMAPEVLRNEP 783
Query: 555 SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604
+NEK DV+SFGVILWEL T+ +PW LN MQVVG VGF +RRLE+P+ +D
Sbjct: 784 ANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDID 833
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 769 (275.8 bits), Expect = 2.4e-76, P = 2.4e-76
Identities = 153/295 (51%), Positives = 202/295 (68%)
Query: 313 AFSRECNDRGTSTGHRELLPGHDVNELDPDGKQYPSLGXXXXXXXXXXXKGDNETSC--A 370
A SR+ + G+++ + GH+ D P+ G + +++ C
Sbjct: 682 AVSRQL-ELGSNSDGDDGSGGHEPQG-SGDSNHGPNSGGERISDKSIGNES-SKSDCDDV 738
Query: 371 TDGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIK 430
+D I WE++ +GE IGLGSY VYRG W+G++VAVK + + L+ ++ E+ I+K
Sbjct: 739 SDCEILWEEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEEFRSEVRIMK 798
Query: 431 KLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMN 490
KLRHPN++LFMGAV L IVTEFLPRGSL++ +H+ LD +RRLRMALD ARGMN
Sbjct: 799 KLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERRRLRMALDAARGMN 858
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL 550
YLH NP IVHRDLKS NLLVDKNW VKV DFGLS +K++TYL++KS GT +WMAPEVL
Sbjct: 859 YLHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMAPEVL 918
Query: 551 RSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
R+EP++EK DV+S+GVILWEL T PW +N MQVVG VGF RRL++P+ +DP
Sbjct: 919 RNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPDFVDP 973
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 743 (266.6 bits), Expect = 1.2e-75, Sum P(2) = 1.2e-75
Identities = 140/244 (57%), Positives = 178/244 (72%)
Query: 362 KGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKN 421
K D + I WE++ + E IGLGSY VYRG W+G+ VAVK + + L+
Sbjct: 697 KSDAAIDDVAECEILWEEITVAERIGLGSYGEVYRGDWHGTAVAVKKFIDQDITGEALEE 756
Query: 422 YQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRM 481
++ E+ ++++LRHPN++LFMGAV L IVTEFLPRGSL++ +H+ LD ++RLRM
Sbjct: 757 FRSEVRMMRRLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERKRLRM 816
Query: 482 ALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGT 541
ALD ARGMNYLH NP IVHRDLKS NLLVDKNW VKV DFGLS +K +TYL++KS GT
Sbjct: 817 ALDAARGMNYLHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGT 876
Query: 542 PQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPE 601
+WMAPEVLR+EP++EK DV+S+GVILWEL T PW +N MQVVG VGF RRL++PE
Sbjct: 877 AEWMAPEVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPE 936
Query: 602 GLDP 605
+DP
Sbjct: 937 FVDP 940
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 751 (269.4 bits), Expect = 1.9e-74, P = 1.9e-74
Identities = 149/290 (51%), Positives = 188/290 (64%)
Query: 319 NDRGTSTGHRELLPGHDVNELDPDGKQYPSLGXXXXXXXXXXXKGDNETSCATDGG---I 375
ND HR+ DP K + S + D + D G I
Sbjct: 608 NDESHIHDHRKYTSDDISTGCDPRLKDHES---TSSSLDSTSYRNDPQVLDDADVGECEI 664
Query: 376 RWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
W DL + E IGLGSY VY W+G++VAVK + ++ L ++ E+ I+++LRHP
Sbjct: 665 PWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLRHP 724
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495
NV+ F+GAV L IVTEFLPRGSL++ LH+ +D +RR++MALDVA GMN LH
Sbjct: 725 NVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMGMNCLHTS 784
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPS 555
P IVHRDLK+ NLLVD NW VKVGDFGLS LK+ T+L++KS GTP+WMAPEVLR+EPS
Sbjct: 785 TPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 844
Query: 556 NEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
NEK DV+SFGVILWEL T +PW +N MQVVG VGF +RRLE+P+ LDP
Sbjct: 845 NEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDP 894
|
|
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 743 (266.6 bits), Expect = 1.4e-73, P = 1.4e-73
Identities = 143/236 (60%), Positives = 177/236 (75%)
Query: 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKK 431
D I W DL + E+IG GS+ V+R W+GSDVAVK+ ++ + + +E+ I+K+
Sbjct: 543 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKR 602
Query: 432 LRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN--YQALDIKRRLRMALDVARGM 489
LRHPN++LFMGAV L IVTE+L RGSL++ LHK+ + LD +RRL MA DVA+GM
Sbjct: 603 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 662
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEV 549
NYLH+RNPPIVHRDLKS NLLVDK +TVKV DFGLS LK +T+L++KS GTP+WMAPEV
Sbjct: 663 NYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 722
Query: 550 LRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
LR EPSNEKSDV+SFGVILWEL T PW NLN QVV VGF +RLE+P L+P
Sbjct: 723 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 778
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | Al_scaffold_0007_1849 | annotation not avaliable (724 aa) | |||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 605 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-61 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-60 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-60 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-57 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-56 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-55 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-51 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-41 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-40 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-40 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-39 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-39 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-39 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-38 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-38 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-38 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-36 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-36 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-35 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-35 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-34 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-34 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-33 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-33 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-33 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-32 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-32 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-32 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-32 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-31 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-31 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-31 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-31 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-30 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-30 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-30 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-30 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-30 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-29 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-29 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-29 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-29 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-28 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-28 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-28 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-28 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-28 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-27 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-27 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-26 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-26 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-26 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-25 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-25 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-25 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-25 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-25 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-25 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-25 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-25 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-25 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-24 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-24 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-24 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-24 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-24 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-24 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-24 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-24 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-24 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-23 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-23 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-23 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-23 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-22 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-21 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-21 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-20 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-20 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-20 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-18 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-17 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-17 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-16 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-16 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-16 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-16 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-16 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-15 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-14 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-14 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-14 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-13 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-12 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-12 | |
| pfam13426 | 101 | pfam13426, PAS_9, PAS domain | 2e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-12 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-10 | |
| pfam00989 | 113 | pfam00989, PAS, PAS fold | 2e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-09 | |
| TIGR00229 | 124 | TIGR00229, sensory_box, PAS domain S-box | 4e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-09 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd00130 | 103 | cd00130, PAS, PAS domain; PAS motifs appear in arc | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-06 | |
| COG2202 | 232 | COG2202, AtoS, FOG: PAS/PAC domain [Signal transdu | 3e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-05 | |
| pfam08448 | 110 | pfam08448, PAS_4, PAS fold | 1e-05 | |
| smart00091 | 67 | smart00091, PAS, PAS domain | 4e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.003 | |
| pfam13188 | 64 | pfam13188, PAS_8, PAS domain | 0.004 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 203 bits (520), Expect = 2e-61
Identities = 90/234 (38%), Positives = 129/234 (55%), Gaps = 17/234 (7%)
Query: 380 LQLGEEIGLGSYAVVYRGIWNGS------DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
L+LG+++G G++ VY+G G VAVK E + + +E I+KKL
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKT-LKEGASEEEREEFLEEASIMKKLS 59
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
HPN++ +G E L IVTE++P G L L K+ + L +K L+MAL +A+GM YL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTPQ-WMAPEVLR 551
+N VHRDL + N LV +N VK+ DFGLS + Y + G P WMAPE L+
Sbjct: 120 SKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 552 SEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
KSDV+SFGV+LWE+ T P+ ++ +V+ ++ G RL PE
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG---YRLPRPEN 228
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 2e-60
Identities = 86/232 (37%), Positives = 127/232 (54%), Gaps = 16/232 (6%)
Query: 380 LQLGEEIGLGSYAVVYRGIWNGS------DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
L LG+++G G++ VY+G G +VAVK + E ++ + +E I++KL
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
HPNV+ +G +E L IV E++ G L L KN L + L AL +ARGM YL
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTPQWMAPEVLRS 552
+N +HRDL + N LV +N VK+ DFGLS L + Y + G+ +WMAPE L+
Sbjct: 120 SKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 553 EPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPE 601
KSDV+SFGV+LWE+ T P+ ++ +V+ + G+ RL P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGY---RLPQPP 226
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 2e-60
Identities = 86/231 (37%), Positives = 127/231 (54%), Gaps = 13/231 (5%)
Query: 380 LQLGEEIGLGSYAVVYRGIWNGS------DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
L LG+++G G++ VY+G G +VAVK + E ++ + +E I++KL
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYL 492
HPN++ +G +E L IV E++P G L L KN + L + L AL +ARGM YL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTPQWMAPEVLR 551
+N +HRDL + N LV +N VK+ DFGLS L + Y K G+ +WMAPE L+
Sbjct: 120 ESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 552 SEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPE 601
KSDV+SFGV+LWE+ T P+ ++ +V+ + RL P
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK-KGYRLPKPP 227
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 193 bits (494), Expect = 1e-57
Identities = 67/209 (32%), Positives = 110/209 (52%), Gaps = 7/209 (3%)
Query: 381 QLGEEIGLGSYAVVYRGIWNGSD--VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
++ E++G GS+ VY + VA+KV + I+ + +EI I+KKL+HPN++
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKV-IKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPP 498
+++L +V E+ G LF L K L + + YLH +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR-GRLSEDEARFYLRQILSALEYLHSKG-- 117
Query: 499 IVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEK 558
IVHRDLK N+L+D++ VK+ DFGL+ + + GTP++MAPEVL + +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFVGTPEYMAPEVLLGKGYGKA 176
Query: 559 SDVFSFGVILWELVTASIPWNNLNLMQVV 587
D++S GVIL+EL+T P+ + + +
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLEL 205
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 1e-57
Identities = 74/190 (38%), Positives = 104/190 (54%), Gaps = 7/190 (3%)
Query: 386 IGLGSYAVVYRGIWNGSD--VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGA 443
+G G + VY + VA+K+ E L+ +EI+I+KKL HPN++ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKI-IKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 444 VASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRD 503
+ L +V E+ GSL L +N L LR+ L + G+ YLH I+HRD
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRD 117
Query: 504 LKSSNLLVDK-NWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPS-NEKSDV 561
LK N+L+D N VK+ DFGLS L + K+ GTP +MAPEVL + +EKSD+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 562 FSFGVILWEL 571
+S GVIL+EL
Sbjct: 178 WSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 4e-56
Identities = 84/237 (35%), Positives = 127/237 (53%), Gaps = 24/237 (10%)
Query: 384 EEIGLGSYAVVYRGIWNGS-----DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
+++G G++ VY+G G +VAVK + E K++ KE ++KKL HPNV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFKTLHKNY--------QALDIKRRLRMALDVARGMN 490
+G +E L +V E++ G L L K+ L +K L A+ +A+GM
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTP-QWMAPE 548
YL + VHRDL + N LV ++ VK+ DFGLS + + Y K+G P +WMAPE
Sbjct: 120 YLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 549 VLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
L+ KSDV+SFGV+LWE+ T + P+ L+ +V+ + G+ RL PE
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY---RLPKPEY 231
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 3e-55
Identities = 74/214 (34%), Positives = 116/214 (54%), Gaps = 9/214 (4%)
Query: 380 LQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNV 437
+L ++G GS+ VY+ G VAVK+ + ++EI I+++L HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 438 LLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNP 497
+ + A ++ L +V E+ G LF L + L ++AL + RG+ YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG-GPLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 498 PIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLR-SEPSN 556
I+HRDLK N+L+D+N VK+ DFGL+ + + + GTP +MAPEVL
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 557 EKSDVFSFGVILWELVTASIPW---NNLNLMQVV 587
K DV+S GVIL+EL+T P+ N L+ +Q++
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 1e-51
Identities = 82/237 (34%), Positives = 120/237 (50%), Gaps = 16/237 (6%)
Query: 379 DLQLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN 436
+ GE +G GS+ VY + G +AVK S E L+ ++EI I+ L+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 437 VLLFMGAVASQER--LGIVTEFLPRGSLFKTLHKNYQALD---IKRRLRMALDVARGMNY 491
++ + G+ +E+ L I E++ GSL L K + L I++ R L G+ Y
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL-KKFGKLPEPVIRKYTRQIL---EGLAY 116
Query: 492 LHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA--KSGRGTPQWMAPEV 549
LH IVHRD+K +N+LVD + VK+ DFG + S RGTP WMAPEV
Sbjct: 117 LHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 550 LRSEPSNEKSDVFSFGVILWELVTASIPWNNL-NLMQVVGVVGFMDRRLELPEGLDP 605
+R E +D++S G + E+ T PW+ L N M + +G E+PE L
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSE 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 1e-41
Identities = 79/235 (33%), Positives = 133/235 (56%), Gaps = 18/235 (7%)
Query: 379 DLQLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN 436
+ QLG+ IG G++ VVY+G+ G VA+K + E LK+ +EID++K L+HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 437 VLLFMGAVASQERLGIVTEFLPRGSLFKTLHK--NYQALDIKRRLRMALDVARGMNYLHH 494
++ ++G++ + + L I+ E+ GSL + + K + + + L +G+ YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL---QGLAYLH- 116
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEP 554
++HRD+K++N+L K+ VK+ DFG+++ N S GTP WMAPEV+
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 555 SNEKSDVFSFGVILWELVTASIPWNNLNLM----QVVGVVGFMDRRLELPEGLDP 605
++ SD++S G + EL+T + P+ +LN M ++V D LPEG+ P
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-----DDHPPLPEGISP 225
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 72/215 (33%), Positives = 117/215 (54%), Gaps = 19/215 (8%)
Query: 384 EEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
++IG GS+ VY R +G +K S E ++ E+ I+KKL HPN++ +
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKN---------YQALDIKRRLRMALDVARGMNYL 492
+ + +L IV E+ G L + + K Q LD +L +AL YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK------YL 119
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS 552
H R I+HRD+K N+ + N VK+GDFG+S + ++T AK+ GTP +++PE+ ++
Sbjct: 120 HSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN 177
Query: 553 EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
+P N KSD++S G +L+EL T P+ NL+++
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 3e-40
Identities = 83/239 (34%), Positives = 127/239 (53%), Gaps = 19/239 (7%)
Query: 376 RWEDLQLGEEIGLGSYAVVYRGI--WNGSDVAVK-VYFGSEYIEG--TLKNYQKEIDIIK 430
RW + GE +G GS+ VY G+ +G AVK V + G +K ++EI ++
Sbjct: 1 RW---RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLS 57
Query: 431 KLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALD---IKRRLRMALDVAR 487
KL+HPN++ ++G ++ L I E +P GSL K L K Y + I+ R L
Sbjct: 58 KLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILL--- 113
Query: 488 GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAP 547
G+ YLH RN VHRD+K +N+LVD N VK+ DFG++ + + AKS +G+P WMAP
Sbjct: 114 GLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSFAKSFKGSPYWMAP 170
Query: 548 EVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
EV+ + +D++S G + E+ T PW+ L + V +G +P+ L
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD 229
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 77/250 (30%), Positives = 128/250 (51%), Gaps = 25/250 (10%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLKNYQKEID 427
+ E + L E+G GS+ +VY G+ G + VA+K + + + + E
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEAS 61
Query: 428 IIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHK---------NYQALDIKRR 478
++K+ +V+ +G V++ + +V E + +G L L +++
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 479 LRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSG 538
++MA ++A GM YL + VHRDL + N +V ++ TVK+GDFG++ T K G
Sbjct: 122 IQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG 179
Query: 539 RGT-P-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDR 595
+G P +WMAPE L+ KSDV+SFGV+LWE+ T A P+ L+ +V+ V +D
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV--IDG 237
Query: 596 R-LELPEGLD 604
L+LPE
Sbjct: 238 GHLDLPENCP 247
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 3e-39
Identities = 88/239 (36%), Positives = 128/239 (53%), Gaps = 29/239 (12%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQK-------EIDIIK 430
++L+LG IG G + V G + G VAVK LK+ E ++
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVK----------CLKDDSTAAQAFLAEASVMT 55
Query: 431 KLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLH-KNYQALDIKRRLRMALDVARGM 489
LRHPN++ +G V L IVTE++ +GSL L + + + ++L ALDV GM
Sbjct: 56 TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGM 115
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEV 549
YL +N VHRDL + N+LV ++ KV DFGL+ K A+ SG+ +W APE
Sbjct: 116 EYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLA--KEASQ-GQDSGKLPVKWTAPEA 170
Query: 550 LRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEGLDP 605
LR + + KSDV+SFG++LWE+ + +P+ + L VV V G+ R+E PEG P
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY---RMEAPEGCPP 226
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 3e-39
Identities = 79/228 (34%), Positives = 115/228 (50%), Gaps = 14/228 (6%)
Query: 384 EEIGLGSYAVVYRGIWNGS-----DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
+++G GS+ VV RG W+ S VAVK S+ + + ++ KE I+ L H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKC-LKSDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQA-LDIKRRLRMALDVARGMNYLHHRNP 497
G V + L +VTE P GSL L K+ I A+ +A GM YL +
Sbjct: 60 RLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR- 117
Query: 498 PIVHRDLKSSNLLVDKNWTVKVGDFGLSS--LKNATYLTAKSGRGTP-QWMAPEVLRSEP 554
+HRDL + N+L+ + VK+GDFGL +N + + P W APE LR+
Sbjct: 118 -FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 555 SNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPE 601
+ SDV+ FGV LWE+ T PW L+ Q++ + RLE PE
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPE 224
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 14/205 (6%)
Query: 380 LQLGEEIGLGSYAVVYRGIWN------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
L+ +++G G + V ++ G VAVK E ++++EI+I++ L
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKS-LNHSGEEQHRSDFEREIEILRTLD 64
Query: 434 HPNVLLFMGAVASQER--LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNY 491
H N++ + G L ++ E+LP GSL L ++ +++KR L + + +GM+Y
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124
Query: 492 LHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT--YLTAKSGRGTP-QWMAPE 548
L + +HRDL + N+LV+ VK+ DFGL+ + Y K +P W APE
Sbjct: 125 LGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 549 VLRSEPSNEKSDVFSFGVILWELVT 573
LR+ + SDV+SFGV L+EL T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 5e-38
Identities = 86/240 (35%), Positives = 132/240 (55%), Gaps = 19/240 (7%)
Query: 377 WE----DLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIK 430
WE D+ + ++G G Y VY G+W VAVK + +E ++ + KE ++K
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTME--VEEFLKEAAVMK 57
Query: 431 KLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHK-NYQALDIKRRLRMALDVARGM 489
+++HPN++ +G + I+TEF+ G+L L + N Q ++ L MA ++ M
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QWMAPE 548
YL +N +HRDL + N LV +N VKV DFGLS L TA +G P +W APE
Sbjct: 118 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 549 VLRSEPSNEKSDVFSFGVILWELVTASI-PWNNLNLMQVVGVV--GFMDRRLELPEGLDP 605
L + KSDV++FGV+LWE+ T + P+ ++L QV ++ G+ R+E PEG P
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---RMERPEGCPP 232
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 7e-38
Identities = 70/214 (32%), Positives = 110/214 (51%), Gaps = 19/214 (8%)
Query: 379 DLQLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN 436
++ E+IG G + VY+ G +VA+KV + + EI I+KK +HPN
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI--KLESKEKKEKIINEIQILKKCKHPN 58
Query: 437 VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALD------IKRRLRMALDVARGMN 490
++ + G+ ++ L IV EF GSL L Q L + + L L+
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE------ 112
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL 550
YLH I+HRD+K++N+L+ + VK+ DFGLS+ + T + GTP WMAPEV+
Sbjct: 113 YLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT-KARNTMVGTPYWMAPEVI 169
Query: 551 RSEPSNEKSDVFSFGVILWELVTASIPWNNLNLM 584
+P + K+D++S G+ EL P++ L M
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPPYSELPPM 203
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 8e-38
Identities = 73/212 (34%), Positives = 115/212 (54%), Gaps = 12/212 (5%)
Query: 376 RWEDLQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH 434
R E L ++G G + V+ G+W N VA+K+ +++QKE+ +K+LRH
Sbjct: 5 REE-FTLERKLGSGYFGEVWEGLWKNRVRVAIKIL--KSDDLLKQQDFQKEVQALKRLRH 61
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHK-NYQALDIKRRLRMALDVARGMNYLH 493
+++ + E + I+TE + +GSL L Q L + + MA VA GM YL
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL-KNATYLTAKSGRGTP-QWMAPEVLR 551
+N +HRDL + N+LV ++ KV DFGL+ L K YL+ S + P +W APE
Sbjct: 122 EQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS--SDKKIPYKWTAPEAAS 177
Query: 552 SEPSNEKSDVFSFGVILWELVT-ASIPWNNLN 582
+ KSDV+SFG++L+E+ T +P+ +N
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 81/217 (37%), Positives = 120/217 (55%), Gaps = 15/217 (6%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGS-DVAVKVYFGSEYIEGTLK--NYQKEIDIIKKLRH 434
E L+L ++G G + V+ G WNG+ VAVK GT+ + +E I+KKLRH
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-----KPGTMSPEAFLQEAQIMKKLRH 60
Query: 435 PNVLLFMGAVASQ-ERLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYL 492
L+ + AV S+ E + IVTE++ +GSL L + L + + + MA +A GM YL
Sbjct: 61 DK-LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL 119
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QWMAPEVLR 551
RN +HRDL + N+LV +N K+ DFGL+ L TA+ G P +W APE
Sbjct: 120 ESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAAN 177
Query: 552 SEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVV 587
KSDV+SFG++L E+VT +P+ + +V+
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL 214
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 4e-36
Identities = 84/246 (34%), Positives = 125/246 (50%), Gaps = 32/246 (13%)
Query: 377 WE----DLQLGEEIGLGSYAVVYRGIWNGS-DVAVKVYFGSEYIEGTLK-------NYQK 424
WE +QL ++G G + V+ G+WN + VAVK TLK ++
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVK----------TLKPGTMDPKDFLA 50
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMAL 483
E I+KKLRHP ++ +E + IVTE + GSL + L +AL + + + MA
Sbjct: 51 EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA 110
Query: 484 DVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP- 542
VA GM YL +N +HRDL + N+LV +N KV DFGL+ + A+ G P
Sbjct: 111 QVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPI 168
Query: 543 QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLEL 599
+W APE + KSDV+SFG++L E+VT +P+ + +V+ V G+ R+
Sbjct: 169 KWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY---RMPC 225
Query: 600 PEGLDP 605
P G
Sbjct: 226 PPGCPK 231
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 77/229 (33%), Positives = 115/229 (50%), Gaps = 17/229 (7%)
Query: 379 DLQLGEEIGLGSYAVVYRGIWNGS-DVAVKVYFGSEYIEGTL--KNYQKEIDIIKKLRHP 435
+L +E+G G + VV+ G W G DVA+K+ EG + ++ +E ++ KL HP
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIR-----EGAMSEDDFIEEAKVMMKLSHP 59
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495
N++ G Q + IVTE++ G L L + L + L M DV M YL
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QWMAPEVLRSEP 554
+HRDL + N LV ++ VKV DFGL+ T+ G P +W PEV
Sbjct: 120 G--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSR 177
Query: 555 SNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELP 600
+ KSDV+SFGV++WE+ + +P+ + +VV V G+ RL P
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY---RLYRP 223
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 4e-35
Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
E + E++G GSY VY+ I G VA+KV +E L+ KEI I+K+ P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV----PVEEDLQEIIKEISILKQCDSP 58
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMAL----------DV 485
++ + G+ L IV E+ GS+ DI + L
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSV----------SDIMKITNKTLTEEEIAAILYQT 108
Query: 486 ARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWM 545
+G+ YLH +HRD+K+ N+L+++ K+ DFG+S T + GTP WM
Sbjct: 109 LKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWM 166
Query: 546 APEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
APEV++ N K+D++S G+ E+ P+++++ M+ +
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 72/203 (35%), Positives = 113/203 (55%), Gaps = 7/203 (3%)
Query: 384 EEIGLGSYAVVYRGIWNGS-DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMG 442
E+IG G++ VY+G+ G+ +VAVK + + K Q E +I+K+ HPN++ +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQ-EAEILKQYDHPNIVKLIG 59
Query: 443 AVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHR 502
++ + IV E +P GSL L K L +K+ L+M+LD A GM YL +N +HR
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHR 117
Query: 503 DLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRG-TP-QWMAPEVLRSEPSNEKSD 560
DL + N LV +N +K+ DFG+S + T G P +W APE L +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 561 VFSFGVILWELVT-ASIPWNNLN 582
V+S+G++LWE + P+ ++
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMS 200
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 74/218 (33%), Positives = 112/218 (51%), Gaps = 15/218 (6%)
Query: 378 EDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
ED +L + IG G+Y VY R I G VA+KV + Q+EI ++K+ RHP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHP 60
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALD---IKRRLRMALDVARGMNYL 492
N++ + G+ +++L IV E+ GSL L I R L +G+ YL
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL---KGLAYL 117
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL-- 550
H +HRD+K +N+L+ ++ VK+ DFG+S+ AT KS GTP WMAPEV
Sbjct: 118 HETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAV 175
Query: 551 -RSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
R + K D+++ G+ EL P +L+ M+ +
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 61/197 (30%), Positives = 107/197 (54%), Gaps = 19/197 (9%)
Query: 384 EEIGLGSYAVVYRGIWN--GSDVAVKVY-FGSEYIEGTLKNYQKEIDIIKKLRHPNVLLF 440
E+IG G+ VY+ G +VA+K + E + EI I+K +HPN++ +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN----EILIMKDCKHPNIVDY 80
Query: 441 MGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIV 500
+ + L +V E++ GSL + +N+ ++ + + +V +G+ YLH +N ++
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VI 138
Query: 501 HRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR-----GTPQWMAPEVLRSEPS 555
HRD+KS N+L+ K+ +VK+ DFG A LT + + GTP WMAPEV++ +
Sbjct: 139 HRDIKSDNILLSKDGSVKLADFGF-----AAQLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 556 NEKSDVFSFGVILWELV 572
K D++S G++ E+
Sbjct: 194 GPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 68/211 (32%), Positives = 110/211 (52%), Gaps = 7/211 (3%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGSD--VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
E L E IG GS+ VY+ I ++ VA+KV E E +++ Q+EI + + R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV-IDLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495
+ + G+ +L I+ E+ GS L LD + +V G+ YLH
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPS 555
+HRD+K++N+L+ + VK+ DFG+S +T + GTP WMAPEV++
Sbjct: 118 GK--IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 556 NEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
+EK+D++S G+ EL P ++L+ M+V
Sbjct: 176 DEKADIWSLGITAIELAKGEPPLSDLHPMRV 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 8e-33
Identities = 73/227 (32%), Positives = 121/227 (53%), Gaps = 24/227 (10%)
Query: 383 GEEIGLGSYAVVYRGI--WNGSDVAVK-VYFGSEYIEG------TLKNYQKEIDIIKKLR 433
G IG GS+ VY G+ +G +AVK V S L +EI ++K+L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALD---IKRRLRMALDVARGMN 490
H N++ ++G+ + L I E++P GS+ L NY A + ++ +R L +G+N
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVRNFVRQIL---KGLN 120
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQ------W 544
YLH+R I+HRD+K +N+LVD +K+ DFG+S A L+ K+ P W
Sbjct: 121 YLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 545 MAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591
MAPEV++ K+D++S G ++ E++T P+ + +Q + +G
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-32
Identities = 88/236 (37%), Positives = 131/236 (55%), Gaps = 19/236 (8%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNG-SDVAVKVYFGSEYIEGTL--KNYQKEIDIIKKLRH 434
E LQL +++G G + V+ G WNG + VAVK GT+ +++ +E I+KKLRH
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-----KPGTMSPESFLEEAQIMKKLRH 60
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHK-NYQALDIKRRLRMALDVARGMNYLH 493
+ L+ + AV S+E + IVTE++ +GSL L +AL + + MA VA GM Y+
Sbjct: 61 -DKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QWMAPEVLRS 552
N +HRDL+S+N+LV K+ DFGL+ L TA+ G P +W APE
Sbjct: 120 RMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 553 EPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEGLDP 605
KSDV+SFG++L ELVT +P+ +N +V+ V G+ R+ P+
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY---RMPCPQDCPI 230
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-32
Identities = 78/232 (33%), Positives = 114/232 (49%), Gaps = 13/232 (5%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGS-DVAVKVYFGSEYIEGTLK--NYQKEIDIIKK 431
I +DL +E+G G + VV G W G DVA+K+ EG++ + +E ++ K
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-----KEGSMSEDEFIEEAKVMMK 55
Query: 432 LRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNY 491
L H ++ G Q + IVTE++ G L L ++ + + L M DV GM Y
Sbjct: 56 LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAY 115
Query: 492 LHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QWMAPEVL 550
L + +HRDL + N LVD VKV DFGLS T+ G P +W PEVL
Sbjct: 116 LESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 551 RSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPE 601
+ KSDV++FGV++WE+ + +P+ N + V V RL P
Sbjct: 174 LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPH 224
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 67/203 (33%), Positives = 102/203 (50%), Gaps = 12/203 (5%)
Query: 379 DLQLGEEIGLGSYAVVYRGIWNGS-----DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
+ + + IG G + V RG DVA+K + + ++ E I+ +
Sbjct: 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKT-LKAGSSDKQRLDFLTEASIMGQFD 63
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
HPN++ G V + I+TE++ GSL K L +N + + + M +A GM YL
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL---KNATYLTAKSGRGTPQWMAPEVL 550
N VHRDL + N+LV+ N KV DFGLS ATY T K G+ +W APE +
Sbjct: 124 EMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY-TTKGGKIPIRWTAPEAI 180
Query: 551 RSEPSNEKSDVFSFGVILWELVT 573
SDV+SFG+++WE+++
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 80/234 (34%), Positives = 128/234 (54%), Gaps = 19/234 (8%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNV 437
++L+L + IG G + V G + G+ VAVK + T + + E ++ +LRH N+
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNL 61
Query: 438 LLFMGAVASQE-RLGIVTEFLPRGSLFKTLH-KNYQALDIKRRLRMALDVARGMNYLHHR 495
+ +G + ++ L IVTE++ +GSL L + L L+ +LDV M YL
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QWMAPEVLRSEP 554
N VHRDL + N+LV ++ KV DFGL+ ++T T K P +W APE LR +
Sbjct: 122 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALREKK 175
Query: 555 SNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEGLDP 605
+ KSDV+SFG++LWE+ + +P+ + L VV V G+ +++ P+G P
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPP 226
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 78/232 (33%), Positives = 127/232 (54%), Gaps = 17/232 (7%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNV 437
+ L LGE IG G + V +G + G VAVK + T + + +E ++ KL H N+
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNL 61
Query: 438 LLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQAL-DIKRRLRMALDVARGMNYLHHRN 496
+ +G + L IV E + +G+L L +AL + + L+ +LDVA GM YL +
Sbjct: 62 VRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120
Query: 497 PPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSN 556
+VHRDL + N+LV ++ KV DFGL+ + + + + + +W APE L+ + +
Sbjct: 121 --LVHRDLAARNILVSEDGVAKVSDFGLARVGS---MGVDNSKLPVKWTAPEALKHKKFS 175
Query: 557 EKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEGLDP 605
KSDV+S+GV+LWE+ + P+ ++L +V V G+ R+E PEG
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY---RMEPPEGCPA 224
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-31
Identities = 75/233 (32%), Positives = 115/233 (49%), Gaps = 11/233 (4%)
Query: 381 QLGEEIGLGSYAVVY--RGIWNGSDVAVK-VYFG--SEYIEGTLKNYQKEIDIIKKLRHP 435
+ G+ +G G++ VY + G ++AVK V F S + + + EI ++K L+H
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495
++ + G + E L I E++P GS+ L K Y AL + + G+ YLH
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEGVEYLH-S 122
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT---AKSGRGTPQWMAPEVLRS 552
N IVHRD+K +N+L D VK+GDFG S + KS GTP WM+PEV+
Sbjct: 123 NM-IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 553 EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
E K+DV+S G + E++T PW M + + +LP + P
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSP 234
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-31
Identities = 73/231 (31%), Positives = 118/231 (51%), Gaps = 18/231 (7%)
Query: 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
RW Q G +IG G++ VY + G +AVK + T+K E+ +++ L+
Sbjct: 1 RW---QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK 57
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
HPN++ + G +E++ I E+ G+L + L + + LD L + G+ YLH
Sbjct: 58 HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLH 116
Query: 494 -HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS-LKNATYLTAKSG---RGTPQWMAPE 548
H IVHRD+K +N+ +D N +K+GDFG + LKN T + GTP +MAPE
Sbjct: 117 SHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 549 VLRSEPSNEK---SDVFSFGVILWELVTASIPWNNL-NLMQVVGVVGFMDR 595
V+ +D++S G ++ E+ T PW+ L N Q++ VG +
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHK 224
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 6e-31
Identities = 71/216 (32%), Positives = 109/216 (50%), Gaps = 14/216 (6%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW-NGSDVAVKVY---FGSEYIEGTLKNYQKEIDIIKKLR 433
+L L +EIG G + +V+ G W VA+K SE +++ +E ++ KL
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE------EDFIEEAQVMMKLS 57
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
HP ++ G + + +V EF+ G L L + L M LDV GM YL
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QWMAPEVLRS 552
N ++HRDL + N LV +N VKV DFG++ T+ +G P +W +PEV
Sbjct: 118 SSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF 175
Query: 553 EPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVV 587
+ KSDV+SFGV++WE+ + P+ N + +VV
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 8e-31
Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 16/214 (7%)
Query: 381 QLGEEIGLGSYAVVY--RGIWNGSDVAVK-VYF---GSEYIEGTLKNYQKEIDIIKKLRH 434
G+++G G+++ Y R + G+ +AVK V + S E ++ +KEI ++ +L H
Sbjct: 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
P+++ +GA + E++ GS+ L Y A + + RG++YLH
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 495 RNPPIVHRDLKSSNLLVDKN-WTVKVGDFGLSSLKNATYLTAK---SGR--GTPQWMAPE 548
I+HRD+K +NLL+D +++ DFG ++ + A T G+ GT +MAPE
Sbjct: 122 NQ--IIHRDVKGANLLIDSTGQRLRIADFG-AAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 549 VLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582
VLR E DV+S G ++ E+ TA PWN
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 68/222 (30%), Positives = 112/222 (50%), Gaps = 14/222 (6%)
Query: 381 QLGEEIGLGSYAVVYRGIWN-GSDVAVK-VYFGSEYIEGTLKNYQK---EIDIIKKLRHP 435
GE +G G+Y VY G+ N G +AVK V + + K Y+K E+D++K L+H
Sbjct: 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHV 62
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495
N++ ++G + I EF+P GS+ L + L + + G+ YLH+
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHNN 121
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLS------SLKNATYLTAKSGRGTPQWMAPEV 549
+VHRD+K +N+++ N +K+ DFG + L KS GTP WMAPEV
Sbjct: 122 C--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 550 LRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591
+ KSD++S G ++E+ T P +++ + + +G
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG 221
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 71/238 (29%), Positives = 122/238 (51%), Gaps = 10/238 (4%)
Query: 374 GIRWEDLQLGEEIGLGSYAVVYRGIW---NGSDVAVKVYFGSEYIEGTLK-NYQKEIDII 429
I+ ED+ LG IG G + VY+G++ +AV V +++ + +E I+
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 430 KKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGM 489
++ HP+++ +G V ++ + IV E P G L L N +LD+ + + ++ +
Sbjct: 62 RQFDHPHIVKLIG-VITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL 120
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAPE 548
YL + VHRD+ + N+LV VK+GDFGLS L++ +Y A G+ +WMAPE
Sbjct: 121 AYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 549 VLRSEPSNEKSDVFSFGVILWELVTASI-PWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
+ SDV+ FGV +WE++ + P+ + V+G + + RL +P P
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPP 235
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 72/207 (34%), Positives = 120/207 (57%), Gaps = 14/207 (6%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNG-SDVAVKVYFGSEYIEGTL--KNYQKEIDIIKKLRH 434
E L+L +++G G + V+ G +NG + VA+K +G++ + + E +++K+L+H
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIK-----SLKQGSMSPEAFLAEANLMKQLQH 60
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLH 493
P L+ + AV +QE + I+TE++ GSL L L I + + MA +A GM ++
Sbjct: 61 PR-LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QWMAPEVLRS 552
+N +HRDL+++N+LV + K+ DFGL+ L TA+ G P +W APE +
Sbjct: 120 RKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 177
Query: 553 EPSNEKSDVFSFGVILWELVT-ASIPW 578
KSDV+SFG++L E+VT IP+
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 63/220 (28%), Positives = 113/220 (51%), Gaps = 21/220 (9%)
Query: 380 LQLGEEIGLGSYAVVYRGIW------NGSDVAVKVYFGSEYIEGTLKNYQKEI----DII 429
L+ + +G G++ VY+G+W VA+KV E T KEI ++
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-----REETSPKANKEILDEAYVM 63
Query: 430 KKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGM 489
+ HP+V+ +G + ++ ++T+ +P G L + + + + L + +A+GM
Sbjct: 64 ASVDHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGM 122
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTPQWMAP 547
+YL + +VHRDL + N+LV VK+ DFGL+ L + A+ G+ +WMA
Sbjct: 123 SYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180
Query: 548 EVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQV 586
E + KSDV+S+GV +WEL+T + P+ + +++
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI 220
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 74/221 (33%), Positives = 110/221 (49%), Gaps = 10/221 (4%)
Query: 379 DLQLGEEIGLGSYAVVYRGIWNGS-DVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRHPN 436
+L +E+G G + VV+ G W VA+K + G+ E ++ +E ++ KL HP
Sbjct: 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE----DFIEEAKVMMKLSHPK 60
Query: 437 VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRN 496
++ G Q+ L IVTEF+ G L L + L L M DV GM YL +
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120
Query: 497 PPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QWMAPEVLRSEPS 555
+HRDL + N LV VKV DFG++ T+ SG P +W PEV
Sbjct: 121 --FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 556 NEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDR 595
+ KSDV+SFGV++WE+ T +P+ + +VV ++ R
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR 219
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 4e-30
Identities = 78/207 (37%), Positives = 117/207 (56%), Gaps = 14/207 (6%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGS-DVAVKVYFGSEYIEGTL--KNYQKEIDIIKKLRH 434
E L+L ++G G + V+ G WNG+ VA+K GT+ + + +E ++KKLRH
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 60
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLH 493
L+ + AV S+E + IVTE++ +GSL L + L + + + MA +A GM Y+
Sbjct: 61 EK-LVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 119
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QWMAPEVLRS 552
N VHRDL+++N+LV +N KV DFGL+ L TA+ G P +W APE
Sbjct: 120 RMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 553 EPSNEKSDVFSFGVILWELVT-ASIPW 578
KSDV+SFG++L EL T +P+
Sbjct: 178 GRFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 2e-29
Identities = 85/233 (36%), Positives = 132/233 (56%), Gaps = 19/233 (8%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGS-DVAVKVYFGSEYIEGTL--KNYQKEIDIIKKLRH 434
E L+L ++G G + V+ G WNG+ VA+K GT+ + + +E I+KKLRH
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-----KPGTMMPEAFLQEAQIMKKLRH 60
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHK-NYQALDIKRRLRMALDVARGMNYLH 493
+ L+ + AV S+E + IVTEF+ +GSL L + + + L + + + MA +A GM Y+
Sbjct: 61 -DKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QWMAPEVLRS 552
N +HRDL+++N+LV N K+ DFGL+ L TA+ G P +W APE
Sbjct: 120 RMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 553 EPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDR--RLELPEG 602
KSDV+SFG++L ELVT +P+ + +V+ V +R R+ P+G
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV---ERGYRMPCPQG 227
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 22/201 (10%)
Query: 384 EEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
E++G G+Y VVY+ G VA+K EG +EI ++K+L+HPN++ +
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALD---IKRRLRMALDVARGMNYLHHRNPP 498
+ ++ +L +V E+ L K L K L IK + L RG+ Y H
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL---RGLAYCHSHR-- 118
Query: 499 IVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQ----WM-APEVLRSE 553
I+HRDLK N+L++++ +K+ DFGL A T + W APE+L
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGL-----ARAFGIPLRTYTHEVVTLWYRAPEILLGS 173
Query: 554 PSNEKS-DVFSFGVILWELVT 573
+ D++S G I E++T
Sbjct: 174 KHYSTAVDIWSVGCIFAEMIT 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 22/215 (10%)
Query: 386 IGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQ---KEIDIIKKLRHPNVLLF 440
IG G ++VVY+ I +G VA+K E ++ K Q KEID++K+L HPNV+ +
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA--KARQDCLKEIDLLKQLDHPNVIKY 67
Query: 441 MGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRL-------RMALDVARGMNYLH 493
+ + L IV E G L + K+++ ++RL + + + + ++H
Sbjct: 68 LASFIENNELNIVLELADAGDL-SRMIKHFKK---QKRLIPERTIWKYFVQLCSALEHMH 123
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSE 553
+ I+HRD+K +N+ + VK+GD GL ++ A S GTP +M+PE +
Sbjct: 124 SKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 554 PSNEKSDVFSFGVILWELVTASIPW--NNLNLMQV 586
N KSD++S G +L+E+ P+ + +NL +
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 76/221 (34%), Positives = 121/221 (54%), Gaps = 18/221 (8%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
+D +L E IG+G+ AVVY I N VA+K E + ++ +KE+ + + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKR-IDLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQA--LD---IKRRLRMALDVARGMN 490
NV+ + + + L +V +L GSL + +Y LD I L+ +V +G+
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK---EVLKGLE 116
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGR---GTPQWMA 546
YLH N I HRD+K+ N+L+ ++ +VK+ DFG+S SL + T K + GTP WMA
Sbjct: 117 YLH-SNGQI-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 547 PEVLRSEPS-NEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
PEV+ + K+D++SFG+ EL T + P++ M+V
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV 215
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 7e-29
Identities = 69/180 (38%), Positives = 103/180 (57%), Gaps = 9/180 (5%)
Query: 401 GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER--LGIVTEFLP 458
G VAVK S L+++++EI+I+K L+H N++ + G S R L +V E+LP
Sbjct: 33 GEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90
Query: 459 RGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVK 518
GSL L K+ + LD ++ L A + +GM YL + VHRDL + N+LV+ VK
Sbjct: 91 YGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVK 148
Query: 519 VGDFGLSSL--KNATYLTAKSGRGTPQ-WMAPEVLRSEPSNEKSDVFSFGVILWELVTAS 575
+GDFGL+ + ++ Y + +P W APE L + SDV+SFGV+L+EL T S
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYS 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 66/220 (30%), Positives = 120/220 (54%), Gaps = 23/220 (10%)
Query: 384 EEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH---PNVL 438
E IG G+Y VYRG G VA+K+ + + + + Q+E+ ++ +LR PN+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKI-INLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFKTLHK------NYQALDIKRRLRMALDVARGMNYL 492
+ G+ RL I+ E+ GS+ +TL K Y ++ I R + +AL Y+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-IIREVLVAL------KYI 117
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS 552
H ++HRD+K++N+LV VK+ DFG+++L N + GTP WMAPEV+
Sbjct: 118 HKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE 175
Query: 553 EPS-NEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591
+ K+D++S G+ ++E+ T + P+++++ + + ++
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP 215
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 69/183 (37%), Positives = 101/183 (55%), Gaps = 8/183 (4%)
Query: 396 RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI--V 453
G G VAVK E + + +KEI+I++ L H N++ + G GI +
Sbjct: 28 EGDNTGEQVAVKS-LKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86
Query: 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK 513
EFLP GSL + L +N +++K++L+ A+ + +GM+YL R VHRDL + N+LV+
Sbjct: 87 MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVES 144
Query: 514 NWTVKVGDFGLSSL--KNATYLTAKSGRGTPQ-WMAPEVLRSEPSNEKSDVFSFGVILWE 570
VK+GDFGL+ + Y T K +P W APE L SDV+SFGV L+E
Sbjct: 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYE 204
Query: 571 LVT 573
L+T
Sbjct: 205 LLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 75/236 (31%), Positives = 120/236 (50%), Gaps = 13/236 (5%)
Query: 378 EDLQLGEEIGLGSYAVVY--RGIWNGSDVAVK-VYF--GSEYIEGTLKNYQKEIDIIKKL 432
+ +LG+ +G G++ VY G ++AVK V F S+ + + EI ++K L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 433 RHPNVLLFMGAV--ASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMN 490
RH ++ + G + +++L I E++P GS+ L K Y AL R + +G++
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVS 120
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA---KSGRGTPQWMAP 547
YLH IVHRD+K +N+L D VK+GDFG S ++ KS GTP WM+P
Sbjct: 121 YLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 548 EVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603
EV+ E K+DV+S + E++T PW M + + + LP+G+
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGV 234
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 67/239 (28%), Positives = 113/239 (47%), Gaps = 32/239 (13%)
Query: 386 IGLGSYAVVY--RGIWNGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMG 442
I G+Y V+ + G A+KV ++ I + + E DI+ + + P V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 443 AVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR--------GMNYLHH 494
+ ++ L +V E+LP G L L N +LD DVAR + YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDE--------DVARIYIAEIVLALEYLHS 111
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL------KNATYLTAKSGR--GTPQWMA 546
I+HRDLK N+L+D N +K+ DFGLS + N + R GTP ++A
Sbjct: 112 NG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 547 PEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
PEV+ + ++ D +S G IL+E + P++ ++ + ++ ++E PE ++
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI--LNGKIEWPEDVEV 226
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 72/237 (30%), Positives = 114/237 (48%), Gaps = 17/237 (7%)
Query: 383 GEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQK--------EIDIIKKL 432
GE IG G+Y VY + G +AVK I G + QK EI+ +K L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 433 RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
H N++ ++G ++E L I E++P GS+ L + Y + + V G+ YL
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVL 550
H + I+HRDLK+ NLLVD + K+ DFG+S + Y S +G+ WMAPEV+
Sbjct: 125 HSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 551 RSEPS--NEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
S + K D++S G ++ E+ PW++ + + +G +P +
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM 239
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 64/209 (30%), Positives = 111/209 (53%), Gaps = 16/209 (7%)
Query: 384 EEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQK-----EIDIIKKLRHPNVL 438
E IG GS+ V + + SD + V+ +Y G + +K E++I+++L+HPN++
Sbjct: 6 ETIGKGSFGTVRK-VRRKSDGKILVWKEIDY--GNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 439 LFMG--AVASQERLGIVTEFLPRG---SLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
+ S + L IV E+ G L + K + ++ + R+ + + H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 494 HRNPP---IVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL 550
+R+ P ++HRDLK +N+ +D N VK+GDFGL+ + AK+ GTP +M+PE L
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182
Query: 551 RSEPSNEKSDVFSFGVILWELVTASIPWN 579
+EKSD++S G +++EL S P+
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 76/232 (32%), Positives = 119/232 (51%), Gaps = 23/232 (9%)
Query: 384 EEIGLGSYAVVYRGIW---NGSDVAVKV-YFGSEYIEGTLKNYQKEIDIIKKLRHPNVLL 439
+E+G G++ V +G++ +G +V V V E+I K + +E ++ +L HP ++
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 440 FMGAVASQERLGIVTEFLPRGSLFKTL--HKNYQALDIKRRLRMALDVARGMNYLHHRNP 497
+G V E L +V E P G L K L + D+K +A VA GM YL ++
Sbjct: 61 LIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE---LAHQVAMGMAYLESKH- 115
Query: 498 PIVHRDLKSSN-LLVDKNWTVKVGDFGLSSLKNA--TYLTAKS-GRGTPQWMAPEVLRSE 553
VHRDL + N LLV+++ K+ DFG+S A Y A + GR +W APE +
Sbjct: 116 -FVHRDLAARNVLLVNRHQ-AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 554 PSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDR--RLELPEG 602
+ KSDV+S+GV LWE + + P+ M+ V+ ++ RL PE
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGE---MKGAEVIAMLESGERLPRPEE 222
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 35/230 (15%)
Query: 378 EDLQLGEEIGLGSYAVVYRGI--WNGSDVAVKV--YFGSEYIEGTLKNYQKEIDIIKKLR 433
DL+ + +G GS VVY+ G A+K G E L E+ ++
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLR---ELKTLRSCE 57
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLR---------MALD 484
P V+ GA + + IV E++ GSL D+ +++ +A
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSL----------ADLLKKVGKIPEPVLAYIARQ 107
Query: 485 VARGMNYLHH-RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQ 543
+ +G++YLH R+ I+HRD+K SNLL++ VK+ DFG+S + T + GT
Sbjct: 108 ILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVT 165
Query: 544 WMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN------LMQVV 587
+M+PE ++ E + +D++S G+ L E P+ LMQ +
Sbjct: 166 YMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI 215
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 29/219 (13%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLKN-YQKEIDII 429
++ EE+G G++ VY+G G + VA+K E E ++ +++E +++
Sbjct: 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL--KENAEPKVQQEFRQEAELM 62
Query: 430 KKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN---------------YQALD 474
L+HPN++ +G ++ ++ E+L G L + L +N +LD
Sbjct: 63 SDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLD 122
Query: 475 IKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL-KNATYL 533
L +A+ +A GM YL + VHRDL + N LV + TVK+ DFGLS +A Y
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180
Query: 534 TAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWEL 571
+S P +WM PE + +SD++SFGV+LWE+
Sbjct: 181 RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 15/209 (7%)
Query: 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN 436
D ++ +IG GS+ VV++ + + A+K S+ + E ++ KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 437 VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRL------RMALDVARGMN 490
++ + + + +L IV E+ G L K L R L R + + G+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ-----RGRPLPEDQVWRFFIQILLGLA 115
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL 550
+LH + I+HRD+KS NL +D VK+GD G++ L + A + GTP +++PE+
Sbjct: 116 HLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC 173
Query: 551 RSEPSNEKSDVFSFGVILWELVTASIPWN 579
+P NEKSDV++ GV+L+E T P++
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 8e-28
Identities = 73/213 (34%), Positives = 117/213 (54%), Gaps = 23/213 (10%)
Query: 379 DLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQK-----EIDIIKKLR 433
D ++ +++G GSY VY+ + SD + Y E G++ ++ EI I+ +
Sbjct: 1 DFKVLKKLGKGSYGSVYK-VKRLSDN--QFYALKEVDLGSMSQKEREDAVNEIRILASVN 57
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRL-------RMALDVA 486
HPN++ + A +L IV E+ P G L K + K + KR+L R+ + +
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKK----KRKLIPEQEIWRIFIQLL 113
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMA 546
RG+ LH + I+HRDLKS+N+L+ N VK+GD G+S K AK+ GTP +MA
Sbjct: 114 RGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGIS--KVLKKNMAKTQIGTPHYMA 169
Query: 547 PEVLRSEPSNEKSDVFSFGVILWELVTASIPWN 579
PEV + P + KSD++S G +L+E+ T + P+
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 71/216 (32%), Positives = 110/216 (50%), Gaps = 22/216 (10%)
Query: 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKL- 432
WED++ + IG G++ V R + +G + + E+ E +++ E++++ KL
Sbjct: 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG 60
Query: 433 RHPNVLLFMGAVASQERLGIVTEFLPRGSL---------------FKTLHKNYQALDIKR 477
HPN++ +GA ++ L I E+ P G+L F H L ++
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 478 RLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKS 537
L+ A DVA GM YL + +HRDL + N+LV +N K+ DFGLS Y+
Sbjct: 121 LLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLASKIADFGLSR-GEEVYVKKTM 177
Query: 538 GRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
GR +WMA E L KSDV+SFGV+LWE+V+
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 69/251 (27%), Positives = 119/251 (47%), Gaps = 27/251 (10%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRG-IWNGSD------VAVKVYFGSEYIEGTLKNYQKEID 427
++ + + L E+G G++ V+ G ++ VAVK + K++++E +
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAE 60
Query: 428 IIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN-------------YQALD 474
++ +H N++ F G + +V E++ G L K L + L
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 475 IKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYL 533
+ + L++A+ +A GM YL ++ VHRDL + N LV + VK+GDFG+S + Y
Sbjct: 121 LSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178
Query: 534 TAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVG 591
P +WM PE + +SDV+SFGV+LWE+ T PW L+ +V+ +
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238
Query: 592 FMDRRLELPEG 602
R L+ P
Sbjct: 239 -QGRLLQRPRT 248
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 60/258 (23%), Positives = 112/258 (43%), Gaps = 41/258 (15%)
Query: 378 EDLQLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQKEI----DIIKK 431
+D + G+ IG GS++ V + A+K+ + + K + +++ +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL-DKRQL--IKEKKVKYVKIEKEVLTR 57
Query: 432 L-RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMN 490
L HP ++ +E L V E+ P G L + + K +LD K A ++ +
Sbjct: 58 LNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALE 116
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS----------SLKNATYLTAKSGR- 539
YLH + I+HRDLK N+L+DK+ +K+ DFG + S K
Sbjct: 117 YLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 540 ---------GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW---NNLNLMQVV 587
GT ++++PE+L +P+ + SD+++ G I+++++T P+ N Q +
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234
Query: 588 GVVGFMDRRLELPEGLDP 605
+ P P
Sbjct: 235 -----LKLEYSFPPNFPP 247
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 75/220 (34%), Positives = 111/220 (50%), Gaps = 31/220 (14%)
Query: 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDII 429
D +E L E IG G+Y VY+ G VA+K+ + IE + ++E +I+
Sbjct: 3 DPTGIFE---LVEVIGEGTYGKVYKARHKKTGQLVAIKI---MDIIEDEEEEIKEEYNIL 56
Query: 430 KKL-RHPNVLLFMGA------VASQERLGIVTEFLPRGS---LFKTLHKNYQALD---IK 476
+K HPN+ F GA + ++L +V E GS L K L K + L I
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116
Query: 477 RRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAK 536
LR L RG+ YLH ++HRD+K N+L+ KN VK+ DFG+S+ ++T
Sbjct: 117 YILRETL---RGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171
Query: 537 SGRGTPQWMAPEVLRSEPSNE-----KSDVFSFGVILWEL 571
+ GTP WMAPEV+ + + +SDV+S G+ EL
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 7e-27
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 17/216 (7%)
Query: 381 QLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNY-QKEIDIIKKLRHP-NVL 438
++ ++G GS+ VY + VA+KV + +EI I+ L HP N++
Sbjct: 3 RILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQ--ALDIKRRLRMALDVARGMNYLHHRN 496
+ L +V E++ GSL L K + L L + + + YLH +
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 497 PPIVHRDLKSSNLLVDKN-WTVKVGDFGLSSL------KNATYLTAKSGRGTPQWMAPEV 549
I+HRD+K N+L+D++ VK+ DFGL+ L ++ + GTP +MAPEV
Sbjct: 122 --IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 550 LRS---EPSNEKSDVFSFGVILWELVTASIPWNNLN 582
L ++ SD++S G+ L+EL+T P+
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215
|
Length = 384 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 9e-27
Identities = 58/205 (28%), Positives = 108/205 (52%), Gaps = 5/205 (2%)
Query: 386 IGLGSY--AVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGA 443
+G G++ A +YR + S V K + E ++ EI I+ L+HPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 444 VASQERLGIVTEFLPRGSLF-KTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHR 502
L I E+ G+L+ K + + Q + + L + ++Y+H I+HR
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHR 125
Query: 503 DLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVF 562
D+K+ N+ + K +K+GDFG+S + + Y A++ GTP +M+PE+ + N KSD++
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIW 185
Query: 563 SFGVILWELVTASIPWNNLNLMQVV 587
+ G +L+EL+T ++ N + +V
Sbjct: 186 ALGCVLYELLTLKRTFDATNPLNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 57/167 (34%), Positives = 99/167 (59%), Gaps = 4/167 (2%)
Query: 423 QKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQAL-DIKRRLRM 481
+KE+ ++ K++HPN++ F + RL IV E+ G L K +++ L + L
Sbjct: 47 KKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW 106
Query: 482 ALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTV-KVGDFGLSSLKNATYLTAKSGRG 540
+ ++ G+ ++H R I+HRD+KS N+ + KN V K+GDFG++ N + A + G
Sbjct: 107 FVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVG 164
Query: 541 TPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
TP +++PE+ ++ P N K+D++S G +L+EL T P+ NL Q+V
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 67/214 (31%), Positives = 114/214 (53%), Gaps = 19/214 (8%)
Query: 385 EIGLGSYAVVYRGIWNGSDV--AVKVY-FGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
E+G G++ VY+ + + A K+ SE L+++ EIDI+ + +HPN++
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESE---EELEDFMVEIDILSECKHPNIVGLY 68
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALD---IKRRLRMALDVARGMNYLHHRNPP 498
A + +L I+ EF G+L + + + L I+ R L+ +N+LH
Sbjct: 69 EAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE---ALNFLHSHK-- 123
Query: 499 IVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL-----RSE 553
++HRDLK+ N+L+ + VK+ DFG+S+ +T + GTP WMAPEV+ +
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183
Query: 554 PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
P + K+D++S G+ L EL P + LN M+V+
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHELNPMRVL 217
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 64/190 (33%), Positives = 105/190 (55%), Gaps = 7/190 (3%)
Query: 384 EEIGLGSYAVVYRG-IWNGSDVAVKVYFGSEYIEGTLK-NYQKEIDIIKKLRHPNVLLFM 441
E +G G++ V++G + + + VAVK E + LK + E I+K+ HPN++ +
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTC--KEDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVH 501
G ++ + IV E +P G L K L K+ ++ ALD A GM YL +N +H
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIH 116
Query: 502 RDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QWMAPEVLRSEPSNEKSD 560
RDL + N LV +N +K+ DFG+S ++ ++ + P +W APE L + +SD
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 561 VFSFGVILWE 570
V+S+G++LWE
Sbjct: 177 VWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 62/209 (29%), Positives = 111/209 (53%), Gaps = 13/209 (6%)
Query: 386 IGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGA 443
+G G++ +V+ R + V +K + + Q E ++K L HPN++ +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 444 VASQERLGIVTEFLPRGSLFKTLHKNYQA-LDIKRRLRMALDVARGMNYLHHRNPPIVHR 502
+ L IV E+ P G+L + + K + LD L + + ++++H + I+HR
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHR 125
Query: 503 DLKSSNLLVDKNWTV-KVGDFGLS---SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEK 558
DLK+ N+L+DK+ V K+GDFG+S S K+ Y GTP +++PE+ +P N+K
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV----GTPCYISPELCEGKPYNQK 181
Query: 559 SDVFSFGVILWELVTASIPWNNLNLMQVV 587
SD+++ G +L+EL + + NL +V
Sbjct: 182 SDIWALGCVLYELASLKRAFEAANLPALV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 69/214 (32%), Positives = 107/214 (50%), Gaps = 20/214 (9%)
Query: 378 EDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQK----EIDIIKK 431
+DL+ E+G G+ VV G +AVK +E QK E+DI+ K
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI----RLEINEA-IQKQILRELDILHK 55
Query: 432 LRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNY 491
P ++ F GA + + I E++ GSL K L + + + ++A+ V +G+ Y
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTY 115
Query: 492 LHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT---AKSGRGTPQWMAPE 548
LH I+HRD+K SN+LV+ +K+ DFG+S L AK+ GT +MAPE
Sbjct: 116 LHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPE 169
Query: 549 VLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582
++ + KSD++S G+ L EL T P+ N
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEN 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 76/227 (33%), Positives = 115/227 (50%), Gaps = 15/227 (6%)
Query: 386 IGLGSYAVVYRGIWNGSD-----VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLF 440
IG G + VY G SD AVK +E ++ + KE I+K HPNVL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE-EVEQFLKEGIIMKDFSHPNVLSL 61
Query: 441 MGAVASQERLG-IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPI 499
+G E +V ++ G L + +K + L VA+GM YL +
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--F 119
Query: 500 VHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTP---QWMAPEVLRSEPS 555
VHRDL + N ++D+++TVKV DFGL+ + + Y + + G +WMA E L+++
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179
Query: 556 NEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPE 601
KSDV+SFGV+LWEL+T + P+ +++ + V RRL PE
Sbjct: 180 TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDIT-VYLLQGRRLLQPE 225
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 74/248 (29%), Positives = 129/248 (52%), Gaps = 25/248 (10%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLKNYQKEIDIIK 430
E + + E+G GS+ +VY GI G + VA+K + + ++ + E ++K
Sbjct: 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMK 64
Query: 431 KLRHPNVLLFMGAVASQERLGIVTEFLPRGSL---FKTLHKNYQA------LDIKRRLRM 481
+ +V+ +G V+ + ++ E + RG L ++L + +K+ ++M
Sbjct: 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124
Query: 482 ALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRG- 540
A ++A GM YL+ VHRDL + N +V +++TVK+GDFG++ T K G+G
Sbjct: 125 AGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 541 -TPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV---GFMDR 595
+WM+PE L+ SDV+SFGV+LWE+ T A P+ ++ QV+ V G +D+
Sbjct: 183 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDK 242
Query: 596 RLELPEGL 603
P+ L
Sbjct: 243 PDNCPDML 250
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 71/234 (30%), Positives = 128/234 (54%), Gaps = 14/234 (5%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGS-DVAVKVYF-GSEYIEGTLKNYQKEIDIIKKLRHP 435
E ++L +++G G + V+ G +N S VAVK G+ ++ L+ E +++K L+H
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE----EANLMKTLQHD 61
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQA-LDIKRRLRMALDVARGMNYLHH 494
++ V +E + I+TE++ +GSL L + + + + + + +A GM Y+
Sbjct: 62 KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 121
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QWMAPEVLRSE 553
+N +HRDL+++N+LV ++ K+ DFGL+ + TA+ G P +W APE +
Sbjct: 122 KN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 179
Query: 554 PSNEKSDVFSFGVILWELVT-ASIPW---NNLNLMQVVGVVGFMDRRLELPEGL 603
KSDV+SFG++L+E+VT IP+ +N ++M + M R P+ L
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDEL 233
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-25
Identities = 65/210 (30%), Positives = 115/210 (54%), Gaps = 9/210 (4%)
Query: 384 EEIGLGSYAVVYRGIWNGSD--VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
E IG GS+ VY+GI N + VA+K+ E E +++ Q+EI ++ + P + +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIV 500
G+ +L I+ E+L GS L + I LR ++ +G++YLH +
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR---EILKGLDYLHSERK--I 123
Query: 501 HRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSD 560
HRD+K++N+L+ + VK+ DFG++ T + + GTP WMAPEV++ + K+D
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183
Query: 561 VFSFGVILWELVTASIPWNNLNLMQVVGVV 590
++S G+ EL P ++L+ M+V+ ++
Sbjct: 184 IWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-25
Identities = 64/209 (30%), Positives = 116/209 (55%), Gaps = 7/209 (3%)
Query: 384 EEIGLGSYAVVYRGIWNGSD--VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
E+IG GS+ V++GI N + VA+K+ E E +++ Q+EI ++ + P V +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVH 501
G+ +L I+ E+L GS L LD + + ++ +G++YLH +H
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKK--IH 124
Query: 502 RDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDV 561
RD+K++N+L+ ++ VK+ DFG++ T + + GTP WMAPEV++ + K+D+
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 184
Query: 562 FSFGVILWELVTASIPWNNLNLMQVVGVV 590
+S G+ EL P + L+ M+V+ ++
Sbjct: 185 WSLGITAIELAKGEPPHSELHPMKVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 26/220 (11%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGS----DVAVKVYFGSEYI-EGTLKNYQKEIDII 429
+ W D++ + IG G++ V + D A+K EY + +++ E++++
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVL 61
Query: 430 KKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSL---------------FKTLHKNYQAL 473
KL HPN++ +GA + L + E+ P G+L F + L
Sbjct: 62 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 474 DIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533
++ L A DVARGM+YL + +HRDL + N+LV +N+ K+ DFGLS Y+
Sbjct: 122 SSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR-GQEVYV 178
Query: 534 TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
GR +WMA E L SDV+S+GV+LWE+V+
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 13/204 (6%)
Query: 380 LQLGEEIGLGSYAVVYRGIWN-----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH 434
+++ E IG G + V RG VA+K Y E +++ E I+ + H
Sbjct: 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDH 64
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
PN++ G V + I+TEF+ G+L L +N + + + M +A GM YL
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL-----KNATYLTAKSGRGTPQWMAPEV 549
N VHRDL + N+LV+ N KV DFGLS + TY ++ G+ +W APE
Sbjct: 125 MN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 550 LRSEPSNEKSDVFSFGVILWELVT 573
+ SDV+S+G+++WE+++
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 74/217 (34%), Positives = 111/217 (51%), Gaps = 13/217 (5%)
Query: 381 QLGEEIGLGSYAVVY--RGIWNGSDVAVK-VYFGSEYIEGT--LKNYQKEIDIIKKLRHP 435
+LG+ +G G++ VY G ++AVK V F E E + + + EI ++K L H
Sbjct: 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 436 NVLLFMGAVA-SQER-LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
++ + G + ER L I E +P GS+ L K+Y AL + + G++YLH
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYLH 123
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA---KSGRGTPQWMAPEVL 550
IVHRD+K +N+L D VK+GDFG S L+ KS GTP WM+PEV+
Sbjct: 124 SNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 551 RSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
E K+D++S G + E++T PW M +
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI 218
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 32/227 (14%)
Query: 376 RWE----DLQLGEEIGLGSYAVVYRGIWNGSD-------VAVKVYFGSEYIEGTLKNYQK 424
WE L LG+ +G G++ V + G D VAVK+ E L +
Sbjct: 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVS 64
Query: 425 EIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN-----YQALDIKRR 478
E++++K + +H N++ +G + L +V E+ G+L L Y + D R
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 479 LR----------MALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS-- 526
A VARGM +L + +HRDL + N+LV ++ +K+ DFGL+
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 527 LKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
Y +GR +WMAPE L +SDV+SFGV+LWE+ T
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 67/222 (30%), Positives = 111/222 (50%), Gaps = 7/222 (3%)
Query: 384 EEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLK-NYQKEIDIIKKLRHPNVLLFMG 442
E IG G++ V+ G + V V E + LK + +E I+K+ HPN++ +G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 443 AVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHR 502
++ + IV E + G L L +K ++M + A GM YL ++ +HR
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHR 118
Query: 503 DLKSSNLLVDKNWTVKVGDFGLSSLK-NATYLTAKSGRGTP-QWMAPEVLRSEPSNEKSD 560
DL + N LV + +K+ DFG+S + + Y + + P +W APE L + +SD
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178
Query: 561 VFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPE 601
V+SFG++LWE + ++P+ NL+ Q + RL PE
Sbjct: 179 VWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPE 219
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 78/236 (33%), Positives = 131/236 (55%), Gaps = 19/236 (8%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNG-SDVAVKVYF-GSEYIEGTLKNYQKEIDIIKKLRHP 435
E L+L +++G G + V+ +N + VAVK GS +E L E +++K L+H
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQH- 60
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLF---KTLHKNYQALDIKRRLRMALDVARGMNYL 492
+ L+ + AV ++E + I+TEF+ +GSL K+ + Q L + + + +A GM ++
Sbjct: 61 DKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFI 118
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QWMAPEVLR 551
RN +HRDL+++N+LV + K+ DFGL+ + TA+ G P +W APE +
Sbjct: 119 EQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 176
Query: 552 SEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GF-MDRRLELPEGL 603
KSDV+SFG++L E+VT IP+ ++ +V+ + G+ M R PE L
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL 232
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 74/218 (33%), Positives = 111/218 (50%), Gaps = 23/218 (10%)
Query: 404 VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLF 463
VAVKV + + +++ KE+ I+ +L PN+ +G L ++ E++ G L
Sbjct: 49 VAVKV-LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 464 KTLHK----------NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK 513
+ L K N ++L L MA +A GM YL N VHRDL + N LV K
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGK 165
Query: 514 NWTVKVGDFGLS-SLKNATYLTAKSGRGTP---QWMAPE-VLRSEPSNEKSDVFSFGVIL 568
N+T+K+ DFG+S +L ++ Y + GR P +WMA E VL + + KSDV++FGV L
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQ-GR-APLPIRWMAWESVLLGKFT-TKSDVWAFGVTL 222
Query: 569 WELVTAS--IPWNNLNLMQVVGVVGFMDRRLELPEGLD 604
WE++T P+ +L QV+ G R L
Sbjct: 223 WEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLP 260
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 69/213 (32%), Positives = 108/213 (50%), Gaps = 17/213 (7%)
Query: 385 EIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMG 442
E+G G++ VY+ G+ A KV E L++Y EI+I+ HP ++ +G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 443 AVASQERLGIVTEFLPRGSLFKT---LHKNYQALDIKRRLRMALDVARGMNYLHHRNPPI 499
A +L I+ EF P G++ L + I+ R L+ + YLH I
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE---ALQYLHSMK--I 131
Query: 500 VHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSE-----P 554
+HRDLK+ N+L+ + +K+ DFG+S+ T S GTP WMAPEV+ E P
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 555 SNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
+ K+D++S G+ L E+ P + LN M+V+
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 224
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 63/207 (30%), Positives = 113/207 (54%), Gaps = 9/207 (4%)
Query: 384 EEIGLGSYAVVYRGIWNGSD--VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
E IG GS+ V++GI N + VA+K+ E E +++ Q+EI ++ + P V +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIV 500
G+ +L I+ E+L GS L + I L+ ++ +G++YLH +
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEKK--I 123
Query: 501 HRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSD 560
HRD+K++N+L+ + VK+ DFG++ T + + GTP WMAPEV++ + K+D
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183
Query: 561 VFSFGVILWELVTASIPWNNLNLMQVV 587
++S G+ EL P ++++ M+V+
Sbjct: 184 IWSLGITAIELAKGEPPNSDMHPMRVL 210
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 69/217 (31%), Positives = 110/217 (50%), Gaps = 22/217 (10%)
Query: 401 GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ--ERLGIVTEFLP 458
G VAVK E + ++KEI+I+K L H N++ + G + Q + L ++ E++P
Sbjct: 33 GEMVAVKT-LKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP 91
Query: 459 RGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVK 518
GSL L K+ L++ + L A + GM YLH ++ +HRDL + N+L+D + VK
Sbjct: 92 LGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVK 147
Query: 519 VGDFGLSSL---KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTAS 575
+GDFGL+ + Y + G W A E L+ + SDV+SFGV L+EL+T
Sbjct: 148 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC 207
Query: 576 IPWNN------------LNLMQVVGVVGFMDRRLELP 600
+ M VV ++ ++R + LP
Sbjct: 208 DSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLP 244
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 66/198 (33%), Positives = 98/198 (49%), Gaps = 15/198 (7%)
Query: 386 IGLGSYAVVYRGIW-----NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLF 440
IG G + V+RGI VA+K Y E +++ E I+ + H N++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKT-LKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 441 MGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIV 500
G V + I+TE++ G+L K L + + + M +A GM YL N V
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YV 129
Query: 501 HRDLKSSNLLVDKNWTVKVGDFGLSSL----KNATYLTAKSGRGTP-QWMAPEVLRSEPS 555
HRDL + N+LV+ N KV DFGLS + TY T SG P +W APE +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT--SGGKIPIRWTAPEAIAYRKF 187
Query: 556 NEKSDVFSFGVILWELVT 573
SDV+SFG+++WE+++
Sbjct: 188 TSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 64/214 (29%), Positives = 111/214 (51%), Gaps = 13/214 (6%)
Query: 386 IGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEI----DIIKKLRHPNVLL 439
+G G++ VY+G+W G V + V E E T KEI ++ + +P+V
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAI-KELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 440 FMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPI 499
+G + + ++T+ +P G L + ++ + + L + +A+GMNYL R +
Sbjct: 74 LLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--L 130
Query: 500 VHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA--TYLTAKSGRGTPQWMAPEVLRSEPSNE 557
VHRDL + N+LV VK+ DFGL+ L A A+ G+ +WMA E +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 558 KSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV 590
+SDV+S+GV +WEL+T S P++ + ++ ++
Sbjct: 191 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 386 IGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKL-RHPNVLLFM 441
IG G++ V + +G + + EY + +++ E++++ KL HPN++ +
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 442 GAVASQERLGIVTEFLPRGSLFKTL---------------HKNYQALDIKRRLRMALDVA 486
GA + L + E+ P G+L L + L ++ L A DVA
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMA 546
RGM+YL + +HRDL + N+LV +N+ K+ DFGLS Y+ GR +WMA
Sbjct: 123 RGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVRWMA 179
Query: 547 PEVLRSEPSNEKSDVFSFGVILWELVT 573
E L SDV+S+GV+LWE+V+
Sbjct: 180 IESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 5e-24
Identities = 67/211 (31%), Positives = 106/211 (50%), Gaps = 13/211 (6%)
Query: 385 EIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAV 444
E+G G++ VY+ + V E L++Y EIDI+ HPN++ + A
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 445 ASQERLGIVTEFLPRGSLFKTLHKNYQAL---DIKRRLRMALDVARGMNYLHHRNPPIVH 501
+ L I+ EF G++ + + + L I+ + L+ +NYLH I+H
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE---ALNYLHENK--IIH 126
Query: 502 RDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSE-----PSN 556
RDLK+ N+L + +K+ DFG+S+ T S GTP WMAPEV+ E P +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186
Query: 557 EKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
K+DV+S G+ L E+ P + LN M+V+
Sbjct: 187 YKADVWSLGITLIEMAQIEPPHHELNPMRVL 217
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 54/193 (27%), Positives = 110/193 (56%), Gaps = 5/193 (2%)
Query: 384 EEIGLGSY--AVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
++IG GS+ A++ + +G +K S+ + +KE+ ++ ++HPN++ +
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRR-LRMALDVARGMNYLHHRNPPIV 500
+ L IV ++ G L+K ++ L + + L + + + ++H R I+
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--IL 123
Query: 501 HRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSD 560
HRD+KS N+ + K+ T+K+GDFG++ + N+T A++ GTP +++PE+ + P N KSD
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSD 183
Query: 561 VFSFGVILWELVT 573
+++ G +L+E+ T
Sbjct: 184 IWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 72/228 (31%), Positives = 115/228 (50%), Gaps = 13/228 (5%)
Query: 383 GEEIGLGSYAVVY--RGIWNGSDVAVK-VYFGSEYIEGT--LKNYQKEIDIIKKLRHPNV 437
G+ +G G++ VY + G ++A K V F E E + + + EI ++K L+H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 438 LLFMGAVA--SQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495
+ + G + +++ L I E++P GS+ L K Y AL + + GM+YLH
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA---KSGRGTPQWMAPEVLRS 552
IVHRD+K +N+L D VK+GDFG S ++ +S GTP WM+PEV+
Sbjct: 126 M--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
Query: 553 EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELP 600
E K+DV+S G + E++T PW M + + +LP
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 54/165 (32%), Positives = 95/165 (57%), Gaps = 8/165 (4%)
Query: 425 EIDIIKK-LRHPNVLLFMGAVASQERLGIVTEFL---PRGSLFKTLHKNYQALDIKRRLR 480
E+ IIK+ LRHPN++ + +RL IV + + P G F +L + Q +R
Sbjct: 58 EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 481 MALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA-TYLTAKSGR 539
+ + + + YLH + IVHRDL +N+++ ++ V + DFGL+ K + LT+ G
Sbjct: 118 IFVQMVLALRYLH-KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVG- 175
Query: 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLM 584
T + PE++++EP EK+DV++FG IL+++ T P+ + N++
Sbjct: 176 -TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 78/241 (32%), Positives = 112/241 (46%), Gaps = 32/241 (13%)
Query: 386 IGLGSYAVVYRG-----IWNGSD---VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNV 437
+G G++ VY G + GS VAVK + K + KE ++ HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-EKKEFLKEAHLMSNFNHPNI 61
Query: 438 LLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQA------LDIKRRLRMALDVARGMNY 491
+ +G E I+ E + G L L L +K L + LDVA+G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 492 LHHRNPPIVHRDLKSSNLLV-----DKNWTVKVGDFGLSS--LKNATYLTAKSGRGTPQW 544
L + +HRDL + N LV D + VK+GDFGL+ K+ Y G +W
Sbjct: 122 LEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 545 MAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPW---NNLNLMQVVGVVGFMDRRLELP 600
MAPE L +SDV+SFGV++WE++T P+ NN ++Q V G RL+ P
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG----RLQKP 235
Query: 601 E 601
E
Sbjct: 236 E 236
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 67/242 (27%), Positives = 112/242 (46%), Gaps = 20/242 (8%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGSD-------VAVKVYFGSEYIEGTLKNYQKEIDIIK 430
+LQ +G G + V+ G + V VK E +++E+D+ +
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKA-LQKTKDENLQSEFRRELDMFR 63
Query: 431 KLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN--------YQALDIKRRLRMA 482
KL H NV+ +G E ++ E+ G L + L L K+++ +
Sbjct: 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 483 LDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK-NATYLTAKSGRGT 541
+A GM++L N VHRDL + N LV VKV LS N+ Y ++
Sbjct: 124 TQIALGMDHLS--NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 542 PQWMAPEVLRSEPSNEKSDVFSFGVILWELVTAS-IPWNNLNLMQVVGVVGFMDRRLELP 600
+W+APE ++ + + KSDV+SFGV++WE+ T +P+ L+ +V+ + L +P
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241
Query: 601 EG 602
EG
Sbjct: 242 EG 243
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 70/236 (29%), Positives = 110/236 (46%), Gaps = 22/236 (9%)
Query: 384 EEIGLGSYAVVYRG-IWNGSDVA---VKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLL 439
+EIG G + V G G A VK S + L + +E+ ++L HPNVL
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL-FLQEVQPYRELNHPNVLQ 59
Query: 440 FMGAVASQERLGIVTEFLPRGSLFKTLHKNY----QALDIKRRLRMALDVARGMNYLHHR 495
+G +V EF P G L L N Q RMA +VA G+ +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGL--SSLKNATYLTAKSGRGTPQWMAPEVLRSE 553
+ +H DL N + + +VK+GD+GL Y+T +W+APE++
Sbjct: 120 D--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 554 PSN-------EKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPE 601
+ +KS+++S GV +WEL T A P+ +L+ QV+ V ++ ++LP+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV-VREQDIKLPK 232
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 74/248 (29%), Positives = 125/248 (50%), Gaps = 25/248 (10%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLKNYQKEIDIIK 430
E + L E+G GS+ +VY G + VAVK S + ++ + E ++K
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMK 64
Query: 431 KLRHPNVLLFMGAVASQERLGIVTEFLPRG---SLFKTLHKNYQ------ALDIKRRLRM 481
+V+ +G V+ + +V E + G S ++L + ++ ++M
Sbjct: 65 GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124
Query: 482 ALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRG- 540
A ++A GM YL+ + VHRDL + N +V ++TVK+GDFG++ T K G+G
Sbjct: 125 AAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 541 -TPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV---GFMDR 595
+WMAPE L+ SD++SFGV+LWE+ + A P+ L+ QV+ V G++D+
Sbjct: 183 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 242
Query: 596 RLELPEGL 603
PE +
Sbjct: 243 PDNCPERV 250
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 380 LQLGEEIGLGSYAVVYRGIWNGSD-----VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH 434
L+LG+ +G G + V G + D VAVK + ++ + E +K H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 435 PNVLLFMGAVASQERLG------IVTEFLPRGSL-----FKTLHKNYQALDIKRRLRMAL 483
PNV+ +G L ++ F+ G L + L + L ++ L+ +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 484 DVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTP 542
D+A GM YL +RN +HRDL + N ++ ++ TV V DFGLS + + Y P
Sbjct: 121 DIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178
Query: 543 -QWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
+W+A E L KSDV++FGV +WE+ T
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 57/219 (26%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 378 EDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEID-------I 428
+D + + +G GS+ V R +G A+K+ ++ ++ K+++ I
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK------LKQVEHVLNEKRI 54
Query: 429 IKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARG 488
++ +RHP ++ G+ L +V E++P G LF + + A V
Sbjct: 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELF-SHLRKSGRFPEPVARFYAAQVVLA 113
Query: 489 MNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAP 547
+ YLH + IV+RDLK NLL+D + +K+ DFG + +K TY GTP+++AP
Sbjct: 114 LEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAP 167
Query: 548 EVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
E++ S+ + D ++ G++++E++ P+ + N +Q+
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-23
Identities = 72/220 (32%), Positives = 110/220 (50%), Gaps = 20/220 (9%)
Query: 378 EDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYF---GSEYIEGTLKNYQKEIDIIKKL 432
ED +L + IG G+Y VY R + G A+KV G ++ Q+EI ++K
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDF-----AVVQQEIIMMKDC 63
Query: 433 RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN--YQALDIKRRLRMALDVARGMN 490
+H N++ + G+ +++L I EF GSL H I R L +G+
Sbjct: 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL---QGLY 120
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL 550
YLH + +HRD+K +N+L+ N VK+ DFG+S+ AT KS GTP WMAPEV
Sbjct: 121 YLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178
Query: 551 RSEPS---NEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
E N+ D+++ G+ EL P +L+ M+ +
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 71/217 (32%), Positives = 113/217 (52%), Gaps = 14/217 (6%)
Query: 378 EDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
D +L + +G G+Y VY R + G AVK+ + +L Q+EI ++K+ +H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMVKECKHC 66
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN--YQALDIKRRLRMALDVARGMNYLH 493
N++ + G+ S+E+L I E+ GSL H L I R L +G+ YLH
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL---QGLAYLH 123
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSE 553
+ +HRD+K +N+L+ N VK+ DFG+++ AT KS GTP WMAPEV E
Sbjct: 124 SKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 554 PS---NEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
+ N+ D+++ G+ EL P +L+ M+ +
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 28/203 (13%)
Query: 394 VYRGIWNGSDVAVKVYFG--SEYIEGTLKNYQKEIDIIKKLRHPNVL----LFMGAVASQ 447
+Y+GI+N +V ++ F + + + + EI ++++ N+L + V
Sbjct: 36 IYKGIFNNKEVIIRT-FKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 448 ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH-HRNPPIVHRDLKS 506
RL ++ E+ RG L + L K + L K +L MA+D +G+ L+ + N P +++L S
Sbjct: 95 PRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151
Query: 507 SNLLVDKNWTVKVGDFGL------SSLKNATYLTAKSGRGTPQWMAPEVLRS--EPSNEK 558
+ LV +N+ +K+ GL KN ++ S ++L K
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFS---------YKMLNDIFSEYTIK 202
Query: 559 SDVFSFGVILWELVTASIPWNNL 581
D++S GV+LWE+ T IP+ NL
Sbjct: 203 DDIYSLGVVLWEIFTGKIPFENL 225
|
Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 68/228 (29%), Positives = 110/228 (48%), Gaps = 37/228 (16%)
Query: 379 DLQLGEEIGLGSYAVVYR-------GIWNGSDVAVKVYF-GSEYIEGTLKNYQKEIDIIK 430
+L LG+ +G G + V + G + VAVK+ + E L++ E +++K
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE--LRDLLSEFNLLK 58
Query: 431 KLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTL-----------------------H 467
++ HP+V+ GA + L ++ E+ GSL L +
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 468 KNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS- 526
+ +AL + + A ++RGM YL +VHRDL + N+LV + +K+ DFGLS
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 527 -LKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
+ +Y+ GR +WMA E L +SDV+SFGV+LWE+VT
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 18/203 (8%)
Query: 404 VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLF 463
VAVK+ ++ + ++ KEI I+ +L++PN++ +G S + L ++TE++ G L
Sbjct: 47 VAVKM-LRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 464 KTLHK-----------NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD 512
+ L + N ++ I L MA+ +A GM YL N VHRDL + N LV
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVG 163
Query: 513 KNWTVKVGDFGLS-SLKNATYLTAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWE 570
++T+K+ DFG+S +L + Y + P +WMA E + SDV++FGV LWE
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 571 LVT--ASIPWNNLNLMQVVGVVG 591
+ T P++ L+ QV+ G
Sbjct: 224 MFTLCKEQPYSLLSDEQVIENTG 246
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 6e-23
Identities = 60/195 (30%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 386 IGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLK-----NYQKEIDIIKKLRHPNVLLF 440
+G G++ VY+GIW VK+ + + T + E I+ + HP+++
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 441 MGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIV 500
+G S + +VT+ +P G L +H++ + + L + +A+GM YL R +V
Sbjct: 75 LGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LV 131
Query: 501 HRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTPQWMAPEVLRSEPSNEK 558
HRDL + N+LV VK+ DFGL+ L + A G+ +WMA E + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191
Query: 559 SDVFSFGVILWELVT 573
SDV+S+GV +WEL+T
Sbjct: 192 SDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 55/183 (30%), Positives = 97/183 (53%), Gaps = 9/183 (4%)
Query: 425 EIDIIKKLRHPNV--LLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMA 482
E +I+ ++ HP + L + A ++E+L +V E+ P G LF L K +R A
Sbjct: 43 ERNILSRINHPFIVKLHY--AFQTEEKLYLVLEYAPGGELFSHLSK-EGRFSEERARFYA 99
Query: 483 LDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP 542
++ + YLH I++RDLK N+L+D + +K+ DFGL+ ++ + GTP
Sbjct: 100 AEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157
Query: 543 QWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEG 602
+++APEVL + + D +S GV+L+E++T P+ + ++ + + L PE
Sbjct: 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPLRFPEF 215
Query: 603 LDP 605
L P
Sbjct: 216 LSP 218
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-22
Identities = 58/174 (33%), Positives = 91/174 (52%), Gaps = 8/174 (4%)
Query: 404 VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLF 463
VA+K Y E +++ E I+ + HPN++ G V + + IVTE++ GSL
Sbjct: 35 VAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 93
Query: 464 KTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFG 523
L K+ + + + M +A GM YL VHRDL + N+LV+ N KV DFG
Sbjct: 94 AFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFG 151
Query: 524 LSSL----KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
LS + A Y T + G+ +W APE + SDV+S+G+++WE+++
Sbjct: 152 LSRVLEDDPEAAY-TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 73/219 (33%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 376 RWEDLQLGEEIGLGSYAVVY--RGIWNGSDVAVK--VYFGSEYIEGTLKNYQKEIDIIKK 431
+ DL+ EIG GS+ VY R + VA+K Y G + E ++ KE+ +++
Sbjct: 16 LFTDLR---EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQQ 71
Query: 432 LRHPNVLLFMGAVASQERLGIVTEFLPRGS---LFKTLHKNYQALDIKRRLRMALDVARG 488
LRHPN + + G + +V E+ GS + + K Q ++I AL G
Sbjct: 72 LRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQ---G 127
Query: 489 MNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPE 548
+ YLH +HRD+K+ N+L+ + TVK+ DFG +SL + A S GTP WMAPE
Sbjct: 128 LAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSP----ANSFVGTPYWMAPE 181
Query: 549 VLRSEPSNE---KSDVFSFGVILWELVTASIPWNNLNLM 584
V+ + + K DV+S G+ EL P N+N M
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 61/216 (28%), Positives = 111/216 (51%), Gaps = 10/216 (4%)
Query: 379 DLQLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLK-NYQKEIDIIKKLRHP 435
+ Q+ ++IG G ++ VYR + + VA+K E ++ + + KEID++K+L HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSL---FKTLHKNYQALDIKRRLRMALDVARGMNYL 492
NV+ ++ + L IV E G L K K + + + + + + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS 552
H R ++HRD+K +N+ + VK+GD GL ++ A S GTP +M+PE +
Sbjct: 123 HSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 553 EPSNEKSDVFSFGVILWELVTASIPW--NNLNLMQV 586
N KSD++S G +L+E+ P+ + +NL +
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 76/249 (30%), Positives = 122/249 (48%), Gaps = 26/249 (10%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRG-IWNGSDVAVKVYFGSEYIE----GTLKNYQKEIDII 429
I+ D+ L E+G G++ V+ +N S K+ + ++ K++Q+E +++
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 61
Query: 430 KKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN------------YQA---LD 474
L+H +++ F G + L +V E++ G L K L + QA L
Sbjct: 62 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 475 IKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYL 533
+ + L +A +A GM YL ++ VHRDL + N LV N VK+GDFG+S + + Y
Sbjct: 122 LSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 179
Query: 534 TAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVG 591
P +WM PE + +SDV+SFGVILWE+ T PW L+ +V+ +
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239
Query: 592 FMDRRLELP 600
R LE P
Sbjct: 240 -QGRVLERP 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-22
Identities = 73/212 (34%), Positives = 109/212 (51%), Gaps = 19/212 (8%)
Query: 385 EIGLGSYAVVY--RGIWNGSDVAVK--VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLF 440
EIG GS+ VY R + N VA+K Y G + E ++ KE+ ++KLRHPN + +
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHPNTIQY 80
Query: 441 MGAVASQERLGIVTEF-LPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPP 498
G + +V E+ L S +HK Q ++I AL +G+ YLH N
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSHN-- 135
Query: 499 IVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNE- 557
++HRD+K+ N+L+ + VK+GDFG +S+ A GTP WMAPEV+ + +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANXFVGTPYWMAPEVILAMDEGQY 191
Query: 558 --KSDVFSFGVILWELVTASIPWNNLNLMQVV 587
K DV+S G+ EL P N+N M +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 5e-22
Identities = 61/213 (28%), Positives = 110/213 (51%), Gaps = 10/213 (4%)
Query: 379 DLQLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLK-NYQKEIDIIKKLRHP 435
+ ++ ++IG G ++ VYR + +G VA+K + ++ + + KEID++K+L HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSL---FKTLHKNYQALDIKRRLRMALDVARGMNYL 492
NV+ + + L IV E G L K K + + K + + + + ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS 552
H R ++HRD+K +N+ + VK+GD GL ++ A S GTP +M+PE +
Sbjct: 123 HSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 553 EPSNEKSDVFSFGVILWELVTASIPW--NNLNL 583
N KSD++S G +L+E+ P+ + +NL
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 8e-22
Identities = 62/229 (27%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIE--GTLKNYQKEID---II 429
++ +L+ + +G G + V++GIW ++K+ + I+ + +Q+ D +
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63
Query: 430 KKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGM 489
L H ++ +G + L +VT+ P GSL + ++ +LD +R L + +A+GM
Sbjct: 64 GSLDHAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGM 122
Query: 490 NYL-HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL-----KNATYLTAKSGRGTP- 542
YL HR +VHR+L + N+L+ + V++ DFG++ L K Y K TP
Sbjct: 123 YYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK----TPI 175
Query: 543 QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV 590
+WMA E + +SDV+S+GV +WE+++ + P+ + +V ++
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 9e-22
Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 384 EEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
+IG G+Y VVY R G VA+K EG K +EI ++K+L HPN++ +
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALD---IKRRLRMALDVARGMNYLHHRNPP 498
+ L +V EF+ L+K + + L IK L L +G+ + H
Sbjct: 65 DVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLL---QGLAFCHSHG-- 118
Query: 499 IVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQ----WM-APEVL-RS 552
I+HRDLK NLL++ +K+ DFGL A + T W APE+L
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGL-----ARSFGSPVRPYTHYVVTRWYRAPELLLGD 173
Query: 553 EPSNEKSDVFSFGVILWELVTASIPW 578
+ + D++S G I EL++ +
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 60/214 (28%), Positives = 112/214 (52%), Gaps = 20/214 (9%)
Query: 376 RWE----DLQLGEEIGLGSYAVVYRGIWNG---SDVAVKVYFGSEYIEGTLKNYQK---- 424
+WE +L G+ +G G++ V G SD +KV + ++ T + ++
Sbjct: 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKV--AVKMLKPTAHSSEREALM 86
Query: 425 -EIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQA-LDIKRRLRM 481
E+ I+ L H N++ +GA + ++TE+ G L L + ++ L ++ L
Sbjct: 87 SELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSF 146
Query: 482 ALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS--LKNATYLTAKSGR 539
+ VA+GM +L +N +HRDL + N+L+ VK+ DFGL+ + ++ Y+ + R
Sbjct: 147 SYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNAR 204
Query: 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
+WMAPE + + +SDV+S+G++LWE+ +
Sbjct: 205 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 71/229 (31%), Positives = 110/229 (48%), Gaps = 34/229 (14%)
Query: 376 RWE----DLQLGEEIGLGSYAVVYRGIWNGSD---------VAVKVYFGSEYIEGTLKNY 422
RWE L LG+ +G G + V G D VAVK+ S+ E L +
Sbjct: 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKM-LKSDATEKDLSDL 70
Query: 423 QKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTL--------------- 466
E++++K + +H N++ +GA L ++ E+ +G+L + L
Sbjct: 71 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPT 130
Query: 467 HKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526
+ L K + A VARGM YL + +HRDL + N+LV ++ +K+ DFGL+
Sbjct: 131 QVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLAR 188
Query: 527 LKNAT--YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
+ Y +GR +WMAPE L +SDV+SFGV+LWE+ T
Sbjct: 189 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 75/255 (29%), Positives = 119/255 (46%), Gaps = 29/255 (11%)
Query: 375 IRWEDLQLGEEIGLGSYAVVY----RGIWNGSD---VAVKVYFGSEYIEGTLKNYQKEID 427
I+ D+ L E+G G++ V+ + D VAVK E E +++Q+E +
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAE 59
Query: 428 IIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN--------------YQAL 473
++ L+H +++ F G L +V E++ G L + L + L
Sbjct: 60 LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL 119
Query: 474 DIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533
+ + L +A +A GM YL + VHRDL + N LV + VK+GDFG+S +T
Sbjct: 120 TLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 177
Query: 534 TAKSGRGT-P-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV 590
GR P +WM PE + +SD++SFGV+LWE+ T PW L+ + + +
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237
Query: 591 GFMDRRLELPEGLDP 605
R LE P P
Sbjct: 238 T-QGRELERPRTCPP 251
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 26/210 (12%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
+D+Q E +G G+ VY+ +AVKV +E K E++I+ K P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-LQKQIMSELEILYKCDSP 59
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRL------RMALDVARGM 489
++ F GA + R+ I TEF+ GSL D+ R++ R+A+ V +G+
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGL 108
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAPE 548
YL I+HRD+K SN+LV+ VK+ DFG+S+ L N+ AK+ GT +MAPE
Sbjct: 109 TYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPE 163
Query: 549 VLRSEPSNEKSDVFSFGVILWELVTASIPW 578
+ E SDV+S G+ EL P+
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 59/214 (27%), Positives = 104/214 (48%), Gaps = 11/214 (5%)
Query: 382 LGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLK-----NYQKEIDIIKKLRHPN 436
L + +G GS+ VY + ++ E G L +E ++ KL HP
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 437 VLLFMGAVASQERLGIVTEFLPRGSL---FKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
++ F + ++ I+TE+ L + L + L + + + G++Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSE 553
R I+HRDLK+ N+ + N +K+GDFG+S L + A + GTP +M+PE L+ +
Sbjct: 124 QRR--ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 554 PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
+ KSD++S G IL+E+ + + N + VV
Sbjct: 181 GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 17/226 (7%)
Query: 385 EIGLGSYAVVYRGIWNGS----DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLF 440
E+G G++ V +G++ DVA+KV +E + +E +I+ +L +P ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKV-LKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 441 MGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIV 500
+G V E L +V E G L K L + + + + V+ GM YL +N V
Sbjct: 61 IG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FV 117
Query: 501 HRDLKSSNLLVDKNWTVKVGDFGLSSLKNA--TYLTAKSGRGTP-QWMAPEVLRSEPSNE 557
HRDL + N+L+ K+ DFGLS A +Y A+S P +W APE + +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 558 KSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDR--RLELP 600
+SDV+S+G+ +WE + P+ M+ V+ F+++ RL+ P
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKK---MKGPEVMSFIEQGKRLDCP 220
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 4e-21
Identities = 67/237 (28%), Positives = 112/237 (47%), Gaps = 34/237 (14%)
Query: 385 EIGLGSYAVVYR----GIWNGSD---VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNV 437
+IG G++ V++ G+ VAVK+ E ++Q+E ++ + HPN+
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADFQREAALMAEFDHPNI 70
Query: 438 LLFMGAVASQERLGIVTEFLPRGSLFKTLHK---------------------NYQALDIK 476
+ +G A + + ++ E++ G L + L N L
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 477 RRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTA 535
+L +A VA GM YL R VHRDL + N LV +N VK+ DFGLS ++ +A Y A
Sbjct: 131 EQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 536 KSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVTASI-PWNNLNLMQVVGVV 590
P +WM PE + +SDV+++GV+LWE+ + + P+ + +V+ V
Sbjct: 189 SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV 245
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 35/208 (16%)
Query: 383 GEEIGLGSYAVVYRGIWNGSD--VAVKVYFGSEYIEGTLKNYQ--------KEIDIIKKL 432
G+++G G+YAVVY+ + VA+K + G K + +EI ++++L
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIK-----KIKLGERKEAKDGINFTALREIKLLQEL 59
Query: 433 RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN---YQALDIKRRLRMALDVARGM 489
+HPN++ + + + +V EF+ L K + DIK + M L RG+
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL---RGL 115
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQ----WM 545
YLH I+HRDLK +NLL+ + +K+ DFGL A + + + T Q W
Sbjct: 116 EYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGL-----ARSFGSPNRKMTHQVVTRWY 168
Query: 546 -APEVL-RSEPSNEKSDVFSFGVILWEL 571
APE+L + D++S G I EL
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 384 EEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
+G G+Y VV R G VA+K + SE E K +E+ ++++LRH N++
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVH 501
A + RL +V E++ R +L + L + L + + + Y H N I+H
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIH 123
Query: 502 RDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR------GTPQWMAPEVLRSEPS 555
RD+K N+LV ++ +K+ DFG A L A+ T + APE+L + +
Sbjct: 124 RDIKPENILVSESGVLKLCDFGF-----ARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 556 NEKS-DVFSFGVILWELVT 573
K DV++ G I+ EL+
Sbjct: 179 YGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 9e-21
Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 8/171 (4%)
Query: 419 LKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRR 478
+++ +KE ++ K++HPN++ F + + L IV E+ G L + + L +
Sbjct: 42 VEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDT 101
Query: 479 -LRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKS 537
L+ + + G+ ++H + ++HRD+KS N+ + +N VK+GDFG + L + A +
Sbjct: 102 ILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159
Query: 538 GRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIP-----WNNLNL 583
GTP ++ PE+ + P N KSD++S G IL+EL T P W NL L
Sbjct: 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-20
Identities = 71/236 (30%), Positives = 113/236 (47%), Gaps = 27/236 (11%)
Query: 355 SRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGS----YAVVYRGIWNGSDVAVKVYF 410
S SSSS + + A +L+ IG G+ Y V++R G A+KV +
Sbjct: 51 SSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRP--TGRLYALKVIY 108
Query: 411 GSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNY 470
G+ + + + +EI+I++ + HPNV+ + ++ EF+ GSL T +
Sbjct: 109 GN-HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADE 167
Query: 471 QALDIKRRLRMALDVAR----GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526
Q L DVAR G+ YLH R+ IVHRD+K SNLL++ VK+ DFG+S
Sbjct: 168 QFLA---------DVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSR 216
Query: 527 LKNATYLTAKSGRGTPQWMAPEVLRSEPSNEK-----SDVFSFGVILWELVTASIP 577
+ T S GT +M+PE + ++ ++ D++S GV + E P
Sbjct: 217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 384 EEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRH-PNVLL 439
+ I G++ VY + G A+KV S+ I + + N + E I+ P V
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 440 FMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPI 499
+ S++ L +V E+L G +L K L + +V G+ LH R I
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDC-ASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--I 118
Query: 500 VHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKS 559
+HRD+K NLL+D+ +K+ DFGLS L K GTP ++APE + ++ S
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNG----LENKKFVGTPDYLAPETILGVGDDKMS 174
Query: 560 DVFSFGVILWELVTASIPWN 579
D +S G +++E + P++
Sbjct: 175 DWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 65/226 (28%), Positives = 104/226 (46%), Gaps = 36/226 (15%)
Query: 371 TDGGIRWEDLQLGEEIGLGSYAVV--YRGIWNGSDVAVKVYFGSEYIEGTLKNYQK---- 424
D G L +IG GS +V G VAVK + L+ Q+
Sbjct: 12 VDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVK--------KMDLRKQQRRELL 63
Query: 425 --EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRM- 481
E+ I++ +HPN++ + + L +V EFL G+L DI RM
Sbjct: 64 FNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL----------TDIVTHTRMN 113
Query: 482 -------ALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534
L V + +++LH + ++HRD+KS ++L+ + VK+ DFG + +
Sbjct: 114 EEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171
Query: 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580
KS GTP WMAPEV+ P + D++S G+++ E+V P+ N
Sbjct: 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 380 LQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYI----EGTLKNYQKEIDIIKKLRHP 435
L LG+ +G G + V G N D +KV + I ++++ E +K+ HP
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 436 NVLLFMGA-VASQERLG-----IVTEFLPRGSL-----FKTLHKNYQALDIKRRLRMALD 484
NV+ +G + + E G ++ F+ G L + L Q L + ++ D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 485 VARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS-LKNATYLTAKSGRGTP- 542
+A GM YL ++ +HRDL + N ++++N V V DFGLS + N Y P
Sbjct: 121 IASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 543 QWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
+W+A E L KSDV+SFGV +WE+ T
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-20
Identities = 65/199 (32%), Positives = 107/199 (53%), Gaps = 20/199 (10%)
Query: 421 NYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL--FKTLHKNYQALDIKRR 478
++ KEI I+ +L+ PN++ + + + L ++TE++ G L F + H+ +A +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 479 --------LRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKN 529
+ MA +A GM YL N VHRDL + N LV KN+T+K+ DFG+S +L +
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 530 ATYLTAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT--ASIPWNNLNLMQV 586
Y + P +WM+ E + SDV++FGV LWE++T P++ L+ QV
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242
Query: 587 VGVVG--FMD--RRLELPE 601
+ G F D R++ LP+
Sbjct: 243 IENTGEFFRDQGRQVYLPK 261
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 4e-20
Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 380 LQLGEEIGLGSYAVVYRGIWNGSD-----VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH 434
LG +G G + V D VAVK+ + ++ + +E +K+ H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 435 PNVLLFMGAV---ASQERLGI---VTEFLPRGSL-----FKTLHKNYQALDIKRRLRMAL 483
PNV+ +G ++ RL I + F+ G L + + L ++ +R +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 484 DVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTP 542
D+A GM YL +N +HRDL + N ++++N TV V DFGLS + + Y P
Sbjct: 121 DIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178
Query: 543 -QWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
+W+A E L SDV++FGV +WE++T
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 55/160 (34%), Positives = 89/160 (55%), Gaps = 11/160 (6%)
Query: 424 KEIDIIKKLRHPNVLLFMGAVA--SQERLGIVTEFLPRGSL---FKTLHKNYQALDIKRR 478
+E++I K + P ++ + GA S +GI E+ GSL +K + K + K
Sbjct: 48 RELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL 107
Query: 479 LRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKS 537
++A V +G++YLH R I+HRD+K SN+L+ + VK+ DFG+S L N+ A +
Sbjct: 108 GKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS---LAGT 162
Query: 538 GRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIP 577
GT +MAPE ++ +P + SDV+S G+ L E+ P
Sbjct: 163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 15/210 (7%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYR--GIWNGSDVAVK-VYFGSEYIEGTLKNYQKEIDIIKK 431
+R EDL+ ++G G+ V + I G+ +A K V+ G++ K +E+ I+ +
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHE 59
Query: 432 LRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNY 491
R P ++ F GA ++ + + EF+ GSL ++K + ++ ++A+ V G+ Y
Sbjct: 60 CRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTY 118
Query: 492 LH--HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTPQWMAPE 548
L+ HR I+HRD+K SN+LV+ +K+ DFG+S L N+ A + GT +M+PE
Sbjct: 119 LYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---ADTFVGTSTYMSPE 172
Query: 549 VLRSEPSNEKSDVFSFGVILWELVTASIPW 578
++ KSDV+S G+ + EL P+
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 34/229 (14%)
Query: 376 RWE----DLQLGEEIGLGSYAVVYRGIWNGSD---------VAVKVYFGSEYIEGTLKNY 422
RWE L LG+ +G G + V G D VAVK+ + E L +
Sbjct: 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKM-LKDDATEKDLSDL 67
Query: 423 QKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNY----------- 470
E++++K + +H N++ +GA L ++ E+ +G+L + L
Sbjct: 68 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIA 127
Query: 471 ----QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS- 525
+ + K + VARGM YL + +HRDL + N+LV +N +K+ DFGL+
Sbjct: 128 RVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 526 SLKNATYLTAKS-GRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
+ N Y + GR +WMAPE L +SDV+SFGV++WE+ T
Sbjct: 186 DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 9e-20
Identities = 65/241 (26%), Positives = 117/241 (48%), Gaps = 46/241 (19%)
Query: 384 EEIGLGSYAVVYRG------IWNGSDVAVKVYFGSEYIEGTLKNY---------QKEIDI 428
EE+G ++ +Y+G + + VA+K TLK+ Q+E +
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIK----------TLKDINNPQQWGEFQQEASL 60
Query: 429 IKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTL-----HKNY-----------QA 472
+ +L HPN++ +G V ++ + ++ E+L +G L + L H + +
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 473 LDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNAT 531
LD L +A+ +A GM YL VH+DL + N+L+ + VK+ D GLS + +A
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178
Query: 532 YLTAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVTASI-PWNNLNLMQVVGV 589
Y + P +WM PE + + SD++SFGV+LWE+ + + P+ + +V+ +
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238
Query: 590 V 590
V
Sbjct: 239 V 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 28/211 (13%)
Query: 384 EEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQK------EIDIIKKLRHP 435
E+IG G+ VY I G +VA+K + L+ K EI ++++ +HP
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIK--------QMNLQQQPKKELIINEILVMRENKHP 76
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495
N++ ++ + + L +V E+L GSL + + +D + + + + + +LH
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN 134
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR----GTPQWMAPEVLR 551
++HRD+KS N+L+ + +VK+ DFG A +S R GTP WMAPEV+
Sbjct: 135 Q--VIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 552 SEPSNEKSDVFSFGVILWELVTASIPWNNLN 582
+ K D++S G++ E+V P+ N N
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 45/237 (18%)
Query: 404 VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL- 462
VAVK+ + + ++ KE+ I+ +L+ PN++ +G ++ L ++TE++ G L
Sbjct: 49 VAVKI-LRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 463 -FKTLHK---------------------NYQALDIKRRLRMALDVARGMNYLHHRNPPIV 500
F + H +Y +L L +AL +A GM YL N V
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSL-----LHVALQIASGMKYLSSLN--FV 160
Query: 501 HRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTP-QWMAPEVLRSEPSNEK 558
HRDL + N LV +N T+K+ DFG+S +L Y + P +WMA E +
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220
Query: 559 SDVFSFGVILWEL--VTASIPWNNLNLMQVVGVVG----------FMDRRLELPEGL 603
SDV++FGV LWE+ + P+ L QV+ G ++ R P+GL
Sbjct: 221 SDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGL 277
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 12/196 (6%)
Query: 386 IGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEI----DIIKKLRHPNVLL 439
+G G++ VY+GIW +G +V + V E T KEI ++ + P V
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAI-KVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 440 FMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPI 499
+G + + +VT+ +P G L + +N + + L + +A+GM+YL +
Sbjct: 74 LLG-ICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--L 130
Query: 500 VHRDLKSSNLLVDKNWTVKVGDFGLSSLKN--ATYLTAKSGRGTPQWMAPEVLRSEPSNE 557
VHRDL + N+LV VK+ DFGL+ L + T A G+ +WMA E +
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTH 190
Query: 558 KSDVFSFGVILWELVT 573
+SDV+S+GV +WEL+T
Sbjct: 191 QSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 68/231 (29%), Positives = 109/231 (47%), Gaps = 17/231 (7%)
Query: 385 EIGLGSYAVVYRGIWN----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLF 440
E+G G++ V +G++ VAVK+ +E +++++L +P ++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 441 MGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIV 500
+G + E +V E G L K L KN + K + V+ GM YL N V
Sbjct: 62 IG-ICEAESWMLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLEETN--FV 117
Query: 501 HRDLKSSNLLVDKNWTVKVGDFGLSSLKNA--TYLTAKS-GRGTPQWMAPEVLRSEPSNE 557
HRDL + N+L+ K+ DFGLS A Y AK+ G+ +W APE + +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 558 KSDVFSFGVILWELVTASI-PWNNLNLMQVVGVVGFMDR--RLELPEGLDP 605
KSDV+SFGV++WE + P+ M+ V ++ R+E P+ P
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKPYKG---MKGNEVTQMIESGERMECPQRCPP 225
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGSD---------VAVKVYFGSEYIEGTLKNYQKEIDI 428
+ L LG+ +G G + V R G D VAVK+ + L + E+++
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM-LKDNATDKDLADLISEMEL 70
Query: 429 IKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSL---------------FKTLHKNYQA 472
+K + +H N++ +G + L ++ E+ +G+L F +
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 473 LDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNAT 531
L K + A VARGM YL R +HRDL + N+LV ++ +K+ DFGL+ + +
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 532 YLTAKS-GRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
Y S GR +WMAPE L +SDV+SFG+++WE+ T
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 70/229 (30%), Positives = 110/229 (48%), Gaps = 34/229 (14%)
Query: 376 RWE----DLQLGEEIGLGSYAVVYRGIWNGSD---------VAVKVYFGSEYIEGTLKNY 422
+WE L LG+ +G G + V G D VAVK+ + + L +
Sbjct: 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM-LKDDATDKDLSDL 64
Query: 423 QKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSL---------------FKTL 466
E++++K + +H N++ +GA L ++ E+ +G+L F T
Sbjct: 65 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124
Query: 467 HKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS- 525
+ L K + A VARGM YL + +HRDL + N+LV ++ +K+ DFGL+
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 526 SLKNATYLTAKS-GRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
+ N Y + GR +WMAPE L +SDV+SFGV+LWE+ T
Sbjct: 183 DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 66/233 (28%), Positives = 112/233 (48%), Gaps = 22/233 (9%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRG-IWN----GSDVAVKVYFGSEYIEGTLKNYQKEIDII 429
I+ ++ L E+G G++ V+ +N + V V + + K++ +E +++
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 430 KKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN------------YQALDIKR 477
L+H +++ F G + L +V E++ G L K L + L +
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 478 RLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAK 536
L +A +A GM YL ++ VHRDL + N LV +N VK+GDFG+S + + Y
Sbjct: 122 MLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG 179
Query: 537 SGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVV 587
P +WM PE + +SDV+S GV+LWE+ T PW L+ +V+
Sbjct: 180 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 381 QLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDI---------IKK 431
L + + G++ ++ GI + E T+K++ EI + +
Sbjct: 9 TLSDLLQEGTFGRIFYGILIDEKPGKE----EEVFVKTVKDHASEIQVTLLLQESCLLYG 64
Query: 432 LRHPNVLLFMGAVASQ--ERLGIVTEFLPRGSLFKTLHK-------NYQALDIKRRLRMA 482
L H N +L + V + E ++ ++ G+L L + N QAL ++ + MA
Sbjct: 65 LSHQN-ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 483 LDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGT 541
+ +A GM+YLH R ++H+D+ + N ++D+ VK+ D LS L Y
Sbjct: 124 IQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181
Query: 542 P-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
P +WMA E L ++ + SDV+SFGV+LWEL+T
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 386 IGLGSYAVVYRGIWNGSDV--AVKVYFGSEYI--EGTLKNYQKEIDIIKKLRHPNVLLFM 441
+G+G + V + A+K +I G ++ E +I+++ HP ++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALK-CVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVH 501
++ + ++ E+ G L+ L + R +A V YLH+R I++
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-VVLAFEYLHNRG--IIY 116
Query: 502 RDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAK---SGR------GTPQWMAPEVLRS 552
RDLK NLL+D N VK+ DFG AK SG+ GTP+++APE++ +
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFG----------FAKKLKSGQKTWTFCGTPEYVAPEIILN 166
Query: 553 EPSNEKSDVFSFGVILWELVTASIPWNN 580
+ + D +S G++L+EL+T P+
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 5e-19
Identities = 62/226 (27%), Positives = 117/226 (51%), Gaps = 11/226 (4%)
Query: 384 EEIGLGSYAVVYRG--IWNGSDVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLF 440
E+IG G+ V+ + G +VA+K + + + + N EI ++K+L++PN++ F
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN---EILVMKELKNPNIVNF 81
Query: 441 MGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIV 500
+ + + L +V E+L GSL + + +D + + + + + +LH ++
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQ--VI 137
Query: 501 HRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSD 560
HRD+KS N+L+ + +VK+ DFG + + GTP WMAPEV+ + K D
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 561 VFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDR-RLELPEGLDP 605
++S G++ E+V P+ N N ++ + ++ L+ PE L P
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSP 243
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-19
Identities = 69/212 (32%), Positives = 109/212 (51%), Gaps = 19/212 (8%)
Query: 385 EIGLGSYAVVY--RGIWNGSDVAVK--VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLF 440
EIG GS+ VY R + VA+K Y G + E ++ KE+ +++++HPN + +
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE-KWQDIIKEVKFLQRIKHPNSIEY 90
Query: 441 MGAVASQERLGIVTEF-LPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPP 498
G + +V E+ L S +HK Q ++I AL +G+ YLH N
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---QGLAYLHSHN-- 145
Query: 499 IVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNE- 557
++HRD+K+ N+L+ + VK+ DFG +S+ + A S GTP WMAPEV+ + +
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASP----ANSFVGTPYWMAPEVILAMDEGQY 201
Query: 558 --KSDVFSFGVILWELVTASIPWNNLNLMQVV 587
K DV+S G+ EL P N+N M +
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLFNMNAMSAL 233
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 65/230 (28%), Positives = 112/230 (48%), Gaps = 29/230 (12%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGSDV--AVKVYFGSEYIEGTLKNYQKEIDIIKKLRH- 434
EDL+ EIG G++ V + + S AVK S E K ++D++ +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVK-RIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRG--SLFKTLHKNYQALDIKRRL------RMALDVA 486
P ++ F GA+ + I E + +K +++ +K + ++A+
Sbjct: 63 PYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEV-----LKSVIPEEILGKIAVATV 117
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWM 545
+ +NYL I+HRD+K SN+L+D+N +K+ DFG+S L ++ T + G +M
Sbjct: 118 KALNYLK-EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA--GCRPYM 174
Query: 546 APEVLRSEPSNE---KSDVFSFGVILWELVTASIP---WNNL--NLMQVV 587
APE + + +SDV+S G+ L+E+ T P WN++ L QVV
Sbjct: 175 APERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV 224
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 67/224 (29%), Positives = 118/224 (52%), Gaps = 22/224 (9%)
Query: 380 LQLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPN 436
+L E +G G+Y VY+G + G A+KV +E E +K EI+++KK H N
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIK---LEINMLKKYSHHRN 74
Query: 437 VLLFMGAVASQ------ERLGIVTEFLPRGSLFKTLHKNYQALDIKRR--LRMALDVARG 488
+ + GA + ++L +V EF GS+ L KN + +K + ++ RG
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIAYICREILRG 133
Query: 489 MNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPE 548
+ +LH ++HRD+K N+L+ +N VK+ DFG+S+ + T + GTP WMAPE
Sbjct: 134 LAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 191
Query: 549 VLRSEPSNE-----KSDVFSFGVILWELVTASIPWNNLNLMQVV 587
V+ + + + +SD++S G+ E+ + P +++ M+ +
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 8e-19
Identities = 48/170 (28%), Positives = 94/170 (55%), Gaps = 4/170 (2%)
Query: 420 KNYQKEIDIIKKLRHPNVLLFMGAVASQE-RLGIVTEFLPRGSLFKTLHKNYQALDIKRR 478
K ++E ++ +L+HPN++ + + ++ L IV F G L+ L + L + +
Sbjct: 44 KAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQ 103
Query: 479 -LRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKS 537
+ + +A + YLH ++ I+HRDLK+ N+ + + +KVGD G++ + A +
Sbjct: 104 VVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST 161
Query: 538 GRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
GTP +M+PE+ ++P N KSDV++ G ++E+ T +N ++ +V
Sbjct: 162 LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 8e-19
Identities = 67/227 (29%), Positives = 121/227 (53%), Gaps = 22/227 (9%)
Query: 380 LQLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPN 436
+L E +G G+Y VY+G + G A+KV + E +K +EI+++KK H N
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSHHRN 64
Query: 437 VLLFMGAVASQ------ERLGIVTEFLPRGSLFKTLHKNYQALDIKRR--LRMALDVARG 488
+ + GA + ++L +V EF GS+ L KN + +K + ++ RG
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 489 MNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPE 548
+++LH ++HRD+K N+L+ +N VK+ DFG+S+ + T + GTP WMAPE
Sbjct: 124 LSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 181
Query: 549 VLRSEPSNE-----KSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590
V+ + + + KSD++S G+ E+ + P +++ M+ + ++
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 35/219 (15%)
Query: 376 RWEDLQLGEEIGLGSYAVV----YRGIWNGSDVAVKVYFGSEYIEGTLKNYQ---KEIDI 428
+ D ++GE +G GS+ V ++G G A+K E ++ +K Q +E I
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKG--TGEYYAIKCLKKREILK--MKQVQHVAQEKSI 71
Query: 429 IKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR- 487
+ +L HP ++ M + + R+ + EF+ G LF L K R DVA+
Sbjct: 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG---------RFPNDVAKF 122
Query: 488 -------GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS-LKNATYLTAKSGR 539
YLH ++ I++RDLK NLL+D VKV DFG + + + T+
Sbjct: 123 YHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC---- 176
Query: 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578
GTP+++APEV++S+ + D ++ GV+L+E + P+
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 47/214 (21%)
Query: 384 EEIGLGSYAVVY--RGIWNGSDVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLF 440
E+IG G+Y VVY R G VA+K + +E EG +EI ++K+L HPN++
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRL 63
Query: 441 MGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRL----RMALD----------VA 486
+ V S+ +L +V EFL LD+K+ + LD +
Sbjct: 64 LDVVHSENKLYLVFEFL--------------DLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109
Query: 487 RGMNYLH-HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS-----LKNATYLTAKSGRG 540
+G+ Y H HR ++HRDLK NLL+D+ +K+ DFGL+ ++ T+
Sbjct: 110 QGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----- 161
Query: 541 TPQWMAPEVLRSEPSNEKS-DVFSFGVILWELVT 573
T + APE+L D++S G I E+V
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 70/212 (33%), Positives = 109/212 (51%), Gaps = 19/212 (8%)
Query: 385 EIGLGSYAVVYRGIWNGSD--VAVK--VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLF 440
EIG GS+ VY + ++ VAVK Y G + E ++ KE+ +++L+HPN + +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEY 86
Query: 441 MGAVASQERLGIVTEF-LPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPP 498
G + +V E+ L S +HK Q ++I AL +G+ YLH N
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---QGLAYLHSHN-- 141
Query: 499 IVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNE- 557
++HRD+K+ N+L+ + VK+ DFG +S + A S GTP WMAPEV+ + +
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----ANSFVGTPYWMAPEVILAMDEGQY 197
Query: 558 --KSDVFSFGVILWELVTASIPWNNLNLMQVV 587
K DV+S G+ EL P N+N M +
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNMNAMSAL 229
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 69/224 (30%), Positives = 113/224 (50%), Gaps = 15/224 (6%)
Query: 386 IGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEID-----IIKKLRHPNVL 438
IG GS+ V + +GS AVKV ++ K Q I ++K L+HP ++
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK---KKEQNHIMAERNVLLKNLKHPFLV 59
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPP 498
+ + E+L V +++ G LF L + L+ + R A +VA + YLH N
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHSLN-- 116
Query: 499 IVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEK 558
I++RDLK N+L+D V + DFGL T + GTP+++APEVLR EP +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT 176
Query: 559 SDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEG 602
D + G +L+E++ P+ + ++ Q+ + + L+LP G
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDVSQMYD--NILHKPLQLPGG 218
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 71/236 (30%), Positives = 119/236 (50%), Gaps = 41/236 (17%)
Query: 378 EDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNY-QK----EIDIIK 430
+DL++ EE+G G+Y VV R + G+ +AVK I T+ + QK ++DI
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVK------RIRATVNSQEQKRLLMDLDISM 54
Query: 431 KLRH-PNVLLFMGAVASQERLGIVTEFLPRGSLFKT-LHKNY-QALDIKRRL------RM 481
+ P + F GA+ + + I E + T L K Y + D + ++
Sbjct: 55 RSVDCPYTVTFYGALFREGDVWICME------VMDTSLDKFYKKVYDKGLTIPEDILGKI 108
Query: 482 ALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS-LKNATYLTAKSGRG 540
A+ + + + YLH ++HRD+K SN+L+++N VK+ DFG+S L ++ T + G
Sbjct: 109 AVSIVKALEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA--G 165
Query: 541 TPQWMAPEVLRSEPS----NEKSDVFSFGVILWELVTASIPWNNL-----NLMQVV 587
+MAPE + E + + KSDV+S G+ + EL T P+++ L QVV
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV 221
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 52/211 (24%), Positives = 98/211 (46%), Gaps = 33/211 (15%)
Query: 386 IGLGSYAVVYRGIWNGSDVAVKVYFGSEYI-------EGTLKNYQKEIDIIKKLRHPNVL 438
IG G++ V K F +Y+ +G+++N E I+++L HP ++
Sbjct: 8 IGKGAFGKV----CIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLV 63
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR--------GMN 490
+ +E + +V + L G L H + ++++ + + + +
Sbjct: 64 NLWYSFQDEENMYLVVDLLLGGDL--RYH-------LSQKVKFSEEQVKFWICEIVLALE 114
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAPEV 549
YLH + I+HRD+K N+L+D+ V + DF +++ + T T+ SG TP +MAPEV
Sbjct: 115 YLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSG--TPGYMAPEV 170
Query: 550 LRSEPSNEKSDVFSFGVILWELVTASIPWNN 580
L + + D +S GV +E + P+
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 5e-18
Identities = 56/210 (26%), Positives = 109/210 (51%), Gaps = 8/210 (3%)
Query: 384 EEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
E+IG G+ VY I G +VA+K + + L EI ++++ ++PN++ ++
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPNIVNYL 82
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVH 501
+ + L +V E+L GSL + + +D + + + + +++LH ++H
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQ--VIH 138
Query: 502 RDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDV 561
RD+KS N+L+ + +VK+ DFG + + GTP WMAPEV+ + K D+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 562 FSFGVILWELVTASIPWNNLNLMQVVGVVG 591
+S G++ E+V P+ N N ++ + ++
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIA 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 70/210 (33%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 384 EEIGLGSYAVVYR--GIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLF 440
E IG G+Y VY+ +GS AVK+ + I + + E +I++ L HPNV+ F
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVDEEIEAEYNILQSLPNHPNVVKF 84
Query: 441 MGAVASQER-----LGIVTEFLPRGS---LFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
G ++ L +V E GS L K L Q LD + G+ +L
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS 552
H N I+HRD+K +N+L+ VK+ DFG+S+ +T L + GTP WMAPEV+
Sbjct: 145 H--NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 202
Query: 553 EPSNEKS-----DVFSFGVILWELVTASIP 577
E + S DV+S G+ EL P
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 20/230 (8%)
Query: 386 IGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQ---KEIDIIKKLRHPNVLLF 440
+G G+Y +VY R + +A+K E E + Q +EI + L+H N++ +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIK-----EIPERDSRYVQPLHEEIALHSYLKHRNIVQY 70
Query: 441 MGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMAL---DVARGMNYLHHRNP 497
+G+ + I E +P GSL L + L + + + G+ YLH
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIIFYTKQILEGLKYLHDNQ- 128
Query: 498 PIVHRDLKSSNLLVDK-NWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPS- 555
IVHRD+K N+LV+ + VK+ DFG S ++ GT Q+MAPEV+ P
Sbjct: 129 -IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 556 -NEKSDVFSFGVILWELVTASIPWNNLNLMQVVGV-VGFMDRRLELPEGL 603
+D++S G + E+ T P+ L Q VG E+PE L
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESL 237
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 9/202 (4%)
Query: 376 RWEDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
++E+L L +G GSY +V + G VA+K + SE + K +EI ++K+LR
Sbjct: 2 KYENLGL---VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
H N++ + ++RL +V EF+ ++ L K LD R + + RG+ + H
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSE 553
N I+HRD+K N+LV ++ VK+ DFG + A T + APE+L +
Sbjct: 118 SHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGD 175
Query: 554 PSNEKS-DVFSFGVILWELVTA 574
++ D+++ G ++ E++T
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 8e-18
Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 31/207 (14%)
Query: 384 EEIGLGSYAVVYRGIWNGSD---VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLF 440
+IG G+Y VY+ N VA+K EG +EI +++KLRHPN++
Sbjct: 5 AQIGEGTYGQVYKAR-NKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 441 MGAVASQERLGI--VTEFLP---RGSLFKTLHKNYQALD--IKRRLRMALDVARGMNYLH 493
V S+ + I V E++ G L + + IK ++ L G+ YLH
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLL---DSPEVKFTESQIKCYMKQLL---EGLQYLH 117
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRG------TPQWMAP 547
I+HRD+K SN+L++ + +K+ DFGL A T ++ T + P
Sbjct: 118 SNG--ILHRDIKGSNILINNDGVLKLADFGL-----ARPYTKRNSADYTNRVITLWYRPP 170
Query: 548 EVLRSEPS-NEKSDVFSFGVILWELVT 573
E+L + D++S G IL EL
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 9e-18
Identities = 56/185 (30%), Positives = 105/185 (56%), Gaps = 9/185 (4%)
Query: 423 QKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN--YQALDIKRRLR 480
+ E DI+ ++ HP ++ A ++ +L ++ +FL G LF L K + D+K L
Sbjct: 46 KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 105
Query: 481 MALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRG 540
++A +++LH + I++RDLK N+L+D+ +K+ DFGLS A S G
Sbjct: 106 ---ELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160
Query: 541 TPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELP 600
T ++MAPEV+ + +D +SFGV+++E++T S+P+ + + + ++ + +L +P
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI--LKAKLGMP 218
Query: 601 EGLDP 605
+ L P
Sbjct: 219 QFLSP 223
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 28/200 (14%)
Query: 389 GSYAVVYRGIWNGSD--VAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL----LFM 441
G+Y VVYR + VA+K + E EG +EI+I+ KL+HPN++ + +
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLREINILLKLQHPNIVTVKEVVV 74
Query: 442 GAVASQERLGIVTEFLPRG--SLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPI 499
G+ + +++ +V E++ SL +T+ + + ++K + L G+ +LH I
Sbjct: 75 GS--NLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLL---SGVAHLHDNW--I 127
Query: 500 VHRDLKSSNLLVDKNWTVKVGDFGL-----SSLKNATYLTAKSGRGTPQWMAPEVLRSEP 554
+HRDLK+SNLL++ +K+ DFGL S LK T L T + APE+L
Sbjct: 128 LHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-----TLWYRAPELLLGAK 182
Query: 555 S-NEKSDVFSFGVILWELVT 573
+ D++S G I EL+T
Sbjct: 183 EYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 67/234 (28%), Positives = 121/234 (51%), Gaps = 17/234 (7%)
Query: 378 EDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQ---KEIDIIKKL 432
+DL+ + +G G++ V+ R + A+KV E I LK Q E ++K++
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR--LKQEQHVHNEKRVLKEV 58
Query: 433 RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
HP ++ Q L ++ E++P G LF L +N L A ++ + YL
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYL 117
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTPQWMAPEVLR 551
H + IV+RDLK N+L+DK +K+ DFG + L++ T+ GTP+++APEV++
Sbjct: 118 HSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYLAPEVIQ 171
Query: 552 SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
S+ N+ D ++ G++++E++ P+ + N + + + +LE P LD
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--LAGKLEFPRHLDL 223
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 48/157 (30%), Positives = 84/157 (53%), Gaps = 5/157 (3%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRM-AL 483
E +++ RHP + A + +RL V E+ G LF H + + + + R R
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA 102
Query: 484 DVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQ 543
++ + YLH R+ +V+RD+K NL++DK+ +K+ DFGL + T K+ GTP+
Sbjct: 103 EIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160
Query: 544 WMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580
++APEVL D + GV+++E++ +P+ N
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 64/219 (29%), Positives = 114/219 (52%), Gaps = 17/219 (7%)
Query: 384 EEIGLGSYAVVYRGI--WNGSDVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLF 440
E++G G+YA VY+G G VA+K ++ +E EGT +EI ++K+L+H N++
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRL 63
Query: 441 MGAVASQERLGIVTEFLPRGSLFKTL--HKNYQALDIKRRLRMALDVARGMNYLH-HRNP 497
+ ++ +L +V E++ L K + H ALD + +G+ + H +R
Sbjct: 64 HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-- 120
Query: 498 PIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLR-SEPSN 556
++HRDLK NLL++K +K+ DFGL+ T + T + AP+VL S +
Sbjct: 121 -VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYS 179
Query: 557 EKSDVFSFGVILWELVTASIPW----NNLNLMQVVGVVG 591
D++S G I+ E++T + N L+++ ++G
Sbjct: 180 TSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG 218
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 47/156 (30%), Positives = 85/156 (54%), Gaps = 4/156 (2%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD 484
E+ I++ H NV+ + + L +V EFL G+L + + ++ ++ + L
Sbjct: 69 EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLS 126
Query: 485 VARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQW 544
V R ++YLH N ++HRD+KS ++L+ + +K+ DFG + + KS GTP W
Sbjct: 127 VLRALSYLH--NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYW 184
Query: 545 MAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580
MAPEV+ P + D++S G+++ E++ P+ N
Sbjct: 185 MAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 73/232 (31%), Positives = 114/232 (49%), Gaps = 34/232 (14%)
Query: 377 WEDLQLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR- 433
WE + E IG G+Y V++ + NGS AVK+ + I + + E +I+K L
Sbjct: 20 WE---IIETIGKGTYGKVFKVLNKKNGSKAAVKIL---DPIHDIDEEIEAEYNILKALSD 73
Query: 434 HPNVLLFMGA-----VASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMA------ 482
HPNV+ F G V + ++L +V E GS+ L K + +KR RM
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-TDLVKGF----LKRGERMEEPIIAY 128
Query: 483 --LDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRG 540
+ G+ +LH +HRD+K +N+L+ VK+ DFG+S+ +T L + G
Sbjct: 129 ILHEALMGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 186
Query: 541 TPQWMAPEVLRSEPS-----NEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
TP WMAPEV+ E + + DV+S G+ EL P +L+ M+ +
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL 238
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 65/197 (32%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 384 EEIGLGSYAVVYRGI--WNGSDVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLF 440
E+IG G+Y VVY+G G VA+K + SE EG +EI ++K+L+HPN++
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCL 64
Query: 441 MGAVASQERLGIVTEFLPRGSLFK---TLHKNYQALDIKRRLRMALDVARGMNYLHHRNP 497
+ + RL ++ EFL L K +L K Q +D + + +G+ + H R
Sbjct: 65 QDVLMQESRLYLIFEFLSM-DLKKYLDSLPKG-QYMDAELVKSYLYQILQGILFCHSRR- 121
Query: 498 PIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPS-N 556
++HRDLK NLL+D +K+ DFGL+ T + APEVL P +
Sbjct: 122 -VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYS 180
Query: 557 EKSDVFSFGVILWELVT 573
D++S G I E+ T
Sbjct: 181 TPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 49/156 (31%), Positives = 84/156 (53%), Gaps = 3/156 (1%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD 484
E ++K RHP + + +++RL V E++ G LF L + + + R A +
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-E 103
Query: 485 VARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQW 544
+ ++YLH + IV+RDLK NL++DK+ +K+ DFGL T K+ GTP++
Sbjct: 104 IVSALDYLH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEY 161
Query: 545 MAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580
+APEVL D + GV+++E++ +P+ N
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 33/207 (15%)
Query: 384 EEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
E+IG G+Y VVY R G VA+K EG +EI ++K+L HPN++ +
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 442 GAVASQERLGIVTEFL-----------PRGSLFKTLHKNY--QALDIKRRLRMALDVARG 488
+ ++ +L +V EFL P + L K+Y Q L +G
Sbjct: 66 DVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLL-------------QG 112
Query: 489 MNYLH-HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAP 547
+ + H HR ++HRDLK NLL++ +K+ DFGL+ T T + AP
Sbjct: 113 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 169
Query: 548 EVLR-SEPSNEKSDVFSFGVILWELVT 573
E+L + + D++S G I E+VT
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 384 EEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
E++G GSYA VY+GI NG VA+KV + EG +E ++K L+H N++L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKV-ISMKTEEGVPFTAIREASLLKGLKHANIVLLH 69
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVH 501
+ ++E L V E++ L + + ++ L + RG+ Y+H ++ I+H
Sbjct: 70 DIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILH 126
Query: 502 RDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL--RSEPSNEKS 559
RDLK NLL+ +K+ DFGL+ K+ T S T + P+VL ++ S+
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA-L 185
Query: 560 DVFSFGVILWELV--------TASIPWNNLNLMQVVGV 589
D++ G I E++ + + + V+GV
Sbjct: 186 DIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGV 223
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 77/250 (30%), Positives = 118/250 (47%), Gaps = 35/250 (14%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGSD-------VAVKVYFGSEYIEGTLKNYQKEIDIIK 430
+ + L +G G++ VY G++ G D VAVK E ++ E I+
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKT-LPESCSEQDESDFLMEALIMS 64
Query: 431 KLRHPNVLLFMGAVASQERLG--IVTEFLPRGSLFKTLHKNY------QALDIKRRLRMA 482
K H N++ +G S ERL I+ E + G L L +N +L +K L A
Sbjct: 65 KFNHQNIVRLIGV--SFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 483 LDVARGMNYLHHRNPPIVHRDLKSSNLLVD---KNWTVKVGDFGLS-SLKNATYLTAKSG 538
DVA+G YL + +HRD+ + N L+ K+ DFG++ + A+Y K G
Sbjct: 123 RDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR-KGG 179
Query: 539 RGT-P-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPW---NNLNLMQVVGVVGF 592
R P +WM PE K+DV+SFGV+LWE+ + +P+ N +M+ V G
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG- 238
Query: 593 MDRRLELPEG 602
RL+ P+G
Sbjct: 239 ---RLDPPKG 245
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 58/194 (29%), Positives = 98/194 (50%), Gaps = 13/194 (6%)
Query: 386 IGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEID-----IIKKLRHPNVL 438
IG GS+ V + +G AVKV ++ K QK I ++K ++HP ++
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK---KKEQKHIMAERNVLLKNVKHPFLV 59
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPP 498
+ + ++L V +++ G LF L + + + R A ++A + YLH N
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHSLN-- 116
Query: 499 IVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEK 558
I++RDLK N+L+D V + DFGL T + GTP+++APEVLR +P +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 559 SDVFSFGVILWELV 572
D + G +L+E++
Sbjct: 177 VDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 5e-17
Identities = 42/108 (38%), Positives = 75/108 (69%), Gaps = 6/108 (5%)
Query: 483 LDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR--- 539
+ V ++++H ++ ++HRD+KS+N+L+ N VK+GDFG S + AT ++ GR
Sbjct: 150 IQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT-VSDDVGRTFC 206
Query: 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
GTP ++APE+ R +P ++K+D+FS GV+L+EL+T P++ N+ +V+
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM 254
|
Length = 496 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 384 EEIGLGSYAVVYRGIWNGSD-------VAVKVYFGSEYIEGTLKN-YQKEIDIIKKLRHP 435
EE+G + VY+G G+ VA+K + EG L+ ++ E + +L+HP
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL--KDKAEGPLREEFKHEAMMRSRLQHP 68
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTL-----HKNYQALDIKRRLRMALD------ 484
N++ +G V ++ L ++ + L + L H + + D + ++ L+
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 485 ----VARGMNYL--HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL-SSLKNATYLTAKS 537
+A GM +L HH +VH+DL + N+LV VK+ D GL + A Y
Sbjct: 129 IVTQIAAGMEFLSSHH----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184
Query: 538 GRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
P +WM+PE + + SD++S+GV+LWE+ +
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 8e-17
Identities = 53/210 (25%), Positives = 108/210 (51%), Gaps = 8/210 (3%)
Query: 384 EEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
E+IG G+ VY + G +VA++ + + L EI ++++ ++PN++ ++
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYL 83
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVH 501
+ + L +V E+L GSL + + +D + + + + + +LH ++H
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ--VIH 139
Query: 502 RDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDV 561
RD+KS N+L+ + +VK+ DFG + + GTP WMAPEV+ + K D+
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 562 FSFGVILWELVTASIPWNNLNLMQVVGVVG 591
+S G++ E++ P+ N N ++ + ++
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 44/134 (32%), Positives = 76/134 (56%), Gaps = 3/134 (2%)
Query: 446 SQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLK 505
++E L V E+L G L + + + D R A ++ G+ +LH + I++RDLK
Sbjct: 67 TKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLHKKG--IIYRDLK 123
Query: 506 SSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFG 565
N+L+DK+ +K+ DFG+ A + GTP ++APE+L+ + NE D +SFG
Sbjct: 124 LDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFG 183
Query: 566 VILWELVTASIPWN 579
V+L+E++ P++
Sbjct: 184 VLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 71/236 (30%), Positives = 114/236 (48%), Gaps = 22/236 (9%)
Query: 384 EEIGLGSYAVVYRGI----WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLL 439
+EIG G + V G + + V VK S ++ +K + +E + L+H N+L
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQ 59
Query: 440 FMGAVASQERLGIVTEFLPRGSLFKTLHKNYQA----LDIKRRLRMALDVARGMNYLHHR 495
+G +V EF P G L L +A D RMA ++A G+ +LH
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTPQWMAPEVLRSE 553
N +H DL N L+ + TVK+GD+GLS K Y+T +W+APE++
Sbjct: 120 N--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 554 PSN-------EKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPE 601
N ++S+V+S GV +WEL S P+ +L+ QV+ +++L+LP+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-VREQQLKLPK 232
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 45/156 (28%), Positives = 85/156 (54%), Gaps = 4/156 (2%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD 484
E+ I++ +H NV+ + + L +V EFL G+L + + ++ ++ + L
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLA 124
Query: 485 VARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQW 544
V + ++ LH + ++HRD+KS ++L+ + VK+ DFG + + KS GTP W
Sbjct: 125 VLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYW 182
Query: 545 MAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580
MAPE++ P + D++S G+++ E+V P+ N
Sbjct: 183 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 381 QLGEEIGLGSYAVVYRGIW--NGSDVAVKV-----YFGSEYIEGTLKNYQKEIDIIKKL- 432
++ +++G G++ VY G VA+K Y E + +E+ ++KL
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN------LREVKSLRKLN 55
Query: 433 RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTL-HKNYQALDIKRRLRMALDVARGMNY 491
HPN++ + L V E++ G+L++ + + + + + +G+ +
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 492 LHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKN-ATYLTAKSGRGTPQWM-APE 548
+H HRDLK NLLV VK+ DFGL+ +++ Y S R W APE
Sbjct: 115 IHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR----WYRAPE 168
Query: 549 V-LRSEPSNEKSDVFSFGVILWELVT 573
+ LRS + D+++ G I+ EL T
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 66/211 (31%), Positives = 96/211 (45%), Gaps = 39/211 (18%)
Query: 386 IGLGSYAVVYRGI--WNGSDVAVKV---YFGSEYIEG--TLKNYQKEIDIIKKLRHPNVL 438
IG G+Y VV + G VA+K F I+ L+ EI +++ LRH N++
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL-IDAKRILR----EIKLLRHLRHENII 62
Query: 439 LFMGAVASQERLG-----IVTEFLPRGSLFKT-LH---KNYQALDIKRRLRMALDVARGM 489
+ + IVTE + T LH K+ Q L + RG+
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTELME------TDLHKVIKSPQPLTDDHIQYFLYQILRGL 116
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-----SLKNATYLTAKSGRGTPQW 544
YLH N ++HRDLK SN+LV+ N +K+ DFGL+ +LT +W
Sbjct: 117 KYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT---EYVVTRW 171
Query: 545 M-APEVLRSEPSNEKS-DVFSFGVILWELVT 573
APE+L S K+ D++S G I EL+T
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 385 EIGLGSYAVV--YRGIWNGSDVAVKVYFGSEYIEGTLKNYQK------EIDIIKKLRHPN 436
+IG GS +V R +G VAVK+ L+ Q+ E+ I++ +H N
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMM--------DLRKQQRRELLFNEVVIMRDYQHQN 79
Query: 437 VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRN 496
V+ + E L ++ EFL G+L + + L+ ++ + V + + YLH +
Sbjct: 80 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT--RLNEEQIATVCESVLQALCYLHSQG 137
Query: 497 PPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSN 556
++HRD+KS ++L+ + VK+ DFG + + KS GTP WMAPEV+ P
Sbjct: 138 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 557 EKSDVFSFGVILWELVTASIPW 578
+ D++S G+++ E+V P+
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 384 EEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
E++G GSYA VY+G NG VA+KV E EGT +E ++K L+H N++L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLH 69
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVH 501
+ ++E L +V E++ L + + K+ L + + RG++Y+H R I+H
Sbjct: 70 DIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILH 126
Query: 502 RDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKS-- 559
RDLK NLL+ +K+ DFGL+ K+ T + T + P+VL S E S
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG--STEYSTC 184
Query: 560 -DVFSFGVILWELV--TASIP 577
D++ G I E++ A+ P
Sbjct: 185 LDMWGVGCIFVEMIQGVAAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 381 QLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
++ IG G++ +V+ + G VA+K G +EI ++ +HP V+
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQAL---DIKRRLRMALDVARGMNYLHHR 495
+ +V E++P L + L + L +K +RM L G+ Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLK---GVAYMHAN 118
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR-GTPQWMAPEVLRSEP 554
I+HRDLK +NLL+ + +K+ DFGL+ L + S + T + APE+L
Sbjct: 119 G--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 555 S-NEKSDVFSFGVILWEL 571
+ D+++ G I EL
Sbjct: 177 KYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 47/156 (30%), Positives = 82/156 (52%), Gaps = 3/156 (1%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD 484
E +++ RHP + + + +RL V E+ G LF L + + + R A +
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-E 103
Query: 485 VARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQW 544
+ + YLH + +V+RDLK NL++DK+ +K+ DFGL + T K+ GTP++
Sbjct: 104 IVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 161
Query: 545 MAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580
+APEVL D + GV+++E++ +P+ N
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 38/94 (40%), Positives = 57/94 (60%), Gaps = 4/94 (4%)
Query: 482 ALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS--LKNATYLTAKSGR 539
+ VARGM +L R +HRDL + N+L+ +N VK+ DFGL+ K+ Y+ R
Sbjct: 179 SFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
+WMAPE + + +SDV+SFGV+LWE+ +
Sbjct: 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 48/151 (31%), Positives = 82/151 (54%), Gaps = 3/151 (1%)
Query: 428 IIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR 487
++K ++HP ++ + + E+L V +F+ G LF L + + + R A ++A
Sbjct: 49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIAS 107
Query: 488 GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAP 547
+ YLH N IV+RDLK N+L+D V + DFGL A T + GTP+++AP
Sbjct: 108 ALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAP 165
Query: 548 EVLRSEPSNEKSDVFSFGVILWELVTASIPW 578
EV+R +P + D + G +L+E++ P+
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 42/146 (28%), Positives = 75/146 (51%), Gaps = 5/146 (3%)
Query: 433 RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
+HP + +++RL V E++ G L + + D R A ++ G+ +L
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFL 112
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY-LTAKSGRGTPQWMAPEVLR 551
H R I++RDLK N+L+D +K+ DFG+ + +T + GTP ++APE+L
Sbjct: 113 HERG--IIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEILS 169
Query: 552 SEPSNEKSDVFSFGVILWELVTASIP 577
+P D ++ GV+L+E++ P
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 51/181 (28%), Positives = 91/181 (50%), Gaps = 4/181 (2%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD 484
E +++ RHP + + + +RL V E+ G LF L + + + R A +
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-E 103
Query: 485 VARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQW 544
+ ++YLH +V+RDLK NL++DK+ +K+ DFGL T K+ GTP++
Sbjct: 104 IVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEY 162
Query: 545 MAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604
+APEVL D + GV+++E++ +P+ N + ++ ++ + R P L
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLS 220
Query: 605 P 605
P
Sbjct: 221 P 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 8e-16
Identities = 46/159 (28%), Positives = 85/159 (53%), Gaps = 3/159 (1%)
Query: 428 IIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR 487
++K ++HP ++ + + ++L V +++ G LF L + L+ + R A ++A
Sbjct: 49 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIAS 107
Query: 488 GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAP 547
+ YLH N IV+RDLK N+L+D + + DFGL T + GTP+++AP
Sbjct: 108 ALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAP 165
Query: 548 EVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
EVL +P + D + G +L+E++ P+ + N ++
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 8e-16
Identities = 62/236 (26%), Positives = 110/236 (46%), Gaps = 29/236 (12%)
Query: 354 RSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSD---VAVKVYF 410
+ ++S S+K +++ED +G GS+ V + D VA+K +
Sbjct: 11 KKKDSDSTKEPKR-----KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFE 65
Query: 411 GSEYIEGTLKNYQKEID-------IIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLF 463
S+ I+ QK++D I+ + HP + G+ + L +V EF+ G F
Sbjct: 66 KSKIIK------QKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFF 119
Query: 464 KTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFG 523
L +N + A + YL N IV+RDLK NLL+DK+ +K+ DFG
Sbjct: 120 TFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFG 176
Query: 524 LSSL-KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578
+ + TY GTP+++APE+L + + +D ++ G+ ++E++ P+
Sbjct: 177 FAKVVDTRTYTLC----GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 49/151 (32%), Positives = 80/151 (52%), Gaps = 13/151 (8%)
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLF---KTLHKNYQALDIKRRLRMALDVARGMN 490
HP + ++E L V E+L G L ++ HK D+ R A ++ G+
Sbjct: 55 HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYAAEIICGLQ 110
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR--GTPQWMAPE 548
+LH + IV+RDLK N+L+D + +K+ DFG+ K AK+ GTP ++APE
Sbjct: 111 FLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAPE 166
Query: 549 VLRSEPSNEKSDVFSFGVILWELVTASIPWN 579
+L + N D +SFGV+L+E++ P++
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 15/209 (7%)
Query: 376 RWEDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
++E L +IG GSY VV+ R G VA+K + SE K +EI ++K+L+
Sbjct: 2 KYEKL---SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK 58
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALD---IKRRLRMALDVARGMN 490
HPN++ + + +L +V E+ ++ L KN + + IK+ + L +N
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQ---AVN 114
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL 550
+ H N +HRD+K N+L+ K +K+ DFG + + T + APE+L
Sbjct: 115 FCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL 172
Query: 551 RSEPS-NEKSDVFSFGVILWELVTASIPW 578
+ DV++ G + EL+T W
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTGQPLW 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 24/201 (11%)
Query: 386 IGLGSYAVVYRG--IWNGSDVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMG 442
IG G+Y +VYR +G VA+K V +E +G + +EI ++ LRHPN++
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKE 73
Query: 443 AVASQ--ERLGIVTEFLPR--GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPP 498
V + + + +V E+ + SL + + +K + L + RG+ YLH
Sbjct: 74 VVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC---LMLQLLRGLQYLHENF-- 128
Query: 499 IVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQ----WM-APEVLRSE 553
I+HRDLK SNLL+ +K+ DFGL+ L AK TP+ W APE+L
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLAR---TYGLPAKP--MTPKVVTLWYRAPELLLGC 183
Query: 554 PSNEKS-DVFSFGVILWELVT 573
+ + D+++ G IL EL+
Sbjct: 184 TTYTTAIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 8/149 (5%)
Query: 431 KLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMN 490
RHP ++ +++ + V E+ G L +H + R + A V G+
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQ 115
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR--GTPQWMAPE 548
YLH IV+RDLK NLL+D VK+ DFGL K ++ GTP+++APE
Sbjct: 116 YLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLC--KEGMGFGDRTSTFCGTPEFLAPE 171
Query: 549 VLRSEPSNEKSDVFSFGVILWELVTASIP 577
VL D + GV+++E++ P
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 52/165 (31%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 420 KNYQKEIDIIKKLRHPN-VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRR 478
+++E + +L HPN V L A L V E++P G + + AL
Sbjct: 23 ARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP-GRTLREVLAADGALPAGET 81
Query: 479 LRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSL------KN 529
R+ L V + H++ IVHRDLK N++V KV DFG+ +L +
Sbjct: 82 GRLMLQVLDALACAHNQG--IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDAD 139
Query: 530 ATYLTAKSGR-GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
LT + GTP + APE LR EP SD++++G+I E +T
Sbjct: 140 VATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 45/215 (20%)
Query: 384 EEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
E IG G+Y VV I +G VA+K + + K +E+ I++ +H N++
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNII--- 67
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALD---------IKRRLRMALD-------- 484
I P G+ FK + Y +D I + +
Sbjct: 68 ---------AIRDILRPPGADFKDV---YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ 115
Query: 485 VARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL------SSLKNATYLTAKSG 538
+ RG+ Y+H N ++HRDLK SNLLV+++ +++GDFG+ S ++ ++T
Sbjct: 116 LLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT--EY 171
Query: 539 RGTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELV 572
T + APE+L S P D++S G I E++
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 39/227 (17%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQK------------EI 426
Q G +G G+Y V + G VA+K E K+ Q E+
Sbjct: 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 427 DIIKKLRHPNVLLFMGAVA---SQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMAL 483
I+ +++H N+ MG V + + +V + + L K + + + + + + + L
Sbjct: 72 KIMNEIKHENI---MGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-L 126
Query: 484 DVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTP 542
+ G+N LH +HRDL +N+ ++ K+ DFGL+ Y S T
Sbjct: 127 QILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 543 Q------------WM-APEVLR-SEPSNEKSDVFSFGVILWELVTAS 575
Q W APE+L +E + D++S G I EL+T
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 3/150 (2%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD 484
E + + H N++ G + + IVTE++ G+L L K+ L + + M
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115
Query: 485 VARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFG-LSSLKNATYLTAKSGRGTPQ 543
+A GM YL VH+ L + +LV+ + K+ F L K+ T SG+
Sbjct: 116 LASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL 173
Query: 544 WMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
W APE ++ + SDV+SFG+++WE+++
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 14/211 (6%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVY-FGSEYIEGTLKNYQKEIDIIKKLRHPN 436
+++++ +E+G G+Y VY+ + + V + + E E E+DI+ K P
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60
Query: 437 VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRR---LRMALDVARGMNYLH 493
++ F GA + + + E++ GSL K L+ A + R+ V +G+ +L
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSE 553
+ I+HRD+K +N+LV+ N VK+ DFG+S N AK+ G +MAPE ++S
Sbjct: 120 EEHN-IIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNIGCQSYMAPERIKSG 176
Query: 554 PSNE------KSDVFSFGVILWELVTASIPW 578
N+ +SDV+S G+ + E+ P+
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 39/94 (41%), Positives = 58/94 (61%), Gaps = 4/94 (4%)
Query: 482 ALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS--LKNATYLTAKSGR 539
+ VARGM +L R +HRDL + N+L+ +N VK+ DFGL+ K+ Y+ S R
Sbjct: 180 SFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
+WMAPE + + +SDV+SFGV+LWE+ +
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 50/159 (31%), Positives = 77/159 (48%), Gaps = 17/159 (10%)
Query: 378 EDLQLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
D ++ ++G G++ VY+ I G VA+K +G +EI I+KKL+HP
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP 67
Query: 436 NV--LLFMGAV---ASQERLGIVTEFLP--RGSLFKTLHK---NYQALDIKRRLRMALDV 485
NV L+ M S+ + G V P L L IK + L+
Sbjct: 68 NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLE- 126
Query: 486 ARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524
G+NYLH + I+HRD+K++N+L+D +K+ DFGL
Sbjct: 127 --GINYLHENH--ILHRDIKAANILIDNQGILKIADFGL 161
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 378 EDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH- 434
DL+ EIG G+ VY R G +AVK + E K ++D++ K H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLK-SHD 72
Query: 435 -PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRL-RMALDVARGMNYL 492
P ++ G + + I E + + L K Q + L +M + + + ++YL
Sbjct: 73 CPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYL 130
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT---AKS-GRGTPQWMAPE 548
++ ++HRD+K SN+L+D + VK+ DFG+S L AK+ G +MAPE
Sbjct: 131 KEKHG-VIHRDVKPSNILLDASGNVKLCDFGISG-----RLVDSKAKTRSAGCAAYMAPE 184
Query: 549 VLRSEPSNEK----SDVFSFGVILWELVTASIPWNNLN 582
+ N K +DV+S G+ L EL T P+ N
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK 222
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 55/194 (28%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 384 EEIGLGSYAVVYRGIWNGSD--VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
+++G G+YA VY+G +D VA+K E+ EG +E+ ++K L+H N++
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALK-EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVH 501
+ +++ L +V E+L + L + L ++++ + RG+NY H R ++H
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLH 127
Query: 502 RDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLR-SEPSNEKSD 560
RDLK NLL+++ +K+ DFGL+ K+ T + T + P++L S + + D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQID 187
Query: 561 VFSFGVILWELVTA 574
++ G I +E+ T
Sbjct: 188 MWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 69/206 (33%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 381 QLGEEIGLGSYAVVYRG--IWNGSDVAVK--VYFGSEYIEGTLKNYQKEIDIIKKLR--- 433
+ EIG G+Y VY+ + G VA+K SE EG + +EI ++K+L
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE--EGIPLSTLREIALLKQLESFE 59
Query: 434 HPNV--LLFMGAVASQER---LGIVTEFLPRGSLFKTLHKNYQA-LDIKRRLRMALDVAR 487
HPN+ LL + +R L +V E + + L L K + L + + + R
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 488 GMNYLH-HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL-KNATYLTAKSGRGTPQWM 545
G+++LH HR IVHRDLK N+LV + VK+ DFGL+ + LT S T +
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT--SVVVTLWYR 173
Query: 546 APEVLRSEPSNEKSDVFSFGVILWEL 571
APEVL D++S G I EL
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 6/156 (3%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL-FKTLHKNYQALDIKRRLRMAL 483
E I++K+ ++ A +++ L +V + G L + + R + A
Sbjct: 43 EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102
Query: 484 DVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTP 542
+ G+ +LH R IV+RDLK N+L+D + V++ D GL+ LK + ++G TP
Sbjct: 103 QIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAG--TP 158
Query: 543 QWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578
+MAPEVL+ E + D F+ G L+E++ P+
Sbjct: 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 42/159 (26%), Positives = 64/159 (40%), Gaps = 44/159 (27%)
Query: 447 QERLGIVTEFLPRGSLFKTLHKNYQALDIKR------RLRMALDVARGMNYLHHRNPPIV 500
+E L +V E++P G L L + L +ALD + + +
Sbjct: 73 EEHLYLVMEYMPGGDLM-NLLIRKDVFPEETARFYIAELVLALDSVHKLGF--------I 123
Query: 501 HRDLKSSNLLVDKNWTVKVGDFGLS----------SLKNATYLTAKSGR----------- 539
HRD+K N+L+D + +K+ DFGL N ++
Sbjct: 124 HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQR 183
Query: 540 --------GTPQWMAPEVLRSEPSNEKSDVFSFGVILWE 570
GTP ++APEVLR P + D +S GVIL+E
Sbjct: 184 RVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 384 EEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
E+IG G+Y VVY+ +A+K + EG +EI ++K+++H N++
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMA----LDVARGMNYLH-HRN 496
V S++RL +V E+L L K + + D + R+ + RG+ Y H HR
Sbjct: 68 DVVHSEKRLYLVFEYLDL-DLKKHMD---SSPDFAKNPRLIKTYLYQILRGIAYCHSHR- 122
Query: 497 PPIVHRDLKSSNLLVDK-NWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLR-SEP 554
++HRDLK NLL+D+ +K+ DFGL+ T T + APE+L S
Sbjct: 123 --VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRH 180
Query: 555 SNEKSDVFSFGVILWELVT 573
+ D++S G I E+V
Sbjct: 181 YSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 6/197 (3%)
Query: 384 EEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
E+IG G+Y V++ VA+K + EG + +EI ++K+L+H N++
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVH 501
+ S ++L +V E+ + L K +D + + +G+ + H N ++H
Sbjct: 66 DVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLH 122
Query: 502 RDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKS-D 560
RDLK NLL++KN +K+ DFGL+ + T + P+VL S D
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 182
Query: 561 VFSFGVILWELVTASIP 577
++S G I EL A P
Sbjct: 183 MWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 44/158 (27%), Positives = 86/158 (54%), Gaps = 6/158 (3%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL-FKTLHKNYQALDIKRRLRMAL 483
E +I++K+ P ++ A S+ L +V + G L + + + L+++R + +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 484 DVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTP 542
+ G+ +LH + IV+RD+K N+L+D ++ D GL+ LK+ +T ++G T
Sbjct: 103 QITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAG--TN 158
Query: 543 QWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580
+MAPE+L+ EP + D F+ G ++E+V P+ +
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 50/154 (32%), Positives = 74/154 (48%), Gaps = 8/154 (5%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKR-RLRMAL 483
E DI+ + ++ + A E L + E++P G F+TL N L R MA
Sbjct: 51 ERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGD-FRTLLNNLGVLSEDHARFYMAE 109
Query: 484 DVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQ 543
++ LH +HRDLK N L+D + +K+ DFGLS A S G+P
Sbjct: 110 MFE-AVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPD 163
Query: 544 WMAPEVLRSEPSNEKSDVFSFGVILWELVTASIP 577
+MAPEVLR + + D +S G +L+E + P
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 60/196 (30%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 384 EEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
+++G GSYA VY+G G VA+K E+ EG +E ++K L+H N++
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKE-IRLEHEEGAPFTAIREASLLKDLKHANIVTLH 69
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMAL-DVARGMNYLHHRNPPIV 500
+ +++ L +V E+L L + + L + +R+ L + RG+ Y H R ++
Sbjct: 70 DIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSM-HNVRLFLFQLLRGLAYCHQRR--VL 125
Query: 501 HRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKS- 559
HRDLK NLL+ + +K+ DFGL+ K+ T + T + P+VL S E S
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG--STEYST 183
Query: 560 --DVFSFGVILWELVT 573
D++ G I +E+ T
Sbjct: 184 SLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 59/196 (30%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 384 EEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
+++G G+YA V++G + VA+K E+ EG +E+ ++K L+H N++
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALK-EIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMAL-DVARGMNYLHHRNPPIV 500
+ ++ L +V E+L S K N L +++ + + RG++Y H R I+
Sbjct: 70 DIIHTERCLTLVFEYLD--SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--IL 125
Query: 501 HRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKS- 559
HRDLK NLL+++ +K+ DFGL+ K+ T + T + P+VL S E S
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG--STEYST 183
Query: 560 --DVFSFGVILWELVT 573
D++ G IL+E+ T
Sbjct: 184 PIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 65/239 (27%), Positives = 113/239 (47%), Gaps = 29/239 (12%)
Query: 384 EEIGLGSYAVVYRG-IWNGSDVA------VKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN 436
+EIG G + V I+ + VA +K S+ L+ D + L+HPN
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQG----DPYRILQHPN 56
Query: 437 VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQAL----DIKRRLRMALDVARGMNYL 492
+L +G +V E+ G L K+ Q + RMA ++A G+ ++
Sbjct: 57 ILQCLGQCVEAIPYLLVFEYCELGDL-KSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTP-QWMAPEV- 549
H N +H DL N + + TVKVGD+G+ S Y+ + + P +W+APE+
Sbjct: 116 HKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 550 ------LRSEPSNEKSDVFSFGVILWELV-TASIPWNNLNLMQVVGVVGFMDRRLELPE 601
L + + S+V++ GV LWEL A+ P+++L+ +V+ V D++++L +
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV-IKDQQVKLFK 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 37/94 (39%), Positives = 56/94 (59%), Gaps = 4/94 (4%)
Query: 482 ALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS--LKNATYLTAKSGR 539
+ VA+GM +L R +HRDL + N+L+ +N VK+ DFGL+ K+ Y+ R
Sbjct: 185 SFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
+WMAPE + +SDV+SFGV+LWE+ +
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 376 RWEDLQLGEEIGLGSYAVV--YRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
R+ DLQ +G+G++ +V R G +VA+K K +E+ ++K LR
Sbjct: 11 RYVDLQ---PVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 434 HPNVLLFMGAVAS-QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRL--RMALDVARGMN 490
H N++ S E + VTE L LH+ + ++++ + RG+
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLG-----TDLHRLLTSRPLEKQFIQYFLYQILRGLK 122
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEV- 549
Y+H + +VHRDLK SN+L+++N +K+ DFGL+ +++ S R + APE+
Sbjct: 123 YVH--SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTR---YYRAPEIM 177
Query: 550 LRSEPSNEKSDVFSFGVILWELV 572
L + + + D++S G I E++
Sbjct: 178 LTWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 9e-14
Identities = 35/103 (33%), Positives = 61/103 (59%), Gaps = 4/103 (3%)
Query: 471 QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS--LK 528
LD+ LR + VA+GM++L +N +HRD+ + N+L+ K+ DFGL+ +
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWEL 571
++ Y+ + R +WMAPE + +SDV+S+G++LWE+
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 394 VYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453
+ + + VAVK + LK Q+EI ++L+HPN+L ++ + L +V
Sbjct: 18 LAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV 77
Query: 454 TEFLPRGS---LFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNL 509
+ + GS L KT L I L+ DV ++Y+H + +HR +K+S++
Sbjct: 78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILK---DVLNALDYIHSKG--FIHRSVKASHI 132
Query: 510 LVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP------------QWMAPEVLRSEPS-- 555
L+ + V LS L+ + + R W++PEVL+
Sbjct: 133 LLSGDGKVV-----LSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY 187
Query: 556 NEKSDVFSFGVILWELVTASIPWNNLNLMQ 585
NEKSD++S G+ EL +P+ ++ Q
Sbjct: 188 NEKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 49/161 (30%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 424 KEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRL---- 479
+E+ ++ + P ++ F GA S + I E + GSL + L K R+
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-------AGRIPENI 100
Query: 480 --RMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAK 536
++++ V RG+ YL ++ I+HRD+K SN+LV+ +K+ DFG+S L ++ A
Sbjct: 101 LGKISIAVLRGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN 156
Query: 537 SGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIP 577
S GT +M+PE L+ +SD++S G+ L E+ P
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 53/202 (26%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 386 IGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH--------PNV 437
IG GSYA V ++ ++Y + ++ L N ++ID ++ +H P +
Sbjct: 3 IGRGSYAKVLLVRLKKTE---RIY-AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 58
Query: 438 LLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNP 497
+ ++ RL V E++ G L + + + + R A +++ +NYLH R
Sbjct: 59 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERG- 116
Query: 498 PIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNE 557
I++RDLK N+L+D +K+ D+G+ T + GTP ++APE+LR E
Sbjct: 117 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 558 KSDVFSFGVILWELVTASIPWN 579
D ++ GV+++E++ P++
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 41/139 (29%), Positives = 75/139 (53%), Gaps = 13/139 (9%)
Query: 446 SQERLGIVTEFLPRGSLFKTLHKNYQALDIKR-----RLRMALDVARGMNYLHHRNPPIV 500
+ +RL V E++ G L YQ + R + A ++A G+ +LH + I+
Sbjct: 72 TMDRLYFVMEYVNGGDLM------YQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--II 123
Query: 501 HRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSD 560
+RDLK N+++D +K+ DFG+ +T K+ GTP ++APE++ +P + D
Sbjct: 124 YRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVD 183
Query: 561 VFSFGVILWELVTASIPWN 579
++FGV+L+E++ P+
Sbjct: 184 WWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKN-YQKEIDIIKKLRHPN 436
+D + E+G G+ VV + S + + I+ ++N +E+ ++ + P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 437 VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRL--RMALDVARGMNYLHH 494
++ F GA S + I E + GSL + L +A I + ++++ V RG+ YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEP 554
++ I+HRD+K SN+LV+ +K+ DFG+S A S GT +M+PE L+
Sbjct: 122 KHQ-IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTH 178
Query: 555 SNEKSDVFSFGVILWELVTASIP 577
+ +SD++S G+ L EL P
Sbjct: 179 YSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 42/139 (30%), Positives = 76/139 (54%), Gaps = 4/139 (2%)
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
P V + A + R ++ + + L ++ ALD + L + VA+GM++L
Sbjct: 173 PGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS 232
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKN-ATYLTAKSGRGTPQWMAPEVLRS 552
+N +HRDL + N+L+ K+ DFGL+ ++N + Y+ + R +WMAPE + +
Sbjct: 233 KN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN 290
Query: 553 EPSNEKSDVFSFGVILWEL 571
+SDV+S+G++LWE+
Sbjct: 291 CVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 57/203 (28%), Positives = 104/203 (51%), Gaps = 9/203 (4%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKN-YQKEIDIIKKLRHPN 436
+D + E+G G+ VV++ S + + I+ ++N +E+ ++ + P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 437 VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRL--RMALDVARGMNYLHH 494
++ F GA S + I E + GSL + L K A I ++ ++++ V +G+ YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEP 554
++ I+HRD+K SN+LV+ +K+ DFG+S A S GT +M+PE L+
Sbjct: 122 KHK-IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTH 178
Query: 555 SNEKSDVFSFGVILWELVTASIP 577
+ +SD++S G+ L E+ P
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 37/92 (40%), Positives = 57/92 (61%), Gaps = 4/92 (4%)
Query: 488 GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTPQWMA 546
G+ +LH R I++RDLK N+L+D + V++ D GL+ LK+ T K GTP +MA
Sbjct: 109 GLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT-KGYAGTPGFMA 165
Query: 547 PEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578
PE+L+ E + D F+ GV L+E++ A P+
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 53/194 (27%), Positives = 99/194 (51%), Gaps = 7/194 (3%)
Query: 384 EEIGLGSYAVVYRGIWNGSD--VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
E++G G+YA V++G ++ VA+K E+ EG +E+ ++K L+H N++
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALK-EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVH 501
V + + L +V E+L + L + + + + + RG+ Y H R ++H
Sbjct: 71 DIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLH 127
Query: 502 RDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLR-SEPSNEKSD 560
RDLK NLL+++ +K+ DFGL+ K+ T + T + P+VL S + + D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQID 187
Query: 561 VFSFGVILWELVTA 574
++ G I +E+ +
Sbjct: 188 MWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 47/168 (27%), Positives = 79/168 (47%), Gaps = 25/168 (14%)
Query: 411 GSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLP--RGSLFKTLHK 468
G+ IE L ++ + HP+V+ + S +V LP L+ L K
Sbjct: 102 GTTLIEAML---------LQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTK 149
Query: 469 NYQALDIKRRLRMALDVARGMNYLH-HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527
+ L I + L + + G+ YLH R I+HRD+K+ N+ ++ V +GD G +
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF 206
Query: 528 KNAT---YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELV 572
A GT + APEVL + N K+D++S G++L+E++
Sbjct: 207 PVVAPAFLGLA----GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 386 IGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH--------P 435
IG GSYA V R N A+KV ++ L + ++ID ++ +H P
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKV------VKKELVHDDEDIDWVQTEKHVFEQASSNP 56
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495
++ + RL +V E++ G L + + + + R A ++ +N+LH R
Sbjct: 57 FLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHER 115
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPS 555
I++RDLK N+L+D + +K+ D+G+ T + GTP ++APE+LR E
Sbjct: 116 G--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 556 NEKSDVFSFGVILWELVTASIPWN 579
D ++ GV+++E++ P++
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 42/140 (30%), Positives = 77/140 (55%), Gaps = 8/140 (5%)
Query: 443 AVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHR 502
A + +L ++ +++ G LF L++ + + R+ +A ++ +++LH I++R
Sbjct: 73 AFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQLG--IIYR 129
Query: 503 DLKSSNLLVDKNWTVKVGDFGLSS--LKNATYLTAKSGRGTPQWMAPEVLRSEPS--NEK 558
D+K N+L+D V + DFGLS L A S GT ++MAPEV+R ++
Sbjct: 130 DIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKA 188
Query: 559 SDVFSFGVILWELVTASIPW 578
D +S GV+ +EL+T + P+
Sbjct: 189 VDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 53/170 (31%), Positives = 83/170 (48%), Gaps = 20/170 (11%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIK-RRLRMAL 483
E DI+ +P V+ + ++ L +V E++ G TL KN AL + R+ A
Sbjct: 51 ERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDC-ATLLKNIGALPVDMARMYFAE 109
Query: 484 DVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL---------------K 528
V + YLH N IVHRDLK NLL+ +K+ DFGLS + K
Sbjct: 110 TVL-ALEYLH--NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578
+ K GTP+++APEV+ + + D ++ G+IL+E + +P+
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 66/244 (27%), Positives = 115/244 (47%), Gaps = 42/244 (17%)
Query: 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSD--VAVKVYFGSEYIEGTLKNYQKEIDII 429
D G R+ DL+ +G GS +V+ + + D VAVK ++ ++K+ +EI II
Sbjct: 2 DLGSRYMDLR---PLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKII 56
Query: 430 KKLRHPNVL-----LFMGAVASQERLGIVTEF--------LPRGSLFKTLHKNYQALDIK 476
++L H N++ L E +G +TE L L + + +
Sbjct: 57 RRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA 116
Query: 477 RRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTV-KVGDFGLSSLKNATYLTA 535
R L RG+ Y+H N ++HRDLK +N+ ++ V K+GDFGL+ + + Y
Sbjct: 117 RLFMYQL--LRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY--- 169
Query: 536 KSGRG------TPQWM-APEVLRSEPSN--EKSDVFSFGVILWELVTASIPW---NNLNL 583
S +G +W +P +L S P+N + D+++ G I E++T + + L
Sbjct: 170 -SHKGYLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ 227
Query: 584 MQVV 587
MQ++
Sbjct: 228 MQLI 231
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 41/141 (29%), Positives = 73/141 (51%), Gaps = 21/141 (14%)
Query: 448 ERLGIVTEFLPRGSL---------FKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPP 498
+RL V E++ G L FK H + A +I A G+ +LH +
Sbjct: 74 DRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEI----------AIGLFFLHSKG-- 121
Query: 499 IVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEK 558
I++RDLK N+++D +K+ DFG+ T ++ GTP ++APE++ +P +
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKS 181
Query: 559 SDVFSFGVILWELVTASIPWN 579
D ++FGV+L+E++ P++
Sbjct: 182 VDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 41/118 (34%), Positives = 65/118 (55%), Gaps = 4/118 (3%)
Query: 458 PRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTV 517
P + TL AL + + VA GM +L +N VHRDL + N+L+ + V
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLICEGKLV 278
Query: 518 KVGDFGLSS--LKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
K+ DFGL+ ++++ Y++ S +WMAPE + + SDV+SFG++LWE+ T
Sbjct: 279 KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|222120 pfam13426, PAS_9, PAS domain | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-12
Identities = 22/89 (24%), Positives = 43/89 (48%), Gaps = 1/89 (1%)
Query: 80 IIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRS 139
I+Y N +A L G+ E+ G+ + + + ++ E L +G + +++
Sbjct: 10 IVYANDAALRLLGYTREELLGKSIRDLFGPGDDEEAVARLREALRNGGEVEVELELRRKD 69
Query: 140 GEILMAVVTKSPLY-EDGELAGFITVSSD 167
GE +V+ SP+ EDGE+ G + + D
Sbjct: 70 GEPFPVLVSASPVRDEDGEVVGIVGILRD 98
|
Length = 101 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 41/134 (30%), Positives = 73/134 (54%), Gaps = 3/134 (2%)
Query: 446 SQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLK 505
++E L V EFL G L + + D+ R A ++ G+ +LH + I++RDLK
Sbjct: 67 TKEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSKG--IIYRDLK 123
Query: 506 SSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFG 565
N+++D++ +K+ DFG+ A + GTP ++APE+L+ D +SFG
Sbjct: 124 LDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFG 183
Query: 566 VILWELVTASIPWN 579
V+L+E++ P++
Sbjct: 184 VLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 39/137 (28%), Positives = 75/137 (54%), Gaps = 13/137 (9%)
Query: 448 ERLGIVTEFLPRGSLFKTLH-----KNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHR 502
+RL V E++ G L + K QA+ A +++ G+ +LH R I++R
Sbjct: 74 DRLYFVMEYVNGGDLMYHIQQVGKFKEPQAV------FYAAEISVGLFFLHRRG--IIYR 125
Query: 503 DLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVF 562
DLK N+++D +K+ DFG+ +T ++ GTP ++APE++ +P + D +
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWW 185
Query: 563 SFGVILWELVTASIPWN 579
++GV+L+E++ P++
Sbjct: 186 AYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 30/228 (13%)
Query: 381 QLGEEIGLG--SYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN 436
+L EIG G + VY R G+ V V++ E LK Q E+ + RHPN
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60
Query: 437 VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRL--RMALDVARGMNYLHH 494
++ + L +++ F+ GS +L K Y + L + RG+NYLH
Sbjct: 61 IMTSWTVFTTGSWLWVISPFMAYGSA-NSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ 119
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGT------PQ----- 543
+HR++K+S++L+ + V + GLS L Y ++G+ PQ
Sbjct: 120 NG--YIHRNIKASHILISGDGLVSLS--GLSHL----YSLVRNGQKAKVVYDFPQFSTSV 171
Query: 544 --WMAPEVLRSEPS--NEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
W++PE+LR + N KSD++S G+ EL T +P+ ++ Q++
Sbjct: 172 LPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 21/170 (12%)
Query: 422 YQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIK----- 476
+++E DI+ P + A ++ L +V E+ P G L L++ D
Sbjct: 48 FEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY 107
Query: 477 -RRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT-YLT 534
L +A+ M Y VHRD+K N+L+D+ +K+ DFG ++ A +
Sbjct: 108 LAELVLAIHSVHQMGY--------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159
Query: 535 AKSGRGTPQWMAPEVLRSEPSNEKS------DVFSFGVILWELVTASIPW 578
+K GTP ++APEVL + + K D +S GVI +E++ P+
Sbjct: 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 46/162 (28%), Positives = 83/162 (51%), Gaps = 9/162 (5%)
Query: 422 YQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRM 481
+ +E DI+ P V+ A + L +V E++P G L L NY + +
Sbjct: 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYT 148
Query: 482 ALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT-AKSGRG 540
A +V ++ +H ++HRD+K N+L+DK+ +K+ DFG + T + + G
Sbjct: 149 A-EVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVG 205
Query: 541 TPQWMAPEVLRSEPSN----EKSDVFSFGVILWELVTASIPW 578
TP +++PEVL+S+ + + D +S GV L+E++ P+
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 70/260 (26%), Positives = 116/260 (44%), Gaps = 34/260 (13%)
Query: 332 PGHDVNELDPDGKQYPSLGESSRSRESSSSK-GDNETSCATD-GGIRWEDLQLGEEIGLG 389
+ + + K L E RS +++ + D E D + +LG IG G
Sbjct: 21 NKGGSGKFEMNDK---KLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNG 77
Query: 390 SYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLL-----FMGAV 444
S+ VVY I D + KV + KN +E+ I+K L H N++ +
Sbjct: 78 SFGVVYEAIC--IDTSEKVAIKKVLQDPQYKN--RELLIMKNLNHINIIFLKDYYYTECF 133
Query: 445 ASQER---LGIVTEFLPRG--SLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPI 499
E+ L +V EF+P+ K +N AL + + + R + Y+H + I
Sbjct: 134 KKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--I 191
Query: 500 VHRDLKSSNLLVDKN-WTVKVGDFG-----LSSLKNATYLTAKSGRGTPQWMAPEV-LRS 552
HRDLK NLL+D N T+K+ DFG L+ ++ +Y+ ++ R APE+ L +
Sbjct: 192 CHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYR------APELMLGA 245
Query: 553 EPSNEKSDVFSFGVILWELV 572
D++S G I+ E++
Sbjct: 246 TNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 47/180 (26%), Positives = 89/180 (49%), Gaps = 5/180 (2%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD 484
E ++ ++ P ++ + S E+L +V F+ G LF L + D+ R +
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQRE-GRFDLSRARFYTAE 101
Query: 485 VARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQW 544
+ + LH N +++RDLK N+L+D + + DFGL L + GTP++
Sbjct: 102 LLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159
Query: 545 MAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604
+APE+L + D ++ GV+L+E++T P+ + N+ ++ + + L P+G D
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI--LQEPLRFPDGFD 217
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 37/106 (34%), Positives = 59/106 (55%), Gaps = 4/106 (3%)
Query: 470 YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS--L 527
+ L L VARGM +L +N VHRDL + N+L+ + VK+ DFGL+ +
Sbjct: 231 SEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIM 288
Query: 528 KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
++ Y++ S +WMAPE + SDV+S+G++LWE+ +
Sbjct: 289 HDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 52/225 (23%)
Query: 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKV---YFGSEYIEGTLKNYQKEIDIIK 430
R+++L IG G+Y +V G VA+K + + + TL+ EI I++
Sbjct: 6 RYQNLSY---IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILR 58
Query: 431 KLRHPNVLLFM-----GAVASQERLGIVTEFLPRGSLFKTLHKN-----------YQALD 474
+ +H N++ + + S + IV E + L+K + YQ L
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQIL- 116
Query: 475 IKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534
RG+ Y+H N ++HRDLK SNLL++ N +K+ DFGL+ + A
Sbjct: 117 ------------RGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLA--RIADPEH 160
Query: 535 AKSGRGT----PQWM-APEVLRSEPSNEKS-DVFSFGVILWELVT 573
+G T +W APE++ + K+ D++S G IL E+++
Sbjct: 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 3/145 (2%)
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
HP + + +RL V EF+ G L + K+ + D R A ++ + +LH
Sbjct: 55 HPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLH 113
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSE 553
+ I++RDLK N+L+D K+ DFG+ T + GTP ++APE+L+
Sbjct: 114 DKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 554 PSNEKSDVFSFGVILWELVTASIPW 578
D ++ GV+L+E++ P+
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 21/201 (10%)
Query: 385 EIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR---HPNVLL 439
EIG+G+Y VY R +G VA+K +G + +E+ ++K+L HPN++
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 440 FMGAVAS-----QERLGIVTEFLP---RGSLFKTLHKNYQALDIKRRLRMALDVARGMNY 491
M A+ + ++ +V E + R L K A IK +R L RG+++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL---RGLDF 123
Query: 492 LHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWM-APEVL 550
LH IVHRDLK N+LV VK+ DFGL+ + + A + W APEVL
Sbjct: 124 LHANC--IVHRDLKPENILVTSGGQVKLADFGLARI--YSCQMALTPVVVTLWYRAPEVL 179
Query: 551 RSEPSNEKSDVFSFGVILWEL 571
D++S G I E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 386 IGLGSYAVVYRGIWNGSD--VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH--------P 435
IG GSYA V + A+KV I+ L N ++ID ++ +H P
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKV------IKKELVNDDEDIDWVQTEKHVFETASNHP 56
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495
++ ++ RL V EF+ G L + + + + R A +++ +N+LH R
Sbjct: 57 FLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHER 115
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPS 555
I++RDLK N+L+D +K+ D+G+ T + GTP ++APE+LR E
Sbjct: 116 G--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 556 NEKSDVFSFGVILWELVTASIPWN 579
D ++ GV+++E++ P++
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-11
Identities = 38/139 (27%), Positives = 67/139 (48%), Gaps = 25/139 (17%)
Query: 461 SLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVG 520
SL K L + + L + + + Y+H + ++HRDLK N+L+ V +
Sbjct: 101 SLSKELA---EKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVIL 155
Query: 521 DFGLSSLKNA-----------------TYLTAKSGR--GTPQWMAPEVLRSEPSNEKSDV 561
D+G + K + +T G+ GTP +MAPE L P++E +D+
Sbjct: 156 DWGAAIFKKLEEEDLLDIDVDERNICYSSMT-IPGKIVGTPDYMAPERLLGVPASESTDI 214
Query: 562 FSFGVILWELVTASIPWNN 580
++ GVIL++++T S P+
Sbjct: 215 YALGVILYQMLTLSFPYRR 233
|
Length = 932 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 385 EIGLGSYAVVYRGIWN--GSDVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
+IG G+Y VY+ G VA+K V +E EG +EI I+++L H N++
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLK 72
Query: 442 GAVASQERLGIVTEFLPRGSLFKTL-----HKNYQALD----------IKRRLRMALDVA 486
V ++ +F F + H L+ IK ++ L+
Sbjct: 73 EIVTDKQD---ALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE-- 127
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWM- 545
G+NY H +N +HRD+K SN+L++ +K+ DFGL+ L N+ + + W
Sbjct: 128 -GLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 546 APEVLRSEPSNEKS-DVFSFGVILWELVT 573
PE+L E + DV+S G IL EL T
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 47/183 (25%), Positives = 97/183 (53%), Gaps = 9/183 (4%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD 484
E +I++ ++HP ++ + A + +L ++ E+L G LF L + ++ ++ +
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-E 108
Query: 485 VARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR--GTP 542
++ + +LH + I++RDLK N+L+D VK+ DFGL K + + + GT
Sbjct: 109 ISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLC--KESIHEGTVTHTFCGTI 164
Query: 543 QWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEG 602
++MAPE+L + D +S G ++++++T + P+ N + + + + +L LP
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI--LKGKLNLPPY 222
Query: 603 LDP 605
L P
Sbjct: 223 LTP 225
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 38/146 (26%), Positives = 73/146 (50%), Gaps = 3/146 (2%)
Query: 433 RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
+HP + +++RL V E++ G L + ++ + D R A +V + +L
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFL 112
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS 552
H +++RDLK N+L+D K+ DFG+ +T + GTP ++APE+L+
Sbjct: 113 HRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE 170
Query: 553 EPSNEKSDVFSFGVILWELVTASIPW 578
D ++ GV+++E++ P+
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 12/212 (5%)
Query: 375 IRWEDLQLGEEIGLGSYAVV--YRGIWNGSDVAVKVYFGSEYIEGTLKNY-QKEIDIIKK 431
++ ED ++ + IG G++ V R A+K+ E I+ + + +E DI+
Sbjct: 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 432 LRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNY 491
P V+ A L +V E++P G L L NY + R A +V ++
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTA-EVVLALDA 157
Query: 492 LHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT-AKSGRGTPQWMAPEVL 550
+H +HRD+K N+L+DK+ +K+ DFG N + + GTP +++PEVL
Sbjct: 158 IHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 215
Query: 551 RSEPSN----EKSDVFSFGVILWELVTASIPW 578
+S+ + + D +S GV L+E++ P+
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 53/214 (24%), Positives = 113/214 (52%), Gaps = 21/214 (9%)
Query: 379 DLQLGEEIGLGSYAVVY-----RGIWNGSDVAVKVYFGSEYI--EGTLKNYQKEIDIIKK 431
+ +L + +G G+Y V+ G G A+KV + + T+++ + E ++++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 432 LRH-PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMN 490
+R P ++ A ++ +L ++ +++ G +F L++ + + R ++ +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALE 119
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR-----GTPQWM 545
+LH IV+RD+K N+L+D V + DFGLS +L+ + R GT ++M
Sbjct: 120 HLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSK----EFLSEEKERTYSFCGTIEYM 173
Query: 546 APEVLRSEPSNEKS-DVFSFGVILWELVTASIPW 578
APE++R + + K+ D +S G++++EL+T + P+
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 386 IGLGSYAVVY--RGIWNGSDVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMG 442
IG G++ V+ R VA+K V +E EG +EI I++ L+H NV+ +
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIE 78
Query: 443 AVASQERLG--------IVTEFLPR--GSLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
++ +V EF L + + +IK+ ++M L+ G+ Y+
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN---GLYYI 135
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS---SLKNATYLTAKSGRGTPQWM-APE 548
H I+HRD+K++N+L+ K+ +K+ DFGL+ SL + + R W PE
Sbjct: 136 HRNK--ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
Query: 549 VLRSEPS-NEKSDVFSFGVILWELVTASIPWNNLNLMQ 585
+L E D++ G I+ E+ W +MQ
Sbjct: 194 LLLGERDYGPPIDMWGAGCIMAEM------WTRSPIMQ 225
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRR------ 478
E I++ + HP+++ G + ++ LPR +KT Y L KR
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPR---YKT--DLYCYLAAKRNIAICDI 184
Query: 479 LRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL-----KNATYL 533
L + V R + YLH I+HRD+K+ N+ ++ V +GDFG + N Y
Sbjct: 185 LAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242
Query: 534 TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
A GT APE+L +P D++S G++L+E+ T
Sbjct: 243 WA----GTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 45/147 (30%), Positives = 77/147 (52%), Gaps = 25/147 (17%)
Query: 446 SQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMAL------------DVARGMNYLH 493
S ++L ++ E+ G L K IK+RL+ L + ++ +H
Sbjct: 136 SDDKLLLIMEYGSGGDLNK---------QIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS--LKNATYLTAKSGRGTPQWMAPEVLR 551
R ++HRDLKS+N+ + +K+GDFG S + + A S GTP ++APE+
Sbjct: 187 SRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWE 244
Query: 552 SEPSNEKSDVFSFGVILWELVTASIPW 578
+ ++K+D++S GVIL+EL+T P+
Sbjct: 245 RKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 47/170 (27%), Positives = 82/170 (48%), Gaps = 25/170 (14%)
Query: 422 YQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRR--- 478
+ +E DI+ ++ A + L +V E++P G L L NY DI +
Sbjct: 90 FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLV-NLMSNY---DIPEKWAR 145
Query: 479 -----LRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533
+ +ALD M + +HRD+K N+L+DK+ +K+ DFG +A +
Sbjct: 146 FYTAEVVLALDAIHSMGF--------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197
Query: 534 T-AKSGRGTPQWMAPEVLRSEPSN----EKSDVFSFGVILWELVTASIPW 578
+ GTP +++PEVL+S+ + + D +S GV L+E++ P+
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 45/223 (20%)
Query: 379 DLQLGEEIGLGSYAVVYRGIW------NGSDVAVK----VYFGSEYIEGTLKNYQKEIDI 428
D++ IG G++ VV W +G VA+K V+ + + K +E+ +
Sbjct: 1 DVEPDRPIGYGAFGVV----WSVTDPRDGKRVALKKMPNVF--QNLV--SCKRVFRELKM 52
Query: 429 IKKLRHPNVL-----LFMGAVASQERLGIVTEFLPRGSLFKTLHK---NYQALD---IKR 477
+ +H NVL L + E + +VTE + LHK + Q L +K
Sbjct: 53 LCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-----SDLHKIIVSPQPLSSDHVKV 107
Query: 478 RLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN---ATYLT 534
L L RG+ YLH I+HRD+K NLLV+ N +K+ DFGL+ ++ + ++T
Sbjct: 108 FLYQIL---RGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162
Query: 535 AKSGRGTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELVTASI 576
+ T + APE+L D++S G I EL+ I
Sbjct: 163 QEV--VTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 9e-11
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 48/215 (22%)
Query: 386 IGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQ------KEIDIIKKLR-HPN 436
+G G+Y +V++ I VA+K F + +N +EI +++L HPN
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDA------FRNATDAQRTFREIMFLQELGDHPN 68
Query: 437 VLLFMGAVASQERLGI--VTEFLP-------RGSLFKTLHKN---YQALDIKRRLRMALD 484
++ + + ++ I V E++ R ++ + +HK YQ L
Sbjct: 69 IVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLL----------- 117
Query: 485 VARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGT--- 541
+ + Y+H N ++HRDLK SN+L++ + VK+ DFGL+ + ++ T
Sbjct: 118 --KALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 542 -PQWM-APEVLRSEPSNEKS-DVFSFGVILWELVT 573
+W APE+L K D++S G IL E++
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 4/155 (2%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL-FKTLHKNYQALDIKRRLRMAL 483
E I++K+ V+ A +++ L +V + G L F H + R + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 484 DVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQ 543
++ G+ LH IV+RDLK N+L+D + +++ D GL+ + T K GT
Sbjct: 110 EICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVG 166
Query: 544 WMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578
+MAPEV+++E D ++ G +L+E++ P+
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 40/123 (32%), Positives = 68/123 (55%), Gaps = 4/123 (3%)
Query: 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNL 509
L +VT+++ G LF L K + + + + +A ++ + +LH + IV+RDLK N+
Sbjct: 71 LYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKYD--IVYRDLKPENI 127
Query: 510 LVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKS-DVFSFGVIL 568
L+D + + DFGLS T + GT +++APEVL E K D +S GV++
Sbjct: 128 LLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLV 187
Query: 569 WEL 571
+E+
Sbjct: 188 FEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 3/88 (3%)
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMA 546
RG+ Y+H N ++HRDLK SNLL++ N +K+ DFGL+ + T + A
Sbjct: 119 RGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRA 176
Query: 547 PEVLRSEPSNEKS-DVFSFGVILWELVT 573
PE+L + + DV+S G I EL+
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|216228 pfam00989, PAS, PAS fold | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-10
Identities = 26/106 (24%), Positives = 47/106 (44%), Gaps = 3/106 (2%)
Query: 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKK 118
R++LES+ + V I+Y N +AE L G EV G+ + + + ++ +
Sbjct: 3 LRAILESLPDGIFV-VDEDGRILYVNAAAEELLGLSREEVIGKSLLDLIPEDDDAEVAEL 61
Query: 119 IMERLASGQSW-SGQFPFKKRSGEILMAVVTKSPLY-EDGELAGFI 162
+ + L G+ + F+ G V SP+ GE+ GF+
Sbjct: 62 LRQALLQGEESRGFEVSFRVPDGRPRHVEVRASPVRDAGGEVRGFL 107
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 113 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 36/177 (20%)
Query: 429 IKKLRHP--NV---------LLFMGAVASQERLGIVTEFLPRGSL--FKTLHKNYQALD- 474
IKKL P NV L+ M V + +G++ F P+ SL F+ ++ + +D
Sbjct: 46 IKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA 105
Query: 475 -IKRRLRMALDVARGMNYL---------HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524
+ + ++M LD R M+YL H + I+HRDLK SN++V + T+K+ DFGL
Sbjct: 106 NLCQVIQMDLDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 164
Query: 525 SSLKNATYLTAKSGRGTPQ-----WMAPEVLRSEPSNEKSDVFSFGVILWELVTASI 576
+ +++ TP + APEV+ E D++S G I+ E++ ++
Sbjct: 165 ARTAGTSFMM------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 49/172 (28%), Positives = 83/172 (48%), Gaps = 26/172 (15%)
Query: 429 IKKLRHP-----------NVLLFMGAVASQERLGIVTEFLPRGSL--FKTLHKNYQALDI 475
IKKL P L+ M V + +G++ F P+ SL F+ ++ + +D
Sbjct: 54 IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA 113
Query: 476 K--RRLRMALDVARGMNYL---------HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524
+ ++M LD R M+YL H + I+HRDLK SN++V + T+K+ DFGL
Sbjct: 114 NLCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 525 SSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASI 576
+ +++ T + APEV+ E D++S G I+ E++ +
Sbjct: 173 ARTAGTSFMMTPY-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 60/228 (26%), Positives = 113/228 (49%), Gaps = 22/228 (9%)
Query: 376 RWEDLQLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
R+ DL+ ++G G+Y V + G+ VA+K + E K +E+ ++K ++
Sbjct: 16 RYRDLK---QVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK 72
Query: 434 HPNVLLFMGAVASQERLGIVTEF---LP-RGSLFKTLHKNYQALDIKRRLRMALDVARGM 489
H NV+ + L +F +P G+ L K ++ L R + + +G+
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGL 131
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWM-APE 548
Y+H I+HRDLK NL V+++ +K+ DFGL+ ++ +G +W APE
Sbjct: 132 KYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM----TGYVVTRWYRAPE 185
Query: 549 VLRS-EPSNEKSDVFSFGVILWELVTASIPW---NNLN-LMQVVGVVG 591
V+ + + D++S G I+ E++T + ++L+ LM+++ V G
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG 233
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 44/209 (21%), Positives = 93/209 (44%), Gaps = 31/209 (14%)
Query: 384 EEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIEGTLK----------NYQKEIDIIKKL 432
E +G G++ +Y+G+ SD+ + + + LK + + ++ +L
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGP--GQEVSVVLKVLGSDHRDSLAFFETASLMSQL 58
Query: 433 RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
H +++ G E + +V E++ G L LH+ + + +L +A +A ++YL
Sbjct: 59 SHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL 117
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWT-------VKVGDFGLSSLKNATYLTAKSGRGTP-QW 544
+ +VH ++ N+LV + +K+ D G+ + ++ R W
Sbjct: 118 EDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP-----ITVLSREERVERIPW 170
Query: 545 MAPEVLRSEPSNEKS--DVFSFGVILWEL 571
+APE +R+ ++ D +SFG L E+
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 26/196 (13%)
Query: 420 KNYQKEIDIIKKLRHPNVLLFMGAVASQERLG------IVTEFLPRGSLFKTLHKNYQAL 473
K +E+ ++K + H N++ + Q+ L +V E + +L + +H L
Sbjct: 65 KRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHME---L 120
Query: 474 DIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533
D +R + + G+ +LH + I+HRDLK SN++V + T+K+ DFGL+ ++
Sbjct: 121 DHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM 178
Query: 534 TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASI---------PWNNLNLM 584
T + APEV+ E D++S G I+ ELV S+ WN ++
Sbjct: 179 MTPY-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN--KVI 235
Query: 585 QVVGV--VGFMDRRLE 598
+ +G FM+R
Sbjct: 236 EQLGTPSAEFMNRLQP 251
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 51/192 (26%), Positives = 96/192 (50%), Gaps = 12/192 (6%)
Query: 386 IGLGSYAVVYRGIWNGSD--VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGA 443
+G G+Y VV + + VA+K + SE E + +E+ +++ L+ N++ A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 444 VASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRD 503
+ +L +V E++ + ++ + L + + ++ + + +++ H + IVHRD
Sbjct: 69 FRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRD 125
Query: 504 LKSSNLLVDKNWTVKVGDFG----LSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKS 559
+K NLL+ N +K+ DFG LS NA Y + R + +PE+L P +
Sbjct: 126 IKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATR---WYRSPELLLGAPYGKAV 182
Query: 560 DVFSFGVILWEL 571
D++S G IL EL
Sbjct: 183 DMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 52/215 (24%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 379 DLQLGEEIGLGSYAVVY-----RGIWNGSDVAVKVYFGSEYIEG--TLKNYQKEIDIIKK 431
+ +L + +G G+Y V+ G +G A+KV + ++ T ++ + E +++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 432 LRH-PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMN 490
+R P ++ A + +L ++ +++ G LF L + + + + ++ ++ +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-EIVLALE 119
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR-----GTPQWM 545
+LH I++RD+K N+L+D N V + DFGLS + + R GT ++M
Sbjct: 120 HLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK----EFHEDEVERAYSFCGTIEYM 173
Query: 546 APEVLR-SEPSNEKS-DVFSFGVILWELVTASIPW 578
AP+++R + ++K+ D +S GV+++EL+T + P+
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 32/212 (15%)
Query: 381 QLGEEIGLGSYAVV----YRGIWNGSDVAVKVY---FGSEYIEGTLKNYQKEIDIIKKLR 433
+L +E+G G+Y +V VA+K F + + K +E+ +++ R
Sbjct: 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKIL---AKRALRELKLLRHFR 59
Query: 434 -HPNV--LLFMGAVASQERLGI-VTEFLPRGSLFKTLHKNYQALD--IKRRLRMALDVAR 487
H N+ L M V + + E L L + + D + + L
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQIL---C 116
Query: 488 GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS------SLKNATYLTAKSGRGT 541
G+ Y+H N ++HRDLK NLLV+ + +K+ DFGL+ +NA ++T
Sbjct: 117 GLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT---EYVA 171
Query: 542 PQWM-APEVLRSEPSNEKS-DVFSFGVILWEL 571
+W APE++ S S K+ DV+S G IL EL
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 385 EIGLGSYAVVY--RGIWNGSD-VAVKVYFGSEYIEGTLKNYQKEIDIIKKLR---HPNVL 438
EIG G+Y V+ R + NG VA+K EG + +E+ +++ L HPNV+
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 439 -LFMGAVAS----QERLGIVTEFLPRG---SLFKTLHKNYQALDIKRRLRMALDVARGMN 490
LF S + +L +V E + + L K IK M + RG++
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD---MMFQLLRGLD 124
Query: 491 YLH-HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEV 549
+LH HR +VHRDLK N+LV + +K+ DFGL+ + + S T + APEV
Sbjct: 125 FLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-SVVVTLWYRAPEV 180
Query: 550 LRSEPSNEKSDVFSFGVILWEL 571
L D++S G I E+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 1e-09
Identities = 54/194 (27%), Positives = 97/194 (50%), Gaps = 44/194 (22%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQ--ERLGIVTEFLPRGSLFKTLHKNYQA---------L 473
E++++++L+H N++ ++ ++ ++L I+ EF G L + + K Y+ +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 474 DIKRRLRMALDVARGMNYLHH-RNPP----IVHRDLKSSNLLVDKNW------------- 515
DI R+L AL Y H+ ++ P ++HRDLK N+ +
Sbjct: 122 DITRQLLHAL------AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175
Query: 516 ----TVKVGDFGLSSLKNATYLT-AKSGRGTPQWMAPEVLRSEPS--NEKSDVFSFGVIL 568
K+GDFGLS KN + A S GTP + +PE+L E ++KSD+++ G I+
Sbjct: 176 NGRPIAKIGDFGLS--KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233
Query: 569 WELVTASIPWNNLN 582
+EL + P++ N
Sbjct: 234 YELCSGKTPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 54/239 (22%), Positives = 100/239 (41%), Gaps = 49/239 (20%)
Query: 379 DLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGT-LKNYQKEIDIIKKLRHP 435
+ + +G G V+ R G A+KV E I+ +K E +I+ L HP
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR-------- 487
+ + ++ L +V ++ P G LF+ L + + ++ +VAR
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQR-------QPGKCLSEEVARFYAAEVLL 114
Query: 488 GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN-ATYLTAKSGR------- 539
+ YLH IV+RDLK N+L+ ++ + + DF LS + +K+ R
Sbjct: 115 ALEYLH--LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 540 ---------------------GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIP 577
GT +++APEV+ + D ++ G++L+E++ + P
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 49/167 (29%), Positives = 86/167 (51%), Gaps = 20/167 (11%)
Query: 420 KNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLP--RGSLFKTLHKN-----YQA 472
K +EIDI+K + H ++ + A + + +V +P + LF + ++ QA
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRSGPLPLEQA 187
Query: 473 LDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNAT 531
+ I+RRL AL YLH R I+HRD+K+ N+ +D+ +GDFG + L
Sbjct: 188 ITIQRRLLEAL------AYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239
Query: 532 YLTAKSG-RGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIP 577
G GT + +PE+L +P K+D++S G++L+E+ ++
Sbjct: 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 41/156 (26%), Positives = 76/156 (48%), Gaps = 6/156 (3%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL-FKTLHKNYQALDIKRRLRMAL 483
E I++K+ V+ A +++ L +V + G L F + D +R + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 484 DVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTP 542
++ G+ LH IV+RDLK N+L+D +++ D GL+ + T + GT
Sbjct: 110 EITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--TIRGRVGTV 165
Query: 543 QWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578
+MAPEV+++E D + G +++E++ P+
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|232884 TIGR00229, sensory_box, PAS domain S-box | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 4e-09
Identities = 29/109 (26%), Positives = 53/109 (48%), Gaps = 6/109 (5%)
Query: 59 YRSVLESMGHAVHVCTASSED-IIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHK 117
YR++ ES A+ E I+Y N + E ++G+ E+ G+ V E LI EE +
Sbjct: 5 YRAIFESSPDAI--IVIDLEGNILYVNPAFEEIFGYSAEELIGRNVLE-LIPEEDREEVR 61
Query: 118 KIMERLASGQS--WSGQFPFKKRSGEILMAVVTKSPLYEDGELAGFITV 164
+ +ER G+ S + +++ G + V+ SP+ +G G + +
Sbjct: 62 ERIERRLEGEREPVSEERRVRRKDGSEIWVEVSVSPIRTNGGELGVVGI 110
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator [Regulatory functions, Small molecule interactions]. Length = 124 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 47/190 (24%), Positives = 86/190 (45%), Gaps = 44/190 (23%)
Query: 424 KEIDIIKKLRHPNVLLFMGAVASQERLG------IVTEFLPRGSLFKTLHKNYQALDIKR 477
+E+ ++K + H NV+ + L +VT + L+ I +
Sbjct: 63 RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-----DLNN------IVK 111
Query: 478 RLRMALD--------VARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529
+++ D + RG+ Y+H I+HRDLK SN+ V+++ +K+ DFGL+ +
Sbjct: 112 CQKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTD 169
Query: 530 A---TYLTAKSGRGTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELVT------ASIPWN 579
Y+ T + APE++ + N+ D++S G I+ EL+T S +
Sbjct: 170 DEMTGYV------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID 223
Query: 580 NLN-LMQVVG 588
L +M +VG
Sbjct: 224 QLKRIMNLVG 233
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 45/181 (24%), Positives = 85/181 (46%), Gaps = 26/181 (14%)
Query: 423 QKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMA 482
Q E+ + K HPN++ + + L +VT F+ GS + ++ +D L +A
Sbjct: 47 QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF--MDGMSELAIA 104
Query: 483 ---LDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539
V + ++Y+HH VHR +K+S++L+ + G LS L++ + R
Sbjct: 105 YILQGVLKALDYIHHMG--YVHRSVKASHILISVD-----GKVYLSGLRSNLSMINHGQR 157
Query: 540 GT-----PQ-------WMAPEVLRS--EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQ 585
P+ W++PEVL+ + + KSD++S G+ EL +P+ ++ Q
Sbjct: 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217
Query: 586 V 586
+
Sbjct: 218 M 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 53/240 (22%), Positives = 112/240 (46%), Gaps = 38/240 (15%)
Query: 384 EEIGLGSYAVVYRGI---------WNGSDVAVKVYFGSEYIEGTLKNYQKEI----DIIK 430
E +G G++ +++GI + ++V +KV ++ + +NY + ++
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKV------LDKSHRNYSESFFEAASMMS 54
Query: 431 KLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMN 490
+L H +++L G + +V E++ GSL L KN ++I +L +A +A ++
Sbjct: 55 QLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALH 114
Query: 491 YLHHRNPPIVHRDLKSSNLLV-----DKNWT---VKVGDFGLSSLKNATYLTAKSGRGTP 542
+L + + H ++ + N+L+ K +K+ D G+S T L +
Sbjct: 115 FLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS----ITVLPKEILLERI 168
Query: 543 QWMAPEVLRSEPS-NEKSDVFSFGVILWELVTA-SIPWNNLNLMQVVGVVGFMDRRLELP 600
W+ PE + + + + +D +SFG LWE+ + P + L+ + + F + R +LP
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFYEDRHQLP 225
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 4/155 (2%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL-FKTLHKNYQALDIKRRLRMAL 483
E I++K+ V+ A +++ L +V + G L F + + +R L A
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 484 DVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQ 543
++ G+ LH N V+RDLK N+L+D +++ D GL ++K + + GT
Sbjct: 110 EILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGL-AVKIPEGESIRGRVGTVG 166
Query: 544 WMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578
+MAPEVL ++ D + G +++E++ P+
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 56/239 (23%), Positives = 113/239 (47%), Gaps = 25/239 (10%)
Query: 378 EDLQLGEEIGLGSYA-VVYRGIWNGSDV-AVKVYFGSEYIE-GTLKNYQKEIDIIKKLRH 434
ED ++ + IG G++ V + N V A+K+ E ++ +++E D++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQAL--DIKR----RLRMALDVARG 488
+ A + L +V ++ G L L K L D+ R + +A+D
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 489 MNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFG--LSSLKNATYLTAKSGRGTPQWMA 546
++Y VHRD+K N+L+D N +++ DFG L +++ T + + GTP +++
Sbjct: 121 LHY--------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYIS 171
Query: 547 PEVLRSEPSNE-----KSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELP 600
PE+L++ + + D +S GV ++E++ P+ +L++ G + R + P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 26/172 (15%)
Query: 429 IKKLRHP-----------NVLLFMGAVASQERLGIVTEFLPRGSL--FKTLHKNYQALDI 475
IKKL P L+ M V + + ++ F P+ SL F+ ++ + +D
Sbjct: 47 IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA 106
Query: 476 K--RRLRMALDVARGMNYL---------HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524
+ ++M LD R M+YL H + I+HRDLK SN++V + T+K+ DFGL
Sbjct: 107 NLCQVIQMELDHER-MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165
Query: 525 SSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASI 576
+ +++ T + APEV+ E D++S G I+ E+V I
Sbjct: 166 ARTAGTSFMMTPY-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 32/98 (32%), Positives = 60/98 (61%), Gaps = 5/98 (5%)
Query: 482 ALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGT 541
A ++ G+ ++H+R +V+RDLK +N+L+D++ V++ D GL+ + + + GT
Sbjct: 103 AAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGT 158
Query: 542 PQWMAPEVLRSEPSNEKS-DVFSFGVILWELVTASIPW 578
+MAPEVL+ + + S D FS G +L++L+ P+
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 59/209 (28%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 384 EEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
E+IG G+Y VY R G VA+K EG +EI +++ L ++ +
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 442 GAVASQER------LGIVTEFLPRGSLFKTLHKNYQA----LDIKRRLRMALDVARGMNY 491
V E L +V E+L L K + N + L K + +G+ +
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 492 LHHRNPPIVHRDLKSSNLLVDKNWTV-KVGDFGLSS-----LKNATYLTAKSGRGTPQWM 545
H ++HRDLK NLLVDK + K+ D GL +K+ T+ T +
Sbjct: 126 CHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-----TLWYR 178
Query: 546 APEVLR-SEPSNEKSDVFSFGVILWELVT 573
APEVL S + D++S G I E+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 58/238 (24%), Positives = 94/238 (39%), Gaps = 64/238 (26%)
Query: 386 IGLGSYAVV--YRGIWNGSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMG 442
IG G++ V + G A+K SE +E + + + E DI+ + +P V+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYY 68
Query: 443 AVASQERLGIVTEFLPRGSLFKTLHKN----------YQALDIKRRLRMALDVARGMNYL 492
+ + L ++ E+LP G + L K Y A I +A+D + Y
Sbjct: 69 SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI-----LAIDSIHKLGY- 122
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS--------------------------- 525
+HRD+K NLL+D +K+ DFGL
Sbjct: 123 -------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 526 -----------SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELV 572
+ K A S GTP ++APEV N++ D +S GVI++E++
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 39/146 (26%), Positives = 80/146 (54%), Gaps = 8/146 (5%)
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRM-ALDVARGMNYLH 493
P ++ A + ++L + + + G L H + + ++ +R A ++ G+ ++H
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLH--YHLSQHGVFSEKEMRFYATEIILGLEHMH 114
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSE 553
+R +V+RDLK +N+L+D++ V++ D GL+ + + + GT +MAPEVL+
Sbjct: 115 NRF--VVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKG 170
Query: 554 PSNEKS-DVFSFGVILWELVTASIPW 578
+ + S D FS G +L++L+ P+
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 40/156 (25%), Positives = 83/156 (53%), Gaps = 14/156 (8%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD 484
EI + KL+HPN++ +G S++ ++ E++ +L + L + L +RR ++A+
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIG 788
Query: 485 VARGMNYLH-HRNPPIVHRDLKSSNLLVDKNWT--VKVGDFGLSSLKNATYLTAKSGRGT 541
+A+ + +LH +P +V +L +++D +++ GL ++++
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA----- 843
Query: 542 PQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIP 577
++APE ++ EKSD++ FG+IL EL+T P
Sbjct: 844 --YVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 45/164 (27%), Positives = 71/164 (43%), Gaps = 38/164 (23%)
Query: 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNL 509
L ++ EFLP G + L K + + + +A + ++ +H +HRD+K NL
Sbjct: 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLG--FIHRDIKPDNL 132
Query: 510 LVDKNWTVKVGDFGL-SSLKNA-----------------TYLTAKSGR------------ 539
L+D VK+ DFGL + LK A T+ S R
Sbjct: 133 LLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQL 192
Query: 540 -----GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578
GTP ++APEV N+ D +S GVI++E++ P+
Sbjct: 193 AFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 47/207 (22%), Positives = 94/207 (45%), Gaps = 38/207 (18%)
Query: 386 IGLGSYAVVYRG--IWNGSDVAVK----VYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVL 438
IG G+++ V + G A+K + E + N +EI +++L HPN+L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-----NNLREIQALRRLSPHPNIL 61
Query: 439 LFMGAVASQE--RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRN 496
+ + ++ RL +V E L +L++ + + L KR + + ++++H
Sbjct: 62 RLIEVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 497 PPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP--------QWM-AP 547
I HRD+K N+L+ + +K+ DFG + + P +W AP
Sbjct: 121 --IFHRDIKPENILIKDD-ILKLADFG----------SCRGIYSKPPYTEYISTRWYRAP 167
Query: 548 EVLRSEPS-NEKSDVFSFGVILWELVT 573
E L ++ K D+++ G + +E+++
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 33/108 (30%), Positives = 59/108 (54%), Gaps = 8/108 (7%)
Query: 500 VHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKS--GRGTPQWMAPEVLRSEPS-- 555
VHRD+K N+L+D N +++ DFG S LK T +S GTP +++PE+L++
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 556 ---NEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELP 600
+ D +S GV ++E++ P+ +L++ G + + R + P
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 47/163 (28%), Positives = 85/163 (52%), Gaps = 17/163 (10%)
Query: 420 KNYQKEIDIIKKLRHPNVL----LFMGAVASQE--RLGIVTEFLPRGSLFKTLHKNYQAL 473
K +E+ ++K ++H NV+ +F A + +E + +VT + G+ + K +
Sbjct: 61 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLT 118
Query: 474 DIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533
D + + + RG+ Y+H + I+HRDLK SNL V+++ +K+ DFGL+ +
Sbjct: 119 DDHVQF-LIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 171
Query: 534 TAKSGRGTPQWM-APEV-LRSEPSNEKSDVFSFGVILWELVTA 574
+G +W APE+ L N+ D++S G I+ EL+T
Sbjct: 172 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 386 IGLGSYAVVYRGI--WNGSDVAVKVY---FGSEYIEGTLKNYQKEIDIIKKLRHPNVLLF 440
+G G+Y V I G VA+K F SE K +E+ ++K ++H NV+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFA---KRAYRELTLLKHMQHENVIGL 79
Query: 441 MGAVASQERLGIVTEF---LP--RGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495
+ S +F +P + L K + ++ + L G+ Y+H
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQML---CGLKYIHSA 136
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWM-APEVLRS-E 553
I+HRDLK NL V+++ +K+ DFGL+ +A +G +W APEV+ +
Sbjct: 137 G--IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVILNWM 190
Query: 554 PSNEKSDVFSFGVILWELVT 573
N+ D++S G I+ E++T
Sbjct: 191 HYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 42/197 (21%), Positives = 78/197 (39%), Gaps = 46/197 (23%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD 484
E DI+ + + V+ + ++ L V +++P G + L + + R +A +
Sbjct: 51 ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-E 109
Query: 485 VARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS------------------ 526
+ + +H +HRD+K N+L+D++ +K+ DFGL +
Sbjct: 110 LTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167
Query: 527 -------------------------LKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDV 561
+ A S GTP ++APEVL + D
Sbjct: 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227
Query: 562 FSFGVILWELVTASIPW 578
+S GVIL+E++ P+
Sbjct: 228 WSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 32/108 (29%), Positives = 58/108 (53%), Gaps = 8/108 (7%)
Query: 500 VHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKS--GRGTPQWMAPEVLRSEPSNE 557
VHRD+K N+L+DKN +++ DFG S L+ T +S GTP +++PE+L++ +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 558 KS-----DVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELP 600
D +S GV ++E++ P+ +L++ G + + P
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP 230
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 39/214 (18%)
Query: 401 GSDVAVKVYFGSEYIEG-TLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPR 459
G A+K+ ++ +E + + + E DI+ + V+ + + L ++ EFLP
Sbjct: 26 GHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85
Query: 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKV 519
G + L K + + +A + ++ +H +HRD+K NLL+D VK+
Sbjct: 86 GDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKL 142
Query: 520 GDFGL-SSLKNA-----------------TYLTAKSGR-----------------GTPQW 544
DFGL + LK A ++ S R GTP +
Sbjct: 143 SDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDY 202
Query: 545 MAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578
+APEV N+ D +S GVI++E++ P+
Sbjct: 203 IAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 4/155 (2%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL-FKTLHKNYQALDIKRRLRMAL 483
E I++K+ V+ A +++ L +V + G L F + D +R + A
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 484 DVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQ 543
++ G+ L IV+RDLK N+L+D +++ D GL +++ T + GT
Sbjct: 110 ELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGL-AVQIPEGETVRGRVGTVG 166
Query: 544 WMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578
+MAPEV+ +E D + G +++E++ P+
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 47/160 (29%), Positives = 80/160 (50%), Gaps = 15/160 (9%)
Query: 425 EIDIIKKLRHPNVL--LFMGAVASQERLGIVTEFLP--RGSLFKTLHKNYQALDIKRRLR 480
E ++++L HP VL L + V G+ LP R L+ L + L + +
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVG-----GLTCLVLPKYRSDLYTYLGARLRPLGLAQVTA 264
Query: 481 MALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT-AKSG- 538
+A + ++Y+H I+HRD+K+ N+LV+ + +GDFG + ++ T G
Sbjct: 265 VARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322
Query: 539 RGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELV--TASI 576
GT APEVL +P D++S G++++E TAS+
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362
|
Length = 461 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 50/180 (27%), Positives = 92/180 (51%), Gaps = 24/180 (13%)
Query: 424 KEIDIIKKLRHPNVL----LFMGAVASQE--RLGIVTEFLPRGSLFKTLHKNYQALDIKR 477
+E+ ++K ++H NV+ +F A + + + +VT + G+ + K Q L +
Sbjct: 63 RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVK-CQKLSDEH 119
Query: 478 RLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKS 537
+ + RG+ Y+H + I+HRDLK SN+ V+++ +++ DFGL+ + +
Sbjct: 120 VQFLIYQLLRGLKYIH--SAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD----DEMT 173
Query: 538 GRGTPQWM-APEV-LRSEPSNEKSDVFSFGVILWELV--TASIPWNNL-----NLMQVVG 588
G +W APE+ L N+ D++S G I+ EL+ A P N+ +M+VVG
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVG 233
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 68/231 (29%)
Query: 385 EIGLGSYAVVYRGIW----NGSDVAVKVYFGSEYIEGTLKNYQ-------KEIDIIKKLR 433
IG G+Y VY+ +G + A+K +G + Y +EI ++++L+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKK------FKGDKEQYTGISQSACREIALLRELK 60
Query: 434 HPNV----------------LLFMGAVASQERLGIVT-------EFLPRGSLFKTLHKNY 470
H NV LLF A + I+ +P + K+L +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLF--DYAEHDLWQIIKFHRQAKRVSIPPSMV-KSL--LW 115
Query: 471 QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV----DKNWTVKVGDFGLSS 526
Q L+ G++YLH ++HRDLK +N+LV + VK+GD GL+
Sbjct: 116 QILN-------------GVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
Query: 527 LKNATYLTAKSGRG---TPQWMAPEVLRSEPSNEKS-DVFSFGVILWELVT 573
L NA T + APE+L K+ D+++ G I EL+T
Sbjct: 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 381 QLGEEIGLGSYAVVYRGIWN--GSDVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRHPNV 437
++ E IG GSY VV I G VA+K + E++ + +EI +++ LRHP++
Sbjct: 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDI 61
Query: 438 LLFMGAVASQER-----LGIVTEFLPRGSLFKTLHKNYQALD--IKRRLRMAL-DVARGM 489
+ + R + +V E + LH+ +A D + L + R +
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELME-----SDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL---SSLKNATYLTAKSGRGTPQWMA 546
Y+H N + HRDLK N+L + + +K+ DFGL + T + T + A
Sbjct: 117 KYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 547 PEVLRSEPSNEKS--DVFSFGVILWELVT 573
PE+ S S D++S G I E++T
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 57/249 (22%), Positives = 99/249 (39%), Gaps = 65/249 (26%)
Query: 378 EDLQLGEEIGLGSYAVV--YRGIWNGSDVAVKVYFGSE-YIEGTLKNYQKEIDIIKKLRH 434
ED + IG G++ V + G A+K SE + + L + + E D++ +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQAL--DIKR----RLRMALDVARG 488
P V+ + + L ++ EFLP G L T+ Y D+ R +A++
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLM-TMLIKYDTFSEDVTRFYMAECVLAIEAVHK 119
Query: 489 MNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS-----LKNATY----------- 532
+ + +HRD+K N+L+D+ +K+ DFGLS+ +A Y
Sbjct: 120 LGF--------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN 171
Query: 533 -------------------------------LTAKSGRGTPQWMAPEVLRSEPSNEKSDV 561
L A S GTP ++APE+ + ++ D
Sbjct: 172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231
Query: 562 FSFGVILWE 570
+S G I++E
Sbjct: 232 WSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 6/154 (3%)
Query: 378 EDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTL-KNYQKEIDIIKKLRH 434
E+ + + I G++ VY R N AVKV ++ I + Q E D + +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
P ++ ++ S + +V E+L G + LH Y D + ++ +VA ++YLH
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHR 122
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528
I+HRDLK N+L+ +K+ DFGLS +
Sbjct: 123 HG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|238075 cd00130, PAS, PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-06
Identities = 23/91 (25%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 79 DIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMER-LASGQSWSGQFPFKK 137
I+Y N +AE L G+ E+ G+ + + I E ++ +E L+ G+ + + ++
Sbjct: 13 RILYANPAAEQLLGYSPEELIGKSLLDL-IHPEDREELRERLENLLSGGEPVTLEVRLRR 71
Query: 138 RSGEILMAVVTKSPLY-EDGELAGFITVSSD 167
+ G ++ +V+ +P+ E GE+ G + V D
Sbjct: 72 KDGSVIWVLVSLTPIRDEGGEVIGLLGVVRD 102
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. Length = 103 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 31/123 (25%), Positives = 57/123 (46%), Gaps = 8/123 (6%)
Query: 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV 511
++ +++ G LF L K L ++ + +N LH N I+H D+K N+L
Sbjct: 86 LIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLY 142
Query: 512 D-KNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWE 570
D + + D+GL + T GT + +PE ++ + D ++ GV+ +E
Sbjct: 143 DRAKDRIYLCDYGLCKIIG----TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYE 198
Query: 571 LVT 573
L+T
Sbjct: 199 LLT 201
|
Length = 267 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 59/242 (24%), Positives = 110/242 (45%), Gaps = 36/242 (14%)
Query: 383 GEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQ--KEIDIIKKLRHPNVLLF 440
G ++G G+Y VY+ D + + + IEGT + +EI ++++L+HPNV+
Sbjct: 6 GCKVGRGTYGHVYKA--KRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIAL 63
Query: 441 MGAVASQ--ERLGIVTEFLPRG-----SLFKTLHKNYQALDIKRRLRMAL--DVARGMNY 491
S ++ ++ ++ + N + + + R + +L + G++Y
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 492 LHHRNPPIVHRDLKSSNLLV----DKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWM 545
LH ++HRDLK +N+LV + VK+ D G + L N+ L W
Sbjct: 124 LHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 546 -APEVLRSEPSNEKS-DVFSFGVILWELVTA-------------SIPWNNLNLMQVVGVV 590
APE+L K+ D+++ G I EL+T+ S P+++ L ++ V+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241
Query: 591 GF 592
GF
Sbjct: 242 GF 243
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|225112 COG2202, AtoS, FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 48.3 bits (113), Expect = 3e-06
Identities = 25/112 (22%), Positives = 57/112 (50%), Gaps = 4/112 (3%)
Query: 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKK 118
R++LE+ + I+Y N +AE L G+ E G+ +++ + E+ +
Sbjct: 114 LRALLEASPDGI-WVLDEDGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERRELE 172
Query: 119 IMERLASGQ--SWSGQFPFKKRSGEILMAVVTK-SPLYEDGELAGFITVSSD 167
+ LA G+ ++ +++ GE + ++++ SP+ +DGE+ G + ++ D
Sbjct: 173 LARALAEGRGGPLEIEYRVRRKDGERVRWILSRISPVRDDGEIVGVVGIARD 224
|
Length = 232 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 53/219 (24%), Positives = 96/219 (43%), Gaps = 48/219 (21%)
Query: 384 EEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN------- 436
E +G G+ +Y GI N Y + +G +Y+KEI +I K+ P+
Sbjct: 1 EHLGRGTRTQIYAGILN--------YKDDDEDDGY--SYEKEIKVILKVLDPSHRDISLA 50
Query: 437 ----------------VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLR 480
VLL+ V E + +V EF+ G L +H+ L + +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENI-MVEEFVEFGPLDLFMHRKSDVLTTPWKFK 109
Query: 481 MALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT-------VKVGDFGLSSLKNATYL 533
+A +A ++YL ++ +VH ++ + N+L+ + +K+ D G+ T L
Sbjct: 110 VAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP----ITVL 163
Query: 534 TAKSGRGTPQWMAPEVLR-SEPSNEKSDVFSFGVILWEL 571
+ + W+APE + S+ + +D +SFG LWE+
Sbjct: 164 SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 59/242 (24%), Positives = 109/242 (45%), Gaps = 36/242 (14%)
Query: 383 GEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQ--KEIDIIKKLRHPNVLLF 440
G ++G G+Y VY+ D + + IEGT + +EI ++++L+HPNV+
Sbjct: 6 GCKVGRGTYGHVYKA--KRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISL 63
Query: 441 MGAVASQ--ERLGIVTEFLPRG-----SLFKTLHKNYQALDIKRRLRMAL--DVARGMNY 491
S ++ ++ ++ + N + + + R + +L + G++Y
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 492 LHHRNPPIVHRDLKSSNLLV----DKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWM 545
LH ++HRDLK +N+LV + VK+ D G + L N+ L W
Sbjct: 124 LHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 546 -APEVLRSEPSNEKS-DVFSFGVILWELVTA-------------SIPWNNLNLMQVVGVV 590
APE+L K+ D+++ G I EL+T+ S P+++ L ++ V+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241
Query: 591 GF 592
GF
Sbjct: 242 GF 243
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|219845 pfam08448, PAS_4, PAS fold | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-05
Identities = 26/109 (23%), Positives = 43/109 (39%), Gaps = 9/109 (8%)
Query: 63 LESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFL---IAEEFHSPHKKI 119
L+S+ A+ V + Y N +A L+G E+ G+ + E L A
Sbjct: 1 LDSLPDALAVLDPDG-RVRYANAAAAELFGLPPEELLGKTLAELLPPEDAARLERA---- 55
Query: 120 MERLASGQSWSGQFPFKKRSGEILMAVVTKSPLY-EDGELAGFITVSSD 167
+ R G+ +GE + +PL DGE+ G + +S D
Sbjct: 56 LRRALEGEEPIDFLEELLLNGEERHYELRLTPLRDPDGEVIGVLVISRD 104
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 110 |
| >gnl|CDD|214512 smart00091, PAS, PAS domain | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-05
Identities = 19/65 (29%), Positives = 33/65 (50%), Gaps = 2/65 (3%)
Query: 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKK 118
R++LES+ + V I+Y N +AE L G+ E+ G+ + E I E ++
Sbjct: 3 LRAILESLPDGIFVLDLDGR-ILYANPAAEELLGYSPEELIGKSLLEL-IHPEDRERVQE 60
Query: 119 IMERL 123
++RL
Sbjct: 61 ALQRL 65
|
PAS motifs appear in archaea, eubacteria and eukarya. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. Length = 67 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 26/101 (25%), Positives = 46/101 (45%), Gaps = 15/101 (14%)
Query: 482 ALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGT 541
L + LH + KS N+L+ W + G + + T + R
Sbjct: 23 CLQCLGALRELHRQA--------KSGNILL--TWDGLLKLDG-----SVAFKTPEQSRPD 67
Query: 542 PQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582
P +MAPEV++ + EK+D++S G+ L+E + +P+N
Sbjct: 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 44/203 (21%), Positives = 82/203 (40%), Gaps = 50/203 (24%)
Query: 423 QKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMA 482
+ E DI+ + + V+ + ++ L V +++P G + L + ++ R +A
Sbjct: 49 KAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA 108
Query: 483 LDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS----LKNATYLT---- 534
++ + +H +HRD+K N+L+D + +K+ DFGL + N+ Y
Sbjct: 109 -ELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSH 165
Query: 535 ---------------------------------------AKSGRGTPQWMAPEVLRSEPS 555
A S GTP ++APEVL +
Sbjct: 166 IRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY 225
Query: 556 NEKSDVFSFGVILWELVTASIPW 578
+ D +S GVIL+E++ P+
Sbjct: 226 TQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 31/126 (24%), Positives = 50/126 (39%), Gaps = 47/126 (37%)
Query: 500 VHRDLKSSNLLVDKNWTVKVGDFGLSS--------------------------------- 526
+HRD+K N+L+D++ +K+ DFGL +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 527 ------LKNATYLTAKSGR--------GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELV 572
LK A+ + GTP ++APEVL + D +S GVIL+E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 573 TASIPW 578
P+
Sbjct: 243 VGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.003
Identities = 36/161 (22%), Positives = 75/161 (46%), Gaps = 18/161 (11%)
Query: 423 QKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE--------FLPRGSL-FKTLHKNYQAL 473
+ EI + +L H N+L + S+ ++T+ F+ + +K Q
Sbjct: 211 ENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR 270
Query: 474 DIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFG-LSSLKNATY 532
I ++L A++ Y+H + ++HRD+K N+ ++ + + +GDFG +
Sbjct: 271 AIMKQLLCAVE------YIHDKK--LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322
Query: 533 LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
GT +PE+L + E +D++S G+IL ++++
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|221967 pfam13188, PAS_8, PAS domain | Back alignment and domain information |
|---|
Score = 35.6 bits (82), Expect = 0.004
Identities = 11/55 (20%), Positives = 22/55 (40%), Gaps = 2/55 (3%)
Query: 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFH 113
R++ E+ + V + I+Y N +A L G++ + + L A
Sbjct: 3 LRALFENAPDGILVLDG--DRILYANPAALELLGYELLGELLGELLDDLEALAEE 55
|
Length = 64 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.004
Identities = 37/164 (22%), Positives = 61/164 (37%), Gaps = 44/164 (26%)
Query: 383 GEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQ-KEIDI-IKKLRH------ 434
+ I G+ A +Y G + G +K K Y+ E+D I++ R
Sbjct: 1 MKLIKRGAEAEIYLGDFLGIKAVIKWRIP--------KRYRHPELDERIRRERTRREARI 52
Query: 435 -----------PNVLLFMGAVASQERLGIVTEFLPRGSLFKTL--HKNYQALDIKRRLRM 481
P V E IV E++ G K L + L++ R +
Sbjct: 53 MSRARKAGVNVPAVYFV-----DPENFIIVMEYIE-GEPLKDLINSNGMEELELSRE--I 104
Query: 482 ALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525
V + LH I+H DL +SN+++ + + DFGL+
Sbjct: 105 GRLVGK----LHSAG--IIHGDLTTSNMILSGG-KIYLIDFGLA 141
|
Length = 211 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 605 | |||
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.98 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.98 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.98 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| COG3829 | 560 | RocR Transcriptional regulator containing PAS, AAA | 99.88 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PRK10820 | 520 | DNA-binding transcriptional regulator TyrR; Provis | 99.7 | |
| PF13426 | 104 | PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_ | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.59 | |
| PF00989 | 113 | PAS: PAS fold; InterPro: IPR013767 PAS domains are | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| PRK11388 | 638 | DNA-binding transcriptional regulator DhaR; Provis | 99.55 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.49 | |
| PF08448 | 110 | PAS_4: PAS fold; InterPro: IPR013656 The PAS fold | 99.48 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.4 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| COG3283 | 511 | TyrR Transcriptional regulator of aromatic amino a | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.35 | |
| PRK11091 | 779 | aerobic respiration control sensor protein ArcB; P | 99.33 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.31 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.29 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| PRK13557 | 540 | histidine kinase; Provisional | 99.2 | |
| PRK13559 | 361 | hypothetical protein; Provisional | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.12 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| PF13596 | 106 | PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D. | 99.08 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 98.99 | |
| PRK13558 | 665 | bacterio-opsin activator; Provisional | 98.99 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.99 | |
| PRK10060 | 663 | RNase II stability modulator; Provisional | 98.96 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 98.94 | |
| TIGR00229 | 124 | sensory_box PAS domain S-box. The PAS domain was p | 98.9 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 98.88 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 98.85 | |
| PF08447 | 91 | PAS_3: PAS fold; InterPro: IPR013655 The PAS fold | 98.85 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.84 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 98.83 | |
| COG5002 | 459 | VicK Signal transduction histidine kinase [Signal | 98.83 | |
| cd00130 | 103 | PAS PAS domain; PAS motifs appear in archaea, euba | 98.8 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.73 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.71 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.7 | |
| PRK11073 | 348 | glnL nitrogen regulation protein NR(II); Provision | 98.65 | |
| TIGR02966 | 333 | phoR_proteo phosphate regulon sensor kinase PhoR. | 98.64 | |
| COG3604 | 550 | FhlA Transcriptional regulator containing GAF, AAA | 98.63 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 98.62 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.57 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.51 | |
| PRK11360 | 607 | sensory histidine kinase AtoS; Provisional | 98.51 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.5 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 98.47 | |
| COG2204 | 464 | AtoC Response regulator containing CheY-like recei | 98.45 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 98.43 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.39 | |
| PF12860 | 115 | PAS_7: PAS fold | 98.38 | |
| PF14598 | 111 | PAS_11: PAS domain; PDB: 1P97_A 3F1O_A 2A24_A 3H7W | 98.37 | |
| PF00158 | 168 | Sigma54_activat: Sigma-54 interaction domain; Inte | 98.31 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.31 | |
| COG3290 | 537 | CitA Signal transduction histidine kinase regulati | 98.31 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.31 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.3 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.29 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.28 | |
| PRK11006 | 430 | phoR phosphate regulon sensor protein; Provisional | 98.28 | |
| PRK11086 | 542 | sensory histidine kinase DcuS; Provisional | 98.22 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.13 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.1 |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-54 Score=411.81 Aligned_cols=310 Identities=24% Similarity=0.367 Sum_probs=254.2
Q ss_pred hhhhhhhcccCCCcccccc----cceeccccccCCCCCCccCCC--CCCCCCCCCCCCCCCC--CCC-----CCCCCC--
Q 038211 291 NANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTGHREL--LPGHDVNELDPDGKQY--PSL-----GESSRS-- 355 (605)
Q Consensus 291 ~~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~~~~~--~~~~~~~~~~~~~~~~--~s~-----~~s~~~-- 355 (605)
||+|.+|.+++||+|+|+| |+++||++||..++..|+.+. .+..++.+.+.+..-. ++. .....+
T Consensus 141 r~~c~ic~d~iwglgrqgyrcinckl~vhkkch~~v~~~cg~~~~~~~~~p~~p~~~s~~~~~~~s~~t~~~~~i~~~~~ 220 (593)
T KOG0695|consen 141 RAYCGICSDRIWGLGRQGYRCINCKLLVHKKCHGLVPLTCGKHMDSVMPSPEPPVDDSNEDADLPSEETDGIAYISSSRK 220 (593)
T ss_pred ceeeeechhhhhhcccccceeecceeehhhhhcccccchhhhhccCCCCCCCCCCCCccccCCCCchhcCcccccCcccc
Confidence 7999999999999999999 999999999999999997764 4444444444433211 110 000000
Q ss_pred CCCC--CC-----CCCCCCcccCCCCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccch-hhhhhHHHH
Q 038211 356 RESS--SS-----KGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE-GTLKNYQKE 425 (605)
Q Consensus 356 ~~~~--~~-----~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~-~~~~~~~~E 425 (605)
..+. .+ ..+........+.+...+|.++++||+|+|++|.+++++ .+.||+|++++..+.+ .....++.|
T Consensus 221 he~~~~~~~~~~~a~~~m~g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqte 300 (593)
T KOG0695|consen 221 HESIKDDSEDLKPAIDGMDGIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTE 300 (593)
T ss_pred chhhhcCccchhhhhhhccccccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhh
Confidence 0000 00 001111223345678899999999999999999999875 4459999998876543 456677888
Q ss_pred HHHHHhC-CCCCeeeEEEEEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccC
Q 038211 426 IDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDL 504 (605)
Q Consensus 426 ~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Di 504 (605)
..+.... +||++|.++.+|++++++++|.||++||+|+.+++++ .+++++.++.|..+|+.||.|||+.| ||+|||
T Consensus 301 k~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rg--iiyrdl 377 (593)
T KOG0695|consen 301 KHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERG--IIYRDL 377 (593)
T ss_pred HHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeec
Confidence 8888877 7999999999999999999999999999999999987 78899999999999999999999999 999999
Q ss_pred CCCCEEEcCCCcEEEEeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCC-----
Q 038211 505 KSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWN----- 579 (605)
Q Consensus 505 k~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~----- 579 (605)
|.+|+|+|.+|++||.|||+++..-.+..+++++||||.|+|||+++|..|.+.+|||+|||+|+||+.|+.||+
T Consensus 378 kldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~ 457 (593)
T KOG0695|consen 378 KLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD 457 (593)
T ss_pred cccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC
Confidence 999999999999999999999998888889999999999999999999999999999999999999999999996
Q ss_pred --CCCHHHHHHHhccCCCccCCCCCCC
Q 038211 580 --NLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 580 --~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
+.+.+..+..|- ...++.||..+|
T Consensus 458 n~d~ntedylfqvi-lekqiriprsls 483 (593)
T KOG0695|consen 458 NPDMNTEDYLFQVI-LEKQIRIPRSLS 483 (593)
T ss_pred CcccchhHHHHHHH-hhhcccccceee
Confidence 345566677663 778899998775
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=425.84 Aligned_cols=308 Identities=22% Similarity=0.349 Sum_probs=244.6
Q ss_pred hhhhhhhcccCCCcccccc----cceeccccccCCCCCCccCCCCCCCCC------CCCCCCCC--CC---------CCC
Q 038211 291 NANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTGHRELLPGHDV------NELDPDGK--QY---------PSL 349 (605)
Q Consensus 291 ~~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~~~~~~~~~~~------~~~~~~~~--~~---------~s~ 349 (605)
.-||.|||+.+|++-.++. |.+++|.+|..+....|+......... .+..+... .. |..
T Consensus 241 ptFc~hCGs~L~r~~qqGlkCs~Cg~n~H~~c~~~va~~CG~s~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (694)
T KOG0694|consen 241 PTFCDHCGSVLYRLRQQGLKCSTCGRNVHNRCVENLAPNCGGSRTFSPEILEEIGTSPRAQSELKPKLPSVEKLFDPPQL 320 (694)
T ss_pred ccHHHhcchhhhhhcccCeeehhhhccccHHHHHhcccCCCCchhhhhhhhhhcccCCCCccccCCCCcchhhcccCccc
Confidence 4599999999999998888 899999999888888775531111110 00000000 00 000
Q ss_pred C----CCCCCC-----C--------C-CCCCCCCCCccc-CCCCccccCceEeeeecccCcEEEEEEEEC--CcceEEEE
Q 038211 350 G----ESSRSR-----E--------S-SSSKGDNETSCA-TDGGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKV 408 (605)
Q Consensus 350 ~----~s~~~~-----~--------~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv 408 (605)
. .++... . . ...+........ ....+..++|.++++||+|+||+|+++..+ ++.||||+
T Consensus 321 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~ 400 (694)
T KOG0694|consen 321 SPRPGPPSSPASLVSPIQESTAPEFPQPTFENSGPPEFPPRRGPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKV 400 (694)
T ss_pred cCCCCCCCCcccccCCcccccCCCCCCccccCCCcccCCCCCCcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEE
Confidence 0 000000 0 0 000000000011 113678899999999999999999999875 45699999
Q ss_pred eeccccc-hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHH
Q 038211 409 YFGSEYI-EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVA 486 (605)
Q Consensus 409 ~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~ 486 (605)
++++... .+.++..+.|.+|+... +||+++.++.+|++.+++|+||||+.||+++.+.+ ...+++..++.|+++|+
T Consensus 401 LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~ 478 (694)
T KOG0694|consen 401 LKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVV 478 (694)
T ss_pred eeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHH
Confidence 9998765 46789999999999998 59999999999999999999999999999433333 37899999999999999
Q ss_pred HHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHH
Q 038211 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGV 566 (605)
Q Consensus 487 ~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 566 (605)
.||+|||++| |||||||.+|||||.+|++||+|||+|+........+.++||||.|||||++.+..|+.++|||||||
T Consensus 479 l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGV 556 (694)
T KOG0694|consen 479 LGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGV 556 (694)
T ss_pred HHHHHHHhcC--ceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHH
Confidence 9999999999 99999999999999999999999999998876667889999999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 567 ILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 567 il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
+||||+.|+.||.+.+-.++...| ....+.+|-++|
T Consensus 557 LlyeML~Gq~PF~gddEee~FdsI--~~d~~~yP~~ls 592 (694)
T KOG0694|consen 557 LLYEMLVGESPFPGDDEEEVFDSI--VNDEVRYPRFLS 592 (694)
T ss_pred HHHHHHcCCCCCCCCCHHHHHHHH--hcCCCCCCCccc
Confidence 999999999999999999999999 666688998876
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=401.14 Aligned_cols=226 Identities=24% Similarity=0.433 Sum_probs=210.7
Q ss_pred CccccCceEeeeecccCcEEEEEEEECCcc--eEEEEeeccccch-hhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCe
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWNGSD--VAVKVYFGSEYIE-GTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQER 449 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~--~avKv~~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~ 449 (605)
.+...+|.++.+||.|+||+|.++..+|++ ||||+++++...+ +.++..+.|.++|... +-|++++++.+|++-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 577789999999999999999999887765 9999999987654 5677888999999888 67899999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+|+||||++||+|+.++++- +.+.+..+..|+.+|+.||-|||++| ||+||||.+|||+|.+|++||+|||+++..-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999999999999876 78888888999999999999999999 9999999999999999999999999999877
Q ss_pred cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
-...++.++||||.|+|||++...+|+.++||||+||+||||+.|++||++.+..++...| ++....+|..+|
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI--~ehnvsyPKslS 574 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI--MEHNVSYPKSLS 574 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--HHccCcCccccc
Confidence 7778889999999999999999999999999999999999999999999999999999999 788899999887
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=393.83 Aligned_cols=226 Identities=27% Similarity=0.484 Sum_probs=207.6
Q ss_pred CccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
.+..++|+++++||+|+||+|+.++. +++.||+|++++....+ ........|..||..++||+||.++..|++.+++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 45678999999999999999999875 57779999999887655 4678899999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
|||+||+.||.|..+|+++ +.+++..++.|+++|+.||.|||++| ||||||||+|||||..|+++|+|||+|+....
T Consensus 101 ylVld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999999987 88999999999999999999999999 99999999999999999999999999998777
Q ss_pred ccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCC-CC
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEG-LD 604 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~-~~ 604 (605)
....+.++|||+.|||||++.+..|+..+||||||+++|||++|.+||.+.+..+++.+| ...+...|+. +|
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I--~~~k~~~~p~~ls 250 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI--LKGKLPLPPGYLS 250 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH--hcCcCCCCCccCC
Confidence 777788899999999999999999999999999999999999999999999999999999 4555444444 54
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-49 Score=384.91 Aligned_cols=222 Identities=28% Similarity=0.482 Sum_probs=203.4
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
...+|.+.+.||+|+||+||+|++ ++..||||.+.+.......++.+..|+.+|+.++|||||++++++..++.+|||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 457899999999999999999987 467799999988877777888899999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC------CcEEEEeecCCcc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN------WTVKVGDFGLSSL 527 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~------~~vkl~Dfg~a~~ 527 (605)
||||+||+|.+++++. +.+++..++.++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+|+.
T Consensus 88 MEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999886 78999999999999999999999999 9999999999999764 4689999999998
Q ss_pred cCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCC
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~ 601 (605)
... .....+.||+|.|||||++....|+.|+|+||+|+++|+|++|+.||+..+..+++..|.+....++.|+
T Consensus 165 L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~ 237 (429)
T KOG0595|consen 165 LQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP 237 (429)
T ss_pred CCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh
Confidence 873 3456778999999999999999999999999999999999999999999999999999987766665443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=367.28 Aligned_cols=223 Identities=26% Similarity=0.463 Sum_probs=207.9
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
...++|+.++.||.|+||.|.+++. .|..||+|++.+..... ++.+...+|..+|+.+.||+++++++.|.+.+.++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 5678999999999999999999986 57779999998877553 66788899999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
|||||++||.|+.++++. +++++..++.|+.||+.||+|||+++ |++|||||+|||+|.+|++||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999999876 88999999999999999999999999 999999999999999999999999999876433
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
+.+.||||.|+|||++...+|..++|||||||++|||+.|.+||.+.++++++.+| ..+++.+|.-|||
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI--~~~~v~fP~~fs~ 266 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI--LEGKVKFPSYFSS 266 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH--HhCcccCCcccCH
Confidence 56779999999999999999999999999999999999999999999999999999 7888999999885
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=384.70 Aligned_cols=223 Identities=29% Similarity=0.466 Sum_probs=207.3
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.+|..++.||+|+|++||++++ .|..||+|++.+.... ....+.+.+|++|.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999987 6888999999775543 456778999999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
|+|..++|..++.+. ..++|..++.++.||+.||.|||+++ |+|||||..|+|++++.+|||+|||+|.....+...
T Consensus 98 ELC~~~sL~el~Krr-k~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR-KPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHHhc-CCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 999999999999854 89999999999999999999999999 999999999999999999999999999998877777
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
..+.||||.|+|||++....+++.+||||+||+||.||.|++||+..+..+++.+|. ...+.+|..+|+
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik--~~~Y~~P~~ls~ 243 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK--LNEYSMPSHLSA 243 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH--hcCcccccccCH
Confidence 889999999999999999999999999999999999999999999999999999995 455889988774
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=374.03 Aligned_cols=226 Identities=28% Similarity=0.481 Sum_probs=205.3
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCee
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERL 450 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~ 450 (605)
....||.+++.||.|+|++|++|+. .++.|||||+.+.... +..++-+.+|..+|.+| .||.|++++..|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 4568999999999999999999986 5777999999887654 34566778999999999 899999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
|+|+||+++|+|.++|.+. +.+++...+.|+.||+.||+|||++| ||||||||+|||||.+|+++|.|||.|+....
T Consensus 150 YFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 9999999999999999886 89999999999999999999999999 99999999999999999999999999986542
Q ss_pred ccc-------------cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCcc
Q 038211 531 TYL-------------TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRL 597 (605)
Q Consensus 531 ~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~ 597 (605)
... ...+++||..|.+||++.+...++.+|||+|||+||+|+.|.+||.+.+...+..+| +...+
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI--~~l~y 304 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI--QALDY 304 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH--HHhcc
Confidence 211 125589999999999999999999999999999999999999999999999999999 77889
Q ss_pred CCCCCCCC
Q 038211 598 ELPEGLDP 605 (605)
Q Consensus 598 ~~P~~~~~ 605 (605)
+||++|+|
T Consensus 305 ~fp~~fp~ 312 (604)
T KOG0592|consen 305 EFPEGFPE 312 (604)
T ss_pred cCCCCCCH
Confidence 99999975
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=359.66 Aligned_cols=226 Identities=32% Similarity=0.505 Sum_probs=204.2
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC-e
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE-R 449 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-~ 449 (605)
..+...+++.++.||+|+.|+||+++++ ++.+|+|++. -...+...+++.+|+++++.++||+||.+|++|..+. .
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 4567788999999999999999999985 6779999983 3445667788999999999999999999999999998 4
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH-RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
++|+||||+||+|.+++... +.+++..+..++.++++||.|||+ ++ ||||||||+|||++..|.|||||||.++..
T Consensus 153 isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 99999999999999998776 889999999999999999999995 88 999999999999999999999999999876
Q ss_pred CcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC-----CCHHHHHHHhccCCCccCCCCC-
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN-----LNLMQVVGVVGFMDRRLELPEG- 602 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~-----~~~~~~~~~I~~~~~~~~~P~~- 602 (605)
-.. ...+++||..|||||.+.+..|+.++||||||++++||++|++||.. .+..+++..|- .+..+.+|++
T Consensus 230 vnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~~ 306 (364)
T KOG0581|consen 230 VNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEGE 306 (364)
T ss_pred hhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCccc
Confidence 544 56788999999999999999999999999999999999999999976 47899999993 5678899997
Q ss_pred CCC
Q 038211 603 LDP 605 (605)
Q Consensus 603 ~~~ 605 (605)
|||
T Consensus 307 fS~ 309 (364)
T KOG0581|consen 307 FSP 309 (364)
T ss_pred CCH
Confidence 775
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=356.64 Aligned_cols=225 Identities=28% Similarity=0.450 Sum_probs=202.6
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEE-EEeeCCe-e
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMG-AVASQER-L 450 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~-~~~~~~~-~ 450 (605)
....+|+++++||+|+||.||++.. +|..+|.|.+..........+.+..|+.+|++++|||||++++ .|..+.. +
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 4567899999999999999999875 6888999999877777788888999999999999999999998 4544444 9
Q ss_pred EEEEEecCCCchHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCC--ceeccCCCCCEEEcCCCcEEEEeecCC
Q 038211 451 GIVTEFLPRGSLFKTLHK---NYQALDIKRRLRMALDVARGMNYLHHRNPP--IVHRDLKSSNLLVDKNWTVKVGDFGLS 525 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~--iiH~Dik~~Nill~~~~~vkl~Dfg~a 525 (605)
+||||+|.+|+|...++. ....+++..+|.++.|++.||..+|+.-+. |+||||||.|||++.+|.+||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999988864 457899999999999999999999995433 999999999999999999999999999
Q ss_pred cccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCC
Q 038211 526 SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELP 600 (605)
Q Consensus 526 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P 600 (605)
+..........+.+|||.||+||++.+.+|+++|||||+||++|||+.-++||.+.+-.++..+|.. +.-+++|
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q-gd~~~~p 249 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ-GDYPPLP 249 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc-CCCCCCc
Confidence 9998888888899999999999999999999999999999999999999999999999999999953 3344577
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=374.50 Aligned_cols=228 Identities=25% Similarity=0.417 Sum_probs=204.2
Q ss_pred CccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
.+..+||+++++||+|+||.||+|+. +|..||+|++++.... ..+++.++.|-++|....+|+||+++..|++.+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45678999999999999999999975 6788999999988765 46778899999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
||||||++||+++.+|.+. +.+++..++.|+.+++.|++.||++| +|||||||+|+|||..|++||+|||+|.-...
T Consensus 217 YLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999999999999999886 88999999999999999999999999 99999999999999999999999999842110
Q ss_pred -----------------------cccc----c--------------------cCCCCCCcccccccccCCCCCchhHHHH
Q 038211 531 -----------------------TYLT----A--------------------KSGRGTPQWMAPEVLRSEPSNEKSDVFS 563 (605)
Q Consensus 531 -----------------------~~~~----~--------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwS 563 (605)
.... . .+.+|||.|||||++.+..|+..+||||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0000 0 0235999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 564 FGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 564 lG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
|||||||||.|.+||...++.++..+|..-+..+.+|+..+
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~ 414 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVD 414 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCc
Confidence 99999999999999999999999999977777899998764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=367.33 Aligned_cols=233 Identities=46% Similarity=0.787 Sum_probs=211.1
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEECCcc-eEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC-e
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSD-VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE-R 449 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~-~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-~ 449 (605)
...+.+.++.+.+.||+|+||+||++.+.|+. +|+|++..........+.|.+|+.+|.+++|||||+++|++..+. .
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 34566778888889999999999999999999 999999887666555789999999999999999999999998877 7
Q ss_pred eEEEEEecCCCchHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC-cEEEEeecCCcc
Q 038211 450 LGIVTEFLPRGSLFKTLHK-NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW-TVKVGDFGLSSL 527 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~-~vkl~Dfg~a~~ 527 (605)
+++||||+++|+|..++.. ....++...++.|+.||+.||+|||++++ |||||||++|||++.++ ++||+|||+++.
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCcccee
Confidence 9999999999999999988 46899999999999999999999999986 89999999999999998 999999999987
Q ss_pred cCcccccccCCCCCCccccccccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLR--SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
............||+.|||||++. ...|+.++||||||++||||+||+.||.+..+.++...+...+.|+.+|..++|
T Consensus 194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~ 273 (362)
T KOG0192|consen 194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPP 273 (362)
T ss_pred eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 665433344468999999999999 568999999999999999999999999999999999999999999999997653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=355.43 Aligned_cols=216 Identities=26% Similarity=0.418 Sum_probs=187.1
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchh-----hhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEG-----TLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~-----~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
.+.|.+.+.||+|+||.|.+|.. +++.||||++.+...... ....+.+|++||++++|||||+++++|..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 36789999999999999999976 588899999988765431 23345799999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC---CcEEEEeecCCc
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN---WTVKVGDFGLSS 526 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~---~~vkl~Dfg~a~ 526 (605)
.||||||+.||+|++.+-.+ +.+.+..-..++.||+.|+.|||++| |+||||||+|||+..+ -.+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999999876 67888888899999999999999999 9999999999999765 689999999999
Q ss_pred ccCcccccccCCCCCCcccccccccCCCC---CchhHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHhccCCCccC
Q 038211 527 LKNATYLTAKSGRGTPQWMAPEVLRSEPS---NEKSDVFSFGVILWELVTASIPWNNLNLMQ-VVGVVGFMDRRLE 598 (605)
Q Consensus 527 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~el~~g~~Pf~~~~~~~-~~~~I~~~~~~~~ 598 (605)
..+ ......+.||||.|.|||++.+..+ ..++|||||||+||-+++|.+||.+..... +.+.|. .+++.
T Consensus 328 ~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~--~G~y~ 400 (475)
T KOG0615|consen 328 VSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL--KGRYA 400 (475)
T ss_pred ccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh--cCccc
Confidence 876 3445678899999999999987654 347899999999999999999998865544 888884 44443
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=342.20 Aligned_cols=229 Identities=28% Similarity=0.455 Sum_probs=211.2
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
...+..++|.++++||+|.||+|.+++. .++.||+|++++.... .+.+.....|-++|+..+||++..+-..|++.+
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 3457889999999999999999999976 5778999999887655 356677788999999999999999999999999
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
++|+||||.+||.|+.++.+. ..+++...+.|-.+|+.||.|||+.+ ||+||||.+|+|+|.+|++||+|||+|+..
T Consensus 242 rlCFVMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred eEEEEEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhc
Confidence 999999999999999999886 78899999999999999999999999 999999999999999999999999999988
Q ss_pred CcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.....+..++||||.|+|||++....|+.++|||.+||+||||++|++||.+.+-..+...| .-..+.+|..+||
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI--l~ed~kFPr~ls~ 393 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI--LMEDLKFPRTLSP 393 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH--HhhhccCCccCCH
Confidence 77778889999999999999999999999999999999999999999999999988888888 5667899998886
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=360.98 Aligned_cols=226 Identities=30% Similarity=0.504 Sum_probs=204.0
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc---hhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI---EGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQE 448 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~---~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~ 448 (605)
.....|.+++.||+|+||+|++|.+ ++..||+|++.+.... ....+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4557899999999999999999987 5788999987665222 234566779999999998 999999999999999
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC-CcEEEEeecCCcc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN-WTVKVGDFGLSSL 527 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~-~~vkl~Dfg~a~~ 527 (605)
.+++|||||.||+|++++.. .+++.+..+..++.||+.|++|||++| |+||||||+|||++.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999999999998 689999999999999999999999999 9999999999999999 9999999999987
Q ss_pred cCcccccccCCCCCCcccccccccCCC-CC-chhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCC-C
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLRSEP-SN-EKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGL-D 604 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~-~ 604 (605)
.........+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.+...+...| ..+++.+|.++ |
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--~~~~~~~p~~~~S 248 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--RKGEFKIPSYLLS 248 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--hcCCccCCCCcCC
Confidence 754445667889999999999999988 85 7899999999999999999999999999999998 77889999998 6
Q ss_pred C
Q 038211 605 P 605 (605)
Q Consensus 605 ~ 605 (605)
+
T Consensus 249 ~ 249 (370)
T KOG0583|consen 249 P 249 (370)
T ss_pred H
Confidence 4
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=360.66 Aligned_cols=221 Identities=32% Similarity=0.532 Sum_probs=203.5
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
++|.+.+.||+|+||+||+|+.+ .+.||+|.+.+....++..+.+.+|++|++.++|||||.++++|++..++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 67999999999999999999865 4569999999988888899999999999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
||.| +|..++... +.++++.+..++.+++.||.|||+++ |+|||+||.|||++.+|++|+||||+|+.........
T Consensus 82 ~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 9976 999998765 88999999999999999999999999 9999999999999999999999999998876655556
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
....|||.|||||++.+..|+..+|+|||||++|||+.|++||-..+..+++..| ....++-|...|
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I--~~d~v~~p~~~S 224 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSI--LKDPVKPPSTAS 224 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH--hcCCCCCccccc
Confidence 6678999999999999999999999999999999999999999999999999999 555566676655
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=334.44 Aligned_cols=210 Identities=24% Similarity=0.364 Sum_probs=190.2
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
+.|+.+.++|+|+||+||+|++ +|+.||||.+.-+...+..-+-.+||+++|++++|+|+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 5788899999999999999987 57789999998776555556678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
||+ .++.+.+.+....++.+.+..|+.|++.|+.|+|+++ +|||||||+|||++.+|.+||||||+|+....+....
T Consensus 82 ~~d-hTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCD-HTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecc-hHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 995 4677788888889999999999999999999999999 9999999999999999999999999999988777778
Q ss_pred cCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 536 KSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
..++.|.+|+|||.+.| ..|+.++||||+||++.||++|.+.|.+.+....+..|
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I 214 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLI 214 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHH
Confidence 88899999999999998 67899999999999999999999999987765544444
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=360.31 Aligned_cols=223 Identities=31% Similarity=0.509 Sum_probs=205.5
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeecc-ccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGS-EYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~-~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..-|++++.||.|+.|.|.+|++ +|+..|||++.+. ...+.....+.+|+-+|+.+.|||++++|+++++..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 46789999999999999999987 7889999999876 44455667789999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
+||++||.|++++.+. +++++..+.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||||.+.. +..
T Consensus 91 lEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~gk 166 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEV-PGK 166 (786)
T ss_pred EEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeeccc-CCc
Confidence 9999999999999887 78888999999999999999999999 9999999999999999999999999998654 345
Q ss_pred cccCCCCCCcccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
...+.||+|.|.+||++.|.+| +.++||||+|||||.|++|++||++.|...++.+| ..+.+++|..+||
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV--~~G~f~MPs~Is~ 237 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV--QRGVFEMPSNISS 237 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH--HcCcccCCCcCCH
Confidence 5678899999999999999999 57899999999999999999999999999999999 7888999999985
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=340.75 Aligned_cols=227 Identities=27% Similarity=0.407 Sum_probs=202.1
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEECC--cceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNG--SDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~--~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
++.+..++|++++.||.|.-|+||++...+ ..+|+||+.+.... .+...+.+.|-+||+.++||+++.+|..|+.+.
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 566788999999999999999999999876 56999999887654 456778889999999999999999999999999
Q ss_pred eeEEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
..|++||||+||+|..+++++. ..+++..++.|+.+++.||+|||..| ||+|||||+||||.++|+|.|+||.++..
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999999999999999998874 67999999999999999999999999 99999999999999999999999998631
Q ss_pred cC-----------------------------------cc---------------------cccccCCCCCCccccccccc
Q 038211 528 KN-----------------------------------AT---------------------YLTAKSGRGTPQWMAPEVLR 551 (605)
Q Consensus 528 ~~-----------------------------------~~---------------------~~~~~~~~gt~~y~aPE~~~ 551 (605)
.. .. .....+++||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 00 00 01122457999999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCC
Q 038211 552 SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 552 ~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
|+..+.++|||+|||++|||++|..||.+.+..+.+.+| ....+.+|+.
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI--v~~~l~Fp~~ 357 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI--VGQPLKFPEE 357 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH--hcCCCcCCCC
Confidence 999999999999999999999999999999999999999 6777888865
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=350.95 Aligned_cols=224 Identities=38% Similarity=0.670 Sum_probs=200.6
Q ss_pred cCCCCccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 370 ATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 370 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
...+++..+++.++..||+|+||+||+|+|.| +||||+++.+...+...+.|++|+.++++-+|.||+-++|++..+..
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 35678888999999999999999999999988 69999999988888899999999999999999999999999988776
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
.||+.||.|.+|+.+++.....++..+.+.|+.||++|+.|||.++ |||||||..|||+.++++|||+|||++....
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceeeee
Confidence 9999999999999999988789999999999999999999999999 9999999999999999999999999997644
Q ss_pred ccc--ccccCCCCCCcccccccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCcc
Q 038211 530 ATY--LTAKSGRGTPQWMAPEVLRS---EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRL 597 (605)
Q Consensus 530 ~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~ 597 (605)
... .......|...|||||+++. .+|++.+|||||||++|||++|.+||...+..+++..|++.-..+
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~p 612 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMP 612 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCc
Confidence 321 12233457889999999975 467899999999999999999999999988999999997653333
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=341.45 Aligned_cols=216 Identities=26% Similarity=0.335 Sum_probs=193.8
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC--Cee
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ--ERL 450 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~ 450 (605)
...+.|+.+++||+|+||.||+|++ +|+.||+|.+..+...+.......||+.||++|+||||+++.+..... +.+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 3457899999999999999999987 577799999998887778888899999999999999999999998876 689
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
|||+|||+ .+|..++....-.+++.++..|+.||+.||+|||.+| |+|||||.+|||||.+|.+||+|||+|++...
T Consensus 194 YlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 194 YLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99999995 6899998886678999999999999999999999999 99999999999999999999999999997654
Q ss_pred ccc-cccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccC
Q 038211 531 TYL-TAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFM 593 (605)
Q Consensus 531 ~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~ 593 (605)
... .....+-|.+|+|||+++|. .|+.++|+||.||||.||+.|++.|.+.+..+.+..|.+.
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfkl 335 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKL 335 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHH
Confidence 432 35566789999999999986 5899999999999999999999999999888877777544
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=312.96 Aligned_cols=226 Identities=27% Similarity=0.490 Sum_probs=204.9
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECCc--ceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNGS--DVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~--~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
..+..++|++++.||+|-||.||+|+.+.+ .+|+|++.++.... ....++.+|++|...++||||+++|++|.+..+
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 345678999999999999999999987544 48999998877543 345678899999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 450 LGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
.||++||.++|+|+..++.. ...+++.....|..|++.||.|+|..+ ||||||||+|+|++..|.+||+|||.+...
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999999854 366999999999999999999999999 999999999999999999999999998765
Q ss_pred CcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
+ ...+.+.|||..|.+||...+..++..+|+|++|++.||++.|.+||...+..+.+.+| ..-++.+|+.++
T Consensus 175 p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI--~k~~~~~p~~is 246 (281)
T KOG0580|consen 175 P--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI--RKVDLKFPSTIS 246 (281)
T ss_pred C--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH--HHccccCCcccC
Confidence 4 55677889999999999999999999999999999999999999999999999999999 555688998876
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=334.73 Aligned_cols=224 Identities=32% Similarity=0.531 Sum_probs=193.9
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC--eeEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE--RLGIV 453 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~~~lv 453 (605)
.+|..++.||+|+||.||++.++ |...|||......... .+.+.+|+.+|..++|||||++++...... .++++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 46788999999999999999885 5889999876652111 677899999999999999999999855444 69999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC-CCcEEEEeecCCcccCc--
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK-NWTVKVGDFGLSSLKNA-- 530 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~-~~~vkl~Dfg~a~~~~~-- 530 (605)
|||+++|+|.+++.+..+.+++..++.++.||+.||.|||++| ||||||||+|||++. ++.+||+|||+++....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999987558999999999999999999999999 999999999999999 79999999999986653
Q ss_pred -ccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhccCCCccCCCCCCCC
Q 038211 531 -TYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNN-LNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 531 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~-~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.........||+.|||||++.+ ....+++|||||||++.||+||+.||.+ ....+.+..|+..+.-+.||+.+|+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~ 250 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSD 250 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCH
Confidence 2223445789999999999995 3334599999999999999999999999 7888888888878877899998874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=310.17 Aligned_cols=213 Identities=25% Similarity=0.373 Sum_probs=192.9
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
.+|...++||+|.||+||+|++ +|+.||||.++..+..+.......||+..|+.++|+||+.++++|.+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999998 57789999998887776667778999999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|++ .+|+..++...-.++...+..|+.++++||+|||+++ |+||||||.|+|++.+|.+||+|||+|+....+....
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 995 6999999988889999999999999999999999999 9999999999999999999999999999887766555
Q ss_pred cCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccC
Q 038211 536 KSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFM 593 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~ 593 (605)
...+-|.+|+|||++.|. .|+..+||||.||++.||+.|.+-|.+.+..+.+..|-..
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~ 217 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRA 217 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHH
Confidence 555789999999999885 5899999999999999999999999998877666666433
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=331.88 Aligned_cols=226 Identities=28% Similarity=0.447 Sum_probs=190.0
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchh------------hhhhHHHHHHHHHhCCCCCe
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEG------------TLKNYQKEIDIIKKLRHPNV 437 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~------------~~~~~~~E~~il~~l~h~ni 437 (605)
.+...+.+|++++.||+|.||+|.+|++ .++.||||++.+.+.... ..+.+.+|+.+|++++||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 4556778999999999999999999988 577799999977654321 23578899999999999999
Q ss_pred eeEEEEEeeC--CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC
Q 038211 438 LLFMGAVASQ--ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW 515 (605)
Q Consensus 438 v~~~~~~~~~--~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~ 515 (605)
|+++++..++ +.+|||+|||..|.+.+.-... ..+++.+++.|+.+++.||+|||.+| ||||||||+|+||+.+|
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~-~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK-PELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCCCc-ccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCC
Confidence 9999998764 6799999999998775433221 23899999999999999999999999 99999999999999999
Q ss_pred cEEEEeecCCcccCc-----ccccccCCCCCCcccccccccCCC---C-CchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 038211 516 TVKVGDFGLSSLKNA-----TYLTAKSGRGTPQWMAPEVLRSEP---S-NEKSDVFSFGVILWELVTASIPWNNLNLMQV 586 (605)
Q Consensus 516 ~vkl~Dfg~a~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~---~-~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~ 586 (605)
++||+|||.+..... ........+|||.|+|||.+.+.. + +.+.||||+||+||.|+.|+.||.+....++
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 999999999875521 222223367999999999988733 2 5678999999999999999999999999999
Q ss_pred HHHhccCCCccCCCCC
Q 038211 587 VGVVGFMDRRLELPEG 602 (605)
Q Consensus 587 ~~~I~~~~~~~~~P~~ 602 (605)
..+| ....+.||+.
T Consensus 328 ~~KI--vn~pL~fP~~ 341 (576)
T KOG0585|consen 328 FDKI--VNDPLEFPEN 341 (576)
T ss_pred HHHH--hcCcccCCCc
Confidence 9999 6667788865
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=320.93 Aligned_cols=224 Identities=29% Similarity=0.470 Sum_probs=195.3
Q ss_pred CCccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
+.+..++|++.++||.|..++||+|+. .+..||||++..++.... +..+.+|+..++.++||||++++..|..+..+
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 445678999999999999999999976 577899999988775554 78899999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 451 GIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
|+||.||.+|++.+++.... ..+++..+..++++++.||.|||.+| .||||||+.||||+.+|.|||+|||.+-...
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999999998753 56999999999999999999999999 9999999999999999999999999864321
Q ss_pred c---ccccc-cCCCCCCccccccccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCC
Q 038211 530 A---TYLTA-KSGRGTPQWMAPEVLR--SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 530 ~---~~~~~-~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~ 601 (605)
. ..... .+++|||.|||||++. ...|+.|+||||||++..||++|..||....+++++..= .+++++.|.
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--Lqn~pp~~~ 253 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--LQNDPPTLL 253 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH--hcCCCCCcc
Confidence 1 11222 5678999999999964 357999999999999999999999999999999988764 455565443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=336.53 Aligned_cols=228 Identities=38% Similarity=0.641 Sum_probs=204.6
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEECCc-ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNGS-DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~-~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
.+.+..+.+++++.||+|.||.||+|.++++ +||+|.++.... ..+.|.+|+.+|++|+|+|||++++++..++.+
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m---~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM---SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc---ChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 4556667889999999999999999999887 799999876533 235678999999999999999999999998899
Q ss_pred EEEEEecCCCchHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 451 GIVTEFLPRGSLFKTLHK-NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+||||||+.|+|.++|+. ....+...+...|+.||+.|++||++++ +|||||-+.||||++++.+||+|||+|+...
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccccC
Confidence 999999999999999997 5678999999999999999999999999 9999999999999999999999999999655
Q ss_pred cccc-cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 530 ATYL-TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 530 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.... ......-+.-|.|||.+....++.+||||||||+||||+| |+.||..+++.+++..|. .+.|++=|+.+++
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~CP~ 431 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGCPD 431 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCCCH
Confidence 4443 3334445778999999999999999999999999999999 999999999999999997 8899999999874
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=324.53 Aligned_cols=213 Identities=26% Similarity=0.497 Sum_probs=196.5
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.+|++.+.||.|.||+|-+|.. .|+.||||.+.++... +..+-.+.+|++||..++||||+.+|.+|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 5799999999999999999975 5888999999887754 456778899999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||..+|.|++++.+. +.+++..+++++.||+.|+.|+|.++ ++|||||.+|||+|.++++||+|||++...... ..
T Consensus 133 EYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kf 208 (668)
T KOG0611|consen 133 EYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KF 208 (668)
T ss_pred EecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhccc-cH
Confidence 999999999999886 88999999999999999999999999 999999999999999999999999999776543 45
Q ss_pred ccCCCCCCcccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMD 594 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~ 594 (605)
..++||+|-|.+||++.|.+| ++.+|-|||||+||.|..|..||++.+-..++.+|+...
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga 269 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA 269 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc
Confidence 678999999999999999998 678999999999999999999999999999999997554
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=337.69 Aligned_cols=222 Identities=26% Similarity=0.360 Sum_probs=193.2
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
++|+++++||+|+||+||++.+ .++.||||++.+.... ......+.+|+.++..++|+||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4799999999999999999987 4677999998765432 234567788999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc--
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY-- 532 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~-- 532 (605)
|||+||+|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++++||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 999999999999765 67899999999999999999999999 9999999999999999999999999986532110
Q ss_pred ---------------------------------ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 038211 533 ---------------------------------LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWN 579 (605)
Q Consensus 533 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~ 579 (605)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00123579999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhccCCCccCCCCC
Q 038211 580 NLNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 580 ~~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
+.+..+...+|......+.+|+.
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~ 260 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPE 260 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCc
Confidence 99999999988655566777764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=335.73 Aligned_cols=225 Identities=27% Similarity=0.438 Sum_probs=206.4
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe-eEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER-LGIV 453 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~-~~lv 453 (605)
.++|.+++++|+|+||.+++++++ ++.+++|.+......+.......+|+.++++++|||||.+.+.|..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 468999999999999999988764 5669999998888777777788999999999999999999999998887 9999
Q ss_pred EEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 454 TEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
|+||+||+|.+.+.+.. ..++++.++.|+.||+.|++|||++. |+|||||+.|||++.++.|+|.|||+|+......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999999999998775 67999999999999999999999999 9999999999999999999999999999988776
Q ss_pred ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
....+..|||.||+||++.+.+|..++|||||||++|||++-+++|.+.+...++.+|- ...-.++|..+|
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~-~~~~~Plp~~ys 231 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN-RGLYSPLPSMYS 231 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh-hccCCCCCcccc
Confidence 67778899999999999999999999999999999999999999999999999999994 222368888776
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=313.10 Aligned_cols=214 Identities=28% Similarity=0.330 Sum_probs=190.6
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC--Cee
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ--ERL 450 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~ 450 (605)
-..+.|+.+..|++|+||.||+|+++ +..||+|.++.+.-.....-...||+.+|.+++|||||.+-.+.... +.+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 44578999999999999999999985 45599999987765555566678999999999999999999988643 579
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
|||||||+ .+|..++..-..++....+.-++.|++.|+.|||.++ |+|||||++|+|++..|.+||+|||+|+....
T Consensus 153 y~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 153 YIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99999994 6999999988789999999999999999999999999 99999999999999999999999999999887
Q ss_pred ccccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
+.......+-|.+|+|||++.|. .|++++||||+|||+.||+++++.|.+.+....+.+|-
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If 291 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIF 291 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHH
Confidence 77666777789999999999985 58999999999999999999999999987766666664
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=324.40 Aligned_cols=223 Identities=26% Similarity=0.415 Sum_probs=204.0
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
..=|.+.+.||+|.|++|-+|++ +|..||||++.+.+...-....+..|++.|+.++|||||++|++..+...+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 35588889999999999999976 8999999999998877766777889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE-cCCCcEEEEeecCCcccCcccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV-DKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill-~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
|+-++|+|++++.+....+.+..+.+|++||+.|+.|+|+.. +|||||||+|+.+ ..-|-|||.|||++..+. +..
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-PG~ 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-PGK 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCC-Ccc
Confidence 999999999999999899999999999999999999999999 9999999999976 567999999999987654 334
Q ss_pred cccCCCCCCcccccccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRSEPSN-EKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
...+.||+..|-|||++.|..|+ +++||||||||||.|.+|++||+..+..+.+..| ++=.+.+|..+|
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI--mDCKYtvPshvS 243 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI--MDCKYTVPSHVS 243 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh--hcccccCchhhh
Confidence 55678999999999999999996 6789999999999999999999999999999999 777799998765
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=329.97 Aligned_cols=223 Identities=27% Similarity=0.471 Sum_probs=197.2
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
.+...+|++.+.||+|+||.||+|.++ ++.||+|++.+.... ....+.+.+|+.+++.++||||+++++++..++.+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 456689999999999999999999874 677999998765432 23456788999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
++||||+++++|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999999998765 67889999999999999999999999 99999999999999999999999999976533
Q ss_pred ccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...| ..+++++|..+|
T Consensus 171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i--~~~~~~~p~~~~ 239 (329)
T PTZ00263 171 R---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI--LAGRLKFPNWFD 239 (329)
T ss_pred C---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH--hcCCcCCCCCCC
Confidence 2 22457899999999999999999999999999999999999999999999998888 456788888776
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.40 Aligned_cols=224 Identities=25% Similarity=0.450 Sum_probs=196.5
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECC---cceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNG---SDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~---~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
..+..++|++.++||+|+||.||+|.+.+ ..||+|++.+.... ....+.+.+|+.+++.++||||+++++++.+++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 44677899999999999999999998643 46999998765432 334567889999999999999999999999999
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
.+++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999999998765 67899999999999999999999999 999999999999999999999999999765
Q ss_pred CcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+...| ....+.+|+.++
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i--~~~~~~~p~~~~ 252 (340)
T PTZ00426 182 DTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI--LEGIIYFPKFLD 252 (340)
T ss_pred CCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH--hcCCCCCCCCCC
Confidence 322 23457899999999999988999999999999999999999999999988888888 455677887765
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=311.65 Aligned_cols=216 Identities=28% Similarity=0.342 Sum_probs=191.3
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCC-eeeEEEEEeeCC-----
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN-VLLFMGAVASQE----- 448 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~~~~~~~~~~----- 448 (605)
...|..+++||+|+||+||+|+. +|+.||+|.+..+...+.......+|+.+|+.++|+| ||.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 56788899999999999999987 5778999998776554555667889999999999999 999999998876
Q ss_pred -eeEEEEEecCCCchHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecC
Q 038211 449 -RLGIVTEFLPRGSLFKTLHKNY---QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524 (605)
Q Consensus 449 -~~~lv~e~~~ggsL~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~ 524 (605)
.+++||||+ ..+|..++.... ..++...++.++.||+.||+|||+++ |+||||||.|||+++.|.+||+|||+
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccch
Confidence 799999999 569999998765 46888899999999999999999999 99999999999999999999999999
Q ss_pred CcccCcccccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCC
Q 038211 525 SSLKNATYLTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDR 595 (605)
Q Consensus 525 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~ 595 (605)
|+....+.......++|.+|+|||++.|. .|++..||||+|||++||+++++.|.+.+..+.+..|-..-+
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lG 238 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLG 238 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcC
Confidence 99777666666777899999999999997 689999999999999999999999999888877777754433
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=330.40 Aligned_cols=222 Identities=28% Similarity=0.459 Sum_probs=197.7
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
...|...++||+|+.|.||.|+. .++.||||.+....... .+-+.+|+.+|+..+|+|||.+++.|...+.+|+||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 46788889999999999999976 46669999887654333 345789999999999999999999999899999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||++||+|.+.+.. ..+++.++..++.+++.||.|||.+| |+|||||.+|||++.+|.+||+|||+|.........
T Consensus 350 Eym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred eecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 99999999999877 45999999999999999999999999 999999999999999999999999999888777777
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCcc--CCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRL--ELPEGLDP 605 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~--~~P~~~~~ 605 (605)
+.+.+|||+|||||++....|++++||||||++++||+.|++||-+.++...+..|. ..+++ ..|+.+||
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-~ng~P~lk~~~klS~ 497 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPKLKNPEKLSP 497 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-hcCCCCcCCccccCH
Confidence 888899999999999999999999999999999999999999999999888888885 33444 55666654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=357.93 Aligned_cols=226 Identities=24% Similarity=0.367 Sum_probs=202.7
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
+..+||.++++||+|+||.|.+++++ ++-||+|++.+-... ......|..|-.+|...+.+-|+.++..|+++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 45689999999999999999999884 566999999885544 345678999999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC-c
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN-A 530 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~-~ 530 (605)
+||||++||+|..++.+.. .+++..++.|+.+|+.||+-||+.| +|||||||+|||||..|++||+|||.|-... .
T Consensus 152 lVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999999999998875 8999999999999999999999999 9999999999999999999999999986555 3
Q ss_pred ccccccCCCCCCcccccccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRS-----EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
........+|||.|++||++.. ..|+..+||||+||++|||++|..||...+..+.+.+|......+.||+.+
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~ 306 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDET 306 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccc
Confidence 4445566789999999999953 457889999999999999999999999999999999997777799999543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=304.09 Aligned_cols=219 Identities=26% Similarity=0.454 Sum_probs=198.1
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
-+.|++-++||+|.|+.||++.+ +|+.+|+|++....+.....+.+.+|++|-+.++|||||++++........|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 46799999999999999998866 6888999999887777777888999999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc---CCCcEEEEeecCCcccCcc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD---KNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~---~~~~vkl~Dfg~a~~~~~~ 531 (605)
|++.|++|..-+-.. ..+++..+-.++.||+.||+|+|.+| |||||+||+|+|+- ...-+||+|||+|.... .
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~ 165 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-D 165 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeC-C
Confidence 999999997776554 56888999999999999999999999 99999999999994 34579999999998877 5
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~ 601 (605)
......++|||.|||||+++..+|+.++|||+.||+||-|+.|.+||.+.+...+++.| +.+.+++|+
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I--~~g~yd~~~ 233 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQI--KAGAYDYPS 233 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH--hccccCCCC
Confidence 55667789999999999999999999999999999999999999999999999999999 556677765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.15 Aligned_cols=219 Identities=27% Similarity=0.448 Sum_probs=193.3
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
++|++.++||+|+||.||+|.+. ++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+...+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999875 778999998764332 234566889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+++++|.+++... +.+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 999999999998765 67889999999999999999999999 999999999999999999999999998765322
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...| ...++++|..++
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~ 222 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--LAGKLEFPRHLD 222 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhCCcCCCccCC
Confidence 22456899999999999999999999999999999999999999999999999888 455678887765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.19 Aligned_cols=216 Identities=25% Similarity=0.440 Sum_probs=188.8
Q ss_pred eeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCC
Q 038211 384 EEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRG 460 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~gg 460 (605)
+.||+|+||.||++.+ .++.||+|++.+.... ......+.+|+.+++.++||||++++++|...+.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 4677999998765332 334566788999999999999999999999999999999999999
Q ss_pred chHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCCC
Q 038211 461 SLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRG 540 (605)
Q Consensus 461 sL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g 540 (605)
+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 999888765 67899999999999999999999999 999999999999999999999999998754333333445679
Q ss_pred CCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 541 TPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 541 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+ ....+.+|..++
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~--~~~~~~~p~~~~ 219 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEEIRFPRTLS 219 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH--HcCCCCCCCCCC
Confidence 99999999999999999999999999999999999999998888888887 445577887765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=330.23 Aligned_cols=222 Identities=25% Similarity=0.381 Sum_probs=191.7
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
++|+++++||+|+||+||+|.+ .++.||||++.+.... ......+.+|+.+++.++||||++++++|.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999987 4678999999765432 234566789999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc-
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL- 533 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~- 533 (605)
||+++|+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.++|+|||++........
T Consensus 81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 999999999998765 57899999999999999999999999 99999999999999999999999999864321100
Q ss_pred -------------------------------------cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCC
Q 038211 534 -------------------------------------TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASI 576 (605)
Q Consensus 534 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 576 (605)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0112468999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHHhccCCCccCCCCC
Q 038211 577 PWNNLNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 577 Pf~~~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
||.+.+..+.+..+......+.+|..
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~ 263 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDE 263 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCC
Confidence 99999988888888555556666664
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=323.53 Aligned_cols=211 Identities=22% Similarity=0.329 Sum_probs=182.4
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCC-ee
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQE-RL 450 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~-~~ 450 (605)
+..++|.++++||.|+||.||+|+. .+..||||.+++.-..-.+ ..-.||+.-|++++ ||||+++.+++.+.+ .+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 3457899999999999999999976 5777999988765443222 22358999999998 999999999999887 89
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
++||||| ..+|+.++..+...+++..++.|+.||++||+|+|.+| ++|||+||+|||+.....+||+|||+|+....
T Consensus 86 ~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEeccccccccccc
Confidence 9999999 57999999988899999999999999999999999999 99999999999999899999999999997654
Q ss_pred ccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.. ..+.++.|.+|+|||++.. ..|+.+.||||+|||++|+++-++.|.+.+....+.+|
T Consensus 163 kp-PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI 222 (538)
T KOG0661|consen 163 KP-PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI 222 (538)
T ss_pred CC-CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH
Confidence 33 3456678999999999755 55799999999999999999999999997765544443
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=331.72 Aligned_cols=222 Identities=26% Similarity=0.376 Sum_probs=190.3
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
++|.++++||+|+||+||++.+ .++.||||++.+... .......+.+|+++++.++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4799999999999999999987 567799999876543 2345567889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc--
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY-- 532 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~-- 532 (605)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999998764 67889999999999999999999999 9999999999999999999999999985321100
Q ss_pred ---------------------------------------------ccccCCCCCCcccccccccCCCCCchhHHHHHHHH
Q 038211 533 ---------------------------------------------LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVI 567 (605)
Q Consensus 533 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 567 (605)
......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 00012469999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCC
Q 038211 568 LWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 568 l~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
+|||++|..||...+..+.+..|......+.+|..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 272 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDD 272 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCC
Confidence 99999999999998888888887544556666653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=330.19 Aligned_cols=221 Identities=22% Similarity=0.317 Sum_probs=188.7
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
.|++++.||+|+||+||+|.+ .+..||||++.+.... ......+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 689999999999999999987 4667999998765432 3455678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc---
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY--- 532 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~--- 532 (605)
|+++|+|.+++.+. ..+++..+..++.||+.||+|||+.| |+||||||+|||++.++++||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 99999999998765 57889999999999999999999999 9999999999999999999999999975321000
Q ss_pred --------------------------------------------ccccCCCCCCcccccccccCCCCCchhHHHHHHHHH
Q 038211 533 --------------------------------------------LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVIL 568 (605)
Q Consensus 533 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 568 (605)
......+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001234799999999999999899999999999999
Q ss_pred HHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCC
Q 038211 569 WELVTASIPWNNLNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 569 ~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
|||++|..||...+..+....|......+.+|..
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 272 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQ 272 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCCCCC
Confidence 9999999999988877777666544555666653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.64 Aligned_cols=221 Identities=22% Similarity=0.393 Sum_probs=191.2
Q ss_pred CceEeeeecccCcEEEEEEEEC--CcceEEEEeecccc-chhhhhhHHHHHHHHHhCCC-CCeeeEEEEEeeCCeeEEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRH-PNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~~~~lv~ 454 (605)
+|++++.||+|+||.||+|.+. ++.||||++.+... .....+.+..|..++..+.| ++|+.++++|...+.+++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999875 45799999876543 23445677889999999966 56889999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+++++|..++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.........
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 999999999888765 67889999999999999999999999 999999999999999999999999998754333333
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..| ....+.+|..++
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i--~~~~~~~~~~~~ 225 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI--MEHNVSYPKSLS 225 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--HcCCCCCCCCCC
Confidence 34557899999999999999999999999999999999999999999999999888 455677887765
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=322.24 Aligned_cols=217 Identities=26% Similarity=0.461 Sum_probs=187.8
Q ss_pred eeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCC
Q 038211 384 EEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRG 460 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~gg 460 (605)
+.||+|+||.||++.+ .+..||+|++.+.... ......+.+|+.+++.++||||++++++|...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999987 4678999998765322 334566778999999999999999999999999999999999999
Q ss_pred chHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCCC
Q 038211 461 SLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRG 540 (605)
Q Consensus 461 sL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g 540 (605)
+|..++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..............|
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 998888765 57899999999999999999999999 999999999999999999999999998754333333345679
Q ss_pred CCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 541 TPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 541 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...+...+...+ ....+.+|..+++
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~--~~~~~~~p~~~~~ 220 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSP 220 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--hcCCCCCCCCCCH
Confidence 99999999999999999999999999999999999999998888888887 3445677777653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=331.07 Aligned_cols=220 Identities=22% Similarity=0.326 Sum_probs=188.7
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
.|+++++||+|+||+||+|.+ .++.||+|++.+... .......+.+|+.+++.++|+||++++++|.+++.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 589999999999999999987 466799999876533 23445678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc----
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT---- 531 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~---- 531 (605)
||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 99999999998765 67889999999999999999999999 999999999999999999999999997532100
Q ss_pred -------------------------------------------cccccCCCCCCcccccccccCCCCCchhHHHHHHHHH
Q 038211 532 -------------------------------------------YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVIL 568 (605)
Q Consensus 532 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 568 (605)
.......+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001234689999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCHHHHHHHhccCCCccCCCC
Q 038211 569 WELVTASIPWNNLNLMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 569 ~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~ 601 (605)
|||++|+.||...++.+....|......+.+|.
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 271 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP 271 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCC
Confidence 999999999999888888877755555566664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=321.78 Aligned_cols=221 Identities=23% Similarity=0.411 Sum_probs=191.3
Q ss_pred CceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~ 454 (605)
+|.+.+.||+|+||.||+|.+. +..||+|++.+.... ......+..|..++..+ +|++|+.+++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999875 557999998765432 23445567788888877 5899999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+++|+|.+.+... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 999999999888765 67899999999999999999999999 999999999999999999999999998754333334
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..| ....+.+|..++
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s 225 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPKSMS 225 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH--HhCCCCCCCcCC
Confidence 44567999999999999999999999999999999999999999999999999888 455677777665
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=323.68 Aligned_cols=210 Identities=30% Similarity=0.483 Sum_probs=191.5
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
..|...+.||+|+||.||+|.+ .++.||+|++..+. .+...+.+++|+.+|..++++||.++|+.|..+..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 3567779999999999999987 46779999987755 34467788999999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
||.||++.+.+... ..+.+..+..++.+++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+..........
T Consensus 92 y~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HhcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 99999999999874 44488888889999999999999999 9999999999999999999999999998887777777
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
.+++|||.|||||++.+..|+.++||||||++++||++|.+||.+..++.++..|.
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp 224 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP 224 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc
Confidence 89999999999999999999999999999999999999999999999988887774
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=322.14 Aligned_cols=216 Identities=26% Similarity=0.454 Sum_probs=188.2
Q ss_pred eeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCC
Q 038211 384 EEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRG 460 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~gg 460 (605)
+.||+|+||.||++.+ .++.||+|++.+.... ......+.+|+.+++.++||||+++++++...+.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 4678999998765332 344567889999999999999999999999999999999999999
Q ss_pred chHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCCC
Q 038211 461 SLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRG 540 (605)
Q Consensus 461 sL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g 540 (605)
+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 998888664 67899999999999999999999999 999999999999999999999999998754333333345679
Q ss_pred CCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 541 TPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 541 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+ ....+.+|..++
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~--~~~~~~~p~~~~ 219 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEDIKFPRTLS 219 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh--ccCCccCCCCCC
Confidence 99999999999999999999999999999999999999998888888887 445577887765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=328.03 Aligned_cols=222 Identities=25% Similarity=0.367 Sum_probs=191.9
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
++|++.+.||+|+||.||++.+ .++.||+|++.+.... ......+.+|+.++..++||||+++++.|.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999987 4677999998764322 334567888999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc--
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY-- 532 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~-- 532 (605)
||++||+|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||+|||++.+|.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 999999999998765 67899999999999999999999999 9999999999999999999999999986432110
Q ss_pred ---------------------------------ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 038211 533 ---------------------------------LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWN 579 (605)
Q Consensus 533 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~ 579 (605)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123479999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhccCCCccCCCCC
Q 038211 580 NLNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 580 ~~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
+.++.+....|......+.+|+.
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~ 260 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPE 260 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCC
Confidence 99998888888654566677765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=327.69 Aligned_cols=225 Identities=25% Similarity=0.393 Sum_probs=193.4
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
+..++|++.++||+|+||.||++.+. ++.+|+|++.+.... ......+.+|+.+++.++||||+++++++.+++.++
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 44578999999999999999999874 567999998764322 233456788999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 99999999999999865 45889999999999999999999999 999999999999999999999999999765432
Q ss_pred cc-cccCCCCCCcccccccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 532 YL-TAKSGRGTPQWMAPEVLRSEP----SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 532 ~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
.. .....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+....+..|......+.+|+..
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 272 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcc
Confidence 22 224567999999999997643 6789999999999999999999999999888888886666667788753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.99 Aligned_cols=215 Identities=25% Similarity=0.414 Sum_probs=188.3
Q ss_pred ecccCcEEEEEEEEC--CcceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCCch
Q 038211 386 IGLGSYAVVYRGIWN--GSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL 462 (605)
Q Consensus 386 LG~G~fg~V~~~~~~--~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ggsL 462 (605)
||+|+||.||++.+. ++.||+|++.+... .......+.+|+.+++.++||||+++++++..++.+++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999874 66799999875432 234456778899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCCCCC
Q 038211 463 FKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP 542 (605)
Q Consensus 463 ~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~ 542 (605)
.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+++............+||+
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 9998765 67899999999999999999999999 99999999999999999999999999976433333344567999
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 543 QWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 543 ~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+ ....+.+|+.+++
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~ 218 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI--LQEPLRFPDGFDR 218 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH--HcCCCCCCCcCCH
Confidence 999999999999999999999999999999999999999988888888 4556788877763
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=330.23 Aligned_cols=221 Identities=23% Similarity=0.315 Sum_probs=188.1
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.+|+++++||+|+||.||++++. ++.||||++.+.... ......+.+|+.+|+.++|+||+++++.|.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 37999999999999999999874 677999998654332 234566889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc---
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT--- 531 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~--- 531 (605)
|||++|+|.+++.+. +.+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|......
T Consensus 81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999999765 67889999999999999999999999 999999999999999999999999997532100
Q ss_pred ----------------------------------------cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHH
Q 038211 532 ----------------------------------------YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWEL 571 (605)
Q Consensus 532 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 571 (605)
.......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001234699999999999999999999999999999999
Q ss_pred HcCCCCCCCCCHHHHHHHhccCCCccCCCC
Q 038211 572 VTASIPWNNLNLMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 572 ~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~ 601 (605)
++|+.||.+.+..+....+......+.+|.
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 267 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPS 267 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCC
Confidence 999999999888887777754445555554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=320.55 Aligned_cols=218 Identities=25% Similarity=0.412 Sum_probs=188.1
Q ss_pred eeeecccCcEEEEEEEE-----CCcceEEEEeeccccc--hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 383 GEEIGLGSYAVVYRGIW-----NGSDVAVKVYFGSEYI--EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~-----~~~~~avKv~~~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
+++||+|+||.||+++. .++.||+|++.+.... ......+.+|+.+++.++||||++++++|..++.+++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36899999999999875 4667999998765322 2334567789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|+++++|.+++.+. +.+.+..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 99999999998765 67788888999999999999999999 9999999999999999999999999987543333333
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.+..+ ..+++.+|+.+++
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~ 225 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI--LKGKLNLPPYLTP 225 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH--HcCCCCCCCCCCH
Confidence 4457899999999999988999999999999999999999999999988888888 4556788887763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=324.87 Aligned_cols=220 Identities=35% Similarity=0.571 Sum_probs=199.5
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
.+++.++...-++-||.|+.|.||+|+.++..||||.++. .-..++.-|++|+|+||+.+.++|.....+|
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 4556666666678899999999999999999999996521 1135788899999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
||||||..|.|+.+|+.. ..+.......|..+|+.|++|||.+. |||||||.-||||..+..|||+|||-++.....
T Consensus 189 IiMEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred EeeeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 999999999999999876 78888899999999999999999999 999999999999999999999999999876654
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.+...++||..|||||+++.++.+.|+|||||||+||||+||..||.+.+.+.|+.-|+-.-..+++|..++
T Consensus 266 -STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP 337 (904)
T KOG4721|consen 266 -STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCP 337 (904)
T ss_pred -hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCc
Confidence 566789999999999999999999999999999999999999999999999999999998889999998875
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.64 Aligned_cols=219 Identities=26% Similarity=0.414 Sum_probs=187.8
Q ss_pred ceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHH---hCCCCCeeeEEEEEeeCCeeEEE
Q 038211 380 LQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIK---KLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~---~l~h~niv~~~~~~~~~~~~~lv 453 (605)
|++++.||+|+||.||++.+ .++.||||++.+.... ....+.+.+|++++. .++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67899999999999999987 4677999998765422 234556777776654 55799999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
|||+++++|...+.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 999999999888765 56899999999999999999999999 99999999999999999999999999875433333
Q ss_pred cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.....+|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..++...| ....+.+|..++
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i--~~~~~~~p~~~~ 225 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI--VNDEVRYPRFLS 225 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhCCCCCCCCCC
Confidence 445567999999999999999999999999999999999999999999988888888 344566777665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=320.85 Aligned_cols=218 Identities=26% Similarity=0.383 Sum_probs=190.0
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.+|++.++||+|+||.||+|.+. ++.||||++.+.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 37999999999999999999874 678999998765332 234566889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+++++|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..... .
T Consensus 81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~ 154 (333)
T cd05600 81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---Y 154 (333)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc---c
Confidence 999999999998764 67889999999999999999999999 99999999999999999999999999975543 2
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~ 601 (605)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+......+..|.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 221 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPV 221 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCC
Confidence 3455789999999999999999999999999999999999999999998888877754444344443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.66 Aligned_cols=221 Identities=22% Similarity=0.413 Sum_probs=191.0
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCeeEEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~ 454 (605)
+|++.+.||+|+||.||+|.+ .++.||+|++.+.... ....+.+..|..+++.+. |++|+.+++++.+.+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 478899999999999999987 4677999998765332 334566778999998885 577889999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+++++|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.........
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 999999999988765 67899999999999999999999999 999999999999999999999999998754333333
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..| ....+.+|..+|
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i--~~~~~~~p~~~~ 225 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI--MEHNVSYPKSLS 225 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--HhCCCCCCccCC
Confidence 44567899999999999988999999999999999999999999999998888888 445677787765
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=320.49 Aligned_cols=224 Identities=21% Similarity=0.331 Sum_probs=192.8
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
++|++.+.||+|+||.||++++. ++.||+|++.+... .......+.+|..++..++|+||+.+++++..++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999874 56699999876432 2234456788999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc-
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL- 533 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~- 533 (605)
||++||+|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999999999876678899999999999999999999999 99999999999999999999999999875443222
Q ss_pred cccCCCCCCcccccccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRS-----EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..|.....++++|+.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 233 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcc
Confidence 2233568999999999876 457889999999999999999999999999888888886666677777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=317.09 Aligned_cols=216 Identities=25% Similarity=0.431 Sum_probs=185.2
Q ss_pred eeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
++||+|+||+||+|.+. ++.||+|++.+.... ....+.+..|..++..+ +||||+++++++...+.+++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999874 556999998765422 23345556677777655 899999999999999999999999999
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
++|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 9999888765 67899999999999999999999999 99999999999999999999999999975433333344567
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+++..| ....+.+|..++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~ 220 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI--LNDRPHFPRWIS 220 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH--HcCCCCCCCCCC
Confidence 999999999999999999999999999999999999999999999988888 445677787765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=317.67 Aligned_cols=216 Identities=25% Similarity=0.390 Sum_probs=187.4
Q ss_pred eeecccCcEEEEEEEEC--CcceEEEEeecccc-chhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
++||+|+||+||+|.++ ++.||+|++.+... .......+..|..++..+ +||||++++++|...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 66799999876532 233456677888888877 699999999999999999999999999
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
++|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.............
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 9999888765 67899999999999999999999999 99999999999999999999999999875433333344567
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+++..| ....+.+|..++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~ 220 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--LNDEVVYPTWLS 220 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH--hcCCCCCCCCCC
Confidence 999999999999999999999999999999999999999999999999988 455677777665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=322.96 Aligned_cols=225 Identities=25% Similarity=0.373 Sum_probs=192.0
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
..+..++|++.+.||+|+||.||++.++ ++.+|+|++.+.... ......+.+|+.+++.++||||+++++++..++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3455689999999999999999999874 667999998654322 2334567889999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 9999999999999998865 45888899999999999999999999 9999999999999999999999999997654
Q ss_pred ccc-ccccCCCCCCcccccccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCC
Q 038211 530 ATY-LTAKSGRGTPQWMAPEVLRSEP----SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 530 ~~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~ 601 (605)
... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......|......+.+|.
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence 322 1233567999999999987643 67899999999999999999999999998888888865555566665
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=317.64 Aligned_cols=223 Identities=22% Similarity=0.337 Sum_probs=190.6
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
++|++++.||+|+||.||++.+. ++.||+|++.+... .....+.+.+|+.+++.++|+||+.++++|.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999874 67799999876432 2334566889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc-
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL- 533 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~- 533 (605)
||+++++|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 999999999999876678999999999999999999999999 99999999999999999999999999865432222
Q ss_pred cccCCCCCCcccccccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRS-----EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....|......+.+|+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 232 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD 232 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCc
Confidence 2223468999999999874 34678999999999999999999999998888888888655555666654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.28 Aligned_cols=217 Identities=26% Similarity=0.456 Sum_probs=187.3
Q ss_pred eeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCC
Q 038211 384 EEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRG 460 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~gg 460 (605)
+.||+|+||.||++.+ .+..||+|++.+.... ......+.+|+++++.++||||++++++|...+.+++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 5677999998765332 234566778999999999999999999999999999999999999
Q ss_pred chHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 461 SLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH-RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 461 sL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
+|..++.+. ..+++..+..++.||+.||+|||+ .| |+||||||+|||++.++.+||+|||+++.............
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 999888765 578999999999999999999997 79 99999999999999999999999999875433333334557
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+ ....+.+|..+++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i--~~~~~~~p~~~~~ 221 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEEIRFPRTLSP 221 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH--hcCCCCCCCCCCH
Confidence 999999999999999999999999999999999999999998888888887 4456777877653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.28 Aligned_cols=222 Identities=27% Similarity=0.447 Sum_probs=194.5
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
++|.+.+.||+|+||+||+|.+. ++.||||++.+..... .....+.+|+.+++.++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999985 7889999987654332 45567889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc--
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY-- 532 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~-- 532 (605)
||+++++|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 999999999999876 78999999999999999999999999 9999999999999999999999999987654332
Q ss_pred ---------------------------ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 038211 533 ---------------------------LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQ 585 (605)
Q Consensus 533 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~ 585 (605)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 12334568999999999999999999999999999999999999999999888
Q ss_pred HHHHhccCCCccCCCCC
Q 038211 586 VVGVVGFMDRRLELPEG 602 (605)
Q Consensus 586 ~~~~I~~~~~~~~~P~~ 602 (605)
....|......+.+|..
T Consensus 238 ~~~~i~~~~~~~~~p~~ 254 (350)
T cd05573 238 TYNKIINWKESLRFPPD 254 (350)
T ss_pred HHHHHhccCCcccCCCC
Confidence 88888654455566654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=317.84 Aligned_cols=216 Identities=23% Similarity=0.379 Sum_probs=187.0
Q ss_pred eeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
++||+|+||.||+|.+. ++.||+|++.+.... ......+..|.+++..+ +||||++++++|...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 567999998765332 33455677889998876 799999999999999999999999999
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
++|...+... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 9999888765 67889999999999999999999999 99999999999999999999999999875443333444567
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+++..| ....+.+|..++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i--~~~~~~~p~~~~ 220 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI--LHDDVLYPVWLS 220 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH--HcCCCCCCCCCC
Confidence 899999999999999999999999999999999999999999999999988 445567776655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.23 Aligned_cols=205 Identities=27% Similarity=0.379 Sum_probs=181.5
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-C-----CCeeeEEEEEeeCCe
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-H-----PNVLLFMGAVASQER 449 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h-----~niv~~~~~~~~~~~ 449 (605)
-+|.+++.||+|+||.|.+|.+ +++.||||+++... ....+...|+.+|..++ | -|+|+++++|...++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 3899999999999999999988 46779999987643 45566788999999996 4 489999999999999
Q ss_pred eEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC--CCcEEEEeecCCc
Q 038211 450 LGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK--NWTVKVGDFGLSS 526 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~--~~~vkl~Dfg~a~ 526 (605)
+|||+|.+ .-+|+++++.+ ...++...++.++.||+.||.+||+.+ |||+||||+||||.. ...||++|||.|+
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEeccccc
Confidence 99999999 67999999875 577999999999999999999999999 999999999999964 3479999999998
Q ss_pred ccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 527 LKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 527 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
....... +++.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.+..+.+..|.
T Consensus 340 ~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~ 401 (586)
T KOG0667|consen 340 FESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARII 401 (586)
T ss_pred ccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHH
Confidence 7754433 6677999999999999999999999999999999999999999988766666663
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=311.63 Aligned_cols=226 Identities=23% Similarity=0.330 Sum_probs=194.2
Q ss_pred ccccCceEeeeecccCcEEEEEEE--ECCcceEEEEeeccccchh-hhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEG-TLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~--~~~~~~avKv~~~~~~~~~-~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
+....|..-++||+|+||.||-++ .+|+.||+|.+.+...... .-....+|..+|.+++.++||.+-.+|++.+.+|
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 455778899999999999999664 5789999998866544322 2344678999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 452 IVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
+||..|+||+|..+|.+. ...+++..++.|+.+|+.||++||+.+ ||+|||||+|||+|+.|+++|+|+|+|.....
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999888765 358999999999999999999999999 99999999999999999999999999987654
Q ss_pred ccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHhccCCCccCCCCCCCC
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL----NLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~----~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.. .....+||.+|||||++.+..|+...|||||||++|||+.|+.||... ..+++=.++ .....++|+.||+
T Consensus 340 g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~--~~~~~ey~~kFS~ 415 (591)
T KOG0986|consen 340 GK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT--LEDPEEYSDKFSE 415 (591)
T ss_pred CC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH--hcchhhcccccCH
Confidence 43 334458999999999999999999999999999999999999999753 234666666 4566788888875
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.18 Aligned_cols=218 Identities=28% Similarity=0.421 Sum_probs=190.0
Q ss_pred eeeecccCcEEEEEEEE-----CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEec
Q 038211 383 GEEIGLGSYAVVYRGIW-----NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFL 457 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~-----~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~ 457 (605)
+++||+|+||.||++++ .++.+|+|++.+..........+.+|+.++++++||||++++++|..++.+|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36799999999999875 4677999999775544444556778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccC
Q 038211 458 PRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKS 537 (605)
Q Consensus 458 ~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~ 537 (605)
++++|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++............
T Consensus 81 ~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 81 RGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceec
Confidence 999999998764 67899999999999999999999999 999999999999999999999999998765443333445
Q ss_pred CCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 538 GRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 538 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
..||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+.+..| ....+.+|+.+++
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i--~~~~~~~p~~~~~ 223 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI--LKAKLGMPQFLSP 223 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH--HcCCCCCCCCCCH
Confidence 67899999999999988999999999999999999999999999988888888 4455778877653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=317.24 Aligned_cols=223 Identities=22% Similarity=0.345 Sum_probs=191.3
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
++|++.++||+|+||.||++.++ ++.+|+|++.+.... ......+.+|+.++..++|+||+.+++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999875 556999998654322 233455788999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc-c
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY-L 533 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~-~ 533 (605)
||+++|+|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 999999999999876678999999999999999999999999 9999999999999999999999999986543221 2
Q ss_pred cccCCCCCCcccccccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRS-----EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+.+|.....++.+|..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 232 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQ 232 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCc
Confidence 2234579999999999863 45788999999999999999999999999999999998666666677764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=321.93 Aligned_cols=225 Identities=24% Similarity=0.369 Sum_probs=191.9
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
.+..++|++.++||+|+||.||++.+. +..||+|++.+.... ......+.+|+.+++.++||||+++++++.+++.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 355689999999999999999999874 667999998764332 23345577899999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
++||||++||+|.+++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999998865 45888899999999999999999999 99999999999999999999999999876533
Q ss_pred cc-ccccCCCCCCcccccccccCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCC
Q 038211 531 TY-LTAKSGRGTPQWMAPEVLRSE----PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 531 ~~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
.. ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...+....+..|......+.+|+.
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD 271 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCc
Confidence 22 123356799999999998754 3788999999999999999999999999888888888655556677764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=315.80 Aligned_cols=195 Identities=31% Similarity=0.476 Sum_probs=177.1
Q ss_pred eeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCCc
Q 038211 384 EEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGS 461 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ggs 461 (605)
++||+|.||+||-|++ +|++||||++.+..+..+....+++|+.||+.++||.||.+...|++.+++++|||-+.|.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 7899999999998865 68999999999988887777889999999999999999999999999999999999997766
Q ss_pred hHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC---CcEEEEeecCCcccCcccccccCC
Q 038211 462 LFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN---WTVKVGDFGLSSLKNATYLTAKSG 538 (605)
Q Consensus 462 L~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~---~~vkl~Dfg~a~~~~~~~~~~~~~ 538 (605)
|+-.+....+++++.....++.||+.||.|||.++ |+|+||||+|||+... -++||||||+|++..... .+.+.
T Consensus 650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-FRrsV 726 (888)
T KOG4236|consen 650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-FRRSV 726 (888)
T ss_pred HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhh-hhhhh
Confidence 66666667799999999999999999999999999 9999999999999643 589999999999876554 45667
Q ss_pred CCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 539 RGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 539 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
+|||.|+|||+++...|...-||||+|||+|--+.|..||...
T Consensus 727 VGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred cCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 8999999999999999999999999999999999999999753
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=317.77 Aligned_cols=226 Identities=29% Similarity=0.489 Sum_probs=202.3
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
+.......|.+.++||+|.|++|.++++ ++..||||++.++.......+.+.+|+++|+.++|||||+++.+...+..
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 3345567899999999999999999987 68889999999887776666678999999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+|+||||+.+|.+++++.+. +...+..+..++.|+++|++|||+++ |+|||||++||||+.+.++||+|||++.++.
T Consensus 130 lylV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred eEEEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeec
Confidence 99999999999999999887 66666888999999999999999999 9999999999999999999999999999887
Q ss_pred cccccccCCCCCCcccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
......++||++.|.|||++.+..| .+.+|+||+|+++|.|+.|.+||++.+..++-.++. .+++.||-.+
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl--~gk~rIp~~m 278 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL--RGKYRIPFYM 278 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe--eeeeccccee
Confidence 4456678899999999999999988 578999999999999999999999999999888884 4445555433
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.33 Aligned_cols=220 Identities=29% Similarity=0.453 Sum_probs=195.5
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccch-hhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCeeEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~l 452 (605)
...|++.+.||+|.||.||++.. +|+.+|+|++.+..... .....+.+|+.+|+++. |||||.++++|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 46799999999999999999987 47779999998876532 24568899999999998 9999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC----CCcEEEEeecCCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK----NWTVKVGDFGLSSLK 528 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~----~~~vkl~Dfg~a~~~ 528 (605)
|||+|.||.|++.+... . +++..+..++.||+.|+.|||+.| |+||||||+|+|+.. ++.+|++|||++...
T Consensus 114 vmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999876 3 999999999999999999999999 999999999999953 358999999999887
Q ss_pred CcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCC
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~ 601 (605)
.. .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+..+...+|...+..+.-|.
T Consensus 190 ~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~ 261 (382)
T KOG0032|consen 190 KP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEP 261 (382)
T ss_pred cC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCC
Confidence 66 4456677999999999999999999999999999999999999999999998888889965554444443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=319.29 Aligned_cols=228 Identities=21% Similarity=0.354 Sum_probs=207.2
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECCcc--eEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNGSD--VAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~--~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
..+.+.+++.+..||-|+||.|-++..+++. +|+|++++.+..+ +..+.+..|.+||..++.|+||++|-.|.+..+
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 3466788999999999999999998876655 8999998877654 566778899999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+|++||-|-||.|+..+... +.+++...+.|+..++.|++|||++| ||+|||||+|++++.+|-+||.|||+|+...
T Consensus 495 vYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 99999999999999999876 88999999999999999999999999 9999999999999999999999999998876
Q ss_pred cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
... .+.++||||.|.|||++.+...+.++|.||||+++|||++|.+||.+.+++.++..|.+.=..+.+|..+.
T Consensus 572 ~g~-KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~ 645 (732)
T KOG0614|consen 572 SGR-KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRIT 645 (732)
T ss_pred cCC-ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccc
Confidence 544 45688999999999999999999999999999999999999999999999999999977766778887653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=316.71 Aligned_cols=227 Identities=29% Similarity=0.474 Sum_probs=183.1
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEe
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVA 445 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~ 445 (605)
.+..++|++.++||+|+||.||+|.+. +..||||++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 455678999999999999999999742 3469999886432 233456788999999999 8999999999887
Q ss_pred eC-CeeEEEEEecCCCchHHHHHhhc------------------------------------------------------
Q 038211 446 SQ-ERLGIVTEFLPRGSLFKTLHKNY------------------------------------------------------ 470 (605)
Q Consensus 446 ~~-~~~~lv~e~~~ggsL~~~l~~~~------------------------------------------------------ 470 (605)
.. ..++++|||+++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 64 46899999999999999987531
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc--ccccCCCCC
Q 038211 471 -------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGT 541 (605)
Q Consensus 471 -------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt 541 (605)
..+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++...... .......++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 24777888899999999999999999 9999999999999999999999999997543221 122233457
Q ss_pred CcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHH-HHHHhccCCCccCCCCCCC
Q 038211 542 PQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQ-VVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 542 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~-~~~~I~~~~~~~~~P~~~~ 604 (605)
+.|+|||++.+..++.++|||||||++|||++ |..||.+....+ +...+ ..+..+..|+.++
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~ 303 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL-KDGTRMRAPENAT 303 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH-hcCCCCCCCCCCC
Confidence 88999999999999999999999999999997 999998866443 33433 3455566666654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=313.03 Aligned_cols=216 Identities=24% Similarity=0.386 Sum_probs=185.2
Q ss_pred eeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
++||+|+||.||++.++ +..||+|++.+.... .........|..++... +||||++++++|...+.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999874 667999998765322 23445667788888765 899999999999999999999999999
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
++|..++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.++|+|||+++............+
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 9999988764 67889999999999999999999999 99999999999999999999999999864332223334567
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...+ ....+.+|..++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~--~~~~~~~~~~~~ 220 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI--RVDTPHYPRWIT 220 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--HhCCCCCCCCCC
Confidence 899999999999999999999999999999999999999999888888888 345577777665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=314.89 Aligned_cols=216 Identities=31% Similarity=0.474 Sum_probs=183.2
Q ss_pred eeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHH-HHHhCCCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEID-IIKKLRHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~-il~~l~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
++||+|+||+||+|.+ .+..||+|++.+.... ......+..|.. +++.++||||++++++|.+.+.+++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999987 4677999998765432 223344555554 67888999999999999999999999999999
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
++|...+.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++............+
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 9998888664 67888899999999999999999999 99999999999999999999999999875433333344567
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..++...| ....+.+|+..+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~ 220 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI--LHKPLQLPGGKT 220 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH--hcCCCCCCCCCC
Confidence 899999999999988999999999999999999999999999988888888 445677776654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=314.79 Aligned_cols=216 Identities=27% Similarity=0.457 Sum_probs=183.7
Q ss_pred eeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHH-HHHhCCCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEID-IIKKLRHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~-il~~l~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
++||+|+||+||+|.+ .++.||+|++.+.... ......+.+|.. +++.++||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4799999999999988 4777999998765332 223344555554 56788999999999999999999999999999
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
++|..++.+. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.............+
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 9999988765 67889999999999999999999999 99999999999999999999999999875433333444567
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..++...| ....+.+|+.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~ 220 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI--LNKPLRLKPNIS 220 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH--HcCCCCCCCCCC
Confidence 999999999999999999999999999999999999999999988888888 344566666654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=305.82 Aligned_cols=220 Identities=22% Similarity=0.299 Sum_probs=183.6
Q ss_pred ceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 380 LQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
|++.+.||+|+||.||++.+ .++.||+|++.+..... .....+.+|+.+++.++|+||+.+++++.+.+.+++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 78899999999999999986 57789999987654322 2334577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 457 LPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 457 ~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
+++|+|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++....... ..
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TV 158 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-ee
Confidence 9999998887653 346899999999999999999999999 9999999999999999999999999987643221 22
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHhccCCCccCCCCCCC
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNL----MQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~----~~~~~~I~~~~~~~~~P~~~~ 604 (605)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+. .++...+ ......+|..+|
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~s 229 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV--KEDQEEYSEKFS 229 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh--hcccccCCccCC
Confidence 345789999999999999999999999999999999999999987543 2333333 334456666655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=307.31 Aligned_cols=210 Identities=26% Similarity=0.405 Sum_probs=180.9
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.++|++.++||.|+||.||+|.+. +..||+|++..... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 468999999999999999999874 66799998865432 223446778999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+++ +|.+++......+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++........
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 99964 898888776567889999999999999999999999 999999999999999999999999999765433333
Q ss_pred ccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 535 AKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 216 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 345568999999999876 55789999999999999999999999988877666655
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=314.51 Aligned_cols=216 Identities=27% Similarity=0.416 Sum_probs=180.5
Q ss_pred eeecccCcEEEEEEEEC--CcceEEEEeeccccch-hhhhhHHHHH-HHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE-GTLKNYQKEI-DIIKKLRHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~-~~~~~~~~E~-~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
+.||+|+||+||+|.+. ++.||+|++.+..... .....+..|. .+++.++||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999874 5669999987643221 2223344444 456788999999999999999999999999999
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
++|..++... ..+.+..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 9999988765 56788888899999999999999999 99999999999999999999999999875433333344567
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+++..|. ...+.+++.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~ 220 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNIT 220 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH--hCCcCCCCCCC
Confidence 9999999999999999999999999999999999999999999888888873 34455665554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.82 Aligned_cols=216 Identities=25% Similarity=0.413 Sum_probs=182.1
Q ss_pred eeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
++||+|+||.||++.+ .++.||+|++.+.... ......+.+|..+++.+ +||||++++++|...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999987 4667999999765432 23456678899999998 799999999999999999999999999
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
++|..++.+. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 9999888765 67999999999999999999999999 99999999999999999999999999875333333344567
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--------H-HHHHHHhccCCCccCCCCCCC
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN--------L-MQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~--------~-~~~~~~I~~~~~~~~~P~~~~ 604 (605)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||.... . ..+...+ ...++.+|..++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~ 229 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--LEKQIRIPRSLS 229 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--HcCCCCCCCCCC
Confidence 9999999999999999999999999999999999999996321 1 2234444 455677887765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=301.80 Aligned_cols=203 Identities=26% Similarity=0.409 Sum_probs=169.6
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC--C---ee
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ--E---RL 450 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~---~~ 450 (605)
-.|.-.+++|.|+||.||.|.. .+..+|||....+.. --.+|+.+|+.++|||||++..+|... . .+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 3578889999999999999976 456799998766542 224799999999999999999988642 2 46
Q ss_pred EEEEEecCCCchHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC-CcEEEEeecCCc
Q 038211 451 GIVTEFLPRGSLFKTLHK---NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN-WTVKVGDFGLSS 526 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~-~~vkl~Dfg~a~ 526 (605)
.+||||++ .+|...++. ....++...++-|..||++||.|||+.| |+||||||.|+|+|.+ |.+||||||.|+
T Consensus 98 nlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 68999995 589888874 2477888888999999999999999999 9999999999999975 999999999998
Q ss_pred ccCcccccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 527 LKNATYLTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 527 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
........ .++..|..|+|||.+.|. .|+.+.||||.||++.||+-|++-|.+.+....+..|
T Consensus 175 ~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eI 238 (364)
T KOG0658|consen 175 VLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEI 238 (364)
T ss_pred eeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHH
Confidence 76544333 455679999999999885 5899999999999999999999999987754444443
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=310.33 Aligned_cols=216 Identities=25% Similarity=0.398 Sum_probs=183.7
Q ss_pred eeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
+.||+|+||+||+|.+. ++.||||++...... .........|..++... +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999874 566999998765321 23345566788888765 899999999999999999999999999
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 9999998764 67889999999999999999999999 99999999999999999999999999875332223334557
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...+. ...+.+|..++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~--~~~~~~~~~~~ 220 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR--MDNPCYPRWLT 220 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCccCC
Confidence 8999999999999999999999999999999999999999999888888884 33466776654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.99 Aligned_cols=221 Identities=23% Similarity=0.367 Sum_probs=184.0
Q ss_pred CceEeeeecccCcEEEEEEEE-----CCcceEEEEeeccccc--hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCee
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW-----NGSDVAVKVYFGSEYI--EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERL 450 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~-----~~~~~avKv~~~~~~~--~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~ 450 (605)
+|+++++||+|+||+||+++. .++.||+|++.+.... ....+.+.+|+.+++.+ +|+||+.++++|...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 589999999999999999875 4677999998764332 23355678899999999 599999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 9999999999999998764 67899999999999999999999999 99999999999999999999999999875432
Q ss_pred cc-ccccCCCCCCcccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHhccCCCccCCCCCCC
Q 038211 531 TY-LTAKSGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTASIPWNNL----NLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 531 ~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~Pf~~~----~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||... ...++...+ ....+.+|..++
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSFIG 235 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCCCC
Confidence 22 2223457899999999998754 788999999999999999999999642 334555555 345567777665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.55 Aligned_cols=216 Identities=29% Similarity=0.443 Sum_probs=182.3
Q ss_pred eeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHH-HHHhCCCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEID-IIKKLRHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~-il~~l~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
++||+|+||+||+|.+ .++.+|+|++.+.... ......+..|.. +++.++||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999987 4778999998765322 223344555554 46778999999999999999999999999999
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
++|..++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 9998888764 67899999999999999999999999 99999999999999999999999999875433333344567
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
||+.|+|||++.+..++.++|||||||++|+|++|..||...+..++...+. ...+.+++.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~ 220 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL--HKPLVLRPGAS 220 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH--cCCccCCCCCC
Confidence 9999999999999999999999999999999999999999999888888873 34455555544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=317.55 Aligned_cols=232 Identities=34% Similarity=0.564 Sum_probs=204.1
Q ss_pred ccCCCCccccCceEeeeecccCcEEEEEEEECC-----cc-eEEEEeecc-ccchhhhhhHHHHHHHHHhCCCCCeeeEE
Q 038211 369 CATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNG-----SD-VAVKVYFGS-EYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441 (605)
Q Consensus 369 ~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~-----~~-~avKv~~~~-~~~~~~~~~~~~E~~il~~l~h~niv~~~ 441 (605)
....+.+.+++..+.++||+|+||.||+|..+- .. ||+|..+.. .........+.+|.++++.++|||||++|
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 344577888899999999999999999997631 12 789987753 34566788899999999999999999999
Q ss_pred EEEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEe
Q 038211 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGD 521 (605)
Q Consensus 442 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~D 521 (605)
|+......+++|||+|+||+|.++|++....++......++.+.+.||+|||+++ +|||||-.+|+|++.++.+||+|
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999999999999999998777999999999999999999999999 99999999999999999999999
Q ss_pred ecCCcccCccccccc-CCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCC
Q 038211 522 FGLSSLKNATYLTAK-SGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLEL 599 (605)
Q Consensus 522 fg~a~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~ 599 (605)
||+++... ...... ...-+..|+|||.+....|++++|||||||++||+++ |..||.++...++...|...+.+.++
T Consensus 306 FGLs~~~~-~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 306 FGLSRAGS-QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI 384 (474)
T ss_pred cccccCCc-ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC
Confidence 99998765 222222 2235789999999999999999999999999999999 89999999999999999878888888
Q ss_pred CCCC
Q 038211 600 PEGL 603 (605)
Q Consensus 600 P~~~ 603 (605)
|...
T Consensus 385 ~~~~ 388 (474)
T KOG0194|consen 385 PSKT 388 (474)
T ss_pred CCCC
Confidence 8753
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.57 Aligned_cols=218 Identities=28% Similarity=0.439 Sum_probs=192.9
Q ss_pred eecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCCchHH
Q 038211 385 EIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFK 464 (605)
Q Consensus 385 ~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ggsL~~ 464 (605)
+||+|.||+||-|++..+.|-|.+...........+.+.+|+.+.++++|.|||+++|++..++++-|.||-++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999876665333333334445678889999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc-CCCcEEEEeecCCcccCcccccccCCCCC
Q 038211 465 TLHKNYQAL--DIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD-KNWTVKVGDFGLSSLKNATYLTAKSGRGT 541 (605)
Q Consensus 465 ~l~~~~~~~--~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt 541 (605)
+++...+++ .+..+-.|..||+.||.|||++. |||||||-+|+|++ -.|.+||+|||-++....-...+.++.||
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT 739 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT 739 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence 999887888 88899999999999999999999 99999999999996 58999999999998877777788899999
Q ss_pred CcccccccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHhccCCCccCCCCCCC
Q 038211 542 PQWMAPEVLRSE--PSNEKSDVFSFGVILWELVTASIPWNNL-NLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 542 ~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~Pf~~~-~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
..|||||++... .|+.++|||||||++.||+||++||..+ ++.....+++.-+-.++||+.+|
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeels 805 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELS 805 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHH
Confidence 999999999654 5789999999999999999999999875 45667778887788999999875
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=310.06 Aligned_cols=216 Identities=25% Similarity=0.428 Sum_probs=186.6
Q ss_pred eeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
+.||+|+||+||++.+. +..||+|++.+.... ......+.+|..+++.+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 567999998765422 23456677899999888 799999999999999999999999999
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
++|..++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 9999888765 57899999999999999999999999 99999999999999999999999999875433333334457
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..++...| ....+.+|..++
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i--~~~~~~~~~~~~ 220 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI--LEDEVRYPRWLS 220 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH--HcCCCCCCCcCC
Confidence 899999999999999999999999999999999999999999988888888 445567777665
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.22 Aligned_cols=222 Identities=26% Similarity=0.387 Sum_probs=190.2
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
++|.+.+.||+|+||+||++.+ .++.||+|++.+... .....+.+.+|+.+++.++|+||+++++++...+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4799999999999999999987 467799999876543 2334566889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc-c
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY-L 533 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~-~ 533 (605)
||+++++|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999999999999887678999999999999999999999999 9999999999999999999999999997654322 1
Q ss_pred cccCCCCCCccccccccc------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLR------SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~ 601 (605)
......||+.|+|||++. +..++.++|||||||++|+|++|+.||...+..+.+..|......+.+|.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE 232 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCC
Confidence 223446899999999987 45577899999999999999999999999888888887754444455554
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=311.26 Aligned_cols=216 Identities=25% Similarity=0.413 Sum_probs=180.8
Q ss_pred eeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
+.||+|+||+||++.+. ++.+|+|++.+.... ......+.+|+.++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999874 567999998765332 23455677899888877 899999999999999999999999999
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
++|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.............
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 9998888665 67899999999999999999999999 99999999999999999999999999875433333344567
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---------CHHHHHHHhccCCCccCCCCCCC
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL---------NLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~---------~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
||+.|+|||++.+..++.++|||||||++|+|++|+.||... ....+...+ ...++.+|..++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~~~~ 229 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSLS 229 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--hcCCCCCCCCCC
Confidence 999999999999999999999999999999999999999521 122344444 445677887765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=306.44 Aligned_cols=202 Identities=30% Similarity=0.457 Sum_probs=175.0
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.++|++.++||+|+||.||+|.+ +++.||+|++..... ......+.+|+.+++.++||||+++++++.++...++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 36899999999999999999987 467799999865432 222345678999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+. ++|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 9995 6888888776677899999999999999999999999 999999999999999999999999998755433334
Q ss_pred ccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
.....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 4456789999999998764 57889999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.35 Aligned_cols=202 Identities=37% Similarity=0.620 Sum_probs=175.4
Q ss_pred cCceEeeeecccCcEEEEEEEECC-cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC-eeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWNG-SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE-RLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~~-~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-~~~lv~e 455 (605)
++|.-...||+|+||.||+|...+ +.||||.+....... ...|.+|+.++.+++|||+|+++|||.+.+ ..+||+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 567777899999999999998755 789999765543321 345999999999999999999999999888 5999999
Q ss_pred ecCCCchHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC-CCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 456 FLPRGSLFKTLHKNYQ-ALDIKRRLRMALDVARGMNYLHHRN-PPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~-~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
|++.|+|.+++..... .++|..+++|+.+++.||+|||+.. ++|||||||++|||||++.+.||+|||+|+.......
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~ 232 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT 232 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccc
Confidence 9999999999988765 8999999999999999999999865 4799999999999999999999999999976654111
Q ss_pred cccCC-CCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 534 TAKSG-RGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 534 ~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
..... .||..|+|||.+.....+.++|||||||+|+||++|+.|.+..
T Consensus 233 ~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 233 SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 11122 7899999999999888999999999999999999999988753
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=309.64 Aligned_cols=216 Identities=25% Similarity=0.406 Sum_probs=181.4
Q ss_pred eeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
++||+|+||+||++.+. ++.+|+|++.+.... ....+.+.+|+.++..+ +||||+.+++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999874 567999998765432 23456788999999888 699999999999999999999999999
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
++|..++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++............+
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 9999888765 67999999999999999999999999 99999999999999999999999999875433333344567
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC------CCHH-HHHHHhccCCCccCCCCCCC
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN------LNLM-QVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~------~~~~-~~~~~I~~~~~~~~~P~~~~ 604 (605)
||+.|+|||++.+..++.++|||||||++|+|++|..||.. .+.. .+...+ ....+.+|..+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~ 227 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIRIPRFLS 227 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH--HhCCCCCCCCCC
Confidence 99999999999999999999999999999999999999953 2223 334444 345567787665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.73 Aligned_cols=226 Identities=23% Similarity=0.416 Sum_probs=190.3
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC-----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN-----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~-----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
+...+|++.+.||+|+||.||+|.++ +..+|+|.+.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 34578999999999999999999753 4468999876542 23345678899999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
.++||||+++++|.+++......+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.++++|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999999999876678899999999999999999999999 9999999999999999999999999876532
Q ss_pred ccc-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 530 ATY-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 530 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+++..+. .+.++++|+.++
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCP 234 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCC
Confidence 221 11123345678999999999999999999999999999775 999999999888888885 334556676654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=301.80 Aligned_cols=221 Identities=24% Similarity=0.418 Sum_probs=188.6
Q ss_pred cCceEe--eeecccCcEEEEEEEECCcceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEee----CCee
Q 038211 378 EDLQLG--EEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVAS----QERL 450 (605)
Q Consensus 378 ~~~~~~--~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~----~~~~ 450 (605)
+++... ..||+|++|.||+|.++++.||||++....... ...+.+.+|+.+|++++||||+++++++.+ ...+
T Consensus 18 ~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~ 97 (283)
T PHA02988 18 DDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL 97 (283)
T ss_pred HHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCce
Confidence 344444 579999999999999999999999987654322 235678899999999999999999999876 3578
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR-NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
++||||+++|+|.+++... ..+++.....++.|++.||.|||+. + ++||||||+|||++.++.+||+|||+++...
T Consensus 98 ~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~ 174 (283)
T PHA02988 98 SLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKILS 174 (283)
T ss_pred EEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence 9999999999999999765 5788889999999999999999984 8 8999999999999999999999999987543
Q ss_pred cccccccCCCCCCcccccccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRS--EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.. .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..++...+...+.++.+|..++
T Consensus 175 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (283)
T PHA02988 175 SP---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCP 248 (283)
T ss_pred cc---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCc
Confidence 22 123467999999999976 6789999999999999999999999999999998888866667778876554
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=297.81 Aligned_cols=208 Identities=27% Similarity=0.467 Sum_probs=192.4
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
+-|.++++||+|+||.||+|.+ .|.-+|+|.+.. +..++.+..|+.++++++.|++|++|+.+.....+|+|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 4578899999999999999987 467789987543 3467888999999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
||..|++.+.++.+...+.+..+..++...+.||+|||... -||||||..|||++.+|+.||+|||.|.........+
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 99999999999988899999999999999999999999998 8999999999999999999999999998887777777
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
.+..|||.|||||++..-.|+.++||||||++..||+.|++||.+..++..+..|.
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP 242 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP 242 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc
Confidence 88899999999999999999999999999999999999999999999988888873
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=294.76 Aligned_cols=209 Identities=26% Similarity=0.395 Sum_probs=178.9
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC-----Cee
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ-----ERL 450 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~ 450 (605)
..|..++.||+|+||.|..+.+ +|..||+|.+...-......++..+|+.+|+.++|+||+.+.+.+..+ ..+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 4566689999999999999987 577899998865444456678899999999999999999999998762 469
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
|+|+|+| +.+|...++.+ ..+++..+..+++||+.||.|+|+.+ |+||||||.|+|++.+..+||+|||+|+....
T Consensus 102 YiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred EEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeeccc
Confidence 9999999 67898888764 56999999999999999999999999 99999999999999999999999999987643
Q ss_pred c--cccccCCCCCCccccccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 531 T--YLTAKSGRGTPQWMAPEVLR-SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 531 ~--~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
. ....+.++-|.+|.|||++. ...|+.+.||||+||||.||++|++.|.+.+-.+-+..|
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI 240 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLI 240 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 2 22234567899999999875 467899999999999999999999999998765555554
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.49 Aligned_cols=226 Identities=26% Similarity=0.389 Sum_probs=193.0
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC-----
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE----- 448 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~----- 448 (605)
..++|.+.++||+|+||+||++.+ .++.||||++............+.+|+.++..++|+||++++..+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 346999999999999999999986 5788999999877666666777889999999999999999988775432
Q ss_pred ---eeEEEEEecCCCchHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEee
Q 038211 449 ---RLGIVTEFLPRGSLFKTLHKN---YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDF 522 (605)
Q Consensus 449 ---~~~lv~e~~~ggsL~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Df 522 (605)
.+++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCEEEEec
Confidence 368999999999999988653 356899999999999999999999999 999999999999999999999999
Q ss_pred cCCcccCcc--cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCC
Q 038211 523 GLSSLKNAT--YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELP 600 (605)
Q Consensus 523 g~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P 600 (605)
|+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+++..+. .+...++|
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~-~~~~~~~~ 266 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL-AGRYDPLP 266 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-cCCCCCCC
Confidence 999764322 122345679999999999999999999999999999999999999999999888888874 33344577
Q ss_pred CCCC
Q 038211 601 EGLD 604 (605)
Q Consensus 601 ~~~~ 604 (605)
+.++
T Consensus 267 ~~~~ 270 (496)
T PTZ00283 267 PSIS 270 (496)
T ss_pred CCCC
Confidence 7665
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.18 Aligned_cols=210 Identities=22% Similarity=0.329 Sum_probs=179.9
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
++|++.+.||+|+||.||+++++ +..+|+|++..........+.+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36999999999999999999884 5679999987665444456678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc-cc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY-LT 534 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~-~~ 534 (605)
|++++.+.. +......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~~~~~l~~-~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLEL-LEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 998876654 4444467899999999999999999999999 9999999999999999999999999997653322 12
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.....||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 23456899999999999988999999999999999999999999987765554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=284.29 Aligned_cols=223 Identities=28% Similarity=0.458 Sum_probs=192.7
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc------hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEee
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI------EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVAS 446 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~------~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~ 446 (605)
.+..|.-.+.||+|..++|.++.+ .+..+|+|++...... ....+...+|+.||+++ .||+|+.+.++|++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 346778889999999999998876 4677999988543221 23355667899999999 79999999999999
Q ss_pred CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCc
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~ 526 (605)
+..+++|+|.|+.|.|++++... -.+++...+.++.||+.|+.|||.++ ||||||||+|||++++.+++|+|||+|+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccceee
Confidence 99999999999999999999775 78999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCcccccccCCCCCCcccccccccCC------CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCC
Q 038211 527 LKNATYLTAKSGRGTPQWMAPEVLRSE------PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELP 600 (605)
Q Consensus 527 ~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P 600 (605)
...... .....||||.|+|||.+... .|+..+|+||+||+||.|+.|.+||-+...+-++..|...+.++.-|
T Consensus 172 ~l~~Ge-kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 172 QLEPGE-KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred ccCCch-hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 776443 44567999999999998643 46778999999999999999999999999999999996556556666
Q ss_pred CC
Q 038211 601 EG 602 (605)
Q Consensus 601 ~~ 602 (605)
+|
T Consensus 251 eW 252 (411)
T KOG0599|consen 251 EW 252 (411)
T ss_pred ch
Confidence 65
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=316.63 Aligned_cols=223 Identities=22% Similarity=0.334 Sum_probs=188.1
Q ss_pred ccCceEeeeecccCcEEEEEEEEC---CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN---GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~---~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
...|.+.+.||+|+||.||+|... +..+++|.+.... ......+.+|+.+|+.++||||++++++|..++.++||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 345999999999999999999763 4558888654332 33445678899999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 454 TEFLPRGSLFKTLHKN---YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
|||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 9999999999887642 356889999999999999999999999 99999999999999999999999999976543
Q ss_pred cc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 531 TY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 531 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..+.. +...++|..++
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~s 296 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY-GKYDPFPCPVS 296 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCCCccCC
Confidence 22 123455799999999999999999999999999999999999999999998888888743 33335565554
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=314.44 Aligned_cols=213 Identities=30% Similarity=0.488 Sum_probs=192.0
Q ss_pred cCceEeeeecccCcEEEEEEEECCcc--eEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWNGSD--VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~~~~--~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
+.|.++..||.|+||+||+|..+... .|-|++... ....++.+.-|++||..++||+||++++.|..++.+||+.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 45789999999999999999876444 456665332 35678889999999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
||.||-....+..-...+.+.++..+++|++.||.|||+++ |||||||..|||++-+|.++|+|||.+-.........
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 99999999888888899999999999999999999999999 9999999999999999999999999997777777778
Q ss_pred cCCCCCCccccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCC
Q 038211 536 KSGRGTPQWMAPEVLR-----SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMD 594 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~ 594 (605)
.++.|||+|||||+.. +.+|+.++||||||++|.||+.+.+|-...+++-++-+|.+..
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe 251 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE 251 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC
Confidence 8999999999999875 4578999999999999999999999999999999999996443
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=297.53 Aligned_cols=215 Identities=23% Similarity=0.352 Sum_probs=178.7
Q ss_pred ecccCcEEEEEEEE--CCcceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCCch
Q 038211 386 IGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL 462 (605)
Q Consensus 386 LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ggsL 462 (605)
||+|+||+||++.+ +++.+|+|++.+..... ...+.+..|+.+++.++|+||++++++|.....+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999987 46789999987654322 2345677899999999999999999999999999999999999999
Q ss_pred HHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 463 FKTLHK---NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 463 ~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
..++.. ....+++..++.++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++..............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 887753 2356899999999999999999999999 99999999999999999999999999876544333344557
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHhccCCCccCCCCCCC
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN----LMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~----~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
||+.|+|||.+.+..++.++|+|||||++|+|++|+.||.... ..++...+ ......+|+.++
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 225 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI--LNDSVTYPDKFS 225 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh--cccCCCCcccCC
Confidence 8999999999999999999999999999999999999998643 23444444 234456666554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=302.89 Aligned_cols=222 Identities=29% Similarity=0.459 Sum_probs=178.4
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
.....+|+++++||+|+||.||++.+. ++.||||++.... .......+.+|+.+++.++|+||+++++++...+.++
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 445678999999999999999999874 6789999986543 2334567889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||||+++++|... ....+..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 149 lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 149 VLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred EEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 99999999998543 34567788889999999999999999 999999999999999999999999999765443
Q ss_pred cccccCCCCCCcccccccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHhccCCCccCCCCCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRS-----EPSNEKSDVFSFGVILWELVTASIPWNNLN---LMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~g~~Pf~~~~---~~~~~~~I~~~~~~~~~P~~~ 603 (605)
........||+.|+|||.+.. ...+.++|||||||++|||++|+.||.... ...+...+. ....+.+|..+
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 300 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQPPEAPATA 300 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCCCCCCCcc
Confidence 333345578999999998853 223568999999999999999999997432 233333332 23344455444
Q ss_pred C
Q 038211 604 D 604 (605)
Q Consensus 604 ~ 604 (605)
+
T Consensus 301 ~ 301 (353)
T PLN00034 301 S 301 (353)
T ss_pred C
Confidence 3
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=301.26 Aligned_cols=211 Identities=27% Similarity=0.402 Sum_probs=184.1
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
+..++|++++.||+|+||.||++.+. +..+|+|++.... .....+.+.+|+++++.++||||+++++++..++.+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 45678999999999999999999885 6668999886542 23345678899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR-NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
||||+++++|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 99999999999998765 5688999999999999999999985 7 999999999999999999999999998754322
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...+.
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~ 215 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG 215 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 2234568999999999999999999999999999999999999999888777666553
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.03 Aligned_cols=229 Identities=26% Similarity=0.414 Sum_probs=186.0
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAV 444 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~ 444 (605)
+.+..++|++.++||+|+||.||++.+. +..||+|++..... ......+.+|+.+++.+ +|+||+++++++
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 3466679999999999999999998752 23599999865432 23456788999999999 899999999999
Q ss_pred eeCCeeEEEEEecCCCchHHHHHhhc------------------------------------------------------
Q 038211 445 ASQERLGIVTEFLPRGSLFKTLHKNY------------------------------------------------------ 470 (605)
Q Consensus 445 ~~~~~~~lv~e~~~ggsL~~~l~~~~------------------------------------------------------ 470 (605)
...+..++|||||++|+|.+++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999999999999886431
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc--
Q 038211 471 ---------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL-- 533 (605)
Q Consensus 471 ---------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~-- 533 (605)
..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 24678888999999999999999999 99999999999999999999999999875432221
Q ss_pred cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
......+++.|+|||++.+..++.++|||||||++|+|++ |+.||........+..+...+.++..|..++
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAP 341 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCC
Confidence 1122235678999999998889999999999999999997 9999988765554444433445556665544
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=304.06 Aligned_cols=204 Identities=25% Similarity=0.393 Sum_probs=171.6
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC-----CeeE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ-----ERLG 451 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~~ 451 (605)
+|++.++||+|+||.||+|.+ .+..||||++............+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999987 467799998865433333445688999999999999999999988543 3589
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||||| +++|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELM-ESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecC-CCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 999999 56898888764 56899999999999999999999999 999999999999999999999999999754221
Q ss_pred c---ccccCCCCCCcccccccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 038211 532 Y---LTAKSGRGTPQWMAPEVLRS--EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586 (605)
Q Consensus 532 ~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~ 586 (605)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~ 216 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 216 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH
Confidence 1 12234578999999999876 5688999999999999999999999988765443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.86 Aligned_cols=194 Identities=23% Similarity=0.361 Sum_probs=169.1
Q ss_pred CccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
++...+|+++++||+|+||.||+|.+ .++.||+|... ...+.+|+.+++.++||||++++++|......+
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 45567899999999999999999987 46679999642 234678999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc-
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA- 530 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~- 530 (605)
+|||++ +++|..++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 160 lv~e~~-~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred EEEecC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 999999 56888887664 56889999999999999999999999 99999999999999999999999999965322
Q ss_pred ccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWN 579 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~ 579 (605)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||-
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 1122334579999999999999999999999999999999999998874
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.42 Aligned_cols=220 Identities=26% Similarity=0.439 Sum_probs=180.9
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC-C-cceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEE-Eee---C
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN-G-SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGA-VAS---Q 447 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~-~-~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~-~~~---~ 447 (605)
+..-++++.+.|.+|||+.||+|.+. + ..||+|.+... .+..++.+.+|+++|+.|+ |+|||.|++. ... .
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 44457788999999999999999884 3 78999988765 4667888999999999996 9999999993 221 1
Q ss_pred ---CeeEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeec
Q 038211 448 ---ERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFG 523 (605)
Q Consensus 448 ---~~~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg 523 (605)
-.++|.||||.||.|-++|..+ ...|++..+++|++++++|+.+||...+||||||||-+||||+.+|+.||||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccc
Confidence 2478999999999999999754 356999999999999999999999999999999999999999999999999999
Q ss_pred CCcccCccccccc---------CCCCCCcccccccc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 524 LSSLKNATYLTAK---------SGRGTPQWMAPEVL---RSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 524 ~a~~~~~~~~~~~---------~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
.++.......... ...-|+.|+|||++ .+...+.|+|||||||+||.||+...||++.....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------ 265 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------ 265 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee------
Confidence 9864322211100 01249999999986 67788999999999999999999999999864322
Q ss_pred cCCCccCCCCC
Q 038211 592 FMDRRLELPEG 602 (605)
Q Consensus 592 ~~~~~~~~P~~ 602 (605)
...+++.||+.
T Consensus 266 Ilng~Y~~P~~ 276 (738)
T KOG1989|consen 266 ILNGNYSFPPF 276 (738)
T ss_pred EEeccccCCCC
Confidence 25667777764
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=295.23 Aligned_cols=221 Identities=23% Similarity=0.306 Sum_probs=183.6
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
.|++.++||+|+||.||++.+ +++.||+|++....... .....+.+|+.+++.++||||+++++++..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 378999999999999999987 46789999987644322 223456789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 456 FLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 456 ~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
|+.+++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-T 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-c
Confidence 99999999887654 356899999999999999999999999 9999999999999999999999999987643222 2
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHhccCCCccCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLM----QVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~----~~~~~I~~~~~~~~~P~~~~ 604 (605)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+.. ++...+ ...+..+|+.++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 229 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV--KEDQEEYSEKFS 229 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHh--hhcccccCcccC
Confidence 23457899999999999988999999999999999999999999876543 233333 334455665554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=296.25 Aligned_cols=209 Identities=27% Similarity=0.387 Sum_probs=176.0
Q ss_pred cCceEeeeecccCcEEEEEEEEC---CcceEEEEeeccccchhhhhhHHHHHHHHHhC---CCCCeeeEEEEEe-----e
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN---GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL---RHPNVLLFMGAVA-----S 446 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~---~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l---~h~niv~~~~~~~-----~ 446 (605)
++|++.++||+|+||+||+|.+. +..+|+|++............+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999873 56699998876544444445566788877766 6999999999885 2
Q ss_pred CCeeEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCC
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a 525 (605)
...+++||||++ ++|.+++... ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 456899999996 6898888754 345899999999999999999999999 999999999999999999999999999
Q ss_pred cccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 526 SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 526 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
+..... .......||+.|+|||.+.+..++.++|||||||++|||++|++||.+.+..+.+..|
T Consensus 158 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i 221 (290)
T cd07862 158 RIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 221 (290)
T ss_pred EeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence 765433 2233456899999999999888999999999999999999999999998877777666
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=309.82 Aligned_cols=208 Identities=32% Similarity=0.555 Sum_probs=179.2
Q ss_pred ceEeeeecccCcEEEEEEEECCcc--eEEEEeecccc--chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe--eEEE
Q 038211 380 LQLGEEIGLGSYAVVYRGIWNGSD--VAVKVYFGSEY--IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER--LGIV 453 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~~~~~--~avKv~~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~--~~lv 453 (605)
.++..+||+|+|-+||+|.+.... ||---++.... .+..++++..|+.+|+.|+||||+++|++|.+... +.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 466789999999999999985444 44222222222 34567899999999999999999999999987544 8899
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC-CCcEEEEeecCCcccCccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK-NWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~-~~~vkl~Dfg~a~~~~~~~ 532 (605)
+|.+..|+|..++.+. +.++...+..|++||+.||.|||++.|||||||||.+||||+. .|.|||+|+|+|+......
T Consensus 122 TEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred eecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999998876 7899999999999999999999999999999999999999975 6999999999999876554
Q ss_pred ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhc
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN-LNLMQVVGVVG 591 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~-~~~~~~~~~I~ 591 (605)
.. ..+|||.|||||++. +.|+..+||||||+||+||+|+.+||.. .++.+++.+|.
T Consensus 201 ak--svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~ 257 (632)
T KOG0584|consen 201 AK--SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT 257 (632)
T ss_pred cc--eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH
Confidence 33 368999999999987 7799999999999999999999999986 67899999984
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=295.28 Aligned_cols=213 Identities=31% Similarity=0.467 Sum_probs=178.0
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC------------------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN------------------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN 436 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~------------------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~n 436 (605)
+..++|++.++||+|+||.||+|.+. +..||+|++.... .......+.+|+.+++.++|||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence 34578999999999999999999752 2258999886543 2334567889999999999999
Q ss_pred eeeEEEEEeeCCeeEEEEEecCCCchHHHHHhhc------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 038211 437 VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNY------------------QALDIKRRLRMALDVARGMNYLHHRNPP 498 (605)
Q Consensus 437 iv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~------------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~ 498 (605)
|+++++++...+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.|
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-- 158 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 9999999999999999999999999999886531 24677888999999999999999999
Q ss_pred ceeccCCCCCEEEcCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc--C
Q 038211 499 IVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT--A 574 (605)
Q Consensus 499 iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~--g 574 (605)
|+||||||+|||++.++.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|+|++ +
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 9999999999999999999999999987543221 11223345789999999998889999999999999999986 7
Q ss_pred CCCCCCCCHHHHHHHh
Q 038211 575 SIPWNNLNLMQVVGVV 590 (605)
Q Consensus 575 ~~Pf~~~~~~~~~~~I 590 (605)
..||...+..+++..+
T Consensus 239 ~~p~~~~~~~~~~~~~ 254 (304)
T cd05096 239 EQPYGELTDEQVIENA 254 (304)
T ss_pred CCCCCcCCHHHHHHHH
Confidence 7899988877766554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.78 Aligned_cols=211 Identities=26% Similarity=0.396 Sum_probs=178.0
Q ss_pred ecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhC---CCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 386 IGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKL---RHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 386 LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l---~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
||+|+||+||+|.+. ++.||+|++.+.... .........|..++... +||||+.++++|...+.+++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999874 678999998664322 22334455677777665 699999999999999999999999999
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
++|..++.+. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.++|+|||++.............+
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 9999888764 67899999999999999999999999 99999999999999999999999999875433333344567
Q ss_pred CCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCC
Q 038211 540 GTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 540 gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~ 601 (605)
||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+++..|... .+.+|.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~ 218 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--KVRFPK 218 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC--CCCCCC
Confidence 99999999998765 4789999999999999999999999999988988888433 355554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=260.80 Aligned_cols=210 Identities=26% Similarity=0.343 Sum_probs=190.7
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
.|.-.++||+|.||+|++++. .+..||+|.+..+...+.......+|+.+|+.++|.|||++++....+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678999999999999976 466799999988877777777889999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccccc
Q 038211 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAK 536 (605)
Q Consensus 457 ~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 536 (605)
| .-+|..+.....+.++.+.++.++.|++.||.|+|+++ +.|||+||.|+|++.+|.+||+|||+++.+..+....+
T Consensus 83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 9 45899999888899999999999999999999999999 99999999999999999999999999998887777777
Q ss_pred CCCCCCcccccccccCCC-CCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhc
Q 038211 537 SGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 537 ~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~ 591 (605)
..+-|.+|.+|.++.|.. |++..|+||.||++.|+.. |++.|.+.+....+.+|-
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif 216 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHH
Confidence 777899999999998864 7899999999999999998 888899998877777764
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.17 Aligned_cols=211 Identities=25% Similarity=0.404 Sum_probs=179.5
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..++|.+.++||+|+||.||+|.+. +..+|+|.+..... ......+.+|+.+++.++||||+++++++..++..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 3478999999999999999999874 56699998865432 22334577899999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
|||+++ +|..++......+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++........
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 999964 888888766567899999999999999999999999 99999999999999999999999999876544333
Q ss_pred cccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 534 TAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 217 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 3344567999999999865 45789999999999999999999999987766555444
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.94 Aligned_cols=226 Identities=30% Similarity=0.542 Sum_probs=189.7
Q ss_pred ccccCceEeeeecccCcEEEEEEEECC-------cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~-------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
+..++|++.+.||+|+||.||+|.+.+ ..+++|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 456789999999999999999998643 348899876433 233456788999999999999999999999988
Q ss_pred CeeEEEEEecCCCchHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNY---------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD 512 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~ 512 (605)
...+++|||+++++|.+++.... ..+++..++.++.||+.||.|||+++ ++|+||||+||+++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG 158 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc
Confidence 89999999999999999987642 45788889999999999999999999 99999999999999
Q ss_pred CCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 038211 513 KNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGV 589 (605)
Q Consensus 513 ~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~ 589 (605)
.++.++|+|||++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++...
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999987543221 12233456889999999998889999999999999999998 9999999998888888
Q ss_pred hccCCCccCCCCCCC
Q 038211 590 VGFMDRRLELPEGLD 604 (605)
Q Consensus 590 I~~~~~~~~~P~~~~ 604 (605)
|. .+..+.+|..++
T Consensus 239 i~-~~~~~~~~~~~~ 252 (283)
T cd05048 239 IR-SRQLLPCPEDCP 252 (283)
T ss_pred HH-cCCcCCCcccCC
Confidence 74 344456666654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=285.81 Aligned_cols=222 Identities=27% Similarity=0.413 Sum_probs=192.8
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+|.+.+.||+|+||.||++.+ .++.+++|.+............+.+|+.+++.++||||+++++++...+.+++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 588999999999999999987 467799999876655556677888999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 457 LPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 457 ~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
+++++|.+++... ...+++..++.++.||+.||.|||+.| ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 9999999998775 467899999999999999999999999 9999999999999999999999999987655443333
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+. .+...++|..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 225 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMY 225 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCcccc
Confidence 44568999999999999889999999999999999999999999888877777764 33344555443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=297.13 Aligned_cols=210 Identities=26% Similarity=0.391 Sum_probs=181.2
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
+..++|++.++||.|+||.||++.+. +..+|+|++.... .......+.+|+++++.++|+||++++++|..++.+++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 45578999999999999999999885 5668899876542 23345678899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR-NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
||||+++++|.+++... ..+++..+..++.||+.||.|||+. + |+|+||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999998765 5688999999999999999999974 7 999999999999999999999999998654322
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||......++...+
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~ 214 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHh
Confidence 223456899999999999988999999999999999999999999887665554443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=286.06 Aligned_cols=224 Identities=30% Similarity=0.505 Sum_probs=192.0
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc---hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI---EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~---~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
+.|++.+.||+|+||.||++.+ .+..+++|++...... ......+.+|+.++++++||||+++++++..++.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4689999999999999999976 4678999988654322 2234578899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
|+||+++++|.+++... ..+++..+..++.|++.||.|||+.| |+|+||+|+||+++.++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999999988765 56889999999999999999999999 9999999999999999999999999987543221
Q ss_pred ccc---cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 533 LTA---KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 533 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.......+......+.+|..++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVS 233 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCC
Confidence 111 234578899999999999899999999999999999999999999888777777766666777887665
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.47 Aligned_cols=226 Identities=27% Similarity=0.430 Sum_probs=182.2
Q ss_pred CCccccCceEeeeecccCcEEEEEEEE-------CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIW-------NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAV 444 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~-------~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~ 444 (605)
..+..++|++.++||+|+||+||+|.+ .+..||||++..... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 345567899999999999999999964 244699998865432 23456788999999999 899999999999
Q ss_pred eeCCeeEEEEEecCCCchHHHHHhhc------------------------------------------------------
Q 038211 445 ASQERLGIVTEFLPRGSLFKTLHKNY------------------------------------------------------ 470 (605)
Q Consensus 445 ~~~~~~~lv~e~~~ggsL~~~l~~~~------------------------------------------------------ 470 (605)
...+..++|||||++|+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999886532
Q ss_pred --------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 471 --------------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 471 --------------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 14678888999999999999999999 99999999999999999999999999975533
Q ss_pred ccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHhccCCCccCCCCC
Q 038211 531 TYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLM-QVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 531 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~-~~~~~I~~~~~~~~~P~~ 602 (605)
... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .....+ ..+.++..|..
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 341 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI-KEGYRMLSPEC 341 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH-HhCccCCCCCC
Confidence 221 1112335678999999999999999999999999999997 99999886543 344444 23444444543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=302.90 Aligned_cols=221 Identities=22% Similarity=0.314 Sum_probs=189.9
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.-|..++.||-|+||.|.+++. +...||+|.+.+..+. ...+..++.|.+||...+.+-||++|..|++.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 3577889999999999999864 4555999998776544 456677889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC-----
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN----- 529 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~----- 529 (605)
+|++||+++.+|.+. +.+++..++.|+.++.+|+++.|..| +|||||||+|||||.+|++||.|||+|+-+.
T Consensus 709 dYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred eccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccceecccc
Confidence 999999999999876 88999999999999999999999999 9999999999999999999999999984210
Q ss_pred ----cc---------------------------------cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHH
Q 038211 530 ----AT---------------------------------YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELV 572 (605)
Q Consensus 530 ----~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 572 (605)
.. .......+||+.|+|||++....|+..+||||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 00 00111335999999999999999999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHhccCCCccCCCC
Q 038211 573 TASIPWNNLNLMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 573 ~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~ 601 (605)
.|++||.+..+.+.-.+|..=..-+.||.
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~ 894 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINWRNFLHIPY 894 (1034)
T ss_pred hCCCCccCCCCCcceeeeeehhhcccccc
Confidence 99999999888888777755555566664
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=291.09 Aligned_cols=219 Identities=26% Similarity=0.466 Sum_probs=192.8
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
++|++.+.||+|+||.||++.+ .++.+|+|++...... ......+.+|+.++++++||||+++++++.....+++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4789999999999999999987 4677999998765432 234567889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+++++|.+++... ..+++..+..++.||+.||.|||+.| ++|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999999999998776 67899999999999999999999999 999999999999999999999999998765433
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+ ..+.+.+|..++
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~ 222 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI--LEGKVRFPSFFS 222 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--hcCCccCCccCC
Confidence 23446899999999998888899999999999999999999999998888888877 356678887765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=295.36 Aligned_cols=225 Identities=28% Similarity=0.535 Sum_probs=186.9
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCc----ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGS----DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~----~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
+...+|++.+.||+|+||+||+|.+ .+. .||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 4557899999999999999999976 333 38899876432 234456788999999999999999999998764
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
..++++||+++|+|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccccccc
Confidence 578999999999999999887677899999999999999999999999 999999999999999999999999999865
Q ss_pred Ccccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 529 NATYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 529 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
..... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....++...+. .+.+++.|+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICT 237 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCC
Confidence 43222 1222334678999999999999999999999999999997 999999988777766554 455566665543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=285.31 Aligned_cols=220 Identities=32% Similarity=0.539 Sum_probs=186.6
Q ss_pred ccCceEeeeecccCcEEEEEEEECC-cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWNG-SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~~-~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
..+|++.+.||+|+||.||++.++. ..+|+|.+..... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 4679999999999999999998754 4799998754432 23567889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc-c
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL-T 534 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~-~ 534 (605)
|+++++|.+++......+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||.++....... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999999998765567899999999999999999999999 99999999999999999999999999875432221 1
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+.+..|.. +.++..|..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~ 225 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKL 225 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCC
Confidence 222345678999999998889999999999999999999 9999999998888888853 334444543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=304.54 Aligned_cols=207 Identities=31% Similarity=0.427 Sum_probs=184.0
Q ss_pred CceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
-|.-++.||.|+||.||-|++. ...||||.+...... ....+.+..|++.|++++|||++.+-+||..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4677899999999999999874 556999988765432 2345678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|| -|+-.+++.-...++.+..+..++.+.+.||+|||+++ .||||||..|||+++.|.|||+|||.|..... .
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----A 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAP----A 179 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCc----h
Confidence 99 56888888877788999999999999999999999999 99999999999999999999999999976542 3
Q ss_pred cCCCCCCcccccccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhcc
Q 038211 536 KSGRGTPQWMAPEVLRS---EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGF 592 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~ 592 (605)
.+++|||+|||||++.. ..|+-++||||||++-.||+..++|+-+++.+..+.-|..
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ 239 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 239 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh
Confidence 57899999999999864 4589999999999999999999999999999999999963
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=303.04 Aligned_cols=228 Identities=29% Similarity=0.444 Sum_probs=183.9
Q ss_pred CccccCceEeeeecccCcEEEEEEEECC-------cceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEe
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVA 445 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~-------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~ 445 (605)
.+..++|.++++||.|+||.||+|.+.+ ..||||++.... .....+.+.+|+.+|+.+. ||||+++++++.
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3445789999999999999999998632 248999886543 2334567889999999996 999999999999
Q ss_pred eCCeeEEEEEecCCCchHHHHHhhc-------------------------------------------------------
Q 038211 446 SQERLGIVTEFLPRGSLFKTLHKNY------------------------------------------------------- 470 (605)
Q Consensus 446 ~~~~~~lv~e~~~ggsL~~~l~~~~------------------------------------------------------- 470 (605)
..+.+++|||||++|+|.+++....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 9999999999999999998886531
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEE
Q 038211 471 ----------------------------------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLL 510 (605)
Q Consensus 471 ----------------------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nil 510 (605)
..+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nil 269 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEE
Confidence 23677888899999999999999999 999999999999
Q ss_pred EcCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 038211 511 VDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVV 587 (605)
Q Consensus 511 l~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~ 587 (605)
++.++.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.........
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~ 349 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence 9999999999999987543221 12223346788999999999889999999999999999996 99999886544433
Q ss_pred HHhccCCCccCCCCCCC
Q 038211 588 GVVGFMDRRLELPEGLD 604 (605)
Q Consensus 588 ~~I~~~~~~~~~P~~~~ 604 (605)
......+.++..|..++
T Consensus 350 ~~~~~~~~~~~~~~~~~ 366 (400)
T cd05105 350 YNKIKSGYRMAKPDHAT 366 (400)
T ss_pred HHHHhcCCCCCCCccCC
Confidence 33323445566665554
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=320.20 Aligned_cols=218 Identities=24% Similarity=0.441 Sum_probs=180.8
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee--C
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS--Q 447 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~ 447 (605)
+++....+|+++++||+|+||+||++.+. +..+|+|++............+..|+.+|+.++|||||+++++|.. .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 45677789999999999999999999884 5568999987765555566788999999999999999999999865 3
Q ss_pred CeeEEEEEecCCCchHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceeccCCCCCEEEcC------
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKN---YQALDIKRRLRMALDVARGMNYLHHRN-----PPIVHRDLKSSNLLVDK------ 513 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~-----~~iiH~Dik~~Nill~~------ 513 (605)
..+||||||+++++|.+++... ...+++..++.|+.||+.||+|||+.+ .+||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5689999999999999998753 357999999999999999999999843 23999999999999964
Q ss_pred -----------CCcEEEEeecCCcccCcccccccCCCCCCcccccccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 514 -----------NWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS--EPSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 514 -----------~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||+|++|..||..
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 2358999999997654322 2234578999999999865 3478899999999999999999999986
Q ss_pred CCH-HHHHHHh
Q 038211 581 LNL-MQVVGVV 590 (605)
Q Consensus 581 ~~~-~~~~~~I 590 (605)
.+. .+++..+
T Consensus 246 ~~~~~qli~~l 256 (1021)
T PTZ00266 246 ANNFSQLISEL 256 (1021)
T ss_pred CCcHHHHHHHH
Confidence 554 4444444
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.48 Aligned_cols=205 Identities=18% Similarity=0.281 Sum_probs=170.0
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCC------CCeeeEEEEEeeC
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH------PNVLLFMGAVASQ 447 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h------~niv~~~~~~~~~ 447 (605)
..++|+++++||+|+||+||+|.+ .+..||||++.... ........|+.+++.++| .+++.++++|..+
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 357899999999999999999987 46679999985422 223345667777777754 4588999988764
Q ss_pred -CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCCCCEEEcCCC----------
Q 038211 448 -ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH-RNPPIVHRDLKSSNLLVDKNW---------- 515 (605)
Q Consensus 448 -~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~~~iiH~Dik~~Nill~~~~---------- 515 (605)
.++|+|||++ |++|.+++.+. +.+++..+..++.||+.||+|||+ .| ||||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccccc
Confidence 5789999998 77888888765 678999999999999999999998 59 99999999999998665
Q ss_pred ------cEEEEeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 038211 516 ------TVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGV 589 (605)
Q Consensus 516 ------~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~ 589 (605)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred cCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 499999998864322 23356789999999999999999999999999999999999999998887666655
Q ss_pred h
Q 038211 590 V 590 (605)
Q Consensus 590 I 590 (605)
|
T Consensus 357 i 357 (467)
T PTZ00284 357 M 357 (467)
T ss_pred H
Confidence 5
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=285.48 Aligned_cols=224 Identities=31% Similarity=0.504 Sum_probs=189.3
Q ss_pred ccCceEeeeecccCcEEEEEEEEC-----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN-----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~-----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
.++|++.+.||+|+||+||+|.+. ...+++|++.... .......+.+|+.+++.++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 468999999999999999999874 2358999876543 3334567888999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
++|||+++++|.+++......+++..+..++.|++.||+|||+++ |+|+||||+|||++.++.++|+|||++......
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999999876678999999999999999999999999 999999999999999999999999999865421
Q ss_pred c--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 532 Y--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 532 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
. .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....++...+. ...+++.|..++
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCP 234 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 1 12222345678999999998889999999999999999998 999999988888888885 333445555443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=287.96 Aligned_cols=226 Identities=27% Similarity=0.477 Sum_probs=187.5
Q ss_pred ccccCceEeeeecccCcEEEEEEEE------CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW------NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~------~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
+.+.+|++.++||+|+||+||+|.+ .+..+++|.+.... .......+.+|+.+++.++||||+++++++..+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4567899999999999999999974 34568999876533 2334467889999999999999999999999999
Q ss_pred eeEEEEEecCCCchHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNY----------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD 512 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~ 512 (605)
..+++|||+++++|.+++.... ..+++..+..++.||+.||.|||+++ ++||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~ 158 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc
Confidence 9999999999999999985321 24788888999999999999999999 99999999999999
Q ss_pred CCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 038211 513 KNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGV 589 (605)
Q Consensus 513 ~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~ 589 (605)
.++.+||+|||+++...... .......++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+...+...
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999997543221 12233445778999999988889999999999999999998 9999998887777777
Q ss_pred hccCCCccCCCCCCC
Q 038211 590 VGFMDRRLELPEGLD 604 (605)
Q Consensus 590 I~~~~~~~~~P~~~~ 604 (605)
+. ....+++|..++
T Consensus 239 ~~-~~~~~~~~~~~~ 252 (283)
T cd05090 239 VR-KRQLLPCSEDCP 252 (283)
T ss_pred HH-cCCcCCCCCCCC
Confidence 74 344456666554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=298.33 Aligned_cols=228 Identities=29% Similarity=0.531 Sum_probs=200.1
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC----Ccc--eEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN----GSD--VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS 446 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~----~~~--~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 446 (605)
.++..+...+.+.||.|-||.||+|.+. |.. ||||..+.+- ..+..+.|..|.-+|+.++||||++++|++..
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 3455566777789999999999999863 333 7888776644 34447889999999999999999999999875
Q ss_pred CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCc
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~ 526 (605)
...|||||.++-|.|..+++.+...++......|+.||+.||.|||+.. +|||||-..|||+....-|||+|||+++
T Consensus 463 -~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred -cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccchhh
Confidence 4689999999999999999999899999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCccc-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 527 LKNATY-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 527 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
...... ...+...-+.-|||||-+.-..++.++|||-|||+|||++. |..||.+..+..++..|. .+.|++.|+.++
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-nGeRlP~P~nCP 618 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-NGERLPCPPNCP 618 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-CCCCCCCCCCCC
Confidence 765443 33344455778999999999999999999999999999887 999999999999999997 788999999998
Q ss_pred C
Q 038211 605 P 605 (605)
Q Consensus 605 ~ 605 (605)
|
T Consensus 619 p 619 (974)
T KOG4257|consen 619 P 619 (974)
T ss_pred h
Confidence 7
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=287.51 Aligned_cols=220 Identities=36% Similarity=0.617 Sum_probs=186.7
Q ss_pred eEeeeecccCcEEEEEEEEC------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 381 QLGEEIGLGSYAVVYRGIWN------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 381 ~~~~~LG~G~fg~V~~~~~~------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.+.+.||.|+||.||+|.+. +..|+||++... ......+.+.+|++.+++++||||+++++++...+.+++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence 46789999999999999887 556999998542 23344778899999999999999999999999888899999
Q ss_pred EecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc--c
Q 038211 455 EFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA--T 531 (605)
Q Consensus 455 e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~--~ 531 (605)
||+++|+|.+++... ...+++..+..++.||+.||.|||+++ ++|+||+++|||++.++.+||+|||++..... .
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence 999999999999886 678999999999999999999999999 99999999999999999999999999876521 1
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
............|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..++...+ ....++++|..++
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 231 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCP 231 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchh
Confidence 222333456889999999999889999999999999999999 78999999999999999 5667777777654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=302.73 Aligned_cols=208 Identities=27% Similarity=0.405 Sum_probs=176.8
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC-----eeE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE-----RLG 451 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~~ 451 (605)
+|+++++||+|+||.||++.+ .++.||||++..........+.+.+|+.+++.++|+||+++++++.... .++
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 578899999999999999986 5778999988654333344567889999999999999999999998776 789
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||||+. ++|...+... ..+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999995 5787777554 67899999999999999999999999 999999999999999999999999999764322
Q ss_pred c-ccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 532 Y-LTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 532 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
. .......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+.+..|
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 217 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 2 122334679999999999875 4789999999999999999999999998877766665
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=283.04 Aligned_cols=222 Identities=26% Similarity=0.409 Sum_probs=190.2
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+|++.++||.|+||.||++.+ .+..+++|.+..... ....+.+.+|+.+++.++|+||+++++.+.+.+.++++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 588999999999999999987 467799998865432 33456788899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 457 LPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 457 ~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
+++++|.+++... ...+++..+..++.||+.||.|||++| |+|+||||+||+++.++.++|+|||++..........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 9999999988653 356889999999999999999999999 9999999999999999999999999987654443333
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+....+..+. .+...++|..++
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 225 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYS 225 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccC
Confidence 45568999999999999889999999999999999999999999988888888774 333345665554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=313.77 Aligned_cols=227 Identities=30% Similarity=0.514 Sum_probs=195.2
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS 446 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 446 (605)
.+...+.++.++||+|.||+||+|+.. ..-||||.++... .....+.|++|++++..++|||||+++|++..
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 456678889999999999999998752 2348999876543 34467889999999999999999999999999
Q ss_pred CCeeEEEEEecCCCchHHHHHhh-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKN-------------YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK 513 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~-------------~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~ 513 (605)
++.++||+|||..|+|..+|... ...++..+.+.++.||+.|++||-++. +|||||-.+|+||.+
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGE 638 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceecc
Confidence 99999999999999999999743 123888999999999999999999999 999999999999999
Q ss_pred CCcEEEEeecCCcccCcc-ccc-ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHh
Q 038211 514 NWTVKVGDFGLSSLKNAT-YLT-AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 514 ~~~vkl~Dfg~a~~~~~~-~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I 590 (605)
+..|||+|||+++..-.. +.. .....-+.+||+||.|....++++|||||+||+|||+++ |+.||.++++.|++..|
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 999999999999754322 222 113345789999999999999999999999999999999 99999999999999999
Q ss_pred ccCCCccCCCCCCC
Q 038211 591 GFMDRRLELPEGLD 604 (605)
Q Consensus 591 ~~~~~~~~~P~~~~ 604 (605)
. .+.-+.-|++++
T Consensus 719 ~-~g~lL~~Pe~CP 731 (774)
T KOG1026|consen 719 R-AGQLLSCPENCP 731 (774)
T ss_pred H-cCCcccCCCCCC
Confidence 5 333478888876
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=299.16 Aligned_cols=203 Identities=27% Similarity=0.381 Sum_probs=172.9
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC-----
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE----- 448 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~----- 448 (605)
..++|++.+.||+|+||.||++.+ .+..||+|++............+.+|+.+++.++||||++++++|....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999987 4678999998765444445667889999999999999999999986543
Q ss_pred -eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 449 -RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 449 -~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
.+++||||+++ +|...+. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 47999999965 5666554 34788899999999999999999999 99999999999999999999999999975
Q ss_pred cCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQ 585 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~ 585 (605)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...
T Consensus 173 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~ 229 (359)
T cd07876 173 ACTNF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID 229 (359)
T ss_pred cccCc-cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 43222 2234568999999999999999999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=283.53 Aligned_cols=222 Identities=32% Similarity=0.543 Sum_probs=187.0
Q ss_pred cccCceEeeeecccCcEEEEEEEECCc-ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWNGS-DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~~~-~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
..++|++.+.||+|+||+||++.+.+. .+|+|.+..... ....+.+|+.++++++||||+++++++.....++++|
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 346899999999999999999987654 599998765432 2356889999999999999999999999888899999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc-
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL- 533 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~- 533 (605)
||+.+++|.+++......+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||.++.......
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999999999876567899999999999999999999999 99999999999999999999999999875433221
Q ss_pred cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
......++..|++||.+.+..++.++|+|||||++|+|++ |..||...+..++...+. .+.++..|...
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 226 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLA 226 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCCCCCCC
Confidence 1122335678999999998889999999999999999998 999999988888888774 34444445433
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=283.78 Aligned_cols=222 Identities=32% Similarity=0.547 Sum_probs=187.2
Q ss_pred ccCceEeeeecccCcEEEEEEEECC-cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWNG-SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~~-~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
..+|++.+.||+|+||.||++.+.+ ..+++|++..... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 4578999999999999999998754 4699998765432 22457789999999999999999999999899999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc-
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT- 534 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~- 534 (605)
|+++++|.+++......+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999999999876567899999999999999999999999 999999999999999999999999998754322211
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+. ...++..|..++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 227 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAP 227 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCC
Confidence 112223557999999998889999999999999999999 899999988888888885 444556665544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=286.80 Aligned_cols=206 Identities=22% Similarity=0.294 Sum_probs=176.7
Q ss_pred CceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
.|+..++||.|+||+||++.+. ++.+|+|++....... .....+.+|+.+++.++|+||+.+++++..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3778899999999999999874 6779999986654332 234557789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 456 FLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 456 ~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-S 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-c
Confidence 99999998888654 346999999999999999999999999 9999999999999999999999999986543221 2
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~ 587 (605)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.......
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~ 210 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR 210 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 23446899999999999988999999999999999999999999987654433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=304.62 Aligned_cols=205 Identities=28% Similarity=0.412 Sum_probs=168.5
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC------
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ------ 447 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------ 447 (605)
...+|+++++||+|+||.||+|.+ .+..||||++.... ....+|+.+++.++||||++++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 446899999999999999999987 46779999875432 2345799999999999999999887432
Q ss_pred --CeeEEEEEecCCCchHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC-cEEEEe
Q 038211 448 --ERLGIVTEFLPRGSLFKTLHK---NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW-TVKVGD 521 (605)
Q Consensus 448 --~~~~lv~e~~~ggsL~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~-~vkl~D 521 (605)
..+++||||+++ +|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeec
Confidence 247799999964 67666643 3467899999999999999999999999 99999999999998665 799999
Q ss_pred ecCCcccCcccccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 522 FGLSSLKNATYLTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 522 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
||+|+...... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..|
T Consensus 215 FGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 283 (440)
T PTZ00036 215 FGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283 (440)
T ss_pred cccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 99997654322 22345789999999998764 6899999999999999999999999987765555444
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=270.73 Aligned_cols=220 Identities=24% Similarity=0.369 Sum_probs=183.9
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCeeEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lv 453 (605)
..+.+++..||.|+.|+||++++. |...|||.+.+... ....+++...++++...+ +|+||+++|+|..+...++.
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 456778889999999999999875 47789998877654 345677888888877764 99999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR-NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
||.| ...+..++.+-.+++++..+-++...++.||.||-++ + |+|||+||+|||+|+.|++||||||++...-...
T Consensus 170 MelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 170 MELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeeccc
Confidence 9999 5678888888888999999999999999999999865 6 9999999999999999999999999996654332
Q ss_pred ccccCCCCCCcccccccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHhccCCCccCCCCC
Q 038211 533 LTAKSGRGTPQWMAPEVLRSE---PSNEKSDVFSFGVILWELVTASIPWNNLN-LMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~~g~~Pf~~~~-~~~~~~~I~~~~~~~~~P~~ 602 (605)
.+....|.+.|||||.+.-. .|+-++||||||++++||+||+.||.+.+ ..+++.+|. ..+.+-+|..
T Consensus 247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl-n~ePP~L~~~ 318 (391)
T KOG0983|consen 247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL-NEEPPLLPGH 318 (391)
T ss_pred -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH-hcCCCCCCcc
Confidence 33445789999999998644 57889999999999999999999999854 477788874 3555555543
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=282.09 Aligned_cols=216 Identities=30% Similarity=0.511 Sum_probs=182.5
Q ss_pred eecccCcEEEEEEEE----CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCC
Q 038211 385 EIGLGSYAVVYRGIW----NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRG 460 (605)
Q Consensus 385 ~LG~G~fg~V~~~~~----~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~gg 460 (605)
+||+|+||.||+|.+ .+..+|+|++..........+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999965 3566999998765544455677899999999999999999999875 45678999999999
Q ss_pred chHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc---cccC
Q 038211 461 SLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL---TAKS 537 (605)
Q Consensus 461 sL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~---~~~~ 537 (605)
+|.+++... ..+++..+..++.|++.||+|||++| |+||||||.||+++.++.++|+|||++........ ....
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 999998764 57899999999999999999999999 99999999999999999999999999876533221 1122
Q ss_pred CCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 538 GRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 538 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
..+++.|+|||.+....++.++|+|||||++|||++ |..||.+.+..++...|. .+..+++|+.+++
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 225 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPP 225 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCH
Confidence 334679999999988888999999999999999997 999999988888888886 4456778877653
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=315.83 Aligned_cols=207 Identities=23% Similarity=0.346 Sum_probs=175.4
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
++|++.++||+|+||.||+|.+. ++.||+|++...... +...+.+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999874 678999998654322 234567889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecC
Q 038211 455 EFLPRGSLFKTLHKN----------YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524 (605)
Q Consensus 455 e~~~ggsL~~~l~~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~ 524 (605)
||++|++|.+++... ....+...+..++.||+.||+|||++| |+||||||+|||++.++.++|+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999988642 123456677889999999999999999 99999999999999999999999999
Q ss_pred CcccCccc------------------ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 038211 525 SSLKNATY------------------LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586 (605)
Q Consensus 525 a~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~ 586 (605)
++...... ......+||+.|+|||.+.+..++.++|||||||++|||++|..||...+...+
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 97542110 011124689999999999999999999999999999999999999987655443
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=298.75 Aligned_cols=208 Identities=25% Similarity=0.342 Sum_probs=177.4
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC------
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ------ 447 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------ 447 (605)
..++|++.++||+|+||.||++.+ .++.+|||++............+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 357899999999999999999987 467799999876544444556788999999999999999999988643
Q ss_pred CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
..+++||||+++ +|...+.. .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 357999999964 67776653 4788889999999999999999999 99999999999999999999999999976
Q ss_pred cCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 176 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 237 (364)
T cd07875 176 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237 (364)
T ss_pred cCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 54322 233457899999999999999999999999999999999999999988876666555
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=281.14 Aligned_cols=221 Identities=34% Similarity=0.608 Sum_probs=187.6
Q ss_pred CccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEe-eCCeeEE
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVA-SQERLGI 452 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-~~~~~~l 452 (605)
.+...+|++.+.||+|+||.||++...+..+++|.+.... ..+.+.+|+.+++.++|+|++++++++. ..+..++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 3567899999999999999999999999999999875432 3456889999999999999999999764 4567899
Q ss_pred EEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 453 VTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+|||+++++|.+++.... ..+++..+..++.||+.||+|||++| ++||||||+||+++.++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999999999987653 35889999999999999999999999 999999999999999999999999998754322
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
. ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..++...+. .+.++.+|+.++
T Consensus 156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 225 (256)
T cd05082 156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCP 225 (256)
T ss_pred C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCC
Confidence 1 23345678999999999889999999999999999997 999999988888888875 334455555544
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=279.39 Aligned_cols=223 Identities=25% Similarity=0.416 Sum_probs=187.5
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee-CCeeEEEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS-QERLGIVTE 455 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~lv~e 455 (605)
+|++.+.||.|+||.||++.+ .++.+++|.+..........+.+.+|+.++++++|+|++++++.+.. ...++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 489999999999999999987 45679999987655445556678899999999999999999998864 446899999
Q ss_pred ecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 456 FLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 456 ~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
|+++++|.+++... ...+++..++.++.|++.||++||+.| ++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 99999999988764 356899999999999999999999999 999999999999999999999999998765433333
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+. .+..+.+|..++
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 227 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYS 227 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccC
Confidence 445568999999999999989999999999999999999999999888777766653 222334554443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=329.63 Aligned_cols=223 Identities=30% Similarity=0.472 Sum_probs=192.8
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+|+-...||.|.||.||-|.. +|...|+|.++...........+.+|..+|..++|||+|++|++-.+.+..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 455677899999999999875 677789998877665566778889999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc----
Q 038211 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY---- 532 (605)
Q Consensus 457 ~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~---- 532 (605)
|.||+|.++++.. +..++.....|..|++.|++|||++| ||||||||.||||+.+|.+|++|||.|.......
T Consensus 1316 C~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred hccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 9999999998764 56777777889999999999999999 9999999999999999999999999997654332
Q ss_pred ccccCCCCCCcccccccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHhccCCCccCCCCCCCC
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEP---SNEKSDVFSFGVILWELVTASIPWNNLNL-MQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~el~~g~~Pf~~~~~-~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.......|||.|||||++.+.. ...+.|||||||++.||+||+.||..++. -++...|+ ++..|+||+.+|+
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~-~gh~Pq~P~~ls~ 1468 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA-AGHKPQIPERLSS 1468 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh-ccCCCCCchhhhH
Confidence 1223457999999999997643 46789999999999999999999998765 66777776 8999999998874
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=288.47 Aligned_cols=228 Identities=30% Similarity=0.525 Sum_probs=189.0
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECC---------cceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNG---------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMG 442 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~---------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~ 442 (605)
..+..++|.+.+.||+|+||.||++.+.+ ..+|+|++.... .......+.+|+.+++.+ +||||+++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 34556889999999999999999997632 348999887543 233456688899999999 7999999999
Q ss_pred EEeeCCeeEEEEEecCCCchHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCC
Q 038211 443 AVASQERLGIVTEFLPRGSLFKTLHKNY---------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSS 507 (605)
Q Consensus 443 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~ 507 (605)
++...+.+++||||+++++|.+++.... ..+++..+..++.||+.||+|||++| ++||||||+
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~ 169 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAAR 169 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHH
Confidence 9999999999999999999999997642 24788899999999999999999999 999999999
Q ss_pred CEEEcCCCcEEEEeecCCcccCccccc--ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 038211 508 NLLVDKNWTVKVGDFGLSSLKNATYLT--AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLM 584 (605)
Q Consensus 508 Nill~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~ 584 (605)
|||++.++.++|+|||.++........ .....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||...+..
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 999999999999999998754322211 122234578999999999889999999999999999998 99999998888
Q ss_pred HHHHHhccCCCccCCCCCCC
Q 038211 585 QVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 585 ~~~~~I~~~~~~~~~P~~~~ 604 (605)
++...+. ...++++|..++
T Consensus 250 ~~~~~~~-~~~~~~~~~~~~ 268 (307)
T cd05098 250 ELFKLLK-EGHRMDKPSNCT 268 (307)
T ss_pred HHHHHHH-cCCCCCCCCcCC
Confidence 8887774 444566776654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=281.16 Aligned_cols=213 Identities=29% Similarity=0.556 Sum_probs=183.8
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
.+..++|+++++||+|+||.||+|.+. +..+++|.+.... ...+.+.+|+.+++.++|+||+++++++...+..++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 456789999999999999999999864 4568999875432 234678899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 453 VTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 99999999999998764 356888899999999999999999999 999999999999999999999999999765432
Q ss_pred ccc-ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhc
Q 038211 532 YLT-AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 532 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~ 591 (605)
... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......++...+.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ 218 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH
Confidence 211 222345678999999998889999999999999999998 999999988888888875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=281.19 Aligned_cols=200 Identities=37% Similarity=0.601 Sum_probs=177.9
Q ss_pred ceEeeeecccCcEEEEEEEECC--cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEec
Q 038211 380 LQLGEEIGLGSYAVVYRGIWNG--SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFL 457 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~~~--~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~ 457 (605)
|++++.||+|+||+||++.+.+ +.+|+|++..............+|+.+++.++||||+++++++.+...+++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 7899999999999999999854 45999999887655555445567999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccC
Q 038211 458 PRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKS 537 (605)
Q Consensus 458 ~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~ 537 (605)
.+++|.+++... ..+++..+..++.||+.||.+||+.+ |+|+||||+||+++.++.++|+|||.+............
T Consensus 81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred cccccccccccc-cccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc
Confidence 999999999843 78899999999999999999999999 999999999999999999999999998754333344456
Q ss_pred CCCCCccccccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 538 GRGTPQWMAPEVLR-SEPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 538 ~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
..+++.|+|||++. +..++.++|+||||+++|+|++|..||...+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~ 203 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN 203 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc
Confidence 67899999999998 7888999999999999999999999999873
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=285.99 Aligned_cols=211 Identities=31% Similarity=0.485 Sum_probs=182.0
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.+.|+++++||.|+||.||++.+. +..+++|++... .....+.+.+|+.+++.++|+||+++++++..++.+++||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 367999999999999999999874 567999987654 2345677889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+++++|..++.+....+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 999999998888766677999999999999999999999999 999999999999999999999999998654333333
Q ss_pred ccCCCCCCccccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 535 AKSGRGTPQWMAPEVLR-----SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
.....+++.|+|||.+. ...++.++|+|||||++|+|++|..||...+..+.+.++.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 228 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 228 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh
Confidence 34456789999999985 3446788999999999999999999999888777666663
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=316.83 Aligned_cols=226 Identities=33% Similarity=0.552 Sum_probs=195.0
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC---Cc--c--eEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN---GS--D--VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~---~~--~--~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
+.....++.+.||+|.||.||+|... +. + ||+|.+.+.. .......|.+|..+|+.++|||||+++|++.+.
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 44667889999999999999999863 32 2 6777665432 355678899999999999999999999999999
Q ss_pred CeeEEEEEecCCCchHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEe
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKN------YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGD 521 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~D 521 (605)
...+|++|||.||+|..+|++. ...++....+.++.+|+.|+.||++++ +|||||..+|+||+....+||+|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcc
Confidence 8999999999999999999987 677999999999999999999999999 99999999999999999999999
Q ss_pred ecCCccc-CcccccccC-CCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccC
Q 038211 522 FGLSSLK-NATYLTAKS-GRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLE 598 (605)
Q Consensus 522 fg~a~~~-~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~ 598 (605)
||||+.. ...+..... ..-...|||||.+....++.++|||||||++||+++ |..||.+.++.+++..+. .++|++
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~-~ggRL~ 924 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL-EGGRLD 924 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH-hCCccC
Confidence 9999833 222222222 234578999999999999999999999999999999 999999999999999664 666999
Q ss_pred CCCCCC
Q 038211 599 LPEGLD 604 (605)
Q Consensus 599 ~P~~~~ 604 (605)
.|..++
T Consensus 925 ~P~~CP 930 (1025)
T KOG1095|consen 925 PPSYCP 930 (1025)
T ss_pred CCCCCC
Confidence 998875
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=281.12 Aligned_cols=225 Identities=34% Similarity=0.602 Sum_probs=190.3
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
++...+|.+.++||+|+||.||+|.+. ++.+++|++..+. .....+.+|+.+++.++|+||+++++++..++.++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 355678999999999999999999874 6779999876432 23456889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 452 IVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
++|||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999999999987643 46889999999999999999999999 99999999999999999999999999876543
Q ss_pred cccc-ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 531 TYLT-AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 531 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+. ...++++|+.++
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 231 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCP 231 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCC
Confidence 3221 112234668999999999999999999999999999998 999999988888877774 344566776654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=280.58 Aligned_cols=224 Identities=30% Similarity=0.485 Sum_probs=185.5
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc---hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC--Cee
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI---EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ--ERL 450 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~---~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~ 450 (605)
.+|++.++||+|+||.||++.+ .+..|++|.+...... ....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4789999999999999999986 4677999987643221 23456788999999999999999999998763 468
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
+++|||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 8999999999999988765 56888899999999999999999999 99999999999999999999999999875432
Q ss_pred cc---ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 531 TY---LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 531 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.. .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+....+..+......+.+|..++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVS 235 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhC
Confidence 11 112234588999999999988899999999999999999999999998776666666654444555665543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=278.92 Aligned_cols=211 Identities=26% Similarity=0.408 Sum_probs=187.2
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+|+++++||.|+||.||.++. .+..+++|.+............+.+|+.++++++|+||+++++++...+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 589999999999999988776 567799998876655555667788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 457 LPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 457 ~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 9999999998765 456899999999999999999999999 9999999999999999999999999987654433333
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~ 214 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV 214 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 44568999999999998888999999999999999999999999988888888874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=283.98 Aligned_cols=225 Identities=31% Similarity=0.533 Sum_probs=184.3
Q ss_pred ccccCceEeeeecccCcEEEEEEEECC-------cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~-------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
+..++|++.+.||+|+||.||+|.+.+ ..+|+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 445789999999999999999987643 4589998754322 22345688999999999999999999999988
Q ss_pred CeeEEEEEecCCCchHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEE
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNY---------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVK 518 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vk 518 (605)
...++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCEE
Confidence 99999999999999999987532 23567788899999999999999999 99999999999999999999
Q ss_pred EEeecCCcccCcccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCC
Q 038211 519 VGDFGLSSLKNATYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDR 595 (605)
Q Consensus 519 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~ 595 (605)
|+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+++..+. ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~ 238 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EGG 238 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCC
Confidence 999999875432221 1122345788999999998889999999999999999999 799999988888887764 333
Q ss_pred ccCCCCCC
Q 038211 596 RLELPEGL 603 (605)
Q Consensus 596 ~~~~P~~~ 603 (605)
.+.+|..+
T Consensus 239 ~~~~~~~~ 246 (277)
T cd05062 239 LLDKPDNC 246 (277)
T ss_pred cCCCCCCC
Confidence 34555544
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=278.84 Aligned_cols=221 Identities=38% Similarity=0.652 Sum_probs=191.4
Q ss_pred ccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
+...+|++.++||.|+||.||++...++.+++|.+..... ..+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 4567899999999999999999999999999999865532 4567889999999999999999999999889999999
Q ss_pred EecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 455 EFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 9999999999987653 36899999999999999999999999 9999999999999999999999999997653222
Q ss_pred cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..++...+. .+.++..|+.++
T Consensus 157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 225 (256)
T cd05039 157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCP 225 (256)
T ss_pred --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCccCCC
Confidence 12344678999999988889999999999999999997 999999988888877774 344556666554
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=286.37 Aligned_cols=223 Identities=34% Similarity=0.591 Sum_probs=183.7
Q ss_pred ccCceEeeeecccCcEEEEEEEECC--c--ceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWNG--S--DVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~~--~--~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~ 451 (605)
+++|++.++||+|+||.||+|..+. . .+++|.++.. ......+.+.+|+.++.++ +||||+++++++...+.++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 4789999999999999999998743 2 3577766532 2233456788999999999 7999999999999889999
Q ss_pred EEEEecCCCchHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc
Q 038211 452 IVTEFLPRGSLFKTLHKNY---------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT 516 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~ 516 (605)
++|||+++++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCe
Confidence 9999999999999997532 35788899999999999999999999 999999999999999999
Q ss_pred EEEEeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCC
Q 038211 517 VKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDR 595 (605)
Q Consensus 517 vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~ 595 (605)
+||+|||++....... .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..++...+. .+.
T Consensus 158 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~-~~~ 235 (297)
T cd05089 158 SKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGY 235 (297)
T ss_pred EEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCC
Confidence 9999999986432211 1122233567999999998889999999999999999997 999999998888888874 344
Q ss_pred ccCCCCCCC
Q 038211 596 RLELPEGLD 604 (605)
Q Consensus 596 ~~~~P~~~~ 604 (605)
.+.+|..++
T Consensus 236 ~~~~~~~~~ 244 (297)
T cd05089 236 RMEKPRNCD 244 (297)
T ss_pred CCCCCCCCC
Confidence 566666554
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=280.18 Aligned_cols=223 Identities=35% Similarity=0.564 Sum_probs=187.4
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
+..++|++.+.||+|+||.||+|.+. ++.||+|.+..... ..+.+.+|+.++++++||||+++++++...+..+++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 45578999999999999999999874 45699998765432 245688999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 454 TEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+.| |+||||||+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999987653 46899999999999999999999999 9999999999999999999999999987654222
Q ss_pred cc-ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 533 LT-AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 533 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
.. ......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+..++...+. ...++..|..+
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 229 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGC 229 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcC
Confidence 11 112223457999999999889999999999999999999 999999998888888885 33344455444
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=283.31 Aligned_cols=225 Identities=29% Similarity=0.528 Sum_probs=185.9
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCc----ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGS----DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~----~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
+...+|++.++||.|+||+||+|.+ ++. .||+|++.... .......+.+|+.+++.+.||||+++++++.. .
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 3457899999999999999999976 333 37899876543 23345678899999999999999999998875 4
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
..++++||+++|+|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeec
Confidence 578999999999999999876677999999999999999999999999 999999999999999999999999999765
Q ss_pred Cccccc--ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 529 NATYLT--AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 529 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
...... .....+++.|++||.+.+..++.++|||||||++|||++ |..||.......+...+. ....++.|..++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICT 237 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCccCC
Confidence 432211 122235678999999998889999999999999999998 999999888877777664 344555555443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=280.41 Aligned_cols=217 Identities=36% Similarity=0.597 Sum_probs=189.8
Q ss_pred eeecccCcEEEEEEEEC-----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecC
Q 038211 384 EEIGLGSYAVVYRGIWN-----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLP 458 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~-----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 458 (605)
++||+|+||.||+|.+. +..+++|++....... ....+.+|+.+++.++|+||+++++++.....++++|||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 47999999999999875 6679999987654333 46778899999999999999999999999999999999999
Q ss_pred CCchHHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 459 RGSLFKTLHKN--------YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 459 ggsL~~~l~~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
+++|.+++... ...+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||.+.....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999999876 478999999999999999999999999 99999999999999999999999999976543
Q ss_pred cc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 531 TY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 531 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.. .......+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..++...+.. +.++.+|..+|
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCP 233 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCC
Confidence 32 22334567889999999988889999999999999999999 6999999999999999863 55677777765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=287.80 Aligned_cols=211 Identities=25% Similarity=0.417 Sum_probs=179.8
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..++|.+.++||.|+||.||++.+. +..||+|.+..... ......+.+|+.+++.++||||+++++++..+..+++|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 4578999999999999999999874 66799998865432 22334577899999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
|||++ ++|..++......+++..+..++.||+.||+|||+++ |+|+||||+|||++.++.++|+|||++........
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 99996 5898888776677899999999999999999999999 99999999999999999999999999876543333
Q ss_pred cccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 534 TAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
......+++.|+|||.+.+. .++.++|||||||++|+|++|++||...+..+.+..+
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~ 217 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 33445678999999998764 4788999999999999999999999988766555443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=296.48 Aligned_cols=205 Identities=25% Similarity=0.347 Sum_probs=174.5
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC------
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ------ 447 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------ 447 (605)
..++|++.+.||+|+||.||++.+ .++.+|+|++............+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999986 467799999876544445566788999999999999999999998643
Q ss_pred CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
...++||||+++ +|...+.. .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCccccc
Confidence 357999999965 66666653 4788899999999999999999999 99999999999999999999999999976
Q ss_pred cCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~ 587 (605)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 169 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 227 (355)
T cd07874 169 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227 (355)
T ss_pred CCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 54322 233457899999999999999999999999999999999999999887754443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=281.75 Aligned_cols=224 Identities=29% Similarity=0.499 Sum_probs=186.8
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--C---cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--G---SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~---~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
.++|++.+.||+|+||.||+|.+. + ..+|+|.+.... .......+.+|+.+++.++||||+++++++..++..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 468999999999999999999763 2 258888875533 2334567889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||||+++++|.+++......+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 999999999999999876677899999999999999999999999 999999999999999999999999998764332
Q ss_pred cc---cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 532 YL---TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 532 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.. ......++..|++||.+.+..++.++|+|||||++|++++ |..||.+.+..+....+.. +.+++.|..++
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE-GYRLPAPMDCP 235 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC-CCcCCCCCCCC
Confidence 11 1112233568999999998889999999999999999886 9999999888888887753 33445554443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=280.36 Aligned_cols=212 Identities=28% Similarity=0.481 Sum_probs=181.6
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
++|++.++||+|+||.||+|.+ .++.||||.+..... .......+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5899999999999999999987 577899998765332 2344566889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 455 EFLPRGSLFKTLHK---NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 455 e~~~ggsL~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
||+++++|.+++.. ....+++..+..++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999999888753 2355889999999999999999999999 999999999999999999999999998765443
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHhc
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL--NLMQVVGVVG 591 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~--~~~~~~~~I~ 591 (605)
........+++.|+|||.+.+..++.++|+||||+++|+|++|+.||... +...+...+.
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 221 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE 221 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHh
Confidence 33333456899999999999888999999999999999999999999654 3456666664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=283.02 Aligned_cols=227 Identities=32% Similarity=0.536 Sum_probs=190.7
Q ss_pred CccccCceEeeeecccCcEEEEEEEECC-------cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS 446 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~-------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 446 (605)
.+..++|.+.+.||+|+||.||++.+++ ..+++|.+..... ......+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 3556799999999999999999998643 4599998754432 2334567899999999999999999999999
Q ss_pred CCeeEEEEEecCCCchHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcE
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNY---------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTV 517 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~v 517 (605)
....++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCE
Confidence 999999999999999999986532 24678889999999999999999999 9999999999999999999
Q ss_pred EEEeecCCcccCcccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCC
Q 038211 518 KVGDFGLSSLKNATYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMD 594 (605)
Q Consensus 518 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~ 594 (605)
||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..++...+. .+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~ 237 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DG 237 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cC
Confidence 9999999875432221 1223456789999999988889999999999999999998 999999999888888885 55
Q ss_pred CccCCCCCCC
Q 038211 595 RRLELPEGLD 604 (605)
Q Consensus 595 ~~~~~P~~~~ 604 (605)
..+.+|..++
T Consensus 238 ~~~~~~~~~~ 247 (277)
T cd05032 238 GHLDLPENCP 247 (277)
T ss_pred CCCCCCCCCC
Confidence 5667777654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=279.30 Aligned_cols=215 Identities=28% Similarity=0.520 Sum_probs=179.2
Q ss_pred eecccCcEEEEEEEEC----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCC
Q 038211 385 EIGLGSYAVVYRGIWN----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRG 460 (605)
Q Consensus 385 ~LG~G~fg~V~~~~~~----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~gg 460 (605)
.||+|+||.||+|.+. +..+|+|++.... .....+.+.+|+.++++++||||+++++++. ....++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 4899999999998763 3458999876542 2344567889999999999999999999875 45789999999999
Q ss_pred chHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc---ccC
Q 038211 461 SLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT---AKS 537 (605)
Q Consensus 461 sL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~---~~~ 537 (605)
+|.+++......+++..+..++.||+.||.|||++| ++||||||+|||++.++.+||+|||++......... ...
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 999998866678999999999999999999999999 999999999999999999999999998754332211 122
Q ss_pred CCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 538 GRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 538 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
..+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....++...+. .+.++++|+.++
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 224 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECP 224 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCC
Confidence 234678999999988889999999999999999996 999999998888888775 445567776654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=294.92 Aligned_cols=197 Identities=24% Similarity=0.370 Sum_probs=169.8
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
+...+|.++++||.|+||.||++... +..+++|.+... ....+|+.+|+.++||||++++++|.....+
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 34568999999999999999999753 345888876543 2356899999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
+++||++. ++|..++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.....
T Consensus 162 ~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99999994 688888843 478999999999999999999999999 99999999999999999999999999875443
Q ss_pred ccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 531 TYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 531 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 222 2234568999999999999999999999999999999999999997643
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=289.67 Aligned_cols=224 Identities=25% Similarity=0.328 Sum_probs=186.8
Q ss_pred ccccCceEeeeecccCcEEEEEEEECC-cceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNG-SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~-~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~l 452 (605)
+....|+++++||+||.+.||++...+ +.||+|.+.........+.-+.+|+..|.++ .|.+|++++++-..++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 455789999999999999999998754 4578877766666777888999999999999 59999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc--
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA-- 530 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~-- 530 (605)
||||- ..+|-..|++...-++.-.++.|..|++.|+.++|++| |||.||||.|+|+- .|.+||+|||+|.....
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 99986 56999999887666665588889999999999999999 99999999999994 57999999999976543
Q ss_pred ccccccCCCCCCcccccccccCCCC-----------CchhHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHhccCCCccC
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSEPS-----------NEKSDVFSFGVILWELVTASIPWNNLN-LMQVVGVVGFMDRRLE 598 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~~~-----------~~~~DiwSlG~il~el~~g~~Pf~~~~-~~~~~~~I~~~~~~~~ 598 (605)
......+.+||+.||+||.+....+ ++++||||||||||+|+.|+.||.... ..+-+.+|-.-+..++
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie 593 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE 593 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence 3344566789999999999965443 468999999999999999999998754 5566666644455556
Q ss_pred CCCC
Q 038211 599 LPEG 602 (605)
Q Consensus 599 ~P~~ 602 (605)
||+.
T Consensus 594 fp~~ 597 (677)
T KOG0596|consen 594 FPDI 597 (677)
T ss_pred ccCC
Confidence 6653
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=278.30 Aligned_cols=217 Identities=29% Similarity=0.509 Sum_probs=180.6
Q ss_pred eeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCCc
Q 038211 384 EEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGS 461 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ggs 461 (605)
+.||+|+||.||+|.+ .++.+|+|.+.... .......+.+|+++++.++||||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 4699999999999987 57779999875432 23345678899999999999999999999999999999999999999
Q ss_pred hHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc--cCCC
Q 038211 462 LFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA--KSGR 539 (605)
Q Consensus 462 L~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~ 539 (605)
|.+++......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......... ....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 99999776567899999999999999999999999 9999999999999999999999999987543221111 1112
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.+..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+. ...++.+|+.++
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 222 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCP 222 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCC
Confidence 3457999999998889999999999999999997 999999888877777774 334455665543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=284.85 Aligned_cols=211 Identities=30% Similarity=0.473 Sum_probs=184.2
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.++|++.+.||.|+||.||++.+ .+..+++|++... .....+.+.+|+.+++.++|+||+++++.+..+..+++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 36799999999999999999987 4677999988643 2344567889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+++++|.+++......+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999999998876677999999999999999999999999 999999999999999999999999998765443333
Q ss_pred ccCCCCCCccccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 535 AKSGRGTPQWMAPEVLR-----SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
.....+++.|++||.+. +..++.++|+|||||++|+|++|+.||.+.+..+.+..+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 221 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL 221 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh
Confidence 44556899999999975 3446778999999999999999999999988877777764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=282.43 Aligned_cols=223 Identities=31% Similarity=0.561 Sum_probs=190.8
Q ss_pred ccCceEeeeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
..+|++.++||.|+||.||+|.+. +..+++|++..... .....+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 357999999999999999999875 56689998765432 234568899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 456 FLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 456 ~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
|+++++|.+++... ...+++..+..++.||+.||.|||+.| |+|+||||+||+++.++.+||+|||.+.........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 99999999999764 356899999999999999999999999 999999999999999999999999999765443333
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.....++..|++||.+.+..++.++||||||+++|+|++ |+.||...+..+++..+. .+.+++.|..++
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCP 230 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCC
Confidence 334456788999999988889999999999999999998 899999988888888875 444556665544
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=284.61 Aligned_cols=213 Identities=31% Similarity=0.527 Sum_probs=182.8
Q ss_pred cccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
..++|.+.+.||+|+||.||+|.+. +..+|+|++..... ....+.+.+|+++++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4578999999999999999999763 35699998865432 224567899999999999999999999999999
Q ss_pred eeEEEEEecCCCchHHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNY-------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW 515 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~ 515 (605)
..++||||+++++|.+++.... ..+++..+..++.||+.||+|||++| ++||||||+||+++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~ 159 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDL 159 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCC
Confidence 9999999999999999997542 34788899999999999999999999 99999999999999999
Q ss_pred cEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhc
Q 038211 516 TVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 516 ~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~ 591 (605)
.++|+|||++....... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+..+.+..+.
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 99999999987532211 11223345788999999999999999999999999999998 999999988888888885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=283.81 Aligned_cols=201 Identities=23% Similarity=0.327 Sum_probs=173.3
Q ss_pred CceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
.|+..++||+|+||.||++.+. ++.||+|.+....... .....+.+|+.+++.++|+||+.+++.+.+.+.+++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3778899999999999999874 6679999886654332 233557789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 456 FLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-T 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-c
Confidence 999999998886542 46899999999999999999999999 9999999999999999999999999986543221 2
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|+.||....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 233468999999999999889999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=279.16 Aligned_cols=224 Identities=31% Similarity=0.520 Sum_probs=188.9
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccc---cchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC--Cee
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSE---YIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ--ERL 450 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~ 450 (605)
.+|.+.+.||+|+||.||++.+ .++.+++|++.... ........+.+|+.+++.++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4799999999999999999986 46779999875432 1234556788999999999999999999998764 468
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
+++|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 8999999999999998765 45889999999999999999999999 99999999999999999999999999975432
Q ss_pred cc---ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 531 TY---LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 531 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.. .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.+....+.+..+.....++.+|+.++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~ 235 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVS 235 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccC
Confidence 11 112234589999999999998889999999999999999999999998877777777755556677887765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=296.75 Aligned_cols=229 Identities=29% Similarity=0.445 Sum_probs=187.4
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECC-------cceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAV 444 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~-------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~ 444 (605)
+.+..++|.++++||+|+||.||+|.+.+ ..||+|++..... ....+.+.+|+.+|..+. ||||+++++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 45666789999999999999999998643 4699999875432 233456889999999997 99999999999
Q ss_pred eeCCeeEEEEEecCCCchHHHHHhhc------------------------------------------------------
Q 038211 445 ASQERLGIVTEFLPRGSLFKTLHKNY------------------------------------------------------ 470 (605)
Q Consensus 445 ~~~~~~~lv~e~~~ggsL~~~l~~~~------------------------------------------------------ 470 (605)
...+..++|||||++|+|.+++.+..
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 99999999999999999999986532
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCC
Q 038211 471 -------------------------------------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSS 507 (605)
Q Consensus 471 -------------------------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~ 507 (605)
..+++..++.++.||+.||+|||+.+ ++||||||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~ 268 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAAR 268 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcc
Confidence 13566778889999999999999999 999999999
Q ss_pred CEEEcCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 038211 508 NLLVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLM 584 (605)
Q Consensus 508 Nill~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~ 584 (605)
|||++.++.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 9999999999999999997543221 11223356889999999998889999999999999999998 99999887665
Q ss_pred HHHHHhccCCCccCCCCCCC
Q 038211 585 QVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 585 ~~~~~I~~~~~~~~~P~~~~ 604 (605)
+........+.++.+|..++
T Consensus 349 ~~~~~~~~~~~~~~~p~~~~ 368 (401)
T cd05107 349 EQFYNAIKRGYRMAKPAHAS 368 (401)
T ss_pred HHHHHHHHcCCCCCCCCCCC
Confidence 55444433556677777654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=282.92 Aligned_cols=225 Identities=31% Similarity=0.506 Sum_probs=187.2
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
+.+.+|.+.+.||+|+||+||++... +..+++|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 45678999999999999999998741 234788877543 233456788999999999999999999999999
Q ss_pred CeeEEEEEecCCCchHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNY------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW 515 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~ 515 (605)
+.+++||||+++++|.+++.... ..+++..++.++.||+.||+|||++| ++||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENL 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCC
Confidence 99999999999999999987542 24899999999999999999999999 99999999999999999
Q ss_pred cEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhcc
Q 038211 516 TVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGF 592 (605)
Q Consensus 516 ~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~ 592 (605)
.++|+|||++....... .......+++.|+|||.+.+..++.++|+|||||++|+|++ |..||...+...++..|.
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~- 236 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT- 236 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 99999999987543221 11223345778999999999889999999999999999998 999999988888888884
Q ss_pred CCCccCCCCCCC
Q 038211 593 MDRRLELPEGLD 604 (605)
Q Consensus 593 ~~~~~~~P~~~~ 604 (605)
.+..+..|..++
T Consensus 237 ~~~~~~~~~~~~ 248 (288)
T cd05093 237 QGRVLQRPRTCP 248 (288)
T ss_pred cCCcCCCCCCCC
Confidence 333345555444
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=281.94 Aligned_cols=209 Identities=32% Similarity=0.482 Sum_probs=179.4
Q ss_pred CceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
-|++.++||.|+||.||++.+. +..+++|.+... .....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 3688899999999999999885 455788877443 234456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccccc
Q 038211 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAK 536 (605)
Q Consensus 457 ~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 536 (605)
+++++|..++.+....+++..+..++.||+.||.|||+.| ++||||||+|||++.++.++|+|||++...........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 9999998888765577999999999999999999999999 99999999999999999999999999875543333334
Q ss_pred CCCCCCccccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 537 SGRGTPQWMAPEVLR-----SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 537 ~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
...+++.|+|||++. +..++.++|+|||||++|+|++|++||...+..+.+..+.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 221 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA 221 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHh
Confidence 456899999999984 3456789999999999999999999999888777776664
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=280.67 Aligned_cols=224 Identities=30% Similarity=0.516 Sum_probs=187.1
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--C---cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--G---SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~---~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
..+|++.+.||+|+||.||+|.+. + ..|++|++.... .......+..|+.+++.++||||+++++++..+...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 467899999999999999999864 2 249999876532 3445677899999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||||+++++|.+++....+.+++..++.++.|++.||+|||++| ++|+||||+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999999999876677899999999999999999999999 999999999999999999999999998754322
Q ss_pred ccc---c--cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 532 YLT---A--KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 532 ~~~---~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
... . .....+..|+|||.+.+..++.++|||||||++|||++ |..||...+..++...|. ...+++.|..++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~ 237 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCP 237 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCC
Confidence 111 1 11112457999999998889999999999999999886 999999988888888884 344555555543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=295.49 Aligned_cols=206 Identities=23% Similarity=0.338 Sum_probs=174.7
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC------C
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ------E 448 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------~ 448 (605)
.++|++++.||.|+||+||+|.+ .+..||+|++............+.+|+.+++.++||||++++++|... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 36899999999999999999986 456799999876543334456677899999999999999999988643 3
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
..+++++++ +++|..++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCccceec
Confidence 478999998 7899877754 56999999999999999999999999 999999999999999999999999999765
Q ss_pred CcccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 169 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07878 169 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228 (343)
T ss_pred CCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 432 234578999999999877 56789999999999999999999999887765555544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=293.20 Aligned_cols=227 Identities=28% Similarity=0.456 Sum_probs=180.8
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEe
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVA 445 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~ 445 (605)
.+..++|++.++||+|+||.||+|... ++.||+|++.... .....+.+.+|+.+++++ +|+||+++++++.
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 345678999999999999999998642 3569999886433 233456678899999999 8999999999886
Q ss_pred e-CCeeEEEEEecCCCchHHHHHhhc------------------------------------------------------
Q 038211 446 S-QERLGIVTEFLPRGSLFKTLHKNY------------------------------------------------------ 470 (605)
Q Consensus 446 ~-~~~~~lv~e~~~ggsL~~~l~~~~------------------------------------------------------ 470 (605)
. ...++++|||+++++|.+++....
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 5 456889999999999998886421
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc--ccccCCCCCC
Q 038211 471 ------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTP 542 (605)
Q Consensus 471 ------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~ 542 (605)
..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++....... .......++.
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 25788899999999999999999999 9999999999999999999999999997643221 1122334577
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 543 QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 543 ~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+.+......+.++..|..+
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYA 301 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence 8999999999999999999999999999997 999998755444333332234445555543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=286.92 Aligned_cols=226 Identities=32% Similarity=0.580 Sum_probs=183.6
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC--Ccc--eEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCC
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN--GSD--VAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQE 448 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~--~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~ 448 (605)
.+.+.+|++.+.||+|+||.||+|.+. +.. +++|.+.. .........+.+|+.++.++ +|+||+++++++...+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc-cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 356789999999999999999999864 333 45555432 22234456788899999999 8999999999999999
Q ss_pred eeEEEEEecCCCchHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNY---------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK 513 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~ 513 (605)
.+++||||+++++|.+++.+.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~ 159 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 159 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecC
Confidence 9999999999999999987542 35789999999999999999999999 999999999999999
Q ss_pred CCcEEEEeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhcc
Q 038211 514 NWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGF 592 (605)
Q Consensus 514 ~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~ 592 (605)
++.+||+|||++....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+.
T Consensus 160 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~- 237 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 237 (303)
T ss_pred CCcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-
Confidence 9999999999986432111 1112234678999999988888999999999999999998 999999888888777774
Q ss_pred CCCccCCCCCCC
Q 038211 593 MDRRLELPEGLD 604 (605)
Q Consensus 593 ~~~~~~~P~~~~ 604 (605)
...++..|..++
T Consensus 238 ~~~~~~~~~~~~ 249 (303)
T cd05088 238 QGYRLEKPLNCD 249 (303)
T ss_pred cCCcCCCCCCCC
Confidence 333444554443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=284.72 Aligned_cols=208 Identities=28% Similarity=0.393 Sum_probs=172.1
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhC---CCCCeeeEEEEEee-----CC
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL---RHPNVLLFMGAVAS-----QE 448 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l---~h~niv~~~~~~~~-----~~ 448 (605)
+|++.+.||+|+||+||+|.+ +++.+|+|++............+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588999999999999999987 467799998876443333334456777777766 69999999998864 34
Q ss_pred eeEEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
.++++|||++ ++|.+++.... ..+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 5899999996 58888886643 45899999999999999999999999 99999999999999999999999999976
Q ss_pred cCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....+.++
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~ 219 (288)
T cd07863 158 YSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 219 (288)
T ss_pred ccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHH
Confidence 54322 223346799999999999988999999999999999999999999887765555444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=281.14 Aligned_cols=210 Identities=31% Similarity=0.455 Sum_probs=178.8
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
...+|++.++||+|+||.||+|.+ .++.+|+|++..... .....+.+|+.+++.++||||+++++++...+.+++|
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 346899999999999999999986 467799998865421 2345678899999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 85 MEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999999988764 67899999999999999999999999 99999999999999999999999999976543333
Q ss_pred cccCCCCCCccccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 534 TAKSGRGTPQWMAPEVLR---SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
......+++.|+|||.+. ...++.++|+|||||++|+|++|+.||...++.+....+
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~ 221 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM 221 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee
Confidence 334456889999999885 344678999999999999999999999877666555444
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=277.22 Aligned_cols=210 Identities=33% Similarity=0.498 Sum_probs=184.6
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
++|++.++||.|+||.||++.+. ++.+++|++..... ...+.+.+|+.+++.++||||+++++++.....++++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 68999999999999999999873 56799999876532 245778899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|+++++|.+++......+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 158 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhhhcc
Confidence 99999999998876678999999999999999999999999 9999999999999999999999999987654333233
Q ss_pred cCCCCCCcccccccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 536 KSGRGTPQWMAPEVLRSE---PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
....++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+....+.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~ 217 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS 217 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 445688899999999877 78899999999999999999999999888777666664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=285.41 Aligned_cols=226 Identities=24% Similarity=0.427 Sum_probs=187.4
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
+...+|.+.++||.|+||.||+|.+. +..+|+|++.... .......+.+|+.++..++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 45678999999999999999999863 3569999886543 223346688999999999999999999999999
Q ss_pred CeeEEEEEecCCCchHHHHHhh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKN---------------YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD 512 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~ 512 (605)
...++++||+.+++|.+++... ...+++..+..++.|++.||+|||++| |+||||||+|||++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~ 158 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec
Confidence 9999999999999999988532 134788888999999999999999999 99999999999999
Q ss_pred CCCcEEEEeecCCcccCcccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 038211 513 KNWTVKVGDFGLSSLKNATYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGV 589 (605)
Q Consensus 513 ~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~ 589 (605)
.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+++..
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999875432221 1223345789999999988889999999999999999998 9999999998889888
Q ss_pred hccCCCccCCCCCCC
Q 038211 590 VGFMDRRLELPEGLD 604 (605)
Q Consensus 590 I~~~~~~~~~P~~~~ 604 (605)
|.. ....++|++++
T Consensus 239 i~~-~~~~~~~~~~~ 252 (283)
T cd05091 239 IRN-RQVLPCPDDCP 252 (283)
T ss_pred HHc-CCcCCCCCCCC
Confidence 853 33445666554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=278.95 Aligned_cols=223 Identities=30% Similarity=0.535 Sum_probs=186.7
Q ss_pred CccccCceEeeeecccCcEEEEEEEE-CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
.+..++|+++++||+|+||.||+|.. .++.+|+|.+..... ....+.+|+.+++.++|+||+++++++. .+.+++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 35668899999999999999999987 457799998865443 2356889999999999999999999864 567899
Q ss_pred EEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 453 VTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+|||+.+++|.+++... ...+++..+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999999988754 356889999999999999999999999 999999999999999999999999998765422
Q ss_pred c-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 532 Y-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 532 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
. .......++..|+|||.+.+..++.++||||||+++|+|++ |++||.+.+..++...+. .+.+++.|..+
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 228 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNC 228 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCCCCC
Confidence 2 12223345778999999998889999999999999999998 999999988888888774 33345555544
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=277.36 Aligned_cols=223 Identities=24% Similarity=0.420 Sum_probs=192.1
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+|++.+.||+|+||.||++.. .++.+++|.+............+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 589999999999999999876 467799999876554445566789999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 457 LPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 457 ~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
+.+++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||+|+|||++.++.++|+|||++..........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 99999999987643 46889999999999999999999999 9999999999999999999999999997654433333
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
....|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+.+..+. .+..+.+|..++
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 226 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYS 226 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCC
Confidence 34468899999999998888999999999999999999999999888888887773 444455665554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=280.59 Aligned_cols=222 Identities=29% Similarity=0.482 Sum_probs=185.6
Q ss_pred ceEeeeecccCcEEEEEEEEC-----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe-----
Q 038211 380 LQLGEEIGLGSYAVVYRGIWN-----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER----- 449 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~~-----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~----- 449 (605)
|++++.||+|+||.||+|... +..+|+|++............+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 578899999999999999763 2559999987665555566788999999999999999999998865443
Q ss_pred -eEEEEEecCCCchHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeec
Q 038211 450 -LGIVTEFLPRGSLFKTLHKN-----YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFG 523 (605)
Q Consensus 450 -~~lv~e~~~ggsL~~~l~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg 523 (605)
.+++|||+++++|..++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCcc
Confidence 79999999999999888543 236889999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCcccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCC
Q 038211 524 LSSLKNATYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELP 600 (605)
Q Consensus 524 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P 600 (605)
+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+++..+. .+..+.+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 237 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-HGNRLKQP 237 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 9875432221 1122335678999999988889999999999999999999 999999998888888885 44566677
Q ss_pred CCCC
Q 038211 601 EGLD 604 (605)
Q Consensus 601 ~~~~ 604 (605)
..++
T Consensus 238 ~~~~ 241 (273)
T cd05035 238 EDCL 241 (273)
T ss_pred cCCC
Confidence 7664
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=282.50 Aligned_cols=227 Identities=31% Similarity=0.492 Sum_probs=185.6
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS 446 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 446 (605)
++..++|++.++||+|+||.||+|..+ +..||+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456689999999999999999998653 33589998754432 2233457889999999999999999999998
Q ss_pred CCeeEEEEEecCCCchHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcE
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNY---------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTV 517 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~v 517 (605)
....++||||+++|+|.+++.... ..++...+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCcE
Confidence 899999999999999999997531 23466778889999999999999999 9999999999999999999
Q ss_pred EEEeecCCcccCccccc--ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCC
Q 038211 518 KVGDFGLSSLKNATYLT--AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMD 594 (605)
Q Consensus 518 kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~ 594 (605)
+|+|||+++........ .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..++...+. .+
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~ 237 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-DG 237 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cC
Confidence 99999998754322211 122345778999999998889999999999999999998 899999988888888774 34
Q ss_pred CccCCCCCCC
Q 038211 595 RRLELPEGLD 604 (605)
Q Consensus 595 ~~~~~P~~~~ 604 (605)
..+++|..++
T Consensus 238 ~~~~~~~~~~ 247 (288)
T cd05061 238 GYLDQPDNCP 247 (288)
T ss_pred CCCCCCCCCC
Confidence 4455665543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=281.61 Aligned_cols=218 Identities=32% Similarity=0.483 Sum_probs=188.2
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
++|++.+.||.|+||.||++.+ .++.+++|++.... .......+.+|+.+++.++|+||+++++++..+..+++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 3688999999999999999987 46779999986653 23344567899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|+++++|.+++... .+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 99999999998764 7899999999999999999999999 9999999999999999999999999997765443334
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCC
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~ 601 (605)
....+++.|+|||.+.+..++.++|||||||++|+|++|..||...++.+....+.. ...+.+|.
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~ 220 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-NNPPSLEG 220 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh-cCCCCCcc
Confidence 455688999999999998899999999999999999999999998888777777642 33344443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=278.89 Aligned_cols=223 Identities=30% Similarity=0.498 Sum_probs=186.8
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc---hhhhhhHHHHHHHHHhCCCCCeeeEEEEEee--CCeeE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI---EGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS--QERLG 451 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~---~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~ 451 (605)
+|+..+.||+|+||.||++.+ .+..|++|++...... ......+.+|+.+++.++||||+++++++.. ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 688999999999999999986 4677999987654322 2345678899999999999999999999875 36789
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
++|||+++++|.+.+... ..+++..++.++.||+.||+|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 83 l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 999999999999998765 56888999999999999999999999 999999999999999999999999998754321
Q ss_pred c---ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 532 Y---LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 532 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
. .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+.+..+......+.+|..++
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHIS 235 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcC
Confidence 1 111234578899999999998899999999999999999999999998887776666655555667776654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=272.11 Aligned_cols=216 Identities=25% Similarity=0.427 Sum_probs=180.6
Q ss_pred CceEe-eeecccCcEEEEEEE--ECCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEEEE
Q 038211 379 DLQLG-EEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 379 ~~~~~-~~LG~G~fg~V~~~~--~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~ 454 (605)
-|++. +.||+|+|+.|--+. .++..||||++.+.. .....++.+|++++.++ .|+||++++++|+++..+||||
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 35554 689999999998765 478889999997763 34567889999999999 6999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC---cEEEEeecCCcccCc-
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW---TVKVGDFGLSSLKNA- 530 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~---~vkl~Dfg~a~~~~~- 530 (605)
|-|.||+|..++++. .-+++..+.++..+|+.||+|||.+| |.||||||+|||-...+ -||||||.+..-...
T Consensus 156 EKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred ecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccC
Confidence 999999999999886 67899999999999999999999999 99999999999997654 489999998753221
Q ss_pred ------ccccccCCCCCCccccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---------------HH
Q 038211 531 ------TYLTAKSGRGTPQWMAPEVLR-----SEPSNEKSDVFSFGVILWELVTASIPWNNLN---------------LM 584 (605)
Q Consensus 531 ------~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~---------------~~ 584 (605)
......+.+|+..|||||+.. ...|+.+.|.||||+|||-|+.|.+||.+.. ..
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~ 312 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN 312 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence 112234567999999999862 2457899999999999999999999997532 34
Q ss_pred HHHHHhccCCCccCCCC
Q 038211 585 QVVGVVGFMDRRLELPE 601 (605)
Q Consensus 585 ~~~~~I~~~~~~~~~P~ 601 (605)
.+...| ..+.++||+
T Consensus 313 ~LFesI--QEGkYeFPd 327 (463)
T KOG0607|consen 313 KLFESI--QEGKYEFPD 327 (463)
T ss_pred HHHHHH--hccCCcCCh
Confidence 566667 788899986
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=280.57 Aligned_cols=223 Identities=26% Similarity=0.497 Sum_probs=181.8
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcc----eEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSD----VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~----~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
+..++|++.+.||+|+||+||+|.+ .+.. +++|.+... ........+..|+..++.+.||||+++++++. ..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 3457899999999999999999987 3443 666665322 12233456778888999999999999999875 45
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
..++++||+++|+|.+++......+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 678999999999999999876678999999999999999999999999 999999999999999999999999999754
Q ss_pred Cccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCC
Q 038211 529 NATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 529 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
.... .......++..|++||.+.+..++.++|||||||++|||++ |..||.+....++...+. .+.++..|..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 235 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQI 235 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCCC
Confidence 3221 12233456788999999998889999999999999999998 999999988777766664 4444555543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.45 Aligned_cols=198 Identities=30% Similarity=0.454 Sum_probs=171.0
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC------ee
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE------RL 450 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------~~ 450 (605)
-|...+.||+|+||.||++++ .|..+|||.+.... .....+...+|+++|++++|+|||++++.-++.. ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 356678999999999999986 57889999987754 3345677889999999999999999998765433 46
Q ss_pred EEEEEecCCCchHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc--CCC--cEEEEeecC
Q 038211 451 GIVTEFLPRGSLFKTLHK--NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD--KNW--TVKVGDFGL 524 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~--~~~--~vkl~Dfg~ 524 (605)
.+|||||.||||...+++ +...+++..++.++..++.||.|||++| |+||||||.||++- .+| -.||+|||.
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 799999999999999975 3467999999999999999999999999 99999999999994 334 369999999
Q ss_pred CcccCcccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 525 SSLKNATYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 525 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
|+...... ...+.+||+.|++||++.. ..|+.-+|.|||||++|+++||..||..
T Consensus 171 Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 171 ARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 99877665 4567789999999999984 7788899999999999999999999964
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=278.01 Aligned_cols=224 Identities=35% Similarity=0.557 Sum_probs=187.3
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
.+..++|++.++||+|+||.||++.+. +..+|+|.+...... .+.+.+|+.++++++|+|++++++++. ....++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 356688999999999999999999864 456899988654432 346889999999999999999999875 456899
Q ss_pred EEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 453 VTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+|||+++++|.+++... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 99999999999998764 345899999999999999999999999 999999999999999999999999999765332
Q ss_pred cc-cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 532 YL-TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 532 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||.+.+..++...+. ...++++|..++
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 229 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCP 229 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCC
Confidence 21 1122335678999999988889999999999999999999 999999988888888885 344556666554
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=280.30 Aligned_cols=226 Identities=29% Similarity=0.462 Sum_probs=184.4
Q ss_pred ccccCceEeeeecccCcEEEEEEEECC-------cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~-------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
+..+.|.+.+.||+|+||.||+|.+.. ..+++|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 345789999999999999999998754 447788764432 223345688899999999999999999999988
Q ss_pred CeeEEEEEecCCCchHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC---cEE
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNY------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW---TVK 518 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~---~vk 518 (605)
...++||||+++++|.+++.... ..+++..+..++.||+.||+|||+++ ++||||||+|||++.++ .+|
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceE
Confidence 89999999999999999987653 25889999999999999999999999 99999999999998654 699
Q ss_pred EEeecCCcccCccccc--ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCC
Q 038211 519 VGDFGLSSLKNATYLT--AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDR 595 (605)
Q Consensus 519 l~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~ 595 (605)
|+|||+++........ ......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..++...+. ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~ 238 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-GGG 238 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCC
Confidence 9999999765322111 112233568999999998889999999999999999997 999999988888777774 344
Q ss_pred ccCCCCCCC
Q 038211 596 RLELPEGLD 604 (605)
Q Consensus 596 ~~~~P~~~~ 604 (605)
++.+|..++
T Consensus 239 ~~~~~~~~~ 247 (277)
T cd05036 239 RLDPPKGCP 247 (277)
T ss_pred cCCCCCCCC
Confidence 566666554
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=281.45 Aligned_cols=206 Identities=30% Similarity=0.410 Sum_probs=175.3
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+|++.+.||+|+||.||+|.+ .+..||+|++............+.+|+.+++.++||||+++++++..++.+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588999999999999999987 467799998866543344456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 457 LPRGSLFKTLHKNY--QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 457 ~~ggsL~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
+. ++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+|||++.++.++|+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 96 58888876532 56899999999999999999999999 999999999999999999999999998755433333
Q ss_pred ccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 038211 535 AKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~ 587 (605)
.....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~ 211 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL 211 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 3344678999999998764 4688999999999999999999999876654333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=264.44 Aligned_cols=204 Identities=23% Similarity=0.372 Sum_probs=173.1
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC-----
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ----- 447 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~----- 447 (605)
++-.+|.+.+.||.|+|+.||+++. ++.-||+|.+.... .+..+..++|++..++++|||+++++++...+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 5568999999999999999999874 67779999987764 35577889999999999999999998876433
Q ss_pred CeeEEEEEecCCCchHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecC
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKN---YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~ 524 (605)
...|++++|...|+|.+.+.+. ...+++.++..|+.+|++||++||+..++++||||||.|||+...+.++|.|||.
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 3489999999999999998764 3479999999999999999999999999999999999999999999999999999
Q ss_pred CcccCccccc---------ccCCCCCCcccccccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 525 SSLKNATYLT---------AKSGRGTPQWMAPEVLRSE---PSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 525 a~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
++........ ......|..|+|||.+.-. ..+.++|||||||+||.|++|..||+-
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 8754322111 1122369999999998644 457899999999999999999999963
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=279.80 Aligned_cols=225 Identities=29% Similarity=0.548 Sum_probs=188.6
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--Cc----ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GS----DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~----~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
+...+|++.+.||+|+||+||+|.+. +. .+++|+...... ......+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 34578999999999999999999763 32 478887765432 3345678899999999999999999999887 7
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
..++||||+++++|.+++......+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 899999999999999999887677999999999999999999999999 999999999999999999999999999765
Q ss_pred Cccccc--ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 529 NATYLT--AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 529 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
...... .....++..|+|||.+....++.++|+|||||++|||++ |+.||......++...+. .+..+..|..++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICT 237 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCC
Confidence 432211 112224568999999988889999999999999999998 999999999888888885 445566666543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=281.03 Aligned_cols=193 Identities=25% Similarity=0.381 Sum_probs=165.9
Q ss_pred ecccCcEEEEEEEE--CCcceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCCch
Q 038211 386 IGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL 462 (605)
Q Consensus 386 LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ggsL 462 (605)
||+|+||.||++.. .++.||+|++....... .....+..|+.+++.++||||+++++++..+.++++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999986 47789999886543322 2234456799999999999999999999999999999999999999
Q ss_pred HHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCCCC
Q 038211 463 FKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGT 541 (605)
Q Consensus 463 ~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt 541 (605)
.+++.... ..+++..+..++.||+.||+|||+.| |+||||||+|||++.++.++|+|||++....... ......|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCC
Confidence 88876542 46889999999999999999999999 9999999999999999999999999987654322 22334689
Q ss_pred CcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 542 PQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 542 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
+.|+|||++.+..++.++|+|||||++|+|++|+.||...
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999988999999999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=281.12 Aligned_cols=225 Identities=31% Similarity=0.506 Sum_probs=186.5
Q ss_pred ccccCceEeeeecccCcEEEEEEEE-------CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW-------NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~-------~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
+.+.+|.+.++||+|+||.||++.. .+..+++|.+... .......+.+|+++++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4567899999999999999999864 2345788876543 234456789999999999999999999999999
Q ss_pred CeeEEEEEecCCCchHHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNY--------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK 513 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~--------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~ 513 (605)
...+++|||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~ 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQ 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcC
Confidence 99999999999999999987643 24788999999999999999999999 999999999999999
Q ss_pred CCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHh
Q 038211 514 NWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 514 ~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I 590 (605)
++.++|+|||++....... .......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+.+..+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 9999999999986543221 11122335788999999999989999999999999999998 99999998888888777
Q ss_pred ccCCCccCCCCCCC
Q 038211 591 GFMDRRLELPEGLD 604 (605)
Q Consensus 591 ~~~~~~~~~P~~~~ 604 (605)
. .+..+..|..++
T Consensus 238 ~-~~~~~~~~~~~~ 250 (280)
T cd05092 238 T-QGRELERPRTCP 250 (280)
T ss_pred H-cCccCCCCCCCC
Confidence 4 334455565554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=276.45 Aligned_cols=224 Identities=33% Similarity=0.557 Sum_probs=189.0
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
++..++|.+.++||+|+||.||++.+. +..++||.+..... ..+.+.+|+.+++.++|+||+++++++......++
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 355689999999999999999999874 35689998865432 23568899999999999999999999998889999
Q ss_pred EEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 453 VTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+|||+++++|.+++.... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999999997653 46899999999999999999999999 999999999999999999999999998765422
Q ss_pred c-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 532 Y-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 532 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
. .......++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.+....+..+. .+.++..|..+
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 229 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNC 229 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 1 11122234678999999998889999999999999999998 999999988888888874 33445555554
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=277.55 Aligned_cols=222 Identities=34% Similarity=0.563 Sum_probs=183.2
Q ss_pred ccccCceEeeeecccCcEEEEEEEECC-cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNG-SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~-~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
+..++|++.++||+|+||.||+|.+.+ ..+++|++..... ..+.+.+|+.+++.++||||+++++++. ....++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence 345689999999999999999998754 4689998865432 2346789999999999999999999874 4568999
Q ss_pred EEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 454 TEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999997643 45788999999999999999999999 9999999999999999999999999987554332
Q ss_pred cc-ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 533 LT-AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 533 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
.. .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+....++...+. ...+++++..+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 228 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPEC 228 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCCCCCcccc
Confidence 21 123345778999999988889999999999999999999 999999988888888774 33334444433
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=276.37 Aligned_cols=223 Identities=28% Similarity=0.440 Sum_probs=190.5
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee--CCeeEEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS--QERLGIVT 454 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~lv~ 454 (605)
+|++.+.||.|+||.||++.+ .+..+++|++..........+.+.+|+.+++.++|+||+++++++.. ...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588999999999999999987 46679999987665555666778899999999999999999998764 45689999
Q ss_pred EecCCCchHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCceeccCCCCCEEEcCCCcEEEEeecCCc
Q 038211 455 EFLPRGSLFKTLHKN---YQALDIKRRLRMALDVARGMNYLH-----HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526 (605)
Q Consensus 455 e~~~ggsL~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH-----~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~ 526 (605)
||+++++|.+++... ...+++..++.++.||+.||+||| +.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEecccccc
Confidence 999999999998764 467899999999999999999999 888 9999999999999999999999999998
Q ss_pred ccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 527 LKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 527 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.............+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+..++...+.. +....+|..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-GKFRRIPYRYS 235 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc-CCCCCCccccC
Confidence 765444323445689999999999998899999999999999999999999999888888888753 23335665543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=280.19 Aligned_cols=210 Identities=32% Similarity=0.474 Sum_probs=179.9
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..++|.+.++||+|+||.||+|.+ .++.||+|++.... ......+.+|+.+++.++||||+++++.+...+.++++
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 346899999999999999999987 46779999886543 22345578899999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
|||+++++|.+++... +.+++..+..++.|++.||+|||+.| ++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 85 MEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred EeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 9999999999988665 67899999999999999999999999 99999999999999999999999999875543333
Q ss_pred cccCCCCCCccccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 534 TAKSGRGTPQWMAPEVLR---SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
......|++.|+|||.+. ...++.++|+|||||++|+|++|..||....+...+..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~ 221 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM 221 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh
Confidence 334557899999999874 445788999999999999999999999876665555544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=278.24 Aligned_cols=222 Identities=28% Similarity=0.469 Sum_probs=181.5
Q ss_pred ceEeeeecccCcEEEEEEEECCc----ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC------Ce
Q 038211 380 LQLGEEIGLGSYAVVYRGIWNGS----DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ------ER 449 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~~~~----~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------~~ 449 (605)
|.++++||+|+||.||+|.+... .+|+|.+..........+.+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999987432 488998776544455677889999999999999999999976432 25
Q ss_pred eEEEEEecCCCchHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecC
Q 038211 450 LGIVTEFLPRGSLFKTLHK-----NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~ 524 (605)
.+++|||+.+++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCc
Confidence 7899999999999887743 2245789999999999999999999999 99999999999999999999999999
Q ss_pred CcccCcccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCC
Q 038211 525 SSLKNATYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 525 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~ 601 (605)
++....... ......+++.|++||.+.+..++.++|||||||++|+|++ |+.||......++...+. .+..++.|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 237 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-QGNRLKQPP 237 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCCCCC
Confidence 876533221 1223346778999999999889999999999999999999 899999988888888875 344455555
Q ss_pred CCC
Q 038211 602 GLD 604 (605)
Q Consensus 602 ~~~ 604 (605)
.++
T Consensus 238 ~~~ 240 (272)
T cd05075 238 DCL 240 (272)
T ss_pred CCC
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=281.94 Aligned_cols=208 Identities=25% Similarity=0.447 Sum_probs=179.4
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
..+|++.+.||+|+||.||++.+ .+..+++|.+...... ..+.+.+|+.+++.++|+||+++++.|....+.++||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 36899999999999999999986 4677999988664432 2466889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+++++|.+++.. ..+++..+..++.|++.||+|||+.| |+||||||+|||++.++.++|+|||++.........
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred cccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 99999999998865 45788999999999999999999999 999999999999999999999999998754333222
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...++......+
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~ 228 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH
Confidence 33456899999999999888899999999999999999999999887765444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=283.35 Aligned_cols=228 Identities=29% Similarity=0.517 Sum_probs=189.3
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC---------CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN---------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMG 442 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~---------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~ 442 (605)
..+..++|.+.+.||+|+||.||++.+. +..+++|++.... .......+.+|+.+++.+ +||||+++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 3466789999999999999999999742 2358899876432 234456788999999999 8999999999
Q ss_pred EEeeCCeeEEEEEecCCCchHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCC
Q 038211 443 AVASQERLGIVTEFLPRGSLFKTLHKNY---------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSS 507 (605)
Q Consensus 443 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~ 507 (605)
++......+++|||+++++|.+++.... ..++...+..++.||+.||+|||++| ++||||||+
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~ 166 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAAR 166 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccc
Confidence 9999999999999999999999987642 24677888999999999999999999 999999999
Q ss_pred CEEEcCCCcEEEEeecCCcccCcccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 038211 508 NLLVDKNWTVKVGDFGLSSLKNATYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLM 584 (605)
Q Consensus 508 Nill~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~ 584 (605)
|||++.++.+||+|||+++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999999976543221 1223345778999999999889999999999999999998 89999999988
Q ss_pred HHHHHhccCCCccCCCCCCC
Q 038211 585 QVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 585 ~~~~~I~~~~~~~~~P~~~~ 604 (605)
++...+. .+.++..|..++
T Consensus 247 ~~~~~~~-~~~~~~~~~~~~ 265 (304)
T cd05101 247 ELFKLLK-EGHRMDKPANCT 265 (304)
T ss_pred HHHHHHH-cCCcCCCCCCCC
Confidence 9888884 444555665543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=284.74 Aligned_cols=228 Identities=29% Similarity=0.520 Sum_probs=187.9
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC---------CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN---------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMG 442 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~---------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~ 442 (605)
..+..++|.+.++||+|+||.||++.+. ...+|+|++.... .......+.+|+.+++.+ +||||+++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3455688999999999999999999752 3358999876533 233456788999999999 6999999999
Q ss_pred EEeeCCeeEEEEEecCCCchHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCC
Q 038211 443 AVASQERLGIVTEFLPRGSLFKTLHKNY---------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSS 507 (605)
Q Consensus 443 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~ 507 (605)
++...+.++++|||+++++|.+++.... ..+++..+..++.||+.||.|||++| ++||||||+
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~ 163 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAAR 163 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccce
Confidence 9998889999999999999999997532 34788889999999999999999999 999999999
Q ss_pred CEEEcCCCcEEEEeecCCcccCcccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 038211 508 NLLVDKNWTVKVGDFGLSSLKNATYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLM 584 (605)
Q Consensus 508 Nill~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~ 584 (605)
|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999975532211 1122234568999999998889999999999999999999 99999999888
Q ss_pred HHHHHhccCCCccCCCCCCC
Q 038211 585 QVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 585 ~~~~~I~~~~~~~~~P~~~~ 604 (605)
++...+. .+..+++|..++
T Consensus 244 ~~~~~~~-~~~~~~~~~~~~ 262 (314)
T cd05099 244 ELFKLLR-EGHRMDKPSNCT 262 (314)
T ss_pred HHHHHHH-cCCCCCCCCCCC
Confidence 8888874 344456665543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=283.24 Aligned_cols=228 Identities=26% Similarity=0.413 Sum_probs=184.7
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAV 444 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~ 444 (605)
..+..++|.+.++||+|+||.||++.+. +..+|+|++.... .....+.+.+|+.+++++ +||||+++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 3456678999999999999999998752 2358899876543 233456788999999999 799999999999
Q ss_pred eeCCeeEEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeec
Q 038211 445 ASQERLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFG 523 (605)
Q Consensus 445 ~~~~~~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg 523 (605)
...+.++++|||+++++|.+++.... ..+++..+..++.||+.||+|||+++ |+|+||||+|||++.++.++|+|||
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999999997643 34899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCcccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCC
Q 038211 524 LSSLKNATYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELP 600 (605)
Q Consensus 524 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P 600 (605)
+++....... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+....+...+.++..|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 266 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP 266 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCC
Confidence 9875432211 1222345788999999999889999999999999999998 999998876554443332233344444
Q ss_pred CCC
Q 038211 601 EGL 603 (605)
Q Consensus 601 ~~~ 603 (605)
..+
T Consensus 267 ~~~ 269 (302)
T cd05055 267 EHA 269 (302)
T ss_pred CCC
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=276.76 Aligned_cols=222 Identities=31% Similarity=0.540 Sum_probs=186.2
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-------hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-------EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-------~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
+|.+.+.||.|+||.||+|.+ .++.+++|.+...... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 478889999999999999987 4677999988654322 1234568899999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
.+++|||+++++|.+++... ..+++..+..++.|++.||+|||++| ++||||+|+||+++.++.++|+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 99999999999999999765 67888999999999999999999999 9999999999999999999999999987654
Q ss_pred ccc------ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 530 ATY------LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 530 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
... .......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+.+..+. ....+.+|..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNI 236 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-ccCCCcCCccc
Confidence 211 11123457899999999998888999999999999999999999999887777766664 23445666554
Q ss_pred C
Q 038211 604 D 604 (605)
Q Consensus 604 ~ 604 (605)
+
T Consensus 237 ~ 237 (267)
T cd06628 237 S 237 (267)
T ss_pred C
Confidence 3
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=279.83 Aligned_cols=210 Identities=25% Similarity=0.362 Sum_probs=178.5
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
++|++.++||+|+||.||++.+. ++.+|+|++..........+.+.+|+.+++.++|+|++++++++.....+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46899999999999999999874 6789999887654333344567899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|++++.|..++.. ...+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 9998877766544 357899999999999999999999999 9999999999999999999999999997654433233
Q ss_pred cCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 536 KSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+....+
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 213 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI 213 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 34567889999999876 45788999999999999999999999987765555443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=290.08 Aligned_cols=227 Identities=27% Similarity=0.454 Sum_probs=181.5
Q ss_pred CccccCceEeeeecccCcEEEEEEEE-------CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEe
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW-------NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVA 445 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~-------~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~ 445 (605)
.+..++|++.++||+|+||+||+|.+ .++.||||++.... .......+.+|+.++..+ +||||+++++++.
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 45567999999999999999999974 35679999986543 233456788999999999 6899999999876
Q ss_pred eC-CeeEEEEEecCCCchHHHHHhhc------------------------------------------------------
Q 038211 446 SQ-ERLGIVTEFLPRGSLFKTLHKNY------------------------------------------------------ 470 (605)
Q Consensus 446 ~~-~~~~lv~e~~~ggsL~~~l~~~~------------------------------------------------------ 470 (605)
.. ..++++||||++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 56889999999999999986431
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc--ccc
Q 038211 471 ------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL--TAK 536 (605)
Q Consensus 471 ------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~--~~~ 536 (605)
..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........ ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 23677788899999999999999999 99999999999999999999999999875432211 112
Q ss_pred CCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHhccCCCccCCCCCCC
Q 038211 537 SGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLM-QVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 537 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~-~~~~~I~~~~~~~~~P~~~~ 604 (605)
...+++.|+|||.+.+..++.++|||||||++|+|++ |..||...... ++...+ ..+.++++|..++
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 308 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTRMRAPDYTT 308 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHH-hccCCCCCCCCCC
Confidence 2345678999999999889999999999999999996 99999876543 333333 3455666776554
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=280.99 Aligned_cols=222 Identities=32% Similarity=0.530 Sum_probs=183.2
Q ss_pred CceEeeeecccCcEEEEEEEECC-------cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~~-------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
+|++.+.||+|+||.||+|.... ..+++|.+.... .......+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 57889999999999999998632 347888775433 2334567889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhh-----------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCC
Q 038211 452 IVTEFLPRGSLFKTLHKN-----------------------YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSN 508 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~-----------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~N 508 (605)
++|||+.+++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n 157 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN 157 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence 999999999999988642 134788899999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 038211 509 LLVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQ 585 (605)
Q Consensus 509 ill~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~ 585 (605)
||++.++.++|+|||+++...... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+.+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999987542221 11222345778999999988889999999999999999998 999999988888
Q ss_pred HHHHhccCCCccCCCCCCC
Q 038211 586 VVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 586 ~~~~I~~~~~~~~~P~~~~ 604 (605)
+...+. ...+++.|..++
T Consensus 238 ~~~~~~-~~~~~~~~~~~~ 255 (290)
T cd05045 238 LFNLLK-TGYRMERPENCS 255 (290)
T ss_pred HHHHHh-CCCCCCCCCCCC
Confidence 877764 334555665543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=280.94 Aligned_cols=223 Identities=33% Similarity=0.527 Sum_probs=184.8
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
+...+|.+.+.||+|+||.||++.+. +..+++|.+.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 35578999999999999999999752 2347788764432 23346788999999999999999999999999
Q ss_pred CeeEEEEEecCCCchHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNY---------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD 512 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~ 512 (605)
+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~ 157 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVG 157 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc
Confidence 99999999999999999987532 34788999999999999999999999 99999999999999
Q ss_pred CCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 038211 513 KNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGV 589 (605)
Q Consensus 513 ~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~ 589 (605)
.++.++|+|||++....... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+..+++..
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999987543322 11223456889999999999989999999999999999998 9999999888888887
Q ss_pred hccCCCccCCCCC
Q 038211 590 VGFMDRRLELPEG 602 (605)
Q Consensus 590 I~~~~~~~~~P~~ 602 (605)
+. .+..+..|..
T Consensus 238 ~~-~~~~~~~~~~ 249 (291)
T cd05094 238 IT-QGRVLERPRV 249 (291)
T ss_pred Hh-CCCCCCCCcc
Confidence 74 3333344443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=275.68 Aligned_cols=212 Identities=28% Similarity=0.504 Sum_probs=181.9
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
++|++.++||+|+||.||+|.+ .++.+++|.+...... ......+.+|+.++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999987 4778999988654333 334677889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 455 EFLPRGSLFKTLHKN---YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 455 e~~~ggsL~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
||+++++|..++... ...+++..++.++.||+.||.|||+.| |+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 999999999988642 356899999999999999999999999 999999999999999999999999998765433
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHhc
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL--NLMQVVGVVG 591 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~--~~~~~~~~I~ 591 (605)
........+++.|+|||.+.+..++.++|+|||||++|+|++|+.||... +..++...+.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 221 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE 221 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh
Confidence 33333456889999999999988999999999999999999999999653 3445555553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=282.98 Aligned_cols=220 Identities=25% Similarity=0.407 Sum_probs=186.8
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
++|++.+.||+|+||.||++.+. +..+|+|.+....... ...+.+.+|+.+++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999874 6789999987764432 35567889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc-
Q 038211 455 EFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY- 532 (605)
Q Consensus 455 e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~- 532 (605)
||+.+++|.+++... ...+++..+..++.||+.||+|||+.| ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999999998764 356899999999999999999999999 9999999999999999999999999986432111
Q ss_pred ----------------------------ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q 038211 533 ----------------------------LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLM 584 (605)
Q Consensus 533 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~ 584 (605)
.......||..|+|||.+.+..++.++||||||+++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0111235789999999999998999999999999999999999999988877
Q ss_pred HHHHHhccCCCccCCCC
Q 038211 585 QVVGVVGFMDRRLELPE 601 (605)
Q Consensus 585 ~~~~~I~~~~~~~~~P~ 601 (605)
+....+. ..++.+|.
T Consensus 239 ~~~~~~~--~~~~~~~~ 253 (316)
T cd05574 239 ETFSNIL--KKEVTFPG 253 (316)
T ss_pred HHHHHHh--cCCccCCC
Confidence 7777663 33444444
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=276.09 Aligned_cols=223 Identities=30% Similarity=0.496 Sum_probs=184.7
Q ss_pred CceEeeeecccCcEEEEEEEE-CCcceEEEEeecccc----chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEY----IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~----~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
+|++.+.||.|+||.||+|.. .+..+|+|.+..... .......+.+|+.+++.++|+||+++++++...+.++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 578899999999999999976 567799998765422 123346688999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc--
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT-- 531 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~-- 531 (605)
|||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999999999765 56889999999999999999999999 999999999999999999999999998653211
Q ss_pred ----cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccC-CCccCCCCCCC
Q 038211 532 ----YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFM-DRRLELPEGLD 604 (605)
Q Consensus 532 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~-~~~~~~P~~~~ 604 (605)
........++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+... ...+.+|..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS 235 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC
Confidence 11122345899999999999988999999999999999999999999987766555554322 23345665543
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=282.09 Aligned_cols=227 Identities=30% Similarity=0.536 Sum_probs=189.2
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECC-------cceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAV 444 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~-------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~ 444 (605)
..+..++|++.+.||+|+||.||++.+.+ ..+|+|++.... .......+.+|+.+++.+ +|+||+++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34566789999999999999999998643 458999876543 233445688999999999 899999999999
Q ss_pred eeCCeeEEEEEecCCCchHHHHHhh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCE
Q 038211 445 ASQERLGIVTEFLPRGSLFKTLHKN---------------YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNL 509 (605)
Q Consensus 445 ~~~~~~~lv~e~~~ggsL~~~l~~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Ni 509 (605)
..++.++++|||+++++|..++... ...+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Ni 163 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNV 163 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeE
Confidence 9999999999999999999998642 246889999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEeecCCcccCcccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 038211 510 LVDKNWTVKVGDFGLSSLKNATYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQV 586 (605)
Q Consensus 510 ll~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~ 586 (605)
|++.++.+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..++
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 999999999999999976543221 1222345678999999998889999999999999999997 9999999988888
Q ss_pred HHHhccCCCccCCCCCC
Q 038211 587 VGVVGFMDRRLELPEGL 603 (605)
Q Consensus 587 ~~~I~~~~~~~~~P~~~ 603 (605)
...+. .+..+.+|..+
T Consensus 244 ~~~~~-~~~~~~~~~~~ 259 (293)
T cd05053 244 FKLLK-EGYRMEKPQNC 259 (293)
T ss_pred HHHHH-cCCcCCCCCCC
Confidence 88774 44455666544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=279.47 Aligned_cols=208 Identities=27% Similarity=0.462 Sum_probs=181.1
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
..+|++.++||.|+||.||++.+ .++.+++|.+..... ...+.+.+|+.+++.++||||+++++++...+.+++|+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 46799999999999999999986 577899998865432 23456789999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+++++|..++.. ..+++..+..++.|++.||+|||+.| ++|+||||+||+++.++.++|+|||++.........
T Consensus 96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 96 EYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred EecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 99999999998865 46899999999999999999999999 999999999999999999999999998765433323
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~ 227 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 33456889999999999888999999999999999999999999988776655555
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=276.65 Aligned_cols=225 Identities=30% Similarity=0.544 Sum_probs=186.6
Q ss_pred ccccCceEeeeecccCcEEEEEEEECC-----cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNG-----SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~-----~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
+...+|.+.++||+|+||.||+|.+.. ..+++|...... .....+.+.+|+.+++.++||||+++++++.+ +.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 345679999999999999999998642 248888775432 23345678899999999999999999998875 56
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
.++||||+++++|.+++......+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeecc
Confidence 78999999999999999876567899999999999999999999999 9999999999999999999999999987543
Q ss_pred cccc-cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 530 ATYL-TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 530 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. .+.++.+|+.++
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 234 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCC
Confidence 3221 1122334568999999988889999999999999999886 999999988888888775 445566776654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=273.12 Aligned_cols=219 Identities=32% Similarity=0.552 Sum_probs=185.6
Q ss_pred ccCceEeeeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
..+|++.+.||+|+||.||++.+. +..+++|++...... ...+.+|+++++.++|||++++++++......+++||
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 468999999999999999999875 677999987654322 3457889999999999999999999999899999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc-c
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL-T 534 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~-~ 534 (605)
|+++++|.+++......+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........ .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999999999876677899999999999999999999999 99999999999999999999999999875432211 1
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~ 601 (605)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+++..+. .+.++..|.
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 224 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFRLYKPR 224 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-CCCCCCCCC
Confidence 222335678999999998889999999999999999998 999999988888888885 233444444
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=281.99 Aligned_cols=208 Identities=26% Similarity=0.355 Sum_probs=175.7
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+|++.++||.|+||.||+|.+ .|+.+++|.+............+.+|+.+++.++||||+++++++.+...+++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 488999999999999999987 477899999876543344445678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccccc
Q 038211 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAK 536 (605)
Q Consensus 457 ~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 536 (605)
++ ++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++...........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 96 5788887765577999999999999999999999999 99999999999999999999999999876544333333
Q ss_pred CCCCCCcccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCC-CCCCHHHHHHH
Q 038211 537 SGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTASIPW-NNLNLMQVVGV 589 (605)
Q Consensus 537 ~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~Pf-~~~~~~~~~~~ 589 (605)
...+++.|+|||.+.+.. ++.++|||||||++|+|++|..|| ...+..+.+..
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~ 212 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 212 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHH
Confidence 456789999999987754 688999999999999999998885 44444444443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=274.29 Aligned_cols=215 Identities=31% Similarity=0.542 Sum_probs=179.5
Q ss_pred eeecccCcEEEEEEEECC-----cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecC
Q 038211 384 EEIGLGSYAVVYRGIWNG-----SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLP 458 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~~-----~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 458 (605)
++||+|+||.||+|.+.. ..+++|.+...... ...+.+.+|+.+++.+.|+||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 479999999999997632 45899988765433 34567889999999999999999999876 456899999999
Q ss_pred CCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc---c
Q 038211 459 RGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT---A 535 (605)
Q Consensus 459 ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~---~ 535 (605)
+++|.+++... ..+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++........ .
T Consensus 79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999999875 47899999999999999999999999 999999999999999999999999998755332211 1
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..++...+. ...+++.|..++
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 224 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECP 224 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCC
Confidence 12223568999999998889999999999999999997 999999998888888885 344556676654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=278.82 Aligned_cols=212 Identities=27% Similarity=0.476 Sum_probs=181.2
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
++|++.+.||+|+||.||++.+ .+..++||.+..... .......+.+|+.+++.++|+||+++++++..++.++++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5789999999999999999986 577899998765432 2334567889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 455 EFLPRGSLFKTLHKN---YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 455 e~~~ggsL~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
||+++++|.+++... ...+++..++.++.||+.||.|||++| ++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999999988642 356899999999999999999999999 999999999999999999999999998765443
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHhc
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN--LMQVVGVVG 591 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~--~~~~~~~I~ 591 (605)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+....+.
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 221 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE 221 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh
Confidence 333344568999999999998889999999999999999999999997543 345555553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=274.33 Aligned_cols=222 Identities=34% Similarity=0.543 Sum_probs=189.8
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeecccc---chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY---IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
+|+..+.||+|+||+||+|.. .+..|++|++..... .....+.+.+|+.+++.++|+||+++++++.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 477789999999999999987 477899998865432 133456788999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
+||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 9999999999998765 56889999999999999999999999 9999999999999999999999999987654332
Q ss_pred cccCCCCCCcccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
......+++.|++||.+.... ++.++|+|||||++|+|++|+.||......+....+........+|+.++
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLS 228 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcC
Confidence 223456899999999987776 88999999999999999999999998877777777765456667776654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=275.57 Aligned_cols=217 Identities=35% Similarity=0.571 Sum_probs=184.7
Q ss_pred eeecccCcEEEEEEEECC---c--ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecC
Q 038211 384 EEIGLGSYAVVYRGIWNG---S--DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLP 458 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~~---~--~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 458 (605)
++||+|+||.||++.+.. + .+|+|.+...... ...+.+.+|+.++++++||||+++++.+.. ..++++|||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998632 2 4899988766543 556788999999999999999999999988 88999999999
Q ss_pred CCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc---cc
Q 038211 459 RGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY---LT 534 (605)
Q Consensus 459 ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~---~~ 534 (605)
+++|.+.+.... ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++....... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999998764 57899999999999999999999999 9999999999999999999999999987653321 11
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.....++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..++...+......+..|..++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACP 227 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCC
Confidence 223456789999999998889999999999999999998 9999999888888888865555566665543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=276.89 Aligned_cols=193 Identities=34% Similarity=0.473 Sum_probs=169.4
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
++|++.++||+|+||.||++.+ .+..+|+|++.... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 4788999999999999999986 56779999886543 23345678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|+++++|..+ ..+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++...... ..
T Consensus 80 ~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~ 150 (279)
T cd06619 80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IA 150 (279)
T ss_pred cCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cc
Confidence 9999988543 34678888999999999999999999 999999999999999999999999998754322 23
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
....||..|+|||.+.+..++.++|+|||||++|+|++|+.||..
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 345789999999999999899999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=277.92 Aligned_cols=220 Identities=24% Similarity=0.367 Sum_probs=189.1
Q ss_pred CceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
.|++.+.||.|+||.||++.+. +..+++|++.+..... ...+.+.+|+.++++++||||+++++++..+..+++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4889999999999999999875 7789999987654333 456788999999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|+.+++|.+++... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LT 156 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cc
Confidence 99999999998775 68899999999999999999999999 9999999999999999999999999987654332 22
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHhccCCCccCCCCCCC
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN---LMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~---~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+ ..++...+. .....+|+.++
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 226 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE--TADVLYPATWS 226 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc--cccccCcccCc
Confidence 34567899999999998889999999999999999999999999877 455554442 25566666554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=280.47 Aligned_cols=207 Identities=27% Similarity=0.397 Sum_probs=178.4
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
++|++.++||+|+||.||++.+. +..+++|.+.... .......+.+|+++++.++||||++++++|..++.+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36999999999999999999874 5568888775432 23345668899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH-RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
|+++++|.+++.+. ..+++..+..++.||+.||.|||+ .+ ++|+||||+|||++.++.++|+|||++...... .
T Consensus 80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~ 154 (308)
T cd06615 80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--M 154 (308)
T ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCccccccc--c
Confidence 99999999998765 678999999999999999999997 58 999999999999999999999999998654322 2
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 210 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF 210 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhh
Confidence 23457899999999998888999999999999999999999999876655555444
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=278.37 Aligned_cols=218 Identities=29% Similarity=0.485 Sum_probs=185.6
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
..|+..++||.|+||.||+|.+ .+..+|+|++..... ......+.+|+.+++.+.|+||+++++++..+...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 4578889999999999999987 466799998865432 3345678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 9999999998865 56888999999999999999999999 9999999999999999999999999986654333233
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCC
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~ 601 (605)
....++..|+|||.+.+..++.++|+|||||++|+|++|..||...++......+. ....+.++.
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~ 223 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTG 223 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCch
Confidence 34467889999999998889999999999999999999999999888777777663 233344443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=274.26 Aligned_cols=219 Identities=34% Similarity=0.609 Sum_probs=185.1
Q ss_pred ccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
+...+|++.+.||+|+||.||++...++.+|+|++.... ....+.+|+.+++.++|||++++++++... ..+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred ccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 345789999999999999999999889999999875432 235688999999999999999999998654 579999
Q ss_pred EecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 455 EFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
||+.+++|.+++.... ..+++..+..++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 9999999999987653 45889999999999999999999999 9999999999999999999999999987543221
Q ss_pred cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.....+..|+|||.+.+..++.++|+|||||++|+|++ |+.||...+..+....+. .+.+++.|+.++
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 223 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCP 223 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCCCCCcCC
Confidence 22234678999999988889999999999999999997 999999998888888875 334455555443
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=273.40 Aligned_cols=223 Identities=34% Similarity=0.573 Sum_probs=183.8
Q ss_pred ccccCceEeeeecccCcEEEEEEEECC-cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNG-SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~-~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
+..++|.+.++||+|+||.||++.+.+ ..+++|.+..... ..+.+.+|+.+++.++|+|++++++++. .+..+++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 345789999999999999999998754 4689998754332 2356788999999999999999999875 4568999
Q ss_pred EEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 454 TEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
|||+.+++|.+++.... ..+++..+..++.||+.||+|||+.| ++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999999997643 45788999999999999999999999 9999999999999999999999999997653322
Q ss_pred c-cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 533 L-TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 533 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
. ......++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+....+....+. .+..+.+|..++
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 229 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCP 229 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccC
Confidence 1 1122345778999999988889999999999999999999 999999988888777774 334455555443
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=271.42 Aligned_cols=217 Identities=30% Similarity=0.525 Sum_probs=181.2
Q ss_pred eeecccCcEEEEEEEE-CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCCch
Q 038211 384 EEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL 462 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ggsL 462 (605)
++||+|+||.||++.. .++.+|+|++.... .......+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 4689999999999976 45669999876543 233345688999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc-ccCCCCC
Q 038211 463 FKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT-AKSGRGT 541 (605)
Q Consensus 463 ~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~gt 541 (605)
.+++......+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++......... .....++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 9998776667899999999999999999999999 999999999999999999999999998654322211 1122346
Q ss_pred CcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 542 PQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 542 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
+.|+|||.+.+..++.++||||||+++|+|++ |..||...........+. ...+..+|..++
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 220 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCP 220 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 78999999998889999999999999999998 999999988888888875 344555555543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=280.20 Aligned_cols=213 Identities=33% Similarity=0.510 Sum_probs=181.9
Q ss_pred cccCceEeeeecccCcEEEEEEEECC------------------cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCe
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWNG------------------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNV 437 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~~------------------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~ni 437 (605)
...+|++.++||+|+||.||++.+.. ..+|+|++..... ....+.+.+|+++++.++||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCE
Confidence 45789999999999999999987643 3478998765432 2445678899999999999999
Q ss_pred eeEEEEEeeCCeeEEEEEecCCCchHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCC
Q 038211 438 LLFMGAVASQERLGIVTEFLPRGSLFKTLHKNY----------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSS 507 (605)
Q Consensus 438 v~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~ 507 (605)
+++++++..++..+++|||+.+++|..++.+.. ..+++..++.++.|++.||+|||+++ |+|+||||+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~ 159 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATR 159 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchh
Confidence 999999999899999999999999999987653 26899999999999999999999999 999999999
Q ss_pred CEEEcCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCCH
Q 038211 508 NLLVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT--ASIPWNNLNL 583 (605)
Q Consensus 508 Nill~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~--g~~Pf~~~~~ 583 (605)
||+++.++.++|+|||++....... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999987543221 12233446788999999988889999999999999999998 8899998888
Q ss_pred HHHHHHhc
Q 038211 584 MQVVGVVG 591 (605)
Q Consensus 584 ~~~~~~I~ 591 (605)
.+++..+.
T Consensus 240 ~~~~~~~~ 247 (296)
T cd05051 240 QQVIENAG 247 (296)
T ss_pred HHHHHHHH
Confidence 87777764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=284.08 Aligned_cols=207 Identities=22% Similarity=0.334 Sum_probs=172.8
Q ss_pred Eeeeeccc--CcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEec
Q 038211 382 LGEEIGLG--SYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFL 457 (605)
Q Consensus 382 ~~~~LG~G--~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~ 457 (605)
++++||+| +|++||++.+ +++.||+|.+............+.+|+.+++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56889999 7899999976 4677999998765544455667888999999999999999999999999999999999
Q ss_pred CCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc----
Q 038211 458 PRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY---- 532 (605)
Q Consensus 458 ~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~---- 532 (605)
++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++++||+.+.......
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999998764 345899999999999999999999999 9999999999999999999999998653321110
Q ss_pred ---ccccCCCCCCcccccccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 533 ---LTAKSGRGTPQWMAPEVLRS--EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 533 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 222 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 222 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH
Confidence 01122356788999999976 45889999999999999999999999987665554443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=281.12 Aligned_cols=222 Identities=28% Similarity=0.443 Sum_probs=181.8
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
++|++++.||+|+||.||++.+. +..+|+|.+.... .......+.+|+.++++++|+||+++++++...+.+++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 47899999999999999999884 7789999876532 33345678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 456 FLPRGSLFKTLHKN--YQALDIKRRLRMALDVARGMNYLHH-RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 456 ~~~ggsL~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~-~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
|+++++|..++... ...+++..+..++.||+.||.|||+ .+ |+|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999998888763 2478999999999999999999996 58 999999999999999999999999998754322
Q ss_pred ccccCCCCCCcccccccccCCC------CCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhcc--CCCccCCCCCCC
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEP------SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGF--MDRRLELPEGLD 604 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~--~~~~~~~P~~~~ 604 (605)
......+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...........+.. ....+.+|+.++
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccC
Confidence 223446788999999986543 47889999999999999999999987655444433221 233456666554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=278.99 Aligned_cols=211 Identities=27% Similarity=0.404 Sum_probs=181.5
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.+|++.+.||+|+||.||++.+. ++.|++|.+...... ......+.+|+.+++.++||||+++++.+..++.+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999874 567999988665432 234567789999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc--
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY-- 532 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~-- 532 (605)
||++|++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 999999999998765 67899999999999999999999999 9999999999999999999999999986421110
Q ss_pred -------------ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 533 -------------LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 533 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+.++.++...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 01112357889999999998889999999999999999999999999988888888774
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=271.59 Aligned_cols=222 Identities=27% Similarity=0.431 Sum_probs=189.5
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+|++.+.||+|+||.||++.. .+..+++|.+............+.+|+.+++.++|||++++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588999999999999999876 466799999877655555677889999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC-CcEEEEeecCCcccCccccc
Q 038211 457 LPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN-WTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 457 ~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~-~~vkl~Dfg~a~~~~~~~~~ 534 (605)
+++++|.+++.... ..+++..+..++.|++.||+|||+++ ++|+||+|+||+++.+ +.++|+|||++....... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-K 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-c
Confidence 99999999997653 45899999999999999999999999 9999999999999865 468999999987654332 2
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+. .....++|+.++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 226 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM-SGTFAPISDRYS 226 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH-hcCCCCCCCCcC
Confidence 223467899999999998888999999999999999999999999988877777774 333456666554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=280.40 Aligned_cols=207 Identities=27% Similarity=0.462 Sum_probs=179.4
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
.+|++.+.||+|+||.||++.+ .++.||+|.+..... ...+.+.+|+.+++.++|+||++++++|...+..++|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 7899999999999999999986 577899998865432 234567889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++..........
T Consensus 97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence 9999999998865 45788899999999999999999999 9999999999999999999999999987544333233
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...++......+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~ 227 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee
Confidence 3456899999999999988999999999999999999999999876654444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=273.87 Aligned_cols=224 Identities=30% Similarity=0.494 Sum_probs=185.5
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--Cc---ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GS---DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~---~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
+...+|+..+.||+|+||.||+|... +. .+++|.+.... .....+.+.+|+.+++.++|+||+++++++...+.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 34467899999999999999999863 32 58888875432 23345678899999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
.++||||+++++|.+++....+.+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999999999876678899999999999999999999999 9999999999999999999999999987543
Q ss_pred ccccc---ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCC
Q 038211 530 ATYLT---AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 530 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
..... ......++.|+|||.+.+..++.++|||||||++|+|++ |+.||...+..++...|.. ..+++.|..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~ 234 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMD 234 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCCCCCC
Confidence 22111 111223567999999998889999999999999999997 9999998888888888853 334444433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=272.34 Aligned_cols=222 Identities=28% Similarity=0.527 Sum_probs=184.3
Q ss_pred CccccCceEeeeecccCcEEEEEEEE-CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
.+..++|++.++||+|+||.||++.+ .+..+++|.+.... .....+.+|+.+++.++|+||+++++++.. ...++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 35668999999999999999999986 34568999876432 234668899999999999999999999877 77899
Q ss_pred EEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 453 VTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+|||+++++|.+++... ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||.+......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 99999999999999764 345788889999999999999999999 999999999999999999999999998754322
Q ss_pred c-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCC
Q 038211 532 Y-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 532 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
. .......++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.+...+...+. .+..++.|..
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 227 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPEN 227 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCccc
Confidence 2 11222345678999999998888999999999999999998 999999988887777774 3333444443
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=282.18 Aligned_cols=216 Identities=31% Similarity=0.480 Sum_probs=185.6
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECC-cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNG-SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~-~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
.++.-+...+.++||+|-||.|.+|...+ ..||+|.++.... ....+.|.+|+++|.+++||||+.++++|..++.++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 34555678899999999999999998876 7899998876543 344688999999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQA-LDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
+|+||++.|+|..++.++..+ ........++.||+.|++||.+.+ +|||||.+.|+|++.++++||+|||+++-.-.
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCccccccccc
Confidence 999999999999999887333 355566779999999999999999 99999999999999999999999999985432
Q ss_pred ccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCCHHHHHHHhc
Q 038211 531 TYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT--ASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 531 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~--g~~Pf~~~~~~~~~~~I~ 591 (605)
... .....+-+.+|||+|.+...++++++|+|+||++|||+++ ...||..+..++++++..
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~ 754 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG 754 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh
Confidence 221 1223356789999999999999999999999999999765 899999999999998853
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=273.03 Aligned_cols=207 Identities=30% Similarity=0.526 Sum_probs=183.1
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
++|++.++||.|+||.||++.+. +..+++|.+.... ..+.+.+|+++++.++|+||+++++++.....+++++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 57999999999999999999875 5779999876542 25678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|+++++|.+++......+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 99999999999876678999999999999999999999999 9999999999999999999999999987655443333
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~ 211 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh
Confidence 3445789999999999988999999999999999999999999987766555544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=264.19 Aligned_cols=213 Identities=26% Similarity=0.402 Sum_probs=179.1
Q ss_pred ccCceEe-eeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEee----CC
Q 038211 377 WEDLQLG-EEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVAS----QE 448 (605)
Q Consensus 377 ~~~~~~~-~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~----~~ 448 (605)
.++|.+. ++||-|-.|+|..+.+ ++..+|+|++.. ....++|+++.-.. .|||||.++++|+. ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 4677766 5799999999999876 577799998743 34567888876555 69999999999864 35
Q ss_pred eeEEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC---CCcEEEEeecC
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK---NWTVKVGDFGL 524 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~---~~~vkl~Dfg~ 524 (605)
.+.+|||+++||.|+..++.+. ..+++..+..++.||..|+.|||+.+ |.||||||+|+|... +-.+||+|||+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEeccccc
Confidence 6889999999999999998763 57999999999999999999999999 999999999999964 45799999999
Q ss_pred CcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHhccCCCccCCC
Q 038211 525 SSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN----LMQVVGVVGFMDRRLELP 600 (605)
Q Consensus 525 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~----~~~~~~~I~~~~~~~~~P 600 (605)
|+.-.. .....+.|.||.|.|||++..+.|+...|+||+||+||-|++|.+||.... ...+..+| +.+++.||
T Consensus 211 AK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI--~~gqy~FP 287 (400)
T KOG0604|consen 211 AKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRI--RTGQYEFP 287 (400)
T ss_pred ccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHh--hccCccCC
Confidence 986553 334556788999999999999999999999999999999999999996432 35667777 66778777
Q ss_pred C
Q 038211 601 E 601 (605)
Q Consensus 601 ~ 601 (605)
.
T Consensus 288 ~ 288 (400)
T KOG0604|consen 288 E 288 (400)
T ss_pred C
Confidence 5
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=252.21 Aligned_cols=224 Identities=27% Similarity=0.382 Sum_probs=182.1
Q ss_pred CccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERL 450 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~ 450 (605)
++..+++.-+..||+|+||.|-+-++ +|+-.|+|.+...-. ...+++..+|+++..+. .+|++|.+|+........
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 34556777788999999999866554 688899998876543 44567788899886666 799999999999999999
Q ss_pred EEEEEecCCCchHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 451 GIVTEFLPRGSLFKTLHK---NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
|+.||.| ..||..+..+ ..+.+++..+-+++..++.||.|||++- .+||||+||+|||++..|++|+||||.+..
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCCcEEEccccccee
Confidence 9999999 5677666543 4578999999999999999999999872 399999999999999999999999999976
Q ss_pred cCcccccccCCCCCCcccccccccC----CCCCchhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhccCCCccCCCCC
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLRS----EPSNEKSDVFSFGVILWELVTASIPWNN-LNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~el~~g~~Pf~~-~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
...... .+...|...|||||.+.. ..|+.++||||||++++||+++++||+. .++.+.+.+|- ..-.+++|.+
T Consensus 199 L~dSiA-kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV-eep~P~Lp~~ 276 (282)
T KOG0984|consen 199 LVDSIA-KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV-EEPSPQLPAD 276 (282)
T ss_pred ehhhhH-HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh-cCCCCCCccc
Confidence 543322 222468899999999854 3688899999999999999999999987 45777777773 5556677753
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=277.54 Aligned_cols=202 Identities=27% Similarity=0.418 Sum_probs=173.1
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.++|++.+.||+|+||.||++.+ .++.||+|.+..... ......+.+|+.+++.++|+||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 47899999999999999999987 467799998865432 222345678999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+. ++|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+++........
T Consensus 83 e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 9997 4899988876667899999999999999999999999 999999999999999999999999998754333223
Q ss_pred ccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+..
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 333456889999999876 457889999999999999999999997655
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=275.56 Aligned_cols=209 Identities=30% Similarity=0.484 Sum_probs=176.3
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeC------C
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQ------E 448 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~------~ 448 (605)
+.|++.+.||+|+||.||+|.+ .++.+|+|++.... .....+.+|+.+++.+ +|+||++++++|... .
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 5688899999999999999987 46679999886543 2335678899999998 799999999998753 4
Q ss_pred eeEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
.++++|||+.+++|.+++... ...+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||++..
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 689999999999999998764 356899999999999999999999999 99999999999999999999999999876
Q ss_pred cCcccccccCCCCCCccccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLR-----SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
............|++.|+|||++. +..++.++|+|||||++|+|++|..||...........+.
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~ 229 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 229 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh
Confidence 543333344567899999999986 3457889999999999999999999998877666665553
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=270.39 Aligned_cols=217 Identities=32% Similarity=0.567 Sum_probs=182.5
Q ss_pred eeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCCch
Q 038211 384 EEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL 462 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ggsL 462 (605)
++||+|+||.||++.+. ++.+++|++...... .....+.+|+.+++.++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 47999999999999875 788999987665432 3456788999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc--cCCCC
Q 038211 463 FKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA--KSGRG 540 (605)
Q Consensus 463 ~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~g 540 (605)
.+++......+++..+..++.+++.||+|||+++ ++||||||+|||++.++.++|+|||++.......... ....+
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9999776567889999999999999999999999 9999999999999999999999999987543211111 12234
Q ss_pred CCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 541 TPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 541 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
+..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+. ...++..|..++
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 221 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCP 221 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-cCCCCCCCccCC
Confidence 667999999988889999999999999999998 999999988877777774 334555565543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=283.56 Aligned_cols=228 Identities=29% Similarity=0.521 Sum_probs=188.0
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEECC---------cceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEE
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNG---------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFM 441 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~---------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~ 441 (605)
.+.+...+|++++.||+|+||.||++.+.+ ..+|+|++.... .....+.+.+|+.+++++ +||||++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 345566789999999999999999997521 248999776432 334456788999999999 899999999
Q ss_pred EEEeeCCeeEEEEEecCCCchHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCC
Q 038211 442 GAVASQERLGIVTEFLPRGSLFKTLHKNY---------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKS 506 (605)
Q Consensus 442 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~ 506 (605)
+++...+.++++|||+++++|.+++.+.. ..++...+..++.||+.||+|||++| ++||||||
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 162 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAA 162 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eecccccc
Confidence 99999899999999999999999987532 24777888899999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEeecCCcccCcccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCH
Q 038211 507 SNLLVDKNWTVKVGDFGLSSLKNATYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNL 583 (605)
Q Consensus 507 ~Nill~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~ 583 (605)
+|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+.
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999875433221 1222334578999999999999999999999999999998 9999999998
Q ss_pred HHHHHHhccCCCccCCCCCC
Q 038211 584 MQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 584 ~~~~~~I~~~~~~~~~P~~~ 603 (605)
.++...+. .+..+++|..+
T Consensus 243 ~~~~~~~~-~~~~~~~~~~~ 261 (334)
T cd05100 243 EELFKLLK-EGHRMDKPANC 261 (334)
T ss_pred HHHHHHHH-cCCCCCCCCCC
Confidence 88888874 34455666544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=278.97 Aligned_cols=212 Identities=32% Similarity=0.500 Sum_probs=177.4
Q ss_pred cccCceEeeeecccCcEEEEEEEECC----------------cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeee
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWNG----------------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLL 439 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~~----------------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~ 439 (605)
...+|++.++||+|+||.||++.+.+ ..||+|.+.... .......+.+|+++++.++|+|+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 45689999999999999999987632 137899876532 3344567889999999999999999
Q ss_pred EEEEEeeCCeeEEEEEecCCCchHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCC
Q 038211 440 FMGAVASQERLGIVTEFLPRGSLFKTLHKNY-----------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSN 508 (605)
Q Consensus 440 ~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~N 508 (605)
+++++...+..++||||+.+++|.+++.... ..+++..+..++.|++.||+|||+++ ++|+||||+|
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~N 159 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRN 159 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhh
Confidence 9999999999999999999999999886531 24678888999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEEeecCCcccCcccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCCHH
Q 038211 509 LLVDKNWTVKVGDFGLSSLKNATYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT--ASIPWNNLNLM 584 (605)
Q Consensus 509 ill~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~--g~~Pf~~~~~~ 584 (605)
|+++.++.+||+|||++........ ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999875432211 1122345778999999998889999999999999999988 78899988877
Q ss_pred HHHHHh
Q 038211 585 QVVGVV 590 (605)
Q Consensus 585 ~~~~~I 590 (605)
+++..+
T Consensus 240 ~~~~~~ 245 (295)
T cd05097 240 QVIENT 245 (295)
T ss_pred HHHHHH
Confidence 776654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=275.99 Aligned_cols=209 Identities=24% Similarity=0.357 Sum_probs=181.4
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+|++.++||.|+||.||+|.+ .++.+++|++............+.+|+.+++.++||||+++++++..+..+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 589999999999999999987 467899999877655455567788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc-cc
Q 038211 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL-TA 535 (605)
Q Consensus 457 ~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~-~~ 535 (605)
+ +++|.+++......+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9 99999999876678999999999999999999999999 99999999999999999999999999876543321 22
Q ss_pred cCCCCCCcccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 536 KSGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
....++..|+|||.+.+.. ++.++|||||||++|+|++|.+||...+..+.+..+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 213 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHH
Confidence 3446899999999987644 588999999999999999999999877665555443
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=280.17 Aligned_cols=213 Identities=26% Similarity=0.360 Sum_probs=180.5
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC--CeeE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ--ERLG 451 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~ 451 (605)
..++|++.++||.|+||.||+|.+ .+..||+|++............+.+|+.+++.++|+||+++++++... +.++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 457899999999999999999987 477899999876543333334567899999999999999999998754 5689
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||||+. ++|.+++......+++..+..++.||+.||.|||+.| ++||||||+||+++.++.++|+|||++......
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999995 5888888776577999999999999999999999999 999999999999999999999999999765443
Q ss_pred cccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 532 YLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
........+++.|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+..+.+..+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~ 222 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII 222 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 222333345888999999876 457899999999999999999999999988887777664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=271.94 Aligned_cols=215 Identities=25% Similarity=0.394 Sum_probs=186.1
Q ss_pred ecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCCch
Q 038211 386 IGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL 462 (605)
Q Consensus 386 LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ggsL 462 (605)
||.|+||.||++.+. ++.+++|++.+.... ....+.+.+|+.+++.++||||+++++.+.++..++++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999986 778999998765433 23456788999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCCCCC
Q 038211 463 FKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP 542 (605)
Q Consensus 463 ~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~ 542 (605)
.+++.+. ..+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......+++
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~ 156 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTP 156 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCc
Confidence 9999765 56899999999999999999999999 9999999999999999999999999987654332 223346799
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHhccCCCccCCCCCCC
Q 038211 543 QWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN--LMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 543 ~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~--~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.|++||.+.+..++.++|+||||+++|+|++|..||.... ..++...+......+.+|..++
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYID 220 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccC
Confidence 9999999988889999999999999999999999998877 7777777754466777776653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=273.12 Aligned_cols=205 Identities=32% Similarity=0.476 Sum_probs=165.8
Q ss_pred eeecccCcEEEEEEEEC----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLGSYAVVYRGIWN----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
++||+|+||.||+|... ...+++|.+.... .......+.+|+.+++.++|+||+++++.+.....+++||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 36899999999999642 2346777654332 233445678899999999999999999999999999999999999
Q ss_pred CchHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc--c
Q 038211 460 GSLFKTLHKNY----QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY--L 533 (605)
Q Consensus 460 gsL~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~--~ 533 (605)
|+|.+++.... ...++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999987643 23467778889999999999999999 9999999999999999999999999986532211 1
Q ss_pred cccCCCCCCcccccccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhc
Q 038211 534 TAKSGRGTPQWMAPEVLRS-------EPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~ 591 (605)
......+++.|+|||++.. ..++.++|||||||++|||++ |..||......+.+..+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 223 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV 223 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh
Confidence 1223345778999998743 346789999999999999999 899999888777666653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=271.36 Aligned_cols=221 Identities=32% Similarity=0.547 Sum_probs=187.5
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+|++.+.||+|+||.||++.+ .+..+++|++..........+.+.+|+.+++.++|+||+++++++...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588999999999999999986 467799999877655445678899999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc-
Q 038211 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA- 535 (605)
Q Consensus 457 ~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~- 535 (605)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 9999999998765 56888999999999999999999999 9999999999999999999999999987654332221
Q ss_pred ---cCCCCCCcccccccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHhccCCCccCCCCCC
Q 038211 536 ---KSGRGTPQWMAPEVLRSEP---SNEKSDVFSFGVILWELVTASIPWNNL-NLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 536 ---~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~el~~g~~Pf~~~-~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
....+++.|++||.+.+.. ++.++||||||+++|+|++|+.||... +.......+. ....+.+|...
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSL 231 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh-cCCCCCCCccc
Confidence 1345789999999998776 788999999999999999999999876 3444554553 35566677654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=273.49 Aligned_cols=220 Identities=30% Similarity=0.496 Sum_probs=186.0
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
+-|++.++||.|+||.||++.+ .+..+|+|++..... ......+.+|+.+++.++||||+++++++..+...++|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 3477889999999999999986 466799998765432 2345678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|+++++|..++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 83 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 9999999988865 46889999999999999999999999 9999999999999999999999999987654333233
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
....++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+. ....+.++..+
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 225 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNY 225 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCccc
Confidence 34567899999999988888999999999999999999999999888777777764 23344454443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=278.39 Aligned_cols=209 Identities=30% Similarity=0.501 Sum_probs=181.3
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
+.|+..+.||.|+||.||+|.+ .+..+|+|++..... ....+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4577889999999999999987 466799998765432 3345678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|+++++|.+++.. ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 83 YLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred ccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 9999999988865 56889999999999999999999999 9999999999999999999999999987654433333
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
....++..|+|||.+.+..++.++|+|||||++|+|++|+.||....+......+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 214 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP 214 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh
Confidence 34567899999999999889999999999999999999999998877776666653
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=283.01 Aligned_cols=191 Identities=26% Similarity=0.409 Sum_probs=158.1
Q ss_pred eeeecccCcEEEEEEEEC----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee--CCeeEEEEEe
Q 038211 383 GEEIGLGSYAVVYRGIWN----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS--QERLGIVTEF 456 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~~----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~lv~e~ 456 (605)
+++||+|+||+||+|.+. +..+|+|.+..... ...+.+|+.+++.++||||++++++|.. +..++++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999863 45699998765432 2346789999999999999999999854 4568999999
Q ss_pred cCCCchHHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE----cCCCcEEEEeecC
Q 038211 457 LPRGSLFKTLHKN--------YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV----DKNWTVKVGDFGL 524 (605)
Q Consensus 457 ~~ggsL~~~l~~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill----~~~~~vkl~Dfg~ 524 (605)
+. ++|..++... ...+++..++.++.||+.||+|||++| |+||||||+|||+ +..+.+||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 94 5888777532 135889999999999999999999999 9999999999999 4567999999999
Q ss_pred CcccCccc---ccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 525 SSLKNATY---LTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 525 a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 97654322 122345789999999999874 578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=277.76 Aligned_cols=212 Identities=30% Similarity=0.465 Sum_probs=176.4
Q ss_pred cccCceEeeeecccCcEEEEEEEEC------------------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCe
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN------------------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNV 437 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~------------------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~ni 437 (605)
..++|++.++||+|+||.||++.+. ...+|+|++.... .....+.+.+|+.+++.++|+||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3467999999999999999998543 2247888876442 23345678899999999999999
Q ss_pred eeEEEEEeeCCeeEEEEEecCCCchHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCC
Q 038211 438 LLFMGAVASQERLGIVTEFLPRGSLFKTLHKNY----------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSS 507 (605)
Q Consensus 438 v~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~ 507 (605)
+++++++...+..+++|||+++++|.+++.... ..+++..+..++.||+.||+|||+.| ++|+||||+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~ 159 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATR 159 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChh
Confidence 999999999999999999999999999987642 23667789999999999999999999 999999999
Q ss_pred CEEEcCCCcEEEEeecCCcccCcccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCCH
Q 038211 508 NLLVDKNWTVKVGDFGLSSLKNATYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT--ASIPWNNLNL 583 (605)
Q Consensus 508 Nill~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~--g~~Pf~~~~~ 583 (605)
|||++.++.++|+|||++........ ......+++.|++||...+..++.++|+|||||++|||++ |..||...+.
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999875432211 1122234678999999888889999999999999999998 8899998887
Q ss_pred HHHHHHh
Q 038211 584 MQVVGVV 590 (605)
Q Consensus 584 ~~~~~~I 590 (605)
.+++..+
T Consensus 240 ~~~~~~~ 246 (296)
T cd05095 240 EQVIENT 246 (296)
T ss_pred HHHHHHH
Confidence 7766654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=292.83 Aligned_cols=191 Identities=23% Similarity=0.380 Sum_probs=166.5
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
...|.+.+.||+|+||.||++.+. +..||||... ...+.+|+++|++++|+|||++++++...+..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 457999999999999999999885 5668888532 234578999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc-
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL- 533 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~- 533 (605)
|++ .++|..++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||+++.......
T Consensus 240 e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 240 PKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred Ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 999 46888888776668999999999999999999999999 99999999999999999999999999976533221
Q ss_pred -cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 038211 534 -TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578 (605)
Q Consensus 534 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf 578 (605)
......||+.|+|||++.+..++.++|||||||+||||++|..|+
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 122456899999999999999999999999999999999987664
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=276.33 Aligned_cols=225 Identities=28% Similarity=0.466 Sum_probs=185.4
Q ss_pred cccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
...+|++.+.||+|+||.||++.+. +..+|+|++.... .......+.+|+.+++.++||||+++++++..+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4578999999999999999999863 4568999876533 2334566889999999999999999999999999
Q ss_pred eeEEEEEecCCCchHHHHHhhc---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCC
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNY---------------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSS 507 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~---------------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~ 507 (605)
.++++|||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~ 159 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATR 159 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHh
Confidence 9999999999999999987432 24678888999999999999999999 999999999
Q ss_pred CEEEcCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 038211 508 NLLVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLM 584 (605)
Q Consensus 508 Nill~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~ 584 (605)
|||++.++.++|+|||++....... ........+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999986543221 11222334678999999998889999999999999999997 99999998888
Q ss_pred HHHHHhccCCCccCCCCCCC
Q 038211 585 QVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 585 ~~~~~I~~~~~~~~~P~~~~ 604 (605)
++...+.. +..+..|+.++
T Consensus 240 ~~~~~~~~-~~~~~~~~~~~ 258 (288)
T cd05050 240 EVIYYVRD-GNVLSCPDNCP 258 (288)
T ss_pred HHHHHHhc-CCCCCCCCCCC
Confidence 88888743 33334455443
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=270.49 Aligned_cols=221 Identities=38% Similarity=0.646 Sum_probs=186.5
Q ss_pred ceEeeeecccCcEEEEEEEECC------cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 380 LQLGEEIGLGSYAVVYRGIWNG------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~~~------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
+++.+.||.|+||.||++.+.. ..+|+|++..... ....+.+..|+.+++.++|+||+++++++...+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 4577899999999999998854 6699999855432 22556788999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 454 TEFLPRGSLFKTLHKNYQA-LDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
|||+++++|.+++...... +++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999999775444 899999999999999999999999 9999999999999999999999999997654331
Q ss_pred ccc-cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 533 LTA-KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 533 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
... ....+++.|+|||.+.+..++.++|+||||+++|+|++ |++||...+..++...+.. ...+.+|..++
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 230 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-GYRLPKPENCP 230 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCcCC
Confidence 111 12336789999999988888999999999999999998 8999999888888888853 34455555543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=275.94 Aligned_cols=201 Identities=29% Similarity=0.423 Sum_probs=171.3
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
.+|.+.++||+|+||.||+|.+ .+..+++|++..... ......+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 6799999999999999999976 477899999865432 2233456789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|+. ++|...+......+.+..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||+++.........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 995 6777777665566788888999999999999999999 9999999999999999999999999987644333333
Q ss_pred cCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 536 KSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 444678999999998764 47889999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=288.99 Aligned_cols=226 Identities=33% Similarity=0.534 Sum_probs=198.9
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC---Cc--ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN---GS--DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~---~~--~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
-|..++.++.++||+|+||+|++|.|+ |+ .||||++..+.... ....|.+|+.+|.+|+|+|++++||++.+ .
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 356678899999999999999999884 33 38999987765443 67889999999999999999999999887 6
Q ss_pred eeEEEEEecCCCchHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 449 RLGIVTEFLPRGSLFKTLHK-NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
.+.||||+++.|+|.+.|.+ ....+....+..|+.||+.|+.||.+++ +|||||-..|+|+-....|||+|||+.+-
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceec
Confidence 78899999999999999987 4567888899999999999999999999 99999999999999999999999999987
Q ss_pred cCccccc---ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 528 KNATYLT---AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 528 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
+...... .....-...|.|||.++...++.++|+|++||++|||++ |..||.+.+..+|+.+|. .+.+++=|+.+
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~c 340 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYC 340 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCC
Confidence 6543322 222334678999999999999999999999999999999 999999999999999998 89999999887
Q ss_pred C
Q 038211 604 D 604 (605)
Q Consensus 604 ~ 604 (605)
+
T Consensus 341 s 341 (1039)
T KOG0199|consen 341 S 341 (1039)
T ss_pred h
Confidence 6
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=277.95 Aligned_cols=211 Identities=27% Similarity=0.340 Sum_probs=181.1
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC--CeeEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ--ERLGI 452 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~l 452 (605)
.++|++.+.||.|+||.||+|.+. ++.+++|.+............+.+|+.+++.++||||+++++++... ..+++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 367999999999999999999884 67799998876544444445667899999999999999999998877 88999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
||||+. ++|.+++......+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++.++|+|||++.......
T Consensus 84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999996 5898988776567999999999999999999999999 9999999999999999999999999987655443
Q ss_pred ccccCCCCCCcccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+.+.++
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~ 219 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI 219 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 3333445788999999987654 588999999999999999999999988877766655
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=268.43 Aligned_cols=213 Identities=27% Similarity=0.399 Sum_probs=175.5
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCe
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQER 449 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~ 449 (605)
..+..++.+-+..||.|+||+|++-.++ |+..|||.+..... +..++++..|.+...+- ++||||++||....++.
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 4566677788889999999999988774 66789998876553 56678888888876555 79999999999999999
Q ss_pred eEEEEEecCCCchHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeccCCCCCEEEcCCCcEEEEeecC
Q 038211 450 LGIVTEFLPRGSLFKTLHK----NYQALDIKRRLRMALDVARGMNYLHHR-NPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~-~~~iiH~Dik~~Nill~~~~~vkl~Dfg~ 524 (605)
.|+.||+| ..||..+... +...++++.+-.+....+.||+||-+. . |||||+||+|||++..|.+||||||.
T Consensus 138 cWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGI 214 (361)
T KOG1006|consen 138 CWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGI 214 (361)
T ss_pred eeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccc
Confidence 99999999 4577665543 346799999999999999999999854 6 99999999999999999999999999
Q ss_pred CcccCcccccccCCCCCCcccccccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHh
Q 038211 525 SSLKNATYLTAKSGRGTPQWMAPEVLRS--EPSNEKSDVFSFGVILWELVTASIPWNNLNL-MQVVGVV 590 (605)
Q Consensus 525 a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~-~~~~~~I 590 (605)
+........ .+...|...|||||.+.. ..|+-+||+||||++|||++||++||+.++. .+.+..|
T Consensus 215 cGqLv~SiA-kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~V 282 (361)
T KOG1006|consen 215 CGQLVDSIA-KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQV 282 (361)
T ss_pred hHhHHHHHH-hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHH
Confidence 976543332 233468999999999854 4589999999999999999999999999764 4445554
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=273.50 Aligned_cols=223 Identities=29% Similarity=0.490 Sum_probs=183.9
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc----hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI----EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~----~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
+|+..+.||+|+||.||++.. .++.+|+|++...... ....+.+.+|+.++++++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999976 5677999998654321 2245678899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC-cEEEEeecCCcccCcc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW-TVKVGDFGLSSLKNAT 531 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~-~vkl~Dfg~a~~~~~~ 531 (605)
||||+++++|.+++.+. ..+++..+..++.||+.||+|||++| ++|+||+|+||+++.++ .++|+|||.+......
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999998764 57889999999999999999999999 99999999999998776 6999999998665432
Q ss_pred cc----cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHhccCCCccCCCCCCC
Q 038211 532 YL----TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN---LMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 532 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~---~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.. ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...+ .......+........+|+.++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 11 1123457889999999998889999999999999999999999997543 3444444444455566666554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=273.44 Aligned_cols=225 Identities=28% Similarity=0.452 Sum_probs=186.6
Q ss_pred cccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
..++|++.+.||+|+||.||+|+.+ ...+++|.+.... .....+.+.+|++++++++|+||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 3468999999999999999999863 3458888775432 2234567899999999999999999999999888
Q ss_pred eeEEEEEecCCCchHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEE
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNY--------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVG 520 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~ 520 (605)
..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEc
Confidence 9999999999999999987653 15899999999999999999999999 9999999999999999999999
Q ss_pred eecCCcccCcc-cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccC
Q 038211 521 DFGLSSLKNAT-YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLE 598 (605)
Q Consensus 521 Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~ 598 (605)
|||++...... ........++..|++||.+.+..++.++||||||+++|+|++ |..||.......++..+......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 99998643221 122233456778999999988888999999999999999998 8999998888888888754444444
Q ss_pred CCCCC
Q 038211 599 LPEGL 603 (605)
Q Consensus 599 ~P~~~ 603 (605)
.|..+
T Consensus 240 ~~~~~ 244 (275)
T cd05046 240 VPEGC 244 (275)
T ss_pred CCCCC
Confidence 45444
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=272.21 Aligned_cols=215 Identities=32% Similarity=0.565 Sum_probs=174.8
Q ss_pred eeecccCcEEEEEEEECC--c--ceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEEEEEecC
Q 038211 384 EEIGLGSYAVVYRGIWNG--S--DVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLP 458 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~~--~--~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 458 (605)
+.||+|+||.||++.+++ . .+++|.+... ......+.+.+|+.+++++ +||||+++++++...+.++++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999998743 2 3577766532 2234456788999999999 89999999999999999999999999
Q ss_pred CCchHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeec
Q 038211 459 RGSLFKTLHKNY---------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFG 523 (605)
Q Consensus 459 ggsL~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg 523 (605)
+++|.+++.... ..+++..++.++.|++.||+|||++| ++||||||+|||++.++.+||+|||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCC
Confidence 999999987532 24788999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCC
Q 038211 524 LSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 524 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
++...... ........+..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..++...+. .+.+++.|..
T Consensus 158 l~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~ 235 (270)
T cd05047 158 LSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLN 235 (270)
T ss_pred Cccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-CCCCCCCCCc
Confidence 98533211 11122234667999999988889999999999999999997 999999988888777774 3334455544
Q ss_pred C
Q 038211 603 L 603 (605)
Q Consensus 603 ~ 603 (605)
+
T Consensus 236 ~ 236 (270)
T cd05047 236 C 236 (270)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=278.03 Aligned_cols=224 Identities=29% Similarity=0.565 Sum_probs=182.9
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCc----ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGS----DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~----~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
+..++|+..+.||+|+||.||++.+ .+. .+|+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 3457899999999999999999986 343 368887754332 23334678999999999999999999988654
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
..++++||+++|+|.+++......+++..+..++.|++.||+|||+++ |+|+||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccccccc
Confidence 567999999999999999876667899999999999999999999999 999999999999999999999999999764
Q ss_pred Ccccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 529 NATYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 529 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
..... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....++...+. .+.+++.|+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQPPIC 236 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCC
Confidence 32221 1223345778999999999889999999999999999997 999999887777666664 44455555443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=285.13 Aligned_cols=193 Identities=23% Similarity=0.355 Sum_probs=165.7
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
...+|++++.||+|+||.||+|.+. +..||+|+.... ....|+.+++.++|+||+++++++......++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 3457999999999999999999985 456899874322 235699999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
||++ .++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||+++......
T Consensus 136 ~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 136 LPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred EEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 9999 46888888776678999999999999999999999999 9999999999999999999999999987533221
Q ss_pred cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCC-CCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASI-PWNN 580 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~-Pf~~ 580 (605)
......||+.|+|||++.+..++.++|||||||++|||+++.. +|..
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 2234568999999999999999999999999999999998544 4443
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=273.26 Aligned_cols=224 Identities=27% Similarity=0.420 Sum_probs=184.7
Q ss_pred ccccCceEeeeecccCcEEEEEEEECC------cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee-C
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNG------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS-Q 447 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~ 447 (605)
+..++|++.++||+|+||.||+|.+.. ..+++|.+... ........+.+|+.+++.++|+||+++++++.. +
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 345789999999999999999998743 56888876533 234456778899999999999999999998765 5
Q ss_pred CeeEEEEEecCCCchHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEE
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNY-------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVG 520 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~ 520 (605)
...+++++|+++++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.+||+
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEEC
Confidence 67899999999999999987642 45889999999999999999999999 9999999999999999999999
Q ss_pred eecCCcccCcccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCcc
Q 038211 521 DFGLSSLKNATYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRL 597 (605)
Q Consensus 521 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~ 597 (605)
|||+++....... ......++..|+|||.+.+..++.++|||||||++|++++ |+.||...++.++...+. .+.++
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~ 238 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-DGYRL 238 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-cCCCC
Confidence 9999975422211 1122345778999999998889999999999999999998 999999988888887775 33344
Q ss_pred CCCCC
Q 038211 598 ELPEG 602 (605)
Q Consensus 598 ~~P~~ 602 (605)
..|..
T Consensus 239 ~~~~~ 243 (280)
T cd05043 239 AQPIN 243 (280)
T ss_pred CCCCc
Confidence 44443
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=267.82 Aligned_cols=222 Identities=30% Similarity=0.488 Sum_probs=194.1
Q ss_pred CceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+|.+.+.||.|+||.||++.+. +..+++|++............+.+|+++++.++|+|++++++.+...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999885 77899999877655555667788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 457 LPRGSLFKTLHKN---YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 457 ~~ggsL~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
+++++|.+++... ...+++..+..++.+++.||.|||+.| ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 9999999999875 377999999999999999999999999 99999999999999999999999999976654433
Q ss_pred cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..++...+. .....++|..+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 227 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-KGQYPPIPSQY 227 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-cCCCCCCCCCC
Confidence 3344568999999999998889999999999999999999999999988888888774 33344566544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=277.41 Aligned_cols=209 Identities=28% Similarity=0.390 Sum_probs=178.9
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc---hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI---EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~---~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
+|.+.++||.|+||.||+|.+ .++.|++|.+...... ......+..|+.+++.++|+||+++++++.+.+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999987 4678999998765433 22345567899999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
|||+ +++|..++......+++..+..++.||+.||+|||++| |+|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 9999 89999999776447999999999999999999999999 99999999999999999999999999976554433
Q ss_pred cccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 534 TAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+....+.++
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~ 215 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI 215 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHH
Confidence 3334456889999998865 45688999999999999999999999887766655555
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=270.40 Aligned_cols=216 Identities=32% Similarity=0.503 Sum_probs=175.0
Q ss_pred eeecccCcEEEEEEEEC-----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEe-eCCeeEEEEEec
Q 038211 384 EEIGLGSYAVVYRGIWN-----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVA-SQERLGIVTEFL 457 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~-----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-~~~~~~lv~e~~ 457 (605)
+.||+|+||.||+|.+. +..+|+|.+.... .....+.+.+|+.+++.++||||+++++++. .+...+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999752 2358899764322 2334567889999999999999999999765 455689999999
Q ss_pred CCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc----c
Q 038211 458 PRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY----L 533 (605)
Q Consensus 458 ~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~----~ 533 (605)
.+++|.+++.+....+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++...... .
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999999876566788888899999999999999999 9999999999999999999999999987543211 1
Q ss_pred cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
......+++.|+|||.+.+..++.++|||||||++|||++ |.+||...+..++...+. .+..+..|..+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 227 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYC 227 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcC
Confidence 1123345778999999988889999999999999999999 677898888888877774 34445555444
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=276.39 Aligned_cols=203 Identities=30% Similarity=0.454 Sum_probs=177.3
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
+..++|+++++||+|+||+||++.+. ++.+|+|++.... .....+.+.+|+++++.++||||+++++++...+.+++
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 45678999999999999999999875 7789999876543 23445678899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH-RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
||||+++++|.+++.+. +.+++..+..++.+++.||.|||+ ++ ++||||+|+||+++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 99999999999888764 678999999999999999999997 58 999999999999999999999999998654222
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCH
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNL 583 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~ 583 (605)
......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+.
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 22345689999999999888899999999999999999999999986554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=273.72 Aligned_cols=210 Identities=24% Similarity=0.342 Sum_probs=179.5
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCC--CC----CeeeEEEE
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR--HP----NVLLFMGA 443 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~--h~----niv~~~~~ 443 (605)
.+++...+|.+++++|+|.||+|..+.+. +..+|||+++. .....+..+-|+++|+++. -| -+|.+.+|
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH---HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 35666789999999999999999999875 45699998744 3456677788999999993 22 37888899
Q ss_pred EeeCCeeEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC---------
Q 038211 444 VASQERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK--------- 513 (605)
Q Consensus 444 ~~~~~~~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~--------- 513 (605)
|...++.|+|+|.+ |.|+++++..+ ..+++..+++.+++||+.+++|||+.+ ++|.||||+|||+..
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEecc
Confidence 99999999999999 77999999875 578999999999999999999999999 999999999999931
Q ss_pred -----------CCcEEEEeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 514 -----------NWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 514 -----------~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
+-.|+++|||.|+...... .+.+.|..|.|||++.+-+|+.++||||+||||+|+++|...|++.+
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 2468999999998765443 44567999999999999999999999999999999999999999988
Q ss_pred HHHHHHHh
Q 038211 583 LMQVVGVV 590 (605)
Q Consensus 583 ~~~~~~~I 590 (605)
+.+.++..
T Consensus 314 n~EHLaMM 321 (415)
T KOG0671|consen 314 NLEHLAMM 321 (415)
T ss_pred cHHHHHHH
Confidence 77755443
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=270.06 Aligned_cols=210 Identities=32% Similarity=0.531 Sum_probs=181.9
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
++|++++.||.|+||+||++.. .+..+++|++....... ....+.+|+.+++.++|+||+++++.+......+++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4799999999999999999986 46679999986654333 56778999999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 456 FLPRGSLFKTLHKNY--QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
++++++|.+++.... ..+++..+..++.||+.||.|||+.| ++|+||+|+||++++++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999997642 46899999999999999999999999 99999999999999999999999999865543322
Q ss_pred c----ccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 534 T----AKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 534 ~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
. .....|+..|++||.+... .++.++|+|||||++|+|++|+.||.+.+..+.+..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 219 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT 219 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH
Confidence 1 2334588999999998776 7889999999999999999999999988876666655
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=270.92 Aligned_cols=222 Identities=31% Similarity=0.509 Sum_probs=185.2
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc--------hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI--------EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~--------~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
+|.+.+.||.|+||.||+|.. .++.+|+|.+...... ....+.+.+|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 478889999999999999976 4677999987543211 122456788999999999999999999999999
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999998776 67899999999999999999999999 999999999999999999999999998754
Q ss_pred Cccc--ccccCCCCCCcccccccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 529 NATY--LTAKSGRGTPQWMAPEVLRSEP--SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 529 ~~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
.... .......++..|+|||.+.... ++.++|+||||+++|+|++|..||...+..+.+..+......+.+|+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 3221 1123345789999999987754 7889999999999999999999998877777676665555556666543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=276.60 Aligned_cols=209 Identities=27% Similarity=0.363 Sum_probs=177.1
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
++|++.++||+|+||.||+|.++ ++.+|+|++..........+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46899999999999999999874 6779999876654434445668899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|+++++|..+.... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 99998887766543 56899999999999999999999999 9999999999999999999999999987654333333
Q ss_pred cCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 038211 536 KSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGV 589 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~ 589 (605)
....++..|+|||.+.+. .++.++|||||||++|+|++|++||...+..+....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~ 212 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYH 212 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 345678999999998764 467899999999999999999999987665444333
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=268.55 Aligned_cols=220 Identities=28% Similarity=0.420 Sum_probs=188.5
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
.+|++.+.||.|++|.||++.+. ++.+++|++...... .....+.+|+..+..++|+||+++++++.....+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 36889999999999999999874 677999988665432 445778899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH-RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
|+++++|.+++... ..+++..+..++.||+.||+|||+ .+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999999765 778999999999999999999999 99 999999999999999999999999998765443333
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHhccCCCccCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL---NLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~---~~~~~~~~I~~~~~~~~~P~~ 602 (605)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||... ...++...+. ....+.+|..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 226 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAE 226 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcc
Confidence 33446789999999999988999999999999999999999999877 5566666664 3333444444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=273.14 Aligned_cols=210 Identities=30% Similarity=0.446 Sum_probs=175.1
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEe-----eC
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVA-----SQ 447 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~-----~~ 447 (605)
..++|++.+.||+|+||.||++.+ .++.+++|++..... ....+.+|+.+++.+ +||||+++++++. .+
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 457899999999999999999987 467799998754322 234577899999999 7999999999874 34
Q ss_pred CeeEEEEEecCCCchHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecC
Q 038211 448 ERLGIVTEFLPRGSLFKTLHK---NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~ 524 (605)
+.+++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEEEccCCc
Confidence 578999999999999988753 2356888999999999999999999999 99999999999999999999999999
Q ss_pred CcccCcccccccCCCCCCcccccccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 525 SSLKNATYLTAKSGRGTPQWMAPEVLRS-----EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 525 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
+..............|++.|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+....+..+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~ 241 (286)
T cd06638 171 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241 (286)
T ss_pred eeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc
Confidence 8765433333344568999999999853 34688999999999999999999999987765555554
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=272.21 Aligned_cols=197 Identities=33% Similarity=0.508 Sum_probs=166.3
Q ss_pred ceEeeeecccCcEEEEEEEE------CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC--CeeE
Q 038211 380 LQLGEEIGLGSYAVVYRGIW------NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ--ERLG 451 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~------~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~ 451 (605)
|++.+.||+|+||+||++.+ .+..+|+|++.... .......+.+|+.+|+.++||||+++++++... ..++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 48999999999999988653 35569999886543 223446678899999999999999999987653 4689
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
++|||+++++|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 85 lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999999876 45899999999999999999999999 999999999999999999999999998765432
Q ss_pred cc---cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 532 YL---TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 532 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
.. ......++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 21 112234567799999998888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=265.18 Aligned_cols=222 Identities=35% Similarity=0.591 Sum_probs=192.3
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+|++.++||+|++|.||++.+ .++.+++|.+............+.+|++++++++|+|++++++++......+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 588999999999999999987 466799999887665445667889999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccccc
Q 038211 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAK 536 (605)
Q Consensus 457 ~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 536 (605)
+++++|.+++... ..+++..+..++.|++.||.|||+.| |+|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 9999999998765 67899999999999999999999999 99999999999999999999999999976654443334
Q ss_pred CCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 537 SGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 537 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
...++..|++||.+.+..++.++|+||||+++|+|++|..||...+.......+. ......+|+.++
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 224 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGIS 224 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCC
Confidence 4568999999999988888899999999999999999999999887766666664 344456665554
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-32 Score=273.37 Aligned_cols=210 Identities=27% Similarity=0.369 Sum_probs=175.2
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
++|++.++||.|+||.||++.++ ++.|++|.+............+.+|+.+++.++||||+++++++.....+++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 67999999999999999999874 6779999886654333444667889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC-CCcEEEEeecCCcccCcccc
Q 038211 456 FLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK-NWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~-~~~vkl~Dfg~a~~~~~~~~ 533 (605)
|++ ++|..++.... ..+++..+..++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++........
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 995 57877776543 34678888899999999999999999 999999999999985 56799999999976543333
Q ss_pred cccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 534 TAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+.+.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~ 216 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 33344578999999998764 5788999999999999999999999887766555544
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=269.89 Aligned_cols=203 Identities=32% Similarity=0.445 Sum_probs=165.7
Q ss_pred eeecccCcEEEEEEEECC----cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLGSYAVVYRGIWNG----SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~~----~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
+.||+|+||.||+|...+ ..+++|.+..... ......+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 468999999999997643 3488887755432 22345688899999999999999999999988899999999999
Q ss_pred CchHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc--c
Q 038211 460 GSLFKTLHKNY----QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY--L 533 (605)
Q Consensus 460 gsL~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~--~ 533 (605)
++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999987532 24567778889999999999999999 9999999999999999999999999986543221 1
Q ss_pred cccCCCCCCcccccccccCC-------CCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 038211 534 TAKSGRGTPQWMAPEVLRSE-------PSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGV 589 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~ 589 (605)
......+++.|+|||++.+. .++.++|||||||++|||++ |+.||......+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 221 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY 221 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Confidence 22234578899999998643 35779999999999999996 9999998776665444
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=273.53 Aligned_cols=209 Identities=25% Similarity=0.335 Sum_probs=178.8
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
++|++.++||+|+||.||+|.+. ++.|++|++..........+.+.+|+++++.++|+||+++++++..++.++++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36899999999999999999874 6679999887654444456778899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc-c
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL-T 534 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~-~ 534 (605)
|++++.+..+.. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 998766655444 3466899999999999999999999999 99999999999999999999999999876554332 2
Q ss_pred ccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 038211 535 AKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGV 589 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~ 589 (605)
.....++..|+|||++.+. .++.++|+||||+++|+|++|+.||.+.+..+.+..
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~ 213 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 3345678999999999888 789999999999999999999999987765554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=272.84 Aligned_cols=208 Identities=30% Similarity=0.489 Sum_probs=175.3
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEee------CC
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVAS------QE 448 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~------~~ 448 (605)
+.|++.+.||.|+||.||+|.+ .++.+|+|++.... .....+..|+.+++++ +|+||++++++|.. ..
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 6789999999999999999987 46679999875542 2345678899999998 79999999999853 45
Q ss_pred eeEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
.++++|||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+|+||+|+||+++.++.++|+|||++..
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 789999999999999998764 356888889999999999999999999 99999999999999999999999999876
Q ss_pred cCcccccccCCCCCCccccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLR-----SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
............|++.|+|||.+. +..++.++|+|||||++|+|++|..||....+...+..+
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 238 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence 543333334556899999999986 345788999999999999999999999887766655554
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=266.67 Aligned_cols=201 Identities=25% Similarity=0.395 Sum_probs=170.4
Q ss_pred ccCceEeeeecccCcEEEEEEEEC------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee-CCe
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS-QER 449 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~ 449 (605)
...|+++..||+|.||.||+|..+ ...+|+|.++.+..........-+|+.+++.++|||++.+..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 467999999999999999999542 2358999887765444455667799999999999999999999977 778
Q ss_pred eEEEEEecCCCchHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC----CcEEEEe
Q 038211 450 LGIVTEFLPRGSLFKTLHKN----YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN----WTVKVGD 521 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~----~~vkl~D 521 (605)
+++++||.+ .+|+..++-. ...++...+..++.||+.|+.|||++. |+||||||.|||+..+ |.|||+|
T Consensus 103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999995 5888887643 256888999999999999999999999 9999999999999766 9999999
Q ss_pred ecCCcccCccccc---ccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 522 FGLSSLKNATYLT---AKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 522 fg~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
||+++....+... ....+-|.+|+|||++.|. .|+.+.|+||+|||+.||++-.+.|.+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999987655433 2334569999999999985 579999999999999999999988864
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=281.22 Aligned_cols=228 Identities=34% Similarity=0.594 Sum_probs=200.4
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEECCc--ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNGS--DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~--~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
.+++...+...-.+||-|.||.||.|.|+.- .||||.++-+. -.++.|..|..+|+.++|||+|+++++|..+..
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 4555566778889999999999999999754 48888775443 356789999999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 450 LGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
+|||+|||..|+|.++|++.. ..++.-.++.++.||..|++||..++ +|||||-..|+|+.++..||++|||++++.
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhhhh
Confidence 999999999999999998764 56777788899999999999999999 999999999999999999999999999987
Q ss_pred Cccccc-ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 529 NATYLT-AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 529 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.....+ +....-..-|.|||-+.-..++.++|||+|||+|||++| |-.||.+.+..+++..+. .+.|++-|++|+|
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-kgyRM~~PeGCPp 493 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-KGYRMDGPEGCPP 493 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-ccccccCCCCCCH
Confidence 544333 333345778999999999999999999999999999998 999999999999999996 7889999999986
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=294.02 Aligned_cols=201 Identities=17% Similarity=0.246 Sum_probs=159.3
Q ss_pred ccccCceEeeeecccCcEEEEEEEECCc---ceEEEE--------------eec-cccchhhhhhHHHHHHHHHhCCCCC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGS---DVAVKV--------------YFG-SEYIEGTLKNYQKEIDIIKKLRHPN 436 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~---~~avKv--------------~~~-~~~~~~~~~~~~~E~~il~~l~h~n 436 (605)
...++|+++++||+|+||+||++..+.. ..+.|. +.+ ..........+.+|+.+|+.++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 3457899999999999999999865321 122220 111 0111223456789999999999999
Q ss_pred eeeEEEEEeeCCeeEEEEEecCCCchHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc
Q 038211 437 VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNY----QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD 512 (605)
Q Consensus 437 iv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~ 512 (605)
|+++++++...+..+++++++ +++|..++.... .......+..++.||+.||+|||++| |+||||||+|||++
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~ 301 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN 301 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC
Confidence 999999999999999999999 457777765421 23345667789999999999999999 99999999999999
Q ss_pred CCCcEEEEeecCCcccCcccc-cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 038211 513 KNWTVKVGDFGLSSLKNATYL-TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578 (605)
Q Consensus 513 ~~~~vkl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf 578 (605)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999976543322 223457999999999999999999999999999999999987643
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-32 Score=267.46 Aligned_cols=211 Identities=29% Similarity=0.502 Sum_probs=182.5
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+|.+.+.||+|+||.||++.+ .+..+++|.+..........+.+.+|+.+++.++|+||+++++.+...+.+++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 588999999999999999987 467799999876544444556788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC-cEEEEeecCCcccCccccc
Q 038211 457 LPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW-TVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 457 ~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~-~vkl~Dfg~a~~~~~~~~~ 534 (605)
+++++|.+++.+.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 99999999987643 35789999999999999999999999 99999999999998876 4699999998765443333
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+.+..+.
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 215 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC 215 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 333468999999999988889999999999999999999999999888777776663
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=270.56 Aligned_cols=213 Identities=23% Similarity=0.370 Sum_probs=170.2
Q ss_pred eecccCcEEEEEEEE--CCcceEEEEeeccccchhh-hhhHHHHH---HHHHhCCCCCeeeEEEEEeeCCeeEEEEEecC
Q 038211 385 EIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGT-LKNYQKEI---DIIKKLRHPNVLLFMGAVASQERLGIVTEFLP 458 (605)
Q Consensus 385 ~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~-~~~~~~E~---~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 458 (605)
.||+|+||.||++.+ .++.||+|++.+....... ...+..|. ..++...||||+.++++|...+.+++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999986 4678999998765432211 12233343 34444579999999999999999999999999
Q ss_pred CCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCC
Q 038211 459 RGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSG 538 (605)
Q Consensus 459 ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 538 (605)
|++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .....
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 155 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCc
Confidence 99999888654 67999999999999999999999999 999999999999999999999999998754322 22345
Q ss_pred CCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHhccCCCccCCCCCCC
Q 038211 539 RGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNL---NLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 539 ~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~---~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.|+..|+|||.+.+. .++.++|+||+||++|+|++|+.||.+. ........+ ....+.+|..+|
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~s 223 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFS 223 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCCCCCcCC
Confidence 689999999998754 5889999999999999999999999876 334443333 334566776654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=267.60 Aligned_cols=222 Identities=28% Similarity=0.442 Sum_probs=178.3
Q ss_pred CceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
.+.....||+|+||.||++.+. +..+++|.+.... ....+.+.+|+.+++.++|+||+++++++..++..++++||
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 3344468999999999999864 4568999775442 23456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhcCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC-CCcEEEEeecCCcccCcccc
Q 038211 457 LPRGSLFKTLHKNYQAL--DIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK-NWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 457 ~~ggsL~~~l~~~~~~~--~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~-~~~vkl~Dfg~a~~~~~~~~ 533 (605)
+++++|.+++......+ ++..+..++.||+.||+|||+.+ |+||||||+||+++. .+.++|+|||++........
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 99999999998754555 88888899999999999999999 999999999999976 67999999999875433322
Q ss_pred cccCCCCCCcccccccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHhccCCCccCCCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRSEP--SNEKSDVFSFGVILWELVTASIPWNNLNL-MQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~~g~~Pf~~~~~-~~~~~~I~~~~~~~~~P~~~~ 604 (605)
......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ......+......+.+|..++
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS 238 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccC
Confidence 333445799999999986643 68899999999999999999999986542 333333333345566776554
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=271.53 Aligned_cols=214 Identities=24% Similarity=0.349 Sum_probs=176.3
Q ss_pred ecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCCch
Q 038211 386 IGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL 462 (605)
Q Consensus 386 LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ggsL 462 (605)
||+|+||+||++.+ .++.+++|++.+.... ......+.+|+.+++.++||||+++++.|...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999976 4778999998654322 22344567899999999999999999999999999999999999999
Q ss_pred HHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCCCC
Q 038211 463 FKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGT 541 (605)
Q Consensus 463 ~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt 541 (605)
.+++.+.. ..+++..+..++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||.+..... ........++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccccCC
Confidence 99987653 36899999999999999999999999 99999999999999999999999999875432 1222344578
Q ss_pred CcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHhccCCCccCCCCCCC
Q 038211 542 PQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNL----MQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 542 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~----~~~~~~I~~~~~~~~~P~~~~ 604 (605)
..|++||.+.+..++.++|+|||||++|+|++|+.||...+. .++...+ ......+|+.++
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 222 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT--LEMAVEYPDKFS 222 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc--ccccccCCccCC
Confidence 899999999888899999999999999999999999977543 3333333 234455665554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=271.83 Aligned_cols=219 Identities=31% Similarity=0.475 Sum_probs=184.5
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
++|++.+.||.|+||.||++.+. ++.+++|.+..... ......+.+|+.+++.++||||+++++++..+..+++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 36888999999999999999885 67799998876532 2445678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH-RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
|+++++|.+++......+++..+..++.|++.||+|||+ .+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 999999999998765788999999999999999999999 99 99999999999999999999999999865432221
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHhccCCCccCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL-----NLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~-----~~~~~~~~I~~~~~~~~~P~~ 602 (605)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||... ...+.+..+. ....+.+|..
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 227 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSG 227 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChh
Confidence 1256889999999999999999999999999999999999999764 3445555542 2334445443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=271.99 Aligned_cols=221 Identities=23% Similarity=0.389 Sum_probs=180.8
Q ss_pred CceEeeeecccCcEEEEEEEE-----CCcceEEEEeeccccc--hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCee
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW-----NGSDVAVKVYFGSEYI--EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERL 450 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~-----~~~~~avKv~~~~~~~--~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~ 450 (605)
.|++.+.||.|+||.||++.. ++..||+|++...... ....+.+.+|+.+++.+ +|+||+.++++|..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478999999999999999876 5677999998754322 22345678899999999 699999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+|||++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 9999999999999998765 56889999999999999999999999 99999999999999999999999999876433
Q ss_pred cc-ccccCCCCCCcccccccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHhccCCCccCCCCCC
Q 038211 531 TY-LTAKSGRGTPQWMAPEVLRSE--PSNEKSDVFSFGVILWELVTASIPWNNL----NLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 531 ~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~Pf~~~----~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
.. .......|+..|+|||.+.+. .++.++|+||||+++|+|++|..||... ....+...+ ....+++|+.+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQEM 235 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh--hccCCCCCccC
Confidence 22 122234689999999998753 3678899999999999999999999743 234555555 33445667665
Q ss_pred C
Q 038211 604 D 604 (605)
Q Consensus 604 ~ 604 (605)
+
T Consensus 236 ~ 236 (290)
T cd05613 236 S 236 (290)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=270.95 Aligned_cols=208 Identities=28% Similarity=0.421 Sum_probs=176.7
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+|++.++||.|++|.||+|.+ .+..+|+|++..... ......+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 588999999999999999987 477799998876432 22345677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 457 LPRGSLFKTLHKNY--QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 457 ~~ggsL~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
+++ +|.+++.... ..+++..+..++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++.........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 975 8888876543 56899999999999999999999999 999999999999999999999999999755433333
Q ss_pred ccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 535 AKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.....+++.|++||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+.+..+
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 213 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 3344578899999998664 4688999999999999999999999987766655544
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=280.88 Aligned_cols=207 Identities=24% Similarity=0.370 Sum_probs=175.2
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC------C
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ------E 448 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------~ 448 (605)
..+|++.+.||+|+||.||++.+ .++.+|+|++.+..........+.+|+.+++.++|+||++++++|... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 57899999999999999999987 577899998865443344456677899999999999999999998643 3
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
..++||||+. ++|.+.+... +++..+..++.||+.||+|||+.| |+||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 5799999995 5888877643 888999999999999999999999 999999999999999999999999999765
Q ss_pred CcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
..... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+
T Consensus 169 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 229 (353)
T cd07850 169 GTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI 229 (353)
T ss_pred CCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 43322 23346789999999999999999999999999999999999999887755444433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=272.06 Aligned_cols=210 Identities=26% Similarity=0.311 Sum_probs=173.4
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCe-----
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQER----- 449 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~----- 449 (605)
++|++.+.||+|+||.||++.+ .++.||+|++............+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4689999999999999999987 4677999987665433334566788999999994 6999999999987655
Q ss_pred eEEEEEecCCCchHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC-CCcEEEEeecC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNY----QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK-NWTVKVGDFGL 524 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~-~~~vkl~Dfg~ 524 (605)
+++||||+++ +|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||+++. ++.++|+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence 8999999975 7888876532 35799999999999999999999999 999999999999998 89999999999
Q ss_pred CcccCcccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 525 SSLKNATYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 525 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
+..............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 224 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI 224 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 8754333222233456889999998865 45689999999999999999999999887765554443
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-31 Score=269.42 Aligned_cols=199 Identities=36% Similarity=0.570 Sum_probs=168.3
Q ss_pred cCceEeeeecccCcEEEEEEEE------CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee--CCe
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW------NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS--QER 449 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~------~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~ 449 (605)
.+|++.+.||+|+||.||++.. .+..|++|.+.... ....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 5799999999999999999874 35679999875432 3445678899999999999999999998754 346
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+++||||+++++|.+++.+....+++..++.++.||+.||+|||++| |+||||||+||+++.++.++|+|||++....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 89999999999999999876567899999999999999999999999 9999999999999999999999999997653
Q ss_pred cccc---cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 530 ATYL---TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 530 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
.... ......++..|+|||.+.+..++.++|||||||++|||++|..|+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 2211 11122345569999999988899999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-31 Score=263.84 Aligned_cols=223 Identities=35% Similarity=0.540 Sum_probs=192.9
Q ss_pred CceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC--CeeEEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ--ERLGIVT 454 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~lv~ 454 (605)
+|.+.+.||+|++|.||+|.+. ++.+++|++..........+.+.+|+.++++++|+||+++++.+... ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999885 77899999877654455677889999999999999999999999888 8899999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc-
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL- 533 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~- 533 (605)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 999999999998775 48999999999999999999999999 99999999999999999999999999876654432
Q ss_pred -cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHhccCCCccCCCCCCC
Q 038211 534 -TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN-LMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 534 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~-~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
......++..|++||.+.+..++.++|+||||+++|+|++|..||...+ .......+........+|..++
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLS 230 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccC
Confidence 1334568999999999988889999999999999999999999998765 5666666654456667776654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=276.52 Aligned_cols=207 Identities=29% Similarity=0.449 Sum_probs=178.6
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
+.|.....||.|+||.||++.+ .+..+|||.+.... ....+.+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 4566678899999999999986 46779999875432 2345668899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|+++++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++..........
T Consensus 100 ~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 100 FLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred CCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 9999999988754 46889999999999999999999999 9999999999999999999999999987543333333
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
....|++.|+|||.+.+..++.++|+||||+++|||++|+.||...+..+.+..+
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~ 230 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 3456899999999998888999999999999999999999999988877766665
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=272.16 Aligned_cols=222 Identities=27% Similarity=0.497 Sum_probs=190.4
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeecccc-chhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCeeEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lv 453 (605)
++|.+.+.||+|+||.||++.. .+..+++|++.+... .......+.+|+.+++.+. |+||+++++++...+.+++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4799999999999999999987 577899999876433 2334466788999999998 99999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc-
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY- 532 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~- 532 (605)
|||+.+++|.+++.+. ..+++..++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 9999999999999775 57999999999999999999999999 9999999999999999999999999987543322
Q ss_pred -------------------ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccC
Q 038211 533 -------------------LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFM 593 (605)
Q Consensus 533 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~ 593 (605)
.......++..|++||.+.+..++.++|+||||+++|+|++|+.||...+..+.+..+ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--~ 235 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI--L 235 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--H
Confidence 1223345789999999998888899999999999999999999999998877777776 3
Q ss_pred CCccCCCCCCC
Q 038211 594 DRRLELPEGLD 604 (605)
Q Consensus 594 ~~~~~~P~~~~ 604 (605)
.....+|+.++
T Consensus 236 ~~~~~~~~~~~ 246 (280)
T cd05581 236 KLEYSFPPNFP 246 (280)
T ss_pred hcCCCCCCccC
Confidence 55566776654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=270.13 Aligned_cols=207 Identities=29% Similarity=0.524 Sum_probs=178.8
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCC---CCCeeeEEEEEeeCCeeEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR---HPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~---h~niv~~~~~~~~~~~~~lv 453 (605)
.|++.++||+|+||.||+|.+ .+..+++|++.... .......+.+|+.+++.++ |||++++++++......++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 478889999999999999987 46779999876542 2334567889999999996 99999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+.| |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999998865 47899999999999999999999999 99999999999999999999999999876554433
Q ss_pred cccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 534 TAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 214 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc
Confidence 3444568999999998865 44688999999999999999999999988777666655
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=276.60 Aligned_cols=192 Identities=25% Similarity=0.402 Sum_probs=157.6
Q ss_pred eeeecccCcEEEEEEEEC----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee--CCeeEEEEEe
Q 038211 383 GEEIGLGSYAVVYRGIWN----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS--QERLGIVTEF 456 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~~----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~lv~e~ 456 (605)
+.+||+|+||.||+|... +..+|+|.+.... ....+.+|+.+++.++||||+++++++.. +..+++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 468999999999999863 3568999875432 22356789999999999999999999854 4678999999
Q ss_pred cCCCchHHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE----cCCCcEEEEeecC
Q 038211 457 LPRGSLFKTLHKN--------YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV----DKNWTVKVGDFGL 524 (605)
Q Consensus 457 ~~ggsL~~~l~~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill----~~~~~vkl~Dfg~ 524 (605)
+. ++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 95 5777776432 235888999999999999999999999 9999999999999 4667999999999
Q ss_pred CcccCcccc---cccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 525 SSLKNATYL---TAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 525 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
++....... ......+|+.|+|||++.+. .++.++|||||||++|||++|++||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 976543221 22345689999999998774 4789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=267.11 Aligned_cols=197 Identities=22% Similarity=0.401 Sum_probs=166.3
Q ss_pred eeecccCcEEEEEEEECCcc------------eEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 384 EEIGLGSYAVVYRGIWNGSD------------VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~~~~------------~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
+.||+|+||.||++.+.... +++|++..... ....+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999885433 67776544321 15678899999999999999999999887 7789
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC-------cEEEEeecC
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW-------TVKVGDFGL 524 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~-------~vkl~Dfg~ 524 (605)
+||||+++++|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .++|+|||+
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999999876557899999999999999999999999 99999999999999887 799999999
Q ss_pred CcccCcccccccCCCCCCcccccccccCC--CCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHh
Q 038211 525 SSLKNATYLTAKSGRGTPQWMAPEVLRSE--PSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 525 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I 590 (605)
+..... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+.....
T Consensus 155 a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~ 219 (259)
T cd05037 155 PITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY 219 (259)
T ss_pred cccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH
Confidence 876433 2234567889999999877 78899999999999999999 69999887655544443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=268.95 Aligned_cols=210 Identities=30% Similarity=0.443 Sum_probs=176.4
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeC-----C
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQ-----E 448 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~-----~ 448 (605)
.++|.+.+.||+|+||.||++.. .++.+|+|++.... .....+.+|+.+++.+ +|||++++++++... +
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 47899999999999999999987 46779999886532 2234567899999999 899999999998753 3
Q ss_pred eeEEEEEecCCCchHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCC
Q 038211 449 RLGIVTEFLPRGSLFKTLHK---NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a 525 (605)
.+++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEeecccc
Confidence 68999999999999998864 2357899999999999999999999999 999999999999999999999999998
Q ss_pred cccCcccccccCCCCCCcccccccccCCC-----CCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 526 SLKNATYLTAKSGRGTPQWMAPEVLRSEP-----SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 526 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
..............|+..|+|||.+.... ++.++|||||||++|+|++|+.||...+..+.+..+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 246 (291)
T cd06639 176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP 246 (291)
T ss_pred hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence 76543333333456889999999986543 5789999999999999999999999888766666663
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=274.14 Aligned_cols=212 Identities=23% Similarity=0.304 Sum_probs=175.5
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC-----
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE----- 448 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~----- 448 (605)
..++|++.++||+|+||.||+|.+ .++.||||++............+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 346899999999999999999987 4677999988655433333445678999999999999999999886543
Q ss_pred ---eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCC
Q 038211 449 ---RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525 (605)
Q Consensus 449 ---~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a 525 (605)
..++||||+. ++|.+.+......+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||++
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCCc
Confidence 4599999995 5888888766567899999999999999999999999 999999999999999999999999998
Q ss_pred cccCcccc----cccCCCCCCcccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 526 SLKNATYL----TAKSGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 526 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
........ ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~ 236 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 75432221 112345788999999887653 688999999999999999999999988766555544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=275.53 Aligned_cols=207 Identities=28% Similarity=0.414 Sum_probs=178.7
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
.|.....||+|+||.||++.+ .++.|++|++..... ...+.+.+|+.+++.++||||++++++|..++..+++|||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 455566899999999999986 477899999865432 2345678999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccccc
Q 038211 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAK 536 (605)
Q Consensus 457 ~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 536 (605)
+++++|..++.. ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++...........
T Consensus 100 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 100 LQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 999999887755 56889999999999999999999999 99999999999999999999999999875443333334
Q ss_pred CCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 537 SGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 537 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
...+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+.+..+.
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 230 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 230 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 4568999999999998889999999999999999999999998887777766663
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=270.28 Aligned_cols=217 Identities=33% Similarity=0.534 Sum_probs=179.0
Q ss_pred eeecccCcEEEEEEEECC--------cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 384 EEIGLGSYAVVYRGIWNG--------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~~--------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
+.||+|+||.||++.+.. ..+++|.+.... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999998642 458899875432 22345678899999999999999999999999899999999
Q ss_pred ecCCCchHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC-----cEEEEeecC
Q 038211 456 FLPRGSLFKTLHKN------YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW-----TVKVGDFGL 524 (605)
Q Consensus 456 ~~~ggsL~~~l~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~-----~vkl~Dfg~ 524 (605)
|+++++|.+++... ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999998753 234788899999999999999999999 99999999999999877 899999999
Q ss_pred CcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCC
Q 038211 525 SSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 525 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~ 601 (605)
+....... .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..+....+. .+.++.+|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 236 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPE 236 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCCcc
Confidence 86543221 11122345788999999998889999999999999999998 999999988888888874 445566666
Q ss_pred CCC
Q 038211 602 GLD 604 (605)
Q Consensus 602 ~~~ 604 (605)
.++
T Consensus 237 ~~~ 239 (269)
T cd05044 237 NCP 239 (269)
T ss_pred cch
Confidence 554
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=268.79 Aligned_cols=214 Identities=23% Similarity=0.353 Sum_probs=168.2
Q ss_pred eecccCcEEEEEEEE--CCcceEEEEeeccccch-hhhhhHHHHHHHHHh---CCCCCeeeEEEEEeeCCeeEEEEEecC
Q 038211 385 EIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKK---LRHPNVLLFMGAVASQERLGIVTEFLP 458 (605)
Q Consensus 385 ~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~---l~h~niv~~~~~~~~~~~~~lv~e~~~ 458 (605)
.||+|+||.||++.+ .++.+|+|++.+..... .....+.+|..+++. .+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999987 46789999887654322 122334455444444 479999999999999999999999999
Q ss_pred CCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCC
Q 038211 459 RGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSG 538 (605)
Q Consensus 459 ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 538 (605)
+++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++...... .....
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 155 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCc
Confidence 99999888765 57899999999999999999999999 999999999999999999999999998654322 22334
Q ss_pred CCCCccccccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHhccCCCccCCCCCCC
Q 038211 539 RGTPQWMAPEVLR-SEPSNEKSDVFSFGVILWELVTASIPWNNLN--LMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 539 ~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~--~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.|++.|+|||.+. +..++.++|+|||||++|+|++|..||.... ....+..+. ......+|+.++
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 223 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFS 223 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccC
Confidence 6899999999986 4567899999999999999999999997543 122222221 234456666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=272.80 Aligned_cols=207 Identities=30% Similarity=0.442 Sum_probs=177.7
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
..|...+.||+|+||.||++.+ .+..+++|++..... .......+.+|+.+++.++|||++++++++..+...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4588899999999999999987 467799998865432 2344567889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+. |+|.+.+......+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 105 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred eCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 9996 4787777666677999999999999999999999999 99999999999999999999999999865432
Q ss_pred ccCCCCCCccccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 535 AKSGRGTPQWMAPEVLR---SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
.....+++.|+|||.+. ...++.++|+|||||++|+|++|..||...+....+..+.
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 237 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 237 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 23446789999999974 3557889999999999999999999999888777777764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=270.50 Aligned_cols=198 Identities=33% Similarity=0.527 Sum_probs=168.5
Q ss_pred cCceEeeeecccCcEEEEEEEE------CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC--Ce
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW------NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ--ER 449 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~------~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~ 449 (605)
.-|+++++||+|+||.||++.+ .+..+|+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3478899999999999999874 35669999875432 233456788999999999999999999998765 56
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
.++||||++|++|.+++.+....+++..+..++.||+.||+|||++| ++||||||+||+++.++.++|+|||+++...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccccccc
Confidence 89999999999999999776567899999999999999999999999 9999999999999999999999999987643
Q ss_pred cccc---cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 038211 530 ATYL---TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578 (605)
Q Consensus 530 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf 578 (605)
.... ......++..|+|||.+.+..++.++|||||||++|+|+++..|+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 2211 122345677899999999888999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-33 Score=274.63 Aligned_cols=225 Identities=24% Similarity=0.381 Sum_probs=182.1
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-----hhhhhhHHHHHHHHHhCCCCCeeeEEEEEe-e
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-----EGTLKNYQKEIDIIKKLRHPNVLLFMGAVA-S 446 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~~~~~~~-~ 446 (605)
...++|-++.+||+|+|+.||+|.+ ..+.||||+-...+.. +...+...+|.+|.+.|.||.||++|++|. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 4457899999999999999999986 5677999986433322 345667789999999999999999999996 4
Q ss_pred CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc---CCCcEEEEeec
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD---KNWTVKVGDFG 523 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~---~~~~vkl~Dfg 523 (605)
.+.+|-|+|||+|.+|..++..+ ..+++..++.|+.||+.||.||.+..+||||-||||.|||+. ..|.+||.|||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 56789999999999998888765 789999999999999999999999999999999999999994 45899999999
Q ss_pred CCcccCccccc-------ccCCCCCCccccccccc-CC---CCCchhHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHH--
Q 038211 524 LSSLKNATYLT-------AKSGRGTPQWMAPEVLR-SE---PSNEKSDVFSFGVILWELVTASIPWNNL-NLMQVVGV-- 589 (605)
Q Consensus 524 ~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~-~~---~~~~~~DiwSlG~il~el~~g~~Pf~~~-~~~~~~~~-- 589 (605)
++++....... +..+.||.+|++||.+. +. ..+.++||||+|||+|.++.|+.||-+. +...++..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99876544322 44567999999999874 32 2477899999999999999999999763 33334332
Q ss_pred hccCCCccCCCC
Q 038211 590 VGFMDRRLELPE 601 (605)
Q Consensus 590 I~~~~~~~~~P~ 601 (605)
|. ....+.||+
T Consensus 699 Il-kAtEVqFP~ 709 (775)
T KOG1151|consen 699 IL-KATEVQFPP 709 (775)
T ss_pred hh-cceeccCCC
Confidence 21 233455554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-33 Score=290.77 Aligned_cols=226 Identities=30% Similarity=0.514 Sum_probs=199.2
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--C---cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--G---SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~---~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
+......+.++||.|.||.|++|+.+ + ..||||.++. .+.++....|+.|+.||-++.||||+++.|+......
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 45566788899999999999999863 3 3489998765 4567778889999999999999999999999998889
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
..||+|||+.|+|..+|+.+.+.++..++..+++-|+.|+.||-+.+ +|||||...|||++.+-..|++|||+++...
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999999999999999999999999999999999999999 9999999999999999999999999999875
Q ss_pred cccc---cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 530 ATYL---TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 530 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.... ++....-+.+|.|||.+.-..++.++||||+|++|||.+. |..||-++++.+++..|. .+.|++=|-+++
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPmDCP 860 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPMDCP 860 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCCCCc
Confidence 4432 2222334679999999999999999999999999999666 999999999999999996 677777777665
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=264.94 Aligned_cols=209 Identities=32% Similarity=0.516 Sum_probs=184.3
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+|++.++||+|+||.||++.+ .+..+++|.+............+.+|+.+++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 588999999999999999977 466799999876554455566778899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 457 LPRGSLFKTLHKN---YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 457 ~~ggsL~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
+++++|..++.+. ...+++..++.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 9999999988662 356899999999999999999999999 999999999999999999999999999766543
Q ss_pred cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 534 TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+..++...+.
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 214 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ 214 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 2233467899999999999889999999999999999999999999988888777774
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=270.49 Aligned_cols=208 Identities=27% Similarity=0.406 Sum_probs=175.6
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+|++++.||.|+||.||+|.+ .+..++||.+............+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488999999999999999987 467799998865543333445788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 457 LPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 457 ~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
+. ++|..++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 95 5888887654 356899999999999999999999999 9999999999999999999999999987654333333
Q ss_pred cCCCCCCcccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 038211 536 KSGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGV 589 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~ 589 (605)
....+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+.......
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~ 212 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 212 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 3445788999999987754 58889999999999999999999987665444433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=268.38 Aligned_cols=210 Identities=31% Similarity=0.478 Sum_probs=178.2
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCC-----
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQE----- 448 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~----- 448 (605)
.++|++.+.||.|+||.||+|.+. +..+++|++..... ....+.+|+.+++++ .|+||++++++|....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 478999999999999999999874 56699998865432 345688999999999 7999999999997644
Q ss_pred -eeEEEEEecCCCchHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecC
Q 038211 449 -RLGIVTEFLPRGSLFKTLHKN---YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524 (605)
Q Consensus 449 -~~~lv~e~~~ggsL~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~ 524 (605)
.+++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999988653 367899999999999999999999999 99999999999999999999999999
Q ss_pred CcccCcccccccCCCCCCcccccccccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 525 SSLKNATYLTAKSGRGTPQWMAPEVLRSE-----PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 525 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
+..............+++.|+|||.+... .++.++|||||||+||+|++|+.||.+......+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 231 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP 231 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh
Confidence 87654443344455689999999987543 35778999999999999999999998877666666653
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=271.52 Aligned_cols=208 Identities=27% Similarity=0.466 Sum_probs=179.4
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
..+|.+.+.||+|+||.||++.. .+..+++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 47899999999999999999976 46779999875432 223466789999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+++++|.+++.+ ..+++..+..++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++.........
T Consensus 96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred ecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999998875 35788899999999999999999999 999999999999999999999999988655433333
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.....+++.|++||.+.+..++.++|+|||||++|+|++|+.||...+....+..+
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~ 227 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh
Confidence 34456889999999998888899999999999999999999999887665554444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=265.81 Aligned_cols=204 Identities=27% Similarity=0.432 Sum_probs=164.3
Q ss_pred eeecccCcEEEEEEEEC-Ccc---eEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLGSYAVVYRGIWN-GSD---VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~-~~~---~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
++||+|+||.||++... +.. +++|.+.... .....+.+.+|+.+++.++||||+++++.+......++||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 36999999999998752 332 4555544322 223456788999999999999999999999999999999999999
Q ss_pred CchHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc--cc
Q 038211 460 GSLFKTLHKNY---QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY--LT 534 (605)
Q Consensus 460 gsL~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~--~~ 534 (605)
++|.+++.+.. ...++..+..++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||++....... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999987642 34667778889999999999999999 9999999999999999999999999975422111 12
Q ss_pred ccCCCCCCcccccccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHh
Q 038211 535 AKSGRGTPQWMAPEVLRS-------EPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I 590 (605)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...+..+.+..+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 221 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV 221 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 234567899999998753 235678999999999999996 68899988877777765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=264.78 Aligned_cols=201 Identities=28% Similarity=0.396 Sum_probs=170.9
Q ss_pred eeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHH-HhCCCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDII-KKLRHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il-~~l~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
+.||.|+||.||+|.+ .++.+|+|++.+.... ......+..|..++ ...+|+|++++++++...+.+++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999987 4678999998654322 22223344555444 445899999999999999999999999999
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~ 154 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFV 154 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc----cccCC
Confidence 9999998765 57899999999999999999999999 99999999999999999999999999875432 23346
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
+++.|++||.+.+..++.++|+||||+++|+|++|..||...+..++...+.
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 206 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL 206 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 7899999999998888999999999999999999999999988888887774
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-31 Score=270.50 Aligned_cols=207 Identities=31% Similarity=0.435 Sum_probs=177.8
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
..|.+.++||+|+||.||++.+ .++.|++|++..... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5699999999999999999987 477899998865432 2334567889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+. |+|.+++......+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 9996 5777777665567999999999999999999999999 999999999999999999999999998654322
Q ss_pred ccCCCCCCccccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 535 AKSGRGTPQWMAPEVLR---SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
....+++.|+|||.+. ...++.++||||||+++|+|++|+.||.+.+....+..+.
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~ 227 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh
Confidence 2346788999999885 3457889999999999999999999999888777766664
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=268.55 Aligned_cols=210 Identities=29% Similarity=0.472 Sum_probs=183.8
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
...|++.+.||.|+||.||++.+. +..+++|++..... ....+.+|+.+++.++|+|++++++++...+..++++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 356888999999999999999885 77799999866433 4566889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+++++|.+++......+++..+..++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++.........
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 999999999999876448999999999999999999999999 999999999999999999999999988654433222
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
.....+++.|++||.+.+..++.++|+|||||++|+|++|+.||.+.++......+.
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~ 229 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT 229 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 334457889999999998889999999999999999999999999888776666653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=268.40 Aligned_cols=209 Identities=23% Similarity=0.423 Sum_probs=170.5
Q ss_pred eeecccCcEEEEEEEECC---------cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 384 EEIGLGSYAVVYRGIWNG---------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~~---------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
+.||+|+||.||+|.+.. ..+++|++.... ....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 469999999999997632 237777764432 234567888999999999999999999999989999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc--------EEEEeecCCc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT--------VKVGDFGLSS 526 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~--------vkl~Dfg~a~ 526 (605)
||+++|+|..++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++. ++++|||.+.
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999876667899999999999999999999999 999999999999987654 6999999886
Q ss_pred ccCcccccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 527 LKNATYLTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTA-SIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 527 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g-~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
.... .....+++.|+|||.+.+. .++.++|||||||++|+|++| ..||...+........ ..+..+|..+
T Consensus 157 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 228 (258)
T cd05078 157 TVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY---EDRHQLPAPK 228 (258)
T ss_pred ccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH---HccccCCCCC
Confidence 5432 2234578899999999874 478899999999999999998 5778777766554433 2345666543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=266.30 Aligned_cols=221 Identities=27% Similarity=0.479 Sum_probs=179.8
Q ss_pred ceEeeeecccCcEEEEEEEEC-----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC------
Q 038211 380 LQLGEEIGLGSYAVVYRGIWN-----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE------ 448 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~~-----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------ 448 (605)
|.+.++||+|+||.||+|.+. +..+|||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999752 467999998776555556677889999999999999999999886532
Q ss_pred eeEEEEEecCCCchHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeec
Q 038211 449 RLGIVTEFLPRGSLFKTLHKN-----YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFG 523 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg 523 (605)
..+++++|+.+++|.+++... ...++...+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECccc
Confidence 247889999999998877532 135788899999999999999999999 9999999999999999999999999
Q ss_pred CCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCC
Q 038211 524 LSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELP 600 (605)
Q Consensus 524 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P 600 (605)
+++...... .......+++.|++||.+.+..++.++|||||||++|+|++ |++||.+.+..++...+. ....+..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 237 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLKQP 237 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCCCC
Confidence 987543221 11223345678999999998889999999999999999999 999999888877777764 23344444
Q ss_pred CCC
Q 038211 601 EGL 603 (605)
Q Consensus 601 ~~~ 603 (605)
+.+
T Consensus 238 ~~~ 240 (273)
T cd05074 238 PDC 240 (273)
T ss_pred CCC
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=265.40 Aligned_cols=196 Identities=24% Similarity=0.439 Sum_probs=163.5
Q ss_pred eeecccCcEEEEEEEECC--------------cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 384 EEIGLGSYAVVYRGIWNG--------------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~~--------------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
+.||+|+||.||+|.... ..+++|++.... ......+.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 468999999999997421 237777764432 3345578889999999999999999999998889
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc-------EEEEee
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT-------VKVGDF 522 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~-------vkl~Df 522 (605)
.+++|||+++++|..++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++++||
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999998888776677999999999999999999999999 999999999999986654 899999
Q ss_pred cCCcccCcccccccCCCCCCccccccccc-CCCCCchhHHHHHHHHHHHHH-cCCCCCCCCCHHHHH
Q 038211 523 GLSSLKNATYLTAKSGRGTPQWMAPEVLR-SEPSNEKSDVFSFGVILWELV-TASIPWNNLNLMQVV 587 (605)
Q Consensus 523 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~-~g~~Pf~~~~~~~~~ 587 (605)
|++..... .....++..|+|||.+. +..++.++|||||||++|+|+ .|..||......+..
T Consensus 157 g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~ 219 (262)
T cd05077 157 GIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE 219 (262)
T ss_pred CCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH
Confidence 99865432 22345788999999887 466889999999999999997 599999877655543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=267.02 Aligned_cols=198 Identities=21% Similarity=0.347 Sum_probs=163.0
Q ss_pred eecccCcEEEEEEEEC--------------------------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCee
Q 038211 385 EIGLGSYAVVYRGIWN--------------------------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438 (605)
Q Consensus 385 ~LG~G~fg~V~~~~~~--------------------------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv 438 (605)
+||+|+||.||+|... ...+++|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 6999999999998641 1237788765432 23345678899999999999999
Q ss_pred eEEEEEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC---
Q 038211 439 LFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW--- 515 (605)
Q Consensus 439 ~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~--- 515 (605)
++++++......++||||+++++|..++.+..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999999888776678899999999999999999999999 99999999999997643
Q ss_pred ----cEEEEeecCCcccCcccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHH-cCCCCCCCCCHHHHHHH
Q 038211 516 ----TVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELV-TASIPWNNLNLMQVVGV 589 (605)
Q Consensus 516 ----~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~-~g~~Pf~~~~~~~~~~~ 589 (605)
.++++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+.+....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred CccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 4899999987543221 22356888999998875 56789999999999999985 79999988776655444
Q ss_pred h
Q 038211 590 V 590 (605)
Q Consensus 590 I 590 (605)
+
T Consensus 234 ~ 234 (274)
T cd05076 234 Y 234 (274)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=267.77 Aligned_cols=199 Identities=30% Similarity=0.469 Sum_probs=164.7
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHH-HHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDI-IKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~i-l~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
++|++.+.||+|+||.||++.++ ++.||+|.+......... ..+..|+.+ ++..+||||+++++++..++..+++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 47999999999999999999874 778999998765433332 344455554 66679999999999999999999999
Q ss_pred EecCCCchHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 455 EFLPRGSLFKTLHKN---YQALDIKRRLRMALDVARGMNYLHHR-NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 455 e~~~ggsL~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~-~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
||++ ++|.+++... ...+++..++.++.||+.||+|||++ + ++||||||+|||++.++.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9996 6887777542 35689999999999999999999997 8 99999999999999999999999999875432
Q ss_pred ccccccCCCCCCcccccccccC----CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRS----EPSNEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
.. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 157 SV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred cc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 21 1222457889999998865 44688999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=265.93 Aligned_cols=212 Identities=29% Similarity=0.463 Sum_probs=182.2
Q ss_pred ecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCCch
Q 038211 386 IGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL 462 (605)
Q Consensus 386 LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ggsL 462 (605)
||.|+||.||++.+. ++.+++|++...... ......+.+|+++++.++||||+++++.+.....++++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999884 778999998665432 24456788999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc--------c
Q 038211 463 FKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL--------T 534 (605)
Q Consensus 463 ~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~--------~ 534 (605)
.+++.+. ..+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 9998775 47899999999999999999999999 99999999999999999999999999875433211 2
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
.....++..|++||.+.+..++.++|+||||+++|+|++|..||......++...+. .+.+..|..
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~ 223 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL--NGKIEWPED 223 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCcCCCcc
Confidence 233457889999999988888999999999999999999999999988888888874 344555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=268.05 Aligned_cols=208 Identities=30% Similarity=0.394 Sum_probs=176.2
Q ss_pred ceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEec
Q 038211 380 LQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFL 457 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~ 457 (605)
|++.++||.|++|.||++.+ .++.|++|++............+.+|+.+++.++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67889999999999999986 5788999998765444444466788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccccc
Q 038211 458 PRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAK 536 (605)
Q Consensus 458 ~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 536 (605)
+ ++|.+++.... ..+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence 5 68988887653 36899999999999999999999999 99999999999999999999999999875543322223
Q ss_pred CCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 537 SGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 537 ~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
...+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+....+..+
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 212 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI 212 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 34568899999988764 4688999999999999999999999887765544443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=285.08 Aligned_cols=209 Identities=30% Similarity=0.496 Sum_probs=186.7
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEee-----CCe
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVAS-----QER 449 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~-----~~~ 449 (605)
+.|++.++||.|.+|+||+++. .++..|+|++.... +..+.+..|.++|+.. .|||++.++++|.. ++.
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 5689999999999999998864 67889999986554 3335567789999988 79999999999863 578
Q ss_pred eEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 450 LGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
+|||||||.||+..+++..- ...+.|..+..++++++.||.+||.+. ++|||||-.|||++.+|.|||+|||.+...
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 99999999999999998764 467999999999999999999999999 999999999999999999999999999988
Q ss_pred CcccccccCCCCCCcccccccccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSE-----PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
..+...+.+++|||.|||||++... .|+..+|+||||++..||.-|.+|+-++-++-.+..|-
T Consensus 174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip 241 (953)
T KOG0587|consen 174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 241 (953)
T ss_pred ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC
Confidence 8888888899999999999999654 35778999999999999999999999999999999884
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-31 Score=259.17 Aligned_cols=208 Identities=33% Similarity=0.548 Sum_probs=182.9
Q ss_pred CceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+|.+.+.||+|++|.||++.+. +..+++|++..... .....+.+|+.+++.++|+|++++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 5888999999999999999885 67799999866433 3456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccccc
Q 038211 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAK 536 (605)
Q Consensus 457 ~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 536 (605)
+++++|.+++......+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 155 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RN 155 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc-cc
Confidence 9999999998876568999999999999999999999999 99999999999999999999999999876543321 33
Q ss_pred CCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 537 SGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 537 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
...++..|++||.+.+..++.++|+||||+++|+|++|+.||...+..+....+.
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 210 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA 210 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Confidence 4567899999999998888999999999999999999999999886666555553
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=268.18 Aligned_cols=202 Identities=32% Similarity=0.537 Sum_probs=173.6
Q ss_pred ccCceEeeeecccCcEEEEEEEEC------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee--CC
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS--QE 448 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~ 448 (605)
.++|++.+.||+|+||.||++.+. +..+|+|++...... .....+.+|+.+++.+.|+||+++++++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 367889999999999999999863 557999998765432 345678999999999999999999999877 55
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
..+++|||+++++|.+++......+++..+..++.||+.||+|||++| ++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 789999999999999999876667999999999999999999999999 999999999999999999999999999765
Q ss_pred Ccccc---cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 529 NATYL---TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 529 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
..... ......++..|++||.+.+..++.++|+|||||++|+|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 42211 111223466799999998888999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=264.31 Aligned_cols=210 Identities=27% Similarity=0.482 Sum_probs=178.6
Q ss_pred CceEeeeecccCcEEEEEEEECC---cceEEEEeeccc--------cchhhhhhHHHHHHHHHh-CCCCCeeeEEEEEee
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWNG---SDVAVKVYFGSE--------YIEGTLKNYQKEIDIIKK-LRHPNVLLFMGAVAS 446 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~~---~~~avKv~~~~~--------~~~~~~~~~~~E~~il~~-l~h~niv~~~~~~~~ 446 (605)
.|++.+.||+|+||.||++.+.+ +.+|+|.+.... ........+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47889999999999999998754 669999875432 122344556788888865 699999999999999
Q ss_pred CCeeEEEEEecCCCchHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCCCCEEEcCCCcEEEEee
Q 038211 447 QERLGIVTEFLPRGSLFKTLHK---NYQALDIKRRLRMALDVARGMNYLHH-RNPPIVHRDLKSSNLLVDKNWTVKVGDF 522 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~~~iiH~Dik~~Nill~~~~~vkl~Df 522 (605)
.+..+++|||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+ ++|+||+|+|||++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988753 34578999999999999999999996 68 999999999999999999999999
Q ss_pred cCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 523 GLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 523 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
|++....... ......|+..|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+.
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~ 226 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV 226 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHh
Confidence 9997654332 3344568999999999998889999999999999999999999999888877777774
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=266.54 Aligned_cols=207 Identities=28% Similarity=0.444 Sum_probs=178.9
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
.|...++||.|++|.||++.+ .++.+++|++.... ....+.+.+|+.+++.++||||+++++++...++.++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 455567999999999999986 46679999875432 22345678999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccccc
Q 038211 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAK 536 (605)
Q Consensus 457 ~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 536 (605)
+++++|.+++.. ..+++..+..++.||+.||+|||++| ++||||+|+||+++.++.++|+|||++...........
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 999999998876 56889999999999999999999999 99999999999999999999999998865443333333
Q ss_pred CCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 537 SGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 537 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
...|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...++.+.+..+.
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~ 228 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR 228 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 4568999999999998889999999999999999999999999888877777764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=269.96 Aligned_cols=214 Identities=26% Similarity=0.363 Sum_probs=178.0
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC----
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE---- 448 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~---- 448 (605)
...++|++.++||.|+||.||+|.+ .++.|++|++............+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4567899999999999999999987 4677999998765433344456778999999999999999999887654
Q ss_pred ------eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEee
Q 038211 449 ------RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDF 522 (605)
Q Consensus 449 ------~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Df 522 (605)
.+++|+||+++ +|...+......+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeCcc
Confidence 79999999975 777777765567999999999999999999999999 999999999999999999999999
Q ss_pred cCCcccCcccc-cccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 523 GLSSLKNATYL-TAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 523 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
|++........ ......++..|+|||.+.+. .++.++|||||||++|+|++|++||...+..+.+..+.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~ 231 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99876543321 11223457889999988654 46889999999999999999999999877666655553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=267.60 Aligned_cols=204 Identities=18% Similarity=0.218 Sum_probs=156.5
Q ss_pred CccccCceEeeeecccCcEEEEEEEECCc-----ceEEEEeeccccch-hh--------hhhHHHHHHHHHhCCCCCeee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWNGS-----DVAVKVYFGSEYIE-GT--------LKNYQKEIDIIKKLRHPNVLL 439 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~-----~~avKv~~~~~~~~-~~--------~~~~~~E~~il~~l~h~niv~ 439 (605)
++...+|++.++||+|+||+||+|.+.+. .+++|+........ .. ......+...+..+.|++++.
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 35557899999999999999999987543 46666543222110 00 011122334455668999999
Q ss_pred EEEEEeeCC----eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC
Q 038211 440 FMGAVASQE----RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW 515 (605)
Q Consensus 440 ~~~~~~~~~----~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~ 515 (605)
+++++.... ..+++++++ ..++.+.+... ...++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNN 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCC
Confidence 998775543 346788887 44666666543 44678888999999999999999999 99999999999999999
Q ss_pred cEEEEeecCCcccCccc-------ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 516 TVKVGDFGLSSLKNATY-------LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 516 ~vkl~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
.++|+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++|.+||.+.
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999997543211 1122346999999999999999999999999999999999999999876
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=271.76 Aligned_cols=201 Identities=25% Similarity=0.417 Sum_probs=168.5
Q ss_pred CceEeeeecccCcEEEEEEEE----CCcceEEEEeeccc-cchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC--CeeE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW----NGSDVAVKVYFGSE-YIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ--ERLG 451 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~----~~~~~avKv~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~ 451 (605)
.|.+.++||+|+||.||+|.+ .+..||+|++.... ........+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 488999999999999999987 45779999987643 1223346678899999999999999999999887 7899
Q ss_pred EEEEecCCCchHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC----CCcEEEEeec
Q 038211 452 IVTEFLPRGSLFKTLHKN----YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK----NWTVKVGDFG 523 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~----~~~vkl~Dfg 523 (605)
+||||+++ +|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 99999964 676666432 136889999999999999999999999 999999999999998 8999999999
Q ss_pred CCcccCcccc---cccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 524 LSSLKNATYL---TAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 524 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
++........ ......+++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 9876543222 22334678999999988764 57889999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=270.14 Aligned_cols=211 Identities=25% Similarity=0.378 Sum_probs=174.0
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC-------
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ------- 447 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------- 447 (605)
.++|++.++||.|+||.||++.+. ++.+++|++............+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 589999999999999999999874 67799998866543333344567899999999999999999887543
Q ss_pred -CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCc
Q 038211 448 -ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526 (605)
Q Consensus 448 -~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~ 526 (605)
..+++||||+. ++|...+......+++..+..++.||+.||+|||+.| |+|+||||+|||++.++.++|+|||++.
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCccch
Confidence 34799999995 4777777665568999999999999999999999999 9999999999999999999999999987
Q ss_pred ccCccccc-----------ccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 527 LKNATYLT-----------AKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 527 ~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
........ .....+++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+..+....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 54322111 1123468889999988664 4788999999999999999999999988776655554
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=276.23 Aligned_cols=208 Identities=25% Similarity=0.412 Sum_probs=174.1
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee----CCeeE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS----QERLG 451 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----~~~~~ 451 (605)
++|++.++||+|+||.||++.. .+..|++|++............+.+|+.+|+.++||||++++++|.. ...++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6899999999999999999986 47789999987654333455677889999999999999999998763 35689
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||||+. ++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999995 6888888654 56899999999999999999999999 999999999999999999999999998654322
Q ss_pred ccc----ccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 038211 532 YLT----AKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGV 589 (605)
Q Consensus 532 ~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~ 589 (605)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~ 223 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKL 223 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHH
Confidence 211 123468899999999866 4578899999999999999999999988775544443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=262.32 Aligned_cols=208 Identities=28% Similarity=0.424 Sum_probs=175.8
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee--CCeeEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS--QERLGIV 453 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~lv 453 (605)
++|...+.||.|++|.||++.+ .++.+|+|++..... ......+.+|+++++.++||||++++++|.. .+.+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 3688999999999999999987 467799998875433 2345678899999999999999999998865 3478999
Q ss_pred EEecCCCchHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 454 TEFLPRGSLFKTLHK---NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
|||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999888754 2356889999999999999999999999 99999999999999999999999999865432
Q ss_pred ccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHh
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL-----NLMQVVGVV 590 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~-----~~~~~~~~I 590 (605)
.. .....++..|++||.+.+..++.++|+|||||++|+|++|..||... ...++...+
T Consensus 158 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 220 (287)
T cd06621 158 SL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI 220 (287)
T ss_pred cc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH
Confidence 22 12345788999999999888999999999999999999999999865 345555555
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=263.13 Aligned_cols=205 Identities=22% Similarity=0.336 Sum_probs=170.3
Q ss_pred ceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeC--CeeEEEE
Q 038211 380 LQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQ--ERLGIVT 454 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~--~~~~lv~ 454 (605)
|++.++||+|+||.||++.+ .++.+|+|++.+...... .....+|+.+++++. |+|++++++++.+. +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 67899999999999999987 467799998865432222 223457888888884 99999999999887 8899999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||++ ++|.+.+......+++..+..++.||+.||.|||+.+ ++||||+|+||+++. +.+||+|||++........
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 9996 5888888765567899999999999999999999999 999999999999999 9999999999976543222
Q ss_pred ccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 535 AKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.....+++.|+|||.+.. ..++.++|||||||++|+|++|..||...+..+.+..+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~ 211 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI 211 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHH
Confidence 123457899999997654 45688999999999999999999999987766655544
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=258.93 Aligned_cols=214 Identities=29% Similarity=0.444 Sum_probs=185.4
Q ss_pred ecccCcEEEEEEEEC--CcceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCCch
Q 038211 386 IGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL 462 (605)
Q Consensus 386 LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ggsL 462 (605)
||.|+||.||++.+. ++.+++|++.+..... .....+.+|+.+++.++|+||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999874 6789999987654332 3456788999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCCCCC
Q 038211 463 FKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP 542 (605)
Q Consensus 463 ~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~ 542 (605)
.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..............++.
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 9999765 46899999999999999999999999 99999999999999999999999999876544322334456789
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 543 QWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 543 ~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.|++||.+.+..++.++|+||||+++|+|++|..||...+..++...+.. .++++|..++
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~ 217 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLS 217 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCC
Confidence 99999999988889999999999999999999999998888888888743 5677777653
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=292.14 Aligned_cols=147 Identities=29% Similarity=0.435 Sum_probs=133.0
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
+++|.++++||+|+||+||+|.+. ++.||||++...... ......+.+|+.+++.++||||+++++++....++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 578999999999999999999986 778999998765432 34456788999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~ 526 (605)
|||+.|++|.+++... ..+++..++.++.||+.||+|||.++ |+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999998764 56889999999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=273.61 Aligned_cols=206 Identities=26% Similarity=0.347 Sum_probs=173.1
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC-----Cee
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ-----ERL 450 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~ 450 (605)
.+|.+.++||.|+||+||++.+ .+..||||.+............+.+|+.+++.++|+||+++++++... ..+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 5799999999999999999987 467899998765433333455677899999999999999999988644 358
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
+++|||+. ++|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99999995 6888887654 67999999999999999999999999 99999999999999999999999999976544
Q ss_pred ccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~ 587 (605)
.........++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+..+.+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 218 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL 218 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH
Confidence 3223334567899999998865 45889999999999999999999999876654433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=295.17 Aligned_cols=219 Identities=25% Similarity=0.433 Sum_probs=178.1
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee--------
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS-------- 446 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-------- 446 (605)
..+|+.++.||+|+||.||+++. +|+.||||.+.... .......+.+|+.+|.+|+|||||+|+..+..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 46889999999999999999987 69999999987765 55667788999999999999999999842100
Q ss_pred ----------------------------------------------------------------------C---------
Q 038211 447 ----------------------------------------------------------------------Q--------- 447 (605)
Q Consensus 447 ----------------------------------------------------------------------~--------- 447 (605)
.
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred --------------------------------CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 038211 448 --------------------------------ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495 (605)
Q Consensus 448 --------------------------------~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 495 (605)
-.+||-||||+...|.+++.++...-.....|++++||+.||.|+|+.
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 126789999998888888877633325778899999999999999999
Q ss_pred CCCceeccCCCCCEEEcCCCcEEEEeecCCcccC------------------cccccccCCCCCCcccccccccCCC---
Q 038211 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN------------------ATYLTAKSGRGTPQWMAPEVLRSEP--- 554 (605)
Q Consensus 496 ~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~~~--- 554 (605)
| ||||||||.|||+++.+.|||+|||+|+... ......+..+||.-|+|||++.+..
T Consensus 717 g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 717 G--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred c--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9 9999999999999999999999999997511 1112345668999999999997765
Q ss_pred CCchhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhccCCCccCCCCCC
Q 038211 555 SNEKSDVFSFGVILWELVTASIPWNN-LNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 555 ~~~~~DiwSlG~il~el~~g~~Pf~~-~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
|+.|+|||||||+|+||+. ||.+ +.-..++..+ .++.++.|++|
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~L--R~g~iP~~~~f 839 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNL--RKGSIPEPADF 839 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhc--ccCCCCCCccc
Confidence 8999999999999999986 4765 6667788887 35556666443
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=264.02 Aligned_cols=208 Identities=26% Similarity=0.353 Sum_probs=177.0
Q ss_pred ceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC--CeeEEEEE
Q 038211 380 LQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ--ERLGIVTE 455 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~lv~e 455 (605)
|++.++||.|+||.||++.+. ++.+++|++............+.+|+.+++.++|+|++++++++... +.+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678999999999999999874 57799999877643334456678899999999999999999999887 88999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc-c
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL-T 534 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~-~ 534 (605)
|++ ++|..++......+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 996 5888888765568999999999999999999999999 99999999999999999999999999876543321 1
Q ss_pred ccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 535 AKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+....+..+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~ 214 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKI 214 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 2233568899999987754 5788999999999999999999999988776665554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=261.21 Aligned_cols=191 Identities=20% Similarity=0.343 Sum_probs=161.4
Q ss_pred cCceEeeee--cccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEE
Q 038211 378 EDLQLGEEI--GLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 378 ~~~~~~~~L--G~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~l 452 (605)
++|.+.+.+ |.|+||.||++.. .+..+++|++....... .|+.+...+ +||||++++++|..++.+++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 456666665 9999999999986 46679999876543221 123333323 79999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC-cEEEEeecCCcccCcc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW-TVKVGDFGLSSLKNAT 531 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~-~vkl~Dfg~a~~~~~~ 531 (605)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.| ++||||||+||+++.++ .++|+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 99999999999999775 48899999999999999999999999 99999999999999988 9999999998754322
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred ----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 23467999999999999889999999999999999999999998654
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=264.75 Aligned_cols=206 Identities=31% Similarity=0.443 Sum_probs=176.0
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
-|...++||+|+||+||+|.+ .+..+++|++..... .......+.+|+.+++.++|||++++++++.+....++|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 467778899999999999986 567799998865433 23344668889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|+. ++|.+++......+++..+..++.||+.||.|||+.| ++|+||+|+||+++.++.++|+|||++..... .
T Consensus 102 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~ 174 (313)
T cd06633 102 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----A 174 (313)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCC----C
Confidence 995 5787887766677899999999999999999999999 99999999999999999999999999864322 2
Q ss_pred cCCCCCCccccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 536 KSGRGTPQWMAPEVLR---SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
....|+..|+|||.+. ...++.++|+|||||++|+|++|..||...+....+..+.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 233 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 233 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 2456889999999984 3557889999999999999999999999888777666664
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=271.60 Aligned_cols=202 Identities=26% Similarity=0.421 Sum_probs=167.9
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC-----Cee
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ-----ERL 450 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~ 450 (605)
++|++.++||+|+||.||++.+ .++.||+|++.... .......+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 6899999999999999999987 46779999885422 223455678899999999999999999887543 358
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
++++||+. ++|..++.. ..+++..++.++.||+.||+|||+.| |+||||||+|||++.++.++|+|||++.....
T Consensus 84 ~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 84 YIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 99999995 588777754 56899999999999999999999999 99999999999999999999999999875432
Q ss_pred ccc---cccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 038211 531 TYL---TAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQ 585 (605)
Q Consensus 531 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~ 585 (605)
... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~ 217 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH 217 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 211 1123468999999998765 457899999999999999999999998765433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=270.53 Aligned_cols=206 Identities=26% Similarity=0.370 Sum_probs=172.7
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC------C
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ------E 448 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------~ 448 (605)
.++|.+.+.||+|+||.||++.+ .++.||+|++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 37899999999999999999976 467799998876443333456678899999999999999999988643 3
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
..+++++++ +++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred cEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEecccccccc
Confidence 478888887 7899887764 46899999999999999999999999 999999999999999999999999998754
Q ss_pred CcccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 230 (345)
T cd07877 171 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230 (345)
T ss_pred ccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 322 234467899999999876 45788999999999999999999999887765554443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=272.60 Aligned_cols=209 Identities=29% Similarity=0.393 Sum_probs=180.0
Q ss_pred CceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC-----eeE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE-----RLG 451 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~~ 451 (605)
+|++.+.||.|+||.||+|.+. +..+++|++..........+.+.+|+.+++.++|+||+++++++.... .++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999874 678999988764433445677889999999999999999999988765 789
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
++|||++ ++|.+++.+. ..+++..+..++.||+.||+|||+.| |+|+||||+|||++.++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999996 5888888664 48999999999999999999999999 999999999999999999999999999765443
Q ss_pred c---ccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 532 Y---LTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 532 ~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
. .......+++.|+|||.+.+. .++.++|+||||+++|+|++|++||...+..+.+..|.
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 220 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIV 220 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 2 123344678999999999887 78999999999999999999999999888777666653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=270.32 Aligned_cols=206 Identities=24% Similarity=0.378 Sum_probs=173.7
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC------
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE------ 448 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------ 448 (605)
.++|++++.||+|+||.||++.+ .+..||||++............+.+|+.+++.++||||++++++|..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 36799999999999999999986 4677999988654333344556889999999999999999999987653
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
.+++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.| |+||||||+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 458999999 7799888764 56899999999999999999999999 999999999999999999999999998754
Q ss_pred CcccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07880 169 DSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI 228 (343)
T ss_pred ccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 322 233457899999999876 45788999999999999999999999987765544443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=264.47 Aligned_cols=208 Identities=27% Similarity=0.374 Sum_probs=179.3
Q ss_pred ceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEec
Q 038211 380 LQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFL 457 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~ 457 (605)
|.+.+.||.|++|.||++.+ .++.+++|.+............+.+|+.+++.++|+||+++++++..++.++++|||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56788999999999999987 4677999988765544445567888999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccC
Q 038211 458 PRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKS 537 (605)
Q Consensus 458 ~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~ 537 (605)
++ +|..++......+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||.+............
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 65 888888776578999999999999999999999999 999999999999999999999999998766544322333
Q ss_pred CCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 538 GRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 538 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+.+..+
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 211 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 4578899999998876 6889999999999999999999999887766655444
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=263.71 Aligned_cols=221 Identities=24% Similarity=0.379 Sum_probs=179.8
Q ss_pred CceEeeeecccCcEEEEEEEE-----CCcceEEEEeeccccc--hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCee
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW-----NGSDVAVKVYFGSEYI--EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERL 450 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~-----~~~~~avKv~~~~~~~--~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~ 450 (605)
+|++.+.||+|+||.||++.. .++.+|||++.+.... ......+.+|+.+++++ +||||+++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 488999999999999999875 3567999998754322 23345678899999999 699999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 9999999999999988764 56889999999999999999999999 99999999999999999999999999876433
Q ss_pred ccc-cccCCCCCCcccccccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHhccCCCccCCCCCC
Q 038211 531 TYL-TAKSGRGTPQWMAPEVLRSEP--SNEKSDVFSFGVILWELVTASIPWNNLN----LMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 531 ~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~~g~~Pf~~~~----~~~~~~~I~~~~~~~~~P~~~ 603 (605)
... ......|+..|++||.+.+.. .+.++|+||||+++|+|++|..||.... ..++...+ ....+++|..+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--LKSKPPFPKTM 235 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH--HccCCCCCccc
Confidence 221 122345799999999987765 6789999999999999999999996422 33444444 33445666665
Q ss_pred C
Q 038211 604 D 604 (605)
Q Consensus 604 ~ 604 (605)
+
T Consensus 236 ~ 236 (288)
T cd05583 236 S 236 (288)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=264.48 Aligned_cols=201 Identities=28% Similarity=0.428 Sum_probs=167.2
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCeeEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lv 453 (605)
.++|...++||+|+||.||++.+ .++.+|+|.+...... .....+.+|+.++.++. |+||+++++++..+...+++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 45788889999999999999987 4677999988654332 34567889999999996 99999999999988899999
Q ss_pred EEecCCCchHHHHH---h-hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 454 TEFLPRGSLFKTLH---K-NYQALDIKRRLRMALDVARGMNYLHHR-NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 454 ~e~~~ggsL~~~l~---~-~~~~~~~~~~~~~~~qi~~aL~~LH~~-~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
|||+. ++|.++.. . ....+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++...
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 99985 45554432 2 236789999999999999999999975 8 999999999999999999999999998654
Q ss_pred CcccccccCCCCCCcccccccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSE---PSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
.... ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+
T Consensus 159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 159 VDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred ccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 3222 12233578999999999776 68899999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=269.10 Aligned_cols=205 Identities=25% Similarity=0.386 Sum_probs=169.4
Q ss_pred eeeccc--CcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLG--SYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G--~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
.+||+| +||+||++.+ .++.||+|++..........+.+.+|+.+++.++||||++++++|..++.+++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999987 578899999876655555667889999999999999999999999999999999999999
Q ss_pred CchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc------
Q 038211 460 GSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY------ 532 (605)
Q Consensus 460 gsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~------ 532 (605)
++|.+++.+.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++++||+.+.......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 99999887653 45889999999999999999999999 9999999999999999999999997543211100
Q ss_pred -ccccCCCCCCcccccccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 533 -LTAKSGRGTPQWMAPEVLRSE--PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 533 -~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.......++..|+|||++.+. .++.++|||||||++|+|++|+.||.+....+.+..+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 222 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK 222 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHH
Confidence 001112346679999999774 4688999999999999999999999987655544443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=264.06 Aligned_cols=220 Identities=33% Similarity=0.551 Sum_probs=183.3
Q ss_pred ccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhC--CCCCeeeEEEEEeeCC----ee
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL--RHPNVLLFMGAVASQE----RL 450 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l--~h~niv~~~~~~~~~~----~~ 450 (605)
....+++++||+|.||.||+|..+++.||||++.. ...+.+++|.+|.+.. +|+||+++++.-.... .+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 45678889999999999999999999999999844 3456788899888776 7999999998876544 79
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCceeccCCCCCEEEcCCCcEEEEeec
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRN-------PPIVHRDLKSSNLLVDKNWTVKVGDFG 523 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-------~~iiH~Dik~~Nill~~~~~vkl~Dfg 523 (605)
+||++|.+.|+|.++|.. ..+++....+++..+++||+|||+.- ++|+|||||..||||..+++..|+|||
T Consensus 284 wLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999999988 57999999999999999999999753 569999999999999999999999999
Q ss_pred CCcccCccc--ccccCCCCCCcccccccccCCCC-C-----chhHHHHHHHHHHHHHcCC------------CCCC----
Q 038211 524 LSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPS-N-----EKSDVFSFGVILWELVTAS------------IPWN---- 579 (605)
Q Consensus 524 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~-----~~~DiwSlG~il~el~~g~------------~Pf~---- 579 (605)
+|..+.... ......+||.+|||||++.+.-. . .+.||||+|.+||||++.- .||.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 997654322 22233589999999999977432 1 2579999999999999843 3454
Q ss_pred -CCCHHHHHHHhccCCCccCCCCCC
Q 038211 580 -NLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 580 -~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
+.+..++-..+...+.|+.||+.+
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W 466 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAW 466 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhh
Confidence 345677778887889999999864
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=271.16 Aligned_cols=210 Identities=23% Similarity=0.398 Sum_probs=173.8
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeC--Cee
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQ--ERL 450 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~--~~~ 450 (605)
..++|++.+.||+|+||.||+|.+ .++.+++|.+............+.+|+.+++.+ +||||++++++|... ..+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 347899999999999999999987 467799998765433333445677899999999 999999999988653 468
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
++||||+. ++|..++... .+++..+..++.||+.||.|||++| |+|+||||+|||++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 99999996 5898888663 7788888999999999999999999 99999999999999999999999999875432
Q ss_pred cc-----ccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 531 TY-----LTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 531 ~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.. .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||......+.+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~ 225 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI 225 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 22 12233468999999998765 45688999999999999999999999887665554443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=264.17 Aligned_cols=205 Identities=27% Similarity=0.428 Sum_probs=175.4
Q ss_pred ceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEec
Q 038211 380 LQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFL 457 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~ 457 (605)
|....+||+|+||.||++.. ++..+|+|.+.... ......+.+|+.+++.++|+||++++++|...+..+++|||+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 34457899999999999977 46779999874322 234566889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccC
Q 038211 458 PRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKS 537 (605)
Q Consensus 458 ~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~ 537 (605)
++++|.+++.. ..+++..+..++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++............
T Consensus 100 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 100 EGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 99999887754 46889999999999999999999999 999999999999999999999999998654433223334
Q ss_pred CCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 538 GRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 538 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
..+++.|++||.+.+..++.++|+||||+++|+|++|..||...+..+.+..+
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~ 228 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 56889999999998888899999999999999999999999987776666655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=260.54 Aligned_cols=207 Identities=29% Similarity=0.363 Sum_probs=174.1
Q ss_pred ceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhC---CCCCeeeEEEEEeeCCe-----
Q 038211 380 LQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL---RHPNVLLFMGAVASQER----- 449 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l---~h~niv~~~~~~~~~~~----- 449 (605)
|++.++||+|+||.||++.++ ++.+|+|++............+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678999999999999999874 67899999875443333344566788877766 59999999999988776
Q ss_pred eEEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 450 LGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
++++|||++ ++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 999999996 47888887643 36899999999999999999999999 999999999999999999999999998765
Q ss_pred CcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
..... .....+++.|+|||.+.+..++.++|+|||||++|+|++|++||...+..+.+.++
T Consensus 158 ~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~ 218 (287)
T cd07838 158 SFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI 218 (287)
T ss_pred cCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH
Confidence 33221 12334788999999999988999999999999999999999999988877666655
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=260.22 Aligned_cols=221 Identities=27% Similarity=0.433 Sum_probs=181.3
Q ss_pred CceEeeeecccCcEEEEEEEECC--cceEEEEeeccc---cchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWNG--SDVAVKVYFGSE---YIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~~--~~~avKv~~~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
+|.+.++||+|+||.||++.+.. ..+++|+++... ........+.+|+.+++.++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58899999999999999998753 346666654322 2223344567899999999999999999999988899999
Q ss_pred EEecCCCchHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 454 TEFLPRGSLFKTLHK---NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.| ++|+||+|+||+++. +.++|+|||.+.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999988864 2357899999999999999999999999 999999999999975 5799999999876544
Q ss_pred ccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
.........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+. .+..+.+|..+
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 229 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETY 229 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchh
Confidence 3333445568899999999988888999999999999999999999999887777777763 33344455444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=266.18 Aligned_cols=204 Identities=25% Similarity=0.321 Sum_probs=172.3
Q ss_pred ceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 380 LQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
+.+++.+|.|+++.||++..+++.||||++............+.+|+.+++.++|+||++++++|...+..+++|||+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 45566677777777777777889999999987654555677899999999999999999999999999999999999999
Q ss_pred CchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc------
Q 038211 460 GSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY------ 532 (605)
Q Consensus 460 gsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~------ 532 (605)
++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||.+.......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999998764 346889999999999999999999999 9999999999999999999999999885432111
Q ss_pred -ccccCCCCCCcccccccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHH
Q 038211 533 -LTAKSGRGTPQWMAPEVLRSE--PSNEKSDVFSFGVILWELVTASIPWNNLNLMQ 585 (605)
Q Consensus 533 -~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~ 585 (605)
.......++..|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~ 217 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 112234578889999998763 57889999999999999999999998866543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=262.46 Aligned_cols=208 Identities=27% Similarity=0.394 Sum_probs=179.7
Q ss_pred ceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEec
Q 038211 380 LQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFL 457 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~ 457 (605)
|++.+.||+|+||.||+|... ++.+++|++..........+.+.+|+.+++.++|+|++++++++...+.+++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 667889999999999999874 678999998776433444566788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccC
Q 038211 458 PRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKS 537 (605)
Q Consensus 458 ~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~ 537 (605)
+ ++|.+++.+....+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||.+............
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 6 5899999876567999999999999999999999999 999999999999999999999999998765544333334
Q ss_pred CCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 538 GRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 538 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
..++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+....+..+
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 4567889999998776 7889999999999999999999999987766655554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=267.27 Aligned_cols=209 Identities=23% Similarity=0.332 Sum_probs=172.3
Q ss_pred cCce-EeeeecccCcEEEEEEEE--CCcceEEEEeeccccchh------------hhhhHHHHHHHHHhCCCCCeeeEEE
Q 038211 378 EDLQ-LGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEG------------TLKNYQKEIDIIKKLRHPNVLLFMG 442 (605)
Q Consensus 378 ~~~~-~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~------------~~~~~~~E~~il~~l~h~niv~~~~ 442 (605)
++|. +.+.||.|+||+||+|.+ .++.||||++........ ....+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 457899999999999986 467799999865432210 0124678999999999999999999
Q ss_pred EEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEee
Q 038211 443 AVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDF 522 (605)
Q Consensus 443 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Df 522 (605)
++..++..++||||+. ++|.+++... ..+++..+..++.||+.||+|||+.| ++|+||+|+||+++.++.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEECCc
Confidence 9999999999999996 6888888654 56899999999999999999999999 999999999999999999999999
Q ss_pred cCCcccCc--------------ccccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 038211 523 GLSSLKNA--------------TYLTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587 (605)
Q Consensus 523 g~a~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~ 587 (605)
|++..... .........+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99875431 11112233468899999998764 3688999999999999999999999988876665
Q ss_pred HHh
Q 038211 588 GVV 590 (605)
Q Consensus 588 ~~I 590 (605)
..|
T Consensus 244 ~~i 246 (335)
T PTZ00024 244 GRI 246 (335)
T ss_pred HHH
Confidence 554
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=266.30 Aligned_cols=206 Identities=24% Similarity=0.334 Sum_probs=168.7
Q ss_pred CceEeeeecccCcEEEEEEEEC----CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeC----Ce
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWN----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQ----ER 449 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~----~~ 449 (605)
+|++.+.||+|+||.||++.+. +..||+|++..........+.+.+|+.+++.+ .||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4889999999999999999875 45799998765432333456678899999999 599999999875432 45
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
.+++++|+. ++|...+... ..+++..++.++.||+.||+|||+.| |+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 789999984 6888888654 67899999999999999999999999 9999999999999999999999999997543
Q ss_pred cccc----cccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 038211 530 ATYL----TAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVG 588 (605)
Q Consensus 530 ~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~ 588 (605)
.... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+....+.
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~ 220 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN 220 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHH
Confidence 2211 1223468999999998766 467899999999999999999999998876544443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=273.74 Aligned_cols=202 Identities=26% Similarity=0.390 Sum_probs=172.7
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~l 452 (605)
..+.|.+...+|.|+|+.|-.+.+ +++.+++|++.+.. ....+|+.++... +||||+++++.+.+..+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeee
Confidence 467899999999999999998876 56679999986652 2234677666655 79999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE-cCCCcEEEEeecCCcccCcc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV-DKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill-~~~~~vkl~Dfg~a~~~~~~ 531 (605)
|||.+.|+-|.+.+.... .+ ...+..|+++|+.|+.|||++| ||||||||+|||+ +..|+++|+|||.++.....
T Consensus 394 v~e~l~g~ell~ri~~~~-~~-~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKP-EF-CSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eehhccccHHHHHHHhcc-hh-HHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999998888776642 22 2677789999999999999999 9999999999999 68999999999999876654
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHh
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNL-MQVVGVV 590 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~-~~~~~~I 590 (605)
..+.+-|..|.|||++...+|+.++||||||++||+|++|+.||..... .++..+|
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i 526 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI 526 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh
Confidence 3445679999999999999999999999999999999999999987554 5888887
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=264.29 Aligned_cols=200 Identities=26% Similarity=0.414 Sum_probs=170.0
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee-CCeeEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS-QERLGIV 453 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~lv 453 (605)
.++|++.++||.|+||.||++.+ .+..+|+|++.+........+.+.+|+.+++.++||||++++++|.. ....+++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 36799999999999999999986 46679999876544334445677899999999999999999999875 4678999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
|||+ +++|..++.. ..+++..+..++.||+.||+|||+.+ |+|+||+|+|||++.++.++|+|||.+......
T Consensus 89 ~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-- 161 (328)
T cd07856 89 TELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQ-- 161 (328)
T ss_pred eehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCCC--
Confidence 9999 6688887764 45788888899999999999999999 999999999999999999999999998754322
Q ss_pred cccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q 038211 534 TAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLM 584 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~ 584 (605)
.....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+..
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~ 212 (328)
T cd07856 162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV 212 (328)
T ss_pred -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 233457889999998866 56889999999999999999999999876653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=260.80 Aligned_cols=213 Identities=26% Similarity=0.384 Sum_probs=174.7
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCe
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQER 449 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~ 449 (605)
..+..++|++.+.||.|+||.||++.+. ++.+|||.+...... .....+.+|+.++... .|+||+++++++.....
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 3466789999999999999999999986 788999998764332 2344556677766666 59999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH-RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
++++|||+ +++|.+++......+++..+..++.||+.||+|||+ .+ |+||||+|+||+++.++.++|+|||++...
T Consensus 89 ~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 89 VFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99999998 457877776655689999999999999999999997 58 999999999999999999999999998654
Q ss_pred CcccccccCCCCCCcccccccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHh
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEP----SNEKSDVFSFGVILWELVTASIPWNNLNL-MQVVGVV 590 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~el~~g~~Pf~~~~~-~~~~~~I 590 (605)
..... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||..... .+.+..+
T Consensus 166 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 231 (296)
T cd06618 166 VDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231 (296)
T ss_pred cCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH
Confidence 32221 12235788999999987654 68899999999999999999999987433 4555555
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=267.16 Aligned_cols=204 Identities=25% Similarity=0.388 Sum_probs=170.5
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC------e
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE------R 449 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------~ 449 (605)
.+|.+.+.||+|+||.||+|.+ +++.+|+|++.+..........+.+|+.+++.++||||++++++|.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 5899999999999999999986 4778999988764433334456789999999999999999999987542 4
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+++|+||+. .+|..++. ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.++|+|||+++...
T Consensus 95 ~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 689999995 46655542 46889999999999999999999999 9999999999999999999999999987543
Q ss_pred cccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.. .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~ 227 (342)
T cd07879 169 AE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 227 (342)
T ss_pred CC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 22 233467889999999876 45788999999999999999999999987766555544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=262.36 Aligned_cols=207 Identities=31% Similarity=0.452 Sum_probs=175.3
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
..|...+.||+|+||.||++.+ .+..+++|.+..... .......+.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 4588889999999999999987 456799998865322 2334556788999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+. ++|.+.+......+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 9996 5887777665567899999999999999999999999 999999999999999999999999998654322
Q ss_pred ccCCCCCCccccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 535 AKSGRGTPQWMAPEVLR---SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
....+++.|+|||.+. ...++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 227 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh
Confidence 2345789999999975 3457889999999999999999999998887766666553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=256.47 Aligned_cols=221 Identities=33% Similarity=0.614 Sum_probs=182.7
Q ss_pred ccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhC--CCCCeeeEEEEEeeC----Cee
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL--RHPNVLLFMGAVASQ----ERL 450 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l--~h~niv~~~~~~~~~----~~~ 450 (605)
..+..+.+.||+|.||.||+|.|.|..||||++... +...+.+|.+|.+.. +|+||+.+++.-..+ ..+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 467899999999999999999999999999998654 245678889998876 999999999876543 369
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-----C-CCceeccCCCCCEEEcCCCcEEEEeecC
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR-----N-PPIVHRDLKSSNLLVDKNWTVKVGDFGL 524 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-----~-~~iiH~Dik~~Nill~~~~~vkl~Dfg~ 524 (605)
|||++|-+.|||+|+|.+ ..++.+...+++..++.||++||.. | |.|.|||||..|||+..+|..-|+|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 999999999999999998 6789999999999999999999954 2 5599999999999999999999999999
Q ss_pred CcccCcc----cccccCCCCCCcccccccccCCCC------CchhHHHHHHHHHHHHHc----------CCCCCCC----
Q 038211 525 SSLKNAT----YLTAKSGRGTPQWMAPEVLRSEPS------NEKSDVFSFGVILWELVT----------ASIPWNN---- 580 (605)
Q Consensus 525 a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DiwSlG~il~el~~----------g~~Pf~~---- 580 (605)
|-..... .......+||.+|||||++...-. -..+||||||.++||++. -++||.+
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9543322 122345679999999999854321 235899999999999886 3678864
Q ss_pred -CCHHHHHHHhccCCCccCCCCCCC
Q 038211 581 -LNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 581 -~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.+.+++...|=..+.||.||..+.
T Consensus 443 DPs~eeMrkVVCv~~~RP~ipnrW~ 467 (513)
T KOG2052|consen 443 DPSFEEMRKVVCVQKLRPNIPNRWK 467 (513)
T ss_pred CCCHHHHhcceeecccCCCCCcccc
Confidence 456788887777888999997654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=268.48 Aligned_cols=206 Identities=24% Similarity=0.361 Sum_probs=175.8
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe-----
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER----- 449 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~----- 449 (605)
.++|++.+.||+|+||.||+|.+. +..||+|++..........+.+.+|+.+++.++|+||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 468999999999999999999884 6679999886543334445667889999999999999999988866554
Q ss_pred -eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 450 -LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 450 -~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
.++|+||+ +++|.+++.. ..+++..++.++.||+.||+|||+.| |+||||||+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 6799888875 56899999999999999999999999 999999999999999999999999998765
Q ss_pred CcccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..|
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i 228 (343)
T cd07851 169 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228 (343)
T ss_pred ccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 332 234467889999999865 35788999999999999999999999988777666654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=264.82 Aligned_cols=206 Identities=24% Similarity=0.426 Sum_probs=168.9
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC--------
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ-------- 447 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-------- 447 (605)
.+|.+.+.||.|+||.||+|.++ +..|++|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 68999999999999999999874 67799998765432 3456688899999999999999999876543
Q ss_pred ------CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC-CCcEEEE
Q 038211 448 ------ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK-NWTVKVG 520 (605)
Q Consensus 448 ------~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~-~~~vkl~ 520 (605)
..+++||||++ ++|.+++.. ..+++..++.++.||+.||+|||+.| |+||||||+||+++. ++.++|+
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEEC
Confidence 35789999996 588887754 46889999999999999999999999 999999999999974 5678999
Q ss_pred eecCCcccCcccc---cccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 521 DFGLSSLKNATYL---TAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 521 Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
|||++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~ 231 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999875432211 1122357889999998754 55788999999999999999999999987765555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=274.38 Aligned_cols=220 Identities=31% Similarity=0.558 Sum_probs=192.4
Q ss_pred ceEeeeecccCcEEEEEEEE--CC----cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 380 LQLGEEIGLGSYAVVYRGIW--NG----SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~--~~----~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
.+..++||+|+||+||+|.+ ++ -+||+|++.... .......+.+|+-+|..++|||++++++++.... +.||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 45568999999999999987 33 358888876543 3344577899999999999999999999998765 8899
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
++|+++|.|.++++.+...+..+..+.|..||++|+.|||+++ ++||||-.+|||+..-.++|+.|||+++.......
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999999999899999999999999999999999999 99999999999999999999999999998754433
Q ss_pred c--ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 534 T--AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 534 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
. .....-.+-|||-|.++...|+.++|||||||++||++| |..||++....++-..+. .+.|+.-|+.++
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-~geRLsqPpiCt 926 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-KGERLSQPPICT 926 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-ccccCCCCCCcc
Confidence 3 334455778999999999999999999999999999998 999999999999999986 566799998764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=267.22 Aligned_cols=200 Identities=28% Similarity=0.435 Sum_probs=173.8
Q ss_pred cccCceEeeeecccCcEEEEEEEECCc--ceEEEEeeccccchh------hhhhHHHHHHHHHhCC---CCCeeeEEEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWNGS--DVAVKVYFGSEYIEG------TLKNYQKEIDIIKKLR---HPNVLLFMGAV 444 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~~~--~~avKv~~~~~~~~~------~~~~~~~E~~il~~l~---h~niv~~~~~~ 444 (605)
...+|..+++||.|+||.|++|.++.. .|+||.+.+.+...+ .+-.+--|+.||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 346799999999999999999998644 488998888764322 2334557999999997 99999999999
Q ss_pred eeCCeeEEEEEecC-CCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeec
Q 038211 445 ASQERLGIVTEFLP-RGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFG 523 (605)
Q Consensus 445 ~~~~~~~lv~e~~~-ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg 523 (605)
++++++||+||.-. |-+|++++..+ ..+++..+..++.|++.|+++||+.| |||||||-+|+.++.+|-+||+|||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeecc
Confidence 99999999999763 55899999876 78999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCcccccccCCCCCCcccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 524 LSSLKNATYLTAKSGRGTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 524 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
.|...... ....++||..|.|||++.|..| +..-|||+||++||.+.....||.+
T Consensus 716 saa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 98654432 2356789999999999999998 5678999999999999999999975
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=249.92 Aligned_cols=215 Identities=22% Similarity=0.325 Sum_probs=180.9
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee-------
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS------- 446 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~------- 446 (605)
....|.-..+||+|.||.||+|+. .++.||+|++..++-.+.......+|+++|..++|+|++.+++.+..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 345777788999999999999876 46678988776554445566678899999999999999998877643
Q ss_pred -CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCC
Q 038211 447 -QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525 (605)
Q Consensus 447 -~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a 525 (605)
...+|+||.+| ..+|..++......++...+..++.++..||.|+|... |+|||+|+.|+|++.+|.+||+|||++
T Consensus 95 ~r~t~ylVf~~c-ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 95 DRATFYLVFDFC-EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccceeeeeHHHh-hhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeeccccc
Confidence 23589999999 56899999887788999999999999999999999999 999999999999999999999999999
Q ss_pred cccCccc----ccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccC
Q 038211 526 SLKNATY----LTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFM 593 (605)
Q Consensus 526 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~ 593 (605)
+.+.... ......+-|.+|++||.+.|. .|+++.|||+.||+|.||++|.+-|++.+..+.+..|+..
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 6543221 123344569999999999885 5899999999999999999999999998888888777543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=254.97 Aligned_cols=205 Identities=23% Similarity=0.343 Sum_probs=171.5
Q ss_pred ceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCeeEEEEEe
Q 038211 380 LQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
|.+.+.||+|+||+||+|.. .++.++||.+...... .......+|+..++.++ |+||+++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 67889999999999999987 4567999987654322 12233457899999998 99999999999999999999999
Q ss_pred cCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 457 LPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 457 ~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
+ +++|.+++.... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~ 155 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PY 155 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCC-Cc
Confidence 9 789988887753 57899999999999999999999999 9999999999999999999999999987654322 22
Q ss_pred cCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 038211 536 KSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGV 589 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~ 589 (605)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|++||...+....+..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~ 210 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYK 210 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHH
Confidence 33457889999998854 4578899999999999999999999987765544443
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=249.09 Aligned_cols=131 Identities=23% Similarity=0.395 Sum_probs=113.1
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCC-----C---CCeeeEEEEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-----H---PNVLLFMGAV 444 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-----h---~niv~~~~~~ 444 (605)
+...+|.+.++||.|.|++||+|.+. .+.||+||.+.. +...+....|+.+|+.++ | .+||++++.|
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 33489999999999999999999984 566999998654 345677889999999993 2 4699999999
Q ss_pred ee----CCeeEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeccCCCCCEEE
Q 038211 445 AS----QERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHR-NPPIVHRDLKSSNLLV 511 (605)
Q Consensus 445 ~~----~~~~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~-~~~iiH~Dik~~Nill 511 (605)
.. +.++|||+|++ |.+|..++... .+.++...+..|++||+.||.|||.. | |||.||||+|||+
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 75 45899999999 88999998775 57899999999999999999999966 6 9999999999998
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-31 Score=249.67 Aligned_cols=211 Identities=28% Similarity=0.403 Sum_probs=173.4
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC-----ee
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE-----RL 450 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~ 450 (605)
.|.+-.+.||.|+||+||-+.+ +|+.+++|.+..-...-...+++.+|+.+|.-++|.|++..++..+... .+
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 4556678999999999998876 6888999976543322344577889999999999999999988876542 36
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
|+++|.+ ..+|...+-. .+.++...+.-+++||+.||.|||+.+ |.||||||.|+|++.+-.+||||||+++....
T Consensus 133 YV~TELm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccch
Confidence 7788888 4567665543 478899999999999999999999999 99999999999999999999999999987654
Q ss_pred cccccc-CCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhcc
Q 038211 531 TYLTAK-SGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGF 592 (605)
Q Consensus 531 ~~~~~~-~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~ 592 (605)
...... ..+-|.+|.|||++.|. .|+.++||||+|||+.||+..+..|...++.+.+..|-.
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd 272 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID 272 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH
Confidence 332222 22458899999999985 579999999999999999999999999998888777643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-31 Score=262.47 Aligned_cols=215 Identities=25% Similarity=0.310 Sum_probs=182.3
Q ss_pred CCccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCC------CCCeeeEEEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR------HPNVLLFMGAV 444 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~------h~niv~~~~~~ 444 (605)
+++.-.+|.+....|+|-|++|.+|.+ .+..||||++..... ..+.=+.|++||++|. --++++++..|
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 456667899999999999999999987 467899999976543 3345578999999995 34789999999
Q ss_pred eeCCeeEEEEEecCCCchHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC-CcEEEEe
Q 038211 445 ASQERLGIVTEFLPRGSLFKTLHKNY--QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN-WTVKVGD 521 (605)
Q Consensus 445 ~~~~~~~lv~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~-~~vkl~D 521 (605)
.+.+++|||||.+ ..+|.+++.+.. -.+....+..|+.||..||..|-..| |+|.||||+|||+++. ..+||||
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeecc
Confidence 9999999999999 679999998753 45778899999999999999999999 9999999999999875 5689999
Q ss_pred ecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCC
Q 038211 522 FGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDR 595 (605)
Q Consensus 522 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~ 595 (605)
||.|........ ..+.-+..|.|||++.|.+|+...|+||+||+||||.||+..|.+..+.+++.......+
T Consensus 581 fGSA~~~~enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 581 FGSASFASENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred Cccccccccccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 999987654432 233346789999999999999999999999999999999999999998888877633333
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=245.80 Aligned_cols=180 Identities=23% Similarity=0.252 Sum_probs=153.9
Q ss_pred cCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCCchHHHH
Q 038211 389 GSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTL 466 (605)
Q Consensus 389 G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ggsL~~~l 466 (605)
|.||+||++.+ +++.||+|.+.... ...+|...+....||||+++++++...+..+++|||+++++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999987 56779999986542 1234455555667999999999999999999999999999999998
Q ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCCCCCcccc
Q 038211 467 HKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMA 546 (605)
Q Consensus 467 ~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~a 546 (605)
.+. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+...... .....++..|+|
T Consensus 77 ~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~a 150 (237)
T cd05576 77 SKF-LNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCA 150 (237)
T ss_pred HHh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccC
Confidence 765 56899999999999999999999999 999999999999999999999999987554322 123345778999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 547 PEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 547 PE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
||.+.+..++.++|+||+||++|+|++|+.||...
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 99998888899999999999999999999998653
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=275.13 Aligned_cols=229 Identities=33% Similarity=0.552 Sum_probs=194.8
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEEC---------CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEE
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWN---------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFM 441 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~---------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~ 441 (605)
.+++..+...+.+.||+|.||.|++|... ...||||.++..... ...+.+..|+.+|+.+ +|+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 45666677788889999999999998642 334899987765544 6778899999999999 699999999
Q ss_pred EEEeeCCeeEEEEEecCCCchHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCC
Q 038211 442 GAVASQERLGIVTEFLPRGSLFKTLHKNY---------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKS 506 (605)
Q Consensus 442 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~ 506 (605)
+++...+.+++|+||+..|+|..++.... ..++......++.||+.|++||++.. +|||||-+
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAa 446 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAA 446 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhh
Confidence 99999899999999999999999998765 34888999999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEeecCCcccCccc-ccccCCCC--CCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 038211 507 SNLLVDKNWTVKVGDFGLSSLKNATY-LTAKSGRG--TPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLN 582 (605)
Q Consensus 507 ~Nill~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~ 582 (605)
+|||+..+..+||+|||+|+...... .......+ +..|||||.+....|+.++||||+||+|||+++ |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999998543322 22122222 456999999999999999999999999999999 999999976
Q ss_pred -HHHHHHHhccCCCccCCCCCCC
Q 038211 583 -LMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 583 -~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
..+++..+ +.+.|++-|+.++
T Consensus 527 ~~~~l~~~l-~~G~r~~~P~~c~ 548 (609)
T KOG0200|consen 527 PTEELLEFL-KEGNRMEQPEHCS 548 (609)
T ss_pred cHHHHHHHH-hcCCCCCCCCCCC
Confidence 67777766 4788999998875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=236.14 Aligned_cols=217 Identities=33% Similarity=0.480 Sum_probs=181.4
Q ss_pred ceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEec
Q 038211 380 LQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFL 457 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~ 457 (605)
|.+.+.||.|++|.||++... +..+++|.+...... ...+.+.+|+..++.++|+|++++++++......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 567899999999999999885 477999998765432 24677889999999999999999999999889999999999
Q ss_pred CCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc-cccc
Q 038211 458 PRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY-LTAK 536 (605)
Q Consensus 458 ~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~-~~~~ 536 (605)
++++|.+++......+++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+....... ....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 999999998875333889999999999999999999999 9999999999999999999999999987654332 1223
Q ss_pred CCCCCCcccccccc-cCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CCH-HHHHHHhccCCCccCCCC
Q 038211 537 SGRGTPQWMAPEVL-RSEPSNEKSDVFSFGVILWELVTASIPWNN-LNL-MQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 537 ~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~~g~~Pf~~-~~~-~~~~~~I~~~~~~~~~P~ 601 (605)
...++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .++ .++...| ..+.+.+++
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~ 223 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW--SFGVPLLWE 223 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH--hcCCccccc
Confidence 34578899999998 666678899999999999999999999988 454 4777777 344444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=228.58 Aligned_cols=192 Identities=21% Similarity=0.394 Sum_probs=162.4
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeC--Cee
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQ--ERL 450 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~--~~~ 450 (605)
..++|++.+++|+|-|+.|+.|.. +...++||+++.- .-+.+.+|+.||+.+. ||||+++++...++ ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 457999999999999999999974 6677899987543 2466889999999996 99999999999775 457
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC-CCcEEEEeecCCcccC
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK-NWTVKVGDFGLSSLKN 529 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~-~~~vkl~Dfg~a~~~~ 529 (605)
.||+||++..+...+. ..++.-.++.++.||+.||+|+|+.| |+|||+||.|+++|. ...++|+|+|+|.+..
T Consensus 111 aLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 8999999887775554 45778888999999999999999999 999999999999986 4689999999998764
Q ss_pred cccccccCCCCCCcccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTASIPWN 579 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~Pf~ 579 (605)
.. ....-.+.+..|.-||.+..-+ |+.+-|+|||||+|..|++.+-||-
T Consensus 185 p~-~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 185 PG-KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred CC-ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 32 2333445688899999998754 6888999999999999999999974
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-29 Score=258.83 Aligned_cols=216 Identities=31% Similarity=0.465 Sum_probs=193.1
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.++|+++..+|.|+||.||++++ +++..|+|+++... .....-++.|+-+++..+|||||.|++.+...+.+|++|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 37899999999999999999987 57778999987653 233556778999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
|||.||+|.+..+-. +.+++.++..++++.+.+|+|||+.| -+|||||-.|||+++.|.+|++|||.+-........
T Consensus 92 EycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred EecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 999999998877654 88999999999999999999999999 999999999999999999999999999888777788
Q ss_pred ccCCCCCCcccccccc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCcc
Q 038211 535 AKSGRGTPQWMAPEVL---RSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRL 597 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~ 597 (605)
...+.|||.|||||+. +...|...+|+|++|+...|+..-++|-.+.-+++.+....+.+.++
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qp 234 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQP 234 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCC
Confidence 8899999999999986 45568899999999999999999999999999999998886665443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=250.20 Aligned_cols=204 Identities=25% Similarity=0.343 Sum_probs=152.8
Q ss_pred ccccCceEeeeecccCcEEEEEEEE------------------CCcceEEEEeeccccc------------hhhhhhHHH
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW------------------NGSDVAVKVYFGSEYI------------EGTLKNYQK 424 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~------------------~~~~~avKv~~~~~~~------------~~~~~~~~~ 424 (605)
+..++|.+.++||+|+||+||+|.. .++.||||.+...... ....+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4567999999999999999999863 2456999987543211 011223345
Q ss_pred HHHHHHhCCCCCe-----eeEEEEEee--------CCeeEEEEEecCCCchHHHHHhhc---------------------
Q 038211 425 EIDIIKKLRHPNV-----LLFMGAVAS--------QERLGIVTEFLPRGSLFKTLHKNY--------------------- 470 (605)
Q Consensus 425 E~~il~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~ggsL~~~l~~~~--------------------- 470 (605)
|+.++.+++|.++ +.++++|.. .+..+|||||+++++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777766554 566666642 356899999999999999886431
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc-ccccCCCCCCccccc
Q 038211 471 --QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY-LTAKSGRGTPQWMAP 547 (605)
Q Consensus 471 --~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aP 547 (605)
..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .......+|+.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356678889999999999999999 9999999999999999999999999986543221 112223458999999
Q ss_pred ccccCCCC----------------------CchhHHHHHHHHHHHHHcCCC-CCCC
Q 038211 548 EVLRSEPS----------------------NEKSDVFSFGVILWELVTASI-PWNN 580 (605)
Q Consensus 548 E~~~~~~~----------------------~~~~DiwSlG~il~el~~g~~-Pf~~ 580 (605)
|.+..... ..+.|+||+||++|+|++|.. ||.+
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 99864321 124699999999999999986 8865
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=280.71 Aligned_cols=185 Identities=26% Similarity=0.420 Sum_probs=156.5
Q ss_pred CceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
.|...++||+|+||.||+|.+ .+..||+|.+..... ....|+.++++++|||||++++++.+++..++||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 456667899999999999986 577799998754321 123568899999999999999999999999999999
Q ss_pred cCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH---HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 457 ~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
+++|+|.++++. +++..+..++.||+.||+||| +.+ |+||||||+||+++.++..++. ||.......
T Consensus 765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPA--VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCC--eecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 999999999853 788999999999999999999 456 9999999999999998888775 665543211
Q ss_pred cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 1233678999999999999999999999999999999999999953
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=229.02 Aligned_cols=204 Identities=24% Similarity=0.345 Sum_probs=172.3
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC------e
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE------R 449 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------~ 449 (605)
.+|.-++.+|.|.- .|..+.+ .+++|++|............++..+|+.++..+.|+||++++.+|.... .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 57888889999988 6666655 5888999987655333445677889999999999999999999996433 4
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
.|+|||++ ..+|...++. .++-..+..++.|++.|+.|||+.| |+||||||+||++..+..+|+.|||+|+..+
T Consensus 96 ~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhcccC
Confidence 88999999 5688888873 4778889999999999999999999 9999999999999999999999999998765
Q ss_pred cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGV 589 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~ 589 (605)
.. ...+..+.|..|.|||++.+..|...+||||+||++.||++|...|.+.+-..-..+
T Consensus 170 ~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~k 228 (369)
T KOG0665|consen 170 TD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNK 228 (369)
T ss_pred cc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHH
Confidence 44 344566789999999999999999999999999999999999999998765433333
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=257.03 Aligned_cols=199 Identities=18% Similarity=0.265 Sum_probs=142.6
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEE----
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGA---- 443 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~---- 443 (605)
.+..++|.+.++||+|+||.||+|.+. +..||+|.+..... .+....| .++...+.++..+...
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 456689999999999999999999874 56799998654221 1111111 1122222222222221
Q ss_pred --EeeCCeeEEEEEecCCCchHHHHHhhcCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCceec
Q 038211 444 --VASQERLGIVTEFLPRGSLFKTLHKNYQA-------------------LDIKRRLRMALDVARGMNYLHHRNPPIVHR 502 (605)
Q Consensus 444 --~~~~~~~~lv~e~~~ggsL~~~l~~~~~~-------------------~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~ 502 (605)
......+++||||+.+++|.+++...... .....+..++.||+.||.|||+++ |+||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHR 279 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHR 279 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 23456799999999999999988754211 123446679999999999999999 9999
Q ss_pred cCCCCCEEEcC-CCcEEEEeecCCcccCcc-cccccCCCCCCcccccccccCCC----------------------CCch
Q 038211 503 DLKSSNLLVDK-NWTVKVGDFGLSSLKNAT-YLTAKSGRGTPQWMAPEVLRSEP----------------------SNEK 558 (605)
Q Consensus 503 Dik~~Nill~~-~~~vkl~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~----------------------~~~~ 558 (605)
||||+|||++. ++.+||+|||+|+..... ........+|+.|+|||.+.... ++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999985 689999999999754322 22334567899999999764322 2345
Q ss_pred hHHHHHHHHHHHHHcCCCCCCC
Q 038211 559 SDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 559 ~DiwSlG~il~el~~g~~Pf~~ 580 (605)
+|||||||+||||+++..|++.
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~ 381 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDS 381 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCch
Confidence 6999999999999998877654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=221.48 Aligned_cols=214 Identities=21% Similarity=0.317 Sum_probs=185.5
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~ 451 (605)
+..-.|+++++||+|+||.+++|.. ++.+||||.-.. ....-++..|.+..+.| ..++|..+|.+...+.+-.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccc----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 4556899999999999999999864 799999997322 23445678899999999 5799999998888888889
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC-----CCcEEEEeecCCc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK-----NWTVKVGDFGLSS 526 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~-----~~~vkl~Dfg~a~ 526 (605)
||+|++ |.+|++++.-+...++...+.-++.|++.-++|+|++. +|+|||||+|+||.. ...|.++|||+|+
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 999999 89999999998899999999999999999999999999 999999999999963 3468999999997
Q ss_pred ccC-------cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHhccCCC
Q 038211 527 LKN-------ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL---NLMQVVGVVGFMDR 595 (605)
Q Consensus 527 ~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~---~~~~~~~~I~~~~~ 595 (605)
... .+...+.+..||.+||+-..+.|.+.+.+.|+-|||-+++.++-|.+||.++ ++.+-+++|+..+.
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr 256 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR 256 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence 643 3445566777999999999999999999999999999999999999999874 56788888875443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=224.91 Aligned_cols=197 Identities=34% Similarity=0.535 Sum_probs=169.8
Q ss_pred CcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCCchHHHHH
Q 038211 390 SYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLH 467 (605)
Q Consensus 390 ~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~ 467 (605)
+||.||++.+. +..+++|++........ .+.+.+|+..++.++|+|++++++++......++++||+.+++|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999885 57799999866543221 5778899999999999999999999999899999999999999999987
Q ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCCCCCccccc
Q 038211 468 KNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAP 547 (605)
Q Consensus 468 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aP 547 (605)
.. ..++...++.++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|++|
T Consensus 80 ~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p 155 (244)
T smart00220 80 KR-GRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP 155 (244)
T ss_pred hc-cCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence 65 33889999999999999999999999 9999999999999999999999999987654432 23345678999999
Q ss_pred ccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhc
Q 038211 548 EVLRSEPSNEKSDVFSFGVILWELVTASIPWNN-LNLMQVVGVVG 591 (605)
Q Consensus 548 E~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~-~~~~~~~~~I~ 591 (605)
|.+.+..++.++|+||||+++|+|++|..||.. .+...+...+.
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~ 200 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG 200 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence 999888889999999999999999999999988 55566666653
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-28 Score=224.84 Aligned_cols=193 Identities=22% Similarity=0.417 Sum_probs=156.0
Q ss_pred cCceEeeeecccCcEEEEEEEECC--cceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEE-EEeeCCeeEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWNG--SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMG-AVASQERLGIV 453 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~~--~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~-~~~~~~~~~lv 453 (605)
+.|.+.+.||+|.||++.++.+.+ +.+++|.+.+.. ..+..|.+|...--.| .|.||+.-|+ .|++.+.++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 579999999999999999999865 457888765532 4567788888765555 5899997664 57888899999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc--CCCcEEEEeecCCcccCcc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD--KNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~--~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||++.|+|..-+.. ..+.+.....++.|+++|++|+|+++ +||||||.+|||+- +..+|||||||.++..+..
T Consensus 101 qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 999999999877765 56788888899999999999999999 99999999999993 3348999999998765433
Q ss_pred cccccCCCCCCcccccccccCC---C--CCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSE---P--SNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~---~--~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
... ...+..|.+||+.... . ..+.+|+|.||+++|.+++|++||+.
T Consensus 177 V~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 177 VKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred ehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 222 2236789999976432 2 25678999999999999999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-27 Score=247.06 Aligned_cols=192 Identities=31% Similarity=0.525 Sum_probs=159.2
Q ss_pred EeeeecccCcEE-EEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 382 LGEEIGLGSYAV-VYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 382 ~~~~LG~G~fg~-V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
--+.+|.|+.|+ ||+|.+.++.||||.+. .......++|+..|+.. .|||||++|+.-.+...+||..|.| .
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~ 586 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYEGREVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A 586 (903)
T ss_pred cHHHcccCCCCcEEEEEeeCCceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence 346789999875 58999999999999653 34456678999999999 6999999999999999999999999 6
Q ss_pred CchHHHHHhh--cC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC---C--CcEEEEeecCCcccCcc
Q 038211 460 GSLFKTLHKN--YQ-ALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK---N--WTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 460 gsL~~~l~~~--~~-~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~---~--~~vkl~Dfg~a~~~~~~ 531 (605)
.+|.+++... .. .......+..+.|++.||++||+.+ ||||||||.||||+. + ..++|+|||+|+.....
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 7999999763 11 1111344668899999999999999 999999999999965 2 47899999999875432
Q ss_pred ---cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCC
Q 038211 532 ---YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTA-SIPWNNL 581 (605)
Q Consensus 532 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g-~~Pf~~~ 581 (605)
.....+..||-+|+|||++.....+.++|||||||++|..++| .+||-+.
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence 2334566799999999999999888999999999999998885 9999764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=215.89 Aligned_cols=226 Identities=25% Similarity=0.387 Sum_probs=185.2
Q ss_pred ccccCceEeeeecccCcEEEEEEEECC-------cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee-
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS- 446 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~-------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~- 446 (605)
+..+++++..++-+|.||.||.|.+.. +.+.+|.++. +..+-++..+..|...+..+.|||+..+.++...
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED 359 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence 334678888899999999999997632 2356665433 3345566778899999999999999999988754
Q ss_pred CCeeEEEEEecCCCchHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEE
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKN-------YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKV 519 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl 519 (605)
....++++.++..|+|..+++.. .+.++..+...++.|++.|++|||.++ |||.||-.+|.++|+.-++||
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhheeEEe
Confidence 46788999999999999999832 245778888999999999999999999 999999999999999999999
Q ss_pred EeecCCccc-Cccccc-ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCc
Q 038211 520 GDFGLSSLK-NATYLT-AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRR 596 (605)
Q Consensus 520 ~Dfg~a~~~-~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~ 596 (605)
+|=.+++-. ...+.. ......+..||+||.+....|+.++|+|||||+||||++ |+.||...++.|+...|. -+.|
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk-dGyR 516 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK-DGYR 516 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh-ccce
Confidence 999888743 222221 122234778999999999999999999999999999999 999999999999999995 6777
Q ss_pred cCCCCCCC
Q 038211 597 LELPEGLD 604 (605)
Q Consensus 597 ~~~P~~~~ 604 (605)
+.-|-+++
T Consensus 517 laQP~NCP 524 (563)
T KOG1024|consen 517 LAQPFNCP 524 (563)
T ss_pred ecCCCCCc
Confidence 77776553
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=205.04 Aligned_cols=211 Identities=23% Similarity=0.305 Sum_probs=177.9
Q ss_pred CccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERL 450 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~ 450 (605)
-+....|.++++||.|+||.+|+|.. .|..||||+-..... .-.+..|..+.+.++ ...|..+..++....+-
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 46678999999999999999999976 688999998654332 234667888999885 46777777777888889
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC---CCcEEEEeecCCcc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK---NWTVKVGDFGLSSL 527 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~---~~~vkl~Dfg~a~~ 527 (605)
.+||+.+ |.+|++++.-....++...++-++-|++.-++|+|.++ +|||||||+|+|+.- ...+.|+|||+|+.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhh
Confidence 9999999 89999999888788999999999999999999999999 999999999999964 45799999999975
Q ss_pred cC-------cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHhc
Q 038211 528 KN-------ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN---LMQVVGVVG 591 (605)
Q Consensus 528 ~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~---~~~~~~~I~ 591 (605)
.. .+........||..|.+-..+.+.+.+.+.|+-|+|.+|..+.-|.+||++.. ..|-+++|.
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~ 237 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS 237 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH
Confidence 32 22333445579999999999999999999999999999999999999999864 456666664
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=204.78 Aligned_cols=183 Identities=40% Similarity=0.634 Sum_probs=159.6
Q ss_pred ecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCCchH
Q 038211 386 IGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLF 463 (605)
Q Consensus 386 LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ggsL~ 463 (605)
||.|++|.||++... +..+++|++....... ....+.+|+.+++.+.|++++++++++......+++||++++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999986 7889999986654321 3467889999999999999999999999989999999999989999
Q ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC-CCcEEEEeecCCcccCcccccccCCCCCC
Q 038211 464 KTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK-NWTVKVGDFGLSSLKNATYLTAKSGRGTP 542 (605)
Q Consensus 464 ~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~ 542 (605)
.++......++...++.++.+++.+|++||+.+ ++|+||+|.||+++. ++.++|+|||.+..............+..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 998775457899999999999999999999999 999999999999999 89999999999876544332233455788
Q ss_pred cccccccccCC-CCCchhHHHHHHHHHHHH
Q 038211 543 QWMAPEVLRSE-PSNEKSDVFSFGVILWEL 571 (605)
Q Consensus 543 ~y~aPE~~~~~-~~~~~~DiwSlG~il~el 571 (605)
.|++||.+... .++.+.|+|++|+++++|
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 99999999887 788899999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=221.74 Aligned_cols=201 Identities=25% Similarity=0.322 Sum_probs=168.4
Q ss_pred CceEeeeecccCcEEEEEEEECCc---ceEEEEeeccccchhhhhhHHHHHHHHHhCC----CCCeeeEEEEE-eeCCee
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWNGS---DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR----HPNVLLFMGAV-ASQERL 450 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~~~---~~avKv~~~~~~~~~~~~~~~~E~~il~~l~----h~niv~~~~~~-~~~~~~ 450 (605)
+|.+.++||+|+||.||++.+... .+|+|+......... ..+..|..++..+. .+++..+++.+ ..+..-
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 899999999999999999997553 589998665432211 15778899998886 26889999998 477789
Q ss_pred EEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC-----CcEEEEeecC
Q 038211 451 GIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN-----WTVKVGDFGL 524 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~-----~~vkl~Dfg~ 524 (605)
++||+.+ |.+|.++..... +.++...+..++.|++.+|++||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 9999999 899999887665 78999999999999999999999999 9999999999999754 4699999999
Q ss_pred CcccC---cc------ccc-ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q 038211 525 SSLKN---AT------YLT-AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLM 584 (605)
Q Consensus 525 a~~~~---~~------~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~ 584 (605)
++... .. ... ...+.||..|.++..+.+.+.+.+.|+||+++++.+|+.|..||.+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~ 243 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT 243 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence 98321 11 111 23456999999999999999999999999999999999999999886643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=209.06 Aligned_cols=227 Identities=30% Similarity=0.585 Sum_probs=196.8
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
..++...++.++.+|.....|..|+|+++|.+++.|++............|..|.-.|+.+.||||+.+++.+..+..+.
T Consensus 184 ~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 184 YTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred ccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 45677788889999999999999999999999999999888887777888999999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEE--eecCCccc
Q 038211 452 IVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVG--DFGLSSLK 528 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~--Dfg~a~~~ 528 (605)
++..|++.|+|+.+++... ..++..++.+++.+++.|++|||+..+-|.---|....+++|++.+.+|. |--++.
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf-- 341 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-- 341 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--
Confidence 9999999999999998764 34677788899999999999999998555555789999999998776664 422221
Q ss_pred CcccccccCCCCCCcccccccccCCCCC---chhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSN---EKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
........|.||+||.+...+-+ .++|+|||++++|||.|...||.++++++.-.+|...+.|+.||+++|+
T Consensus 342 -----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~ 416 (448)
T KOG0195|consen 342 -----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISR 416 (448)
T ss_pred -----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccH
Confidence 11233458999999999876654 4789999999999999999999999999999999999999999999985
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-25 Score=218.45 Aligned_cols=194 Identities=26% Similarity=0.414 Sum_probs=160.8
Q ss_pred cccCceEeeeecccCcEEEEEEEE-----CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCe
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW-----NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQER 449 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~-----~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~ 449 (605)
....|.++++||.|+|++||++.+ +...||+|.+.... ...++.+|+++|..+ .+.||+++.+++..++.
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 346789999999999999999865 34568999875543 456789999999999 69999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC-CCcEEEEeecCCccc
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK-NWTVKVGDFGLSSLK 528 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~-~~~vkl~Dfg~a~~~ 528 (605)
.++||||++-....+++.. ++...+..|++.++.||.++|.+| ||||||||.|+|.+. .+.-.|+|||+|...
T Consensus 110 v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred eEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHH
Confidence 9999999988777777644 668888999999999999999999 999999999999985 578899999998510
Q ss_pred C---------------cc-----------------------------cccccCCCCCCcccccccccCCC-CCchhHHHH
Q 038211 529 N---------------AT-----------------------------YLTAKSGRGTPQWMAPEVLRSEP-SNEKSDVFS 563 (605)
Q Consensus 529 ~---------------~~-----------------------------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwS 563 (605)
. .. ........||++|.|||++...+ .++++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 0 00 00011234999999999987754 588999999
Q ss_pred HHHHHHHHHcCCCCCC
Q 038211 564 FGVILWELVTASIPWN 579 (605)
Q Consensus 564 lG~il~el~~g~~Pf~ 579 (605)
.|||++.++++++||-
T Consensus 264 ~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFF 279 (418)
T ss_pred ccceeehhhccccccc
Confidence 9999999999999984
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=212.53 Aligned_cols=166 Identities=20% Similarity=0.159 Sum_probs=127.2
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC---CcceEEEEeecccc---chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN---GSDVAVKVYFGSEY---IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~---~~~~avKv~~~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
....+|.+.++||+|+||+||+|.+. ++.+|||++..... .......+.+|+++|+.++|+|++..+..+ +
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence 45578999999999999999999873 55579998653211 123356689999999999999998533222 4
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccC-CCCCEEEcCCCcEEEEeecCCcc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDL-KSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Di-k~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
..++|||||+|++|.. +.. .. ...++.|++.||.|||++| |+|||| ||+|||++.++.+||+|||+|+.
T Consensus 92 ~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred CcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 6899999999999962 211 11 1457889999999999999 999999 99999999999999999999986
Q ss_pred cCccccc--------ccCCCCCCcccccccccCC
Q 038211 528 KNATYLT--------AKSGRGTPQWMAPEVLRSE 553 (605)
Q Consensus 528 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~ 553 (605)
....... .....+++.|+|||.+...
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 5432211 1244578889999988654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-25 Score=227.27 Aligned_cols=205 Identities=27% Similarity=0.380 Sum_probs=172.8
Q ss_pred eecccCcEEEEEEE-----ECCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCeeEEEEEecC
Q 038211 385 EIGLGSYAVVYRGI-----WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERLGIVTEFLP 458 (605)
Q Consensus 385 ~LG~G~fg~V~~~~-----~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 458 (605)
++|.|+||.|++++ +.+.-||+|+.++.....+.......|..++..++ ||++|+++.+|+.+..++++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999753 45667999998776543333335667888899996 9999999999999999999999999
Q ss_pred CCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCC
Q 038211 459 RGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSG 538 (605)
Q Consensus 459 ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 538 (605)
||.|...+... ..+.+.....+..+++.|++++|..+ |+|||+|++||+++.+|++++.|||+++..-.... .
T Consensus 81 gg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----A 153 (612)
T ss_pred cchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhh----c
Confidence 99998888665 56777778888999999999999999 99999999999999999999999999876533222 2
Q ss_pred CCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 539 RGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 539 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
|||..|||||+++ ....++|+||||++++||++|..||.. ++...| .+..+.+|..++
T Consensus 154 cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I--l~~~~~~p~~l~ 211 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI--LKAELEMPRELS 211 (612)
T ss_pred ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH--hhhccCCchhhh
Confidence 8999999999999 456789999999999999999999999 777777 455678887665
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-21 Score=199.72 Aligned_cols=211 Identities=30% Similarity=0.462 Sum_probs=179.8
Q ss_pred ceEeeeecccCcEEEEEEEECCcceEEEEeeccccchh-hhhhHHHHHHHHHhCCCC-CeeeEEEEEeeCCeeEEEEEec
Q 038211 380 LQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEG-TLKNYQKEIDIIKKLRHP-NVLLFMGAVASQERLGIVTEFL 457 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~-~~~~~~~E~~il~~l~h~-niv~~~~~~~~~~~~~lv~e~~ 457 (605)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +++.+++.+......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 788899999999999999887 7789998877655443 577889999999999988 7999999998777789999999
Q ss_pred CCCchHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC-cEEEEeecCCcccCcccc-
Q 038211 458 PRGSLFKTLHKNY--QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW-TVKVGDFGLSSLKNATYL- 533 (605)
Q Consensus 458 ~ggsL~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~-~vkl~Dfg~a~~~~~~~~- 533 (605)
.++++.+++.... ..+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999996666543 27899999999999999999999999 99999999999999988 799999999875443321
Q ss_pred -----cccCCCCCCcccccccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHhccC
Q 038211 534 -----TAKSGRGTPQWMAPEVLRS---EPSNEKSDVFSFGVILWELVTASIPWNNLN----LMQVVGVVGFM 593 (605)
Q Consensus 534 -----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~g~~Pf~~~~----~~~~~~~I~~~ 593 (605)
......||..|++||.+.+ ..+....|+||+|++++++++|..||.... ..+....+...
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 230 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc
Confidence 3456679999999999988 577889999999999999999999998776 35666666433
|
|
| >COG3829 RocR Transcriptional regulator containing PAS, AAA-type ATPase, and DNA-binding domains [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-23 Score=215.19 Aligned_cols=180 Identities=17% Similarity=0.266 Sum_probs=144.0
Q ss_pred cccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEE
Q 038211 56 VGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPF 135 (605)
Q Consensus 56 ~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~ 135 (605)
...|+.|++.+.+++ +++|.+|+|+++|+++++++|++.++++|+++.+++ .....+..++++.++++.....+.
T Consensus 116 ~~~l~~il~~~~~~l-~vvD~~G~~i~~N~~~~~~~gl~~e~~~gk~~~~v~----~~~~~s~~l~vl~~~kp~~~~~~~ 190 (560)
T COG3829 116 RQRLEAILDSIDDGL-LVVDEDGIIIYYNKAYAKLLGLSPEEVLGKHLLDVV----SAGEDSTLLEVLRTGKPIRDVVQT 190 (560)
T ss_pred HHHHHHHHhhccCce-EEEcCCCcEEEEcHHHHHHhCCCHHHHcCCcHHHHH----hccCCceehhhhhcCCcceeeeee
Confidence 357889999998888 999999999999999999999999999999999843 111124467889999998776665
Q ss_pred EcCCCCEEEEEEEEEEEeeCCeEEEEEEEEeccccccccCCCCCCCCCCCCCCccccccccCCCCCccccccccchhhhh
Q 038211 136 KKRSGEILMAVVTKSPLYEDGELAGFITVSSDAAIFNSINPQHPRPYPNRGQMHGLNLKKIQWQPHQPQIAQVPNIASSV 215 (605)
Q Consensus 136 ~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~a~~v 215 (605)
+..++. .++..|++.+|.+.|+|.+++|++.+..+..+..+.... ......+.+++++.-++.+.+++++|+++
T Consensus 191 ~~~~~~----i~~~~pv~~~g~l~G~v~~~~~~~~l~~l~~~~~~~~~~--~~~~a~y~f~~Iig~S~~m~~~~~~akr~ 264 (560)
T COG3829 191 YNGNKI----IVNVAPVYADGQLIGVVGISKDVSELERLTRELEESEGL--LRLKAKYTFDDIIGESPAMLRVLELAKRI 264 (560)
T ss_pred ecCCce----eEeeccEecCCcEEEEEEeecchHHHHHHHHHHHHHhhh--hccccccchhhhccCCHHHHHHHHHHHhh
Confidence 544333 478889888899999999999999998885411111000 00124467777777777777799999999
Q ss_pred cchhhhhhhceeccCCCcc----ccCCCCCcccCCCCc
Q 038211 216 TNLTAKVLEKMHIGETGTY----VGGDDGSLRQNGLRY 249 (605)
Q Consensus 216 a~~~~~~~~vli~GEsGtg----~~~~h~~s~~~~~~f 249 (605)
|. +|+||||.|||||| |++||+.|+|.++||
T Consensus 265 A~---tdstVLi~GESGTGKElfA~~IH~~S~R~~~PF 299 (560)
T COG3829 265 AK---TDSTVLILGESGTGKELFARAIHNLSPRANGPF 299 (560)
T ss_pred cC---CCCcEEEecCCCccHHHHHHHHHhcCcccCCCe
Confidence 99 99999999999999 999999999999999
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-23 Score=235.99 Aligned_cols=147 Identities=20% Similarity=0.226 Sum_probs=114.5
Q ss_pred CCC-CCeeeEEEEE-------eeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceecc
Q 038211 432 LRH-PNVLLFMGAV-------ASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRD 503 (605)
Q Consensus 432 l~h-~niv~~~~~~-------~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~D 503 (605)
+.| +||+.++++| .....++++|||+ +++|.+++......+++..++.++.||+.||+|||++| |+|||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrD 105 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVHN 105 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeecc
Confidence 345 5777777776 2234577889988 67999999765567999999999999999999999999 99999
Q ss_pred CCCCCEEEcCCCcE-------------------EEEeecCCcccCccc----------------ccccCCCCCCcccccc
Q 038211 504 LKSSNLLVDKNWTV-------------------KVGDFGLSSLKNATY----------------LTAKSGRGTPQWMAPE 548 (605)
Q Consensus 504 ik~~Nill~~~~~v-------------------kl~Dfg~a~~~~~~~----------------~~~~~~~gt~~y~aPE 548 (605)
|||+||||+..|.+ |++|||+++...... .......||+.|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 99999999655444 555555554211000 0011235789999999
Q ss_pred cccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 549 VLRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 549 ~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
++.+..++.++|||||||+||||++|.+||...
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~ 218 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEK 218 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence 999999999999999999999999999998753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=186.37 Aligned_cols=174 Identities=13% Similarity=0.066 Sum_probs=134.0
Q ss_pred ccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccch-hhhhh------HHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIE-GTLKN------YQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~-~~~~~------~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
+...+|++.++||.|+||.||++..++..+|+|++....... ..... +.+|+..+.++.|++|..+.+++...
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 445789999999999999999987777889999986543222 22222 57899999999999999998886643
Q ss_pred --------CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEE
Q 038211 448 --------ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKV 519 (605)
Q Consensus 448 --------~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl 519 (605)
+..+|+|||++|.+|.+.. .+++. ...+++.+|..||+.| ++|||+||+||+++++| ++|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~~----~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-----EISED----VKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-----hccHH----HHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-EEE
Confidence 3578999999999997763 23332 3569999999999999 99999999999999988 999
Q ss_pred EeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHH
Q 038211 520 GDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELV 572 (605)
Q Consensus 520 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 572 (605)
+|||..+........ ..++....++.++|+||||+++.-+.
T Consensus 176 iDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999987544211100 11334445667899999999987543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.4e-21 Score=180.85 Aligned_cols=140 Identities=24% Similarity=0.215 Sum_probs=108.0
Q ss_pred eeeecccCcEEEEEEEE-CCcceEEEEeeccccchhh------------------------hhhHHHHHHHHHhCCCCCe
Q 038211 383 GEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIEGT------------------------LKNYQKEIDIIKKLRHPNV 437 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~~~~------------------------~~~~~~E~~il~~l~h~ni 437 (605)
...||+|+||.||+|.+ +|+.||||++......... .....+|+.+++.+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999987 5888999998765321111 1123459999999987776
Q ss_pred eeEEEEEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceeccCCCCCEEEcCCCc
Q 038211 438 LLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYL-HHRNPPIVHRDLKSSNLLVDKNWT 516 (605)
Q Consensus 438 v~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~L-H~~~~~iiH~Dik~~Nill~~~~~ 516 (605)
........ . ..+|||||++|+++...... ...++...+..++.|++.+|.+| |+.| |+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL-K-SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe-c-CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-CCc
Confidence 43332222 2 23899999988777654333 26788999999999999999999 6999 99999999999998 578
Q ss_pred EEEEeecCCccc
Q 038211 517 VKVGDFGLSSLK 528 (605)
Q Consensus 517 vkl~Dfg~a~~~ 528 (605)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=175.02 Aligned_cols=186 Identities=15% Similarity=0.155 Sum_probs=140.6
Q ss_pred eEeeeecccCcEEEEEEEECCcceEEEEeeccccchh--hhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCeeEEEEEec
Q 038211 381 QLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEG--TLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERLGIVTEFL 457 (605)
Q Consensus 381 ~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~--~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 457 (605)
.+...|++|+||+||.+...+..++.+.+........ ....+.+|+++|+++. |++++.++++ +..+++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 3567899999999998877777787776654433211 1225789999999995 5889999886 4579999999
Q ss_pred CCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccC-CCCCEEEcCCCcEEEEeecCCcccCcccc---
Q 038211 458 PRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDL-KSSNLLVDKNWTVKVGDFGLSSLKNATYL--- 533 (605)
Q Consensus 458 ~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Di-k~~Nill~~~~~vkl~Dfg~a~~~~~~~~--- 533 (605)
.|.+|...+.. . ...++.|++.+|.++|++| |+|||| ||+|||++.+|.++|+|||+|........
T Consensus 81 ~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 81 AGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred cCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99988654321 1 1347789999999999999 999999 79999999999999999999975443321
Q ss_pred --c--------ccCCCCCCcccccccccCC-CCC-chhHHHHHHHHHHHHHcCCCCCCC
Q 038211 534 --T--------AKSGRGTPQWMAPEVLRSE-PSN-EKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 534 --~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
. ..-..+++.|++|+...-. ..+ ...++++.|+-+|.++|+..|+-.
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0011268889999764332 223 567999999999999999998643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=175.47 Aligned_cols=141 Identities=22% Similarity=0.196 Sum_probs=110.2
Q ss_pred eeeecccCcEEEEEEEEC-CcceEEEEeeccccchh------------------------hhhhHHHHHHHHHhCCCCCe
Q 038211 383 GEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEG------------------------TLKNYQKEIDIIKKLRHPNV 437 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~------------------------~~~~~~~E~~il~~l~h~ni 437 (605)
.+.||+|+||.||+|.+. |+.||||++........ ....+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 578999999999999874 88999999876532100 01234578999999999987
Q ss_pred eeEEEEEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCCCCEEEcCCCc
Q 038211 438 LLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH-RNPPIVHRDLKSSNLLVDKNWT 516 (605)
Q Consensus 438 v~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~~~iiH~Dik~~Nill~~~~~ 516 (605)
.....+... ..+|||||++|+++....... ..++...+..++.|++.+|.+||+ .| |+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-CCC
Confidence 544443332 248999999887554332222 567788889999999999999999 99 99999999999999 889
Q ss_pred EEEEeecCCcccC
Q 038211 517 VKVGDFGLSSLKN 529 (605)
Q Consensus 517 vkl~Dfg~a~~~~ 529 (605)
++|+|||+++...
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999987554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=174.71 Aligned_cols=108 Identities=29% Similarity=0.463 Sum_probs=96.7
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
|+|.+++......+++..++.++.||+.||+|||+.+ ||+|||++.++.+++ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-----cCC
Confidence 6899999876677999999999999999999999887 999999999999999 9998765432 236
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8999999999999999999999999999999999999997654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.6e-21 Score=208.05 Aligned_cols=198 Identities=27% Similarity=0.383 Sum_probs=157.0
Q ss_pred eEeeeecccCcEEEEEEEE--CCcceEEEEee----ccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 381 QLGEEIGLGSYAVVYRGIW--NGSDVAVKVYF----GSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 381 ~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~----~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.....+|.|++|.|+.+.. ..+.++.|.+. ...........+..|+.+-..+.|+|++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999997776543 23334444332 22222223333777888888999999987776666555555559
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc-
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL- 533 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~- 533 (605)
|||++ +|+.++... ..+....+..++.||+.|++|||+.| |.|||+|++|++++.+|.+||+|||.+..+..+..
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 999998775 56778888889999999999999999 99999999999999999999999999987655443
Q ss_pred ---cccCCCCCCcccccccccCCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 534 ---TAKSGRGTPQWMAPEVLRSEPSNE-KSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 534 ---~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
.....+|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||.-..
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~ 529 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK 529 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence 345678999999999999999975 5799999999999999999997543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.1e-20 Score=198.99 Aligned_cols=181 Identities=29% Similarity=0.471 Sum_probs=137.8
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
.+|..++.|..|+||-||.++++ .+++|+|+- ++... .+- ++.....|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~li-------lRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNLI-------LRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhccc-ccchh-------hhc--cccccCCccee-----------------
Confidence 67899999999999999999886 778999653 22211 110 34444555555
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc---
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY--- 532 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~--- 532 (605)
|+-...+..- +.++.. ++.+++|||+.| |+|||+||+|.+|+.-|++|+.|||+++.+....
T Consensus 136 ----gDc~tllk~~-g~lPvd--------mvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ----GDCATLLKNI-GPLPVD--------MVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ----chhhhhcccC-CCCcch--------hhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 3333444332 444433 277999999999 9999999999999999999999999986532111
Q ss_pred ------------ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCC
Q 038211 533 ------------LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELP 600 (605)
Q Consensus 533 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P 600 (605)
...+..+|||.|+|||++....|...+|||++|+|+||++-|..||.+..+++++..+ .......|
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v--isd~i~wp 278 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV--ISDDIEWP 278 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh--hhhhcccc
Confidence 1123447999999999999999999999999999999999999999999999999987 44445555
Q ss_pred CC
Q 038211 601 EG 602 (605)
Q Consensus 601 ~~ 602 (605)
+.
T Consensus 279 E~ 280 (1205)
T KOG0606|consen 279 EE 280 (1205)
T ss_pred cc
Confidence 54
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-18 Score=165.43 Aligned_cols=134 Identities=19% Similarity=0.304 Sum_probs=103.8
Q ss_pred eeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhC-----CCCCeeeEEEEEeeCC---e-eEEE
Q 038211 383 GEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-----RHPNVLLFMGAVASQE---R-LGIV 453 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-----~h~niv~~~~~~~~~~---~-~~lv 453 (605)
.+.||+|+||.||... .....+||++..... ...+.+.+|+.+++.+ .||||++++++++++. . +.+|
T Consensus 7 ~~~LG~G~~~~Vy~hp-~~~~k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYAHP-EDAQRCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEECC-CCcCeEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 4689999999999622 223347888765322 2345689999999999 5799999999998863 3 3378
Q ss_pred EEe--cCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceeccCCCCCEEEcC----CCcEEEEe-ecCC
Q 038211 454 TEF--LPRGSLFKTLHKNYQALDIKRRLRMALDVARGM-NYLHHRNPPIVHRDLKSSNLLVDK----NWTVKVGD-FGLS 525 (605)
Q Consensus 454 ~e~--~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL-~~LH~~~~~iiH~Dik~~Nill~~----~~~vkl~D-fg~a 525 (605)
+|| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++ |+||||||+|||++. ++.++|+| ||..
T Consensus 84 ~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred ecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 999 5579999999763 45555 35678888887 9999999 999999999999974 34899999 5543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.8e-18 Score=165.47 Aligned_cols=137 Identities=23% Similarity=0.342 Sum_probs=115.2
Q ss_pred eeecccCcEEEEEEEECCcceEEEEeeccccch------hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEec
Q 038211 384 EEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIE------GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFL 457 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~------~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~ 457 (605)
++||+|++|.||+|.+.+..+++|+........ .....+.+|+.++..+.|++++....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 679999999999999999999999865432211 12345778999999999999887777777777889999999
Q ss_pred CCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 458 PRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 458 ~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
+|++|.+.+.... . ....++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||.+...
T Consensus 82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999998886531 1 67788999999999999999 99999999999999 789999999998764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-19 Score=197.85 Aligned_cols=209 Identities=20% Similarity=0.257 Sum_probs=161.0
Q ss_pred CceEeeeecccCcEEEEEEEECCcceEEEEeeccccc--hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYI--EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+|...+.||++.|=+|.+|++....++||++.+.... -....+..+|++ ...+++||++.+.-+..++...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6888899999999999999987667999999876522 122233334555 5666999999998887788888999999
Q ss_pred cCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc--
Q 038211 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT-- 534 (605)
Q Consensus 457 ~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~-- 534 (605)
+ ..+|+|.+..+ ..+.....+.|+.||+.||..+|..| |+|||||.+|||++.-+.+.|+||..-+.---+...
T Consensus 103 v-khnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 V-KHNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred H-hhhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 9 67999988765 55666677779999999999999999 999999999999999999999999765321111111
Q ss_pred -----ccCCCCCCcccccccccCCC-----------CCchhHHHHHHHHHHHHHc-CCCCCC-----------CCCHHHH
Q 038211 535 -----AKSGRGTPQWMAPEVLRSEP-----------SNEKSDVFSFGVILWELVT-ASIPWN-----------NLNLMQV 586 (605)
Q Consensus 535 -----~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwSlG~il~el~~-g~~Pf~-----------~~~~~~~ 586 (605)
..+...-..|+|||.+.... .+++-||||+||+++||++ |++||. ..++.++
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 11223345799999986522 3567899999999999998 899994 3456777
Q ss_pred HHHhcc
Q 038211 587 VGVVGF 592 (605)
Q Consensus 587 ~~~I~~ 592 (605)
++.|..
T Consensus 259 Le~Ied 264 (1431)
T KOG1240|consen 259 LEKIED 264 (1431)
T ss_pred HHhCcC
Confidence 777743
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-18 Score=193.70 Aligned_cols=193 Identities=23% Similarity=0.295 Sum_probs=153.9
Q ss_pred ccccCceEeeeecccCcEEEEEEEE-CCcceEEEEeeccccchhhhhhHHHHHHHHHhCC---CCCeeeEEEEEeeCCee
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR---HPNVLLFMGAVASQERL 450 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~---h~niv~~~~~~~~~~~~ 450 (605)
+..+.|.+-+.||+|+||+||+|.. +|+.||||+-+.....+-.+. .+++.+|+ -+.|..+..+..-.+..
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~-----~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYIC-----LQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeeh-----HHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 5557899999999999999999976 577899998766554432211 12233333 24455566666667788
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc-------CCCcEEEEeec
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD-------KNWTVKVGDFG 523 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~-------~~~~vkl~Dfg 523 (605)
+||+||.+.|+|.+++.. ...+++..+..+..|++.-++.||..+ |||+||||+|+||. ..--++|+|||
T Consensus 770 ~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEecc
Confidence 999999999999999984 478999999999999999999999999 99999999999994 23468999999
Q ss_pred CCcc---cCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCC
Q 038211 524 LSSL---KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASI 576 (605)
Q Consensus 524 ~a~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 576 (605)
.+-- +... ......++|-.+-.+|+..|..|++..|.|.|+-+++-|++|++
T Consensus 847 ~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 8842 2222 23345578889999999999999999999999999999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-17 Score=160.00 Aligned_cols=134 Identities=22% Similarity=0.322 Sum_probs=109.4
Q ss_pred eecccCcEEEEEEEECCcceEEEEeeccccch------hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecC
Q 038211 385 EIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIE------GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLP 458 (605)
Q Consensus 385 ~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~------~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 458 (605)
.||+|+||.||++.+.+..+++|+........ ....++.+|+.++..+.|+++.....++...+..+++|||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 48999999999999999999999865432211 123567789999999988876555555556677899999999
Q ss_pred CCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 459 RGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 459 ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
|++|.+.+..... .++.+++.+|.+||+.| ++|+|++|.||+++ ++.++++|||++....
T Consensus 81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999888755311 67889999999999999 99999999999999 8899999999987643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=162.55 Aligned_cols=199 Identities=22% Similarity=0.334 Sum_probs=129.9
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeecccc-chhhhhhHHHHHHHHHhCC----------CCCeeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLR----------HPNVLLFMGAV 444 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~----------h~niv~~~~~~ 444 (605)
..+...+.||.|+++.||.+.+. ++.+|||++..... .....+.+.+|.-....+. |-.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 35677889999999999999995 58899999876542 2334566666654444432 21222222222
Q ss_pred e---------eC---C-----eeEEEEEecCCCchHHHHHh---hcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCcee
Q 038211 445 A---------SQ---E-----RLGIVTEFLPRGSLFKTLHK---NYQ---ALDIKRRLRMALDVARGMNYLHHRNPPIVH 501 (605)
Q Consensus 445 ~---------~~---~-----~~~lv~e~~~ggsL~~~l~~---~~~---~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH 501 (605)
. .. . ..+++|+-+ -++|.+++.. ... .+.......+..|+++.+++||..| ++|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVH 168 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVH 168 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEe
Confidence 1 11 1 236788887 5688777642 211 1333444566789999999999999 999
Q ss_pred ccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCCCCCcccccccccC--------CCCCchhHHHHHHHHHHHHHc
Q 038211 502 RDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS--------EPSNEKSDVFSFGVILWELVT 573 (605)
Q Consensus 502 ~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el~~ 573 (605)
+||+|+|+|++.+|.+.|+||+.....+..... ...+..|.+||.... ..++.+.|.|+||+++|.|++
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 999999999999999999999876554433322 223678999997643 246788999999999999999
Q ss_pred CCCCCCCCC
Q 038211 574 ASIPWNNLN 582 (605)
Q Consensus 574 g~~Pf~~~~ 582 (605)
|..||.-..
T Consensus 246 ~~lPf~~~~ 254 (288)
T PF14531_consen 246 GRLPFGLSS 254 (288)
T ss_dssp SS-STCCCG
T ss_pred ccCCCCCCC
Confidence 999998543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=161.51 Aligned_cols=143 Identities=24% Similarity=0.234 Sum_probs=110.1
Q ss_pred CceEeeeecccCcEEEEEEE-E--CCcceEEEEeeccccchh----------------------hhhhHHHHHHHHHhCC
Q 038211 379 DLQLGEEIGLGSYAVVYRGI-W--NGSDVAVKVYFGSEYIEG----------------------TLKNYQKEIDIIKKLR 433 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~-~--~~~~~avKv~~~~~~~~~----------------------~~~~~~~E~~il~~l~ 433 (605)
.|.+.+.||.|+||.||+|. + .|+.||+|++........ ....+.+|+.+++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47889999999999999998 3 688899999875432100 1123568999999997
Q ss_pred CCC--eeeEEEEEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE
Q 038211 434 HPN--VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV 511 (605)
Q Consensus 434 h~n--iv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill 511 (605)
+.. +..++.+ ...++||||++|.+|....... ..+....+..++.||+.+|.+||+.| .|+||||||+||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEE
Confidence 533 3344432 2358999999988886654332 44566667789999999999999886 49999999999999
Q ss_pred cCCCcEEEEeecCCccc
Q 038211 512 DKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 512 ~~~~~vkl~Dfg~a~~~ 528 (605)
+ ++.++|+|||.+...
T Consensus 183 ~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred E-CCCEEEEEChhhhcc
Confidence 9 889999999988644
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.5e-17 Score=178.01 Aligned_cols=140 Identities=24% Similarity=0.278 Sum_probs=116.1
Q ss_pred cCceEeeeecccCcEEEEEEEECCcceEEEEeeccccch------hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIE------GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~------~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
..|...++||+|+||+||++.+.+..+++|+........ ...+.+.+|+++++.++|++++....++......+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 345667899999999999999888887777654322111 12356789999999999999988777777777889
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+||||++|++|.+++. ....++.+++.+|.+||+.+ ++||||||+|||+ .++.++|+|||+++...
T Consensus 413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 9999999999988875 23568899999999999999 9999999999999 67899999999997653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.5e-17 Score=160.84 Aligned_cols=232 Identities=25% Similarity=0.368 Sum_probs=153.2
Q ss_pred ccCCCCccccCceEeeeecccCcEEEEEEEECC---------c----------------------------ceEEEEeec
Q 038211 369 CATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNG---------S----------------------------DVAVKVYFG 411 (605)
Q Consensus 369 ~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~---------~----------------------------~~avKv~~~ 411 (605)
...+..+.+++|++++.||+|-...||.+.... . +.|||.+..
T Consensus 148 ~r~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN 227 (598)
T KOG4158|consen 148 NRIDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFN 227 (598)
T ss_pred chhhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcc
Confidence 344667889999999999999999999764310 0 145555432
Q ss_pred cccc---hhhhhhHHHHH------H--------HHHh--------CCCCCeeeEEEEEeeC-------------------
Q 038211 412 SEYI---EGTLKNYQKEI------D--------IIKK--------LRHPNVLLFMGAVASQ------------------- 447 (605)
Q Consensus 412 ~~~~---~~~~~~~~~E~------~--------il~~--------l~h~niv~~~~~~~~~------------------- 447 (605)
-... ...++..-+|. . ..+. -+|||||++..+|.+.
T Consensus 228 ~~~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~ 307 (598)
T KOG4158|consen 228 FEHDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARW 307 (598)
T ss_pred cccCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCccccccee
Confidence 1111 11111111111 0 1111 1499999999887431
Q ss_pred --------CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc--CC--C
Q 038211 448 --------ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD--KN--W 515 (605)
Q Consensus 448 --------~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~--~~--~ 515 (605)
..+|+||... ..+|..++..+ ..+.....-++.|+++|+.|||.+| |.|||+|.+|||+. ++ -
T Consensus 308 ~p~g~g~~~tlylvMkrY-~~tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P 382 (598)
T KOG4158|consen 308 YPSGAGEPKTLYLVMKRY-RQTLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIP 382 (598)
T ss_pred cccccCCCceEEEehhcc-hhhHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCc
Confidence 2478899887 46888888663 4556666778999999999999999 99999999999993 33 3
Q ss_pred cEEEEeecCCcccCc-----cccc-ccCCCCCCcccccccccCCCC------CchhHHHHHHHHHHHHHcCCCCCCCCCH
Q 038211 516 TVKVGDFGLSSLKNA-----TYLT-AKSGRGTPQWMAPEVLRSEPS------NEKSDVFSFGVILWELVTASIPWNNLNL 583 (605)
Q Consensus 516 ~vkl~Dfg~a~~~~~-----~~~~-~~~~~gt~~y~aPE~~~~~~~------~~~~DiwSlG~il~el~~g~~Pf~~~~~ 583 (605)
.+.++|||+|---.. ++.. ....-|....||||+....+- -.++|.|+.|-+.||++....||...-.
T Consensus 383 ~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe 462 (598)
T KOG4158|consen 383 QLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE 462 (598)
T ss_pred EEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch
Confidence 688999998732211 1111 112236778899999866532 2478999999999999999999976322
Q ss_pred HHHHHHhccCCCccCCCCCCCC
Q 038211 584 MQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 584 ~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
+-+-.+=.....-+.+|+.++|
T Consensus 463 m~L~~r~Yqe~qLPalp~~vpp 484 (598)
T KOG4158|consen 463 MLLDTRTYQESQLPALPSRVPP 484 (598)
T ss_pred heechhhhhhhhCCCCcccCCh
Confidence 2111111234455677777665
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=152.89 Aligned_cols=137 Identities=22% Similarity=0.229 Sum_probs=106.7
Q ss_pred ceEeeeecccCcEEEEEEEE-CCcceEEEEeeccccch--------------------hhhhhHHHHHHHHHhCCCCC--
Q 038211 380 LQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIE--------------------GTLKNYQKEIDIIKKLRHPN-- 436 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~~--------------------~~~~~~~~E~~il~~l~h~n-- 436 (605)
|.+.+.||.|+||.||++.. +++.+|||++....... .......+|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 77789999999999999987 58889999876533110 01123567899999987774
Q ss_pred eeeEEEEEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc
Q 038211 437 VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT 516 (605)
Q Consensus 437 iv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~ 516 (605)
++..++ ....++||||++|++|...... .....++.+++.++.++|+.| |+||||||+||+++.++.
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCCCc
Confidence 444443 2456899999999988665321 234568889999999999999 999999999999999999
Q ss_pred EEEEeecCCcccC
Q 038211 517 VKVGDFGLSSLKN 529 (605)
Q Consensus 517 vkl~Dfg~a~~~~ 529 (605)
++|+|||++....
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK10820 DNA-binding transcriptional regulator TyrR; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-17 Score=181.40 Aligned_cols=175 Identities=14% Similarity=0.131 Sum_probs=129.6
Q ss_pred ccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEE
Q 038211 55 SVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFP 134 (605)
Q Consensus 55 ~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~ 134 (605)
+.+.++++++++++++ +++|.+|+|+++|++|++++|++.++++|+++.+++ +... +.+.+.++..... ..
T Consensus 78 e~~~L~aIL~sm~eGV-i~vD~~G~I~~iN~aA~~Llg~~~eel~Gk~i~eli-~~~~------l~~~le~~~~~~~-~~ 148 (520)
T PRK10820 78 EHRALSALLEALPEPV-LSIDMKGKVELANPASCQLFGQSEEKLRNHTAAQLI-NGFN------FLRWLESEPQDSH-NE 148 (520)
T ss_pred HHHHHHHHHHhCCCcE-EEECCCCeeeHhHHHHHHHHCcCHHHHCCCcHHHHc-Ccch------HHHHHHcCCCccc-eE
Confidence 3456889999999999 999999999999999999999999999999999844 3221 2334555544111 12
Q ss_pred EEcCCCCEEEEEEEEEEEe--e-CCe--EEEEEEEEeccccccccCCCCCCCCCCCCCCccccccccCCCCCcccccccc
Q 038211 135 FKKRSGEILMAVVTKSPLY--E-DGE--LAGFITVSSDAAIFNSINPQHPRPYPNRGQMHGLNLKKIQWQPHQPQIAQVP 209 (605)
Q Consensus 135 ~~~k~G~~~~v~~~~~Pi~--d-~g~--i~g~v~i~~D~t~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 209 (605)
....+|..++ +...|++ + +|+ ++|+|.+++|++++.+.+..... .....++.++...+.+.++.
T Consensus 149 ~v~~~g~~~~--v~~~PI~~~d~~g~~~~~GaVivlrd~~~l~~~~~~~~~---------~~~~~f~~~ig~s~~~~~~~ 217 (520)
T PRK10820 149 HVVINGQDFL--MEITPVYLQDENDQHVLVGAVVMLRSTARMGRQLQNLAV---------NDDSAFSQIVAVSPKMRQVV 217 (520)
T ss_pred EEEECCEEEE--EEEEeeeecCCCCceeEEEEEEEeccHHHHHHHHHhhhc---------cccccccceeECCHHHHHHH
Confidence 2344677665 5678886 4 454 48999999999887432211000 02245556666555555599
Q ss_pred chhhhhcchhhhhhhceeccCCCcc----ccCCCCCcccCCCCcccc
Q 038211 210 NIASSVTNLTAKVLEKMHIGETGTY----VGGDDGSLRQNGLRYKSF 252 (605)
Q Consensus 210 ~~a~~va~~~~~~~~vli~GEsGtg----~~~~h~~s~~~~~~f~~~ 252 (605)
..++++|. ++.||||+||+||| |+.||..|.|+++||-.+
T Consensus 218 ~~~~~~A~---~~~pvlI~GE~GtGK~~lA~aiH~~s~r~~~pfv~i 261 (520)
T PRK10820 218 EQARKLAM---LDAPLLITGDTGTGKDLLAYACHLRSPRGKKPFLAL 261 (520)
T ss_pred HHHHHHhC---CCCCEEEECCCCccHHHHHHHHHHhCCCCCCCeEEe
Confidence 99999999 99999999999999 999999999999999654
|
|
| >PF13426 PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_B 3P7N_B 1LL8_A 3MJQ_A 3BWL_A 4EET_B 4EEP_A | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.9e-15 Score=127.47 Aligned_cols=103 Identities=27% Similarity=0.557 Sum_probs=88.6
Q ss_pred CCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEcCCCCEEEEE
Q 038211 67 GHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRSGEILMAV 146 (605)
Q Consensus 67 ~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~k~G~~~~v~ 146 (605)
|+++ +++|.+|+|+++|++|++++||+.+|++|+++.+++...........+.+.+..++.+..++..++++|+.+|+.
T Consensus 1 p~~i-~i~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~ 79 (104)
T PF13426_consen 1 PDGI-FILDPDGRILYVNPAFERLFGYSREELIGKSISDFFPEEDRPEFEEQIERALEEGGSWSGEVRLRRKDGETFWVE 79 (104)
T ss_dssp -SEE-EEEETTSBEEEE-HHHHHHHTS-HHHHTTSBGGGGCSTTSCHHHHHHHHHHHHHTSSEEEEEEEEETTSEEEEEE
T ss_pred CEEE-EEECCcCcEEehhHHHHHHHCcCHHHHcCCCcccccCcccchhhHHHHHHHHhcCCceeEEEEEEcCCCCEEEEE
Confidence 4566 899999999999999999999999999999999854433444456777888888999999999999999999999
Q ss_pred EEEEEEee-CCeEEEEEEEEecccc
Q 038211 147 VTKSPLYE-DGELAGFITVSSDAAI 170 (605)
Q Consensus 147 ~~~~Pi~d-~g~i~g~v~i~~D~t~ 170 (605)
++++|+.+ +|++.+++.+++|+|+
T Consensus 80 ~~~~~i~~~~g~~~~~i~~~~DiTe 104 (104)
T PF13426_consen 80 VSASPIRDEDGEITGIIGIFRDITE 104 (104)
T ss_dssp EEEEEEEETTSSEEEEEEEEEEEHH
T ss_pred EEEEEEECCCCCEEEEEEEEEECCC
Confidence 99999998 8999999999999885
|
... |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=144.44 Aligned_cols=137 Identities=27% Similarity=0.267 Sum_probs=98.1
Q ss_pred eeeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhh----------------------HHHHHHHHHhCCCCC--e
Q 038211 383 GEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKN----------------------YQKEIDIIKKLRHPN--V 437 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~----------------------~~~E~~il~~l~h~n--i 437 (605)
++.||+|+||+||+|.+. ++.||||++............ ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 568999999999999875 888999998754322111111 135666666664432 4
Q ss_pred eeEEEEEeeCCeeEEEEEecCCCchHH-HHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCCCCEEEcCCC
Q 038211 438 LLFMGAVASQERLGIVTEFLPRGSLFK-TLHKNYQALDIKRRLRMALDVARGMNYLHH-RNPPIVHRDLKSSNLLVDKNW 515 (605)
Q Consensus 438 v~~~~~~~~~~~~~lv~e~~~ggsL~~-~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~~~iiH~Dik~~Nill~~~~ 515 (605)
.+++++ ...++||||++++.+.. .+... . .. .....++.+++.++.++|. .+ |+|+||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~-~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R-LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-h-hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-CC
Confidence 445443 24689999999854322 12111 1 11 5567789999999999999 99 99999999999999 89
Q ss_pred cEEEEeecCCcccC
Q 038211 516 TVKVGDFGLSSLKN 529 (605)
Q Consensus 516 ~vkl~Dfg~a~~~~ 529 (605)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.5e-15 Score=146.93 Aligned_cols=137 Identities=17% Similarity=0.201 Sum_probs=105.3
Q ss_pred eeec-ccCcEEEEEEEECCcceEEEEeeccccc-----------hhhhhhHHHHHHHHHhCCCCCe--eeEEEEEeeCC-
Q 038211 384 EEIG-LGSYAVVYRGIWNGSDVAVKVYFGSEYI-----------EGTLKNYQKEIDIIKKLRHPNV--LLFMGAVASQE- 448 (605)
Q Consensus 384 ~~LG-~G~fg~V~~~~~~~~~~avKv~~~~~~~-----------~~~~~~~~~E~~il~~l~h~ni--v~~~~~~~~~~- 448 (605)
..|| .|+.|+||.+...+..++||.+...... ......+.+|+.++..+.|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4566 7777888888878889999988643321 1223567889999999988775 56666544322
Q ss_pred ---eeEEEEEecCC-CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecC
Q 038211 449 ---RLGIVTEFLPR-GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524 (605)
Q Consensus 449 ---~~~lv~e~~~g-gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~ 524 (605)
..++|||+++| .+|.+++.. ..+++.. +.+|+.+|.+||+.| |+||||||.|||++.++.++|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEECCC
Confidence 23599999997 688888765 3455543 568999999999999 99999999999999999999999998
Q ss_pred Cccc
Q 038211 525 SSLK 528 (605)
Q Consensus 525 a~~~ 528 (605)
+...
T Consensus 189 ~~~~ 192 (239)
T PRK01723 189 GELR 192 (239)
T ss_pred cccC
Confidence 8654
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=5e-15 Score=134.04 Aligned_cols=133 Identities=19% Similarity=0.171 Sum_probs=111.9
Q ss_pred EeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCC--CCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 382 LGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH--PNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 382 ~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h--~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
+++.||.|.++.||++...+..+++|+...... ...+.+|+.+++.++| .++++++.++...+..+++|||++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 457899999999999998888899998755432 3567889999999976 5889999888877889999999988
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR---NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
+.+..+ +......++.+++.+|.+||.. + ++|+|++|+||+++..+.++++|||.+...
T Consensus 78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~--i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLV--LCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceE--EEecCCCcceEEEECCcEEEEEecccccCC
Confidence 777543 4455567889999999999984 6 999999999999999999999999987643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.2e-15 Score=156.30 Aligned_cols=162 Identities=34% Similarity=0.546 Sum_probs=136.0
Q ss_pred HHhCCCCCeeeEEEEEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCc-eeccCCCC
Q 038211 429 IKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPI-VHRDLKSS 507 (605)
Q Consensus 429 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~i-iH~Dik~~ 507 (605)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+......+++-....+..+|+.||+|||.-- | .|+.++..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccc
Confidence 35678999999999999999999999999999999999987788999999999999999999999775 5 99999999
Q ss_pred CEEEcCCCcEEEEeecCCcccCc--ccccccCCCCCCcccccccccCCC-------CCchhHHHHHHHHHHHHHcCCCCC
Q 038211 508 NLLVDKNWTVKVGDFGLSSLKNA--TYLTAKSGRGTPQWMAPEVLRSEP-------SNEKSDVFSFGVILWELVTASIPW 578 (605)
Q Consensus 508 Nill~~~~~vkl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlG~il~el~~g~~Pf 578 (605)
|.++|..+.+||.|||+...... .........-..-|.|||.+++.. .+.+.|+||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 99999999999999999877642 111111122355789999998752 355689999999999999999999
Q ss_pred CC----CCHHHHHHHhcc
Q 038211 579 NN----LNLMQVVGVVGF 592 (605)
Q Consensus 579 ~~----~~~~~~~~~I~~ 592 (605)
.. .++.+++..|..
T Consensus 159 ~~~~~~~~~~eii~~~~~ 176 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK 176 (484)
T ss_pred ccccccCChHHHHHHHHh
Confidence 75 344678888865
|
|
| >PF00989 PAS: PAS fold; InterPro: IPR013767 PAS domains are involved in many signalling proteins where they are used as a signal sensor domain [] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.7e-14 Score=123.66 Aligned_cols=111 Identities=24% Similarity=0.484 Sum_probs=88.8
Q ss_pred ccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEE-EEEE
Q 038211 57 GPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSG-QFPF 135 (605)
Q Consensus 57 ~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~-~~~~ 135 (605)
++|+++++++++++ +++|.+|+|+|+|+++++++||+.++++|+++.+++.+++.......+.+.+..++.... ....
T Consensus 1 e~~~~i~~~~~~~i-~~~d~~g~I~~~N~a~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (113)
T PF00989_consen 1 ERYRAILENSPDGI-FVIDEDGRILYVNQAAEELLGYSREELIGKSLFDLIHPEDRRELRERLRQALSQGESGESFEVRF 79 (113)
T ss_dssp HHHHHHHHCSSSEE-EEEETTSBEEEECHHHHHHHSS-HHHHTTSBGGGGCSGGGHHHHHHHHHHHHHHCCHECEEEEEE
T ss_pred CHHHHHHhcCCceE-EEEeCcCeEEEECHHHHHHHccCHHHHcCCcHHHhcCchhhHHHHHHHHHHHHcCCCceeEEEEE
Confidence 36899999999988 899999999999999999999999999999999955444333345555666666665443 3334
Q ss_pred EcCCCCEEEEEEEEEEEee-CCeEEEEEEEEecc
Q 038211 136 KKRSGEILMAVVTKSPLYE-DGELAGFITVSSDA 168 (605)
Q Consensus 136 ~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~ 168 (605)
..++|+.+|+.+..+|+++ +|++.|++++++|+
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~DI 113 (113)
T PF00989_consen 80 RLRDGRPRWVEVRASPVRDEDGQIIGILVIFRDI 113 (113)
T ss_dssp EETTSCEEEEEEEEEEEEETTEEEEEEEEEEEE-
T ss_pred EecCCcEEEEEEEEEEEEeCCCCEEEEEEEEEeC
Confidence 4469999999999999998 78899999999995
|
PAS domains appear in archaea, bacteria and eukaryotes. Several PAS-domain proteins are known to detect their signal by way of an associated cofactor. Haeme, flavin, and a 4-hydroxycinnamyl chromophore are used in different proteins. The PAS domain was named after three proteins that it occurs in: Per- period circadian protein Arnt- Ah receptor nuclear translocator protein Sim- single-minded protein. PAS domains are often associated with PAC domains IPR001610 from INTERPRO. It appears that these domains are directly linked, and that together they form the conserved 3D PAS fold. The division between the PAS and PAC domains is caused by major differences in sequences in the region connecting these two motifs []. In human PAS kinase, this region has been shown to be very flexible, and adopts different conformations depending on the bound ligand []. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels [].; GO: 0006355 regulation of transcription, DNA-dependent; PDB: 2GJ3_A 4F3L_B 1XFN_A 1OTD_A 2PYR_A 1KOU_A 1XFQ_A 2ZOI_A 2ZOH_A 1OTA_A .... |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.5e-16 Score=173.88 Aligned_cols=203 Identities=28% Similarity=0.437 Sum_probs=163.6
Q ss_pred cCceEeeeecccCcEEEEEEEEC---CcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCeeEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN---GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~---~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lv 453 (605)
..|.+.+.||.|+|+.|-..... ...+|+|.+...............|..+-+.+. |+|++.+++........+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45777888999999999876542 233566655444333444556667888888886 99999999999999999999
Q ss_pred EEecCCCchHHHH-HhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceeccCCCCCEEEcCCC-cEEEEeecCCcccCc
Q 038211 454 TEFLPRGSLFKTL-HKNYQALDIKRRLRMALDVARGMNYLH-HRNPPIVHRDLKSSNLLVDKNW-TVKVGDFGLSSLKNA 530 (605)
Q Consensus 454 ~e~~~ggsL~~~l-~~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~~~iiH~Dik~~Nill~~~~-~vkl~Dfg~a~~~~~ 530 (605)
++|..|+++.+-+ .......+......++.|+..++.|+| ..+ +.|+||||+|.+++..+ .++++|||+|.....
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999998888 443325566667779999999999999 999 99999999999999999 999999999976544
Q ss_pred ---ccccccCCCC-CCcccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 531 ---TYLTAKSGRG-TPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 531 ---~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
........+| ++.|+|||.+.+.. .....|+||+|+++.-+++|..||....
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 2233345578 99999999998854 4677899999999999999999997644
|
|
| >PRK11388 DNA-binding transcriptional regulator DhaR; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=8.5e-15 Score=164.03 Aligned_cols=174 Identities=16% Similarity=0.221 Sum_probs=126.6
Q ss_pred cHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEc
Q 038211 58 PYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKK 137 (605)
Q Consensus 58 ~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~ 137 (605)
.+..+++++.+++ +++|.+|+|+++|+++++++|++.++++|+++.+++ +.. ..+..++.+++.+........
T Consensus 204 ~~~~il~~~~~gV-l~vD~~G~I~~~N~aa~~llg~s~~~l~G~~i~~l~-~~~-----~~l~~vl~~~~~~~~~~~~l~ 276 (638)
T PRK11388 204 QLNALLESMDDGV-IAWDEQGNLQFLNAQAARLLRLDATASQGRAITELL-TLP-----AVLQQAIKQAHPLKHVEVTFE 276 (638)
T ss_pred HHHHHHhccCCcE-EEECCCCeEehhhHHHHHHhCcCHHHHCCCcHHHHh-ccc-----hHHHHHHhcCCceeeEEEEEe
Confidence 4556889998877 999999999999999999999999999999999854 211 123455667766554333344
Q ss_pred CCCCEEEEEEEEEEEee-CCeEEEEEEEEeccccccccCCCCCCCCCCCCCCccccccccCCCCCccccccccchhhhhc
Q 038211 138 RSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFNSINPQHPRPYPNRGQMHGLNLKKIQWQPHQPQIAQVPNIASSVT 216 (605)
Q Consensus 138 k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~a~~va 216 (605)
.+|..+++.++..|+.+ .| .+++.+++|++++..+.... .. .....+..++.....+.++.+.|+++|
T Consensus 277 ~~g~~~~~~v~~~Pi~~~~g--~~~v~~l~~~~~~~~~~~~~---~~------~~~~~~~~l~g~s~~~~~~~~~~~~~a 345 (638)
T PRK11388 277 SQGQFIDAVITLKPIIEGQG--TSFILLLHPVEQMRQLMTSQ---LG------KVSHTFDHMPQDSPQMRRLIHFGRQAA 345 (638)
T ss_pred cCCceEEEEEEEEeecccCc--eEEEEEehhhHHHHHHHHHh---hc------cccccccceEECCHHHHHHHHHHHHHh
Confidence 56777788899999975 34 34666677876654321100 00 012234444554455555999999999
Q ss_pred chhhhhhhceeccCCCcc----ccCCCCCcccCCCCcccc
Q 038211 217 NLTAKVLEKMHIGETGTY----VGGDDGSLRQNGLRYKSF 252 (605)
Q Consensus 217 ~~~~~~~~vli~GEsGtg----~~~~h~~s~~~~~~f~~~ 252 (605)
. ++.+|||+||+||| |+.||+.|+|.++||-.+
T Consensus 346 ~---~~~pvli~Ge~GtGK~~~A~~ih~~s~r~~~pfv~v 382 (638)
T PRK11388 346 K---SSFPVLLCGEEGVGKALLAQAIHNESERAAGPYIAV 382 (638)
T ss_pred C---cCCCEEEECCCCcCHHHHHHHHHHhCCccCCCeEEE
Confidence 9 99999999999999 999999999999999553
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.8e-15 Score=152.00 Aligned_cols=121 Identities=28% Similarity=0.471 Sum_probs=104.4
Q ss_pred CeeEEEEEecCCCchHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCC
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKN--YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a 525 (605)
.++++.|++|.-.+|.+.+.+. ....+......++.|+..|++| +| .+|+|+||.||++..+..+||.|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence 3689999999999999999743 2456677788899999999999 78 999999999999999999999999998
Q ss_pred cccCcc------cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc
Q 038211 526 SLKNAT------YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573 (605)
Q Consensus 526 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 573 (605)
...... ...+....||..||+||.+.+..|+.++||||||++|+||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 654322 223445679999999999999999999999999999999998
|
|
| >PF08448 PAS_4: PAS fold; InterPro: IPR013656 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.2e-13 Score=113.73 Aligned_cols=107 Identities=24% Similarity=0.382 Sum_probs=85.8
Q ss_pred HHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHH-HHHHcCCceEEEEEEEcCCCC
Q 038211 63 LESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIM-ERLASGQSWSGQFPFKKRSGE 141 (605)
Q Consensus 63 l~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~-~~l~~g~~~~~~~~~~~k~G~ 141 (605)
|+++++++ +++|.+|+|+++|+++++++|++.++++|+++.+ ++++.........+ +++..+.....+... ..+|.
T Consensus 1 l~~~p~~i-~v~D~~~~i~~~N~~~~~~~~~~~~~~~G~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 77 (110)
T PF08448_consen 1 LDSSPDGI-FVIDPDGRIVYANQAAAELFGVSPEELIGRSLFD-LLPPEDREEFQAALRRALAGGEPVFFEEIL-LRDGE 77 (110)
T ss_dssp HHHCSSEE-EEEETTSBEEEE-HHHHHHHTSTHHHHTTSBHHH-HSCCGCHHHHHHHHHHHHHHTSEEEEEEEE-CTTSC
T ss_pred CCCCCcee-EEECCCCEEEEEHHHHHHHhCCCHHHHhhccchh-ccccchhhhhHHHHHHhhccCceEEEEEEE-eecCC
Confidence 57888888 8889999999999999999999999999999999 55555554444444 455555555544444 44899
Q ss_pred EEEEEEEEEEEee-CCeEEEEEEEEecccccc
Q 038211 142 ILMAVVTKSPLYE-DGELAGFITVSSDAAIFN 172 (605)
Q Consensus 142 ~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~ 172 (605)
..|..++.+|+++ +|++.|++.+++|+|+..
T Consensus 78 ~~~~~~~~~Pi~~~~g~~~g~~~~~~DiT~~r 109 (110)
T PF08448_consen 78 ERWFEVSISPIFDEDGEVVGVLVIIRDITERR 109 (110)
T ss_dssp EEEEEEEEEEEECTTTCEEEEEEEEEEECCHH
T ss_pred cEEEEEEEEEeEcCCCCEEEEEEEEEECchhh
Confidence 9999999999998 999999999999998754
|
The PAS fold appears in archaea, eubacteria and eukarya. ; PDB: 3K3D_A 3K3C_B 3KX0_X 3FC7_B 3LUQ_D 3MXQ_A 3BWL_C 3FG8_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.6e-13 Score=150.50 Aligned_cols=218 Identities=23% Similarity=0.276 Sum_probs=168.5
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
....+++.+.+-+-+|+++.++.+.-. +...+.|+........ ...+....+-.++-..++|.++.....|.....+
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 456788999999999999999987653 3334555543332222 2234444455555555678888776666667789
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC-
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN- 529 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~- 529 (605)
+|+++|+.+++|...++.. +..+.+..+.+...++.++++||... +.|+|++|.|+|....|+.++.|||......
T Consensus 880 ~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred chhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCcccccccccc
Confidence 9999999999999988876 46777777778889999999999998 9999999999999999999999998432110
Q ss_pred c------------------------------ccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 038211 530 A------------------------------TYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWN 579 (605)
Q Consensus 530 ~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~ 579 (605)
. .........+|+.|.+||.+.+......+|||++|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 0011123358999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhccCC
Q 038211 580 NLNLMQVVGVVGFMD 594 (605)
Q Consensus 580 ~~~~~~~~~~I~~~~ 594 (605)
...+.++..+|..++
T Consensus 1037 a~tpq~~f~ni~~~~ 1051 (1205)
T KOG0606|consen 1037 AETPQQIFENILNRD 1051 (1205)
T ss_pred CcchhhhhhccccCC
Confidence 999999999995444
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.6e-12 Score=136.57 Aligned_cols=140 Identities=23% Similarity=0.239 Sum_probs=96.9
Q ss_pred eeecccCcEEEEEEEE-CCcceEEEEeeccccc--hhh------------------------------------hhhHHH
Q 038211 384 EEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYI--EGT------------------------------------LKNYQK 424 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~--~~~------------------------------------~~~~~~ 424 (605)
+.||.|++|.||+|+. +|+.||||+....... ..+ .-.+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999987 6889999997543100 000 012445
Q ss_pred HHHHHHhCC-----CCCeeeEEEEE-eeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 038211 425 EIDIIKKLR-----HPNVLLFMGAV-ASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR-GMNYLHHRNP 497 (605)
Q Consensus 425 E~~il~~l~-----h~niv~~~~~~-~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~-aL~~LH~~~~ 497 (605)
|.+.+.+++ ++++. +-..+ ......+|||||++|++|.+.........+ ...++.+++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g- 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVY-VPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG- 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEE-eCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC-
Confidence 666666652 33332 22222 223457899999999999887654322222 2345556655 478899999
Q ss_pred CceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 498 PIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 498 ~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
++|+|+||.||+++.+|.++++|||++....
T Consensus 278 -~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 -FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred -ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG3283 TyrR Transcriptional regulator of aromatic amino acids metabolism [Transcription / Amino acid transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.1e-13 Score=131.55 Aligned_cols=170 Identities=15% Similarity=0.124 Sum_probs=117.7
Q ss_pred cHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEc
Q 038211 58 PYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKK 137 (605)
Q Consensus 58 ~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~ 137 (605)
.+.++++++++.+ +.+|..|.|..+|+|+++++|.+.+++.|+.+..++ +..+ +..+..+...........
T Consensus 81 ~L~aLL~al~~pV-lsvd~kg~v~~aNpAa~~l~~~~~~~~~g~~~~~l~-~~~n-------f~~~l~~~~~~~~~~~V~ 151 (511)
T COG3283 81 ALSALLEALPEPV-LSVDMKGKVDMANPAACQLFGRKEDRLRGHTAAQLI-NGFN-------FLRWLEGEPQRSHNEHVV 151 (511)
T ss_pred HHHHHHHhCCCce-EEecccCceeecCHHHHHHhCCChhhhcCccHHHhc-CcCC-------HHHHHhcCCCcCCCceEE
Confidence 4678899999988 999999999999999999999999999999998744 2221 122223332222122223
Q ss_pred CCCCEEEEEEEEEEEee---CC--eEEEEEEEEeccccccccCCCCCCCCCCCCCCccccccccCCCCCcccccc-ccch
Q 038211 138 RSGEILMAVVTKSPLYE---DG--ELAGFITVSSDAAIFNSINPQHPRPYPNRGQMHGLNLKKIQWQPHQPQIAQ-VPNI 211 (605)
Q Consensus 138 k~G~~~~v~~~~~Pi~d---~g--~i~g~v~i~~D~t~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~ 211 (605)
-+|..+. .-++||+. ++ .+.|++...+....+-+-++....+ ....+.. +...|..++ +.+-
T Consensus 152 ~~gq~~l--meitPv~~~~~~~e~~lagav~~L~~~~r~ge~~~~~~~~---------~~~~F~~-~v~~S~~mk~~v~q 219 (511)
T COG3283 152 INGQNFL--MEITPVYLQDENDEHVLAGAVVMLRSTNRMGEQLQNVAAQ---------DVSGFEQ-IVAVSPKMKHVVEQ 219 (511)
T ss_pred Ecchhhe--eeccceeecCCcchhheeheeeeehhhhhHHHHHhhcccc---------cccchHH-HhhccHHHHHHHHH
Confidence 3677664 56778863 33 3678888877644332222111100 1122333 444455555 9999
Q ss_pred hhhhcchhhhhhhceeccCCCcc----ccCCCCCcccCCCCccc
Q 038211 212 ASSVTNLTAKVLEKMHIGETGTY----VGGDDGSLRQNGLRYKS 251 (605)
Q Consensus 212 a~~va~~~~~~~~vli~GEsGtg----~~~~h~~s~~~~~~f~~ 251 (605)
|+|+|. .|.|.||.|||||| |+.-|..|||.++||=.
T Consensus 220 A~k~Am---lDAPLLI~GeTGTGKdLlAkaCH~~S~R~~~pFla 260 (511)
T COG3283 220 AQKLAM---LDAPLLITGETGTGKDLLAKACHLASPRHSKPFLA 260 (511)
T ss_pred HHHhhc---cCCCeEEecCCCchHHHHHHHHhhcCcccCCCeeE
Confidence 999999 99999999999999 99999999999999944
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.3e-12 Score=119.44 Aligned_cols=130 Identities=18% Similarity=0.126 Sum_probs=97.0
Q ss_pred eeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCee-eEEEEEeeCCeeEEEEEecCCCc
Q 038211 383 GEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL-LFMGAVASQERLGIVTEFLPRGS 461 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv-~~~~~~~~~~~~~lv~e~~~ggs 461 (605)
++.|+.|.++.||++...+..+++|+...... ....+.+|+.+++.+.+.+++ +++.+. ....++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 46789999999999998889999998654321 123467899999998655544 455443 234589999999987
Q ss_pred hHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC---CceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 462 LFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNP---PIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 462 L~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~---~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
+... .. ....++.+++.+|+.||..+. .++|+|++|.||+++ ++.++++||+.+..
T Consensus 78 l~~~------~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTE------DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc------cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 7543 01 112356799999999999871 149999999999999 67899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=7.2e-12 Score=132.42 Aligned_cols=163 Identities=23% Similarity=0.305 Sum_probs=123.9
Q ss_pred CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHH
Q 038211 400 NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRL 479 (605)
Q Consensus 400 ~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~ 479 (605)
.+.++.|.+++...- .......+-+..|+.++||||++|++.++..+.+|||+|-+. -|..++.+. ....+.
T Consensus 36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHHH
Confidence 466677777655432 344557788899999999999999999999999999999984 577777664 255666
Q ss_pred HHHHHHHHHHHHHH-hCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCCCCCcccccccccCCCCCch
Q 038211 480 RMALDVARGMNYLH-HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEK 558 (605)
Q Consensus 480 ~~~~qi~~aL~~LH-~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 558 (605)
.-+.||+.||-||| ..+ ++|++|..+.|+++..|..||++|..+..............---.|..|+.+.... -.
T Consensus 108 ~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s 183 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WS 183 (690)
T ss_pred HHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cc
Confidence 67899999999998 556 99999999999999999999999988754433222112222233466666554433 34
Q ss_pred hHHHHHHHHHHHHHcC
Q 038211 559 SDVFSFGVILWELVTA 574 (605)
Q Consensus 559 ~DiwSlG~il~el~~g 574 (605)
.|.|-|||++++++.|
T Consensus 184 ~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhhHHHHHHHHhCc
Confidence 6999999999999999
|
|
| >PRK11091 aerobic respiration control sensor protein ArcB; Provisional | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.9e-11 Score=141.26 Aligned_cols=122 Identities=16% Similarity=0.156 Sum_probs=101.0
Q ss_pred hcccccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcch-HHHHHHHHHcCCce
Q 038211 51 TTSDSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSP-HKKIMERLASGQSW 129 (605)
Q Consensus 51 ~~~~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~-~~~~~~~l~~g~~~ 129 (605)
++.++.+.++.+++++++++ +++|.+|+|++||+++++++||+.++++|+++.++ ++++.... .......+..+..+
T Consensus 149 ~l~~~~~~l~~il~~~~~~i-~~~D~~g~i~~~N~a~~~l~G~~~~eliG~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~ 226 (779)
T PRK11091 149 ELEQQSSLLRSFLDASPDLV-YYRNEDGEFSGCNRAMELLTGKSEKQLIGLTPKDV-YSPEAAEKVIETDEKVFRHNVSL 226 (779)
T ss_pred HHHHHHHHHHHHHhcCcceE-EEECCCCcEEeEcHHHHHHhCcCHHHHcCCChHHh-CCHHHHHHHHHHHHHHHhcCCCe
Confidence 44556677999999999888 89999999999999999999999999999999984 44332222 33334456677788
Q ss_pred EEEEEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEecccccccc
Q 038211 130 SGQFPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFNSI 174 (605)
Q Consensus 130 ~~~~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~~l 174 (605)
..+....+++|+.+|+.++..|+++ +|.+.|++.+++|+|+..+.
T Consensus 227 ~~e~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~ 272 (779)
T PRK11091 227 TYEQWLDYPDGRKACFELRKVPFYDRVGKRHGLMGFGRDITERKRY 272 (779)
T ss_pred EEEEEEEcCCCCEEEEEEEeeeEEcCCCCEEEEEEEEeehhHHHHH
Confidence 8888888999999999999999998 89999999999999986543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.9e-11 Score=108.98 Aligned_cols=135 Identities=25% Similarity=0.324 Sum_probs=105.4
Q ss_pred eeecccCcEEEEEEEECCcceEEEEeeccccchh------hhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEec
Q 038211 384 EEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEG------TLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFL 457 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~------~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~ 457 (605)
..+++|+-+.+|.+.+.|.++.+|.-.+..+... ...+..+|++++.+++--.|...+=++.+++...|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 4578999999999988888888886544333211 2345678999999997666655555566777888999999
Q ss_pred CCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 458 PRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 458 ~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+|..|.+.+... ...++..+-.-+.-||..| |+|+||.++||++..++ +.++|||++....
T Consensus 82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 82 EGELLKDALEEA--------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred CChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 998888888764 1346677888889999999 99999999999997764 9999999987543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.3e-11 Score=106.68 Aligned_cols=145 Identities=25% Similarity=0.263 Sum_probs=111.2
Q ss_pred EeeeecccCcEEEEEEEECCcceEEEEeeccccch------hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 382 LGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIE------GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 382 ~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~------~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
.+..|-+|+-+.|+++.+.|+...||.-....+.. -..++..+|++.|.++.--.|....-+|.+...-+|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 46788899999999999999998888643333221 124567789999999976566554555667777889999
Q ss_pred ecCC-CchHHHHHhhcCCCCHHHH-HHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC---cEEEEeecCCccc
Q 038211 456 FLPR-GSLFKTLHKNYQALDIKRR-LRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW---TVKVGDFGLSSLK 528 (605)
Q Consensus 456 ~~~g-gsL~~~l~~~~~~~~~~~~-~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~---~vkl~Dfg~a~~~ 528 (605)
|++| .++.+++........+... ..++..|-..+.-||.++ |||+||..+||++.++| .+.|+|||++...
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9977 4778888765443333333 678889999999999999 99999999999996544 4589999998654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.7e-11 Score=112.38 Aligned_cols=137 Identities=21% Similarity=0.170 Sum_probs=97.5
Q ss_pred eeecccCcEEEEEEEEC--------CcceEEEEeecccc--------c------------hhhhhhH----HHHHHHHHh
Q 038211 384 EEIGLGSYAVVYRGIWN--------GSDVAVKVYFGSEY--------I------------EGTLKNY----QKEIDIIKK 431 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~--------~~~~avKv~~~~~~--------~------------~~~~~~~----~~E~~il~~ 431 (605)
..||.|--+.||.|... +..+|||+++.... . ....+.+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999754 36799999753211 0 0112222 379999999
Q ss_pred CCC--CCeeeEEEEEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceeccCCCCC
Q 038211 432 LRH--PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYL-HHRNPPIVHRDLKSSN 508 (605)
Q Consensus 432 l~h--~niv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~L-H~~~~~iiH~Dik~~N 508 (605)
+.. -++...+++ ..-+|||||+.+..+..-..+. ..++......+..+++.+|..| |..| |||+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHH
Confidence 943 456666654 4578999999765442221111 2345556667789999999998 8999 9999999999
Q ss_pred EEEcCCCcEEEEeecCCccc
Q 038211 509 LLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 509 ill~~~~~vkl~Dfg~a~~~ 528 (605)
||++ ++.+.|+|||-+...
T Consensus 156 IL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EEEE-CCcEEEEECCCceeC
Confidence 9997 478999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.1e-12 Score=135.79 Aligned_cols=143 Identities=18% Similarity=0.150 Sum_probs=92.4
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc--------------------------------hhhhh--
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI--------------------------------EGTLK-- 420 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~--------------------------------~~~~~-- 420 (605)
+.+|.. +.||.|++|.||+|+.+ |+.||||+....... ....+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 355666 78999999999999873 789999998643100 01111
Q ss_pred ----hHHHHHHHHHhCC----CCCeeeEEEEEee-CCeeEEEEEecCCCchHHHH--HhhcC---CCCHHHHHHHHHHHH
Q 038211 421 ----NYQKEIDIIKKLR----HPNVLLFMGAVAS-QERLGIVTEFLPRGSLFKTL--HKNYQ---ALDIKRRLRMALDVA 486 (605)
Q Consensus 421 ----~~~~E~~il~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~ggsL~~~l--~~~~~---~~~~~~~~~~~~qi~ 486 (605)
.+.+|...+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++- ..... .+.+..+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 2334444444442 3333333333322 34568999999999997642 22111 23333333444444
Q ss_pred HHHHHHHhCCCCceeccCCCCCEEEcCCC----cEEEEeecCCcccC
Q 038211 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNW----TVKVGDFGLSSLKN 529 (605)
Q Consensus 487 ~aL~~LH~~~~~iiH~Dik~~Nill~~~~----~vkl~Dfg~a~~~~ 529 (605)
...| ++|+|+||.||+++.+| .++++|||++....
T Consensus 277 ------f~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ------FRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------HhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4578 99999999999999888 99999999986543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.4e-11 Score=129.19 Aligned_cols=200 Identities=25% Similarity=0.207 Sum_probs=158.4
Q ss_pred ccCceEeeeecc--cCcEEEEEEEE----CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCe
Q 038211 377 WEDLQLGEEIGL--GSYAVVYRGIW----NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQER 449 (605)
Q Consensus 377 ~~~~~~~~~LG~--G~fg~V~~~~~----~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~ 449 (605)
...+.+.+.+|. |.+|.||.+.. ....+|+|.-+.....+.....=.+|+.-.+.+ .|+|.++.+..+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345677788999 99999997654 455688886433222222333345666666666 49999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceeccCCCCCEEEcCC-CcEEEEeecC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR----GMNYLHHRNPPIVHRDLKSSNLLVDKN-WTVKVGDFGL 524 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~----aL~~LH~~~~~iiH~Dik~~Nill~~~-~~vkl~Dfg~ 524 (605)
+++-+|+| +.+|..+.......++...++..+.+... ||..+|+.+ ++|-|+||.||++..+ ...++.|||+
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcce
Confidence 99999999 67888888877677888899999999999 999999999 9999999999999998 7889999999
Q ss_pred CcccCcccccc-----cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 525 SSLKNATYLTA-----KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 525 a~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
........... ....|...|++||...+. ++..+|+++||.++.+-.++..++..
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccC
Confidence 87654433222 222578899999988776 78899999999999999988777643
|
|
| >PRK13557 histidine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=1e-10 Score=129.24 Aligned_cols=119 Identities=15% Similarity=0.253 Sum_probs=100.4
Q ss_pred ccccHHHHHHhcCCeEEEEEcC---CCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEE
Q 038211 55 SVGPYRSVLESMGHAVHVCTAS---SEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSG 131 (605)
Q Consensus 55 ~~~~~~~il~~~~d~ii~v~D~---~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~ 131 (605)
....|+.+++.+++++ +++|. +|+|+|+|++|++++||+.+|++|+++.+++.+.........++..+..+..+..
T Consensus 28 ~~~~~~~~~~~~~~~i-~v~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (540)
T PRK13557 28 RSDIFFAAVETTRMPM-IVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERREIAT 106 (540)
T ss_pred hhHHHHHHHHhCcCcE-EEEcCCCCCCCEEEEcHHHHHHhCCCHHHhcCCChHhhcCCCCCHHHHHHHHHHHHcCCCceE
Confidence 3567889999999888 77874 8999999999999999999999999999744343334446667777888888888
Q ss_pred EEEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEecccccccc
Q 038211 132 QFPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFNSI 174 (605)
Q Consensus 132 ~~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~~l 174 (605)
+...++++|+.+|+.++..|+++ +|.+++++.+.+|+|+..+.
T Consensus 107 ~~~~~~~~G~~~~~~~~~~~i~~~~g~~~~~~~~~~dit~~~~~ 150 (540)
T PRK13557 107 EILNYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSRRRDA 150 (540)
T ss_pred EEEEEeCCCCEEEEEEEEEEeECCCCCEEEEEEEecChHHHHHH
Confidence 88888999999999999999998 89999999999999876543
|
|
| >PRK13559 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.4e-10 Score=118.51 Aligned_cols=117 Identities=21% Similarity=0.236 Sum_probs=96.2
Q ss_pred cccccHHHHHHhcCCeEEEEEcC---CCCEEEecHHHHHHhCCChhhhcCCCccccccccCCc-chHHHHHHHHHcCCce
Q 038211 54 DSVGPYRSVLESMGHAVHVCTAS---SEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFH-SPHKKIMERLASGQSW 129 (605)
Q Consensus 54 ~~~~~~~~il~~~~d~ii~v~D~---~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~-~~~~~~~~~l~~g~~~ 129 (605)
++.+.|+.+++.+++++ +++|. +|+|++||+++++++||+.+|++|+++.+ +..+... .....+...+..+..+
T Consensus 40 ~~~~~~~~~~e~~~~~i-~i~D~~~~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~ 117 (361)
T PRK13559 40 ASGRLFEQAMEQTRMAM-CITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRF-LQGAATDPIAVAKIRAAIAAEREI 117 (361)
T ss_pred hhhhHHHHHHHhCCCcE-EEecCCCCCCcEEEEchHHHHHhCCCHHHHcCCChhh-hcCCCCCHHHHHHHHHHhccCCce
Confidence 34567888999999888 88886 67899999999999999999999999876 4333322 2244555667777888
Q ss_pred EEEEEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEecccccc
Q 038211 130 SGQFPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFN 172 (605)
Q Consensus 130 ~~~~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~ 172 (605)
..+....+++|..+|+.++..|+++ +|.+.+++.+++|+|+..
T Consensus 118 ~~e~~~~~~dG~~~~~~~~~~~i~d~~G~~~~~v~~~~DITerk 161 (361)
T PRK13559 118 VVELLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVTDIR 161 (361)
T ss_pred EEEEEEEcCCCCEEEEEEEEEEEEcCCCCEEEeeeeeeehhcch
Confidence 8888888999999999999999998 889999999999988743
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.6e-10 Score=108.17 Aligned_cols=142 Identities=19% Similarity=0.218 Sum_probs=105.9
Q ss_pred eeecccCcEEEEEEEECC-cceEEEEeeccccchhhhhhHHHHHHHHHhCCC--CCeeeEEEEEeeC---CeeEEEEEec
Q 038211 384 EEIGLGSYAVVYRGIWNG-SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH--PNVLLFMGAVASQ---ERLGIVTEFL 457 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~~-~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h--~niv~~~~~~~~~---~~~~lv~e~~ 457 (605)
+.|+.|.++.||++...+ ..+++|+....... .....+.+|+.+++.+.+ .++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 578999999999998765 78999987554321 234567899999999965 3456677766543 3678999999
Q ss_pred CCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 038211 458 PRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRN----------------------------------------- 496 (605)
Q Consensus 458 ~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~----------------------------------------- 496 (605)
+|.++...+.. ..+++.....++.+++.+|..||+..
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888665432 34666666677778888888887421
Q ss_pred -------------CCceeccCCCCCEEEcC--CCcEEEEeecCCccc
Q 038211 497 -------------PPIVHRDLKSSNLLVDK--NWTVKVGDFGLSSLK 528 (605)
Q Consensus 497 -------------~~iiH~Dik~~Nill~~--~~~vkl~Dfg~a~~~ 528 (605)
..++|+|+++.||+++. ++.+.|+||+.+...
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 12799999999999998 667899999987654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.1e-11 Score=113.93 Aligned_cols=149 Identities=24% Similarity=0.418 Sum_probs=114.3
Q ss_pred HHhCCCCCeeeEEEEEeeC-----CeeEEEEEecCCCchHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 038211 429 IKKLRHPNVLLFMGAVASQ-----ERLGIVTEFLPRGSLFKTLHKN---YQALDIKRRLRMALDVARGMNYLHHRNPPIV 500 (605)
Q Consensus 429 l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~ggsL~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~~~ii 500 (605)
|-.+-|.|||+++.++.+. .+..++.||+..|+|..+|++. ...+......+|+-||+.||.|||+..|+|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 3444699999999988653 4588999999999999998763 3567888888999999999999999999999
Q ss_pred eccCCCCCEEEcCCCcEEEEeecCCcccCc----ccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCC
Q 038211 501 HRDLKSSNLLVDKNWTVKVGDFGLSSLKNA----TYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASI 576 (605)
Q Consensus 501 H~Dik~~Nill~~~~~vkl~Dfg~a~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 576 (605)
|+++..+-|++..+|-+|+.--.....-.. ......-..+-++|.+||.=.....+.++|||+||.+..+|..+..
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 999999999999999988753211111000 0011112235788999987555556778999999999999998776
Q ss_pred C
Q 038211 577 P 577 (605)
Q Consensus 577 P 577 (605)
-
T Consensus 281 q 281 (458)
T KOG1266|consen 281 Q 281 (458)
T ss_pred c
Confidence 4
|
|
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.6e-10 Score=120.21 Aligned_cols=109 Identities=10% Similarity=0.017 Sum_probs=84.0
Q ss_pred cHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCC-hhhhcCCCccccccccCCcchHHHHHHHHHcCCc-eEEEEEE
Q 038211 58 PYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWK-DREVFGQRVTEFLIAEEFHSPHKKIMERLASGQS-WSGQFPF 135 (605)
Q Consensus 58 ~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~-~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~-~~~~~~~ 135 (605)
+|+.+++++++++ +++|.+|+|+++|++|++++||+ .++++|+++.+++ +.... ....+...+...+. ...+...
T Consensus 253 ~~~~l~e~~~d~I-~v~D~~G~I~~~N~a~~~l~G~~~~~~l~G~~~~~~~-~~~~~-~~~~~~~~~~~~g~~~~~~~~~ 329 (442)
T TIGR02040 253 NLARLYHEAPDAI-VFSDADGTIRGANEAFLELTDSSSLEAVRGRTLDRWL-GRGGV-DLRVLLSNVRRTGQVRLYATTL 329 (442)
T ss_pred HHHHHHHhCCceE-EEEcCCCcEEehhHHHHHHhCCCChHHHcCCCHHHHh-CCCcc-cHHHHHHHHhhcCceEEEEEEE
Confidence 5899999999988 88999999999999999999997 5789999998744 32222 23444444544443 3345566
Q ss_pred EcCCCCEEEEEEEEEEEeeCCeEEEEEEEEecccc
Q 038211 136 KKRSGEILMAVVTKSPLYEDGELAGFITVSSDAAI 170 (605)
Q Consensus 136 ~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~ 170 (605)
.+++|+.+|+.++.+|+.+.+. ..++++++|+|+
T Consensus 330 ~~~~G~~~~ve~s~~~i~~~~~-~~~~~v~rDITe 363 (442)
T TIGR02040 330 TGEFGAQTEVEISAAWVDQGER-PLIVLVIRDISR 363 (442)
T ss_pred EcCCCCEEEEEEEEEEeccCCc-eEEEEEEecchh
Confidence 7999999999999999987433 457788999877
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.7e-10 Score=121.19 Aligned_cols=198 Identities=23% Similarity=0.235 Sum_probs=146.3
Q ss_pred CccccCceEeeeecccCcEEEEEEEE---CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCe
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW---NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQER 449 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~---~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~ 449 (605)
.....+|.++..||.|.|+.|+.+.. .+..|++|-....-.....-..-..|+-+...+ .|.++++++..|.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34557899999999999999998654 345588886655433332222334566666666 58889998888877777
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC-CcEEEEeecCCccc
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN-WTVKVGDFGLSSLK 528 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~-~~vkl~Dfg~a~~~ 528 (605)
.++-.|||.++++.... .....+++...+.+..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||..+-.
T Consensus 341 ~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred ccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccccccc
Confidence 88999999998876555 22356788888999999999999999999 9999999999999875 78899999987532
Q ss_pred CcccccccCCCCCCcc-cccccccCCCCCchhHHHHHHHHHHHHHcCCC
Q 038211 529 NATYLTAKSGRGTPQW-MAPEVLRSEPSNEKSDVFSFGVILWELVTASI 576 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 576 (605)
... .......+..| .++.......+..+.|++|||..+.+.+++..
T Consensus 418 ~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 418 AFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred cee--cccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 111 11111123334 35555566677889999999999999888765
|
|
| >PF13596 PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D | Back alignment and domain information |
|---|
Probab=99.08 E-value=6.1e-10 Score=94.50 Aligned_cols=105 Identities=23% Similarity=0.341 Sum_probs=75.3
Q ss_pred HHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEcC
Q 038211 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKR 138 (605)
Q Consensus 59 ~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~k 138 (605)
++.+|++++.++ +++|.+++|+++|+++.++++... ..+|+++.+ +.++........+++.+..|+....+... ..
T Consensus 1 L~~il~s~~~~i-~~vD~~~~I~~~n~~a~~~f~~~~-~~iGr~l~~-~~~~~~~~~l~~~i~~~~~~~~~~~~~~~-~~ 76 (106)
T PF13596_consen 1 LNNILDSMPIGI-IFVDRNLRIRYFNPAAARLFNLSP-SDIGRPLFD-IHPPLSYPNLKKIIEQVRSGKEEEFEIVI-PN 76 (106)
T ss_dssp HHHHHHHSSSEE-EEEETTSBEEEE-SCGC-SS---G-GGTTSBCCC-SS-HHHHHHHHHHHHHHHTTSBSEEEEEE-EE
T ss_pred ChHHHhcCCCCE-EEEcCCCeEEEeChhHhhhcCCCh-HHCCCCHHH-cCCccchHHHHHHHHHHHcCCCceEEEEe-cC
Confidence 467899999888 889999999999999999999765 558999998 55554444566777888888864433333 34
Q ss_pred CCCEEEEEEEEEEEee-CCeEEEEEEEEeccc
Q 038211 139 SGEILMAVVTKSPLYE-DGELAGFITVSSDAA 169 (605)
Q Consensus 139 ~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t 169 (605)
+|+.+ .+...|+++ +|++.|++.++.|+|
T Consensus 77 ~~~~~--~~~~~P~~~~~g~~~G~v~~~~DIT 106 (106)
T PF13596_consen 77 GGRWY--LVRYRPYRDEDGEYAGAVITFQDIT 106 (106)
T ss_dssp TTEEE--EEEEEEEE-TTS-EEEEEEEEEE-G
T ss_pred CCEEE--EEEEEEEECCCCCEEEEEEEEEecC
Confidence 56554 578999998 899999999999976
|
|
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.5e-09 Score=124.21 Aligned_cols=126 Identities=12% Similarity=0.192 Sum_probs=98.3
Q ss_pred chHHHH----hcccccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHH-H
Q 038211 45 DVDEVA----TTSDSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKK-I 119 (605)
Q Consensus 45 ~l~~~~----~~~~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~-~ 119 (605)
++++++ ++.++.++|+.+++++++++ +++|.+|+|+++|+++++++||+.+|++|+++.+ +.++........ .
T Consensus 188 DIT~rk~ae~~l~~~~~~l~~l~e~~~~~i-~~~d~~g~i~~~N~~~~~~~G~~~~e~~g~~~~~-~~~~~~~~~~~~~~ 265 (807)
T PRK13560 188 DITERKRAEERIDEALHFLQQLLDNIADPA-FWKDEDAKVFGCNDAACLACGFRREEIIGMSIHD-FAPAQPADDYQEAD 265 (807)
T ss_pred ccchHHHHHHHHHHHHHHHHHHHhhCCCeE-EEEcCCCCEEEEhHHHHHHhCCCHHHHcCCcchh-cCCcchhHHHHHHH
Confidence 455544 45566778999999999888 8899999999999999999999999999999998 444443333322 3
Q ss_pred HHHHHcCCceEEEEEEEcCCCCEEEEEEEE--EEEee-CCeEEEEEEEEecccccc
Q 038211 120 MERLASGQSWSGQFPFKKRSGEILMAVVTK--SPLYE-DGELAGFITVSSDAAIFN 172 (605)
Q Consensus 120 ~~~l~~g~~~~~~~~~~~k~G~~~~v~~~~--~Pi~d-~g~i~g~v~i~~D~t~~~ 172 (605)
...+..++....+...++++|+.+|+.+.. .|+.+ +|.+.|++++++|+|+..
T Consensus 266 ~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~~~~~g~~~g~~~~~~DITerk 321 (807)
T PRK13560 266 AAKFDADGSQIIEAEFQNKDGRTRPVDVIFNHAEFDDKENHCAGLVGAITDISGRR 321 (807)
T ss_pred HHHhccCCceEEEEEEEcCCCCEEEEEEEecceEEEcCCCCEEEEEEEEEechHHH
Confidence 344556677777888899999999766555 45556 788999999999998754
|
|
| >PRK13558 bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.1e-09 Score=118.83 Aligned_cols=113 Identities=18% Similarity=0.299 Sum_probs=94.3
Q ss_pred cHHHHHHhcCCeEEEEEc---CCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCc-chHHHHHHHHHcCCceEEEE
Q 038211 58 PYRSVLESMGHAVHVCTA---SSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFH-SPHKKIMERLASGQSWSGQF 133 (605)
Q Consensus 58 ~~~~il~~~~d~ii~v~D---~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~-~~~~~~~~~l~~g~~~~~~~ 133 (605)
.++.+++.+++++ ++.| .+|+|+|||+++++++||+.++++|+++.+ +.++... .....+...+..+..+..+.
T Consensus 149 ~~~~~~~~~~~gi-~~~d~~~~dg~i~~~N~~~~~l~G~~~eel~g~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~e~ 226 (665)
T PRK13558 149 LKERALDEAPVGI-TIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRF-LQGEDTNEERVAELREAIDEERPTSVEL 226 (665)
T ss_pred HHHHHHhcCCccE-EEEcCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHHH-hcCCCccHHHHHHHHHHHhcCCCeEEEE
Confidence 3567899998887 7776 489999999999999999999999999887 4433332 33455666777888888899
Q ss_pred EEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEecccccc
Q 038211 134 PFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFN 172 (605)
Q Consensus 134 ~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~ 172 (605)
..++++|..+|+.++..|+++ +|.+.|++++++|+|+..
T Consensus 227 ~~~~~dG~~~~~~~~~~pi~d~~G~~~~~vgi~~DITerk 266 (665)
T PRK13558 227 RNYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERK 266 (665)
T ss_pred EEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeCcHHH
Confidence 999999999999999999997 899999999999988754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.3e-08 Score=100.63 Aligned_cols=134 Identities=19% Similarity=0.115 Sum_probs=96.4
Q ss_pred EEEEEEEECCcceEEEEeeccccch---------hhhhhHHHHHHHHHhCCCCCe--eeEEEEEee-----CCeeEEEEE
Q 038211 392 AVVYRGIWNGSDVAVKVYFGSEYIE---------GTLKNYQKEIDIIKKLRHPNV--LLFMGAVAS-----QERLGIVTE 455 (605)
Q Consensus 392 g~V~~~~~~~~~~avKv~~~~~~~~---------~~~~~~~~E~~il~~l~h~ni--v~~~~~~~~-----~~~~~lv~e 455 (605)
..|++....|+.|.||......... .....+.+|...+.++...+| +..+.++.. ....+||||
T Consensus 36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 3466777788889999764333111 001136789998888843333 333444432 235789999
Q ss_pred ecCCC-chHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC-------CCcEEEEeecCCc
Q 038211 456 FLPRG-SLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK-------NWTVKVGDFGLSS 526 (605)
Q Consensus 456 ~~~gg-sL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~-------~~~vkl~Dfg~a~ 526 (605)
++++. +|.+++... ....+......++.+++..+.-||..| |+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99876 788887643 244566677789999999999999999 999999999999975 4689999999875
Q ss_pred c
Q 038211 527 L 527 (605)
Q Consensus 527 ~ 527 (605)
.
T Consensus 194 ~ 194 (268)
T PRK15123 194 I 194 (268)
T ss_pred c
Confidence 3
|
|
| >PRK10060 RNase II stability modulator; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.3e-09 Score=118.75 Aligned_cols=118 Identities=20% Similarity=0.238 Sum_probs=90.9
Q ss_pred cccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcch-HHHHHHHHHcCCceEEE
Q 038211 54 DSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSP-HKKIMERLASGQSWSGQ 132 (605)
Q Consensus 54 ~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~-~~~~~~~l~~g~~~~~~ 132 (605)
+....++.+++.+++++ +++|.+|+|+++|+++++++||+.+|++|+++.+++.++..... ...+...+..+..|..+
T Consensus 108 ~~~~~~~~v~~~~~~gI-~i~D~~g~I~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~e 186 (663)
T PRK10060 108 HGLSFAEQVVSEANSVI-VILDSRGNIQRFNRLCEEYTGLKEHDVIGQSVFKLFMSRREAAASRRNIRGFFRSGNAYEVE 186 (663)
T ss_pred HHHHHHHHHHhhCCceE-EEEeCCCCEEEEcHHHHHHHCcCHHHHcCCCHHHHhCChhhHHHHHHHHHHHHhcCCceEEE
Confidence 34456778899998877 99999999999999999999999999999999875555443333 33344556778889999
Q ss_pred EEEEcCCCCEEEEEEEEEEEeeCCe-EEEEEEEEecccccc
Q 038211 133 FPFKKRSGEILMAVVTKSPLYEDGE-LAGFITVSSDAAIFN 172 (605)
Q Consensus 133 ~~~~~k~G~~~~v~~~~~Pi~d~g~-i~g~v~i~~D~t~~~ 172 (605)
.+..+++|..+|+..+..+..++|. ..+++++.+|+|+..
T Consensus 187 ~~~~~~~G~~~~~~~~~~~~~~~g~~~~~~i~~~~DITe~k 227 (663)
T PRK10060 187 RWIKTRKGQRLFLFRNKFVHSGSGKNEIFLICSGTDITEER 227 (663)
T ss_pred EEEEeCCCCEEEEEeeeEEEcCCCCceEEEEEEEEechHHH
Confidence 9999999999987655444333443 467888899998654
|
|
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.6e-09 Score=118.06 Aligned_cols=115 Identities=20% Similarity=0.396 Sum_probs=96.3
Q ss_pred ccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEE
Q 038211 57 GPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFK 136 (605)
Q Consensus 57 ~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~ 136 (605)
+.|+.+++.+++++ +++|.+|+++|+|+++++++||++++++|++...+..+.........+.+.+..++.+..+....
T Consensus 4 ~~~~~i~~~~~~~i-~~~d~~g~~~~~N~~~~~~~G~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (494)
T TIGR02938 4 EAYRQTVDQAPLAI-SITDLKANILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNR 82 (494)
T ss_pred HHHHHHHHhCCceE-EEECCCCcEEEEchhheeecCCCHHHHhCCCchhhcCCCCCHHHHHHHHHHHHhCCcccceeecc
Confidence 45888999999887 89999999999999999999999999999987753322233333556667777888888888888
Q ss_pred cCCCCEEEEEEEEEEEee-CCeEEEEEEEEecccccc
Q 038211 137 KRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFN 172 (605)
Q Consensus 137 ~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~ 172 (605)
+++|+.+|+.....|+++ +|.+.+++.+++|+|+..
T Consensus 83 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIt~~k 119 (494)
T TIGR02938 83 RKDGELYLAELTVAPVLNEAGETTHFLGMHRDITELH 119 (494)
T ss_pred CCCccchhhheeeEEEECCCCCEEEEEEehhhhhHHH
Confidence 999999999999999998 899999999999988754
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >TIGR00229 sensory_box PAS domain S-box | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.9e-08 Score=83.89 Aligned_cols=114 Identities=25% Similarity=0.411 Sum_probs=85.0
Q ss_pred ccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHH-HHHHHHcCCc-eEEEEE
Q 038211 57 GPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKK-IMERLASGQS-WSGQFP 134 (605)
Q Consensus 57 ~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~-~~~~l~~g~~-~~~~~~ 134 (605)
+.++.+++.+++++ +++|.+|+|+++|+++.+++|++.++++|+++.+ +.++........ +...+..+.. ......
T Consensus 3 ~~~~~~~~~~~~~~-~~~d~~~~i~~~n~~~~~~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (124)
T TIGR00229 3 ERYRAIFESSPDAI-IVIDLEGNILYVNPAFEEIFGYSAEELIGRNVLE-LIPEEDREEVRERIERLLEGEREPVSEERR 80 (124)
T ss_pred hHHHHHHhhCCceE-EEEcCCCcEEEEchHHHHHhCCChHHhcCcchhh-hcChhhhHHHHHHHHHHHcCCCCCcceEee
Confidence 35677899998877 8899999999999999999999999999999987 444333333222 2233332222 233444
Q ss_pred EEcCCCCEEEEEEEEEEEeeCCeEEEEEEEEecccccc
Q 038211 135 FKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAAIFN 172 (605)
Q Consensus 135 ~~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~~~ 172 (605)
...++|...|+..+..|+..+|...+++.++.|+++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dit~~~ 118 (124)
T TIGR00229 81 VRRKDGSEIWVEVSVSPIRTNGGELGVVGIVRDITERK 118 (124)
T ss_pred eEcCCCCEEEEEEEEeehhhCCCeeEEEEEeeehhHHH
Confidence 45789999999999999875677889999999988754
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. |
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=6e-09 Score=125.22 Aligned_cols=123 Identities=21% Similarity=0.290 Sum_probs=100.3
Q ss_pred HhcccccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCC--
Q 038211 50 ATTSDSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQ-- 127 (605)
Q Consensus 50 ~~~~~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~-- 127 (605)
+++.+++++|+.+++.+++++ +++|.+|+|+++|+++++++||+.+|++|+++.+ +.++++..........+..++
T Consensus 276 ~~l~~~e~r~~~l~e~~~~~i-~~~d~dG~i~~~N~~~~~l~G~~~~el~g~~~~~-~~~~~d~~~~~~~~~~~~~~~~~ 353 (1092)
T PRK09776 276 KHISESETRFRNAMEYSAIGM-ALVGTEGQWLQVNKALCQFLGYSQEELRGLTFQQ-LTWPEDLNKDLQQVEKLLSGEIN 353 (1092)
T ss_pred HHHHHHHHHHHHHHHhCCceE-EEEcCCCcEEehhHHHHHHhCCCHHHHccCCcee-ccCcchhHhHHHHHHHHHcCCcc
Confidence 345566778999999999888 8999999999999999999999999999999998 445554444334444444443
Q ss_pred ceEEEEEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEecccccccc
Q 038211 128 SWSGQFPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFNSI 174 (605)
Q Consensus 128 ~~~~~~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~~l 174 (605)
.+..+.+..+++|+.+|+..+..|+.+ +|++.+++++++|+|+..+.
T Consensus 354 ~~~~e~~~~~~dG~~~~~~~~~~~~~~~~g~~~~~i~~~~DITerk~~ 401 (1092)
T PRK09776 354 SYSMEKRYYRRDGEVVWALLAVSLVRDTDGTPLYFIAQIEDINELKRT 401 (1092)
T ss_pred ceeeeeEEEcCCCCEEEEEEEEEEEECCCCCEeeehhhHHhhHHHHHH
Confidence 456678888999999999999999998 89999999999999886543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.2e-08 Score=93.39 Aligned_cols=126 Identities=28% Similarity=0.278 Sum_probs=80.1
Q ss_pred EEEEEEE-CCcceEEEEeeccccc------------------------hhhhhhHHHHHHHHHhCCCC--CeeeEEEEEe
Q 038211 393 VVYRGIW-NGSDVAVKVYFGSEYI------------------------EGTLKNYQKEIDIIKKLRHP--NVLLFMGAVA 445 (605)
Q Consensus 393 ~V~~~~~-~~~~~avKv~~~~~~~------------------------~~~~~~~~~E~~il~~l~h~--niv~~~~~~~ 445 (605)
.||.|.. .+..+|||+....... .-......+|.+.|.++..- ++.+.+.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3888876 6778999987532110 01123456899999999765 455666442
Q ss_pred eCCeeEEEEEecC--CCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHH-HHhCCCCceeccCCCCCEEEcCCCcEEEEee
Q 038211 446 SQERLGIVTEFLP--RGSLFKTLHKNYQALDIKRRLRMALDVARGMNY-LHHRNPPIVHRDLKSSNLLVDKNWTVKVGDF 522 (605)
Q Consensus 446 ~~~~~~lv~e~~~--ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~-LH~~~~~iiH~Dik~~Nill~~~~~vkl~Df 522 (605)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|..| |+|+||.+.|||++++ .+.++||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEEec
Confidence 4579999998 65564443322 1123344567788875555 57999 9999999999999887 9999999
Q ss_pred cCCccc
Q 038211 523 GLSSLK 528 (605)
Q Consensus 523 g~a~~~ 528 (605)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.4e-08 Score=122.09 Aligned_cols=123 Identities=24% Similarity=0.329 Sum_probs=96.1
Q ss_pred hcccccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccc--cCCcchHHHHHHHHHcCCc
Q 038211 51 TTSDSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIA--EEFHSPHKKIMERLASGQS 128 (605)
Q Consensus 51 ~~~~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~--~~~~~~~~~~~~~l~~g~~ 128 (605)
++.++.++++.+++++++++ +++|.+|+|+++|+++++++||+.+|++|+++.+++.. .........+.........
T Consensus 530 ~L~~~~~~l~~~l~~~~~~i-~~~D~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (1092)
T PRK09776 530 ALFQEKERLHITLDSIGEAV-VCTDMAMKVTFMNPVAEKMTGWTQEEALGVPLLTVLHITFGDNGPLMENIYSCLTSRSA 608 (1092)
T ss_pred HHHHHHHHHHHHHhccccEE-EEECCCCeEEEEcHHHHHHhCCCHHHHcCCCHHHHcccccCCcchhhHHHHHHHhcCCC
Confidence 34455678899999999887 88999999999999999999999999999999874422 1222222334444444433
Q ss_pred --eEEEEEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEecccccccc
Q 038211 129 --WSGQFPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFNSI 174 (605)
Q Consensus 129 --~~~~~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~~l 174 (605)
+..+....+++|+.+|+..+..|+.+ +|++.|++.+++|+|+.++.
T Consensus 609 ~~~~~~~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~ 657 (1092)
T PRK09776 609 AYLEQDVVLHCRSGGSYDVHYSITPLSTLDGENIGSVLVIQDVTESRKM 657 (1092)
T ss_pred ccccceEEEEeCCCcEEEEEEEeeeeecCCCCEEEEEEEEEecchHHHH
Confidence 44566778999999999999999998 89999999999999986543
|
|
| >PF08447 PAS_3: PAS fold; InterPro: IPR013655 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.2e-08 Score=82.13 Aligned_cols=84 Identities=21% Similarity=0.508 Sum_probs=65.0
Q ss_pred EEEecHHHHHHhCCChhhhcCCC----ccccccccCCcchHHHHHHH--HHcCCceEEEEEEEcCCCCEEEEEEEEEEEe
Q 038211 80 IIYWNRSAESLYGWKDREVFGQR----VTEFLIAEEFHSPHKKIMER--LASGQSWSGQFPFKKRSGEILMAVVTKSPLY 153 (605)
Q Consensus 80 Ii~~N~a~~~l~G~~~~eliGk~----~~~l~~~~~~~~~~~~~~~~--l~~g~~~~~~~~~~~k~G~~~~v~~~~~Pi~ 153 (605)
|+|||+++++++||+++++ |.. +.. +++|++.......+.. +..+..+..+++.++++|+..|+.....+++
T Consensus 1 ~i~~s~~~~~i~G~~~~~~-~~~~~~~~~~-~ihpdD~~~~~~~~~~~~~~~~~~~~~e~R~~~~~G~~~wi~~~~~~~~ 78 (91)
T PF08447_consen 1 IIYWSDNFYEIFGYSPEEI-GKPDFEEWLE-RIHPDDRERVRQAIQQAALQNGEPFEIEYRIRRKDGEYRWIEVRGRPIF 78 (91)
T ss_dssp -EEE-THHHHHHTS-HHHH-TCBEHHHHHH-HB-TTTHHHHHHHHHHHHHHTT-EEEEEEEEEGTTSTEEEEEEEEEEEE
T ss_pred CEEEeHHHHHHhCCCHHHh-ccCCHHHHHh-hcCHHHHHHHHHHHHHHhhccCcceEEEEEEECCCCCEEEEEEEEEEEE
Confidence 7899999999999999999 777 665 4566666665544444 5567789999999999999999999999999
Q ss_pred e-CCeEEEEEEEE
Q 038211 154 E-DGELAGFITVS 165 (605)
Q Consensus 154 d-~g~i~g~v~i~ 165 (605)
+ +|+++.++++.
T Consensus 79 d~~g~~~~~~Gv~ 91 (91)
T PF08447_consen 79 DENGKPIRIIGVI 91 (91)
T ss_dssp TTTS-EEEEEEEE
T ss_pred CCCCCEEEEEEEC
Confidence 8 89998888763
|
The PAS fold appears in archaea, eubacteria and eukarya. The PAS domain contains a sensory box, or S-box domain that occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include haem in the oxygen sensor FixL [], FAD in the redox potential sensor NifL [], and a 4-hydroxycinnamyl chromophore in photoactive yellow protein []. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. This domain has been found in the gene product of the madA gene of the filamentous zygomycete fungus Phycomyces blakesleeanus. It has been shown that MadA encodes a blue-light photoreceptor for phototropism and other light responses. The gene is involved in the phototropic responses associated with sporangiophore growth; they exhibit phototropism by bending toward near-UV and blue wavelengths and away from far-UV wavelengths in a manner that is physiologically similar to plant phototropic responses [].; GO: 0005515 protein binding; PDB: 3NJA_D 3H9W_A 3GDI_B 3ICY_A 3EEH_A 3MR0_B. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.9e-08 Score=99.74 Aligned_cols=193 Identities=17% Similarity=0.221 Sum_probs=129.9
Q ss_pred ceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEE-------eeCCeeE
Q 038211 380 LQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAV-------ASQERLG 451 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~-------~~~~~~~ 451 (605)
...++.||+|+-+.+|-.-. -.+.+-|++.+..... . ..-+..|... .||-+-.-+.|= .....+.
T Consensus 13 i~~gr~LgqGgea~ly~l~e-~~d~VAKIYh~Pppa~--~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGE-VRDQVAKIYHAPPPAA--Q---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred cCCCccccCCccceeeecch-hhchhheeecCCCchH--H---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 34568899999999995322 1234567775543211 1 1122233333 455332211110 1123377
Q ss_pred EEEEecCCCch-HHHH-----HhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCC
Q 038211 452 IVTEFLPRGSL-FKTL-----HKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525 (605)
Q Consensus 452 lv~e~~~ggsL-~~~l-----~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a 525 (605)
+.|..++|..- ..++ ++.+....+....+.+..|+.+.+.||+.| .+-+|+.++|+|+.+++.|.|.|-..-
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccce
Confidence 88888876421 1222 223456888999999999999999999999 999999999999999999999974432
Q ss_pred cccCcccccccCCCCCCccccccccc-----CCCCCchhHHHHHHHHHHHHHcC-CCCCCCC
Q 038211 526 SLKNATYLTAKSGRGTPQWMAPEVLR-----SEPSNEKSDVFSFGVILWELVTA-SIPWNNL 581 (605)
Q Consensus 526 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g-~~Pf~~~ 581 (605)
.+ ..........+|.+.|.+||.-. +..-+...|.|.||+++++++.| ++||.+.
T Consensus 165 qi-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 165 QI-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ee-ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 21 22333445567999999999754 44556778999999999999996 9999864
|
|
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.1e-08 Score=118.64 Aligned_cols=127 Identities=17% Similarity=0.253 Sum_probs=101.4
Q ss_pred chHHHHhcccccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcch-HHHHHHHH
Q 038211 45 DVDEVATTSDSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSP-HKKIMERL 123 (605)
Q Consensus 45 ~l~~~~~~~~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~-~~~~~~~l 123 (605)
++++.++..++.+.+..+++.+++++ +++|.+|+|+++|+++++++||+.++++|+++.+++.++..... ...+...+
T Consensus 124 DiT~~~~~~~~~~~~~~~~~~~~~~i-~~~d~~g~i~~~N~~~~~l~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~ 202 (799)
T PRK11359 124 DASVEMAQKEQTRQLIIAVDHLDRPV-IVLDPERRIVQCNRAFTEMFGYCISEASGMQPDTLLNIPEFPADNRIRLQQLL 202 (799)
T ss_pred eccchhhhHHHHHHHHHHHhcCCCcE-EEEcCCCcEEEEChhhHhhhCCCHHHHCCCChHHhcCCCCCcHHHHHHHHHhh
Confidence 45555555555666777899998887 88999999999999999999999999999999875444333332 33344555
Q ss_pred HcCCceEEEEEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEecccccc
Q 038211 124 ASGQSWSGQFPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFN 172 (605)
Q Consensus 124 ~~g~~~~~~~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~ 172 (605)
..+..+..+....+++|+.+|+.++..|+.+ +|.+.|++.+.+|+|+-+
T Consensus 203 ~~~~~~~~e~~~~~~dG~~~~~~~~~~~v~d~~g~~~~~~~~~~DITerk 252 (799)
T PRK11359 203 WKTARDQDEFLLLTRTGEKIWIKASISPVYDVLAHLQNLVMTFSDITEER 252 (799)
T ss_pred ccCCCCcceeEEeCCCCCEEEEEeeeeeeecCCCceeEEEEEeehhhhHH
Confidence 6666777788888999999999999999987 788999999999998744
|
|
| >COG5002 VicK Signal transduction histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.6e-08 Score=94.91 Aligned_cols=155 Identities=20% Similarity=0.257 Sum_probs=110.4
Q ss_pred chHHHHHHHHhHHhh--hHHH----HHHHHHHHHHHhhhhhchHHHHhcccc-cccHHHHHHhcCCeEEEEEcCCCCEEE
Q 038211 10 LYRDLLDRFEGLEAG--HAKL----REELNDLLLQEKKKNDDVDEVATTSDS-VGPYRSVLESMGHAVHVCTASSEDIIY 82 (605)
Q Consensus 10 ~~~d~~~~~~~l~~g--~~~L----~~~~~~~~l~~~~~~~~l~~~~~~~~~-~~~~~~il~~~~d~ii~v~D~~G~Ii~ 82 (605)
++.|.-+.+.+|..| .+.+ -.+|-++...-..+...+++.++.+++ .+++..++..|.||+ +.+|+.|+|+.
T Consensus 57 pi~~m~kq~~~m~~G~ysr~v~~~g~dEIgeLa~~fn~Lt~~~~~aq~n~e~Er~kL~SvlayMtDGV-iATdRrG~iI~ 135 (459)
T COG5002 57 PITDMRKQAVDMARGNYSRKVKVYGTDEIGELADSFNDLTKRVQEAQANTEQERRKLDSVLAYMTDGV-IATDRRGKIIL 135 (459)
T ss_pred hHHHHHHHHHHHhcCcccccccccCchHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHcCce-EeecCCCcEEE
Confidence 455666777788888 1111 223345555666666667666655554 467999999999998 99999999999
Q ss_pred ecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEcCCCCEEEEEEEEEEEee-CCeEEEE
Q 038211 83 WNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLYE-DGELAGF 161 (605)
Q Consensus 83 ~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~ 161 (605)
+|..|++++|.+.++++|+++.+++--.+.. .+..+ +........+ .+..++.+.+.++.+.+.. .|-+.|+
T Consensus 136 iN~~A~k~L~~~~E~~~~~~i~elL~i~d~y-~~~dL---~e~~~s~lld---~~~~~E~~~lrv~Fs~i~rEsGfisGl 208 (459)
T COG5002 136 INKPALKMLGVSKEDALGRSILELLKIEDTY-TFEDL---VEKNDSLLLD---SSDEEEGYVLRVNFSVIQRESGFISGL 208 (459)
T ss_pred eccHHHHHhCcCHHHHhcccHHHHhCCccce-eHHHH---HhcCCcEEEe---ecCCCccEEEEEEEEEEeeccccccee
Confidence 9999999999999999999999965332322 22222 2223333222 2236778888888888875 8999999
Q ss_pred EEEEecccccc
Q 038211 162 ITVSSDAAIFN 172 (605)
Q Consensus 162 v~i~~D~t~~~ 172 (605)
+++.+|+|+-+
T Consensus 209 IaVlhDvTEqe 219 (459)
T COG5002 209 IAVLHDVTEQE 219 (459)
T ss_pred EEEEecccHHH
Confidence 99999998754
|
|
| >cd00130 PAS PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.5e-07 Score=74.63 Aligned_cols=99 Identities=21% Similarity=0.465 Sum_probs=76.8
Q ss_pred CeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchH-HHHHHHHHcCCceEEEEEEEcCCCCEEEEE
Q 038211 68 HAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPH-KKIMERLASGQSWSGQFPFKKRSGEILMAV 146 (605)
Q Consensus 68 d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~-~~~~~~l~~g~~~~~~~~~~~k~G~~~~v~ 146 (605)
+++ +++|.+|.++++|+++++++|++.++++|+++.+++ ++...... ..+...+..+..+..+......+|...|+.
T Consensus 3 ~~i-~~~d~~~~~~~~n~~~~~~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (103)
T cd00130 3 DGV-IVLDLDGRILYANPAAEQLLGYSPEELIGKSLLDLI-HPEDREELRERLENLLSGGEPVTLEVRLRRKDGSVIWVL 80 (103)
T ss_pred ceE-EEECCCCcEEEECHHHHHHhCCCHHHHcCccHHHhc-CCccchHHHHHHHHHHhcCcCeEEEEEEEccCCCEEEEE
Confidence 445 889999999999999999999999999999988744 33433332 333334444556666777778889999999
Q ss_pred EEEEEEee-CCeEEEEEEEEecc
Q 038211 147 VTKSPLYE-DGELAGFITVSSDA 168 (605)
Q Consensus 147 ~~~~Pi~d-~g~i~g~v~i~~D~ 168 (605)
+...|+.+ +|...+++.+.+|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~di 103 (103)
T cd00130 81 VSLTPIRDEGGEVIGLLGVVRDI 103 (103)
T ss_pred EEEEEEecCCCCEEEEEEEEecC
Confidence 99999887 77888999988884
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.2e-07 Score=90.63 Aligned_cols=106 Identities=26% Similarity=0.279 Sum_probs=82.2
Q ss_pred hhHHHHHHHHHhCCCC--CeeeEEEEEeeC----CeeEEEEEecCCC-chHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Q 038211 420 KNYQKEIDIIKKLRHP--NVLLFMGAVASQ----ERLGIVTEFLPRG-SLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492 (605)
Q Consensus 420 ~~~~~E~~il~~l~h~--niv~~~~~~~~~----~~~~lv~e~~~gg-sL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~L 492 (605)
....+|...+..+... .....+++.... ...+||+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 4567888888887433 234455555432 2458999999874 78888876422 66667788999999999999
Q ss_pred HhCCCCceeccCCCCCEEEcCCC---cEEEEeecCCccc
Q 038211 493 HHRNPPIVHRDLKSSNLLVDKNW---TVKVGDFGLSSLK 528 (605)
Q Consensus 493 H~~~~~iiH~Dik~~Nill~~~~---~vkl~Dfg~a~~~ 528 (605)
|+.| |+|+|+++.|||++.++ .+.|+||+-++..
T Consensus 135 H~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 99999999999999887 8999999977643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.7e-07 Score=96.80 Aligned_cols=164 Identities=18% Similarity=0.291 Sum_probs=122.6
Q ss_pred EEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee----CCeeEEEEEecCC-CchHH
Q 038211 392 AVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS----QERLGIVTEFLPR-GSLFK 464 (605)
Q Consensus 392 g~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----~~~~~lv~e~~~g-gsL~~ 464 (605)
.+.|++.. +|..|++|.+...+. ........-++.|+++.|+|+|++.++|.+ +..+++|++|.++ ++|++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 57788875 688899998733221 112223455788999999999999999873 4579999999986 47766
Q ss_pred HHHhh--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 465 TLHKN--------------YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 465 ~l~~~--------------~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
+.-.. ....+++.+|.|+.||..||.++|+.| +..+-|.+.+||++.+.+++|...|...+...
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 65321 235778999999999999999999999 99999999999999988999987776544332
Q ss_pred ccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCC
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASI 576 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 576 (605)
.. . +.+.+ -.+-|.=.||.+++-|.+|..
T Consensus 446 d~------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DP------------T--EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC------------C--cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 21 0 11211 235689999999999999844
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=8.2e-08 Score=92.10 Aligned_cols=134 Identities=23% Similarity=0.272 Sum_probs=95.9
Q ss_pred ceEeeeecccCcEEEEEEEE-CCcceEEEEeeccccc--------------------hhhhhhHHHHHHHHHhCCCC--C
Q 038211 380 LQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYI--------------------EGTLKNYQKEIDIIKKLRHP--N 436 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~--------------------~~~~~~~~~E~~il~~l~h~--n 436 (605)
+.++.+||-|--+.||.|.+ +|.+++||.=...... .-.....++|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 35678999999999999987 5889999964221110 11133467899999999544 5
Q ss_pred eeeEEEEEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc
Q 038211 437 VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT 516 (605)
Q Consensus 437 iv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~ 516 (605)
+.+.+++ ++..+|||+++|-.|...-. +......++..|+.-+.-+-..| |||+|+++-||+++++|.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecCCC
Confidence 6666544 57789999999876654431 23333344555555555555788 999999999999999999
Q ss_pred EEEEeecCC
Q 038211 517 VKVGDFGLS 525 (605)
Q Consensus 517 vkl~Dfg~a 525 (605)
+.++||--+
T Consensus 241 ~~vIDwPQ~ 249 (304)
T COG0478 241 IVVIDWPQA 249 (304)
T ss_pred EEEEeCccc
Confidence 999999644
|
|
| >PRK11073 glnL nitrogen regulation protein NR(II); Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.2e-07 Score=98.77 Aligned_cols=111 Identities=18% Similarity=0.169 Sum_probs=83.9
Q ss_pred ccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEE
Q 038211 55 SVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFP 134 (605)
Q Consensus 55 ~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~ 134 (605)
+...++++++++++++ +++|.+|+|+++|++|++++||+.++++|+++.+++ +... .....+...+..+..+.....
T Consensus 5 ~~~~~~~il~~~~~gi-~~~d~~~~i~~~N~a~~~~~g~~~~~~~g~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~ 81 (348)
T PRK11073 5 TLPDAGQILNSLINSI-LLLDDDLAIHYANPAAQQLLAQSSRKLFGTPLPELL-SYFS-LNIELMRESLQAGQGFTDNEV 81 (348)
T ss_pred CcchHHHHHhcCcCeE-EEECCCCeEeeEcHHHHHHhCCCHHHHcCCCHHHHc-Ccch-hhHHHHHHHHHcCCcccccce
Confidence 3456789999999988 889999999999999999999999999999999844 3221 123344456666665554444
Q ss_pred EEcCCCCEEEEEEEEEEEeeCCeEEEEEEEEecccccc
Q 038211 135 FKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAAIFN 172 (605)
Q Consensus 135 ~~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~~~ 172 (605)
.+.++|+.+|+.++.+|+.+ .+++..++|+++..
T Consensus 82 ~~~~~g~~~~~~~~~~~~~~----~~~~~~~~dit~~~ 115 (348)
T PRK11073 82 TLVIDGRSHILSLTAQRLPE----GMILLEMAPMDNQR 115 (348)
T ss_pred EEEECCceEEEEEEEEEccC----ceeEEEEechhHHH
Confidence 55679999999999999872 24566788876643
|
|
| >TIGR02966 phoR_proteo phosphate regulon sensor kinase PhoR | Back alignment and domain information |
|---|
Probab=98.64 E-value=8.2e-08 Score=98.79 Aligned_cols=106 Identities=22% Similarity=0.325 Sum_probs=80.5
Q ss_pred cccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEE
Q 038211 56 VGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPF 135 (605)
Q Consensus 56 ~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~ 135 (605)
.++|+.+++++++++ +++|.+|+|++||++|++++||+.++++|+++.+++.+ ..+...+..+.. ......
T Consensus 5 ~~~l~~~~~~~~~~i-~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~-------~~~~~~l~~~~~-~~~~~~ 75 (333)
T TIGR02966 5 LSRFRAAAQALPDAV-VVLDEEGQIEWCNPAAERLLGLRWPDDLGQRITNLIRH-------PEFVEYLAAGRF-SEPLEL 75 (333)
T ss_pred HHHHHHHHHhCcCcE-EEECCCCcEEEEcHHHHHHhCCChHHHcCCcHHHHccC-------HHHHHHHHhccc-CCCeEe
Confidence 356889999999988 99999999999999999999999999999999985422 122333333322 223445
Q ss_pred EcCCCCEEEEEEEEEEEeeCCeEEEEEEEEecccccccc
Q 038211 136 KKRSGEILMAVVTKSPLYEDGELAGFITVSSDAAIFNSI 174 (605)
Q Consensus 136 ~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~~~~l 174 (605)
..++|...|+.+...|+.+.+ ++.+++|+++.+++
T Consensus 76 ~~~~~~~~~~~~~~~p~~~~~----~~~~~~dit~~~~~ 110 (333)
T TIGR02966 76 PSPINSERVLEIRIAPYGEEQ----KLLVARDVTRLRRL 110 (333)
T ss_pred ecCCCCceEEEEEEEEcCCCc----eEEEEeCchHHHHH
Confidence 567888889999999987643 67788998876543
|
Members of this protein family are the regulatory histidine kinase PhoR associated with the phosphate ABC transporter in most Proteobacteria. Related proteins from Gram-positive organisms are not included in this model. The phoR gene usually is adjacent to the response regulator phoB gene (TIGR02154). |
| >COG3604 FhlA Transcriptional regulator containing GAF, AAA-type ATPase, and DNA binding domains [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=9e-09 Score=105.67 Aligned_cols=50 Identities=12% Similarity=-0.008 Sum_probs=44.9
Q ss_pred CCCcccccc-ccchhhhhcchhhhhhhceeccCCCcc----ccCCCCCcccCCCCccc
Q 038211 199 QPHQPQIAQ-VPNIASSVTNLTAKVLEKMHIGETGTY----VGGDDGSLRQNGLRYKS 251 (605)
Q Consensus 199 ~~~~~~~~~-i~~~a~~va~~~~~~~~vli~GEsGtg----~~~~h~~s~~~~~~f~~ 251 (605)
++++|+.+. +++.+..||. ++++|||.|||||| |+.||..|+|+++||=.
T Consensus 225 iIG~S~am~~ll~~i~~VA~---Sd~tVLi~GETGtGKElvAraIH~~S~R~~kPfV~ 279 (550)
T COG3604 225 IIGRSPAMRQLLKEIEVVAK---SDSTVLIRGETGTGKELVARAIHQLSPRRDKPFVK 279 (550)
T ss_pred ceecCHHHHHHHHHHHHHhc---CCCeEEEecCCCccHHHHHHHHHhhCcccCCCcee
Confidence 556666666 9999999999 99999999999999 99999999999999943
|
|
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.8e-07 Score=108.64 Aligned_cols=120 Identities=18% Similarity=0.283 Sum_probs=91.7
Q ss_pred hcccccccHHHHHHhcCCeEEEEEcCCCCEEEe-cHHHHHHhCCChhhhcCCCccccccccCCcch--------------
Q 038211 51 TTSDSVGPYRSVLESMGHAVHVCTASSEDIIYW-NRSAESLYGWKDREVFGQRVTEFLIAEEFHSP-------------- 115 (605)
Q Consensus 51 ~~~~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~-N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~-------------- 115 (605)
++.++.++|+.+++++++++ +++|.+|+|+++ |+++++++||+.+|++|+++.+ +.++.....
T Consensus 326 ~L~~se~~l~~l~~~~~~~i-~~~d~~g~i~~~nn~~~~~~~G~~~~e~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 403 (807)
T PRK13560 326 ELLEKEDMLRAIIEAAPIAA-IGLDADGNICFVNNNAAERMLGWSAAEVMGKPLPG-MDPELNEEFWCGDFQEWYPDGRP 403 (807)
T ss_pred HHHHHHHHHHHHHHhCcccE-EEEcCCCCEEEecCHHHHHHhCCCHHHHcCCCccc-cChhhhhhhhhchhhhcCCcCCc
Confidence 44455678999999999888 899999999987 6888899999999999998875 222111111
Q ss_pred ----HHHHHHHHHcCCceE-EEEEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEecccccc
Q 038211 116 ----HKKIMERLASGQSWS-GQFPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFN 172 (605)
Q Consensus 116 ----~~~~~~~l~~g~~~~-~~~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~ 172 (605)
...+...+..++.+. .+....+++|..+|+.++..|+++ +|+++|++++++|+|+..
T Consensus 404 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~p~~d~~g~~~~~~~~~~DITerk 466 (807)
T PRK13560 404 MAFDACPMAKTIKGGKIFDGQEVLIEREDDGPADCSAYAEPLHDADGNIIGAIALLVDITERK 466 (807)
T ss_pred chhhhhhHHHHHhcCCcccCceEEEEcCCCCeEEEEEEEeeeECCCCCEEEEEEEeehhhhHH
Confidence 011223355665544 356777899999999999999998 899999999999988743
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.5e-06 Score=81.65 Aligned_cols=139 Identities=19% Similarity=0.037 Sum_probs=101.1
Q ss_pred cccCcEEEEEEEECCcceEEEEeeccc----cchhhhhhHHHHHHHHHhCCCC--CeeeEEEEEee----CCeeEEEEEe
Q 038211 387 GLGSYAVVYRGIWNGSDVAVKVYFGSE----YIEGTLKNYQKEIDIIKKLRHP--NVLLFMGAVAS----QERLGIVTEF 456 (605)
Q Consensus 387 G~G~fg~V~~~~~~~~~~avKv~~~~~----~~~~~~~~~~~E~~il~~l~h~--niv~~~~~~~~----~~~~~lv~e~ 456 (605)
|+||-+.|+.....|..+-+|.-.... ..+--...|.+|+..|+.+..- .+.+...+-.. .-+.+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 568888999988888778888653110 0022346789999999999532 24444422111 1246799998
Q ss_pred cCC-CchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc--EEEEeecCCcc
Q 038211 457 LPR-GSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT--VKVGDFGLSSL 527 (605)
Q Consensus 457 ~~g-gsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~--vkl~Dfg~a~~ 527 (605)
++| -+|.+++... ....+......++.+++.++.-||+.| +.|+|+.+.|||++.+|. ++++||.-++.
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 854 5888877653 245677777889999999999999999 999999999999987677 99999976643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.8e-06 Score=83.73 Aligned_cols=139 Identities=14% Similarity=0.186 Sum_probs=85.6
Q ss_pred eeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCC--eeeEEEEEeeCCeeEEEEEecCCCc
Q 038211 384 EEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN--VLLFMGAVASQERLGIVTEFLPRGS 461 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~ggs 461 (605)
..||.|..+.||+. .+..+++|+..... ......+|.++++.+..-. +.+.+.+....+..++|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999984 35678889875422 2344688999999985433 4677777777778899999998863
Q ss_pred -hHHHH--------------Hh-----hc---CCCCHHH-HHHHHHH----------HHH-HHHHHH--hCCCCceeccC
Q 038211 462 -LFKTL--------------HK-----NY---QALDIKR-RLRMALD----------VAR-GMNYLH--HRNPPIVHRDL 504 (605)
Q Consensus 462 -L~~~l--------------~~-----~~---~~~~~~~-~~~~~~q----------i~~-aL~~LH--~~~~~iiH~Di 504 (605)
+...+ .+ +. ....... ...+..+ +.. ...+|. ...+.++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 11111 00 00 0001000 0011000 111 112222 22233789999
Q ss_pred CCCCEEEcCCCcEEEEeecCCcccC
Q 038211 505 KSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 505 k~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
.|.||++++++ +.++||+.+..+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~Gd 184 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGYGN 184 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCcCC
Confidence 99999999888 9999999886543
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK11360 sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=5.8e-07 Score=100.54 Aligned_cols=116 Identities=22% Similarity=0.306 Sum_probs=90.1
Q ss_pred cccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceE-EE
Q 038211 54 DSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWS-GQ 132 (605)
Q Consensus 54 ~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~-~~ 132 (605)
+....++.+++++++++ +++|.+|+|+++|+++++++||+.++++|+++.++ +++. ......+...+..+..+. .+
T Consensus 259 ~~~~~~~~i~~~~~~~i-~~~d~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~ 335 (607)
T PRK11360 259 ETRSLNELILESIADGV-IAIDRQGKITTMNPAAEVITGLQRHELVGKPYSEL-FPPN-TPFASPLLDTLEHGTEHVDLE 335 (607)
T ss_pred HHHHHHHHHHHhccCeE-EEEcCCCCEEEECHHHHHHhCCChHHhcCCcHHHH-cCCc-hhHHHHHHHHHhcCCCccceE
Confidence 33456778999998888 89999999999999999999999999999999984 3322 222334455555555443 34
Q ss_pred EEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEeccccccc
Q 038211 133 FPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFNS 173 (605)
Q Consensus 133 ~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~~ 173 (605)
+...+++|..+ +.++..|+++ +|++.|++.+++|+|+..+
T Consensus 336 ~~~~~~~~~~~-~~~~~~~i~~~~g~~~~~i~~~~Dite~~~ 376 (607)
T PRK11360 336 ISFPGRDRTIE-LSVSTSLLHNTHGEMIGALVIFSDLTERKR 376 (607)
T ss_pred EEEEcCCCcEE-EEEEEeeEEcCCCCEEEEEEEEeechHHHH
Confidence 55667778776 8899999997 8999999999999887643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.3e-06 Score=80.74 Aligned_cols=140 Identities=16% Similarity=0.127 Sum_probs=92.5
Q ss_pred ccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccch-hhhhh------HHHHHHHHHhCC---CCCeeeEEEEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIE-GTLKN------YQKEIDIIKKLR---HPNVLLFMGAV 444 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~-~~~~~------~~~E~~il~~l~---h~niv~~~~~~ 444 (605)
+.-.+|.+.+++-......|.+-..++..+.+|......... ..... ..+.+..+..+. ......++.+.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 344678888888888888888888889999999875533211 11111 123333333332 22223322222
Q ss_pred e-----eCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEE
Q 038211 445 A-----SQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKV 519 (605)
Q Consensus 445 ~-----~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl 519 (605)
+ -....+|+|||++|..|.++.. +++ .+...|..++..||..| +.|+|.+|.|++++.+ .+++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~-~i~i 175 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNN-GIRI 175 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECC-cEEE
Confidence 2 1234678999999988765532 222 24456778899999999 9999999999999855 5999
Q ss_pred EeecCCc
Q 038211 520 GDFGLSS 526 (605)
Q Consensus 520 ~Dfg~a~ 526 (605)
+||+..+
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=7.1e-07 Score=103.74 Aligned_cols=112 Identities=21% Similarity=0.450 Sum_probs=83.6
Q ss_pred ccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHH-HHHcCC----ceEE
Q 038211 57 GPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIME-RLASGQ----SWSG 131 (605)
Q Consensus 57 ~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~-~l~~g~----~~~~ 131 (605)
..+..+++.+++++ +++|.+|+|++||+++++++||+.+|++|+++.+ +.++........... ....+. .+..
T Consensus 12 ~~~~~~le~~~~~i-~~~d~~g~i~~~N~~~~~l~G~s~eeliG~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (799)
T PRK11359 12 GIFFPALEQNMMGA-VLINENDEVLFFNPAAEKLWGYKREEVIGNNIDM-LIPRDLRPAHPEYIRHNREGGKARVEGMSR 89 (799)
T ss_pred hhHHHHHHhhcCcE-EEEcCCCeEEEEcHHHHHHhCCCHHHHcCCCHHH-hcCccccccchHHHhhhhccCCccccccce
Confidence 34567788888888 8899999999999999999999999999999998 444443333222222 222222 2344
Q ss_pred EEEEEcCCCCEEEEEEEEEEEeeCCeEEEEEEEEeccccc
Q 038211 132 QFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAAIF 171 (605)
Q Consensus 132 ~~~~~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~~ 171 (605)
+....+++|..+|+.++..|+..+|. .+++.+.+|+|+-
T Consensus 90 e~~~~~~dG~~~~v~~~~~~~~~~g~-~~~~~~~~DiT~~ 128 (799)
T PRK11359 90 ELQLEKKDGSKIWTRFALSKVSAEGK-VYYLALVRDASVE 128 (799)
T ss_pred eeEEecCCcCEEEEEEEeeeeccCCc-eEEEEEEeeccch
Confidence 77888999999999999988755665 4568888998864
|
|
| >COG2204 AtoC Response regulator containing CheY-like receiver, AAA-type ATPase, and DNA-binding domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.6e-08 Score=103.95 Aligned_cols=50 Identities=12% Similarity=0.064 Sum_probs=44.6
Q ss_pred CCCcccccc-ccchhhhhcchhhhhhhceeccCCCcc----ccCCCCCcccCCCCccc
Q 038211 199 QPHQPQIAQ-VPNIASSVTNLTAKVLEKMHIGETGTY----VGGDDGSLRQNGLRYKS 251 (605)
Q Consensus 199 ~~~~~~~~~-i~~~a~~va~~~~~~~~vli~GEsGtg----~~~~h~~s~~~~~~f~~ 251 (605)
++++|+.|+ +.+.+.+||. ++++|||+|||||| |++||..|+|.++||=.
T Consensus 143 liG~S~am~~l~~~i~kvA~---s~a~VLI~GESGtGKElvAr~IH~~S~R~~~PFVa 197 (464)
T COG2204 143 LVGESPAMQQLRRLIAKVAP---SDASVLITGESGTGKELVARAIHQASPRAKGPFIA 197 (464)
T ss_pred ceecCHHHHHHHHHHHHHhC---CCCCEEEECCCCCcHHHHHHHHHhhCcccCCCcee
Confidence 555555555 9999999999 99999999999999 99999999999999944
|
|
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=98.43 E-value=1e-06 Score=94.90 Aligned_cols=114 Identities=24% Similarity=0.235 Sum_probs=75.7
Q ss_pred hcccccccHHHHHHhcCCeEEEEEcC-CCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHH-HHHHcCCc
Q 038211 51 TTSDSVGPYRSVLESMGHAVHVCTAS-SEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIM-ERLASGQS 128 (605)
Q Consensus 51 ~~~~~~~~~~~il~~~~d~ii~v~D~-~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~-~~l~~g~~ 128 (605)
++.+.+++|+.+++.+++++ +++|. +|+|+++|+++++++||+.+|++|+++.++ +++.+.......+ .....+..
T Consensus 127 ~l~~~e~r~~~l~e~~~~~i-~~~d~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~~-~~~~~~~~~~~~l~~~~~~g~~ 204 (442)
T TIGR02040 127 TLREMETRYRVVLEVSSDAV-LLVDMSTGRIVEANSAAAALLGGVGQSLVGRAFPQE-FEGRRREELMLTLRNVRATGSA 204 (442)
T ss_pred HHHHHHHHHHHHHhhCCceE-EEEECCCCEEEEEcHHHHHHhCcCHHHHcCCCHHHh-CCHHHHHHHHHHHHHHHhcCCC
Confidence 34445568999999999888 88887 899999999999999999999999999884 4444444333333 33444544
Q ss_pred eEEEEEEEcCCCCEEEEEEEEEEEeeCCeEEEEEEEEecccc
Q 038211 129 WSGQFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAAI 170 (605)
Q Consensus 129 ~~~~~~~~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~ 170 (605)
...++. .+++|..+ .+..+++..+|. ..++..++|+++
T Consensus 205 ~~~~~~-~~~~~~~~--~~~~~~~~~~~~-~~~l~~~~dit~ 242 (442)
T TIGR02040 205 APVRIL-LRRSQKRL--LVVVSVFRQDGE-SLFLCQLSPAGA 242 (442)
T ss_pred cceEEE-EcCCCeEE--EEEEEEEEeCCc-eEEEEEEcccch
Confidence 433333 23344433 345556655443 355666777543
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.7e-06 Score=77.85 Aligned_cols=133 Identities=26% Similarity=0.272 Sum_probs=93.8
Q ss_pred eEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeee-EEEEEeeCCeeEEEEEecCC
Q 038211 381 QLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLL-FMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 381 ~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~-~~~~~~~~~~~~lv~e~~~g 459 (605)
...+.|++|.+|.||++.+.+..+|+|+-..+ .....+..|+++|..+..-++.+ ++.+. .-++.|||+.|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G 96 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDG 96 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcC
Confidence 45678999999999999999999999985443 34567889999999998766654 44332 34556999999
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCC-CCEEEcCCCcEEEEeecCCcccCcc
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKS-SNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~-~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
..|.+.-... +.+++. .++.+---|-..| |-|+.|.- ...++..++.+.|+||..|+....+
T Consensus 97 ~~L~~~~~~~----~rk~l~----~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p 159 (201)
T COG2112 97 RPLGKLEIGG----DRKHLL----RVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKP 159 (201)
T ss_pred cchhhhhhcc----cHHHHH----HHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhhccCC
Confidence 8887665421 333333 4455544556678 99998864 4444445559999999998855433
|
|
| >PF12860 PAS_7: PAS fold | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.6e-06 Score=74.58 Aligned_cols=101 Identities=23% Similarity=0.389 Sum_probs=69.6
Q ss_pred HHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhh-cCCCccccccc-------c-CC-cchHHHHHHHHHcCCceEEE
Q 038211 63 LESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREV-FGQRVTEFLIA-------E-EF-HSPHKKIMERLASGQSWSGQ 132 (605)
Q Consensus 63 l~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~el-iGk~~~~l~~~-------~-~~-~~~~~~~~~~l~~g~~~~~~ 132 (605)
|++|++|+ ++.|.+|++++||++|.+++|++.+.+ .|.++.+++.. . .. .......+......... .
T Consensus 1 Ld~l~~Gv-~v~D~~~rl~~~N~~~~~l~~~~~~~~~~G~~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~--~ 77 (115)
T PF12860_consen 1 LDSLPQGV-AVFDSDGRLVFWNQRFRELFGLPPEMLRPGASFRDLLRRLAERGEFPPGDPEAWVRQRLARLRRRQPR--S 77 (115)
T ss_pred CCCcCceE-EEEcCCCeEEeEcHHHHHHhCCCHHHhcCCCCHHHHHHHHHHcCCCCCCCHHHHHHHHHHHHhcCCCc--e
Confidence 46788888 999999999999999999999999998 89998874411 1 11 11123333333343333 2
Q ss_pred EEEEcCCCCEEEEEEEEEEEeeCCeEEEEEEEEecccccc
Q 038211 133 FPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAAIFN 172 (605)
Q Consensus 133 ~~~~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~~~ 172 (605)
......+|+.+ .++..|+-+ | |+|.+++|+|+..
T Consensus 78 ~~~~~~dgr~l--~~~~~~~~~-G---g~v~~~~DVT~~~ 111 (115)
T PF12860_consen 78 FELRLPDGRWL--EVRAQPLPD-G---GFVLTFTDVTERR 111 (115)
T ss_pred eEEECCCCEEE--EEEeEECCC-C---CEEEEEEeCCHHH
Confidence 34456788766 567777644 4 6888899988754
|
|
| >PF14598 PAS_11: PAS domain; PDB: 1P97_A 3F1O_A 2A24_A 3H7W_A 3F1P_A 3H82_A 3F1N_A 4F3L_B 4DJ3_A 2KDK_A | Back alignment and domain information |
|---|
Probab=98.37 E-value=8.3e-06 Score=69.41 Aligned_cols=96 Identities=18% Similarity=0.274 Sum_probs=75.0
Q ss_pred EEEcCCCCEEEecHH-HHHHhCCChhhhcCCCccccccccCCcch-HHH-HHHHHHcCCceEEEEEEEcCCCCEEEEEEE
Q 038211 72 VCTASSEDIIYWNRS-AESLYGWKDREVFGQRVTEFLIAEEFHSP-HKK-IMERLASGQSWSGQFPFKKRSGEILMAVVT 148 (605)
Q Consensus 72 ~v~D~~G~Ii~~N~a-~~~l~G~~~~eliGk~~~~l~~~~~~~~~-~~~-~~~~l~~g~~~~~~~~~~~k~G~~~~v~~~ 148 (605)
.-.+.||+|+++-+. ...++||.++|++|+++.+ ++++++... ... ....+..|.....-++++.++|..+|+...
T Consensus 6 trhs~dgki~~~d~~~v~~~lgy~~~eLvG~s~y~-~~H~~D~~~~~~~~~~~~~~~g~~~~~~yR~~~k~g~~vwvqt~ 84 (111)
T PF14598_consen 6 TRHSLDGKITYVDSRAVSSLLGYLPEELVGRSIYD-FVHPDDLQRVLKQHHREVLQKGQSVSPYYRFRTKNGGYVWVQTK 84 (111)
T ss_dssp EEEETTSBEEEEETTHHHHHHSS-HHHHTTSBGGG-GBSCCTHHHHHHHHHHHHHHHSSEEEEEEEEE-TTSSEEEEEEE
T ss_pred EEECCCcEEEEEcCccChhhcCCCcHHHcCCchHH-hCCHhhhhhHHHHHHHHHhhCCCcCcceEEEEecCCcEEEEEEE
Confidence 556899999999999 5999999999999999999 566666653 443 445567788777778999999999999999
Q ss_pred EEEEee--CCeEEEEEEEEecc
Q 038211 149 KSPLYE--DGELAGFITVSSDA 168 (605)
Q Consensus 149 ~~Pi~d--~g~i~g~v~i~~D~ 168 (605)
..++++ .++...++++-+=+
T Consensus 85 ~~~~~n~~~~~~~~Iv~~n~vl 106 (111)
T PF14598_consen 85 ATLFYNPWTSKPEFIVCTNTVL 106 (111)
T ss_dssp EEEEEETTTTCEEEEEEEEEEE
T ss_pred EEEEECCCCCCccEEEEEEEEe
Confidence 999986 56666666665433
|
... |
| >PF00158 Sigma54_activat: Sigma-54 interaction domain; InterPro: IPR002078 Some bacterial regulatory proteins activate the expression of genes from promoters recognised by core RNA polymerase associated with the alternative sigma-54 factor | Back alignment and domain information |
|---|
Probab=98.31 E-value=6.8e-08 Score=88.73 Aligned_cols=49 Identities=16% Similarity=0.127 Sum_probs=40.4
Q ss_pred Ccccccc-ccchhhhhcchhhhhhhceeccCCCcc----ccCCCCCcccCCCCcccc
Q 038211 201 HQPQIAQ-VPNIASSVTNLTAKVLEKMHIGETGTY----VGGDDGSLRQNGLRYKSF 252 (605)
Q Consensus 201 ~~~~~~~-i~~~a~~va~~~~~~~~vli~GEsGtg----~~~~h~~s~~~~~~f~~~ 252 (605)
+.+..++ +.+.++++|. .+.||||+||+||| |+.||+.|+|+++||=.+
T Consensus 3 G~s~~m~~~~~~~~~~a~---~~~pVlI~GE~GtGK~~lA~~IH~~s~r~~~pfi~v 56 (168)
T PF00158_consen 3 GESPAMKRLREQAKRAAS---SDLPVLITGETGTGKELLARAIHNNSPRKNGPFISV 56 (168)
T ss_dssp --SHHHHHHHHHHHHHTT---STS-EEEECSTTSSHHHHHHHHHHCSTTTTS-EEEE
T ss_pred eCCHHHHHHHHHHHHHhC---CCCCEEEEcCCCCcHHHHHHHHHHhhhcccCCeEEE
Confidence 3444455 9999999999 99999999999999 999999999999999553
|
These have a conserved domain of about 230 residues involved in the ATP-dependent [, ] interaction with sigma-54. About half of the proteins in which this domain is found (algB, dcdT, flbD, hoxA, hupR1, hydG, ntrC, pgtA and pilR) belong to signal transduction two-component systems [] and possess a domain that can be phosphorylated by a sensor-kinase protein in their N-terminal section. Almost all of these proteins possess a helix-turn-helix DNA-binding domain in their C-terminal section. The domain which interacts with the sigma-54 factor has an ATPase activity. This may be required to promote a conformational change necessary for the interaction []. The domain contains an atypical ATP-binding motif A (P-loop) as well as a form of motif B. The two ATP-binding motifs are located in the N-terminal section of the domain.; GO: 0005524 ATP binding, 0008134 transcription factor binding, 0006355 regulation of transcription, DNA-dependent, 0005622 intracellular; PDB: 1NY6_K 3M0E_G 1NY5_A 1OJL_A 3DZD_B 2C9C_A 2C98_A 2C96_A 2BJV_A 2C99_A .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.31 E-value=8.5e-06 Score=80.23 Aligned_cols=139 Identities=18% Similarity=0.138 Sum_probs=84.6
Q ss_pred ecccCc-EEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCeeEEEEEecCCCchH
Q 038211 386 IGLGSY-AVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERLGIVTEFLPRGSLF 463 (605)
Q Consensus 386 LG~G~f-g~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ggsL~ 463 (605)
|..|.. ..||+....+..+.+|+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 334444 7899987766778888764332 234678999988883 444567787777666789999999987765
Q ss_pred HHHH----------------h---hc---CCCCHH--HHHHHHH--------------------HHHHHHHHHHh-----
Q 038211 464 KTLH----------------K---NY---QALDIK--RRLRMAL--------------------DVARGMNYLHH----- 494 (605)
Q Consensus 464 ~~l~----------------~---~~---~~~~~~--~~~~~~~--------------------qi~~aL~~LH~----- 494 (605)
.... + .. ..+... ....... .+...++.|-.
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 3310 0 00 011100 0000000 01111222211
Q ss_pred CCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 495 ~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
..+.++|+|+.|.|||+++++.+.|+||+.+....
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~gd 195 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVAD 195 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccccc
Confidence 11238999999999999998778899999876543
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG3290 CitA Signal transduction histidine kinase regulating citrate/malate metabolism [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.8e-06 Score=90.23 Aligned_cols=106 Identities=21% Similarity=0.378 Sum_probs=82.5
Q ss_pred HHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChh--hhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEc
Q 038211 60 RSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDR--EVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKK 137 (605)
Q Consensus 60 ~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~--eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~ 137 (605)
.++|+++.+|+ +++|..|.|..+|.+|++|+|+... +++|+++.+++.|..+ +...+..+++...+.. +
T Consensus 218 ~A~l~si~EGv-iAvd~~G~It~~N~~A~~ll~~~~~~~~~ig~~i~~v~~p~~~------l~~vl~~~~~~~~~e~--~ 288 (537)
T COG3290 218 QAMLQSIKEGV-IAVDKKGVITLINQAAQKLLGLRQPSGDPIGRSIVEVLPPDSD------LPEVLETGKPQHDEEI--R 288 (537)
T ss_pred HHHHHHhhceE-EEECCCCeEeehhHHHHHHhcccCcCcccccccceEeeccccC------cHHHHhcCCcccchhh--h
Confidence 45678887777 9999999999999999999999876 7999999995433222 2445667776554332 3
Q ss_pred CCCCEEEEEEEEEEEeeCCeEEEEEEEEeccccccccCC
Q 038211 138 RSGEILMAVVTKSPLYEDGELAGFITVSSDAAIFNSINP 176 (605)
Q Consensus 138 k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~~~~l~~ 176 (605)
-+|+.+ .++..||..+|+++|+|..|||-+++.+|.+
T Consensus 289 ~ng~~~--i~nr~pI~~~~~~~GaI~tFRdktei~~L~e 325 (537)
T COG3290 289 INGRLL--VANRVPIRSGGQIVGAIITFRDKTEIKKLTE 325 (537)
T ss_pred cCCeEE--EEEeccEEECCEEeEEEEEEecHHHHHHHHH
Confidence 356654 5789999999999999999999999988865
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.31 E-value=7.9e-06 Score=77.93 Aligned_cols=137 Identities=23% Similarity=0.157 Sum_probs=91.5
Q ss_pred eeecccCcEEEEEEEE-CCcceEEEEeeccccchhh----------------------hhhHHHHHHHHHhCC--CCCee
Q 038211 384 EEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIEGT----------------------LKNYQKEIDIIKKLR--HPNVL 438 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~~~~----------------------~~~~~~E~~il~~l~--h~niv 438 (605)
..|..|-.+.||+|.. .+..+|+|++...-..... ......|+.-|+++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 3677788889999875 5788999998643221111 012345777888773 44455
Q ss_pred eEEEEEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCCCCEEEcCCCcE
Q 038211 439 LFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH-RNPPIVHRDLKSSNLLVDKNWTV 517 (605)
Q Consensus 439 ~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~~~iiH~Dik~~Nill~~~~~v 517 (605)
+-+.+. .-.|||||+... ..-.-.-....+.......+..++++.+.-|-. .+ +||+||+.=|||+. ++.+
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~-g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDD-GLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred Cceeec----CCeEEEEeccCC-CCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-CCeE
Confidence 555554 347999999543 110000011223333566678888888888876 78 99999999999999 8899
Q ss_pred EEEeecCCccc
Q 038211 518 KVGDFGLSSLK 528 (605)
Q Consensus 518 kl~Dfg~a~~~ 528 (605)
.++|||-|...
T Consensus 206 ~iID~~QaV~~ 216 (268)
T COG1718 206 YIIDVSQAVTI 216 (268)
T ss_pred EEEECcccccc
Confidence 99999977543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.30 E-value=7.7e-06 Score=79.63 Aligned_cols=141 Identities=18% Similarity=0.194 Sum_probs=82.9
Q ss_pred eeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCC--CeeeEEEEEee---CCeeEEEEEec
Q 038211 383 GEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP--NVLLFMGAVAS---QERLGIVTEFL 457 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~--niv~~~~~~~~---~~~~~lv~e~~ 457 (605)
++.|+.|..+.||+....+..+++|+.... .....+.+|..+++.+... .+.+++.+... ....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 467999999999999988888999986443 3445677888888888433 34566654332 33578999999
Q ss_pred CCCchHH----------------HHH---hhc---CCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 038211 458 PRGSLFK----------------TLH---KNY---QALDIKR---------RLRM------------ALDVAR-GMNYLH 493 (605)
Q Consensus 458 ~ggsL~~----------------~l~---~~~---~~~~~~~---------~~~~------------~~qi~~-aL~~LH 493 (605)
+|..+.. .+. ... ..+.... .... ...+.. .++.++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9987766 111 110 0001000 0000 111222 333333
Q ss_pred h-----CCCCceeccCCCCCEEEc-CCCcEEEEeecCCcc
Q 038211 494 H-----RNPPIVHRDLKSSNLLVD-KNWTVKVGDFGLSSL 527 (605)
Q Consensus 494 ~-----~~~~iiH~Dik~~Nill~-~~~~vkl~Dfg~a~~ 527 (605)
. ....++|+|+.+.|||++ .++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 112399999999999999 667778999987654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.9e-06 Score=91.08 Aligned_cols=140 Identities=23% Similarity=0.243 Sum_probs=90.6
Q ss_pred eeecccCcEEEEEEEEC-CcceEEEEeeccccc--hh------------------------------hh------hhHHH
Q 038211 384 EEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYI--EG------------------------------TL------KNYQK 424 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~--~~------------------------------~~------~~~~~ 424 (605)
+.|+.+|-|.||+|..+ |+.|||||....-.. .. .. -.+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67899999999999875 899999997432100 00 00 11334
Q ss_pred HHHHHHhCC-----CCCeeeEEEEEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHH-HHHHHhCCCC
Q 038211 425 EIDIIKKLR-----HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARG-MNYLHHRNPP 498 (605)
Q Consensus 425 E~~il~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~a-L~~LH~~~~~ 498 (605)
|..-+.+++ .+++.--.=+++-.+.-.|+|||++|-.+.+.........+...+.. .++.+ +..+=..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~---~~~~~f~~q~~~dg-- 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAE---LLVRAFLRQLLRDG-- 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHH---HHHHHHHHHHHhcC--
Confidence 555555542 34332222222334556899999999988887543335555433332 22222 33344568
Q ss_pred ceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 499 IVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 499 iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
++|.|.+|.||+++.+|++.+.|||+....
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecC
Confidence 999999999999999999999999998644
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=7.5e-08 Score=101.63 Aligned_cols=187 Identities=20% Similarity=0.203 Sum_probs=134.3
Q ss_pred CceEeeeecccCcEEEEEEEECCcc-eEEEEeeccccchhhhhhHHHHHHHHHhCCCCC-eeeEEEEEeeCCeeEEEEEe
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWNGSD-VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN-VLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~~~~-~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~~~~~~~~~~~~~lv~e~ 456 (605)
.+.+.+.+++|+++++++.+...+. ...+++... ....-++++|.+++||| .+.+++-++.+++.++++++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3456677899999999987654333 223332211 33455789999999999 77777777778899999999
Q ss_pred cCCC-chHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 457 LPRG-SLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 457 ~~gg-sL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
+.++ +-...+....-.+.+-+.......-+.+|++||+.- =+|+| ||+..+ +..+..||+......... ..
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~ 387 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KP 387 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc-cc
Confidence 9877 222221111122333344445566677899999875 58998 776654 688999999887665443 55
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
.+..+|+.++|||+.....+....|.|++|+-..+|.-|-+|-..
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 677899999999999999999999999999988888888777543
|
|
| >PRK11006 phoR phosphate regulon sensor protein; Provisional | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.2e-06 Score=91.98 Aligned_cols=108 Identities=24% Similarity=0.339 Sum_probs=72.5
Q ss_pred hcccccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceE
Q 038211 51 TTSDSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWS 130 (605)
Q Consensus 51 ~~~~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~ 130 (605)
++.+..++|+.+++++++++ +++|.+|+|+++|++|++++||+.++++|+++.+++.++ ... ..+.... ..
T Consensus 92 ~l~~~~~~~~~~~~~~~~~i-~~~d~~g~i~~~N~~a~~l~g~~~~~~~g~~~~~~~~~~----~~~---~~~~~~~-~~ 162 (430)
T PRK11006 92 ELGNLIKRFRSGAESLPDAV-VLTTEEGNIFWCNGLAQQLLGFRWPEDNGQNILNLLRYP----EFT---QYLKTRD-FS 162 (430)
T ss_pred HHHHHHHHHHHHHHhCCCeE-EEEcCCCceeHHHHHHHHHhCCCChHhCCCcHHHHhcCH----HHH---HHHHhcc-cC
Confidence 34445567999999999988 899999999999999999999999999999998744221 111 1222211 11
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEeeCCeEEEEEEEEeccccccc
Q 038211 131 GQFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAAIFNS 173 (605)
Q Consensus 131 ~~~~~~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~~~~ 173 (605)
.......++|..+ .+...|..+ + +++.+++|+|+..+
T Consensus 163 ~~~~~~~~~~~~~--~~~~~~~~~-~---~~~~~~~dit~~~~ 199 (430)
T PRK11006 163 RPLTLVLNNGRHL--EIRVMPYTE-G---QLLMVARDVTQMHQ 199 (430)
T ss_pred CCeEEEcCCCCEE--EEEEEEcCC-C---cEEEEEehhhHHHH
Confidence 1223334566644 455566543 3 25667899887643
|
|
| >PRK11086 sensory histidine kinase DcuS; Provisional | Back alignment and domain information |
|---|
Probab=98.22 E-value=5.4e-06 Score=91.75 Aligned_cols=106 Identities=19% Similarity=0.387 Sum_probs=77.6
Q ss_pred ccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCC---hhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEE
Q 038211 57 GPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWK---DREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQF 133 (605)
Q Consensus 57 ~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~---~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~ 133 (605)
+.++++++++++++ +++|.+|+|++||++|++++|++ ..+.+|+.+.++. +. ..+...+..+.+.....
T Consensus 221 ~~~~~il~~~~~gI-i~~D~~g~I~~~N~~a~~llg~~~~~~~~~~~~~~~~~~-~~------~~~~~~~~~~~~~~~~~ 292 (542)
T PRK11086 221 EQRQAMLQSIKEGV-IAVDDRGEVTLINDEAKRLFNYKKGLEDDPLGTDVESWM-PV------SRLKEVLRTGTPRRDEE 292 (542)
T ss_pred HHHHHHHHHhcCcE-EEECCCCeEEEEhHHHHHHhCCCcCCcccccCCcHHHhC-Cc------hhHHHHHhcCCCccceE
Confidence 45678999999888 89999999999999999999875 3577888877632 21 12334455665543322
Q ss_pred EEEcCCCCEEEEEEEEEEEeeCCeEEEEEEEEecccccccc
Q 038211 134 PFKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAAIFNSI 174 (605)
Q Consensus 134 ~~~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~~~~l 174 (605)
...+|..+ .++..|+.++|.+.|++.+++|+|++.++
T Consensus 293 --~~~~g~~~--~~~~~pi~~~g~~~g~v~~~rDite~~~l 329 (542)
T PRK11086 293 --ININGRLL--LTNTVPVRVNGEIIGAIATFRDKTEVRQL 329 (542)
T ss_pred --EEECCEEE--EEEEEEEeECCEEEEEEEEEEEchHHHHH
Confidence 22245544 46778998899999999999999987655
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.13 E-value=8.8e-05 Score=69.31 Aligned_cols=127 Identities=25% Similarity=0.352 Sum_probs=92.5
Q ss_pred cCceEeeeecccCc-EEEEEEEECCcceEEEEeec---cc-------cch---------hhhhhHHHHHHHHHhCC---C
Q 038211 378 EDLQLGEEIGLGSY-AVVYRGIWNGSDVAVKVYFG---SE-------YIE---------GTLKNYQKEIDIIKKLR---H 434 (605)
Q Consensus 378 ~~~~~~~~LG~G~f-g~V~~~~~~~~~~avKv~~~---~~-------~~~---------~~~~~~~~E~~il~~l~---h 434 (605)
.++++++.||.|.- |.||++...|..||||++.. .. ... .....|..|.+...+++ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78999999999999 99999999999999999321 10 000 22345677888777774 4
Q ss_pred CCe--eeEEEEEeeC------------------CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 038211 435 PNV--LLFMGAVASQ------------------ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494 (605)
Q Consensus 435 ~ni--v~~~~~~~~~------------------~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~ 494 (605)
.++ |+++|++.-. ....||.||++... .+... -+.+|++-+..+|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHHH
Confidence 556 8999987311 12457888886543 12222 34578888899999
Q ss_pred CCCCceeccCCCCCEEEcCCCcEEEEeecCC
Q 038211 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525 (605)
Q Consensus 495 ~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a 525 (605)
.| |+-+|+++.|.. .=+|+|||.+
T Consensus 183 ~g--I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LG--IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CC--eeeccCcccccc-----CCEEEecccC
Confidence 99 999999999986 3378999864
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=6.5e-07 Score=95.84 Aligned_cols=98 Identities=23% Similarity=0.373 Sum_probs=75.8
Q ss_pred HHHHHHHHHHHhC-CCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc----cc-----ccCCCCCCcccccccccC
Q 038211 483 LDVARGMNYLHHR-NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY----LT-----AKSGRGTPQWMAPEVLRS 552 (605)
Q Consensus 483 ~qi~~aL~~LH~~-~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~----~~-----~~~~~gt~~y~aPE~~~~ 552 (605)
.+.+.||.|+|.. + +||++|.|++|.++.+|..||+.|+++.....+. .. .....-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3555899999966 5 9999999999999999999999999875433211 01 111124668999999999
Q ss_pred CCCCchhHHHHHHHHHHHHH-cCCCCCCCCC
Q 038211 553 EPSNEKSDVFSFGVILWELV-TASIPWNNLN 582 (605)
Q Consensus 553 ~~~~~~~DiwSlG~il~el~-~g~~Pf~~~~ 582 (605)
...+.++|++||||++|.+. .|+.-|...+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~ 214 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANG 214 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccC
Confidence 88899999999999999999 5666665543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 605 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-79 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-78 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-39 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-38 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-38 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-37 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-37 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-37 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-37 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-37 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-37 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-37 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-36 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-36 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-36 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-36 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-33 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-32 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-31 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-31 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-31 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-31 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-31 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-31 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-31 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-31 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-31 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-31 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-31 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-31 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-31 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-31 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-31 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-31 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-31 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-31 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-31 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-31 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-31 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-31 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-30 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-30 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-27 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-26 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-26 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-26 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-26 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-26 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-26 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-26 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-26 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-26 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-26 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-26 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-26 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-26 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-26 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-26 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-26 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-26 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-26 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-26 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-26 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-25 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-25 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-25 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-25 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-25 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-25 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-25 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-25 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-25 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-25 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-25 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-25 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-25 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-25 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-25 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-25 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-25 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-25 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-25 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-25 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-25 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-25 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-25 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-25 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-24 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-24 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-24 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-24 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-24 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-24 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-24 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-24 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-24 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-24 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-24 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-24 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-24 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-24 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-24 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-24 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-23 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-23 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-23 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-23 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-23 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-23 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-23 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-23 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-23 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-23 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-23 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-23 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-23 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-23 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-23 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-23 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-23 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-22 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-22 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-22 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-22 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-22 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-22 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-22 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-22 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-22 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-22 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-22 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-22 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-22 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-22 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-22 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-22 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-22 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-22 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-22 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-22 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-22 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-22 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-22 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-22 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-22 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-22 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-22 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-22 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-22 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-22 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-22 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-22 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-22 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-22 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-22 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-22 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-22 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-22 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-22 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-22 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-21 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-21 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-21 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-21 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-21 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-21 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-21 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-21 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-21 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-21 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-21 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-21 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-21 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-21 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-21 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-21 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-21 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-21 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-21 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-21 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-21 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-21 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-21 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-21 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-21 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-21 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-21 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-21 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-20 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-20 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-20 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-20 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-20 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-20 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-20 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-20 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-20 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-20 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-20 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-20 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-20 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-20 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-20 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-20 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-20 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-20 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-20 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-20 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-20 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-20 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-19 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-19 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-19 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-19 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-19 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-19 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-19 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-19 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-19 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-19 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-19 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-19 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-19 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-19 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-19 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-19 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-19 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-19 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-19 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-19 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-19 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-19 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-19 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-19 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-19 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-18 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-18 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-18 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-18 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-18 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-18 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-18 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-18 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-18 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-18 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-17 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-17 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-17 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-17 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-16 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-16 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-16 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-16 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-16 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-16 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-16 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-15 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-15 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-15 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-15 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-15 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-15 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-14 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-14 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-14 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-13 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-13 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-13 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-13 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-09 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-09 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-06 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 378 bits (974), Expect = e-128
Identities = 145/260 (55%), Positives = 181/260 (69%), Gaps = 5/260 (1%)
Query: 351 ESSRSRESSSSKGDNETSCATDGG---IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVK 407
S + + A DG I W DL + E+IG GS+ V+R W+GSDVAVK
Sbjct: 7 HHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVK 66
Query: 408 VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLH 467
+ ++ + + +E+ I+K+LRHPN++LFMGAV L IVTE+L RGSL++ LH
Sbjct: 67 ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH 126
Query: 468 KNYQA--LDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525
K+ LD +RRL MA DVA+GMNYLH+RNPPIVHR+LKS NLLVDK +TVKV DFGLS
Sbjct: 127 KSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186
Query: 526 SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQ 585
LK +T+L++KS GTP+WMAPEVLR EPSNEKSDV+SFGVILWEL T PW NLN Q
Sbjct: 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246
Query: 586 VVGVVGFMDRRLELPEGLDP 605
VV VGF +RLE+P L+P
Sbjct: 247 VVAAVGFKCKRLEIPRNLNP 266
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 344 bits (886), Expect = e-116
Identities = 67/238 (28%), Positives = 123/238 (51%), Gaps = 11/238 (4%)
Query: 374 GIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
GI ++ L ++ +++G W G+D+ VKV ++ +++ +E ++
Sbjct: 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 434 HPNVLLFMGAVAS--QERLGIVTEFLPRGSLFKTLHKNYQ-ALDIKRRLRMALDVARGMN 490
HPNVL +GA S ++T ++P GSL+ LH+ +D + ++ ALD+ARGM
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL 550
+LH P I L S ++++D++ T ++ + + P W+APE L
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK-----FSFQSPGRMYAPAWVAPEAL 180
Query: 551 RSEPSN---EKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
+ +P + +D++SF V+LWELVT +P+ +L+ M++ V R +P G+ P
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 342 bits (879), Expect = e-115
Identities = 85/242 (35%), Positives = 127/242 (52%), Gaps = 15/242 (6%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYF--GSEYIEGTLKNYQKEIDIIKKL 432
I + +L L E IG+G + VYR W G +VAVK E I T++N ++E + L
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 433 RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
+HPN++ G + L +V EF G L + L + + A+ +ARGMNYL
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYL 121
Query: 493 HHRNP-PIVHRDLKSSNLLVDK--------NWTVKVGDFGLSSLKNATYLTAKSGRGTPQ 543
H PI+HRDLKSSN+L+ + N +K+ DFGL+ + T S G
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM--SAAGAYA 179
Query: 544 WMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603
WMAPEV+R+ ++ SDV+S+GV+LWEL+T +P+ ++ + V V L +P
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239
Query: 604 DP 605
Sbjct: 240 PE 241
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 334 bits (859), Expect = e-111
Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 18/273 (6%)
Query: 347 PSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAV 406
P + S S S K + + I +E L++GE IG G + VY G W+G +VA+
Sbjct: 2 PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAI 60
Query: 407 KVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTL 466
++ E LK +++E+ ++ RH NV+LFMGA S L I+T +L+ +
Sbjct: 61 RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 467 HKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526
LD+ + ++A ++ +GM YLH + I+H+DLKS N+ D N V + DFGL S
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFS 177
Query: 527 LKNATYLTAKSG-----RGTPQWMAPEVLRS---------EPSNEKSDVFSFGVILWELV 572
+ + G +APE++R P ++ SDVF+ G I +EL
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237
Query: 573 TASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
P+ ++ +G + G+
Sbjct: 238 AREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 328 bits (844), Expect = e-109
Identities = 91/258 (35%), Positives = 153/258 (59%), Gaps = 18/258 (6%)
Query: 350 GESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVY 409
G S + D E I + +G+ IG GS+ VY+G W+G DVAVK+
Sbjct: 4 GHHHHHHGSRDAADDWE--------IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKML 54
Query: 410 FGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN 469
+ L+ ++ E+ +++K RH N+LLFMG + +L IVT++ SL+ LH +
Sbjct: 55 NVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHAS 113
Query: 470 YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529
++K+ + +A ARGM+YLH ++ I+HRDLKS+N+ + ++ TVK+GDFGL++ K+
Sbjct: 114 ETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171
Query: 530 ATYLTAK--SGRGTPQWMAPEVLRSEPSN---EKSDVFSFGVILWELVTASIPWNNL-NL 583
+ + G+ WMAPEV+R + SN +SDV++FG++L+EL+T +P++N+ N
Sbjct: 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231
Query: 584 MQVVGVVGFMDRRLELPE 601
Q++ +VG +L +
Sbjct: 232 DQIIEMVGRGSLSPDLSK 249
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 323 bits (831), Expect = e-107
Identities = 72/261 (27%), Positives = 128/261 (49%), Gaps = 21/261 (8%)
Query: 361 SKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY---- 414
+ G +E + + +++ ++IG G + +V++G + S VA+K +
Sbjct: 2 AMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET 61
Query: 415 -IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQAL 473
+ + +Q+E+ I+ L HPN++ G + +V EF+P G L+ L +
Sbjct: 62 EMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPI 119
Query: 474 DIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK-----NWTVKVGDFGLSSLK 528
+LR+ LD+A G+ Y+ ++NPPIVHRDL+S N+ + KV DFGLS
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179
Query: 529 NATYLTAKSGRGTPQWMAPEVL--RSEPSNEKSDVFSFGVILWELVTASIPWNNLNL--M 584
+ G QWMAPE + E EK+D +SF +IL+ ++T P++ + +
Sbjct: 180 VH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236
Query: 585 QVVGVVGFMDRRLELPEGLDP 605
+ + ++ R +PE P
Sbjct: 237 KFINMIREEGLRPTIPEDCPP 257
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 320 bits (821), Expect = e-105
Identities = 74/246 (30%), Positives = 112/246 (45%), Gaps = 17/246 (6%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH 434
R DL GE +G G + + + + + + E T + + KE+ +++ L H
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH 66
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
PNVL F+G + +RL +TE++ G+L + +R+ A D+A GM YLH
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS--------------SLKNATYLTAKSGRG 540
N I+HRDL S N LV +N V V DFGL+ SLK + G
Sbjct: 127 MN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 541 TPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQV-VGVVGFMDRRLEL 599
P WMAPE++ +EK DVFSFG++L E++ + + G+
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244
Query: 600 PEGLDP 605
P P
Sbjct: 245 PPNCPP 250
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 316 bits (813), Expect = e-104
Identities = 71/236 (30%), Positives = 117/236 (49%), Gaps = 14/236 (5%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH 434
I ++++++ E +G G++ VV + W DVA+K E K + E+ + ++ H
Sbjct: 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIES----ESERKAFIVELRQLSRVNH 60
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHK--NYQALDIKRRLRMALDVARGMNYL 492
PN++ GA + +V E+ GSL+ LH + L ++G+ YL
Sbjct: 61 PNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 493 HHRNP-PIVHRDLKSSNLLVDKNWTV-KVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL 550
H P ++HRDLK NLL+ TV K+ DFG + T++T + +G+ WMAPEV
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-THMT--NNKGSAAWMAPEVF 175
Query: 551 RSEPSNEKSDVFSFGVILWELVTASIPWNNLN-LMQVVGVVGFMDRRLELPEGLDP 605
+EK DVFS+G+ILWE++T P++ + + R L + L
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK 231
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 3e-94
Identities = 89/301 (29%), Positives = 130/301 (43%), Gaps = 49/301 (16%)
Query: 345 QYPSLGESSR-----SRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIW 399
Y GES R S+ S S G T + +Q+ ++IG G Y V+ G W
Sbjct: 3 TYIPPGESLRDLIEQSQSSGSGSGLPLLVQRTI----AKQIQMVKQIGKGRYGEVWMGKW 58
Query: 400 NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAV----ASQERLGIVTE 455
G VAVKV+F +E + EI +RH N+L F+ A S +L ++T+
Sbjct: 59 RGEKVAVKVFFTTEEAS---WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD 115
Query: 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH------HRNPPIVHRDLKSSNL 509
+ GSL+ L LD K L++A G+ +LH P I HRDLKS N+
Sbjct: 116 YHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI 173
Query: 510 LVDKNWTVKVGDFGLS----SLKNATYLTAKSGRGTPQWMAPEVL------RSEPSNEKS 559
LV KN T + D GL+ S N + + GT ++M PEVL S +
Sbjct: 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA 233
Query: 560 DVFSFGVILWELVTAS----------IPWNNLNLMQ-----VVGVVGFMDRRLELPEGLD 604
D++SFG+ILWE+ +P+++L + +V R P
Sbjct: 234 DMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWS 293
Query: 605 P 605
Sbjct: 294 S 294
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 7e-93
Identities = 75/261 (28%), Positives = 122/261 (46%), Gaps = 44/261 (16%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIK--KLRHP 435
D+ L E +G G Y V+RG W G +VAVK++ + K++ +E ++ LRH
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDE-----KSWFRETELYNTVMLRHE 62
Query: 436 NVLLFMGAV----ASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNY 491
N+L F+ + S +L ++T + GSL+ L LD LR+ L +A G+ +
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAH 120
Query: 492 LH------HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY----LTAKSGRGT 541
LH P I HRDLKS N+LV KN + D GL+ + + + + GT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 542 PQWMAPEVLRSEP------SNEKSDVFSFGVILWELVTAS----------IPWNNLN--- 582
++MAPEVL S ++ D+++FG++LWE+ P+ ++
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 583 --LMQVVGVVGFMDRRLELPE 601
+ VV +R +P
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPN 261
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 2e-87
Identities = 80/296 (27%), Positives = 131/296 (44%), Gaps = 46/296 (15%)
Query: 341 PDGKQYPSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIWN 400
+G L + S S G T + L E IG G + V+RG W
Sbjct: 11 SEGTTLKDLIYDMTT--SGSGSGLPLLVQRTI----ARTIVLQESIGKGRFGEVWRGKWR 64
Query: 401 GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAV----ASQERLGIVTEF 456
G +VAVK++ E + EI LRH N+L F+ A + +L +V+++
Sbjct: 65 GEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 121
Query: 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH------HRNPPIVHRDLKSSNLL 510
GSLF L++ + ++ +++AL A G+ +LH P I HRDLKS N+L
Sbjct: 122 HEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 179
Query: 511 VDKNWTVKVGDFGLS----SLKNATYLTAKSGRGTPQWMAPEVLRSE------PSNEKSD 560
V KN T + D GL+ S + + GT ++MAPEVL S +++D
Sbjct: 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 239
Query: 561 VFSFGVILWELVTAS----------IPWNNL-----NLMQVVGVVGFMDRRLELPE 601
+++ G++ WE+ +P+ +L ++ ++ VV R +P
Sbjct: 240 IYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN 295
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 3e-84
Identities = 66/266 (24%), Positives = 109/266 (40%), Gaps = 40/266 (15%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH 434
+ LQL E G + V++ VAVK++ + + E+ + ++H
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQS---WQNEYEVYSLPGMKH 77
Query: 435 PNVLLFMGAV----ASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMN 490
N+L F+GA + L ++T F +GSL L N + +A +ARG+
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLA 135
Query: 491 YLHH--------RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK--NATYLTAKSGRG 540
YLH P I HRD+KS N+L+ N T + DFGL+ + G
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 541 TPQWMAPEVLRSEP-----SNEKSDVFSFGVILWELVTASIP----------------WN 579
T ++MAPEVL + + D+++ G++LWEL +
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255
Query: 580 NLNLMQVVGVVGFMDRRLELPEGLDP 605
+ +L + VV +R L +
Sbjct: 256 HPSLEDMQEVVVHKKKRPVLRDYWQK 281
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 2e-80
Identities = 78/278 (28%), Positives = 118/278 (42%), Gaps = 54/278 (19%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDI--IKKL 432
+ ++L+L E IG G Y VY+G + VAVKV+ + +N+ E +I + +
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-----QNFINEKNIYRVPLM 64
Query: 433 RHPNVLLFMGA-----VASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR 487
H N+ F+ + +V E+ P GSL K L + D R+A V R
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTR 122
Query: 488 GMNYLH-------HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA----- 535
G+ YLH H P I HRDL S N+LV + T + DFGLS L
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 536 ---KSGRGTPQWMAPEVLRS-------EPSNEKSDVFSFGVILWELV---TASIPWNNLN 582
S GT ++MAPEVL E + ++ D+++ G+I WE+ T P ++
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
Query: 583 LMQV---------------VGVVGFMDRRLELPEGLDP 605
Q+ +V +R + PE
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE 280
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-65
Identities = 75/263 (28%), Positives = 137/263 (52%), Gaps = 14/263 (5%)
Query: 351 ESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKV 408
+ R+++ + + R+ L+ EIG GS+ VY+G+ +VA
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRF--LKFDIEIGRGSFKTVYKGLDTETTVEVAWCE 58
Query: 409 YFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGA----VASQERLGIVTEFLPRGSLFK 464
+ + + +++E +++K L+HPN++ F + V ++ + +VTE + G+L K
Sbjct: 59 LQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL-K 117
Query: 465 TLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD-KNWTVKVGDFG 523
T K ++ + IK + +G+ +LH R PPI+HRDLK N+ + +VK+GD G
Sbjct: 118 TYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177
Query: 524 LSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL-N 582
L++LK A+ AK+ GTP++MAPE+ E +E DV++FG+ + E+ T+ P++ N
Sbjct: 178 LATLKRAS--FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN 234
Query: 583 LMQVVGVVGFMDRRLELPEGLDP 605
Q+ V + + P
Sbjct: 235 AAQIYRRVTSGVKPASFDKVAIP 257
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-57
Identities = 76/232 (32%), Positives = 111/232 (47%), Gaps = 13/232 (5%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGS--DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
EDL LGE+IG G++ V+ G VAVK + +E I+K+ HP
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS-CRETLPPDLKAKFLQEARILKQYSHP 172
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495
N++ +G ++ + IV E + G L L +K L+M D A GM YL +
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGT-P-QWMAPEVLRSE 553
+HRDL + N LV + +K+ DFG+S + A G P +W APE L
Sbjct: 233 C--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 554 PSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
+ +SDV+SFG++LWE + + P+ NL+ Q V G RL PE
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG---RLPCPEL 339
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 3e-56
Identities = 76/243 (31%), Positives = 119/243 (48%), Gaps = 33/243 (13%)
Query: 377 WE----DLQLGEEIGLGSYAVVYRGIWNGS-DVAVKVYFGSEYIEGTLKN-------YQK 424
E ++ L +E+G G + VV G W G DVAVK +K + +
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVK----------MIKEGSMSEDEFFQ 52
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD 484
E + KL HP ++ F G + + + IVTE++ G L L + + L+ + L M D
Sbjct: 53 EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 485 VARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTP- 542
V GM +L +HRDL + N LVD++ VKV DFG++ + + Y + G P
Sbjct: 113 VCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPV 169
Query: 543 QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLEL 599
+W APEV + KSDV++FG+++WE+ + +P++ +VV V G RL
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH---RLYR 226
Query: 600 PEG 602
P
Sbjct: 227 PHL 229
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 5e-56
Identities = 70/240 (29%), Positives = 107/240 (44%), Gaps = 27/240 (11%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGS-DVAVKVYFGSEYIEGTLKN-------YQKEI 426
I +DL +E+G G + VV G W G DVA+K +K + +E
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIK----------MIKEGSMSEDEFIEEA 70
Query: 427 DIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVA 486
++ L H ++ G Q + I+TE++ G L L + ++ L M DV
Sbjct: 71 KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 130
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QWM 545
M YL + +HRDL + N LV+ VKV DFGLS T+ G P +W
Sbjct: 131 EAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188
Query: 546 APEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
PEVL + KSD+++FGV++WE+ + +P+ + + G RL P
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---RLYRPHL 245
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-55
Identities = 76/240 (31%), Positives = 116/240 (48%), Gaps = 27/240 (11%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGS-DVAVKVYFGSEYIEGTLKN-------YQKEI 426
I +L +EIG G + +V+ G W VA+K T++ + +E
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIK----------TIREGAMSEEDFIEEA 54
Query: 427 DIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVA 486
+++ KL HP ++ G Q + +VTEF+ G L L + L M LDV
Sbjct: 55 EVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 114
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QWM 545
GM YL ++HRDL + N LV +N +KV DFG++ T+ +G P +W
Sbjct: 115 EGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 172
Query: 546 APEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
+PEV + KSDV+SFGV++WE+ + IP+ N + +VV + GF RL P
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---RLYKPRL 229
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-55
Identities = 71/249 (28%), Positives = 114/249 (45%), Gaps = 25/249 (10%)
Query: 368 SCATDGGIRWE----DLQLGEEIGLGSYAVVYRGIWNGSD-----VAVKVYFGSEYIEGT 418
S ++ D+ L +G G + VY G++ VAVK +
Sbjct: 1 SMGGP---QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKT-CKKDCTLDN 56
Query: 419 LKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRR 478
+ + E I+K L HP+++ +G + +E I+ E P G L L +N +L +
Sbjct: 57 KEKFMSEAVIMKNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTL 115
Query: 479 LRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKS 537
+ +L + + M YL N VHRD+ N+LV VK+GDFGLS +++ Y S
Sbjct: 116 VLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKAS 172
Query: 538 GRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFM 593
P +WM+PE + SDV+ F V +WE+++ P+ L V+GV+ G
Sbjct: 173 VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD- 231
Query: 594 DRRLELPEG 602
RL P+
Sbjct: 232 --RLPKPDL 238
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 4e-55
Identities = 63/239 (26%), Positives = 113/239 (47%), Gaps = 18/239 (7%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD------VAVKVYFGSEYIEGTLKNYQKEIDI 428
++ + + + +G G++ VY+G+W VA+K K E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEAYV 70
Query: 429 IKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARG 488
+ + +P+V +G + + ++T+ +P G L + ++ + + L + +A+G
Sbjct: 71 MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 489 MNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTP-QWMA 546
MNYL R +VHRDL + N+LV VK+ DFGL+ L G P +WMA
Sbjct: 130 MNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 547 PEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
E + +SDV+S+GV +WEL+T S P++ + ++ ++ G RL P
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPI 243
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 9e-55
Identities = 79/235 (33%), Positives = 115/235 (48%), Gaps = 13/235 (5%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGSD-----VAVKVY-FGSEYIEGTLKNYQKEIDIIKK 431
+DL+L E++G GS+ VV RG W+ VAVK + ++ +E++ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 432 LRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNY 491
L H N++ G V + +VTE P GSL L K+ + R A+ VA GM Y
Sbjct: 78 LDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 492 LHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTP-QWMAPE 548
L + +HRDL + NLL+ VK+GDFGL +N + + R P W APE
Sbjct: 137 LESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 549 VLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEG 602
L++ + SD + FGV LWE+ T PW LN Q++ + RL PE
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 8e-54
Identities = 79/244 (32%), Positives = 125/244 (51%), Gaps = 33/244 (13%)
Query: 376 RWE----DLQLGEEIGLGSYAVVYRGIWNGS-DVAVKVYFGSEYIEGTLKN-------YQ 423
WE L+L E +G G + V+ G +NG VAVK +LK +
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVK----------SLKQGSMSPDAFL 56
Query: 424 KEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMA 482
E +++K+L+H ++ V +QE + I+TE++ GSL L L I + L MA
Sbjct: 57 AEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 483 LDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP 542
+A GM ++ RN +HRDL+++N+LV + K+ DFGL+ L TA+ G P
Sbjct: 116 AQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 543 -QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLE 598
+W APE + KSDV+SFG++L E+VT IP+ + +V+ + G+ R+
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---RMV 230
Query: 599 LPEG 602
P+
Sbjct: 231 RPDN 234
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-53
Identities = 86/245 (35%), Positives = 127/245 (51%), Gaps = 33/245 (13%)
Query: 376 RWE----DLQLGEEIGLGSYAVVYRGIWNGS--DVAVKVYFGSEYIEGTLKN-------Y 422
+WE D+ + ++G G Y VY G+W VAVK TLK +
Sbjct: 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK----------TLKEDTMEVEEF 56
Query: 423 QKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHK-NYQALDIKRRLRM 481
KE ++K+++HPN++ +G + I+TEF+ G+L L + N Q + L M
Sbjct: 57 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 482 ALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGT 541
A ++ M YL +N +HRDL + N LV +N VKV DFGLS L TA +G
Sbjct: 117 ATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 542 P-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRL 597
P +W APE L + KSDV++FGV+LWE+ T P+ ++L QV ++ + R+
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RM 231
Query: 598 ELPEG 602
E PEG
Sbjct: 232 ERPEG 236
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 4e-53
Identities = 79/242 (32%), Positives = 124/242 (51%), Gaps = 33/242 (13%)
Query: 376 RWE----DLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKN------YQKE 425
W +L+L + IG G + V G + G+ VAVK +KN + E
Sbjct: 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK----------CIKNDATAQAFLAE 64
Query: 426 IDIIKKLRHPNVLLFMGAVASQE-RLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMAL 483
++ +LRH N++ +G + ++ L IVTE++ +GSL L L L+ +L
Sbjct: 65 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 124
Query: 484 DVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQ 543
DV M YL N VHRDL + N+LV ++ KV DFGL+ T +G+ +
Sbjct: 125 DVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKE---ASSTQDTGKLPVK 179
Query: 544 WMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELP 600
W APE LR + + KSDV+SFG++LWE+ + +P+ + L VV V G+ +++ P
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAP 236
Query: 601 EG 602
+G
Sbjct: 237 DG 238
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 8e-53
Identities = 67/239 (28%), Positives = 119/239 (49%), Gaps = 20/239 (8%)
Query: 377 WE----DLQLGEEIGLGSYAVVYRGIWNGSD-----VAVKVYFGSEYIEGTLKNYQKEID 427
+E ++LG IG G + V++GI+ + VA+K + + + + +E
Sbjct: 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEAL 68
Query: 428 IIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR 487
+++ HP+++ +G V ++ + I+ E G L L +LD+ + A ++
Sbjct: 69 TMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127
Query: 488 GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTPQWMA 546
+ YL + VHRD+ + N+LV N VK+GDFGLS ++++TY A G+ +WMA
Sbjct: 128 ALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 185
Query: 547 PEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
PE + SDV+ FGV +WE++ P+ + V+G + G RL +P
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPN 241
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-52
Identities = 71/259 (27%), Positives = 125/259 (48%), Gaps = 40/259 (15%)
Query: 377 WE----DLQLGEEIGLGSYAVVYRGIWNGSD------VAVKVYFGSEYIEGTLKNYQKEI 426
+ L+ +++G G++ V ++ VAVK E L+++++EI
Sbjct: 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREI 62
Query: 427 DIIKKLRHPNVLLFMGAVASQER--LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD 484
+I+K L+H N++ + G S R L ++ E+LP GSL L K+ + +D + L+
Sbjct: 63 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 485 VARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTP 542
+ +GM YL + +HRDL + N+LV+ VK+GDFGL+ + ++ + K +P
Sbjct: 123 ICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 543 -QWMAPEVLRSEPSNEKSDVFSFGVILWELVT----------------ASIPWNNLNLMQ 585
W APE L + SDV+SFGV+L+EL T + + +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 586 VVGVV--GFMDRRLELPEG 602
++ ++ RL P+G
Sbjct: 241 LIELLKNNG---RLPRPDG 256
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 5e-52
Identities = 70/237 (29%), Positives = 115/237 (48%), Gaps = 18/237 (7%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGS------DVAVKVYFGSEYIEGTLKNYQKEIDIIKK 431
+ + IG G + VY+G+ S VA+K + Y E ++ E I+ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEAGIMGQ 102
Query: 432 LRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNY 491
H N++ G ++ + + I+TE++ G+L K L + + + + M +A GM Y
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162
Query: 492 LHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL---KNATYLTAKSGRGTPQWMAPE 548
L + N VHRDL + N+LV+ N KV DFGLS + T G+ +W APE
Sbjct: 163 LANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 549 VLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
+ SDV+SFG+++WE++T P+ L+ +V+ + GF RL P
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF---RLPTPMD 274
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 5e-52
Identities = 71/239 (29%), Positives = 117/239 (48%), Gaps = 19/239 (7%)
Query: 377 WEDLQLGEEIGLGSYAVVYRGIWNGSD-----VAVKVYFGSEYIEGTLKNYQKEIDIIKK 431
IG G + VVY G + A+K ++ + +E +++
Sbjct: 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS-LSRITEMQQVEAFLREGLLMRG 78
Query: 432 LRHPNVLLFMGAVASQE-RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMN 490
L HPNVL +G + E ++ ++ G L + + + +K + L VARGM
Sbjct: 79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGT--P-QWMA 546
YL + VHRDL + N ++D+++TVKV DFGL+ + + Y + + R P +W A
Sbjct: 139 YLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 547 PEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
E L++ KSDV+SFGV+LWEL+T + P+ +++ + + G RRL PE
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG---RRLPQPEY 252
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 6e-52
Identities = 63/239 (26%), Positives = 112/239 (46%), Gaps = 18/239 (7%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD------VAVKVYFGSEYIEGTLKNYQKEIDI 428
++ + + + +G G++ VY+G+W VA+K K E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEAYV 70
Query: 429 IKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARG 488
+ + +P+V +G + ++T+ +P G L + ++ + + L + +A+G
Sbjct: 71 MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 489 MNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTP-QWMA 546
MNYL R +VHRDL + N+LV VK+ DFGL+ L G P +WMA
Sbjct: 130 MNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 547 PEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
E + +SDV+S+GV +WEL+T S P++ + ++ ++ G RL P
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPI 243
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 8e-52
Identities = 72/257 (28%), Positives = 124/257 (48%), Gaps = 36/257 (14%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD------VAVKVYFGSEYIEGTLKNYQKEIDI 428
L+ +++G G++ V ++ VAVK E L+++++EI+I
Sbjct: 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEI 95
Query: 429 IKKLRHPNVLLFMGAVASQER--LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVA 486
+K L+H N++ + G S R L ++ E+LP GSL L K+ + +D + L+ +
Sbjct: 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 155
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTP-Q 543
+GM YL + +HRDL + N+LV+ VK+GDFGL+ + ++ Y K +P
Sbjct: 156 KGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 213
Query: 544 WMAPEVLRSEPSNEKSDVFSFGVILWELVT----------------ASIPWNNLNLMQVV 587
W APE L + SDV+SFGV+L+EL T + + + ++
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273
Query: 588 GVV--GFMDRRLELPEG 602
++ RL P+G
Sbjct: 274 ELLKNNG---RLPRPDG 287
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 9e-52
Identities = 65/249 (26%), Positives = 107/249 (42%), Gaps = 26/249 (10%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD-----VAVKVYFGSEYIEGTLKNYQKEIDII 429
I + LG +G G + V D VAVK+ ++ + +E +
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79
Query: 430 KKLRHPNVLLFMGAV------ASQERLGIVTEFLPRGSLFKTL-----HKNYQALDIKRR 478
K+ HP+V +G ++ F+ G L L +N L ++
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 479 LRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKS 537
+R +D+A GM YL RN +HRDL + N ++ ++ TV V DFGLS + + Y
Sbjct: 140 VRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGC 197
Query: 538 GRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFM 593
P +W+A E L SDV++FGV +WE++T P+ + ++ + G
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG-- 255
Query: 594 DRRLELPEG 602
RL+ P
Sbjct: 256 -NRLKQPPE 263
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 69/248 (27%), Positives = 109/248 (43%), Gaps = 25/248 (10%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD-----VAVKVYFGSEYIEGTLKNYQKEIDII 429
I L LG+ +G G + V G D VAVK + ++ + E +
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM 90
Query: 430 KKLRHPNVLLFMGAVASQERLG-----IVTEFLPRGSLFKTL-----HKNYQALDIKRRL 479
K HPNV+ +G G ++ F+ G L L + + ++ L
Sbjct: 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 480 RMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSG 538
+ +D+A GM YL +RN +HRDL + N ++ + TV V DFGLS + + Y
Sbjct: 151 KFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRI 208
Query: 539 RGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMD 594
P +W+A E L KSDV++FGV +WE+ T P+ + ++ + G
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG--- 265
Query: 595 RRLELPEG 602
RL+ PE
Sbjct: 266 HRLKQPED 273
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-51
Identities = 84/271 (30%), Positives = 133/271 (49%), Gaps = 23/271 (8%)
Query: 345 QYPSLGESSRSRESSSSKGDNETSCATDGGIRWE----DLQLGEEIGLGSYAVVYRGIWN 400
+ G + + + + +WE D+ + ++G G Y VY G+W
Sbjct: 183 STVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWK 242
Query: 401 GS--DVAVKVYFGSEYIEGT--LKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456
VAVK E T ++ + KE ++K+++HPN++ +G + I+TEF
Sbjct: 243 KYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297
Query: 457 LPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW 515
+ G+L L + Q + L MA ++ M YL +N +HR+L + N LV +N
Sbjct: 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENH 355
Query: 516 TVKVGDFGLSSLKNATYLTAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT- 573
VKV DFGLS L TA +G P +W APE L + KSDV++FGV+LWE+ T
Sbjct: 356 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 415
Query: 574 ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
P+ ++L QV ++ + R+E PEG
Sbjct: 416 GMSPYPGIDLSQVYELLEKDY---RMERPEG 443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-51
Identities = 76/239 (31%), Positives = 114/239 (47%), Gaps = 15/239 (6%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD-----VAVKVYFGSEYIEGTLKNYQKEIDII 429
+ E IG G + VY G +D AVK G + + E I+
Sbjct: 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQFLTEGIIM 80
Query: 430 KKLRHPNVLLFMGAVASQER-LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARG 488
K HPNVL +G E +V ++ G L + +K + L VA+G
Sbjct: 81 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 140
Query: 489 MNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGT--P-QW 544
M YL + VHRDL + N ++D+ +TVKV DFGL+ + + Y + + G P +W
Sbjct: 141 MKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 545 MAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEG 602
MA E L+++ KSDV+SFGV+LWEL+T + P+ ++N + + RRL PE
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEY 256
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-51
Identities = 82/238 (34%), Positives = 126/238 (52%), Gaps = 23/238 (9%)
Query: 377 WE----DLQLGEEIGLGSYAVVYRGIWNGS-DVAVKVYFGSEYIEGTL--KNYQKEIDII 429
WE L+L ++G G + V+ G WNG+ VA+K GT+ + + +E ++
Sbjct: 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVM 233
Query: 430 KKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARG 488
KKLRH ++ V S+E + IVTE++ +GSL L + L + + + MA +A G
Sbjct: 234 KKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 489 MNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QWMAP 547
M Y+ N VHRDL+++N+LV +N KV DFGL+ L TA+ G P +W AP
Sbjct: 293 MAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 350
Query: 548 EVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
E KSDV+SFG++L EL T +P+ + +V+ V G+ R+ P
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPCPPE 405
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 4e-51
Identities = 74/236 (31%), Positives = 107/236 (45%), Gaps = 17/236 (7%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGS-----DVAVKVYFGSEYIEGTLKNYQKEIDIIKKL 432
+ + + IG G V G VA+K + Y E +++ E I+ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA-LKAGYTERQRRDFLSEASIMGQF 107
Query: 433 RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
HPN++ G V IVTE++ GSL L + I + + M V GM YL
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGT--P-QWMAPEV 549
VHRDL + N+LVD N KV DFGLS + A + G P +W APE
Sbjct: 168 SDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 550 LRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
+ + SDV+SFGV++WE++ P+ N+ V+ V G+ RL P G
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY---RLPAPMG 278
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-51
Identities = 74/239 (30%), Positives = 114/239 (47%), Gaps = 15/239 (6%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD-----VAVKVYFGSEYIEGTLKNYQKEIDII 429
+ E IG G + VY G +D AVK G + + E I+
Sbjct: 86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQFLTEGIIM 144
Query: 430 KKLRHPNVLLFMGAVASQER-LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARG 488
K HPNVL +G E +V ++ G L + +K + L VA+G
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 204
Query: 489 MNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGT--P-QW 544
M +L + VHRDL + N ++D+ +TVKV DFGL+ + + + + + G P +W
Sbjct: 205 MKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 545 MAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEG 602
MA E L+++ KSDV+SFGV+LWEL+T + P+ ++N + + RRL PE
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEY 320
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 6e-51
Identities = 72/210 (34%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIW------NGSDVAVKVYFGSEYIEGTLKNYQKEIDI 428
L+ ++G G + V + G VAVK E + + +KEI+I
Sbjct: 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGGNHIADLKKEIEI 76
Query: 429 IKKLRHPNVLLFMGAVASQER--LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVA 486
++ L H N++ + G + ++ EFLP GSL + L KN +++K++L+ A+ +
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 136
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTP-Q 543
+GM+YL R VHRDL + N+LV+ VK+GDFGL+ + Y T K R +P
Sbjct: 137 KGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194
Query: 544 WMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
W APE L SDV+SFGV L EL+T
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 7e-51
Identities = 76/293 (25%), Positives = 135/293 (46%), Gaps = 18/293 (6%)
Query: 321 RGTSTGHRELLPGHDVNELDPDGKQ--YPSLGESSRSRESSSSKGDNETSCATDGGIRWE 378
R G R L + + G + S+ E+ E + D I+ E
Sbjct: 331 RPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRE 390
Query: 379 DLQLGEEIGLGSYAVVYRGIWNGSD-----VAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
++LG IG G + V++GI+ + VA+K + + + + +E +++
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT-CKNCTSDSVREKFLQEALTMRQFD 449
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
HP+++ +G + ++ + I+ E G L L +LD+ + A ++ + YL
Sbjct: 450 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTPQWMAPEVLRS 552
+ VHRD+ + N+LV N VK+GDFGLS ++++TY A G+ +WMAPE +
Sbjct: 509 SKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 553 EPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
SDV+ FGV +WE++ P+ + V+G + G RL +P
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPN 616
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 8e-51
Identities = 66/241 (27%), Positives = 114/241 (47%), Gaps = 22/241 (9%)
Query: 377 WE----DLQLGEEIGLGSYAVVYRGIWNGSD------VAVKVYFGSEYIEGTLKNYQKEI 426
+L+ + +G G + V++G+W V +KV + + + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV-IEDKSGRQSFQAVTDHM 66
Query: 427 DIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVA 486
I L H +++ +G L +VT++LP GSL + ++ AL + L + +A
Sbjct: 67 LAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTP-QW 544
+GM YL +VHR+L + N+L+ V+V DFG++ L S TP +W
Sbjct: 126 KGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 545 MAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPE 601
MA E + +SDV+S+GV +WEL+T + P+ L L +V ++ G RL P+
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE---RLAQPQ 240
Query: 602 G 602
Sbjct: 241 I 241
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 9e-51
Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD------VAVKVYFGSEYIEGTLKNYQKEIDI 428
L+ ++G G++ V ++ VAVK +++Q+EI I
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQI 77
Query: 429 IKKLRHPNVLLFMGAVASQER--LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVA 486
+K L ++ + G R L +V E+LP G L L ++ LD R L + +
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTP-Q 543
+GM YL R VHRDL + N+LV+ VK+ DFGL+ L + Y + +P
Sbjct: 138 KGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195
Query: 544 WMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
W APE L + +SDV+SFGV+L+EL T
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-50
Identities = 67/242 (27%), Positives = 116/242 (47%), Gaps = 22/242 (9%)
Query: 376 RWE----DLQLGE-EIGLGSYAVVYRGIWNGS----DVAVKVYFGSEYIEGTLKNYQKEI 426
+ +L + + E+G G++ V +G++ DVA+KV + + +E
Sbjct: 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREA 61
Query: 427 DIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVA 486
I+ +L +P ++ +G V E L +V E G L K L + + + + V+
Sbjct: 62 QIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTP-Q 543
GM YL +N VHRDL + N+L+ K+ DFGLS + +Y TA+S P +
Sbjct: 121 MGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 544 WMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELP 600
W APE + + +SDV+S+GV +WE ++ P+ + +V+ + G R+E P
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECP 235
Query: 601 EG 602
Sbjct: 236 PE 237
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-50
Identities = 82/238 (34%), Positives = 126/238 (52%), Gaps = 23/238 (9%)
Query: 377 WE----DLQLGEEIGLGSYAVVYRGIWNGS-DVAVKVYFGSEYIEGTL--KNYQKEIDII 429
WE L+L ++G G + V+ G WNG+ VA+K GT+ + + +E ++
Sbjct: 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVM 316
Query: 430 KKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARG 488
KKLRH ++ V S+E + IVTE++ +GSL L + L + + + MA +A G
Sbjct: 317 KKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 489 MNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QWMAP 547
M Y+ N VHRDL+++N+LV +N KV DFGL+ L TA+ G P +W AP
Sbjct: 376 MAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 433
Query: 548 EVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
E KSDV+SFG++L EL T +P+ + +V+ V G+ R+ P
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPCPPE 488
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-50
Identities = 65/236 (27%), Positives = 110/236 (46%), Gaps = 17/236 (7%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGSD-----VAVKVYFGSEYIEGTLKNYQKEIDIIKKL 432
++ + + +G G + V G VA+K Y E +++ E I+ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT-LKVGYTEKQRRDFLGEASIMGQF 103
Query: 433 RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
HPN++ G V + + IVTE++ GSL L K+ + + + M +A GM YL
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL---KNATYLTAKSGRGTPQWMAPEV 549
VHRDL + N+L++ N KV DFGL + T + G+ +W +PE
Sbjct: 164 SDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 550 LRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
+ SDV+S+G++LWE+++ P+ ++ V+ V G+ RL P
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPPPMD 274
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 4e-50
Identities = 67/238 (28%), Positives = 125/238 (52%), Gaps = 23/238 (9%)
Query: 377 WE----DLQLGEEIGLGSYAVVYRGIWNGS-DVAVKVYFGSEYIEGT--LKNYQKEIDII 429
WE L+L +++G G + V+ +N VAVK G+ ++ + E +++
Sbjct: 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-----KPGSMSVEAFLAEANVM 237
Query: 430 KKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARG 488
K L+H ++ V ++E + I+TEF+ +GSL L + + + + + +A G
Sbjct: 238 KTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296
Query: 489 MNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTPQWMAP 547
M ++ RN +HRDL+++N+LV + K+ DFGL+ +++ Y + + +W AP
Sbjct: 297 MAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 354
Query: 548 EVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
E + KSDV+SFG++L E+VT IP+ ++ +V+ + G+ R+ PE
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---RMPRPEN 409
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 7e-50
Identities = 81/241 (33%), Positives = 127/241 (52%), Gaps = 33/241 (13%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKN------YQKEIDI 428
+ ++L+L + IG G + V G + G+ VAVK +KN + E +
Sbjct: 190 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK----------CIKNDATAQAFLAEASV 239
Query: 429 IKKLRHPNVLLFMGAVASQER--LGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDV 485
+ +LRH N++ +G V +E+ L IVTE++ +GSL L L L+ +LDV
Sbjct: 240 MTQLRHSNLVQLLG-VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 486 ARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTP-QW 544
M YL N VHRDL + N+LV ++ KV DFGL+ K A+ + P +W
Sbjct: 299 CEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLT--KEASS--TQDTGKLPVKW 352
Query: 545 MAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPE 601
APE LR + + KSDV+SFG++LWE+ + +P+ + L VV V G+ +++ P+
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPD 409
Query: 602 G 602
G
Sbjct: 410 G 410
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-49
Identities = 55/213 (25%), Positives = 110/213 (51%), Gaps = 5/213 (2%)
Query: 378 EDLQLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
E ++IG GS+ +G +K S + ++E+ ++ ++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHK-NYQALDIKRRLRMALDVARGMNYLHH 494
N++ + + L IV ++ G LFK ++ + L + + + ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEP 554
R I+HRD+KS N+ + K+ TV++GDFG++ + N+T A++ GTP +++PE+ ++P
Sbjct: 144 RK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 555 SNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
N KSD+++ G +L+EL T + ++ +V
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV 234
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-49
Identities = 67/256 (26%), Positives = 120/256 (46%), Gaps = 36/256 (14%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD------VAVKVYFGSEYIEGTLKNYQKEIDI 428
L+ ++G G + V ++ ++ VAVK ++ +++EIDI
Sbjct: 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA-LKADAGPQHRSGWKQEIDI 86
Query: 429 IKKLRHPNVLLFMGAVASQER--LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVA 486
++ L H +++ + G L +V E++P GSL L ++ ++ + + L A +
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQIC 144
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTP-Q 543
GM YLH ++ +HRDL + N+L+D + VK+GDFGL+ + Y + +P
Sbjct: 145 EGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202
Query: 544 WMAPEVLRSEPSNEKSDVFSFGVILWELVT---------------ASIPWNNLNLMQVVG 588
W APE L+ SDV+SFGV L+EL+T I + ++++
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262
Query: 589 VV--GFMDRRLELPEG 602
++ G RL P+
Sbjct: 263 LLERG---ERLPRPDK 275
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 4e-49
Identities = 66/236 (27%), Positives = 111/236 (47%), Gaps = 18/236 (7%)
Query: 378 EDLQLGE-EIGLGSYAVVYRGIWNGS----DVAVKVYFGSEYIEGTLKNYQKEIDIIKKL 432
+ L L + E+G G++ V +G + VAVK+ E +++++L
Sbjct: 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75
Query: 433 RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
+P ++ +G + E +V E G L K L +N + + K + + V+ GM YL
Sbjct: 76 DNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYL 133
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTP-QWMAPEV 549
N VHRDL + N+L+ K+ DFGLS + Y A++ P +W APE
Sbjct: 134 EESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191
Query: 550 LRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
+ + KSDV+SFGV++WE + P+ + +V ++ G R+ P G
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---RMGCPAG 244
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 6e-49
Identities = 75/263 (28%), Positives = 116/263 (44%), Gaps = 50/263 (19%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD-------VAVKVYFGSEYIEGTLKN------ 421
I+ D+ L E+G G++ V+ VAVK LK+
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK----------ALKDPTLAAR 61
Query: 422 --YQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL---------------FK 464
+Q+E +++ L+H +++ F G + L +V E++ G L
Sbjct: 62 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121
Query: 465 TLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524
+ L + + L +A +A GM YL ++ VHRDL + N LV N VK+GDFG+
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGM 179
Query: 525 S-SLKNATYLTAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNL 581
S + + Y P +WM PE + +SDV+SFGVILWE+ T PW L
Sbjct: 180 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 239
Query: 582 NLMQVVGVV--GFMDRRLELPEG 602
+ +V+ + G R LE P
Sbjct: 240 SNTEVIECITQG---RVLERPRV 259
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 7e-49
Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 45/258 (17%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD-------VAVKVYFGSEYIEGTLK------- 420
+ E + + E+G GS+ +VY G+ G VA+K T+
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK----------TVNEAASMRE 71
Query: 421 --NYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN--------- 469
+ E ++K+ +V+ +G V+ + ++ E + RG L L
Sbjct: 72 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 131
Query: 470 YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLK 528
+ + ++MA ++A GM YL+ VHRDL + N +V +++TVK+GDFG++ +
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189
Query: 529 NATYLTAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQV 586
Y P +WM+PE L+ SDV+SFGV+LWE+ T A P+ L+ QV
Sbjct: 190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249
Query: 587 VGVV--GFMDRRLELPEG 602
+ V G L+ P+
Sbjct: 250 LRFVMEGG---LLDKPDN 264
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-48
Identities = 55/259 (21%), Positives = 106/259 (40%), Gaps = 52/259 (20%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD---------VAVKVYFGSEYIEGTLKN---- 421
IR EDL E +G G++ +++G+ V +K L
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLK----------VLDKAHRN 54
Query: 422 ----YQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKR 477
+ + ++ KL H +++L G + +V EF+ GSL L KN ++I
Sbjct: 55 YSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW 114
Query: 478 RLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK--------NWTVKVGDFGLS-SLK 528
+L +A +A M++L ++H ++ + N+L+ + +K+ D G+S ++
Sbjct: 115 KLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172
Query: 529 NATYLTAKSGRGTP-QWMAPEVLR-SEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQ 585
L W+ PE + + N +D +SFG LWE+ + P + L+ +
Sbjct: 173 PKDILQE------RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
Query: 586 VVGVV--GFMDRRLELPEG 602
+ +L P+
Sbjct: 227 KLQFYEDRH---QLPAPKA 242
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-48
Identities = 62/244 (25%), Positives = 110/244 (45%), Gaps = 10/244 (4%)
Query: 352 SSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRG--IWNGSDVAVK-V 408
+ G + ++ ++IG G ++ VYR + +G VA+K V
Sbjct: 6 QGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65
Query: 409 YFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLF---KT 465
+ KEID++K+L HPNV+ + + L IV E G L K
Sbjct: 66 QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH 125
Query: 466 LHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525
K + + + + + + + ++H R ++HRD+K +N+ + VK+GD GL
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLG 183
Query: 526 SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW--NNLNL 583
++ A S GTP +M+PE + N KSD++S G +L+E+ P+ + +NL
Sbjct: 184 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 243
Query: 584 MQVV 587
+
Sbjct: 244 YSLC 247
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-48
Identities = 63/253 (24%), Positives = 109/253 (43%), Gaps = 29/253 (11%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD-------VAVKVYFGSEYIEGTLKNYQKEID 427
I ++ EE+G + VY+G G VA+K + + ++ E
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT-LKDKAEGPLREEFRHEAM 64
Query: 428 IIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN---------------YQA 472
+ +L+HPNV+ +G V + L ++ + G L + L A
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 473 LDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNAT 531
L+ + + +A GM YL + +VH+DL + N+LV VK+ D GL + A
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 532 YLTAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGV 589
Y P +WMAPE + + SD++S+GV+LWE+ + P+ + VV +
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 242
Query: 590 VGFMDRRLELPEG 602
+ + L P+
Sbjct: 243 IR-NRQVLPCPDD 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-48
Identities = 72/261 (27%), Positives = 117/261 (44%), Gaps = 50/261 (19%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD----VAVKVYFGSEYIEGTLKNY-------- 422
+ W D++ + IG G++ V + A+K +K Y
Sbjct: 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK----------RMKEYASKDDHRD 71
Query: 423 -QKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSL---------------FKT 465
E++++ KL HPN++ +GA + L + E+ P G+L F
Sbjct: 72 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131
Query: 466 LHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525
+ L ++ L A DVARGM+YL + +HRDL + N+LV +N+ K+ DFGLS
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLS 189
Query: 526 SLKNATYLTAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNL 583
+ K+ P +WMA E L SDV+S+GV+LWE+V+ P+ +
Sbjct: 190 --RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247
Query: 584 MQVVGVV--GFMDRRLELPEG 602
++ + G+ RLE P
Sbjct: 248 AELYEKLPQGY---RLEKPLN 265
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 6e-48
Identities = 72/260 (27%), Positives = 112/260 (43%), Gaps = 45/260 (17%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD-------VAVKVYFGSEYIEGTLK------- 420
I+ D+ L E+G G++ V+ + VAVK LK
Sbjct: 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK----------ALKEASESAR 87
Query: 421 -NYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL--------------FKT 465
++Q+E +++ L+H +++ F G L +V E++ G L
Sbjct: 88 QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGG 147
Query: 466 LHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525
L + + L +A VA GM YL + VHRDL + N LV + VK+GDFG+S
Sbjct: 148 EDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMS 205
Query: 526 -SLKNATYLTAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLN 582
+ + Y P +WM PE + +SDV+SFGV+LWE+ T PW L+
Sbjct: 206 RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265
Query: 583 LMQVVGVVGFMDRRLELPEG 602
+ + + R LE P
Sbjct: 266 NTEAIDCIT-QGRELERPRA 284
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 8e-48
Identities = 75/196 (38%), Positives = 116/196 (59%), Gaps = 11/196 (5%)
Query: 386 IGLGSYAVVYRG-IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMG-A 443
+G G + VY+G + +G+ VAVK E +G +Q E+++I H N+L G
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLK-EERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 444 VASQERLGIVTEFLPRGSLFKTLH---KNYQALDIKRRLRMALDVARGMNYLHHR-NPPI 499
+ ERL +V ++ GS+ L ++ LD +R R+AL ARG+ YLH +P I
Sbjct: 97 MTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155
Query: 500 VHRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTPQWMAPEVLRSEPSNE 557
+HRD+K++N+L+D+ + VGDFGL+ L T++T RGT +APE L + S+E
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKSSE 214
Query: 558 KSDVFSFGVILWELVT 573
K+DVF +GV+L EL+T
Sbjct: 215 KTDVFGYGVMLLELIT 230
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-47
Identities = 66/250 (26%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD-------VAVKVYFGSEYIEGTLKNYQKEID 427
+ +++ L +G G++ VY G +G VAVK E ++ E
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEAL 85
Query: 428 IIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTL------HKNYQALDIKRRLRM 481
II K H N++ +G I+ E + G L L +L + L +
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 482 ALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK---NWTVKVGDFGLS-SLKNATYLTAKS 537
A D+A G YL + +HRD+ + N L+ K+GDFG++ + A+Y K
Sbjct: 146 ARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY-YRKG 202
Query: 538 GRGT-P-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GF 592
G P +WM PE K+D +SFGV+LWE+ + +P+ + + +V+ V G
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262
Query: 593 MDRRLELPEG 602
R++ P+
Sbjct: 263 ---RMDPPKN 269
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-47
Identities = 64/258 (24%), Positives = 115/258 (44%), Gaps = 16/258 (6%)
Query: 358 SSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGI--WNGSDVAVK-VYFGSEY 414
S++ + S + +++ +G G+Y +VY G N +A+K +
Sbjct: 2 MRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS- 60
Query: 415 IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALD 474
+ +EI + K L+H N++ ++G+ + + I E +P GSL L + L
Sbjct: 61 --RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118
Query: 475 IKRRL--RMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD-KNWTVKVGDFGLSSLKNAT 531
+ + G+ YLH IVHRD+K N+L++ + +K+ DFG S
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176
Query: 532 YLTAKSGRGTPQWMAPEVLRSEPS--NEKSDVFSFG-VILWELVTASIPWNNL-NLMQVV 587
++ GT Q+MAPE++ P + +D++S G I+ E+ T P+ L +
Sbjct: 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII-EMATGKPPFYELGEPQAAM 235
Query: 588 GVVGFMDRRLELPEGLDP 605
VG E+PE +
Sbjct: 236 FKVGMFKVHPEIPESMSA 253
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-46
Identities = 65/222 (29%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 376 RWEDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
R ED ++ IG GSY R +G + K E + E++++++L+
Sbjct: 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 63
Query: 434 HPNVLLFMGAVASQE--RLGIVTEFLPRGSLF---KTLHKNYQALDIKRRLRMALDVARG 488
HPN++ + + + L IV E+ G L K Q LD + LR+ +
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 489 MNYLHHRNPP---IVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWM 545
+ H R+ ++HRDLK +N+ +D VK+GDFGL+ + N AK+ GTP +M
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 546 APEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
+PE + NEKSD++S G +L+EL P+ + ++
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA 225
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 3e-46
Identities = 66/250 (26%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD-------VAVKVYFGSEYIEGTLKNYQKEID 427
+ +++ L +G G++ VY G +G VAVK E ++ E
Sbjct: 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEAL 126
Query: 428 IIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN------YQALDIKRRLRM 481
II K H N++ +G I+ E + G L L + +L + L +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 482 ALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK---NWTVKVGDFGLS-SLKNATYLTAKS 537
A D+A G YL + +HRD+ + N L+ K+GDFG++ + A Y K
Sbjct: 187 ARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY-YRKG 243
Query: 538 GRGT-P-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GF 592
G P +WM PE K+D +SFGV+LWE+ + +P+ + + +V+ V G
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303
Query: 593 MDRRLELPEG 602
R++ P+
Sbjct: 304 ---RMDPPKN 310
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 5e-46
Identities = 72/275 (26%), Positives = 118/275 (42%), Gaps = 63/275 (22%)
Query: 376 RWE----DLQLGEEIGLGSYAVVYRGIWNGSD-------VAVKVYFGSEYIEGTLK---- 420
+WE +L LG+ +G G + V + VAVK LK
Sbjct: 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK----------MLKENAS 66
Query: 421 -----NYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL------------- 462
+ E +++K++ HP+V+ GA + L ++ E+ GSL
Sbjct: 67 PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 463 ----------FKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD 512
H + +AL + + A +++GM YL +VHRDL + N+LV
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVA 184
Query: 513 KNWTVKVGDFGLS-SLKNATYLTAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWE 570
+ +K+ DFGLS + +S P +WMA E L +SDV+SFGV+LWE
Sbjct: 185 EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 571 LVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
+VT P+ + ++ ++ G R+E P+
Sbjct: 245 IVTLGGNPYPGIPPERLFNLLKTGH---RMERPDN 276
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 5e-46
Identities = 68/239 (28%), Positives = 123/239 (51%), Gaps = 20/239 (8%)
Query: 352 SSRSRESSSSKGDNETSCATDGGIRW---EDLQL-------GEEIGLGSYAVVYRG-IWN 400
S S+ ++S +S DL+ IG G + VY+G + +
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 401 GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRG 460
G+ VA+K E +G ++ ++ EI+ + RHP+++ +G + + ++ +++ G
Sbjct: 63 GAKVALKR-RTPESSQG-IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 461 SLFKTLH---KNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTV 517
+L + L+ ++ ++RL + + ARG++YLH I+HRD+KS N+L+D+N+
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVP 178
Query: 518 KVGDFGLSSLKNATYLTAKSGR--GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTA 574
K+ DFG+S T S GT ++ PE EKSDV+SFGV+L+E++ A
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 7e-46
Identities = 56/263 (21%), Positives = 92/263 (34%), Gaps = 10/263 (3%)
Query: 327 HRELLPGHDVNELDPDGKQYPSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEI 386
H L S E+S + + + Q +
Sbjct: 6 HHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRL 65
Query: 387 GLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGA 443
G GSY V++ +G AVK E+ +K+ +HP + A
Sbjct: 66 GHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA 125
Query: 444 VASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRD 503
L + TE SL + +L + D + +LH + +VH D
Sbjct: 126 WEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLD 182
Query: 504 LKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVF 562
+K +N+ + K+GDFGL L A + G P++MAPE+L+ +DVF
Sbjct: 183 VKPANIFLGPRGRCKLGDFGLLVELGTAG--AGEVQEGDPRYMAPELLQ-GSYGTAADVF 239
Query: 563 SFGVILWELVTASIPWNNLNLMQ 585
S G+ + E+ + Q
Sbjct: 240 SLGLTILEVACNMELPHGGEGWQ 262
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 58/292 (19%), Positives = 117/292 (40%), Gaps = 27/292 (9%)
Query: 332 PGHDVNELDPDGKQYPSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSY 391
G + E + + + + C + G + + ++IG G
Sbjct: 13 RGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIY---SILKQIGSGGS 69
Query: 392 AVVYRGI-WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN---VLLFMGAVASQ 447
+ V++ + A+K E TL +Y+ EI + KL+ + + L+ +
Sbjct: 70 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY-DYEITD 128
Query: 448 ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSS 507
+ + +V E L L K +++D R ++ ++ +H IVH DLK +
Sbjct: 129 QYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPA 184
Query: 508 NLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTPQWMAPEVLRSEPSN--------- 556
N L+ +K+ DFG+++ + T + S G +M PE ++ S+
Sbjct: 185 NFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSK 243
Query: 557 --EKSDVFSFGVILWELVTASIPWNNL-NLMQVVGVVGFMDRRLELPEGLDP 605
KSDV+S G IL+ + P+ + N + + + + +E P+ +
Sbjct: 244 ISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 295
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-45
Identities = 70/272 (25%), Positives = 114/272 (41%), Gaps = 61/272 (22%)
Query: 376 RWE----DLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLK---- 420
+WE L G+ +G G++ V G VAVK LK
Sbjct: 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK----------MLKPSAH 66
Query: 421 -----NYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSL------------ 462
E+ ++ L H N++ +GA ++TE+ G L
Sbjct: 67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 463 -----FKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTV 517
+ + ALD++ L + VA+GM +L +N +HRDL + N+L+
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRIT 184
Query: 518 KVGDFGLS-SLKNATYLTAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-A 574
K+ DFGL+ +KN + K P +WMAPE + + +SDV+S+G+ LWEL +
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244
Query: 575 SIPW----NNLNLMQVVGVVGFMDRRLELPEG 602
S P+ + +++ GF R+ PE
Sbjct: 245 SSPYPGMPVDSKFYKMI-KEGF---RMLSPEH 272
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 65/295 (22%), Positives = 107/295 (36%), Gaps = 29/295 (9%)
Query: 324 STGHRELLPGHDVNELDPDGKQYPSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLG 383
S+G L K E+ + ++ + W +
Sbjct: 6 SSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHW--MTHQ 63
Query: 384 EEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNY-QKEIDIIKKLRHPNVLLF 440
+G GS+ V+R G AVK + L+ + +E+ L P ++
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKK------VR--LEVFRVEELVACAGLSSPRIVPL 115
Query: 441 MGAVASQERLGIVTEFLPRGSLFKTLHKNYQALD---IKRRLRMALDVARGMNYLHHRNP 497
GAV + I E L GSL + + K L L AL G+ YLH R
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQAL---EGLEYLHTRR- 170
Query: 498 PIVHRDLKSSNLLVDKN-WTVKVGDFGLS-----SLKNATYLTAKSGRGTPQWMAPEVLR 551
I+H D+K+ N+L+ + + DFG + + LT GT MAPEV+
Sbjct: 171 -ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 552 SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDR-RLELPEGLDP 605
+P + K D++S ++ ++ PW + + E+P P
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAP 284
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-45
Identities = 69/270 (25%), Positives = 119/270 (44%), Gaps = 58/270 (21%)
Query: 376 RWE----DLQLGEEIGLGSYAVVYRGIWNGSD---------VAVKVYFGSEYIEGTLK-- 420
+WE L LG+ +G G++ V G D VAVK LK
Sbjct: 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK----------MLKDD 78
Query: 421 -------NYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSL---------- 462
+ E++++K + +H N++ +GA L ++ E+ +G+L
Sbjct: 79 ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 463 -----FKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTV 517
+ + + K + +ARGM YL + +HRDL + N+LV +N +
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVM 196
Query: 518 KVGDFGLS-SLKNATYLTAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-A 574
K+ DFGL+ + N Y + P +WMAPE L +SDV+SFGV++WE+ T
Sbjct: 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 575 SIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
P+ + + ++ ++ G R++ P
Sbjct: 257 GSPYPGIPVEELFKLLKEGH---RMDKPAN 283
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-45
Identities = 67/238 (28%), Positives = 113/238 (47%), Gaps = 17/238 (7%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGS----DVAVKVYFGSEYIEGTLKNYQKEIDIIK 430
R L E+G G++ V +G++ DVA+KV + + +E I+
Sbjct: 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREAQIMH 391
Query: 431 KLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMN 490
+L +P ++ +G V E L +V E G L K L + + + + V+ GM
Sbjct: 392 QLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 450
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTP-QWMAP 547
YL +N VHR+L + N+L+ K+ DFGLS + +Y TA+S P +W AP
Sbjct: 451 YLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508
Query: 548 EVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
E + + +SDV+S+GV +WE ++ P+ + +V+ + G R+E P
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPE 563
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-45
Identities = 72/270 (26%), Positives = 121/270 (44%), Gaps = 58/270 (21%)
Query: 376 RWE----DLQLGEEIGLGSYAVVYRGIWNG---------SDVAVKVYFGSEYIEGTLK-- 420
RWE L LG+ +G G++ V G + VAVK LK
Sbjct: 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK----------MLKSD 112
Query: 421 -------NYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSL---------- 462
+ E++++K + +H N++ +GA L ++ E+ +G+L
Sbjct: 113 ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 172
Query: 463 -----FKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTV 517
+ H + L K + A VARGM YL + +HRDL + N+LV ++ +
Sbjct: 173 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVM 230
Query: 518 KVGDFGLS-SLKNATYLTAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-A 574
K+ DFGL+ + + Y + P +WMAPE L +SDV+SFGV+LWE+ T
Sbjct: 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 290
Query: 575 SIPWNNLNLMQVVGVV--GFMDRRLELPEG 602
P+ + + ++ ++ G R++ P
Sbjct: 291 GSPYPGVPVEELFKLLKEGH---RMDKPSN 317
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-45
Identities = 70/216 (32%), Positives = 110/216 (50%), Gaps = 11/216 (5%)
Query: 365 NETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGT--LKNY 422
E T+ G ++G G + VVY+G N + VAVK I + +
Sbjct: 18 YELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQF 77
Query: 423 QKEIDIIKKLRHPNVLLFMG-AVASQERLGIVTEFLPRGSLFKTLH--KNYQALDIKRRL 479
+EI ++ K +H N++ +G + + +V ++P GSL L L R
Sbjct: 78 DQEIKVMAKCQHENLVELLGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 480 RMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539
++A A G+N+LH +HRD+KS+N+L+D+ +T K+ DFGL+ T + R
Sbjct: 137 KIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR 194
Query: 540 --GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
GT +MAPE LR E KSD++SFGV+L E++T
Sbjct: 195 IVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIIT 229
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 6e-45
Identities = 69/271 (25%), Positives = 115/271 (42%), Gaps = 57/271 (21%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD-------VAVKVYFGSEYIEGTLK------- 420
+++ +IG G++ V++ G VAVK LK
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK----------MLKEEASADM 93
Query: 421 --NYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSL---------------- 462
++Q+E ++ + +PN++ +G A + + ++ E++ G L
Sbjct: 94 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 463 -------FKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW 515
+ L +L +A VA GM YL R VHRDL + N LV +N
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENM 211
Query: 516 TVKVGDFGLS-SLKNATYLTAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
VK+ DFGLS ++ +A Y A P +WM PE + +SDV+++GV+LWE+ +
Sbjct: 212 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
Query: 574 -ASIPWNNLNLMQVVGVVGFMDR-RLELPEG 602
P+ + +V+ V D L PE
Sbjct: 272 YGLQPYYGMAHEEVIYYV--RDGNILACPEN 300
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-44
Identities = 58/268 (21%), Positives = 112/268 (41%), Gaps = 24/268 (8%)
Query: 356 RESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGI-WNGSDVAVKVYFGSEY 414
SS E ++ + ++IG G + V++ + A+K E
Sbjct: 6 HHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA 65
Query: 415 IEGTLKNYQKEIDIIKKLRHPN---VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQ 471
TL +Y+ EI + KL+ + + L+ + + + +V E L L K +
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLY-DYEITDQYIYMVMEC-GNIDLNSWL-KKKK 122
Query: 472 ALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--KN 529
++D R ++ ++ +H IVH DLK +N L+ +K+ DFG+++ +
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPD 179
Query: 530 ATYLTAKSGRGTPQWMAPEVLRSEPS-----------NEKSDVFSFGVILWELVTASIPW 578
T + S GT +M PE ++ S + KSDV+S G IL+ + P+
Sbjct: 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239
Query: 579 NNL-NLMQVVGVVGFMDRRLELPEGLDP 605
+ N + + + + +E P+ +
Sbjct: 240 QQIINQISKLHAIIDPNHEIEFPDIPEK 267
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 68/273 (24%), Positives = 110/273 (40%), Gaps = 64/273 (23%)
Query: 376 RWE----DLQLGEEIGLGSYAVVYRGIWNGSD-------VAVKVYFGSEYIEGTLK---- 420
+WE L+LG+ +G G++ V G D VAVK LK
Sbjct: 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK----------MLKEGAT 70
Query: 421 -----NYQKEIDIIKKL-RHPNVLLFMGAVASQER-LGIVTEFLPRGSL----------- 462
E+ I+ + H NV+ +GA L ++ EF G+L
Sbjct: 71 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 130
Query: 463 ----FKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVK 518
L ++ + + VA+GM +L R +HRDL + N+L+ + VK
Sbjct: 131 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVK 188
Query: 519 VGDFGLS-SLKNATYLTAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-AS 575
+ DFGL+ + K P +WMAPE + +SDV+SFGV+LWE+ + +
Sbjct: 189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248
Query: 576 IPW----NNLNLMQVV--GVVGFMDRRLELPEG 602
P+ + + + G R+ P+
Sbjct: 249 SPYPGVKIDEEFCRRLKEG------TRMRAPDY 275
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-44
Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 63/304 (20%)
Query: 347 PSLGESSRSRESSSSKGDNETSCATDGGI-----RWE----DLQLGEEIGLGSYAVVYRG 397
S R SS D +WE L LG+ +G G + V
Sbjct: 41 NSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMA 100
Query: 398 IWNGSD---------VAVKVYFGSEYIEGTLK---------NYQKEIDIIKKL-RHPNVL 438
G D VAVK LK + E++++K + +H N++
Sbjct: 101 EAVGIDKDKPKEAVTVAVK----------MLKDDATEKDLSDLVSEMEMMKMIGKHKNII 150
Query: 439 LFMGAVASQERLGIVTEFLPRGSL---------------FKTLHKNYQALDIKRRLRMAL 483
+GA L ++ E+ +G+L + + + K +
Sbjct: 151 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 210
Query: 484 DVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTP 542
+ARGM YL + +HRDL + N+LV +N +K+ DFGL+ + N Y + P
Sbjct: 211 QLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 268
Query: 543 -QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV--GFMDRRLE 598
+WMAPE L +SDV+SFGV++WE+ T P+ + + ++ ++ G R++
Sbjct: 269 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH---RMD 325
Query: 599 LPEG 602
P
Sbjct: 326 KPAN 329
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-44
Identities = 55/252 (21%), Positives = 102/252 (40%), Gaps = 29/252 (11%)
Query: 351 ESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYF 410
S + S+ S + D ++ + G + + + A+K Y
Sbjct: 4 GSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYE 63
Query: 411 GSE---------------YIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455
S I+ +++ E+ II +++ L G + + + + I+ E
Sbjct: 64 KSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYE 123
Query: 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVAR--------GMNYLHHRNPPIVHRDLKSS 507
++ S+ K LD + + V + +Y+H+ I HRD+K S
Sbjct: 124 YMENDSILKFDEYF-FVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPS 181
Query: 508 NLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEP--SNEKSDVFSFG 565
N+L+DKN VK+ DFG S + K RGT ++M PE +E + K D++S G
Sbjct: 182 NILMDKNGRVKLSDFGESEYMVDKKI--KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLG 239
Query: 566 VILWELVTASIP 577
+ L+ + +P
Sbjct: 240 ICLYVMFYNVVP 251
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-44
Identities = 54/237 (22%), Positives = 95/237 (40%), Gaps = 35/237 (14%)
Query: 378 EDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
D + +G G++ V R + A+K + E L E+ ++ L H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQ 62
Query: 436 NVLLFMGA-------------VASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMA 482
V+ + A V + L I E+ G+L+ +H R+
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 483 LDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR--- 539
+ ++Y+H + I+HRDLK N+ +D++ VK+GDFGL+ + + K
Sbjct: 123 RQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 540 -----------GTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELVTASIPWNNLNLM 584
GT ++A EVL NEK D++S G+I +E++ +
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI 237
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 55/243 (22%), Positives = 107/243 (44%), Gaps = 24/243 (9%)
Query: 381 QLGEEIGLGSYAVVYRGI-WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN--- 436
+ ++IG G + V++ + A+K E TL +Y+ EI + KL+ +
Sbjct: 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 437 VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRN 496
+ L+ + + + +V E L L K +++D R ++ ++ +H
Sbjct: 72 IRLY-DYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 497 PPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTPQWMAPEVLRSEP 554
IVH DLK +N L+ +K+ DFG+++ + T + S GT +M PE ++
Sbjct: 129 --IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 555 S-----------NEKSDVFSFGVILWELVTASIPWNNL-NLMQVVGVVGFMDRRLELPEG 602
S + KSDV+S G IL+ + P+ + N + + + + +E P+
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 603 LDP 605
+
Sbjct: 246 PEK 248
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-43
Identities = 52/215 (24%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 378 EDLQLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
D + E IG G + V++ +G +K ++ + ++E+ + KL H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR------VKYNNEKAEREVKALAKLDHV 64
Query: 436 NVLLFMGA----------------VASQERLGIVTEFLPRGSLFKTLHK-NYQALDIKRR 478
N++ + G + + L I EF +G+L + + K + LD
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 479 LRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSG 538
L + + +G++Y+H + +++RDLK SN+ + VK+GDFGL +
Sbjct: 125 LELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK-RTRS 181
Query: 539 RGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
+GT ++M+PE + S+ ++ D+++ G+IL EL+
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 65/268 (24%), Positives = 110/268 (41%), Gaps = 57/268 (21%)
Query: 376 RWE----DLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLK---- 420
+WE +LQ G+ +G G++ V G VAVK LK
Sbjct: 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK----------MLKSTAH 89
Query: 421 -----NYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSL------------ 462
E+ I+ L +H N++ +GA + ++TE+ G L
Sbjct: 90 ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLE 149
Query: 463 -FKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGD 521
+ L + VA+GM +L +N +HRD+ + N+L+ K+GD
Sbjct: 150 TDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGD 207
Query: 522 FGLS-SLKNATYLTAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPW 578
FGL+ + N + K P +WMAPE + +SDV+S+G++LWE+ + P+
Sbjct: 208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267
Query: 579 ----NNLNLMQVVGVVGFMDRRLELPEG 602
N ++V G+ ++ P
Sbjct: 268 PGILVNSKFYKLV-KDGY---QMAQPAF 291
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-43
Identities = 46/236 (19%), Positives = 93/236 (39%), Gaps = 32/236 (13%)
Query: 378 EDLQLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RH 434
+ E+IG G + V++ + +G A+K +N +E+ L +H
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTL---HKNYQALDIKRRLRMALDVARGMNY 491
+V+ + A A + + I E+ GSL + ++ + L V RG+ Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 492 LHHRNPPIVHRDLKSSNLLVDKN-------------------WTVKVGDFGLSSLKNATY 532
+H + +VH D+K SN+ + + K+GD G + ++
Sbjct: 131 IHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP- 187
Query: 533 LTAKSGRGTPQWMAPEVLR-SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
+ G +++A EVL+ + K+D+F+ + + A N + +
Sbjct: 188 ---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI 240
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-43
Identities = 66/277 (23%), Positives = 114/277 (41%), Gaps = 66/277 (23%)
Query: 376 RWE----DLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLK---- 420
+WE +L+ G+ +G G++ V G VAVK LK
Sbjct: 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK----------MLKEKAD 88
Query: 421 -----NYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSL------------ 462
E+ ++ +L H N++ +GA + ++ E+ G L
Sbjct: 89 SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFS 148
Query: 463 ----------FKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD 512
++ L + L A VA+GM +L ++ VHRDL + N+LV
Sbjct: 149 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVT 206
Query: 513 KNWTVKVGDFGLS-SLKNATYLTAKSGRGTP-QWMAPEVLRSEPSNEKSDVFSFGVILWE 570
VK+ DFGL+ + + + + P +WMAPE L KSDV+S+G++LWE
Sbjct: 207 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 266
Query: 571 LVT-ASIPW----NNLNLMQVVGVVGFMDRRLELPEG 602
+ + P+ + N +++ GF +++ P
Sbjct: 267 IFSLGVNPYPGIPVDANFYKLI-QNGF---KMDQPFY 299
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-42
Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 15/226 (6%)
Query: 368 SCATDGGIRWEDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYI-EGTLKNYQK 424
S AT G + ED ++G +G GS+A VY I G +VA+K+ G ++ Q
Sbjct: 1 SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD 484
E+ I +L+HP++L + +V E G + + L +
Sbjct: 61 EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 485 VARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR----- 539
+ GM YLH I+HRDL SNLL+ +N +K+ DFGL+ T L +
Sbjct: 121 IITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLC 173
Query: 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQ 585
GTP +++PE+ +SDV+S G + + L+ P++ +
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-41
Identities = 60/224 (26%), Positives = 108/224 (48%), Gaps = 18/224 (8%)
Query: 370 ATDGGIRWEDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIE-GTLKNYQKEI 426
+ ED ++G +G G + VY R + +A+KV F ++ + G ++E+
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 427 DIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVA 486
+I LRHPN+L G R+ ++ E+ P G++++ L K D +R ++A
Sbjct: 61 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELA 119
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR-----GT 541
++Y H + ++HRD+K NLL+ +K+ DFG S A S R GT
Sbjct: 120 NALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVH-------APSSRRTDLCGT 170
Query: 542 PQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQ 585
++ PE++ +EK D++S GV+ +E + P+ +
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 51/244 (20%), Positives = 96/244 (39%), Gaps = 25/244 (10%)
Query: 351 ESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKV 408
SS SS +N I + +++G G ++ V G+ +G A+K
Sbjct: 2 GSSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR 61
Query: 409 YFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG----IVTEFLPRGSLF- 463
E + + Q+E D+ + HPN+L + + ++ F RG+L+
Sbjct: 62 ILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWN 119
Query: 464 --KTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGD 521
+ L L + L + L + RG+ +H HRDLK +N+L+ + D
Sbjct: 120 EIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMD 177
Query: 522 FGLSSLKNATYLTAKSGR---------GTPQWMAPEVL---RSEPSNEKSDVFSFGVILW 569
G + ++ T + APE+ +E++DV+S G +L+
Sbjct: 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLY 237
Query: 570 ELVT 573
++
Sbjct: 238 AMMF 241
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-41
Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 32/221 (14%)
Query: 381 QLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNV 437
G +G G +A + A K+ S + + EI I + L H +V
Sbjct: 18 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 77
Query: 438 LLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR--------GM 489
+ F G + + +V E R SL + KRR + AR G
Sbjct: 78 VGFHGFFEDNDFVFVVLELCRRRSLLEL---------HKRRKALTEPEARYYLRQIVLGC 128
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR-----GTPQW 544
YLH ++HRDLK NL ++++ VK+GDFGL+ T + R GTP +
Sbjct: 129 QYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNY 181
Query: 545 MAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQ 585
+APEVL + + + DV+S G I++ L+ P+ L +
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 222
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 64/261 (24%), Positives = 104/261 (39%), Gaps = 33/261 (12%)
Query: 341 PDGKQYPSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRG--I 398
D + G ++ +++ D G +G G +A +
Sbjct: 5 ADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPR-SRRRYVRGRFLGKGGFAKCFEISDA 63
Query: 399 WNGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFL 457
A K+ S + + EI I + L H +V+ F G + + +V E
Sbjct: 64 DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC 123
Query: 458 PRGSLFKTLHKNYQALDIKRRLRMALDVAR--------GMNYLHHRNPPIVHRDLKSSNL 509
R SL + KRR + AR G YLH ++HRDLK NL
Sbjct: 124 RRRSLLEL---------HKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNL 172
Query: 510 LVDKNWTVKVGDFGLSSLKNATYLTAKSGR-----GTPQWMAPEVLRSEPSNEKSDVFSF 564
++++ VK+GDFGL+ T + R GTP ++APEVL + + + DV+S
Sbjct: 173 FLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI 227
Query: 565 GVILWELVTASIPWNNLNLMQ 585
G I++ L+ P+ L +
Sbjct: 228 GCIMYTLLVGKPPFETSCLKE 248
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 8e-41
Identities = 65/216 (30%), Positives = 111/216 (51%), Gaps = 18/216 (8%)
Query: 378 EDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRH 434
+D +G +G G + VY R N +A+KV F S+ + G ++EI+I LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
PN+L ++R+ ++ EF PRG L+K L K+ D +R ++A ++Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHE 132
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR-----GTPQWMAPEV 549
R ++HRD+K NLL+ +K+ DFG S A S R GT ++ PE+
Sbjct: 133 RK--VIHRDIKPENLLMGYKGELKIADFGWSVH-------APSLRRRTMCGTLDYLPPEM 183
Query: 550 LRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQ 585
+ + +EK D++ GV+ +E + P+++ + +
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 382 LGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNV-- 437
L + +G G+ A V+RG G A+KV F + + +E +++KKL H N+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKV-FNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 438 LLFMGAVASQERLGIVTEFLPRGSLFKTL--HKNYQALDIKRRLRMALDVARGMNYLHHR 495
L + + ++ EF P GSL+ L N L L + DV GMN+L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 496 NPPIVHRDLKSSNLLV----DKNWTVKVGDFGLS-SLKNATYLTAKSGRGTPQWMAPEVL 550
IVHR++K N++ D K+ DFG + L++ S GT +++ P++
Sbjct: 132 G--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPDMY 187
Query: 551 R--------SEPSNEKSDVFSFGVILWELVTASIPW 578
+ D++S GV + T S+P+
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-40
Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 19/216 (8%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
++ E +G G + V R I G VA+K E + + EI I+KKL HPNV+
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQ-CRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 439 -LF-----MGAVASQERLGIVTEFLPRGSLFKTL--HKNYQALDIKRRLRMALDVARGMN 490
+ +A + + E+ G L K L +N L + D++ +
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKN---WTVKVGDFGLS-SLKNATYLTAKSGRGTPQWMA 546
YLH I+HRDLK N+++ K+ D G + L GT Q++A
Sbjct: 136 YLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQYLA 191
Query: 547 PEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582
PE+L + D +SFG + +E +T P+
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW 227
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-40
Identities = 52/227 (22%), Positives = 96/227 (42%), Gaps = 35/227 (15%)
Query: 378 EDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKV--YFGSEYIEGTLKNYQKEIDIIKKLR 433
D + + +G G + VV+ + + + A+K E + +E+ + KL
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL---AREKVMREVKALAKLE 61
Query: 434 HPNVLLFMGA------------VASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRR--L 479
HP ++ + A + + L I + + +L ++ + +R L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 480 RMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAK--- 536
+ L +A + +LH + ++HRDLK SN+ + VKVGDFGL + +
Sbjct: 122 HIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 537 ---------SGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTA 574
GT +M+PE + + K D+FS G+IL+EL+
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP 226
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-40
Identities = 66/227 (29%), Positives = 110/227 (48%), Gaps = 24/227 (10%)
Query: 378 EDLQLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
+D +L E IG G+ AVV VA+K E + ++ KEI + + HP
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKR-INLEKCQTSMDELLKEIQAMSQCHHP 73
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRR----------LRMALDV 485
N++ + + ++ L +V + L GS+ + + K LR L
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL-- 131
Query: 486 ARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGR----G 540
G+ YLH +HRD+K+ N+L+ ++ +V++ DFG+S L +T R G
Sbjct: 132 -EGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 541 TPQWMAPEVL-RSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
TP WMAPEV+ + + K+D++SFG+ EL T + P++ M+V
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-40
Identities = 68/214 (31%), Positives = 112/214 (52%), Gaps = 13/214 (6%)
Query: 378 EDLQLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
E E+IG GS+ V++GI VA+K+ E E +++ Q+EI ++ + P
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALD---IKRRLRMALDVARGMNYL 492
V + G+ +L I+ E+L GS L LD I LR L +G++YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREIL---KGLDYL 135
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS 552
H +HRD+K++N+L+ ++ VK+ DFG++ T + + GTP WMAPEV++
Sbjct: 136 HSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 553 EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
+ K+D++S G+ EL P + L+ M+V
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSELHPMKV 227
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-39
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNV- 437
L + +G G+ A V+RG G A+KV F + + +E +++KKL H N+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKV-FNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 438 -LLFMGAVASQERLGIVTEFLPRGSLFKTL--HKNYQALDIKRRLRMALDVARGMNYLHH 494
L + + ++ EF P GSL+ L N L L + DV GMN+L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 495 RNPPIVHRDLKSSNLLV----DKNWTVKVGDFGLS-SLKNATYLTAKSGRGTPQWMAPEV 549
IVHR++K N++ D K+ DFG + L++ S GT +++ P++
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPDM 186
Query: 550 LR--------SEPSNEKSDVFSFGVILWELVTASIPW 578
+ D++S GV + T S+P+
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 9e-39
Identities = 59/234 (25%), Positives = 109/234 (46%), Gaps = 7/234 (2%)
Query: 347 PSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGI--WNGSDV 404
L E + T G ++ +D + E+G G+ VV++ +G +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61
Query: 405 AVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFK 464
A K+ E +E+ ++ + P ++ F GA S + I E + GSL +
Sbjct: 62 ARKL-IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 465 TLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524
+ K + + ++++ V +G+ YL ++ I+HRD+K SN+LV+ +K+ DFG+
Sbjct: 121 -VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV 178
Query: 525 SSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578
S + A S GT +M+PE L+ + +SD++S G+ L E+ P
Sbjct: 179 SGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-38
Identities = 60/252 (23%), Positives = 106/252 (42%), Gaps = 28/252 (11%)
Query: 349 LGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYA-VVYRGIWNGSDVAVK 407
+G S + GD ETS G I + + +G G+ +VYRG+++ DVAVK
Sbjct: 1 MGSSPSLEQD---DGDEETSVVIVGKISFC---PKDVLGHGAEGTIVYRGMFDNRDVAVK 54
Query: 408 VYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTL 466
+ +E+ ++++ HPNV+ + ++ I E +L + +
Sbjct: 55 RILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV 108
Query: 467 HKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV-----DKNWTVKVGD 521
+ A + + G+ +LH N IVHRDLK N+L+ + D
Sbjct: 109 EQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISD 166
Query: 522 FGLS---SLKNATYLTAKSGRGTPQWMAPEVLRSEPS---NEKSDVFSFGVILWELVTA- 574
FGL ++ ++ GT W+APE+L + D+FS G + + +++
Sbjct: 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEG 226
Query: 575 SIPWNNLNLMQV 586
S P+ Q
Sbjct: 227 SHPFGKSLQRQA 238
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 64/241 (26%), Positives = 111/241 (46%), Gaps = 18/241 (7%)
Query: 351 ESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRG--IWNGSDVAVKV 408
+ K D ++ ++ L E++G GSY VY+ G VA+K
Sbjct: 6 QLRNPPRRQLKKLDEDSL-TKQPEEVFDVL---EKLGEGSYGSVYKAIHKETGQIVAIKQ 61
Query: 409 YFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHK 468
+E L+ KEI I+++ P+V+ + G+ L IV E+ GS+ +
Sbjct: 62 V----PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL 117
Query: 469 NYQALD---IKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525
+ L I L+ L +G+ YLH +HRD+K+ N+L++ K+ DFG++
Sbjct: 118 RNKTLTEDEIATILQSTL---KGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVA 172
Query: 526 SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQ 585
T + GTP WMAPEV++ N +D++S G+ E+ P+ +++ M+
Sbjct: 173 GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232
Query: 586 V 586
Sbjct: 233 A 233
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 64/265 (24%), Positives = 115/265 (43%), Gaps = 32/265 (12%)
Query: 350 GESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVY--RGIWNGSDVAVK 407
G S S + D G +R + + G +A VY + + +G + A+K
Sbjct: 3 GPGSLGGASGRDQSDFVGQTVELGELRLR---VRRVLAEGGFAFVYEAQDVGSGREYALK 59
Query: 408 VYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERLG-------IVTEFLPR 459
+E E + +E+ +KKL HPN++ F A + + ++ L +
Sbjct: 60 RLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK 117
Query: 460 GSLFKTLHKNYQA--LDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTV 517
G L + L K L L++ R + ++H + PPI+HRDLK NLL+ T+
Sbjct: 118 GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177
Query: 518 KVGDFGLSSLKNATYLTAKSGR------------GTPQWMAPEVL---RSEPSNEKSDVF 562
K+ DFG ++ + + S + TP + PE++ + P EK D++
Sbjct: 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIW 237
Query: 563 SFGVILWELVTASIPWNNLNLMQVV 587
+ G IL+ L P+ + +++V
Sbjct: 238 ALGCILYLLCFRQHPFEDGAKLRIV 262
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 69/245 (28%), Positives = 112/245 (45%), Gaps = 53/245 (21%)
Query: 381 QLGEEIGLGSYAVVY--RGIWNGSDVAVKV------------------------YFGSEY 414
L +EIG GSY VV + + A+KV G
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 415 IEGTLKNYQKEIDIIKKLRHPNVL-LF-MGAVASQERLGIVTEFLPRGSLFKTLHKNYQA 472
G ++ +EI I+KKL HPNV+ L + +++ L +V E + +G +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM--------- 126
Query: 473 LDIKRRLRMALDVAR--------GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524
++ ++ D AR G+ YLH++ I+HRD+K SNLLV ++ +K+ DFG+
Sbjct: 127 -EVPTLKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 525 SSL-KNATYLTAKSGRGTPQWMAPEVLRSEPSN---EKSDVFSFGVILWELVTASIPWNN 580
S+ K + L + + GTP +MAPE L + DV++ GV L+ V P+ +
Sbjct: 184 SNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
Query: 581 LNLMQ 585
+M
Sbjct: 243 ERIMC 247
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-38
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 376 RWEDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
W+ L + +G G+Y V VAVK+ + +N +KEI I K L
Sbjct: 8 DWD---LVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLN 63
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR------ 487
H NV+ F G + E+ G LF + I+ + M A+
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELF-----DR----IEPDIGMPEPDAQRFFHQL 114
Query: 488 --GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR------ 539
G+ YLH I HRD+K NLL+D+ +K+ DFGL+ + R
Sbjct: 115 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLA----TVFRYNNRERLLNKMC 168
Query: 540 GTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTASIPWN 579
GT ++APE+L+ E DV+S G++L ++ +PW+
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 48/226 (21%), Positives = 91/226 (40%), Gaps = 22/226 (9%)
Query: 378 EDLQLGEEIGLG--SYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
+L IG G V G V V+ + Q E+ + K
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQ-ALD---IKRRLRMALDVARGM 489
HPN++ + + L +VT F+ GS + ++ ++ I L+ V + +
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ---GVLKAL 141
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-------SLKNATYLTAKSGRGTP 542
+Y+HH VHR +K+S++L+ + V + + + + K
Sbjct: 142 DYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 543 QWMAPEVLRSEPS--NEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
W++PEVL+ + KSD++S G+ EL +P+ ++ Q+
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 245
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 33/216 (15%)
Query: 381 QLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
L + +G G+Y V VAVK+ + +N +KEI I K L H NV+
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR--------GMN 490
F G + E+ G LF + I+ + M A+ G+
Sbjct: 69 KFYGHRREGNIQYLFLEYCSGGELF-----DR----IEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR------GTPQW 544
YLH I HRD+K NLL+D+ +K+ DFGL+ + R GT +
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLA----TVFRYNNRERLLNKMCGTLPY 173
Query: 545 MAPEVLRSEP-SNEKSDVFSFGVILWELVTASIPWN 579
+APE+L+ E DV+S G++L ++ +PW+
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 20/221 (9%)
Query: 376 RWEDLQLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
WE + E+G G++ VY+ G+ A KV E L++Y EI+I+
Sbjct: 20 VWEIV---GELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCD 74
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALD---IKRRLRMALDVARGMN 490
HP ++ +GA +L I+ EF P G++ + + + L I+ R L +N
Sbjct: 75 HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---EALN 131
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL 550
+LH + I+HRDLK+ N+L+ +++ DFG+S+ T S GTP WMAPEV+
Sbjct: 132 FLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 551 RSEPS-----NEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
E + K+D++S G+ L E+ P + LN M+V
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 230
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 14/214 (6%)
Query: 378 EDLQLGEEIGLGSYAVVYRGI--WNGSDVAVKV--YFGSEYIEGTLKNYQKEIDIIKKLR 433
+ E+IG G+ VY + G +VA++ E EI ++++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE----LIINEILVMRENK 75
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYL 492
+PN++ ++ + + L +V E+L GSL + + I R L + + +L
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFL 132
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS 552
H ++HRD+KS N+L+ + +VK+ DFG + + GTP WMAPEV+
Sbjct: 133 HSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 553 EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
+ K D++S G++ E++ P+ N N ++
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 65/217 (29%), Positives = 113/217 (52%), Gaps = 25/217 (11%)
Query: 381 QLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
+L + IG G++A V I G +VA+K+ ++ +L+ +E+ I+K L HPN++
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR--------GMN 490
+ +++ L ++ E+ G +F +Y + RM AR +
Sbjct: 78 KLFEVIETEKTLYLIMEYASGGEVF-----DY----LVAHGRMKEKEARSKFRQIVSAVQ 128
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL-KNATYLTAKSGRGTPQWMAPEV 549
Y H + IVHRDLK+ NLL+D + +K+ DFG S+ L + G P + APE+
Sbjct: 129 YCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAPEL 184
Query: 550 LRSEPSN-EKSDVFSFGVILWELVTASIPWNNLNLMQ 585
+ + + + DV+S GVIL+ LV+ S+P++ NL +
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 28/221 (12%)
Query: 378 EDLQLGEEIGLGSYAVVYRGI--WNGSDVAVKV--YFGSEYIEGTLKNYQKEIDIIKKLR 433
L +IG GS +V +G VAVK+ + E E+ I++ +
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRE----LLFNEVVIMRDYQ 100
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRM--------ALDV 485
H NV+ + E L ++ EFL G+L DI ++R+ V
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGAL----------TDIVSQVRLNEEQIATVCEAV 150
Query: 486 ARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWM 545
+ + YLH + ++HRD+KS ++L+ + VK+ DFG + + KS GTP WM
Sbjct: 151 LQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWM 208
Query: 546 APEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
APEV+ + D++S G+++ E+V P+ + + +Q
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 27/244 (11%)
Query: 358 SSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYI 415
S S G + S EDL+ EIG G+Y V + + +G +AVK S
Sbjct: 2 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR-IRSTVD 60
Query: 416 EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALD 474
E K ++D++ + P ++ F GA+ + I E + S K Y LD
Sbjct: 61 EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLD 119
Query: 475 IKRRL------RMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528
+ ++ L + +N+L N I+HRD+K SN+L+D++ +K+ DFG+S
Sbjct: 120 --DVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGIS--- 173
Query: 529 NATYLTAKSGR----GTPQWMAPEVLRSEPSNE----KSDVFSFGVILWELVTASIPWNN 580
L + G +MAPE + S + +SDV+S G+ L+EL T P+
Sbjct: 174 --GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231
Query: 581 LNLM 584
N +
Sbjct: 232 WNSV 235
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 72/254 (28%), Positives = 123/254 (48%), Gaps = 31/254 (12%)
Query: 352 SSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGI--WNGSDVAVKVY 409
S S + S + + S D +E + E +G G+Y VY+G G A+KV
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELV---ELVGNGTYGQVYKGRHVKTGQLAAIKVM 57
Query: 410 FGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGA------VASQERLGIVTEFLPRGSL 462
+ + ++EI+++KK H N+ + GA ++L +V EF GS+
Sbjct: 58 ---DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV 114
Query: 463 FKTLHKNYQALDIKRR-----LRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTV 517
L KN + +K R L RG+++LH ++HRD+K N+L+ +N V
Sbjct: 115 -TDLIKNTKGNTLKEEWIAYICREIL---RGLSHLHQHK--VIHRDIKGQNVLLTENAEV 168
Query: 518 KVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPS-----NEKSDVFSFGVILWELV 572
K+ DFG+S+ + T + GTP WMAPEV+ + + + KSD++S G+ E+
Sbjct: 169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228
Query: 573 TASIPWNNLNLMQV 586
+ P +++ M+
Sbjct: 229 EGAPPLCDMHPMRA 242
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-35
Identities = 59/218 (27%), Positives = 111/218 (50%), Gaps = 26/218 (11%)
Query: 381 QLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNV 437
LG+ +G+G++ V G G VAVK+ + + ++EI +K RHP++
Sbjct: 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 438 LLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR--------GM 489
+ +++ +V E++ G LF +Y I + R+ AR +
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELF-----DY----ICKHGRVEEMEARRLFQQILSAV 124
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL-KNATYLTAKSGRGTPQWMAPE 548
+Y H +VHRDLK N+L+D + K+ DFGLS++ + +L ++ G+P + APE
Sbjct: 125 DYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPE 180
Query: 549 VLRSEP-SNEKSDVFSFGVILWELVTASIPWNNLNLMQ 585
V+ + + D++S GVIL+ L+ ++P+++ ++
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 78/275 (28%), Positives = 119/275 (43%), Gaps = 27/275 (9%)
Query: 324 STGHRELLPGHDVNELDPDGKQYPSLGESSRSRESSSSKGD---NETSCATDGGIRWEDL 380
S H HD + + + + + + S D E D + DL
Sbjct: 2 SYYHHH--HHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDL 59
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKV-YFGSEYIEGTLKNYQKEIDIIKKLRHPNV 437
EIG GS+ VY N VA+K + + ++ KE+ ++KLRHPN
Sbjct: 60 ---REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116
Query: 438 LLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALD---IKRRLRMALDVARGMNYLHH 494
+ + G + +V E+ GS L + + L I AL +G+ YLH
Sbjct: 117 IQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHS 172
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEP 554
N ++HRD+K+ N+L+ + VK+GDFG + + A S GTP WMAPEV+ +
Sbjct: 173 HN--MIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANSFVGTPYWMAPEVILAMD 226
Query: 555 S---NEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
+ K DV+S G+ EL P N+N M
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 261
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 59/250 (23%), Positives = 107/250 (42%), Gaps = 29/250 (11%)
Query: 359 SSSKGDNETSCATDGGIRW----EDLQLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGS 412
SS +T T GG R+ DL+ E+G G+ V++ G +AVK
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ-MRR 60
Query: 413 EYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQ 471
+ K ++D++ K P ++ G + + I E + K +
Sbjct: 61 SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG 119
Query: 472 ALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531
+ + +M + + + + YL ++ ++HRD+K SN+L+D+ +K+ DFG+S
Sbjct: 120 PIPERILGKMTVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGIS-----G 173
Query: 532 YLTAKSGR----GTPQWMAPEVLRSEPSNE-----KSDVFSFGVILWELVTASIPWNNLN 582
L + G +MAPE + + ++DV+S G+ L EL T P+ N
Sbjct: 174 RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233
Query: 583 -----LMQVV 587
L +V+
Sbjct: 234 TDFEVLTKVL 243
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 49/330 (14%), Positives = 105/330 (31%), Gaps = 52/330 (15%)
Query: 321 RGTSTGHRELLPGHDVNELDPDGKQYPSLGESSRSRESSSSKG----DNETSCATDGGIR 376
RGT G + ++ P + + +S S ++ G R
Sbjct: 20 RGTDPGDVVI---EELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGER 76
Query: 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKV-YFGSEYIEGTLKNYQKEIDIIKKLR 433
L G +G G V V YF +K ++E+ ++ LR
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 434 ----------------------HPNVLLFMGAVASQERLGIVTEFLP----------RGS 461
P + + + +++ F G
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 462 LFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGD 521
+ + +++L RL++ L V R + LHH +VH L+ ++++D+ V +
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTG 254
Query: 522 FGLSSLKNATYLTA-KSGRGTPQWMAPEVLRSEPSNEK-----SDVFSFGVILWELVTAS 575
F A+ ++ G P+ A +L + D ++ G+ ++ + A
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 576 IPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
+P + + + +P+ +
Sbjct: 315 LPNTDDAALGGSEWI--FRSCKNIPQPVRA 342
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 40/263 (15%), Positives = 86/263 (32%), Gaps = 36/263 (13%)
Query: 339 LDPDGKQYPSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGI 398
L YP+ E + K + + + + + +G G++A VY
Sbjct: 34 LSKPVSSYPNTFEWQCKLPAIKPKTEFQLGS--------KLVYVHHLLGEGAFAQVYEAT 85
Query: 399 W-------NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451
N +KV + E + ++ +K + F A Q
Sbjct: 86 QGDLNDAKNKQKFVLKVQKPANPWE--FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV 143
Query: 452 IVTEFLPRGSLFKTLHK----NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSS 507
+V E G+L ++ + + + A+ + + +H I+H D+K
Sbjct: 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPD 201
Query: 508 NLLV-----------DKNWTVKVGDFGLSSLKNA--TYLTAKSGRGTPQWMAPEVLRSEP 554
N ++ D + + + D G S + T + E+L ++P
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP 261
Query: 555 SNEKSDVFSFGVILWELVTASIP 577
N + D F ++ ++ +
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTYM 284
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 28/218 (12%)
Query: 381 QLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
++IG G++ V R VAVK I+ +N Q+EI + LRHPN++
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIV 79
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR--------GMN 490
F + + L I+ E+ G L+ I R + D AR G++
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELY-----ER----ICNAGRFSEDEARFFFQQLLSGVS 130
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWT--VKVGDFGLSSLKNATYLTAKSGRGTPQWMAPE 548
Y H I HRDLK N L+D + +K+ DFG S KS GTP ++APE
Sbjct: 131 YCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPE 187
Query: 549 VLRSEPSN-EKSDVFSFGVILWELVTASIPWNNLNLMQ 585
VL + + + +DV+S GV L+ ++ + P+ + +
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-34
Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 36/227 (15%)
Query: 381 QLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGS--EYIEGTLKNYQKEIDIIKKLRHPN 436
+G+ +G GSY V AVK+ I N +KEI ++++LRH N
Sbjct: 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKN 67
Query: 437 VL-LF--MGAVASQERLGIVTEFLPRGS--LF-KTLHKNYQALDIKRRLRMALDVAR--- 487
V+ L + ++++ +V E+ G + K R + A
Sbjct: 68 VIQLVDVLYN-EEKQKMYMVMEYCVCGMQEMLDSVPEK-----------RFPVCQAHGYF 115
Query: 488 -----GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL--TAKSGRG 540
G+ YLH + IVH+D+K NLL+ T+K+ G++ + T ++ +G
Sbjct: 116 CQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQG 173
Query: 541 TPQWMAPEVLRSEP--SNEKSDVFSFGVILWELVTASIPWNNLNLMQ 585
+P + PE+ S K D++S GV L+ + T P+ N+ +
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK 220
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 61/229 (26%), Positives = 108/229 (47%), Gaps = 27/229 (11%)
Query: 378 EDLQLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RH 434
+DL+ E+G G+Y VV + +G +AVK + K ++DI +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKR-IRATVNSQEQKRLLMDLDISMRTVDC 65
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSL---FKTLHKNYQALDIKRRLRMALDVARGMNY 491
P + F GA+ + + I E + SL +K + Q + ++A+ + + + +
Sbjct: 66 PFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 492 LHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR----GTPQWMAP 547
LH + ++HRD+K SN+L++ VK+ DFG+S YL + G +MAP
Sbjct: 125 LHSKLS-VIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDDVAKDIDAGCKPYMAP 178
Query: 548 EVLRSEPS----NEKSDVFSFGVILWELVTASIPWNNLN-----LMQVV 587
E + E + + KSD++S G+ + EL P+++ L QVV
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 55/196 (28%), Positives = 101/196 (51%), Gaps = 15/196 (7%)
Query: 381 QLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
+ EE+G G+++VV R + G + A K+ + + ++E I +KL+HPN++
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFK--TLHKNYQALDIKRRLRMALDVARGMNYLHHRN 496
++ + +V + + G LF+ + Y D ++ L+ + Y H
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES---IAYCHSNG 125
Query: 497 PPIVHRDLKSSNLLV---DKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAPEVLRS 552
IVHR+LK NLL+ K VK+ DFGL+ + ++ +G TP +++PEVL+
Sbjct: 126 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG--TPGYLSPEVLKK 181
Query: 553 EPSNEKSDVFSFGVIL 568
+P ++ D+++ GVIL
Sbjct: 182 DPYSKPVDIWACGVIL 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 365 NETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNY 422
+ G E + +G GS+ V + + AVKV +
Sbjct: 10 GRENLYFQGTFA-ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68
Query: 423 QKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTL--HKNYQALDIKRRLR 480
+E++++KKL HPN++ + IV E G LF + K + D R ++
Sbjct: 69 LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK 128
Query: 481 MALDVARGMNYLHHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSS-LKNATYLTAK 536
+ Y+H N IVHRDLK N+L+ +K+ +K+ DFGLS+ + T + +
Sbjct: 129 QVFSG---ITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183
Query: 537 SGRGTPQWMAPEVLRSEPSNEKSDVFSFGVIL 568
GT ++APEVLR +EK DV+S GVIL
Sbjct: 184 I--GTAYYIAPEVLR-GTYDEKCDVWSAGVIL 212
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 59/227 (25%), Positives = 104/227 (45%), Gaps = 27/227 (11%)
Query: 361 SKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGI--WNGSDVAVKV-------YFG 411
++ + G E+ + E +G G +VV R I + AVK+ F
Sbjct: 1 TRDAALPGSHSTHGFY-ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS 59
Query: 412 SEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSLFK--TLHK 468
+E ++ + KE+DI++K+ HPN++ + +V + + +G LF T
Sbjct: 60 AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV 119
Query: 469 NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS-L 527
+ ++ +R + + LH N IVHRDLK N+L+D + +K+ DFG S L
Sbjct: 120 TLSEKETRKIMR---ALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQL 174
Query: 528 KNATYLTAKSGRGTPQWMAPEVLRSEPS------NEKSDVFSFGVIL 568
L GTP ++APE++ + ++ D++S GVI+
Sbjct: 175 DPGEKLREVC--GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 7e-33
Identities = 59/218 (27%), Positives = 113/218 (51%), Gaps = 26/218 (11%)
Query: 381 QLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNV 437
LG+ +G+G++ V G G VAVK+ + + ++EI +K RHP++
Sbjct: 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 438 LLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR--------GM 489
+ +++ + +V E++ G LF +Y I + R+ +R G+
Sbjct: 79 IKLYQVISTPSDIFMVMEYVSGGELF-----DY----ICKNGRLDEKESRRLFQQILSGV 129
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL-KNATYLTAKSGRGTPQWMAPE 548
+Y H +VHRDLK N+L+D + K+ DFGLS++ + +L ++ G+P + APE
Sbjct: 130 DYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPE 185
Query: 549 VLRSEP-SNEKSDVFSFGVILWELVTASIPWNNLNLMQ 585
V+ + + D++S GVIL+ L+ ++P+++ ++
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT 223
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 55/196 (28%), Positives = 102/196 (52%), Gaps = 15/196 (7%)
Query: 381 QLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
+ EE+G G+++VV R + G + A K+ + + ++E I +KL+HPN++
Sbjct: 32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFKTL--HKNYQALDIKRRLRMALDVARGMNYLHHRN 496
++ + +V + + G LF+ + + Y D ++ L+ + Y H
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES---IAYCHSNG 148
Query: 497 PPIVHRDLKSSNLLV---DKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAPEVLRS 552
IVHR+LK NLL+ K VK+ DFGL+ + ++ +G TP +++PEVL+
Sbjct: 149 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG--TPGYLSPEVLKK 204
Query: 553 EPSNEKSDVFSFGVIL 568
+P ++ D+++ GVIL
Sbjct: 205 DPYSKPVDIWACGVIL 220
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 59/255 (23%), Positives = 112/255 (43%), Gaps = 28/255 (10%)
Query: 332 PGHDVNELDPDGKQYPSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSY 391
+ + E P E+ + + + A + + + IG G
Sbjct: 51 SANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKE--FY-QKYDPKDVIGRGVS 107
Query: 392 AVVYRGI--WNGSDVAVKV------YFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMG 442
+VV R + G + AVK+ E +E + ++E I++++ HP+++ +
Sbjct: 108 SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167
Query: 443 AVASQERLGIVTEFLPRGSLFK--TLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIV 500
+ S + +V + + +G LF T + + +R + +++LH N IV
Sbjct: 168 SYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR---SLLEAVSFLHANN--IV 222
Query: 501 HRDLKSSNLLVDKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAPEVLRSEPS---- 555
HRDLK N+L+D N +++ DFG S L+ L GTP ++APE+L+
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC--GTPGYLAPEILKCSMDETHP 280
Query: 556 --NEKSDVFSFGVIL 568
++ D+++ GVIL
Sbjct: 281 GYGKEVDLWACGVIL 295
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 381 QLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKN-YQKEIDIIKKLRHPNV 437
+ E +G GS+ V VA+K + + ++EI +K LRHP++
Sbjct: 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI 71
Query: 438 LLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR--------GM 489
+ + + + +V E+ G LF +Y I + RM D R +
Sbjct: 72 IKLYDVITTPTDIVMVIEYAG-GELF-----DY----IVEKKRMTEDEGRRFFQQIICAI 121
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL-KNATYLTAKSGRGTPQWMAPE 548
Y H IVHRDLK NLL+D N VK+ DFGLS++ + +L K+ G+P + APE
Sbjct: 122 EYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYAAPE 177
Query: 549 VLRSEP-SNEKSDVFSFGVILWELVTASIPWNNLNLMQ 585
V+ + + + DV+S G++L+ ++ +P+++ +
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 56/248 (22%), Positives = 99/248 (39%), Gaps = 42/248 (16%)
Query: 359 SSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRG--IWNGSDVAVK------VYF 410
K A G + +G G++ V+ +V VK V
Sbjct: 5 EPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLE 64
Query: 411 GSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGS-LFKTLHKN 469
+ L EI I+ ++ H N++ + +Q +V E G LF
Sbjct: 65 DCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLF-----A 119
Query: 470 YQALDIKRRLRMALDVAR--------GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGD 521
+ I R R+ +A + YL ++ I+HRD+K N+++ +++T+K+ D
Sbjct: 120 F----IDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLID 173
Query: 522 FGLSSLKNATYLTAKSGR------GTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTA 574
FG ++ + G+ GT ++ APEVL P + +++S GV L+ LV
Sbjct: 174 FGSAAY-------LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226
Query: 575 SIPWNNLN 582
P+ L
Sbjct: 227 ENPFCELE 234
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 1e-32
Identities = 35/278 (12%), Positives = 76/278 (27%), Gaps = 46/278 (16%)
Query: 341 PDGKQYPSLGESSRSRESSSSK---GDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRG 397
+ +L E + E+ ++ + ET+ + L+L E + +G +VV+
Sbjct: 22 IGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLV 81
Query: 398 IW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVL---------------- 438
D A+KV+ L+ + +L +
Sbjct: 82 RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141
Query: 439 -----LFMGAVASQERLGIVTEFL----------PRGSLFKTLHKNYQALDIKRRLRMAL 483
F Q+ + L S ++ I +
Sbjct: 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTA 201
Query: 484 DVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQ 543
+ R L + +VH NL + + + +GD P
Sbjct: 202 QLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA----SSVPV 255
Query: 544 WMAPEVL---RSEPSNEKSDVFSFGVILWELVTASIPW 578
AP + + + G+ ++ + +P+
Sbjct: 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 24/199 (12%)
Query: 381 QLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE----GTLKNYQKEIDIIKKLRH 434
E +G G+++ V+ G A+K I+ + + EI ++KK++H
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKC------IKKSPAFRDSSLENEIAVLKKIKH 65
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFK--TLHKNYQALDIKRRLRMALDVARGMNYL 492
N++ S +V + + G LF Y D ++ L + YL
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSA---VKYL 122
Query: 493 HHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEV 549
H IVHRDLK NLL ++N + + DFGLS ++ ++ G TP ++APEV
Sbjct: 123 HENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACG--TPGYVAPEV 178
Query: 550 LRSEPSNEKSDVFSFGVIL 568
L +P ++ D +S GVI
Sbjct: 179 LAQKPYSKAVDCWSIGVIT 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKV-----YFGSEYIEGTLKNYQKEIDIIKKLR 433
+L E IG G ++VV R I G AVK+ + S + ++ ++E I L+
Sbjct: 27 ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS--TEDLKREASICHMLK 84
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLF------KTLHKNYQALDIKRRLRMALDVAR 487
HP+++ + +S L +V EF+ L Y +R L+
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA-- 142
Query: 488 GMNYLHHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQW 544
+ Y H N I+HRD+K +L+ + + VK+G FG++ + L A GTP +
Sbjct: 143 -LRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199
Query: 545 MAPEVLRSEPSNEKSDVFSFGVIL 568
MAPEV++ EP + DV+ GVIL
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-32
Identities = 53/195 (27%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 381 QLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
QL EE+G G+++VV R + G + A + + + ++E I + L+HPN++
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFKTL--HKNYQALDIKRRLRMALDVARGMNYLHHRN 496
+++ + ++ + + G LF+ + + Y D ++ L+ + + H
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA---VLHCHQMG 130
Query: 497 PPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSE 553
+VHR+LK NLL+ K VK+ DFGL+ GTP +++PEVLR +
Sbjct: 131 --VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD 188
Query: 554 PSNEKSDVFSFGVIL 568
P + D+++ GVIL
Sbjct: 189 PYGKPVDLWACGVIL 203
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 26/200 (13%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNV 437
++ E+IG+GSY+V R I + AVK+ I+ + ++ +EI+I+ + +HPN+
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKI------IDKSKRDPTEEIEILLRYGQHPNI 78
Query: 438 LLFMGAVASQERLGIVTEFLPRGSLFK--TLHKNY---QALDIKRRLRMALDVARGMNYL 492
+ + + +VTE + G L K + +A + + + + YL
Sbjct: 79 ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLF------TITKTVEYL 132
Query: 493 HHRNPPIVHRDLKSSNLLV----DKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPE 548
H + +VHRDLK SN+L ++++ DFG + A + T ++APE
Sbjct: 133 HAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190
Query: 549 VLRSEPSNEKSDVFSFGVIL 568
VL + + D++S GV+L
Sbjct: 191 VLERQGYDAACDIWSLGVLL 210
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 53/201 (26%), Positives = 104/201 (51%), Gaps = 20/201 (9%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKV----YFGSEYIEGTLKNYQKEIDIIKKLRH 434
++GEE+G G +A+V + G + A K S + + ++E++I++++RH
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTL--HKNYQALDIKRRLRMALDVARGMNYL 492
PN++ ++ + ++ E + G LF L ++ + + L+ LD G++YL
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYL 124
Query: 493 HHRNPPIVHRDLKSSNLLV----DKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAP 547
H + I H DLK N+++ N +K+ DFG++ ++ G TP+++AP
Sbjct: 125 HSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG--TPEFVAP 180
Query: 548 EVLRSEPSNEKSDVFSFGVIL 568
E++ EP ++D++S GVI
Sbjct: 181 EIVNYEPLGLEADMWSIGVIT 201
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 46/326 (14%), Positives = 102/326 (31%), Gaps = 62/326 (19%)
Query: 332 PGHDVNELDPDGKQYPSLGESSRSRESSSSK--------GDNETSCATDGGIRWEDLQLG 383
PG V E + ++ +S +S++ ++ G R L G
Sbjct: 19 PGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRG 78
Query: 384 EEIGLGSYAVVYRGIW--NGSDVAVKV-YFGSEYIEGTLKNYQKEIDIIKKLR------- 433
+G G V V YF +K ++E+ ++ LR
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 434 ---------------HPNVLLFMGAVASQERLGIVTEFL-------PRGSLFKTLH---K 468
P + + + +++ F + + L
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 469 NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528
+++L RL++ L V R + LHH +VH L+ ++++D+ V + F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 529 NATYLTAKSGRGTPQWMAPEVLRSE-----------PSNEKSDVFSFGVILWELVTASIP 577
A ++ + + PE+ D ++ G++++ + A +P
Sbjct: 257 GARVVS----SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
Query: 578 WNNLNLMQVVGVVGFMDRRLELPEGL 603
+ + +P+ +
Sbjct: 313 ITKDAALGGSEWI--FRSCKNIPQPV 336
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 51/228 (22%), Positives = 87/228 (38%), Gaps = 40/228 (17%)
Query: 382 LGEEIGLGSYA-VVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLL 439
+ +G GS VV++G + G VAVK EI ++ + HPNV+
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-----DIALMEIKLLTESDDHPNVIR 73
Query: 440 FMGAVASQERLGIVTEFLPRGSLF------KTLHKNYQALDIKRRLRMALDVARGMNYLH 493
+ + + L I E +L +N + + + +A G+ +LH
Sbjct: 74 YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 494 HRNPPIVHRDLKSSNLLVD-------------KNWTVKVGDFGLSSL----KNATYLTAK 536
I+HRDLK N+LV +N + + DFGL +++
Sbjct: 133 SLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 537 SGRGTPQWMAPEVLRS-------EPSNEKSDVFSFGVILWELVTASIP 577
+ GT W APE+L D+FS G + + +++
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 51/201 (25%), Positives = 99/201 (49%), Gaps = 20/201 (9%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKV----YFGSEYIEGTLKNYQKEIDIIKKLRH 434
+GEE+G G +A+V + G + A K + + + ++E+ I++++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTL--HKNYQALDIKRRLRMALDVARGMNYL 492
NV+ ++ + ++ E + G LF L ++ + ++ LD G+NYL
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNYL 131
Query: 493 HHRNPPIVHRDLKSSNLLV----DKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAP 547
H + I H DLK N+++ +K+ DFGL+ +++ G TP+++AP
Sbjct: 132 HTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG--TPEFVAP 187
Query: 548 EVLRSEPSNEKSDVFSFGVIL 568
E++ EP ++D++S GVI
Sbjct: 188 EIVNYEPLGLEADMWSIGVIT 208
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 5e-31
Identities = 63/249 (25%), Positives = 105/249 (42%), Gaps = 54/249 (21%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQK---EIDIIKKLRHP 435
L IG GSY VV I + A+K+ ++ + K+ ++ E+ ++KKL HP
Sbjct: 29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRL---------------- 479
N+ ++ + +V E G L L+ K +
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 480 -------------------RMALDVAR----GMNYLHHRNPPIVHRDLKSSNLLV--DKN 514
++ ++ R ++YLH++ I HRD+K N L +K+
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKS 206
Query: 515 WTVKVGDFGLS----SLKNATYLTAKSGRGTPQWMAPEVLR--SEPSNEKSDVFSFGVIL 568
+ +K+ DFGLS L N Y + GTP ++APEVL +E K D +S GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 569 WELVTASIP 577
L+ ++P
Sbjct: 267 HLLLMGAVP 275
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-31
Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 381 QLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYI--EGTLKNYQKEIDIIKKLRHPN 436
++ +++G G + VY VA+K F E TLK +++E+ +L H N
Sbjct: 14 KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 437 VLLFMGAVA------SQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMN 490
+ V+ + +V E++ G +++ L + + + G+
Sbjct: 73 I------VSMIDVDEEDDCYYLVMEYIE-GPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR-GTPQWMAPEV 549
+ H IVHRD+K N+L+D N T+K+ DFG++ + T LT + GT Q+ +PE
Sbjct: 126 HAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 550 LRSEPSNEKSDVFSFGVILWELVTASIP 577
+ E ++E +D++S G++L+E++ P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 26/199 (13%)
Query: 382 LGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLR-HPNV 437
+ +G GS+++ + + + AVK+ I N QKEI +K HPN+
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVKI------ISKRMEANTQKEITALKLCEGHPNI 68
Query: 438 LLFMGAVASQERLGIVTEFLPRGSLFK--TLHKNY---QALDIKRRLRMALDVARGMNYL 492
+ Q +V E L G LF+ K++ +A I R + ++++
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR------KLVSAVSHM 122
Query: 493 HHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEV 549
H +VHRDLK NLL + N +K+ DFG + LK K+ T + APE+
Sbjct: 123 HDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180
Query: 550 LRSEPSNEKSDVFSFGVIL 568
L +E D++S GVIL
Sbjct: 181 LNQNGYDESCDLWSLGVIL 199
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKVY----FGSEYIEGTLKNYQKEIDIIKKLRH 434
GEE+G G +AVV + G A K S + ++ ++E+ I+K+++H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTL--HKNYQALDIKRRLRMALDVARGMNYL 492
PNV+ ++ + ++ E + G LF L ++ + L+ L+ G+ YL
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---GVYYL 130
Query: 493 HHRNPPIVHRDLKSSNLLV----DKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAP 547
H I H DLK N+++ +K+ DFGL+ + G TP+++AP
Sbjct: 131 HSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG--TPEFVAP 186
Query: 548 EVLRSEPSNEKSDVFSFGVIL 568
E++ EP ++D++S GVI
Sbjct: 187 EIVNYEPLGLEADMWSIGVIT 207
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 26/200 (13%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIE-GTLKNYQK---EIDIIKKLRH 434
L IG GS+ V + A K I +++ + EI+I+K L H
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKK------IPKYFVEDVDRFKQEIEIMKSLDH 65
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTL--HKNYQALDIKRRLRMALDVARGMNYL 492
PN++ + +V E G LF+ + + ++ D R ++ L + Y
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA---VAYC 122
Query: 493 HHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAPE 548
H N + HRDLK N L + +K+ DFGL++ K + K GTP +++P+
Sbjct: 123 HKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQ 178
Query: 549 VLRSEPSNEKSDVFSFGVIL 568
VL + D +S GV++
Sbjct: 179 VLE-GLYGPECDEWSAGVMM 197
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 51/201 (25%), Positives = 99/201 (49%), Gaps = 20/201 (9%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKV----YFGSEYIEGTLKNYQKEIDIIKKLRH 434
+GEE+G G +A+V + G + A K + + ++E+ I++++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTL--HKNYQALDIKRRLRMALDVARGMNYL 492
PN++ ++ + ++ E + G LF L ++ + ++ LD G+NYL
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNYL 131
Query: 493 HHRNPPIVHRDLKSSNLLV----DKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAP 547
H + I H DLK N+++ +K+ DFGL+ +++ G TP+++AP
Sbjct: 132 HTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG--TPEFVAP 187
Query: 548 EVLRSEPSNEKSDVFSFGVIL 568
E++ EP ++D++S GVI
Sbjct: 188 EIVNYEPLGLEADMWSIGVIT 208
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 62/238 (26%), Positives = 100/238 (42%), Gaps = 27/238 (11%)
Query: 348 SLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGI--WNGSDVA 405
+L S ++ S +R ++ + + +G G+ V VA
Sbjct: 107 ALSLSRNKVFVFFDLTVDDQSVYP-KALR-DEYIMSKTLGSGACGEVKLAFERKTCKKVA 164
Query: 406 VKV------YFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPR 459
+++ GS N + EI+I+KKL HP ++ + E IV E +
Sbjct: 165 IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEG 223
Query: 460 GSLFK--TLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV---DKN 514
G LF +K + K + + YLH I+HRDLK N+L+ +++
Sbjct: 224 GELFDKVVGNKRLKEATCK---LYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEED 278
Query: 515 WTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAPEVLRSEPS---NEKSDVFSFGVIL 568
+K+ DFG S L + + GTP ++APEVL S + N D +S GVIL
Sbjct: 279 CLIKITDFGHSKILGETSLMRTLC--GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-30
Identities = 40/191 (20%), Positives = 77/191 (40%), Gaps = 16/191 (8%)
Query: 395 YRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454
++ + + + + +I + N + + + + L I
Sbjct: 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140
Query: 455 EFLPRGSLFKTLH--KNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD 512
+ + +L ++ + + + L + + +A + +LH + ++HRDLK SN+
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT 198
Query: 513 KNWTVKVGDFGLS------------SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSD 560
+ VKVGDFGL Y T GT +M+PE + + K D
Sbjct: 199 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVD 258
Query: 561 VFSFGVILWEL 571
+FS G+IL+EL
Sbjct: 259 IFSLGLILFEL 269
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKV------YFGSEYIEGTLKNYQKEIDIIKKL 432
+ + +G G+ V VA+K+ GS N + EI+I+KKL
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 433 RHPNVLLFMGAVASQERLGIVTEFLPRGSLFK--TLHKNYQALDIKRRLRMALDVARGMN 490
HP ++ + E IV E + G LF +K + K + +
Sbjct: 73 NHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY---QMLLAVQ 128
Query: 491 YLHHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMA 546
YLH I+HRDLK N+L+ +++ +K+ DFG S L + + GTP ++A
Sbjct: 129 YLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLA 184
Query: 547 PEVLRSEPS---NEKSDVFSFGVIL 568
PEVL S + N D +S GVIL
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 66/243 (27%), Positives = 111/243 (45%), Gaps = 17/243 (6%)
Query: 343 GKQYPSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGI--WN 400
+ S G + + + G + E Q +++G G+Y V
Sbjct: 3 HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLS-EMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 401 GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRG 460
+ A+K+ + + +E+ ++K L HPN++ + +V E G
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121
Query: 461 SLFKTL--HKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV---DKNW 515
LF + + +D ++ V G+ YLH N IVHRDLK NLL+ +K+
Sbjct: 122 ELFDEIIHRMKFNEVDAAVIIK---QVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDA 176
Query: 516 TVKVGDFGLSSL-KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTA 574
+K+ DFGLS++ +N + + GT ++APEVLR + +EK DV+S GVIL+ L+
Sbjct: 177 LIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAG 233
Query: 575 SIP 577
P
Sbjct: 234 YPP 236
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 60/233 (25%), Positives = 105/233 (45%), Gaps = 20/233 (8%)
Query: 344 KQYPSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSD 403
Q S +S + ++S D + + + ++ E+G G+ ++VYR G+
Sbjct: 20 FQSMSSVTASAAPGTASLVPDYWIDGSNRDALS-DFFEVESELGRGATSIVYRCKQKGTQ 78
Query: 404 --VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGS 461
A+KV + + + EI ++ +L HPN++ + + +V E + G
Sbjct: 79 KPYALKVLKKTVDKK----IVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE 134
Query: 462 LFKTL--HKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV---DKNWT 516
LF + Y D ++ L+ + YLH IVHRDLK NLL +
Sbjct: 135 LFDRIVEKGYYSERDAADAVKQILEA---VAYLHENG--IVHRDLKPENLLYATPAPDAP 189
Query: 517 VKVGDFGLSS-LKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVIL 568
+K+ DFGLS +++ + G TP + APE+LR + D++S G+I
Sbjct: 190 LKIADFGLSKIVEHQVLMKTVCG--TPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 42/196 (21%), Positives = 85/196 (43%), Gaps = 18/196 (9%)
Query: 381 QLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
+ E++G G + +V+R + + K + +K EI I+ RH N+L
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---EISILNIARHRNIL 64
Query: 439 LFMGAVASQERLGIVTEFLPRGSLF-KTLHKN--YQALDIKRRLRMALDVARGMNYLHHR 495
+ S E L ++ EF+ +F + +I + + + +LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE---ALQFLHSH 121
Query: 496 NPPIVHRDLKSSNLLV--DKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAPEVLRS 552
N I H D++ N++ ++ T+K+ +FG + LK P++ APEV +
Sbjct: 122 N--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAPEVHQH 177
Query: 553 EPSNEKSDVFSFGVIL 568
+ + +D++S G ++
Sbjct: 178 DVVSTATDMWSLGTLV 193
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 55/251 (21%), Positives = 101/251 (40%), Gaps = 38/251 (15%)
Query: 352 SSRSRESSSSKGDNETSCATDGGIRWEDL----QLGEEIGLGSYAVVYRG--IWNGSDVA 405
R S + ++ + G E L Q+G +G G + VY G + + VA
Sbjct: 13 GLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVA 72
Query: 406 VKV----YFGSEYIEGTLKNYQKEIDIIKKLRH--PNVLLFMGAVASQERLGIVTEF-LP 458
+K E+ ++KK+ V+ + + ++ E P
Sbjct: 73 IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 132
Query: 459 RGSLFKTLHKNYQALDIKRRLRMALDVAR--------GMNYLHHRNPPIVHRDLKSSNLL 510
LF ++ I R + ++AR + + H+ ++HRD+K N+L
Sbjct: 133 VQDLF-----DF----ITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENIL 181
Query: 511 VDKN-WTVKVGDFGLSSL-KNATYLTAKSGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVI 567
+D N +K+ DFG +L K+ Y GT + PE +R + V+S G++
Sbjct: 182 IDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEWIRYHRYHGRSAAVWSLGIL 238
Query: 568 LWELVTASIPW 578
L+++V IP+
Sbjct: 239 LYDMVCGDIPF 249
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-29
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
+ +G GS+ V + + AVKV + +E++++KKL HPN++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFKTL--HKNYQALDIKRRLRMALDVARGMNYLHHRN 496
+ IV E G LF + K + D R ++ + Y+H N
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG---ITYMHKHN 141
Query: 497 PPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSL-KNATYLTAKSGRGTPQWMAPEVLRS 552
IVHRDLK N+L+ +K+ +K+ DFGLS+ + T + + GT ++APEVLR
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLR- 196
Query: 553 EPSNEKSDVFSFGVILWELVTASIP 577
+EK DV+S GVIL+ L++ + P
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 49/196 (25%), Positives = 93/196 (47%), Gaps = 17/196 (8%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
+ EE+G G++ VV+R + G K ++ + EI I+ +L HP ++
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLI 111
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFKTLHK---NYQALDIKRRLRMALDVARGMNYLHHR 495
A + + ++ EFL G LF + ++ +R A + G+ ++H
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMHEH 168
Query: 496 NPPIVHRDLKSSNLLV--DKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAPEVLRS 552
+ IVH D+K N++ K +VK+ DFGL++ L + + T ++ APE++
Sbjct: 169 S--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA--TAEFAAPEIVDR 224
Query: 553 EPSNEKSDVFSFGVIL 568
EP +D+++ GV+
Sbjct: 225 EPVGFYTDMWAIGVLG 240
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKV-----------YFGSEYIEGTLKNYQKEID 427
++G G+Y V S+ A+KV ++ IE + EI
Sbjct: 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 428 IIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTL--HKNYQALDIKRRLRMALDV 485
++K L HPN++ ++ +VTEF G LF+ + + D ++ +
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK---QI 155
Query: 486 ARGMNYLHHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSS-LKNATYLTAKSGRGT 541
G+ YLH N IVHRD+K N+L+ + +K+ DFGLSS L + GT
Sbjct: 156 LSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL--GT 211
Query: 542 PQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIP 577
++APEVL+ + NEK DV+S GVI++ L+ P
Sbjct: 212 AYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-29
Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKV-----YFGSEYIEGTLKNYQKEIDIIKKLR 433
+ +G GS+ V G + AVKV E +L E+ ++K+L
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE-SLLR---EVQLLKQLD 84
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTL--HKNYQALDIKRRLRMALDVARGMNY 491
HPN++ + +V E G LF + K + +D R +R L + Y
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG---ITY 141
Query: 492 LHHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSL-KNATYLTAKSGRGTPQWMAP 547
+H IVHRDLK NLL+ K+ +++ DFGLS+ + + + K GT ++AP
Sbjct: 142 MHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAP 197
Query: 548 EVLRSEPSNEKSDVFSFGVILWELVTASIP 577
EVL +EK DV+S GVIL+ L++ P
Sbjct: 198 EVLH-GTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 44/208 (21%), Positives = 78/208 (37%), Gaps = 21/208 (10%)
Query: 381 QLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYI--EGTLKNYQKEIDIIKKLRHPN 436
+L +G G VY VA+K+ Q+E +L+ P+
Sbjct: 37 RLRRLVGRGGMGDVYEAEDTVRERIVALKL-MSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 437 VLLFMGAVA------SQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMN 490
V V +L + + L + + L R + + + ++
Sbjct: 96 V------VPIHDFGEIDGQLYVDMRLINGVDL-AAMLRRQGPLAPPRAVAIVRQIGSALD 148
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR-GTPQWMAPEV 549
H HRD+K N+LV + + DFG++S LT GT +MAPE
Sbjct: 149 AAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206
Query: 550 LRSEPSNEKSDVFSFGVILWELVTASIP 577
+ ++D+++ +L+E +T S P
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 18/198 (9%)
Query: 382 LGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH-PNVL 438
+E+G G +AVV + I G + A K + EI +++ + P V+
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 439 LFMGAVASQERLGIVTEFLPRGSLF-KTLHKNYQAL---DIKRRLRMALDVARGMNYLHH 494
+ + ++ E+ G +F L + + + D+ R ++ L+ G+ YLH
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE---GVYYLHQ 149
Query: 495 RNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAPEVL 550
N IVH DLK N+L+ +K+ DFG+S + +A L G TP+++APE+L
Sbjct: 150 NN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMG--TPEYLAPEIL 205
Query: 551 RSEPSNEKSDVFSFGVIL 568
+P +D+++ G+I
Sbjct: 206 NYDPITTATDMWNIGIIA 223
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 46/200 (23%), Positives = 90/200 (45%), Gaps = 21/200 (10%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
++G G++ V+ +G + +K + + ++ + EI+++K L HPN++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKT-INKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 439 LFMGAVASQERLGIVTEFLPRGSLF------KTLHKNYQALDIKRRLRMALDVARGMNYL 492
+ IV E G L + K + ++ ++ + Y
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYF 140
Query: 493 HHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAPE 548
H ++ +VH+DLK N+L + +K+ DFGL+ K+ + T + GT +MAPE
Sbjct: 141 HSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYMAPE 196
Query: 549 VLRSEPSNEKSDVFSFGVIL 568
V + K D++S GV++
Sbjct: 197 VFK-RDVTFKCDIWSAGVVM 215
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 58/255 (22%), Positives = 103/255 (40%), Gaps = 40/255 (15%)
Query: 352 SSRSRESSSSKGDNETSCATDGGIRWEDL----QLGEEIGLGSYAVVYRG--IWNGSDVA 405
S ++ T GG E +LG +G G + V+ G + + VA
Sbjct: 1 SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVA 60
Query: 406 VKVYFGSEYIEGTLKNYQK----EIDIIKKLR----HPNVLLFMGAVASQERLGIVTEF- 456
+KV + + + + E+ ++ K+ HP V+ + +QE +V E
Sbjct: 61 IKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERP 120
Query: 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVAR--------GMNYLHHRNPPIVHRDLKSSN 508
LP LF +Y I + + +R + + H R +VHRD+K N
Sbjct: 121 LPAQDLF-----DY----ITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDEN 169
Query: 509 LLVD-KNWTVKVGDFGLSSL-KNATYLTAKSGRGTPQWMAPEVLRSEP-SNEKSDVFSFG 565
+L+D + K+ DFG +L + Y GT + PE + + V+S G
Sbjct: 170 ILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTRVYSPPEWISRHQYHALPATVWSLG 226
Query: 566 VILWELVTASIPWNN 580
++L+++V IP+
Sbjct: 227 ILLYDMVCGDIPFER 241
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 34/202 (16%)
Query: 384 EEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLF 440
+ +GLG V G A+K+ + ++E+D + P+++
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKL------LY-DSPKARQEVDHHWQASGGPHIVCI 87
Query: 441 MGA----VASQERLGIVTEFLPRGSLF----KTLHKNY---QALDIKRRLRMALDVARGM 489
+ + L I+ E + G LF + + + +A +I R D+ +
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR------DIGTAI 141
Query: 490 NYLHHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMA 546
+LH N I HRD+K NLL +K+ +K+ DFG + L TP ++A
Sbjct: 142 QFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY--TPYYVA 197
Query: 547 PEVLRSEPSNEKSDVFSFGVIL 568
PEVL E ++ D++S GVI+
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIM 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 50/198 (25%), Positives = 94/198 (47%), Gaps = 17/198 (8%)
Query: 379 DLQLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN 436
+ E +G G + V++ G +A K+ + + + EI ++ +L H N
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHAN 147
Query: 437 VLLFMGAVASQERLGIVTEFLPRGSLF-KTLHKNYQA--LDIKRRLRMALDVARGMNYLH 493
++ A S+ + +V E++ G LF + + ++Y LD ++ + G+ ++H
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMH 204
Query: 494 HRNPPIVHRDLKSSNLLV--DKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAPEVL 550
I+H DLK N+L +K+ DFGL+ K L G TP+++APEV+
Sbjct: 205 QMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG--TPEFLAPEVV 260
Query: 551 RSEPSNEKSDVFSFGVIL 568
+ + +D++S GVI
Sbjct: 261 NYDFVSFPTDMWSVGVIA 278
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 42/216 (19%)
Query: 381 QLGEE-IGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIE----GTLKNYQKEIDIIKKLR 433
QL E+ +G G++A V I + AVK+ IE +E++++ + +
Sbjct: 15 QLQEDVLGEGAHARVQTCINLITSQEYAVKI------IEKQPGHIRSRVFREVEMLYQCQ 68
Query: 434 -HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHK--NY---QALDIKRRLRMALDVAR 487
H NVL + ++R +V E + GS+ +HK ++ +A + + DVA
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ------DVAS 122
Query: 488 GMNYLHHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSL--KNATYLTAKSGR--- 539
+++LH++ I HRDLK N+L ++ VK+ DF L S N +
Sbjct: 123 ALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 540 --GTPQWMAPEVLRSEPSNEKS-----DVFSFGVIL 568
G+ ++MAPEV+ + D++S GVIL
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 37/206 (17%)
Query: 382 LGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVL 438
+ +GLG V + A+K+ ++ ++E+++ + + P+++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKM------LQ-DCPKARREVELHWRASQCPHIV 118
Query: 439 LFMGA----VASQERLGIVTEFLPRGSLF----KTLHKNY---QALDIKRRLRMALDVAR 487
+ A ++ L IV E L G LF + + +A +I + +
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK------SIGE 172
Query: 488 GMNYLHHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSLKNA--TYLTAKSGRGTP 542
+ YLH N I HRD+K NLL N +K+ DFG + + + T TP
Sbjct: 173 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC---YTP 227
Query: 543 QWMAPEVLRSEPSNEKSDVFSFGVIL 568
++APEVL E ++ D++S GVI+
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 55/214 (25%), Positives = 104/214 (48%), Gaps = 27/214 (12%)
Query: 381 QLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYI--EGTLKNYQKEIDIIKKLRHPN 436
+LGE +G G + V+ + + DVAVKV ++ +++E L HP
Sbjct: 15 ELGEILGFGGMSEVHLARDLRDHRDVAVKV-LRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 437 VLLFMGAVA------SQERLG----IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVA 486
+ VA ++ G IV E++ G + + + KR + + D
Sbjct: 74 I------VAVYDTGEAETPAGPLPYIVMEYVD-GVTLRDIVHTEGPMTPKRAIEVIADAC 126
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGR--GTPQ 543
+ +N+ H I+HRD+K +N+++ VKV DFG++ ++ ++ ++ GT Q
Sbjct: 127 QALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 544 WMAPEVLRSEPSNEKSDVFSFGVILWELVTASIP 577
+++PE R + + +SDV+S G +L+E++T P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 21/198 (10%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVKV--YFGSEYIEGTLKNYQKEIDIIKKLRHPN 436
+ EE+G G++ VV+R G++ A K E +KEI + LRHP
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE----TVRKEIQTMSVLRHPT 215
Query: 437 VLLFMGAVASQERLGIVTEFLPRGSLFKTL---HKNYQALDIKRRLRMALDVARGMNYLH 493
++ A + ++ EF+ G LF+ + H + +R G+ ++H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK---GLCHMH 272
Query: 494 HRNPPIVHRDLKSSNLLV--DKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAPEVL 550
N VH DLK N++ ++ +K+ DFGL++ L + +G T ++ APEV
Sbjct: 273 ENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG--TAEFAAPEVA 328
Query: 551 RSEPSNEKSDVFSFGVIL 568
+P +D++S GV+
Sbjct: 329 EGKPVGYYTDMWSVGVLS 346
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-27
Identities = 59/285 (20%), Positives = 111/285 (38%), Gaps = 38/285 (13%)
Query: 341 PDGKQYPSLGESSRSRESSSSKGDNETSCATDG-------GIRWEDL-----QLGEEIGL 388
P+ K++ R S +KG +E C G + D+ ++ I
Sbjct: 31 PESKRFCWNCGRPVGRSDSETKGASEGWCPYCGSPYSFLPQLNPGDIVAGQYEVKGCIAH 90
Query: 389 GSYAVVYRG---IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVA 445
G +Y NG V +K S E + ++ HP+++ V
Sbjct: 91 GGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVE 149
Query: 446 SQERLG-----IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIV 500
+R G IV E++ SL ++ Q L + + L++ ++YLH +V
Sbjct: 150 HTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIG--LV 204
Query: 501 HRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR-GTPQWMAPEVLRSEPSNEKS 559
+ DLK N+++ + +K+ D G + + + GTP + APE++R+ P+ +
Sbjct: 205 YNDLKPENIMLTEE-QLKLIDLGA-----VSRINSFGYLYGTPGFQAPEIVRTGPT-VAT 257
Query: 560 DVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604
D+++ G L L N + V + D L+ +
Sbjct: 258 DIYTVGRTLAALTLDLPTRNG----RYVDGLPEDDPVLKTYDSYG 298
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 384 EEIGLGSYAVVYRG--IWNGSDVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLF 440
E+IG G+Y V++ VA+K V + EG + +EI ++K+L+H N++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRL 66
Query: 441 MGAVASQERLGIVTEFLPR--GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPP 498
+ S ++L +V EF + F + + + +K L L +G+ + H RN
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHSRN-- 121
Query: 499 IVHRDLKSSNLLVDKNWTVKVGDFGLS---SLKNATYLTAKSGRGTPQ----WM-APEVL 550
++HRDLK NLL+++N +K+ +FGL+ + Y + + W P+VL
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--------SAEVVTLWYRPPDVL 173
Query: 551 -RSEPSNEKSDVFSFGVILWELVTASIP 577
++ + D++S G I EL A P
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 58/271 (21%), Positives = 113/271 (41%), Gaps = 34/271 (12%)
Query: 352 SSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVY 409
++ + + R ED + G+ +G GS++ V R + + A+K+
Sbjct: 4 TAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI- 62
Query: 410 FGSEYI--EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLH 467
+I E + +E D++ +L HP + E+L + G L K +
Sbjct: 63 LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI- 121
Query: 468 KNYQALDIKRRLRMALDVAR--------GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKV 519
++ R + YLH + I+HRDLK N+L++++ +++
Sbjct: 122 --------RKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQI 171
Query: 520 GDFGLS--SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIP 577
DFG + + A S GT Q+++PE+L + + + SD+++ G I+++LV P
Sbjct: 172 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
Query: 578 WNNLNLMQVVGVVGF---MDRRLELPEGLDP 605
+ N + F + + PE P
Sbjct: 232 FRAGNEYLI-----FQKIIKLEYDFPEKFFP 257
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 52/204 (25%), Positives = 96/204 (47%), Gaps = 28/204 (13%)
Query: 384 EEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
+IG GSY VV++ G VA+K + SE K +EI ++K+L+HPN++ +
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALD---IKRRLRMALDVARGMNYLHHRNPP 498
+ RL +V E+ ++ L + + + +K L + +N+ H N
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL---QAVNFCHKHN-- 122
Query: 499 IVHRDLKSSNLLVDKNWTVKVGDFGLS---SLKNATYLTAKSGRGTPQ----WM-APEVL 550
+HRD+K N+L+ K+ +K+ DFG + + + Y + W +PE+L
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--------DDEVATRWYRSPELL 174
Query: 551 RSEPSNEKS-DVFSFGVILWELVT 573
+ DV++ G + EL++
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLS 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 58/236 (24%), Positives = 101/236 (42%), Gaps = 27/236 (11%)
Query: 349 LGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRG--IWNGSDVAV 406
+G S G + E + +G GSY +V + G VA+
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSM-----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAI 55
Query: 407 KVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTL 466
K + S+ + K +EI ++K+LRH N++ + ++R +V EF+ ++ L
Sbjct: 56 KKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL 114
Query: 467 HKNYQALD---IKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFG 523
LD +++ L + G+ + H N I+HRD+K N+LV ++ VK+ DFG
Sbjct: 115 ELFPNGLDYQVVQKYLFQII---NGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFG 169
Query: 524 LSSLKNATYLTAKSGRGTPQ----WM-APEVL-RSEPSNEKSDVFSFGVILWELVT 573
A L A + W APE+L + DV++ G ++ E+
Sbjct: 170 F-----ARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM 220
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 27/203 (13%)
Query: 384 EEIGLGSYAVVYRGI-WNGSDVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
E++G G+Y VVY+ G VA+K + +E EG +EI ++K+L HPN++ +
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLI 85
Query: 442 GAVASQERLGIVTEFLPR--GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPI 499
+ S+ L +V EF+ + + Q IK L L RG+ + H I
Sbjct: 86 DVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQHR--I 140
Query: 500 VHRDLKSSNLLVDKNWTVKVGDFGLS---SLKNATYLTAKSGRGTPQ----WM-APEVL- 550
+HRDLK NLL++ + +K+ DFGL+ + +Y T + W AP+VL
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--------THEVVTLWYRAPDVLM 192
Query: 551 RSEPSNEKSDVFSFGVILWELVT 573
S+ + D++S G I E++T
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMIT 215
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 41/139 (29%), Positives = 70/139 (50%), Gaps = 13/139 (9%)
Query: 471 QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS--SLK 528
L ++ + + VA+GM +L R +HRDL + N+L+ + VK+ DFGL+ K
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYK 245
Query: 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPW----NNLNL 583
+ Y+ R +WMAPE + +SDV+SFGV+LWE+ + + P+ +
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305
Query: 584 MQVVGVVGFMDRRLELPEG 602
+ + G R+ P+
Sbjct: 306 CRRL-KEGT---RMRAPDY 320
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 29/206 (14%)
Query: 384 EEIGLGSYAVVYRG--IWNGSDVA---VKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
+ +G G +A VY+ VA +K+ SE +G + +EI ++++L HPN++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 439 LFMGAVASQERLGIVTEFLPR--GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRN 496
+ A + + +V +F+ + K IK + M L +G+ YLH
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL---QGLEYLHQHW 132
Query: 497 PPIVHRDLKSSNLLVDKNWTVKVGDFGLS---SLKNATYLTAKSGRGTPQ----WM-APE 548
I+HRDLK +NLL+D+N +K+ DFGL+ N Y T Q W APE
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--------THQVVTRWYRAPE 182
Query: 549 VLRSEPS-NEKSDVFSFGVILWELVT 573
+L D+++ G IL EL+
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLL 208
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWN-GSDVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
E E+IG G+Y VVY+ N G A+K + E EG +EI I+K+L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHS 60
Query: 436 NVLLFMGAVASQERLGIVTEFLPR--GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
N++ + +++RL +V E L + L +++ K L L G+ Y H
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCH 117
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS---SLKNATYLTAKSGRGTPQ----WM- 545
R ++HRDLK NLL+++ +K+ DFGL+ + Y T + W
Sbjct: 118 DRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--------THEIVTLWYR 167
Query: 546 APEVLRSEPS-NEKSDVFSFGVILWELVT 573
AP+VL + D++S G I E+V
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 378 EDLQLGEEIGLGSYAVVYRG--IWNGSDVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRH 434
E +++G G+YA VY+G + VA+K + E EG +E+ ++K L+H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKH 59
Query: 435 PNVLLFMGAVASQERLGIVTEFLPR--GSLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
N++ + +++ L +V E+L + ++K L L RG+ Y
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLL---RGLAYC 116
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS---SLKNATYLTAKSGRGTPQ----WM 545
H + ++HRDLK NLL+++ +K+ DFGL+ S+ TY + W
Sbjct: 117 HRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--------DNEVVTLWY 166
Query: 546 -APEVL-RSEPSNEKSDVFSFGVILWELVT 573
P++L S + + D++ G I +E+ T
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMAT 196
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 34/209 (16%)
Query: 384 EEIGLGSYAVVYRG--IWNGSDVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLF 440
E++G G+YA VY+G G VA+K V SE EGT +EI ++K+L+H N++
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRL 68
Query: 441 MGAVASQERLGIVTEFLP-------RGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
+ ++ +L +V EF+ + + +K L +G+ + H
Sbjct: 69 YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL---QGLAFCH 125
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS---SLKNATYLTAKSGRGTPQ----WM- 545
I+HRDLK NLL++K +K+GDFGL+ + T+ + + W
Sbjct: 126 ENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--------SSEVVTLWYR 175
Query: 546 APEVLRSEPS-NEKSDVFSFGVILWELVT 573
AP+VL + + D++S G IL E++T
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMIT 204
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 44/204 (21%), Positives = 79/204 (38%), Gaps = 54/204 (26%)
Query: 382 LGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVL 438
+ +GLG V + A+K+ ++ ++E+++ + + P+++
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKM------LQ-DCPKARREVELHWRASQCPHIV 74
Query: 439 LFMGA----VASQERLGIVTEFLPRGSLF----KTLHKNY---QALDIKRRLRMALDVAR 487
+ A ++ L IV E L G LF + + +A +I + +
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK------SIGE 128
Query: 488 GMNYLHHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQW 544
+ YLH N I HRD+K NLL N +K+ DFG
Sbjct: 129 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------- 166
Query: 545 MAPEVLRSEPSNEKSDVFSFGVIL 568
A E E ++ D++S GVI+
Sbjct: 167 -AKETTG-EKYDKSCDMWSLGVIM 188
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 54/243 (22%), Positives = 100/243 (41%), Gaps = 34/243 (13%)
Query: 350 GESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVYRG--IWNGSDVAVK 407
+ E+ + + + A + + ++G G+Y VY+ VA+K
Sbjct: 6 HHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK 65
Query: 408 -VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTL 466
+ E EG +E+ ++K+L+H N++ + RL ++ E+ L K +
Sbjct: 66 RIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM 123
Query: 467 --HKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT-----VKV 519
+ + IK L + G+N+ H R +HRDLK NLL+ + +K+
Sbjct: 124 DKNPDVSMRVIKSFLYQLI---NGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKI 178
Query: 520 GDFGLS---SLKNATYLTAKSGRGTPQ----WM-APEVL-RSEPSNEKSDVFSFGVILWE 570
GDFGL+ + + T + W PE+L S + D++S I E
Sbjct: 179 GDFGLARAFGIPIRQF--------THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAE 230
Query: 571 LVT 573
++
Sbjct: 231 MLM 233
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 26/209 (12%)
Query: 384 EEIGLGSYAVVYRG--IWNGSDVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLF 440
+IG G++ V++ G VA+K V +E EG +EI I++ L+H NV+
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNL 81
Query: 441 MGAVASQERLG--------IVTEFLPR--GSLFKTLHKNYQALDIKRRLRMALDVARGMN 490
+ ++ +V +F L + + +IKR ++M L G+
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL---NGLY 138
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQ----WM- 545
Y+H I+HRD+K++N+L+ ++ +K+ DFGL+ + ++ R T + W
Sbjct: 139 YIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLA-KNSQPNRYTNRVVTLWYR 195
Query: 546 APEVLRSEPS-NEKSDVFSFGVILWELVT 573
PE+L E D++ G I+ E+ T
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMWT 224
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 53/263 (20%), Positives = 110/263 (41%), Gaps = 39/263 (14%)
Query: 341 PDGKQYPSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVY--RGI 398
K+ + + + + + + +G GS+ V +
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK 63
Query: 399 WNGSDVAVKVYFGSEYIEGTLKNYQKEID-------IIKKLRHPNVLLFMGAVASQERLG 451
+G+ A+K+ + ++ K+I+ I++ + P ++ + L
Sbjct: 64 ESGNHYAMKILDKQKVVK------LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR--------GMNYLHHRNPPIVHRD 503
+V E++ G +F L +R R + AR YLH + +++RD
Sbjct: 118 MVMEYVAGGEMFSHL---------RRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRD 166
Query: 504 LKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVF 562
LK NLL+D+ ++V DFG + +K T+ + GTP+ +APE++ S+ N+ D +
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTW----TLCGTPEALAPEIILSKGYNKAVDWW 222
Query: 563 SFGVILWELVTASIPWNNLNLMQ 585
+ GV+++E+ P+ +Q
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQ 245
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 7e-21
Identities = 62/259 (23%), Positives = 103/259 (39%), Gaps = 59/259 (22%)
Query: 347 PSLGESSRSRESSSSKGDNETSCATDGGIRWEDL--QLGEEIGLGSYAVVYRGIW--NGS 402
+ G SR+ SK + G R +++ + IG GS+ VVY+ +G
Sbjct: 21 SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 80
Query: 403 DVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER------LGIVTE 455
VA+K V + KN +E+ I++KL H N++ S L +V +
Sbjct: 81 LVAIKKVLQDKRF-----KN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133
Query: 456 FLPRGSLFKTLHKNYQALDIKRRLRMALD----------VARGMNYLHHRNPPIVHRDLK 505
++P +T++ + R + L + R + Y+H I HRD+K
Sbjct: 134 YVP-----ETVY---RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIK 183
Query: 506 SSNLLVDKN-WTVKVGDFGLSSLKNATYLTAKSGRGTPQ--------WM-APEV-LRSEP 554
NLL+D + +K+ DFG AK + APE+ +
Sbjct: 184 PQNLLLDPDTAVLKLCDFGS----------AKQLVRGEPNVSYICSRYYRAPELIFGATD 233
Query: 555 SNEKSDVFSFGVILWELVT 573
DV+S G +L EL+
Sbjct: 234 YTSSIDVWSAGCVLAELLL 252
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 384 EEIGLGSYAVVYRGI---WNGSDVAVK-VYFGSEYIEGTLKNYQKEIDIIKKLR---HPN 436
EIG G+Y V++ G VA+K V + EG + +E+ +++ L HPN
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPN 75
Query: 437 VL----LFMGAVASQE-RLGIVTEFLP---RGSLFKTLHKNYQALDIKRRLRMALDVARG 488
V+ + + +E +L +V E + L K IK + L RG
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL---RG 132
Query: 489 MNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA--TYLTAKSGRGTPQ--- 543
+++LH +VHRDLK N+LV + +K+ DFGL+ + + T
Sbjct: 133 LDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--------TSVVVT 182
Query: 544 -WM-APEVLRSEPSNEKSDVFSFGVILWELVT 573
W APEVL D++S G I E+
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 214
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 384 EEIGLGSYAVVYRG--IWNGSDVAVK-VYFGSEYIEGTLK---NYQKEIDIIKKLR---H 434
EIG+G+Y VY+ +G VA+K V + G + +E+ ++++L H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGG-GGGGGLPISTVREVALLRRLEAFEH 73
Query: 435 PNVL----LFMGAVASQE-RLGIVTEFLP---RGSLFKTLHKNYQALDIKRRLRMALDVA 486
PNV+ + + +E ++ +V E + R L K A IK +R L
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL--- 130
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN--ATYLTAKSGRGTPQ- 543
RG+++LH IVHRDLK N+LV TVK+ DFGL+ + + TP
Sbjct: 131 RGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--------TPVV 180
Query: 544 ---WM-APEVLRSEPSNEKSDVFSFGVILWELVT 573
W APEVL D++S G I E+
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-20
Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 52/217 (23%)
Query: 384 EEIGLGSYAVVYRGIWNGSD-VAVK-VYFGSEYIEGTLKNYQKEIDIIKKLRHPNV--LL 439
+ IG GS+ VV++ SD VA+K V + KN +E+ I++ ++HPNV L
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KN--RELQIMRIVKHPNVVDLK 98
Query: 440 FM----GAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD--------VAR 487
G + L +V E++P +T+++ K + M + + R
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVP-----ETVYR-ASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 488 GMNYLHHRNPPIVHRDLKSSNLLVDKN-WTVKVGDFGLSSLKNATYLTAKSGRGTPQWM- 545
+ Y+H I HRD+K NLL+D +K+ DFG AK +
Sbjct: 153 SLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGS----------AKILIAGEPNVS 200
Query: 546 --------APEV-LRSEPSNEKSDVFSFGVILWELVT 573
APE+ + D++S G ++ EL+
Sbjct: 201 YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 7e-20
Identities = 59/281 (20%), Positives = 115/281 (40%), Gaps = 17/281 (6%)
Query: 339 LDPDGKQYPSLGESSRSRESSSS----KGDNETSCATDGGIRWEDLQLGEEIGLGSYAVV 394
LD Y S RE + TS + ED ++ + IG G++ V
Sbjct: 31 LDILICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEV 90
Query: 395 Y--RGIWNGSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451
+ A+K+ E ++ +++E D++ + A L
Sbjct: 91 AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150
Query: 452 IVTEFLPRGSLFKTLHKNYQALDIKR-RLRMALDVARGMNYLHHRNPPIVHRDLKSSNLL 510
+V ++ G L L K L + R +A ++ ++ +H + VHRD+K N+L
Sbjct: 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVHQLH--YVHRDIKPDNIL 207
Query: 511 VDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKS-----DVFSF 564
+D N +++ DFG L + + GTP +++PE+L++ + D +S
Sbjct: 208 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267
Query: 565 GVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
GV ++E++ P+ +L++ G + R + P +
Sbjct: 268 GVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 8e-20
Identities = 56/251 (22%), Positives = 109/251 (43%), Gaps = 28/251 (11%)
Query: 351 ESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKV 408
+++ ++ S+ + + D ++ ED ++ + IG G++ V R A+K+
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 101
Query: 409 YFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLH 467
E I+ + +E DI+ P V+ A L +V E++P G L +
Sbjct: 102 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM- 160
Query: 468 KNYQALDIKRRLRMALDVAR--------GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKV 519
+ AR ++ +H +HRD+K N+L+DK+ +K+
Sbjct: 161 ---------SNYDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKL 209
Query: 520 GDFGLS-SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEK----SDVFSFGVILWELVTA 574
DFG + + + GTP +++PEVL+S+ + D +S GV L+E++
Sbjct: 210 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
Query: 575 SIPWNNLNLMQ 585
P+ +L+
Sbjct: 270 DTPFYADSLVG 280
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD 484
E +++ RHP + A + +RL V E+ G LF H + R +
Sbjct: 55 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF--FH-------LSRERVFTEE 105
Query: 485 VAR--------GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAK 536
AR + YLH R+ +V+RD+K NL++DK+ +K+ DFGL + T K
Sbjct: 106 RARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163
Query: 537 SGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582
+ GTP+++APEVL D + GV+++E++ +P+ N +
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 58/255 (22%), Positives = 109/255 (42%), Gaps = 14/255 (5%)
Query: 335 DVNELDPDGKQYPSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVV 394
+ L S S S + + + + + + + + +G G++ V
Sbjct: 106 VADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLA-KPKHRVTMNEFEYLKLLGKGTFGKV 164
Query: 395 Y--RGIWNGSDVAVKVY-----FGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447
+ G A+K+ + + TL E +++ RHP + + +
Sbjct: 165 ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT----ENRVLQNSRHPFLTALKYSFQTH 220
Query: 448 ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSS 507
+RL V E+ G LF L + + R ++ ++YLH +V+RDLK
Sbjct: 221 DRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLE 278
Query: 508 NLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVI 567
NL++DK+ +K+ DFGL T K+ GTP+++APEVL D + GV+
Sbjct: 279 NLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 338
Query: 568 LWELVTASIPWNNLN 582
++E++ +P+ N +
Sbjct: 339 MYEMMCGRLPFYNQD 353
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 5e-19
Identities = 55/223 (24%), Positives = 90/223 (40%), Gaps = 47/223 (21%)
Query: 382 LGEEIGLGSYAVVYRG----IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNV 437
G ++G G+Y VY+ + D A+K G + +EI ++++L+HPNV
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACREIALLRELKHPNV 80
Query: 438 LLFMGAVASQ--ERLGIVTEFL----------PRGSLFKTLHKNYQALDIKRRLRMALDV 485
+ S ++ ++ ++ R S +K L L
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL-- 138
Query: 486 ARGMNYLHHRNPPIVHRDLKSSNLLV----DKNWTVKVGDFGL-----SSLKNATYLTAK 536
G++YLH ++HRDLK +N+LV + VK+ D G S LK
Sbjct: 139 -DGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA----- 190
Query: 537 SGRGTPQ----WM-APEVLRSEPSNEKS-DVFSFGVILWELVT 573
P W APE+L K+ D+++ G I EL+T
Sbjct: 191 --DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 7e-19
Identities = 59/225 (26%), Positives = 113/225 (50%), Gaps = 37/225 (16%)
Query: 378 EDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEID-------I 428
+D Q+ +G GS+ V+ R NG A+KV + K+++ +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR------LKQVEHTNDERLM 59
Query: 429 IKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR- 487
+ + HP ++ G +++ ++ +++ G LF L ++ R VA+
Sbjct: 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL---------RKSQRFPNPVAKF 110
Query: 488 -------GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRG 540
+ YLH ++ I++RDLK N+L+DKN +K+ DFG + K +T + G
Sbjct: 111 YAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFA--KYVPDVT-YTLCG 165
Query: 541 TPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQ 585
TP ++APEV+ ++P N+ D +SFG++++E++ P+ + N M+
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 52/224 (23%), Positives = 91/224 (40%), Gaps = 53/224 (23%)
Query: 381 QLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR---HP 435
Q+ G G++ V G G VA+K + +N +E+ I++ L HP
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI----QDPRFRN--RELQIMQDLAVLHHP 79
Query: 436 NVL----LFMGAVASQER---LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD---- 484
N++ F R L +V E++P TLH+ + +R++
Sbjct: 80 NIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNY-YRRQVAPPPILIKV 133
Query: 485 ----VARGMNYLHHRNPPIVHRDLKSSNLLVDK-NWTVKVGDFGLSSLKNATYLTAKS-G 538
+ R + LH + + HRD+K N+LV++ + T+K+ DFG AK
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS----------AKKLS 183
Query: 539 RGTPQ-------WM-APEV-LRSEPSNEKSDVFSFGVILWELVT 573
P + APE+ ++ D++S G I E++
Sbjct: 184 PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 44/162 (27%), Positives = 74/162 (45%), Gaps = 15/162 (9%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD 484
E I+ K+ ++ A ++ L +V + G + ++ +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDE-----DNPGFQEP 289
Query: 485 VAR--------GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAK 536
A G+ +LH RN I++RDLK N+L+D + V++ D GL+ A K
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347
Query: 537 SGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578
GTP +MAPE+L E + D F+ GV L+E++ A P+
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 25/213 (11%), Positives = 56/213 (26%), Gaps = 35/213 (16%)
Query: 381 QLGEEIGLGSYAVVYRG--IWNGSDVAVKV-YFGSEYIEGTLKNYQKEIDIIKKLRHPNV 437
+L G ++ VA+ + L+ + ++ P V
Sbjct: 34 RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 438 LLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNP 497
+ V ++ +V E++ GSL + + +R +A + H
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVAD---TSPSPVGAIRAMQSLAAAADAAHRAG- 149
Query: 498 PIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNE 557
+ S + V + V + +N
Sbjct: 150 -VALSIDHPSRVRVSIDGDVVLAYPATMP---------------------------DANP 181
Query: 558 KSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590
+ D+ G L+ L+ P + +
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA 214
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 45/166 (27%), Positives = 86/166 (51%), Gaps = 19/166 (11%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD 484
E DI+ ++ HP ++ A ++ +L ++ +FL G LF + + + +
Sbjct: 76 ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF--TR-------LSKEVMFTEE 126
Query: 485 VAR--------GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAK 536
+ +++LH I++RDLK N+L+D+ +K+ DFGLS A
Sbjct: 127 DVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 184
Query: 537 SGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582
S GT ++MAPEV+ + +D +SFGV+++E++T ++P+ +
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 3e-18
Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 6/156 (3%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRM-AL 483
E I++K+ V+ A +++ L +V + G L ++ QA + R A
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 484 DVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR-GTP 542
++ G+ LH IV+RDLK N+L+D + +++ D GL+ + GR GT
Sbjct: 294 EICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTV 349
Query: 543 QWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578
+MAPEV+++E D ++ G +L+E++ P+
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 58/242 (23%), Positives = 99/242 (40%), Gaps = 48/242 (19%)
Query: 358 SSSSKGDNETSCATDGGIRWEDL---QLGEEIGLGSYAVVYRGI--WNGSDVAVK----V 408
S SK DN G + L Q + IG G+ +V +VA+K
Sbjct: 2 GSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 61
Query: 409 YFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG------IVTEFLPRGSL 462
+ + + + E+ ++K + H N++ + Q+ L IV E + +L
Sbjct: 62 FQNQTHAKRAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANL 116
Query: 463 FKTLHKN----------YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD 512
+ + YQ L G+ +LH I+HRDLK SN++V
Sbjct: 117 CQVIQMELDHERMSYLLYQML-------------CGIKHLHSAG--IIHRDLKPSNIVVK 161
Query: 513 KNWTVKVGDFGLS-SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWEL 571
+ T+K+ DFGL+ + + +T T + APEV+ E D++S G I+ E+
Sbjct: 162 SDCTLKILDFGLARTAGTSFMMT--PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 572 VT 573
+
Sbjct: 220 IK 221
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 5e-18
Identities = 42/166 (25%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD 484
E +I+++++HP ++ + A + +L ++ E+L G LF + ++R D
Sbjct: 71 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELF--MQ-------LEREGIFMED 121
Query: 485 VAR--------GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAK 536
A + +LH + I++RDLK N++++ VK+ DFGL
Sbjct: 122 TACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179
Query: 537 SGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582
+ GT ++MAPE+L N D +S G ++++++T + P+ N
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 51/217 (23%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 372 DGGIRWEDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIE-GTLKNYQKEIDI 428
+ + ++ ++ IG GS+ V + A+K + +E ++N KE+ I
Sbjct: 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQI 68
Query: 429 IKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR- 487
++ L HP ++ + +E + +V + L G L H +++ + + +
Sbjct: 69 MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR--YH-------LQQNVHFKEETVKL 119
Query: 488 -------GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS-LKNATYLTAKSGR 539
++YL ++ I+HRD+K N+L+D++ V + DF +++ L T +T +
Sbjct: 120 FICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA-- 175
Query: 540 GTPQWMAPEVLRSEPSNEKS---DVFSFGVILWELVT 573
GT +MAPE+ S S D +S GV +EL+
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 51/224 (22%), Positives = 79/224 (35%), Gaps = 50/224 (22%)
Query: 381 QLGEEIGLGSYAVVYRGI-WNGSDVAVKVYFGSEYIEGTLKNYQK---------EIDIIK 430
+ I GSY V G+ G VA+K F + T+ EI ++
Sbjct: 25 TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN 84
Query: 431 KLRHPNVLLFMGAVASQERLG-----IVTEFLPRGSLFKTLHKN-------------YQA 472
HPN+L E +VTE + L + +H Y
Sbjct: 85 HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHI 143
Query: 473 LDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNAT 531
L G++ LH +VHRDL N+L+ N + + DF L+
Sbjct: 144 L-------------LGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 532 YLTAKSGRGTPQWM-APEVLRSEPSNEKS-DVFSFGVILWELVT 573
T T +W APE++ K D++S G ++ E+
Sbjct: 189 NKT---HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 58/290 (20%), Positives = 97/290 (33%), Gaps = 66/290 (22%)
Query: 338 ELDPDGKQYPSLGESSRSRESSSSKGDNETSCATDGGIRWEDL---QLGEEIGLGSYAVV 394
+ G Q+ G ++ T+ W+ ++ IG GSY V
Sbjct: 10 QQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHV 69
Query: 395 YRGI--WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNV--LLFMGAVASQERL 450
VA+K K +EI I+ +L H +V +L + E+
Sbjct: 70 CEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129
Query: 451 G---IVTEFLPRGSLFKTLHKN------------YQALDIKRRLRMALDVARGMNYLHHR 495
+V E K Y L G+ Y+H
Sbjct: 130 DELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLL-------------VGVKYVHSA 175
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-----------------SLKNATYLTAKSG 538
I+HRDLK +N LV+++ +VKV DFGL+ + +T
Sbjct: 176 G--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233
Query: 539 RGTPQWM----------APEVLRSEPSNEKS-DVFSFGVILWELVTASIP 577
+ + + APE++ + + ++ DV+S G I EL+
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 54/237 (22%), Positives = 90/237 (37%), Gaps = 69/237 (29%)
Query: 373 GGIRWE---DLQLGEEIGLGSYAVVYRGI--WNGSDVAVK----VYFGSEYIEGTLKNYQ 423
WE +G G+Y V I +G VA+K + + + +
Sbjct: 16 NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR--- 72
Query: 424 KEIDIIKKLRHPNVLLFMGAVASQERLG------IVTEFLPRGSLFKTLHKN-------- 469
E+ ++K ++H NV+ + L +V F+ L K +
Sbjct: 73 -ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY 130
Query: 470 --YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527
YQ L +G+ Y+H +VHRDLK NL V+++ +K+ DFGL+
Sbjct: 131 LVYQML-------------KGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLA-- 173
Query: 528 KNATYLTAKSGRGTPQWM----------APEVLRSEPSNEKS-DVFSFGVILWELVT 573
R M APEV+ S ++ D++S G I+ E++T
Sbjct: 174 -----------RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 3e-17
Identities = 38/151 (25%), Positives = 77/151 (50%), Gaps = 6/151 (3%)
Query: 429 IKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARG 488
+ P ++ A + ++L + + + G L L ++ A ++ G
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILG 304
Query: 489 MNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPE 548
+ ++H+R +V+RDLK +N+L+D++ V++ D GL+ + + + GT +MAPE
Sbjct: 305 LEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPE 360
Query: 549 VLRSEPSNEKS-DVFSFGVILWELVTASIPW 578
VL+ + + S D FS G +L++L+ P+
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 48/232 (20%), Positives = 102/232 (43%), Gaps = 15/232 (6%)
Query: 386 IGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMG 442
IG G+++ V + G A+K+ + ++ G + +++E D++ +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 443 AVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKR-RLRMALDVARGMNYLHHRNPPIVH 501
A + L +V E+ G L L K + + + R +A ++ ++ +H VH
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRLG--YVH 185
Query: 502 RDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKS- 559
RD+K N+L+D+ +++ DFG L+ + + GTP +++PE+L++ +
Sbjct: 186 RDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTG 245
Query: 560 ------DVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
D ++ GV +E+ P+ + + G + L LP +
Sbjct: 246 SYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} Length = 124 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 4e-17
Identities = 22/110 (20%), Positives = 47/110 (42%), Gaps = 2/110 (1%)
Query: 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKK 118
+ + A+ V II WN+ +E+LYG+ + GQ V + + +
Sbjct: 9 RAKAFDYVFDAIVVTDLQGF-IIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSE 67
Query: 119 IMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLY-EDGELAGFITVSSD 167
++ + + W+G+ + G I P+Y E+ ++ G + ++ D
Sbjct: 68 VISAVENQGKWTGEIRMLHKDGHIGWIESMCVPIYGENYQMVGALGINRD 117
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 59/224 (26%), Positives = 86/224 (38%), Gaps = 50/224 (22%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVK---VYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
QL +G G+Y VV G VA+K + + TL+ EI I+K +H
Sbjct: 14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHE 69
Query: 436 NVLLFMGAVASQERLG-----IVTEFLP-------RGSLFKTLHKN---YQALDIKRRLR 480
N++ I+ E + + H YQ L
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL------- 122
Query: 481 MALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRG 540
R + LH N ++HRDLK SNLL++ N +KV DFGL+ + + + G
Sbjct: 123 ------RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 541 TPQWM----------APEVLRSEPS-NEKSDVFSFGVILWELVT 573
M APEV+ + + DV+S G IL EL
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 60/247 (24%), Positives = 98/247 (39%), Gaps = 51/247 (20%)
Query: 358 SSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYI 415
SSK N + + ++ + +G GS+ V R G AVKV
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV------- 55
Query: 416 EGTLKNYQKEIDIIKK----------------LRHPNVLLFMGAVASQERLGIVTEFLPR 459
LK K+ I++ HP + + +RL V EF+
Sbjct: 56 ---LK---KD-VILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNG 108
Query: 460 GSLFKTLHKNYQALDIKRRLRMALDVAR--------GMNYLHHRNPPIVHRDLKSSNLLV 511
G L H I++ R AR + +LH + I++RDLK N+L+
Sbjct: 109 GDLM--FH-------IQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLL 157
Query: 512 DKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWEL 571
D K+ DFG+ +T + GTP ++APE+L+ D ++ GV+L+E+
Sbjct: 158 DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEM 217
Query: 572 VTASIPW 578
+ P+
Sbjct: 218 LCGHAPF 224
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 4e-17
Identities = 57/242 (23%), Positives = 100/242 (41%), Gaps = 50/242 (20%)
Query: 359 SSSKGDNETSCATDGGIRWEDL---QLGEEIGLGSYAVVYRGI--WNGSDVAVK----VY 409
S SK DN+ G + L Q + IG G+ +V +VA+K +
Sbjct: 40 SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 99
Query: 410 FGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG------IVTEFLPRGSLF 463
+ + + E+ ++K + H N++ + Q+ L +V E + +L
Sbjct: 100 QNQTHAKRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLC 154
Query: 464 KTLHKN----------YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK 513
+ + YQ L G+ +LH I+HRDLK SN++V
Sbjct: 155 QVIQMELDHERMSYLLYQML-------------CGIKHLHSAG--IIHRDLKPSNIVVKS 199
Query: 514 NWTVKVGDFGLS-SLKNATYLTAKSGRGTPQWM-APEVLRSEPSNEKSDVFSFGVILWEL 571
+ T+K+ DFGL+ + + +T ++ APEV+ E D++S G I+ E+
Sbjct: 200 DCTLKILDFGLARTAGTSFMMT---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
Query: 572 VT 573
V
Sbjct: 257 VR 258
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 19/145 (13%)
Query: 446 SQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR--------GMNYLHHRNP 497
++E L V E+L G L H I+ + L A G+ +LH +
Sbjct: 89 TKENLFFVMEYLNGGDLM--YH-------IQSCHKFDLSRATFYAAEIILGLQFLHSKG- 138
Query: 498 PIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNE 557
IV+RDLK N+L+DK+ +K+ DFG+ + GTP ++APE+L + N
Sbjct: 139 -IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNH 197
Query: 558 KSDVFSFGVILWELVTASIPWNNLN 582
D +SFGV+L+E++ P++ +
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHGQD 222
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 5e-17
Identities = 60/308 (19%), Positives = 117/308 (37%), Gaps = 52/308 (16%)
Query: 298 QHRLPNASEEIFCDLAFSRECNDRGTSTGHRELLPGHDVNELDPDGKQYPSLGESSRS-R 356
+ ++ D F + G G + NE + +G+ +++
Sbjct: 260 LSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPE 319
Query: 357 ESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEY 414
E +++ + ++ D +G GS+ V AVK+
Sbjct: 320 EKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKI------ 373
Query: 415 IEGTLKNYQKEIDIIKK----------------LRHPNVLLFMGAVASQERLGIVTEFLP 458
LK K+ +I+ + P + + +RL V E++
Sbjct: 374 ----LK---KD-VVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425
Query: 459 RGSLFKTLHKNYQALDIKRRLRMALDVAR--------GMNYLHHRNPPIVHRDLKSSNLL 510
G L H I++ R A G+ +L + I++RDLK N++
Sbjct: 426 GGDLM--YH-------IQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVM 474
Query: 511 VDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWE 570
+D +K+ DFG+ +T K+ GTP ++APE++ +P + D ++FGV+L+E
Sbjct: 475 LDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 534
Query: 571 LVTASIPW 578
++ P+
Sbjct: 535 MLAGQAPF 542
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 41/142 (28%), Positives = 73/142 (51%), Gaps = 19/142 (13%)
Query: 446 SQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR--------GMNYLHHRNP 497
++ RL V E++ G L H ++R+ ++ + AR +NYLH R
Sbjct: 81 TESRLFFVIEYVNGGDLM--FH-------MQRQRKLPEEHARFYSAEISLALNYLHERG- 130
Query: 498 PIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNE 557
I++RDLK N+L+D +K+ D+G+ T + GTP ++APE+LR E
Sbjct: 131 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 189
Query: 558 KSDVFSFGVILWELVTASIPWN 579
D ++ GV+++E++ P++
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFD 211
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 42/145 (28%), Positives = 69/145 (47%), Gaps = 19/145 (13%)
Query: 446 SQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR--------GMNYLHHRNP 497
+ ++L V +++ G LF H ++R AR + YLH N
Sbjct: 110 TADKLYFVLDYINGGELF--YH-------LQRERCFLEPRARFYAAEIASALGYLHSLN- 159
Query: 498 PIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNE 557
IV+RDLK N+L+D + + DFGL T + GTP+++APEVL +P +
Sbjct: 160 -IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDR 218
Query: 558 KSDVFSFGVILWELVTASIPWNNLN 582
D + G +L+E++ P+ + N
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRN 243
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 39/141 (27%), Positives = 71/141 (50%), Gaps = 19/141 (13%)
Query: 446 SQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR--------GMNYLHHRNP 497
+ +RL V E++ G L H I++ R A G+ +L +
Sbjct: 92 TMDRLYFVMEYVNGGDLM--YH-------IQQVGRFKEPHAVFYAAEIAIGLFFLQSKG- 141
Query: 498 PIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNE 557
I++RDLK N+++D +K+ DFG+ +T K+ GTP ++APE++ +P +
Sbjct: 142 -IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 200
Query: 558 KSDVFSFGVILWELVTASIPW 578
D ++FGV+L+E++ P+
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPF 221
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 49/244 (20%)
Query: 374 GIRWE---DLQLGEEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQK---- 424
+ W D QL ++G G Y+ V+ I N V VK+ LK +K
Sbjct: 29 VVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI----------LKPVKKKKIK 78
Query: 425 -EIDIIKKLR-HPNVLLFMGAVASQE--RLGIVTEFLPRGSLFKTLHKNYQAL---DIKR 477
EI I++ LR PN++ V +V E + + YQ L DI+
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV----NNTDFKQLYQTLTDYDIRF 134
Query: 478 RLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD-KNWTVKVGDFGL--SSLKNATYLT 534
+ L + ++Y H I+HRD+K N+++D ++ +++ D+GL Y
Sbjct: 135 YMYEIL---KALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-- 187
Query: 535 AKSGRGTPQWM-APEVLRSEPSNEKS-DVFSFGVILWELVTASIPW----NNLN-LMQVV 587
+ R ++ PE+L + S D++S G +L ++ P+ +N + L+++
Sbjct: 188 --NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245
Query: 588 GVVG 591
V+G
Sbjct: 246 KVLG 249
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 63/273 (23%), Positives = 109/273 (39%), Gaps = 53/273 (19%)
Query: 333 GHDVNELDPDGKQYPSLGESSRSRESSSSKGDNETSCATDGGIRWEDLQLGEEIGLGSYA 392
HD + + + S E + ++ G+ +D L IG GSYA
Sbjct: 9 HHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGL--QDFDLLRVIGRGSYA 66
Query: 393 VVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKK----------------LRH 434
V R A++V +K KE + H
Sbjct: 67 KVLLVRLKKTDRIYAMRV----------VK---KE-LVNDDEDIDWVQTEKHVFEQASNH 112
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR------- 487
P ++ ++ RL V E++ G L H ++R+ ++ + AR
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLM--FH-------MQRQRKLPEEHARFYSAEIS 163
Query: 488 -GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMA 546
+NYLH R I++RDLK N+L+D +K+ D+G+ T + GTP ++A
Sbjct: 164 LALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221
Query: 547 PEVLRSEPSNEKSDVFSFGVILWELVTASIPWN 579
PE+LR E D ++ GV+++E++ P++
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 52/237 (21%), Positives = 91/237 (38%), Gaps = 68/237 (28%)
Query: 373 GGIRWE---DLQLGEEIGLGSYAVVYRGI--WNGSDVAVK----VYFGSEYIEGTLKNYQ 423
WE + + +G G+Y V + G+ VA+K + + + +
Sbjct: 17 TKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR--- 73
Query: 424 KEIDIIKKLRHPNVLLFMGAVASQERLG------IVTEFLP-------RGSLFKTLHKN- 469
E+ ++K +RH NV+ + E L +V F+ +
Sbjct: 74 -ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 132
Query: 470 --YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527
YQ L +G+ Y+H I+HRDLK NL V+++ +K+ DFGL+
Sbjct: 133 LVYQML-------------KGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLA-- 175
Query: 528 KNATYLTAKSGRGTPQWM----------APEVLRSEPSNEKS-DVFSFGVILWELVT 573
R M APEV+ + ++ D++S G I+ E++T
Sbjct: 176 -----------RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 58/237 (24%), Positives = 92/237 (38%), Gaps = 68/237 (28%)
Query: 373 GGIRWE---DLQLGEEIGLGSYAVVYRGI--WNGSDVAVK----VYFGSEYIEGTLKNYQ 423
WE Q +G G+Y V G VAVK + + + T +
Sbjct: 21 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR--- 77
Query: 424 KEIDIIKKLRHPNVLLFMGAVASQERLG------IVTEFLP-------RGSLFKTLHKN- 469
E+ ++K ++H NV+ + L +VT + + H
Sbjct: 78 -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 470 --YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527
YQ L RG+ Y+H + I+HRDLK SNL V+++ +K+ DFGL+
Sbjct: 137 LIYQIL-------------RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA-- 179
Query: 528 KNATYLTAKSGRGTPQWM----------APEVLRSEPS-NEKSDVFSFGVILWELVT 573
R T M APE++ + N+ D++S G I+ EL+T
Sbjct: 180 -----------RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 40/145 (27%), Positives = 73/145 (50%), Gaps = 24/145 (16%)
Query: 446 SQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR--------GMNYLHHRNP 497
++ +L ++ +++ G LF H + +R R + + +LH
Sbjct: 130 TETKLHLILDYINGGELF--TH-------LSQRERFTEHEVQIYVGEIVLALEHLHKLG- 179
Query: 498 PIVHRDLKSSNLLVDKNWTVKVGDFGLS--SLKNATYLTAKSGRGTPQWMAPEVLRSEPS 555
I++RD+K N+L+D N V + DFGLS + + T A GT ++MAP+++R S
Sbjct: 180 -IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDS 237
Query: 556 NEKSDV--FSFGVILWELVTASIPW 578
V +S GV+++EL+T + P+
Sbjct: 238 GHDKAVDWWSLGVLMYELLTGASPF 262
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 50/239 (20%), Positives = 85/239 (35%), Gaps = 66/239 (27%)
Query: 381 QLGEEIGLGSYAVVYRGI--WNGSDVAVK----VYFGSEYIEGTLKNYQKEIDIIKKLRH 434
+ IG GSY VY +VA+K ++ + L+ EI I+ +L+
Sbjct: 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKS 84
Query: 435 PNV--LLFMGAVASQERLG---IVTEFLPRGSLFKTLHKN------------YQALDIKR 477
+ L + + IV E L K Y L
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLL---- 139
Query: 478 RLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS------------ 525
G N++H I+HRDLK +N L++++ +VKV DFGL+
Sbjct: 140 ---------LGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 526 SLKNATYLTAKSGRGTPQWM----------APEVLRSEPS-NEKSDVFSFGVILWELVT 573
+ + + + APE++ + + + D++S G I EL+
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 53/235 (22%), Positives = 96/235 (40%), Gaps = 63/235 (26%)
Query: 376 RWEDLQLGEEIGLGSYAVVYRGI--WNGSDVAVK-VYFGSE-YIEGTLKNYQKEIDIIKK 431
R+ DL+ +G G +V+ + VA+K + ++ L+ EI II++
Sbjct: 12 RYMDLK---PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRR 64
Query: 432 LRHPNVLLFMGAVASQERLG--------------IVTEFLPRGSLFKTLHKN-------- 469
L H N++ + IV E++ L L +
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHAR 123
Query: 470 ---YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD-KNWTVKVGDFGL- 524
YQ L RG+ Y+H N ++HRDLK +NL ++ ++ +K+GDFGL
Sbjct: 124 LFMYQLL-------------RGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLA 168
Query: 525 ----SSLKNATYLTAKSGRGTPQWM-APEVLRSEPS-NEKSDVFSFGVILWELVT 573
+ +L+ +W +P +L S + + D+++ G I E++T
Sbjct: 169 RIMDPHYSHKGHLS---EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 51/258 (19%), Positives = 88/258 (34%), Gaps = 72/258 (27%)
Query: 356 RESSSSKGDNETSCATDGGIRWE---DLQLGEEIGLGSYAVVYRGI--WNGSDVAVKVYF 410
G ++ IG G+Y +V N VA+K
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK--- 58
Query: 411 GSEYIEGTLKNYQK---------EIDIIKKLRHPNVLLFMGAVASQERLG-----IVTEF 456
+ ++ EI I+ + RH N++ + + IV +
Sbjct: 59 -------KISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL 111
Query: 457 LP-------RGSLFKTLHKN---YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKS 506
+ + H YQ L RG+ Y+H N ++HRDLK
Sbjct: 112 METDLYKLLKTQHLSNDHICYFLYQIL-------------RGLKYIHSAN--VLHRDLKP 156
Query: 507 SNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWM----------APEVLRSEPS- 555
SNLL++ +K+ DFGL+ A ++ APE++ +
Sbjct: 157 SNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 556 NEKSDVFSFGVILWELVT 573
+ D++S G IL E+++
Sbjct: 210 TKSIDIWSVGCILAEMLS 227
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 46/211 (21%), Positives = 84/211 (39%), Gaps = 38/211 (18%)
Query: 384 EEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQK-------EIDIIKKLRH 434
IG GS+ V + VA+K+ +KN + E+ +++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKI----------IKNKKAFLNQAQIEVRLLELMNK 109
Query: 435 P------NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVAR 487
++ + L +V E L +L+ L ++ + + + A +
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 488 GMNYLHHRNPPIVHRDLKSSNLLV--DKNWTVKVGDFGLSSLKN---ATYLTAKSGRGTP 542
+ +L I+H DLK N+L+ K +K+ DFG S Y+ ++ R
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--- 225
Query: 543 QWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
+PEVL P + D++S G IL E+ T
Sbjct: 226 ---SPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 54/245 (22%), Positives = 102/245 (41%), Gaps = 63/245 (25%)
Query: 373 GGIRWE---DLQLGEEIGLGSYAVVYRGI--WNGSDVAVK----VYFGSEYIEGTLKNYQ 423
G + +L +++G G+Y +V++ I G VAVK + S + T +
Sbjct: 1 GRVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR--- 57
Query: 424 KEIDIIKKLR-HPNVLLFMGAVASQERLGI--VTEFLP-------RGSLFKTLHKN---Y 470
EI I+ +L H N++ + + + + V +++ R ++ + +HK Y
Sbjct: 58 -EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY 116
Query: 471 QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS----- 525
Q + + + YLH ++HRD+K SN+L++ VKV DFGLS
Sbjct: 117 QLI-------------KVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161
Query: 526 ------SLKNATYLTAKSGRGTPQWM----------APEVLRSEPS-NEKSDVFSFGVIL 568
++ + ++ + APE+L + D++S G IL
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221
Query: 569 WELVT 573
E++
Sbjct: 222 GEILC 226
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 53/254 (20%), Positives = 95/254 (37%), Gaps = 78/254 (30%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL 432
++ + +G GS+ +V G A+K + KN +E+DI+K L
Sbjct: 7 KKYSLG---KTLGTGSFGIVCEVFDIESGKRFALKKVL----QDPRYKN--RELDIMKVL 57
Query: 433 RHPNV--------------------------------------LLFMGAVASQERLGIVT 454
H N+ + + + L ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALD--------VARGMNYLHHRNPPIVHRDLKS 506
E++P TLHK I+ + ++ + R + ++H I HRD+K
Sbjct: 118 EYVP-----DTLHK-VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKP 169
Query: 507 SNLLVD-KNWTVKVGDFGL-----SSLKNATYLTAKSGRGTPQWMAPEV-LRSEPSNEKS 559
NLLV+ K+ T+K+ DFG S + Y+ ++ R APE+ L +
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPSI 223
Query: 560 DVFSFGVILWELVT 573
D++S G + EL+
Sbjct: 224 DLWSIGCVFGELIL 237
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 46/255 (18%), Positives = 108/255 (42%), Gaps = 56/255 (21%)
Query: 384 EEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQK-------EIDIIKKLR- 433
++G G ++ V+ + N + VA+K+ ++ + EI +++++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKI----------VRGDKVYTEAAEDEIKLLQRVND 74
Query: 434 -------HPNV-----LL--FMGAVASQERLGIVTEFLPRGSLFKTLHKN-YQALDIKRR 478
LL F + + +V E L +L + K ++ + +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYV 133
Query: 479 LRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD------KNWTVKVGDFGLSSLKNATY 532
+++ + G++Y+H R I+H D+K N+L++ +K+ D G + + Y
Sbjct: 134 KQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 533 LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT----------ASIPWNNLN 582
+ T ++ +PEVL P +D++S +++EL+T S ++ +
Sbjct: 193 TNSIQ---TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
Query: 583 LMQVVGVVGFMDRRL 597
+ Q++ ++G + L
Sbjct: 250 IAQIIELLGELPSYL 264
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 40/211 (18%)
Query: 384 EEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQK-------EIDIIKKLRH 434
+ IG GS+ V + VA+K+ ++N ++ EI I++ LR
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKM----------VRNEKRFHRQAAEEIRILEHLRK 152
Query: 435 ------PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVAR 487
NV+ + + + + E L +L++ + KN +Q + + A + +
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 488 GMNYLHHRNPPIVHRDLKSSN-LLVDKNWT-VKVGDFGLSSLKN---ATYLTAKSGRGTP 542
++ LH I+H DLK N LL + + +KV DFG S ++ TY+ ++ R
Sbjct: 212 CLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR--- 266
Query: 543 QWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
APEV+ D++S G IL EL+T
Sbjct: 267 ---APEVILGARYGMPIDMWSLGCILAELLT 294
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 28/218 (12%)
Query: 381 QLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH---- 434
+LG +IG GS+ +Y G I G +VA+K+ E ++ E I K ++
Sbjct: 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTKHPQLHIESKIYKMMQGGVGI 67
Query: 435 PNVLLFMGAVASQERLGI-VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
P + ++ + V E L SL + + +K L +A + + Y+H
Sbjct: 68 PTIRWC----GAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 494 HRNPPIVHRDLKSSNLLVDKNWT---VKVGDFGLS-------SLKNATYLTAKSGRGTPQ 543
+N +HRD+K N L+ V + DFGL+ + ++ Y K+ GT +
Sbjct: 123 SKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 544 WMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581
+ + + + D+ S G +L S+PW L
Sbjct: 181 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 51/223 (22%), Positives = 91/223 (40%), Gaps = 34/223 (15%)
Query: 381 QLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH---- 434
++G++IG G++ + G ++ VA+K+ E ++ E K+L
Sbjct: 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKL----EPMKSRAPQLHLEYRFYKQLGSGDGI 67
Query: 435 PNVLLFMGAVASQERL--GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
P V F +V E L SL + +K L +A+ + M Y+
Sbjct: 68 PQVYYF-----GPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVG-----DFGLS-------SLKNATYLTAKSGRG 540
H +N +++RD+K N L+ + DF L+ + K+ Y KS G
Sbjct: 122 HSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
Query: 541 TPQWMAPEV-LRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582
T ++M+ L E S + D+ + G + + S+PW L
Sbjct: 180 TARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLK 221
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 32/222 (14%)
Query: 381 QLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH---- 434
++G IG GS+ V++ G + N VA+K E + E K L
Sbjct: 13 KVGRRIGEGSFGVIFEGTNLLNNQQVAIK----FEPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 435 PNVLLFMGAVASQERLG--IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
PNV F QE L +V + L SL L + +K A + + +
Sbjct: 69 PNVYYF-----GQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWT-----VKVGDFGLS-------SLKNATYLTAKSGRG 540
H ++ +V+RD+K N L+ + + + V DFG+ + ++ Y K+ G
Sbjct: 123 HEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 541 TPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582
T ++M+ + + D+ + G + + S+PW L
Sbjct: 181 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 2e-11
Identities = 37/209 (17%), Positives = 64/209 (30%), Gaps = 54/209 (25%)
Query: 369 CATDGGIRWED------LQLGEEIGLGSYAVVYRGIWNGSDVAVKV--YFGSEYIEG--- 417
C+ G + + LQ E+IG G + V++ I + + VA+K+ G + + G
Sbjct: 5 CSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQ 64
Query: 418 -TLKNYQKEIDIIKKL---------RHPNVLLFMGAVASQER------------------ 449
T + EI I K+L R + Q
Sbjct: 65 KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124
Query: 450 ------------LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNP 497
L IV EF G + + + + + + + +
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASL-AVAEASL 181
Query: 498 PIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526
HRDL N+L+ K K+
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 30/220 (13%)
Query: 381 QLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH---- 434
+LG +IG GS+ +Y G I +VA+K+ E ++ E I + L+
Sbjct: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKIYRILQGGTGI 65
Query: 435 PNVLLFMGAVASQERL--GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
PNV F E +V + L SL + + L +K L +A + + ++
Sbjct: 66 PNVRWF-----GVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWT---VKVGDFGLS-------SLKNATYLTAKSGRGTP 542
H ++ +HRD+K N L+ V + DFGL+ + ++ Y K+ GT
Sbjct: 120 HSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 543 QWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582
++ + + + D+ S G +L + S+PW L
Sbjct: 178 RYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} Length = 115 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 4e-10
Identities = 22/107 (20%), Positives = 41/107 (38%), Gaps = 3/107 (2%)
Query: 51 TTSDSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAE 110
+ + ++L +M A + I Y N +AE L+ + + Q +++ +
Sbjct: 1 SNAMDTSLPSAILNNMVTATLILDDGLA-IRYANPAAELLFSQSAKRIVEQSLSQLIQHA 59
Query: 111 EFHSPHKKIMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLYEDGE 157
+ + L SGQS + G LM VT SP+ +
Sbjct: 60 SLDLAL--LTQPLQSGQSITDSDVTFVVDGRPLMLEVTVSPITWQRQ 104
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A Length = 120 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 6e-10
Identities = 19/112 (16%), Positives = 39/112 (34%), Gaps = 7/112 (6%)
Query: 59 YRSVLESMGHAVHVCTASSED--IIYWNRSAESLYGWKDREVFGQRVTEFLI-AEEFHSP 115
Y++ + S D I N +++ ++ G+ ++EF
Sbjct: 5 YKTAFHLAPIGL----VLSRDRVIEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERI 60
Query: 116 HKKIMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSD 167
++I + + S++ K+ GE+ VT L LA + D
Sbjct: 61 GERISPVMIAHGSYADDRIMKRAGGELFWCHVTGRALDRTAPLAAGVWTFED 112
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 17/89 (19%), Positives = 36/89 (40%), Gaps = 1/89 (1%)
Query: 80 IIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRS 139
I+Y N + ++ + E+ GQ + + + ++ G W G+F +++
Sbjct: 11 ILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNIWQGEFCNRRKD 70
Query: 140 GEILMAVVTKSPLY-EDGELAGFITVSSD 167
G T PL G+ +I++ D
Sbjct: 71 GTRYWVDSTIVPLMDNAGKPRQYISIRRD 99
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 6e-08
Identities = 21/95 (22%), Positives = 40/95 (42%), Gaps = 7/95 (7%)
Query: 80 IIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRS 139
IIY N + G + E+ GQ + + E L +GQ WSG+ ++R+
Sbjct: 133 IIYANPALCRFSGMAEGELLGQSPSILDSPLADQETLAAMQEALQAGQPWSGRLLNRRRT 192
Query: 140 GEILMAV------VTKSPLY-EDGELAGFITVSSD 167
G ++ +P++ + L G++ + D
Sbjct: 193 GPAPHDAEDYWAEISTTPIHTDGNGLVGYVQIQHD 227
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 41/238 (17%), Positives = 82/238 (34%), Gaps = 37/238 (15%)
Query: 374 GIRWEDLQLGEEIGLGSYAVVYRG-IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL 432
W ++G IG G + +Y + + V + E+ ++
Sbjct: 34 AAAW---KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRA 90
Query: 433 RHPNVLLFMGAVASQERLGI-------------------VTEFLPRGSLFKTLHKNYQAL 473
P + + LG+ + + L K N +
Sbjct: 91 AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRF 149
Query: 474 DIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKV--GDFGLS------ 525
K L+++L + + Y+H VH D+K+SNLL++ +V D+GL+
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207
Query: 526 -SLKNATYLTAKSGRGTPQWMAPEV-LRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581
K + GT ++ + + PS + D+ G + + +T +PW +
Sbjct: 208 GVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDN 264
|
| >3a0r_A Sensor protein; four helix bundle, PAS fold, kinase, phosphoprotein, transfe two-component regulatory system; 3.80A {Thermotoga maritima} Length = 349 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 26/109 (23%), Positives = 39/109 (35%), Gaps = 6/109 (5%)
Query: 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKK 118
S+LES+ A+ + I WN+ AE L+G K V G+R+ + EE S +
Sbjct: 10 SESILESLETAIITLSKDGR-ITEWNKKAEQLFGLKKENVLGRRLKDLPDFEEIGSVAES 68
Query: 119 IMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSD 167
+ E F K + + L G I D
Sbjct: 69 VFENKE-----PVFLNFYKFGERYFNIRFSPFRNAKTQLLEGVIITIDD 112
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} Length = 126 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 6e-09
Identities = 15/98 (15%), Positives = 37/98 (37%), Gaps = 2/98 (2%)
Query: 60 RSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKI 119
++ LE++ + + ++Y N + G+ E+ + + + + +KI
Sbjct: 2 KNFLETIEDMILIINREGR-LLYANTAVPKKLGYTHEELMSMHILT-ITSAGKMAEGEKI 59
Query: 120 MERLASGQSWSGQFPFKKRSGEILMAVVTKSPLYEDGE 157
+ L +G+ S +K+ G + A E
Sbjct: 60 LAELFAGKKESLPLSLEKKEGTSIPAKARIWQGKWHNE 97
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} Length = 126 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 6e-09
Identities = 18/109 (16%), Positives = 40/109 (36%), Gaps = 3/109 (2%)
Query: 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKK 118
++ E+ + V A I N+ + G+ + EV G+ + E +
Sbjct: 19 LEALFENSPDMIDVLDADGT-ICEVNQRFCAELGYDESEVLGRSIWE-FDLMFDAEDVQT 76
Query: 119 IMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSD 167
+ + + + +++R G + V +GE F+ +S D
Sbjct: 77 QLSGFSVDERRKFEGLYERRDGSTMSVEVHLLRFNLEGEDR-FLAISRD 124
|
| >1d06_A Nitrogen fixation regulatory protein FIXL; oxygen sensor, histidine kinase, PAS, high-resolution, two-C system, signaling protein; HET: HEM; 1.40A {Sinorhizobium meliloti} SCOP: d.110.3.2 PDB: 1ew0_A* Length = 130 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 8e-09
Identities = 20/71 (28%), Positives = 40/71 (56%), Gaps = 3/71 (4%)
Query: 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKK 118
RS+L+++ A V +A+ I+ +N +A +G+ + EV GQ + L+ E + H
Sbjct: 18 LRSILDTVPDAT-VVSATDGTIVSFNAAAVRQFGYAEEEVIGQNL-RILMPEPYRHEHDG 75
Query: 119 IMER-LASGQS 128
++R +A+G+
Sbjct: 76 YLQRYMATGEK 86
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 46/241 (19%), Positives = 84/241 (34%), Gaps = 46/241 (19%)
Query: 374 GIRWEDLQLGEEIGLGSYAVVYRG--IWNGSDVAVKVYFGSEYIEGTLKNYQ--KEIDII 429
G +W LG++IG G + ++Y A V +E +N E+
Sbjct: 36 GNQW---VLGKKIGSGGFGLIYLAFPTNKPEKDARHV----VKVEYQ-ENGPLFSELKFY 87
Query: 430 KKLRHPNVLLFMGAVASQERLGI-------------------VTEFLPRGSLFKTLHKNY 470
+++ + + + LGI V E L G + +
Sbjct: 88 QRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQN 145
Query: 471 QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKV--GDFGLSSL- 527
L++ + + + Y+H VH D+K++NLL+ +V D+GLS
Sbjct: 146 GTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
Query: 528 ------KNATYLTAKSGRGTPQWMAPEVLR-SEPSNEKSDVFSFGVILWELVTASIPWNN 580
K K GT ++ + + + S +SDV G + + +PW
Sbjct: 204 CPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQ 262
Query: 581 L 581
Sbjct: 263 N 263
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-08
Identities = 16/109 (14%), Positives = 36/109 (33%), Gaps = 6/109 (5%)
Query: 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKK 118
+ S++ + T + I+ N S G + GQ+++ + +E + +
Sbjct: 21 FESLVSDSPDGIVHLTTNGT-ILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLEA 79
Query: 119 IMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSD 167
+ +G + + R P+ + F VS D
Sbjct: 80 GKSAVENGTATRSEDAVGGRHYH-----NQYIPVDSHRKSDTFQLVSRD 123
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 2e-08
Identities = 45/210 (21%), Positives = 70/210 (33%), Gaps = 50/210 (23%)
Query: 379 DLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNY--QKEIDIIKKLRHPN 436
D + GE Y Y+ I + + A F + ++ K+ ++EID I +
Sbjct: 8 DFETGEH----QYQ--YKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAV 61
Query: 437 V---LLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQAL--DIKRRLRMALDVARGMNY 491
LF ++ QE +V +F+ + L NY+ L IK R + R
Sbjct: 62 SGTLRLFWTLLSKQEE--MVQKFVE-----EVLRINYKFLMSPIKTEQRQPSMMTRMYIE 114
Query: 492 LHHR----NPPI----VHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT----AKSGR 539
R N V R L + L L+ A + SG+
Sbjct: 115 QRDRLYNDNQVFAKYNVSRLQPYLKL---RQA--------LLELRPAKNVLIDGVLGSGK 163
Query: 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILW 569
W+A +V S K F I W
Sbjct: 164 ---TWVALDVCLSYKVQCK---MDFK-IFW 186
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 2e-04
Identities = 71/639 (11%), Positives = 157/639 (24%), Gaps = 236/639 (36%)
Query: 5 ESGPSLYRDLLDRFEGLEAGH----AKLREELNDLLLQEKKKNDDVDEVATTSDSVGPY- 59
+ + ++ E L + + ++ E + + + D + + Y
Sbjct: 73 SKQEEMVQKFVE--EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYN 130
Query: 60 ----------RSVLESMGHA----VH-------------VCTASSEDI-------IYW-N 84
R L + A + VC S + I+W N
Sbjct: 131 VSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVC--LSYKVQCKMDFKIFWLN 188
Query: 85 RSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRSGEILM 144
+ + E +I S S + S + +
Sbjct: 189 --------------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL 234
Query: 145 AVVTKSPLYEDG-----------ELAGF-------ITVSSDAAIFNSINPQHPRPYPNRG 186
+ KS YE+ F +T + + + ++
Sbjct: 235 RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLT-TRFKQVTDFLSAATTTHISLDH 293
Query: 187 QMHGLNLKK-----IQWQPHQPQIAQVPNIASSVTNLTAKVLEKMHIGETGTYVGGDDGS 241
L + +++ +PQ +P + + I E S
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQ--DLPREVLTTNPRRLSI-----IAE----------S 336
Query: 242 LRQNGLRYKSF----CNEITN---------KPNSSR--------FP-DQHTSS------- 272
+R + ++ C+++T +P R FP H +
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIW 396
Query: 273 SEDKAKCVGKI-----NSSFAAENANANICQHRLPNASEEIFCDLAFSRECNDRGTSTGH 327
+ V + S + + +P + + H
Sbjct: 397 FDVIKSDVMVVVNKLHKYSLVEKQPKES--TISIP--------SIYLELKVKLENEYALH 446
Query: 328 RELLPGHDVNELDPDGKQYPSLGESSRSRESSSSKGDNETSCATDGGIRW------EDLQ 381
R ++ Y + D+ D ++++
Sbjct: 447 RSIV------------DHY---------NIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIE 485
Query: 382 LGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFM 441
E + L +R V+ ++E +K+RH +
Sbjct: 486 HPERMTL------FR----------MVFLDFRFLE-------------QKIRHDS----- 511
Query: 442 GAVASQERLGIVTEFLPRGSLFKTLH-----KNYQALDIKRRLRMALDVARGMNYLHHRN 496
T + GS+ TL K Y + + R+ + +++L
Sbjct: 512 ------------TAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAI---LDFLPKIE 556
Query: 497 PPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535
++ K ++LL L + A + A
Sbjct: 557 ENLICS--KYTDLL----------RIALMAEDEAIFEEA 583
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 51/229 (22%), Positives = 88/229 (38%), Gaps = 58/229 (25%)
Query: 384 EEIGLGSYAVVYRGI---WNGSDVAVKVYFGSEYIEGTLKNYQK-------EIDIIKKLR 433
+ +G G++ V I G VAVK+ +KN + EI +++ L
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKI----------VKNVDRYCEAARSEIQVLEHLN 69
Query: 434 HP------NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVA 486
+ + + IV E L S + + +N + + +MA +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 487 RGMNYLHHRNPPIVHRDLKSSN-LLVD------------------KNWTVKVGDFGLSSL 527
+ +N+LH + H DLK N L V N +KV DFG ++
Sbjct: 129 KSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY 186
Query: 528 KN---ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
+ +T ++ + R APEV+ + ++ DV+S G IL E
Sbjct: 187 DDEHHSTLVSTRHYR------APEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} Length = 114 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-08
Identities = 19/90 (21%), Positives = 33/90 (36%), Gaps = 6/90 (6%)
Query: 81 IYWNRSAESLYGWKDREVFGQRVTEFL--IAEEFHSPHKKIMERLASGQSWSGQFPFKKR 138
+ +R YG D ++ G + I EE+ S H++ LA + F +
Sbjct: 26 LAVSRRWREDYGLGDGDILGMSHYDIFPEIGEEWKSVHRRG---LAGEVIRVEEDCFVRA 82
Query: 139 SGEILMAVVTKSPLY-EDGELAGFITVSSD 167
G P Y +G + G + + D
Sbjct: 83 DGRTQWLRWEVRPWYEGEGRVGGVVIFTED 112
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 55/210 (26%)
Query: 400 NGSDVAVKVYFGSEYIEGTLKNYQK-------EIDIIKKLRHP------NVLLFMGAVAS 446
S VA+K+ ++N K EI+++KK++ +L
Sbjct: 44 GKSQVALKI----------IRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93
Query: 447 QERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLK 505
+ I E L + F+ L +N +Q + MA + + +LH + H DLK
Sbjct: 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLK 150
Query: 506 SSN-LLVD------------------KNWTVKVGDFGLSSLKN---ATYLTAKSGRGTPQ 543
N L V+ KN +++V DFG ++ + T + + R
Sbjct: 151 PENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYR---- 206
Query: 544 WMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
PEV+ + DV+S G IL+E
Sbjct: 207 --PPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >1v9y_A Heme PAS sensor protein; signaling protein; HET: HEM; 1.32A {Escherichia coli} SCOP: d.110.3.2 PDB: 1v9z_A* 1vb6_A* 1s67_L* 1s66_L* Length = 167 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-08
Identities = 16/71 (22%), Positives = 34/71 (47%), Gaps = 3/71 (4%)
Query: 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKK 118
+ LE V +++++++N +AE L+G+K EV G + + LI + H +
Sbjct: 42 FFPALEQNMMGA-VLINENDEVMFFNPAAEKLWGYKREEVIGNNI-DMLIPRDLRPAHPE 99
Query: 119 IMER-LASGQS 128
+ G++
Sbjct: 100 YIRHNREGGKA 110
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 56/230 (24%), Positives = 102/230 (44%), Gaps = 56/230 (24%)
Query: 384 EEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYIEGTLKNYQK-------EIDIIKKLRH 434
++G G++ V N AVKV ++N +K E DI+KK+++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKV----------VRNIKKYTRSAKIEADILKKIQN 90
Query: 435 -----PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARG 488
N++ + G + + ++ E L SL++ + +N Y I+ +++ +
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 489 MNYLHHRNPPIVHRDLKSSN-LLVD------------------------KNWTVKVGDFG 523
+NYL + + H DLK N LL D K+ +K+ DFG
Sbjct: 150 LNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
Query: 524 LSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT 573
++ K+ + + + R Q+ APEV+ + + SD++SFG +L EL T
Sbjct: 208 CATFKSDYHGSIINTR---QYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >3a0s_A Sensor protein; PAS-fold, kinase, phosphoprotein, transferase, two-component regulatory system; HET: PG4 PGE; 1.47A {Thermotoga maritima} PDB: 3a0v_A* Length = 96 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-07
Identities = 21/92 (22%), Positives = 32/92 (34%), Gaps = 8/92 (8%)
Query: 66 MGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLAS 125
M A+ + I WN+ AE L+G K V G+R+ + EE S +
Sbjct: 1 METAIITLSKDGR-ITEWNKKAEQLFGLKKENVLGRRLKDLPDFEEIGS---VAESVFEN 56
Query: 126 GQSWSGQFPFKKRSGEILMAVVTKSPLYEDGE 157
+ F + GE + SP
Sbjct: 57 KEPVFLNF---YKFGERYFN-IRFSPFRNAKT 84
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 52/257 (20%), Positives = 95/257 (36%), Gaps = 72/257 (28%)
Query: 381 QLGEEIGLGSYAVVY--RGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR----- 433
+ ++G G ++ V+ I VA+KV +E+ T + EI ++K +R
Sbjct: 40 HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVRNSDPN 96
Query: 434 HPNVLLFMGAVASQERLG-------IVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDV 485
PN + + + + G +V E L L K + K+ YQ L + ++ V
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQV 155
Query: 486 ARGMNYLHHRNPPIVHRDLKSSNLLV---------------------------------- 511
+G++YLH + I+H D+K N+L+
Sbjct: 156 LQGLDYLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 512 ---------------DKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSN 556
+ VK+ D G + + + T Q+ + EVL N
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ---TRQYRSLEVLIGSGYN 271
Query: 557 EKSDVFSFGVILWELVT 573
+D++S + +EL T
Sbjct: 272 TPADIWSTACMAFELAT 288
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} Length = 117 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 3e-07
Identities = 17/104 (16%), Positives = 34/104 (32%), Gaps = 3/104 (2%)
Query: 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKK 118
YR++ E + + A + N + S G+ E
Sbjct: 13 YRALFEHAIDGIFIMDAEGH-YLDVNPAICSAIGYTRDEFLALDWGVL-SRGVDSGWAAA 70
Query: 119 IMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLYEDGELAGFI 162
+ R+ G+ + R+G+ L ++ L DG++ G
Sbjct: 71 SLARIVGGEPLREERTVWTRNGDQLTVELSAHLL-PDGKILGIA 113
|
| >2vv6_A FIXL, sensor protein FIXL; signaling protein, transferase, phosphoprotein, nitrogen FIX PER-ARNT-SIM, metal-binding, PAS, iron, heme; HET: HEM; 1.5A {Bradyrhizobium japonicum} PDB: 1xj6_A* 1xj4_A* 2vv7_A* 2vv8_A* 1lsw_A* 1dp8_A* 1dp9_A* 1drm_A* 1lsv_A* 1dp6_A* 1lsx_A* 1lt0_A* 1y28_A* 2cmn_A* 1xj3_A* 1xj2_A* 2owh_A* 2owj_A* Length = 119 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 5e-07
Identities = 15/50 (30%), Positives = 23/50 (46%), Gaps = 2/50 (4%)
Query: 80 IIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMER-LASGQS 128
I ++ +AE L+GW + E GQ V L+ E S H + R +
Sbjct: 15 IQLFSTAAERLFGWSELEAIGQNV-NILMPEPDRSRHDSYISRYRTTSDP 63
|
| >1ll8_A PAS kinase; PAS domain, ligand binding, ligand screening, kinase regulation, transferase; NMR {Homo sapiens} SCOP: d.110.3.5 Length = 114 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 7e-07
Identities = 16/102 (15%), Positives = 36/102 (35%), Gaps = 6/102 (5%)
Query: 61 SVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIM 120
++ A+ A + +I+ N A L G+ +++ GQ++T+ + +
Sbjct: 2 AMDPEFNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQ-FFLRSDSDVVEALS 60
Query: 121 ERLASGQS-----WSGQFPFKKRSGEILMAVVTKSPLYEDGE 157
E + RSGE + V + ++
Sbjct: 61 EEHMEADGHAAVVFGTVVDIISRSGEKIPVSVWMKRMRQERR 102
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 44/280 (15%), Positives = 93/280 (33%), Gaps = 52/280 (18%)
Query: 340 DPDGKQYPSLGESSRSRESSSSKGDNETSCATD-GGIRWEDLQLGEEIGLGSYAVVYRGI 398
++S + + TD G +W +L + ++Y
Sbjct: 6 HHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQW---KLKSFQTRDNQGILYEAA 62
Query: 399 ----------WNGSDVAVKVYFGSEYIEGTLKNYQK-----EIDIIKKLRH------PNV 437
++K+ + +Q+ +++ KKL P
Sbjct: 63 PTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTC 122
Query: 438 LLFMGAVASQ------ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNY 491
+ F G + LG + S K L + L++A + + +
Sbjct: 123 MGF-GVHQDKYRFLVLPSLGRSLQ-----SALDVSPK--HVLSERSVLQVACRLLDALEF 174
Query: 492 LHHRNPPIVHRDLKSSNLLVDKNWTVKV--GDFGLS-----SLKNATYL--TAKSGRGTP 542
LH VH ++ + N+ VD +V +G + S K+ Y+ + G
Sbjct: 175 LHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDL 232
Query: 543 QWMAPEV-LRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581
++++ ++ PS +SD+ S G + + + +PW N
Sbjct: 233 EFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNC 271
|
| >3mfx_A Sensory BOX/ggdef family protein; alpha-beta protein, structural genomics, PSI-2, protein structure initiative; 2.40A {Shewanella oneidensis} Length = 129 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-05
Identities = 16/117 (13%), Positives = 38/117 (32%), Gaps = 12/117 (10%)
Query: 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKK 118
++ + A+ + ++ I N+ + L + GQ FL E + +
Sbjct: 9 IELFIQHLTEAM-ILVNANGFIRSCNQRSAELLDCPQVSLKGQDWRNFL-TEHHQARYDN 66
Query: 119 IMERLASG--------QSWSGQFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSD 167
++ Q + + SG+ ++ S + + F+ V D
Sbjct: 67 LLSHDVQLGTNCGQPVQHPAQETTLICASGKAKDVELSISYIPGHEPM--FVMVMHD 121
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A Length = 138 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 6e-05
Identities = 24/113 (21%), Positives = 40/113 (35%), Gaps = 7/113 (6%)
Query: 61 SVLESMGHAVHVCTASSED--IIYWNRSAESLYGWKDREVFGQRVT-EFLIAEEFHSPH- 116
E + A E+ +IY N L G+ EV + T +FL
Sbjct: 23 RKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPR-TQRRA 81
Query: 117 -KKIMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLY-EDGELAGFITVSSD 167
+I + L + + F ++ G + +V P+ EDG + FI
Sbjct: 82 AAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEV 134
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} Length = 118 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 8e-05
Identities = 10/99 (10%), Positives = 37/99 (37%), Gaps = 6/99 (6%)
Query: 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKK 118
++ + A + + +Y N + + + ++ + + I +F
Sbjct: 15 AHYLINNAVEASFCLGDNWQ-FLYVNDATCRMTEYSREQLLSMNLQD--IDVDFALHD-- 69
Query: 119 IMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLYEDGE 157
E + +++ + ++ +SG I + ++ + L +
Sbjct: 70 -WEEIRQKNNYTFKTRYRSQSGRIFLVEMSLTFLEDQER 107
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* Length = 166 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 8e-05
Identities = 24/115 (20%), Positives = 41/115 (35%), Gaps = 11/115 (9%)
Query: 60 RSVLESMGHAVHVCTASSED--IIYWNRSAESLYGWKDREVFGQ--RVTEFLIAEEFHSP 115
L+ + AS D I+Y +R +L G+ ++ G+ R FL E P
Sbjct: 38 VKALQMAQQNFVITDASLPDNPIVYASRGFLTLTGYSLDQILGRNCR---FLQGPE-TDP 93
Query: 116 H--KKIMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLY-EDGELAGFITVSSD 167
KI + G S ++ G + + L G + ++ V S
Sbjct: 94 RAVDKIRNAITKGVDTSVCLLNYRQDGTTFWNLFFVAGLRDSKGNIVNYVGVQSK 148
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} Length = 120 | Back alignment and structure |
|---|
Score = 40.9 bits (97), Expect = 1e-04
Identities = 26/112 (23%), Positives = 53/112 (47%), Gaps = 6/112 (5%)
Query: 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPH-- 116
+R +E A+ T +I+Y NR+ ++ G+ EV G+ E +++
Sbjct: 7 FRQTVEHAPIAI-SITDLKANILYANRAFRTITGYGSEEVLGK--NESILSNGTTPRLVY 63
Query: 117 KKIMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLY-EDGELAGFITVSSD 167
+ + RLA + WSG +++ + +A +T +P+ E GE ++ + D
Sbjct: 64 QALWGRLAQKKPWSGVLVNRRKDKTLYLAELTVAPVLNEAGETIYYLGMHRD 115
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} Length = 162 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 1e-04
Identities = 22/115 (19%), Positives = 48/115 (41%), Gaps = 11/115 (9%)
Query: 60 RSVLESMGHAVHVCTASSED--IIYWNRSAESLYGWKDREVFGQ--RVTEFLIAEEFHSP 115
+S++++ + V +D +IY N + E L G+ E+ Q R FL ++
Sbjct: 28 QSMVDASNDGIVVAEKEGDDTILIYVNAAFEYLTGYSRDEILYQDCR---FLQGDD-RDQ 83
Query: 116 H--KKIMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLY-EDGELAGFITVSSD 167
+I + +A G+ ++ G ++ +P+ + + FI + D
Sbjct: 84 LGRARIRKAMAEGRPCREVLRNYRKDGSAFWNELSITPVKSDFDQRTYFIGIQKD 138
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* Length = 146 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 1e-04
Identities = 24/115 (20%), Positives = 44/115 (38%), Gaps = 11/115 (9%)
Query: 60 RSVLESMGHAVHVCTASSED--IIYWNRSAESLYGWKDREVFGQ--RVTEFLIAEEFHSP 115
+ LE + + D II+ + S L + E+ G+ R FL E
Sbjct: 5 ATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCR---FLQGPE-TDR 60
Query: 116 H--KKIMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLY-EDGELAGFITVSSD 167
+KI + + + + Q +SG+ + P+ + G++ FI V D
Sbjct: 61 ATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLD 115
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* Length = 115 | Back alignment and structure |
|---|
Score = 40.2 bits (95), Expect = 2e-04
Identities = 24/112 (21%), Positives = 42/112 (37%), Gaps = 11/112 (9%)
Query: 63 LESMGHAVHVCTASSED--IIYWNRSAESLYGWKDREVFGQ--RVTEFLIAEEFHSPH-- 116
E + + D II+ + L + E+ G+ R FL E
Sbjct: 3 PEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNAR---FLQGPE-TDQATV 58
Query: 117 KKIMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLY-EDGELAGFITVSSD 167
+KI + + + + Q +SG+ ++ P+ + GEL FI V D
Sbjct: 59 QKIRDAIRDQRETTVQLINYTKSGKKFWNLLHLQPVRDQKGELQYFIGVQLD 110
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} Length = 128 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 2e-04
Identities = 25/112 (22%), Positives = 44/112 (39%), Gaps = 11/112 (9%)
Query: 63 LESMGHAVHVCTASSED--IIYWNRSAESLYGWKDREVFGQ--RVTEFLIAEEFHSPH-- 116
E + + D I++ N + L G++ EV G+ R FL P
Sbjct: 3 SEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCR---FLQGHG-TDPAHV 58
Query: 117 KKIMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLY-EDGELAGFITVSSD 167
+ I +A+ + K+SGE + SP++ +G L F++ D
Sbjct: 59 RAIKSAIAAEKPIDIDIINYKKSGEAFWNRLHISPVHNANGRLQHFVSSQLD 110
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} Length = 258 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 25/128 (19%), Positives = 44/128 (34%), Gaps = 7/128 (5%)
Query: 45 DVDEVATTSDSVGPYRSVLESMGHAVHVCTASSED--IIYWNRSAESLYGWKDREVFGQR 102
D ++E+ A V D +I N++ L G+ + E G+
Sbjct: 51 ADDTRVEVQPPAQWVLDLIEASPIASVVSDPRLADNPLIAINQAFTDLTGYSEEECVGRN 110
Query: 103 VTEFLIAEEFHSPH--KKIMERLASGQSWSGQFPFKKRSGEILMAVVTKSPLY-EDGELA 159
FL P KI + + + + K+ G V +P+Y +D EL
Sbjct: 111 -CRFLAGSG-TEPWLTDKIRQGVREHKPVLVEILNYKKDGTPFRNAVLVAPIYDDDDELL 168
Query: 160 GFITVSSD 167
F+ +
Sbjct: 169 YFLGSQVE 176
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 605 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 99.75 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 99.69 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 99.65 | |
| 1d06_A | 130 | Nitrogen fixation regulatory protein FIXL; oxygen | 99.62 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 99.61 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 99.61 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 99.61 | |
| 4hia_A | 176 | LOV protein; PAS, HTH, signaling protein; HET: FMN | 99.61 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 99.6 | |
| 3f1p_B | 121 | ARYL hydrocarbon receptor nuclear translocator; PA | 99.59 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 99.58 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 99.58 | |
| 3mxq_A | 152 | Sensor protein; PSI2, MCSG, structural genomics, p | 99.57 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 99.56 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 99.55 | |
| 3f1p_A | 117 | Endothelial PAS domain-containing protein 1; PAS d | 99.55 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 99.54 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 99.53 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 99.53 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 99.51 | |
| 2qkp_A | 151 | Uncharacterized protein; structural genomics, unkn | 99.51 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 99.49 | |
| 3mfx_A | 129 | Sensory BOX/ggdef family protein; alpha-beta prote | 99.49 | |
| 3nja_A | 125 | Probable ggdef family protein; structural genomics | 99.49 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 99.47 | |
| 3eeh_A | 125 | Putative light and redox sensing histidine kinase; | 99.47 | |
| 2vv6_A | 119 | FIXL, sensor protein FIXL; signaling protein, tran | 99.47 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 99.45 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 99.44 | |
| 2kdk_A | 121 | ARYL hydrocarbon receptor nuclear translocator-LI | 99.42 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 99.41 | |
| 4hi4_A | 121 | Aerotaxis transducer AER2; PAS domain, diatomic GA | 99.41 | |
| 3k3c_A | 158 | Protein RV1364C/MT1410; sensor, PAS, signal transd | 99.4 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 99.4 | |
| 3mr0_A | 142 | Sensory box histidine kinase/response regulator; P | 99.39 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 99.38 | |
| 3kx0_X | 185 | Uncharacterized protein RV1364C/MT1410; PAS domain | 99.37 | |
| 4eho_A | 635 | Bacteriophytochrome, PAS/PAC sensor; photoreceptor | 99.36 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 99.35 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 99.35 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 99.35 | |
| 1v9y_A | 167 | Heme PAS sensor protein; signaling protein; HET: H | 99.33 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 99.32 | |
| 3vol_A | 233 | Aerotaxis transducer AER2; heme, oxygen sensor pro | 99.29 | |
| 3h9w_A | 115 | Diguanylate cyclase with PAS/PAC sensor; alpha-bet | 99.27 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 99.26 | |
| 3cax_A | 369 | Uncharacterized protein PF0695; structural genomic | 99.22 | |
| 3fg8_A | 118 | Uncharacterized protein RHA05790; PAS domain, stru | 99.22 | |
| 1ll8_A | 114 | PAS kinase; PAS domain, ligand binding, ligand scr | 99.22 | |
| 1nwz_A | 125 | PYP, photoactive yellow protein; PAS, LOV, GAF, do | 99.21 | |
| 1mzu_A | 129 | PPR; photoactive yellow protein, PAS, PYP, signali | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 3a0s_A | 96 | Sensor protein; PAS-fold, kinase, phosphoprotein, | 99.09 | |
| 2w0n_A | 118 | Sensor protein DCUS; signal transduction, two-comp | 99.08 | |
| 4f3l_A | 361 | Mclock, circadian locomoter output cycles protein | 99.02 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.98 | |
| 4f3l_B | 387 | BMAL1B; BHLH, PAS, circadian rhythm proteins, tran | 98.97 | |
| 2jhe_A | 190 | Transcription regulator TYRR; aromatic hydrocarbon | 98.94 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.83 | |
| 3rty_A | 339 | Period circadian protein; PAS domain, signalling, | 98.8 | |
| 3a0r_A | 349 | Sensor protein; four helix bundle, PAS fold, kinas | 98.79 | |
| 4dj3_A | 317 | Period circadian protein homolog 3; PAS domain, ci | 98.66 | |
| 3gdi_A | 309 | Period circadian protein homolog 2; tandem PAS dom | 98.61 | |
| 4dj2_A | 320 | Period circadian protein homolog 1; PAS domains, c | 98.58 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.52 | |
| 2ykf_A | 305 | Pdtas, probable sensor histidine kinase pdtas; tra | 97.86 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.44 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.4 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.26 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.17 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.07 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.03 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.85 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.7 | |
| 3rty_A | 339 | Period circadian protein; PAS domain, signalling, | 97.66 | |
| 4f3l_A | 361 | Mclock, circadian locomoter output cycles protein | 97.6 | |
| 4f3l_B | 387 | BMAL1B; BHLH, PAS, circadian rhythm proteins, tran | 97.47 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.38 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.37 | |
| 1oj5_A | 132 | Steroid receptor coactivator 1A; transcriptional c | 97.35 | |
| 2enz_A | 65 | NPKC-theta, protein kinase C theta type; zinc bind | 97.33 | |
| 2yuu_A | 83 | NPKC-delta, protein kinase C delta type; metal bin | 97.31 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.28 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.23 | |
| 1ptq_A | 50 | Protein kinase C delta type; phosphotransferase; 1 | 97.21 | |
| 3n70_A | 145 | Transport activator; sigma-54, ntpase, PSI, MCSG, | 97.17 | |
| 3uej_A | 65 | NPKC-delta, protein kinase C delta type; proteine | 97.14 | |
| 2row_A | 84 | RHO-associated protein kinase 2; ATP-binding, coil | 97.07 | |
| 2eli_A | 85 | Protein kinase C alpha type; PKC-alpha, PKC-A, str | 97.0 | |
| 2enn_A | 77 | NPKC-theta, protein kinase C theta type; zinc bind | 96.98 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.98 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.97 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.97 | |
| 4dj2_A | 320 | Period circadian protein homolog 1; PAS domains, c | 96.88 | |
| 4dj3_A | 317 | Period circadian protein homolog 3; PAS domain, ci | 96.87 | |
| 3gdi_A | 309 | Period circadian protein homolog 2; tandem PAS dom | 96.85 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.84 | |
| 1y8f_A | 66 | UNC-13 homolog A, MUNC13-1; cysteine-rich domain, | 96.84 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.81 | |
| 1ojl_A | 304 | Transcriptional regulatory protein ZRAR; response | 96.76 | |
| 2db6_A | 74 | SH3 and cysteine rich domain 3; STAC3, C1 domain, | 96.67 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.67 | |
| 1ny5_A | 387 | Transcriptional regulator (NTRC family); AAA+ ATPa | 96.21 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.13 | |
| 2bjv_A | 265 | PSP operon transcriptional activator; AAA, transcr | 95.91 | |
| 3co5_A | 143 | Putative two-component system transcriptional RES | 95.82 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.71 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.57 | |
| 2fnf_X | 72 | Putative RAS effector NORE1; zinc, signal transduc | 95.52 | |
| 4b6d_A | 61 | RAC GTPase-activating protein 1; signaling protein | 95.45 | |
| 1faq_A | 52 | RAF-1; transferase, serine/threonine-protein kinas | 95.07 | |
| 2ool_A | 337 | Sensor protein; bacteriophytochrome, photoconversi | 95.0 | |
| 1p0z_A | 131 | Sensor kinase CITA; transferase; HET: FLC MO7; 1.6 | 94.98 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 94.37 | |
| 3dzd_A | 368 | Transcriptional regulator (NTRC family); sigma43 a | 94.21 | |
| 1rfh_A | 59 | RAS association (ralgds/AF-6) domain family 5; zin | 94.12 | |
| 3ky9_A | 587 | Proto-oncogene VAV; calponin homology domain, DBL | 93.59 | |
| 4dah_A | 217 | Sporulation kinase D; alpha-beta-alpha structure, | 92.08 | |
| 1kbe_A | 49 | Kinase suppressor of RAS; KSR, cysteine-rich domai | 92.03 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.81 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 91.46 | |
| 2vrw_B | 406 | P95VAV, VAV1, proto-oncogene VAV; lipoprotein, GTP | 91.09 | |
| 3by8_A | 142 | Sensor protein DCUS; histidine kinase sensor domai | 90.03 | |
| 4e04_A | 327 | Bacteriophytochrome (light-regulated signal trans | 89.8 | |
| 3e4o_A | 305 | C4-dicarboxylate transport sensor protein DCTB; PA | 86.51 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.78 | |
| 3lif_A | 254 | Putative diguanylate cyclase (ggdef) with PAS/PAC; | 82.56 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.02 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.82 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=425.83 Aligned_cols=226 Identities=25% Similarity=0.443 Sum_probs=204.1
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
...++|+++++||+|+||+||+|++ +++.||||++.+.... ....+.+.+|+++|+.++|||||+++++|++++.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3457899999999999999999998 4778999999876532 345677899999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
||||||+||+|.+++.+. +.+++..++.|+.||+.||+|||++| |+||||||+|||++.+|++||+|||+|+.....
T Consensus 109 ivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999999876 78999999999999999999999999 999999999999999999999999999875432
Q ss_pred --cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 532 --YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 532 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.....+.+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+++.+| ...++++|+.+||
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i--~~~~~~~p~~~s~ 259 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI--IKLEYDFPEKFFP 259 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHTCCCCCTTCCH
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HcCCCCCCcccCH
Confidence 23345678999999999999999999999999999999999999999999999999999 4566889998874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=424.66 Aligned_cols=226 Identities=24% Similarity=0.399 Sum_probs=197.8
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.++|+++++||+|+||+||+|++. ++.||||++.+........+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 479999999999999999999984 778999999887766667788999999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 455 EFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
|||+||+|.+++.... ..+++..++.|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+.......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 9999999999997653 56799999999999999999999999 99999999999999999999999999987765444
Q ss_pred cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
...+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++.+|.. +..+++|..+|+
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-~~~~~~~~~~s~ 251 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS-GSFPPVSLHYSY 251 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCH
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-CCCCCCCccCCH
Confidence 44566899999999999999999999999999999999999999999999999999853 334567777663
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-52 Score=419.20 Aligned_cols=225 Identities=27% Similarity=0.400 Sum_probs=196.2
Q ss_pred cccCceEeeeecccCcEEEEEEEE-----CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW-----NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~-----~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
..++|+++++||+|+||+||+|++ .++.||||++.+..........+.+|+.+|+.++|||||+++++|.+++.+
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 347899999999999999999986 355699999987665554556788999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
|||||||+||+|.+++.+. +.+++..+..++.||+.||+|||++| |+||||||+|||++.+|++||+|||+|+....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 9999999999999999876 68999999999999999999999999 99999999999999999999999999987655
Q ss_pred ccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
......+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++.+| ....+++|+.+||
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--~~~~~~~p~~~s~ 251 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI--LKAKLGMPQFLSP 251 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCCCCCCTTSCH
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH--HcCCCCCCCcCCH
Confidence 445556778999999999999999999999999999999999999999999999999999 4566889998875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=411.49 Aligned_cols=209 Identities=27% Similarity=0.404 Sum_probs=192.0
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.+.|+++++||+|+||+||+|+++ |+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 367999999999999999999984 77899999976542 33566889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
|||+||+|.+++.+ ..+++..+..|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+........
T Consensus 151 Ey~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 151 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp CCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred eCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999999999876 57999999999999999999999999 999999999999999999999999999877655555
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
..+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++..|.
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~ 283 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 283 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 667899999999999999999999999999999999999999999999999998884
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=397.54 Aligned_cols=223 Identities=27% Similarity=0.486 Sum_probs=183.6
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
..++|+++++||+|+||+||+|.+ +++.||||++.+.... ......+.+|+.+|+.++|||||+++++|.+++.+|+
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 457899999999999999999987 4778999999776543 3345678999999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
||||| +|+|.+++.+. +.+++..+..++.||+.||+|||++| |+||||||+|||++.+|++||+|||+|+......
T Consensus 91 vmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 99999 78999998765 78999999999999999999999999 9999999999999999999999999998654332
Q ss_pred ccccCCCCCCcccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
...+.+||+.|||||++.+..| +.++|||||||++|+|++|++||.+.+..++...| ....+++|+.+|+
T Consensus 167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i--~~~~~~~p~~~s~ 237 (275)
T 3hyh_A 167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI--SNGVYTLPKFLSP 237 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHTCCCCCTTSCH
T ss_pred -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--HcCCCCCCCCCCH
Confidence 3345789999999999999886 57999999999999999999999999999999998 4566889988874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=413.50 Aligned_cols=222 Identities=26% Similarity=0.377 Sum_probs=197.2
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.++|+++++||+|+||+||+|++. |+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 367999999999999999999984 77899999976542 33567899999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
|||+||+|.+++.. ..+++..+..|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+........
T Consensus 228 Ey~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 228 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp ECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred eCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 99999999999875 56999999999999999999999999 999999999999999999999999999876655555
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccC-CCccCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFM-DRRLELPEGLD 604 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~-~~~~~~P~~~~ 604 (605)
..+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++..|... ...++.+..+|
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s 374 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVS 374 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCC
Confidence 66789999999999999999999999999999999999999999999999999888432 12334445554
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=398.22 Aligned_cols=216 Identities=38% Similarity=0.708 Sum_probs=185.4
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
.+++..+++++.++||+|+||+||+|.+++ .||||+++.........+.|.+|+.+|++++|||||++++++. ++.++
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~ 107 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLA 107 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEE
Confidence 467888999999999999999999998765 5999998766656667788999999999999999999999875 45789
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
||||||+||+|.+++......+++..+..++.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999999999887788999999999999999999999999 999999999999999999999999999865432
Q ss_pred --cccccCCCCCCcccccccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHhc
Q 038211 532 --YLTAKSGRGTPQWMAPEVLRSE---PSNEKSDVFSFGVILWELVTASIPWNNLNLMQ-VVGVVG 591 (605)
Q Consensus 532 --~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~-~~~~I~ 591 (605)
.......+||+.|||||++.+. .|+.++|||||||+||||++|+.||.+.+... +...+.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~ 251 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG 251 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh
Confidence 2234456899999999999653 58999999999999999999999999876554 444443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=393.26 Aligned_cols=221 Identities=31% Similarity=0.539 Sum_probs=189.6
Q ss_pred ceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee----CCeeEEE
Q 038211 380 LQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS----QERLGIV 453 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----~~~~~lv 453 (605)
|++.++||+|+||+||+|.+. +..||+|++..........+.+.+|+.+|+.++|||||+++++|.+ +..+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 478889999999999999985 5679999998776666677889999999999999999999999875 3568999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc-CCCcEEEEeecCCcccCccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD-KNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~-~~~~vkl~Dfg~a~~~~~~~ 532 (605)
||||+||+|.+++.+. ..+++..+..|+.||+.||+|||+++++||||||||+||||+ .+|.+||+|||+|+.....
T Consensus 108 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 9999999999999875 789999999999999999999999987799999999999997 4799999999999865433
Q ss_pred ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHhccCCCccCCCCCCC
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL-NLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~-~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
...+.+||+.|||||++.+ .|+.++|||||||+||||++|++||.+. +..++...|......+.+|..++
T Consensus 186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 256 (290)
T 3fpq_A 186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCC
Confidence 3345689999999999876 5999999999999999999999999865 45667777754433445565554
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=403.68 Aligned_cols=220 Identities=25% Similarity=0.336 Sum_probs=190.2
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..++|++.++||+|+||+||+|+++ |+.||||++..+.. ..+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3467999999999999999999984 77899999876432 24799999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC-cEEEEeecCCcccCccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW-TVKVGDFGLSSLKNATY 532 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~-~vkl~Dfg~a~~~~~~~ 532 (605)
||||+||+|.+++.+. +.+++..+..|+.||+.||+|||++| ||||||||+||||+.+| ++||+|||+|+......
T Consensus 129 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp ECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999999875 78999999999999999999999999 99999999999999887 69999999998654322
Q ss_pred -----ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCc-cCCCCCCCC
Q 038211 533 -----LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRR-LELPEGLDP 605 (605)
Q Consensus 533 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~-~~~P~~~~~ 605 (605)
......+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++.+|...... .++|+.+|+
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~ 284 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAP 284 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCH
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCH
Confidence 1233457999999999999999999999999999999999999999998888888887544333 257887764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=400.63 Aligned_cols=227 Identities=32% Similarity=0.513 Sum_probs=194.0
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS 446 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 446 (605)
.+..++|.+.++||+|+||+||+|.+. +..||||++... .....+.|.+|+++|++++|||||++++++.+
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 456688999999999999999999864 566999998653 34456789999999999999999999999999
Q ss_pred CCeeEEEEEecCCCchHHHHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNY--------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD 512 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~--------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~ 512 (605)
++.++||||||++|+|.+++.... ..+++..+..|+.||+.||+|||+++ ||||||||+||||+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVG 192 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEEC
Confidence 999999999999999999997532 46899999999999999999999999 99999999999999
Q ss_pred CCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 038211 513 KNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGV 589 (605)
Q Consensus 513 ~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~ 589 (605)
.++.+||+|||+|+...... ......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+++..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999998654322 22334579999999999999999999999999999999998 9999999999999999
Q ss_pred hccCCCccCCCCCCCC
Q 038211 590 VGFMDRRLELPEGLDP 605 (605)
Q Consensus 590 I~~~~~~~~~P~~~~~ 605 (605)
|. .+.++++|+.+++
T Consensus 273 i~-~g~~~~~p~~~~~ 287 (329)
T 4aoj_A 273 IT-QGRELERPRACPP 287 (329)
T ss_dssp HH-HTCCCCCCTTCCH
T ss_pred HH-cCCCCCCcccccH
Confidence 85 5568899998864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=398.52 Aligned_cols=227 Identities=30% Similarity=0.504 Sum_probs=198.2
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS 446 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 446 (605)
.+..++|.+.++||+|+||+||+|.+. +..||||++... .....+.|.+|+++|++++|||||++++++.+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 356688999999999999999999863 556999998653 34456789999999999999999999999999
Q ss_pred CCeeEEEEEecCCCchHHHHHhh------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKN------------YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN 514 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~ 514 (605)
++.++||||||++|+|.+++... ...+++..+..++.||+.||+|||+++ ||||||||+|||++.+
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC
Confidence 99999999999999999999764 246999999999999999999999999 9999999999999999
Q ss_pred CcEEEEeecCCcccCcccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhc
Q 038211 515 WTVKVGDFGLSSLKNATYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 515 ~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~ 591 (605)
+.+||+|||+|+....... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+++..|.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999976543322 2233468999999999999999999999999999999998 999999999999999995
Q ss_pred cCCCccCCCCCCCC
Q 038211 592 FMDRRLELPEGLDP 605 (605)
Q Consensus 592 ~~~~~~~~P~~~~~ 605 (605)
.+.++++|+.+|+
T Consensus 245 -~~~~~~~p~~~~~ 257 (299)
T 4asz_A 245 -QGRVLQRPRTCPQ 257 (299)
T ss_dssp -HTCCCCCCTTCCH
T ss_pred -cCCCCCCCccchH
Confidence 5567889988863
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=395.58 Aligned_cols=229 Identities=26% Similarity=0.441 Sum_probs=199.9
Q ss_pred CCccccCceEeeeecccCcEEEEEEEE-------CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEe
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIW-------NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVA 445 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~-------~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 445 (605)
.++...+++++++||+|+||+||+|.+ +++.||||++.... .....+.|.+|+.+|++++|||||++++++.
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 346678899999999999999999986 34679999986542 3344577999999999999999999999999
Q ss_pred eCCeeEEEEEecCCCchHHHHHhh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEE
Q 038211 446 SQERLGIVTEFLPRGSLFKTLHKN---------------YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLL 510 (605)
Q Consensus 446 ~~~~~~lv~e~~~ggsL~~~l~~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nil 510 (605)
+++.++||||||++|+|.+++... ...+++..+..++.||+.||+|||+++ ||||||||+|||
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NIL 177 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVL 177 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceE
Confidence 999999999999999999999653 246899999999999999999999999 999999999999
Q ss_pred EcCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 038211 511 VDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVV 587 (605)
Q Consensus 511 l~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~ 587 (605)
|+.++.+||+|||+|+...... ......+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..+++
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999998654322 23345679999999999999999999999999999999998 99999999999999
Q ss_pred HHhccCCCccCCCCCCCC
Q 038211 588 GVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 588 ~~I~~~~~~~~~P~~~~~ 605 (605)
..|. .+.++++|+.+++
T Consensus 258 ~~i~-~~~~~~~p~~~~~ 274 (308)
T 4gt4_A 258 EMIR-NRQVLPCPDDCPA 274 (308)
T ss_dssp HHHH-TTCCCCCCTTCCH
T ss_pred HHHH-cCCCCCCcccchH
Confidence 9995 5667889988763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=390.93 Aligned_cols=230 Identities=27% Similarity=0.442 Sum_probs=195.2
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECC-------cceEEEEeeccccchhhhhhHHHHHHHHHhCCC-CCeeeEEEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH-PNVLLFMGAV 444 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~-------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~ 444 (605)
+++..++|+++++||+|+||+||+|.+.+ +.||||++.... .....+.+.+|+.+|++++| ||||+++++|
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 56778999999999999999999998754 358999886543 33456778999999999965 8999999998
Q ss_pred eeC-CeeEEEEEecCCCchHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCC
Q 038211 445 ASQ-ERLGIVTEFLPRGSLFKTLHKNY---------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSN 508 (605)
Q Consensus 445 ~~~-~~~~lv~e~~~ggsL~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~N 508 (605)
..+ +.++||||||++|+|.++++... ..+++..+..|+.||+.||+|||+++ ||||||||+|
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~N 215 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARN 215 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccc
Confidence 664 57899999999999999997532 34889999999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 038211 509 LLVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQ 585 (605)
Q Consensus 509 ill~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~ 585 (605)
||++.++.+||+|||+|+...... ......+||+.|||||++.+..|+.++|||||||+||||++ |+.||.+.+..+
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998654322 23345578999999999999999999999999999999998 999999977554
Q ss_pred HHHHhccCCCccCCCCCCCC
Q 038211 586 VVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 586 ~~~~I~~~~~~~~~P~~~~~ 605 (605)
.+..+-..+.++++|+.++|
T Consensus 296 ~~~~~i~~g~~~~~p~~~~~ 315 (353)
T 4ase_A 296 EFCRRLKEGTRMRAPDYTTP 315 (353)
T ss_dssp HHHHHHHHTCCCCCCTTCCH
T ss_pred HHHHHHHcCCCCCCCccCCH
Confidence 44444346778999998874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=405.96 Aligned_cols=225 Identities=22% Similarity=0.370 Sum_probs=192.5
Q ss_pred CccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccch-hhhhhHHH---HHHHHHhCCCCCeeeEEEEEeeC
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE-GTLKNYQK---EIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~-~~~~~~~~---E~~il~~l~h~niv~~~~~~~~~ 447 (605)
.+..++|+++++||+|+||+||+|++ +|+.||||++.+..... .....+.+ ++.+++.++|||||+++++|+++
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 35678999999999999999999998 47789999998765332 22223334 45666777999999999999999
Q ss_pred CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
+.+|||||||+||+|.+++.+. +.+++..++.|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+.
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999999999876 78999999999999999999999999 99999999999999999999999999986
Q ss_pred cCcccccccCCCCCCccccccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHhccCCCccCCCCCC
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLR-SEPSNEKSDVFSFGVILWELVTASIPWNN---LNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~g~~Pf~~---~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
.... ...+.+||+.|||||++. +..|+.++|||||||+||||++|++||.+ .+..++...| ....+.+|+.+
T Consensus 342 ~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~~~~~~p~~~ 417 (689)
T 3v5w_A 342 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSF 417 (689)
T ss_dssp CSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HHCCCCCCTTS
T ss_pred cCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cCCCCCCCccC
Confidence 5433 345679999999999996 46799999999999999999999999975 3455666666 45668899988
Q ss_pred CC
Q 038211 604 DP 605 (605)
Q Consensus 604 ~~ 605 (605)
||
T Consensus 418 S~ 419 (689)
T 3v5w_A 418 SP 419 (689)
T ss_dssp CH
T ss_pred CH
Confidence 74
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=388.87 Aligned_cols=211 Identities=25% Similarity=0.421 Sum_probs=185.5
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee------CCe
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS------QER 449 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~------~~~ 449 (605)
++|+++++||+|+||+||+|++. |+.||||++.+........+.+.+|+.+|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999984 7889999997766555667788999999999999999999999864 357
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+|||||||+ |+|.+++.+. +.+++..+..|+.||+.||+|||++| ||||||||+|||++.+|.+||+|||+|+...
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 899999995 6899998765 78999999999999999999999999 9999999999999999999999999998653
Q ss_pred cc----cccccCCCCCCcccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhcc
Q 038211 530 AT----YLTAKSGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGF 592 (605)
Q Consensus 530 ~~----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~ 592 (605)
.. .....+.+||+.|||||++.+.. ++.++||||+||++|||++|++||.+.+..+.+..|..
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~ 277 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 277 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 22 22345678999999999998864 68999999999999999999999999998888887743
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=370.13 Aligned_cols=208 Identities=25% Similarity=0.415 Sum_probs=167.2
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC------
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE------ 448 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------ 448 (605)
..+|+++++||+|+||+||+|+++ ++.||||++.... .+...+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 357999999999999999999984 7789999987654 3344567899999999999999999999997544
Q ss_pred ------eeEEEEEecCCCchHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEE
Q 038211 449 ------RLGIVTEFLPRGSLFKTLHKNY--QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVG 520 (605)
Q Consensus 449 ------~~~lv~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~ 520 (605)
++|+|||||+||+|.+++.... ...++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEEC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEc
Confidence 4799999999999999998653 23566778899999999999999999 9999999999999999999999
Q ss_pred eecCCcccCcccc------------cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-HHHHH
Q 038211 521 DFGLSSLKNATYL------------TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN-LMQVV 587 (605)
Q Consensus 521 Dfg~a~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~-~~~~~ 587 (605)
|||+|+....... ...+.+||+.|||||++.+..|+.++|||||||++|||++ ||.+.. ....+
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 9999986543221 1234579999999999999999999999999999999996 887532 33444
Q ss_pred HHh
Q 038211 588 GVV 590 (605)
Q Consensus 588 ~~I 590 (605)
..+
T Consensus 238 ~~~ 240 (299)
T 4g31_A 238 TDV 240 (299)
T ss_dssp HHH
T ss_pred HHH
Confidence 444
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=368.92 Aligned_cols=219 Identities=32% Similarity=0.521 Sum_probs=177.0
Q ss_pred cCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC----eeEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE----RLGIV 453 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~----~~~lv 453 (605)
++|.+.++||+|+||+||+|.++|+.||||++..... .......|+..+..++|||||++++++..++ .++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~---~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch---hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 5789999999999999999999999999999865421 1122334666667889999999999997653 58999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCceeccCCCCCEEEcCCCcEEEEeecCC
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR--------NPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a 525 (605)
||||++|+|.+++.. ..+++..+..++.|++.||+|||++ + ||||||||+||||+.++++||+|||+|
T Consensus 80 ~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCC--EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--EeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999976 5689999999999999999999987 6 999999999999999999999999999
Q ss_pred cccCcccc----cccCCCCCCcccccccccCC------CCCchhHHHHHHHHHHHHHcCCCCC----------CC-----
Q 038211 526 SLKNATYL----TAKSGRGTPQWMAPEVLRSE------PSNEKSDVFSFGVILWELVTASIPW----------NN----- 580 (605)
Q Consensus 526 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~el~~g~~Pf----------~~----- 580 (605)
+....... .....+||+.|||||++.+. .++.++|||||||+||||++|.+|| .+
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 76543322 22345799999999999765 3567899999999999999997655 32
Q ss_pred CCHHHHHHHhccCCCccCCCCCC
Q 038211 581 LNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 581 ~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
....++...+.....++++|+.+
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~ 258 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRW 258 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGG
T ss_pred chHHHHHHHHhcccCCCCCCccc
Confidence 23456667776667778888653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=401.26 Aligned_cols=227 Identities=22% Similarity=0.388 Sum_probs=201.7
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeecccc-chhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCe
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQER 449 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~ 449 (605)
.+..++|+++++||+|+||+||+|.+. ++.||||++.+... .....+.+..|..++..+ +||||+.++++|.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 356789999999999999999999985 55699999987543 234556788899999988 79999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+||||||++||+|..++... +.+++..++.|+.||+.||+|||++| |+||||||+||||+.+|++||+|||+|+...
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999999999876 67999999999999999999999999 9999999999999999999999999998654
Q ss_pred cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.........+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+++..| ....+.+|..+|+
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~ 567 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPKSMSK 567 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HSSCCCCCTTSCH
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH--HhCCCCCCccCCH
Confidence 4445566778999999999999999999999999999999999999999999999999999 5566888988763
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=389.12 Aligned_cols=214 Identities=26% Similarity=0.440 Sum_probs=192.6
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..++|+++++||+|+||+||+|.+ +|+.||+|++.+.. ....+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 457899999999999999999998 47789999987653 23356788999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC--CCcEEEEeecCCcccCcc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK--NWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~--~~~vkl~Dfg~a~~~~~~ 531 (605)
||||+||+|.+++......+++..+..|+.||+.||+|||++| |+||||||+|||++. .+.+||+|||+|+.....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999999999876678999999999999999999999999 999999999999985 489999999999876533
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMD 594 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~ 594 (605)
. .....+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+..+++.+|....
T Consensus 311 ~-~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~ 372 (573)
T 3uto_A 311 Q-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 372 (573)
T ss_dssp S-EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred C-ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC
Confidence 2 3345689999999999999999999999999999999999999999999999999995444
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=365.16 Aligned_cols=203 Identities=23% Similarity=0.371 Sum_probs=172.1
Q ss_pred cCceEeeeecccCcEEEEEEEEC-----CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN-----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~-----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~ 451 (605)
++|++.++||+|+||+||+|+++ ++.||+|++.+.. ....+.+|+.+|+.+ +|||||+++++|.+.+++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 67999999999999999999863 4569999886543 234578999999998 6999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC-CcEEEEeecCCcccCc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN-WTVKVGDFGLSSLKNA 530 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~-~~vkl~Dfg~a~~~~~ 530 (605)
+|||||+||+|.+++. .+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+|+....
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999999999884 4899999999999999999999999 9999999999999876 8999999999975432
Q ss_pred cc----------------------------ccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCC-
Q 038211 531 TY----------------------------LTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNN- 580 (605)
Q Consensus 531 ~~----------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~- 580 (605)
.. ....+.+||+.|+|||++.+. .|+.++||||+||++|||++|+.||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 11 112345799999999999876 489999999999999999999999954
Q ss_pred CCHHHHHHHh
Q 038211 581 LNLMQVVGVV 590 (605)
Q Consensus 581 ~~~~~~~~~I 590 (605)
.+..+.+..|
T Consensus 251 ~~~~~~l~~I 260 (361)
T 4f9c_A 251 SDDLTALAQI 260 (361)
T ss_dssp SSHHHHHHHH
T ss_pred CCHHHHHHHH
Confidence 4555555444
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=360.91 Aligned_cols=227 Identities=24% Similarity=0.393 Sum_probs=194.7
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCC
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQE 448 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~ 448 (605)
..+..++|+++++||+|+||+||+|+++ ++.||||++.+.... ......+.+|..+++.+ +||||++++++|.+.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 3466789999999999999999999874 677999999775432 34556788999999998 7999999999999999
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
.+|+|||||+||+|..++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+|+..
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999999999876 67999999999999999999999999 999999999999999999999999999865
Q ss_pred CcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+++..| ....+.+|..++
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i--~~~~~~~p~~~~ 248 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--LNDEVVYPTWLH 248 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCCCCCCTTSC
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH--HcCCCCCCCCCC
Confidence 55555566778999999999999999999999999999999999999999999999999999 456678888776
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=354.68 Aligned_cols=226 Identities=25% Similarity=0.435 Sum_probs=201.3
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
+..++|+++++||+|+||+||+|+++ ++.||||++.+... .......+.+|+.+|+.++||||++++++|.+.+.++
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45689999999999999999999884 77899999976543 2344567889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||||++||+|..++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++.....
T Consensus 82 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999999998765 67999999999999999999999999 999999999999999999999999999865444
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...|. ...+.+|..+|+
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~ 230 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSP 230 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCH
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCH
Confidence 445566789999999999999999999999999999999999999999999999998884 455778887763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=350.08 Aligned_cols=234 Identities=61% Similarity=1.030 Sum_probs=200.5
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
...+...+|++.++||+|+||+||+|.++++.||||++..........+.+.+|+.++++++||||+++++++...+.++
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 34577889999999999999999999999999999999877666666778999999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 452 IVTEFLPRGSLFKTLHKNY--QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+||||+++++|.+++.... ..+++..++.++.||+.||+|||++|++|+||||||+|||++.++.+||+|||+++...
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999999997642 24899999999999999999999998779999999999999999999999999998665
Q ss_pred cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
..........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+.....++.+|..+++
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (309)
T 3p86_A 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred ccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 5544455667999999999999999999999999999999999999999999999999998777888899988764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=353.49 Aligned_cols=227 Identities=22% Similarity=0.396 Sum_probs=200.4
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCe
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQER 449 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~ 449 (605)
.+..++|+++++||+|+||+||+|.++ ++.||||++.+.... ....+.+.+|..+++.+ +||||++++++|.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 466789999999999999999999985 466999999775432 23456788999999988 89999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+|+||||++||+|.+++.+. +.+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++...
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999999999875 67999999999999999999999999 9999999999999999999999999998654
Q ss_pred cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...| ....+.+|+.+|+
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~ 246 (353)
T 2i0e_A 173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPKSMSK 246 (353)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCCCCCCTTSCH
T ss_pred cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH--HhCCCCCCCCCCH
Confidence 4444556678999999999999999999999999999999999999999999999999998 4456788887763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.94 Aligned_cols=228 Identities=25% Similarity=0.405 Sum_probs=196.4
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCC
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQE 448 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~ 448 (605)
..+..++|+++++||+|+||+||+|+++ ++.||||++.+.... ......+.+|..+++.+ +||||++++++|.+.+
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 3467789999999999999999999885 567999999876543 23456688999999887 8999999999999999
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
.+++||||++||+|..++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+|+..
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999999999875 67999999999999999999999999 999999999999999999999999999865
Q ss_pred CcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---------CHHHHHHHhccCCCccCC
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL---------NLMQVVGVVGFMDRRLEL 599 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~---------~~~~~~~~I~~~~~~~~~ 599 (605)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+...| ...++.+
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~ 281 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRI 281 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--HHCCCCC
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--hccccCC
Confidence 54455566778999999999999999999999999999999999999999632 234455566 4566888
Q ss_pred CCCCCC
Q 038211 600 PEGLDP 605 (605)
Q Consensus 600 P~~~~~ 605 (605)
|..+|+
T Consensus 282 p~~~s~ 287 (396)
T 4dc2_A 282 PRSLSV 287 (396)
T ss_dssp CTTSCH
T ss_pred CCcCCH
Confidence 888763
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=347.80 Aligned_cols=224 Identities=28% Similarity=0.486 Sum_probs=201.3
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
...++|++++.||+|+||+||+|.+ +++.||||++.+........+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 4567999999999999999999997 57889999998776666667788999999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
||||+++++|.+++... +.+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 92 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 99999999999999776 67999999999999999999999999 9999999999999999999999999997654332
Q ss_pred ccccCCCCCCcccccccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEPSN-EKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..++...| ..+.+.+|..+|
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i--~~~~~~~p~~~s 238 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGKYRIPFYMS 238 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCCCCCCTTSC
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--HhCCCCCCCCCC
Confidence 34556899999999999988875 7899999999999999999999999999999998 445677887765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=350.92 Aligned_cols=227 Identities=25% Similarity=0.422 Sum_probs=199.5
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCe
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQER 449 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~ 449 (605)
.+..++|++.++||+|+||+||+|+++ ++.||||++.+.... ......+.+|..+++.+ +||||++++++|.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 456789999999999999999999984 677999999775432 33456678899999887 99999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+++||||++||+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 99999999999999999875 67999999999999999999999999 9999999999999999999999999998654
Q ss_pred cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...|. ...+.+|..+|+
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~ 243 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--MDNPFYPRWLEK 243 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCH
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--hCCCCCCcccCH
Confidence 44444566789999999999999999999999999999999999999999999999999984 445778887763
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=353.84 Aligned_cols=226 Identities=26% Similarity=0.420 Sum_probs=191.7
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHH-HHhCCCCCeeeEEEEEeeCCe
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDI-IKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~i-l~~l~h~niv~~~~~~~~~~~ 449 (605)
.+..++|+++++||+|+||+||+|+++ +..||||++.+.... ......+.+|..+ ++.++||||++++++|.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 456789999999999999999999985 566999999876543 2344556677776 567899999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+|+||||++||+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++...
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999999999875 67899999999999999999999999 9999999999999999999999999998654
Q ss_pred cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...| ....+.+|+.++
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~ 263 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNKPLQLKPNIT 263 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH--HHSCCCCCSSSC
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--HhcccCCCCCCC
Confidence 4444556778999999999999999999999999999999999999999999999999998 445677787765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=343.62 Aligned_cols=222 Identities=27% Similarity=0.456 Sum_probs=198.0
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
+..++|+++++||+|+||+||+|++ +++.||+|++.+.... ....+.+.+|+.+++.++||||++++++|.+...++
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 4568999999999999999999988 4778999998765432 234567889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||||++||+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999999999775 67999999999999999999999999 999999999999999999999999999765432
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+++..|. ...+.+|+.++
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~~ 227 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL--NAELRFPPFFN 227 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HCCCCCCTTSC
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCC
Confidence 345679999999999999999999999999999999999999999999999998884 45577888776
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=345.65 Aligned_cols=226 Identities=25% Similarity=0.401 Sum_probs=196.8
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCe
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQER 449 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~ 449 (605)
.+..++|++++.||+|+||+||+|+++ ++.||||++.+.... ....+.+.+|+.+++.+ +||||++++++|.+.+.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 356789999999999999999999985 677999999876543 34566788999999988 89999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+++||||++||+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++...
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999999999775 67999999999999999999999999 9999999999999999999999999998654
Q ss_pred cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC---------CCHHHHHHHhccCCCccCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN---------LNLMQVVGVVGFMDRRLELP 600 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~---------~~~~~~~~~I~~~~~~~~~P 600 (605)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.. .....+...| ...++.+|
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p 239 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIP 239 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH--HHCCCCCC
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH--HcCCCCCC
Confidence 444455667899999999999999999999999999999999999999975 2344555666 34567788
Q ss_pred CCCC
Q 038211 601 EGLD 604 (605)
Q Consensus 601 ~~~~ 604 (605)
..+|
T Consensus 240 ~~~s 243 (345)
T 3a8x_A 240 RSLS 243 (345)
T ss_dssp TTSC
T ss_pred CCCC
Confidence 8776
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=358.36 Aligned_cols=226 Identities=21% Similarity=0.338 Sum_probs=198.3
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
+..++|+++++||+|+||+||+|++. ++.||+|++.+.... ......+.+|+.+++.++||||++++++|.+.+.++
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 45689999999999999999999985 567999998764332 233456889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+|||||+||+|.+++.+....+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+|+.....
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 999999999999999886678999999999999999999999999 999999999999999999999999999765433
Q ss_pred c-ccccCCCCCCccccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCC
Q 038211 532 Y-LTAKSGRGTPQWMAPEVLR-----SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 532 ~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
. ......+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+..+++.+|.....++.+|+.
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 305 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQ 305 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSS
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcc
Confidence 2 2334568999999999997 456899999999999999999999999999999999998655556777765
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.69 Aligned_cols=227 Identities=25% Similarity=0.388 Sum_probs=188.4
Q ss_pred CCccccCceEeeeecccCcEEEEEEEE-----CCcceEEEEeeccccc--hhhhhhHHHHHHHHHhCCCCCeeeEEEEEe
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIW-----NGSDVAVKVYFGSEYI--EGTLKNYQKEIDIIKKLRHPNVLLFMGAVA 445 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~-----~~~~~avKv~~~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 445 (605)
..+..++|++.++||+|+||.||++++ .++.||+|++.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 346678999999999999999999986 4677999998765432 234456788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCC
Q 038211 446 SQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525 (605)
Q Consensus 446 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a 525 (605)
..+.+++||||++|++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999999999765 67899999999999999999999999 999999999999999999999999999
Q ss_pred cccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 526 SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 526 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
+............+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..|. ...+.+|+.++
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~~ 245 (327)
T 3a62_A 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL--KCKLNLPPYLT 245 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HTCCCCCTTSC
T ss_pred cccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--hCCCCCCCCCC
Confidence 765444344456689999999999999999999999999999999999999999999998888884 45577887765
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=354.27 Aligned_cols=224 Identities=21% Similarity=0.349 Sum_probs=196.2
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
+..++|+++++||+|+||+||++++ +++.||||++.+.... ......+.+|..++..++||||++++++|.+.+.+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4568999999999999999999998 4778999999765432 344567899999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||||++||+|.+++.+....+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++.....
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 999999999999999887668999999999999999999999999 999999999999999999999999999765433
Q ss_pred cc-cccCCCCCCccccccccc-------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCC
Q 038211 532 YL-TAKSGRGTPQWMAPEVLR-------SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELP 600 (605)
Q Consensus 532 ~~-~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P 600 (605)
.. .....+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+++.+|......+.+|
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 292 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC
Confidence 22 234568999999999997 3568999999999999999999999999999999998885444445555
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=354.81 Aligned_cols=223 Identities=25% Similarity=0.384 Sum_probs=195.2
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
+..++|+++++||+|+||+||+|++. ++.||+|++.+.... ......+.+|+.+++.++||||++++++|.+++.+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 45689999999999999999999984 667999998764432 234556889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+|||||+||+|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+|+.....
T Consensus 146 lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 99999999999999876 46899999999999999999999999 999999999999999999999999999765433
Q ss_pred c-ccccCCCCCCcccccccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCC
Q 038211 532 Y-LTAKSGRGTPQWMAPEVLRSEP----SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 532 ~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~ 601 (605)
. ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+++.+|......+.+|.
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence 2 2344678999999999998765 78899999999999999999999999999999999865444566665
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.16 Aligned_cols=223 Identities=21% Similarity=0.363 Sum_probs=199.5
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
...++|++++.||+|+||.||+|.+. ++.||||++.+.... ....+.+.+|+.+|+.++||||++++++|.+.+.++
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 45689999999999999999999984 778999998765432 244567889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||||++|++|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 999999999999999875 67999999999999999999999999 999999999999999999999999999765432
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...|. .+++.+|+.+|+
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~ 263 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV--SGKVRFPSHFSS 263 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTCCH
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCH
Confidence 235679999999999999999999999999999999999999999999999999984 456788887763
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=345.71 Aligned_cols=227 Identities=22% Similarity=0.372 Sum_probs=195.9
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
.+.+..++|+++++||+|+||+||++.+. ++.||+|++.+.... ......+.+|+.+|+.++|||||+++++|.+.+
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45678899999999999999999999884 566999998765432 344567889999999999999999999999999
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
.+++||||+.||+|..++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.+|++||+|||+++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 999999999999999999765 67999999999999999999999999 999999999999999999999999999865
Q ss_pred CcccccccCCCCCCcccccccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHhccCCCccCCCCC
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRS---EPSNEKSDVFSFGVILWELVTASIPWNN---LNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~g~~Pf~~---~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.. ....+++..+ ....+.+|..
T Consensus 166 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~p~~ 242 (384)
T 4fr4_A 166 PRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYPSA 242 (384)
T ss_dssp CTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--HHCCCCCCTT
T ss_pred cCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--hhcccCCCCc
Confidence 432 23456689999999999974 4588999999999999999999999974 4456666666 3455777777
Q ss_pred CC
Q 038211 603 LD 604 (605)
Q Consensus 603 ~~ 604 (605)
+|
T Consensus 243 ~s 244 (384)
T 4fr4_A 243 WS 244 (384)
T ss_dssp SC
T ss_pred CC
Confidence 65
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=355.57 Aligned_cols=228 Identities=25% Similarity=0.421 Sum_probs=190.0
Q ss_pred CCccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
..+..++|+++++||+|+||.||+|.+ .++.||||++.+... .......+.+|+.+++.++||||++++++|...+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 345678999999999999999999987 467899999876532 23345667889999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH-RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
+++||||+++++|.+++.+. ..+++..+..++.||+.||+|||+ +| |+||||||+|||++.++.+||+|||+++..
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999999999998775 689999999999999999999998 99 999999999999999999999999999865
Q ss_pred CcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
..........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...|. ...+.+|..+++
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~ 374 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLGP 374 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCH
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH--hCCCCCCccCCH
Confidence 544445566789999999999999999999999999999999999999999999999998884 445778877663
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=331.12 Aligned_cols=223 Identities=25% Similarity=0.437 Sum_probs=193.0
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
...+|++.++||+|+||+||+|.+ .++.||+|++..... ...+.+.+|+.+++.++||||++++++|...+.+++|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 347899999999999999999986 577899999875532 2345688999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
|||+++++|.+++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999999976 46899999999999999999999999 99999999999999999999999999987655555
Q ss_pred cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccC-CCccCCCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFM-DRRLELPEGLD 604 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~-~~~~~~P~~~~ 604 (605)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+... ...+..|+.++
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSC
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Confidence 555678999999999999999999999999999999999999999998877766665322 22334454443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.30 Aligned_cols=219 Identities=24% Similarity=0.381 Sum_probs=195.1
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..++|+++++||+|+||+||+|.+ .++.+|+|++..........+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 347899999999999999999987 577899999987766666677899999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc---CCCcEEEEeecCCcccCc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD---KNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~---~~~~vkl~Dfg~a~~~~~ 530 (605)
||||+||+|.+.+... ..+++..+..++.||+.||+|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 89 ~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp ECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 9999999999998775 67999999999999999999999999 99999999999998 468899999999987665
Q ss_pred ccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCcc
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRL 597 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~ 597 (605)
.........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..++...|......+
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 232 (444)
T 3soa_A 166 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF 232 (444)
T ss_dssp TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC
T ss_pred CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC
Confidence 5444556789999999999999999999999999999999999999999999999999985444333
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=339.09 Aligned_cols=228 Identities=29% Similarity=0.511 Sum_probs=197.0
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC---------CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN---------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMG 442 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~---------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~ 442 (605)
..+..++|++++.||+|+||.||+|.+. +..||||++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 4566789999999999999999999863 2349999986543 344567789999999999 8999999999
Q ss_pred EEeeCCeeEEEEEecCCCchHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCC
Q 038211 443 AVASQERLGIVTEFLPRGSLFKTLHKNY---------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSS 507 (605)
Q Consensus 443 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~ 507 (605)
++...+.+++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~ 232 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAAR 232 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchh
Confidence 9999999999999999999999998653 34789999999999999999999999 999999999
Q ss_pred CEEEcCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 038211 508 NLLVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLM 584 (605)
Q Consensus 508 Nill~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~ 584 (605)
|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999999997544322 22334567889999999999999999999999999999999 99999999988
Q ss_pred HHHHHhccCCCccCCCCCCC
Q 038211 585 QVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 585 ~~~~~I~~~~~~~~~P~~~~ 604 (605)
++...+. .+.++++|..++
T Consensus 313 ~~~~~~~-~~~~~~~~~~~~ 331 (370)
T 2psq_A 313 ELFKLLK-EGHRMDKPANCT 331 (370)
T ss_dssp GHHHHHH-TTCCCCCCTTSC
T ss_pred HHHHHHh-cCCCCCCCCCCC
Confidence 8888874 555677887665
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=354.46 Aligned_cols=228 Identities=23% Similarity=0.342 Sum_probs=198.7
Q ss_pred CccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
.+..++|.+.++||+|+||+||+|++ +++.||||++.+..... .....+.+|+.+++.++||||++++++|.+.+.+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 45668999999999999999999998 47789999997654332 3456788999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 451 GIVTEFLPRGSLFKTLHKN---YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
|+||||++||+|..++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeee
Confidence 9999999999999998764 346999999999999999999999999 99999999999999999999999999987
Q ss_pred cCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHhccCCCccCCCCCC
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL----NLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~----~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+. ...++...| ....+.+|+.+
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i--~~~~~~~p~~~ 416 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV--LEQAVTYPDKF 416 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH--HHCCCCCCTTS
T ss_pred ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH--hhcccCCCccc
Confidence 654444445568999999999999999999999999999999999999999875 456777777 34557788777
Q ss_pred CC
Q 038211 604 DP 605 (605)
Q Consensus 604 ~~ 605 (605)
|+
T Consensus 417 s~ 418 (543)
T 3c4z_A 417 SP 418 (543)
T ss_dssp CH
T ss_pred CH
Confidence 63
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=336.19 Aligned_cols=213 Identities=25% Similarity=0.425 Sum_probs=189.7
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccch----hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE----GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~----~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
..++|+++++||+|+||+||+|.+. ++.||+|++.+..... ...+.+.+|+.+|+.++||||++++++|.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3468999999999999999999984 7789999997764332 134678899999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC----cEEEEeecCC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW----TVKVGDFGLS 525 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~----~vkl~Dfg~a 525 (605)
+++||||++|++|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 99999999999999999764 67999999999999999999999999 99999999999998776 7999999999
Q ss_pred cccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhcc
Q 038211 526 SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGF 592 (605)
Q Consensus 526 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~ 592 (605)
....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+++..|..
T Consensus 167 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~ 232 (361)
T 2yab_A 167 HEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232 (361)
T ss_dssp EECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred eEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 7654332 33456799999999999999999999999999999999999999999999999999843
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=337.43 Aligned_cols=215 Identities=25% Similarity=0.437 Sum_probs=191.9
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..++|++.++||+|+||.||+|.+. +..||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3468999999999999999999884 77899999987766666677899999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC---CcEEEEeecCCcccCc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN---WTVKVGDFGLSSLKNA 530 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~---~~vkl~Dfg~a~~~~~ 530 (605)
|||++|++|.+.+... ..+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 9999999999988765 67899999999999999999999999 9999999999999765 4599999999976653
Q ss_pred ccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCC
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMD 594 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~ 594 (605)
.. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...|....
T Consensus 184 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~ 246 (362)
T 2bdw_A 184 SE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 246 (362)
T ss_dssp CC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred Cc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 32 2345679999999999999999999999999999999999999999999999998885443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=332.55 Aligned_cols=228 Identities=32% Similarity=0.479 Sum_probs=196.8
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC-----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN-----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~-----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
..+...+|++.+.||+|+||+||+|.+. +..||||++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 4567789999999999999999999873 3349999986543 344567789999999999999999999999999
Q ss_pred CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
+.+++||||+++++|.+++......+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++.
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 9999999999999999999877678999999999999999999999999 99999999999999999999999999976
Q ss_pred cCccc---ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 528 KNATY---LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 528 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
..... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...+. .+.+++.|..+
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 279 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGC 279 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCCCCCCc
Confidence 54322 12233456889999999998889999999999999999999 999999999999999885 45667777766
Q ss_pred C
Q 038211 604 D 604 (605)
Q Consensus 604 ~ 604 (605)
+
T Consensus 280 ~ 280 (325)
T 3kul_A 280 P 280 (325)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.81 Aligned_cols=224 Identities=26% Similarity=0.454 Sum_probs=193.6
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
...++|.+.+.||+|+||+||+|.+ .++.||+|++.+..... .....+.+|+.+++.++||||+++++++.+++.++
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 4568999999999999999999998 57789999987653322 23457889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||||+ +|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 86 lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999999 78999988765 67999999999999999999999999 999999999999999999999999999765433
Q ss_pred cccccCCCCCCcccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+....++...+ ....+.+|+.+|+
T Consensus 162 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~ 233 (336)
T 3h4j_B 162 N-FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSP 233 (336)
T ss_dssp B-TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCH
T ss_pred c-ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCH
Confidence 2 3345679999999999998876 68999999999999999999999987766666666 4455677777653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=321.81 Aligned_cols=228 Identities=29% Similarity=0.595 Sum_probs=202.3
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC--Cee
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ--ERL 450 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~ 450 (605)
.++..++|++.+.||+|+||.||+|.++++.+|||++..........+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 456788999999999999999999999999999999987766666677899999999999999999999999876 788
Q ss_pred EEEEEecCCCchHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQ-ALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
++||||+++++|.+++..... .+++..++.++.||+.||+|||+++.+|+||||||+|||++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999999987543 5899999999999999999999988789999999999999999999999998875422
Q ss_pred cccccccCCCCCCcccccccccCCCCCc---hhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNE---KSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.....||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+..+....+...+.++.+|+.+++
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence 23446899999999998765544 799999999999999999999999999988888777888888888763
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=325.20 Aligned_cols=215 Identities=26% Similarity=0.429 Sum_probs=184.2
Q ss_pred CCccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
+.+..++|++++.||+|+||.||+|.+ .+..||+|++..... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 445668999999999999999999987 467799999865433 23456788999999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+++||||++|++|.+++... +.+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999999999776 67999999999999999999999999 9999999999999999999999999997654
Q ss_pred ccc-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 530 ATY-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 530 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~ 224 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH 224 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 332 2233456899999999999999999999999999999999999999998876665544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=328.69 Aligned_cols=213 Identities=28% Similarity=0.377 Sum_probs=182.9
Q ss_pred ccccCceEeeeecccCcEEEEEEEE-CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
...++|+++++||+|+||+||+|.+ +++.||+|++............+.+|+.+++.++||||+++++++.++..+++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 3568999999999999999999998 567799999876654445567788999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
|||++ ++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 98 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 98 FEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp EECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred EcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 99996 5888888877677999999999999999999999999 99999999999999999999999999987654444
Q ss_pred cccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 534 TAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 232 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI 232 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 4555678999999999987 45799999999999999999999999887665555544
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=326.03 Aligned_cols=218 Identities=30% Similarity=0.479 Sum_probs=183.5
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccch------------------------hhhhhHHHHHHH
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE------------------------GTLKNYQKEIDI 428 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~------------------------~~~~~~~~E~~i 428 (605)
+..++|++.+.||+|+||.||+|.+ .++.||||++....... ...+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 5668999999999999999999987 46779999987654221 124568899999
Q ss_pred HHhCCCCCeeeEEEEEee--CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCC
Q 038211 429 IKKLRHPNVLLFMGAVAS--QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKS 506 (605)
Q Consensus 429 l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~ 506 (605)
++.++||||+++++++.+ ...+++||||+++++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp 165 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKP 165 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCH
Confidence 999999999999999986 5689999999999999876543 57999999999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEeecCCcccCcccccccCCCCCCcccccccccCCCC---CchhHHHHHHHHHHHHHcCCCCCCCCCH
Q 038211 507 SNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPS---NEKSDVFSFGVILWELVTASIPWNNLNL 583 (605)
Q Consensus 507 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~el~~g~~Pf~~~~~ 583 (605)
+|||++.++.+||+|||++..............||+.|+|||++.+... +.++|||||||++|+|++|+.||.+.+.
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 9999999999999999999876544444455679999999999987653 7789999999999999999999999988
Q ss_pred HHHHHHhccCCCc
Q 038211 584 MQVVGVVGFMDRR 596 (605)
Q Consensus 584 ~~~~~~I~~~~~~ 596 (605)
..+...+......
T Consensus 246 ~~~~~~~~~~~~~ 258 (298)
T 2zv2_A 246 MCLHSKIKSQALE 258 (298)
T ss_dssp HHHHHHHHHCCCC
T ss_pred HHHHHHHhcccCC
Confidence 8888887544433
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=324.29 Aligned_cols=210 Identities=29% Similarity=0.402 Sum_probs=181.7
Q ss_pred cCceEeeeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
++|+++++||+|+||+||+|.+. ++.||+|++............+.+|+.+++.++||||+++++++.+.+.+++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 68999999999999999999884 77899999876654444556788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccccc
Q 038211 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAK 536 (605)
Q Consensus 457 ~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 536 (605)
+++ +|.+++......+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 965 999999876678999999999999999999999999 99999999999999999999999999976544433344
Q ss_pred CCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 537 SGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 537 ~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
...||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 213 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 55789999999999764 4899999999999999999999999998877766665
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=320.86 Aligned_cols=210 Identities=26% Similarity=0.375 Sum_probs=186.0
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
++|+++++||+|+||+||+|.+ .++.||+|++............+.+|+.+++.++||||+++++++.+++.+++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999998 46779999998766555566788899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|+++ +|.+.+......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 9965 777777766688999999999999999999999999 9999999999999999999999999998766555555
Q ss_pred cCCCCCCcccccccccCCC-CCchhHHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHh
Q 038211 536 KSGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTASIP-WNNLNLMQVVGVV 590 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~P-f~~~~~~~~~~~I 590 (605)
....||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+.+..|
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i 215 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHH
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence 6678899999999998766 79999999999999999987777 6667766666665
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=344.85 Aligned_cols=228 Identities=29% Similarity=0.542 Sum_probs=200.3
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
.+.+..++|.+++.||+|+||+||+|.+. ++.||||++.+.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 45677889999999999999999999984 788999998765432 234567889999999999999999999999999
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
.+++||||++|++|.+++... +.+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 999999999999999998764 67999999999999999999999999 999999999999999999999999999865
Q ss_pred CcccccccCCCCCCcccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..++...| ..+.+.+|..+++
T Consensus 167 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~ 241 (476)
T 2y94_A 167 SDGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--CDGIFYTPQYLNP 241 (476)
T ss_dssp CTTC-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH--HTTCCCCCTTCCH
T ss_pred cccc-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH--hcCCcCCCccCCH
Confidence 4322 3345689999999999998876 68999999999999999999999999888888888 4556777877663
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=337.05 Aligned_cols=229 Identities=32% Similarity=0.494 Sum_probs=199.3
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
.+.+..++|++.++||+|+||.||+|.+. ++.||||++.... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 34567789999999999999999999984 7779999986542 33455678899999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+++||||+++|+|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999999999887677999999999999999999999999 9999999999999999999999999997644
Q ss_pred ccccccc--CCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 530 ATYLTAK--SGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 530 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
....... ...+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+. .+.++++|+.++
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 341 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCP 341 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 3222211 1235778999999998889999999999999999998 999999999999888885 566788888765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.96 Aligned_cols=211 Identities=21% Similarity=0.347 Sum_probs=188.0
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.++|++.+.||+|+||+||+|.+. +..+|+|++.... .....+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 478999999999999999999884 6679999886432 34456889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC--CCcEEEEeecCCcccCccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK--NWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~--~~~vkl~Dfg~a~~~~~~~ 532 (605)
|||+|++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 999999999999876668999999999999999999999999 999999999999987 7899999999997654332
Q ss_pred ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccC
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFM 593 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~ 593 (605)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+++..|...
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 218 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA 218 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcC
Confidence 223456899999999999988899999999999999999999999999999998888433
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=317.75 Aligned_cols=226 Identities=31% Similarity=0.516 Sum_probs=197.8
Q ss_pred CCccccCceEeeeecccCcEEEEEEEE-CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
..+..++|++.+.||+|+||.||++.+ .+..||+|++...... .+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence 446678999999999999999999998 5667999998765432 356889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||||+++++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEecccccccccccc
Confidence 999999999999999887778999999999999999999999999 999999999999999999999999999765433
Q ss_pred c-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 532 Y-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 532 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
. .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..++...+. ...++..|..++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLAS 233 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSC
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCccCCCCCcCC
Confidence 2 22334457889999999999999999999999999999999 999999999999998885 445566666554
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=347.96 Aligned_cols=227 Identities=23% Similarity=0.304 Sum_probs=195.0
Q ss_pred CccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
.+..++|++.++||+|+||.||+|.+ +++.||||++.+.... ......+.+|+.+|+.++||||++++++|.+.+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 35668899999999999999999998 4778999999765432 23456678999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 451 GIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
++||||++||+|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999987653 35999999999999999999999999 9999999999999999999999999997654
Q ss_pred cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHhccCCCccCCCCCCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL----NLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~----~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+. ...++...| ......+|..+|+
T Consensus 338 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i--~~~~~~~p~~~s~ 414 (576)
T 2acx_A 338 EGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--KEVPEEYSERFSP 414 (576)
T ss_dssp TTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH--HHCCCCCCTTSCH
T ss_pred cCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh--hcccccCCccCCH
Confidence 332 233458999999999999999999999999999999999999999875 345666666 3445677776653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=330.41 Aligned_cols=212 Identities=28% Similarity=0.430 Sum_probs=183.7
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccch---hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE---GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~---~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
..++|++.+.||+|+||+||+|.+ +++.||||++....... ...+.+.+|+.+++.++||||+++++++...+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 446899999999999999999987 47789999986543221 1356788999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc---EEEEeecC
Q 038211 451 GIVTEFLPRGSLFKTLHKN---YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT---VKVGDFGL 524 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~---vkl~Dfg~ 524 (605)
++|||||+|++|.+.+... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+|||+
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998887653 235899999999999999999999999 999999999999986654 99999999
Q ss_pred CcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 525 SSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 525 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
+.............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ..++...|
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i 244 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGI 244 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHH
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHH
Confidence 987655444455668999999999999999999999999999999999999999885 35555555
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=339.24 Aligned_cols=224 Identities=34% Similarity=0.612 Sum_probs=196.3
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC-ee
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE-RL 450 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-~~ 450 (605)
...+..++|++.++||+|+||.||++.++++.||||++.... ..+.+.+|+.+|+.++||||+++++++.... .+
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 456778899999999999999999999999999999987543 4567899999999999999999999987654 79
Q ss_pred EEEEEecCCCchHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQ-ALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
++||||+++|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999999987643 4799999999999999999999999 9999999999999999999999999997543
Q ss_pred cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.. .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. .+.++++|+.+++
T Consensus 341 ~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~ 413 (450)
T 1k9a_A 341 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPP 413 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCH
T ss_pred cc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCH
Confidence 32 223357899999999999999999999999999999998 999999998888888885 5567888887763
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=329.20 Aligned_cols=228 Identities=30% Similarity=0.522 Sum_probs=198.4
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECC---------cceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNG---------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMG 442 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~---------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~ 442 (605)
+.+..++|.+.++||+|+||+||+|.+.+ ..||||++.... .......+.+|+.+++.+ +||||+++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 45677899999999999999999998632 359999986653 344567789999999999 9999999999
Q ss_pred EEeeCCeeEEEEEecCCCchHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCC
Q 038211 443 AVASQERLGIVTEFLPRGSLFKTLHKNY---------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSS 507 (605)
Q Consensus 443 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~ 507 (605)
++..++.+++||||+++++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~ 220 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAAR 220 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcc
Confidence 9999999999999999999999998753 35899999999999999999999999 999999999
Q ss_pred CEEEcCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 038211 508 NLLVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLM 584 (605)
Q Consensus 508 Nill~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~ 584 (605)
|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998654322 22334567899999999999999999999999999999999 99999999999
Q ss_pred HHHHHhccCCCccCCCCCCC
Q 038211 585 QVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 585 ~~~~~I~~~~~~~~~P~~~~ 604 (605)
++...+. .+.++..|..++
T Consensus 301 ~~~~~~~-~~~~~~~~~~~~ 319 (382)
T 3tt0_A 301 ELFKLLK-EGHRMDKPSNCT 319 (382)
T ss_dssp HHHHHHH-TTCCCCCCSSCC
T ss_pred HHHHHHH-cCCCCCCCccCC
Confidence 9888885 555677777665
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=315.63 Aligned_cols=226 Identities=37% Similarity=0.618 Sum_probs=187.1
Q ss_pred ccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccc--hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYI--EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
+..++|++.++||+|+||.||+|.+.++.+|||++...... ....+.+.+|+.+++.++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred cchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 45689999999999999999999999999999998664322 2345678899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-CceeccCCCCCEEEcC--------CCcEEEEeec
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNP-PIVHRDLKSSNLLVDK--------NWTVKVGDFG 523 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~-~iiH~Dik~~Nill~~--------~~~vkl~Dfg 523 (605)
||||+++++|.+++.. ..+++..++.++.||+.||.|||++|. +|+||||||+|||++. ++.+||+|||
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999998864 579999999999999999999999983 3789999999999985 7789999999
Q ss_pred CCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 524 LSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 524 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.......+......+++|..+
T Consensus 162 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3dtc_A 162 LAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239 (271)
T ss_dssp C---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence 997654332 234568999999999999999999999999999999999999999999988888887777777888776
Q ss_pred C
Q 038211 604 D 604 (605)
Q Consensus 604 ~ 604 (605)
+
T Consensus 240 ~ 240 (271)
T 3dtc_A 240 P 240 (271)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=313.55 Aligned_cols=225 Identities=32% Similarity=0.558 Sum_probs=195.5
Q ss_pred CccccCceEeeeecccCcEEEEEEEECCc-ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWNGS-DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~-~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
.+..++|++.+.||+|+||.||++.+.+. .||+|++...... .+.+.+|+.+++.++||||+++++++......++
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI 80 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence 45678999999999999999999988654 6999998765432 3568899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
||||+++++|.+++......+++..++.++.||+.||.|||+.| |+||||||+|||++.++.++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999887677999999999999999999999999 9999999999999999999999999997654332
Q ss_pred -ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 533 -LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 533 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. .+.++..|..++
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 231 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLAS 231 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSC
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcCh
Confidence 22334456788999999999889999999999999999999 999999999988888885 444555565544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=316.89 Aligned_cols=227 Identities=29% Similarity=0.498 Sum_probs=194.3
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEECC-cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNG-SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~-~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
...+..++|++++.||+|+||.||++.+.+ ..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 345677899999999999999999998864 46999998765432 35688999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 9999999999999999876678999999999999999999999999 99999999999999999999999999976543
Q ss_pred cc-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 531 TY-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 531 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.. .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+. ...+...|..++
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 247 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLAS 247 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCCCCCCcCC
Confidence 22 22334457889999999998889999999999999999998 999999999999988885 444556665554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=322.62 Aligned_cols=214 Identities=26% Similarity=0.415 Sum_probs=188.6
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccch----hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE----GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~----~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
..++|.+.+.||+|+||.||+|.+. +..||+|++.+..... ...+.+.+|+.+|+.++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3467999999999999999999984 7789999987654322 135678899999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC----cEEEEeecCC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW----TVKVGDFGLS 525 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~----~vkl~Dfg~a 525 (605)
+++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 99999999999999998764 67999999999999999999999999 99999999999998877 8999999999
Q ss_pred cccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccC
Q 038211 526 SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFM 593 (605)
Q Consensus 526 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~ 593 (605)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 166 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 232 (326)
T 2y0a_A 166 HKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232 (326)
T ss_dssp EECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHT
T ss_pred eECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhc
Confidence 7654322 234457999999999999999999999999999999999999999998888888887433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=317.62 Aligned_cols=225 Identities=28% Similarity=0.465 Sum_probs=170.5
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
..++|++.+.||+|+||.||+|.+ .++.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 457899999999999999999987 5778999998654322 2335678899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 99999999999999877678999999999999999999999999 9999999999999999999999999998665443
Q ss_pred ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+.+..+. ...+.+|..++
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~ 236 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--LADYEMPSFLS 236 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC--SSCCCCCTTSC
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh--hcccCCccccC
Confidence 33445678999999999999889999999999999999999999999877777777663 33456676654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=327.19 Aligned_cols=228 Identities=28% Similarity=0.453 Sum_probs=196.4
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECC-------cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEe
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVA 445 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~-------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 445 (605)
..+..++|++++.||+|+||.||+|.+.+ +.||||++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 35667899999999999999999998864 679999987543 3345677899999999999999999999999
Q ss_pred eCCeeEEEEEecCCCchHHHHHhhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceec
Q 038211 446 SQERLGIVTEFLPRGSLFKTLHKNY-----------------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHR 502 (605)
Q Consensus 446 ~~~~~~lv~e~~~ggsL~~~l~~~~-----------------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~ 502 (605)
..+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~ 198 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHR 198 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecC
Confidence 9999999999999999999997642 57899999999999999999999999 9999
Q ss_pred cCCCCCEEEcCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 038211 503 DLKSSNLLVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWN 579 (605)
Q Consensus 503 Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~ 579 (605)
||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 999999999999999999999987543222 22334567999999999999899999999999999999999 999999
Q ss_pred CCCHHHHHHHhccCCCccCCCCCCC
Q 038211 580 NLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 580 ~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
+.+..++...+. .+..+.+|+.++
T Consensus 279 ~~~~~~~~~~~~-~~~~~~~~~~~~ 302 (343)
T 1luf_A 279 GMAHEEVIYYVR-DGNILACPENCP 302 (343)
T ss_dssp TSCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred CCChHHHHHHHh-CCCcCCCCCCCC
Confidence 999999988885 444567777665
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=322.54 Aligned_cols=210 Identities=29% Similarity=0.443 Sum_probs=170.6
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.++|+++++||+|+||+||+|.+. ++.||+|++.... .......+.+|+.+++.++||||+++++++..++.+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 368999999999999999999874 7789999987654 2334466889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 455 EFLPRGSLFKTLHKNY-----QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
||++ ++|.+++.... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9997 59999887642 45899999999999999999999999 9999999999999999999999999998765
Q ss_pred cccccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
..........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..|
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 221 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 444444556789999999999874 5899999999999999999999999998887777665
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=322.31 Aligned_cols=224 Identities=26% Similarity=0.377 Sum_probs=197.4
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
...+|.+.+.||+|+||.||++.+. ++.+|+|++...... ....+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 4578999999999999999999984 567999998765432 3456778899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
||||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 119 v~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 99999999999988765 67999999999999999999999999 9999999999999999999999999998765444
Q ss_pred ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. ...+.+|..++
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~ 265 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHIN 265 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSC
T ss_pred ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh--cCCCCCCccCC
Confidence 44455679999999999999999999999999999999999999999988888888774 34567777665
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=316.67 Aligned_cols=227 Identities=28% Similarity=0.506 Sum_probs=184.2
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC-----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN-----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~-----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
..+..++|++.+.||+|+||.||+|.+. +..+|+|++.... .....+.+.+|+.+++.++||||+++++++. +
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 4566789999999999999999999874 2348888875432 3345567889999999999999999999984 5
Q ss_pred CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
+..++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC------
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECccccccc
Confidence 6789999999999999999877668999999999999999999999999 99999999999999999999999999976
Q ss_pred cCccc-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 528 KNATY-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 528 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
..... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...|. .+.++++|+.++
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~ 243 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 243 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 54322 12233456889999999998899999999999999999996 999999998888888885 445567777765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=331.07 Aligned_cols=228 Identities=26% Similarity=0.417 Sum_probs=194.4
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEe
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVA 445 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 445 (605)
..+..++|+++++||+|+||+||+|.+. +..||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4567789999999999999999999853 4469999986432 3344557889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCchHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC---c
Q 038211 446 SQERLGIVTEFLPRGSLFKTLHKNY------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW---T 516 (605)
Q Consensus 446 ~~~~~~lv~e~~~ggsL~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~---~ 516 (605)
.....++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.+| .
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCC
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCce
Confidence 9999999999999999999998753 45899999999999999999999999 99999999999999555 5
Q ss_pred EEEEeecCCcccCcc--cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccC
Q 038211 517 VKVGDFGLSSLKNAT--YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFM 593 (605)
Q Consensus 517 vkl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~ 593 (605)
+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++ |..||...+..++...+. .
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-~ 301 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 301 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-T
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 999999999753221 122234467999999999999999999999999999999998 999999999999999885 4
Q ss_pred CCccCCCCCCC
Q 038211 594 DRRLELPEGLD 604 (605)
Q Consensus 594 ~~~~~~P~~~~ 604 (605)
+.++..|..++
T Consensus 302 ~~~~~~~~~~~ 312 (367)
T 3l9p_A 302 GGRMDPPKNCP 312 (367)
T ss_dssp TCCCCCCTTCC
T ss_pred CCCCCCCccCC
Confidence 55667777665
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=313.89 Aligned_cols=224 Identities=26% Similarity=0.377 Sum_probs=197.6
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
..++|.+.+.||+|+||.||++.+. ++.+|+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 4578999999999999999999985 667999998765432 3456678899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
||||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 93 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 99999999999988765 67999999999999999999999999 9999999999999999999999999998765444
Q ss_pred ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+. ...+.+|..++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~ 239 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHIN 239 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSC
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCCCccccC
Confidence 44455678999999999999989999999999999999999999999998888888873 44567777665
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=327.51 Aligned_cols=213 Identities=23% Similarity=0.391 Sum_probs=188.0
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..++|+++++||+|+||.||+|.+. ++.+|+|++.... ......+.+|+.+|+.++||||++++++|.+...+++|
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 4578999999999999999999884 6779999986543 22345688999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC--CCcEEEEeecCCcccCcc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK--NWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~--~~~vkl~Dfg~a~~~~~~ 531 (605)
|||+++++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++. .+.+||+|||+++.....
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999999999876668999999999999999999999999 999999999999974 578999999999865433
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFM 593 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~ 593 (605)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..|...
T Consensus 205 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~ 265 (387)
T 1kob_A 205 E-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 265 (387)
T ss_dssp S-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC
T ss_pred c-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 2 223346899999999999999999999999999999999999999999988888888544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=314.30 Aligned_cols=224 Identities=25% Similarity=0.495 Sum_probs=192.8
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
.+..++|++.+.||+|+||.||+|.+. +..||+|++....... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 456789999999999999999999885 4569999986654322 2346688999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
++||||+++++|.+++... ..+++..++.++.||+.||+|||+.| |+||||||+|||++.++.++|+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999999999775 67999999999999999999999999 99999999999999999999999999865433
Q ss_pred ccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
. ......||+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+. ...+.+|+.++
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~ 231 (279)
T 3fdn_A 162 S--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVT 231 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSC
T ss_pred c--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH--hCCCCCCCcCC
Confidence 2 2334578999999999999999999999999999999999999999999998888884 44566777654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.79 Aligned_cols=203 Identities=35% Similarity=0.558 Sum_probs=180.0
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
+..++|++.++||+|+||+||+|.+. +..||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 45689999999999999999999984 677999987543 34556788999999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
||||+++++|.+++......+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999999999887788999999999999999999999999 9999999999999999999999999997643322
Q ss_pred cc--------------ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 533 LT--------------AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 533 ~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 11 11457999999999999999999999999999999999999999753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=330.23 Aligned_cols=228 Identities=28% Similarity=0.481 Sum_probs=184.9
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC-----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN-----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~-----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
..+...+|.+.+.||+|+||.||+|.+. +..||||++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 3566789999999999999999999864 5569999986543 344567789999999999999999999999999
Q ss_pred CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
+.+++||||+++++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999999999887678999999999999999999999999 99999999999999999999999999976
Q ss_pred cCcccc---cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 528 KNATYL---TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 528 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. .+.+++.|..+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~ 275 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDC 275 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCCTTC
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccc
Confidence 543221 1223345788999999999999999999999999999998 999999999999888885 34455555554
Q ss_pred C
Q 038211 604 D 604 (605)
Q Consensus 604 ~ 604 (605)
+
T Consensus 276 ~ 276 (373)
T 2qol_A 276 P 276 (373)
T ss_dssp B
T ss_pred c
Confidence 3
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=322.83 Aligned_cols=204 Identities=29% Similarity=0.420 Sum_probs=176.1
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..++|+++++||+|+||+||+|.+. ++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 3478999999999999999999874 77799999865432 22346788999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc--
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT-- 531 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~-- 531 (605)
|||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 84 LEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp EECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 9999999999988654 67999999999999999999999999 999999999999999999999999999764322
Q ss_pred cccccCCCCCCcccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCH
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELVTASIPWNNLNL 583 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~Pf~~~~~ 583 (605)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 222345679999999999988776 6789999999999999999999987554
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=310.00 Aligned_cols=218 Identities=25% Similarity=0.431 Sum_probs=193.3
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.++|++.++||+|+||.||+|.+. ++.||+|++..........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999874 678999999877666666778899999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc---EEEEeecCCcccCcc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT---VKVGDFGLSSLKNAT 531 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~---vkl~Dfg~a~~~~~~ 531 (605)
||+++++|.+.+... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 999999999888775 67999999999999999999999999 999999999999986655 999999999765433
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLE 598 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~ 598 (605)
. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..++...+......++
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (284)
T 3kk8_A 162 E-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP 227 (284)
T ss_dssp C-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred c-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC
Confidence 2 23445789999999999999999999999999999999999999999999998888855444433
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=326.88 Aligned_cols=208 Identities=26% Similarity=0.472 Sum_probs=181.7
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~l 452 (605)
..++|++.+.||+|+||+||+|.++ ++.||||++.+.. ....+|+.++.++ +||||++++++|.+.+.+++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT------CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc------CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 3478999999999999999999984 6779999986643 2345788888888 79999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC----CcEEEEeecCCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN----WTVKVGDFGLSSLK 528 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~----~~vkl~Dfg~a~~~ 528 (605)
|||||+||+|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||+|||+... +.+||+|||+++..
T Consensus 94 v~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999999765 67999999999999999999999999 9999999999998433 35999999999876
Q ss_pred CcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHhcc
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN---LNLMQVVGVVGF 592 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~---~~~~~~~~~I~~ 592 (605)
..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+ .+..+++..|..
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 237 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS 237 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH
T ss_pred cCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc
Confidence 5444445567899999999999988889999999999999999999999985 467788888843
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.59 Aligned_cols=225 Identities=28% Similarity=0.517 Sum_probs=196.3
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccch-hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
..+..++|++.+.||+|+||.||+|.+. +..||+|++....... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 3466789999999999999999999985 5669999987653322 234678899999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.++|+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999999999876 67999999999999999999999999 9999999999999999999999999986544
Q ss_pred cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+ ....+.+|+.++
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~ 236 (284)
T 2vgo_A 166 SL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI--VNVDLKFPPFLS 236 (284)
T ss_dssp SS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HTTCCCCCTTSC
T ss_pred cc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH--hccccCCCCcCC
Confidence 32 234557899999999999999999999999999999999999999999988888887 345567777665
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=328.75 Aligned_cols=211 Identities=24% Similarity=0.372 Sum_probs=173.3
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCC--ee
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQE--RL 450 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~--~~ 450 (605)
..++|+++++||+|+||+||+|.+ .++.||||++..........+.+.+|+.+++.+. ||||+++++++..++ .+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999987 4778999998765445556677889999999997 999999999997544 78
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
|+|||||+ ++|..++.. ..+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+|+....
T Consensus 87 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 99999996 689888876 57899999999999999999999999 99999999999999999999999999975422
Q ss_pred c---------------------cccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 038211 531 T---------------------YLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVG 588 (605)
Q Consensus 531 ~---------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~ 588 (605)
. .......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1 112234579999999999987 678999999999999999999999999998887777
Q ss_pred Hhc
Q 038211 589 VVG 591 (605)
Q Consensus 589 ~I~ 591 (605)
.|.
T Consensus 242 ~i~ 244 (388)
T 3oz6_A 242 RII 244 (388)
T ss_dssp HHH
T ss_pred HHH
Confidence 763
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=328.57 Aligned_cols=229 Identities=27% Similarity=0.439 Sum_probs=191.3
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAV 444 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~ 444 (605)
..+..++|++.++||+|+||.||+|.+. ++.||||++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 4566789999999999999999999853 3569999986543 334456789999999999 799999999999
Q ss_pred eeCC-eeEEEEEecCCCchHHHHHhhcC----------------------------------------------------
Q 038211 445 ASQE-RLGIVTEFLPRGSLFKTLHKNYQ---------------------------------------------------- 471 (605)
Q Consensus 445 ~~~~-~~~lv~e~~~ggsL~~~l~~~~~---------------------------------------------------- 471 (605)
...+ .+++|||||++|+|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8754 49999999999999999976532
Q ss_pred -------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc--ccccc
Q 038211 472 -------------ALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT--YLTAK 536 (605)
Q Consensus 472 -------------~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~--~~~~~ 536 (605)
.+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence 1889999999999999999999999 999999999999999999999999999754322 22333
Q ss_pred CCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 537 SGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 537 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
...||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+......+..+.+|..++
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT 322 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCC
T ss_pred ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCC
Confidence 4568899999999999999999999999999999998 9999998775555444444566777887765
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=322.17 Aligned_cols=225 Identities=28% Similarity=0.509 Sum_probs=187.5
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--Ccc----eEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSD----VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~----~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
+..++|+++++||+|+||+||+|.+. +.. +++|++.... .......+.+|+.+++.++||||+++++++. .+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 45678999999999999999999874 444 5566553322 2233456788999999999999999999886 46
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
..++||||+.+++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCccccc
Confidence 789999999999999999876678999999999999999999999999 999999999999999999999999999865
Q ss_pred Cccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 529 NATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 529 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.... .......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..++...+. ...++..|..++
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 243 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQICT 243 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCBCCCCTTBC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCCCcCc
Confidence 4332 22334567889999999999999999999999999999999 999999988888888875 445667776655
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=316.87 Aligned_cols=211 Identities=25% Similarity=0.370 Sum_probs=179.6
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.++|+++++||+|+||+||+|.+. ++.||+|++..........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999984 778999998776655555677889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+++++|..++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.........
T Consensus 82 e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 999998888877654 67999999999999999999999999 999999999999999999999999999876544444
Q ss_pred ccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 535 AKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 215 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI 215 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 456678999999999986 56799999999999999999999999998877666554
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=314.89 Aligned_cols=216 Identities=40% Similarity=0.730 Sum_probs=176.0
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
.+++..++|++.++||+|+||+||++.+.+ .+|+|++..........+.+.+|+.+++.++||||+++++++ ....++
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 467788999999999999999999998765 599999987665666678899999999999999999999965 556789
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999999999877778999999999999999999999999 999999999999999999999999999754321
Q ss_pred --cccccCCCCCCccccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHhc
Q 038211 532 --YLTAKSGRGTPQWMAPEVLR---SEPSNEKSDVFSFGVILWELVTASIPWNNLNL-MQVVGVVG 591 (605)
Q Consensus 532 --~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~-~~~~~~I~ 591 (605)
........||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+. .++...+.
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 239 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhc
Confidence 12233456899999999987 56678899999999999999999999988554 44444443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=322.89 Aligned_cols=200 Identities=30% Similarity=0.446 Sum_probs=172.6
Q ss_pred CccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC----e
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE----R 449 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~----~ 449 (605)
.+...+|++.++||+|+||+||+|.+.++.||||++.... .......+|+.+++.++||||+++++++.... .
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred ccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 3566899999999999999999999999999999986542 23344566899999999999999999998744 4
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCceeccCCCCCEEEcCCCcEEE
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR----------NPPIVHRDLKSSNLLVDKNWTVKV 519 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~----------~~~iiH~Dik~~Nill~~~~~vkl 519 (605)
+++||||+++|+|.+++.. ..+++..++.++.||+.||+|||+. + |+||||||+|||++.++.+||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCCCeEEE
Confidence 7999999999999999976 4589999999999999999999999 9 999999999999999999999
Q ss_pred EeecCCcccCcccc--cccCCCCCCcccccccccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 520 GDFGLSSLKNATYL--TAKSGRGTPQWMAPEVLRSE-----PSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 520 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 99999976443222 23345799999999999874 345678999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=321.11 Aligned_cols=229 Identities=26% Similarity=0.428 Sum_probs=180.2
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECCc-----ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNGS-----DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~-----~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
..+..++|++.+.||+|+||+||+|.+... .||||++..........+.+.+|+.+++.++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 345668899999999999999999987432 689999877655556678899999999999999999999999876
Q ss_pred Cee------EEEEEecCCCchHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc
Q 038211 448 ERL------GIVTEFLPRGSLFKTLHKNY-----QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT 516 (605)
Q Consensus 448 ~~~------~lv~e~~~ggsL~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~ 516 (605)
... ++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSC
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCCCC
Confidence 554 99999999999999986542 25899999999999999999999999 999999999999999999
Q ss_pred EEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccC
Q 038211 517 VKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFM 593 (605)
Q Consensus 517 vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~ 593 (605)
+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..++...+. .
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~ 254 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-G 254 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-T
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh-c
Confidence 9999999997653322 12233456889999999999999999999999999999999 999999999888888874 4
Q ss_pred CCccCCCCCCC
Q 038211 594 DRRLELPEGLD 604 (605)
Q Consensus 594 ~~~~~~P~~~~ 604 (605)
+..+..|+.++
T Consensus 255 ~~~~~~~~~~~ 265 (323)
T 3qup_A 255 GNRLKQPPECM 265 (323)
T ss_dssp TCCCCCCTTCC
T ss_pred CCCCCCCCccC
Confidence 55667776655
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=324.44 Aligned_cols=229 Identities=26% Similarity=0.406 Sum_probs=190.9
Q ss_pred CCccccCceEeeeecccCcEEEEEEEE-------CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIW-------NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAV 444 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~-------~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~ 444 (605)
..+..++|++.+.||+|+||.||+|.+ .+..||+|++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 456778999999999999999999986 23469999986543 234457789999999999 899999999999
Q ss_pred eeCCeeEEEEEecCCCchHHHHHhhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceec
Q 038211 445 ASQERLGIVTEFLPRGSLFKTLHKNYQ----------------------ALDIKRRLRMALDVARGMNYLHHRNPPIVHR 502 (605)
Q Consensus 445 ~~~~~~~lv~e~~~ggsL~~~l~~~~~----------------------~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~ 502 (605)
...+.+++||||+++++|.+++..... .+++..++.++.||+.||+|||++| |+||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~ 196 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHR 196 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccC
Confidence 999999999999999999999986532 3789999999999999999999999 9999
Q ss_pred cCCCCCEEEcCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 038211 503 DLKSSNLLVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWN 579 (605)
Q Consensus 503 Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~ 579 (605)
||||+|||++.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 999999999999999999999997653322 12233457889999999999999999999999999999998 999999
Q ss_pred CCCHHHHHHHhccCCCccCCCCCCC
Q 038211 580 NLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 580 ~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
+.+....+..+...+.+++.|..++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (344)
T 1rjb_A 277 GIPVDANFYKLIQNGFKMDQPFYAT 301 (344)
T ss_dssp TCCCSHHHHHHHHTTCCCCCCTTCC
T ss_pred cCCcHHHHHHHHhcCCCCCCCCCCC
Confidence 8776555555544566677777665
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=319.30 Aligned_cols=215 Identities=25% Similarity=0.386 Sum_probs=179.7
Q ss_pred CccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe-
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER- 449 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~- 449 (605)
....++|++.++||+|+||.||+|.+ .++.||||++...... ......+.+|+.+++.++||||+++++++.....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 34557899999999999999999997 5677999998765432 3445678899999999999999999999876543
Q ss_pred ---eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCc
Q 038211 450 ---LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526 (605)
Q Consensus 450 ---~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~ 526 (605)
+++||||++|++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred CcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 49999999999999999765 67999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCccc---ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 527 LKNATY---LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 527 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+.
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~ 232 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence 653321 22234568999999999999999999999999999999999999999988877766653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=319.28 Aligned_cols=210 Identities=32% Similarity=0.448 Sum_probs=184.8
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
..|++++.||+|+||+||+|.+ .++.||||++..... .....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 5699999999999999999986 577899999876533 2344567889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+. |+|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCC----
Confidence 9996 6888888776688999999999999999999999999 99999999999999999999999999976542
Q ss_pred ccCCCCCCccccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCC
Q 038211 535 AKSGRGTPQWMAPEVLR---SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMD 594 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~ 594 (605)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 269 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 269 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Confidence 23457899999999985 4668899999999999999999999999988887777775443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=320.12 Aligned_cols=208 Identities=21% Similarity=0.301 Sum_probs=181.5
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~l 452 (605)
..++|++.+.||+|+||+||+|.+ .++.||||++.... ....+.+|+.+++.+ +||||+++++++...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 447899999999999999999996 57789999986543 234688999999999 99999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc-----EEEEeecCCcc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT-----VKVGDFGLSSL 527 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~-----vkl~Dfg~a~~ 527 (605)
||||+ +++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+|||+++.
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99999 99999999876678999999999999999999999999 999999999999998887 99999999976
Q ss_pred cCcccc-------cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHh
Q 038211 528 KNATYL-------TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL---NLMQVVGVV 590 (605)
Q Consensus 528 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~---~~~~~~~~I 590 (605)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+. +..+.+..|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i 232 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI 232 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH
Confidence 433221 124567999999999999999999999999999999999999999874 344555555
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.10 Aligned_cols=226 Identities=28% Similarity=0.519 Sum_probs=196.5
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
...+..++|++.++||+|+||+||+|.++ +..||||++.... ...+.+.+|+.+|+.++||||+++++++. .+.+
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 45677789999999999999999999985 6679999987643 23567899999999999999999999986 5679
Q ss_pred EEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 451 GIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999999997543 46889999999999999999999999 9999999999999999999999999998654
Q ss_pred cccc-cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 530 ATYL-TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 530 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.... ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..+++..|. .+.+++.|+.++
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~ 411 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCP 411 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSC
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 3322 2233456889999999998889999999999999999999 999999999999999885 456677787765
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=316.68 Aligned_cols=208 Identities=27% Similarity=0.390 Sum_probs=186.2
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
..|...++||+|+||.||+|.+ .++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 3478888999999999999987 47889999986543 2335668899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|+++++|.+++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..........
T Consensus 123 ~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (321)
T 2c30_A 123 FLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 198 (321)
T ss_dssp CCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred cCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccc
Confidence 9999999998865 56999999999999999999999999 9999999999999999999999999997765444444
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~ 254 (321)
T 2c30_A 199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 254 (321)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 56689999999999999999999999999999999999999999988888887774
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=312.10 Aligned_cols=227 Identities=31% Similarity=0.579 Sum_probs=190.3
Q ss_pred CccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchh-----hhhhHHHHHHHHHhCCCCCeeeEEEEEee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEG-----TLKNYQKEIDIIKKLRHPNVLLFMGAVAS 446 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~-----~~~~~~~E~~il~~l~h~niv~~~~~~~~ 446 (605)
.+..++|++.+.||+|+||+||+|.+ .++.||+|++........ ..+.+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 35568999999999999999999998 477799999865443221 12678899999999999999999999876
Q ss_pred CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc-----EEEEe
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT-----VKVGD 521 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~-----vkl~D 521 (605)
.. ++||||+++++|.+++......+++..++.++.||+.||+|||++|.+|+||||||+|||++.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 54 799999999999999987777899999999999999999999999877999999999999988776 99999
Q ss_pred ecCCcccCcccccccCCCCCCccccccccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHhccCCCcc
Q 038211 522 FGLSSLKNATYLTAKSGRGTPQWMAPEVLR--SEPSNEKSDVFSFGVILWELVTASIPWNNLNL--MQVVGVVGFMDRRL 597 (605)
Q Consensus 522 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~--~~~~~~I~~~~~~~ 597 (605)
||+++.... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...+. ......+.....++
T Consensus 173 fg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 4f0f_A 173 FGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249 (287)
T ss_dssp CTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred CCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence 999975433 233457899999999984 44568899999999999999999999987553 44466665567777
Q ss_pred CCCCCCCC
Q 038211 598 ELPEGLDP 605 (605)
Q Consensus 598 ~~P~~~~~ 605 (605)
.+|+.+++
T Consensus 250 ~~~~~~~~ 257 (287)
T 4f0f_A 250 TIPEDCPP 257 (287)
T ss_dssp CCCTTSCH
T ss_pred CCCcccCH
Confidence 88887753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=308.91 Aligned_cols=225 Identities=32% Similarity=0.531 Sum_probs=195.8
Q ss_pred CccccCceEeeeecccCcEEEEEEEE-CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
.+..++|++.+.||+|+||.||++.+ .+..||+|++...... .+.+.+|+.+++.++||||+++++++...+..++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 80 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence 45668999999999999999999998 4667999998765432 3568899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEccccccccccccc
Confidence 99999999999999887678999999999999999999999999 9999999999999999999999999997654322
Q ss_pred -ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 533 -LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 533 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..++...+. .+.++..|..++
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~ 231 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLAS 231 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSC
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh-cCCcCCCCccCc
Confidence 22234457889999999998889999999999999999999 999999999999988885 344555666554
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=318.66 Aligned_cols=228 Identities=30% Similarity=0.483 Sum_probs=190.5
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECCc------ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNGS------DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS 446 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~------~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 446 (605)
.++...+|.+.+.||+|+||+||+|.+... .||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 456778999999999999999999987432 39999986543 33445678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCc
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~ 526 (605)
.+.+++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcch
Confidence 99999999999999999999877678999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCcccc---cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCC
Q 038211 527 LKNATYL---TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 527 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..++...+. .+.+++.|..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~ 274 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMD 274 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-CCCcCCCccc
Confidence 6543221 2223346889999999999999999999999999999998 999999999999888885 4445666665
Q ss_pred CC
Q 038211 603 LD 604 (605)
Q Consensus 603 ~~ 604 (605)
++
T Consensus 275 ~~ 276 (333)
T 1mqb_A 275 CP 276 (333)
T ss_dssp CB
T ss_pred CC
Confidence 54
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=321.95 Aligned_cols=210 Identities=24% Similarity=0.395 Sum_probs=176.0
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
++|+++++||+|+||+||+|.+. ++.||+|++..... ......+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 68999999999999999999984 67799999865432 2223345679999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
|++ ++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 996 5999999887678999999999999999999999999 9999999999999999999999999998665544445
Q ss_pred cCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 536 KSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..|.
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 214 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIF 214 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 55678999999999987 567999999999999999999999999998887777664
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=318.44 Aligned_cols=206 Identities=26% Similarity=0.441 Sum_probs=161.4
Q ss_pred cCceEe---eeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCeeE
Q 038211 378 EDLQLG---EEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERLG 451 (605)
Q Consensus 378 ~~~~~~---~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~ 451 (605)
++|.+. ++||+|+||+||+|.+. ++.||||++.+. ....+.+|+.+++.+. ||||+++++++.+....+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 556665 78999999999999984 677999998653 3456778999999996 999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC---cEEEEeecCCccc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW---TVKVGDFGLSSLK 528 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~---~vkl~Dfg~a~~~ 528 (605)
+||||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 999999999999999875 67999999999999999999999999 99999999999998765 8999999999876
Q ss_pred CcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-------CHHHHHHHhc
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL-------NLMQVVGVVG 591 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~-------~~~~~~~~I~ 591 (605)
..........+||+.|+|||++.+..++.++|||||||++|+|++|+.||... ...+++..|.
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~ 229 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK 229 (325)
T ss_dssp CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT
T ss_pred CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH
Confidence 55544555667899999999999999999999999999999999999999864 3467777774
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=316.16 Aligned_cols=227 Identities=31% Similarity=0.520 Sum_probs=185.6
Q ss_pred CCccccCceEeeeecccCcEEEEEEEE------CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIW------NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS 446 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~------~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 446 (605)
..+..++|+++++||+|+||+||+|.+ .++.||||++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 456678999999999999999999984 4677999998654 23455778999999999999999999999865
Q ss_pred --CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecC
Q 038211 447 --QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524 (605)
Q Consensus 447 --~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~ 524 (605)
...+++||||+++++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCcc
Confidence 35689999999999999999887677999999999999999999999999 99999999999999999999999999
Q ss_pred CcccCccc---ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHH----------------H
Q 038211 525 SSLKNATY---LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLM----------------Q 585 (605)
Q Consensus 525 a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~----------------~ 585 (605)
+....... .......+++.|+|||.+.+..++.++|||||||++|+|++|..||...... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 97654322 2223345788899999999999999999999999999999999998753221 2
Q ss_pred HHHHhccCCCccCCCCCCC
Q 038211 586 VVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 586 ~~~~I~~~~~~~~~P~~~~ 604 (605)
+...+ ..+.+++.|+.++
T Consensus 241 ~~~~~-~~~~~~~~~~~~~ 258 (295)
T 3ugc_A 241 LIELL-KNNGRLPRPDGCP 258 (295)
T ss_dssp HHHHH-HTTCCCCCCTTCC
T ss_pred HHHHH-hccCcCCCCcCcC
Confidence 33333 2455667777665
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=337.07 Aligned_cols=221 Identities=31% Similarity=0.475 Sum_probs=192.2
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
...++|+++++||+|+||+||+|.+. ++.||||++.+..........+.+|+.+++.++||||+++++++.+...+++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 34578999999999999999999984 7789999987655444456778999999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc---CCCcEEEEeecCCcccC
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD---KNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~---~~~~vkl~Dfg~a~~~~ 529 (605)
|||||.+++|.+.+... ..+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++...
T Consensus 99 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 99999999999998776 67999999999999999999999999 99999999999995 45689999999997654
Q ss_pred cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELP 600 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P 600 (605)
... .....+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.+..+++..|......++.|
T Consensus 176 ~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (486)
T 3mwu_A 176 QNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244 (486)
T ss_dssp CC-----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG
T ss_pred CCC-ccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 332 23455799999999999874 8999999999999999999999999999999999986555444444
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=321.48 Aligned_cols=225 Identities=28% Similarity=0.534 Sum_probs=184.7
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--Ccce----EEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDV----AVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~----avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
+..++|++.++||+|+||+||+|.+. ++.+ |+|.+.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence 45678999999999999999999873 4444 666554322 234457789999999999999999999999875
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
..++|+||+.+|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 478999999999999999887788999999999999999999999999 999999999999999999999999999765
Q ss_pred Cccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 529 NATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 529 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.... .......+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||.+.+..++...+. .+.+++.|+.++
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 245 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICT 245 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBC
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-cCCCCCCCccCC
Confidence 3322 22233456889999999999999999999999999999999 999999988888877775 445566666554
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=322.22 Aligned_cols=211 Identities=24% Similarity=0.357 Sum_probs=180.2
Q ss_pred cCceE--eeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 378 EDLQL--GEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 378 ~~~~~--~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..|.+ .+.||+|+||.||+|.+ .+..||+|++..... ...+.+.+|+.+++.++||||+++++++...+.+++|
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 34444 67899999999999987 477899999876532 3456788999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE--cCCCcEEEEeecCCcccCcc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV--DKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill--~~~~~vkl~Dfg~a~~~~~~ 531 (605)
|||+++++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 9999999999999876678999999999999999999999999 9999999999999 56789999999999865433
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFM 593 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~ 593 (605)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..|...
T Consensus 243 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 303 (373)
T 2x4f_A 243 E-KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC 303 (373)
T ss_dssp C-BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred c-ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 2 233457999999999999988999999999999999999999999999988888887433
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=322.06 Aligned_cols=213 Identities=23% Similarity=0.334 Sum_probs=174.6
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
...++|+++++||+|+||+||+|.+ .++.||||++..........+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999987 47779999987665555556677899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc-----CCCcEEEEeecCCcc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD-----KNWTVKVGDFGLSSL 527 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~-----~~~~vkl~Dfg~a~~ 527 (605)
||||++ ++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++ ..+.+||+|||+++.
T Consensus 111 v~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 999996 5999998765 57999999999999999999999999 99999999999994 455699999999976
Q ss_pred cCcccccccCCCCCCcccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 251 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF 251 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHH
Confidence 654444445567899999999998754 7999999999999999999999999988877776653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=325.13 Aligned_cols=213 Identities=22% Similarity=0.322 Sum_probs=187.1
Q ss_pred cccCceEeeeeccc--CcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 376 RWEDLQLGEEIGLG--SYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 376 ~~~~~~~~~~LG~G--~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
..++|+++++||+| +||+||+|.+. ++.||||++..........+.+.+|+.+++.++||||++++++|.+++.++
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45789999999999 99999999985 778999999877666666788899999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 452 IVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
+|||||++++|.+++... ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||.+.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999999999765 366999999999999999999999999 99999999999999999999999998754321
Q ss_pred c-------cccccCCCCCCcccccccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 531 T-------YLTAKSGRGTPQWMAPEVLRS--EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 531 ~-------~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 249 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 1 112233478999999999988 57899999999999999999999999987766666554
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=320.66 Aligned_cols=209 Identities=27% Similarity=0.416 Sum_probs=167.7
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
...++|++.+.||+|+||+||+|.+. ++.||||++.... ..+.+.+|+.+++.++||||++++++|...+.+++
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 44578999999999999999999985 5679999987543 23567889999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC---CCcEEEEeecCCcccC
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK---NWTVKVGDFGLSSLKN 529 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~---~~~vkl~Dfg~a~~~~ 529 (605)
||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+++...
T Consensus 126 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999999998765 67899999999999999999999999 999999999999975 8899999999997654
Q ss_pred cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHhc
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQ-VVGVVG 591 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~-~~~~I~ 591 (605)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+ +...|.
T Consensus 203 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~ 264 (349)
T 2w4o_A 203 HQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL 264 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHH
T ss_pred ccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHH
Confidence 322 2334578999999999999999999999999999999999999998765444 666663
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.70 Aligned_cols=229 Identities=30% Similarity=0.500 Sum_probs=196.4
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEE
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAV 444 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 444 (605)
...+..++|.+.+.||+|+||.||+|.+. +..||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 34566789999999999999999999862 3569999986543 344567789999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCchHHHHHhhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCcee
Q 038211 445 ASQERLGIVTEFLPRGSLFKTLHKNY-----------------------QALDIKRRLRMALDVARGMNYLHHRNPPIVH 501 (605)
Q Consensus 445 ~~~~~~~lv~e~~~ggsL~~~l~~~~-----------------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH 501 (605)
...+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH 173 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVH 173 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 99999999999999999999998642 23889999999999999999999999 999
Q ss_pred ccCCCCCEEEcCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCC
Q 038211 502 RDLKSSNLLVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPW 578 (605)
Q Consensus 502 ~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf 578 (605)
|||||+|||++.++.+||+|||++....... .......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999997653322 22334567889999999999889999999999999999999 99999
Q ss_pred CCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 579 NNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 579 ~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.+.+..++...+. .+..+.+|..++
T Consensus 254 ~~~~~~~~~~~~~-~~~~~~~~~~~~ 278 (314)
T 2ivs_A 254 PGIPPERLFNLLK-TGHRMERPDNCS 278 (314)
T ss_dssp TTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred CCCCHHHHHHHhh-cCCcCCCCccCC
Confidence 9998888888774 445667777665
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.86 Aligned_cols=199 Identities=17% Similarity=0.218 Sum_probs=174.1
Q ss_pred ccccCceEeeeecccCcEEEEEEE-------ECCcceEEEEeeccccchhhhhhHHHHHHHHHhCC---CCCeeeEEEEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGI-------WNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR---HPNVLLFMGAV 444 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~-------~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~---h~niv~~~~~~ 444 (605)
+..++|.+.++||+|+||+||+|. ..++.||||++... ....+.+|+.+++.++ |+||+.+++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 455789999999999999999993 25778999998654 2345778888888886 99999999999
Q ss_pred eeCCeeEEEEEecCCCchHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC-------
Q 038211 445 ASQERLGIVTEFLPRGSLFKTLHK----NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK------- 513 (605)
Q Consensus 445 ~~~~~~~lv~e~~~ggsL~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~------- 513 (605)
...+..++|||||++|+|.+++.. ....+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC--
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCccc
Confidence 999999999999999999999975 2467999999999999999999999999 999999999999988
Q ss_pred ----CCcEEEEeecCCcccC--cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 514 ----NWTVKVGDFGLSSLKN--ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 514 ----~~~vkl~Dfg~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
++.+||+|||+|+... .........+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 8999999999996532 222334556799999999999999999999999999999999999999853
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=321.80 Aligned_cols=217 Identities=27% Similarity=0.410 Sum_probs=174.4
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..++|+++++||+|+||+||++++ .++.||||++..... ..+.+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 457899999999999999999998 467799999876432 235578999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc--EEEEeecCCcccCcc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT--VKVGDFGLSSLKNAT 531 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~--vkl~Dfg~a~~~~~~ 531 (605)
|||+++++|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|||+++.....
T Consensus 95 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 95 MEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999999998765 67999999999999999999999999 999999999999987665 999999998743322
Q ss_pred cccccCCCCCCcccccccccCCCCCch-hHHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHhccCCCccCCCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEK-SDVFSFGVILWELVTASIPWNNLN----LMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~Pf~~~~----~~~~~~~I~~~~~~~~~P~ 601 (605)
.......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+ ...++..+. ...+.+|.
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~ 243 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL--SVKYSIPD 243 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHH--TTCCCCCT
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh--cCCCCCCC
Confidence 22344579999999999988888665 899999999999999999998743 355556653 33344444
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.69 Aligned_cols=207 Identities=25% Similarity=0.346 Sum_probs=176.1
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC------C
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ------E 448 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------~ 448 (605)
.++|+++++||+|+||+||+|.+ .++.||||++.+........+.+.+|+.+|+.++||||++++++|... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999987 467799999987655556677889999999999999999999999654 3
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
.+++||||+++ +|...+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 57999999965 5666664 34899999999999999999999999 999999999999999999999999999865
Q ss_pred CcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..|
T Consensus 215 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i 275 (464)
T 3ttj_A 215 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 275 (464)
T ss_dssp --C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 432 2334568999999999999999999999999999999999999999998877766665
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.17 Aligned_cols=226 Identities=23% Similarity=0.379 Sum_probs=188.4
Q ss_pred CccccCceEeeeecccCcEEEEEEEE-----CCcceEEEEeeccccc--hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEe
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW-----NGSDVAVKVYFGSEYI--EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVA 445 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~-----~~~~~avKv~~~~~~~--~~~~~~~~~E~~il~~l-~h~niv~~~~~~~ 445 (605)
.+..++|+++++||+|+||+||++++ .++.||||++.+.... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 45668999999999999999999987 5778999998765422 23445677899999999 6999999999999
Q ss_pred eCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCC
Q 038211 446 SQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525 (605)
Q Consensus 446 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a 525 (605)
..+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999999999775 67999999999999999999999999 999999999999999999999999999
Q ss_pred cccCcc-cccccCCCCCCcccccccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHhccCCCccC
Q 038211 526 SLKNAT-YLTAKSGRGTPQWMAPEVLRSE--PSNEKSDVFSFGVILWELVTASIPWNNL----NLMQVVGVVGFMDRRLE 598 (605)
Q Consensus 526 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~Pf~~~----~~~~~~~~I~~~~~~~~ 598 (605)
+..... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||... ...++...+ ....++
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~ 284 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPP 284 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCCCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH--hccCCC
Confidence 754322 2223345799999999999863 4688999999999999999999999743 345555555 334566
Q ss_pred CCCCCC
Q 038211 599 LPEGLD 604 (605)
Q Consensus 599 ~P~~~~ 604 (605)
+|+.++
T Consensus 285 ~~~~~~ 290 (355)
T 1vzo_A 285 YPQEMS 290 (355)
T ss_dssp CCTTSC
T ss_pred CCcccC
Confidence 777665
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=319.84 Aligned_cols=225 Identities=23% Similarity=0.340 Sum_probs=184.9
Q ss_pred ccccCceEeeeecccCcEEEEEEEE-CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCC--CCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH--PNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h--~niv~~~~~~~~~~~~~ 451 (605)
+...+|++++.||+|+||.||++.+ .++.||||++..........+.+.+|+.+|+.++| |||+++++++..+..++
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 3457899999999999999999987 45669999998766566667889999999999976 99999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+|||+ .+++|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++ ++.+||+|||+++.....
T Consensus 86 lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99995 588999999875 67899999999999999999999999 99999999999997 678999999999865433
Q ss_pred cc--cccCCCCCCcccccccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHhccCCCcc
Q 038211 532 YL--TAKSGRGTPQWMAPEVLRS-----------EPSNEKSDVFSFGVILWELVTASIPWNNL-NLMQVVGVVGFMDRRL 597 (605)
Q Consensus 532 ~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~el~~g~~Pf~~~-~~~~~~~~I~~~~~~~ 597 (605)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... +....+..+......+
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence 22 2335579999999999865 66888999999999999999999999874 4445555554455666
Q ss_pred CCCCCCC
Q 038211 598 ELPEGLD 604 (605)
Q Consensus 598 ~~P~~~~ 604 (605)
.+|...+
T Consensus 241 ~~~~~~~ 247 (343)
T 3dbq_A 241 EFPDIPE 247 (343)
T ss_dssp CCCCCSC
T ss_pred CCcccCC
Confidence 7776554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=324.13 Aligned_cols=225 Identities=23% Similarity=0.339 Sum_probs=186.6
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhhHHHHHHHHHhCC--CCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR--HPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~--h~niv~~~~~~~~~~~~~ 451 (605)
+...+|+++++||+|+||+||++.+. ++.||||++..........+.+.+|+.+|+.+. ||||+++++++..++.++
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 34467999999999999999999874 667999999876655666788999999999996 599999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||| +.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ ++.+||+|||+++.....
T Consensus 133 lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9999 5588999999875 57889999999999999999999999 99999999999995 589999999999865432
Q ss_pred c--ccccCCCCCCcccccccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHhccCCCcc
Q 038211 532 Y--LTAKSGRGTPQWMAPEVLRS-----------EPSNEKSDVFSFGVILWELVTASIPWNNL-NLMQVVGVVGFMDRRL 597 (605)
Q Consensus 532 ~--~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~el~~g~~Pf~~~-~~~~~~~~I~~~~~~~ 597 (605)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... +....+..+......+
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence 2 12345679999999999876 36888999999999999999999999875 4455666665455666
Q ss_pred CCCCCCC
Q 038211 598 ELPEGLD 604 (605)
Q Consensus 598 ~~P~~~~ 604 (605)
++|...+
T Consensus 288 ~~~~~~~ 294 (390)
T 2zmd_A 288 EFPDIPE 294 (390)
T ss_dssp CCCCCSC
T ss_pred CCCccch
Confidence 7776654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=310.45 Aligned_cols=225 Identities=28% Similarity=0.521 Sum_probs=193.5
Q ss_pred ccccCceEee-eecccCcEEEEEEEE----CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 375 IRWEDLQLGE-EIGLGSYAVVYRGIW----NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 375 ~~~~~~~~~~-~LG~G~fg~V~~~~~----~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
+..++|.+.+ .||+|+||.||+|.+ .+..||+|++.... .....+.+.+|+.+++.++||||+++++++ ..+.
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence 4457788887 999999999999975 45669999987643 344567789999999999999999999999 4567
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 99999999999999999876678999999999999999999999999 9999999999999999999999999997653
Q ss_pred ccc---ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 530 ATY---LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 530 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
... .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..++...+. .+.++.+|+.++
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~ 239 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECP 239 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTCC
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-cCCcCCCCCCcC
Confidence 322 12233457899999999998889999999999999999998 999999998888888885 455677887765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=319.36 Aligned_cols=225 Identities=28% Similarity=0.537 Sum_probs=184.5
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcce----EEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDV----AVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~----avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
+...+|+++++||+|+||+||+|.+ .++.+ ++|.+... ......+.+.+|+.+++.++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 4568899999999999999999987 45555 44444322 12345677889999999999999999999998754
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
.++|++|+.+++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 78999999999999999887788999999999999999999999999 999999999999999999999999999765
Q ss_pred Cccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 529 NATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 529 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.... .......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..++...+. .+.+++.|+.++
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 245 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICT 245 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBC
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCC
Confidence 3322 22233457889999999999999999999999999999999 999999998888888775 455667776654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=315.54 Aligned_cols=229 Identities=30% Similarity=0.502 Sum_probs=195.1
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEE
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAV 444 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 444 (605)
...+..++|++.+.||+|+||.||+|.+. ++.||+|++.... .......+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 45566789999999999999999999764 4669999986543 233456688999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCchHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC
Q 038211 445 ASQERLGIVTEFLPRGSLFKTLHKNY---------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW 515 (605)
Q Consensus 445 ~~~~~~~lv~e~~~ggsL~~~l~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~ 515 (605)
.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTC
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCCC
Confidence 99999999999999999999987532 45789999999999999999999999 99999999999999999
Q ss_pred cEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhcc
Q 038211 516 TVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGF 592 (605)
Q Consensus 516 ~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~ 592 (605)
.+||+|||++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...+.
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~- 254 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM- 254 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH-
Confidence 99999999997553322 22234457899999999999999999999999999999999 999999999998888884
Q ss_pred CCCccCCCCCCC
Q 038211 593 MDRRLELPEGLD 604 (605)
Q Consensus 593 ~~~~~~~P~~~~ 604 (605)
.+..+..|..++
T Consensus 255 ~~~~~~~~~~~~ 266 (322)
T 1p4o_A 255 EGGLLDKPDNCP 266 (322)
T ss_dssp TTCCCCCCTTCC
T ss_pred cCCcCCCCCCCC
Confidence 344456666554
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=319.21 Aligned_cols=211 Identities=26% Similarity=0.384 Sum_probs=186.0
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-----CCCeeeEEEEE
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-----HPNVLLFMGAV 444 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-----h~niv~~~~~~ 444 (605)
.+.+..++|+++++||+|+||+||+|.+ .++.||||++... ......+..|+.+++.+. ||||+++++++
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 4556678999999999999999999998 5777999998643 234456778999999996 99999999999
Q ss_pred eeCCeeEEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC----------
Q 038211 445 ASQERLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK---------- 513 (605)
Q Consensus 445 ~~~~~~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~---------- 513 (605)
...+.+++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEE
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccch
Confidence 9999999999999 899999998753 46999999999999999999999999 999999999999975
Q ss_pred ---------------CCcEEEEeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 038211 514 ---------------NWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578 (605)
Q Consensus 514 ---------------~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf 578 (605)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred hcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 789999999999764332 23557899999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhc
Q 038211 579 NNLNLMQVVGVVG 591 (605)
Q Consensus 579 ~~~~~~~~~~~I~ 591 (605)
...+..+.+..+.
T Consensus 260 ~~~~~~~~~~~~~ 272 (360)
T 3llt_A 260 RTHEHMEHLAMME 272 (360)
T ss_dssp CCSSHHHHHHHHH
T ss_pred CCCcHHHHHHHHH
Confidence 9988887777763
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=335.07 Aligned_cols=218 Identities=28% Similarity=0.408 Sum_probs=185.3
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..++|+++++||+|+||+||+|.+. +..+|+|++.+..........+.+|+.+++.++||||++++++|.+...+++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3468999999999999999999984 66799999987655555567789999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC---CcEEEEeecCCcccCc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN---WTVKVGDFGLSSLKNA 530 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~---~~vkl~Dfg~a~~~~~ 530 (605)
||||++|+|.+.+... ..+++..+..++.||+.||.|||++| |+||||||+|||++.. +.+||+|||++.....
T Consensus 115 ~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999999988765 67999999999999999999999999 9999999999999764 4599999999976543
Q ss_pred ccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccC
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLE 598 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~ 598 (605)
.. .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+++..|......++
T Consensus 192 ~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 257 (494)
T 3lij_A 192 QK-KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD 257 (494)
T ss_dssp TB-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred Cc-cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 32 3345679999999999874 589999999999999999999999999999999999865544443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=317.20 Aligned_cols=228 Identities=29% Similarity=0.512 Sum_probs=195.1
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC---------CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN---------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMG 442 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~---------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~ 442 (605)
..+..++|++.+.||+|+||.||+|.+. +..||+|++.... .......+.+|+.+++.+ +||||+++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 4566789999999999999999999863 4569999986543 344567788999999999 8999999999
Q ss_pred EEeeCCeeEEEEEecCCCchHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCC
Q 038211 443 AVASQERLGIVTEFLPRGSLFKTLHKNY---------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSS 507 (605)
Q Consensus 443 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~ 507 (605)
++...+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~ 186 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAAR 186 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccc
Confidence 9999999999999999999999998653 24889999999999999999999999 999999999
Q ss_pred CEEEcCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 038211 508 NLLVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLM 584 (605)
Q Consensus 508 Nill~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~ 584 (605)
|||++.++.+||+|||++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 9999999999999999997654322 22334457889999999998889999999999999999999 99999999988
Q ss_pred HHHHHhccCCCccCCCCCCC
Q 038211 585 QVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 585 ~~~~~I~~~~~~~~~P~~~~ 604 (605)
++...+. .+.++.+|..++
T Consensus 267 ~~~~~~~-~~~~~~~~~~~~ 285 (334)
T 2pvf_A 267 ELFKLLK-EGHRMDKPANCT 285 (334)
T ss_dssp HHHHHHH-HTCCCCCCTTCC
T ss_pred HHHHHHh-cCCCCCCCccCC
Confidence 8888875 344566776654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=315.21 Aligned_cols=229 Identities=27% Similarity=0.406 Sum_probs=191.7
Q ss_pred CCccccCceEeeeecccCcEEEEEEEE-------CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIW-------NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAV 444 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~-------~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~ 444 (605)
..+..++|++.+.||+|+||.||+|.+ .+..||+|++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 456678999999999999999999985 24569999987543 233457789999999999 999999999999
Q ss_pred eeCCeeEEEEEecCCCchHHHHHhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCC
Q 038211 445 ASQERLGIVTEFLPRGSLFKTLHKNYQ-----------------ALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSS 507 (605)
Q Consensus 445 ~~~~~~~lv~e~~~ggsL~~~l~~~~~-----------------~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~ 507 (605)
..++..++||||+++++|.+++..... .+++..++.++.||+.||.|||++| |+||||||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~ 174 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAAR 174 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccc
Confidence 999999999999999999999986532 4899999999999999999999999 999999999
Q ss_pred CEEEcCCCcEEEEeecCCcccCcccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 038211 508 NLLVDKNWTVKVGDFGLSSLKNATYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLM 584 (605)
Q Consensus 508 Nill~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~ 584 (605)
|||++.++.+||+|||++........ ......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999999976543322 2234457889999999999999999999999999999998 99999987755
Q ss_pred HHHHHhccCCCccCCCCCCC
Q 038211 585 QVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 585 ~~~~~I~~~~~~~~~P~~~~ 604 (605)
.....+.....+...|..++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~ 274 (313)
T 1t46_A 255 SKFYKMIKEGFRMLSPEHAP 274 (313)
T ss_dssp HHHHHHHHHTCCCCCCTTSC
T ss_pred hHHHHHhccCCCCCCcccCC
Confidence 44444433444555555544
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.33 Aligned_cols=227 Identities=33% Similarity=0.587 Sum_probs=198.5
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
.+.+...+|++.++||+|+||.||+|.+. +..||||++.... ...+.+.+|+.+|+.++||||+++++++...+.
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 35667789999999999999999999986 6779999986543 235678999999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 450 LGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
+++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeecccceec
Confidence 99999999999999999864 356899999999999999999999999 999999999999999999999999999865
Q ss_pred Cccc-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 529 NATY-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 529 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.... .......+++.|+|||++.+..++.++|||||||+||||++ |..||.+.+..++...+. .+.+++.|..++
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 445 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 445 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 4322 22334456789999999998889999999999999999999 999999999888888875 556778887765
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=310.34 Aligned_cols=222 Identities=29% Similarity=0.482 Sum_probs=194.6
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.+.|++++.||+|+||.||+|.+ .++.||||++..... ....+.+.+|+.+++.++||||+++++++.....+++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 36799999999999999999987 467799999876542 334677899999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+++++|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.........
T Consensus 100 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 100 EYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp ECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 99999999999865 57899999999999999999999999 999999999999999999999999999766544444
Q ss_pred ccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+.. ...+.+|..++
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 244 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-NNPPTLEGNYS 244 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCCCCCCSSCC
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-CCCCCCccccC
Confidence 4566799999999999999999999999999999999999999999998888887742 33445555554
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=316.78 Aligned_cols=212 Identities=25% Similarity=0.332 Sum_probs=181.1
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..++|++++.||+|+||.||+|.+. ++.||||++..........+.+.+|+.+++.++||||+++++++...+.+++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 4589999999999999999999985 77899999877655555567788999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
|||+++++|..++... ..+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||++........
T Consensus 103 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 9999988887766543 67999999999999999999999999 99999999999999999999999999976655444
Q ss_pred cccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 534 TAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 237 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHI 237 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 44566789999999999875 6899999999999999999999999998876666554
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=314.13 Aligned_cols=213 Identities=25% Similarity=0.414 Sum_probs=188.4
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccch----hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE----GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~----~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
..++|++.+.||+|+||.||+|.+. ++.||+|++....... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3468999999999999999999984 7789999987654322 135678899999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC----cEEEEeecCC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW----TVKVGDFGLS 525 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~----~vkl~Dfg~a 525 (605)
+++||||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 99999999999999999764 67899999999999999999999999 99999999999999887 8999999999
Q ss_pred cccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhcc
Q 038211 526 SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGF 592 (605)
Q Consensus 526 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~ 592 (605)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 167 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 232 (321)
T 2a2a_A 167 HEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS 232 (321)
T ss_dssp EECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred eecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 7654332 23445789999999999999999999999999999999999999999998888888743
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=307.60 Aligned_cols=227 Identities=26% Similarity=0.511 Sum_probs=188.1
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
.+.+..++|++.+.||+|+||.||+|.+. ++.||||++...... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 45677889999999999999999999884 778999998764322 234567889999999999999999999999999
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+|+||||+|||++.++.++|+|||++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred eEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeeccccccc
Confidence 999999999999999999775 67899999999999999999999999 999999999999999999999999999765
Q ss_pred CcccccccCCCCCCcccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.... ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||...+..++...+. ...+.+|+.++
T Consensus 162 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (276)
T 2h6d_A 162 SDGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR--GGVFYIPEYLN 235 (276)
T ss_dssp CC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSC
T ss_pred CCCc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh--cCcccCchhcC
Confidence 4332 2234568999999999988776 589999999999999999999999999888888884 34466776654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=312.79 Aligned_cols=228 Identities=29% Similarity=0.446 Sum_probs=192.1
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee--CCeeE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS--QERLG 451 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~ 451 (605)
..++|++++.||+|+||.||++.+ .++.||+|++..........+.+.+|+.+++.++||||+++++++.. ...++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 357899999999999999999988 46779999998766556667789999999999999999999998854 57899
Q ss_pred EEEEecCCCchHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---CCceeccCCCCCEEEcCCCcEEEEeecCC
Q 038211 452 IVTEFLPRGSLFKTLHKNY---QALDIKRRLRMALDVARGMNYLHHRN---PPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---~~iiH~Dik~~Nill~~~~~vkl~Dfg~a 525 (605)
+||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 9999999999999997642 45999999999999999999999876 23999999999999999999999999998
Q ss_pred cccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 526 SLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 526 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
..............||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..++...|. .+....+|..++
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~ 241 (279)
T 2w5a_A 164 RILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYS 241 (279)
T ss_dssp HHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HTCCCCCCTTSC
T ss_pred eeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh-hcccccCCcccC
Confidence 765433322334468999999999999999999999999999999999999999999888888884 333446776655
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=309.07 Aligned_cols=227 Identities=31% Similarity=0.500 Sum_probs=190.4
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECCc-----ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNGS-----DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~-----~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
.++..++|++.+.||+|+||+||+|.+.+. .||+|++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE- 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence 456678999999999999999999986432 38999887643 33456778999999999999999999999865
Q ss_pred CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
+..++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 4578999999999999999887778999999999999999999999999 99999999999999999999999999976
Q ss_pred cCccc-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 528 KNATY-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 528 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
..... .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+..++...+. .+.+++.|..++
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 240 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCP 240 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCCTTCC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCCCCCC
Confidence 54322 12234457889999999998899999999999999999998 999999888777777774 344566676654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.04 Aligned_cols=202 Identities=27% Similarity=0.324 Sum_probs=161.3
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC-----Ce
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ-----ER 449 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~ 449 (605)
.++|+++++||+|+||+||+|.+ .++.||||++..........+.+.+|+.+|+.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 37899999999999999999987 467899999876544455667889999999999999999999999543 56
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 99999998 67998888764 67999999999999999999999999 9999999999999999999999999998654
Q ss_pred ccc---------------------------ccccCCCCCCcccccccc-cCCCCCchhHHHHHHHHHHHHHc--------
Q 038211 530 ATY---------------------------LTAKSGRGTPQWMAPEVL-RSEPSNEKSDVFSFGVILWELVT-------- 573 (605)
Q Consensus 530 ~~~---------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~~-------- 573 (605)
... ......+||+.|+|||++ .+..++.++|||||||+||||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 221 123345789999999986 45678999999999999999999
Q ss_pred ---CCCCCCCCC
Q 038211 574 ---ASIPWNNLN 582 (605)
Q Consensus 574 ---g~~Pf~~~~ 582 (605)
|++||.+.+
T Consensus 288 ~~~~~p~f~g~~ 299 (458)
T 3rp9_A 288 HADRGPLFPGSS 299 (458)
T ss_dssp GGGCCCSCC---
T ss_pred cccccccCCCCc
Confidence 778887654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=332.32 Aligned_cols=216 Identities=31% Similarity=0.476 Sum_probs=185.8
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccch-----------hhhhhHHHHHHHHHhCCCCCeeeE
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE-----------GTLKNYQKEIDIIKKLRHPNVLLF 440 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~-----------~~~~~~~~E~~il~~l~h~niv~~ 440 (605)
+...++|.++++||+|+||+||+|.+. +..||+|++.+..... ...+.+.+|+.+|+.++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 345688999999999999999999984 5679999987654321 335678899999999999999999
Q ss_pred EEEEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC---cE
Q 038211 441 MGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW---TV 517 (605)
Q Consensus 441 ~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~---~v 517 (605)
++++.+...+++|||||+||+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSE
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccE
Confidence 99999999999999999999999998775 67999999999999999999999999 99999999999998776 69
Q ss_pred EEEeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCC
Q 038211 518 KVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMD 594 (605)
Q Consensus 518 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~ 594 (605)
||+|||++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..|....
T Consensus 189 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 263 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263 (504)
T ss_dssp EECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred EEEECCCCEEcCCCC-ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 999999997654332 3345579999999999875 58999999999999999999999999999999999985444
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=311.32 Aligned_cols=205 Identities=23% Similarity=0.252 Sum_probs=172.9
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCC
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQE 448 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~ 448 (605)
.+.+..++|++.++||+|+||+||+|.+. ++.||||++...............|+..+..+ +||||++++++|...+
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 34555678999999999999999999984 77899999866544444444555666665555 9999999999999999
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
.+++||||+ +++|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 999999999 77999999887778999999999999999999999999 999999999999999999999999998765
Q ss_pred CcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|..||...
T Consensus 208 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~ 258 (311)
T 3p1a_A 208 GTAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG 258 (311)
T ss_dssp C-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred ccCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 4332 2344568999999999887 6899999999999999999997776553
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=311.03 Aligned_cols=227 Identities=34% Similarity=0.590 Sum_probs=197.4
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
.+.+...+|++.+.||+|+||.||+|.+. +..||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45677889999999999999999999985 6679999986543 345678899999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 450 LGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
+++||||+++++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||+++.++.++|+|||++...
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999999764 356899999999999999999999999 999999999999999999999999999765
Q ss_pred Cccc-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 529 NATY-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 529 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+..++...+. ...++..|..++
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 238 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCCCCCCCCCC
Confidence 4332 22333456889999999999999999999999999999999 999999998888888775 445667776665
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=312.39 Aligned_cols=215 Identities=28% Similarity=0.371 Sum_probs=178.5
Q ss_pred CCccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc---hhhhhhHHHHHHHHHhCC---CCCeeeEEEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI---EGTLKNYQKEIDIIKKLR---HPNVLLFMGAV 444 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~---~~~~~~~~~E~~il~~l~---h~niv~~~~~~ 444 (605)
+.+..++|++.++||+|+||+||+|.+ .++.||||++...... ......+.+|+.+++.++ ||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 345568999999999999999999996 5778999998754321 122345667888777774 99999999999
Q ss_pred eeCC-----eeEEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEE
Q 038211 445 ASQE-----RLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVK 518 (605)
Q Consensus 445 ~~~~-----~~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vk 518 (605)
.... .+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEE
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEE
Confidence 8754 5899999996 59999988753 34999999999999999999999999 99999999999999999999
Q ss_pred EEeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 519 VGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 519 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..|.
T Consensus 161 l~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 232 (308)
T 3g33_A 161 LADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232 (308)
T ss_dssp ECSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH
T ss_pred EeeCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999997654332 2344578999999999999999999999999999999999999999988877777663
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=310.51 Aligned_cols=226 Identities=28% Similarity=0.474 Sum_probs=190.3
Q ss_pred CccccCceEee-eecccCcEEEEEEEEC----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 374 GIRWEDLQLGE-EIGLGSYAVVYRGIWN----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 374 ~~~~~~~~~~~-~LG~G~fg~V~~~~~~----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
.+...+|.+.+ .||+|+||+||+|.+. ++.||||++..........+.+.+|+.+++.++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 34557899998 9999999999999652 46699999877654455567899999999999999999999998 567
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
.+++||||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 789999999999999999775 67999999999999999999999999 999999999999999999999999999765
Q ss_pred Ccccc---cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 529 NATYL---TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 529 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
..... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..++...+. .+.++.+|..++
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 246 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCP 246 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 43221 1223456789999999998888999999999999999999 999999999999888885 455677777765
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=329.49 Aligned_cols=226 Identities=33% Similarity=0.532 Sum_probs=191.2
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEECC-cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNG-SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~-~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
.+.+..++|++.++||+|+||.||+|.+.+ ..||||++..... ..+.+.+|+.+|+.++||||+++++++.. +.+
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 355677899999999999999999999865 5699999876432 24568999999999999999999999866 678
Q ss_pred EEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 451 GIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
++||||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 9999999999999999754 356899999999999999999999999 9999999999999999999999999998654
Q ss_pred ccc-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 530 ATY-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 530 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.+.+..+++..+. .+.++++|+.++
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~ 407 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 407 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSC
T ss_pred CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 322 22233456889999999998899999999999999999999 999999999999999885 556778887765
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=318.44 Aligned_cols=213 Identities=23% Similarity=0.320 Sum_probs=184.3
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee-------
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS------- 446 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~------- 446 (605)
..++|+++++||+|+||+||+|.+ .++.||||++............+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 357899999999999999999998 47789999987765555555678899999999999999999999976
Q ss_pred -CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCC
Q 038211 447 -QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525 (605)
Q Consensus 447 -~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a 525 (605)
.+.+++||||++ ++|.+.+......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 95 CKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp --CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 346899999996 5888888777678999999999999999999999999 999999999999999999999999999
Q ss_pred cccCc----ccccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 526 SLKNA----TYLTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 526 ~~~~~----~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
+.... .........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+..|.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 242 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 76432 12223445789999999999874 57999999999999999999999999988877777764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=309.87 Aligned_cols=222 Identities=34% Similarity=0.598 Sum_probs=186.6
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC-CeeE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ-ERLG 451 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-~~~~ 451 (605)
..+..++|++.+.||+|+||+||++.++++.||||++.... ..+.+.+|+.+++.++||||+++++++... +.++
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence 45677899999999999999999999999999999986542 456788999999999999999999987554 5799
Q ss_pred EEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 452 IVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
+||||+++++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999999997653 24889999999999999999999999 99999999999999999999999999875443
Q ss_pred ccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.. ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..++...+. .+.++.+|..++
T Consensus 170 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 240 (278)
T 1byg_A 170 TQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCP 240 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCC
T ss_pred cc---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCcccCC
Confidence 22 23457899999999999899999999999999999998 999999998888888885 445667777665
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.67 Aligned_cols=222 Identities=31% Similarity=0.532 Sum_probs=186.7
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee----CCee
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS----QERL 450 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----~~~~ 450 (605)
...|++.++||+|+||.||+|.+. +..||+|++..........+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 356899999999999999999884 5568999988776666677889999999999999999999999875 3568
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc-CCCcEEEEeecCCcccC
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD-KNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~-~~~~vkl~Dfg~a~~~~ 529 (605)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+.+|+||||||+|||++ .++.+||+|||++....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999999999775 678999999999999999999999876799999999999997 78999999999997554
Q ss_pred cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhccCCCccCCCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN-LNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~-~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.. .+..++...+........+|..
T Consensus 184 ~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (290)
T 1t4h_A 184 AS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp TT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred cc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCC
Confidence 33 2234568999999998875 489999999999999999999999987 4456666666433333344433
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=308.59 Aligned_cols=220 Identities=25% Similarity=0.436 Sum_probs=185.3
Q ss_pred CccccCceEeeeecccCcEEEEEEEECC---------cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEE
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWNG---------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAV 444 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~---------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 444 (605)
.+..++|++.+.||+|+||+||+|.+.. ..||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 4567899999999999999999998743 359999886542 34456789999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc--------
Q 038211 445 ASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT-------- 516 (605)
Q Consensus 445 ~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~-------- 516 (605)
..++..++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccce
Confidence 9999999999999999999999887666999999999999999999999999 999999999999988876
Q ss_pred EEEEeecCCcccCcccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCC
Q 038211 517 VKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMD 594 (605)
Q Consensus 517 vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~ 594 (605)
+||+|||++....... ...||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+.......+.
T Consensus 160 ~kl~Dfg~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~--- 232 (289)
T 4fvq_A 160 IKLSDPGISITVLPKD----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE--- 232 (289)
T ss_dssp EEECCCCSCTTTSCHH----HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH---
T ss_pred eeeccCcccccccCcc----ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh---
Confidence 9999999986543322 2346889999999988 678999999999999999999 666777777666555543
Q ss_pred CccCCCCCCC
Q 038211 595 RRLELPEGLD 604 (605)
Q Consensus 595 ~~~~~P~~~~ 604 (605)
....+|..++
T Consensus 233 ~~~~~~~~~~ 242 (289)
T 4fvq_A 233 DRHQLPAPKA 242 (289)
T ss_dssp TTCCCCCCSS
T ss_pred ccCCCCCCCC
Confidence 3445555443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=309.98 Aligned_cols=228 Identities=31% Similarity=0.480 Sum_probs=188.0
Q ss_pred CCccccCceEeeeecccCcEEEEEEEE------CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIW------NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS 446 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~------~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 446 (605)
..+....|+++++||+|+||.||+|.+ .++.||+|++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 345567899999999999999999984 46779999987543 23345778899999999999999999999987
Q ss_pred C--CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecC
Q 038211 447 Q--ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524 (605)
Q Consensus 447 ~--~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~ 524 (605)
. ..+++||||+++++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECcccc
Confidence 6 6789999999999999999877788999999999999999999999999 99999999999999999999999999
Q ss_pred CcccCccc---ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---------------CHHHH
Q 038211 525 SSLKNATY---LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL---------------NLMQV 586 (605)
Q Consensus 525 a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~---------------~~~~~ 586 (605)
+....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||... ....+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 97654332 2234456888999999999988999999999999999999999986432 22334
Q ss_pred HHHhccCCCccCCCCCCC
Q 038211 587 VGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 587 ~~~I~~~~~~~~~P~~~~ 604 (605)
...+ ..+.++++|+.++
T Consensus 253 ~~~~-~~~~~~~~~~~~~ 269 (302)
T 4e5w_A 253 VNTL-KEGKRLPCPPNCP 269 (302)
T ss_dssp HHHH-HTTCCCCCCTTCC
T ss_pred HHHH-hccCCCCCCCCCC
Confidence 4444 3455667777665
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=310.66 Aligned_cols=214 Identities=20% Similarity=0.269 Sum_probs=175.6
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
...++|++.+.||+|+||.||++.+. ++.||+|++...... ....+.+.+|+.+++.++||||+++++++..++.++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 45689999999999999999999874 677999998765432 234577889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 999999999999999875 67999999999999999999999999 999999999999999999999999998765433
Q ss_pred c-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 532 Y-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 532 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+...+...+.
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 248 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN 248 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc
Confidence 2 22234568999999999999999999999999999999999999999887776666654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=335.65 Aligned_cols=222 Identities=31% Similarity=0.459 Sum_probs=193.8
Q ss_pred CccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
.+..++|++.++||+|+||.||+|.+ .++.||||++.+.... ......+.+|+.+++.++||||+++++++.+.+.+
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34567899999999999999999998 4778999998765433 34467789999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE---cCCCcEEEEeecCCcc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSL 527 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill---~~~~~vkl~Dfg~a~~ 527 (605)
++|||||.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999999998765 67999999999999999999999999 9999999999999 5678999999999876
Q ss_pred cCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCC
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELP 600 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P 600 (605)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+++..|......+++|
T Consensus 179 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 249 (484)
T 3nyv_A 179 FEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP 249 (484)
T ss_dssp BCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG
T ss_pred ccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 54332 2234468999999999987 58999999999999999999999999999999999996665555554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=339.94 Aligned_cols=225 Identities=27% Similarity=0.517 Sum_probs=189.8
Q ss_pred ccccCceEee-eecccCcEEEEEEEEC----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 375 IRWEDLQLGE-EIGLGSYAVVYRGIWN----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 375 ~~~~~~~~~~-~LG~G~fg~V~~~~~~----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
+..+++.+.+ +||+|+||.||+|.+. +..||||++.... .....+.+.+|+.+|+.++|||||++++++.. +.
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 3445666666 8999999999999763 3459999987642 33456778999999999999999999999976 56
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+++|||||++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999999999999999877678999999999999999999999999 9999999999999999999999999998654
Q ss_pred cccc---cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 530 ATYL---TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 530 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.... ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..++...|. .+.++++|+.++
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~ 565 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECP 565 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCCCCCTTCC
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCC
Confidence 3221 1223346789999999999999999999999999999998 999999999999999985 566788888776
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=322.97 Aligned_cols=198 Identities=26% Similarity=0.412 Sum_probs=164.6
Q ss_pred ccccCceEe-eeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHH-hCCCCCeeeEEEEEee----
Q 038211 375 IRWEDLQLG-EEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIK-KLRHPNVLLFMGAVAS---- 446 (605)
Q Consensus 375 ~~~~~~~~~-~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~-~l~h~niv~~~~~~~~---- 446 (605)
...++|.+. ++||+|+||+||++.+. ++.||||++... ..+.+|+.++. ..+||||++++++|..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 445778887 78999999999999884 677999998532 34678888874 4589999999999875
Q ss_pred CCeeEEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC---CCcEEEEee
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK---NWTVKVGDF 522 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~---~~~vkl~Df 522 (605)
...+|+|||||+||+|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEec
Confidence 567999999999999999998653 46999999999999999999999999 999999999999987 789999999
Q ss_pred cCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 523 GLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 523 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
|+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 209 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 209 GFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp TTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred ccccccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 9998654322 2345678999999999999999999999999999999999999998754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=320.24 Aligned_cols=206 Identities=25% Similarity=0.393 Sum_probs=176.1
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC------
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE------ 448 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------ 448 (605)
.++|++++.||+|+||.||+|.+ +++.||||++..........+.+.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 36899999999999999999987 4778999998665444555678899999999999999999999997653
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
.+++||||+ +++|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 8899999876 57899999999999999999999999 999999999999999999999999999865
Q ss_pred CcccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..|
T Consensus 179 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i 238 (367)
T 1cm8_A 179 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 238 (367)
T ss_dssp CSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 432 345678999999999987 67899999999999999999999999998877766665
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=314.11 Aligned_cols=227 Identities=32% Similarity=0.583 Sum_probs=189.2
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC--Ccc--eEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeC
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSD--VAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQ 447 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~--~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~ 447 (605)
..+.+++|++.+.||+|+||.||+|.+. +.. +++|.+.... .....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98 (327)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred ccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence 3467789999999999999999999874 443 4888776432 234456788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCchHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNY---------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD 512 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~ 512 (605)
+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG 176 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEc
Confidence 99999999999999999997643 47999999999999999999999999 99999999999999
Q ss_pred CCCcEEEEeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhc
Q 038211 513 KNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 513 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~ 591 (605)
.++.+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++...+.
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp GGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 9999999999998743322 22233457889999999998889999999999999999998 999999999999988885
Q ss_pred cCCCccCCCCCCC
Q 038211 592 FMDRRLELPEGLD 604 (605)
Q Consensus 592 ~~~~~~~~P~~~~ 604 (605)
.+.++..|..++
T Consensus 256 -~~~~~~~~~~~~ 267 (327)
T 1fvr_A 256 -QGYRLEKPLNCD 267 (327)
T ss_dssp -GTCCCCCCTTBC
T ss_pred -cCCCCCCCCCCC
Confidence 344566666654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=304.67 Aligned_cols=226 Identities=31% Similarity=0.540 Sum_probs=193.2
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEECC-cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNG-SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~-~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
.+.+..++|++++.||+|+||.||+|.+.+ ..||+|++..... ..+.+.+|+.+++.++||||+++++++. .+..
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 82 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPI 82 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCc
Confidence 456777899999999999999999998864 4799999865432 3467889999999999999999999886 4568
Q ss_pred EEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 451 GIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999999999987642 36999999999999999999999999 9999999999999999999999999997654
Q ss_pred ccc-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 530 ATY-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 530 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
... .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..++...+. .+.++..|..++
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 236 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCP 236 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-cccCCCCccccc
Confidence 332 22334457889999999998889999999999999999999 999999999988888885 344556666554
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=312.45 Aligned_cols=201 Identities=27% Similarity=0.422 Sum_probs=174.8
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC--eeE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE--RLG 451 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~~~ 451 (605)
..++|++.++||+|+||+||+|.+. ++.||||++..... ....+.+.+|+.+++.++||||+++++++.... .++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 4478999999999999999999985 77899999875432 233566789999999999999999999998654 789
Q ss_pred EEEEecCCCchHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE----cCCCcEEEEeecCC
Q 038211 452 IVTEFLPRGSLFKTLHKNY--QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV----DKNWTVKVGDFGLS 525 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill----~~~~~vkl~Dfg~a 525 (605)
+||||+++++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999998653 33999999999999999999999999 9999999999999 77888999999999
Q ss_pred cccCcccccccCCCCCCccccccccc--------CCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 526 SLKNATYLTAKSGRGTPQWMAPEVLR--------SEPSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 526 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
+...... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||..
T Consensus 164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp EECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred eecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 7654432 233457899999999986 56788999999999999999999999974
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=314.69 Aligned_cols=229 Identities=25% Similarity=0.419 Sum_probs=191.1
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECC-------cceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAV 444 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~-------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~ 444 (605)
..+..++|++.+.||+|+||.||+|.+.+ ..||+|++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45667899999999999999999998743 358999886543 234457788999999999 899999999999
Q ss_pred eeCCeeEEEEEecCCCchHHHHHhh-------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE
Q 038211 445 ASQERLGIVTEFLPRGSLFKTLHKN-------------YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV 511 (605)
Q Consensus 445 ~~~~~~~lv~e~~~ggsL~~~l~~~-------------~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill 511 (605)
...+.+++||||+++|+|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL 197 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEE
Confidence 9999999999999999999998754 245799999999999999999999999 9999999999999
Q ss_pred cCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 038211 512 DKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVG 588 (605)
Q Consensus 512 ~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~ 588 (605)
+.++.+||+|||++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 999999999999997543222 12233457889999999999999999999999999999998 999999876655555
Q ss_pred HhccCCCccCCCCCCC
Q 038211 589 VVGFMDRRLELPEGLD 604 (605)
Q Consensus 589 ~I~~~~~~~~~P~~~~ 604 (605)
.+.....++..|..++
T Consensus 278 ~~~~~~~~~~~~~~~~ 293 (333)
T 2i1m_A 278 KLVKDGYQMAQPAFAP 293 (333)
T ss_dssp HHHHHTCCCCCCTTCC
T ss_pred HHHhcCCCCCCCCCCC
Confidence 5444455556665544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=317.49 Aligned_cols=213 Identities=26% Similarity=0.331 Sum_probs=179.6
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccch---hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE---GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~---~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
..++|++++.||+|+||.||+|.+. ++.||||++....... .....+.+|+.+++.++||||++++++|.+.+.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999874 6789999986543221 2235678999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
++||||+++ +|..++......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 999999975 898888877678999999999999999999999999 99999999999999999999999999987655
Q ss_pred ccccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
.........||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..|.
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~ 226 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 226 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 54445566799999999999764 47899999999999999999999999988877777663
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=311.41 Aligned_cols=229 Identities=28% Similarity=0.442 Sum_probs=185.2
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECC-----cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNG-----SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~-----~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
..+..++|.+.+.||+|+||.||+|.+.. ..||+|++..........+.+.+|+.+++.++||||+++++++...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 34566899999999999999999997632 3699999877665566677899999999999999999999999765
Q ss_pred C-----eeEEEEEecCCCchHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcE
Q 038211 448 E-----RLGIVTEFLPRGSLFKTLHK-----NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTV 517 (605)
Q Consensus 448 ~-----~~~lv~e~~~ggsL~~~l~~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~v 517 (605)
+ ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTTSCE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcE
Confidence 4 45999999999999999853 2356999999999999999999999999 9999999999999999999
Q ss_pred EEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCC
Q 038211 518 KVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMD 594 (605)
Q Consensus 518 kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~ 594 (605)
||+|||++....... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+..++...+. .+
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~ 265 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL-HG 265 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TT
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH-cC
Confidence 999999997653322 12233457889999999999999999999999999999999 999999988888888774 44
Q ss_pred CccCCCCCCC
Q 038211 595 RRLELPEGLD 604 (605)
Q Consensus 595 ~~~~~P~~~~ 604 (605)
.++.+|+.++
T Consensus 266 ~~~~~~~~~~ 275 (313)
T 3brb_A 266 HRLKQPEDCL 275 (313)
T ss_dssp CCCCCBTTCC
T ss_pred CCCCCCcccc
Confidence 5667777665
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.21 Aligned_cols=211 Identities=28% Similarity=0.460 Sum_probs=182.7
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
...++|++.+.||+|+||.||+|.+. ++.||+|++.... ..+.+.+|+.+++.++||||+++++++...+.+++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 34578999999999999999999885 7789999986543 34568899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
||||+++++|.+++......+++..++.++.||+.||.|||+.| |+|+||||+||+++.++.+||+|||++.......
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999999866678999999999999999999999999 9999999999999999999999999997665444
Q ss_pred ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+.
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 238 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP 238 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence 44455678999999999999999999999999999999999999999988777666553
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=303.63 Aligned_cols=209 Identities=25% Similarity=0.377 Sum_probs=184.6
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.++|++.++||+|+||.||+|.+. +..+|+|++..... ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 467999999999999999999985 44689998865432 33567889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE---cCCCcEEEEeecCCcccCcc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill---~~~~~vkl~Dfg~a~~~~~~ 531 (605)
||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.++|+|||++......
T Consensus 86 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 86 ELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp ECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred eccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 999999999988775 67899999999999999999999999 9999999999999 78899999999999765433
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhcc
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGF 592 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~ 592 (605)
. ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||...+..++...+..
T Consensus 163 ~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 221 (277)
T 3f3z_A 163 K-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE 221 (277)
T ss_dssp S-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred c-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 2 33455789999999998765 89999999999999999999999999998888888843
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=317.89 Aligned_cols=220 Identities=29% Similarity=0.408 Sum_probs=182.2
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeecccc---chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEY---IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
.++|++.+.||+|+||+||+|.+. +..||+|++.+... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 368999999999999999999874 56799999876532 2345678899999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhh---------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 038211 452 IVTEFLPRGSLFKTLHKN---------------------------------------YQALDIKRRLRMALDVARGMNYL 492 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~---------------------------------------~~~~~~~~~~~~~~qi~~aL~~L 492 (605)
+||||++|++|.+++... ...+++..++.++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999988521 11235778889999999999999
Q ss_pred HhCCCCceeccCCCCCEEEcCCC--cEEEEeecCCcccCcc----cccccCCCCCCcccccccccC--CCCCchhHHHHH
Q 038211 493 HHRNPPIVHRDLKSSNLLVDKNW--TVKVGDFGLSSLKNAT----YLTAKSGRGTPQWMAPEVLRS--EPSNEKSDVFSF 564 (605)
Q Consensus 493 H~~~~~iiH~Dik~~Nill~~~~--~vkl~Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSl 564 (605)
|+++ |+||||||+|||++.++ .+||+|||++...... ........||+.|+|||++.+ ..++.++|||||
T Consensus 185 H~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 185 HNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 9999 99999999999998776 8999999999754321 112345578999999999976 678899999999
Q ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccC
Q 038211 565 GVILWELVTASIPWNNLNLMQVVGVVGFMDRRLE 598 (605)
Q Consensus 565 G~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~ 598 (605)
||++|+|++|+.||.+.+..+.+..+......++
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 296 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE 296 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC
Confidence 9999999999999999998888888754444443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=309.63 Aligned_cols=227 Identities=34% Similarity=0.554 Sum_probs=186.1
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC---Cc--ceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN---GS--DVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~---~~--~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
+..++|++.+.||+|+||+||+|.+. ++ .||+|++..... .....+.+.+|+.+++.++||||+++++++..+.
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 45678999999999999999999863 22 489998866533 2345678899999999999999999999998754
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
.++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999999887678999999999999999999999999 999999999999999999999999999765
Q ss_pred Ccccc---cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 529 NATYL---TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 529 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+++..+.....+++.|..++
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 43221 2233457889999999998888999999999999999999 9999999999999999977777777777665
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=318.68 Aligned_cols=203 Identities=20% Similarity=0.283 Sum_probs=170.0
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccch-h--------hhhhHHHHHHHHHhCCCCCee
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIE-G--------TLKNYQKEIDIIKKLRHPNVL 438 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~-~--------~~~~~~~E~~il~~l~h~niv 438 (605)
+...+|++.++||+|+||.||+|.+. ++.||||++....... . ....+..|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 44568999999999999999999874 3679999986643210 0 111234566677788899999
Q ss_pred eEEEEEeeC----CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc--
Q 038211 439 LFMGAVASQ----ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD-- 512 (605)
Q Consensus 439 ~~~~~~~~~----~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~-- 512 (605)
++++++... ..+++||||+ |++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYK 188 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESS
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecC
Confidence 999998764 4589999999 99999999887678999999999999999999999999 99999999999999
Q ss_pred CCCcEEEEeecCCcccCcccc-------cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 513 KNWTVKVGDFGLSSLKNATYL-------TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 513 ~~~~vkl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 889999999999976543221 11334599999999999999999999999999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=302.21 Aligned_cols=213 Identities=25% Similarity=0.466 Sum_probs=185.1
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccch----hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE----GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~----~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
.++|++.+.||+|+||.||++.+. ++.||+|++....... ...+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 367999999999999999999985 7789999987654332 1356788999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC----cEEEEeecCCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW----TVKVGDFGLSS 526 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~----~vkl~Dfg~a~ 526 (605)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++ .+||+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 9999999999999999765 67999999999999999999999999 99999999999998877 89999999997
Q ss_pred ccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccC
Q 038211 527 LKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFM 593 (605)
Q Consensus 527 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~ 593 (605)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+...
T Consensus 161 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 226 (283)
T 3bhy_A 161 KIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 226 (283)
T ss_dssp ECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred eccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhc
Confidence 654322 223456899999999999999999999999999999999999999999988888887433
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=309.15 Aligned_cols=218 Identities=33% Similarity=0.592 Sum_probs=178.7
Q ss_pred ccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHh--CCCCCeeeEEEEEee----CC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKK--LRHPNVLLFMGAVAS----QE 448 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~--l~h~niv~~~~~~~~----~~ 448 (605)
+..++|++.++||+|+||+||+|.++++.||||++... ....+.+|.+++.. ++||||+++++++.. ..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 45679999999999999999999999999999998543 23455667777777 799999999998654 35
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceeccCCCCCEEEcCCCcEEEE
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH--------HRNPPIVHRDLKSSNLLVDKNWTVKVG 520 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH--------~~~~~iiH~Dik~~Nill~~~~~vkl~ 520 (605)
.+++||||+++|+|.++++. ..+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEEC
T ss_pred eeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEEe
Confidence 68999999999999999965 57999999999999999999999 889 9999999999999999999999
Q ss_pred eecCCcccCcccc----cccCCCCCCcccccccccCC------CCCchhHHHHHHHHHHHHHcC----------CCCCCC
Q 038211 521 DFGLSSLKNATYL----TAKSGRGTPQWMAPEVLRSE------PSNEKSDVFSFGVILWELVTA----------SIPWNN 580 (605)
Q Consensus 521 Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~el~~g----------~~Pf~~ 580 (605)
|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 9999975432221 12344799999999999887 345789999999999999999 999965
Q ss_pred C-----CHHHHHHHhccCCCccCCCC
Q 038211 581 L-----NLMQVVGVVGFMDRRLELPE 601 (605)
Q Consensus 581 ~-----~~~~~~~~I~~~~~~~~~P~ 601 (605)
. ....+...+.....++.+|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQRPNIPN 261 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred cCCCCcchhhhhHHHhccCCCCCCCh
Confidence 3 23444444544555566664
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.75 Aligned_cols=200 Identities=26% Similarity=0.404 Sum_probs=170.8
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC------
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE------ 448 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------ 448 (605)
.++|++++.||+|+||.||+|.+ +++.||||++.... .....+.+.+|+.+++.++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 46899999999999999999998 47789999987654 3345577899999999999999999999986543
Q ss_pred ---------------------------------------------------eeEEEEEecCCCchHHHHHhhc--CCCCH
Q 038211 449 ---------------------------------------------------RLGIVTEFLPRGSLFKTLHKNY--QALDI 475 (605)
Q Consensus 449 ---------------------------------------------------~~~lv~e~~~ggsL~~~l~~~~--~~~~~ 475 (605)
.+++|||||++++|.+++.... ...++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 3899999999999999998753 34566
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc------------ccccCCCCCCc
Q 038211 476 KRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY------------LTAKSGRGTPQ 543 (605)
Q Consensus 476 ~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~------------~~~~~~~gt~~ 543 (605)
..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...... .......||+.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 678899999999999999999 9999999999999999999999999997654332 22344579999
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 038211 544 WMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWN 579 (605)
Q Consensus 544 y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~ 579 (605)
|+|||++.+..++.++|||||||++|+|++|..|+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999988764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=337.88 Aligned_cols=222 Identities=29% Similarity=0.484 Sum_probs=187.0
Q ss_pred cCceEe-eeecccCcEEEEEEEE----CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 378 EDLQLG-EEIGLGSYAVVYRGIW----NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 378 ~~~~~~-~~LG~G~fg~V~~~~~----~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
..+.+. ++||+|+||.||+|.+ .++.||||++..........+.+.+|+.+|+.++|||||++++++.. +.+++
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 334443 4899999999999965 24569999997765555556789999999999999999999999864 56889
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
||||+++|+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 447 v~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred EEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 99999999999999764 67999999999999999999999999 9999999999999999999999999997654322
Q ss_pred ---ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 533 ---LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 533 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...|. .+.++.+|..++
T Consensus 524 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~ 598 (635)
T 4fl3_A 524 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCP 598 (635)
T ss_dssp -----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred cccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 12233456889999999999999999999999999999998 999999999999999885 556778888775
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=305.97 Aligned_cols=216 Identities=27% Similarity=0.467 Sum_probs=174.3
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
....+|++.+.||+|+||.||+|.+ +++.||||++..... .......+.+|+.+++.++||||+++++++...+.++
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 4567899999999999999999987 577899999876432 3345677889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 452 IVTEFLPRGSLFKTLHK---NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999998865 2467899999999999999999999999 999999999999999999999999999765
Q ss_pred CcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHhcc
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL--NLMQVVGVVGF 592 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~--~~~~~~~~I~~ 592 (605)
...........|++.|+|||++.+..++.++||||||+++|+|++|..||.+. +..++...+..
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 252 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 252 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc
Confidence 54443444557899999999999999999999999999999999999999753 45566666643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=307.30 Aligned_cols=211 Identities=27% Similarity=0.397 Sum_probs=184.2
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..++|.+.+.||+|+||.||++.+. ++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 3468999999999999999999984 77899999875432 2235678999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE---cCCCcEEEEeecCCcccCc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill---~~~~~vkl~Dfg~a~~~~~ 530 (605)
|||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.++|+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 85 MQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp ECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999999998765 67899999999999999999999999 9999999999999 7889999999999876443
Q ss_pred ccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccC
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFM 593 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~ 593 (605)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..++...|...
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 222 (304)
T 2jam_A 162 G--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG 222 (304)
T ss_dssp B--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHC
T ss_pred C--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence 2 222345899999999999999999999999999999999999999999988888888543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=309.14 Aligned_cols=212 Identities=29% Similarity=0.467 Sum_probs=176.8
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEee------
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVAS------ 446 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~------ 446 (605)
..++|++++.||+|+||.||+|.+ .++.||||++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 457899999999999999999998 57789999986543 2346688999999999 89999999999976
Q ss_pred CCeeEEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCC
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a 525 (605)
.+.+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 467999999999999999998643 57899999999999999999999999 999999999999999999999999999
Q ss_pred cccCcccccccCCCCCCccccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhcc
Q 038211 526 SLKNATYLTAKSGRGTPQWMAPEVLR-----SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGF 592 (605)
Q Consensus 526 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~ 592 (605)
..............||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 76654433444567899999999987 55688999999999999999999999999888877777643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=304.67 Aligned_cols=211 Identities=20% Similarity=0.285 Sum_probs=182.7
Q ss_pred CCccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCe
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQER 449 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~ 449 (605)
+.+..++|++.+.||+|+||.||+|.+ .++.||||++.... ....+.+|+.+++.+ +|+|++.+++++.....
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 345668899999999999999999996 57789999886432 345688999999999 89999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc-----EEEEeecC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT-----VKVGDFGL 524 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~-----vkl~Dfg~ 524 (605)
.++||||+ +++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+|||+
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 99999999 99999999877677999999999999999999999999 999999999999987765 99999999
Q ss_pred CcccCcccc-------cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHh
Q 038211 525 SSLKNATYL-------TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL---NLMQVVGVV 590 (605)
Q Consensus 525 a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~---~~~~~~~~I 590 (605)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. +..+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence 976543221 234557999999999999999999999999999999999999999874 445555544
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.81 Aligned_cols=226 Identities=33% Similarity=0.532 Sum_probs=196.5
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEECC-cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNG-SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~-~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
.+.+..++|++.++||+|+||.||+|.+.+ ..||||++..... ..+.+.+|+.+|+.++||||+++++++.. +.+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 456777899999999999999999999865 5699999876432 24568999999999999999999999866 679
Q ss_pred EEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 451 GIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+|||||+.+|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 9999999999999999754 356899999999999999999999999 9999999999999999999999999998654
Q ss_pred ccc-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 530 ATY-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 530 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
... .......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.+..+++..|. .+.++++|+.++
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~ 490 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 490 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 322 22234456889999999998899999999999999999999 999999999999999985 556777787765
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=303.97 Aligned_cols=214 Identities=24% Similarity=0.399 Sum_probs=181.3
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..++|.+.++||+|+||+||++.+. +..+|+|++.... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 3478999999999999999999874 6779999987654 233456788999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE---cCCCcEEEEeecCCcc
Q 038211 454 TEFLPRGSLFKTLHKN---YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSL 527 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill---~~~~~vkl~Dfg~a~~ 527 (605)
|||+++++|.+++... ...+++..++.++.||+.||+|||+.| |+||||||+|||+ +.++.+||+|||++..
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 9999999999988643 367999999999999999999999999 9999999999999 4568899999999976
Q ss_pred cCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCC
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMD 594 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~ 594 (605)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..++...+....
T Consensus 177 ~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 241 (285)
T 3is5_A 177 FKSDE-HSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE 241 (285)
T ss_dssp -----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred cCCcc-cCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC
Confidence 54332 2345578999999999864 58899999999999999999999999999888887775443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=315.19 Aligned_cols=202 Identities=25% Similarity=0.412 Sum_probs=177.4
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccch------hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE------GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~------~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
..++|++.+.||+|+||+||+|.+ .++.||||++....... .....+.+|+.+++.++||||++++++|.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 347899999999999999999987 56779999997764322 2445678899999999999999999999999
Q ss_pred CeeEEEEEecCCC-chHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCc
Q 038211 448 ERLGIVTEFLPRG-SLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526 (605)
Q Consensus 448 ~~~~lv~e~~~gg-sL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~ 526 (605)
+.+++||||+.+| +|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999999999766 999888765 67999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCcccccccCCCCCCcccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 527 LKNATYLTAKSGRGTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 527 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus 179 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 179 YLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp ECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred ECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 654332 2334578999999999998877 78999999999999999999999763
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.76 Aligned_cols=209 Identities=24% Similarity=0.335 Sum_probs=174.4
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC-----
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE----- 448 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~----- 448 (605)
..++|++++.||+|+||.||+|.+ .++.||||++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 357899999999999999999987 4677999998765544556677889999999999999999999997654
Q ss_pred -eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 449 -RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 449 -~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
.+++||||++ ++|.+.+. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred cceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 7899999996 57888775 45899999999999999999999999 99999999999999999999999999976
Q ss_pred cCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..|.
T Consensus 177 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 239 (371)
T 2xrw_A 177 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 239 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 54322 2344578999999999999999999999999999999999999999988877777663
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=312.55 Aligned_cols=227 Identities=27% Similarity=0.452 Sum_probs=188.3
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEe
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVA 445 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~ 445 (605)
.+..++|++.+.||+|+||+||+|.+. ++.||||++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 456689999999999999999999852 3569999986543 334456788999999999 7999999999987
Q ss_pred eCC-eeEEEEEecCCCchHHHHHhhcCC---------------CCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCE
Q 038211 446 SQE-RLGIVTEFLPRGSLFKTLHKNYQA---------------LDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNL 509 (605)
Q Consensus 446 ~~~-~~~lv~e~~~ggsL~~~l~~~~~~---------------~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Ni 509 (605)
..+ .+++||||+++++|.+++...... +++..++.++.||+.||.|||++| |+||||||+||
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Ni 179 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNI 179 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceE
Confidence 654 599999999999999999875332 889999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHH-
Q 038211 510 LVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQ- 585 (605)
Q Consensus 510 ll~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~- 585 (605)
|++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 99999999999999997653322 22234457889999999999999999999999999999998 999998876443
Q ss_pred HHHHhccCCCccCCCCCCC
Q 038211 586 VVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 586 ~~~~I~~~~~~~~~P~~~~ 604 (605)
+...+ ..+.++.+|..++
T Consensus 260 ~~~~~-~~~~~~~~~~~~~ 277 (316)
T 2xir_A 260 FCRRL-KEGTRMRAPDYTT 277 (316)
T ss_dssp HHHHH-HHTCCCCCCTTCC
T ss_pred HHHHh-ccCccCCCCCCCC
Confidence 33443 3455667777665
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=307.43 Aligned_cols=224 Identities=32% Similarity=0.498 Sum_probs=185.3
Q ss_pred ccCceEeeeecccCcEEEEEEEECC---c--ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEE-eeCCee
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWNG---S--DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAV-ASQERL 450 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~~---~--~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-~~~~~~ 450 (605)
..+|++.++||+|+||+||+|.+.. + .+|+|.+.... .....+.+.+|+.+++.++||||+++++++ ..++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 4579999999999999999998632 2 37888775532 334567788999999999999999999985 456688
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
++||||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 9999999999999999877778999999999999999999999999 99999999999999999999999999976543
Q ss_pred cc----ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 531 TY----LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 531 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.. .......+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||.+.+..++...+. .+.+...|+.++
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 258 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCP 258 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTTCC
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCccCC
Confidence 22 12234457889999999999999999999999999999999 788888888777777764 344455565554
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.84 Aligned_cols=212 Identities=26% Similarity=0.399 Sum_probs=186.4
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
+.+..++|++.++||+|+||.||++.+. +..||+|++.... .....+.+.+|+.+++.++||||+++++++..++.+
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 4567789999999999999999999985 7779999987653 344567789999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR-NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+. | |+||||||+|||++.++.+||+|||++....
T Consensus 107 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999999999775 6799999999999999999999985 9 9999999999999999999999999986543
Q ss_pred cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..++...+
T Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 242 (360)
T 3eqc_A 184 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242 (360)
T ss_dssp HH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHH
T ss_pred cc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 22 233457899999999999999999999999999999999999999998877665554
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=314.86 Aligned_cols=219 Identities=33% Similarity=0.565 Sum_probs=187.1
Q ss_pred CCCCccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 371 TDGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 371 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
....+..++|++.+.||+|+||.||+|.+.+ .+|+|++..........+.+.+|+.+++.++||||+++++++...+.+
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 3566778999999999999999999999866 599999876655455567788999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
++||||+++++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++ ++.+||+|||++.....
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999999999876667999999999999999999999999 99999999999998 68999999999865421
Q ss_pred c-----cccccCCCCCCcccccccccC---------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccC
Q 038211 531 T-----YLTAKSGRGTPQWMAPEVLRS---------EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFM 593 (605)
Q Consensus 531 ~-----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~ 593 (605)
. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..++...+...
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence 1 122233458999999999875 34788999999999999999999999999988888887533
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.80 Aligned_cols=197 Identities=27% Similarity=0.329 Sum_probs=167.5
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC-----Ce
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ-----ER 449 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~ 449 (605)
.++|+++++||+|+||+||+|.+. ++.||||++..........+.+.+|+.+|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999884 66799999876544455667889999999999999999999999766 57
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 999999995 6999998764 67999999999999999999999999 9999999999999999999999999997654
Q ss_pred cccc----------------------cccCCCCCCcccccccc-cCCCCCchhHHHHHHHHHHHHHcCCCC
Q 038211 530 ATYL----------------------TAKSGRGTPQWMAPEVL-RSEPSNEKSDVFSFGVILWELVTASIP 577 (605)
Q Consensus 530 ~~~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~~g~~P 577 (605)
.... .....+||+.|+|||++ .+..++.++|||||||++|||++|..|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 3221 23556899999999986 556689999999999999999984333
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.23 Aligned_cols=218 Identities=31% Similarity=0.596 Sum_probs=178.0
Q ss_pred ccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
+..++|++.+.||+|+||+||++.+.++.||+|++... ...+.+.+|+.+++.++||||+++++++. +..++||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~ 78 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVM 78 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEE
Confidence 56689999999999999999999999999999997543 34567889999999999999999999886 4589999
Q ss_pred EecCCCchHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeccCCCCCEEEcCCCc-EEEEeecCCccc
Q 038211 455 EFLPRGSLFKTLHKNY--QALDIKRRLRMALDVARGMNYLHH---RNPPIVHRDLKSSNLLVDKNWT-VKVGDFGLSSLK 528 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~~~iiH~Dik~~Nill~~~~~-vkl~Dfg~a~~~ 528 (605)
||+++++|.+++.... ..+++..++.++.||+.||+|||+ +| |+||||||+|||++.++. +||+|||++...
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 9999999999998653 247889999999999999999999 78 999999999999998886 799999998754
Q ss_pred CcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHhccCCCccCCCCCCC
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN--LMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~--~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ...+...+. .+.++++|..++
T Consensus 157 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (307)
T 2eva_A 157 QTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTRPPLIKNLP 230 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-TTCCCCCBTTCC
T ss_pred ccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-cCCCCCcccccC
Confidence 322 223468999999999999999999999999999999999999998643 334444442 344556666554
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=316.27 Aligned_cols=222 Identities=26% Similarity=0.414 Sum_probs=192.2
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhh---------------hhhHHHHHHHHHhCCCCCe
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGT---------------LKNYQKEIDIIKKLRHPNV 437 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~---------------~~~~~~E~~il~~l~h~ni 437 (605)
+.+..++|++.+.||+|+||.||+|.+.++.||||++......... .+.+.+|+.+++.++||||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 4566789999999999999999999999999999998765432211 1778999999999999999
Q ss_pred eeEEEEEeeCCeeEEEEEecCCCchHHH------HHhh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCCCCE
Q 038211 438 LLFMGAVASQERLGIVTEFLPRGSLFKT------LHKN-YQALDIKRRLRMALDVARGMNYLHH-RNPPIVHRDLKSSNL 509 (605)
Q Consensus 438 v~~~~~~~~~~~~~lv~e~~~ggsL~~~------l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~-~~~~iiH~Dik~~Ni 509 (605)
+++++++.+.+.+++||||+++++|.++ +... ...+++..++.++.||+.||.|||+ +| |+||||||+||
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Ni 183 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNI 183 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhE
Confidence 9999999999999999999999999988 5542 4779999999999999999999999 99 99999999999
Q ss_pred EEcCCCcEEEEeecCCcccCcccccccCCCCCCcccccccccCC-CCCc-hhHHHHHHHHHHHHHcCCCCCCCCCH-HHH
Q 038211 510 LVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSE-PSNE-KSDVFSFGVILWELVTASIPWNNLNL-MQV 586 (605)
Q Consensus 510 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwSlG~il~el~~g~~Pf~~~~~-~~~ 586 (605)
|++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||...+. .++
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 9999999999999999765433 33456789999999999887 5665 89999999999999999999998776 888
Q ss_pred HHHhccCCCccCCC
Q 038211 587 VGVVGFMDRRLELP 600 (605)
Q Consensus 587 ~~~I~~~~~~~~~P 600 (605)
...+ ....+.+|
T Consensus 262 ~~~i--~~~~~~~~ 273 (348)
T 2pml_X 262 FNNI--RTKNIEYP 273 (348)
T ss_dssp HHHH--TSCCCCCC
T ss_pred HHHH--hccCcCCc
Confidence 8888 34455666
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.91 Aligned_cols=228 Identities=26% Similarity=0.409 Sum_probs=189.6
Q ss_pred CCccccCceEeeeecccCcEEEEEEEE-------CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEe
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIW-------NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVA 445 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~-------~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 445 (605)
..+..++|++++.||+|+||.||+|.+ .+..||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 456678999999999999999999984 34569999986432 3344567889999999999999999999999
Q ss_pred eCCeeEEEEEecCCCchHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC---CCc
Q 038211 446 SQERLGIVTEFLPRGSLFKTLHKNY------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK---NWT 516 (605)
Q Consensus 446 ~~~~~~lv~e~~~ggsL~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~---~~~ 516 (605)
.....++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcce
Confidence 9999999999999999999998753 45889999999999999999999999 999999999999984 446
Q ss_pred EEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccC
Q 038211 517 VKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFM 593 (605)
Q Consensus 517 vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~ 593 (605)
+||+|||++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..++...+. .
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~ 260 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 260 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-T
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-c
Confidence 9999999986432221 12233457899999999999899999999999999999998 999999999888888885 4
Q ss_pred CCccCCCCCCC
Q 038211 594 DRRLELPEGLD 604 (605)
Q Consensus 594 ~~~~~~P~~~~ 604 (605)
+.++.+|..++
T Consensus 261 ~~~~~~~~~~~ 271 (327)
T 2yfx_A 261 GGRMDPPKNCP 271 (327)
T ss_dssp TCCCCCCTTCC
T ss_pred CCCCCCCCCCC
Confidence 45666676655
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=303.68 Aligned_cols=213 Identities=25% Similarity=0.348 Sum_probs=167.0
Q ss_pred CccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
++..++|++.++||+|+||+||+|.+ +++.||+|++............+.++...++.++||||+++++++.+++..+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 45678999999999999999999998 6778999998765444444455556666688889999999999999999999
Q ss_pred EEEEecCCCchHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 452 IVTEFLPRGSLFKTLHK---NYQALDIKRRLRMALDVARGMNYLHHR-NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~-~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
+||||++ ++|.+++.. ....+++..++.++.||+.||+|||++ | |+||||||+|||++.++.+||+|||++..
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999996 588777654 346899999999999999999999998 9 99999999999999999999999999976
Q ss_pred cCcccccccCCCCCCcccccccc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHh
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVL----RSEPSNEKSDVFSFGVILWELVTASIPWNN-LNLMQVVGVV 590 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~el~~g~~Pf~~-~~~~~~~~~I 590 (605)
..... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.. ....+.+..+
T Consensus 160 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 226 (290)
T 3fme_A 160 LVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH
T ss_pred ccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH
Confidence 54332 22334689999999996 556688999999999999999999999986 3344444433
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=320.85 Aligned_cols=223 Identities=32% Similarity=0.497 Sum_probs=178.9
Q ss_pred cCceEeeeecccCcEEEEEEEECC-----cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEe-eCCeeE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWNG-----SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVA-SQERLG 451 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~~-----~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-~~~~~~ 451 (605)
..|.+.++||+|+||+||+|.+.. ..+|+|++.... .....+.+.+|+.+++.++||||+++++++. .++..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 458889999999999999998632 247888875432 3345678899999999999999999999865 456889
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||||+++++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccccc
Confidence 999999999999999877678999999999999999999999999 999999999999999999999999999754322
Q ss_pred c----ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 532 Y----LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 532 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
. .......+|+.|+|||.+.+..++.++|||||||++|||++ |.+||.+.+..++...+. .+.++..|+.++
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~~~ 322 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCP 322 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTTCC
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 1 11233457889999999999999999999999999999999 889999887777777764 445566676654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=302.20 Aligned_cols=218 Identities=23% Similarity=0.346 Sum_probs=183.1
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lv 453 (605)
.++|++.+.||+|+||+||+|.+. ++.||+|++............+.+|+..+..+ +||||+++++++.+++.+++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 468999999999999999999984 78899999887655555567788999999999 999999999999999999999
Q ss_pred EEecCCCchHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC----------------
Q 038211 454 TEFLPRGSLFKTLHKNY---QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN---------------- 514 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~---------------- 514 (605)
|||+++++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999999997642 66899999999999999999999999 9999999999999844
Q ss_pred ---CcEEEEeecCCcccCcccccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 515 ---WTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 515 ---~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+||......+ .+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~ 240 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EI 240 (289)
T ss_dssp --CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH---HH
T ss_pred CCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH---HH
Confidence 47999999998765432 234589999999999876 45689999999999999999998886654333 23
Q ss_pred ccCCCccCCCCCCC
Q 038211 591 GFMDRRLELPEGLD 604 (605)
Q Consensus 591 ~~~~~~~~~P~~~~ 604 (605)
. .+..+.+|+.++
T Consensus 241 ~-~~~~~~~~~~~~ 253 (289)
T 1x8b_A 241 R-QGRLPRIPQVLS 253 (289)
T ss_dssp H-TTCCCCCSSCCC
T ss_pred H-cCCCCCCCcccC
Confidence 1 234456676665
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=304.43 Aligned_cols=222 Identities=31% Similarity=0.520 Sum_probs=186.9
Q ss_pred CceEeeeecccCcEEEEEEEEC--Cc---ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee-EE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWN--GS---DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL-GI 452 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~--~~---~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~-~l 452 (605)
.|.+.++||+|+||+||+|.+. +. .+|+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 4667799999999999999862 22 58999876532 334567788999999999999999999999876655 99
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
||||+.+++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 99999999999999887678999999999999999999999999 9999999999999999999999999997543321
Q ss_pred ----ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 533 ----LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 533 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.......+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||...+..++...+. ....+..|..++
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 254 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQPEYCP 254 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-cCCCCCCCccch
Confidence 22334567899999999999999999999999999999999 666777888888887775 444566666654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.28 Aligned_cols=205 Identities=26% Similarity=0.376 Sum_probs=163.6
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC------Ce
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ------ER 449 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------~~ 449 (605)
++|++++.||+|+||.||+|.+ .++.||||++..........+.+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 7899999999999999999987 477799999876544445567788999999999999999999998654 56
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+++|||++ +++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 109 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 89999999 7899888865 57999999999999999999999999 9999999999999999999999999997654
Q ss_pred cccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..|
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i 242 (367)
T 2fst_X 184 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 22 334578999999999987 67899999999999999999999999998877666665
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=309.48 Aligned_cols=225 Identities=31% Similarity=0.476 Sum_probs=188.6
Q ss_pred ccccCceEeeeecccCcEEEEEEEE------CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEe--e
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW------NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVA--S 446 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~------~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~--~ 446 (605)
+..++|+++++||+|+||.||+|.+ .+..||||++.... ....+.+.+|+.+++.++||||+++++++. .
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 5568999999999999999999984 46679999986542 344567899999999999999999999886 4
Q ss_pred CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCc
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~ 526 (605)
...+++||||+++++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEcccccce
Confidence 56689999999999999999886678999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCccc---ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCH---------------HHHHH
Q 038211 527 LKNATY---LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNL---------------MQVVG 588 (605)
Q Consensus 527 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~---------------~~~~~ 588 (605)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .++..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 654322 223345688899999999998899999999999999999999999965332 23333
Q ss_pred HhccCCCccCCCCCCC
Q 038211 589 VVGFMDRRLELPEGLD 604 (605)
Q Consensus 589 ~I~~~~~~~~~P~~~~ 604 (605)
.+ ..+.+++.|+.++
T Consensus 256 ~~-~~~~~~~~~~~~~ 270 (327)
T 3lxl_A 256 LL-EEGQRLPAPPACP 270 (327)
T ss_dssp HH-HTTCCCCCCTTCC
T ss_pred Hh-hcccCCCCCCccc
Confidence 33 2455666676665
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=309.32 Aligned_cols=215 Identities=24% Similarity=0.388 Sum_probs=184.5
Q ss_pred ccCceEe-eeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEE
Q 038211 377 WEDLQLG-EEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 377 ~~~~~~~-~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~l 452 (605)
.++|.+. ++||+|+||+||+|.+. ++.||+|++............+.+|+.+++.+ +||||+++++++...+.+++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 3567777 89999999999999885 77899999987655555567788999999999 56999999999999999999
Q ss_pred EEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC---CCcEEEEeecCCccc
Q 038211 453 VTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK---NWTVKVGDFGLSSLK 528 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~---~~~vkl~Dfg~a~~~ 528 (605)
||||+++++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||+|||+++..
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 99999999999988653 367999999999999999999999999 999999999999987 789999999999765
Q ss_pred CcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCC
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMD 594 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~ 594 (605)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 185 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 249 (327)
T 3lm5_A 185 GHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN 249 (327)
T ss_dssp ----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc
Confidence 4332 2234578999999999999999999999999999999999999999999888887775443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=306.57 Aligned_cols=213 Identities=31% Similarity=0.487 Sum_probs=181.7
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..++|++++.||+|+||.||+|.+. +..+|+|++.... ....+.+.+|+.+++.++||||+++++++...+.+++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 4478999999999999999999985 6779999886542 33456788999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
|||+++++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++........
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 9999999999998877678999999999999999999999999 99999999999999999999999998754332222
Q ss_pred cccCCCCCCcccccccc-----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhcc
Q 038211 534 TAKSGRGTPQWMAPEVL-----RSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGF 592 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~ 592 (605)
......||+.|+|||++ .+..++.++|||||||++|+|++|..||...+....+..+..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 236 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 236 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc
Confidence 33455789999999998 466788999999999999999999999999988887777643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=312.48 Aligned_cols=214 Identities=27% Similarity=0.462 Sum_probs=186.0
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc------hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeC
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI------EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQ 447 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~------~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~ 447 (605)
.++|.+.+.||+|+||.||+|.+. |+.||||++...... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 367999999999999999999984 788999998764311 12345678999999999 899999999999999
Q ss_pred CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
+..++||||++|++|.+++... ..+++..+..++.||+.||.|||+.| |+||||||+|||++.+|.+||+|||++..
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 9999999999999999998765 67999999999999999999999999 99999999999999999999999999876
Q ss_pred cCcccccccCCCCCCcccccccccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCC
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLRS------EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMD 594 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~ 594 (605)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+++..|....
T Consensus 250 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 321 (365)
T 2y7j_A 250 LEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ 321 (365)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred cCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 54332 2345679999999999863 357889999999999999999999999988888888875443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=307.16 Aligned_cols=199 Identities=31% Similarity=0.502 Sum_probs=172.8
Q ss_pred cCceEeeeecccCcEEEEEEEE------CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC--Ce
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW------NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ--ER 449 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~------~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~ 449 (605)
+.|+++++||+|+||+||++.+ .++.||||++.... .....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 3459999999999999998865 46679999987653 344567789999999999999999999999874 67
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+++||||+++++|.+++... .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++....
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 89999999999999999764 5899999999999999999999999 9999999999999999999999999997654
Q ss_pred ccc---ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 530 ATY---LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 530 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 332 2233456788999999999988999999999999999999999999764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=305.20 Aligned_cols=223 Identities=24% Similarity=0.410 Sum_probs=185.6
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc--hhhhhhHHHHHHHHHhCCCCCeeeEEEEEe--eCCee
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI--EGTLKNYQKEIDIIKKLRHPNVLLFMGAVA--SQERL 450 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~~--~~~~~ 450 (605)
.++|++.+.||+|+||.||++.+ .+..+|+|++...... ......+.+|+.+++.++||||+++++++. ....+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999988 4667999998765422 234567899999999999999999999984 45689
Q ss_pred EEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 451 GIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
++||||++++ |.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 9999999765 66766553 467999999999999999999999999 9999999999999999999999999997653
Q ss_pred cc--cccccCCCCCCcccccccccCCCC--CchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 530 AT--YLTAKSGRGTPQWMAPEVLRSEPS--NEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 530 ~~--~~~~~~~~gt~~y~aPE~~~~~~~--~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.. ........||+.|+|||++.+... +.++|||||||++|+|++|+.||.+.+..++...|. ...+.+|..++
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~--~~~~~~~~~~~ 237 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG--KGSYAIPGDCG 237 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HCCCCCCSSSC
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh--cCCCCCCCccC
Confidence 21 222335568999999999987544 779999999999999999999999999999888884 34567777665
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=299.20 Aligned_cols=218 Identities=27% Similarity=0.431 Sum_probs=188.1
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeecccc-------chhhhhhHHHHHHHHHhCC-CCCeeeEEEEEe
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY-------IEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVA 445 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~-------~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~ 445 (605)
..++|++.+.||+|+||.||+|.+ .++.||||++..... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 457899999999999999999998 467799999876431 1233466789999999995 999999999999
Q ss_pred eCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCC
Q 038211 446 SQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525 (605)
Q Consensus 446 ~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a 525 (605)
.....++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecccch
Confidence 999999999999999999999765 67999999999999999999999999 999999999999999999999999999
Q ss_pred cccCcccccccCCCCCCccccccccc------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCcc
Q 038211 526 SLKNATYLTAKSGRGTPQWMAPEVLR------SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRL 597 (605)
Q Consensus 526 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~ 597 (605)
....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||.+.+..++...+......+
T Consensus 172 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 172 CQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp EECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred hhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence 7654322 234457899999999985 4567889999999999999999999999999888888875444333
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=299.63 Aligned_cols=203 Identities=30% Similarity=0.430 Sum_probs=177.6
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.++|++.+.||+|+||.||+|.+. ++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 468999999999999999999884 77899999865442 234567889999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc--
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY-- 532 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~-- 532 (605)
||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999999999988654 67899999999999999999999999 9999999999999999999999999997543221
Q ss_pred ccccCCCCCCcccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCH
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELVTASIPWNNLNL 583 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~Pf~~~~~ 583 (605)
.......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||...+.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 22345578999999999988765 6789999999999999999999987553
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=303.35 Aligned_cols=226 Identities=27% Similarity=0.447 Sum_probs=183.2
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
+..++|....+||+|+||.||+|.+ ++..||+|++.... ....+.+.+|+.+++.++||||+++++++...+.+++
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 96 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 96 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence 4456666677999999999999997 46679999886543 3345678899999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC-CCcEEEEeecCCcccC
Q 038211 453 VTEFLPRGSLFKTLHKNY--QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK-NWTVKVGDFGLSSLKN 529 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~-~~~vkl~Dfg~a~~~~ 529 (605)
||||+++++|.+++.... ..+++..+..++.||+.||+|||++| |+|+||||+|||++. ++.+||+|||++....
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 999999999999998753 35678899999999999999999999 999999999999987 8999999999997665
Q ss_pred cccccccCCCCCCcccccccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHhccCCCccCCCCCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEP--SNEKSDVFSFGVILWELVTASIPWNNLN-LMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~~g~~Pf~~~~-~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
..........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.... .......+......+.+|+.++
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (295)
T 2clq_A 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS 252 (295)
T ss_dssp C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSC
T ss_pred CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCC
Confidence 4433445567899999999997653 7889999999999999999999997643 2333333323345567777665
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=305.55 Aligned_cols=201 Identities=27% Similarity=0.401 Sum_probs=169.4
Q ss_pred ccCceEe-eeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEE
Q 038211 377 WEDLQLG-EEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 377 ~~~~~~~-~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~l 452 (605)
.+.|++. ++||+|+||+||+|.+ .++.||||++.... ......+.+|+.+++++ +||||+++++++.+.+.+++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 4678885 7899999999999987 57789999987653 23456788999999985 79999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc---EEEEeecCCcccC
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT---VKVGDFGLSSLKN 529 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~---vkl~Dfg~a~~~~ 529 (605)
||||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999999876 67899999999999999999999999 999999999999988765 9999999987543
Q ss_pred ccc-------ccccCCCCCCcccccccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 530 ATY-------LTAKSGRGTPQWMAPEVLRS-----EPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 530 ~~~-------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 211 11223468999999999875 457889999999999999999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.32 Aligned_cols=203 Identities=29% Similarity=0.518 Sum_probs=177.4
Q ss_pred cccCceEeeeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
..++|++.+.||+|+||+||+|.+. ++.||||++.... ....+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 4578999999999999999999874 7789999876542 234567899999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 455 EFLPRGSLFKTLHKNY---QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
||+++++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999986542 35899999999999999999999999 999999999999999999999999999764322
Q ss_pred c--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 532 Y--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 532 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~ 245 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence 1 12233458999999999998889999999999999999999999997643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=309.30 Aligned_cols=223 Identities=33% Similarity=0.491 Sum_probs=175.6
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHH--HHhCCCCCeeeEEEEEee----
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDI--IKKLRHPNVLLFMGAVAS---- 446 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~i--l~~l~h~niv~~~~~~~~---- 446 (605)
..+..++|+++++||+|+||.||+|.++++.||||++.... ...+..|..+ +..++||||+++++++..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 35677899999999999999999999999999999986542 2334444444 445799999999986542
Q ss_pred -CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCceeccCCCCCEEEcCCCc
Q 038211 447 -QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR---------NPPIVHRDLKSSNLLVDKNWT 516 (605)
Q Consensus 447 -~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---------~~~iiH~Dik~~Nill~~~~~ 516 (605)
...+++||||+++|+|.+++... ..++..++.++.||+.||+|||+. | |+||||||+|||++.++.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTTSC
T ss_pred CCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCCCc
Confidence 33678999999999999999764 458888999999999999999999 8 999999999999999999
Q ss_pred EEEEeecCCcccCcc--------cccccCCCCCCcccccccccC-------CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 517 VKVGDFGLSSLKNAT--------YLTAKSGRGTPQWMAPEVLRS-------EPSNEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 517 vkl~Dfg~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
+||+|||+++..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 999999999764322 122234569999999999987 34567899999999999999997776321
Q ss_pred ------------------CHHHHHHHhccCCCccCCCCCCC
Q 038211 582 ------------------NLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 582 ------------------~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
....+...+.....++.+|+.++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK 279 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccc
Confidence 12334444555666777777653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=300.79 Aligned_cols=221 Identities=31% Similarity=0.469 Sum_probs=190.4
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
...++|+++++||+|+||.||+|.+ .++.||+|++............+.+|+.+++.++||||+++++++...+.+++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 4457899999999999999999998 47789999997765555556788999999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC---CcEEEEeecCCcccC
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN---WTVKVGDFGLSSLKN 529 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~---~~vkl~Dfg~a~~~~ 529 (605)
||||+++++|.+.+... ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++....
T Consensus 99 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999988765 57899999999999999999999999 9999999999999754 479999999987654
Q ss_pred cccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELP 600 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P 600 (605)
... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..++...+......+++|
T Consensus 176 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (287)
T 2wei_A 176 QNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244 (287)
T ss_dssp CCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG
T ss_pred CCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCch
Confidence 322 22233578999999998775 8899999999999999999999999999988888886544444433
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.52 Aligned_cols=219 Identities=34% Similarity=0.587 Sum_probs=178.4
Q ss_pred ccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhC--CCCCeeeEEEEEeeC----C
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL--RHPNVLLFMGAVASQ----E 448 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l--~h~niv~~~~~~~~~----~ 448 (605)
...++|++.++||+|+||.||+|.++++.||||++.... .....+|.+++..+ +||||+++++++... .
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 445789999999999999999999999999999985432 23445566666655 899999999999876 6
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCceeccCCCCCEEEcCCCcEEEE
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR--------NPPIVHRDLKSSNLLVDKNWTVKVG 520 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------~~~iiH~Dik~~Nill~~~~~vkl~ 520 (605)
.+++||||+++++|.+++.. ..+++..++.++.|++.||.|||++ | |+||||||+|||++.++.+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSCEEEC
T ss_pred ceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCCEEEE
Confidence 89999999999999999976 4689999999999999999999998 8 9999999999999999999999
Q ss_pred eecCCcccCccccc----ccCCCCCCcccccccccCCCCCch------hHHHHHHHHHHHHHcC----------CCCCCC
Q 038211 521 DFGLSSLKNATYLT----AKSGRGTPQWMAPEVLRSEPSNEK------SDVFSFGVILWELVTA----------SIPWNN 580 (605)
Q Consensus 521 Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------~DiwSlG~il~el~~g----------~~Pf~~ 580 (605)
|||++......... .....||+.|+|||++.+..++.. +|||||||++|||++| ..||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 99999654332211 234579999999999988766654 9999999999999999 888865
Q ss_pred C-----CHHHHHHHhccCCCccCCCCC
Q 038211 581 L-----NLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 581 ~-----~~~~~~~~I~~~~~~~~~P~~ 602 (605)
. ....+...+.....++.+|..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNR 291 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGG
T ss_pred hcCCCCchhhhHHHHhhhccCcccccc
Confidence 3 234455555445556666653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=332.88 Aligned_cols=229 Identities=29% Similarity=0.519 Sum_probs=192.5
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEECC-----cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNG-----SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS 446 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~-----~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 446 (605)
...+..++|++.+.||+|+||+||+|.+.. ..+|+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 345667899999999999999999998742 348888765432 3344577899999999999999999999984
Q ss_pred CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCc
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~ 526 (605)
++.+++||||+++|+|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 56789999999999999999877668999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCccc-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 527 LKNATY-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 527 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+++..|. .+.++++|+.++
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~ 618 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 618 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-HTCCCCCCTTCC
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCcccc
Confidence 654332 22233457889999999999999999999999999999997 999999999999998885 455677888776
Q ss_pred C
Q 038211 605 P 605 (605)
Q Consensus 605 ~ 605 (605)
+
T Consensus 619 ~ 619 (656)
T 2j0j_A 619 P 619 (656)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.38 Aligned_cols=208 Identities=23% Similarity=0.296 Sum_probs=180.7
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhC------CCCCeeeEEEEEe
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL------RHPNVLLFMGAVA 445 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l------~h~niv~~~~~~~ 445 (605)
+....+|+++++||+|+||+||+|.+. ++.||||++.... .....+.+|+.+++.+ .|+||+.+++++.
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 445578999999999999999999874 6779999986542 3345677888888887 5779999999999
Q ss_pred eCCeeEEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc--EEEEee
Q 038211 446 SQERLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT--VKVGDF 522 (605)
Q Consensus 446 ~~~~~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~--vkl~Df 522 (605)
....+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+||
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeec
Confidence 9999999999995 68999887653 45999999999999999999999999 999999999999999887 999999
Q ss_pred cCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 523 GLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 523 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
|++...... ....+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..|
T Consensus 247 G~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i 311 (429)
T 3kvw_A 247 GSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM 311 (429)
T ss_dssp TTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999754432 33557899999999999999999999999999999999999999998877776665
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.95 Aligned_cols=202 Identities=23% Similarity=0.305 Sum_probs=166.9
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC-----CcceEEEEeeccccch---------hhhhhHHHHHHHHHhCCCCCeeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN-----GSDVAVKVYFGSEYIE---------GTLKNYQKEIDIIKKLRHPNVLLF 440 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~-----~~~~avKv~~~~~~~~---------~~~~~~~~E~~il~~l~h~niv~~ 440 (605)
+..++|++.+.||+|+||.||+|.+. +..+|+|++....... .....+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 44578999999999999999999984 4669999987653211 112346678899999999999999
Q ss_pred EEEEee----CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC-
Q 038211 441 MGAVAS----QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW- 515 (605)
Q Consensus 441 ~~~~~~----~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~- 515 (605)
++++.. ...+++||||+ +++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSST
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCC
Confidence 999987 67899999999 99999998765 48999999999999999999999999 99999999999998877
Q ss_pred -cEEEEeecCCcccCccc-------ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 516 -TVKVGDFGLSSLKNATY-------LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 516 -~vkl~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99999999997653221 112445799999999999999999999999999999999999999965
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=311.45 Aligned_cols=202 Identities=34% Similarity=0.555 Sum_probs=175.7
Q ss_pred ccccCceEeeeecccCcEEEEEEEE-CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
+..++|++.+.||+|+||.||+|.+ +++.||||++...... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 105 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 105 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEE
T ss_pred HHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEE
Confidence 4457899999999999999999986 4778999998765422 2234688999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 454 TEFLPRGSLFKTLHKNY---QALDIKRRLRMALDVARGMNYLHHR---NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
|||+++++|.+++.... ..+++..+..++.||+.||+|||++ | |+||||||+|||++.++.+||+|||++..
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCCEEeccCccccc
Confidence 99999999999998643 3499999999999999999999999 9 99999999999999999999999999976
Q ss_pred cCccc-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 038211 528 KNATY-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWN 579 (605)
Q Consensus 528 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~ 579 (605)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 54322 22344569999999999988889999999999999999999999995
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.42 Aligned_cols=207 Identities=25% Similarity=0.379 Sum_probs=177.9
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC-----Cee
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ-----ERL 450 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~ 450 (605)
.+|+++++||+|+||.||+|.+. +..||||++.... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 58999999999999999999874 6679999986533 234457788999999999999999999999764 368
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
++||||+. ++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 106 ~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 99999996 599998876 56999999999999999999999999 99999999999999999999999999976543
Q ss_pred cccc---ccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 531 TYLT---AKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 531 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..|
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i 244 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH
Confidence 3221 234579999999998765 44899999999999999999999999988776666655
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=302.70 Aligned_cols=210 Identities=27% Similarity=0.372 Sum_probs=181.3
Q ss_pred ccCceEeeeecccCcEEEEEEEEC---CcceEEEEeeccccchhhhhhHHHHHHHHHhC---CCCCeeeEEEEEe-----
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN---GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL---RHPNVLLFMGAVA----- 445 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~---~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l---~h~niv~~~~~~~----- 445 (605)
.++|++.+.||+|+||.||+|.+. ++.||+|++............+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 378999999999999999999873 56799999876554444445677888888777 8999999999987
Q ss_pred eCCeeEEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecC
Q 038211 446 SQERLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524 (605)
Q Consensus 446 ~~~~~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~ 524 (605)
....+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecCcc
Confidence 4567999999997 69999987653 45899999999999999999999999 99999999999999999999999999
Q ss_pred CcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 525 SSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 525 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..|
T Consensus 167 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i 231 (326)
T 1blx_A 167 ARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 231 (326)
T ss_dssp CCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 97654332 334567899999999999999999999999999999999999999998877776665
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=306.46 Aligned_cols=212 Identities=28% Similarity=0.468 Sum_probs=158.4
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEe------
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVA------ 445 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~------ 445 (605)
+...+|++.++||+|+||.||+|.+ .++.||||++.... ......+.+|+.+++.+. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 4456899999999999999999998 67789999885542 334567889999999995 999999999984
Q ss_pred --eCCeeEEEEEecCCCchHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEe
Q 038211 446 --SQERLGIVTEFLPRGSLFKTLHK--NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGD 521 (605)
Q Consensus 446 --~~~~~~lv~e~~~ggsL~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~D 521 (605)
....+++||||+. |+|.+++.. ....+++..++.++.||+.||.|||++|++|+||||||+|||++.++.+||+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEec
Confidence 3345899999995 799888865 34679999999999999999999999877799999999999999999999999
Q ss_pred ecCCcccCcccc------------cccCCCCCCcccccccc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 038211 522 FGLSSLKNATYL------------TAKSGRGTPQWMAPEVL---RSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586 (605)
Q Consensus 522 fg~a~~~~~~~~------------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~ 586 (605)
||++........ ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.....+
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 999976543211 11144589999999998 566788999999999999999999999988766555
Q ss_pred HHH
Q 038211 587 VGV 589 (605)
Q Consensus 587 ~~~ 589 (605)
...
T Consensus 262 ~~~ 264 (337)
T 3ll6_A 262 VNG 264 (337)
T ss_dssp ---
T ss_pred hcC
Confidence 443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=310.40 Aligned_cols=205 Identities=23% Similarity=0.382 Sum_probs=172.7
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee-------
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS------- 446 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~------- 446 (605)
...+|+++++||+|+||+||+|.+ +++.||||++..+. ....+|+.+++.++||||++++++|..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 346899999999999999999987 57789999886542 223479999999999999999999844
Q ss_pred -------------------------------CCeeEEEEEecCCCchHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHH
Q 038211 447 -------------------------------QERLGIVTEFLPRGSLFKTLHK---NYQALDIKRRLRMALDVARGMNYL 492 (605)
Q Consensus 447 -------------------------------~~~~~lv~e~~~ggsL~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~L 492 (605)
...+++||||++ ++|.+.+.. ....+++..++.++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334889999997 587777653 347799999999999999999999
Q ss_pred HhCCCCceeccCCCCCEEEc-CCCcEEEEeecCCcccCcccccccCCCCCCcccccccccCCC-CCchhHHHHHHHHHHH
Q 038211 493 HHRNPPIVHRDLKSSNLLVD-KNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVILWE 570 (605)
Q Consensus 493 H~~~~~iiH~Dik~~Nill~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~e 570 (605)
|++| |+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+
T Consensus 158 H~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 158 HSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp HTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 9999 99999999999998 68999999999998654332 334557899999999988754 8999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHh
Q 038211 571 LVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 571 l~~g~~Pf~~~~~~~~~~~I 590 (605)
|++|+.||.+.+..+.+..|
T Consensus 235 ll~g~~pf~~~~~~~~~~~i 254 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLVRI 254 (383)
T ss_dssp HHHSSCSSCCSSHHHHHHHH
T ss_pred HHhCCCCCCCCChHHHHHHH
Confidence 99999999998877666665
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=301.51 Aligned_cols=193 Identities=23% Similarity=0.394 Sum_probs=169.4
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEee--CCee
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVAS--QERL 450 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~--~~~~ 450 (605)
..++|+++++||+|+||+||+|.+ .++.||||++... ..+.+.+|+.+++.++ ||||+++++++.. ....
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 457899999999999999999987 5778999998643 2466889999999997 9999999999987 5678
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC-cEEEEeecCCcccC
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW-TVKVGDFGLSSLKN 529 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~-~vkl~Dfg~a~~~~ 529 (605)
++||||+++++|..++. .+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+++...
T Consensus 109 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999988874 3889999999999999999999999 99999999999999776 89999999997654
Q ss_pred cccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 183 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 183 PGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp TTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 332 2345578999999999987 6689999999999999999999999954
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.51 Aligned_cols=205 Identities=24% Similarity=0.331 Sum_probs=170.5
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC------
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ------ 447 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------ 447 (605)
...+|++.++||+|+||+||+|.+ .++.||||++.... ....+|+.+|+.++||||++++++|...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 345799999999999999999998 47789999886542 2234799999999999999999998542
Q ss_pred CeeEEEEEecCCCchHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC-CcEEEEeec
Q 038211 448 ERLGIVTEFLPRGSLFKTLHK---NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN-WTVKVGDFG 523 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~-~~vkl~Dfg 523 (605)
.++++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccch
Confidence 247899999965 66666543 3477999999999999999999999999 9999999999999965 678999999
Q ss_pred CCcccCcccccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 524 LSSLKNATYLTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 524 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..|
T Consensus 203 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i 269 (420)
T 1j1b_A 203 SAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 269 (420)
T ss_dssp TCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred hhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 998653322 23456789999999999775 6899999999999999999999999998765555444
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=322.07 Aligned_cols=206 Identities=16% Similarity=0.175 Sum_probs=166.3
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeecccc-chhhhhhHHHHHHH---HHhCCCCCeeeEE-------EE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY-IEGTLKNYQKEIDI---IKKLRHPNVLLFM-------GA 443 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~-~~~~~~~~~~E~~i---l~~l~h~niv~~~-------~~ 443 (605)
.++|++.+.||+|+||+||+|.+ .++.||||++..... .....+.+.+|+.+ ++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46899999999999999999986 478899999976532 33456778899954 5555799999988 66
Q ss_pred EeeCC-----------------eeEEEEEecCCCchHHHHHhhcCCCC-------HHHHHHHHHHHHHHHHHHHhCCCCc
Q 038211 444 VASQE-----------------RLGIVTEFLPRGSLFKTLHKNYQALD-------IKRRLRMALDVARGMNYLHHRNPPI 499 (605)
Q Consensus 444 ~~~~~-----------------~~~lv~e~~~ggsL~~~l~~~~~~~~-------~~~~~~~~~qi~~aL~~LH~~~~~i 499 (605)
+..++ ..++||||+ +|+|.+++.... .++ +..++.++.||+.||+|||++| |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 66543 288999999 689999998652 233 4788889999999999999999 9
Q ss_pred eeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCCCCCcccccccccCC-----------CCCchhHHHHHHHHH
Q 038211 500 VHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSE-----------PSNEKSDVFSFGVIL 568 (605)
Q Consensus 500 iH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwSlG~il 568 (605)
+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 9999999999999999999999999986433 2334567 999999999887 899999999999999
Q ss_pred HHHHcCCCCCCCCCHHHHHHHh
Q 038211 569 WELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 569 ~el~~g~~Pf~~~~~~~~~~~I 590 (605)
|||++|+.||.+.+..+....+
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~ 325 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWI 325 (377)
T ss_dssp HHHHHSSCCC------CCSGGG
T ss_pred HHHHHCCCCCcccccccchhhh
Confidence 9999999999876655444444
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=319.09 Aligned_cols=210 Identities=27% Similarity=0.425 Sum_probs=168.0
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc------hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI------EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~------~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
..++|.+.++||+|+||+||+|.+. ++.||||++.+.... ......+.+|+.+|+.++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3478999999999999999999874 567999998765432 1233468899999999999999999999854
Q ss_pred CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC---cEEEEeecC
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW---TVKVGDFGL 524 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~---~vkl~Dfg~ 524 (605)
+.+++||||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeeccc
Confidence 5689999999999999888664 67999999999999999999999999 99999999999997544 599999999
Q ss_pred CcccCcccccccCCCCCCcccccccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHh
Q 038211 525 SSLKNATYLTAKSGRGTPQWMAPEVLRS---EPSNEKSDVFSFGVILWELVTASIPWNNLNL-MQVVGVV 590 (605)
Q Consensus 525 a~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~-~~~~~~I 590 (605)
++...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ..+...+
T Consensus 289 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i 357 (419)
T 3i6u_A 289 SKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 357 (419)
T ss_dssp TTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH
T ss_pred ceecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH
Confidence 98765332 2345679999999999864 5678899999999999999999999986433 3333444
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.12 Aligned_cols=204 Identities=25% Similarity=0.386 Sum_probs=176.8
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee-----
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL----- 450 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~----- 450 (605)
++|.+.+.||+|+||.||+|.+. ++.||||++..........+.+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 68999999999999999999874 77899999977655555677889999999999999999999999876654
Q ss_pred -EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 451 -GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 451 -~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
++||||+. ++|.+++. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 122 ~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred EEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999996 68877764 45999999999999999999999999 9999999999999999999999999997654
Q ss_pred cccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 196 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 254 (371)
T 4exu_A 196 AE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 254 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 32 334578999999999987 67899999999999999999999999998877777666
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=316.36 Aligned_cols=211 Identities=26% Similarity=0.398 Sum_probs=178.4
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC--eeE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE--RLG 451 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~~~ 451 (605)
..++|++.++||+|+||+||+|.+. ++.||||++..... ....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 4578999999999999999999985 77899999875432 233566789999999999999999999998754 789
Q ss_pred EEEEecCCCchHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE----cCCCcEEEEeecCC
Q 038211 452 IVTEFLPRGSLFKTLHKNY--QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV----DKNWTVKVGDFGLS 525 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill----~~~~~vkl~Dfg~a 525 (605)
+|||||++++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999997643 33999999999999999999999999 9999999999999 77888999999999
Q ss_pred cccCcccccccCCCCCCcccccccccC--------CCCCchhHHHHHHHHHHHHHcCCCCCCC----CCHHHHHHHh
Q 038211 526 SLKNATYLTAKSGRGTPQWMAPEVLRS--------EPSNEKSDVFSFGVILWELVTASIPWNN----LNLMQVVGVV 590 (605)
Q Consensus 526 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el~~g~~Pf~~----~~~~~~~~~I 590 (605)
+...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.. ....+++..+
T Consensus 164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp EECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred eEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 8654432 2345679999999999875 4567899999999999999999999964 2334555554
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=310.80 Aligned_cols=208 Identities=24% Similarity=0.346 Sum_probs=171.8
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC---
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE--- 448 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--- 448 (605)
+.....+|++.++||+|+||+||+|.+. +..+|+|.+.... ....+|+.+++.++||||++++++|...+
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK------RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc------chHHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 3445578999999999999999999984 4458888875532 22347999999999999999999996543
Q ss_pred ---eeEEEEEecCCCchHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc-CCCcEEEEe
Q 038211 449 ---RLGIVTEFLPRGSLFKTLH---KNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD-KNWTVKVGD 521 (605)
Q Consensus 449 ---~~~lv~e~~~ggsL~~~l~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~-~~~~vkl~D 521 (605)
.+++||||++++ +...+. .....+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|
T Consensus 109 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 109 DEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp SCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECC
T ss_pred CceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEee
Confidence 388999999764 444332 23478999999999999999999999999 99999999999999 799999999
Q ss_pred ecCCcccCcccccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 522 FGLSSLKNATYLTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 522 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..|
T Consensus 186 FG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i 254 (394)
T 4e7w_A 186 FGSAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI 254 (394)
T ss_dssp CTTCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99997653332 23456789999999999775 4899999999999999999999999998876666554
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=303.09 Aligned_cols=200 Identities=34% Similarity=0.555 Sum_probs=174.5
Q ss_pred ceEeeeecccCcEEEEEEEECCcceEEEEeecccc--chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEec
Q 038211 380 LQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEY--IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFL 457 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~ 457 (605)
|...+.||+|+||.||+|.+.++.+|+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 45568999999999999999999999999865432 2344677889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc--c
Q 038211 458 PRGSLFKTLHKN--YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY--L 533 (605)
Q Consensus 458 ~ggsL~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~--~ 533 (605)
++++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++....... .
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 999999998753 356899999999999999999999999 9999999999999999999999999987654322 2
Q ss_pred cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
......||+.|+|||.+.+. ++.++|||||||++|+|++|..||...+
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred cccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 23345789999999998764 7899999999999999999999998754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.80 Aligned_cols=211 Identities=22% Similarity=0.318 Sum_probs=173.8
Q ss_pred ccCceEeeeecccCcEEEEEEEE-CCcceEEEEeeccccch---------hhhhhHHHHHHHHHhCCCCCeeeEEEEEee
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIE---------GTLKNYQKEIDIIKKLRHPNVLLFMGAVAS 446 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~~---------~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 446 (605)
.++|++.+.||+|+||.||+|.+ .+..||||++....... ...+.+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 47899999999999999999986 46779999986543221 224678999999999999999999999854
Q ss_pred -----CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEe
Q 038211 447 -----QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGD 521 (605)
Q Consensus 447 -----~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~D 521 (605)
...+++||||+. ++|.+.+......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|
T Consensus 101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred ccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCCCEEEEe
Confidence 336899999996 6888888877678999999999999999999999999 99999999999999999999999
Q ss_pred ecCCcccCcccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 522 FGLSSLKNATYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 522 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus 178 fg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 178 FNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp TTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99997543322 2334578999999999987 678999999999999999999999999988777776663
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=304.87 Aligned_cols=215 Identities=29% Similarity=0.489 Sum_probs=165.2
Q ss_pred CCccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
..+..++|++.+.||+|+||.||+|.+ +++.||||++..... ......+.+|+.+++.++||||+++++++...+..
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 456678999999999999999999986 577899998865432 23456688999999999999999999999999999
Q ss_pred EEEEEecCCCchHHHHHh-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeec
Q 038211 451 GIVTEFLPRGSLFKTLHK-------NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFG 523 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~-------~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg 523 (605)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999999874 2356899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccCccc-----ccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 524 LSSLKNATY-----LTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 524 ~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 239 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT 239 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH
Confidence 986543221 12234568999999999876 56899999999999999999999999987776655544
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=299.24 Aligned_cols=225 Identities=23% Similarity=0.335 Sum_probs=183.6
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhhHHHHHHHHHhCC--CCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR--HPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~--h~niv~~~~~~~~~~~~~ 451 (605)
+..++|++++.||+|+||.||++.+. ++.||||++..........+.+.+|+.+++.++ ||||+++++++...+.++
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 45578999999999999999999874 667999999776655666788999999999996 599999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+|||+ .+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++. +.+||+|||++......
T Consensus 105 lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 105 MVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEECC-CSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred EEEec-CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 99994 588999999875 67899999999999999999999999 999999999999964 89999999999765432
Q ss_pred cc--cccCCCCCCcccccccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHhccCCCcc
Q 038211 532 YL--TAKSGRGTPQWMAPEVLRS-----------EPSNEKSDVFSFGVILWELVTASIPWNNL-NLMQVVGVVGFMDRRL 597 (605)
Q Consensus 532 ~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~el~~g~~Pf~~~-~~~~~~~~I~~~~~~~ 597 (605)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... +....+..+......+
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 259 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc
Confidence 21 2234568999999999876 46788999999999999999999999875 3444555554455666
Q ss_pred CCCCCCC
Q 038211 598 ELPEGLD 604 (605)
Q Consensus 598 ~~P~~~~ 604 (605)
.+|..++
T Consensus 260 ~~~~~~~ 266 (313)
T 3cek_A 260 EFPDIPE 266 (313)
T ss_dssp CCCCCSC
T ss_pred CCcccch
Confidence 6776553
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=314.11 Aligned_cols=200 Identities=15% Similarity=0.139 Sum_probs=157.1
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeecccc-chhhhhhHHHHHHHHHhC--CCCCeeeEE-------EEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKL--RHPNVLLFM-------GAV 444 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l--~h~niv~~~-------~~~ 444 (605)
..+|++.++||+|+||+||+|.+ +++.||||++..... .....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 35699999999999999999997 467799999987654 234556677885555554 699988865 444
Q ss_pred eeC-----------------CeeEEEEEecCCCchHHHHHhhcCCCCHHHH------HHHHHHHHHHHHHHHhCCCCcee
Q 038211 445 ASQ-----------------ERLGIVTEFLPRGSLFKTLHKNYQALDIKRR------LRMALDVARGMNYLHHRNPPIVH 501 (605)
Q Consensus 445 ~~~-----------------~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~------~~~~~qi~~aL~~LH~~~~~iiH 501 (605)
..+ ..+++||||++ ++|.+++......+++..+ +.++.||+.||+|||++| |+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivH 217 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVH 217 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 332 34899999997 8999999876455566666 677899999999999999 999
Q ss_pred ccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCCCCCcccccccccC--CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 038211 502 RDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS--EPSNEKSDVFSFGVILWELVTASIPWN 579 (605)
Q Consensus 502 ~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~Pf~ 579 (605)
|||||+|||++.+|.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999998654322 13456799999999987 678999999999999999999999998
Q ss_pred CCC
Q 038211 580 NLN 582 (605)
Q Consensus 580 ~~~ 582 (605)
+..
T Consensus 295 ~~~ 297 (371)
T 3q60_A 295 LVT 297 (371)
T ss_dssp BCC
T ss_pred CcC
Confidence 764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=310.02 Aligned_cols=201 Identities=25% Similarity=0.355 Sum_probs=172.5
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCC--------CCCeeeEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR--------HPNVLLFMG 442 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~--------h~niv~~~~ 442 (605)
+++..++|++.++||+|+||+||+|++. ++.||||++... ....+.+.+|+.+++.++ |+||+++++
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 4555689999999999999999999874 677999998653 334567889999999995 788999999
Q ss_pred EEe----eCCeeEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeccCCCCCEEEcCCC-
Q 038211 443 AVA----SQERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHR-NPPIVHRDLKSSNLLVDKNW- 515 (605)
Q Consensus 443 ~~~----~~~~~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~-~~~iiH~Dik~~Nill~~~~- 515 (605)
+|. ....+++||||+ +++|.+.+... ...+++..++.++.||+.||+|||++ | |+||||||+|||++.++
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHH
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccch
Confidence 997 456899999999 55666665543 46799999999999999999999998 9 99999999999998775
Q ss_pred ------------------------------------------------cEEEEeecCCcccCcccccccCCCCCCccccc
Q 038211 516 ------------------------------------------------TVKVGDFGLSSLKNATYLTAKSGRGTPQWMAP 547 (605)
Q Consensus 516 ------------------------------------------------~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aP 547 (605)
.+||+|||++...... .....||+.|+||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aP 262 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCH
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCC
Confidence 7999999999765432 3345789999999
Q ss_pred ccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 548 EVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 548 E~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
|++.+..++.++|||||||++|+|++|+.||...+
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 99999999999999999999999999999998654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=300.89 Aligned_cols=210 Identities=23% Similarity=0.351 Sum_probs=182.3
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEE---CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCC------CeeeEEE
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIW---NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP------NVLLFMG 442 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~---~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~------niv~~~~ 442 (605)
.+.+..++|++.++||+|+||+||+|.+ .++.||||++... ....+.+.+|+.+++.++|+ +++++++
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~ 84 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence 3456678999999999999999999987 4677999998643 23456788999999998655 5999999
Q ss_pred EEeeCCeeEEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC--------
Q 038211 443 AVASQERLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK-------- 513 (605)
Q Consensus 443 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~-------- 513 (605)
++...+.+++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccC
Confidence 999999999999999 889999987653 46899999999999999999999999 999999999999987
Q ss_pred -----------CCcEEEEeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 514 -----------NWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 514 -----------~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred CccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 668999999999764332 235578999999999999999999999999999999999999999988
Q ss_pred HHHHHHHh
Q 038211 583 LMQVVGVV 590 (605)
Q Consensus 583 ~~~~~~~I 590 (605)
..+....+
T Consensus 239 ~~~~~~~~ 246 (339)
T 1z57_A 239 SKEHLAMM 246 (339)
T ss_dssp HHHHHHHH
T ss_pred hHHHHHHH
Confidence 77766655
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=303.99 Aligned_cols=218 Identities=33% Similarity=0.595 Sum_probs=183.7
Q ss_pred cccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHh--CCCCCeeeEEEEEeeCC----e
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKK--LRHPNVLLFMGAVASQE----R 449 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~--l~h~niv~~~~~~~~~~----~ 449 (605)
..++|++.+.||+|+||.||+|.++++.||||++... ....+.+|.++++. ++||||+++++++.... .
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 3478999999999999999999999999999998543 23557789999988 68999999999998765 7
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceeccCCCCCEEEcCCCcEEEEe
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH--------HRNPPIVHRDLKSSNLLVDKNWTVKVGD 521 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH--------~~~~~iiH~Dik~~Nill~~~~~vkl~D 521 (605)
+++||||+++++|.+++.+ ..+++..++.++.||+.||.||| +.+ |+||||||+|||++.++.+||+|
T Consensus 115 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEEECC
T ss_pred eEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEEEEE
Confidence 9999999999999999976 46899999999999999999999 889 99999999999999999999999
Q ss_pred ecCCcccCcccc----cccCCCCCCcccccccccCCC------CCchhHHHHHHHHHHHHHcC----------CCCCCCC
Q 038211 522 FGLSSLKNATYL----TAKSGRGTPQWMAPEVLRSEP------SNEKSDVFSFGVILWELVTA----------SIPWNNL 581 (605)
Q Consensus 522 fg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~el~~g----------~~Pf~~~ 581 (605)
||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++| ..||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 999976443221 234457999999999998763 23689999999999999999 8899764
Q ss_pred -----CHHHHHHHhccCCCccCCCCC
Q 038211 582 -----NLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 582 -----~~~~~~~~I~~~~~~~~~P~~ 602 (605)
....+...+.....++.+|..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (342)
T 1b6c_B 271 VPSDPSVEEMRKVVCEQKLRPNIPNR 296 (342)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGG
T ss_pred CcCcccHHHHHHHHHHHHhCCCCccc
Confidence 345666666555566666653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=298.13 Aligned_cols=198 Identities=25% Similarity=0.345 Sum_probs=171.2
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEE-eeCCeeEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAV-ASQERLGIV 453 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-~~~~~~~lv 453 (605)
.++|++.+.||+|+||.||+|.+ .++.||||++..... ...+.+|+.+++.++|++++..+.++ ......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 46899999999999999999996 577899999865432 34578999999999888766555544 567788999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE---cCCCcEEEEeecCCcccCc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill---~~~~~vkl~Dfg~a~~~~~ 530 (605)
|||+ +++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++.....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 9999 99999999876678999999999999999999999999 9999999999999 4788999999999976543
Q ss_pred ccc-------cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 531 TYL-------TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 531 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 321 224557999999999999999999999999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=297.05 Aligned_cols=216 Identities=25% Similarity=0.456 Sum_probs=175.4
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee---------
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS--------- 446 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--------- 446 (605)
++|++++.||+|+||.||+|.+ .++.||||++... ....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 6799999999999999999997 4778999998543 3445778899999999999999999998864
Q ss_pred ----CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEee
Q 038211 447 ----QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDF 522 (605)
Q Consensus 447 ----~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Df 522 (605)
.+.+++||||+++++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEeeC
Confidence 45789999999999999999876677889999999999999999999999 999999999999999999999999
Q ss_pred cCCcccCcc--------------cccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCC-CCHHHH
Q 038211 523 GLSSLKNAT--------------YLTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNN-LNLMQV 586 (605)
Q Consensus 523 g~a~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~-~~~~~~ 586 (605)
|++...... ........||+.|+|||++.+. .++.++|||||||++|+|++ ||.. .+..++
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 999764321 1122345689999999999865 68999999999999999998 6654 344566
Q ss_pred HHHhccCCCccCCCCCC
Q 038211 587 VGVVGFMDRRLELPEGL 603 (605)
Q Consensus 587 ~~~I~~~~~~~~~P~~~ 603 (605)
...+. .....+|+.+
T Consensus 238 ~~~~~--~~~~~~~~~~ 252 (303)
T 1zy4_A 238 LKKLR--SVSIEFPPDF 252 (303)
T ss_dssp HHHHH--STTCCCCTTC
T ss_pred HHhcc--ccccccCccc
Confidence 66663 3345555554
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=302.88 Aligned_cols=203 Identities=33% Similarity=0.546 Sum_probs=176.4
Q ss_pred CccccCceEeeeecccCcEEEEEEEE------CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW------NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~------~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
.+..++|+++++||+|+||.||++.+ .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 35567899999999999999999984 4677999998653 234567789999999999999999999998764
Q ss_pred C--eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCC
Q 038211 448 E--RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525 (605)
Q Consensus 448 ~--~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a 525 (605)
+ .+++||||+++++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcch
Confidence 3 789999999999999999887677999999999999999999999999 999999999999999999999999999
Q ss_pred cccCcccc---cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 526 SLKNATYL---TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 526 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
........ ......+++.|+|||.+.+..++.++|||||||++|+|++|..||..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 76543321 12334578889999999988899999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=295.72 Aligned_cols=199 Identities=25% Similarity=0.348 Sum_probs=168.8
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEE-eeCCeeEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAV-ASQERLGIV 453 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-~~~~~~~lv 453 (605)
.++|++.+.||+|+||+||+|.+ .++.||||++.... ....+.+|+.+++.++|++++..+..+ ...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 36899999999999999999996 57789999865543 234578899999999887766655554 667889999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE---cCCCcEEEEeecCCcccCc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill---~~~~~vkl~Dfg~a~~~~~ 530 (605)
|||+ +++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 9999 99999999876678999999999999999999999999 9999999999999 7889999999999976543
Q ss_pred ccc-------cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 531 TYL-------TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 531 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 221 2235578999999999999999999999999999999999999998643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=306.54 Aligned_cols=195 Identities=16% Similarity=0.243 Sum_probs=170.4
Q ss_pred ccCceEeeeecccCcEEEEEEEEC----------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeee-------
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN----------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLL------- 439 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~----------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~------- 439 (605)
.++|++.+.||+|+||.||+|.+. ++.||||++... +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 478999999999999999999874 567999998653 46789999999999999887
Q ss_pred --------EEEEEee-CCeeEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCE
Q 038211 440 --------FMGAVAS-QERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNL 509 (605)
Q Consensus 440 --------~~~~~~~-~~~~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Ni 509 (605)
+++++.. ...+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NI 190 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENI 190 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHE
Confidence 6677765 67899999999 99999999865 467999999999999999999999999 99999999999
Q ss_pred EEcCCC--cEEEEeecCCcccCcccc-------cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 510 LVDKNW--TVKVGDFGLSSLKNATYL-------TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 510 ll~~~~--~vkl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
|++.++ .+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 999999999976543221 12344799999999999999999999999999999999999999987
Q ss_pred C
Q 038211 581 L 581 (605)
Q Consensus 581 ~ 581 (605)
.
T Consensus 271 ~ 271 (352)
T 2jii_A 271 C 271 (352)
T ss_dssp G
T ss_pred C
Confidence 5
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=302.02 Aligned_cols=209 Identities=27% Similarity=0.357 Sum_probs=176.7
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC-----C
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ-----E 448 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~ 448 (605)
..++|++.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 3478999999999999999999985 7789999986432 234456778999999999999999999988654 6
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
..++||||+. ++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 7899999996 689988876 57999999999999999999999999 999999999999999999999999999765
Q ss_pred Ccccc----------cccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 529 NATYL----------TAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 529 ~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 235 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 42211 1223478999999998765 67899999999999999999999999998866555544
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=304.50 Aligned_cols=204 Identities=25% Similarity=0.381 Sum_probs=175.3
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe------
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER------ 449 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~------ 449 (605)
++|.+.+.||+|+||.||+|.+. ++.||||++..........+.+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 68999999999999999999874 7789999987655455556788899999999999999999999987654
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+++||||+. ++|.+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 499999996 68877764 35899999999999999999999999 9999999999999999999999999997654
Q ss_pred cccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..|
T Consensus 178 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i 236 (353)
T 3coi_A 178 AE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 236 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHH
T ss_pred CC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 32 234578999999999987 67899999999999999999999999998877666655
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=300.92 Aligned_cols=201 Identities=28% Similarity=0.447 Sum_probs=168.3
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc------hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI------EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~------~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
.++|++.+.||+|+||.||+|.+. ++.||||++...... ......+.+|+.+++.++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 468999999999999999999884 577999998764321 223456889999999999999999999987654
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc---EEEEeecCC
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT---VKVGDFGLS 525 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~---vkl~Dfg~a 525 (605)
+++||||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+|||++
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred -eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 89999999999999988764 67999999999999999999999999 999999999999987654 999999999
Q ss_pred cccCcccccccCCCCCCccccccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 526 SLKNATYLTAKSGRGTPQWMAPEVLR---SEPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 526 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
....... ......||+.|+|||++. +..++.++|||||||++|+|++|..||....
T Consensus 165 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 165 KILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp EECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred eeccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 7654332 122346899999999974 4668899999999999999999999997644
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.09 Aligned_cols=211 Identities=22% Similarity=0.316 Sum_probs=181.0
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CC-----CeeeEEEE
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HP-----NVLLFMGA 443 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~-----niv~~~~~ 443 (605)
.+....++|++.++||+|+||+||+|.+. ++.||||++... ......+.+|+.+++.++ |+ +|+.++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 34556789999999999999999999874 667999998653 234566778899988884 54 49999999
Q ss_pred EeeCCeeEEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh--CCCCceeccCCCCCEEEc--CCCcEE
Q 038211 444 VASQERLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHH--RNPPIVHRDLKSSNLLVD--KNWTVK 518 (605)
Q Consensus 444 ~~~~~~~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~--~~~~iiH~Dik~~Nill~--~~~~vk 518 (605)
+...+.+++||||++ ++|.+++.... ..+++..++.++.||+.||.|||. .| |+||||||+|||++ .++.+|
T Consensus 125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~--ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS--IIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC--EECCCCSGGGEEESSTTSCCEE
T ss_pred eccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC--EEcCCCCcccEEEecCCCCcEE
Confidence 999999999999995 59999987753 569999999999999999999994 57 99999999999994 478899
Q ss_pred EEeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 519 VGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 519 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..|.
T Consensus 202 L~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~ 271 (382)
T 2vx3_A 202 IVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271 (382)
T ss_dssp ECCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEeccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999765432 235678999999999999999999999999999999999999999988877777663
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.56 Aligned_cols=208 Identities=24% Similarity=0.418 Sum_probs=171.5
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEe--------
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVA-------- 445 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-------- 445 (605)
..++|++++.||+|+||.||+|.+. ++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 4578999999999999999999985 6789999886542 345677889999999999999999999873
Q ss_pred ------eCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc-CCCcEE
Q 038211 446 ------SQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD-KNWTVK 518 (605)
Q Consensus 446 ------~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~-~~~~vk 518 (605)
....+++||||+. ++|.+++.. +.+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999996 699998865 57899999999999999999999999 99999999999997 567999
Q ss_pred EEeecCCcccCccc---ccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 519 VGDFGLSSLKNATY---LTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 519 l~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
|+|||+++...... .......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999998654221 12233457999999998876 67899999999999999999999999998877776665
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=312.97 Aligned_cols=200 Identities=23% Similarity=0.321 Sum_probs=173.7
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCC-CCeeeEEEEEeeCCeeEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH-PNVLLFMGAVASQERLGI 452 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~~~~l 452 (605)
..++|+++++||+|+||.||+|.+. ++.||||++..... ...+.+|+.+++.+.| +++..+..++...+..+|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 4578999999999999999999974 77899998765432 3457899999999976 566666667777888999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE---cCCCcEEEEeecCCcccC
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill---~~~~~vkl~Dfg~a~~~~ 529 (605)
||||+ +++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||| +.++.+||+|||+++...
T Consensus 81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99999 99999999876678999999999999999999999999 9999999999999 588999999999997654
Q ss_pred cccc-------cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 530 ATYL-------TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 530 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
.... ......||+.|+|||++.+..++.++|||||||+||+|++|+.||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~ 217 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 3321 2235679999999999999999999999999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=299.35 Aligned_cols=205 Identities=27% Similarity=0.404 Sum_probs=154.9
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHH-HHHhCCCCCeeeEEEEEeeCCe
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEID-IIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~-il~~l~h~niv~~~~~~~~~~~ 449 (605)
..+..++|++++.||+|+||.||+|.+. ++.||||++...... .....+.+|+. +++.++||||+++++++..++.
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE-KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH-HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc-hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 4566789999999999999999999985 778999998765432 23344555555 7777899999999999999999
Q ss_pred eEEEEEecCCCchHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeccCCCCCEEEcCCCcEEEEeecC
Q 038211 450 LGIVTEFLPRGSLFKTLHK----NYQALDIKRRLRMALDVARGMNYLHHR-NPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~-~~~iiH~Dik~~Nill~~~~~vkl~Dfg~ 524 (605)
.++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+. | |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccCCC
Confidence 9999999975 88777763 246789999999999999999999998 9 99999999999999999999999999
Q ss_pred CcccCcccccccCCCCCCcccccccc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 525 SSLKNATYLTAKSGRGTPQWMAPEVL----RSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 525 a~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
++...... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||...+
T Consensus 173 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 173 SGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp SCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred ceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 97654332 22334689999999998 45668999999999999999999999998754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=292.69 Aligned_cols=196 Identities=27% Similarity=0.429 Sum_probs=172.8
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee-------
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS------- 446 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~------- 446 (605)
...+|++++.||+|+||.||+|.+. ++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 3468999999999999999999985 7889999986542 356789999999999999999998864
Q ss_pred ---------CCeeEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc
Q 038211 447 ---------QERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT 516 (605)
Q Consensus 447 ---------~~~~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~ 516 (605)
...+++||||+++++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCC
Confidence 44589999999999999999764 367999999999999999999999999 999999999999999999
Q ss_pred EEEEeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 517 VKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 517 vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 161 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp EEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred EEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 9999999987654332 23345689999999999999999999999999999999999999854
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=297.88 Aligned_cols=202 Identities=22% Similarity=0.362 Sum_probs=170.8
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee----CC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS----QE 448 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----~~ 448 (605)
+..++|++.+.||+|+||.||++.+ .++.||||++... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 4457899999999999999999986 5778999988653 23456778899999999999999999999863 34
Q ss_pred eeEEEEEecCCCchHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCC
Q 038211 449 RLGIVTEFLPRGSLFKTLHK---NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS 525 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a 525 (605)
..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 78999999999999999876 3467999999999999999999999999 999999999999999999999999998
Q ss_pred cccCcccc---------cccCCCCCCcccccccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 526 SLKNATYL---------TAKSGRGTPQWMAPEVLRSEP---SNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 526 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 65432111 012234799999999997654 68899999999999999999999964
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=298.40 Aligned_cols=210 Identities=23% Similarity=0.364 Sum_probs=179.7
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEEC--C-cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCC------eeeEEE
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWN--G-SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN------VLLFMG 442 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~-~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~n------iv~~~~ 442 (605)
.+.+..++|++.+.||+|+||+||+|.+. + ..||+|++... ....+.+.+|+.+++.++|++ ++.+++
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 89 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSD 89 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence 35566789999999999999999999874 3 56999998643 234566788999999997655 999999
Q ss_pred EEeeCCeeEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE----------
Q 038211 443 AVASQERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV---------- 511 (605)
Q Consensus 443 ~~~~~~~~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill---------- 511 (605)
++...+.+++||||+ +++|.+.+... ...+++..++.++.||+.||+|||++| |+||||||+|||+
T Consensus 90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccc
Confidence 999999999999999 56676766654 357999999999999999999999999 9999999999999
Q ss_pred ---------cCCCcEEEEeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 512 ---------DKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 512 ---------~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 56789999999999764332 234578999999999999999999999999999999999999999988
Q ss_pred HHHHHHHh
Q 038211 583 LMQVVGVV 590 (605)
Q Consensus 583 ~~~~~~~I 590 (605)
..+.+..+
T Consensus 244 ~~~~~~~~ 251 (355)
T 2eu9_A 244 NREHLVMM 251 (355)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 77666555
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=296.04 Aligned_cols=212 Identities=24% Similarity=0.357 Sum_probs=164.9
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
...++|++++.||+|+||.||+|.+. ++.||||++..........+.+.++..+++.++||||+++++++..++.+++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 45689999999999999999999984 7789999997765444444555566677888899999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR-NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
||||+ ++.+..+.......+++..++.++.||+.||.|||+. | |+||||||+|||++.++.+||+|||++......
T Consensus 102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 99999 6677666666567899999999999999999999995 9 999999999999999999999999998755432
Q ss_pred cccccCCCCCCccccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHh
Q 038211 532 YLTAKSGRGTPQWMAPEVLR-----SEPSNEKSDVFSFGVILWELVTASIPWNN-LNLMQVVGVV 590 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~~Pf~~-~~~~~~~~~I 590 (605)
. ......||+.|+|||++. +..++.++|||||||++|+|++|+.||.. .+..+.+..+
T Consensus 179 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 242 (318)
T 2dyl_A 179 K-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred c-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence 2 223456899999999995 45678899999999999999999999987 4455666655
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=310.83 Aligned_cols=198 Identities=25% Similarity=0.399 Sum_probs=155.3
Q ss_pred cCceE-eeeecccCcEEEEEEEEC----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee--CCee
Q 038211 378 EDLQL-GEEIGLGSYAVVYRGIWN----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS--QERL 450 (605)
Q Consensus 378 ~~~~~-~~~LG~G~fg~V~~~~~~----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~ 450 (605)
+.|.+ +++||+|+||+||+|.+. +..||||++..... ...+.+|+.+|+.++||||++++++|.. ...+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 45666 568999999999999964 56799999865432 3457899999999999999999999954 6789
Q ss_pred EEEEEecCCCchHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE----cCCCcEE
Q 038211 451 GIVTEFLPRGSLFKTLHKNY--------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV----DKNWTVK 518 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill----~~~~~vk 518 (605)
++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+|
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999995 58888775321 24999999999999999999999999 9999999999999 6778999
Q ss_pred EEeecCCcccCccc---ccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 519 VGDFGLSSLKNATY---LTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 519 l~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
|+|||+++...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||...+
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999998654321 223456789999999999885 48999999999999999999999997644
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=299.45 Aligned_cols=210 Identities=21% Similarity=0.285 Sum_probs=165.3
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe---
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER--- 449 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~--- 449 (605)
...++|++.++||+|+||+||+|.+. +..||||++.... .......+++..++.++||||++++++|...+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 45689999999999999999999984 7789999886543 233456778888899999999999999975433
Q ss_pred ----eEEEEEecCCCchHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceeccCCCCCEEEcC-CCcEEE
Q 038211 450 ----LGIVTEFLPRGSLFKTLHK---NYQALDIKRRLRMALDVARGMNYLH--HRNPPIVHRDLKSSNLLVDK-NWTVKV 519 (605)
Q Consensus 450 ----~~lv~e~~~ggsL~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH--~~~~~iiH~Dik~~Nill~~-~~~vkl 519 (605)
+++||||+++ +|...+.. ....+++..+..++.||+.||.||| ++| |+||||||+|||++. ++.+||
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEE
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEE
Confidence 8899999976 55444432 3467899999999999999999999 889 999999999999996 899999
Q ss_pred EeecCCcccCcccccccCCCCCCcccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 520 GDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 520 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus 174 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 245 (360)
T 3e3p_A 174 CDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245 (360)
T ss_dssp CCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence 9999998654332 234557899999999997655 7999999999999999999999999988877776663
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.58 Aligned_cols=208 Identities=25% Similarity=0.386 Sum_probs=167.3
Q ss_pred ccccCceEeeeecccCcEEE-EEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVV-YRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V-~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~l 452 (605)
+...+|.+.++||+|+||+| |++..+++.||||++.... ...+.+|+.+|+.+ +||||+++++++.+...+++
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT-----EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 33456999999999999985 5666788999999986533 23467899999999 89999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC-----CCcEEEEeecCCcc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK-----NWTVKVGDFGLSSL 527 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~-----~~~vkl~Dfg~a~~ 527 (605)
|||||. |+|.+++........+..++.++.||+.||.|||++| |+||||||+|||++. ...+||+|||+++.
T Consensus 96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 999995 6999999876655666667789999999999999999 999999999999953 23688999999976
Q ss_pred cCccc---ccccCCCCCCccccccccc---CCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHh
Q 038211 528 KNATY---LTAKSGRGTPQWMAPEVLR---SEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 528 ~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I 590 (605)
..... ......+||+.|+|||++. ...++.++|||||||++|+|++ |..||......+....+
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~ 242 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh
Confidence 54321 2334567999999999998 4567889999999999999999 99999876655544444
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=295.88 Aligned_cols=203 Identities=23% Similarity=0.358 Sum_probs=175.6
Q ss_pred CccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccch----hhhhhHHHHHHHHHhCC--CCCeeeEEEEEe
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE----GTLKNYQKEIDIIKKLR--HPNVLLFMGAVA 445 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~----~~~~~~~~E~~il~~l~--h~niv~~~~~~~ 445 (605)
....++|++.+.||+|+||.||+|.+ .++.||||++....... .....+.+|+.+++.++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34567899999999999999999987 56779999987654332 23356778999999996 599999999999
Q ss_pred eCCeeEEEEEecCC-CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc-CCCcEEEEeec
Q 038211 446 SQERLGIVTEFLPR-GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD-KNWTVKVGDFG 523 (605)
Q Consensus 446 ~~~~~~lv~e~~~g-gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~-~~~~vkl~Dfg 523 (605)
.++..++|||++.+ ++|.+++... ..+++..++.++.||+.||+|||+.| |+||||||+|||++ .++.+||+|||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999976 8999998775 67999999999999999999999999 99999999999999 78999999999
Q ss_pred CCcccCcccccccCCCCCCcccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 524 LSSLKNATYLTAKSGRGTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 524 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...
T Consensus 196 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 196 SGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp TCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 99765433 2334568999999999987766 67899999999999999999999764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=296.25 Aligned_cols=202 Identities=26% Similarity=0.423 Sum_probs=147.3
Q ss_pred ccccCceEee-eecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee----C
Q 038211 375 IRWEDLQLGE-EIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS----Q 447 (605)
Q Consensus 375 ~~~~~~~~~~-~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----~ 447 (605)
...++|.+.+ +||+|+||+||+|.+. ++.||||++.... ....+....++.+.||||+++++++.. .
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 3457899965 6999999999999985 7789999986532 112233344667799999999999976 4
Q ss_pred CeeEEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC---CCcEEEEeec
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK---NWTVKVGDFG 523 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~---~~~vkl~Dfg 523 (605)
..+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 56899999999999999998753 47999999999999999999999999 999999999999976 4559999999
Q ss_pred CCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 038211 524 LSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586 (605)
Q Consensus 524 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~ 586 (605)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......+
T Consensus 177 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (336)
T 3fhr_A 177 FAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237 (336)
T ss_dssp TCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred cceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh
Confidence 99765432 23345689999999999888889999999999999999999999987654443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=296.70 Aligned_cols=204 Identities=25% Similarity=0.394 Sum_probs=166.2
Q ss_pred CCccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccch----hhhhhHHHHHHHHHhC----CCCCeeeEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE----GTLKNYQKEIDIIKKL----RHPNVLLFMG 442 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~----~~~~~~~~E~~il~~l----~h~niv~~~~ 442 (605)
.....++|++.+.||+|+||.||+|.+ .++.||||++....... .....+.+|+.+++.+ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999987 56779999986654322 2334566899999999 8999999999
Q ss_pred EEeeCCeeEEEEEe-cCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc-CCCcEEEE
Q 038211 443 AVASQERLGIVTEF-LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD-KNWTVKVG 520 (605)
Q Consensus 443 ~~~~~~~~~lv~e~-~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~-~~~~vkl~ 520 (605)
++...+..++|||+ +.+++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEEC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEE
Confidence 99999999999999 7899999999875 67999999999999999999999999 99999999999999 88999999
Q ss_pred eecCCcccCcccccccCCCCCCcccccccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 521 DFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSN-EKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 521 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
|||++...... ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||...
T Consensus 183 dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 183 DFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp CCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred EcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 99999765433 23345689999999999877664 5899999999999999999999763
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=307.51 Aligned_cols=196 Identities=20% Similarity=0.212 Sum_probs=166.9
Q ss_pred ccccCceEeeeecccCcEEEEEEEECCcceEEEEeecccc------chhhhhhHHHHHHHHHhCC---------CCCeee
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEY------IEGTLKNYQKEIDIIKKLR---------HPNVLL 439 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~------~~~~~~~~~~E~~il~~l~---------h~niv~ 439 (605)
+..++|+++++||+|+||+||+|+++++.||||++..... .....+.+.+|+.+++.++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4457899999999999999999999999999999977542 2233467889999999886 777777
Q ss_pred EEEEEe------------------------------eCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHH
Q 038211 440 FMGAVA------------------------------SQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGM 489 (605)
Q Consensus 440 ~~~~~~------------------------------~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL 489 (605)
+.+++. ..+.+++|||||++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 777642 26789999999999977776644 5689999999999999999
Q ss_pred HHHH-hCCCCceeccCCCCCEEEcCCC--------------------cEEEEeecCCcccCcccccccCCCCCCcccccc
Q 038211 490 NYLH-HRNPPIVHRDLKSSNLLVDKNW--------------------TVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPE 548 (605)
Q Consensus 490 ~~LH-~~~~~iiH~Dik~~Nill~~~~--------------------~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE 548 (605)
+||| ++| |+||||||+|||++.++ .+||+|||+|+..... ..+||+.|+|||
T Consensus 175 ~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSG
T ss_pred HHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChh
Confidence 9999 999 99999999999999887 9999999999865432 347899999999
Q ss_pred cccCCCCCchhHHHHHHHH-HHHHHcCCCCCCC
Q 038211 549 VLRSEPSNEKSDVFSFGVI-LWELVTASIPWNN 580 (605)
Q Consensus 549 ~~~~~~~~~~~DiwSlG~i-l~el~~g~~Pf~~ 580 (605)
++.+.. +.++|||||+++ .++++.|..||.+
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 999876 889999998777 7889999999965
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=296.58 Aligned_cols=199 Identities=21% Similarity=0.380 Sum_probs=169.6
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-----------CCCeeeEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-----------HPNVLLFM 441 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-----------h~niv~~~ 441 (605)
+...+|++.++||+|+||+||+|.+ .++.||||++.... .....+.+|+.+++.+. ||||++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc---cchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 4557899999999999999999997 57789999986532 23456788999999886 89999999
Q ss_pred EEEeeCC----eeEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeccCCCCCEEEc---
Q 038211 442 GAVASQE----RLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHR-NPPIVHRDLKSSNLLVD--- 512 (605)
Q Consensus 442 ~~~~~~~----~~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~-~~~iiH~Dik~~Nill~--- 512 (605)
+++...+ .+++||||+ +++|.+++... ...+++..++.++.||+.||+|||++ | |+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEE
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccC
Confidence 9997654 789999999 89999999764 35699999999999999999999998 9 99999999999994
Q ss_pred ---CCCcEEEEeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 513 ---KNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 513 ---~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4458999999999765432 234578999999999999999999999999999999999999998654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=279.06 Aligned_cols=178 Identities=15% Similarity=0.131 Sum_probs=155.9
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
+..++|++.+.||+|+||.||+|.+. ++.||||++...... ....+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 55578999999999999999999985 778999998765433 345577899999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+||||++|++|.+++... .....+..++.||+.||+|||++| |+||||||+|||++.+|.+||++++
T Consensus 108 lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999999998542 455678889999999999999999 9999999999999999999997443
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLM 584 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~ 584 (605)
|++| ++.++|||||||++|+|++|+.||.+.+..
T Consensus 175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence 3333 688999999999999999999999876543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=317.25 Aligned_cols=196 Identities=23% Similarity=0.331 Sum_probs=168.2
Q ss_pred CCccccCceEeeeecccCcEEEEEEEEC---CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWN---GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~---~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
+.+..++|++.++||+|+||+||++.+. ++.||||++.... .......+.+|+.+++.++||||++++++|...+.
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence 4455689999999999999999999873 6779999886533 23455678899999999999999999999987655
Q ss_pred -----eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecC
Q 038211 450 -----LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524 (605)
Q Consensus 450 -----~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~ 524 (605)
.||||||++|++|.+++.. .+++..++.++.||+.||+|||++| |+||||||+|||++.+ .+||+|||+
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp TSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred CCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEeccc
Confidence 7999999999999887654 6899999999999999999999999 9999999999999875 999999999
Q ss_pred CcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 525 SSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 525 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+
T Consensus 228 a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 228 VSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp CEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred chhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 9765433 345789999999998775 48899999999999999999999865
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=311.86 Aligned_cols=203 Identities=27% Similarity=0.362 Sum_probs=173.1
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee------
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS------ 446 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~------ 446 (605)
...++|++.++||+|+||.||+|.+ .++.||||++... ......+.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 3457899999999999999999987 4778999988654 234456778999999999999999999998765
Q ss_pred CCeeEEEEEecCCCchHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCc---EEEEe
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNY--QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWT---VKVGD 521 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~---vkl~D 521 (605)
.+..++||||++|++|.+++.... ..+++..++.++.||+.||+|||+.| |+||||||+|||++.++. +||+|
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcc
Confidence 677899999999999999998643 36889999999999999999999999 999999999999997764 99999
Q ss_pred ecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 522 FGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 522 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 168 FG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 168 LGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 99998754332 234567999999999999999999999999999999999999999764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=296.36 Aligned_cols=198 Identities=24% Similarity=0.366 Sum_probs=156.9
Q ss_pred cCceEeeeecccCcEEEEEE-EECCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRG-IWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~-~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lv~e 455 (605)
+.|.+.++||+|+||+||.+ ..+++.||||++... ..+.+.+|+.+++.+ +||||+++++++.+++.+++|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 44666789999999999754 457889999988653 234577899999876 89999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC-------------Cc
Q 038211 456 FLPRGSLFKTLHKNYQA------LDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN-------------WT 516 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~------~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~-------------~~ 516 (605)
||+ |+|.+++...... ..+..++.++.||+.||+|||++| |+||||||+|||++.+ +.
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceE
Confidence 995 6999999764221 122345679999999999999999 9999999999999754 48
Q ss_pred EEEEeecCCcccCcccc----cccCCCCCCcccccccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCCH
Q 038211 517 VKVGDFGLSSLKNATYL----TAKSGRGTPQWMAPEVLRS-------EPSNEKSDVFSFGVILWELVT-ASIPWNNLNL 583 (605)
Q Consensus 517 vkl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~ 583 (605)
+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+...
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 99999999986543321 1234579999999999976 568899999999999999999 9999987543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=296.67 Aligned_cols=208 Identities=19% Similarity=0.198 Sum_probs=161.7
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeecccc-chhhhhhHHHHHHHHHhCCC-CCe---------e----
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRH-PNV---------L---- 438 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h-~ni---------v---- 438 (605)
....|.+.+.||+|+||+||+|.+. ++.||||++..... .....+.+.+|+.+++.++| +|. +
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3456889999999999999999985 88899999874332 23346778999999999976 211 1
Q ss_pred --------eEEEEEee-----CCeeEEEEEecCCCchHHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 038211 439 --------LFMGAVAS-----QERLGIVTEFLPRGSLFKTLHK------NYQALDIKRRLRMALDVARGMNYLHHRNPPI 499 (605)
Q Consensus 439 --------~~~~~~~~-----~~~~~lv~e~~~ggsL~~~l~~------~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~i 499 (605)
.+..++.. ...++++|+++ +++|.+++.. ....+++..++.++.||+.||+|||++| |
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 232 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--L 232 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--c
Confidence 11111111 12467777776 7899998852 2345778888999999999999999999 9
Q ss_pred eeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCCCCCcccccccc----------cCCCCCchhHHHHHHHHHH
Q 038211 500 VHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL----------RSEPSNEKSDVFSFGVILW 569 (605)
Q Consensus 500 iH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwSlG~il~ 569 (605)
+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++|
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 99999999999999999999999998765433 345577 999999999 5566888999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHh
Q 038211 570 ELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 570 el~~g~~Pf~~~~~~~~~~~I 590 (605)
+|++|+.||...+..+....+
T Consensus 309 elltg~~Pf~~~~~~~~~~~~ 329 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSEWI 329 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSGGG
T ss_pred HHHHCCCCCCCcchhhhHHHH
Confidence 999999999987766555554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=269.72 Aligned_cols=182 Identities=24% Similarity=0.408 Sum_probs=152.4
Q ss_pred ccccCceEe-eeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHH-HhCCCCCeeeEEEEEee----
Q 038211 375 IRWEDLQLG-EEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDII-KKLRHPNVLLFMGAVAS---- 446 (605)
Q Consensus 375 ~~~~~~~~~-~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il-~~l~h~niv~~~~~~~~---- 446 (605)
...++|.+. +.||+|+||.||++.+ .++.||+|++... ..+.+|+.++ +..+||||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 345778887 7899999999999988 4678999998542 3467888887 55699999999999986
Q ss_pred CCeeEEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC---CCcEEEEee
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK---NWTVKVGDF 522 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~---~~~vkl~Df 522 (605)
...+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEecc
Confidence 678999999999999999998753 47999999999999999999999999 999999999999997 789999999
Q ss_pred cCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 038211 523 GLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587 (605)
Q Consensus 523 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~ 587 (605)
|++.... +..++.++|||||||++|+|++|+.||.+.+...+.
T Consensus 165 g~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 207 (299)
T 3m2w_A 165 GFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 207 (299)
T ss_dssp TTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------
T ss_pred ccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh
Confidence 9985432 234678999999999999999999999876655443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=293.46 Aligned_cols=187 Identities=15% Similarity=0.101 Sum_probs=134.9
Q ss_pred eeecccCcEEEEEEE--ECCcceEEEEeeccccc--------hhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCCeeEE
Q 038211 384 EEIGLGSYAVVYRGI--WNGSDVAVKVYFGSEYI--------EGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~--~~~~~~avKv~~~~~~~--------~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~l 452 (605)
..++.|++|.+..++ +.|+.|++|++.++... +...+.+.+|+++|+++ .|+||++++++++++..+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 456677777776543 46999999999765321 23456789999999999 79999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
|||||+|++|.+++.+. +.+++. .++.||+.||+|||++| ||||||||+|||++.+|++||+|||+|+......
T Consensus 320 VMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999999875 667765 47889999999999999 9999999999999999999999999998776555
Q ss_pred ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCC
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIP 577 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~P 577 (605)
....+.+||+.|||||++.+. +..++|+||+|+++++|.++..|
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 555567899999999999875 56789999999998877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=260.72 Aligned_cols=186 Identities=18% Similarity=0.180 Sum_probs=148.5
Q ss_pred eEeeeecccCcEEEEEEEECCcceEEEEeeccccch------hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 381 QLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIE------GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 381 ~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~------~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
...++||+|+||+||++...+..+++|......... ...+.+.+|++++++++||||+++..++...+..+|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 445789999999999998889999999875543221 12456889999999999999995555555677889999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||++|++|.+++.. +..++.||+.||+|||+++ |+||||||+|||++. ++||+|||+++........
T Consensus 419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 99999999999875 4578999999999999999 999999999999998 9999999999876543221
Q ss_pred -------ccCCCCCCcccccccccC--CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 038211 535 -------AKSGRGTPQWMAPEVLRS--EPSNEKSDVFSFGVILWELVTASIPWN 579 (605)
Q Consensus 535 -------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~Pf~ 579 (605)
....+||+.|||||++.+ ..|+..+|+|+..+-..+...++.+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 235679999999999987 567778899999999999888887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.5e-23 Score=208.29 Aligned_cols=145 Identities=20% Similarity=0.185 Sum_probs=114.9
Q ss_pred CceEeeeecccCcEEEEEEEE-CCcceEEEEeeccccch----------------hhhhhHHHHHHHHHhCCCCCeeeEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIE----------------GTLKNYQKEIDIIKKLRHPNVLLFM 441 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~~----------------~~~~~~~~E~~il~~l~h~niv~~~ 441 (605)
.|.+++.||+|+||.||+|.+ .++.||||++....... .....+.+|+.+++.++ | +.+.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 456679999999999999998 47789999986432211 13456889999999998 4 5555
Q ss_pred EEEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEe
Q 038211 442 GAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGD 521 (605)
Q Consensus 442 ~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~D 521 (605)
+++.. +..++||||++|++|.+ +.. .....++.||+.||.|||++| |+||||||+|||++ ++.+||+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEEECC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEEEEE
Confidence 55433 56799999999999987 421 123468999999999999999 99999999999999 99999999
Q ss_pred ecCCcccCcccccccCCCCCCccccccccc
Q 038211 522 FGLSSLKNATYLTAKSGRGTPQWMAPEVLR 551 (605)
Q Consensus 522 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 551 (605)
||+|+. +..++|||.+.
T Consensus 236 FG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE-------------TTSTTHHHHHH
T ss_pred CCCCeE-------------CCCCCHHHHHH
Confidence 999852 44578898864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=5.3e-20 Score=181.81 Aligned_cols=137 Identities=20% Similarity=0.175 Sum_probs=105.5
Q ss_pred ceEeeeecccCcEEEEEEEE--CCcc--eEEEEeeccccch----------------------hhhhhHHHHHHHHHhCC
Q 038211 380 LQLGEEIGLGSYAVVYRGIW--NGSD--VAVKVYFGSEYIE----------------------GTLKNYQKEIDIIKKLR 433 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~--~~~~--~avKv~~~~~~~~----------------------~~~~~~~~E~~il~~l~ 433 (605)
|.+.+.||+|+||.||+|.+ .|+. ||||++....... .....+.+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999987 7888 9999975432110 01135788999999998
Q ss_pred CCCe--eeEEEEEeeCCeeEEEEEecCC-C----chHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceeccCC
Q 038211 434 HPNV--LLFMGAVASQERLGIVTEFLPR-G----SLFKTLHKNYQALDIKRRLRMALDVARGMNYLH-HRNPPIVHRDLK 505 (605)
Q Consensus 434 h~ni--v~~~~~~~~~~~~~lv~e~~~g-g----sL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~~~iiH~Dik 505 (605)
|+++ +.++.+ ...+|||||+.+ | +|.+.... .++..+..++.||+.||.||| +.| |+|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE--LVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCC
Confidence 7754 344432 367899999942 3 66655432 224456788999999999999 999 9999999
Q ss_pred CCCEEEcCCCcEEEEeecCCccc
Q 038211 506 SSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 506 ~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
|+|||++. .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999988 9999999998643
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.8e-17 Score=142.63 Aligned_cols=114 Identities=22% Similarity=0.371 Sum_probs=99.2
Q ss_pred cccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCc-chHHHHHHHHHcCCceEEEEE
Q 038211 56 VGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFH-SPHKKIMERLASGQSWSGQFP 134 (605)
Q Consensus 56 ~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~-~~~~~~~~~l~~g~~~~~~~~ 134 (605)
+++|+.+++++++++ +++|.+|+|+|+|++|++++||+.+|++|+++.+ +.++... .....++..+..++.|..++.
T Consensus 4 ~~~~~~~~~~~~~~i-~~~d~~g~i~~~N~a~~~~~G~~~~elig~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 81 (120)
T 2gj3_A 4 PEIFRQTVEHAPIAI-SITDLKANILYANRAFRTITGYGSEEVLGKNESI-LSNGTTPRLVYQALWGRLAQKKPWSGVLV 81 (120)
T ss_dssp HHHHHHHHHHCSSEE-EEECTTCBEEEECHHHHHHHCCCTTGGGGCBGGG-GCCTTSCHHHHHHHHHHHHTTCCEEEEEE
T ss_pred HHHHHHHHHhCCCeE-EEECCCCCEEeehHHHHHHHCcCHHHHcCCCHHH-cCCCCCCHHHHHHHHHHHHcCCCEEEEEE
Confidence 456889999999888 8999999999999999999999999999999987 4443333 235566778888999999999
Q ss_pred EEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEeccccc
Q 038211 135 FKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIF 171 (605)
Q Consensus 135 ~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~ 171 (605)
.++++|+.+|+.++..|+++ +|.+.+++++++|+|+.
T Consensus 82 ~~~~dG~~~~~~~~~~pi~~~~g~~~~~v~~~~DITe~ 119 (120)
T 2gj3_A 82 NRRKDKTLYLAELTVAPVLNEAGETIYYLGMHRDTSEL 119 (120)
T ss_dssp EECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCSC
T ss_pred EEcCCCCEEEEEEEEEEEECCCCCEEEEEEEeccCccc
Confidence 99999999999999999998 89999999999998863
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=3.5e-16 Score=132.38 Aligned_cols=103 Identities=20% Similarity=0.355 Sum_probs=89.1
Q ss_pred cCCeEEEEEc---CCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCc-chHHHHHHHHHcCCceEEEEEEEcCCCC
Q 038211 66 MGHAVHVCTA---SSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFH-SPHKKIMERLASGQSWSGQFPFKKRSGE 141 (605)
Q Consensus 66 ~~d~ii~v~D---~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~-~~~~~~~~~l~~g~~~~~~~~~~~k~G~ 141 (605)
+++++ +++| .+|+|+|+|++|++++||+.+|++|+++.. +.++... .....+++.+..++.+..++..++|||+
T Consensus 2 ~~~~i-~i~d~~~~~g~i~~~N~a~~~l~Gy~~~e~~G~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~ 79 (109)
T 1n9l_A 2 LRHTF-VVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRF-LQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGT 79 (109)
T ss_dssp CSCEE-EEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGG-GCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSC
T ss_pred CccEE-EEEcCCCCCCeEEEEchHHHHHHCcCHHHHcCCCchh-cCCCCCCHHHHHHHHHHHHcCCcEEEEEEEEcCCCC
Confidence 45666 8899 479999999999999999999999999875 4443332 3466788889999999999999999999
Q ss_pred EEEEEEEEEEEee-CCeEEEEEEEEecccc
Q 038211 142 ILMAVVTKSPLYE-DGELAGFITVSSDAAI 170 (605)
Q Consensus 142 ~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~ 170 (605)
.+|+.++..|+++ +|++.+++++++|+|+
T Consensus 80 ~~~~~~~~~pi~d~~G~~~~~v~~~~DITe 109 (109)
T 1n9l_A 80 PFWNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEEEECCCCCEEEEEEEEEeCCC
Confidence 9999999999998 8999999999999875
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.9e-17 Score=168.72 Aligned_cols=134 Identities=16% Similarity=0.131 Sum_probs=97.6
Q ss_pred ceEeeeecccCcEEEEEEEE-CCcceEEEEeeccccchh------------hh--------hhHHHHHHHHHhCCCCCee
Q 038211 380 LQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIEG------------TL--------KNYQKEIDIIKKLRHPNVL 438 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~~~------------~~--------~~~~~E~~il~~l~h~niv 438 (605)
|.+++.||.|+||.||+|.+ .|+.||||+++....... .. ....+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 89999999999999999987 578899999754321100 00 1123577777777544432
Q ss_pred --eEEEEEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC-
Q 038211 439 --LFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW- 515 (605)
Q Consensus 439 --~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~- 515 (605)
..+++ ...+|||||++|++|..+.. . .....++.||+.+|.+||++| ||||||||.|||++++|
T Consensus 177 vp~p~~~----~~~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 177 VPEPIAQ----SRHTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCCEEEE----ETTEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEEC
T ss_pred CCeeeec----cCceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCC
Confidence 22322 23479999999988855432 1 123457889999999999999 99999999999998776
Q ss_pred ---------cEEEEeecCCc
Q 038211 516 ---------TVKVGDFGLSS 526 (605)
Q Consensus 516 ---------~vkl~Dfg~a~ 526 (605)
.+.|+||+-+.
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCE
T ss_pred cccccccccceEEEEeCCcc
Confidence 48999999663
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.4e-15 Score=130.27 Aligned_cols=110 Identities=15% Similarity=0.185 Sum_probs=89.2
Q ss_pred cccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEE
Q 038211 54 DSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQF 133 (605)
Q Consensus 54 ~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~ 133 (605)
+++++|+.+++++++++ +++|.+|+|+++|+++++++||+.+|++|+++.+ +.++.........+..+..++.+..+.
T Consensus 8 ~se~~~~~l~e~~~d~i-~~~d~~g~i~~vN~a~~~l~Gy~~~el~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~e~ 85 (117)
T 2r78_A 8 FQSNAYRALFEHAIDGI-FIMDAEGHYLDVNPAICSAIGYTRDEFLALDWGV-LSRGVDSGWAAASLARIVGGEPLREER 85 (117)
T ss_dssp HHHHHHHHHHHHCSSEE-EEECTTSBEEEECHHHHHHHCCCHHHHTTCBTTT-TTTCSTTSHHHHHHHHHHTTCCEEEEE
T ss_pred HhHHHHHHHHhcCCceE-EEECCCCCEEEecHHHHHHHCcCHHHHcCCCHHH-hCCccchhHHHHHHHHHHcCCcEEEEE
Confidence 44567899999999988 8999999999999999999999999999999876 433333233445566777888888888
Q ss_pred EEEcCCCCEEEEEEEEEEEeeCCeEEEEEEEEeccc
Q 038211 134 PFKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAA 169 (605)
Q Consensus 134 ~~~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t 169 (605)
..+++||+.+|+.++..|+. +|. ++++++|||
T Consensus 86 ~~~~kdG~~~~v~~~~~~~~-~g~---~~~i~~DIT 117 (117)
T 2r78_A 86 TVWTRNGDQLTVELSAHLLP-DGK---ILGIARDVS 117 (117)
T ss_dssp EEECTTSCEEEEEEEEEECT-TSC---EEEEEEC--
T ss_pred EEEecCCCEEEEEEEEEEec-CCe---EEEEEEeCC
Confidence 99999999999999999986 565 567789975
|
| >1d06_A Nitrogen fixation regulatory protein FIXL; oxygen sensor, histidine kinase, PAS, high-resolution, two-C system, signaling protein; HET: HEM; 1.40A {Sinorhizobium meliloti} SCOP: d.110.3.2 PDB: 1ew0_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=5.1e-15 Score=129.13 Aligned_cols=116 Identities=22% Similarity=0.381 Sum_probs=88.4
Q ss_pred hcccccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHH-HHcCCc-
Q 038211 51 TTSDSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMER-LASGQS- 128 (605)
Q Consensus 51 ~~~~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~-l~~g~~- 128 (605)
++.++..+|+.+++++++++ +++|.+|+|++||+++++++||+.+|++|+++.+ ++++.........+.. ...+..
T Consensus 10 ~l~~~~~~~~~l~~~~~d~i-~~~d~~g~i~~~N~a~~~l~Gy~~~eliG~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~ 87 (130)
T 1d06_A 10 VVRARDAHLRSILDTVPDAT-VVSATDGTIVSFNAAAVRQFGYAEEEVIGQNLRI-LMPEPYRHEHDGYLQRYMATGEKR 87 (130)
T ss_dssp HHHHHTSCHHHHHTTCSSEE-EEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGG-GSCTTHHHHHHHHHHHHHHHCCCS
T ss_pred HHHHHHHHHHHHHhhCcCeE-EEECCCCeEEEEcHHHHHHHCCCHHHHcCCcHHH-HCCchhHHHHHHHHHHHHhcCCcc
Confidence 34455678999999999988 8899999999999999999999999999999987 4444433332222322 233322
Q ss_pred ---eEEEEEEEcCCCCEEEEEEEEEEEeeCCeEEEEEEEEeccc
Q 038211 129 ---WSGQFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAA 169 (605)
Q Consensus 129 ---~~~~~~~~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t 169 (605)
...+...+++||+.+|+.++..|+.+++. .+++++++|+|
T Consensus 88 ~~~~~~e~~~~~kdG~~~~~~~~~~~~~~~~~-~~~~~~~~DIT 130 (130)
T 1d06_A 88 IIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGE-RFFTGFIRDLT 130 (130)
T ss_dssp STTSCEEEEEECTTSCEEEEEEEEEEEEETTE-EEEEEEEEECC
T ss_pred ccCCeeEEEEEeCCCCEEEEEEEEEEEEECCe-EEEEEEEEECc
Confidence 23356778999999999999999987554 45888999976
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} | Back alignment and structure |
|---|
Probab=99.61 E-value=5.3e-15 Score=145.61 Aligned_cols=124 Identities=17% Similarity=0.160 Sum_probs=100.1
Q ss_pred HHHHhcccccccHHHHHHhcCCeEEEEEcC---CCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHH
Q 038211 47 DEVATTSDSVGPYRSVLESMGHAVHVCTAS---SEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERL 123 (605)
Q Consensus 47 ~~~~~~~~~~~~~~~il~~~~d~ii~v~D~---~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l 123 (605)
...+++.++.++|+.+++++++++ +++|. +|+|+|||+++++++||+.+|++|+++.+++.+.........+...+
T Consensus 53 ~~~~~l~~~~~~~~~i~~~~~~~i-~~~d~~~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~l~~~~~~~~~~~~~~~~l 131 (258)
T 3p7n_A 53 DTRVEVQPPAQWVLDLIEASPIAS-VVSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGV 131 (258)
T ss_dssp --------CCHHHHHHHHTCSSEE-EEECTTSTTCCEEEECHHHHHHHCCCGGGTTTSCGGGGCCTTCCHHHHHHHHHHH
T ss_pred hhHHHHHhHHHHHHHHHhcCCccE-EEEcCCCCCCcEEEEhHHHHHHcCCCHHHHCCCChhhccCCCCchhHHHHHHHHH
Confidence 344456667788999999999988 89999 99999999999999999999999999987433333333456677788
Q ss_pred HcCCceEEEEEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEeccccc
Q 038211 124 ASGQSWSGQFPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIF 171 (605)
Q Consensus 124 ~~g~~~~~~~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~ 171 (605)
..+..+..+...++++|..+|+.++..|+++ +|.+.+++++++|+|+.
T Consensus 132 ~~~~~~~~e~~~~~~dG~~~~~~~~~~pi~d~~g~~~~~v~~~~DITer 180 (258)
T 3p7n_A 132 REHKPVLVEILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDD 180 (258)
T ss_dssp HHTCCEEEEEEEECTTSCEEEEEEEEEEEECTTSCSEEEEEEEEEC---
T ss_pred HcCCCeEEEEEEEcCCCCEEEEeeEEEEEEcCCCCEEEEEEEeeecchh
Confidence 8899999999999999999999999999998 89999999999998875
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=6.5e-15 Score=128.80 Aligned_cols=110 Identities=17% Similarity=0.268 Sum_probs=90.6
Q ss_pred HHHHhcCCeEEEEEcCCC---CEEEecHHHHHHhCCChhhhcCCCccccccccCCc-chHHHHHHHHHcCCceEEEEEEE
Q 038211 61 SVLESMGHAVHVCTASSE---DIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFH-SPHKKIMERLASGQSWSGQFPFK 136 (605)
Q Consensus 61 ~il~~~~d~ii~v~D~~G---~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~-~~~~~~~~~l~~g~~~~~~~~~~ 136 (605)
.+++++++++ +++|.+| +|+|+|+++++++||+.+|++|+++.. +.++... .....+...+..++.+..+...+
T Consensus 3 ~~~~~~~~~i-~~~d~~g~~~~i~~~N~a~~~~~G~~~~el~g~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 80 (132)
T 2pr5_A 3 HMLDHVRVGV-VITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRF-LQGKHTDPAEVDNIRTALQNKEPVTVQIQNY 80 (132)
T ss_dssp ---CCCCCEE-EEECTTSTTCCEEEECHHHHHHHSCCHHHHTTSCGGG-GCCTTCCHHHHHHHHHHHHHTCCEEEEEEEE
T ss_pred hHHhcCCCcE-EEEeCCCCCCcEEEECHHHHHHhCcCHHHHcCCChhh-hCCCCCCHHHHHHHHHHHHcCCCeEEEEEEE
Confidence 4688888888 8899876 999999999999999999999999976 4443332 23556667788888899999999
Q ss_pred cCCCCEEEEEEEEEEEeeCCeEEEEEEEEeccccccc
Q 038211 137 KRSGEILMAVVTKSPLYEDGELAGFITVSSDAAIFNS 173 (605)
Q Consensus 137 ~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~~~~ 173 (605)
++||+.+|+.++..|+.+++ +.+++++++|+|+..+
T Consensus 81 ~kdG~~~~~~~~~~~~~~~~-~~~~~~~~~DITe~k~ 116 (132)
T 2pr5_A 81 KKDGTMFWNELNIDPMEIED-KTYFVGIQNDITKQKE 116 (132)
T ss_dssp CTTSCEEEEEEEEEEEEETT-EEEEEEEEEECHHHHH
T ss_pred ecCCCeeeeEEEEEeccCCC-eeEEEEEEEeCcHHHH
Confidence 99999999999999999866 8899999999997543
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.8e-15 Score=144.67 Aligned_cols=123 Identities=20% Similarity=0.367 Sum_probs=106.6
Q ss_pred hchHHHHhcccccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHH
Q 038211 44 DDVDEVATTSDSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERL 123 (605)
Q Consensus 44 ~~l~~~~~~~~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l 123 (605)
.+++++++.++..++++.+++++++++ +++|.+|+|+|+|+++++++||+.+|++|+++..+..+.........+++.+
T Consensus 98 ~DIT~~k~~e~~l~~~~~~~~~~~~~i-~~~d~~g~i~~~N~~~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~ 176 (227)
T 3ewk_A 98 RDITAQKEAEAQLARLKQAMDANSEMI-LLTDRAGRIIYANPALCRFSGMAEGELLGQSPSILDSPLADQETLAAMQEAL 176 (227)
T ss_dssp EECTTTTHHHHHHHHHHHHHHTCCSEE-EEECTTSCEEEECHHHHHHHTCCTHHHHSSCGGGGBCTTSCHHHHHHHHHHH
T ss_pred EehhhHHHHHHHHHHHHHHHhcCcCeE-EEEcCCCcEEEEchHHHHHhCCCHHHHcCCChhhccCCCCCHHHHHHHHHHH
Confidence 456666666666778889999999888 8899999999999999999999999999999987444444444577788889
Q ss_pred HcCCceEEEEEEEcCCCC------EEEEEEEEEEEee-CCeEEEEEEEEec
Q 038211 124 ASGQSWSGQFPFKKRSGE------ILMAVVTKSPLYE-DGELAGFITVSSD 167 (605)
Q Consensus 124 ~~g~~~~~~~~~~~k~G~------~~~v~~~~~Pi~d-~g~i~g~v~i~~D 167 (605)
..++.|.+++..++++|. .+|+.++++|++| +|.++|++++++|
T Consensus 177 ~~~~~~~~e~~~~~k~G~~~~dg~~~~~~~~~~pi~d~~g~~~~~v~i~~D 227 (227)
T 3ewk_A 177 QAGQPWSGRLLNRRRTGPAPHDAEDYWAEISTTPIHTDGNGLVGYVQIQHD 227 (227)
T ss_dssp HHTCCEECCEEEEEECCSSSSCEEEEEEEEEEEEEECSSSCEEEEEEEEEC
T ss_pred HcCCceeEEEEEECCCCCcCcccceEEEEEEEEEEECCCCCEEEEEEEecC
Confidence 999999999999999997 8999999999998 8999999999987
|
| >4hia_A LOV protein; PAS, HTH, signaling protein; HET: FMN; 1.95A {Rhodobacter sphaeroides} PDB: 4hnb_A* 4hj4_A* 4hj6_A* 4hj3_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=4.3e-15 Score=136.68 Aligned_cols=116 Identities=13% Similarity=0.142 Sum_probs=99.7
Q ss_pred cccHHHHHHhcCCeEEEEEcCC---CCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEE
Q 038211 56 VGPYRSVLESMGHAVHVCTASS---EDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQ 132 (605)
Q Consensus 56 ~~~~~~il~~~~d~ii~v~D~~---G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~ 132 (605)
.++|+.+++++++++ +++|.+ |+|+|+|+++++++||+.++++|+++.+++.+.........+...+..+..+..+
T Consensus 6 ~~~~~~~~~~~~~~i-~~~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 84 (176)
T 4hia_A 6 FEKIRAVFDRSGVAL-TLVDMSLPEQPVVLANPPFLRMTGYTEGQILGFNCRFLQRGDENAQARADIRDALKLGRELQVV 84 (176)
T ss_dssp HHHHHHHHHHCSSCC-EEEETTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEE
T ss_pred HHHHHHHHhcCCCcE-EEEecCCCCCcEEEECHHHHHHHCcCHHHHcCCCcceeeCCCCCHHHHHHHHHHHHcCCceEEE
Confidence 356888999999988 889999 9999999999999999999999999987443333333455666778889999999
Q ss_pred EEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEecccccc
Q 038211 133 FPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFN 172 (605)
Q Consensus 133 ~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~ 172 (605)
...++++|..+|+.++..|+++ +|.+.|++++++|+|+..
T Consensus 85 ~~~~~~dG~~~~~~~~~~pi~~~~g~~~~~~~~~~DITe~k 125 (176)
T 4hia_A 85 LRNYRANDEPFDNLLFLHPVGGRPDAPDYFLGSQFELGRSG 125 (176)
T ss_dssp EEEECTTCCEEEEEEEEEEESSBTTBCSEEEEEEEEESSSG
T ss_pred EEEEcCCCCEEEEEEEEEEeeCCCCCeEEEEEEEEECcHhh
Confidence 9999999999999999999987 899999999999988754
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.1e-14 Score=132.09 Aligned_cols=122 Identities=16% Similarity=0.177 Sum_probs=102.6
Q ss_pred HhcccccccHHHHHHhcCCeEEEEEcC---CCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcC
Q 038211 50 ATTSDSVGPYRSVLESMGHAVHVCTAS---SEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASG 126 (605)
Q Consensus 50 ~~~~~~~~~~~~il~~~~d~ii~v~D~---~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g 126 (605)
+++.++..+|+.+++++++++ +++|. +|+|+++|+++++++||+.++++|+++.+++.+.........+...+..+
T Consensus 28 ~~l~~~~~~~~~~~~~~~~~i-~~~d~~~~~g~i~~~N~~~~~l~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~ 106 (166)
T 3ue6_A 28 RILEDPDYSLVKALQMAQQNF-VITDASLPDNPIVYASRGFLTLTGYSLDQILGRNCRFLQGPETDPRAVDKIRNAITKG 106 (166)
T ss_dssp ---CCCCCHHHHHHHHTTSCE-EEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhcCCceE-EEEEccCCCCcEEEECHHHHHHhCcCHHHHcCCCHhheeCCCCCHHHHHHHHHHHhcC
Confidence 345566788999999999988 88998 79999999999999999999999999987433333333455667778889
Q ss_pred CceEEEEEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEecccccc
Q 038211 127 QSWSGQFPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFN 172 (605)
Q Consensus 127 ~~~~~~~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~ 172 (605)
..+..+....+++|..+|+.++..|+++ +|.+.|++++++|+|+..
T Consensus 107 ~~~~~e~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k 153 (166)
T 3ue6_A 107 VDTSVCLLNYRQDGTTFWNLFFVAGLRDSKGNIVNYVGVQSKVSEDY 153 (166)
T ss_dssp CCEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEECCBCCHHH
T ss_pred CceEEEEEEEcCCCCEEEEEEEEEeeeCCCCCEEEEEEEEEechHHH
Confidence 9999999999999999999999999998 899999999999998754
|
| >3f1p_B ARYL hydrocarbon receptor nuclear translocator; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.0 PDB: 3f1o_B* 3f1n_B 3h7w_B* 3h82_B* 1x0o_A 2hv1_A 4h6j_B 2b02_A* 2k7s_A 2a24_B | Back alignment and structure |
|---|
Probab=99.59 E-value=6.3e-15 Score=126.59 Aligned_cols=111 Identities=13% Similarity=0.174 Sum_probs=89.5
Q ss_pred HHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHH--cCCceEEEEEEEc
Q 038211 60 RSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLA--SGQSWSGQFPFKK 137 (605)
Q Consensus 60 ~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~--~g~~~~~~~~~~~ 137 (605)
..+++++++.+ +++|.+|+|+|+|+++++++||+++|++|+++.+ ++++++.......+..+. .+..+..+++.++
T Consensus 5 ~ll~e~~~d~i-~~~d~~g~i~~~n~~~~~~~G~~~~el~g~~~~~-~i~p~d~~~~~~~~~~~~~~~~~~~~~e~r~~~ 82 (121)
T 3f1p_B 5 GLNVCQPTRFI-SRHNIEGIFTFVDHRCVATVGYQPQELLGKNIVE-FCHPEDQQLLRDSFQQVVKLKGQVLSVMFRFRS 82 (121)
T ss_dssp ---CCCCCEEE-EEECTTSBEEEECTTHHHHHSCCGGGTTTSBGGG-GBCTTTHHHHHHHHHHHTTSTTCCEEEEEEEEC
T ss_pred cceecCCCceE-EEECCCceEEEECcchhhhhCCChHHHcCCCHHH-eECHHHHHHHHHHHHHHHhcCCCcccEEEEEEe
Confidence 44677777666 9999999999999999999999999999999998 556666655444444433 4556888999999
Q ss_pred CCCCEEEEEEEEEEEee--CCeEEEEEEEEecccccc
Q 038211 138 RSGEILMAVVTKSPLYE--DGELAGFITVSSDAAIFN 172 (605)
Q Consensus 138 k~G~~~~v~~~~~Pi~d--~g~i~g~v~i~~D~t~~~ 172 (605)
++|+.+|+.++..|+++ +|.+.+++++.+|+|+.+
T Consensus 83 ~dG~~~w~~~~~~~~~~~~~g~~~~iv~~~~DIT~~k 119 (121)
T 3f1p_B 83 KNQEWLWMRTSSFTFQNPYSDEIEYIICTNTNVKNSS 119 (121)
T ss_dssp TTSCEEEEEEEEEEECCTTCCCCCEEEEEEEECCCC-
T ss_pred cCCCEEEEEEEEEEEECCCCCceeEEEEEeEEccccc
Confidence 99999999999999986 578899999999988753
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=3.6e-14 Score=119.33 Aligned_cols=108 Identities=20% Similarity=0.238 Sum_probs=90.9
Q ss_pred HHHhcCCeEEEEEcC---CCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEcC
Q 038211 62 VLESMGHAVHVCTAS---SEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKR 138 (605)
Q Consensus 62 il~~~~d~ii~v~D~---~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~k 138 (605)
.++++++++ +++|. +|+|+++|+++++++||+.++++|+++.+++.+.........+...+..++.+..+....++
T Consensus 2 ~l~~~~~~i-~~~d~~~~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (115)
T 4eet_B 2 SPEFIEKNF-VITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKIRDAIRDQRETTVQLINYTK 80 (115)
T ss_dssp ---CCCCSE-EEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEECT
T ss_pred ccccCCCcE-EEEcCCCCCCcEEEEcHHHHHHHCcCHHHHhCCCHHHhcCCCCChHHHHHHHHHHHcCCCcceEEEEecC
Confidence 467888888 88999 99999999999999999999999999887433333333355667778888999899999999
Q ss_pred CCCEEEEEEEEEEEee-CCeEEEEEEEEecccc
Q 038211 139 SGEILMAVVTKSPLYE-DGELAGFITVSSDAAI 170 (605)
Q Consensus 139 ~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~ 170 (605)
+|+.+|+.++..|+++ +|.+.+++.+++|+|+
T Consensus 81 ~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DITe 113 (115)
T 4eet_B 81 SGKKFWNLLHLQPVRDQKGELQYFIGVQLDGSD 113 (115)
T ss_dssp TCCEEEEEEEEEEEECTTSCEEEEEEEEEECSC
T ss_pred CCCEEEEEEEEEEEECCCCCEEEEEEEEEeecc
Confidence 9999999999999998 8999999999999886
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.9e-14 Score=119.89 Aligned_cols=111 Identities=18% Similarity=0.231 Sum_probs=91.6
Q ss_pred cccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEE-E
Q 038211 56 VGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQF-P 134 (605)
Q Consensus 56 ~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~-~ 134 (605)
+++|+.+++++++++ +++|.+|+|+++|+++++++|++.++++|+++.+++ +.........+..+..++....+. .
T Consensus 2 e~~~~~~~~~~~~~i-~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (114)
T 3luq_A 2 DERLRLFTEHAPAAL-AMFDREMRYLAVSRRWREDYGLGDGDILGMSHYDIF--PEIGEEWKSVHRRGLAGEVIRVEEDC 78 (114)
T ss_dssp CHHHHHHHHTCSSEE-EEEETTCBEEEECHHHHHHTTCCSSCCTTCBHHHHC--TTCCHHHHHHHHHHHTTCCEEEEEEE
T ss_pred hHHHHHHHhcCCceE-EEEcCCcEEEEECHHHHHHHCCCHHHHcCCcHHHHC--CccHHHHHHHHHHHhcCCcceeeeeE
Confidence 356889999999888 889999999999999999999999999999999844 344444555566666677665544 6
Q ss_pred EEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEeccc
Q 038211 135 FKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAA 169 (605)
Q Consensus 135 ~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t 169 (605)
..+++|..+|+.++..|+++ +|.+.|++.+++|+|
T Consensus 79 ~~~~~g~~~~~~~~~~p~~~~~g~~~~~~~~~~DIT 114 (114)
T 3luq_A 79 FVRADGRTQWLRWEVRPWYEGEGRVGGVVIFTEDIT 114 (114)
T ss_dssp EEC--CCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEcCCCcEEEEEEEEEEeECCCCCEEEEEEEEeeCC
Confidence 77899999999999999998 899999999999976
|
| >3mxq_A Sensor protein; PSI2, MCSG, structural genomics, protein structure initiativ midwest center for structural genomics; 2.78A {Vibrio cholerae o1 biovar el tor} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.6e-15 Score=133.29 Aligned_cols=119 Identities=18% Similarity=0.145 Sum_probs=88.7
Q ss_pred hcccccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchH-HHHHHHHHcCCce
Q 038211 51 TTSDSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPH-KKIMERLASGQSW 129 (605)
Q Consensus 51 ~~~~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~-~~~~~~l~~g~~~ 129 (605)
+++++...|+.+++++++++ +++|.+|+|++||+++++++|++++|++|+++.+ +++. ....+ ..+..++.+|.+.
T Consensus 16 ~~~~~~~~l~~il~~~~~gi-~v~D~~g~I~~~N~a~~~~~G~~~~eviG~~~~~-~~p~-~~~~~~~~l~~vl~~G~~~ 92 (152)
T 3mxq_A 16 AMAKSRLLLSELLDQLSFAL-CIVRNDYVIVKVNEYFESRVIFDGETMQGKNILE-LFPE-SADYLKRKIDTALVIESSS 92 (152)
T ss_dssp HHHHHHHHHHHHHHHHCCEE-EEEETTSBEEEECHHHHHTSSSCHHHHTTSBHHH-HSGG-GHHHHHHHHHHHHHHTSCE
T ss_pred HHHHHHHHHHHHHhcCCCCE-EEEcCCCEEEEECHHHHHHHCcCHHHHCCCCHHH-hcCC-hHHHHHHHHHHHHhcCCce
Confidence 34444556788999999888 8999999999999999999999999999999998 4444 33333 3355566766653
Q ss_pred EEE---------EEE---EcCCCCEEEEEEEEEEEee-CCeEEEEEEEEecccccc
Q 038211 130 SGQ---------FPF---KKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFN 172 (605)
Q Consensus 130 ~~~---------~~~---~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~ 172 (605)
... +.. .+++|+..+..++.+|+.| +|++.|++.+++|+|+..
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ti~Pl~d~~G~v~gv~~ii~DVTe~~ 148 (152)
T 3mxq_A 93 FSSWEQKPHLLPFKSSRPVSGEEEQMYQNLEVIPIHSEDGTIEHVCLCVYDVTIQA 148 (152)
T ss_dssp EEECCSSSCSSCC----------CCEEEEEEEEEEECTTSCEEEEEEEEEEEECC-
T ss_pred eeecccccccccccccCCCCCCCcEEEEEEEEEEEECCCCCEEEEEEEEEECCHHH
Confidence 221 111 2356778888999999998 899999999999998753
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} | Back alignment and structure |
|---|
Probab=99.56 E-value=3.2e-14 Score=122.79 Aligned_cols=111 Identities=19% Similarity=0.199 Sum_probs=94.9
Q ss_pred HHHhcCCeEEEEEcC---CCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEcC
Q 038211 62 VLESMGHAVHVCTAS---SEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKR 138 (605)
Q Consensus 62 il~~~~d~ii~v~D~---~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~k 138 (605)
+++++++++ +++|. +|+|+++|+++++++||+.++++|+++.+++.+.........+...+..+..+..+....++
T Consensus 2 ~~~~~~~~i-~~~d~~~~~g~i~~~N~~~~~l~g~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 80 (128)
T 3t50_A 2 ASEFTLMPM-LITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAIKSAIAAEKPIDIDIINYKK 80 (128)
T ss_dssp CCCCCSSCE-EEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEEEECT
T ss_pred ccccCcccE-EEecCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHhhhcCCccCHHHHHHHHHHHHcCCCceeEEEEEcC
Confidence 456777887 88999 99999999999999999999999999987443333333456667778888899999999999
Q ss_pred CCCEEEEEEEEEEEee-CCeEEEEEEEEeccccccc
Q 038211 139 SGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFNS 173 (605)
Q Consensus 139 ~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~~ 173 (605)
+|..+|+.++..|+.+ +|.+.|++++++|+|+..+
T Consensus 81 ~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DITe~k~ 116 (128)
T 3t50_A 81 SGEAFWNRLHISPVHNANGRLQHFVSSQLDVTLELV 116 (128)
T ss_dssp TCCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHC
T ss_pred CCCEEEEEEEEEEEECCCCCEEEEEEEEEEcchhhh
Confidence 9999999999999997 8999999999999998653
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} | Back alignment and structure |
|---|
Probab=99.55 E-value=5.6e-14 Score=118.95 Aligned_cols=117 Identities=20% Similarity=0.360 Sum_probs=98.4
Q ss_pred ccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcch-HHHHHHHHHcCCceEEEE
Q 038211 55 SVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSP-HKKIMERLASGQSWSGQF 133 (605)
Q Consensus 55 ~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~-~~~~~~~l~~g~~~~~~~ 133 (605)
..++|+.+++++++++ +++|.+|+|+++|+++++++|++.++++|+++.. +.++..... ...+...+..+..+..+.
T Consensus 5 ~~~~~~~~~~~~~~~i-~~~d~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (124)
T 3lyx_A 5 ILKQRAKAFDYVFDAI-VVTDLQGFIIDWNKGSETLYGYSKEQAIGQPVNM-LHVPGDTEHITSEVISAVENQGKWTGEI 82 (124)
T ss_dssp HHHHHHHGGGTCSSEE-EEEETTCBEEEECHHHHHHHCCCHHHHTTSBGGG-GSCTTTHHHHHHHHHHHHHHTSCEEEEE
T ss_pred HHHHHHHHHhhcCceE-EEECCCCcEeehhhHHHHHhCCCHHHHcCCCHHH-hcCcchhhHHHHHHHHHHHcCCcccceE
Confidence 3456788899999888 8899999999999999999999999999999985 544444332 445666778888888888
Q ss_pred EEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEeccccccc
Q 038211 134 PFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFNS 173 (605)
Q Consensus 134 ~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~~ 173 (605)
...+++|..+|+.++..|+.+ +|.+.|++.+++|+|+..+
T Consensus 83 ~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~~ 123 (124)
T 3lyx_A 83 RMLHKDGHIGWIESMCVPIYGENYQMVGALGINRDITKRKK 123 (124)
T ss_dssp EEECTTSCEEEEEEEEEEEECSTTCEEEEEEEEEECSCC--
T ss_pred EEEccCCCEEEEEEEEEEEECCCCCEEEEEEEEecchhhhc
Confidence 889999999999999999997 8999999999999887543
|
| >3f1p_A Endothelial PAS domain-containing protein 1; PAS domain, heterodimer, internal cavity, activator, angiogenesis, congenital erythrocytosis; 1.17A {Homo sapiens} SCOP: d.110.3.7 PDB: 3f1o_A* 3f1n_A 3h7w_A* 3h82_A* 1p97_A 2a24_A 4h6j_A | Back alignment and structure |
|---|
Probab=99.55 E-value=3.4e-14 Score=121.09 Aligned_cols=103 Identities=14% Similarity=0.168 Sum_probs=86.4
Q ss_pred eEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHH-HHHHHHHcCCceEEEEEEEcCCCCEEEEEE
Q 038211 69 AVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHK-KIMERLASGQSWSGQFPFKKRSGEILMAVV 147 (605)
Q Consensus 69 ~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~-~~~~~l~~g~~~~~~~~~~~k~G~~~~v~~ 147 (605)
.+|+++|.+|+|+|+|+++++++||+++|++|+++.+ ++++++..... .+...+..+..+..+++.++++|+.+|+.+
T Consensus 10 ~~i~~~d~~g~i~~~n~~~~~~~Gy~~~el~g~~~~~-~~~p~d~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~~w~~~ 88 (117)
T 3f1p_A 10 TFLSEHSMDMKFTYCDDRITELIGYHPEELLGRSAYE-FYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYVWLET 88 (117)
T ss_dssp EEEEEECTTCBEEEECTHHHHHHCCCHHHHTTSBGGG-GBCGGGHHHHHHHHHHHHHHSEEECCCEEEECTTSSEEEEEE
T ss_pred cEEEEECCCceEEEECcChhhhhCCCHHHHcCCchhh-eECHHHHHHHHHHHHHHHhCCCeeeeEEEEEecCCCEEEEEE
Confidence 3458999999999999999999999999999999998 45555555443 344455667777778899999999999999
Q ss_pred EEEEEee--CCeEEEEEEEEecccccc
Q 038211 148 TKSPLYE--DGELAGFITVSSDAAIFN 172 (605)
Q Consensus 148 ~~~Pi~d--~g~i~g~v~i~~D~t~~~ 172 (605)
+..|+++ +|.+.+++++.+|+|+.+
T Consensus 89 ~~~~~~d~~~g~~~~iv~~~~DITer~ 115 (117)
T 3f1p_A 89 QGTVIYNPRNLQPQCIMCVNYVLSEIE 115 (117)
T ss_dssp EEEEEEETTTTEEEEEEEEEEECSCCB
T ss_pred eeEEEECCCCCCceEEEEEeeeccccc
Confidence 9999986 588999999999988754
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} | Back alignment and structure |
|---|
Probab=99.54 E-value=8e-14 Score=118.18 Aligned_cols=107 Identities=8% Similarity=0.148 Sum_probs=86.9
Q ss_pred cccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEE
Q 038211 56 VGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPF 135 (605)
Q Consensus 56 ~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~ 135 (605)
.+.++.+++++++++ +++|.+|+|+++|+++++++||+.+|++|+++.++ .+...... +..+..+..+..+...
T Consensus 12 ~~~~~~~~~~~~~~i-~~~d~~g~i~~~N~~~~~l~G~~~~el~g~~~~~~-~~~~~~~~----~~~~~~~~~~~~e~~~ 85 (118)
T 3olo_A 12 FKFAHYLINNAVEAS-FCLGDNWQFLYVNDATCRMTEYSREQLLSMNLQDI-DVDFALHD----WEEIRQKNNYTFKTRY 85 (118)
T ss_dssp HHHHHHHHHHCSSEE-EEECTTSBEEEECHHHHHHHCCCHHHHTTCBGGGT-BTTGGGSC----HHHHHHHSEEEEEEEE
T ss_pred HHHHHHHHhcCCceE-EEECCCCcEEEEHHHHHHHHCCCHHHHhCCChhhc-ccccCHHH----HHHHHhcCcEEEEEEE
Confidence 345678899999988 88999999999999999999999999999999984 34333222 4455566778888888
Q ss_pred EcCCCCEEEEEEEEEEEeeCCeEEEEEEEEeccc
Q 038211 136 KKRSGEILMAVVTKSPLYEDGELAGFITVSSDAA 169 (605)
Q Consensus 136 ~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t 169 (605)
.+++|+.+|+.++..|+.++|. .+++++++|+|
T Consensus 86 ~~~~g~~~~~~~~~~~~~~~~~-~~~~~~~~DIT 118 (118)
T 3olo_A 86 RSQSGRIFLVEMSLTFLEDQER-RFSCVFVREKS 118 (118)
T ss_dssp ECTTCCEEEEEEEEEEEEETTE-EEEEEEEEEC-
T ss_pred EccCCCEEEEEEEEEEEEECCc-cEEEEEEEeCC
Confidence 9999999999999999987664 36778899975
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.5e-14 Score=124.00 Aligned_cols=113 Identities=15% Similarity=0.158 Sum_probs=90.5
Q ss_pred ccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCc--chHHHHHHHHHcCCceEEEEE
Q 038211 57 GPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFH--SPHKKIMERLASGQSWSGQFP 134 (605)
Q Consensus 57 ~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~--~~~~~~~~~l~~g~~~~~~~~ 134 (605)
..|+.+++++++++ ++ |.+|+|+++|+++++++||+.+|++|+++.+ ++++... .....+...+..++.+..+..
T Consensus 3 ~~~~~~~~~~~~~i-~~-~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 79 (120)
T 3mqq_A 3 IDYKTAFHLAPIGL-VL-SRDRVIEDCNDELAAIFRCARADLIGRSFEV-LYPSSDEFERIGERISPVMIAHGSYADDRI 79 (120)
T ss_dssp CCHHHHHHHCSSEE-EE-EETTEEEEECHHHHHHTTSCHHHHTTCBGGG-GSSSHHHHHHHHHHHHHHHHHHSCEEEEEE
T ss_pred chHHHHHhcCCceE-EE-ecCCEEHHHHHHHHHHhCcCHHHhCCCchhh-ccCChhhHHHHHHHHHHHHhcCCcceEEEE
Confidence 35889999999988 54 6699999999999999999999999999987 4433211 123344556677888888999
Q ss_pred EEcCCCCEEEEEEEEEEEeeCCeEEEEEEEEecccccc
Q 038211 135 FKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAAIFN 172 (605)
Q Consensus 135 ~~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~~~ 172 (605)
.++++|+.+|+.++..|+..+|...+++.+++|+|+-.
T Consensus 80 ~~~~dG~~~~~~~~~~~~~~~~~~~~~v~~~~DITerk 117 (120)
T 3mqq_A 80 MKRAGGELFWCHVTGRALDRTAPLAAGVWTFEDLSATR 117 (120)
T ss_dssp EECTTSCEEEEEEEEEESSTTSTTSSEEEEEEESCC--
T ss_pred EEeCCCCEEEEEEEEEECCCCCCceeEEEEEEcccHhh
Confidence 99999999999999999844666778999999988754
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=1.3e-14 Score=148.44 Aligned_cols=108 Identities=20% Similarity=0.267 Sum_probs=94.9
Q ss_pred HHHhcCCeEEEEEcC---CCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEcC
Q 038211 62 VLESMGHAVHVCTAS---SEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKR 138 (605)
Q Consensus 62 il~~~~d~ii~v~D~---~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~k 138 (605)
+++++++++ +++|. +|+|+|||+++++++||+++|++|+++.++..+.........+...+..++.+..+...+++
T Consensus 16 ~~~~~~~~i-~~~D~~~~~g~i~~~N~a~~~l~G~~~~el~G~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 94 (332)
T 2wkq_A 16 TLERIEKNF-VITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARFLQGPETDRATVRKIRDAIDNQTEVTVQLINYTK 94 (332)
T ss_dssp CGGGCCSEE-EEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECT
T ss_pred HhhcCCCcE-EEecCCCCCCCEEEeehHHHHHhCCCHHHHcCCCchhhcCCCCCHHHHHHHHHHHHcCCeeEEEEEEEcC
Confidence 578888888 89999 99999999999999999999999999987443333444466677888899999999999999
Q ss_pred CCCEEEEEEEEEEEee-CCeEEEEEEEEecccc
Q 038211 139 SGEILMAVVTKSPLYE-DGELAGFITVSSDAAI 170 (605)
Q Consensus 139 ~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~ 170 (605)
+|+.+|+.++..|+++ +|++.|++++++|+|+
T Consensus 95 dG~~~~~~~~~~pi~d~~g~~~~~v~~~~DITe 127 (332)
T 2wkq_A 95 SGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTE 127 (332)
T ss_dssp TCCEEEEEEEEEEEECTTSCEEEEEEEEEEESS
T ss_pred CCCEEEEeeEEEEeEcCCCCEEEEEEEeccCch
Confidence 9999999999999998 8999999999999876
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=4.4e-13 Score=114.15 Aligned_cols=117 Identities=16% Similarity=0.328 Sum_probs=97.6
Q ss_pred ccccHHHHHHhcCCeEEEEEc---CCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEE
Q 038211 55 SVGPYRSVLESMGHAVHVCTA---SSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSG 131 (605)
Q Consensus 55 ~~~~~~~il~~~~d~ii~v~D---~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~ 131 (605)
..+.++.+++++++++ +++| .+|+|+++|+++++++|++.++++|+++.+++.+.........+...+..+..+..
T Consensus 4 ~~~~~~~~~~~~~~~i-~~~d~~d~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (130)
T 2z6d_A 4 VSQELKTALSTLQQTF-VVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGPDTDKNEVAKIRDCVKNGKSYCG 82 (130)
T ss_dssp ---CHHHHHHHTTCEE-EEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEE
T ss_pred HHHHHHHHHHhcccce-eeeeccCCCCcEEEecHHHHHHhCcCHHHHcCCChhhccCCCCCchHHHHHHHHHHcCCccee
Confidence 3457889999999888 8889 89999999999999999999999999998744333333335566677888888888
Q ss_pred EEEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEecccccc
Q 038211 132 QFPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFN 172 (605)
Q Consensus 132 ~~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~ 172 (605)
+....+++|..+|+.++..|+.+ +|.+.|++.+++|+|+..
T Consensus 83 ~~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~~ 124 (130)
T 2z6d_A 83 RLLNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEVSKYT 124 (130)
T ss_dssp EEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCTTC
T ss_pred EEEEEcCCCcEEEEEEEEEEEECCCCCeeEEEEEEecchHHH
Confidence 88888999999999999999998 899999999999988643
|
| >2qkp_A Uncharacterized protein; structural genomics, unknown function, PSI-2, protein struct initiative; 1.75A {Streptococcus mutans} | Back alignment and structure |
|---|
Probab=99.51 E-value=4.7e-14 Score=126.66 Aligned_cols=115 Identities=19% Similarity=0.298 Sum_probs=92.7
Q ss_pred ccHHHHHHhcCCeEEEEEcCCCCEEEecHH---HHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEE
Q 038211 57 GPYRSVLESMGHAVHVCTASSEDIIYWNRS---AESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQF 133 (605)
Q Consensus 57 ~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a---~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~ 133 (605)
+.+++||+++++++ +++|.+|+|+|||++ +++++| ..++++|+++.+ ++++........++..+++|+....++
T Consensus 19 ~~l~~IL~~~~~gI-~~vD~~g~I~~~N~a~~~~~~i~g-~~~~~iGr~v~~-~~~~~~~~~v~~i~~~l~~g~~~~~~~ 95 (151)
T 2qkp_A 19 EQANLILNHLPLEI-TFVNKDDIFQYYNDSVPAAEMVFK-RTPSQVGRNVEL-CHPPKVLDKVKKVFELLRNGQRDKVNM 95 (151)
T ss_dssp HHHHHHHHHSSSEE-EEEETTSBEEEECCCSCGGGCSSC-CCGGGTTSBGGG-SSCHHHHHHHHHHHHHHHTTSBSEEEE
T ss_pred HHHHHHHHhCCCce-EEEcCCCeEEEEeCCCchhhhhcC-CCHHHcCCCHHH-hCCHHHHHHHHHHHHHHHcCCccEEEE
Confidence 45889999999999 889999999999999 999999 668999999998 444333333566778888888776665
Q ss_pred EEEcCC-CCEEEEEEEEEEEee-CCeEEEEEEEEeccccccccCC
Q 038211 134 PFKKRS-GEILMAVVTKSPLYE-DGELAGFITVSSDAAIFNSINP 176 (605)
Q Consensus 134 ~~~~k~-G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~~l~~ 176 (605)
+...++ |. ++.++..|++| +|+++|++.+++|+|++.++-.
T Consensus 96 ~~~~~~~~~--~v~v~~~Pi~d~~G~~~G~vev~~Dit~l~~le~ 138 (151)
T 2qkp_A 96 WFQSERLGK--FVYVTYAAVRDQAGDFQGVLEYVQDIKPFFELDS 138 (151)
T ss_dssp EEEETTTTE--EEEEEEEEEECTTCCEEEEEEEEEECGGGGGGGG
T ss_pred EEecCCCCe--EEEEEEEEEECCCCCEEEEEEEEEECHHHHhhhh
Confidence 553332 43 45789999998 8999999999999999887754
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} | Back alignment and structure |
|---|
Probab=99.49 E-value=2.8e-13 Score=116.74 Aligned_cols=113 Identities=12% Similarity=0.141 Sum_probs=82.2
Q ss_pred cccccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhh--cCCCccccccccCCcchHHHHHHHHHcCCce
Q 038211 52 TSDSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREV--FGQRVTEFLIAEEFHSPHKKIMERLASGQSW 129 (605)
Q Consensus 52 ~~~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~el--iGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~ 129 (605)
+.++.++|+.+++++++++ +++|.+|+|++||+++++++||+.+|+ +|+++.++ ++ +.......+.....+...
T Consensus 12 L~~~~~~~~~l~e~~~~~i-~~~d~~g~i~~~N~a~~~~~G~~~~el~g~g~~~~~~-~~--~~~~~~~~~~~~~~~~~~ 87 (126)
T 3bwl_A 12 LEETSSRLEALFENSPDMI-DVLDADGTICEVNQRFCAELGYDESEVLGRSIWEFDL-MF--DAEDVQTQLSGFSVDERR 87 (126)
T ss_dssp HHHHHHHHHHHHHHCSSEE-EEECTTCBEEEECHHHHHHHTCCGGGTTTSBGGGTBT-TC--CHHHHHHHHHTCCTTCEE
T ss_pred HHHHHHHHHHHHhhCCcEE-EEEcCCCCEEEEcHHHHHHhCCCHHHHhhCCCchhhc-cC--CHHHHHHHHHHHhcCCCc
Confidence 3344567899999999988 889999999999999999999999999 56777763 33 221111111112234445
Q ss_pred EEEEEEEcCCCCEEEEEEEEEEEeeCCeEEEEEEEEeccc
Q 038211 130 SGQFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAA 169 (605)
Q Consensus 130 ~~~~~~~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t 169 (605)
..+....+++|+.+|+.++..|+.++|.. +++++++|+|
T Consensus 88 ~~e~~~~~~dG~~~~~~~~~~~~~~~~~~-~~~~~~~DIT 126 (126)
T 3bwl_A 88 KFEGLYERRDGSTMSVEVHLLRFNLEGED-RFLAISRDIT 126 (126)
T ss_dssp EEEEEEECTTSCEEEEEEEEEEEEETTEE-EEEEEEEEC-
T ss_pred ceEEEEEeCCCCEEEEEEEeEEEecCCcE-EEEEEEEeCC
Confidence 55667779999999999888887656654 5778899975
|
| >3mfx_A Sensory BOX/ggdef family protein; alpha-beta protein, structural genomics, PSI-2, protein structure initiative; 2.40A {Shewanella oneidensis} | Back alignment and structure |
|---|
Probab=99.49 E-value=8.2e-14 Score=121.69 Aligned_cols=108 Identities=15% Similarity=0.148 Sum_probs=81.0
Q ss_pred ccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHc-C-------Cc
Q 038211 57 GPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLAS-G-------QS 128 (605)
Q Consensus 57 ~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~-g-------~~ 128 (605)
..++.+++++++++ +++|.+|+|+++|++|++++||+.+|++|+++.++ +++.........+..... + ..
T Consensus 7 ~~l~~i~~~~~d~i-~~~D~~g~I~~~N~aa~~l~G~~~~el~G~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (129)
T 3mfx_A 7 ETIELFIQHLTEAM-ILVNANGFIRSCNQRSAELLDCPQVSLKGQDWRNF-LTEHHQARYDNLLSHDVQLGTNCGQPVQH 84 (129)
T ss_dssp HHHHHHHTTCSSEE-EEEETTSBEEEECHHHHHHTTSCHHHHTTSBGGGG-BCTTCCGGGGCTTC----------CCSCE
T ss_pred HHHHHHHhcCCceE-EEECCCCEEEeEhHHHHHHHCcCHHHHcCCcHHHH-cChHhHHHHHHHHHHHHhcCcccccccCC
Confidence 35778999999988 88999999999999999999999999999999984 444443332222221111 1 12
Q ss_pred eEEEEEEEcCCCCEEEEEEEEEEEeeCCeEEEEEEEEecc
Q 038211 129 WSGQFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSDA 168 (605)
Q Consensus 129 ~~~~~~~~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~ 168 (605)
+..++..+++||+.+|+.++++|+.+++. -+|++++|+
T Consensus 85 ~~~E~~~~rkdG~~~~velsis~i~~~~~--~~v~~~~~~ 122 (129)
T 3mfx_A 85 PAQETTLICASGKAKDVELSISYIPGHEP--MFVMVMHDL 122 (129)
T ss_dssp EEEEEEEECTTSCEEEEEEEEEEECSSSC--EEEEEEEEC
T ss_pred CceEEEEEcCCCCEEEEEEEEEEecCCCc--EEEEEEech
Confidence 45688889999999999999999985333 267778885
|
| >3nja_A Probable ggdef family protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; 2.37A {Chromobacterium violaceum} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.8e-13 Score=116.84 Aligned_cols=116 Identities=5% Similarity=0.102 Sum_probs=85.6
Q ss_pred cccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcC--CCccccccccCCcchHH-HHHHHHHcCCceE
Q 038211 54 DSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFG--QRVTEFLIAEEFHSPHK-KIMERLASGQSWS 130 (605)
Q Consensus 54 ~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliG--k~~~~l~~~~~~~~~~~-~~~~~l~~g~~~~ 130 (605)
++.++|+.+++.+++++ +++|.+|+++++|+++++++||+.++++| ..+.+ ++++++..... .+...+..+..+.
T Consensus 4 ~~~~~l~~~~~~~~~~i-~~~d~~~~~~~~n~~~~~~~G~~~~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~~~ 81 (125)
T 3nja_A 4 MAEKLLHTAESDAGIGS-WVLHMESGRLEWSQAVHDIFGTDSATFDATEDAYFQ-RVHPDDRARVRRELDRHVLGDRPFD 81 (125)
T ss_dssp -------------CCEE-EEEETTTTEEEECHHHHHHHTCCTTTCCCBHHHHHH-HBCTTTHHHHHHHHHHHHHSCCCEE
T ss_pred HHHHHHHHHHHhCCeeE-EEEEcCCCcEEECHHHHHHhCCCcccccccHHHHHh-hcChhHHHHHHHHHHHHHhcCCCce
Confidence 45567888999999888 99999999999999999999999999999 44555 34555554433 3445566777788
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEeccccc
Q 038211 131 GQFPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIF 171 (605)
Q Consensus 131 ~~~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~ 171 (605)
.++...+++|+.+|+.++..|+++ +|.+.+++++++|+|+.
T Consensus 82 ~e~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~g~~~DITe~ 123 (125)
T 3nja_A 82 VEYRIVRPDGQVRELLERNHIQRQASGQVDHLWGTVIDMTEH 123 (125)
T ss_dssp EEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECCC-
T ss_pred EEEEEECCCCCEEEEEEeeEEEECCCCCEEEEEEEEEecccc
Confidence 889999999999999999999998 89999999999998864
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} | Back alignment and structure |
|---|
Probab=99.47 E-value=3.1e-13 Score=121.87 Aligned_cols=120 Identities=15% Similarity=0.196 Sum_probs=102.6
Q ss_pred cccccHHHHHHhcCCeEEEEEcCCC---CEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceE
Q 038211 54 DSVGPYRSVLESMGHAVHVCTASSE---DIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWS 130 (605)
Q Consensus 54 ~~~~~~~~il~~~~d~ii~v~D~~G---~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~ 130 (605)
++.+.|+.+++.+++++ +++|.+| +|+++|+++++++||+.++++|+++.+++.+.........+...+..+..+.
T Consensus 22 ~~~~~~~~i~~~~~~~i-~~~d~~~~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (162)
T 3sw1_A 22 INAQLLQSMVDASNDGI-VVAEKEGDDTILIYVNAAFEYLTGYSRDEILYQDCRFLQGDDRDQLGRARIRKAMAEGRPCR 100 (162)
T ss_dssp CCHHHHHHHHHTCSSEE-EEEEEETTEEEEEEECHHHHHHHTCCHHHHTTSBGGGGTTTCCCCHHHHHHHHHHHHTCCEE
T ss_pred chHHHHHHHHhhccCcE-EEEeCCCCccEEEEECHHHHHHHCCCHHHHcCCCcceecCCCcCHHHHHHHHHHHhcCCCCc
Confidence 34467889999999888 8899999 9999999999999999999999999874433334444566777788888998
Q ss_pred EEEEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEecccccccc
Q 038211 131 GQFPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFNSI 174 (605)
Q Consensus 131 ~~~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~~l 174 (605)
.+....+++|..+|+.++..|+.+ +|.+.|++++++|+|+..++
T Consensus 101 ~~~~~~~~~g~~~~~~~~~~~i~~~~g~~~~~~~~~~DiTe~k~~ 145 (162)
T 3sw1_A 101 EVLRNYRKDGSAFWNELSITPVKSDFDQRTYFIGIQKDVSRQVEL 145 (162)
T ss_dssp EEEEEECTTCCEEEEEEEEEEEECSSSSCEEEEEEEEECHHHHHH
T ss_pred ceEEEECCCCCEEEEEEEEEEeecCCCCEEEEEEEEEeCcHHHHH
Confidence 888889999999999999999997 89999999999999986554
|
| >3eeh_A Putative light and redox sensing histidine kinase; structural genomic MCSG, protein structure initiative, midwest center for STRU genomics; HET: PG5; 1.95A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.9e-13 Score=116.07 Aligned_cols=117 Identities=15% Similarity=0.140 Sum_probs=95.8
Q ss_pred hcccccccHHHHHHhcCCeEEEEEcCC-CCEEEecHHHHHHhCCChhhhcCCC--ccccccccCCcchHHHHHHHHHcCC
Q 038211 51 TTSDSVGPYRSVLESMGHAVHVCTASS-EDIIYWNRSAESLYGWKDREVFGQR--VTEFLIAEEFHSPHKKIMERLASGQ 127 (605)
Q Consensus 51 ~~~~~~~~~~~il~~~~d~ii~v~D~~-G~Ii~~N~a~~~l~G~~~~eliGk~--~~~l~~~~~~~~~~~~~~~~l~~g~ 127 (605)
++.++.++|+.+++++++++ +++|.+ |+|+++|+++++++||+.++++|+. +.+ ++++++.......+..+..++
T Consensus 5 ~l~~~~~~~~~~~~~~~~~i-~~~d~~~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 82 (125)
T 3eeh_A 5 QAAKSERRVRELTEATNDIL-WEFTADLSEVLVINSAYEDIWGRSVAKLRENPHDFLN-GIHPEDRELMKDTMQSLMDGE 82 (125)
T ss_dssp -----CHHHHHHHSCCCCEE-EEEETTSSCEEEECTHHHHHHSSCHHHHHHCGGGGGG-GBCHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhcCCceE-EEEEcCCCcEEEecHHHHHHHCCCHHHHccCcHHHHH-hcCHHHHHHHHHHHHHHHcCC
Confidence 34456678899999999888 889999 9999999999999999999999988 444 344454444555566677888
Q ss_pred ceEEEEEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEeccc
Q 038211 128 SWSGQFPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAA 169 (605)
Q Consensus 128 ~~~~~~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t 169 (605)
.+..++...+++|+..|+.++..|+.+ +|.+.+++++++|+|
T Consensus 83 ~~~~e~~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIT 125 (125)
T 3eeh_A 83 SADVECRVNATEEYQRWVWIQGEPITNDAGETVRVAGFARDIT 125 (125)
T ss_dssp CEEEEEEECGGGTTCEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred CccEEEEEEcCCCCEEEEEEecEEEECCCCCEEEEEEEEEecC
Confidence 888888888999999999999999998 899999999999975
|
| >2vv6_A FIXL, sensor protein FIXL; signaling protein, transferase, phosphoprotein, nitrogen FIX PER-ARNT-SIM, metal-binding, PAS, iron, heme; HET: HEM; 1.5A {Bradyrhizobium japonicum} PDB: 1xj6_A* 1xj4_A* 2vv7_A* 2vv8_A* 1lsw_A* 1dp8_A* 1dp9_A* 1drm_A* 1lsv_A* 1dp6_A* 1lsx_A* 1lt0_A* 1y28_A* 2cmn_A* 1xj3_A* 1xj2_A* 2owh_A* 2owj_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=4.4e-13 Score=114.63 Aligned_cols=104 Identities=22% Similarity=0.336 Sum_probs=75.8
Q ss_pred cCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHH-HHcCCc----eEEEEEEEcCCC
Q 038211 66 MGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMER-LASGQS----WSGQFPFKKRSG 140 (605)
Q Consensus 66 ~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~-l~~g~~----~~~~~~~~~k~G 140 (605)
+++++ +++|.+|+|++||++|++++||+.+|++|+++.+ ++++.........+.. ...+.. ...++..+++||
T Consensus 2 ~~d~i-~~~d~~g~i~~~N~a~~~l~G~~~~el~G~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dG 79 (119)
T 2vv6_A 2 IPDAM-IVIDGHGIIQLFSTAAERLFGWSELEAIGQNVNI-LMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDG 79 (119)
T ss_dssp CCCEE-EEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGG-GSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTS
T ss_pred CcceE-EEECCCCeEEEEhHHHHHHhCCCHHHHcCCCHHH-hCCchHHHHHHHHHHHHhcCCCcccCCCceEEEEEeCCC
Confidence 45666 8899999999999999999999999999999987 4444433322222222 233322 234567789999
Q ss_pred CEEEEEEEEEEEeeCCeEEEEEEEEecccccc
Q 038211 141 EILMAVVTKSPLYEDGELAGFITVSSDAAIFN 172 (605)
Q Consensus 141 ~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~~~ 172 (605)
+.+|+.++..|+.+++. .+++++++|+|+..
T Consensus 80 ~~~~~~~~~~~~~~~~~-~~~~~~~~DITerk 110 (119)
T 2vv6_A 80 TTFPMHLSIGEMQSGGE-PYFTGFVRDLTEHQ 110 (119)
T ss_dssp CEEEEEEEEEEEEETTE-EEEEEEEEECC---
T ss_pred CEEEEEEEEEEEEECCe-EEEEEEEEEcHHHH
Confidence 99999999999987544 46889999988643
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} | Back alignment and structure |
|---|
Probab=99.45 E-value=6.2e-13 Score=128.10 Aligned_cols=100 Identities=18% Similarity=0.276 Sum_probs=87.6
Q ss_pred EEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEcCCCCEEEEEEEEE
Q 038211 71 HVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRSGEILMAVVTKS 150 (605)
Q Consensus 71 i~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~k~G~~~~v~~~~~ 150 (605)
|+++|.+|+|+|+|++|++++||+.+|++|+++..+..+.........++..+..++.+..+...+++||+.+|+.++..
T Consensus 2 i~i~D~~g~i~~~N~a~~~l~Gy~~~el~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~ 81 (227)
T 3ewk_A 2 VSITDLQGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNIWQGEFCNRRKDGTRYWVDSTIV 81 (227)
T ss_dssp EEEEETTCBEEEECHHHHHHTTCCHHHHTTSBGGGGCCSCSCHHHHHHHHHHHTTTCCEEEEEEEECSSSCEEEEEEEEE
T ss_pred EEEECCCCcEEehHHHHHHHHCcCHHHHcCCCHHHcCCCCCCHHHHHHHHHHHHcCCeEEEEEEEEcCCCCEEeeeeEEE
Confidence 48899999999999999999999999999999986433333333466677888899999999999999999999999999
Q ss_pred EEee-CCeEEEEEEEEecccc
Q 038211 151 PLYE-DGELAGFITVSSDAAI 170 (605)
Q Consensus 151 Pi~d-~g~i~g~v~i~~D~t~ 170 (605)
|+++ +|++.+++++.+|+|+
T Consensus 82 p~~d~~g~~~~~~~~~~DIT~ 102 (227)
T 3ewk_A 82 PLMDNAGKPRQYISIRRDITA 102 (227)
T ss_dssp EEECSSSCEEEEEEEEEECTT
T ss_pred EEEcCCCCEEEEEEEEEehhh
Confidence 9998 8999999999999775
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* | Back alignment and structure |
|---|
Probab=99.44 E-value=3.8e-13 Score=119.65 Aligned_cols=104 Identities=13% Similarity=0.215 Sum_probs=88.0
Q ss_pred HHHHhcCCeEEEEEc---CCCCEEEecHHHHHHhCCChhhhcCCCccccccccC------------CcchHHHHHHHHHc
Q 038211 61 SVLESMGHAVHVCTA---SSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEE------------FHSPHKKIMERLAS 125 (605)
Q Consensus 61 ~il~~~~d~ii~v~D---~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~------------~~~~~~~~~~~l~~ 125 (605)
.++++. +++ +++| .+|+|+|+|+++++++||+.+|++|+++.+ +.++. .......+...+..
T Consensus 30 ~~~~~~-~~i-~~~d~~d~~g~i~~~N~a~~~l~G~~~~el~g~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (149)
T 3d72_A 30 GPVDTS-VAL-ILCDLKQKDTPIVYASEAFLYMTGYSNAEVLGRNCRF-LQSPDGMVKPKSTRKYVDSNTINTMRKAIDR 106 (149)
T ss_dssp CSCCTT-SCE-EEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGG-GGSTTSCCCTTCCCSSSCHHHHHHHHHHHHH
T ss_pred HhhcCC-ccE-EEEeccCCCCcEEEECHHHHHHHCcCHHHHcCCChhH-hCCccccccccccccccChHHHHHHHHHHHC
Confidence 456664 667 7888 799999999999999999999999999987 44444 33345667777888
Q ss_pred CCceEEEEEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEec
Q 038211 126 GQSWSGQFPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSD 167 (605)
Q Consensus 126 g~~~~~~~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D 167 (605)
++.+..+...++++|+.+|+.++..|+++ +|++.|++++++|
T Consensus 107 ~~~~~~e~~~~~~dG~~~~~~~~~~~i~~~~g~~~~~v~~~~D 149 (149)
T 3d72_A 107 NAEVQVEVVNFKKNGQRFVNFLTMIPVRDETGEYRYSMGFQCE 149 (149)
T ss_dssp TCCEEEEEEEECTTCCEEEEEEEEEEEECTTSSEEEEEEECCC
T ss_pred CCceEEEEEEECCCCCEEEEEEEEEEEEcCCCCEEEEEEEEeC
Confidence 88998999999999999999999999998 8999999999887
|
| >2kdk_A ARYL hydrocarbon receptor nuclear translocator-LI 2; circadian clock, PAS domain, transcription, activator, biolo rhythms, DNA-binding, nucleus; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=1e-12 Score=112.30 Aligned_cols=108 Identities=15% Similarity=0.218 Sum_probs=84.8
Q ss_pred HHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHH-HHHcCC-ceEEEEEEEcCC
Q 038211 62 VLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIME-RLASGQ-SWSGQFPFKKRS 139 (605)
Q Consensus 62 il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~-~l~~g~-~~~~~~~~~~k~ 139 (605)
+++++++.+ +++|.+|+|+|+|+++++++||+.+|++|+++.+ ++++++.......+. .+..+. ....+++.++++
T Consensus 8 ~~~~~~~~i-~~~d~~g~i~~~N~~~~~~~G~~~~el~g~~~~~-~~~p~d~~~~~~~~~~~~~~~~~~~~~e~r~~~~d 85 (121)
T 2kdk_A 8 INVKPTEFI-TRFAVNGKFVYVDQRATAILGYLPQELLGTSCYE-YFHQDDHNNLTDKHKAVLQSKEKILTDSYKFRAKD 85 (121)
T ss_dssp CCCCSSEEE-EEECTTSBEEEECTHHHHHTCCCTTTSBTSBTTT-TBCSSSHHHHHHHHHHHHTSSSCEEEEEEEEECSS
T ss_pred cccCCccEE-EEECCCeeEEEEChhHHHHHCCCHHHHcCCcHHH-eeCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Confidence 456666655 8999999999999999999999999999999988 455565554444444 344433 456788889999
Q ss_pred CCEEEEEEEEEEEee-C-CeEEEEEEEEeccccc
Q 038211 140 GEILMAVVTKSPLYE-D-GELAGFITVSSDAAIF 171 (605)
Q Consensus 140 G~~~~v~~~~~Pi~d-~-g~i~g~v~i~~D~t~~ 171 (605)
|+.+|+.++..|+++ + +.+.+++++.+|+++.
T Consensus 86 G~~~~~~~~~~~~~d~~~~~~~~~v~~~~~i~~~ 119 (121)
T 2kdk_A 86 GSFVTLKSQWFSFTNPDTKELEYIVSVNTLVLGH 119 (121)
T ss_dssp SCEEEEEEEEEEEECCSSSCEEEEEEEEECCSSC
T ss_pred CCEEEEEEEEEEEECCCCCeeeEEEEEEEecccc
Confidence 999999999999987 4 5677888889987653
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=1.9e-12 Score=112.99 Aligned_cols=113 Identities=19% Similarity=0.246 Sum_probs=95.8
Q ss_pred cHHHHHHhcCCeEEEEEcC---CCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEE
Q 038211 58 PYRSVLESMGHAVHVCTAS---SEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFP 134 (605)
Q Consensus 58 ~~~~il~~~~d~ii~v~D~---~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~ 134 (605)
+|+.+++++++++ +++|. +|+|+++|+++++++||+.++++|+++.+++.+.........+...+..+..+..+..
T Consensus 3 ~l~~~~~~~~~~i-~~~d~~~~~~~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (146)
T 2v0u_A 3 FLATTLERIEKNF-VITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATVRKIRDAIDNQTEVTVQLI 81 (146)
T ss_dssp SCCCTGGGSSSCE-EEECTTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHTTCCEEEEEE
T ss_pred hHHHHHhcCCCcE-EEEcCCCCCceEEEEcHHHHHHHCcCHHHHcCCCHHHhcCCcCChHHHHHHHHHHhcCCCcceEEE
Confidence 4556788998888 88999 9999999999999999999999999998744333333335666777888888888888
Q ss_pred EEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEeccccc
Q 038211 135 FKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIF 171 (605)
Q Consensus 135 ~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~ 171 (605)
..+++|..+|+.++..|+.+ +|.+.|++.+++|+|+.
T Consensus 82 ~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~~ 119 (146)
T 2v0u_A 82 NYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEH 119 (146)
T ss_dssp EECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEEESSC
T ss_pred EEecCCcEEEEEEEEEEeECCCCCEEEEEEEEeechHH
Confidence 89999999999999999998 89999999999998764
|
| >4hi4_A Aerotaxis transducer AER2; PAS domain, diatomic GAS sensor, signaling protein; HET: HEM GOL; 2.30A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.41 E-value=1.6e-12 Score=111.84 Aligned_cols=103 Identities=16% Similarity=0.312 Sum_probs=76.7
Q ss_pred ccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhC------------CChhhhcCCCccccccccCCcchHHHHHHHHH
Q 038211 57 GPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYG------------WKDREVFGQRVTEFLIAEEFHSPHKKIMERLA 124 (605)
Q Consensus 57 ~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G------------~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~ 124 (605)
.+++++|+++++++ +++|.+|+|+|+|++|++++| |+.++++|+++.+++ +. ......++..+.
T Consensus 5 ~rl~~il~~~~~gv-iv~D~~g~I~~~N~a~~~llg~~~~~i~~~~~g~~~~~~~G~~~~~~~-~~--~~~~~~~~~~~~ 80 (121)
T 4hi4_A 5 ARIASALDNVSANV-MIADNDLNIIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFH-KN--PAHQRHLLANLT 80 (121)
T ss_dssp HHHHHHHTTSSSEE-EEEETTCBEEEECHHHHHHHHHTHHHHHHHCTTCCGGGCTTCBGGGGC-SS--HHHHHHHHHHCS
T ss_pred HHHHHHHhcCCccE-EEEcCCCeEEEecHHHHHHHHHHHHHHHHhcCCCChHHhcCCCHHHhc-CC--HHHHHHHHhCcC
Confidence 36788999999988 899999999999999999995 899999999999843 21 112223333322
Q ss_pred cCCceEEEEEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEecccc
Q 038211 125 SGQSWSGQFPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAI 170 (605)
Q Consensus 125 ~g~~~~~~~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~ 170 (605)
..+..++. .+|+. +.++.+|+++ +|++.|+|.+++|+|+
T Consensus 81 --~~~~~~~~---~~~~~--~~~~~~pi~~~~g~~~g~v~~~~DiTe 120 (121)
T 4hi4_A 81 --GVHKAELN---LGGRR--FSLDVVPVFNDANARLGSAVQWTDRTE 120 (121)
T ss_dssp --SCEEEEEE---ETTEE--EEEEEEEEECTTSCEEEEEEEEEECC-
T ss_pred --CCcEEEEE---ECCEE--EEEEEEEEECCCCCEEEEEEEEEEecC
Confidence 33433332 24543 4689999998 8999999999999885
|
| >3k3c_A Protein RV1364C/MT1410; sensor, PAS, signal transduction, fatty-acid binding, sigma regulator, signaling protein; HET: PLM; 1.62A {Mycobacterium tuberculosis} PDB: 3k3d_A | Back alignment and structure |
|---|
Probab=99.40 E-value=1.1e-12 Score=118.00 Aligned_cols=117 Identities=15% Similarity=0.103 Sum_probs=91.6
Q ss_pred ccccccHHHHHHhcCCeEEEEEc-CCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcc-hHHHHHHHHHcCCceE
Q 038211 53 SDSVGPYRSVLESMGHAVHVCTA-SSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHS-PHKKIMERLASGQSWS 130 (605)
Q Consensus 53 ~~~~~~~~~il~~~~d~ii~v~D-~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~-~~~~~~~~l~~g~~~~ 130 (605)
+.+.++|+.+++++++++ +++| .+|+|+++|+++++++|++ +++|+++.++ +++.... ....+.+.+.+|++..
T Consensus 13 ~~~~~~~~~~~~~~~~~i-~~~d~~~~~i~~~N~~~~~~~g~~--~~~G~~~~~~-~~~~~~~~~~~~~~~~~~~g~~~~ 88 (158)
T 3k3c_A 13 VGAAEDVRRIFEHIPAIL-VGLEGPDHRFVAVNAAYRGFSPLL--DTVGQPAREV-YPELEGQQIYEMLDRVYQTGEPQS 88 (158)
T ss_dssp TCCHHHHHHHHHHCSSEE-EEEETTTTEEEEECHHHHHHCTTC--CSTTSBHHHH-SGGGGGTTHHHHHHHHHHHCCCEE
T ss_pred HHHHHHHHHHHhcCCceE-EEEECCCcEeHHHHHHHHHHcCCc--hhcCCcHHHh-CCchhHHHHHHHHHHHHHhCCccc
Confidence 455668999999999988 7788 9999999999999999999 9999999984 4444333 3444555666888755
Q ss_pred EEEE-E--Ec-CC-CCEEEEEEEEEEEee-CCeEEEEEEEEeccccccc
Q 038211 131 GQFP-F--KK-RS-GEILMAVVTKSPLYE-DGELAGFITVSSDAAIFNS 173 (605)
Q Consensus 131 ~~~~-~--~~-k~-G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~~ 173 (605)
.+.. . .+ .+ |...|+.++..|+++ +|.+.|++++++|+|+..+
T Consensus 89 ~~~~~~~~~~~~~~g~~~~~~~~~~pi~~~~g~~~g~~~~~~DITe~k~ 137 (158)
T 3k3c_A 89 GSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVR 137 (158)
T ss_dssp EEEEEEEEESSSSCEEEEEEEEEEEEEECTTSCEEEEEEEEEECHHHHH
T ss_pred ccceeEEeccCCCCcceEEEEEEEEEeECCCCCEEEEEEEEEehhHHHH
Confidence 4322 2 22 22 678899999999998 8999999999999997543
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} | Back alignment and structure |
|---|
Probab=99.40 E-value=4.5e-13 Score=113.46 Aligned_cols=112 Identities=10% Similarity=0.081 Sum_probs=94.1
Q ss_pred cccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCc--cccccccCCcchHHH-HHHHHHcCCceEEE
Q 038211 56 VGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRV--TEFLIAEEFHSPHKK-IMERLASGQSWSGQ 132 (605)
Q Consensus 56 ~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~--~~l~~~~~~~~~~~~-~~~~l~~g~~~~~~ 132 (605)
+++|+.+++++++++ +.+|.+|.++++|+++++++||+.++++|+.. .+ ++++++...... +...+..+..+..+
T Consensus 3 ~~~~~~l~~~~~~~i-~~~d~~~~~~~~n~~~~~~~G~~~~~~~~~~~~~~~-~i~p~d~~~~~~~~~~~~~~~~~~~~e 80 (118)
T 3icy_A 3 AEELQALVDNIPAAI-YHLDVSGQATIRFRPPAFLKTLVSEHAGTTRLNTLS-MIHHDDRHMLSNAYSKLREAKHSLTLV 80 (118)
T ss_dssp HHHHHHHHTTCCCCC-EEECTTSCEEECCCCCGGGGGGEEEETTEEEEGGGG-GBCGGGHHHHHHHHHHHHHSCCEEEEE
T ss_pred HHHHHHHHhcCCceE-EEEEcCCCceEEechhHhhcCCCHHHccCChhHHHH-HcCHHHHHHHHHHHHHHHhcCCCceEE
Confidence 357889999999888 99999999999999999999999999988764 44 445555554433 44455777788889
Q ss_pred EEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEeccc
Q 038211 133 FPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAA 169 (605)
Q Consensus 133 ~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t 169 (605)
++..+++|+..|+.....|+++ +|.+.+++++++|+|
T Consensus 81 ~r~~~~~g~~~w~~~~~~~~~~~~g~~~~~~g~~~DIT 118 (118)
T 3icy_A 81 YRIVTPEGKLHWIEDHMRSSFSDDGLFSGIDGILCEVT 118 (118)
T ss_dssp EEEECTTCCEEEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 9999999999999999999998 899999999999976
|
| >3mr0_A Sensory box histidine kinase/response regulator; PAS fold, structural genomics, PSI-2; HET: PG5; 1.49A {Burkholderia thailandensis} | Back alignment and structure |
|---|
Probab=99.39 E-value=4.8e-12 Score=112.05 Aligned_cols=120 Identities=13% Similarity=0.181 Sum_probs=95.2
Q ss_pred hcccccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCC--CccccccccCCcchH-HHHHHHHHcCC
Q 038211 51 TTSDSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQ--RVTEFLIAEEFHSPH-KKIMERLASGQ 127 (605)
Q Consensus 51 ~~~~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk--~~~~l~~~~~~~~~~-~~~~~~l~~g~ 127 (605)
++.+++++|+.+++.+++++ +.+|.++.+++||+++.+++||+.+++.+. .+.+ +++|++.... ..+...+..+.
T Consensus 3 aL~~se~rl~~~~~~~~~g~-w~~d~~~~~~~~s~~~~~~~G~~~~~~~~~~~~~~~-~ihpdD~~~~~~~~~~~~~~~~ 80 (142)
T 3mr0_A 3 ALSASEERFQLAVSGASAGL-WDWNPKTGAMYLSPHFKKIMGYEDHELPDEITGHRE-SIHPDDRARVLAALKAHLEHRD 80 (142)
T ss_dssp ------CCHHHHHHHTTCEE-EEECTTTCCEEECHHHHHHTTCCGGGSCSEEC---C-CBCTTTHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHHHHhCCcEE-EEEEcCCCeEEECHHHHHHhCCCccccCCCHHHHHh-hcCHHHHHHHHHHHHHHHhCCC
Confidence 45567789999999998887 999999999999999999999999998773 3445 4556665543 34445667778
Q ss_pred ceEEEEEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEecccccc
Q 038211 128 SWSGQFPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFN 172 (605)
Q Consensus 128 ~~~~~~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~ 172 (605)
.+..+++.++++|...|+.....|+++ +|.+.+++++++|||+-.
T Consensus 81 ~~~~e~r~~~~~G~~~w~~~~~~~~~d~~g~~~~~~G~~~DITerk 126 (142)
T 3mr0_A 81 TYDVEYRVRTRSGDFRWIQSRGQALWNSAGEPYRMVGWIMDVTDRK 126 (142)
T ss_dssp CEEEEEEEECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEECHHHH
T ss_pred ceEEEEEEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEcCchHH
Confidence 888899999999999999999999998 899999999999998754
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.9e-13 Score=117.28 Aligned_cols=107 Identities=14% Similarity=0.148 Sum_probs=73.7
Q ss_pred ccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHH-HHHHHcCCceEEEE
Q 038211 55 SVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKI-MERLASGQSWSGQF 133 (605)
Q Consensus 55 ~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~-~~~l~~g~~~~~~~ 133 (605)
+.++|+.+++++++++ +++|.+|+|+++|+++++++||+.++++|+++.+++ ++......... ......+...
T Consensus 17 ~~~~~~~i~~~~~~~i-~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~---- 90 (125)
T 3fc7_A 17 TRKKFESLVSDSPDGI-VHLTTNGTILSVNPSMAGRLGADPDTLVGQQLSAVM-DSEAANQRLEAGKSAVENGTAT---- 90 (125)
T ss_dssp ---------CCSCCEE-EEEETTSBEEEECHHHHHHHTSCHHHHTTSBGGGSS-CHHHHHHHHHHHHHHHHHTSCE----
T ss_pred HHHHHHHHHhcCCCeE-EEEcCCCeEEEECHHHHHHhCCCHHHHcCccHHHhC-CHHHHHHHHHHHHHHhcCCCeE----
Confidence 5678899999999988 889999999999999999999999999999999854 43322222222 2334444433
Q ss_pred EEEcCCCC-EEEEEEEEEEEeeCCeEEEEEEEEeccc
Q 038211 134 PFKKRSGE-ILMAVVTKSPLYEDGELAGFITVSSDAA 169 (605)
Q Consensus 134 ~~~~k~G~-~~~v~~~~~Pi~d~g~i~g~v~i~~D~t 169 (605)
..++|. ..|+.++..|+.++|...|++.+++|+|
T Consensus 91 --~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~DIT 125 (125)
T 3fc7_A 91 --RSEDAVGGRHYHNQYIPVDSHRKSDTFQLVSRDIT 125 (125)
T ss_dssp --EEEEEETTEEEEEEEEESSTTTTTTEEEEEEEECC
T ss_pred --EeEcCCCcEEEEEEEEeEecCCCeEEEEEEEecCC
Confidence 223444 6788899999877777789999999976
|
| >3kx0_X Uncharacterized protein RV1364C/MT1410; PAS domain, sensory domain, mycobacteium tuberculos molecule binding domain; 2.30A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.37 E-value=3e-12 Score=119.01 Aligned_cols=118 Identities=15% Similarity=0.082 Sum_probs=91.7
Q ss_pred ccccccHHHHHHhcCCeEEEEEc-CCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcc-hHHHHHHHHHcCCceE
Q 038211 53 SDSVGPYRSVLESMGHAVHVCTA-SSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHS-PHKKIMERLASGQSWS 130 (605)
Q Consensus 53 ~~~~~~~~~il~~~~d~ii~v~D-~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~-~~~~~~~~l~~g~~~~ 130 (605)
..+.++|+.+++++++++ +++| .+|+|+++|+++++++||+ +++|+++.+++ ++.... ....+...+.+|++..
T Consensus 33 ~~~~~~l~~l~~~~~~~i-~~~d~~~g~i~~~N~a~~~l~G~~--~~~G~~~~~~~-~~~~~~~~~~~~~~~~~~g~~~~ 108 (185)
T 3kx0_X 33 VGAAEDVRRIFEHIPAIL-VGLEGPDHRFVAVNAAYRGFSPLL--DTVGQPAREVY-PELEGQQIYEMLDRVYQTGEPQS 108 (185)
T ss_dssp TCCHHHHHHHHHHCSSEE-EEEETTTTEEEEECHHHHHHCCCC--SCTTSBHHHHC-TTSCSSSSHHHHHHHHHHCCCEE
T ss_pred hhhHHHHHHHHhcCCceE-EEEECCCcEEEEEcHHHHHHcCCc--cccCCcHHHHC-CchhhhhHHHHHHHHHHcCCccc
Confidence 455678999999999988 7888 9999999999999999999 99999999844 444333 3445556667888766
Q ss_pred EEEEEE---cC-C-CCEEEEEEEEEEEee-CCeEEEEEEEEecccccccc
Q 038211 131 GQFPFK---KR-S-GEILMAVVTKSPLYE-DGELAGFITVSSDAAIFNSI 174 (605)
Q Consensus 131 ~~~~~~---~k-~-G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~~l 174 (605)
.+.... ++ + |...|+.++..|+++ +|.+.|++++++|+|+..+.
T Consensus 109 ~~~~~~~~~~~~~gg~~~~~~~~~~pi~~~~g~~~g~~~~~~DITerk~~ 158 (185)
T 3kx0_X 109 GSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRA 158 (185)
T ss_dssp EEEEEEC--------CCEEEEEEEEEEECTTSCEEEEEEEEEECHHHHTT
T ss_pred ccceeEEeeccCCCCccEEEEEEEEEEECCCCCEEEEEEEEEeCCHHHHH
Confidence 543222 22 2 778899999999998 89999999999999986543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=3.4e-12 Score=125.82 Aligned_cols=144 Identities=17% Similarity=0.081 Sum_probs=113.2
Q ss_pred ccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCeeEEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e 455 (605)
...|.+...++.|+++.||++...+..+++|+...... .....+.+|+.+++.+. +..+.++++++...+..|+|||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 35688999999999999999987788899998754321 22346889999999984 6778889999988889999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRN--------------------------------------- 496 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--------------------------------------- 496 (605)
|++|.+|.+.+. +......++.++..+|..||+..
T Consensus 91 ~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 91 EADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred ecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 999999876531 11122357789999999999810
Q ss_pred ------------------CCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 497 ------------------PPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 497 ------------------~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
..++|+|+++.|||+++++.+.|+||+.+...
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 12899999999999987656679999987544
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} | Back alignment and structure |
|---|
Probab=99.35 E-value=2.2e-12 Score=110.46 Aligned_cols=110 Identities=14% Similarity=0.193 Sum_probs=86.2
Q ss_pred HHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEcCC
Q 038211 60 RSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRS 139 (605)
Q Consensus 60 ~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~k~ 139 (605)
+.+++++++++ +++|.+|+|+++|+++++++||+.++++|+++.+ ++++.........+..+..++....+....+++
T Consensus 2 ~~l~~~~~~~i-~~~d~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (126)
T 3mjq_A 2 KNFLETIEDMI-LIINREGRLLYANTAVPKKLGYTHEELMSMHILT-ITSAGKMAEGEKILAELFAGKKESLPLSLEKKE 79 (126)
T ss_dssp CTTGGGCSSEE-EEEETTSBEEEECTHHHHHHSCCHHHHHHSBHHH-HHCTTCHHHHHHHHHHHHHTCCSEEEEEEECTT
T ss_pred hhHHhhCCceE-EEEeCCCcEEEEcHHHHHHHCCCHHHHcCCCHHH-HcCchhHHHHHHHHHHHHhCCCceeEEEEEccC
Confidence 45688888888 8899999999999999999999999999999998 455555544455555555555556778888999
Q ss_pred CCEEEEEEEEEEEeeCCeEEEEEEEEecccccc
Q 038211 140 GEILMAVVTKSPLYEDGELAGFITVSSDAAIFN 172 (605)
Q Consensus 140 G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~~~ 172 (605)
|..+|+.++..|+..++ ..+++++++|+|+..
T Consensus 80 g~~~~~~~~~~~~~~~~-~~~~~~~~~DITe~k 111 (126)
T 3mjq_A 80 GTSIPAKARIWQGKWHN-EPCLFAIIKDLSKEE 111 (126)
T ss_dssp SCEEEEEEEEEEEESSS-SEEEEEEEEECC---
T ss_pred CCEEEEEEEEEeeeECC-ceEEEEEEEechHHH
Confidence 99999999988876544 568899999988754
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.5e-11 Score=106.17 Aligned_cols=110 Identities=18% Similarity=0.288 Sum_probs=89.2
Q ss_pred HHHHHhcCCeEEEEEcC---CCCEEEecHHHHHHhCCChhhhcCCCc-cccccccCCcch-HHHHHHHHHcCCceEEEEE
Q 038211 60 RSVLESMGHAVHVCTAS---SEDIIYWNRSAESLYGWKDREVFGQRV-TEFLIAEEFHSP-HKKIMERLASGQSWSGQFP 134 (605)
Q Consensus 60 ~~il~~~~d~ii~v~D~---~G~Ii~~N~a~~~l~G~~~~eliGk~~-~~l~~~~~~~~~-~~~~~~~l~~g~~~~~~~~ 134 (605)
...++++++++ +++|. +|+|+++|+++++++||+.++++|+++ .+.+.++..... ...+...+..+..+..+..
T Consensus 22 ~~~~~~~~~~i-~~~d~~~~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (138)
T 2l0w_A 22 IRKFEGQSRKF-IIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIA 100 (138)
T ss_dssp HHHHTTTTSEE-EEEESSSTTCBEEEECSHHHHHHSCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHTTCSSCEEEEEE
T ss_pred HHHHhcCCCCE-EEEecCCCCCEEEEeCHHHHHHhCCCHHHHcCCCCcccccCCcccchhHHHHHHHHHhhcCCceeEEE
Confidence 34455588877 88999 999999999999999999999999993 443444433332 4455566677778888888
Q ss_pred EEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEecccc
Q 038211 135 FKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAI 170 (605)
Q Consensus 135 ~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~ 170 (605)
..+++|..+|+.++..|+.+ +|.+.|++.+++|+|+
T Consensus 101 ~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~Dit~ 137 (138)
T 2l0w_A 101 FYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVME 137 (138)
T ss_dssp EECTTSCEEEEEEEEEEEECTTSCEEEEEEEEEEEEE
T ss_pred EECCCCCEEEEEEEEEEEeCCCCCEEEEEEEEEeccC
Confidence 88999999999999999998 8999999999999875
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=2e-11 Score=100.48 Aligned_cols=101 Identities=19% Similarity=0.301 Sum_probs=83.1
Q ss_pred eEEEEEcC---CCCEEEecHHHHHHhCCChhhhcCCCc-cccccccCCcc-hHHHHHHHHHcCCceEEEEEEEcCCCCEE
Q 038211 69 AVHVCTAS---SEDIIYWNRSAESLYGWKDREVFGQRV-TEFLIAEEFHS-PHKKIMERLASGQSWSGQFPFKKRSGEIL 143 (605)
Q Consensus 69 ~ii~v~D~---~G~Ii~~N~a~~~l~G~~~~eliGk~~-~~l~~~~~~~~-~~~~~~~~l~~g~~~~~~~~~~~k~G~~~ 143 (605)
++ +++|. +|+|+++|+++++++||+.++++|+++ .+++.++.... ....+...+..+..+..+....+++|+.+
T Consensus 3 ~i-~i~d~~~~~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~ 81 (110)
T 1byw_A 3 KF-IIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCF 81 (110)
T ss_dssp EE-EEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEE
T ss_pred CE-EEEeccCCCCcEEEECHHHHHHhCCCHHHHccCCCccccccCCcCCHHHHHHHHHHHhcCCCceEEEEEEcCCCCEE
Confidence 45 77886 599999999999999999999999992 44344433332 24556677788888888888889999999
Q ss_pred EEEEEEEEEee-CCeEEEEEEEEecccc
Q 038211 144 MAVVTKSPLYE-DGELAGFITVSSDAAI 170 (605)
Q Consensus 144 ~v~~~~~Pi~d-~g~i~g~v~i~~D~t~ 170 (605)
|+.++..|+.+ +|.+.+++.+++|+|+
T Consensus 82 ~~~~~~~~~~~~~g~~~~~~~~~~DiTe 109 (110)
T 1byw_A 82 LCLVDVVPVKNEDGAVIMFILNFEVVME 109 (110)
T ss_dssp EEEEEEEEEECTTCCEEEEEEEEEEEEE
T ss_pred EEEEEEEEeecCCCCEEEEEEEEEeccC
Confidence 99999999998 8899999999999885
|
| >1v9y_A Heme PAS sensor protein; signaling protein; HET: HEM; 1.32A {Escherichia coli} SCOP: d.110.3.2 PDB: 1v9z_A* 1vb6_A* 1s67_L* 1s66_L* | Back alignment and structure |
|---|
Probab=99.33 E-value=2.1e-11 Score=109.89 Aligned_cols=119 Identities=20% Similarity=0.413 Sum_probs=85.2
Q ss_pred hcccccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCc--
Q 038211 51 TTSDSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQS-- 128 (605)
Q Consensus 51 ~~~~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~-- 128 (605)
++.++..+|+.+++.+++++ +++|.+|+|+++|+++++++||+.++++|+++.+ ++++.........+..+..+..
T Consensus 34 ~~~~~~~~~~~~l~~~~~~i-~~~d~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 111 (167)
T 1v9y_A 34 ADNAADGIFFPALEQNMMGA-VLINENDEVMFFNPAAEKLWGYKREEVIGNNIDM-LIPRDLRPAHPEYIRHNREGGKAR 111 (167)
T ss_dssp ------CCHHHHHHTCSSEE-EEECTTSBEEEECHHHHHHHSCCGGGTTTSBGGG-GSCGGGTTTHHHHHHHHHC-----
T ss_pred HHhhhhHHHHHHHHhCCCCE-EEECCCCcEEEECHHHHHHhCCCHHHHcCCChhh-ccCccccchHHHHHHHHhhcCCCc
Confidence 34455678999999999888 8899999999999999999999999999999998 4444444444444444444432
Q ss_pred ---eEEEEEEEcCCCCEEEEEEEEEEEeeCCeEEEEEEEEecccccc
Q 038211 129 ---WSGQFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAAIFN 172 (605)
Q Consensus 129 ---~~~~~~~~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~~~ 172 (605)
+..+....+++|..+|+.++..|+.++|.+. ++.+++|+|+..
T Consensus 112 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~g~~~-~~~~~~DiT~~~ 157 (167)
T 1v9y_A 112 VEGMSRELQLEKKDGSKIWTRFALSKVSAEGKVY-YLALVRDASVEM 157 (167)
T ss_dssp -----CEEEEECTTSCEEEEEEEEEEEEETTEEE-EEEEEEC-----
T ss_pred ccccceEEEEEcCCCcEEEEEEEEEEEecCCCEE-EEEEEecCcHHH
Confidence 4456777899999999999999995577764 899999988754
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.5e-11 Score=103.90 Aligned_cols=105 Identities=22% Similarity=0.252 Sum_probs=82.0
Q ss_pred HHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceE-EEEEEEc
Q 038211 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWS-GQFPFKK 137 (605)
Q Consensus 59 ~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~-~~~~~~~ 137 (605)
...+++++++++ +++|.+|+|+++|++|++++|++.++++|+++.+++ ++... ....+.+.+..++... .+....
T Consensus 9 ~~~il~~~~~~i-~~~D~~g~I~~~N~aa~~l~g~~~~~~~g~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~- 84 (115)
T 3b33_A 9 PSAILNNMVTAT-LILDDGLAIRYANPAAELLFSQSAKRIVEQSLSQLI-QHASL-DLALLTQPLQSGQSITDSDVTFV- 84 (115)
T ss_dssp HHHHHHHCSSEE-EEECTTCBEEEECHHHHHHTTSCHHHHTTCBHHHHC-SEEEC-CTHHHHHHHHHCCCEEEEEEEEE-
T ss_pred HHHHHhhcCceE-EEECCCCcEEEECHHHHHHhCCCHHHHhCCCHHHHh-Cccch-hhHHHHHHHHcCCcccCCceEEe-
Confidence 456899999888 899999999999999999999999999999999843 32211 1233444566666543 455555
Q ss_pred CCCCEEEEEEEEEEEeeCCeEEEEEEEEecc
Q 038211 138 RSGEILMAVVTKSPLYEDGELAGFITVSSDA 168 (605)
Q Consensus 138 k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~ 168 (605)
++|+.+|+.++..|+.++|. .|++.+++|+
T Consensus 85 ~~g~~~~~~~~~~pi~~~g~-~~~l~~~~Di 114 (115)
T 3b33_A 85 VDGRPLMLEVTVSPITWQRQ-LMLLVEMRKI 114 (115)
T ss_dssp ETTEEEEEEEEEEEEEETTE-EEEEEEEEEC
T ss_pred cCCCEEEEEEEEEEeecCCc-eEEEEEEEeC
Confidence 78999999999999988665 7899999995
|
| >3vol_A Aerotaxis transducer AER2; heme, oxygen sensor protein, PAS, HAMP, cyanoMet, CN-bound, protein; HET: HEM; 2.40A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.29 E-value=8e-12 Score=120.89 Aligned_cols=110 Identities=15% Similarity=0.291 Sum_probs=82.8
Q ss_pred cccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHh------------CCChhhhcCCCccccccccCCcchHHHHHH
Q 038211 54 DSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLY------------GWKDREVFGQRVTEFLIAEEFHSPHKKIME 121 (605)
Q Consensus 54 ~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~------------G~~~~eliGk~~~~l~~~~~~~~~~~~~~~ 121 (605)
++.++++.+|+++++++ +++|.+|+|+|+|++|++++ ||+.++++|+++.+++ +. ......++.
T Consensus 19 ~e~~~l~~iLd~~~~~v-ii~D~~g~I~~~N~a~~~ll~~~~~~~~~~l~G~~~~eliG~~~~~~~-~~--~~~~~~~~~ 94 (233)
T 3vol_A 19 SHMARIKSALDNVSANV-MIADNDLNIIYMNRTVSEMLGRAEADIRKQLPNFDAGRLMGANIDVFH-KN--PAHQRHLLA 94 (233)
T ss_dssp THHHHHHHHHTTSSSEE-EEEETTSBEEEECHHHHHHHHHTHHHHHTTCTTCCTTSCTTCBGGGGS-SS--HHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCcE-EEECCCCcEEEecHHHHHHHHHHHHHHHhhcCCCCHHHHcCCCHHHHc-CC--HHHHHHHHH
Confidence 33456888999999888 89999999999999999999 8999999999999743 21 122233333
Q ss_pred HHHcCCceEEEEEEEcCCCCEEEEEEEEEEEee-CCeEEEEEEEEecccccccc
Q 038211 122 RLASGQSWSGQFPFKKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFNSI 174 (605)
Q Consensus 122 ~l~~g~~~~~~~~~~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~~l 174 (605)
.+. ..+..++. .+|. |+.++.+|+++ +|++.|+|.+++|+|+..++
T Consensus 95 ~~~--~~~~~~~~---~~g~--~~~~~~~Pi~d~~G~~~g~v~~~~DITe~~~~ 141 (233)
T 3vol_A 95 NLT--GVHKAELN---LGGR--RFSLDVVPVFNDANERLGSAVQWTDRTEEHRA 141 (233)
T ss_dssp TCC--SCEEEEEE---ETTE--EEEEEEEEEECTTCCEEEEEEEEEECHHHHHH
T ss_pred hcc--cceeEEEE---ECCE--EEEEEEEEEECCCCCEEEEEEEEehhhHHHHH
Confidence 322 23443332 3554 55889999998 89999999999999986654
|
| >3h9w_A Diguanylate cyclase with PAS/PAC sensor; alpha-beta protein., structural genomics, PSI-2, protein STR initiative; 1.90A {Marinobacter aquaeolei} | Back alignment and structure |
|---|
Probab=99.27 E-value=2.2e-11 Score=103.08 Aligned_cols=102 Identities=13% Similarity=0.115 Sum_probs=82.8
Q ss_pred CeEEEEEc-CCCCEEEecHHHHHHhCCChhhhcCCC-ccccccccCCcchH-HHHHHHHHcCCceEEEEEEEcCCCCEEE
Q 038211 68 HAVHVCTA-SSEDIIYWNRSAESLYGWKDREVFGQR-VTEFLIAEEFHSPH-KKIMERLASGQSWSGQFPFKKRSGEILM 144 (605)
Q Consensus 68 d~ii~v~D-~~G~Ii~~N~a~~~l~G~~~~eliGk~-~~~l~~~~~~~~~~-~~~~~~l~~g~~~~~~~~~~~k~G~~~~ 144 (605)
+++ +.+| .+|+++|+|+++++++||+.++++|.. +.+ +++|++.... ..+...+..+..+..+++.++++|+.+|
T Consensus 4 ~gi-w~~d~~~~~~~~~n~~~~~l~G~~~~e~~~~~~~~~-~ihpdd~~~~~~~~~~~~~~~~~~~~e~r~~~~dG~~~w 81 (115)
T 3h9w_A 4 AIP-WKINWQTMAFEYIGPQIEALLGWPQGSWKSVEDWAT-RMHPEDQEWVVNFCVKQSECGVDHEADYRALHRDGHYVW 81 (115)
T ss_dssp CEE-EEEETTTTEEEEECTHHHHHHCSCGGGCCBHHHHHH-SBCHHHHHHHHHHHHHHHHTTCCEEEEEEEECTTSCEEE
T ss_pred eEE-EEEEcCCCcEEEEChhHHHHhCCChHHccCHHHHHH-hcCHHHHHHHHHHHHHHHhcCCcccEEEEEEcCCCCEEE
Confidence 444 8888 789999999999999999999999832 233 4455555443 3444566677778889999999999999
Q ss_pred EEEEEEEEee-CCeEEEEEEEEeccccc
Q 038211 145 AVVTKSPLYE-DGELAGFITVSSDAAIF 171 (605)
Q Consensus 145 v~~~~~Pi~d-~g~i~g~v~i~~D~t~~ 171 (605)
+.....|+++ +|++++++++..|+|+-
T Consensus 82 ~~~~~~~~~d~~G~~~~~~G~~~Dit~~ 109 (115)
T 3h9w_A 82 IRDVVHVVRDDSGEVEALIGFMFDISLE 109 (115)
T ss_dssp EEEEEEEEECTTSCEEEEEEEEEECGGG
T ss_pred EEEEEEEEECCCCCEEEEEEEEeccCcc
Confidence 9999999998 89999999999998873
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.4e-11 Score=104.33 Aligned_cols=90 Identities=17% Similarity=0.169 Sum_probs=65.6
Q ss_pred HHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEcCCC
Q 038211 61 SVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRSG 140 (605)
Q Consensus 61 ~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~k~G 140 (605)
.+++++++.+ +++|.+|+|+|+|+++++++||+++|++|+++.+ +++|++.......+. ..+.....++++++|||
T Consensus 3 ~lle~~~d~i-~v~d~~G~i~yvn~~~~~~lGy~~~el~G~~~~~-~ihp~D~~~~~~~~~--~~~~~~~~e~r~~~kdG 78 (111)
T 2vlg_A 3 FPLQTKTDIH-AVLASNGRIIYISANSKLHLGYLQGEMIGSFLKT-FLHEEDQFLVESYFY--NEHHLMPCTFRFIKKDH 78 (111)
T ss_dssp ------CCEE-EEECTTSBEEEECTTHHHHHSCCHHHHTTSBGGG-GBCGGGHHHHHHHHH--CSCCSSCEEEEEECTTS
T ss_pred chhhcCCCEE-EEEcCCCeEEEEChHHHHHhCCCHHHHcCCcHHH-eECHhHHHHHHHHHh--ccCCCccEEEEEEcCCC
Confidence 4678887766 8899999999999999999999999999999998 556666544333221 12333445778889999
Q ss_pred CEEEEEEEEEEEee
Q 038211 141 EILMAVVTKSPLYE 154 (605)
Q Consensus 141 ~~~~v~~~~~Pi~d 154 (605)
+.+|+.++..++.+
T Consensus 79 ~~~wve~~~~~v~~ 92 (111)
T 2vlg_A 79 TIVWVEAAVEIVTT 92 (111)
T ss_dssp CEEEEEEEEEEC--
T ss_pred CEEEEEEEEEEEec
Confidence 99999999999986
|
| >3cax_A Uncharacterized protein PF0695; structural genomics, unknown function, PSI-2, protein struct initiative; 2.43A {Pyrococcus furiosus dsm 3638} | Back alignment and structure |
|---|
Probab=99.22 E-value=3.1e-11 Score=124.89 Aligned_cols=113 Identities=16% Similarity=0.307 Sum_probs=91.6
Q ss_pred ccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEE
Q 038211 57 GPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFK 136 (605)
Q Consensus 57 ~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~ 136 (605)
.++++|++++++++ +++|.+|+|+|||++ ++++ ++.++++|+++.+ ++++........+...+.+|+....+....
T Consensus 239 ~~l~~IL~~l~dgI-ivvD~~g~I~~~N~a-e~i~-~~~~e~iGr~v~~-~~p~~~~~~~~~l~~~l~~g~~~~~~~~~~ 314 (369)
T 3cax_A 239 EELKAIFEALPVDV-TFIDKDDRVRFFSPG-ERIF-TRTPSVLGRPVQL-CHPPKSVYVVNKILKAFKEGRKKEATFWLR 314 (369)
T ss_dssp HHHHHHHHHSSSEE-EEECTTSBEEEECCS-SCSS-CCCGGGTTCBTTT-SSCGGGHHHHHHHHHHHHHTSCSCEEEEEE
T ss_pred HHHHHHHHhCCCcE-EEECCCCcEEEEcCH-HHcc-CChHHHcCCcHHH-HCChhhHHHHHHHHHHHHcCCceEEEEEEe
Confidence 46889999999988 899999999999999 9999 9999999999998 445443334556777888888765554443
Q ss_pred cCCCCEEEEEEEEEEEee-CCeEEEEEEEEeccccccccCC
Q 038211 137 KRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFNSINP 176 (605)
Q Consensus 137 ~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~~l~~ 176 (605)
.+| .++.++.+||+| +|+++|++.+++|+|++.++-.
T Consensus 315 -~~g--~~v~v~~~PI~d~~G~~~G~v~v~~DITe~~~le~ 352 (369)
T 3cax_A 315 -LRE--KYVYIKYVPLFNEKGEYIGTLEMTMDIAPYKKIEG 352 (369)
T ss_dssp -ETT--EEEEEEEEEEECTTSCEEEEEEEEEECHHHHTCCS
T ss_pred -eCC--EEEEEEEEEEECCCCCEEEEEEEEEcCHHHHHHHH
Confidence 356 366789999998 8999999999999999876643
|
| >3fg8_A Uncharacterized protein RHA05790; PAS domain, structural genomics, PS protein structure initiative, midwest center for structural genomics, MCSG; HET: 3PB; 1.80A {Rhodococcus SP} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.4e-11 Score=105.18 Aligned_cols=105 Identities=18% Similarity=0.121 Sum_probs=78.3
Q ss_pred ccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcch-HHHHHHHHHcCCceEEEEEE
Q 038211 57 GPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSP-HKKIMERLASGQSWSGQFPF 135 (605)
Q Consensus 57 ~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~-~~~~~~~l~~g~~~~~~~~~ 135 (605)
+.++++++++++++ +++|.+|+|+++|+++++++|++.++++|+++.++ +++..... ...+.+.+.+++.+..++..
T Consensus 12 ~~~~~il~~~~~~i-~~~D~~g~i~~~N~a~~~l~g~~~~e~~G~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (118)
T 3fg8_A 12 SGRENLYFQGGLGF-MALDEDLRIIYVNSGCLRHVRRSRDELLGRVVTEV-LPETQGSYFDALCRKVLATGREQQTRVDS 89 (118)
T ss_dssp -CCCCSSSCTTCEE-EEECTTCBEEEECHHHHHHHTCCHHHHTTSBHHHH-CGGGTTSHHHHHHHHHHHHCCCEEEEEEC
T ss_pred chHHHHHhhCCceE-EEECCCCeEEEECHHHHHHhCCCHHHHcCCcHHHH-cCccchHHHHHHHHHHHHcCCceEEEEEE
Confidence 34566789999888 89999999999999999999999999999999984 44433333 44555677788887663333
Q ss_pred EcCCCCEEEEEEEEEEEeeCCeEEEEEEEEecccc
Q 038211 136 KKRSGEILMAVVTKSPLYEDGELAGFITVSSDAAI 170 (605)
Q Consensus 136 ~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~ 170 (605)
...+|. |+.++..|+.+ |++.+++|+|+
T Consensus 90 ~~~~g~--~~~~~~~p~~~-----g~v~~~~DITe 117 (118)
T 3fg8_A 90 LYSPGM--TIEVTAAADSG-----ALVVHFRDVTA 117 (118)
T ss_dssp SSSTTC--EEEEEEEEETT-----EEEEEEEECSC
T ss_pred EcCCCe--EEEEEEEEcCC-----cEEEEEEeccC
Confidence 333664 56778888743 37888999875
|
| >1ll8_A PAS kinase; PAS domain, ligand binding, ligand screening, kinase regulation, transferase; NMR {Homo sapiens} SCOP: d.110.3.5 | Back alignment and structure |
|---|
Probab=99.22 E-value=3.4e-12 Score=108.08 Aligned_cols=101 Identities=16% Similarity=0.202 Sum_probs=70.9
Q ss_pred CCeEEEEEcCC-CCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHH-Hc-CCce---EEEEEEEcCCC
Q 038211 67 GHAVHVCTASS-EDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERL-AS-GQSW---SGQFPFKKRSG 140 (605)
Q Consensus 67 ~d~ii~v~D~~-G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l-~~-g~~~---~~~~~~~~k~G 140 (605)
...+|+++|.+ |+|+++|++|++++||+.+|++|+++.+ ++++........+.... .. +... ..+...++++|
T Consensus 7 ~~~~i~~~d~~~g~I~~~N~aa~~l~G~~~~el~g~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dG 85 (114)
T 1ll8_A 7 FNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQ-FFLRSDSDVVEALSEEHMEADGHAAVVFGTVVDIISRSG 85 (114)
T ss_dssp TTCEEEEEETTTCBEEEECTTHHHHHTCCTTTTTTSBGGG-GSSCTTTHHHHHTTSSTTSSSSCSSCCCSSSEEECCTTC
T ss_pred CCceEEEEECCCCeEEEehHHHHHHhCCCHHHHcCCCHHH-hcCcchhHHHHHHHHHhhccCCcceeccCcEEEEEecCC
Confidence 33344899999 9999999999999999999999999998 44444332222222211 11 1111 22456679999
Q ss_pred CEEEEEEEEEEEeeCCeEEEEEEEEeccc
Q 038211 141 EILMAVVTKSPLYEDGELAGFITVSSDAA 169 (605)
Q Consensus 141 ~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t 169 (605)
+.+|+.++.+|+.+++. .+++.+++|+.
T Consensus 86 ~~~~v~~~~~~~~~~~~-~~~v~~~~~~~ 113 (114)
T 1ll8_A 86 EKIPVSVWMKRMRQERR-LCCVVVLEPVE 113 (114)
T ss_dssp CCEEEECCEECCBSSSS-BEEEEEEEECC
T ss_pred CEEEEEEEEEeeccCCc-cEEEEEEeecC
Confidence 99999999999987433 36778888853
|
| >1nwz_A PYP, photoactive yellow protein; PAS, LOV, GAF, domains fold, signaling protein; HET: HC4; 0.82A {Halorhodospira halophila} SCOP: d.110.3.1 PDB: 1kou_A* 1ot9_A* 1otb_A* 1s4r_A* 1s4s_A* 1ts0_A* 1ts6_A* 1ts7_A* 1ts8_A* 1uwn_X* 1uwp_X* 2d01_A* 2phy_A* 2pyp_A* 2pyr_A* 2qj5_A* 2qj7_A* 2qws_A* 2zoh_A* 2zoi_A* ... | Back alignment and structure |
|---|
Probab=99.21 E-value=9.4e-11 Score=99.78 Aligned_cols=99 Identities=14% Similarity=0.153 Sum_probs=75.8
Q ss_pred HHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcc-hHHHHHHHHHcCCceEEEEEEE-c
Q 038211 60 RSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHS-PHKKIMERLASGQSWSGQFPFK-K 137 (605)
Q Consensus 60 ~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~-~~~~~~~~l~~g~~~~~~~~~~-~ 137 (605)
..+++++++|+ +++|.+|+|++||++++++.||++++++|+++.+.+.+..... ....+.+.+.+|. +..+..++ +
T Consensus 20 ~~~ld~l~~Gi-i~lD~~g~I~~~N~~~e~~sG~~~~eviGk~~f~~~~~~~~~~~f~~rf~~~~~~g~-l~~~~~~v~~ 97 (125)
T 1nwz_A 20 DGQLDGLAFGA-IQLDGDGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGN-LNTMFEYTFD 97 (125)
T ss_dssp HHHHTTCSSEE-EEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTC-CEEEEEEEEC
T ss_pred HHHHhccCceE-EEECCCCEEEEEHHHHHHHhCCCHHHHcCCchhhhccchhcccHHHHHHHHHHhcCc-eeEEEEEEEc
Confidence 55799999888 8899999999999999999999999999999987444433333 3556667777666 66666665 9
Q ss_pred CCCCEEEEEEEEEEEee-CCeEEEEE
Q 038211 138 RSGEILMAVVTKSPLYE-DGELAGFI 162 (605)
Q Consensus 138 k~G~~~~v~~~~~Pi~d-~g~i~g~v 162 (605)
++|+.++ +++.+..+ +|...++.
T Consensus 98 ~~~~p~~--v~i~l~~~~~~~~~~i~ 121 (125)
T 1nwz_A 98 YQMTPTK--VKVHMKKALSGDSYWVF 121 (125)
T ss_dssp TTSCCEE--EEEEEEECSSSSEEEEE
T ss_pred CCCCEEE--EEEEEEEcCCCCEEEEE
Confidence 9999554 56666666 67666654
|
| >1mzu_A PPR; photoactive yellow protein, PAS, PYP, signaling protein; HET: HC4; 2.00A {Rhodospirillum centenum} SCOP: d.110.3.1 | Back alignment and structure |
|---|
Probab=99.20 E-value=9.2e-11 Score=99.95 Aligned_cols=98 Identities=14% Similarity=0.109 Sum_probs=74.4
Q ss_pred HHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcc-hHHHHHHHHHcCCceEEEEEEE-cC
Q 038211 61 SVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHS-PHKKIMERLASGQSWSGQFPFK-KR 138 (605)
Q Consensus 61 ~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~-~~~~~~~~l~~g~~~~~~~~~~-~k 138 (605)
.++++++.|+ +++|.+|+|++||.+++++.||++++++|+++.+.+.+..... ....+.+.+.+|. +..+..++ ++
T Consensus 26 ~~ld~l~~Gi-ivlD~dg~I~~~N~~~e~isG~s~eeviGk~~f~~~~p~~~~~~f~grf~~~~~~G~-l~~~~~yv~~~ 103 (129)
T 1mzu_A 26 AEFDALPVGA-IQVDGSGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGT-LDARFDFVFDF 103 (129)
T ss_dssp TTGGGCSSEE-EEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSC-CEEEEEEEEEC
T ss_pred HHHhccCceE-EEECCCCeEEEEHHHHHHHhCCCHHHHcCCchhhhccchhcccHHHHHHHHHHhcCc-eeEEEEEEEcC
Confidence 3689999888 8899999999999999999999999999999987444433333 3556667777665 66666655 89
Q ss_pred CCCEEEEEEEEEEEee-CCeEEEEE
Q 038211 139 SGEILMAVVTKSPLYE-DGELAGFI 162 (605)
Q Consensus 139 ~G~~~~v~~~~~Pi~d-~g~i~g~v 162 (605)
+|+.++ +++.++.+ +|..+++.
T Consensus 104 ~~~p~~--v~i~l~~~~~~~~~~i~ 126 (129)
T 1mzu_A 104 QMAPVR--VQIRMQNAGVPDRYWIF 126 (129)
T ss_dssp SSCEEE--EEEEEEECSSTTEEEEE
T ss_pred CCCEEE--EEEEEEEcCCCCEEEEE
Confidence 999554 56666666 67666654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.8e-10 Score=118.98 Aligned_cols=144 Identities=17% Similarity=0.214 Sum_probs=108.0
Q ss_pred EeeeecccCcEEEEEEEECCcceEEEEee--ccccchhhhhhHHHHHHHHHhCC--CCCeeeEEEEEeeC---CeeEEEE
Q 038211 382 LGEEIGLGSYAVVYRGIWNGSDVAVKVYF--GSEYIEGTLKNYQKEIDIIKKLR--HPNVLLFMGAVASQ---ERLGIVT 454 (605)
Q Consensus 382 ~~~~LG~G~fg~V~~~~~~~~~~avKv~~--~~~~~~~~~~~~~~E~~il~~l~--h~niv~~~~~~~~~---~~~~lv~ 454 (605)
-++.|+.|.++.||+....+..+++|+.. .... ......+.+|+.+++.+. +..+++++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 46789999999999998878889999765 3221 122457889999999996 45578888887765 4589999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR--------------------------------------- 495 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--------------------------------------- 495 (605)
||++|..+.+. ....++......++.+++.+|..||..
T Consensus 121 e~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99998877432 123467788888999999999999973
Q ss_pred -----------------CCCceeccCCCCCEEEcCCCc--EEEEeecCCcccC
Q 038211 496 -----------------NPPIVHRDLKSSNLLVDKNWT--VKVGDFGLSSLKN 529 (605)
Q Consensus 496 -----------------~~~iiH~Dik~~Nill~~~~~--vkl~Dfg~a~~~~ 529 (605)
...++|+|+++.|||++.++. +.|+||+.+....
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 123899999999999987653 6899999987654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.10 E-value=2.1e-10 Score=112.55 Aligned_cols=137 Identities=18% Similarity=0.117 Sum_probs=99.8
Q ss_pred cCceEeeeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCC--eeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN--VLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~~~~~~~~~~~~~lv~ 454 (605)
..+.+....+.|+.+.||++... |..+++|+.... ....+.+|+.+++.+.+.+ +.+++.++..++..++||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 45565554456777999998754 567999986543 2356789999999985444 556888888778899999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRN-------------------------------------- 496 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-------------------------------------- 496 (605)
||++|.+|. .. .... ..++.+++..|..||+..
T Consensus 95 e~i~G~~l~--~~----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 95 GEVPGQDLL--SS----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp ECCSSEETT--TS----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EecCCcccC--cC----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 999998883 21 1222 245667777888888643
Q ss_pred ------------------CCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 497 ------------------PPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 497 ------------------~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
..++|+|++|.|||++.++.+.|+||+.+...
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 01899999999999987766779999987643
|
| >3a0s_A Sensor protein; PAS-fold, kinase, phosphoprotein, transferase, two-component regulatory system; HET: PG4 PGE; 1.47A {Thermotoga maritima} PDB: 3a0v_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=6.9e-10 Score=88.77 Aligned_cols=93 Identities=22% Similarity=0.324 Sum_probs=69.0
Q ss_pred CCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEcCCCCEEEEE
Q 038211 67 GHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRSGEILMAV 146 (605)
Q Consensus 67 ~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~k~G~~~~v~ 146 (605)
++++ +++|.+|+|+++|+++++++|++.++++|+++.++ +........+...+..+..+.. ... +|...|+.
T Consensus 2 ~~~i-~~~d~~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~---~~~~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~ 73 (96)
T 3a0s_A 2 ETAI-ITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDL---PDFEEIGSVAESVFENKEPVFL--NFY--KFGERYFN 73 (96)
T ss_dssp CCEE-EEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGGS---TTCHHHHHHHHHHHHHTCCEEE--EEE--EETTEEEE
T ss_pred CceE-EEEcCCCCEeehhHHHHHHhCCCHHHhcCCCHHHC---cchHHHHHHHHHHhccCCeEEE--EEE--cCCcEEEE
Confidence 4566 88999999999999999999999999999999873 2333333444555666666532 222 34445788
Q ss_pred EEEEEEee-CCe-EEEEEEEEec
Q 038211 147 VTKSPLYE-DGE-LAGFITVSSD 167 (605)
Q Consensus 147 ~~~~Pi~d-~g~-i~g~v~i~~D 167 (605)
++..|+.+ +|+ +.|++.+++|
T Consensus 74 ~~~~p~~~~~~~~~~g~v~~~~D 96 (96)
T 3a0s_A 74 IRFSPFRNAKTQLLEGVIITIDD 96 (96)
T ss_dssp EEEEEEECTTTCCEEEEEEEEEC
T ss_pred EEEEEeEcCCCCeeeEEEEEecC
Confidence 99999987 454 6899999887
|
| >2w0n_A Sensor protein DCUS; signal transduction, two-component regulatory system, PAS, kinase, membrane, transferase, solid state cell inner membrane; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.08 E-value=2e-11 Score=103.03 Aligned_cols=106 Identities=17% Similarity=0.267 Sum_probs=79.6
Q ss_pred cccccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCC---ChhhhcCCCccccccccCCcchHHHHHHHHHcCCc
Q 038211 52 TSDSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGW---KDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQS 128 (605)
Q Consensus 52 ~~~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~---~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~ 128 (605)
+.+..+.++.+++++++++ +++|.+|+|+++|+++++++|| +.++++|+++.+++ ++. .+...+..+..
T Consensus 10 l~~~~~~~~~il~~~~~~i-~~~d~~g~i~~~N~~~~~~~g~~~~~~~~~~g~~~~~~~-~~~------~~~~~~~~~~~ 81 (118)
T 2w0n_A 10 ISTLFEQRQAMLQSIKEGV-VAVDDRGEVTLINDAAQELLNYRKSQDDEKLSTLSHSWS-QVV------DVSEVLRDGTP 81 (118)
T ss_dssp HCTTHHHHHHHHHCCCCCC-EEEBTTTBCCCBCHHHHHHHCSCTTTTTSSCCCTTCCCS-CTH------HHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhhccccE-EEECCCCcEeehhHHHHHHhCCCccChhhhhccCccccc-Cch------hHHHHhccCce
Confidence 3444566788999999988 8899999999999999999998 88999999999843 222 13445555554
Q ss_pred eEEEEEEEcCCCCEEEEEEEEEEEeeCCeEEEEEEEEeccc
Q 038211 129 WSGQFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAA 169 (605)
Q Consensus 129 ~~~~~~~~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t 169 (605)
..... ...+|. |+.++..|+.++|++.|++.+++|+|
T Consensus 82 ~~~~~--~~~~~~--~~~~~~~p~~~~g~~~g~v~~~~DiT 118 (118)
T 2w0n_A 82 RRDEE--ITIKDR--LLLINTVPVRSNGVIIGAISTFRDKT 118 (118)
T ss_dssp CCCCC--EESSSC--EECCCEECCCCSSCCCCEEECCCCCC
T ss_pred eccEE--EEECCE--EEEEeeceeeeCCEEEEEEEEEEeCC
Confidence 32211 234564 55678889988888889999999975
|
| >4f3l_A Mclock, circadian locomoter output cycles protein kaput; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.02 E-value=5.1e-10 Score=115.49 Aligned_cols=103 Identities=9% Similarity=0.056 Sum_probs=86.2
Q ss_pred eEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHH-HHHHHHHcCCceEEEEEEEcCCCCEEEEEE
Q 038211 69 AVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHK-KIMERLASGQSWSGQFPFKKRSGEILMAVV 147 (605)
Q Consensus 69 ~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~-~~~~~l~~g~~~~~~~~~~~k~G~~~~v~~ 147 (605)
..++..|.+|+++|+|++++.++||+++|++|+++.+ ++++++..... .+...+..|.....++++++++|..+|+..
T Consensus 252 ~f~~~~~~dg~~~~vn~~~~~ilGY~~eEl~g~~~~~-~iHpdD~~~~~~~~~~~l~~g~~~~~eyR~~~kdG~~vWv~~ 330 (361)
T 4f3l_A 252 EFTSRHSLEWKFLFLDHRAPPIIGYLPFEVLGTSGYD-YYHVDDLENLAKCHEHLMQYGKGKSCYYRFLTKGQQWIWLQT 330 (361)
T ss_dssp EEEEEECTTSBEEEECTTSHHHHCCCHHHHTTSBGGG-GBCHHHHHHHHHHHHHHHHHSEEECCCEEEECTTSEEEEEEE
T ss_pred eeEEEEcCCceEEEECChhhhhhCcCHHHHcCCCHHH-eECHHHHHHHHHHHHHHHhCCCcceEEEEEEecCCCEEEEEE
Confidence 4457789999999999999999999999999999998 55566555433 344456667666678899999999999999
Q ss_pred EEEEEee--CCeEEEEEEEEecccccc
Q 038211 148 TKSPLYE--DGELAGFITVSSDAAIFN 172 (605)
Q Consensus 148 ~~~Pi~d--~g~i~g~v~i~~D~t~~~ 172 (605)
+..|+++ +|++.++|++.+|+|+-+
T Consensus 331 ~~~~v~~~~~g~~~~iv~~~~dITe~~ 357 (361)
T 4f3l_A 331 HYYITYHQWNSRPEFIVCTHTVVSYAE 357 (361)
T ss_dssp EEEEEECTTTCCEEEEEEEEEECCHHH
T ss_pred EEEEEEcCCCCCeeEEEEEEEECChhH
Confidence 9999997 689999999999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.98 E-value=8.2e-10 Score=111.24 Aligned_cols=187 Identities=20% Similarity=0.188 Sum_probs=123.5
Q ss_pred eeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCC--eeeEEEEEeeCC---eeEEEEEe
Q 038211 383 GEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPN--VLLFMGAVASQE---RLGIVTEF 456 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~n--iv~~~~~~~~~~---~~~lv~e~ 456 (605)
++.++.|.+..||+. +..+++|+.... .....+.+|.++|+.+ .+.. +..++......+ ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v---~~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI---NRDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEES---TTSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEE---CCEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 356899999999986 367999985432 3356788999999888 3333 345554433333 35889999
Q ss_pred cCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 038211 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRN---------------------------------------- 496 (605)
Q Consensus 457 ~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---------------------------------------- 496 (605)
++|.+|..... ..++......++.+++..|..||+..
T Consensus 98 i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 98 IKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred cCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99988865433 34667777778888888888888621
Q ss_pred ----------------CCceeccCCCCCEEEcC--CCcEEEEeecCCcccCcccccccCCCCCCccccccccc----CCC
Q 038211 497 ----------------PPIVHRDLKSSNLLVDK--NWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLR----SEP 554 (605)
Q Consensus 497 ----------------~~iiH~Dik~~Nill~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~ 554 (605)
+.++|+|+++.||+++. .+.+.|+||+.+................ .-..|+... ...
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHHHHHHHHT
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHHHHHHHcC
Confidence 12799999999999988 5567899999987654322111110000 001222111 000
Q ss_pred -C---------CchhHHHHHHHHHHHHHcCCCCCCC
Q 038211 555 -S---------NEKSDVFSFGVILWELVTASIPWNN 580 (605)
Q Consensus 555 -~---------~~~~DiwSlG~il~el~~g~~Pf~~ 580 (605)
. ....+.|+++.++|.+.+|..+|..
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 1 1236899999999999999988743
|
| >4f3l_B BMAL1B; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.97 E-value=2.5e-09 Score=111.31 Aligned_cols=101 Identities=9% Similarity=0.152 Sum_probs=83.2
Q ss_pred eEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHH-cCCc-eEEEEEEEcCCCCEEEEE
Q 038211 69 AVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLA-SGQS-WSGQFPFKKRSGEILMAV 146 (605)
Q Consensus 69 ~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~-~g~~-~~~~~~~~~k~G~~~~v~ 146 (605)
..++..|.+|+++|+|++++.++||+++|++|+++.+ ++++++.......+..+. .++. ...+++++++||..+|+.
T Consensus 279 ~fi~~~~~dg~~~~vn~~~~~ilGY~~eEl~g~~~~~-~iHpdD~~~~~~~~~~~l~~~~~~~~~eyR~~~kdG~~vWv~ 357 (387)
T 4f3l_B 279 EYVSRHAIDGKFVFVDQRATAILAYLPQELLGTSCYE-YFHQDDIGHLAECHRQVLQTREKITTNCYKFKIKDGSFITLR 357 (387)
T ss_dssp EEEEEECTTSBEEEECTHHHHHHCCCHHHHTTSBGGG-TBCHHHHHHHHHHHHHHTTCSSCEECCCEEEECTTSCEEEEE
T ss_pred eEEEEECCCCEEEEECCCcccccCCCHHHHcCCcHHH-eeCHHHHHHHHHHHHHHHhcCCCeeeEEEEEEccCCCEEEEE
Confidence 3447789999999999999999999999999999998 556666666555555443 4443 446889999999999999
Q ss_pred EEEEEEee--CCeEEEEEEEEecccc
Q 038211 147 VTKSPLYE--DGELAGFITVSSDAAI 170 (605)
Q Consensus 147 ~~~~Pi~d--~g~i~g~v~i~~D~t~ 170 (605)
.+..++++ +|++.++|++.+|||+
T Consensus 358 ~~~~~~~~~~~g~~~~ivg~~~dIT~ 383 (387)
T 4f3l_B 358 SRWFSFMNPWTKEVEYIVSTNTVVLA 383 (387)
T ss_dssp EEEEEEEETTTTEEEEEEEEEEECC-
T ss_pred EEEEEEECCCCCCEEEEEEEEEEcch
Confidence 99999987 6899999999999876
|
| >2jhe_A Transcription regulator TYRR; aromatic hydrocarbons catabolism, TYRR protei nucleotide-binding, transcription regulation, activator; HET: PG4; 2.30A {Escherichia coli} | Back alignment and structure |
|---|
Probab=98.94 E-value=7.9e-10 Score=102.85 Aligned_cols=104 Identities=15% Similarity=0.228 Sum_probs=77.2
Q ss_pred cccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCC-c-eEEEE
Q 038211 56 VGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQ-S-WSGQF 133 (605)
Q Consensus 56 ~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~-~-~~~~~ 133 (605)
.+.++.+++++++++ +++|.+|+|+++|++|++++|++.++++|+++.++ ++... . ...+..+. . +..++
T Consensus 79 ~~~l~~il~~~~~gv-i~~D~~g~I~~~N~aa~~llg~~~~~~~g~~~~~~-~~~~~---~---~~~~~~~~~~~~~~~~ 150 (190)
T 2jhe_A 79 HLALSALLEALPEPV-LSVDMKSKVDMANPASCQLFGQKLDRLRNHTAAQL-INGFN---F---LRWLESEPQDSHNEHV 150 (190)
T ss_dssp HHHHHHHHHHCSSCE-EEECTTCBEEEECHHHHHHHTSCHHHHTTSBGGGT-STTCC---H---HHHHHTCCCSCEEEEE
T ss_pred HHHHHHHHHhCCCcE-EEEcCCCCEEEEcHHHHHHhCCCHHHhcCccHHHH-hCCCC---H---HHHHhcCCCCCcceEE
Confidence 356889999999988 89999999999999999999999999999999984 33321 1 22344443 2 22233
Q ss_pred EEEcCCCCEEEEEEEEEEEee-CCe----EEEEEEEEecccccc
Q 038211 134 PFKKRSGEILMAVVTKSPLYE-DGE----LAGFITVSSDAAIFN 172 (605)
Q Consensus 134 ~~~~k~G~~~~v~~~~~Pi~d-~g~----i~g~v~i~~D~t~~~ 172 (605)
.. +|..+ .++.+|+++ +|+ +.|++.+++|+|++.
T Consensus 151 ~~---~g~~~--~~~~~pi~~~~~~~~~~~~g~v~~~~DiTe~~ 189 (190)
T 2jhe_A 151 VI---NGQNF--LMEITPVYLQDENDQHVLTGAVVMLRSTIRMG 189 (190)
T ss_dssp EE---TTEEE--EEEEEEETTTTEEEEEEEE-HHHHHHHHTTTC
T ss_pred EE---CCeEE--EEEEEEEEecCCCCcceEEeEEEEEeccchhc
Confidence 22 66544 577899976 555 889999999998764
|
| >3rty_A Period circadian protein; PAS domain, signalling, timeless, circadian clock protein; 2.85A {Drosophila melanogaster} PDB: 1wa9_A 3gec_A | Back alignment and structure |
|---|
Probab=98.80 E-value=1.8e-08 Score=102.17 Aligned_cols=101 Identities=14% Similarity=0.145 Sum_probs=81.4
Q ss_pred eEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHH-HHHHcCCc-----eEEEEEEEcCCCCE
Q 038211 69 AVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIM-ERLASGQS-----WSGQFPFKKRSGEI 142 (605)
Q Consensus 69 ~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~-~~l~~g~~-----~~~~~~~~~k~G~~ 142 (605)
..++..|.+|+++|+|++++.++||.++|++|+++.+ ++++++........ ..+..|+. ...++++++++|..
T Consensus 155 ~fi~r~~~dG~~~yvn~~~~~lLGY~peELiG~s~~~-~vHPdD~~~~~~~~~~~l~~G~~~~~~~~s~~yR~~~kdG~~ 233 (339)
T 3rty_A 155 KFAIRHTATGIISHVDSAAVSALGYLPQDLIGRSIMD-FYHHEDLSVMKETYETVMKKGQTAGASFCSKPYRFLIQNGCY 233 (339)
T ss_dssp EEEEEEETTCBEEEECTTHHHHHCCCHHHHTTSBGGG-GBCGGGHHHHHHHHHHHHHHTTSTTCCCBCCCEEEECTTSCE
T ss_pred eEEEEECCCCeEEEcChhhhcccCCCHHHHcCCcHHH-EECHHHHHHHHHHHHHHHHcCCcccccccceEEEEEccCCCE
Confidence 3457889999999999999999999999999999998 56666666544444 44555553 34678999999999
Q ss_pred EEEEEEEEEEee--CCeEEEEEEEEecccc
Q 038211 143 LMAVVTKSPLYE--DGELAGFITVSSDAAI 170 (605)
Q Consensus 143 ~~v~~~~~Pi~d--~g~i~g~v~i~~D~t~ 170 (605)
+|+..+.++++| .+++..+|++-+.++.
T Consensus 234 vWlet~~~~~~np~s~~~~~II~~h~vi~~ 263 (339)
T 3rty_A 234 VLLETEWTSFVNPWSRKLEFVVGHHRVFQG 263 (339)
T ss_dssp EEEEEEEEEEECTTTCSEEEEEEEEEEEEC
T ss_pred EEEEEEEEEEECCCCCCeeEEEEEEEECCC
Confidence 999999999997 5677788888877654
|
| >3a0r_A Sensor protein; four helix bundle, PAS fold, kinase, phosphoprotein, transfe two-component regulatory system; 3.80A {Thermotoga maritima} | Back alignment and structure |
|---|
Probab=98.79 E-value=2.7e-09 Score=109.33 Aligned_cols=109 Identities=21% Similarity=0.274 Sum_probs=77.9
Q ss_pred cccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEE
Q 038211 56 VGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPF 135 (605)
Q Consensus 56 ~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~ 135 (605)
.+.|+.+++++++++ +++|.+|+|++||++|++++||+.+|++|+++.++ . ............+..+......
T Consensus 7 ~~~~~~i~~~~~~~i-~~~d~~g~i~~~N~a~~~l~G~~~~e~~G~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~--- 79 (349)
T 3a0r_A 7 RNFSESILESLETAI-ITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDL-P--DFEEIGSVAESVFENKEPVFLN--- 79 (349)
T ss_dssp --CCCSSGGGSSSEE-EEEESSSBCSCBCHHHHHHHSCCSTTTTTCBSTTS-T--TTTHHHHHHHHHHHHCCCCEEE---
T ss_pred HHHHHHHHhhhcCeE-EEECCCCCEEeeHHHHHHHhCCCHHHHcCcCHHHC-c--ChhHHHHHHHHHHhcCCceeec---
Confidence 455677899999888 88999999999999999999999999999999984 2 2222223334445555554322
Q ss_pred EcCCCCEEEEEEEEEEEee-CCeE-EEEEEEEecccccc
Q 038211 136 KKRSGEILMAVVTKSPLYE-DGEL-AGFITVSSDAAIFN 172 (605)
Q Consensus 136 ~~k~G~~~~v~~~~~Pi~d-~g~i-~g~v~i~~D~t~~~ 172 (605)
...+...|+.++..|+.+ +|.. .|++.+++|+|+..
T Consensus 80 -~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~DiTe~~ 117 (349)
T 3a0r_A 80 -FYKFGERYFNIRFSPFRNAKTQLLEGVIITIDDVTELY 117 (349)
T ss_dssp -CCCBTTBCCEEEEEEECCTTTTSSCEEEEEEECCSTTT
T ss_pred -ccccCceEEEEEEEEEEcCCCceeeEEEEEEEechHHH
Confidence 112223466788999987 5554 69999999988753
|
| >4dj3_A Period circadian protein homolog 3; PAS domain, circadian rhythm, protein binding; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.66 E-value=1.7e-07 Score=94.02 Aligned_cols=99 Identities=11% Similarity=0.116 Sum_probs=79.0
Q ss_pred eEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHH-HcCCc---eEEEEEEEcCCCCEEE
Q 038211 69 AVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERL-ASGQS---WSGQFPFKKRSGEILM 144 (605)
Q Consensus 69 ~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l-~~g~~---~~~~~~~~~k~G~~~~ 144 (605)
..+...|.+|+++|+|+++..++||.++|++|+++.+ ++++++..........+ ..++. ...+++++++||..+|
T Consensus 175 ~Fitrh~~dG~~~yvs~~~~~lLGY~peELig~s~~~-~vHPdD~~~~~~~~~~~l~~~~~~~f~s~~yR~~~kdG~~vw 253 (317)
T 4dj3_A 175 IFTTTHTPGCVFLEVDERAVPLLGYLPQDLIGTSILT-YLHPEDRPLMVAIHQKVLKYAGHPPFEHSPVRFCTQNGEYVI 253 (317)
T ss_dssp EEEEEECTTSBEEEECTTHHHHHSCCHHHHTTSBGGG-GBCTTTTTHHHHHHHHHHHTTTSCCEECCCEEEECTTSCEEE
T ss_pred ceEEEecCCCeEEEEChHHhhhcCcChHHHcCCCHHH-eECHHHHHHHHHHHHHHHHcCCCccccceEEEEEccCCCEEE
Confidence 3457779999999999999999999999999999999 56667776655555544 44444 2467889999999999
Q ss_pred EEEEEEEEee--CCeEEEEEEEEecc
Q 038211 145 AVVTKSPLYE--DGELAGFITVSSDA 168 (605)
Q Consensus 145 v~~~~~Pi~d--~g~i~g~v~i~~D~ 168 (605)
+....+++++ .+++..+|+.-+-+
T Consensus 254 vet~~~~~~np~s~~~e~II~~h~v~ 279 (317)
T 4dj3_A 254 LDSSWSSFVNPWSRKVSFIIGRHKVR 279 (317)
T ss_dssp EEEEEEEEECSSSCCEEEEEEEEEEC
T ss_pred EEEEEEEEECCCCCcccEEEEEEEec
Confidence 9999999987 56777777766653
|
| >3gdi_A Period circadian protein homolog 2; tandem PAS domains, biological rhythms, cytoplasm, nucleus, phosphoprotein, transcription; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.61 E-value=2.6e-07 Score=92.41 Aligned_cols=100 Identities=13% Similarity=0.136 Sum_probs=80.2
Q ss_pred EEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHH-HHcCCc-eE-EEEEEEcCCCCEEEEE
Q 038211 70 VHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMER-LASGQS-WS-GQFPFKKRSGEILMAV 146 (605)
Q Consensus 70 ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~-l~~g~~-~~-~~~~~~~k~G~~~~v~ 146 (605)
.+...|.+|+++|+|+++..++||.++|++|+++.+ ++++++........+. +..++. .. .++++++++|..+|++
T Consensus 167 Fitrh~~dG~~~yvd~~~~~lLGY~peELig~s~~~-~iHpdD~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~vwve 245 (309)
T 3gdi_A 167 FTTTHTPNCLFQAVDERAVPLLGYLPQDLIETPVLV-QLHPSDRPLMLAIHKKILQAGGQPFDYSPIRFRTRNGEYITLD 245 (309)
T ss_dssp EEEEECTTCBEEEECTTHHHHHSCCHHHHTTSBHHH-HBCTTSHHHHHHHHHHHHHTTTCCEEEEEEEEECTTSCEEEEE
T ss_pred EEEEecCCCeEEEECcccccccCcCHHHHcCCCHHH-hCCHHHHHHHHHHHHHHHhcCCceeeceEEEEEccCCCEEEEE
Confidence 457779999999999999999999999999999998 5667776665555544 443443 44 5788999999999999
Q ss_pred EEEEEEee--CCeEEEEEEEEecccc
Q 038211 147 VTKSPLYE--DGELAGFITVSSDAAI 170 (605)
Q Consensus 147 ~~~~Pi~d--~g~i~g~v~i~~D~t~ 170 (605)
...+++++ .+++..+|++-+-++.
T Consensus 246 t~~~~~~np~s~~~e~ii~~h~v~~g 271 (309)
T 3gdi_A 246 TSWSSFINPWSRKISFIIGRHKVRVG 271 (309)
T ss_dssp EEEEEEECTTTCCEEEEEEEEEEEEC
T ss_pred EEEEEEECCCCCcccEEEEEEEEccC
Confidence 99999887 6777788877776543
|
| >4dj2_A Period circadian protein homolog 1; PAS domains, circadian clock protein, protein binding; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.58 E-value=2.2e-07 Score=93.36 Aligned_cols=101 Identities=14% Similarity=0.136 Sum_probs=81.1
Q ss_pred eEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHc-C-Cce-EEEEEEEcCCCCEEEE
Q 038211 69 AVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLAS-G-QSW-SGQFPFKKRSGEILMA 145 (605)
Q Consensus 69 ~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~-g-~~~-~~~~~~~~k~G~~~~v 145 (605)
..+...|.+|+++|+|++++.++||.++|++|+++.+ ++++++..........+.. + ... ..+++++++||..+|+
T Consensus 177 ~Fitrh~~dG~~~yvd~~~~~lLGY~peELig~s~~~-~vHPdD~~~~~~~~~~~l~~~g~~~~~~~yR~~~kdG~~vwv 255 (320)
T 4dj2_A 177 IFTTRHTPSCLFQDVDERAAPLLGYLPQDLLGAPVLL-FLHPEDRPLMLAIHKKILQLAGQPFDHSPIRFCARNGEYVTM 255 (320)
T ss_dssp EEEEEECTTCBEEEECTTHHHHHSCCHHHHTTSBGGG-GBCGGGHHHHHHHHHHHTTSSSCCEECCCEEEECSSSCEEEE
T ss_pred eEEEEecCCceEEEcCcceeccCCcChHHHcCCcHHH-hCCHHHHHHHHHHHHHHHhcCCCcccceEEEEEccCCCEEEE
Confidence 3457779999999999999999999999999999999 5666776666555555544 3 344 3578899999999999
Q ss_pred EEEEEEEee--CCeEEEEEEEEecccc
Q 038211 146 VVTKSPLYE--DGELAGFITVSSDAAI 170 (605)
Q Consensus 146 ~~~~~Pi~d--~g~i~g~v~i~~D~t~ 170 (605)
....+++++ .+++..+|+.-+-++.
T Consensus 256 et~~~~~~np~s~~~e~II~~h~v~~g 282 (320)
T 4dj2_A 256 DTSWAGFVHPWSRKVAFVLGRHKVRTA 282 (320)
T ss_dssp ECEEEEEECTTTCSEEEEEEEEEESSC
T ss_pred EEEEEEEECCCCCCccEEEEEEEEccC
Confidence 999999987 6778888887776443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=1.3e-06 Score=87.74 Aligned_cols=137 Identities=20% Similarity=0.160 Sum_probs=94.4
Q ss_pred eeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCC---CeeeEEEEEe-eCCeeEEEEEecC
Q 038211 383 GEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP---NVLLFMGAVA-SQERLGIVTEFLP 458 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~ 458 (605)
++.++.|....||+. +..+++|+... ......+.+|.++|+.+.+. .+.+++.+.. ..+..++|||+++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456788998999987 77899998422 23356788999999999642 2456666653 4456789999999
Q ss_pred CCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 038211 459 RGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRN------------------------------------------ 496 (605)
Q Consensus 459 ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~------------------------------------------ 496 (605)
|..|..... ..++......++.++...|..||+..
T Consensus 97 G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 97 GQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp SEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 988865321 12344444445555555555555432
Q ss_pred ----------------CCceeccCCCCCEEEcC---CCc-EEEEeecCCcccC
Q 038211 497 ----------------PPIVHRDLKSSNLLVDK---NWT-VKVGDFGLSSLKN 529 (605)
Q Consensus 497 ----------------~~iiH~Dik~~Nill~~---~~~-vkl~Dfg~a~~~~ 529 (605)
+.++|+|+++.|||++. ++. +.|+||+.+....
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 12699999999999987 455 4899999887654
|
| >2ykf_A Pdtas, probable sensor histidine kinase pdtas; transferase, two-component system, GAF domain, PAS domain; 2.00A {Mycobacterium tuberculosis} PDB: 2ykh_A | Back alignment and structure |
|---|
Probab=97.86 E-value=1.8e-08 Score=101.05 Aligned_cols=105 Identities=15% Similarity=0.162 Sum_probs=70.9
Q ss_pred HHhcCCeEEEEEcCCCCEEEecHHHHHHhC---CChhhhcCCCccccccccC---Ccc--hHHH-HHHHHHc-CCceEEE
Q 038211 63 LESMGHAVHVCTASSEDIIYWNRSAESLYG---WKDREVFGQRVTEFLIAEE---FHS--PHKK-IMERLAS-GQSWSGQ 132 (605)
Q Consensus 63 l~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G---~~~~eliGk~~~~l~~~~~---~~~--~~~~-~~~~l~~-g~~~~~~ 132 (605)
++++++++ +++|.+|+|+|+|++|++++| ++ ++++|+++.+++ +.. ... .... +...+.. +..+..+
T Consensus 176 ~~~~~dGI-ivvD~~G~Ii~~N~aA~~ll~~lG~~-~~~iGk~l~el~-~~~~~~~~~~~~~~~~l~~vl~~~~~~~~~e 252 (305)
T 2ykf_A 176 SPRAGDGF-IRLDVDGVVSYASPNALSAYHRMGLT-TELEGVNLIDAT-RPLISDPFEAHEVDEHVQDLLAGDGKGMRME 252 (305)
Confidence 45898888 899999999999999999985 54 799999999844 221 100 1111 1112332 2332222
Q ss_pred EEEEcCCCCEEEEEEEEEEEeeCCeEEEEEEEEeccccccccC
Q 038211 133 FPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAAIFNSIN 175 (605)
Q Consensus 133 ~~~~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~~~~l~ 175 (605)
. ...| .++.++..|++++|++.|++.+++|+|++.++-
T Consensus 253 i---~~~~--~~l~v~~~Pi~~~g~~~G~Vvv~rDITE~~~lE 290 (305)
T 2ykf_A 253 V---DAGG--ATVLLRTLPLVVAGRNVGAAILIRDVTEVKRRD 290 (305)
Confidence 2 1223 345678899988888999999999999876553
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=3e-06 Score=83.28 Aligned_cols=133 Identities=17% Similarity=0.206 Sum_probs=94.2
Q ss_pred cccCc-EEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCeeEEEEEecCCCch
Q 038211 387 GLGSY-AVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERLGIVTEFLPRGSL 462 (605)
Q Consensus 387 G~G~f-g~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ggsL 462 (605)
..|.. +.||+... .+..+.+|+... .....+.+|..+|+.+. +--+.+++.++.+.+..++|||+++|.++
T Consensus 33 ~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 33 NVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp ECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred cCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 33443 47888765 355689997543 23456788999998884 33366788888888999999999999888
Q ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 038211 463 FKTLHKNYQALDIKRRLRMALDVARGMNYLHHRN---------------------------------------------- 496 (605)
Q Consensus 463 ~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---------------------------------------------- 496 (605)
.+..... ......++.++...|..||...
T Consensus 108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 7665432 1122345566677777777532
Q ss_pred ----------CCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 497 ----------PPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 497 ----------~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+.++|+|+.+.|||++.++.+-|+||+.+....
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd 225 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD 225 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence 117899999999999987777899999886543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=2.3e-06 Score=87.86 Aligned_cols=82 Identities=6% Similarity=-0.082 Sum_probs=55.9
Q ss_pred Eeeee-cccCcEEEEEEEEC--------CcceEEEEeecccc-chhhhhhHHHHHHHHHhCC-C--CCeeeEEEEEeeC-
Q 038211 382 LGEEI-GLGSYAVVYRGIWN--------GSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLR-H--PNVLLFMGAVASQ- 447 (605)
Q Consensus 382 ~~~~L-G~G~fg~V~~~~~~--------~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~-h--~niv~~~~~~~~~- 447 (605)
..+.| +.|....+|+.... +..+++|+...... .......+.+|+.+++.+. + -.+.+++.+..+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 45678 88989999988654 66789997543220 0001246788999998884 2 3466778776554
Q ss_pred --CeeEEEEEecCCCchH
Q 038211 448 --ERLGIVTEFLPRGSLF 463 (605)
Q Consensus 448 --~~~~lv~e~~~ggsL~ 463 (605)
+..++||||++|..+.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3578999999886653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.07 E-value=2.3e-05 Score=79.56 Aligned_cols=140 Identities=19% Similarity=0.112 Sum_probs=80.0
Q ss_pred eeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCC--CCCeeeEEE------EEeeCCeeEEEE
Q 038211 383 GEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR--HPNVLLFMG------AVASQERLGIVT 454 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~--h~niv~~~~------~~~~~~~~~lv~ 454 (605)
++.|+.|..+.||++...+..+++|+.... . ..+..|..+++.+. .-.+.+++. +....+..+++|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 456677788999998877667999987642 1 22334555555552 112233332 123456789999
Q ss_pred EecCCCchH--------------HHHHhhcCCC-------------CHHH------------------------------
Q 038211 455 EFLPRGSLF--------------KTLHKNYQAL-------------DIKR------------------------------ 477 (605)
Q Consensus 455 e~~~ggsL~--------------~~l~~~~~~~-------------~~~~------------------------------ 477 (605)
+|++|..+. ..++.....+ .+..
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986431 1111111100 1110
Q ss_pred -HHHHHHHHHHHHHHHHh-----------CCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 478 -RLRMALDVARGMNYLHH-----------RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 478 -~~~~~~qi~~aL~~LH~-----------~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
+..+..++..++++|+. ....++|+|+++.|||++.++.+.|+||+.+...
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 01111223445666653 1223999999999999988889999999988654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=1.6e-05 Score=82.89 Aligned_cols=76 Identities=18% Similarity=0.075 Sum_probs=49.8
Q ss_pred eeeecccCcEEEEEEEE--CCcceEEEEeecccc--c---hhhhhhHHHHHHHHHhCCC--CC-eeeEEEEEeeCCeeEE
Q 038211 383 GEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEY--I---EGTLKNYQKEIDIIKKLRH--PN-VLLFMGAVASQERLGI 452 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~--~---~~~~~~~~~E~~il~~l~h--~n-iv~~~~~~~~~~~~~l 452 (605)
.+.||.|.++.||++.. .+..++||....... . .....++..|.++|+.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 57899999999999954 457799997643211 0 1123456789999988732 33 3455543 3456789
Q ss_pred EEEecCCC
Q 038211 453 VTEFLPRG 460 (605)
Q Consensus 453 v~e~~~gg 460 (605)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.85 E-value=9e-05 Score=74.21 Aligned_cols=76 Identities=22% Similarity=0.102 Sum_probs=60.7
Q ss_pred EeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCC---CCCeeeEEEEEeeCCeeEEEEEecC
Q 038211 382 LGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR---HPNVLLFMGAVASQERLGIVTEFLP 458 (605)
Q Consensus 382 ~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~---h~niv~~~~~~~~~~~~~lv~e~~~ 458 (605)
-.+.|+.|....+|+....+..+++|+.... ....+..|...|+.+. ...+++++.+....+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3567899999999999877788999986532 2456788999998883 3567788888877788999999999
Q ss_pred CCch
Q 038211 459 RGSL 462 (605)
Q Consensus 459 ggsL 462 (605)
|..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00014 Score=76.36 Aligned_cols=75 Identities=15% Similarity=0.150 Sum_probs=45.5
Q ss_pred ceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCC-CCCCcccccccccCCCC---CchhHHHHHHHHHHHHHcC
Q 038211 499 IVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSG-RGTPQWMAPEVLRSEPS---NEKSDVFSFGVILWELVTA 574 (605)
Q Consensus 499 iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~el~~g 574 (605)
++|+|+++.|||++.++ ++++||+.+............. .-...|.+|+....... ....++..+...+|+.+.+
T Consensus 234 liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~ 312 (420)
T 2pyw_A 234 LIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLFNK 312 (420)
T ss_dssp EECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998876 9999999987654322111100 00234566655432111 1234455677777776654
|
| >3rty_A Period circadian protein; PAS domain, signalling, timeless, circadian clock protein; 2.85A {Drosophila melanogaster} PDB: 1wa9_A 3gec_A | Back alignment and structure |
|---|
Probab=97.66 E-value=0.0001 Score=74.53 Aligned_cols=57 Identities=9% Similarity=0.229 Sum_probs=45.3
Q ss_pred CeEEEEEc-CCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCc
Q 038211 68 HAVHVCTA-SSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQS 128 (605)
Q Consensus 68 d~ii~v~D-~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~ 128 (605)
|+-++|++ .+|+|+|+|++++.++||+.+|++|+++.+ ++++++... ++..+..+.+
T Consensus 3 dgF~~vv~~~~G~i~yvS~~~~~~LGy~~~el~G~s~~d-~ihp~D~~~---f~~~L~~gl~ 60 (339)
T 3rty_A 3 DSFCCVISMHDGIVLYTTPSITDVLGYPRDMWLGRSFID-FVHLKDRAT---FASQITTGIP 60 (339)
T ss_dssp SCEEEEEETTTCBEEEECTTHHHHHCCCTTSSTTSBGGG-GBCHHHHHH---HHHHHHTTSC
T ss_pred cEEEEEEECCCcEEEEEChHHHHHcCCCHHHHCCCcHHH-hcCHHHHHH---HHHHHhcCCC
Confidence 66778888 699999999999999999999999999999 555555433 4555555543
|
| >4f3l_A Mclock, circadian locomoter output cycles protein kaput; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.60 E-value=4.7e-05 Score=78.17 Aligned_cols=59 Identities=24% Similarity=0.281 Sum_probs=48.0
Q ss_pred cHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHH
Q 038211 58 PYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKK 118 (605)
Q Consensus 58 ~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~ 118 (605)
....++++++ +.++++|.+|+|+|+|+++++++||+.+|++|+++.+ +++|++......
T Consensus 87 ~~~~~l~a~~-~~i~v~~~~G~i~yvs~~~~~~lGy~~~el~g~~~~~-~ihp~D~~~~~~ 145 (361)
T 4f3l_A 87 FTQLMLEALD-GFFLAIMTDGSIIYVSESVTSLLEHLPSDLVDQSIFN-FIPEGEHSEVYK 145 (361)
T ss_dssp HHHHHHHHTT-EEEEEEETTSBEEEECTTHHHHHCCCHHHHTTSBGGG-GSCGGGHHHHHH
T ss_pred HHHHHHHhcC-ceEEEEcCCccEEEEechhhhhcCCCHHHhcCCcHHH-hcCHHHHHHHHH
Confidence 3455677775 5558899999999999999999999999999999999 566666655433
|
| >4f3l_B BMAL1B; BHLH, PAS, circadian rhythm proteins, transcription-activato; 2.27A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00016 Score=74.91 Aligned_cols=55 Identities=9% Similarity=0.217 Sum_probs=45.4
Q ss_pred HHHHHhcCCeEEEEEcCC-CCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchH
Q 038211 60 RSVLESMGHAVHVCTASS-EDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPH 116 (605)
Q Consensus 60 ~~il~~~~d~ii~v~D~~-G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~ 116 (605)
..+++++ ++++++++.+ |+|+|+|++++.++||+.+|++|+++.+ ++++++...+
T Consensus 89 ~~ll~~~-~gfi~v~~~~~G~i~yvs~~~~~~lG~~~~el~g~~~~~-~ihp~D~~~~ 144 (387)
T 4f3l_B 89 HLILRAA-DGFLFVVGCDRGKILFVSESVFKILNYSQNDLIGQSLFD-YLHPKDIAKV 144 (387)
T ss_dssp HHHHHTC-CSEEEEEETTTCBEEEECTTHHHHHSCCHHHHTTSBGGG-GBCGGGHHHH
T ss_pred HHHHhcC-CCEEEEEecCCeEEEEEchhhHHHcCCCHHHHCCCcHHH-hcCCCCHHHH
Confidence 4456666 5666899987 9999999999999999999999999999 5566665443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00097 Score=66.90 Aligned_cols=144 Identities=15% Similarity=0.107 Sum_probs=80.9
Q ss_pred eEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCC--eeeEEEE------EeeCCeeEE
Q 038211 381 QLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN--VLLFMGA------VASQERLGI 452 (605)
Q Consensus 381 ~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~~~~~------~~~~~~~~l 452 (605)
.-++.|+.|....+|+....+..+++|+..... ....+..|+.+++.+...+ +.+++.. ....+..++
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 100 (322)
T ss_dssp EEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred eEeeccCCCcccceEEEEeCCccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence 345678888889999988766689999876521 2234566777777773212 2233211 122456789
Q ss_pred EEEecCCCchH-----------HH---HHhhc---C-C----CC---HHHHHH------------HHHHHHHHHHHHHhC
Q 038211 453 VTEFLPRGSLF-----------KT---LHKNY---Q-A----LD---IKRRLR------------MALDVARGMNYLHHR 495 (605)
Q Consensus 453 v~e~~~ggsL~-----------~~---l~~~~---~-~----~~---~~~~~~------------~~~qi~~aL~~LH~~ 495 (605)
+|+|++|..+. .. ++... . . .. +...+. +...+...++++...
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 99999886431 11 11110 0 0 01 111000 001134455555532
Q ss_pred -----CCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 496 -----NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 496 -----~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
...++|+|+++.|||++.++.+.++||+.+...
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~g 218 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACND 218 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred CcccCCcccCCCCCCccCEEEeCCceEEEecchhccCc
Confidence 112899999999999988766689999988653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00059 Score=67.91 Aligned_cols=137 Identities=15% Similarity=0.109 Sum_probs=77.2
Q ss_pred eeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCe-eeEEEEEeeCCeeEEEEEec-CCC
Q 038211 383 GEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNV-LLFMGAVASQERLGIVTEFL-PRG 460 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~gg 460 (605)
++.|+.|....+|+. ..+++|+..... .......+|+.+++.+...++ .+++.++ .+.-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 678989999999998 679999875421 111234568888887742222 4555443 33457899999 765
Q ss_pred chHHH---------------H---HhhcCCC----C-HHHHHHHHH--------------HHHHHHHHH----Hh--CCC
Q 038211 461 SLFKT---------------L---HKNYQAL----D-IKRRLRMAL--------------DVARGMNYL----HH--RNP 497 (605)
Q Consensus 461 sL~~~---------------l---~~~~~~~----~-~~~~~~~~~--------------qi~~aL~~L----H~--~~~ 497 (605)
+|... + +.....+ . ...+..+.. .+...+..| .. ...
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 55211 0 0000000 0 111111111 111111111 11 112
Q ss_pred CceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 498 PIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 498 ~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
.++|+|+.+.||+ ..++.+.++||..+....
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence 2899999999999 566788999999886543
|
| >1oj5_A Steroid receptor coactivator 1A; transcriptional coactivator, complex, LXXLL motif, transcriptional regulation; 2.2A {Mus musculus} SCOP: d.110.3.8 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00033 Score=59.15 Aligned_cols=96 Identities=13% Similarity=0.166 Sum_probs=68.8
Q ss_pred EEEEEcCCCCEEEecHHHHHHhCCCh--hhhcCCCccccccccCCcc--hHHH-HHHHHHcCCceEEEEEEEcCCCCEEE
Q 038211 70 VHVCTASSEDIIYWNRSAESLYGWKD--REVFGQRVTEFLIAEEFHS--PHKK-IMERLASGQSWSGQFPFKKRSGEILM 144 (605)
Q Consensus 70 ii~v~D~~G~Ii~~N~a~~~l~G~~~--~eliGk~~~~l~~~~~~~~--~~~~-~~~~l~~g~~~~~~~~~~~k~G~~~~ 144 (605)
.+.-.|.+|+|+++..+..+ .+|.. +|++|+.+.+ ++++++.. .... ..+++..|.....-++++.++|..+|
T Consensus 9 F~sRh~~dGKf~~vDq~~~r-~~~~~g~qdLlGrsiy~-f~H~~D~~~s~l~~h~~~vl~~Gq~~S~~YRfr~k~g~~V~ 86 (132)
T 1oj5_A 9 FMTKQDTTGKIISIDTSSLR-AAGRTGWEDLVRKCIYA-FFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLS 86 (132)
T ss_dssp EEEEECTTCCEEEEECHHHH-TTCCSCHHHHHHHHHHH-HTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEE
T ss_pred eEEeecCCCcEEEEeccccc-ccccccHHHHHHHHHHH-HhCcccchHHHHHHHHHHHHHcCCccccceEEEecCCcEEE
Confidence 33566999999999999874 77778 9999999999 55555533 3333 34455666666667888999999999
Q ss_pred EEEEEEEEee--CCe---EEEEEEEEec
Q 038211 145 AVVTKSPLYE--DGE---LAGFITVSSD 167 (605)
Q Consensus 145 v~~~~~Pi~d--~g~---i~g~v~i~~D 167 (605)
+...+..+++ .++ |+++=.+.+|
T Consensus 87 ~qT~sk~f~np~t~e~e~Ivs~n~v~r~ 114 (132)
T 1oj5_A 87 AHTRCKLCYPQSPDMQPFIMGIHIIDRE 114 (132)
T ss_dssp EEEEEEEECC----CCCEEEEEEEEECC
T ss_pred EEEEEEEecCCCCCCCCEEEEEEEEEcC
Confidence 9999988876 344 3444444444
|
| >2enz_A NPKC-theta, protein kinase C theta type; zinc binding, DAG/PE-binding protein, diacylglycerol, phorbol ester, TCR, T-cell, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.33 E-value=8.2e-05 Score=55.41 Aligned_cols=37 Identities=11% Similarity=0.237 Sum_probs=34.0
Q ss_pred hhhhhhhcccCCCcccccc----cceeccccccCCCCCCcc
Q 038211 291 NANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTGH 327 (605)
Q Consensus 291 ~~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~~ 327 (605)
-.+|.+|++.|||+.+|++ |++.+|++|...++..|+
T Consensus 23 pt~C~~C~~~l~Gl~~qg~~C~~C~~~~Hk~C~~~v~~~C~ 63 (65)
T 2enz_A 23 PTFCEHCGTLLWGLARQGLKCDACGMNVHHRCQTKVANLCG 63 (65)
T ss_dssp CCBCSSSCCBCCCSSSCSEEESSSCCEECTTTTTTSCSCTT
T ss_pred CcCchhcChhheecCCcccccCCCCCccCHhHHhhCcCcCC
Confidence 3689999999999999999 999999999999888775
|
| >2yuu_A NPKC-delta, protein kinase C delta type; metal binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00016 Score=56.79 Aligned_cols=38 Identities=13% Similarity=0.345 Sum_probs=34.6
Q ss_pred hhhhhhhcccCCCcccccc----cceeccccccCCCCCCccC
Q 038211 291 NANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTGHR 328 (605)
Q Consensus 291 ~~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~~~ 328 (605)
-.+|.+|++.|||++.|++ |++.+|++|...++..|..
T Consensus 28 pt~C~~C~~~lwGl~kqg~~C~~C~~~~Hk~C~~~v~~~C~~ 69 (83)
T 2yuu_A 28 PTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTG 69 (83)
T ss_dssp CCCCSSSCCCCCSSSCCEEEETTTCCEECTTGGGTCCSCCSS
T ss_pred CcChhhcChhhccccccccccCCcCCeeChhhhhhCCCcCCC
Confidence 4689999999999999999 9999999999998888864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00096 Score=65.89 Aligned_cols=78 Identities=15% Similarity=0.107 Sum_probs=54.3
Q ss_pred cCceEeeeecccCcEEEEEEEE-CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCC---CCeeeEEEEEeeCCeeEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH---PNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h---~niv~~~~~~~~~~~~~lv 453 (605)
....-++.+|.|..+.||+... +|+.|.+|+..... ......+..|...|+.+.. --+.+++.+ +.-++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEE
Confidence 4456678899999999999986 57889999754332 1223457889999998842 234455543 234789
Q ss_pred EEecCCCc
Q 038211 454 TEFLPRGS 461 (605)
Q Consensus 454 ~e~~~ggs 461 (605)
|||++++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0011 Score=66.96 Aligned_cols=32 Identities=38% Similarity=0.397 Sum_probs=27.8
Q ss_pred ceeccCCCCCEEEcCC----CcEEEEeecCCcccCc
Q 038211 499 IVHRDLKSSNLLVDKN----WTVKVGDFGLSSLKNA 530 (605)
Q Consensus 499 iiH~Dik~~Nill~~~----~~vkl~Dfg~a~~~~~ 530 (605)
++|+|+.+.|||++.+ +.+.|+||+.+.....
T Consensus 185 lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 185 FVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp EECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred eEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 9999999999999874 6899999999876543
|
| >1ptq_A Protein kinase C delta type; phosphotransferase; 1.95A {Mus musculus} SCOP: g.49.1.1 PDB: 1ptr_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=7.9e-05 Score=52.28 Aligned_cols=35 Identities=11% Similarity=0.303 Sum_probs=31.5
Q ss_pred hhhhhhcccCCCcccccc----cceeccccccCCCCCCc
Q 038211 292 ANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTG 326 (605)
Q Consensus 292 ~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~ 326 (605)
.+|.+|++.|||+++|++ |++.+|++|...++..|
T Consensus 12 t~C~~C~~~l~g~~~qg~~C~~C~~~~H~~C~~~v~~~C 50 (50)
T 1ptq_A 12 TFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLC 50 (50)
T ss_dssp CBCTTTCCBCCSSSSCEEEETTTCCEECHHHHTTSCSCC
T ss_pred CCcCCCCceeeccCCccCEeCCCCCeECHHHhhhcCCCC
Confidence 589999999999999999 89999999998877543
|
| >3n70_A Transport activator; sigma-54, ntpase, PSI, MCSG, structural genomics, center for structural genomics; 2.80A {Escherichia coli} | Back alignment and structure |
|---|
Probab=97.17 E-value=3.5e-05 Score=67.93 Aligned_cols=47 Identities=9% Similarity=-0.048 Sum_probs=40.4
Q ss_pred Ccccccc-ccchhhhhcchhhhhhhceeccCCCcc----ccCCCCCcccCCCCcc
Q 038211 201 HQPQIAQ-VPNIASSVTNLTAKVLEKMHIGETGTY----VGGDDGSLRQNGLRYK 250 (605)
Q Consensus 201 ~~~~~~~-i~~~a~~va~~~~~~~~vli~GEsGtg----~~~~h~~s~~~~~~f~ 250 (605)
+++..++ +.+.+.+++. ...+|||+||+||| |+.||+.+.|.+.||-
T Consensus 5 G~s~~~~~~~~~~~~~a~---~~~~vll~G~~GtGKt~lA~~i~~~~~~~~~~~v 56 (145)
T 3n70_A 5 GRSEWINQYRRRLQQLSE---TDIAVWLYGAPGTGRMTGARYLHQFGRNAQGEFV 56 (145)
T ss_dssp CSSHHHHHHHHHHHHHTT---CCSCEEEESSTTSSHHHHHHHHHHSSTTTTSCCE
T ss_pred eCCHHHHHHHHHHHHHhC---CCCCEEEECCCCCCHHHHHHHHHHhCCccCCCEE
Confidence 3444444 8888888888 99999999999999 9999999999999986
|
| >3uej_A NPKC-delta, protein kinase C delta type; proteine kinase cdelta, phosphotransferase, anesthetic bindi metal binding protein; 1.30A {Mus musculus} PDB: 3ugi_A 3ugl_A 3uey_A 3ugd_A 3uff_A 1ptq_A 1ptr_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=7.1e-05 Score=55.74 Aligned_cols=38 Identities=11% Similarity=0.246 Sum_probs=34.8
Q ss_pred hhhhhhhcccCCCcccccc----cceeccccccCCCCCCccC
Q 038211 291 NANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTGHR 328 (605)
Q Consensus 291 ~~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~~~ 328 (605)
-.+|.+|++.|||+.+|++ |++.+|++|...++..|+.
T Consensus 20 pt~C~~C~~~l~Gl~~qg~~C~~C~~~~Hk~C~~~v~~~C~~ 61 (65)
T 3uej_A 20 PTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCEF 61 (65)
T ss_dssp CCBCTTTCCBCCSSSSCEEEETTTCCEECHHHHTTSCSEEEE
T ss_pred CCcccccChhhhccCceeeECCCCCCeEchhHhhhCCCcCCC
Confidence 4689999999999999998 8999999999999988864
|
| >2row_A RHO-associated protein kinase 2; ATP-binding, coiled coil, cytoplasm, membrane, metal-binding, nucleotide-binding, phorbol-ester binding; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=97.07 E-value=7.1e-05 Score=58.13 Aligned_cols=38 Identities=13% Similarity=0.229 Sum_probs=33.7
Q ss_pred hhhhhhhcccCCCcccc--cc----cceeccccccC---CCCCCccC
Q 038211 291 NANANICQHRLPNASEE--IF----CDLAFSRECND---RGTSTGHR 328 (605)
Q Consensus 291 ~~~c~~c~~~l~~~~~~--~~----~~~~~~~~c~~---~~~~~~~~ 328 (605)
-.||.+|++.|||+++| ++ |++++|++|+. .+...|+.
T Consensus 35 PT~Cd~C~~~lWGl~kqp~G~~C~~C~~~~HkrC~~k~~~v~~~C~~ 81 (84)
T 2row_A 35 PTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMDKKEEIIAPCKV 81 (84)
T ss_dssp CEECSSSSSEECCSSSCCCEEEESSSCCEEEHHHHHHTCTTCCCCST
T ss_pred CcchhhcCHhhhccccCCCCCEecCCCCccchhHhCCccccccccCc
Confidence 36899999999999998 88 99999999998 78877763
|
| >2eli_A Protein kinase C alpha type; PKC-alpha, PKC-A, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.00026 Score=55.74 Aligned_cols=38 Identities=16% Similarity=0.213 Sum_probs=34.8
Q ss_pred hhhhhhhcccCCCcccccc----cceeccccccCCCCCCccC
Q 038211 291 NANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTGHR 328 (605)
Q Consensus 291 ~~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~~~ 328 (605)
-.+|.+|++.|||+.+|++ |++.+|++|...++..|..
T Consensus 28 pt~C~~C~~~l~Gl~kqG~~C~~C~~~~Hk~C~~~v~~~C~~ 69 (85)
T 2eli_A 28 PTFCDHCGSLLYGLIHQGMKCDTCDMNVHKQCVINVPSLCGM 69 (85)
T ss_dssp CCBCSSSCCBCCCSSSCEEECSSSCCEEETTTTTTSCSCCCC
T ss_pred CcCCcccCccccccccCCCcCCCcCCccCHhHHhhcCCcCCc
Confidence 4689999999999999999 9999999999999888864
|
| >2enn_A NPKC-theta, protein kinase C theta type; zinc binding, DAG/PE-binding protein, diacylglycerol, phorbol ester, TCR, T-cell, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.00021 Score=55.05 Aligned_cols=37 Identities=14% Similarity=0.381 Sum_probs=33.9
Q ss_pred hhhhhhhcccCCCcccccc----cceeccccccCCCCCCcc
Q 038211 291 NANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTGH 327 (605)
Q Consensus 291 ~~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~~ 327 (605)
-.+|.+|++.|||+..|++ |++.+|++|...++..|.
T Consensus 34 pt~C~~C~~~lwGl~kqG~~C~~C~~~~Hk~C~~~v~~~C~ 74 (77)
T 2enn_A 34 PTFCSVCHEFVWGLNKQGYQCRQCNAAIHKKCIDKVIAKCT 74 (77)
T ss_dssp CEECSSSCCEECCTTCCEEECSSSCCEEESGGGSSCCSCCC
T ss_pred CcCccccChhhccccccccCcCCCCCcCCHhHHhhCcCCCC
Confidence 4689999999999999999 899999999999887775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0019 Score=67.70 Aligned_cols=72 Identities=22% Similarity=0.278 Sum_probs=48.3
Q ss_pred eeeecccCcEEEEEEEEC---------CcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCeeEE
Q 038211 383 GEEIGLGSYAVVYRGIWN---------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~~---------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~l 452 (605)
++.|+.|-...||++... +..+++|+..... ....+.+|..+++.+. +....++++.+.. .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 467888888999998764 3678999873311 1134457999988884 3333567766542 38
Q ss_pred EEEecCCCch
Q 038211 453 VTEFLPRGSL 462 (605)
Q Consensus 453 v~e~~~ggsL 462 (605)
|+||++|.+|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0014 Score=67.27 Aligned_cols=138 Identities=15% Similarity=0.179 Sum_probs=81.0
Q ss_pred eeecccCcEEEEEEEEC---------CcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCeeEEE
Q 038211 384 EEIGLGSYAVVYRGIWN---------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~---------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lv 453 (605)
+.|..|-...+|++... +..+++|+.-.. ........+|.++++.+. +.-..++++++.. .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 56766878888988753 356889985221 112345568999998884 3333567766543 399
Q ss_pred EEecCCCchHH--------------HHH---hhc----CCCC--HHHHHHHHHHHHH-------------------HHHH
Q 038211 454 TEFLPRGSLFK--------------TLH---KNY----QALD--IKRRLRMALDVAR-------------------GMNY 491 (605)
Q Consensus 454 ~e~~~ggsL~~--------------~l~---~~~----~~~~--~~~~~~~~~qi~~-------------------aL~~ 491 (605)
|||++|..|.. .+. ... .... +.++..|..++-. .++.
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99998865421 111 110 1122 3455555544422 2333
Q ss_pred HH----hCC--CCceeccCCCCCEEEcCC----CcEEEEeecCCccc
Q 038211 492 LH----HRN--PPIVHRDLKSSNLLVDKN----WTVKVGDFGLSSLK 528 (605)
Q Consensus 492 LH----~~~--~~iiH~Dik~~Nill~~~----~~vkl~Dfg~a~~~ 528 (605)
|. ..+ ..++|+|+.+.|||++.+ +.+.++||..+...
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 32 222 138999999999999876 78999999998643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0033 Score=66.34 Aligned_cols=73 Identities=16% Similarity=0.140 Sum_probs=48.2
Q ss_pred eeeecccCcEEEEEEEECC--cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCe-eeEEEEEeeCCeeEEEEEecCC
Q 038211 383 GEEIGLGSYAVVYRGIWNG--SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNV-LLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~~~--~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~g 459 (605)
++.|+.|-...+|++...+ ..+++|+..... . ..-...+|..+++.+...++ .++++++. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--D-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--C-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--h-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4678888889999998765 779999874321 1 11123589999999964444 56777663 2 359999987
Q ss_pred Cch
Q 038211 460 GSL 462 (605)
Q Consensus 460 gsL 462 (605)
..|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >4dj2_A Period circadian protein homolog 1; PAS domains, circadian clock protein, protein binding; 2.75A {Mus musculus} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00047 Score=68.99 Aligned_cols=51 Identities=24% Similarity=0.249 Sum_probs=42.1
Q ss_pred HHhcCCeEEEEEcCC-CCEEEecHHHHHHhCCChhhhcCCCccccccccCCcch
Q 038211 63 LESMGHAVHVCTASS-EDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSP 115 (605)
Q Consensus 63 l~~~~d~ii~v~D~~-G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~ 115 (605)
|+++ |+.++++..+ |+|+|+++++..++||+.+|++|+++.+ ++++++...
T Consensus 32 Lqal-dGF~~vvs~~~G~i~yvS~sv~~~Lg~~~~~l~g~s~~d-~iHp~D~~~ 83 (320)
T 4dj2_A 32 LRNQ-DTFSVAVSFLTGRIVYISEQAGVLLRCKRDVFRGARFSE-LLAPQDVGV 83 (320)
T ss_dssp TSCS-SEEEEEEETTTCBEEEECTHHHHHHTSCSTTTTTSBGGG-GBCHHHHHH
T ss_pred Hhcc-CCEEEEEECCCceEEEECcHHHHHhCcCHHHHcCCcHHH-hcCHHHHHH
Confidence 4444 7777888875 9999999999999999999999999999 555555544
|
| >4dj3_A Period circadian protein homolog 3; PAS domain, circadian rhythm, protein binding; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.00066 Score=67.83 Aligned_cols=53 Identities=8% Similarity=-0.004 Sum_probs=44.0
Q ss_pred HHHhcCCeEEEEEcCC-CCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchH
Q 038211 62 VLESMGHAVHVCTASS-EDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPH 116 (605)
Q Consensus 62 il~~~~d~ii~v~D~~-G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~ 116 (605)
+|+++ |+.++|++.+ |+|+|++++++.++||+.+|++|+++.+ ++++++...+
T Consensus 31 ~L~al-dgF~~vvs~~~G~i~yvS~~~~~~Lg~~~~el~g~s~~d-~ihp~D~~~f 84 (317)
T 4dj3_A 31 TSKNT-DTFAAVFSFLSGRLVHISEQAALILNSKRGFLKSVHFVD-LLAPQDVRAF 84 (317)
T ss_dssp HTSCT-TEEEEEEETTTCBEEEECTTHHHHTTCCHHHHHTSBGGG-GBCGGGHHHH
T ss_pred HHhcc-CCEEEEEEcCCcEEEEECCHHHHHcCCCHHHHcCCchhh-hcChhhHHHH
Confidence 45555 7787889886 9999999999999999999999999999 5566655443
|
| >3gdi_A Period circadian protein homolog 2; tandem PAS domains, biological rhythms, cytoplasm, nucleus, phosphoprotein, transcription; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.00039 Score=69.27 Aligned_cols=53 Identities=15% Similarity=0.233 Sum_probs=36.1
Q ss_pred HHHhcCCeEEEEEcCC-CCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchH
Q 038211 62 VLESMGHAVHVCTASS-EDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPH 116 (605)
Q Consensus 62 il~~~~d~ii~v~D~~-G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~ 116 (605)
+|+++ |+.+++++.+ |+|+|+++++..++||+.+|++|+++.+ ++++++...+
T Consensus 20 ll~a~-dgF~~vvs~~~G~i~yvS~s~~~~Lg~~~~el~g~s~~d-~iHp~D~~~~ 73 (309)
T 3gdi_A 20 IVKNA-DMFAVAVSLVSGKILYISNQVASIFHCKKDAFSDAKFVE-FLAPHDVSVF 73 (309)
T ss_dssp ---CT-TEEEEEECTTTCBEEEECTTTTTTC-------CCSBGGG-GBCTTTHHHH
T ss_pred HHHhc-CCEEEEEECCCceEEEECCHHHHHcCCCHHHHcCCchhh-ccCHhHHHHH
Confidence 46666 6787999986 9999999999999999999999999999 5566665543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.003 Score=64.75 Aligned_cols=73 Identities=16% Similarity=0.178 Sum_probs=44.6
Q ss_pred eeeecccCcEEEEEEEECC----------cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCC-eeeEEEEEeeCCeeE
Q 038211 383 GEEIGLGSYAVVYRGIWNG----------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN-VLLFMGAVASQERLG 451 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~~~----------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~~~~~~~~~~~~~ 451 (605)
.+.|+.|....+|+....+ ..+++|+..... ........|..+++.+...+ ..++++.+ . -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 4567888888999987653 578888864321 11223467888888884333 44666554 2 37
Q ss_pred EEEEecCCCch
Q 038211 452 IVTEFLPRGSL 462 (605)
Q Consensus 452 lv~e~~~ggsL 462 (605)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987543
|
| >1y8f_A UNC-13 homolog A, MUNC13-1; cysteine-rich domain, C1-domain, zinc-binding domain, endocytosis/exocytosis,signaling protein complex; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.00019 Score=53.52 Aligned_cols=37 Identities=14% Similarity=0.248 Sum_probs=32.9
Q ss_pred hhhhhhhcccCCCcccccc----cceeccccccCCCCCCcc
Q 038211 291 NANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTGH 327 (605)
Q Consensus 291 ~~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~~ 327 (605)
-.+|.+|++.|||+.+|++ |++.+|++|...++..|.
T Consensus 24 pt~C~~C~~~l~Gl~~qg~~C~~C~~~~Hk~C~~~v~~~C~ 64 (66)
T 1y8f_A 24 PTYCYECEGLLWGIARQGMRCTECGVKCHEKCQDLLNADCK 64 (66)
T ss_dssp CCCCTTTCCCCCSSCCEEEEETTTCCEECTTHHHHSCCCC-
T ss_pred CcChhhcChhhcccCcceeEcCCCCCeeCHHHHhhCcCcCC
Confidence 4689999999999999999 899999999998887764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0044 Score=62.69 Aligned_cols=31 Identities=23% Similarity=0.400 Sum_probs=27.8
Q ss_pred ceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 499 IVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 499 iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
++|+|+.+.||+++.++.+.|+||+.+....
T Consensus 208 ~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 208 LCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp EECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred eEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 9999999999999988889999999886544
|
| >1ojl_A Transcriptional regulatory protein ZRAR; response regulator, two component system, AAA domain, NTRC family, DNA-binding; HET: ATP; 3.0A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.00014 Score=72.64 Aligned_cols=49 Identities=12% Similarity=0.015 Sum_probs=42.0
Q ss_pred CCcccccc-ccchhhhhcchhhhhhhceeccCCCcc----ccCCCCCcccCCCCccc
Q 038211 200 PHQPQIAQ-VPNIASSVTNLTAKVLEKMHIGETGTY----VGGDDGSLRQNGLRYKS 251 (605)
Q Consensus 200 ~~~~~~~~-i~~~a~~va~~~~~~~~vli~GEsGtg----~~~~h~~s~~~~~~f~~ 251 (605)
++++..++ +.+.+.+++. .+.+|||+||+||| |+.||+.++|.+.||-.
T Consensus 5 ig~s~~~~~~~~~~~~~a~---~~~~vLi~Ge~GtGKt~lAr~i~~~~~~~~~~~v~ 58 (304)
T 1ojl_A 5 IGSSPAMQHLLNEIAMVAP---SDATVLIHGDSGTGKELVARALHACSARSDRPLVT 58 (304)
T ss_dssp CCCSHHHHHHHHHHHHHCS---TTSCEEEESCTTSCHHHHHHHHHHHSSCSSSCCCE
T ss_pred EECCHHHHHHHHHHHHHhC---CCCcEEEECCCCchHHHHHHHHHHhCcccCCCeEE
Confidence 34444444 9999999998 99999999999999 99999999999999844
|
| >2db6_A SH3 and cysteine rich domain 3; STAC3, C1 domain, cystein-rich domain, zinc-binding domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.00028 Score=53.93 Aligned_cols=37 Identities=8% Similarity=0.188 Sum_probs=32.9
Q ss_pred hhhhhhhcccCCCcccccc----cceeccccccCCCCC-Ccc
Q 038211 291 NANANICQHRLPNASEEIF----CDLAFSRECNDRGTS-TGH 327 (605)
Q Consensus 291 ~~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~-~~~ 327 (605)
-.+|.+|++.|||+.+|++ |++.+|++|...++. .|.
T Consensus 28 pt~C~~C~~~lwGl~kqG~~C~~C~~~~Hk~C~~~v~~~~C~ 69 (74)
T 2db6_A 28 PKFCDVCARMIVLNNKFGLRCKNCKTNIHEHCQSYVEMQRCS 69 (74)
T ss_dssp CEECSSSCCEECHHHHEEEEESSSCCEECTTTTGGGSSSBCC
T ss_pred CcCchhcChhhccccCCccccCCCCCccChhHHhhCCCCcCC
Confidence 4799999999999999999 999999999998875 464
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0079 Score=60.28 Aligned_cols=140 Identities=12% Similarity=0.044 Sum_probs=78.1
Q ss_pred eeecccCcEEEEEEEE-CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCC--CeeeEEEE-----EeeCCeeEEEEE
Q 038211 384 EEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP--NVLLFMGA-----VASQERLGIVTE 455 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~--niv~~~~~-----~~~~~~~~lv~e 455 (605)
..|+ |....||+... .|+.+++|+...... ....+..|..+++.+... .+++++.. ....+..+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 77789998765 355799998753322 234566788888777321 23334332 123456788999
Q ss_pred ecCCCchH-----------HH---HHhh---c-----CCCCHHHH----HHH---------------HHHHHHHHHHHHh
Q 038211 456 FLPRGSLF-----------KT---LHKN---Y-----QALDIKRR----LRM---------------ALDVARGMNYLHH 494 (605)
Q Consensus 456 ~~~ggsL~-----------~~---l~~~---~-----~~~~~~~~----~~~---------------~~qi~~aL~~LH~ 494 (605)
|++|..+. .. ++.. . ...+.... ..+ ...+-..++.+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99875431 11 1110 0 01111110 000 0011112233321
Q ss_pred -----CCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 495 -----RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 495 -----~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
....++|+|+++.|||++ + .+.++||+.+....
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~ 225 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNGP 225 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEEC
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcCc
Confidence 122389999999999998 4 89999999886554
|
| >1ny5_A Transcriptional regulator (NTRC family); AAA+ ATPase, sigma54 activator, bacterial transcription, DIM transcription; HET: ADP; 2.40A {Aquifex aeolicus} SCOP: c.23.1.1 c.37.1.20 PDB: 1ny6_A* 3m0e_A* 1zy2_A* | Back alignment and structure |
|---|
Probab=96.21 E-value=0.00042 Score=71.69 Aligned_cols=49 Identities=6% Similarity=-0.020 Sum_probs=41.8
Q ss_pred CCcccccc-ccchhhhhcchhhhhhhceeccCCCcc----ccCCCCCcccCCCCccc
Q 038211 200 PHQPQIAQ-VPNIASSVTNLTAKVLEKMHIGETGTY----VGGDDGSLRQNGLRYKS 251 (605)
Q Consensus 200 ~~~~~~~~-i~~~a~~va~~~~~~~~vli~GEsGtg----~~~~h~~s~~~~~~f~~ 251 (605)
..++..++ +.+.+.++|. ++.+|||+||+||| |+.||..|+|+++||-.
T Consensus 140 ig~s~~m~~l~~~i~~~a~---~~~~vli~Ge~GtGK~~lAr~ih~~s~r~~~~fv~ 193 (387)
T 1ny5_A 140 VFESPKMKEILEKIKKISC---AECPVLITGESGVGKEVVARLIHKLSDRSKEPFVA 193 (387)
T ss_dssp CCCSHHHHHHHHHHHHHTT---CCSCEEEECSTTSSHHHHHHHHHHHSTTTTSCEEE
T ss_pred hhccHHhhHHHHHHHHhcC---CCCCeEEecCCCcCHHHHHHHHHHhcCCCCCCeEE
Confidence 33444444 8888889888 99999999999999 99999999999999854
|
| >2bjv_A PSP operon transcriptional activator; AAA, transcription activation, gene regulation, sigma54 activator, enhancer binding protein, PSPF; 1.7A {Escherichia coli} PDB: 2bjw_A 2c96_A* 2c98_A* 2c99_A* 2c9c_A* 2vii_A* | Back alignment and structure |
|---|
Probab=95.91 E-value=0.00071 Score=65.97 Aligned_cols=55 Identities=16% Similarity=-0.037 Sum_probs=40.6
Q ss_pred cccCCCCCccccccccchhhhhcchhhhhhhceeccCCCcc----ccCCCCCcccCCCCccc
Q 038211 194 KKIQWQPHQPQIAQVPNIASSVTNLTAKVLEKMHIGETGTY----VGGDDGSLRQNGLRYKS 251 (605)
Q Consensus 194 ~~~~~~~~~~~~~~i~~~a~~va~~~~~~~~vli~GEsGtg----~~~~h~~s~~~~~~f~~ 251 (605)
+++.++.....+..+.+.+.+++. ...+|||+||+||| |+.+|+.++|.+.||-.
T Consensus 4 ~f~~~ig~~~~~~~~~~~~~~~~~---~~~~vll~G~~GtGKt~la~~i~~~~~~~~~~~~~ 62 (265)
T 2bjv_A 4 YKDNLLGEANSFLEVLEQVSHLAP---LDKPVLIIGERGTGKELIASRLHYLSSRWQGPFIS 62 (265)
T ss_dssp ------CCCHHHHHHHHHHHHHTT---SCSCEEEECCTTSCHHHHHHHHHHTSTTTTSCEEE
T ss_pred ccccceeCCHHHHHHHHHHHHHhC---CCCCEEEECCCCCcHHHHHHHHHHhcCccCCCeEE
Confidence 344555444444448888888888 88999999999999 99999999999888743
|
| >3co5_A Putative two-component system transcriptional RES regulator; structural genomics, APC89341.1; 2.40A {Neisseria gonorrhoeae} | Back alignment and structure |
|---|
Probab=95.82 E-value=0.0012 Score=57.81 Aligned_cols=40 Identities=10% Similarity=0.013 Sum_probs=33.1
Q ss_pred Ccccccc-ccchhhhhcchhhhhhhceeccCCCcc----ccCCCCCcc
Q 038211 201 HQPQIAQ-VPNIASSVTNLTAKVLEKMHIGETGTY----VGGDDGSLR 243 (605)
Q Consensus 201 ~~~~~~~-i~~~a~~va~~~~~~~~vli~GEsGtg----~~~~h~~s~ 243 (605)
+++..++ +.+.+.+++. ...+|||+||+||| |+.||+.+.
T Consensus 8 G~s~~~~~l~~~~~~~~~---~~~~vll~G~~GtGKt~lA~~i~~~~~ 52 (143)
T 3co5_A 8 GNSAAIQEMNREVEAAAK---RTSPVFLTGEAGSPFETVARYFHKNGT 52 (143)
T ss_dssp CCCHHHHHHHHHHHHHHT---CSSCEEEEEETTCCHHHHHGGGCCTTS
T ss_pred eCCHHHHHHHHHHHHHhC---CCCcEEEECCCCccHHHHHHHHHHhCC
Confidence 3444444 8888888887 99999999999999 999999876
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.71 E-value=0.024 Score=58.99 Aligned_cols=73 Identities=15% Similarity=0.175 Sum_probs=48.2
Q ss_pred eeeecccCcEEEEEEEEC---------CcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCeeEE
Q 038211 383 GEEIGLGSYAVVYRGIWN---------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~~---------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~l 452 (605)
++.|..|-...+|+.... +..+++|+..... ...-...+|..+++.+. +.-..++++.+. -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence 456777888899998765 5779999863321 12223467888888884 333456665432 378
Q ss_pred EEEecCCCch
Q 038211 453 VTEFLPRGSL 462 (605)
Q Consensus 453 v~e~~~ggsL 462 (605)
||||++|..|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.57 E-value=0.067 Score=49.57 Aligned_cols=101 Identities=16% Similarity=0.196 Sum_probs=68.4
Q ss_pred chHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccccCCC
Q 038211 461 SLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH-RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGR 539 (605)
Q Consensus 461 sL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 539 (605)
+|.+.|+....+++++++|.++.|.+.+|.-+-. .. -..+=+.|..|++..+|.|.+.+ ..+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc------------c
Confidence 8999999999999999999999999999877622 11 11233456899999999998764 1110 1
Q ss_pred CCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCC
Q 038211 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIP 577 (605)
Q Consensus 540 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~P 577 (605)
....+.+||... ...+.+.=|||||+++|.-+--..|
T Consensus 99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 134567888763 2345778899999999998875444
|
| >2fnf_X Putative RAS effector NORE1; zinc, signal transduction, apoptosis, cysteine rich domain; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=95.52 E-value=0.0042 Score=46.93 Aligned_cols=33 Identities=12% Similarity=0.350 Sum_probs=28.9
Q ss_pred hhhhhhhcccCCCcccccc----cceeccccccCCCCCCc
Q 038211 291 NANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTG 326 (605)
Q Consensus 291 ~~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~ 326 (605)
-.+|.+|++.| .+|++ |++++|++|+..++..|
T Consensus 35 pt~C~~C~~~l---~~qG~kC~~C~~~cHkkC~~~V~~~C 71 (72)
T 2fnf_X 35 PGWCDLCGREV---LRQALRCANCKFTCHSECRSLIQLDC 71 (72)
T ss_dssp CCBCTTTSSBC---SSCCEECTTSSCEECTGGGGGCCSCC
T ss_pred CcchhhhhHHH---HhCcCccCCCCCeechhhhccCcCCC
Confidence 46899999999 67777 99999999999888766
|
| >4b6d_A RAC GTPase-activating protein 1; signaling protein, cytokinesis, plasma membrane, phospholipi centralspindlin, spindle midzone, central spindle; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.45 E-value=0.0035 Score=45.55 Aligned_cols=35 Identities=20% Similarity=0.356 Sum_probs=31.5
Q ss_pred hhhhhhcccCCCcccccc----cceeccccccCCCCCCcc
Q 038211 292 ANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTGH 327 (605)
Q Consensus 292 ~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~~ 327 (605)
.+|.+|+++++ ++.|++ |++.+|++|++..+..|.
T Consensus 20 ~~C~~Cg~~i~-~gkq~~kC~dC~~~cH~~C~~~~~~~C~ 58 (61)
T 4b6d_A 20 ESCVPCGKRIK-FGKLSLKCRDCRVVSHPECRDRCPLPCI 58 (61)
T ss_dssp EECTTTCCEEC-TTCEEEEESSSSCEECGGGGGGSCSSCC
T ss_pred cccccccCEEE-EeeEeeECCCCCCeEchhHhhcCCCCCC
Confidence 79999999986 899988 999999999998888774
|
| >1faq_A RAF-1; transferase, serine/threonine-protein kinase, proto- oncogene, zinc, ATP-binding, phorbol-ester binding; NMR {Homo sapiens} SCOP: g.49.1.1 PDB: 1far_A | Back alignment and structure |
|---|
Probab=95.07 E-value=0.0075 Score=42.36 Aligned_cols=33 Identities=27% Similarity=0.479 Sum_probs=29.0
Q ss_pred hhhhhhhcccCCCcccccc----cceeccccccCCCCCCcc
Q 038211 291 NANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTGH 327 (605)
Q Consensus 291 ~~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~~ 327 (605)
-.+|.+|++.|| |++ |++.+|++|...++..|.
T Consensus 14 pt~C~~C~~~l~----qG~~C~~C~~~~H~~C~~~v~~~C~ 50 (52)
T 1faq_A 14 LAFCDICQKFLL----NGFRCQTCGYKFHEHCSTKVPTMCV 50 (52)
T ss_dssp CEECTTSSSEEC----SEEECTTTTCCBCSTTSSSSSSCCC
T ss_pred CcCCCCcccccc----cCCEeCCCCCeEChhHHhhCcCcCC
Confidence 368999999999 677 999999999998887774
|
| >2ool_A Sensor protein; bacteriophytochrome, photoconversion, photoreceptor, biliver signaling protein; HET: LBV; 2.20A {Rhodopseudomonas palustris} SCOP: d.110.2.1 d.110.3.9 | Back alignment and structure |
|---|
Probab=95.00 E-value=0.024 Score=56.74 Aligned_cols=40 Identities=13% Similarity=0.169 Sum_probs=34.9
Q ss_pred CeEEEEEcC-CCCEEEecHHHHHHhCCChhhhcCCCccccc
Q 038211 68 HAVHVCTAS-SEDIIYWNRSAESLYGWKDREVFGQRVTEFL 107 (605)
Q Consensus 68 d~ii~v~D~-~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~ 107 (605)
.|+.+++|. +++|+.+|..+++++|+++++++|+++.+++
T Consensus 42 ~G~Ll~~~~~~~~i~~~S~N~~~~lg~~~~~llG~~l~~ll 82 (337)
T 2ool_A 42 HGYLFVVSETDLRIASVSANVEDLLRQPPASLLNVPIAHYL 82 (337)
T ss_dssp TSEEEEECTTTCBEEEEETTHHHHHSSCGGGGTTCBGGGGB
T ss_pred CEEEEEEECCCCEEEEEehhHHHHHCcCHHHHcCCCHHHHc
Confidence 466677776 4899999999999999999999999999844
|
| >1p0z_A Sensor kinase CITA; transferase; HET: FLC MO7; 1.60A {Klebsiella pneumoniae} SCOP: d.110.6.1 PDB: 2v9a_A 2j80_A* | Back alignment and structure |
|---|
Probab=94.98 E-value=0.47 Score=40.20 Aligned_cols=85 Identities=14% Similarity=0.217 Sum_probs=51.4
Q ss_pred HHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEcCCCCE
Q 038211 63 LESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRSGEI 142 (605)
Q Consensus 63 l~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~k~G~~ 142 (605)
-+......|+++|.+|++++... .+.+|+++.. . ..+ ..++ .|+.+.... ....|
T Consensus 45 ~~~~~~~~i~v~d~~G~~~a~~~----------~~~iG~~~~~-----~--~~~---~~al-~G~~~~~~~--~g~~g-- 99 (131)
T 1p0z_A 45 RSFSDATYITVGDASGQRLYHVN----------PDEIGKSMEG-----G--DSD---EALI-NAKSYVSVR--KGSLG-- 99 (131)
T ss_dssp HHHSCCSEEEEEETTSBEEECSS----------GGGTTSBCCS-----S--CCH---HHHH-HCCCEEEEE--EETTE--
T ss_pred HHhcCCCEEEEEcCCCcEEEecC----------hhhCCCcccC-----C--CcH---HHHh-CCCeEEEEE--Eccce--
Confidence 33344445699999999877542 4558876542 1 111 1223 566654422 11223
Q ss_pred EEEEEEEEEEee-CCeEEEEEEEEeccccccc
Q 038211 143 LMAVVTKSPLYE-DGELAGFITVSSDAAIFNS 173 (605)
Q Consensus 143 ~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~~ 173 (605)
+......||++ +|+++|+|.+--++..+++
T Consensus 100 -~~~~~~~PV~~~~g~viGvv~vg~~l~~v~~ 130 (131)
T 1p0z_A 100 -SSLRGKSPIQDATGKVIGIVSVGYTIEQLEH 130 (131)
T ss_dssp -EEEEEEEEEECTTCCEEEEEEEEEEGGGCCC
T ss_pred -eeEEEEEeEECCCCCEEEEEEEEEEhHHhhc
Confidence 22345569997 8999999999999877653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=94.37 E-value=0.0073 Score=67.19 Aligned_cols=38 Identities=13% Similarity=0.259 Sum_probs=0.0
Q ss_pred hhhhhhhcccCCCcccccc----cceeccccccCCCCCCccC
Q 038211 291 NANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTGHR 328 (605)
Q Consensus 291 ~~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~~~ 328 (605)
-.||.+|++.|||++.|++ |++++|++|+..+...|..
T Consensus 48 p~~C~~C~~~i~g~~~qg~~C~~C~~~~H~~C~~~v~~~c~~ 89 (674)
T 3pfq_A 48 PTFCSHCTDFIWGFGKQGFQCQVCSFVVHKRCHEFVTFSCPG 89 (674)
T ss_dssp ------------------------------------------
T ss_pred CCccccccccccccCCceeECCCCCCCcChhhcCcCcccCCC
Confidence 5799999999999999998 8999999999999988843
|
| >3dzd_A Transcriptional regulator (NTRC family); sigma43 activator, AAA+ ATPase, response regulator, transcriptional activator, ATP-binding; HET: ADP; 2.40A {Aquifex aeolicus} PDB: 1zit_A 2jrl_A | Back alignment and structure |
|---|
Probab=94.21 E-value=0.0035 Score=64.16 Aligned_cols=45 Identities=11% Similarity=0.057 Sum_probs=37.7
Q ss_pred CCcccccc-ccchhhhhcchhhhhhhceeccCCCcc----ccCCCCCcccCCC
Q 038211 200 PHQPQIAQ-VPNIASSVTNLTAKVLEKMHIGETGTY----VGGDDGSLRQNGL 247 (605)
Q Consensus 200 ~~~~~~~~-i~~~a~~va~~~~~~~~vli~GEsGtg----~~~~h~~s~~~~~ 247 (605)
...+..+. +...+.+++. ++.+|||+||+||| |+.||..|.|.+.
T Consensus 132 ig~s~~~~~~~~~~~~~a~---~~~~vli~GesGtGKe~lAr~ih~~s~r~~~ 181 (368)
T 3dzd_A 132 VGEHPKILEIKRLIPKIAK---SKAPVLITGESGTGKEIVARLIHRYSGRKGA 181 (368)
T ss_dssp CCCSHHHHHHHHHHHHHHT---SCSCEEEECCTTSSHHHHHHHHHHHHCCCSC
T ss_pred cccchHHHHHHhhhhhhhc---cchhheEEeCCCchHHHHHHHHHHhccccCC
Confidence 33444444 8888888888 99999999999999 9999999998865
|
| >1rfh_A RAS association (ralgds/AF-6) domain family 5; zinc, signal transduction, apoptosis, cysteine rich domain, metal binding protein; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=94.12 E-value=0.0099 Score=42.93 Aligned_cols=33 Identities=12% Similarity=0.350 Sum_probs=28.4
Q ss_pred hhhhhhhcccCCCcccccc----cceeccccccCCCCCCc
Q 038211 291 NANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTG 326 (605)
Q Consensus 291 ~~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~ 326 (605)
-.+|++|++.| .+|++ |++++|++|+..++..|
T Consensus 22 pt~C~~C~~~i---~kqg~kC~~C~~~cH~kC~~~v~~~C 58 (59)
T 1rfh_A 22 PGWCDLCGREV---LRQALRCANCKFTCHSECRSLIQLDC 58 (59)
T ss_dssp CEECTTTCSEE---CSCCEECTTTSCEECHHHHTTCCCCC
T ss_pred CeEchhcchhh---hhCccEeCCCCCeEehhhhhhCcCCC
Confidence 36899999999 57777 99999999999888765
|
| >3ky9_A Proto-oncogene VAV; calponin homology domain, DBL homology domain, pleckst homology domain, C1 domain, guanine-nucleotide releasing FA metal-binding; 2.73A {Homo sapiens} PDB: 2d86_A | Back alignment and structure |
|---|
Probab=93.59 E-value=0.019 Score=62.56 Aligned_cols=38 Identities=21% Similarity=0.363 Sum_probs=32.0
Q ss_pred hhhhhhhcccCCCcccccc----cceeccccccCCCCCCccCC
Q 038211 291 NANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTGHRE 329 (605)
Q Consensus 291 ~~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~~~~ 329 (605)
-.+|.+|++.+||+..|++ |++.+|++|+..+ ..|+..
T Consensus 529 ~t~C~~C~~~l~gl~~qg~~C~~C~~~vHk~C~~~v-~~C~~~ 570 (587)
T 3ky9_A 529 TTSCKACQMLLRGTFYQGYRCHRCRASAHKECLGRV-PPCGRH 570 (587)
T ss_dssp CCBCTTTCSBCCSSSCCEEEETTTCCEECSGGGGGS-CCC---
T ss_pred CcccccccccccccccCCcCCCCCCCccchhhhhcC-CCCCCC
Confidence 3699999999999999998 9999999999988 477643
|
| >1kbe_A Kinase suppressor of RAS; KSR, cysteine-rich domain, zinc- binding protein, signaling protein; NMR {Mus musculus} SCOP: g.49.1.1 PDB: 1kbf_A | Back alignment and structure |
|---|
Probab=92.03 E-value=0.056 Score=37.13 Aligned_cols=28 Identities=21% Similarity=0.481 Sum_probs=23.9
Q ss_pred hhhhhhcccCCCcccccc----cceeccccccCCCC
Q 038211 292 ANANICQHRLPNASEEIF----CDLAFSRECNDRGT 323 (605)
Q Consensus 292 ~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~ 323 (605)
.+|++|++.|| +++ |++..|++|...++
T Consensus 15 t~C~~C~k~i~----~G~kC~~Ck~~cH~kC~~~vp 46 (49)
T 1kbe_A 15 QVCNVCQKSMI----FGVKCKHCRLKCHNKCTKEAP 46 (49)
T ss_dssp CCCSSSCCSSC----CEEEETTTTEEESSSCTTTSC
T ss_pred cCccccCceeE----CcCCCCCCCCccchhhcCcCC
Confidence 78999999999 345 89999999988554
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.81 E-value=0.68 Score=47.58 Aligned_cols=30 Identities=27% Similarity=0.431 Sum_probs=25.5
Q ss_pred ceeccCCCCCEEE------cCCCcEEEEeecCCccc
Q 038211 499 IVHRDLKSSNLLV------DKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 499 iiH~Dik~~Nill------~~~~~vkl~Dfg~a~~~ 528 (605)
++|+|+.+.|||+ ++++.+.++||..|...
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 5799999999999 34678999999998653
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=91.46 E-value=0.048 Score=57.49 Aligned_cols=38 Identities=11% Similarity=0.207 Sum_probs=34.2
Q ss_pred hhhhhhhcccCCCcccccc----cceeccccccCCCCCCccC
Q 038211 291 NANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTGHR 328 (605)
Q Consensus 291 ~~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~~~ 328 (605)
-.+|.+|++.+||+.+|++ |++.+|++|....+..|..
T Consensus 220 pt~C~~C~~~l~g~~~qg~~C~~C~~~~Hk~C~~~vp~~C~~ 261 (463)
T 3cxl_A 220 PHWCEYCANFMWGLIAQGVKCADCGLNVHKQCSKMVPNDCKP 261 (463)
T ss_dssp CCBCTTTCCBCCSSSCCEEEETTTCCEECHHHHTTSCSBCCG
T ss_pred CCcchhhhhhhhhHHhcCeeccccCccccccccccccccccc
Confidence 4789999999999999988 8999999999988887764
|
| >2vrw_B P95VAV, VAV1, proto-oncogene VAV; lipoprotein, GTP-binding, metal-binding, phosphoprotein, exchange factor, RAC, GTPase, membrane domain; 1.85A {Mus musculus} PDB: 3bji_A 1f5x_A | Back alignment and structure |
|---|
Probab=91.09 E-value=0.064 Score=55.53 Aligned_cols=37 Identities=22% Similarity=0.362 Sum_probs=32.0
Q ss_pred hhhhhhhcccCCCcccccc----cceeccccccCCCCCCccC
Q 038211 291 NANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTGHR 328 (605)
Q Consensus 291 ~~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~~~ 328 (605)
-.+|.+|++.+||+.+|++ |.+.+|++|+..++. |+.
T Consensus 357 ~t~C~~C~~~~~g~~~qg~~C~~C~~~~h~~C~~~~~~-C~~ 397 (406)
T 2vrw_B 357 TTSCKACQMLLRGTFYQGYRCYRCRAPAHKECLGRVPP-CGR 397 (406)
T ss_dssp CCBCTTTCCBCCSSSSCEEEETTTCCEECGGGGGGSCC-C--
T ss_pred CCCCccccchhceeCCCCCCCCCCcCccchhhhhhCCC-CCC
Confidence 3689999999999999998 899999999998885 854
|
| >3by8_A Sensor protein DCUS; histidine kinase sensor domain, inner membrane, membrane, phosphoprotein, transferase, transmembrane; 1.45A {Escherichia coli} SCOP: d.110.6.1 PDB: 1ojg_A | Back alignment and structure |
|---|
Probab=90.03 E-value=0.48 Score=40.78 Aligned_cols=87 Identities=13% Similarity=0.161 Sum_probs=52.4
Q ss_pred HHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEcCCC
Q 038211 61 SVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRSG 140 (605)
Q Consensus 61 ~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~k~G 140 (605)
.+-+......|+++|.+|.+++... .+.+|+++.. +.. ..++ .|+.+... .....|
T Consensus 49 ~~~~~~~~~~i~v~d~~G~~~~~~~----------~~~iG~~~~~----~~~-------~~al-~G~~~~~~--~~~~~g 104 (142)
T 3by8_A 49 AVRKRNDLLFIVVTDMQSLRYSHPE----------AQRIGQPFKG----DDI-------LKAL-NGEENVAI--NRGFLA 104 (142)
T ss_dssp HHHHHTTCSEEEEEETTCBBSCCSS----------GGGTTSBCCC----GGG-------TGGG-GTCCEEEE--ECSSSS
T ss_pred HHHhhcCCcEEEEECCCCcEEECCC----------hHHCCCcCCC----CCH-------HHHh-CCCeEEEE--ecCccE
Confidence 3344444456699999998776442 4578876542 110 1122 56655432 122233
Q ss_pred CEEEEEEEEEEEee-CCeEEEEEEEEecccccccc
Q 038211 141 EILMAVVTKSPLYE-DGELAGFITVSSDAAIFNSI 174 (605)
Q Consensus 141 ~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~~l 174 (605)
..+ ....||++ +|+++|+|.+-.++..+++.
T Consensus 105 ~~~---~~~~PV~~~~g~viGvv~vg~~~~~~~~~ 136 (142)
T 3by8_A 105 QAL---RVFTPIYDENHKQIGVVAIGLELSRVTQQ 136 (142)
T ss_dssp CEE---EEEEEEECTTSCEEEEEEEEEEHHHHHHH
T ss_pred EEE---EEEEeEEcCCCCEEEEEEEeEEHHHHHHH
Confidence 333 34559997 89999999999998777654
|
| >4e04_A Bacteriophytochrome (light-regulated signal trans histidine kinase), PHYB1; bacteriophytochrome chromophore binding domain; HET: LBV; 1.79A {Rhodopseudomonas palustris} | Back alignment and structure |
|---|
Probab=89.80 E-value=1 Score=44.49 Aligned_cols=40 Identities=15% Similarity=0.246 Sum_probs=36.3
Q ss_pred CeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccc
Q 038211 68 HAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFL 107 (605)
Q Consensus 68 d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~ 107 (605)
.|+.+++|.+++|+.+...++.++|.+.++++|+++.+++
T Consensus 29 hG~Ll~~~~~~~I~~~S~N~~~~lg~~~~~~lG~~l~~ll 68 (327)
T 4e04_A 29 HGLLLALAADMTIVAGSDNLPELTGLAIGALIGRSAADVF 68 (327)
T ss_dssp TSEEEEECTTCBEEEEETTHHHHHSCCHHHHTTCBHHHHB
T ss_pred CeEEEEEcCCCeEEEEcccHHHHhCCChHhhcCCCHHHHc
Confidence 5677888988999999999999999999999999999844
|
| >3e4o_A C4-dicarboxylate transport sensor protein DCTB; PAS domain, N-TERM helical dimerization domain, transferase; 2.30A {Sinorhizobium meliloti} PDB: 3e4p_A 3e4q_A 2zbb_A | Back alignment and structure |
|---|
Probab=86.51 E-value=12 Score=36.55 Aligned_cols=95 Identities=12% Similarity=0.013 Sum_probs=53.4
Q ss_pred HHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEcC
Q 038211 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKR 138 (605)
Q Consensus 59 ~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~k 138 (605)
++.+.+...-..++++|.+|+++..+.. -.....+|.+..+ ...+.. ++..+.... +..-..
T Consensus 104 L~~~~~~~~~~~i~v~d~~G~viass~~------~~p~~~~g~d~~~-------R~yf~~---Al~g~~~~~--~~~~~~ 165 (305)
T 3e4o_A 104 LEALATSAEAAVIYLIDRSGVAVAASNW------QEPTSFVGNDYAF-------RDYFRL---AVRDGMAEH--FAMGTV 165 (305)
T ss_dssp HHHHHHHSSCSEEEEEETTSBEEEETTT------TSTTCCTTCBCTT-------SHHHHH---HHHHSEEEE--EEECTT
T ss_pred HHHHHhccCccEEEEECCCCCEEEeCCC------cCcccccCCCccc-------cHHHHH---HHhcCCcEE--EEEecC
Confidence 3344444333445899999999976531 1122345544432 222322 333332221 122233
Q ss_pred CCCEEEEEEEEEEEeeCCeEEEEEEEEeccccccc
Q 038211 139 SGEILMAVVTKSPLYEDGELAGFITVSSDAAIFNS 173 (605)
Q Consensus 139 ~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t~~~~ 173 (605)
.|+.. ...+.||+++|+++|++.+.-|+..+.+
T Consensus 166 tg~~~--i~~a~PV~~~G~viGVv~v~i~l~~l~~ 198 (305)
T 3e4o_A 166 SKRPG--LYISRRVDGPGGPLGVIVAKLEFDGVEA 198 (305)
T ss_dssp TCCEE--EEEEEEEEETTEEEEEEEEEECCHHHHH
T ss_pred CCCEE--EEEEEEEccCCeEEEEEEEEEcHHHHHH
Confidence 45543 5678899989999999999999766543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.78 E-value=2.3 Score=39.25 Aligned_cols=115 Identities=10% Similarity=0.131 Sum_probs=75.7
Q ss_pred CCCCeeeEEEEEeeCCeeEEEEEecCCC-chHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEE
Q 038211 433 RHPNVLLFMGAVASQERLGIVTEFLPRG-SLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLV 511 (605)
Q Consensus 433 ~h~niv~~~~~~~~~~~~~lv~e~~~gg-sL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill 511 (605)
.||+++.. .+-.+.+.+.+.++.-+.+ ++.. + ...+....++++.+|+....+++. -+|--|+|+|+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEE
Confidence 68888876 4556666666666654322 3322 3 346788888899999887754442 4788899999999
Q ss_pred cCCCcEEEEeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 038211 512 DKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWN 579 (605)
Q Consensus 512 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~ 579 (605)
+.++.+++.=.|+-.. ++|. ..+...=+-.+=|++..++.++..|+
T Consensus 113 ~~~~~p~i~~RGik~~-----------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNV-----------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CTTSCEEESCCEETTT-----------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cCCCCEEEEEccCccC-----------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999986664211 2221 12222233456677888888888875
|
| >3lif_A Putative diguanylate cyclase (ggdef) with PAS/PAC; PDC fold, signaling protein; HET: CIT; 2.70A {Rhodopseudomonas palustris} | Back alignment and structure |
|---|
Probab=82.56 E-value=18 Score=33.55 Aligned_cols=96 Identities=13% Similarity=0.075 Sum_probs=55.6
Q ss_pred HHHHHHhcCCe-EEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHH--cCCceEEEEEE
Q 038211 59 YRSVLESMGHA-VHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLA--SGQSWSGQFPF 135 (605)
Q Consensus 59 ~~~il~~~~d~-ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~--~g~~~~~~~~~ 135 (605)
++.++...+.- .++++|.+|+ +..... . ...+.++ .+...+ ...+. .++.+..+...
T Consensus 60 L~~~~~~~~~~~~i~i~d~~G~-~~~s~~------~---~~~~~~~-------~~r~~f---~~a~~~~~~~~~is~p~~ 119 (254)
T 3lif_A 60 LRALADNLPQLSDVAILDADGQ-LTYASV------K---PVPALDN-------SDRSYF---RYHRANDDHTLLITGPIQ 119 (254)
T ss_dssp HHHHHHHCTTEEEEEEECTTSB-EEEESS------S---SEECCBC-------TTSHHH---HHHHHCCCCCCEEEEEEE
T ss_pred HHHHHhcCCccceEEEECCCCC-EecCCC------C---CCCCCCc-------ccHHHH---HHHHhCCCCCeEECCcee
Confidence 45555555542 3588999999 554321 0 1112222 222222 22334 34554444333
Q ss_pred EcCCCCEEEEEEEEEEEee-CCeEEEEEEEEeccccccccCC
Q 038211 136 KKRSGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFNSINP 176 (605)
Q Consensus 136 ~~k~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~~l~~ 176 (605)
-...|+. +...+.||++ +|+++|++.+.-++..+.+++.
T Consensus 120 ~~~~g~~--~i~~~~pi~~~~g~~~Gvl~~~i~l~~l~~~~~ 159 (254)
T 3lif_A 120 SRTSGVW--VFVVSRRLETTDGKFFGVVVATIESEYFSTFYK 159 (254)
T ss_dssp CTTTCCE--EEEEEEEEECTTCCEEEEEEEEECHHHHHHHHT
T ss_pred cCCCCcE--EEEEEeeeeCCCCCEeEEEEEEECHHHHHHHHH
Confidence 3345654 4567889998 9999999999999888777654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.02 E-value=8.1 Score=35.66 Aligned_cols=82 Identities=12% Similarity=0.132 Sum_probs=57.3
Q ss_pred CCCCeeeEEEEEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHH-HHHhCCCCceeccCCCCCEEE
Q 038211 433 RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMN-YLHHRNPPIVHRDLKSSNLLV 511 (605)
Q Consensus 433 ~h~niv~~~~~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~-~LH~~~~~iiH~Dik~~Nill 511 (605)
.||++ -..+-.+++.+.+.++.-+++.=+..+ ...+....++++.+|+.... +++ . -+|--|+|+||++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~--~--r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSA--R--RLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCS--S--SEECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhh--C--ceeEEEeCceEEE
Confidence 57887 333346677777777765443323344 34678888888888877655 343 3 5788899999999
Q ss_pred cCCCcEEEEeecC
Q 038211 512 DKNWTVKVGDFGL 524 (605)
Q Consensus 512 ~~~~~vkl~Dfg~ 524 (605)
+.++.+++.=.|+
T Consensus 118 ~~~~~p~i~hRGi 130 (219)
T 4ano_A 118 NRALEPFFLHVGV 130 (219)
T ss_dssp CTTCCEEESCCEE
T ss_pred eCCCcEEEEEcCC
Confidence 9999999986664
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.82 E-value=0.16 Score=53.48 Aligned_cols=62 Identities=13% Similarity=0.050 Sum_probs=17.7
Q ss_pred eEeeeecccCcEEEEEEEECC--cceEE------EEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEe
Q 038211 381 QLGEEIGLGSYAVVYRGIWNG--SDVAV------KVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVA 445 (605)
Q Consensus 381 ~~~~~LG~G~fg~V~~~~~~~--~~~av------Kv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 445 (605)
.+.+.|| ||.||++.+.+ .+||+ |..............+.+|..+++.+.|||+++.+.+..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456676 99999998764 46888 654433333444566788999999999999999888754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 605 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-65 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-17 | |
| d1n9la_ | 109 | d.110.3.6 (A:) Putative blue light receptor, phot- | 4e-10 | |
| d1jnua_ | 104 | d.110.3.6 (A:) Photoreceptor phy3 flavin-binding d | 2e-09 | |
| d1ll8a_ | 114 | d.110.3.5 (A:) N-terminal PAS domain of Pas kinase | 2e-05 | |
| d1bywa_ | 110 | d.110.3.6 (A:) Erg potassium channel, N-terminal d | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 3e-65
Identities = 79/218 (36%), Positives = 139/218 (63%), Gaps = 9/218 (4%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH 434
I + +G+ IG GS+ VY+G W+G DVAVK+ + L+ ++ E+ +++K RH
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
N+LLFMG ++ +L IVT++ SL+ LH ++ + + +A A+GM+YLH
Sbjct: 64 VNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTPQWMAPEVLRS 552
++ I+HRDLKS+N+ + ++ TVK+GDFGL+++ + + + G+ WMAPEV+R
Sbjct: 123 KS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 553 E---PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
+ P + +SDV++FG++L+EL+T +P++N+N +
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 1e-59
Identities = 66/240 (27%), Positives = 114/240 (47%), Gaps = 11/240 (4%)
Query: 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
R ED ++ IG GSY + +G + K E + E++++++L+
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 434 HPNVLLFMGAVASQE--RLGIVTEFLPRGSLFKTLHKN---YQALDIKRRLRMALDVARG 488
HPN++ + + + L IV E+ G L + K Q LD + LR+ +
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 489 MNYLHHRN---PPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWM 545
+ H R+ ++HRDLK +N+ +D VK+GDFGL+ + N AK+ GTP +M
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 546 APEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
+PE + NEKSD++S G +L+EL P+ + ++ G + + +P
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSD 240
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-58
Identities = 77/234 (32%), Positives = 126/234 (53%), Gaps = 13/234 (5%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH 434
+ ++L+L + IG G + V G + G+ VAVK + T + + E ++ +LRH
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFLAEASVMTQLRH 59
Query: 435 PNVLLFMGAVA-SQERLGIVTEFLPRGSLFKTLH-KNYQALDIKRRLRMALDVARGMNYL 492
N++ +G + + L IVTE++ +GSL L + L L+ +LDV M YL
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS 552
N VHRDL + N+LV ++ KV DFGL+ ++T +G+ +W APE LR
Sbjct: 120 EGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALRE 174
Query: 553 EPSNEKSDVFSFGVILWELVTA-SIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
+ + KSDV+SFG++LWE+ + +P+ + L VV V +++ P+G P
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPP 227
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 7e-58
Identities = 55/214 (25%), Positives = 106/214 (49%), Gaps = 7/214 (3%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL 432
++ +D + E+G G+ VV++ +G +A K+ E +E+ ++ +
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLHEC 61
Query: 433 RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
P ++ F GA S + I E + GSL + L K + + ++++ V +G+ YL
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYL 120
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS 552
++ I+HRD+K SN+LV+ +K+ DFG+S + S GT +M+PE L+
Sbjct: 121 REKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQG 177
Query: 553 EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
+ +SD++S G+ L E+ P + ++
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 1e-57
Identities = 71/234 (30%), Positives = 126/234 (53%), Gaps = 12/234 (5%)
Query: 380 LQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNV 437
L+ EIG GS+ VY+G+ +VA + + + +++E +++K L+HPN+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 438 LLFMGA----VASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
+ F + V ++ + +VTE + G+L L + + + IK + +G+ +LH
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH 129
Query: 494 HRNPPIVHRDLKSSN-LLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS 552
R PPI+HRDLK N + +VK+GD GL++LK A++ AK+ GTP++MAPE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYE- 186
Query: 553 EPSNEKSDVFSFGVILWELVTASIPWNNL-NLMQVVGVVGFMDRRLELPEGLDP 605
E +E DV++FG+ + E+ T+ P++ N Q+ V + + P
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-56
Identities = 68/236 (28%), Positives = 111/236 (47%), Gaps = 12/236 (5%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
+ ++ E+G G++ VY+ A KV E L++Y EIDI+ HP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHP 69
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495
N++ + A + L I+ EF G++ + + + L + + +NYLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL----- 550
I+HRDLK+ N+L + +K+ DFG+S+ T S GTP WMAPEV+
Sbjct: 130 K--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 551 RSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDR-RLELPEGLDP 605
+ P + K+DV+S G+ L E+ P + LN M+V+ + + L P
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 243
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 4e-55
Identities = 58/235 (24%), Positives = 111/235 (47%), Gaps = 12/235 (5%)
Query: 376 RW--EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIK 430
+W ED ++G +G G + VY + +A+KV F ++ G ++E++I
Sbjct: 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61
Query: 431 KLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMN 490
LRHPN+L G R+ ++ E+ P G++++ L K D +R ++A ++
Sbjct: 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALS 120
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL 550
Y H + ++HRD+K NLL+ +K+ DFG S ++ + GT ++ PE++
Sbjct: 121 YCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMI 176
Query: 551 RSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
+EK D++S GV+ +E + P+ + + P+ +
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTE 229
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-54
Identities = 66/234 (28%), Positives = 107/234 (45%), Gaps = 9/234 (3%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
I +DL +E+G G + VV G W DVA+K+ E + +E ++ L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLS 57
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
H ++ G Q + I+TE++ G L L + ++ L M DV M YL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTPQWMAPEVLRS 552
+ +HRDL + N LV+ VKV DFGLS + + Y ++ + +W PEVL
Sbjct: 118 SKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 553 EPSNEKSDVFSFGVILWELVTA-SIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
+ KSD+++FGV++WE+ + +P+ + + RL P
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASE 228
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-54
Identities = 72/234 (30%), Positives = 115/234 (49%), Gaps = 9/234 (3%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
I +L +EIG G + +V+ G W N VA+K E +++ +E +++ KL
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLS 58
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
HP ++ G Q + +V EF+ G L L + L M LDV GM YL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAPEVLRS 552
++HRDL + N LV +N +KV DFG++ + + Y ++ + +W +PEV
Sbjct: 119 EAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 553 EPSNEKSDVFSFGVILWELVTAS-IPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
+ KSDV+SFGV++WE+ + IP+ N + +VV + RL P
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLAST 229
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 5e-54
Identities = 70/235 (29%), Positives = 120/235 (51%), Gaps = 11/235 (4%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
+ E L+L E +G G + V+ G +N + VAVK + E +++K+L+
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQ 66
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYL 492
H ++ V +QE + I+TE++ GSL L L I + L MA +A GM ++
Sbjct: 67 HQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS-LKNATYLTAKSGRGTPQWMAPEVLR 551
RN +HRDL+++N+LV + K+ DFGL+ +++ Y + + +W APE +
Sbjct: 126 EERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 552 SEPSNEKSDVFSFGVILWELVTA-SIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
KSDV+SFG++L E+VT IP+ + +V+ + R+ P+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPE 237
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-53
Identities = 78/241 (32%), Positives = 115/241 (47%), Gaps = 13/241 (5%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD-----VAVKVYFGSEYI-EGTLKNYQKEIDI 428
I +DL+L E++G GS+ VV RG W+ VAVK + ++ +E++
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 429 IKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARG 488
+ L H N++ G V + +VTE P GSL L K+ + R A+ VA G
Sbjct: 65 MHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 489 MNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL---KNATYLTAKSGRGTPQWM 545
M YL + +HRDL + NLL+ VK+GDFGL + Y+ + + W
Sbjct: 124 MGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 546 APEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604
APE L++ + SD + FGV LWE+ T PW LN Q++ + RL PE
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241
Query: 605 P 605
Sbjct: 242 Q 242
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-53
Identities = 61/240 (25%), Positives = 117/240 (48%), Gaps = 14/240 (5%)
Query: 375 IRWEDLQLGE-EIGLGSYAVVYRGIW----NGSDVAVKVYFGSEYIEGTLKNYQKEIDII 429
++ ++L + + E+G G++ V +G++ DVA+KV + + +E I+
Sbjct: 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREAQIM 63
Query: 430 KKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGM 489
+L +P ++ +G ++ + +V E G L K L + + + + V+ GM
Sbjct: 64 HQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL---KNATYLTAKSGRGTPQWMA 546
YL +N VHRDL + N+L+ K+ DFGLS ++ Y +G+ +W A
Sbjct: 123 KYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 547 PEVLRSEPSNEKSDVFSFGVILWELVTA-SIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
PE + + +SDV+S+GV +WE ++ P+ + +V+ + +R+E P P
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPP 239
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (461), Expect = 4e-53
Identities = 73/242 (30%), Positives = 115/242 (47%), Gaps = 15/242 (6%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD-----VAVKVYFGSEYIEGTLKNYQKEIDII 429
I +++ + IG G + V G VA+K S Y E +++ E I+
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEASIM 81
Query: 430 KKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGM 489
+ HPNV+ G V + I+TEF+ GSL L +N + + + M +A GM
Sbjct: 82 GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 141
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL-----KNATYLTAKSGRGTPQW 544
YL N VHRDL + N+LV+ N KV DFGLS + TY +A G+ +W
Sbjct: 142 KYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199
Query: 545 MAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603
APE ++ SDV+S+G+++WE+++ P+ ++ V+ + D RL P
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMDC 258
Query: 604 DP 605
Sbjct: 259 PS 260
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-52
Identities = 73/252 (28%), Positives = 120/252 (47%), Gaps = 26/252 (10%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGS----DVAVKVYFGSEYIEGTLKNYQKEIDIIK 430
+ W D++ + IG G++ V + D A+K + +++ E++++
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVLC 65
Query: 431 KL-RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNY---------------QALD 474
KL HPN++ +GA + L + E+ P G+L L K+ L
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 475 IKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534
++ L A DVARGM+YL + +HRDL + N+LV +N+ K+ DFGLS + Y+
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQE-VYVK 182
Query: 535 AKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTA-SIPWNNLNLMQVVGVVGFM 593
GR +WMA E L SDV+S+GV+LWE+V+ P+ + ++ +
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 241
Query: 594 DRRLELPEGLDP 605
RLE P D
Sbjct: 242 GYRLEKPLNCDD 253
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 5e-52
Identities = 62/264 (23%), Positives = 109/264 (41%), Gaps = 36/264 (13%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD-------VAVKVYFGSEYIEGTLKNYQKEID 427
E+L+ G+ +G G++ V G VAVK+ + + E+
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM-LKEKADSSEREALMSELK 92
Query: 428 IIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKN----------------- 469
++ +L H N++ +GA + ++ E+ G L L
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 470 -----YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524
L + L A VA+GM +L ++ VHRDL + N+LV VK+ DFGL
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 525 SSL--KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTA-SIPWNNL 581
+ ++ Y+ + R +WMAPE L KSDV+S+G++LWE+ + P+ +
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 582 NLMQVVGVVGFMDRRLELPEGLDP 605
+ + +++ P
Sbjct: 271 PVDANFYKLIQNGFKMDQPFYATE 294
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 177 bits (450), Expect = 2e-51
Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 13/231 (5%)
Query: 381 QLGEEIGLGSYAVVYRGIW--NGSDVAVKVY-FGSEYIEGTLKNYQKEIDIIKKLRHPNV 437
EIG GS+ VY N VA+K + + ++ KE+ ++KLRHPN
Sbjct: 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77
Query: 438 LLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNP 497
+ + G + +V E+ + + L + +G+ YLH N
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN- 135
Query: 498 PIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSE---P 554
++HRD+K+ N+L+ + VK+GDFG +S+ A S GTP WMAPEV+ +
Sbjct: 136 -MIHRDVKAGNILLSEPGLVKLGDFGSASIMA----PANSFVGTPYWMAPEVILAMDEGQ 190
Query: 555 SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
+ K DV+S G+ EL P N+N M + + +
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 3e-51
Identities = 70/228 (30%), Positives = 110/228 (48%), Gaps = 25/228 (10%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNV 437
+ L E IG G + V+RG W G +VAVK+ F S + + EI LRH N+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKI-FSSREERSWFR--EAEIYQTVMLRHENI 59
Query: 438 LLFMGAV----ASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
L F+ A + +L +V+++ GSLF L++ + ++ +++AL A G+ +LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLH 117
Query: 494 H------RNPPIVHRDLKSSNLLVDKNWTVKVGDFGL----SSLKNATYLTAKSGRGTPQ 543
P I HRDLKS N+LV KN T + D GL S + + GT +
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 544 WMAPEVLRSE------PSNEKSDVFSFGVILWELVTASIPWNNLNLMQ 585
+MAPEVL S +++D+++ G++ WE+ Q
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (446), Expect = 3e-51
Identities = 81/236 (34%), Positives = 123/236 (52%), Gaps = 11/236 (4%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL 432
+ D+ + ++G G Y VY G+W VAVK ++ + KE ++K++
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEI 70
Query: 433 RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLH-KNYQALDIKRRLRMALDVARGMNY 491
+HPN++ +G + I+TEF+ G+L L N Q + L MA ++ M Y
Sbjct: 71 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130
Query: 492 LHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSG-RGTPQWMAPEVL 550
L +N +HRDL + N LV +N VKV DFGLS L TA +G + +W APE L
Sbjct: 131 LEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 551 RSEPSNEKSDVFSFGVILWELVTA-SIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
+ KSDV++FGV+LWE+ T P+ ++L QV ++ D R+E PEG
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 243
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 5e-51
Identities = 63/240 (26%), Positives = 109/240 (45%), Gaps = 14/240 (5%)
Query: 375 IRWEDLQLGE-EIGLGSYAVVYRGIWN----GSDVAVKVYFGSEYIEGTLKNYQKEIDII 429
+ + L L + E+G G++ V +G + VAVK+ E +++
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 430 KKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGM 489
++L +P ++ +G ++ + +V E G L K L +N + + K + + V+ GM
Sbjct: 63 QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGM 120
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL---KNATYLTAKSGRGTPQWMA 546
YL N VHRDL + N+L+ K+ DFGLS Y G+ +W A
Sbjct: 121 KYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 547 PEVLRSEPSNEKSDVFSFGVILWELVTA-SIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
PE + + KSDV+SFGV++WE + P+ + +V ++ R+ P G
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPR 237
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 5e-51
Identities = 67/238 (28%), Positives = 120/238 (50%), Gaps = 12/238 (5%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD-----VAVKVYFGSEYIEGTLKNYQKEIDII 429
I+ E ++LG IG G + V++GI+ + VA+K + + + + +E +
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEALTM 62
Query: 430 KKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGM 489
++ HP+++ +G + ++ + I+ E G L L +LD+ + A ++ +
Sbjct: 63 RQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS-SLKNATYLTAKSGRGTPQWMAPE 548
YL + VHRD+ + N+LV N VK+GDFGLS ++++TY A G+ +WMAPE
Sbjct: 122 AYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 549 VLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
+ SDV+ FGV +WE++ P+ + V+G + RL +P P
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPP 236
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 8e-51
Identities = 56/231 (24%), Positives = 113/231 (48%), Gaps = 9/231 (3%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
+ E+IG G+ VY + G +VA++ + + + EI ++++ ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNP 77
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495
N++ ++ + + L +V E+L GSL + + D + + + + + +LH
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHSN 135
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPS 555
++HRD+KS N+L+ + +VK+ DFG + + GTP WMAPEV+ +
Sbjct: 136 Q--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 556 NEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDR-RLELPEGLDP 605
K D++S G++ E++ P+ N N ++ + ++ L+ PE L
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 8e-51
Identities = 78/235 (33%), Positives = 122/235 (51%), Gaps = 11/235 (4%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD-VAVKVYFGSEYIEGTLKNYQKEIDIIKKLR 433
I E L+L ++G G + V+ G WNG+ VA+K + + +E ++KKLR
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 70
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLH-KNYQALDIKRRLRMALDVARGMNYL 492
H ++ V S+E + IVTE++ +GSL L + + L + + + MA +A GM Y+
Sbjct: 71 HEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSG-RGTPQWMAPEVLR 551
N VHRDL+++N+LV +N KV DFGL+ L TA+ G + +W APE
Sbjct: 130 ERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 552 SEPSNEKSDVFSFGVILWELVTA-SIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
KSDV+SFG++L EL T +P+ + +V+ V R+ P
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPE 241
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-49
Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 10/234 (4%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
ED L + +G G+Y V + VAVK+ + +N +KEI I K L H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHE 63
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495
NV+ F G + E+ G LF + + + R + G+ YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTPQWMAPEVLRSE 553
I HRD+K NLL+D+ +K+ DFGL+++ N GT ++APE+L+
Sbjct: 123 G--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 554 P-SNEKSDVFSFGVILWELVTASIPWNNLN-LMQVVGVVGFMDRRLELPEGLDP 605
E DV+S G++L ++ +PW+ + Q L + +D
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 3e-49
Identities = 57/236 (24%), Positives = 109/236 (46%), Gaps = 10/236 (4%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKK 431
R ED + G+ +G GS++ V + A+K+ I E + +E D++ +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 432 LRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNY 491
L HP + E+L + G L K + K + D ++ + Y
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEY 123
Query: 492 LHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN--ATYLTAKSGRGTPQWMAPEV 549
LH I+HRDLK N+L++++ +++ DFG + + + + A S GT Q+++PE+
Sbjct: 124 LHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 550 LRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
L + + + SD+++ G I+++LV P+ N + + + + PE P
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFP 235
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-49
Identities = 62/239 (25%), Positives = 114/239 (47%), Gaps = 12/239 (5%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKV---YFGSEYIEGTLKNYQKEIDII 429
++ + + + +G G++ VY+G+W G V + V K E ++
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 430 KKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGM 489
+ +P+V +G + + ++T+ +P G L + ++ + + L + +A+GM
Sbjct: 66 ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAKSGRGTPQWMAP 547
NYL R +VHRDL + N+LV VK+ DFGL+ L A+ G+ +WMA
Sbjct: 125 NYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 548 EVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
E + +SDV+S+GV +WEL+T S P++ + ++ ++ RL P
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTI 240
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (436), Expect = 5e-49
Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 9/214 (4%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
+ + EE+G G++ VV+R G++ A K E + +KEI + LRHP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHP 83
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495
++ A + ++ EF+ G LF+ + + + + V +G+ ++H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 496 NPPIVHRDLKSSNLLV--DKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSE 553
N VH DLK N++ ++ +K+ DFGL++ + + K GT ++ APEV +
Sbjct: 144 N--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-SVKVTTGTAEFAAPEVAEGK 200
Query: 554 PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
P +D++S GV+ + L++ P+ N + +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 234
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 7e-49
Identities = 64/264 (24%), Positives = 111/264 (42%), Gaps = 37/264 (14%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIW-------NGSDVAVKVYFGSEYIEGTLKNYQKEID 427
+++ +IG G++ V++ + VAVK+ E ++Q+E
Sbjct: 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADFQREAA 68
Query: 428 IIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHK------------------- 468
++ + +PN++ +G A + + ++ E++ G L + L
Sbjct: 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 469 ----NYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGL 524
L +L +A VA GM YL R VHRDL + N LV +N VK+ DFGL
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGL 186
Query: 525 SSL--KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASI-PWNNL 581
S Y + +WM PE + +SDV+++GV+LWE+ + + P+ +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246
Query: 582 NLMQVVGVVGFMDRRLELPEGLDP 605
+V+ V L PE
Sbjct: 247 AHEEVIYYVR-DGNILACPENCPL 269
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 7e-49
Identities = 68/241 (28%), Positives = 111/241 (46%), Gaps = 14/241 (5%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD------VAVKVYFGSEYIEGTLKNYQKEIDI 428
I + + IG G + VY+G+ S VA+K + Y E ++ E I
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEAGI 62
Query: 429 IKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARG 488
+ + H N++ G ++ + + I+TE++ G+L K L + + + + M +A G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 489 MNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN---ATYLTAKSGRGTPQWM 545
M YL N VHRDL + N+LV+ N KV DFGLS + T G+ +W
Sbjct: 123 MKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 546 APEVLRSEPSNEKSDVFSFGVILWELVTASIPWN-NLNLMQVVGVVGFMDRRLELPEGLD 604
APE + SDV+SFG+++WE++T L+ +V+ + RL P
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDCP 239
Query: 605 P 605
Sbjct: 240 S 240
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 8e-48
Identities = 72/237 (30%), Positives = 109/237 (45%), Gaps = 15/237 (6%)
Query: 380 LQLGEEIGLGSYAVVYRGIWNGSD-----VAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH 434
+ E IG G + VY G +D AVK G + + E I+K H
Sbjct: 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 435 PNVLLFMGAVASQE-RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
PNVL +G E +V ++ G L + +K + L VA+GM +L
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL----KNATYLTAKSGRGTPQWMAPEV 549
VHRDL + N ++D+ +TVKV DFGL+ + + + +WMA E
Sbjct: 148 S--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 550 LRSEPSNEKSDVFSFGVILWELVTA-SIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
L+++ KSDV+SFGV+LWEL+T + P+ ++N + + RRL PE
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEYCPD 261
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-47
Identities = 60/259 (23%), Positives = 104/259 (40%), Gaps = 31/259 (11%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIW-------NGSDVAVKVYFGSEYIEGTLKNYQKEID 427
L G+ +G G++ V VAVK+ + E+
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSELK 78
Query: 428 IIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNY---------------- 470
++ L H N++ +GA ++TE+ G L L +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 471 -QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL-- 527
ALD++ L + VA+GM +L +N +HRDL + N+L+ K+ DFGL+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 528 KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWN-NLNLMQV 586
++ Y+ + R +WMAPE + + +SDV+S+G+ LWEL + + +
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 587 VGVVGFMDRRLELPEGLDP 605
+ R+ PE
Sbjct: 257 FYKMIKEGFRMLSPEHAPA 275
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 167 bits (423), Expect = 4e-47
Identities = 50/218 (22%), Positives = 103/218 (47%), Gaps = 9/218 (4%)
Query: 374 GIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKK 431
G ++ + EE+G G++ VV+R + G K ++ + EI I+ +
Sbjct: 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQ 82
Query: 432 LRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNY 491
L HP ++ A + + ++ EFL G LF + + + G+ +
Sbjct: 83 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142
Query: 492 LHHRNPPIVHRDLKSSNLLVD--KNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEV 549
+H + IVH D+K N++ + K +VK+ DFGL++ N + + T ++ APE+
Sbjct: 143 MHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-TATAEFAAPEI 199
Query: 550 LRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
+ EP +D+++ GV+ + L++ P+ + ++ +
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 237
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 6e-46
Identities = 45/215 (20%), Positives = 99/215 (46%), Gaps = 10/215 (4%)
Query: 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH 434
+E + E++G G + +V+R + + K + +K EI I+ RH
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---EISILNIARH 60
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
N+L + S E L ++ EF+ +F+ ++ + L+ + + V + +LH
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 495 RNPPIVHRDLKSSNLLVD--KNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS 552
N I H D++ N++ ++ T+K+ +FG + + P++ APEV +
Sbjct: 121 HN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQH 177
Query: 553 EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
+ + +D++S G +++ L++ P+ Q++
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 9e-46
Identities = 57/232 (24%), Positives = 104/232 (44%), Gaps = 9/232 (3%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVY-FGSEYIEGTLKNYQKEIDIIKK-LR 433
ED L + +G GS+ V+ + A+K ++ ++ E ++
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 434 HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLH 493
HP + ++E L V E+L G L + D+ R A ++ G+ +LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH 120
Query: 494 HRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSE 553
+ IV+RDLK N+L+DK+ +K+ DFG+ + GTP ++APE+L +
Sbjct: 121 SKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 554 PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
N D +SFGV+L+E++ P++ + ++ + P L+
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEK 228
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 160 bits (406), Expect = 1e-45
Identities = 63/241 (26%), Positives = 117/241 (48%), Gaps = 20/241 (8%)
Query: 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKV-------YFGSEYIEGTLKNYQKEID 427
+E+ + E +G G +VV R I + AVK+ F +E ++ + KE+D
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 428 IIKKLR-HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVA 486
I++K+ HPN++ + +V + + +G LF L + L K ++ +
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALL 120
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMA 546
+ LH N IVHRDLK N+L+D + +K+ DFG S + + GTP ++A
Sbjct: 121 EVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTPSYLA 177
Query: 547 PEVLRSEPS------NEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELP 600
PE++ + ++ D++S GVI++ L+ S P+ + M ++ ++ + + P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 601 E 601
E
Sbjct: 238 E 238
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-45
Identities = 69/250 (27%), Positives = 117/250 (46%), Gaps = 23/250 (9%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIW-------NGSDVAVKVYFGSEYIEGTLKNYQKEID 427
+ E + + E+G GS+ +VY G+ + VA+K + E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEAS 75
Query: 428 IIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQA---------LDIKRR 478
++K+ +V+ +G V+ + ++ E + RG L L A + +
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 479 LRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--KNATYLTAK 536
++MA ++A GM YL+ VHRDL + N +V +++TVK+GDFG++ + Y
Sbjct: 136 IQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 537 SGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDR 595
G +WM+PE L+ SDV+SFGV+LWE+ T A P+ L+ QV+ V
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEGG 252
Query: 596 RLELPEGLDP 605
L+ P+
Sbjct: 253 LLDKPDNCPD 262
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 6e-45
Identities = 71/259 (27%), Positives = 121/259 (46%), Gaps = 32/259 (12%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD---------VAVKVYFGSEYIEGTLKNYQKE 425
+ + L LG+ +G G++ V G D VAVK+ S+ E L + E
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDLISE 68
Query: 426 IDIIKKL-RHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNY-------------- 470
++++K + +H N++ +GA L ++ E+ +G+L + L
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 471 -QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL-- 527
+ L K + A VARGM YL + +HRDL + N+LV ++ +K+ DFGL+
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 528 KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTA-SIPWNNLNLMQV 586
Y +GR +WMAPE L +SDV+SFGV+LWE+ T P+ + + ++
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246
Query: 587 VGVVGFMDRRLELPEGLDP 605
++ R++ P
Sbjct: 247 FKLLK-EGHRMDKPSNCTN 264
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 8e-45
Identities = 58/228 (25%), Positives = 108/228 (47%), Gaps = 10/228 (4%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
+ + +G G+++ V VA+K + +EG + + EI ++ K++HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKC-IAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495
N++ S L ++ + + G LF + + + R+ V + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDL 126
Query: 496 NPPIVHRDLKSSNLLV---DKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS 552
IVHRDLK NLL D++ + + DFGLS +++ + + GTP ++APEVL
Sbjct: 127 G--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL-STACGTPGYVAPEVLAQ 183
Query: 553 EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELP 600
+P ++ D +S GVI + L+ P+ + N ++ + + + P
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 231
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-43
Identities = 62/258 (24%), Positives = 109/258 (42%), Gaps = 30/258 (11%)
Query: 375 IRWEDLQLGEEIGLGSYAVVYRGIWNGSD-------VAVKVYFGSEYIEGTLKNYQKEID 427
+ L+LG+ +G G++ V G D VAVK+ + E+
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRALMSELK 68
Query: 428 IIKKLRHPNVLLFMGAVASQE--RLGIVTEFLPRGSLFKTLHKNY--------------- 470
I+ + H ++ + ++ L ++ EF G+L L
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 471 QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL--K 528
L ++ + + VA+GM +L R +HRDL + N+L+ + VK+ DFGL+ K
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASI-PWNNLNLMQVV 587
+ Y+ R +WMAPE + +SDV+SFGV+LWE+ + P+ + + +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246
Query: 588 GVVGFMDRRLELPEGLDP 605
R+ P+ P
Sbjct: 247 CRRLKEGTRMRAPDYTTP 264
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 156 bits (395), Expect = 1e-43
Identities = 59/231 (25%), Positives = 117/231 (50%), Gaps = 11/231 (4%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE-GTLKNYQKEIDIIKKLRH 434
+D Q+ +G GS+ V+ NG A+KV + +++ E ++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
P ++ G +++ ++ +++ G LF L K+ + + + A +V + YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEYLHS 122
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEP 554
++ I++RDLK N+L+DKN +K+ DFG + T GTP ++APEV+ ++P
Sbjct: 123 KD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC---GTPDYIAPEVVSTKP 177
Query: 555 SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
N+ D +SFG++++E++ P+ + N M+ + ++ L P +
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNE 226
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 4e-42
Identities = 58/231 (25%), Positives = 108/231 (46%), Gaps = 8/231 (3%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRH 434
D + +G G++ V G A+K+ I + + + E +++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
P + A + +RL V E+ G LF L + +R ++ + YLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHS 123
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEP 554
R+ +V+RD+K NL++DK+ +K+ DFGL + T K+ GTP+++APEVL
Sbjct: 124 RD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 555 SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
D + GV+++E++ +P+ N + ++ ++ + + P L P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSP 230
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 153 bits (387), Expect = 4e-42
Identities = 54/236 (22%), Positives = 103/236 (43%), Gaps = 13/236 (5%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKV----YFGSEYIEGTLKNYQKEIDIIKK 431
D + IG G + VY G A+K + E N + + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 432 LRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNY 491
P ++ A + ++L + + + G L L ++ + R A ++ G+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR-FYAAEIILGLEH 122
Query: 492 LHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL- 550
+H+R +V+RDLK +N+L+D++ V++ D GL+ + A GT +MAPEVL
Sbjct: 123 MHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQ 178
Query: 551 RSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV-GFMDRRLELPEGLDP 605
+ + +D FS G +L++L+ P+ + + +ELP+ P
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 150 bits (379), Expect = 8e-42
Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 13/220 (5%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRH 434
+ +LGE +G G + V+ DVAVKV +++E L H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 435 PNVLLFMGAVASQERLG----IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMN 490
P ++ ++ G IV E++ +L +H + KR + + D + +N
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALN 125
Query: 491 YLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLS---SLKNATYLTAKSGRGTPQWMAP 547
+ H I+HRD+K +N+++ VKV DFG++ + + + GT Q+++P
Sbjct: 126 FSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 548 EVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
E R + + +SDV+S G +L+E++T P+ + + V
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 223
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-41
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 5/212 (2%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
E+ Q E+IG G+Y VVY+ G VA+K EG +EI ++K+L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495
N++ + + ++ +L +V EFL + + + + +G+ + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL-RSEP 554
++HRDLK NLL++ +K+ DFGL+ T T + APE+L +
Sbjct: 122 R--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 555 SNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
+ D++S G I E+VT + + +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 143 bits (360), Expect = 4e-39
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 5/212 (2%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN 436
E E+IG G+Y VVY+ N G A+K + EG +EI I+K+L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 437 VLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRN 496
++ + +++RL +V E L L K L L+ L + G+ Y H R
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 497 PPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPS- 555
++HRDLK NLL+++ +K+ DFGL+ T + AP+VL
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 556 NEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
+ D++S G I E+V + + ++ +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-39
Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 14/224 (6%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW---NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-- 432
+ + EIG G+Y V++ G VA+K EG + +E+ +++ L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 433 -RHPNVLLFMGAVASQE-----RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVA 486
HPNV+ +L +V E + + + + M +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMA 546
RG+++LH +VHRDLK N+LV + +K+ DFGL+ + + + S T + A
Sbjct: 127 RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYS-FQMALTSVVVTLWYRA 183
Query: 547 PEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590
PEVL D++S G I E+ + + + +G +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-38
Identities = 47/235 (20%), Positives = 90/235 (38%), Gaps = 22/235 (9%)
Query: 381 QLGEEIGLGSYAVVYRGIW--NGSDVAVKV----YFGSEYIEGTLKNYQKEIDIIKKLR- 433
Q+G +G G + VY GI + VA+K E+ ++KK+
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 434 -HPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
V+ + + ++ E AL + V + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 493 HHRNPPIVHRDLKSSNLLVDKN-WTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLR 551
H+ ++HRD+K N+L+D N +K+ DFG +L T T GT + PE +R
Sbjct: 127 HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT--DFDGTRVYSPPEWIR 182
Query: 552 SEP-SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
+ V+S G++L+++V IP+ + + + ++ + +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQVFFRQRVSS 229
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-38
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 9/210 (4%)
Query: 384 EEIGLGSYAVVYRGIW--NGSDVAVKV---YFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
+ +G G +A VY+ VA+K SE +G + +EI ++++L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPP 498
+ A + + +V +F+ L + N L L +G+ YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 499 IVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPS-NE 557
I+HRDLK +NLL+D+N +K+ DFGL+ + T + APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 558 KSDVFSFGVILWELVTASIPWNNLNLMQVV 587
D+++ G IL EL+ + + +
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQL 210
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-38
Identities = 58/230 (25%), Positives = 110/230 (47%), Gaps = 14/230 (6%)
Query: 381 QLGEEIGLGSYAVVYRGIW--NGSDVAVKV----YFGSEYIEGTLKNYQKEIDIIKKLRH 434
GEE+G G +AVV + G A K S + ++ ++E+ I+K+++H
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
PNV+ ++ + ++ E + G LF L + ++L + + G+ YLH
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHS 131
Query: 495 RNPPIVHRDLKSSNLLVDKNWT----VKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL 550
I H DLK N+++ +K+ DFGL+ + K+ GTP+++APE++
Sbjct: 132 LQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-KNIFGTPEFVAPEIV 188
Query: 551 RSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELP 600
EP ++D++S GVI + L++ + P+ + + V ++ E
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 238
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 382 LGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVL 438
+ +GLG V + A+K+ ++E+++ + + P+++
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-------RREVELHWRASQCPHIV 68
Query: 439 ----LFMGAVASQERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLH 493
++ A ++ L IV E L G LF + QA + + + + YLH
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 494 HRNPPIVHRDLKSSNLLVDK---NWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVL 550
N I HRD+K NLL N +K+ DFG + + + + TP ++APEVL
Sbjct: 129 SIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEVL 185
Query: 551 RSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
E ++ D++S GVI++ L+ P+ + + + +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (357), Expect = 4e-38
Identities = 48/231 (20%), Positives = 101/231 (43%), Gaps = 11/231 (4%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRH 434
+ + +G GS+ V +G+ A+K+ + + +++ E I++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 435 PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
P ++ + L +V E++ G +F L + A + YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHS 159
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEP 554
+ +++RDLK NLL+D+ ++V DFG + T GTP+ +APE++ S+
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL---CGTPEALAPEIILSKG 214
Query: 555 SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605
N+ D ++ GV+++E+ P+ +Q+ + + ++ P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVRFPSHFSS 263
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (348), Expect = 3e-37
Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 18/219 (8%)
Query: 381 QLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
+LG +IG GS+ +Y G G +VA+K+ E ++ E I K ++ +
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTKHPQLHIESKIYKMMQGGVGI 65
Query: 439 LFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPP 498
+ ++ ++ L SL + + +K L +A + + Y+H +N
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN-- 123
Query: 499 IVHRDLKSSNLLV---DKNWTVKVGDFGLS-------SLKNATYLTAKSGRGTPQWMAPE 548
+HRD+K N L+ K V + DFGL+ + ++ Y K+ GT ++ +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 549 VLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
+ + D+ S G +L S+PW L
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 138 bits (348), Expect = 3e-37
Identities = 47/245 (19%), Positives = 90/245 (36%), Gaps = 26/245 (10%)
Query: 374 GIRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKK 431
G+ ++ +G IG GS+ V++ G N VA+K E + E K
Sbjct: 4 GVHYK---VGRRIGEGSFGVIFEGTNLLNNQQVAIKF----EPRRSDAPQLRDEYRTYKL 56
Query: 432 LRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNY 491
L + + + ++ L SL L + +K A + +
Sbjct: 57 LAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 492 LHHRNPPIVHRDLKSSNLLVDK-----NWTVKVGDFGLSSL-------KNATYLTAKSGR 539
+H ++ +V+RD+K N L+ + + V DFG+ ++ Y K+
Sbjct: 117 IHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 540 GTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW---NNLNLMQVVGVVGFMDRR 596
GT ++M+ + + D+ + G + + S+PW Q +G +
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
Query: 597 LELPE 601
L E
Sbjct: 235 TPLRE 239
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-36
Identities = 48/224 (21%), Positives = 92/224 (41%), Gaps = 18/224 (8%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
+ +IG G++ V++ G VA+K EG +EI I++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 436 NVLLFMGAVASQE--------RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVAR 487
NV+ + ++ + +V +F + + + R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLN 128
Query: 488 GMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL----KNATYLTAKSGRGTPQ 543
G+ Y+H I+HRD+K++N+L+ ++ +K+ DFGL+ KN+ + T
Sbjct: 129 GLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 544 WMAPEVLRSEPS-NEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
+ PE+L E D++ G I+ E+ T S
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 230
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 6e-36
Identities = 51/215 (23%), Positives = 92/215 (42%), Gaps = 15/215 (6%)
Query: 381 QLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
IG G+Y +V N VA+K + + +EI I+ + RH N++
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKK-ISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 439 LFMGAVAS----QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
+ + Q + + L L+K L + L + RG+ Y+H
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIHS 127
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL---KNATYLTAKSGRGTPQWMAPEVL- 550
N ++HRDLK SNLL++ +K+ DFGL+ + + T + APE++
Sbjct: 128 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 551 RSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQ 585
S+ + D++S G IL E+++ + + +
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 2e-35
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 6/204 (2%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
+ + E+IG G+Y V++ VA+K + EG + +EI ++K+L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 436 NVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHR 495
N++ + S ++L +V EF + N D + + +G+ + H R
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSR 120
Query: 496 NPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPS 555
N ++HRDLK NLL+++N +K+ +FGL+ + T + P+VL
Sbjct: 121 N--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 556 -NEKSDVFSFGVILWELVTASIPW 578
+ D++S G I EL A P
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPL 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 8e-34
Identities = 52/213 (24%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 381 QLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
+ + +G G+Y V + G+ VA+K + E K +E+ ++K +RH NV+
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80
Query: 439 LFMGAVASQERLGIVTEFL----PRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH 494
+ E L T+F G+ L K+ + L R + + +G+ Y+H
Sbjct: 81 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 495 RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS-E 553
HRDLK NL V+++ +K+ DFGL+ ++ T + APEV+ +
Sbjct: 140 AGII--HRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILNWM 194
Query: 554 PSNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
+ D++S G I+ E++T + + +
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 227
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-33
Identities = 47/219 (21%), Positives = 83/219 (37%), Gaps = 19/219 (8%)
Query: 379 DLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN 436
+ IG GS+ VVY+ +G VA+K + + +E+ I++KL H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK------VLQDKRFKNRELQIMRKLDHCN 74
Query: 437 VLLFMGAVASQER------LGIVTEFLPRGSLFKTLH--KNYQALDIKRRLRMALDVARG 488
++ S L +V +++P H + Q L + + R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 489 MNYLHHRNPPIVHRDLKSSNLLVDKN-WTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAP 547
+ Y+H I HRD+K NLL+D + +K+ DFG +
Sbjct: 135 LAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 548 EVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
+ + DV+S G +L EL+ + + +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-33
Identities = 54/241 (22%), Positives = 111/241 (46%), Gaps = 16/241 (6%)
Query: 378 EDLQLGEEIGLGSYAVVYRGI-----WNGSDVAVKVYFGSEYIE--GTLKNYQKEIDIIK 430
E+ +L + +G G+Y V+ G A+KV + ++ T ++ + E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 431 KLRH-PNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGM 489
+R P ++ A ++ +L ++ +++ G LF L + + ++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLAL 142
Query: 490 NYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT-AKSGRGTPQWMAPE 548
+LH I++RD+K N+L+D N V + DFGLS A A GT ++MAP+
Sbjct: 143 EHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 549 VLRSEPS--NEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV--GFMDRRLELPEGLD 604
++R S ++ D +S GV+++EL+T + P+ + + P+ +
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 605 P 605
Sbjct: 261 A 261
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 9e-31
Identities = 48/214 (22%), Positives = 91/214 (42%), Gaps = 15/214 (7%)
Query: 381 QLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
Q + IG G+ +V +VA+K + K +E+ ++K + H N++
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 439 LFMGAVASQ------ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYL 492
+ Q + + +V E + + D +R + + G+ +L
Sbjct: 80 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHL 135
Query: 493 HHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRS 552
H +HRDLK SN++V + T+K+ DFGL+ +++ T + APEV+
Sbjct: 136 HSAGI--IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILG 192
Query: 553 EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586
E D++S G I+ E+V I + + +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 116 bits (291), Expect = 2e-29
Identities = 47/214 (21%), Positives = 92/214 (42%), Gaps = 22/214 (10%)
Query: 375 IRW---EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDII 429
+ W +D QL ++G G Y+ V+ I N V VK+ + K ++EI I+
Sbjct: 29 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKIL 83
Query: 430 KKLR-HPNVLLFMGAVASQ--ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVA 486
+ LR PN++ V +V E + + YQ L ++
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF----KQLYQTLTDYDIRFYMYEIL 139
Query: 487 RGMNYLHHRNPPIVHRDLKSSNLLVD-KNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWM 545
+ ++Y H I+HRD+K N+++D ++ +++ D+GL+ + + +
Sbjct: 140 KALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFK 196
Query: 546 APEVLRSEPS-NEKSDVFSFGVILWELVTASIPW 578
PE+L + D++S G +L ++ P+
Sbjct: 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 13/217 (5%)
Query: 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHP 435
E Q +G G+Y V G VAVK K +E+ ++K ++H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 436 NVLLFMGAVASQERLGIVTEFL----PRGSLFKTLHKNYQALDIKRRLRMALDVARGMNY 491
NV+ + L + G+ + K Q L + + RG+ Y
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 136
Query: 492 LHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEV-L 550
+H + I+HRDLK SNL V+++ +K+ DFGL+ + T + APE+ L
Sbjct: 137 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIML 191
Query: 551 RSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587
N+ D++S G I+ EL+T + + + +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (265), Expect = 1e-25
Identities = 40/218 (18%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 381 QLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVL 438
L ++G G ++ V+ N + VA+K+ G + + + EI +++++ +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT---EAAEDEIKLLQRVNDADNT 72
Query: 439 L---------------FMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMAL 483
F + + +V E L L ++ + + +++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 484 DVARGMNYLHHRNPPIVHRDLKSSNLLVDKN-WTVKVGDFGLSSLKNATYL--TAKSGRG 540
+ G++Y+H R I+H D+K N+L++ + ++ L NA + +
Sbjct: 133 QLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 541 TPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPW 578
T ++ +PEVL P +D++S +++EL+T +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.7 bits (193), Expect = 2e-17
Identities = 29/192 (15%), Positives = 60/192 (31%), Gaps = 45/192 (23%)
Query: 382 LGEEIGLGSYAVVYRGI-WNGSDVAVKVYFGS----------------EYIEGTLKNYQK 424
+G+ +G G + V+ + VK + + +++ +
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 425 EIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALD 484
E ++KL+ V E ++ E + K + ++ +
Sbjct: 64 EFRALQKLQGLAVPKVYAW----EGNAVLMELID--------AKELYRVRVENPDEVLDM 111
Query: 485 VARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAKSGRGTPQW 544
+ + +HR IVH DL N+LV + + DF S +
Sbjct: 112 ILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWIIDFPQS-------------VEVGEE 155
Query: 545 MAPEVLRSEPSN 556
E+L + N
Sbjct: 156 GWREILERDVRN 167
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 109 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 55.2 bits (132), Expect = 4e-10
Identities = 21/105 (20%), Positives = 44/105 (41%), Gaps = 3/105 (2%)
Query: 66 MGHAVHVCTASSED--IIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERL 123
+ H V A+ D ++Y + ++ G+ EV G +KI + +
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 124 ASGQSWSGQFPFKKRSGEILMAVVTKSPLY-EDGELAGFITVSSD 167
G++ S + ++ G ++T +P+ DG ++ F+ V D
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVD 106
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Score = 53.0 bits (126), Expect = 2e-09
Identities = 15/99 (15%), Positives = 31/99 (31%), Gaps = 3/99 (3%)
Query: 72 VCTASSED--IIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSW 129
+ D II+ + L + EV G + I + + +
Sbjct: 5 ITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDV 64
Query: 130 SGQFPFKKRSGEILMAVVTKSPLY-EDGELAGFITVSSD 167
+ Q + G + + E+G++ FI V +
Sbjct: 65 TVQVLNYTKGGRAFWNLFHLQVMRDENGDVQYFIGVQQE 103
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 2e-05
Identities = 18/112 (16%), Positives = 38/112 (33%), Gaps = 7/112 (6%)
Query: 61 SVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIM 120
++ A+ A + +I+ N A L G+ +++ GQ++T + +
Sbjct: 2 AMDPEFNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLT-QFFLRSDSDVVEALS 60
Query: 121 ERLASGQS-----WSGQFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSD 167
E + RSGE + V + ++ L + V
Sbjct: 61 EEHMEADGHAAVVFGTVVDIISRSGEKIPVSVWMKRMRQERRLC-CVVVLEP 111
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.0 bits (84), Expect = 0.001
Identities = 16/101 (15%), Positives = 28/101 (27%), Gaps = 5/101 (4%)
Query: 72 VCTASSED--IIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSW 129
+ A E+ +IY N L G+ EV + T + A +
Sbjct: 6 IANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAE 65
Query: 130 SGQFPFKKRSGEILMAVVTKSPLY---EDGELAGFITVSSD 167
+ + + + EDG + FI
Sbjct: 66 ERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEV 106
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 605 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1n9la_ | 109 | Putative blue light receptor, phot-lov1 domain {Gr | 99.78 | |
| d1ew0a_ | 130 | Histidine kinase FixL heme domain {Rhizobium melil | 99.7 | |
| d1jnua_ | 104 | Photoreceptor phy3 flavin-binding domain, lov2 {Ma | 99.69 | |
| d1bywa_ | 110 | Erg potassium channel, N-terminal domain {Human (H | 99.66 | |
| d1v9ya_ | 113 | Direct oxygen sensor protein, DOS {Escherichia col | 99.58 | |
| d1xj3a1 | 106 | Histidine kinase FixL heme domain {Bradyrhizobium | 99.52 | |
| d1p97a_ | 114 | Hypoxia-inducible factor Hif2a, C-terminal domain | 99.51 | |
| d1mzua_ | 110 | PYP domain of sensor histidine kinase Ppr {Rhodosp | 99.48 | |
| d1nwza_ | 125 | Photoactive yellow protein, PYP {Ectothiorhodospir | 99.42 | |
| d1ll8a_ | 114 | N-terminal PAS domain of Pas kinase {Human (Homo s | 99.24 | |
| d1oj5a_ | 109 | PAS domain of steroid receptor coactivator 1A, NCo | 98.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.52 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.91 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.8 | |
| d2oola2 | 114 | Sensor protein PhyB2 {Rhodopseudomonas palustris [ | 97.43 | |
| d1ny5a2 | 247 | Transcriptional activator sigm54 (NtrC1), C-termin | 97.06 | |
| d1ptqa_ | 50 | Protein kinase C-delta (PKCdelta) {Mouse (Mus musc | 96.58 | |
| d1tbna_ | 66 | Protein kinase c-gamma {Rat (Rattus rattus) [TaxId | 96.42 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.38 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.26 | |
| d1xa6a3 | 62 | Beta-chimaerin, middle domain {Human (Homo sapiens | 96.22 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.04 | |
| d2o9ca2 | 127 | Bacteriophytochrome BphP {Deinococcus radiodurans | 95.67 | |
| d2veaa3 | 127 | Phytochrome-like protein Cph1 {Synechocystis sp. p | 95.3 | |
| d1p0za_ | 131 | Sensor kinase CitA {Klebsiella pneumoniae [TaxId: | 95.29 | |
| d3c2wa3 | 113 | Bacteriophytochrome BphP {Pseudomonas aeruginosa [ | 92.08 | |
| d1r79a_ | 84 | Diacylglycerol kinase delta {Human (Homo sapiens) | 91.76 | |
| d1faqa_ | 52 | RAF-1 {Human (Homo sapiens) [TaxId: 9606]} | 90.99 | |
| d1kbea_ | 49 | Kinase suppressor of Ras, Ksr {Mouse (Mus musculus | 89.33 | |
| d3by8a1 | 133 | Fumarate sensor DcuS {Escherichia coli [TaxId: 562 | 86.92 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=389.17 Aligned_cols=224 Identities=25% Similarity=0.493 Sum_probs=200.8
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
+..++|++++.||+|+||+||+|+++ ++.||+|++.+.... ....+.+.+|+.+++.++|||||++++++.+++.++
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 34689999999999999999999984 667999998765433 234567889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+|||||++|+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 83 ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999999999875 67999999999999999999999999 999999999999999999999999999765433
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.....+||+.|||||++.+..++.++|||||||+||+|++|+.||.+.+..+++.+| ...++.+|+.+|+
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~ 229 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTE 229 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HTTCCCCCTTSCH
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH--HcCCCCCCccCCH
Confidence 234567999999999999999999999999999999999999999999999999998 4566888988764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-49 Score=399.73 Aligned_cols=226 Identities=26% Similarity=0.452 Sum_probs=205.9
Q ss_pred ccccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
+..++|+++++||+|+||+||+|++ +++.||||++.+.... ....+.+.+|+.+|+.++||||++++++|.+++.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 5678999999999999999999997 4778999999876432 345677889999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+|||||+||+|..++.+. +.+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 82 iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred cceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999999998876 78899999999999999999999999 999999999999999999999999999876655
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..++...| ....+++|+.+||
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i--~~~~~~~p~~~s~ 230 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSP 230 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCCCCCCTTSCH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH--hcCCCCCCccCCH
Confidence 55566778999999999999999999999999999999999999999999999999998 4566899998875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-49 Score=392.00 Aligned_cols=226 Identities=25% Similarity=0.431 Sum_probs=199.2
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeecccc-chhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEY-IEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
...++|+++++||+|+||+||+|.+. ++.||||++.+... .....+.+.+|+.+|++++||||++++++|.+++.+|
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence 34578999999999999999999984 77899999976543 2345677899999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+|||||+||+|.+++... +.+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 85 ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999999988765 78999999999999999999999999 999999999999999999999999999875432
Q ss_pred --cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 532 --YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 532 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++..+| ...++++|+.+|+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~ 235 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFP 235 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HTTCCCCCTTCCH
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH--HcCCCCCCccCCH
Confidence 22334567999999999999999999999999999999999999999999999999999 4566889988874
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=387.39 Aligned_cols=221 Identities=25% Similarity=0.443 Sum_probs=195.2
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
++|+++++||+|+||+||+|.+. |+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+++.+|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 57999999999999999999874 78899999876542 234678999999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
||+||+|.+++.+ ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+|+.........
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence 9999999988765 56999999999999999999999999 9999999999999999999999999998765555555
Q ss_pred cCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccC-CCccCCCCCCC
Q 038211 536 KSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFM-DRRLELPEGLD 604 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~-~~~~~~P~~~~ 604 (605)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+... ...+++|+.+|
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s 243 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSC
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCC
Confidence 6678999999999999999999999999999999999999999998887777766432 23456666665
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=384.79 Aligned_cols=228 Identities=29% Similarity=0.433 Sum_probs=187.7
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee--CCeeEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS--QERLGI 452 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~l 452 (605)
.++|++++.||+|+||+||+|+++ |+.||||++......+...+.+.+|+.+|++++|||||++++++.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 478999999999999999999884 7789999998876666677889999999999999999999999864 456899
Q ss_pred EEEecCCCchHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---CCceeccCCCCCEEEcCCCcEEEEeecCCc
Q 038211 453 VTEFLPRGSLFKTLHKN---YQALDIKRRLRMALDVARGMNYLHHRN---PPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~ 526 (605)
|||||++|+|.+++.+. ...+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998653 467999999999999999999999854 139999999999999999999999999998
Q ss_pred ccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 527 LKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 527 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
............+||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..++..+|.. +...++|..+|+
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~ 240 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSD 240 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCH
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCH
Confidence 765554455567899999999999999999999999999999999999999999999999999853 333467877763
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-48 Score=385.08 Aligned_cols=223 Identities=30% Similarity=0.459 Sum_probs=194.9
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
+.|+++++||+|+||+||+|++. +..||||++.... ....+.+.+|+.+|+.++|||||+++++|.+++.+++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 46899999999999999999984 6679999987642 3456788999999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
||++|+|.+++.+....+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+|+.........
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 99999999998877678999999999999999999999999 9999999999999999999999999997665444445
Q ss_pred cCCCCCCccccccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCC-ccCCCCCCC
Q 038211 536 KSGRGTPQWMAPEVLR-----SEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDR-RLELPEGLD 604 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~-~~~~P~~~~ 604 (605)
...+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+..+++.+|..... .+..|+.+|
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s 242 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSC
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCC
Confidence 5678999999999984 45578999999999999999999999999999888888854321 234455554
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-47 Score=386.11 Aligned_cols=222 Identities=26% Similarity=0.462 Sum_probs=199.3
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
.+++|+++++||+|+||+||+|+++ |+.||||++.+.... ....+.+.+|+.+|+.++|||||+++++|.+++.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 3578999999999999999999974 778999998765432 3456778999999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
|||||+||+|..++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 82 vmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp EECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EeeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 99999999998888765 67889999999999999999999999 999999999999999999999999999876433
Q ss_pred ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
....+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+++.+| ....+++|+.+|+
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~ 226 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNE 226 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HHCCCCCCTTSCH
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH--HcCCCCCCCCCCH
Confidence 34568999999999999999999999999999999999999999999999999998 4456788888764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=378.42 Aligned_cols=202 Identities=30% Similarity=0.439 Sum_probs=176.9
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.++|+++++||+|+||+||+|.+. ++.||||++.+... ....+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 478999999999999999999984 77899999876543 234567899999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc--
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY-- 532 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~-- 532 (605)
|||+||+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+......
T Consensus 83 Ey~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred eccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999999998654 68999999999999999999999999 9999999999999999999999999998654322
Q ss_pred ccccCCCCCCcccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
......+||+.|||||++.+..+ +.++|||||||++|||++|++||...+
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 23445689999999999998876 578999999999999999999997654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=378.15 Aligned_cols=215 Identities=38% Similarity=0.700 Sum_probs=184.0
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
++++..++|+++++||+|+||+||+|++++ .||||++..........+.+.+|+.+|++++|||||++++++. .+.++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~ 79 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 79 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence 456778899999999999999999998765 5999999877666667788999999999999999999999865 45789
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
+|||||++|+|.+++......+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999999999877778999999999999999999999999 999999999999999999999999999765432
Q ss_pred c--ccccCCCCCCcccccccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHh
Q 038211 532 Y--LTAKSGRGTPQWMAPEVLRSE---PSNEKSDVFSFGVILWELVTASIPWNNLNLMQ-VVGVV 590 (605)
Q Consensus 532 ~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~-~~~~I 590 (605)
. .......||+.|||||++.+. .++.++|||||||+||||++|+.||.+.+... +...+
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~ 222 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 2 233456799999999999753 47899999999999999999999999876544 44444
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=369.35 Aligned_cols=222 Identities=31% Similarity=0.530 Sum_probs=188.6
Q ss_pred CceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee----CCeeEE
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS----QERLGI 452 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----~~~~~l 452 (605)
.|++.++||+|+||+||+|.+. +..||+|++..........+.+.+|+++|++++|||||+++++|.+ +..+++
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 3578889999999999999985 5679999988776666667789999999999999999999999875 346899
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc-CCCcEEEEeecCCcccCcc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD-KNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~-~~~~vkl~Dfg~a~~~~~~ 531 (605)
|||||++|+|.+++.+. ..+++..++.++.||+.||+|||+++++|+||||||+|||++ +++.+||+|||+|+.....
T Consensus 90 vmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 99999999999999775 689999999999999999999999887799999999999996 5789999999999865433
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHhccCCCccCCCCCCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL-NLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~-~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.....+||+.|||||++.+ .++.++|||||||++|||++|+.||.+. +..++...|........+|..++
T Consensus 169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (270)
T d1t4ha_ 169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239 (270)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCC
Confidence 2345689999999999876 5999999999999999999999999865 45667777754333445555544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=379.92 Aligned_cols=224 Identities=25% Similarity=0.424 Sum_probs=199.5
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccc-hhhhhhHHHHHHHHH-hCCCCCeeeEEEEEeeCCeeEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYI-EGTLKNYQKEIDIIK-KLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~-~~~~~~~~~E~~il~-~l~h~niv~~~~~~~~~~~~~l 452 (605)
.++|+++++||+|+||+||+|.+ +++.||||++.+.... ....+.+..|..++. .++|||||+++++|.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 36899999999999999999998 4777999999765432 334556667777665 6899999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
|||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+|++||+|||+++......
T Consensus 81 vmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhccccc
Confidence 99999999999999765 77899999999999999999999999 9999999999999999999999999998766555
Q ss_pred ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++..+|. ...+.+|+.+|+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~ 228 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--MDNPFYPRWLEK 228 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCccCCH
Confidence 55666789999999999999999999999999999999999999999999999999994 456889988774
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-46 Score=384.74 Aligned_cols=222 Identities=21% Similarity=0.373 Sum_probs=200.3
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
..++|+++++||+|+||+||+|+++ |+.||||++.+.... ....+.+.+|+.+|+.++|||||+++++|.+...+++
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 4579999999999999999999984 778999998765432 3456778999999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~ 532 (605)
||||+.||+|..++.+. +.+++..++.++.||+.||.|||++| ||||||||+|||++.+|++||+|||+|+.....
T Consensus 119 v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 99999999999998776 67999999999999999999999999 999999999999999999999999999876433
Q ss_pred ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
....+||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+++.+| ....+.+|+.+||
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~ 263 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVRFPSHFSS 263 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCCCCCCTTCCH
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH--hcCCCCCCccCCH
Confidence 23567999999999999999999999999999999999999999999999999999 4556788888764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-46 Score=377.79 Aligned_cols=216 Identities=25% Similarity=0.410 Sum_probs=175.0
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.+.|++.++||+|+||+||+|+++ ++.||||++.+..... ....+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 366999999999999999999984 6779999987654332 3456789999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc---CCCcEEEEeecCCcccCcc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD---KNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~---~~~~vkl~Dfg~a~~~~~~ 531 (605)
|||+||+|.+++... +.+++..+..++.||+.||+|||++| |+||||||+|||+. .++.+||+|||+|+.....
T Consensus 87 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred eccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 999999999999764 78999999999999999999999999 99999999999994 5789999999999865433
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCcc
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRL 597 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~ 597 (605)
. ...+.+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..++...|......+
T Consensus 164 ~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~ 228 (307)
T d1a06a_ 164 S-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 228 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC
T ss_pred C-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC
Confidence 2 3345689999999999999999999999999999999999999999999999999986554433
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-46 Score=374.62 Aligned_cols=227 Identities=31% Similarity=0.515 Sum_probs=188.2
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC--Cc---ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN--GS---DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~---~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
++..++|++.++||+|+||+||+|.++ ++ .||||.+.... .....+.+.+|+.+|++++|||||++++++..++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 456688999999999999999999874 22 36777665432 3445677999999999999999999999999999
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
.+++|||||++|+|.+++....+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999999999999887778999999999999999999999999 999999999999999999999999999865
Q ss_pred Ccccc-----cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCC
Q 038211 529 NATYL-----TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEG 602 (605)
Q Consensus 529 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~ 602 (605)
..... ......||+.|||||.+.+..++.++|||||||+||||++ |+.||.+.+..+++..|. .+.+++.|..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~ 257 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMD 257 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcc
Confidence 43221 1122457999999999999999999999999999999998 899999999999999985 5677888887
Q ss_pred CC
Q 038211 603 LD 604 (605)
Q Consensus 603 ~~ 604 (605)
++
T Consensus 258 ~~ 259 (299)
T d1jpaa_ 258 CP 259 (299)
T ss_dssp CC
T ss_pred ch
Confidence 75
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-46 Score=374.45 Aligned_cols=220 Identities=29% Similarity=0.374 Sum_probs=189.8
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
+.|+.+++||+|+||+||+|++. ++.||||++...... ....+.+.+|+.+|+.++|||||+++++|.+++.+++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35999999999999999999874 667999998776543 345577899999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
|||.+|+|..++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 99999988665544 378999999999999999999999999 99999999999999999999999999976543
Q ss_pred ccCCCCCCcccccccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 535 AKSGRGTPQWMAPEVLRS---EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..|.........|..+|
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 240 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSC
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCC
Confidence 235679999999999975 3478999999999999999999999999999888888854443334444454
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-46 Score=372.78 Aligned_cols=228 Identities=34% Similarity=0.594 Sum_probs=197.6
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
.+++..++|++.++||+|+||+||+|.+. ++.||||++..+. ...+.+.+|+.+|++++|||||+++++|.+++.
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 45677889999999999999999999984 6679999986543 234678999999999999999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 450 LGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
+++|||||++|+|.+++... ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+..
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceeec
Confidence 99999999999999998764 467899999999999999999999999 999999999999999999999999999876
Q ss_pred Ccccc-cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCC-CCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 529 NATYL-TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASI-PWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 529 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~-Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
..... ......||+.|+|||++.+..++.++|||||||++|||++|.. ||.+.+..++...|. .+.++++|+.+|+
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 243 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 243 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCH
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh-cCCCCCCCccchH
Confidence 54332 2333458999999999999999999999999999999999555 566777777777774 5678889988763
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=367.20 Aligned_cols=223 Identities=30% Similarity=0.524 Sum_probs=188.1
Q ss_pred cccCceEeeeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
..++|+++++||+|+||+||+|.+. ++.||||++..... ..+.+.+|+.++++++|||||++++++..++.+++||
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 4568999999999999999999985 56699999876433 2356899999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc-
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL- 533 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~- 533 (605)
|||++|+|.+++......+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999999999887788999999999999999999999999 99999999999999999999999999986543322
Q ss_pred cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+++..|. .+.++.+|..++
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~ 228 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLAS 228 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-HTCCCCCCTTSC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-hcCCCCCccccC
Confidence 2334568999999999999999999999999999999999 688888899999999985 456778887765
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-46 Score=370.01 Aligned_cols=225 Identities=28% Similarity=0.519 Sum_probs=195.7
Q ss_pred cccCceEeee-ecccCcEEEEEEEEC----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCee
Q 038211 376 RWEDLQLGEE-IGLGSYAVVYRGIWN----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERL 450 (605)
Q Consensus 376 ~~~~~~~~~~-LG~G~fg~V~~~~~~----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 450 (605)
..++|.+.+. ||+|+||+||+|.+. +..||||++.... .....+.+.+|+++|++++|||||++++++.+ +.+
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 3467888884 999999999999763 3359999986543 34456789999999999999999999999865 468
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
++|||||++|+|.+++......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 9999999999999998776678999999999999999999999999 99999999999999999999999999986543
Q ss_pred cc---ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 531 TY---LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 531 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.. .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+++..|. .+.++++|+.+|+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~ 239 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPP 239 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTCCH
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCH
Confidence 22 22334568999999999999999999999999999999998 999999999999999985 5678899998874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.5e-46 Score=380.15 Aligned_cols=214 Identities=24% Similarity=0.396 Sum_probs=191.5
Q ss_pred cccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..++|+++++||+|+||+||+|.+ +|+.||||++.+... ...+.+.+|+.+|++++|||||+++++|.+++.+|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 347899999999999999999997 477899999876542 2345788999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc--CCCcEEEEeecCCcccCcc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD--KNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~--~~~~vkl~Dfg~a~~~~~~ 531 (605)
||||+||+|.+.+......+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|+.....
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999999999988777678999999999999999999999999 99999999999997 5789999999999876543
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMD 594 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~ 594 (605)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..|....
T Consensus 183 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 244 (352)
T d1koba_ 183 E-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD 244 (352)
T ss_dssp S-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC
T ss_pred C-ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 2 2344578999999999999999999999999999999999999999999999999985444
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=380.47 Aligned_cols=204 Identities=27% Similarity=0.403 Sum_probs=181.0
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGI 452 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 452 (605)
+.-++|+++++||+|+||+||+|++. ++.||+|++.... .....+.+.+|+.+|+.++|||||+++++|.+++++++
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45578999999999999999999984 6779999987643 33445678999999999999999999999999999999
Q ss_pred EEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 453 VTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH-RNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 453 v~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
|||||+||+|.+++.+. +.+++..++.++.||+.||+|||+ +| |+||||||+|||++.+|++||+|||+|+.....
T Consensus 82 VmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 99999999999999876 679999999999999999999997 59 999999999999999999999999999865322
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHH
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLM 584 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~ 584 (605)
...+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 234568999999999999999999999999999999999999999876543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-45 Score=378.97 Aligned_cols=214 Identities=26% Similarity=0.443 Sum_probs=191.7
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIV 453 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv 453 (605)
..++|+++++||+|+||+||+|++. |+.||||++.+.. ....+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3579999999999999999999984 7789999987653 23456788999999999999999999999999999999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEc--CCCcEEEEeecCCcccCcc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVD--KNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~--~~~~vkl~Dfg~a~~~~~~ 531 (605)
||||+||+|.+++.+..+.+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|+.....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999999999776678999999999999999999999999 99999999999995 4689999999999865433
Q ss_pred cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCC
Q 038211 532 YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMD 594 (605)
Q Consensus 532 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~ 594 (605)
. ......||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+++..|....
T Consensus 180 ~-~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 241 (350)
T d1koaa2 180 Q-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 241 (350)
T ss_dssp S-CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred c-ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 2 3345679999999999999999999999999999999999999999999999999985444
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-46 Score=378.20 Aligned_cols=230 Identities=27% Similarity=0.405 Sum_probs=194.1
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECCc-------ceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNGS-------DVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAV 444 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~-------~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~ 444 (605)
+++..++|+++++||+|+||+||+|++.+. .||+|++.... .......+.+|+.+|+++ +|||||++++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 456678999999999999999999987432 37888775543 234456788999999998 899999999999
Q ss_pred eeCCeeEEEEEecCCCchHHHHHhhc----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceec
Q 038211 445 ASQERLGIVTEFLPRGSLFKTLHKNY----------------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHR 502 (605)
Q Consensus 445 ~~~~~~~lv~e~~~ggsL~~~l~~~~----------------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~ 502 (605)
.+.+.+++|||||++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHR 188 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHR 188 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence 99999999999999999999997643 34889999999999999999999999 9999
Q ss_pred cCCCCCEEEcCCCcEEEEeecCCcccCcccc--cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 038211 503 DLKSSNLLVDKNWTVKVGDFGLSSLKNATYL--TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWN 579 (605)
Q Consensus 503 Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~ 579 (605)
||||+|||++.++++||+|||+|+....... ......||+.|||||++.+..++.++|||||||++|||++ |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999976543322 2234568999999999999999999999999999999997 999999
Q ss_pred CCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 580 NLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 580 ~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
+.+..+.+.++...+.++++|+.+|+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~p~~~~~ 294 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKMDQPFYATE 294 (325)
T ss_dssp TCCCSHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCCHHHHHHHHHhcCCCCCCCCcCCH
Confidence 98777766666667788899988763
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=360.43 Aligned_cols=223 Identities=28% Similarity=0.498 Sum_probs=199.4
Q ss_pred cccCceEeeeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
..++|+++++||+|+||+||+|+++ ++.||||++.+.... .+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 3468999999999999999999985 457999998875443 356899999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc-
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL- 533 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~- 533 (605)
||+++|+|..++......+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 999999999998887788999999999999999999999999 99999999999999999999999999976543322
Q ss_pred cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 534 TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 534 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++..+|. .+.++++|..++
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~ 227 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLAS 227 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCccccc
Confidence 3334678999999999999999999999999999999998 899999999999999995 566788888765
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=368.47 Aligned_cols=213 Identities=26% Similarity=0.431 Sum_probs=190.4
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccch----hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE----GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLG 451 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~----~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 451 (605)
++|+++++||+|+||+||+|+++ |+.||||++.+..... ...+.+.+|+.+|++++|||||+++++|.+++.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57999999999999999999984 7789999997754332 23567899999999999999999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC----cEEEEeecCCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW----TVKVGDFGLSSL 527 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~----~vkl~Dfg~a~~ 527 (605)
||||||+||+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|..
T Consensus 90 iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhhh
Confidence 999999999999999775 68999999999999999999999999 99999999999998776 599999999987
Q ss_pred cCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCC
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMD 594 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~ 594 (605)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+++..|....
T Consensus 167 ~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 232 (293)
T d1jksa_ 167 IDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 232 (293)
T ss_dssp CTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred cCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Confidence 65433 3345678999999999999999999999999999999999999999999999999985443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=363.03 Aligned_cols=228 Identities=31% Similarity=0.523 Sum_probs=197.3
Q ss_pred CCCCccccCceEeeeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 371 TDGGIRWEDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 371 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
.++++..++|+++++||+|+||+||+|.++ ++.||||++..... ..+.+.+|+.+|++++|||||++++++. ++.
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~ 81 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEP 81 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeec-cCC
Confidence 456778899999999999999999999986 46799999865432 3456899999999999999999999875 456
Q ss_pred eEEEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 450 LGIVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
+++|||||++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEc
Confidence 899999999999998876543 46999999999999999999999999 999999999999999999999999999876
Q ss_pred Cccc-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 529 NATY-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 529 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+++..|. .+.++.+|+.+++
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~ 237 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPE 237 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCH
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChH
Confidence 5432 23345578999999999998889999999999999999999 567778888899999985 5678888888763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=365.21 Aligned_cols=217 Identities=29% Similarity=0.491 Sum_probs=185.4
Q ss_pred eeecccCcEEEEEEEEC----CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEecCC
Q 038211 384 EEIGLGSYAVVYRGIWN----GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEFLPR 459 (605)
Q Consensus 384 ~~LG~G~fg~V~~~~~~----~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~~~g 459 (605)
++||+|+||+||+|.+. ++.||||++..........+.+.+|+.+|++++|||||++++++.+ +.++||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999863 2459999987665555566789999999999999999999999865 457899999999
Q ss_pred CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccc---cccc
Q 038211 460 GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATY---LTAK 536 (605)
Q Consensus 460 gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~---~~~~ 536 (605)
|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...... ....
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 9999998765 67999999999999999999999999 9999999999999999999999999997654322 2233
Q ss_pred CCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 537 SGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 537 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
...||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...|. .+.++++|+.+|+
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~ 237 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPR 237 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCH
Confidence 4568999999999999999999999999999999997 999999999999999985 5678899988763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-44 Score=373.49 Aligned_cols=223 Identities=22% Similarity=0.363 Sum_probs=188.2
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchh-hhhhHH---HHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEG-TLKNYQ---KEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~-~~~~~~---~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
..++|+++++||+|+||+||+|++. |+.||||++.+...... ....+. +|+.+++.++|||||+++++|.+++.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 4679999999999999999999984 77899999876543221 222233 44677777789999999999999999
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+|+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+|+...
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999999999776 77899999999999999999999999 9999999999999999999999999998654
Q ss_pred cccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHhccCCCccCCCCCCCC
Q 038211 530 ATYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLN---LMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 530 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~---~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.. .....+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.+.+ ..++...+ ....+.+|+.+||
T Consensus 159 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~s~ 234 (364)
T d1omwa3 159 KK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSP 234 (364)
T ss_dssp SS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS--SSCCCCCCSSSCH
T ss_pred CC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCCCCH
Confidence 33 3345679999999999964 568999999999999999999999998654 34455554 5666788888774
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=362.14 Aligned_cols=228 Identities=29% Similarity=0.515 Sum_probs=187.5
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECC-----cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNG-----SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~-----~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
+++..++|+++++||+|+||+||+|.+.. ..||||.+.... .....+.+.+|+.+|++++|||||++++++. +
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 45677899999999999999999998742 236677654322 3445677899999999999999999999985 5
Q ss_pred CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
+.+++|||||++|+|.+++......+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+|+.
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhhee
Confidence 6789999999999999998877788999999999999999999999999 99999999999999999999999999986
Q ss_pred cCccc-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 528 KNATY-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 528 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+++.+|. .+.++++|+.+|+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 236 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 236 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 54322 23344568999999999999999999999999999999998 999999999999999985 5677889998874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=359.70 Aligned_cols=227 Identities=30% Similarity=0.487 Sum_probs=190.6
Q ss_pred CccccCceEeeeecccCcEEEEEEEECC------cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWNG------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ 447 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 447 (605)
++..++|++.++||+|+||.||+|.+++ ..||||++.... .+.....+.+|+.+|++++|||||++++++.+.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 4566789999999999999999998743 248999886543 334456789999999999999999999999999
Q ss_pred CeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
+.+++|||||.+++|.+++......+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999999999988887788999999999999999999999999 99999999999999999999999999986
Q ss_pred cCccc---ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCC
Q 038211 528 KNATY---LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 528 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+++..|. .+.++++|..+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~ 238 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDC 238 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-ccCCCCCchhh
Confidence 53322 22334568999999999999999999999999999999998 566677788888888885 56778888876
Q ss_pred C
Q 038211 604 D 604 (605)
Q Consensus 604 ~ 604 (605)
+
T Consensus 239 ~ 239 (283)
T d1mqba_ 239 P 239 (283)
T ss_dssp B
T ss_pred H
Confidence 5
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.2e-44 Score=355.52 Aligned_cols=217 Identities=27% Similarity=0.424 Sum_probs=190.3
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccch-------hhhhhHHHHHHHHHhCC-CCCeeeEEEEEee
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE-------GTLKNYQKEIDIIKKLR-HPNVLLFMGAVAS 446 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~-------~~~~~~~~E~~il~~l~-h~niv~~~~~~~~ 446 (605)
.++|++.+.||+|+||+||+|++ +++.||||++.+..... ...+.+.+|+.++++++ ||||++++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999998 57889999987754321 23456889999999996 9999999999999
Q ss_pred CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCc
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~ 526 (605)
++.+|||||||++|+|.+++..+ +.+++..++.|+.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999999775 68999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCcccccccCCCCCCcccccccccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCcc
Q 038211 527 LKNATYLTAKSGRGTPQWMAPEVLRS------EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRL 597 (605)
Q Consensus 527 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~ 597 (605)
...... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+..++...|.....++
T Consensus 159 ~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 159 QLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234 (277)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred EccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 765433 3345679999999999864 345789999999999999999999999999999998885444333
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=367.47 Aligned_cols=216 Identities=21% Similarity=0.340 Sum_probs=190.7
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.++|+++++||+|+||+||+|.++ ++.||||++.+... ....+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 578999999999999999999984 67799999876532 3355789999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC--CCcEEEEeecCCcccCccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK--NWTVKVGDFGLSSLKNATY 532 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~--~~~vkl~Dfg~a~~~~~~~ 532 (605)
|||+||+|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++. .+.+||+|||+++......
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 999999999999877668999999999999999999999999 999999999999985 4589999999998654332
Q ss_pred ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCC
Q 038211 533 LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELP 600 (605)
Q Consensus 533 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P 600 (605)
......+|+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+++.+|.. .++.+|
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~ 223 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN--AEYTFD 223 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCCC
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCC
Confidence 23345689999999999999999999999999999999999999999999999999843 344444
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=355.58 Aligned_cols=223 Identities=35% Similarity=0.609 Sum_probs=191.0
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee-CCeeE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS-QERLG 451 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~ 451 (605)
+.+..++|+++++||+|+||.||+|.++|+.||||+++++. ..+.+.+|+.++++++||||+++++++.+ .+.++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 46778999999999999999999999999999999986543 34678899999999999999999998854 46789
Q ss_pred EEEEecCCCchHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 452 IVTEFLPRGSLFKTLHKNY-QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999999997642 46899999999999999999999999 99999999999999999999999999986543
Q ss_pred ccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
. .....+|+.|+|||++.+..++.++|||||||++|||++ |++||...+..+++..|. .+.++++|+.++|
T Consensus 156 ~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 227 (262)
T d1byga_ 156 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPP 227 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCH
T ss_pred C---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCH
Confidence 2 234567999999999999999999999999999999998 899999999999999995 5788899998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.3e-44 Score=356.72 Aligned_cols=215 Identities=26% Similarity=0.381 Sum_probs=181.4
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC----e
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE----R 449 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~----~ 449 (605)
.++|++.+.||+|+||+||+|.+. ++.||||++.+.... ....+.+.+|+.+|+.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367999999999999999999974 778999999775443 345667899999999999999999999997653 4
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
+|+|||||+|++|..++... +.+++..++.++.||+.||+|||++| |+||||||+|||++.++.++++|||.+....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhhhc
Confidence 89999999999999888765 68999999999999999999999999 9999999999999999999999999986543
Q ss_pred ccc---ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCC
Q 038211 530 ATY---LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMD 594 (605)
Q Consensus 530 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~ 594 (605)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+++.++...+
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~ 230 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED 230 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcC
Confidence 222 23345679999999999999999999999999999999999999999999888887774333
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=357.55 Aligned_cols=228 Identities=34% Similarity=0.549 Sum_probs=189.5
Q ss_pred ccccCceEeeeecccCcEEEEEEEECC-----cceEEEEeeccccc-hhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWNG-----SDVAVKVYFGSEYI-EGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE 448 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~~-----~~~avKv~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 448 (605)
+..++|++++.||+|+||.||+|.+.+ ..||||++.+.... ....+.+.+|+.+|++++|||||++++++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 445789999999999999999998632 24899988765432 3456789999999999999999999999975 4
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
.+++|||||++|+|.+++......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhhc
Confidence 688999999999999998887778999999999999999999999999 999999999999999999999999999865
Q ss_pred Cccc---ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 529 NATY---LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 529 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+++..|...+.++++|+.+|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccccc
Confidence 4332 12233457889999999999999999999999999999998 8999999999999999988888899998876
Q ss_pred C
Q 038211 605 P 605 (605)
Q Consensus 605 ~ 605 (605)
+
T Consensus 242 ~ 242 (273)
T d1u46a_ 242 Q 242 (273)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-44 Score=354.75 Aligned_cols=228 Identities=32% Similarity=0.526 Sum_probs=190.7
Q ss_pred CCCCccccCceEeeeecccCcEEEEEEEECC-cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 371 TDGGIRWEDLQLGEEIGLGSYAVVYRGIWNG-SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 371 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~-~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
..+++..++|++.+.||+|+||+||+|.+++ +.||||++..... ..+.+.+|+.++++++|||||++++++.+ +.
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~ 85 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 85 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec-CC
Confidence 3567778999999999999999999999854 4699999865543 24678999999999999999999999854 56
Q ss_pred eEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 450 LGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
+++|||||++|+|..++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+..
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhc
Confidence 89999999999999888654 367999999999999999999999999 999999999999999999999999999865
Q ss_pred Cccc-ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 529 NATY-LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 529 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.... .......||+.|+|||.+.+..++.++|||||||++|||++ |++||.+.+..+++..|. .+.++++|+.+|+
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 241 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPE 241 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCH
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCcccCH
Confidence 4332 23334568999999999999999999999999999999999 566677888888998885 5667888888763
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=359.48 Aligned_cols=212 Identities=26% Similarity=0.377 Sum_probs=183.3
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.++|+++++||+|+||+||+|.+. ++.||||++......+...+.+.+|+++|++++|||||+++++|.+++.+++||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 368999999999999999999984 778999999766554555678899999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
||+.++.+..........+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+........
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 999655444444445577999999999999999999999999 999999999999999999999999999877666666
Q ss_pred ccCCCCCCcccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 535 AKSGRGTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.....||+.|+|||++....+ +.++|||||||++|+|++|+.||.+.+..+.+.++
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i 215 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHH
Confidence 667789999999999877664 78999999999999999999999998887777665
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-44 Score=361.61 Aligned_cols=225 Identities=28% Similarity=0.524 Sum_probs=188.9
Q ss_pred cccCceEeeeecccCcEEEEEEEEC--Cc----ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 038211 376 RWEDLQLGEEIGLGSYAVVYRGIWN--GS----DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQER 449 (605)
Q Consensus 376 ~~~~~~~~~~LG~G~fg~V~~~~~~--~~----~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 449 (605)
...+|+++++||+|+||+||+|.+. ++ .||+|.+.... .....+.+.+|+.+|++++|||||++++++.++ .
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 3468999999999999999999874 33 36777665432 334567799999999999999999999999765 5
Q ss_pred eEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccC
Q 038211 450 LGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKN 529 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~ 529 (605)
.++++|++.+++|.+.+......+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+...
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 67889999999999999888889999999999999999999999999 9999999999999999999999999998654
Q ss_pred ccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhccCCCccCCCCCCCC
Q 038211 530 ATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 530 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
... .......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..++...|. .+.++++|+.+++
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~ 240 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 240 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-HTCCCCCCTTBCH
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCH
Confidence 322 22334568999999999999999999999999999999998 899999999888888884 5677888988763
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=356.49 Aligned_cols=207 Identities=26% Similarity=0.316 Sum_probs=177.1
Q ss_pred EeeeecccCcEEEEEEEE--CCcceEEEEeeccccch---hhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEEe
Q 038211 382 LGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIE---GTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 382 ~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~---~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
.+++||+|+||+||+|++ +++.||||++....... ...+.+.+|+.+|+.++|||||+++++|.+++++++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468999999999999987 47779999987654322 2345688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccccc
Q 038211 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTAK 536 (605)
Q Consensus 457 ~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~ 536 (605)
|.++++..+. .....+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+..........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 9887665554 44477999999999999999999999999 99999999999999999999999999987766555566
Q ss_pred CCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 537 SGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 537 ~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
..+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+.+|.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~ 214 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHH
Confidence 67899999999998754 57999999999999999999999999998888777763
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-43 Score=353.71 Aligned_cols=228 Identities=28% Similarity=0.456 Sum_probs=196.2
Q ss_pred CccccCceEeeeecccCcEEEEEEEECC-------cceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS 446 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~-------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 446 (605)
++..++|+++++||+|+||+||+|++.+ +.||||++.... .....+.+.+|+.+|+.++||||+++++++..
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3455789999999999999999998754 569999986543 34456779999999999999999999999999
Q ss_pred CCeeEEEEEecCCCchHHHHHhhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceecc
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNY-----------------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRD 503 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~-----------------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~D 503 (605)
.+..+++|||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrD 165 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRD 165 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeE
Confidence 999999999999999999986431 24888999999999999999999999 99999
Q ss_pred CCCCCEEEcCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCC-CCCCC
Q 038211 504 LKSSNLLVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTAS-IPWNN 580 (605)
Q Consensus 504 ik~~Nill~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~-~Pf~~ 580 (605)
|||+|||++.++++||+|||+|+...... .......||+.|+|||.+.+..++.++|||||||++|||++|. +||.+
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999999999999999999997543322 2233457899999999999999999999999999999999985 78999
Q ss_pred CCHHHHHHHhccCCCccCCCCCCCC
Q 038211 581 LNLMQVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 581 ~~~~~~~~~I~~~~~~~~~P~~~~~ 605 (605)
.+..+++..|. .+.++++|+.+++
T Consensus 246 ~~~~e~~~~v~-~~~~~~~p~~~~~ 269 (301)
T d1lufa_ 246 MAHEEVIYYVR-DGNILACPENCPL 269 (301)
T ss_dssp SCHHHHHHHHH-TTCCCCCCTTCCH
T ss_pred CCHHHHHHHHH-cCCCCCCCccchH
Confidence 99999999995 5557888988764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-43 Score=356.59 Aligned_cols=202 Identities=25% Similarity=0.411 Sum_probs=172.7
Q ss_pred cccCceEee-eecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEee----C
Q 038211 376 RWEDLQLGE-EIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVAS----Q 447 (605)
Q Consensus 376 ~~~~~~~~~-~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~----~ 447 (605)
..++|.++. +||+|+||+||+|++ +++.||||++... ..+.+|+.++.++ +|||||+++++|.+ .
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 457899875 599999999999997 4678999998542 4567899987654 89999999999975 4
Q ss_pred CeeEEEEEecCCCchHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC---CCcEEEEeec
Q 038211 448 ERLGIVTEFLPRGSLFKTLHKN-YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK---NWTVKVGDFG 523 (605)
Q Consensus 448 ~~~~lv~e~~~ggsL~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~---~~~vkl~Dfg 523 (605)
..+|+|||||+||+|.+++.+. ...+++..++.++.||+.||+|||++| |+||||||+|||++. .+.+||+|||
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccc
Confidence 6799999999999999999865 357999999999999999999999999 999999999999975 5679999999
Q ss_pred CCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 038211 524 LSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVV 587 (605)
Q Consensus 524 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~ 587 (605)
+|+...... .....+||+.|+|||++.+..|+.++|||||||+||+|++|++||.+.+..+..
T Consensus 160 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~ 222 (335)
T d2ozaa1 160 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 222 (335)
T ss_dssp TCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---
T ss_pred eeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH
Confidence 998654432 334568999999999999999999999999999999999999999876654443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.4e-43 Score=350.00 Aligned_cols=212 Identities=27% Similarity=0.361 Sum_probs=182.1
Q ss_pred ccCceEeeeecccCcEEEEEEEEC-CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN-GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVTE 455 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~-~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~e 455 (605)
.++|+++++||+|+||+||+|+++ ++.||||++......+...+.+.+|+.+|++++|||||+++++|.+++..+++||
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 368999999999999999999884 6789999997766555567889999999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccccc
Q 038211 456 FLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLTA 535 (605)
Q Consensus 456 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 535 (605)
++.++.+..+ ....+.+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|..........
T Consensus 81 ~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 81 HLDQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp CCSEEHHHHH-HTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred eehhhhHHHH-HhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 9976655544 444588999999999999999999999999 9999999999999999999999999998765555555
Q ss_pred cCCCCCCcccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 536 KSGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 536 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
....+++.|+|||.+.+.. ++.++|||||||++|||++|++||.+.+..+.+.+|.
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~ 214 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 5667899999999997654 5899999999999999999999999988877777653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=349.42 Aligned_cols=229 Identities=30% Similarity=0.518 Sum_probs=194.9
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECC---------cceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNG---------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMG 442 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~---------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~ 442 (605)
+++..++|+++++||+|+||.||+|++.+ ..||||++.++. .......+.+|...+.++ +|||||++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 55777999999999999999999998633 358999987654 334556788899998888 8999999999
Q ss_pred EEeeCCeeEEEEEecCCCchHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCC
Q 038211 443 AVASQERLGIVTEFLPRGSLFKTLHKNY---------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSS 507 (605)
Q Consensus 443 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~ 507 (605)
+|.+++.+++|||||++|+|.+++.... ..+++..++.++.||+.||+|||+++ ||||||||+
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~ 164 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAAR 164 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeeccc
Confidence 9999999999999999999999997543 35899999999999999999999999 999999999
Q ss_pred CEEEcCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCHH
Q 038211 508 NLLVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNLM 584 (605)
Q Consensus 508 Nill~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~~ 584 (605)
|||++.++.+||+|||+++...... .......||+.|+|||.+.+..|+.++|||||||++|||++ |.+||.+.+..
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 9999999999999999998654332 22344568999999999999999999999999999999998 89999999999
Q ss_pred HHHHHhccCCCccCCCCCCCC
Q 038211 585 QVVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 585 ~~~~~I~~~~~~~~~P~~~~~ 605 (605)
++...|. .+.++++|..+++
T Consensus 245 ~~~~~i~-~~~~~~~p~~~~~ 264 (299)
T d1fgka_ 245 ELFKLLK-EGHRMDKPSNCTN 264 (299)
T ss_dssp HHHHHHH-TTCCCCCCSSCCH
T ss_pred HHHHHHH-cCCCCCCCccchH
Confidence 9998885 5788899988763
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=351.67 Aligned_cols=227 Identities=32% Similarity=0.577 Sum_probs=191.1
Q ss_pred CccccCceEeeeecccCcEEEEEEEEC--Ccc--eEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEEeeCC
Q 038211 374 GIRWEDLQLGEEIGLGSYAVVYRGIWN--GSD--VAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAVASQE 448 (605)
Q Consensus 374 ~~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~--~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~ 448 (605)
.+.+++|++.++||+|+||+||+|.++ +.. ||||.+.... .....+.+.+|+++|+++ +|||||++++++.+++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 467799999999999999999999874 333 5666654322 234566799999999999 7999999999999999
Q ss_pred eeEEEEEecCCCchHHHHHhh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC
Q 038211 449 RLGIVTEFLPRGSLFKTLHKN---------------YQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK 513 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~ 513 (605)
.+++||||+++|+|.+++++. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcC
Confidence 999999999999999999753 357999999999999999999999999 999999999999999
Q ss_pred CCcEEEEeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHhcc
Q 038211 514 NWTVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTA-SIPWNNLNLMQVVGVVGF 592 (605)
Q Consensus 514 ~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g-~~Pf~~~~~~~~~~~I~~ 592 (605)
++.+||+|||+|+...... ......||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..+++..|.
T Consensus 163 ~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~- 240 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 240 (309)
T ss_dssp GGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-
T ss_pred CCceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-
Confidence 9999999999997654332 23345689999999999999999999999999999999996 56899999999999985
Q ss_pred CCCccCCCCCCCC
Q 038211 593 MDRRLELPEGLDP 605 (605)
Q Consensus 593 ~~~~~~~P~~~~~ 605 (605)
.+.++++|..+++
T Consensus 241 ~~~~~~~~~~~~~ 253 (309)
T d1fvra_ 241 QGYRLEKPLNCDD 253 (309)
T ss_dssp GTCCCCCCTTBCH
T ss_pred hcCCCCCCccCCH
Confidence 4567888888763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-43 Score=351.29 Aligned_cols=230 Identities=27% Similarity=0.442 Sum_probs=182.3
Q ss_pred CCccccCceEeeeecccCcEEEEEEEECC-------cceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEEE
Q 038211 373 GGIRWEDLQLGEEIGLGSYAVVYRGIWNG-------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGAV 444 (605)
Q Consensus 373 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~-------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~ 444 (605)
+++..++|+++++||+|+||+||+|.+.+ +.||||++.... .....+.+.+|..++.++ +|+||+.+++++
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 45677899999999999999999998732 459999886543 233456677788877777 789999999987
Q ss_pred eeC-CeeEEEEEecCCCchHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCC
Q 038211 445 ASQ-ERLGIVTEFLPRGSLFKTLHKNY---------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSN 508 (605)
Q Consensus 445 ~~~-~~~~lv~e~~~ggsL~~~l~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~N 508 (605)
..+ ..+++|||||++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~N 164 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARN 164 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccc
Confidence 654 56899999999999999997542 34889999999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCCHHH
Q 038211 509 LLVDKNWTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTA-SIPWNNLNLMQ 585 (605)
Q Consensus 509 ill~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g-~~Pf~~~~~~~ 585 (605)
||++.++++||+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++| .+||.+.+..+
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999997644322 233456799999999999999999999999999999999986 67898876555
Q ss_pred HHHHhccCCCccCCCCCCCC
Q 038211 586 VVGVVGFMDRRLELPEGLDP 605 (605)
Q Consensus 586 ~~~~I~~~~~~~~~P~~~~~ 605 (605)
.+..+-..+.++++|+.++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~ 264 (299)
T d1ywna1 245 EFCRRLKEGTRMRAPDYTTP 264 (299)
T ss_dssp HHHHHHHHTCCCCCCTTCCH
T ss_pred HHHHHHhcCCCCCCCccCCH
Confidence 44444346778899988764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=348.94 Aligned_cols=210 Identities=25% Similarity=0.351 Sum_probs=182.7
Q ss_pred cCceEeeeecccCcEEEEEEEEC---CcceEEEEeeccccchhhhhhHHHHHHHHHhC---CCCCeeeEEEEEee-----
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN---GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL---RHPNVLLFMGAVAS----- 446 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~---~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l---~h~niv~~~~~~~~----- 446 (605)
++|+++++||+|+||+||+|++. ++.||||++......+.....+.+|+.+|+.+ +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 68999999999999999999984 44589999977655555556677888887776 79999999999853
Q ss_pred CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCc
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~ 526 (605)
...++++||||+++.+..........+++..++.++.||+.||+|||+++ |+||||||+|||++..+.+||+|||+++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 35789999999888776666666678999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 527 LKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 527 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
...... ......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|
T Consensus 165 ~~~~~~-~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 227 (305)
T d1blxa_ 165 IYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227 (305)
T ss_dssp CCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred hhcccc-cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 654332 345668999999999999999999999999999999999999999999888877776
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=348.23 Aligned_cols=231 Identities=29% Similarity=0.492 Sum_probs=201.5
Q ss_pred CCCCccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEE
Q 038211 371 TDGGIRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGA 443 (605)
Q Consensus 371 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 443 (605)
.++++..++|+++++||+|+||+||+|.++ ++.||||++.... .......+.+|+.++++++|||||+++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 357788899999999999999999999874 3569999987543 34455678999999999999999999999
Q ss_pred EeeCCeeEEEEEecCCCchHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCC
Q 038211 444 VASQERLGIVTEFLPRGSLFKTLHKNY---------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKN 514 (605)
Q Consensus 444 ~~~~~~~~lv~e~~~ggsL~~~l~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~ 514 (605)
+..++..++|||||++|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED 169 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCC
Confidence 999999999999999999999886431 34788999999999999999999999 9999999999999999
Q ss_pred CcEEEEeecCCcccCccc--ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHhc
Q 038211 515 WTVKVGDFGLSSLKNATY--LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTA-SIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 515 ~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g-~~Pf~~~~~~~~~~~I~ 591 (605)
+++||+|||+|+...... .......||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..+++..|.
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999998654332 233445689999999999999999999999999999999997 68999999999999985
Q ss_pred cCCCccCCCCCCCC
Q 038211 592 FMDRRLELPEGLDP 605 (605)
Q Consensus 592 ~~~~~~~~P~~~~~ 605 (605)
.+.++++|+.+++
T Consensus 250 -~~~~~~~p~~~~~ 262 (308)
T d1p4oa_ 250 -EGGLLDKPDNCPD 262 (308)
T ss_dssp -TTCCCCCCTTCCH
T ss_pred -hCCCCCCcccchH
Confidence 5667888988763
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=343.86 Aligned_cols=214 Identities=22% Similarity=0.360 Sum_probs=179.5
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccch----hhhhhHHHHHHHHHhCC--CCCeeeEEEEEeeCCe
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIE----GTLKNYQKEIDIIKKLR--HPNVLLFMGAVASQER 449 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~----~~~~~~~~E~~il~~l~--h~niv~~~~~~~~~~~ 449 (605)
++|+++++||+|+||+||+|++. ++.||||++.+..... .....+.+|+.+|++++ |||||+++++|.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999984 7789999987654332 22345678999999996 8999999999999999
Q ss_pred eEEEEEecCC-CchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC-CCcEEEEeecCCcc
Q 038211 450 LGIVTEFLPR-GSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK-NWTVKVGDFGLSSL 527 (605)
Q Consensus 450 ~~lv~e~~~g-gsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~-~~~vkl~Dfg~a~~ 527 (605)
+++||||+.+ +++.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||+|||+|+.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECcccccee
Confidence 9999999976 5777777665 78999999999999999999999999 999999999999985 57999999999986
Q ss_pred cCcccccccCCCCCCcccccccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhccCCCccCCCCCCC
Q 038211 528 KNATYLTAKSGRGTPQWMAPEVLRSEPS-NEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 528 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.... ...+..||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+ + | ....+.+|+.+|
T Consensus 161 ~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~----i--~~~~~~~~~~~s 228 (273)
T d1xwsa_ 161 LKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----I--IRGQVFFRQRVS 228 (273)
T ss_dssp CCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----H--HHCCCCCSSCCC
T ss_pred cccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H----H--hhcccCCCCCCC
Confidence 5433 2345689999999999988776 567899999999999999999998642 2 2 223456666665
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-42 Score=345.76 Aligned_cols=230 Identities=27% Similarity=0.420 Sum_probs=198.1
Q ss_pred CCCccccCceEeeeecccCcEEEEEEEEC-------CcceEEEEeeccccchhhhhhHHHHHHHHHhC-CCCCeeeEEEE
Q 038211 372 DGGIRWEDLQLGEEIGLGSYAVVYRGIWN-------GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKL-RHPNVLLFMGA 443 (605)
Q Consensus 372 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~-------~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~ 443 (605)
.+++..++|+++++||+|+||.||+|.+. ++.||||++.... .......+.+|+.+++.+ +|||||+++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 35677789999999999999999999863 3459999987654 334556788999999999 69999999999
Q ss_pred EeeCCeeEEEEEecCCCchHHHHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCC
Q 038211 444 VASQERLGIVTEFLPRGSLFKTLHKNY-----------------QALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKS 506 (605)
Q Consensus 444 ~~~~~~~~lv~e~~~ggsL~~~l~~~~-----------------~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~ 506 (605)
+.++..+++|||||++|+|.+++.+.. ..+++..+..++.||+.||+|||+++ |+||||||
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp 173 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA 173 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccc
Confidence 999999999999999999999987642 35899999999999999999999999 99999999
Q ss_pred CCEEEcCCCcEEEEeecCCcccCcc--cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCH
Q 038211 507 SNLLVDKNWTVKVGDFGLSSLKNAT--YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVT-ASIPWNNLNL 583 (605)
Q Consensus 507 ~Nill~~~~~vkl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~Pf~~~~~ 583 (605)
+|||++.++.+|++|||+++..... .......+||+.|+|||.+.+..++.++|||||||++|||++ |.+||...+.
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999865432 233344678999999999999999999999999999999998 7778888877
Q ss_pred HHHHHHhccCCCccCCCCCCC
Q 038211 584 MQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 584 ~~~~~~I~~~~~~~~~P~~~~ 604 (605)
.+.+.++-..+.++.+|+.+|
T Consensus 254 ~~~~~~~i~~~~~~~~~~~~~ 274 (311)
T d1t46a_ 254 DSKFYKMIKEGFRMLSPEHAP 274 (311)
T ss_dssp SHHHHHHHHHTCCCCCCTTSC
T ss_pred HHHHHHHHhcCCCCCCccccc
Confidence 776666656778888888775
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-42 Score=347.03 Aligned_cols=228 Identities=23% Similarity=0.372 Sum_probs=189.1
Q ss_pred ccccCceEeeeecccCcEEEEEEEE-----CCcceEEEEeeccccc--hhhhhhHHHHHHHHHhCCC-CCeeeEEEEEee
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIW-----NGSDVAVKVYFGSEYI--EGTLKNYQKEIDIIKKLRH-PNVLLFMGAVAS 446 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~-----~~~~~avKv~~~~~~~--~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~ 446 (605)
+..++|+++++||+|+||+||+|.+ +|+.||||++.+.... ....+.+.+|+.+|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 4568999999999999999999986 3567999998765432 2345678899999999966 899999999999
Q ss_pred CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCc
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~ 526 (605)
...++++|||+.+|+|.+++... +.+.+..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred CCceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999999999876 67788999999999999999999999 9999999999999999999999999997
Q ss_pred ccCcc-cccccCCCCCCcccccccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhcc--CCCccCCCC
Q 038211 527 LKNAT-YLTAKSGRGTPQWMAPEVLRSEP--SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVGF--MDRRLELPE 601 (605)
Q Consensus 527 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~~--~~~~~~~P~ 601 (605)
..... ........|++.|++||.+.+.. ++.++|||||||+||+|++|+.||.+.+..+....|.. ....+++|.
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence 65432 23344567999999999997654 57899999999999999999999987543333222211 344577777
Q ss_pred CCCC
Q 038211 602 GLDP 605 (605)
Q Consensus 602 ~~~~ 605 (605)
.+|+
T Consensus 258 ~~s~ 261 (322)
T d1vzoa_ 258 EMSA 261 (322)
T ss_dssp TSCH
T ss_pred cCCH
Confidence 7663
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=336.58 Aligned_cols=221 Identities=32% Similarity=0.502 Sum_probs=182.4
Q ss_pred ceEeeeecccCcEEEEEEEECC---c--ceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee-CCeeEEE
Q 038211 380 LQLGEEIGLGSYAVVYRGIWNG---S--DVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS-QERLGIV 453 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~~~---~--~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~lv 453 (605)
+.+.++||+|+||+||+|.+.. + .||||.+.+.. .....+.+.+|+++|++++||||+++++++.. ++.+++|
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 3457899999999999998732 2 47899876432 44566889999999999999999999999765 5689999
Q ss_pred EEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcccc
Q 038211 454 TEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYL 533 (605)
Q Consensus 454 ~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~ 533 (605)
||||++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999999999887778889999999999999999999999 99999999999999999999999999986543221
Q ss_pred ----cccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHhccCCCccCCCCCCC
Q 038211 534 ----TAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWN-NLNLMQVVGVVGFMDRRLELPEGLD 604 (605)
Q Consensus 534 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~-~~~~~~~~~~I~~~~~~~~~P~~~~ 604 (605)
......||+.|+|||.+.+..++.++||||||+++|||++|..||. ..+..++...|. .+.++.+|+.++
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~-~g~~~~~p~~~~ 260 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCP 260 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-TTCCCCCCTTCC
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCcccCc
Confidence 2223468999999999999999999999999999999999666664 556677777774 567788888765
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-40 Score=330.24 Aligned_cols=211 Identities=25% Similarity=0.330 Sum_probs=186.0
Q ss_pred ccCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCCeeEEEE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQERLGIVT 454 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lv~ 454 (605)
.++|+++++||+|+||+||+|++ +++.||||+++...........+.+|+.+|+.++||||++++++|.+....++++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 36899999999999999999998 4667999999877666667788999999999999999999999999999999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCccccc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNATYLT 534 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 534 (605)
+++.+++|..++.. .+.+++..++.++.|++.||+|||++| |+||||||+|||++.++.+||+|||.|+........
T Consensus 81 ~~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 99998888777654 478899999999999999999999999 999999999999999999999999999877655555
Q ss_pred ccCCCCCCcccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHh
Q 038211 535 AKSGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTASIPW-NNLNLMQVVGVV 590 (605)
Q Consensus 535 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~Pf-~~~~~~~~~~~I 590 (605)
.....+++.|+|||++.+.. ++.++|||||||++|||++|+.|| ...+..+.+.++
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~ 215 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHH
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 55667889999999988765 589999999999999999999985 455666666654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=335.76 Aligned_cols=212 Identities=22% Similarity=0.318 Sum_probs=178.1
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee--------
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS-------- 446 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-------- 446 (605)
.++|+++++||+|+||+||+|++. |+.||||++......+.....+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 589999999999999999999984 7789999987776656667778999999999999999999998854
Q ss_pred CCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCc
Q 038211 447 QERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSS 526 (605)
Q Consensus 447 ~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~ 526 (605)
...+++|||||.++.+ .........+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~iv~e~~~~~~~-~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHH-HHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCcc-chhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecceee
Confidence 3468999999976554 444455578999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCccc----ccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 527 LKNATY----LTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 527 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
...... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......|.
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~ 235 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence 543221 223345799999999999875 58999999999999999999999999988877777663
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-40 Score=341.04 Aligned_cols=206 Identities=25% Similarity=0.390 Sum_probs=175.8
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC------
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE------ 448 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------ 448 (605)
.++|+++++||+|+||+||+|.+. ++.||||++.+....+...+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 478999999999999999999984 788999999876655666778999999999999999999999997654
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
++|+||||| +.+|..++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccccccceecc
Confidence 579999999 6788777654 57999999999999999999999999 999999999999999999999999999865
Q ss_pred CcccccccCCCCCCcccccccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSE-PSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
... .....||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+..+
T Consensus 172 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~ 231 (346)
T d1cm8a_ 172 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231 (346)
T ss_dssp CSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHH
Confidence 433 3456789999999999875 4689999999999999999999999998877666554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.9e-40 Score=329.03 Aligned_cols=200 Identities=21% Similarity=0.305 Sum_probs=175.0
Q ss_pred ccccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCC-CCeeeEEEEEeeCCeeE
Q 038211 375 IRWEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH-PNVLLFMGAVASQERLG 451 (605)
Q Consensus 375 ~~~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~~~~ 451 (605)
+..++|+++++||+|+||+||+|++. ++.||||++.... ....+.+|+++++.+.| +|++.+++++......+
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 34578999999999999999999974 6789999876543 23457889999999965 89999999999999999
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC-----CCcEEEEeecCCc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK-----NWTVKVGDFGLSS 526 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~-----~~~vkl~Dfg~a~ 526 (605)
+||||+ +++|.+++......++...+..++.|++.||+|||++| |+||||||+|||++. .+.+||+|||+|+
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 999999 78999999887778999999999999999999999999 999999999999964 5789999999997
Q ss_pred ccCcc-------cccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 527 LKNAT-------YLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 527 ~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
..... .......+||+.|||||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~ 216 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence 64322 12234567999999999999999999999999999999999999999754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=334.47 Aligned_cols=217 Identities=32% Similarity=0.542 Sum_probs=175.1
Q ss_pred cCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHH--HHHHHHhCCCCCeeeEEEEEeeCC----eeE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQK--EIDIIKKLRHPNVLLFMGAVASQE----RLG 451 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~--E~~il~~l~h~niv~~~~~~~~~~----~~~ 451 (605)
++|.+.++||+|+||.||+|+++|+.||||++..+. .+.+.+ |+..+..++|||||++++++.+.+ .++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 679999999999999999999999999999986442 223333 455556779999999999997653 689
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCCCceeccCCCCCEEEcCCCcEEEEeec
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHH--------RNPPIVHRDLKSSNLLVDKNWTVKVGDFG 523 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~--------~~~~iiH~Dik~~Nill~~~~~vkl~Dfg 523 (605)
+|||||++|+|.+++++ ..+++..++.++.|++.||+|||+ +| |+||||||+||||+.++.+||+|||
T Consensus 78 lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~--IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--eeccccCccceEEcCCCCeEEEecC
Confidence 99999999999999986 468899999999999999999997 47 9999999999999999999999999
Q ss_pred CCcccCcccc----cccCCCCCCcccccccccCCC------CCchhHHHHHHHHHHHHHcCCCCCCC-------------
Q 038211 524 LSSLKNATYL----TAKSGRGTPQWMAPEVLRSEP------SNEKSDVFSFGVILWELVTASIPWNN------------- 580 (605)
Q Consensus 524 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~el~~g~~Pf~~------------- 580 (605)
+++....... ......||+.|+|||++.+.. ++.++|||||||+||||++|..||..
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 9976543321 233457999999999987653 46689999999999999999887632
Q ss_pred --CCHHHHHHHhccCCCccCCCCCC
Q 038211 581 --LNLMQVVGVVGFMDRRLELPEGL 603 (605)
Q Consensus 581 --~~~~~~~~~I~~~~~~~~~P~~~ 603 (605)
.....+...+.....++++|..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~ 258 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRW 258 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGG
T ss_pred ccchHHHHHHHHhccccCCCCCccc
Confidence 23455556665556667776643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-40 Score=336.23 Aligned_cols=208 Identities=25% Similarity=0.350 Sum_probs=173.2
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeCC----eeE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQE----RLG 451 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~----~~~ 451 (605)
++|+++++||+|+||+||+|.+. ++.||||++.+.. .....+.+.+|+.+|+.++||||+++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46999999999999999999874 7789999987644 3445677899999999999999999999997643 234
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCcc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~~ 531 (605)
++++++.+|+|.+++.. ..+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+.....
T Consensus 87 ~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 45556669999999976 46999999999999999999999999 999999999999999999999999999765433
Q ss_pred c---ccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 532 Y---LTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 532 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
. ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+.......+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~ 225 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH
Confidence 2 22345679999999999855 45688999999999999999999999988876555554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-40 Score=336.99 Aligned_cols=204 Identities=25% Similarity=0.314 Sum_probs=170.9
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC------Ce
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ------ER 449 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------~~ 449 (605)
-+|+.+++||+|+||+||+|++. ++.||||++..+. ....+|+.+|++++||||++++++|... .+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 36999999999999999999984 7779999987643 2234799999999999999999998542 35
Q ss_pred eEEEEEecCCCchHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC-cEEEEeecCCc
Q 038211 450 LGIVTEFLPRGSLFKTLH--KNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW-TVKVGDFGLSS 526 (605)
Q Consensus 450 ~~lv~e~~~ggsL~~~l~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~-~vkl~Dfg~a~ 526 (605)
++||||||+++.+..+.. .....+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+++
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchh
Confidence 899999997654433332 23467999999999999999999999999 99999999999999775 89999999997
Q ss_pred ccCcccccccCCCCCCcccccccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 527 LKNATYLTAKSGRGTPQWMAPEVLRS-EPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 527 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
...... ...+.+||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+.+..|
T Consensus 172 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i 235 (350)
T d1q5ka_ 172 QLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235 (350)
T ss_dssp ECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH
T ss_pred hccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHH
Confidence 654332 3345679999999998876 46899999999999999999999999988877766665
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-39 Score=323.48 Aligned_cols=202 Identities=24% Similarity=0.327 Sum_probs=169.3
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCC-eeeEEEEEeeCCeeEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPN-VLLFMGAVASQERLGIVT 454 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~~~~~~~~~~~~~lv~ 454 (605)
++|+++++||+|+||+||+|++. ++.||||++.... ....+.+|+++++.++|+| |+.+..++.+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 46999999999999999999974 7789999876543 2345789999999997665 556666677888999999
Q ss_pred EecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcC---CCcEEEEeecCCcccCcc
Q 038211 455 EFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDK---NWTVKVGDFGLSSLKNAT 531 (605)
Q Consensus 455 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~---~~~vkl~Dfg~a~~~~~~ 531 (605)
||+ +++|...+......+++..+..++.|++.||+|||++| |+||||||+|||++. +..++|+|||+|+.....
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 999 66777777776688999999999999999999999999 999999999999864 457999999999865432
Q ss_pred c-------ccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 038211 532 Y-------LTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQV 586 (605)
Q Consensus 532 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~ 586 (605)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~ 221 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHH
Confidence 1 223456799999999999999999999999999999999999999987654443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-39 Score=332.06 Aligned_cols=207 Identities=25% Similarity=0.346 Sum_probs=170.6
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEee------CC
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVAS------QE 448 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~------~~ 448 (605)
.++|+++++||+|+||+||+|++. |+.||||++.+..........+.+|+.+|+.++|||||+++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999985 7889999998776666667788999999999999999999999964 36
Q ss_pred eeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 449 RLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 449 ~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
++|+|||||.++ +...+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.++++|||+++..
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eeEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhcc
Confidence 899999999654 444443 56899999999999999999999999 999999999999999999999999998765
Q ss_pred CcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 038211 529 NATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVV 590 (605)
Q Consensus 529 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I 590 (605)
.... .....++|+.|+|||++.+..++.++||||+||++|+|++|++||.+.+......+|
T Consensus 170 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i 230 (355)
T d2b1pa1 170 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cccc-ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHH
Confidence 4332 334557899999999999999999999999999999999999999988776665554
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-39 Score=331.48 Aligned_cols=207 Identities=25% Similarity=0.330 Sum_probs=177.2
Q ss_pred cCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCeeeEEEEEeeC-----Cee
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNVLLFMGAVASQ-----ERL 450 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~ 450 (605)
++|+++++||+|+||+||+|++. ++.||||++.+........+.+.+|+.+|+.++|||||+++++|... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 68999999999999999999874 77899999987665555667889999999999999999999998643 334
Q ss_pred EEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEeecCCcccCc
Q 038211 451 GIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLKNA 530 (605)
Q Consensus 451 ~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~~~ 530 (605)
+++|+++.||+|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+|++|||++.....
T Consensus 98 ~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred EEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhcccCc
Confidence 666777889999999865 57999999999999999999999999 99999999999999999999999999976543
Q ss_pred ccccccCCCCCCcccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhc
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTASIPWNNLNLMQVVGVVG 591 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~Pf~~~~~~~~~~~I~ 591 (605)
. ..+..||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......|.
T Consensus 174 ~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~ 232 (348)
T d2gfsa1 174 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232 (348)
T ss_dssp G---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred c---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2 34567899999999977765 5889999999999999999999999988777777663
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-38 Score=324.43 Aligned_cols=194 Identities=23% Similarity=0.375 Sum_probs=168.1
Q ss_pred ccCceEeeeecccCcEEEEEEEEC--CcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEee--CCeeE
Q 038211 377 WEDLQLGEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVAS--QERLG 451 (605)
Q Consensus 377 ~~~~~~~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~--~~~~~ 451 (605)
.++|+++++||+|+||+||+|++. ++.||||++.... .+.+.+|+.+|+.+. ||||++++++|.. ...++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 368999999999999999999984 7789999986532 456889999999995 9999999999974 35699
Q ss_pred EEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCC-cEEEEeecCCcccCc
Q 038211 452 IVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNW-TVKVGDFGLSSLKNA 530 (605)
Q Consensus 452 lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~-~vkl~Dfg~a~~~~~ 530 (605)
+|||||++++|..+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+|+....
T Consensus 109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999999986653 56999999999999999999999999 99999999999998654 699999999986543
Q ss_pred ccccccCCCCCCcccccccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 038211 531 TYLTAKSGRGTPQWMAPEVLRSEP-SNEKSDVFSFGVILWELVTASIPWNNLN 582 (605)
Q Consensus 531 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~Pf~~~~ 582 (605)
.. .....++|+.|+|||.+.+.. ++.++|||||||++|+|++|+.||....
T Consensus 183 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 183 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 32 344567899999999988754 7999999999999999999999997643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-33 Score=289.67 Aligned_cols=196 Identities=20% Similarity=0.355 Sum_probs=160.4
Q ss_pred cCceEeeeecccCcEEEEEEEE--CCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-----------CCCeeeEEEEE
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIW--NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-----------HPNVLLFMGAV 444 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~--~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-----------h~niv~~~~~~ 444 (605)
.+|+++++||+|+||+||+|++ +|+.||||++.++. ...+.+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999987 47889999987653 23456778999888875 57899999888
Q ss_pred ee--CCeeEEEEEecCCCchHHHH--HhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeccCCCCCEEEcCCC----
Q 038211 445 AS--QERLGIVTEFLPRGSLFKTL--HKNYQALDIKRRLRMALDVARGMNYLHH-RNPPIVHRDLKSSNLLVDKNW---- 515 (605)
Q Consensus 445 ~~--~~~~~lv~e~~~ggsL~~~l--~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~~~iiH~Dik~~Nill~~~~---- 515 (605)
.. ....+++|+++..+...... ......+++..++.++.||+.||+|||+ .| |+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccc
Confidence 64 35667777777655443333 2334788999999999999999999997 89 99999999999998654
Q ss_pred --cEEEEeecCCcccCcccccccCCCCCCcccccccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 038211 516 --TVKVGDFGLSSLKNATYLTAKSGRGTPQWMAPEVLRSEPSNEKSDVFSFGVILWELVTASIPWNNL 581 (605)
Q Consensus 516 --~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~Pf~~~ 581 (605)
.++++|||.+...... ....+||+.|+|||++.+..++.++||||+||++++|++|+.||...
T Consensus 168 ~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 4999999999765432 34567999999999999999999999999999999999999999754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.1e-23 Score=196.13 Aligned_cols=166 Identities=17% Similarity=0.152 Sum_probs=119.8
Q ss_pred ceEeeeecccCcEEEEEEEE-CCcceEEEEeeccccc----------------hhhhhhHHHHHHHHHhCCCCCeeeEEE
Q 038211 380 LQLGEEIGLGSYAVVYRGIW-NGSDVAVKVYFGSEYI----------------EGTLKNYQKEIDIIKKLRHPNVLLFMG 442 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~-~~~~~avKv~~~~~~~----------------~~~~~~~~~E~~il~~l~h~niv~~~~ 442 (605)
+.++++||+|+||+||+|.+ +|+.||||++...... ........+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46789999999999999986 5788999987532111 011233456889999999999998886
Q ss_pred EEeeCCeeEEEEEecCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeccCCCCCEEEcCCCcEEEEee
Q 038211 443 AVASQERLGIVTEFLPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRNPPIVHRDLKSSNLLVDKNWTVKVGDF 522 (605)
Q Consensus 443 ~~~~~~~~~lv~e~~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~~~iiH~Dik~~Nill~~~~~vkl~Df 522 (605)
+. ..+++|||+++..+.. ++...+..++.||+.+|.|||++| |+||||||+|||++++ .++|+||
T Consensus 82 ~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECCC
T ss_pred ec----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEEC
Confidence 53 2479999998765532 344455678999999999999999 9999999999999865 5899999
Q ss_pred cCCcccCcccccccCCCCCCcccccc-----cccCCCCCchhHHHHHHHHH
Q 038211 523 GLSSLKNATYLTAKSGRGTPQWMAPE-----VLRSEPSNEKSDVFSFGVIL 568 (605)
Q Consensus 523 g~a~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DiwSlG~il 568 (605)
|.|.....+. ...|.... .+....|+.++|+||+.--+
T Consensus 147 G~a~~~~~~~--------~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEG--------WREILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTT--------HHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCC--------cHHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9986543221 11122110 01234577889999976543
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.78 E-value=1.3e-18 Score=145.59 Aligned_cols=103 Identities=18% Similarity=0.315 Sum_probs=90.3
Q ss_pred cCCeEEEEEc---CCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEcCCCCE
Q 038211 66 MGHAVHVCTA---SSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRSGEI 142 (605)
Q Consensus 66 ~~d~ii~v~D---~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~k~G~~ 142 (605)
+.+++ +++| +||+|+|||++|++++||+.+|++|+++..+..+.........+.+.+..++.|..++..++|||+.
T Consensus 2 i~~~~-vi~Da~~pdg~Ii~vN~a~~~~~Gy~~~El~G~~~~~l~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~kdG~~ 80 (109)
T d1n9la_ 2 LRHTF-VVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTP 80 (109)
T ss_dssp CSCEE-EEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCE
T ss_pred ccceE-EEEeCCCCCCeEEEEcHHHHHHHCcCHHHHcCCcceeeecccCCHHHhhhhhhHhhcCCceeeeEEEEecCCeE
Confidence 34566 8889 5899999999999999999999999999864333334445777888999999999999999999999
Q ss_pred EEEEEEEEEEee-CCeEEEEEEEEeccc
Q 038211 143 LMAVVTKSPLYE-DGELAGFITVSSDAA 169 (605)
Q Consensus 143 ~~v~~~~~Pi~d-~g~i~g~v~i~~D~t 169 (605)
+|+.++.+|++| +|++.+++++++|+|
T Consensus 81 ~w~~~~~~pi~d~~G~v~~~v~~~~DIT 108 (109)
T d1n9la_ 81 FWNLLTVTPIKTPDGRVSKFVGVQVDVT 108 (109)
T ss_dssp EEEEEEEEEEECTTSCEEEEEEEEEECC
T ss_pred EEEEEEEEEEECCCCCEEEEEEEEEECC
Confidence 999999999998 999999999999987
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Probab=99.70 E-value=1.4e-16 Score=137.39 Aligned_cols=118 Identities=21% Similarity=0.364 Sum_probs=95.0
Q ss_pred HHhcccccccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHH-HHcCC
Q 038211 49 VATTSDSVGPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMER-LASGQ 127 (605)
Q Consensus 49 ~~~~~~~~~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~-l~~g~ 127 (605)
.+++.+++++|+.+++++++++ +++|.+|+|++||+++++++||+.+|++|+++.+ ++++.........++. +..+.
T Consensus 8 e~~l~~~e~~~~~i~~~~~~~i-~~~d~~g~i~~~N~~~~~l~Gy~~~el~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 85 (130)
T d1ew0a_ 8 EDVVRARDAHLRSILDTVPDAT-VVSATDGTIVSFNAAAVRQFGYAEEEVIGQNLRI-LMPEPYRHEHDGYLQRYMATGE 85 (130)
T ss_dssp HHHHHHHTSCHHHHHTTCSSEE-EEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGG-GSCTTTGGGHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHcCCCeE-EEEeCCccEEEEHHHHHHhhcCCHHHhcCCcccc-ccccchhHHHHHHHHHHHHhCC
Confidence 4455567789999999999988 8899999999999999999999999999999987 5555555554444443 44443
Q ss_pred c----eEEEEEEEcCCCCEEEEEEEEEEEeeCCeEEEEEEEEeccc
Q 038211 128 S----WSGQFPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSDAA 169 (605)
Q Consensus 128 ~----~~~~~~~~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t 169 (605)
. ...++...++||+.+|+.++.+|+.+++.. +++++++|+|
T Consensus 86 ~~~~~~~~e~~~~~~dG~~~~v~~~~~~i~~~~~~-~~~~i~rDIT 130 (130)
T d1ew0a_ 86 KRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGER-FFTGFIRDLT 130 (130)
T ss_dssp CSSTTSCEEEEEECTTSCEEEEEEEEEEEEETTEE-EEEEEEEECC
T ss_pred CccccceeeEEEEcCCCCEEEEEEEEEEEEECCeE-EEEEEEEECC
Confidence 2 456788899999999999999999886654 4888899976
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Probab=99.69 E-value=8.2e-17 Score=133.23 Aligned_cols=97 Identities=15% Similarity=0.179 Sum_probs=87.2
Q ss_pred EEEc---CCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEcCCCCEEEEEEE
Q 038211 72 VCTA---SSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRSGEILMAVVT 148 (605)
Q Consensus 72 ~v~D---~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~k~G~~~~v~~~ 148 (605)
+++| +||+|+|+|++|++++||+.+|++|+++.++..+.........+...+..++.+..+.+.++++|+.+|+.++
T Consensus 4 vi~d~~~pd~~I~y~N~a~~~~~G~s~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~~~~~ 83 (104)
T d1jnua_ 4 VITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTKGGRAFWNLFH 83 (104)
T ss_dssp EEECTTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEEEE
T ss_pred EEEcCCCCCCEEEEEcHHHHHHHCcCHHHHCCccceeccccccchHHHhhhhhhhhcCceeEeEEEEEecccceEEEEEE
Confidence 7888 5899999999999999999999999999875545554545777888899999999999999999999999999
Q ss_pred EEEEee-CCeEEEEEEEEecc
Q 038211 149 KSPLYE-DGELAGFITVSSDA 168 (605)
Q Consensus 149 ~~Pi~d-~g~i~g~v~i~~D~ 168 (605)
++|++| +|++.|++++.+||
T Consensus 84 ~~pi~d~~G~v~~~i~i~~DI 104 (104)
T d1jnua_ 84 LQVMRDENGDVQYFIGVQQEM 104 (104)
T ss_dssp EEEECTTTSSCCEEEEEEEEC
T ss_pred EEEEECCCCCEEEEEEEEEcC
Confidence 999998 99999999999995
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=6.5e-16 Score=129.09 Aligned_cols=99 Identities=18% Similarity=0.264 Sum_probs=86.3
Q ss_pred EEEc---CCCCEEEecHHHHHHhCCChhhhcCCCcccccc-ccC-CcchHHHHHHHHHcCCceEEEEEEEcCCCCEEEEE
Q 038211 72 VCTA---SSEDIIYWNRSAESLYGWKDREVFGQRVTEFLI-AEE-FHSPHKKIMERLASGQSWSGQFPFKKRSGEILMAV 146 (605)
Q Consensus 72 ~v~D---~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~-~~~-~~~~~~~~~~~l~~g~~~~~~~~~~~k~G~~~~v~ 146 (605)
+++| .|+.|+|+|++|++++||+.+|++|+++.+++. +++ .......+...+..++++..++..++++|+.+|+.
T Consensus 5 ~i~~~~~~d~~I~~~N~a~~~l~G~~~~eiiG~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~~~g~~~w~~ 84 (110)
T d1bywa_ 5 IIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCL 84 (110)
T ss_dssp EEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEEEEE
T ss_pred EEEcCCCCCCEEEEEcHHHHHHhCCCHHHhcccCcccccceeeheecccccccchhhcccccccceeeeeecccceeeee
Confidence 6678 467899999999999999999999999876443 233 23347777888999999999999999999999999
Q ss_pred EEEEEEee-CCeEEEEEEEEecccc
Q 038211 147 VTKSPLYE-DGELAGFITVSSDAAI 170 (605)
Q Consensus 147 ~~~~Pi~d-~g~i~g~v~i~~D~t~ 170 (605)
++.+|++| +|++++++++++|+|+
T Consensus 85 ~~~~pi~d~~G~v~~~i~~~~DITe 109 (110)
T d1bywa_ 85 VDVVPVKNEDGAVIMFILNFEVVME 109 (110)
T ss_dssp EEEEEEECTTCCEEEEEEEEEEEEE
T ss_pred eeEEEEECCCCCEEEEEEEEEECCC
Confidence 99999998 9999999999999986
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Probab=99.58 E-value=1.3e-14 Score=121.22 Aligned_cols=107 Identities=21% Similarity=0.453 Sum_probs=81.0
Q ss_pred cHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHH-HHHcC----CceEEE
Q 038211 58 PYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIME-RLASG----QSWSGQ 132 (605)
Q Consensus 58 ~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~-~l~~g----~~~~~~ 132 (605)
.|.++++++++++ +++|.+|+|+++|++|++++||+.+|++|+++.+ +.+............ .+..+ .....+
T Consensus 2 ~~~~~~e~~~d~i-~~~d~~g~i~~~N~~~~~l~Gy~~~e~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 79 (113)
T d1v9ya_ 2 IFFPALEQNMMGA-VLINENDEVMFFNPAAEKLWGYKREEVIGNNIDM-LIPRDLRPAHPEYIRHNREGGKARVEGMSRE 79 (113)
T ss_dssp CHHHHHHTCSSEE-EEECTTSBEEEECHHHHHHHSCCGGGTTTSBGGG-GSCGGGTTTHHHHHHHHHC----------CE
T ss_pred HHHHHHHcCcCcE-EEEeCCCCEEEEchhHhhhhccchhhhcCcceec-cccccccccccccccccccccccccccccee
Confidence 4788999999988 8899999999999999999999999999999987 444444433333322 22222 234457
Q ss_pred EEEEcCCCCEEEEEEEEEEEeeCCeEEEEEEEEec
Q 038211 133 FPFKKRSGEILMAVVTKSPLYEDGELAGFITVSSD 167 (605)
Q Consensus 133 ~~~~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D 167 (605)
...++++|+.+|+.++++|+.++|... +++++||
T Consensus 80 ~~~~~~dG~~~~v~~~~~~i~~~~~~~-~~~v~rD 113 (113)
T d1v9ya_ 80 LQLEKKDGSKIWTRFALSKVSAEGKVY-YLALVRD 113 (113)
T ss_dssp EEEECTTSCEEEEEEEEEEEEETTEEE-EEEEEEC
T ss_pred eeeccccceeEEEEEEEEEEEECCeEE-EEEEEEC
Confidence 788899999999999999999866543 7778887
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Probab=99.52 E-value=3.7e-14 Score=116.85 Aligned_cols=100 Identities=22% Similarity=0.323 Sum_probs=77.0
Q ss_pred CeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHH-HHHcCC----ceEEEEEEEcCCCCE
Q 038211 68 HAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIME-RLASGQ----SWSGQFPFKKRSGEI 142 (605)
Q Consensus 68 d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~-~l~~g~----~~~~~~~~~~k~G~~ 142 (605)
|++ +++|.+|+|++||++|++++||+.+|++|+++.. ++++........... .+.... ....++..++++|..
T Consensus 1 dgi-~~~D~~G~I~~~N~a~~~l~Gy~~~el~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~ 78 (106)
T d1xj3a1 1 DAM-IVIDGHGIIQLFSTAAERLFGWSELEAIGQNVNI-LMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGTT 78 (106)
T ss_dssp CCE-EEEETTSBEEEECHHHHHHHCCCHHHHTTSBGGG-GSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSCE
T ss_pred CEE-EEECCCCcEEEEcHHHHHHhhhchHhhcCCCccc-ccccccccchhhhhhhhhhhcccccccccceeeeeeccceE
Confidence 355 8999999999999999999999999999999987 555444444333332 233222 244578889999999
Q ss_pred EEEEEEEEEEeeCCeEEEEEEEEecccc
Q 038211 143 LMAVVTKSPLYEDGELAGFITVSSDAAI 170 (605)
Q Consensus 143 ~~v~~~~~Pi~d~g~i~g~v~i~~D~t~ 170 (605)
+|+.++++|+.+++. .+++++++|+|+
T Consensus 79 ~~v~~~~~~~~~~~~-~~~~~~~~DITE 105 (106)
T d1xj3a1 79 FPMHLSIGEMQSGGE-PYFTGFVRDLTE 105 (106)
T ss_dssp EEEEEEEEEEEETTE-EEEEEEEEECHH
T ss_pred EEEEEEEEEEEECCe-EEEEEEEEeCCC
Confidence 999999999988443 358889999986
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=1.9e-14 Score=120.81 Aligned_cols=101 Identities=15% Similarity=0.196 Sum_probs=84.9
Q ss_pred EEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcC-CceEEEEEEEcCCCCEEEEEEEEE
Q 038211 72 VCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASG-QSWSGQFPFKKRSGEILMAVVTKS 150 (605)
Q Consensus 72 ~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g-~~~~~~~~~~~k~G~~~~v~~~~~ 150 (605)
+..|.+|+|+|+|+++++++||+.+|++|+++.+ ++++++.......+..+..+ ..+..+++++++||+.+|+.++.+
T Consensus 10 ~r~~~dG~i~~~N~~~~~~~G~~~~el~g~~~~~-~~~~ed~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~wv~~~~~ 88 (114)
T d1p97a_ 10 SRHSMDMKFTYCDDRITELIGYHPEELLGRSAYE-FYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYVWLETQGT 88 (114)
T ss_dssp EEECTTTSCSEECTTHHHHTSSCHHHHTTSCHHH-HSCSSSHHHHHHHHHHHTTTSEEEEEEEEEECTTSCEEEEEEEEE
T ss_pred EEECCCCcEEEECHHHHHHcCCCccccccccccc-cccccccccceeeeeecccccceeecceeeeeecCcceEEEEEEE
Confidence 4469999999999999999999999999999998 45566665555555555444 456778899999999999999999
Q ss_pred EEee--CCeEEEEEEEEeccccccc
Q 038211 151 PLYE--DGELAGFITVSSDAAIFNS 173 (605)
Q Consensus 151 Pi~d--~g~i~g~v~i~~D~t~~~~ 173 (605)
|+++ +|++.+++++.+|+|+.++
T Consensus 89 ~~~~~~~~~~~~ii~~~~dite~k~ 113 (114)
T d1p97a_ 89 VIYNPRNLQPQCIMCVNYVLSEIEK 113 (114)
T ss_dssp EEECTTTCSEEEEEEEEEEEEEEEC
T ss_pred EEEeCCCCCEEEEEEEEEECChhhc
Confidence 9997 5889999999999998753
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Probab=99.48 E-value=1.2e-13 Score=114.81 Aligned_cols=100 Identities=11% Similarity=-0.001 Sum_probs=77.8
Q ss_pred cHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcch-HHHHHHHHHcCCceEEEEEEE
Q 038211 58 PYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSP-HKKIMERLASGQSWSGQFPFK 136 (605)
Q Consensus 58 ~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~-~~~~~~~l~~g~~~~~~~~~~ 136 (605)
.+.++|+++++++ +++|.+|+|++||+++++|+||+++|++|+++.+++.++..... ...+.+.+.+|.........+
T Consensus 4 ~~~A~ld~~p~gv-i~~D~~G~I~~~N~aa~~~~G~~~eellG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~l 82 (110)
T d1mzua_ 4 MGTAEFDALPVGA-IQVDGSGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGTLDARFDFVF 82 (110)
T ss_dssp --CTTGGGCSSEE-EEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSCCEEEEEEEE
T ss_pred HHHHHHhCCCcEE-EEEcCCCCEEEeHHHHHHHHcCCHHHHcCCCHHHhcCChhhhHHHHHHHHHHHhccccCcceEEEE
Confidence 4567899999998 88999999999999999999999999999999876665554444 455666777776543333345
Q ss_pred cCCCCEEEEEEEEEEEeeCCeE
Q 038211 137 KRSGEILMAVVTKSPLYEDGEL 158 (605)
Q Consensus 137 ~k~G~~~~v~~~~~Pi~d~g~i 158 (605)
+++|..+++.++..+..++|.+
T Consensus 83 ~~~G~~~~v~v~~~~~~~~~~~ 104 (110)
T d1mzua_ 83 DFQMAPVRVQIRMQNAGVPDRY 104 (110)
T ss_dssp ECSSCEEEEEEEEEECSSTTEE
T ss_pred ecCCceEEEEEEEEEecCCCEE
Confidence 8899999999998887666654
|
| >d1nwza_ d.110.3.1 (A:) Photoactive yellow protein, PYP {Ectothiorhodospira halophila [TaxId: 1053]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: Photoactive yellow protein, PYP species: Ectothiorhodospira halophila [TaxId: 1053]
Probab=99.42 E-value=6.5e-13 Score=113.17 Aligned_cols=107 Identities=11% Similarity=0.021 Sum_probs=85.2
Q ss_pred ccHHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcch-HHHHHHHHHcCCceEEEEEE
Q 038211 57 GPYRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSP-HKKIMERLASGQSWSGQFPF 135 (605)
Q Consensus 57 ~~~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~-~~~~~~~l~~g~~~~~~~~~ 135 (605)
+.+..+++++++++ +++|.+|+|++||+++++++||+++|++|+++.+++.++..... ...+.+.+.+|.....+...
T Consensus 17 ~~~d~~ld~~p~gi-~~lD~~G~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~ 95 (125)
T d1nwza_ 17 KMDDGQLDGLAFGA-IQLDGDGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGNLNTMFEYT 95 (125)
T ss_dssp TCCHHHHTTCSSEE-EEEETTCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTCCEEEEEEE
T ss_pred HHHHHHHhCCCccE-EEEeCCCCEEEEcHHHHHhhccchHhhcCCCHHHccCchhhhhheeeeceeeeecCCcceEEEEE
Confidence 45678899999988 88999999999999999999999999999999886656555444 45556667788777766677
Q ss_pred EcCCCCEEEEEEEEEEEeeCCeEEEEEEEEec
Q 038211 136 KKRSGEILMAVVTKSPLYEDGELAGFITVSSD 167 (605)
Q Consensus 136 ~~k~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D 167 (605)
++++|+.+|+.++..+..+.+... ..++|
T Consensus 96 ~~~~G~~~~v~v~l~~~~~g~~~~---v~V~d 124 (125)
T d1nwza_ 96 FDYQMTPTKVKVHMKKALSGDSYW---VFVKR 124 (125)
T ss_dssp ECTTSCCEEEEEEEEECSSSSEEE---EEEEE
T ss_pred eccCCcEEEEEEEEEEecCCCEEE---EEEEE
Confidence 899999999999988876655432 34555
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=1.6e-12 Score=108.69 Aligned_cols=102 Identities=17% Similarity=0.269 Sum_probs=76.5
Q ss_pred hcCCeEEEEEcC-CCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCC-----ceEEEEEEEcC
Q 038211 65 SMGHAVHVCTAS-SEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQ-----SWSGQFPFKKR 138 (605)
Q Consensus 65 ~~~d~ii~v~D~-~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~-----~~~~~~~~~~k 138 (605)
.+.+++ +++|. +|+|+++|+++++++||+.+|++|+++.+ +.++........+++....++ .+..++..+++
T Consensus 6 ~~n~AI-~~id~~~G~I~~~N~a~~~l~Gy~~~el~g~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 83 (114)
T d1ll8a_ 6 EFNKAI-FTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQ-FFLRSDSDVVEALSEEHMEADGHAAVVFGTVVDIISR 83 (114)
T ss_dssp TTTCEE-EEEETTTCBEEEECTTHHHHHTCCTTTTTTSBGGG-GSSCTTTHHHHHTTSSTTSSSSCSSCCCSSSEEECCT
T ss_pred hcCcEE-EEEECCCCEEEEECHHHHHhhcCCHHHHcCCCeee-ecCcccHHHHHHHHHHHHhcCCCccceeeEEEEEEcc
Confidence 344566 88884 69999999999999999999999999998 555555544444443333322 12235777899
Q ss_pred CCCEEEEEEEEEEEeeCCeEEEEEEEEeccc
Q 038211 139 SGEILMAVVTKSPLYEDGELAGFITVSSDAA 169 (605)
Q Consensus 139 ~G~~~~v~~~~~Pi~d~g~i~g~v~i~~D~t 169 (605)
+|+.+|+.++..++..+|+.. ++.+++|++
T Consensus 84 ~G~~~pvevs~~~i~~~~~~~-~l~vi~dV~ 113 (114)
T d1ll8a_ 84 SGEKIPVSVWMKRMRQERRLC-CVVVLEPVE 113 (114)
T ss_dssp TCCCEEEECCEECCBSSSSBE-EEEEEEECC
T ss_pred CCcEEEEEEEEEEEEECCeEE-EEEEEEECc
Confidence 999999999999987666644 688999963
|
| >d1oj5a_ d.110.3.8 (A:) PAS domain of steroid receptor coactivator 1A, NCo-A1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PAS domain of steroid receptor coactivator 1A, NCo-A1 domain: PAS domain of steroid receptor coactivator 1A, NCo-A1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.93 E-value=1e-09 Score=90.20 Aligned_cols=96 Identities=15% Similarity=0.225 Sum_probs=73.5
Q ss_pred EEEEcCCCCEEEecHHHHHHhCCCh-hhhcCCCccccccccCCcch--HHHH-HHHHHcCCceEEEEEEEcCCCCEEEEE
Q 038211 71 HVCTASSEDIIYWNRSAESLYGWKD-REVFGQRVTEFLIAEEFHSP--HKKI-MERLASGQSWSGQFPFKKRSGEILMAV 146 (605)
Q Consensus 71 i~v~D~~G~Ii~~N~a~~~l~G~~~-~eliGk~~~~l~~~~~~~~~--~~~~-~~~l~~g~~~~~~~~~~~k~G~~~~v~ 146 (605)
+.-.|.+|+|+++|+++.+++||.. +|++|+++.+ +++|++.+. .... ...+..|.....++++++|||..+|+.
T Consensus 5 ~trh~~~g~~~~vd~~~~~~~gy~~~eelig~s~~~-f~HPeD~~~~~~~~~~~~~~~~g~~~~~~yR~~~kdG~~vWv~ 83 (109)
T d1oj5a_ 5 MTKQDTTGKIISIDTSSLRAAGRTGWEDLVRKCIYA-FFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSAH 83 (109)
T ss_dssp EEEECTTCCEEEEECHHHHTTCCSCHHHHHHHHHHH-HTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEEEE
T ss_pred EEEECCCceEEEECHHHhhHhhcCCHHHHcCCcHHH-eECcccchHHHhhHHHHHHHhhcccchhhhhhhhccCcEEEEE
Confidence 3556999999999999999999985 8999999999 555665432 3333 344566777888899999999999999
Q ss_pred EEEEEEee--CCe---EEEEEEEEec
Q 038211 147 VTKSPLYE--DGE---LAGFITVSSD 167 (605)
Q Consensus 147 ~~~~Pi~d--~g~---i~g~v~i~~D 167 (605)
.+..++++ +++ |+|+-.|.||
T Consensus 84 t~~~~~~~~~~~~~~~Ii~~h~i~~~ 109 (109)
T d1oj5a_ 84 TRCKLCYPQSPDMQPFIMGIHIIDRE 109 (109)
T ss_dssp EEEEEECC----CCCEEEEEEEEECC
T ss_pred EEEEEEECCCCCcccEEEEEEEEecC
Confidence 99999986 333 4555555554
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.52 E-value=2.2e-07 Score=88.59 Aligned_cols=143 Identities=16% Similarity=0.086 Sum_probs=99.6
Q ss_pred cCceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCCeeEEEEEe
Q 038211 378 EDLQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQERLGIVTEF 456 (605)
Q Consensus 378 ~~~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lv~e~ 456 (605)
+.|++.+..+.++.+.||+....+..+.+|+..... ......+.+|..+++.+. +--+.+++.+...++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~--~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRY--KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGG--TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCc--ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 567777776666678999988778889999765432 223445778988888774 43456778888888899999999
Q ss_pred cCCCchHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 038211 457 LPRGSLFKTLHKNYQALDIKRRLRMALDVARGMNYLHHRN---------------------------------------- 496 (605)
Q Consensus 457 ~~ggsL~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---------------------------------------- 496 (605)
++|..+....... .. ...++.++...+..||+..
T Consensus 92 l~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 92 ADGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred ccccccccccccc---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 9988775543211 11 1223445555555666421
Q ss_pred -----------------CCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 497 -----------------PPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 497 -----------------~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
..++|+|+.|.|||+++++.+-|+||+.+...
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 11789999999999997766679999987654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.91 E-value=1.9e-05 Score=74.32 Aligned_cols=129 Identities=21% Similarity=0.190 Sum_probs=81.7
Q ss_pred ecccC-cEEEEEEEECC-cceEEEEeeccccchhhhhhHHHHHHHHHhCCC--CCeeeEEEEEeeCCeeEEEEEecCCCc
Q 038211 386 IGLGS-YAVVYRGIWNG-SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH--PNVLLFMGAVASQERLGIVTEFLPRGS 461 (605)
Q Consensus 386 LG~G~-fg~V~~~~~~~-~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h--~niv~~~~~~~~~~~~~lv~e~~~ggs 461 (605)
+..|. .+.||+....+ ..+.+|..... ....+..|...++.+.. -.+.+++.+..+++..++||++++|.+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 33443 46899887754 45788875332 23457788888887732 335677887788888999999998866
Q ss_pred hHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q 038211 462 LFKTLHKNYQALDIKRRLRMALDVARGMNYLH------------------------------------------------ 493 (605)
Q Consensus 462 L~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH------------------------------------------------ 493 (605)
+.... .... ..+.++...|..||
T Consensus 93 ~~~~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 93 LLSSH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTTSC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred ccccc------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 53210 1110 01122222333333
Q ss_pred ---hCC-----CCceeccCCCCCEEEcCCCcEEEEeecCCccc
Q 038211 494 ---HRN-----PPIVHRDLKSSNLLVDKNWTVKVGDFGLSSLK 528 (605)
Q Consensus 494 ---~~~-----~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~~ 528 (605)
... +.++|+|+.|.|||+++++.+-|+||+.+...
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 206 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence 221 11799999999999998766789999987543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.80 E-value=2.7e-05 Score=78.43 Aligned_cols=78 Identities=18% Similarity=0.064 Sum_probs=49.7
Q ss_pred eeeecccCcEEEEEEEEC--CcceEEEEeeccc-----cchhhhhhHHHHHHHHHhCC-C--CCeeeEEEEEeeCCeeEE
Q 038211 383 GEEIGLGSYAVVYRGIWN--GSDVAVKVYFGSE-----YIEGTLKNYQKEIDIIKKLR-H--PNVLLFMGAVASQERLGI 452 (605)
Q Consensus 383 ~~~LG~G~fg~V~~~~~~--~~~~avKv~~~~~-----~~~~~~~~~~~E~~il~~l~-h--~niv~~~~~~~~~~~~~l 452 (605)
.+.||.|....||++... ++.++||.-.... ..+....+...|..+|+.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 567899999999998753 5568888543211 11123445667888888772 2 335555543 4556789
Q ss_pred EEEecCCCch
Q 038211 453 VTEFLPRGSL 462 (605)
Q Consensus 453 v~e~~~ggsL 462 (605)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d2oola2 d.110.3.9 (A:26-139) Sensor protein PhyB2 {Rhodopseudomonas palustris [TaxId: 1076]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Sensor protein PhyB2 species: Rhodopseudomonas palustris [TaxId: 1076]
Probab=97.43 E-value=8.5e-05 Score=60.39 Aligned_cols=43 Identities=12% Similarity=0.162 Sum_probs=37.3
Q ss_pred CeEEEEEcC-CCCEEEecHHHHHHhCCChhhhcCCCccccccccC
Q 038211 68 HAVHVCTAS-SEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEE 111 (605)
Q Consensus 68 d~ii~v~D~-~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~ 111 (605)
.|+++++|. +|+|+|+.+..+.++|+++++++|+++.+++ ++.
T Consensus 17 hG~Llvld~~d~~I~~vS~N~~~lLG~~~~~llG~~l~dll-~~~ 60 (114)
T d2oola2 17 HGYLFVVSETDLRIASVSANVEDLLRQPPASLLNVPIAHYL-TAA 60 (114)
T ss_dssp TSEEEEECTTTCBEEEEETTHHHHHSSCGGGGTTCBGGGGB-CHH
T ss_pred CcEEEEEECCCCEEEEEcCCHHHHhCCChHHHcCCCHHHhC-CHH
Confidence 567788885 7999999999999999999999999999944 444
|
| >d1ny5a2 c.37.1.20 (A:138-384) Transcriptional activator sigm54 (NtrC1), C-terminal domain {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: P-loop containing nucleoside triphosphate hydrolases superfamily: P-loop containing nucleoside triphosphate hydrolases family: Extended AAA-ATPase domain domain: Transcriptional activator sigm54 (NtrC1), C-terminal domain species: Aquifex aeolicus [TaxId: 63363]
Probab=97.06 E-value=2.1e-05 Score=73.63 Aligned_cols=51 Identities=6% Similarity=-0.018 Sum_probs=43.7
Q ss_pred CCcccccc-ccchhhhhcchhhhhhhceeccCCCcc----ccCCCCCcccCCCCccccc
Q 038211 200 PHQPQIAQ-VPNIASSVTNLTAKVLEKMHIGETGTY----VGGDDGSLRQNGLRYKSFC 253 (605)
Q Consensus 200 ~~~~~~~~-i~~~a~~va~~~~~~~~vli~GEsGtg----~~~~h~~s~~~~~~f~~~~ 253 (605)
+++|..++ +.+.+.++|. .++||||+||.||| |+.||..|+++..||-.+.
T Consensus 3 v~~S~~~~~~~~~~~~~a~---~~~pvlI~Ge~GtGK~~~A~~ih~~s~~~~~~~~~~~ 58 (247)
T d1ny5a2 3 VFESPKMKEILEKIKKISC---AECPVLITGESGVGKEVVARLIHKLSDRSKEPFVALN 58 (247)
T ss_dssp CCCSHHHHHHHHHHHHHTT---CCSCEEEECSTTSSHHHHHHHHHHHSTTTTSCEEEEE
T ss_pred EecCHHHHHHHHHHHHHhC---CCCCEEEECCCCcCHHHHHHHHHHhcCCcccccccch
Confidence 44555566 9999999999 99999999999999 9999999999999985533
|
| >d1ptqa_ g.49.1.1 (A:) Protein kinase C-delta (PKCdelta) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Protein kinase C-delta (PKCdelta) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.58 E-value=0.00025 Score=47.90 Aligned_cols=35 Identities=11% Similarity=0.303 Sum_probs=31.3
Q ss_pred hhhhhhcccCCCcccccc----cceeccccccCCCCCCc
Q 038211 292 ANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTG 326 (605)
Q Consensus 292 ~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~ 326 (605)
.+|.+|.+.|||++.|++ |++.+|++|.+.++..|
T Consensus 12 ~~C~~C~~~i~g~~~qg~~C~~C~~~~H~~C~~~v~~~C 50 (50)
T d1ptqa_ 12 TFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLC 50 (50)
T ss_dssp CBCTTTCCBCCSSSSCEEEETTTCCEECHHHHTTSCSCC
T ss_pred cCCcccCCcccCcccCcEECCCCCCeeChhHcccccCCC
Confidence 589999999999999999 99999999998776543
|
| >d1tbna_ g.49.1.1 (A:) Protein kinase c-gamma {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Protein kinase c-gamma species: Rat (Rattus rattus) [TaxId: 10117]
Probab=96.42 E-value=0.00071 Score=48.56 Aligned_cols=37 Identities=16% Similarity=0.247 Sum_probs=33.9
Q ss_pred hhhhhhcccCCCcccccc----cceeccccccCCCCCCccC
Q 038211 292 ANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTGHR 328 (605)
Q Consensus 292 ~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~~~ 328 (605)
.+|.+|++.|||++.|++ |++.+|++|...++..|+.
T Consensus 20 ~~C~~C~~~i~g~~~~g~~C~~C~~~~H~~C~~~v~~~C~~ 60 (66)
T d1tbna_ 20 TFCDHCGSLLYGLVHQGMKCSCCEMNVHRRCVRSVPSLCGV 60 (66)
T ss_dssp CBCSSSCCBCCTTSSSCEEETTTCCEECTTTTTTSCCCSSC
T ss_pred cCCcCCCCcccCcccCccccCcccCeEChHHhccccccCCC
Confidence 579999999999999988 9999999999999888853
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.38 E-value=0.0052 Score=61.14 Aligned_cols=75 Identities=23% Similarity=0.329 Sum_probs=49.6
Q ss_pred CceEeeeecccCcEEEEEEEECC---------cceEEEEeeccccchhhhhhHHHHHHHHHhCC-CCCeeeEEEEEeeCC
Q 038211 379 DLQLGEEIGLGSYAVVYRGIWNG---------SDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLR-HPNVLLFMGAVASQE 448 (605)
Q Consensus 379 ~~~~~~~LG~G~fg~V~~~~~~~---------~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~ 448 (605)
++++ +.|+.|-.-.+|++.... ..+.+++.-... ......+|..+++.+. +.-..+++++|..
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~idr~~E~~i~~~ls~~gl~Pkll~~~~~-- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TESHLVAESVIFTLLSERHLGPKLYGIFSG-- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--
Confidence 3443 678888889999987532 347777764221 1234567999999884 4444577877642
Q ss_pred eeEEEEEecCCCch
Q 038211 449 RLGIVTEFLPRGSL 462 (605)
Q Consensus 449 ~~~lv~e~~~ggsL 462 (605)
++|+||++|..|
T Consensus 117 --g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 --GRLEEYIPSRPL 128 (395)
T ss_dssp --EEEECCCCEEEC
T ss_pred --ceEEEEeccccC
Confidence 689999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.26 E-value=0.0061 Score=58.82 Aligned_cols=66 Identities=17% Similarity=0.036 Sum_probs=42.2
Q ss_pred EEEEEEEE-CCcceEEEEeeccccchhhhhhHHHHHHHHHhCCCCCe--eeEE-----EEEeeCCeeEEEEEecCCC
Q 038211 392 AVVYRGIW-NGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRHPNV--LLFM-----GAVASQERLGIVTEFLPRG 460 (605)
Q Consensus 392 g~V~~~~~-~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h~ni--v~~~-----~~~~~~~~~~lv~e~~~gg 460 (605)
-.||++.. +|..|++|+...... ....+..|..++..|....+ +..+ ..+...+..+.++++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 58999875 677899999755432 23456778888887742221 1111 1223456788999999764
|
| >d1xa6a3 g.49.1.1 (A:209-270) Beta-chimaerin, middle domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Beta-chimaerin, middle domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.22 E-value=0.001 Score=46.99 Aligned_cols=37 Identities=11% Similarity=0.247 Sum_probs=33.8
Q ss_pred hhhhhhcccCCCcccccc----cceeccccccCCCCCCccC
Q 038211 292 ANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTGHR 328 (605)
Q Consensus 292 ~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~~~ 328 (605)
.+|.+|.+.|||++.|++ |++.+|++|....+..|..
T Consensus 16 t~C~~C~~~i~g~~~~g~~C~~C~~~~H~~C~~~v~~~C~~ 56 (62)
T d1xa6a3 16 HWCEYCANFMWGLIAQGVRCSDCGLNVHKQCSKHVPNDCQP 56 (62)
T ss_dssp CBCTTTCCBCCTTTTCEECCSSSCCCBCTGGGTTSCSCCCT
T ss_pred CCCcccCccccccccCeEEcCCCCchhhHHHHhhCCCcCCC
Confidence 479999999999999988 9999999999998888863
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.04 E-value=0.0093 Score=57.05 Aligned_cols=144 Identities=14% Similarity=0.027 Sum_probs=75.1
Q ss_pred ceEeeeecccCcEEEEEEEECCcceEEEEeeccccchhhhhhHHHHHHHHHhCCC-----CCeeeEE-E--EEeeCCeeE
Q 038211 380 LQLGEEIGLGSYAVVYRGIWNGSDVAVKVYFGSEYIEGTLKNYQKEIDIIKKLRH-----PNVLLFM-G--AVASQERLG 451 (605)
Q Consensus 380 ~~~~~~LG~G~fg~V~~~~~~~~~~avKv~~~~~~~~~~~~~~~~E~~il~~l~h-----~niv~~~-~--~~~~~~~~~ 451 (605)
..-.+.|..|---+.|+...++..|++|++.... ....+..|+.++..+.. |..+... + +........
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~ 95 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 95 (316)
T ss_dssp EEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred ceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC----CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccc
Confidence 3334556677778889988877789999975432 22334556677777632 2211110 0 112234566
Q ss_pred EEEEecCCCchH--------------HHHHhhc--------------------------CCCCHHHHHHHHHHHHHHHHH
Q 038211 452 IVTEFLPRGSLF--------------KTLHKNY--------------------------QALDIKRRLRMALDVARGMNY 491 (605)
Q Consensus 452 lv~e~~~ggsL~--------------~~l~~~~--------------------------~~~~~~~~~~~~~qi~~aL~~ 491 (605)
.++.++.|.... ..++... ...........+..+...+.-
T Consensus 96 ~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 175 (316)
T d2ppqa1 96 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 175 (316)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred eeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhc
Confidence 677776654221 0000000 000011111222333333333
Q ss_pred HHhCC--CCceeccCCCCCEEEcCCCcEEEEeecCCcc
Q 038211 492 LHHRN--PPIVHRDLKSSNLLVDKNWTVKVGDFGLSSL 527 (605)
Q Consensus 492 LH~~~--~~iiH~Dik~~Nill~~~~~vkl~Dfg~a~~ 527 (605)
.+..+ .++||+|+.++||+++.+...-++||+.+..
T Consensus 176 ~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 176 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 33221 1299999999999999887778999999854
|
| >d2o9ca2 d.110.3.9 (A:4-130) Bacteriophytochrome BphP {Deinococcus radiodurans [TaxId: 1299]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Deinococcus radiodurans [TaxId: 1299]
Probab=95.67 E-value=0.0088 Score=48.83 Aligned_cols=76 Identities=16% Similarity=0.205 Sum_probs=50.7
Q ss_pred CeEEEEEcC-CCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCc--eEEEEEEEcCCCCEEE
Q 038211 68 HAVHVCTAS-SEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQS--WSGQFPFKKRSGEILM 144 (605)
Q Consensus 68 d~ii~v~D~-~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~--~~~~~~~~~k~G~~~~ 144 (605)
.|+++++|. +++|++++.....++|++.++++|+++.+++ +. ....+...+..... ..........++..++
T Consensus 35 hG~LLald~~~~~I~~~S~N~~~~lG~~~~~llG~~l~~ll-~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~ 109 (127)
T d2o9ca2 35 HGALLTADGHSGEVLQMSLNAATFLGQEPTVLRGQTLAALL-PE----QWPALQAALPPGCPDALQYRATLDWPAAGHLS 109 (127)
T ss_dssp TSEEEEEETTTCBEEEEETTHHHHHSSCHHHHTTCBHHHHC-TT----THHHHHHHSCTTCCTTCCEEEEECCSSSSEEE
T ss_pred CeEEEEEECCCCEEEEECCCHHHHhCCChHHHcCCCHHHHC-CH----HHHHHHHHhhhcCcccccceeeeecCCCceEE
Confidence 567788885 7999999999999999999999999999954 32 22333344333322 1222233345667776
Q ss_pred EEEE
Q 038211 145 AVVT 148 (605)
Q Consensus 145 v~~~ 148 (605)
+.+.
T Consensus 110 ~~~H 113 (127)
T d2o9ca2 110 LTVH 113 (127)
T ss_dssp EEEE
T ss_pred EEEE
Confidence 6544
|
| >d2veaa3 d.110.3.9 (A:4-130) Phytochrome-like protein Cph1 {Synechocystis sp. pcc 6803 [TaxId: 1148]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Phytochrome-like protein Cph1 species: Synechocystis sp. pcc 6803 [TaxId: 1148]
Probab=95.30 E-value=0.0063 Score=49.70 Aligned_cols=40 Identities=15% Similarity=0.297 Sum_probs=35.8
Q ss_pred CeEEEEEc-CCCCEEEecHHHHHHhCCChhhhcCCCccccc
Q 038211 68 HAVHVCTA-SSEDIIYWNRSAESLYGWKDREVFGQRVTEFL 107 (605)
Q Consensus 68 d~ii~v~D-~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~ 107 (605)
.|+.+++| .+++|+.+...++.++|+++++++|+++.+++
T Consensus 26 hG~LLald~~~~~I~~aS~N~~~~lG~~~~~lLG~~l~~ll 66 (127)
T d2veaa3 26 HGLVVVLQEPDLTISQISANCTGILGRSPEDLLGRTLGEVF 66 (127)
T ss_dssp TSEEEEEETTTTEEEEEETTHHHHTSCCTTTSSTTTTTTTS
T ss_pred CeEEEEEECCCCEEEEEcCCHHHHhCcChHHHcCCCHHHHC
Confidence 56778887 58999999999999999999999999999954
|
| >d1p0za_ d.110.6.1 (A:) Sensor kinase CitA {Klebsiella pneumoniae [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: Sensory domain-like family: Sensory domain of two-component sensor kinase domain: Sensor kinase CitA species: Klebsiella pneumoniae [TaxId: 573]
Probab=95.29 E-value=0.12 Score=42.02 Aligned_cols=88 Identities=16% Similarity=0.187 Sum_probs=56.5
Q ss_pred HHHHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEcC
Q 038211 59 YRSVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKR 138 (605)
Q Consensus 59 ~~~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~k 138 (605)
++.+.+...-..|+++|.+|+++.-. ..+.+|+++.. ... .+.+..|+++.... ..
T Consensus 41 ~~~l~~~~~~~~i~v~D~~G~v~a~~----------~~~~iG~~~~~-----~~~------~~a~~~g~~~~~~~--~g- 96 (131)
T d1p0za_ 41 IDPMRSFSDATYITVGDASGQRLYHV----------NPDEIGKSMEG-----GDS------DEALINAKSYVSVR--KG- 96 (131)
T ss_dssp HHHHHHHSCCSEEEEEETTSBEEECS----------SGGGTTSBCCS-----SCC------HHHHHHCCCEEEEE--EE-
T ss_pred HHHHHHHcCCcEEEEECCCCCEEEcc----------ChhhcCCcccc-----cch------HHHHHcCCcEEEEE--ec-
Confidence 34445555555669999999988643 23456776553 111 34566777654422 12
Q ss_pred CCCEEEEEEEEEEEee-CCeEEEEEEEEecccccc
Q 038211 139 SGEILMAVVTKSPLYE-DGELAGFITVSSDAAIFN 172 (605)
Q Consensus 139 ~G~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~ 172 (605)
.+.. ......||++ +|+++|+|.+--++.+++
T Consensus 97 ~~g~--~~~~~~PI~~~~G~viGvV~Vg~~l~~ie 129 (131)
T d1p0za_ 97 SLGS--SLRGKSPIQDATGKVIGIVSVGYTIEQLE 129 (131)
T ss_dssp TTEE--EEEEEEEEECTTCCEEEEEEEEEEGGGCC
T ss_pred CCcc--EEEEEEEEECCCCcEEEEEEEEEEhHHhh
Confidence 3332 2367889997 899999999999988765
|
| >d3c2wa3 d.110.3.9 (A:5-117) Bacteriophytochrome BphP {Pseudomonas aeruginosa [TaxId: 287]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Pseudomonas aeruginosa [TaxId: 287]
Probab=92.08 E-value=0.2 Score=39.43 Aligned_cols=75 Identities=12% Similarity=0.151 Sum_probs=48.2
Q ss_pred CeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEcCCCCEEEEEE
Q 038211 68 HAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRSGEILMAVV 147 (605)
Q Consensus 68 d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~k~G~~~~v~~ 147 (605)
.|+.+++|.+++|+.+...++.++|++. +.+|+.+.+++ .+ .....+.+.+.......... ..+.+|+.+++.+
T Consensus 22 hG~LLald~~~~I~~~S~N~~~~lg~~~-~~L~~~~~~~~-~~---~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~d~~~ 95 (113)
T d3c2wa3 22 HGALVTLRADGMVLAASENIQALLGFVA-SPGSYLTQEQV-GP---EVLRMLEEGLTGNGPWSNSV-ETRIGEHLFDVIG 95 (113)
T ss_dssp TEEEEEECTTSBEEEEETTHHHHTSSCC-CTTCBCCHHHH-HH---HHHHHHHHHHSCSSCCCCEE-EECCSSSCEEEEE
T ss_pred CeEEEEEcCCCeEEEEcCCHHHHhCCCh-hHhcccHHHHh-CH---HHHHHHHhhhhcCCCceeEE-EeccCCeEEEEEE
Confidence 5777899999999999999999999986 56788887743 21 12233333333333332222 2345677776644
Q ss_pred E
Q 038211 148 T 148 (605)
Q Consensus 148 ~ 148 (605)
.
T Consensus 96 H 96 (113)
T d3c2wa3 96 H 96 (113)
T ss_dssp E
T ss_pred E
Confidence 4
|
| >d1r79a_ g.49.1.1 (A:) Diacylglycerol kinase delta {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Diacylglycerol kinase delta species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.76 E-value=0.012 Score=44.02 Aligned_cols=37 Identities=11% Similarity=0.325 Sum_probs=32.6
Q ss_pred hhhhhhhcccCCCc-ccccc----cceeccccccCCCCCCcc
Q 038211 291 NANANICQHRLPNA-SEEIF----CDLAFSRECNDRGTSTGH 327 (605)
Q Consensus 291 ~~~c~~c~~~l~~~-~~~~~----~~~~~~~~c~~~~~~~~~ 327 (605)
.++|.+|.+.||+. +.|++ |++.+|++|....+..|.
T Consensus 38 ~~~C~~C~~~i~~~~~~qg~~C~~C~~~~H~~C~~~v~~~C~ 79 (84)
T d1r79a_ 38 SAKCTVCDKTCGSVLRLQDWRCLWCKAMVHTSCKESLLTKCS 79 (84)
T ss_dssp TCBCSSSCCBCCCTTTCCCEEESSSCCEECHHHHHHCCSCBC
T ss_pred CCCCcccCcccCCccccCcEecCcCCchhhhhhcCCCCCcCc
Confidence 67999999999997 57877 999999999998887775
|
| >d1faqa_ g.49.1.1 (A:) RAF-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: RAF-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.99 E-value=0.033 Score=37.24 Aligned_cols=31 Identities=29% Similarity=0.563 Sum_probs=26.8
Q ss_pred hhhhhhcccCCCcccccc----cceeccccccCCCCCCc
Q 038211 292 ANANICQHRLPNASEEIF----CDLAFSRECNDRGTSTG 326 (605)
Q Consensus 292 ~~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~~~~ 326 (605)
++|.+|++.|| +++ |++.+|++|...++..|
T Consensus 15 ~~C~~C~~~i~----~g~~C~~C~~~~H~~C~~~v~~~C 49 (52)
T d1faqa_ 15 AFCDICQKFLL----NGFRCQTCGYKFHEHCSTKVPTMC 49 (52)
T ss_dssp EECTTSSSEEC----SEEECTTTTCCBCSTTSSSSSSCC
T ss_pred cCCccCCCccc----cCCCcCCCCChhhhhhhccccccc
Confidence 68999999998 445 99999999999888766
|
| >d1kbea_ g.49.1.1 (A:) Kinase suppressor of Ras, Ksr {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Cysteine-rich domain superfamily: Cysteine-rich domain family: Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) domain: Kinase suppressor of Ras, Ksr species: Mouse (Mus musculus) [TaxId: 10090]
Probab=89.33 E-value=0.076 Score=34.81 Aligned_cols=27 Identities=22% Similarity=0.501 Sum_probs=23.3
Q ss_pred hhhhhcccCCCcccccc----cceeccccccCCCC
Q 038211 293 NANICQHRLPNASEEIF----CDLAFSRECNDRGT 323 (605)
Q Consensus 293 ~c~~c~~~l~~~~~~~~----~~~~~~~~c~~~~~ 323 (605)
.|.+|++.|| |++ |++.+|++|.+..+
T Consensus 16 tC~~C~~~l~----qg~~C~~C~~~~Hk~C~~~~P 46 (49)
T d1kbea_ 16 VCNVCQKSMI----FGVKCKHCRLKCHNKCTKEAP 46 (49)
T ss_dssp CCSSSCCSSC----CEEEETTTTEEESSSCTTTSC
T ss_pred Cchhhchhhh----CcCCcCCCCChHhHhhcccCC
Confidence 4999999998 566 99999999988665
|
| >d3by8a1 d.110.6.1 (A:46-178) Fumarate sensor DcuS {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: Sensory domain-like family: Sensory domain of two-component sensor kinase domain: Fumarate sensor DcuS species: Escherichia coli [TaxId: 562]
Probab=86.92 E-value=1.7 Score=34.79 Aligned_cols=87 Identities=13% Similarity=0.174 Sum_probs=52.0
Q ss_pred HHHHhcCCeEEEEEcCCCCEEEecHHHHHHhCCChhhhcCCCccccccccCCcchHHHHHHHHHcCCceEEEEEEEcCCC
Q 038211 61 SVLESMGHAVHVCTASSEDIIYWNRSAESLYGWKDREVFGQRVTEFLIAEEFHSPHKKIMERLASGQSWSGQFPFKKRSG 140 (605)
Q Consensus 61 ~il~~~~d~ii~v~D~~G~Ii~~N~a~~~l~G~~~~eliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~~~~~~~k~G 140 (605)
.+.+...-..|+++|.+|+++.-. ..+-+|+++.. +.. ..++ .|+.+.... ....|
T Consensus 43 ~~~~~~ga~~i~v~D~~G~~~a~~----------~~~~ig~~~~g----~~~-------~~Al-~G~~~~~~~--~gt~g 98 (133)
T d3by8a1 43 AVRKRNDLLFIVVTDMQSLRYSHP----------EAQRIGQPFKG----DDI-------LKAL-NGEENVAIN--RGFLA 98 (133)
T ss_dssp HHHHHTTCSEEEEEETTCBBSCCS----------SGGGTTSBCCC----GGG-------TGGG-GTCCEEEEE--CSSSS
T ss_pred HHHHHcCCcEEEEEcCCccEEEeC----------ChhhcCCcccC----Cch-------hHHh-CCCceEEEE--EecCc
Confidence 334444445569999999887543 23456665432 110 1123 466543321 12223
Q ss_pred CEEEEEEEEEEEee-CCeEEEEEEEEecccccccc
Q 038211 141 EILMAVVTKSPLYE-DGELAGFITVSSDAAIFNSI 174 (605)
Q Consensus 141 ~~~~v~~~~~Pi~d-~g~i~g~v~i~~D~t~~~~l 174 (605)
. ......|+++ +|+++|+|.+--++.++++.
T Consensus 99 ~---~~~~~~Pv~~~~G~viGvV~Vg~~~~~ie~~ 130 (133)
T d3by8a1 99 Q---ALRVFTPIYDENHKQIGVVAIGLELSRVTQQ 130 (133)
T ss_dssp C---EEEEEEEEECTTSCEEEEEEEEEEHHHHHHH
T ss_pred e---EEEEEEeeECCCCcEEEEEEEEEEHHHHHHH
Confidence 3 3456789997 89999999999998877653
|